PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baker, JG; Gardiner, SM; Woolard, J; Fromont, C; Jadhav, GP; Mistry, SN; Thompson, KSJ; Kellam, B; Hill, SJ; Fischer, PM				Baker, Jillian G.; Gardiner, Sheila M.; Woolard, Jeanette; Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Thompson, Kevin S. J.; Kellam, Barrie; Hill, Stephen J.; Fischer, Peter M.			Novel selective beta(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease	FASEB JOURNAL			English	Article						beta-blocker; selectivity; heart disease; asthma	BETA-BLOCKERS; BRONCHODILATOR REVERSIBILITY; FATAL BRONCHOSPASM; HEART-FAILURE; ASTHMA; BISOPROLOL; COPD; METAANALYSIS; BINDING; PHARMACOKINETICS	beta-Blockers reduce mortality and improve symptoms in people with heart disease; however, current clinically available beta-blockers have poor selectivity for the cardiac I31-adrenoceptor (AR) over the lung I32-AR. Unwanted beta 2 blockade risks causing life-threatening bronchospasm and reduced efficacy of beta 2-agonist emergency rescue therapy. Thus, current life-prolonging beta-blockers are contraindicated in patients with both heart disease and asthma. Here, we describe NDD-713 and-825, novel highly beta(1)-selective neutral antagonists with good pharmaceutical properties that can potentially overcome this limitation. Radioligand binding studies and functional assays that use human receptors expressed in Chinese hamster ovary cells demonstrate that NDD-713 and-825 have nanomolar beta(1)-AR affinity >500-fold beta(1)-AR vs. beta(2)-AR selectivity and no agonism. Studies in conscious rats demonstrate that these antagonists are orally bioavailable and cause pronounced beta(1)-mediated reduction of heart rate while showing no effect on I32-mediated hindquarters vasodilatation. These compounds also have good disposition properties and show no adverse toxicologic effects. They potentially offer a truly cardioselective beta-blocker therapy for the large number of patients with heart and respiratory or peripheral vascular comorbidities. Baker, J. G., Gardiner, S. M., Woolard, J., Fromont, C., Jadhav, G. P., Mistry, S. N., Thompson, K. S. J., Kellam, B., Hill, S. J., Fischer, P. M. Novel selective I31-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.	[Baker, Jillian G.; Gardiner, Sheila M.; Woolard, Jeanette; Thompson, Kevin S. J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Cell Signalling Res Grp, Nottingham, England; [Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Kellam, Barrie; Fischer, Peter M.] Univ Nottingham, Sch Pharm, Nottingham, England; [Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Kellam, Barrie; Fischer, Peter M.] Univ Nottingham, Ctr Biomol Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Baker, JG (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England.; Fischer, PM (corresponding author), Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England.	jillian.baker@nottingham.ac.uk; peter.fischer@nottingham.ac.uk	Mistry, Shailesh/O-2697-2014; Jadhav, Gopal P/R-7901-2018; Kellam, Barrie/AAE-2960-2019; Hill, Stephen/N-6753-2013; Hill, Stephen J/M-6243-2018	Mistry, Shailesh/0000-0002-2252-1689; Jadhav, Gopal P/0000-0002-2883-5574; Hill, Stephen/0000-0002-4424-239X; Hill, Stephen J/0000-0002-4424-239X; baker, jillian/0000-0003-2371-8202; Woolard, Jeanette/0000-0001-5406-6847; Kellam, Barrie/0000-0003-0030-9908	Wellcome Trust [086039/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Seeding Drug Discovery award (Grant 086039/Z/08/Z). The authors thank Richard Proudman, Marleen Groenen, June McCulloch, Philip Kemp, Julie March, and Thomas Clayton (all from the University of Nottingham) for technical assistance, Etienne Daras (University of Nottingham) for chemistry assistance, and Fiona Marshall (Heptares Therapeutics, London, United Kingdom), John Camm (St. George's London, London, United Kingdom), Robert Wilcox (University of Nottingham), John Harris (CJH Consultants, Brockenhurst, United Kingdom), John Dixon (Wellcome Trust, London, United Kingdom), and Nicola Shepherd (Wellcome Trust) for advice.	[Anonymous], 1990, Lancet, V336, P1; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baker JG, 2008, BRIT J PHARMACOL, V153, P1011, DOI 10.1038/sj.bjp.0707644; Baker J.G., 2012, WO patent, Patent No. [WO 2012104659, 2012104659]; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2017, THORAX, V72, P271, DOI 10.1136/thoraxjnl-2016-208412; Baker JG, 2015, MOL PHARMACOL, V87, P103, DOI 10.1124/mol.114.095364; Baker JG, 2011, FASEB J, V25, P4486, DOI 10.1096/fj.11-192435; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bell DSH, 2004, AM J CARDIOL, V93, p49B, DOI 10.1016/j.amjcard.2004.01.026; Berthold R., 1982, Eur. Pat. Appl. Publ. EP52072, Patent No. 52072; Bevan CD, 2000, ANAL CHEM, V72, P1781, DOI 10.1021/ac9912247; BLACK JW, 1973, BRIT MED BULL, V29, P163, DOI 10.1093/oxfordjournals.bmb.a070988; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; British Thoracic Society, BRIT GUID MAN ASTHM; BUHRING KU, 1986, J CARDIOVASC PHARM, V8, pS21; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Cruickshank JM, 2007, INT J CARDIOL, V120, P10, DOI 10.1016/j.ijcard.2007.01.069; DECALMER PBS, 1978, BRIT HEART J, V40, P184; DOOLEY DJ, 1986, EUR J PHARMACOL, V130, P137, DOI 10.1016/0014-2999(86)90193-7; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Finlayson K, 2001, EUR J PHARMACOL, V412, P203, DOI 10.1016/S0014-2999(01)00731-2; Foresi A, 2010, RESPIRATION, V80, P177, DOI 10.1159/000318583; FRALEY DS, 1980, SOUTHERN MED J, V73, P238, DOI 10.1097/00007611-198002000-00030; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hanania NA, 2011, CHEST, V140, P1055, DOI 10.1378/chest.10-2974; Hawkins NM, 2011, J AM COLL CARDIOL, V57, P2127, DOI 10.1016/j.jacc.2011.02.020; HJALMARSON A, 1981, LANCET, V2, P823; Hjalmarson A, 1999, LANCET, V353, P2001; Jovanovic D, 2006, J CLIN PHARMACOL, V46, P1217, DOI 10.1177/0091270006291626; LAURSEN SO, 1982, ACTA MED SCAND, V211, P505; Lechat P, 1999, LANCET, V353, P9; LEOPOLD G, 1986, J CLIN PHARMACOL, V26, P616, DOI 10.1002/j.1552-4604.1986.tb02959.x; LEOPOLD G, 1986, BRIT J CLIN PHARMACO, V22, P293, DOI 10.1111/j.1365-2125.1986.tb02890.x; LEWIS RV, 1993, DRUG SAFETY, V9, P272, DOI 10.2165/00002018-199309040-00005; Lombardo F, 2001, J MED CHEM, V44, P2490, DOI 10.1021/jm0100990; Loth DW, 2014, BRIT J CLIN PHARMACO, V77, P190, DOI 10.1111/bcp.12181; Malerba M, 2015, DRUG DISCOV TODAY, V20, P129, DOI 10.1016/j.drudis.2014.09.005; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Miki A, 2003, INT J CLIN PHARM TH, V41, P358; Mistry SN, 2013, J MED CHEM, V56, P3852, DOI 10.1021/jm400348g; Morales DR, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0781-0; Morales DR, 2016, BRIT J CLIN PHARMACO, V82, P814, DOI 10.1111/bcp.13006; Morales DR, 2014, CHEST, V145, P779, DOI 10.1378/chest.13-1235; ODEH M, 1991, J FAM PRACTICE, V32, P97; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; RAINE JM, 1981, BRIT MED J, V282, P548, DOI 10.1136/bmj.282.6263.548; SANO M, 1993, LIFE SCI, V52, P1063, DOI 10.1016/0024-3205(93)90199-D; SCHLIEP HJ, 1984, J CARDIOVASC PHARM, V6, P1156; Schnabel P, 2000, J CARDIOVASC PHARM, V36, P466, DOI 10.1097/00005344-200010000-00008; SCHUTZ W, 1983, EUR HEART J, V4, P367; SCHWARTZ S, 1980, CHEST, V78, P100, DOI 10.1378/chest.78.1.100; Scottish Intercollegiate Guidelines Network, GUID 147 MAN CHRON H; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; THEODORSSONNORHEIM E, 1987, COMPUT BIOL MED, V17, P85, DOI 10.1016/0010-4825(87)90003-5; UK Department of Health, OUTC STRAT CHRON OBS; Valko K, 2003, J PHARM SCI-US, V92, P2236, DOI 10.1002/jps.10494; WILCOX RG, 1980, LANCET, V2, P765; WILLIAMS IP, 1980, THORAX, V35, P160, DOI 10.1136/thx.35.2.160; Yamada Y, 1995, J PHARMACOKINET BIOP, V23, P463, DOI 10.1007/BF02353469	63	7	7	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3150	3166		10.1096/fj.201601305R	http://dx.doi.org/10.1096/fj.201601305R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28400472	hybrid, Green Published			2022-12-26	WOS:000405931000038
J	Poppelaars, F; van Werkhoven, MB; Kotimaa, J; Veldhuis, ZJ; Ausema, A; Broeren, SGM; Damman, J; Hempel, JC; Leuvenink, HGD; Daha, MR; van Son, WJ; van Kooten, C; van Os, RP; Hillebrands, JL; Seelen, MA				Poppelaars, Felix; van Werkhoven, Maaike B.; Kotimaa, Juha; Veldhuis, Zwanida J.; Ausema, Albertina; Broeren, Stefan G. M.; Damman, Jeffrey; Hempel, Julia C.; Leuvenink, Henri G. D.; Daha, Mohamed R.; van Son, Willem J.; van Kooten, Cees; van Os, Ronald P.; Hillebrands, Jan-Luuk; Seelen, Marc A.			Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury	FASEB JOURNAL			English	Article						innate immunity; PMNs; kidney	ACUTE KIDNEY INJURY; DONOR BRAIN-DEATH; ISCHEMIA/REPERFUSION INJURY; CHEMOATTRACTANT RECEPTOR; 2 PARTS; C5L2; ACTIVATION; CELLS; ANAPHYLATOXIN; PATHWAY	The complement system, and specifically C5a, is involved in renal ischemia-reperfusion (IR) injury. The 2 receptors for complement anaphylatoxin C5a (C5aR1 and C5aR2) are expressed on leukocytes as well as on renal epithelium. Extensive evidence shows that C5aR1 inhibition protects kidneys from IR injury; however, the role of C5aR2 in IR injury is less clear as initial studies proposed the hypothesis that C5aR2 functions as a decoy receptor. By Using wild-type, C5aR1(-/-), and C5aR2(-/-) mice in a model of renal IR injury, we found that a deficiency of either of these receptors protected mice from renal IR injury. Surprisingly, C5aR2(-/-) mice were most protected and had lower creatinine levels and reduced acute tubular necrosis. Next, an in vivo migration study demonstrated that leukocyte chemotaxis was unaffected in C5aR2(-/-) mice, whereas neutrophil activation was reduced by C5aR2 deficiency. To further investigate the contribution of renal cell-expressed C5aR2 vs. leukocyte-expressed C5aR2 to renal IR injury, bone marrow chimeras were created. Our data show that both renal cell-expressed C5aR2 and leukocyte-expressed C5aR2 mediate IR-induced renal dysfunction. These studies reveal the importance of C5aR2 in renal IR injury. They further show that C5aR2 is a functional receptor, rather than a decoy receptor, and may provide a new target for intervention.-Poppelaars, F., van Werkhoven, M. B., Kotimaa, J., Veldhuis, Z. J., Ausema, A., Broeren, S. G. M., Damman, J., Hempel, J. C., Leuvenink, H. G. D., Daha, M. R., van Son, W. J., van Kooten, C., van Os, R. P., Hillebrands, J.-L., Seelen, M. A. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury. FASEB J. 31, 3193-3204 (2017). www.fasebj.org	[Poppelaars, Felix; van Werkhoven, Maaike B.; Broeren, Stefan G. M.; Hempel, Julia C.; Daha, Mohamed R.; van Son, Willem J.; Seelen, Marc A.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Veldhuis, Zwanida J.; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Ausema, Albertina; van Os, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Lab Ageing Biol & Stem Cells, Groningen, Netherlands; [Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Kotimaa, Juha; Daha, Mohamed R.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Damman, Jeffrey] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Seelen, MA (corresponding author), Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, AA53,Postbus 196, NL-9700 AD Groningen, Netherlands.	m.seelen@umcg.nl	van Kooten, Cees/E-5694-2018; Kotimaa, Juha/N-2443-2015; Poppelaars, Felix/Y-2120-2019	van Kooten, Cees/0000-0002-6257-0899; Poppelaars, Felix/0000-0002-5173-8078; Hillebrands, Jan-Luuk/0000-0003-3135-3274; Leuvenink, Henri/0000-0001-5036-2999	Dutch Kidney Foundation [IP1167]; Graduate School of Medical Sciences of the University of Groningen; Jan Kornelis de Cock Foundation of the University Medical Centre Groningen	Dutch Kidney Foundation; Graduate School of Medical Sciences of the University of Groningen; Jan Kornelis de Cock Foundation of the University Medical Centre Groningen	This work was supported by the Dutch Kidney Foundation (Project IP1167), Graduate School of Medical Sciences of the University of Groningen, and the Jan Kornelis de Cock Foundation of the University Medical Centre Groningen. The authors thank Andre Zandvoort, Anita Meter-Arkema, Annemieke Smit-van Oosten, Bianca Meijeringh, Mariana Gaya da Costa, Petra Ottens, Pieter Klok, Tina Jager (all from the University of Groningen), and Michel Weij (Beatrix Children's Hospital, Groningen, The Netherlands) for excellent technical assistance. The authors declare no conflicts of interest.	Arumugam TV, 2003, KIDNEY INT, V63, P134, DOI 10.1046/j.1523-1755.2003.00737.x; Asgari E, 2014, CURR OPIN ORGAN TRAN, V19, P342, DOI 10.1097/MOT.0000000000000094; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Damman J, 2008, TRANSPLANTATION, V85, P923, DOI 10.1097/TP.0b013e3181683cf5; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Damman J, 2011, AM J TRANSPLANT, V11, P660, DOI 10.1111/j.1600-6143.2011.03475.x; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; de Vries B, 2003, J IMMUNOL, V170, P3883, DOI 10.4049/jimmunol.170.7.3883; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Farrar CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00341; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066305; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kotimaa JP, 2015, J IMMUNOL METHODS, V419, P25, DOI 10.1016/j.jim.2015.02.010; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lewis AG, 2008, CLIN EXP IMMUNOL, V153, P117, DOI 10.1111/j.1365-2249.2008.03678.x; Li QJ, 2010, J AM SOC NEPHROL, V21, P1344, DOI 10.1681/ASN.2009090977; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; MARDER SR, 1985, J IMMUNOL, V134, P3325; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nataf S, 1999, J IMMUNOL, V162, P4018; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rusai K, 2008, TRANSPL INT, V21, P572, DOI 10.1111/j.1432-2277.2008.00651.x; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Singbartl K, 2001, FASEB J, V15, P2337, DOI 10.1096/fj.01-0199com; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; Thurman JM, 2005, KIDNEY INT, V67, P524, DOI 10.1111/j.1523-1755.2005.67109.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Werkhoven MB, 2013, AM J TRANSPLANT, V13, P875, DOI 10.1111/ajt.12130; van Werkhoven MB, 2013, MOL IMMUNOL, V53, P237, DOI 10.1016/j.molimm.2012.08.013; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wysoczynski M, 2007, LEUKEMIA, V21, P973, DOI 10.1038/sj.leu.2404629; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yago T, 2015, J EXP MED, V212, P1267, DOI 10.1084/jem.20142358; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; Zheng XF, 2008, AM J PATHOL, V173, P973, DOI 10.2353/ajpath.2008.080103; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621; Zwirner J, 1999, MOL IMMUNOL, V36, P877, DOI 10.1016/S0161-5890(99)00109-1	58	26	27	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3193	3204		10.1096/fj.201601218R	http://dx.doi.org/10.1096/fj.201601218R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28396344				2022-12-26	WOS:000405931000041
J	Song, QT; Wu, ZG; Fan, YY; Song, WR; Zhang, PR; Wang, L; Wang, FX; Xu, YY; Wang, PG; Cheng, JS				Song, Qitao; Wu, Zhigang; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong			Production of homogeneous glycoprotein with multisite modifications by an engineered N-glycosyltransferase mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosyltransferase; N-linked glycosylation; post-translational modification (PTM); protein engineering	O-GLCNAC TRANSFERASE; PROTEIN DATA-BANK; ACTINOBACILLUS-PLEUROPNEUMONIAE; LINKED GLYCOSYLATION; STRUCTURAL INSIGHTS; CHEMICAL-SYNTHESIS; ESCHERICHIA-COLI; CARBOHYDRATE; SPECIFICITY; MECHANISM	Naturally occurring N-glycoproteins exhibit glycoform heterogeneity with respect to N-glycan sequon occupancy (macroheterogeneity) and glycan structure (microheterogeneity). However, access to well-defined glycoproteins is always important for both basic research and therapeutic purposes. As a result, there has been a substantial effort to identify and understand the catalytic properties of N-glycosyltransferases, enzymes that install the first glycan on the protein chain. In this study we found that ApNGT, a newly discovered cytoplasmic N-glycosyltransferase from Actinobacillus pleuropneumoniae, has strict selectivity toward the residues around the Asn of N-glycosylation sequon by screening a small library of synthetic peptides. The inherent stringency was subsequently demonstrated to be closely associated with a critical residue (Gln-469) of ApNGT which we propose hinders the access of bulky residues surrounding the occupied Asn into the active site. Site-saturated mutagenesis revealed that the introduction of small hydrophobic residues at the site cannot only weaken the stringency of ApNGT but can also contribute to enormous improvement of glycosylation efficiency against both short peptides and proteins. We then employed the most efficient mutant (Q469A) other than the wild-type ApNGT to produce a homogeneous glycoprotein carrying multiple (up to 10) N-glycans, demonstrating that this construct is a promising biocatalyst for potentially addressing the issue of macroheterogeneity in glycoprotein preparation.	[Song, Qitao; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong] Nankai Univ, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China; [Song, Qitao; Fan, Yueyuan; Song, Woran; Zhang, Peiru; Wang, Li; Wang, Faxing; Xu, Yangyang; Wang, Peng G.; Cheng, Jiansong] Nankai Univ, Coll Pharm, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China; [Wu, Zhigang] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	Nankai University; Nankai University; University System of Georgia; Georgia State University	Wang, PG; Cheng, JS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.; Wang, PG; Cheng, JS (corresponding author), Nankai Univ, Coll Pharm, Haihe Educ Pk,38 Tongyan Rd, Tianjin 300353, Peoples R China.	pwang@nankai.edu.cn; jiansongcheng@nankai.edu.cn	WANG, Peng/GSN-5263-2022	Wu, Zhigang/0000-0001-5117-8480	Natural Science Foundation [21372130, 81302682]	Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation Grants 21372130 and 81302682.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; BEAVIS RC, 1990, ANAL CHEM, V62, P1836, DOI 10.1021/ac00216a020; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Doerr A, 2015, NAT METHODS, V12, P14, DOI 10.1038/nmeth.3246; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Grogan MJ, 2002, ANNU REV BIOCHEM, V71, P593, DOI 10.1146/annurev.biochem.71.110601.135334; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lomino JV, 2013, BIOORGAN MED CHEM, V21, P2262, DOI 10.1016/j.bmc.2013.02.007; Lutteke T, 2004, CARBOHYD RES, V339, P1015, DOI 10.1016/j.carres.2003.09.038; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mazola Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002285; McCann JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003977; Muthana MM, 2012, CHEM COMMUN, V48, P2728, DOI 10.1039/c2cc17577k; Naegeli A, 2014, J BIOL CHEM, V289, P24521, DOI 10.1074/jbc.M114.579326; Naegeli A, 2014, J BIOL CHEM, V289, P2170, DOI 10.1074/jbc.M113.524462; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Spahn PN, 2014, CURR OPIN BIOTECH, V30, P218, DOI 10.1016/j.copbio.2014.08.004; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Wu ZG, 2016, BIOCONJUGATE CHEM, V27, P1972, DOI 10.1021/acs.bioconjchem.6b00385; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280	40	25	25	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8856	8863		10.1074/jbc.M117.777383	http://dx.doi.org/10.1074/jbc.M117.777383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381551	hybrid, Green Published			2022-12-26	WOS:000402153900039
J	Tsai, HJ; Chang, FK				Tsai, Hsin-Jen; Chang, Fu-Kuei			Associations between body mass index, mid-arm circumference, calf circumference, and functional ability over time in an elderly Taiwanese population	PLOS ONE			English	Article							MINI NUTRITIONAL ASSESSMENT; PHYSICAL FUNCTION; ANTHROPOMETRIC MEASUREMENTS; MORTALITY RISK; HEALTH-STATUS; OBESITY; BMI; DISABILITY; DECLINE; FRAILTY	Background Anthropometric measurements such as body mass index (BMI), mid-arm circumference (MAC), and calf-circumference (CC) are assessed with ease during regular health visits, but the associations between these anthropometric parameters and functional ability in elderly population over time has not been studied in detail. This study aimed to examine the associations between functional ability and the anthropometric parameters BMI, MAC, and CC in Taiwanese adults >= 65 years old. Methods Data were obtained from the Taiwan Longitudinal Study of Aging and analyzed retrospectively. Results Functional decline over a 4- and 8-year period was noted in approximately 14% and 21% of study participants, respectively. BMI was negatively associated with participants' current Activities of Daily Living (ADL) scores, and was positively associated with 4-year ADL scores in adults >= 65 years old (beta = -1.19 and 1.14, P = 0.0010 and 0.0420, respectively). MAC and CC were negatively associated with current ADL scores (beta = -1.46, P < 0.0001 and beta = -4.68, P < 0.0001, respectively). The association between CC and current ADL score was stronger than the association between current ADL score and either BMI or MAC. For adults >= 65 years old, a high BMI increased the risk of ADL decline over 4 and 8 years by 4-fold and 3-fold (adjusted odds ratio = 4.23 and 2.64, 95% confidential interval = 1.95-9.19 and 1.22-5.71, P = 0.0003 and 0.0141, respectively). Conclusions BMI is a significant predictor of decline of functional ability in Taiwanese adults >= 65 years old. CC is an important anthropometric indicator of current functional ability among older adults.	[Tsai, Hsin-Jen; Chang, Fu-Kuei] I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan	I Shou University	Tsai, HJ (corresponding author), I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan.	hsinjen@gmail.com						Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Aoki Y, 2014, NCHS DATA BRIEF, V140, P1; Asakawa T, 2000, INT J AGING HUM DEV, V50, P319, DOI 10.2190/3TR1-4V6R-MA5M-U1BV; Bahat G, 2012, ARCH GERONTOL GERIAT, V54, P78, DOI 10.1016/j.archger.2011.04.019; Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Corona LP, 2014, PUBLIC HEALTH NUTR, V17, P390, DOI 10.1017/S1368980012005319; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Deschamps V, 2002, EUR J CLIN NUTR, V56, P305, DOI 10.1038/sj.ejcn.1601311; Enoki H, 2007, CLIN NUTR, V26, P597, DOI 10.1016/j.clnu.2007.06.008; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hermalin A. L., 1989, 891 U MICH; Izawa S, 2010, BRIT J NUTR, V103, P289, DOI 10.1017/S0007114509991723; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Landi F, 2014, CLIN NUTR, V33, P539, DOI 10.1016/j.clnu.2013.07.013; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; Lin SJ, 2012, J NURS RES, V20, P110, DOI 10.1097/jnr.0b013e318254eac9; National Development Council, 2018, AN POP PROJ TAIW AR; REUBEN DB, 1992, J GERONTOL, V47, pM106, DOI 10.1093/geronj/47.4.M106; Rolland Y, 2003, J AM GERIATR SOC, V51, P1120, DOI 10.1046/j.1532-5415.2003.51362.x; Scott WK, 1997, J CLIN EPIDEMIOL, V50, P291, DOI 10.1016/S0895-4356(96)00365-4; Tsai AC, 2008, J NUTR HEALTH AGING, V12, P696; Tsai AC, 2011, BRIT J NUTR, V105, P275, DOI 10.1017/S0007114510003429; Tsai ACH, 2007, ASIA PAC J CLIN NUTR, V16, P656; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Tsai ACH, 2011, ARCH GERONTOL GERIAT, V53, P298, DOI 10.1016/j.archger.2010.12.003; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wikstrom K, 2015, EUR J INTERN MED, V26, P211, DOI 10.1016/j.ejim.2015.02.012; Wong CH, 2010, AGING CLIN EXP RES, V22, P54, DOI [10.1007/BF03324816, 10.3275/6675]; Woo J, 2001, J AM GERIATR SOC, V49, P737, DOI 10.1046/j.1532-5415.2001.49150.x; World Health Organization, 1995, 854 WHO; World Health Organization, 2013, WHAT WHO IS DOING GU; Wu CY, 2013, ARCH GERONTOL GERIAT, V57, P177, DOI 10.1016/j.archger.2013.04.011; Zimmer Z, 1998, DEMOGRAPHY, V35, P361, DOI 10.2307/3004043; Zimmer Z, 2002, POP STUD-J DEMOG, V56, P265, DOI 10.1080/00324720215931	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175062	10.1371/journal.pone.0175062	http://dx.doi.org/10.1371/journal.pone.0175062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399183	gold, Green Published, Green Submitted			2022-12-26	WOS:000399949000017
J	Kishi, A; Van Dongen, HPA; Natelson, BH; Bender, AM; Palombini, LO; Bittencourt, L; Tufik, S; Ayappa, I; Rapoport, DM				Kishi, Akifumi; Van Dongen, Hans P. A.; Natelson, Benjamin H.; Bender, Amy M.; Palombini, Luciana O.; Bittencourt, Lia; Tufik, Sergio; Ayappa, Indu; Rapoport, David M.			Sleep continuity is positively correlated with sleep duration in laboratory nighttime sleep recordings	PLOS ONE			English	Article							STAGE TRANSITIONS; LONG; PERFORMANCE; PHYSIOLOGY; DYNAMICS; DEPRIVATION; GUIDELINES; PRESSURE; QUALITY; MODEL	Sleep duration varies widely across individuals and appears to be trait-like. Differences in the stability of underlying sleep processes may underlie this phenomenon. To investigate underlying mechanisms, we examined the relationship between sleep duration and sleep continuity in baseline polysomnography (PSG) recordings from three independently collected datasets: 1) 134 healthy controls (ages 37 +/- 13 years) from the Sao Paulo Epidemiologic Sleep Study, who spent one night in a sleep laboratory, 2) 21 obstructive sleep apnea (OSA) patients who were treated with continuous positive airway pressure for at least 2 months (45 +/- 12 years, respiratory disturbance index <15), who spent one night in a sleep laboratory with previous experience of multiple PSG studies, and 3) 62 healthy controls (28 +/- 6 years) who, as part of larger experiments, spent 2 consecutive nights in a sleep laboratory. For each dataset, we used total sleep time (TST) to separate subjects into those with shorter sleep (S-TST) and those with longer sleep (L-TST). In all three datasets, survival curves of continuous sleep segments showed greater sleep continuity in L-TST than in S-TST. Correlation analyses with TST as a continuous variable corroborated the results; and the results also held true after controlling for age. There were no significant differences in baseline waking performance and sleepiness between S-TST and L-TST. In conclusion, in both healthy controls and treated OSA patients, sleep continuity was positively correlated with sleep duration. These findings suggest that S-TST may differ from L-TST in processes underlying sleep continuity, shedding new light on mechanisms underlying individual differences in sleep duration.	[Kishi, Akifumi; Ayappa, Indu; Rapoport, David M.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Kishi, Akifumi; Natelson, Benjamin H.] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA; [Kishi, Akifumi; Natelson, Benjamin H.] Albert Einstein Coll Med, New York, NY USA; [Kishi, Akifumi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Van Dongen, Hans P. A.; Bender, Amy M.] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA; [Palombini, Luciana O.; Bittencourt, Lia; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psicobiol, Discipline Med & Biol Sono, Sao Paulo, SP, Brazil; [Natelson, Benjamin H.] Mt Sinai Beth Israel, Dept Neurol, New York, NY USA; [Natelson, Benjamin H.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ayappa, Indu; Rapoport, David M.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, Dept Med, New York, NY 10029 USA	New York University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University; University of Tokyo; Washington State University; Universidade Federal de Sao Paulo (UNIFESP); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kishi, A (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY USA.; Kishi, A (corresponding author), Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA.; Kishi, A (corresponding author), Albert Einstein Coll Med, New York, NY USA.; Kishi, A (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	kishi@p.u-tokyo.ac.jp	Van Dongen, Hans P. A./GPW-9160-2022; Bittencourt, Lia/C-6551-2012	Van Dongen, Hans P. A./0000-0002-4678-2971; Bittencourt, Lia/0000-0001-7738-0927; Kishi, Akifumi/0000-0002-9324-536X; Rapoport, David/0000-0002-4855-2600	JSPS KAKENHI [15K16416]; Foundation for Research in Sleep Disorders; Georg Waechter Foundation; NIH [R01HL70154, R01HL81310]; ONR [N00014-13-1-0302]; AFIP; FAPESP [98/14303-3]; the Japan Society for the Promotion of Science; CNPq fellowships	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Foundation for Research in Sleep Disorders; Georg Waechter Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); AFIP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by JSPS KAKENHI Grant Number 15K16416, grants from the Foundation for Research in Sleep Disorders and the Georg Waechter Foundation to A.K., NIH grant R01HL70154 and ONR grant N00014-13-1-0302 to H.V.D., NIH grant R01HL81310 to I.A., and AFIP and FAPESP (CEPID no. 98/14303-3) grants to L.O.P., L.B. and S.T. In addition, A.K. received a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science, and L.B. and S.T. received CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Aeschbach D, 2001, NEUROSCIENCE, V102, P493, DOI 10.1016/S0306-4522(00)00518-2; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; American Academy of Sleep Medicine, 2005, INTERNATIONAL CLASSI; Ayappa I, 2000, SLEEP, V23, P763, DOI 10.1093/sleep/23.6.763; Bender AM, 2012, THESIS; Borbely A A, 1982, Hum Neurobiol, V1, P195; BRENDEL DH, 1990, PSYCHOPHYSIOLOGY, V27, P677, DOI 10.1111/j.1469-8986.1990.tb03193.x; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen CY, 2013, SLEEP MED, V14, P1076, DOI 10.1016/j.sleep.2013.06.011; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; Comte JC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056127; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; de Castro JM, 2002, PHYSIOL BEHAV, V76, P479, DOI 10.1016/S0031-9384(02)00699-6; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Grant DA, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P189; Gumenyuk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059007; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Kishi A, 2011, SLEEP, V34, P1423, DOI 10.5665/SLEEP.1292; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; Klerman EB, 2013, NEUROBIOL AGING, V34, P309, DOI 10.1016/j.neurobiolaging.2012.05.018; Kuo TBJ, 2008, SLEEP, V31, P311, DOI 10.1093/sleep/31.3.311; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PARTINEN M, 1983, SLEEP, V6, P179, DOI 10.1093/sleep/6.3.179; Rasch B, 2007, PSYCHONEUROENDOCRINO, V32, P884, DOI 10.1016/j.psyneuen.2007.06.007; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Somiah M, 2012, J CLIN SLEEP MED, V8, P489, DOI 10.5664/jcsm.2138; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2011, SLEEP, V34, P917, DOI 10.5665/SLEEP.1128; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Van Dongen HPA, 2010, FMCSAMCRRR10062; WEBB WB, 1970, SCIENCE, V168, P146, DOI 10.1126/science.168.3927.146; Zhang JH, 2011, SLEEP, V34, P225, DOI 10.1093/sleep/34.2.225	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175504	10.1371/journal.pone.0175504	http://dx.doi.org/10.1371/journal.pone.0175504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394943	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800042
J	Pieraccini, M; Betti, M; Forcellini, D; Dei, D; Papi, F; Bartoli, G; Facchini, L; Corazzi, R; Kovacevic, VC				Pieraccini, Massimiliano; Betti, Michele; Forcellini, Davide; Dei, Devis; Papi, Federico; Bartoli, Gianni; Facchini, Luca; Corazzi, Riccardo; Kovacevic, Vladimir Cerisano			Radar detection of pedestrian-induced vibrations on Michelangelo's David	PLOS ONE			English	Article							INTERFEROMETRIC RADAR; IDENTIFICATION	This paper summarizes the results of a two-day dynamic monitoring of Michelangelo's David subject to environmental loads (city traffic and pedestrian loading induced by tourists visiting the Accademia Gallery). The monitoring was carried out by a no-contact technique using an interferometric radar, whose effectiveness in measuring the resonant frequencies of structures and historic monuments has proved over the last years through numerous monitoring activities. Owing to the dynamic behavior of the measurement system (radar and tripod), an accelerometer has been installed on the radar head to filter out the movement component of the measuring instrument from the measurement of the David's displacement. Measurements were carried out in the presence and absence of visitors, to assess their influence on the dynamic behavior of the statue. A numerical model of the statue was employed to evaluate the experimental results.	[Pieraccini, Massimiliano; Papi, Federico] Univ Florence, Dept Informat Engn DINFO, Florence, Italy; [Betti, Michele; Bartoli, Gianni; Facchini, Luca; Corazzi, Riccardo; Kovacevic, Vladimir Cerisano] Univ Florence, Dept Civil & Environm Engn DICEA, Florence, Italy; [Forcellini, Davide] Univ San Marino, San Marino, San Marino; [Dei, Devis] Florence Engn Srl, Florence, Italy	University of Florence; University of Florence	Betti, M (corresponding author), Univ Florence, Dept Civil & Environm Engn DICEA, Florence, Italy.	mbetti@dicea.unifi.it	Betti, Michele/F-2911-2013; Forcellini, Davide/AAS-1650-2020; Bartoli, Gianni/O-3743-2015	Betti, Michele/0000-0002-8389-3355; Forcellini, Davide/0000-0003-1253-8572; Bartoli, Gianni/0000-0002-5536-3269	foundation "Friends of Florence"	foundation "Friends of Florence"	The Authors wish to acknowledge the support of Dr. Angelo Tartuferi, former Director of the Accademia Gallery in Florence. The authors also express their gratitude to Prof. Marc Levoy (Stanford University) for the release of the 3D laser scan of the Michelangelo's David, here employed to build the FE model. This research was financially supported by the foundation "Friends of Florence" (www.friendsofflorence.org) that is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeni C, 2010, IEEE GEOSCI REMOTE S, V7, P185, DOI 10.1109/LGRS.2009.2030903; Borri A, 2006, J CULT HERIT, V7, P273, DOI 10.1016/j.culher.2006.06.004; Corti G, 2015, J CULT HERIT, V16, P26, DOI 10.1016/j.culher.2014.03.001; Facchini L, 2014, COMPUT STRUCT, V138, P183, DOI 10.1016/j.compstruc.2014.01.013; Falletti F, 2003, DAVID GREAT ART MICH; Fratini M, 2011, J CULT HERIT, V12, P323, DOI 10.1016/j.culher.2011.01.003; Peruzzi G, 2016, INT J NEW TECHNOLOGY, V2, P95; Pieraccini M, 2013, SENSOR ACTUAT A-PHYS, V204, P25, DOI 10.1016/j.sna.2013.09.028; Pieraccini M, 2013, J NONDESTRUCTIVE EVA, V32; Pieraccini M, 2007, NDT&E INT, V40, P390, DOI 10.1016/j.ndteint.2006.12.010; Pieraccini M, 2006, IEEE T GEOSCI REMOTE, V44, P3284, DOI 10.1109/TGRS.2006.879112; Pieraccini M, 2014, J CULT HERIT, V15, P275, DOI 10.1016/j.culher.2013.07.006; Pieraccini M, 2013, SCI WORLD J, DOI 10.1155/2013/786961; Pieraccini M, 2008, NDT&E INT, V41, P258, DOI 10.1016/j.ndteint.2007.11.002; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	15	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174480	10.1371/journal.pone.0174480	http://dx.doi.org/10.1371/journal.pone.0174480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394932	Green Published, gold			2022-12-26	WOS:000399954800003
J	Rogers, S; Hii, H; Huang, J; Ancliffe, M; Gottardo, NG; Dallas, P; Lee, S; Endersby, R				Rogers, Sasha; Hii, Hilary; Huang, Joel; Ancliffe, Mathew; Gottardo, Nick G.; Dallas, Peter; Lee, Sharon; Endersby, Raelene			A novel technique of serial biopsy in mouse brain tumour models	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; DIAGNOSIS; RESECTION; TISSUE; ASTROCYTOMA; EPENDYMOMA; ACCURACY; MICE	Biopsy is often used to investigate brain tumour-specific abnormalities so that treatments can be appropriately tailored. Dacomitinib (PF-00299804) is a tyrosine kinase inhibitor (TKI), which is predicted to only be effective in cancers where the targets of this drug (EGFR, ERBB2, ERBB4) are abnormally active. Here we describe a method by which serial biopsy can be used to validate response to dacomitinib treatment in vivo using a mouse glioblastoma model. In order to determine the feasibility of conducting serial brain biopsies in mouse models with minimal morbidity, and if successful, investigate whether this can facilitate evaluation of chemotherapeutic response, an orthotopic model of glioblastoma was used. Immunodeficient mice received cortical implants of the human glioblastoma cell line, U87MG, modified to express the constitutively-active EGFR mutant, EGFRvIII, GFP and luciferase. Tumour growth was monitored using bioluminescence imaging. Upon attainment of a moderate tumour size, free-hand biopsy was performed on a subgroup of animals. Animal monitoring using a neurological severity score (NSS) showed that all mice survived the procedure with minimal perioperative morbidity and recovered to similar levels as controls over a period of five days. The technique was used to evaluate dacomitinib-mediated inhibition of EGFRvIII two hours after drug administration. We show that serial tissue samples can be obtained, that the samples retain histological features of the tumour, and are of sufficient quality to determine response to treatment. This approach represents a significant advance in murine brain surgery that may be applicable to other brain tumour models. Importantly, the methodology has the potential to accelerate the preclinical in vivo drug screening process.	[Rogers, Sasha; Hii, Hilary; Huang, Joel; Ancliffe, Mathew; Gottardo, Nick G.; Dallas, Peter; Endersby, Raelene] Telethon Kids Inst, Perth, WA, Australia; [Rogers, Sasha; Hii, Hilary; Ancliffe, Mathew; Dallas, Peter; Endersby, Raelene] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Rogers, Sasha; Lee, Sharon] Princess Margaret Hosp, Dept Neurosurg, Perth, WA, Australia; [Gottardo, Nick G.] Princess Margaret Hosp, Dept Oncol, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Rogers, S (corresponding author), Telethon Kids Inst, Perth, WA, Australia.; Rogers, S (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia.; Rogers, S (corresponding author), Princess Margaret Hosp, Dept Neurosurg, Perth, WA, Australia.	sjoerog1@gmail.com	Endersby, Raelene/A-2969-2013	Endersby, Raelene/0000-0003-3554-2769; Gottardo, Nicholas/0000-0002-1082-6776	Ethan Davies Scholarship for Brain Cancer Research (SR); Raine Clinician Research Fellowship (NGG); Telethon Adventurers; Cure Brain Cancer Foundation; Bright Blue: the Police Commissioner's Fund for Sick Kids	Ethan Davies Scholarship for Brain Cancer Research (SR); Raine Clinician Research Fellowship (NGG); Telethon Adventurers; Cure Brain Cancer Foundation; Bright Blue: the Police Commissioner's Fund for Sick Kids	We wish to acknowledge the support of the Ethan Davies Scholarship for Brain Cancer Research (SR) and Raine Clinician Research Fellowship (NGG). Funding was also provided by the Telethon Adventurers and Cure Brain Cancer Foundation. We acknowledge Bright Blue: the Police Commissioner's Fund for Sick Kids for supporting the purchase of microscopy equipment for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker FV, 2005, NEUROPATHOLOGY, V25, P207, DOI 10.1111/j.1440-1789.2005.00634.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; David KA, 2014, ONCOTARGET, V5, P11017, DOI 10.18632/oncotarget.2669; FEIDEN W, 1991, NEUROSURG REV, V14, P51; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; Hesselager G, 2003, NEUROSURGERY, V53, P685, DOI 10.1227/01.NEU.0000081304.57547.B5; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kim JH, 2013, CLIN TRANSL ONCOL, V15, P759, DOI 10.1007/s12094-013-1041-1; Krieger MD, 1998, SEMIN SURG ONCOL, V14, P13; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lesniak MS, 2004, NAT REV DRUG DISCOV, V3, P499, DOI 10.1038/nrd1414; Mittler MA, 1996, J NEUROSURG, V85, P1091, DOI 10.3171/jns.1996.85.6.1091; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tilgner J, 2005, NEUROSURGERY, V56, P257, DOI 10.1227/01.neu.0000148899.39020.87	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175169	10.1371/journal.pone.0175169	http://dx.doi.org/10.1371/journal.pone.0175169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394918	gold, Green Published			2022-12-26	WOS:000399954800019
J	Roodi, FZ; Aminzadeh, S; Farrokhi, N; Karkhane, A; Haghbeen, K				Roodi, Fatemeh Zebardast; Aminzadeh, Saeed; Farrokhi, Naser; Karkhane, AliAsghar; Haghbeen, Kamahldin			Cohnella amylopullulanases: Biochemical characterization of two recombinant thermophilic enzymes	PLOS ONE			English	Article							GENE-ENCODING AMYLOPULLULANASE; ALPHA-1,6 HYDROLYTIC ACTIVITY; ION-EXCHANGE CHROMATOGRAPHY; GEOBACILLUS-THERMOLEOVORANS; PYROCOCCUS-FURIOSUS; PULLULANASE; EXPRESSION; PURIFICATION; CHITINASE; AMYLASE	Some industries require newer, more efficient recombinant enzymes to accelerate their ongoing biochemical reactions in harsh environments with less replenishment. Thus, the search for native enzymes from extremophiles that are suitable for use under industrial conditions is a permanent challenge for R & D departments. Here and toward such discoveries, two sequences homologous to amylopullulanases (EC 3.2.1.41, GH57) from an endogenous Cohnella sp., [ Coh00831 (KP335161; 1998 bp) and Coh01133 (KP335160: 3678 bp)] were identified. The genes were heterologously expressed in E. coli to both determine their type and further characterize their properties. The isolated DNA was PCR amplified with gene specific primers and cloned in pET28a, and the recombinant proteins were expressed in E. coliBL21 (DE3). The temperatures and pH optima of purified recombinants Coh 01133 and Coh 00831 enzymes were 70 degrees C and 8, and 60 degrees C and 6, respectively. These enzymes are stable more than 0% in 60 degrees C and 50 degrees C for 90 min respectively. The major reactions released sugars which could be fractionated by HPLC analysis, from soluble starch were mainly maltose (G2), maltotriose (G3) and maltotetraose (G4). The enzymes hydrolyzed pullulan to maltotriose (G3) only. Enzyme activities for both proteins were improved in the availability of Mn2+, Ba2+, Ca2+, and Mg2+ and reduced in the presence of Fe2+, Li2+, Na2+, Triton X100 and urea. Moreover, Co2+, K+, and Cu2+ had a negative effect only on Coh 01133 enzyme.	[Roodi, Fatemeh Zebardast; Aminzadeh, Saeed; Karkhane, AliAsghar; Haghbeen, Kamahldin] NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran; [Farrokhi, Naser] Shahid Beheshti Univ, GC, Fac New Technol Engn, Dept Biotechnol Engn, Tehran, Iran	Shahid Beheshti University	Aminzadeh, S (corresponding author), NIGEB, Dept Ind & Environm Biotechnol, Tehran, Iran.	aminzade@nigeb.ac.ir	Farrokhi, Naser/AAS-2481-2021	Farrokhi, Naser/0000-0003-4676-1545	NIGEB [920901-I-473]; National Institute of Genetic Engineering and Biotechnology (NIGEB) [920901-I-473]	NIGEB; National Institute of Genetic Engineering and Biotechnology (NIGEB)	This study was supported by 920901-I-473 (NIGEB).r We would like to thank National Institute of Genetic Engineering and Biotechnology (NIGEB) for the financial support under grant number 920901-I-473.	Aliabadi N, 2016, BRAZ J MICROBIOL, V47, P931, DOI 10.1016/j.bjm.2016.07.009; ARA K, 1995, BBA-GEN SUBJECTS, V1243, P315, DOI 10.1016/0304-4165(94)00148-Q; Asoodeh A, 2012, PROCESS BIOCH; Babashpour S, 2012, BIOCHEM GENET, V50, P722, DOI 10.1007/s10528-012-9515-3; BROWN SH, 1993, APPL ENVIRON MICROB, V59, P2614, DOI 10.1128/AEM.59.8.2614-2621.1993; Chen JT, 2001, BIOTECHNOL APPL BIOC, V33, P189, DOI 10.1042/BA20010003; Dewan SS, 2014, GLOBAL MARKETS ENZYM; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; Dong GQ, 1997, APPL ENVIRON MICROB, V63, P3577, DOI 10.1128/AEM.63.9.3577-3584.1997; Duffner F, 2000, J BACTERIOL, V182, P6331, DOI 10.1128/JB.182.22.6331-6338.2000; Erra-Pujada M, 1999, J BACTERIOL, V181, P3284, DOI 10.1128/JB.181.10.3284-3287.1999; Fernandes Pedro, 2010, Enzyme Res, V2010, P862537, DOI 10.4061/2010/862537; Ghollasi M, 2008, BIOLOGIA, V63, P1051, DOI 10.2478/s11756-008-0174-0; Golaki BP, 2015, PROTEIN EXPRES PURIF, V109, P120, DOI 10.1016/j.pep.2014.10.002; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAMILTON PB, 1962, ANN NY ACAD SCI, V102, P55, DOI 10.1111/j.1749-6632.1962.tb13625.x; Han T, 2013, LETT APPL MICROBIOL, V57, P336, DOI 10.1111/lam.12118; Hii Siew Ling, 2009, American Journal of Biochemistry and Biotechnology, V5, P170, DOI 10.3844/ajbbsp.2009.170.179; KIM CH, 1993, BIOSCI BIOTECH BIOCH, V57, P1632, DOI 10.1271/bbb.57.1632; Kim JH, 2009, J BIOSCI BIOENG, V107, P124, DOI 10.1016/j.jbiosc.2008.10.019; Kim JH, 2008, J BIOSCI BIOENG, V106, P449, DOI 10.1263/jbb.106.449; KIMURA T, 1990, APPL MICROBIOL BIOT, V34, P52; KITAGAWA N, 1988, J CHROMATOGR, V443, P133, DOI 10.1016/S0021-9673(00)94788-5; Leveque E, 2000, ENZYME MICROB TECH, V26, P3, DOI 10.1016/S0141-0229(99)00142-8; Lin HY, 2008, EXTREMOPHILES, V12, P641, DOI 10.1007/s00792-008-0168-4; MATHUPALA SP, 1993, J BIOL CHEM, V268, P16332; Mehta D, 2017, CURRENT DEVELOPMENTS IN BIOTECHNOLOGY AND BIOENGINEERING: FUNCTIONAL GENOMICS AND METABOLIC ENGINEERING, P45, DOI 10.1016/B978-0-444-63667-6.00003-1; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nisha M, 2017, APPL MICROBIOL BIOT, V101, P2357, DOI 10.1007/s00253-016-8025-3; Nisha M, 2013, BIOENGINEERED, V4, P388, DOI 10.4161/bioe.24629; Nisha M, 2013, APPL MICROBIOL BIOT, V97, P6279, DOI 10.1007/s00253-012-4538-6; Noorwez S. M., 2006, Indian Journal of Biotechnology, V5, P337; Puspasari F, 2011, STARCH-STARKE, V63, P461, DOI 10.1002/star.201000127; SAHA BC, 1990, APPL ENVIRON MICROB, V56, P881, DOI 10.1128/AEM.56.4.881-886.1990; Sambrook J, 1989, MOL CLONING; Zhang QG, 2017, PROCESS BIOCHEM, V53, P88, DOI 10.1016/j.procbio.2016.11.012	36	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175013	10.1371/journal.pone.0175013	http://dx.doi.org/10.1371/journal.pone.0175013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394913	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800014
J	Gai, ZJ; Zhang, JT; Li, CF				Gai, Zhijia; Zhang, Jingtao; Li, Caifeng			Effects of starter nitrogen fertilizer on soybean root activity, leaf photosynthesis and grain yield	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; SEED YIELD; NODULE FORMATION; PLANTING DATE; GROWTH; SOIL; SIMULATION; WEIGHT; MODEL; FIELD	The objective of this study was to examine the impact of starter nitrogen fertilizer on soybean root activity, leaf photosynthesis, grain yield and their relationship. To achieve this objective, field experiments were conducted in 2013 and 2014, using a randomized complete block design, with three replications. Nitrogen was applied at planting at rates of 0, 25, 50, and 75 kg N ha-1. In both years, starter nitrogen fertilizer benefited root activity, leaf photosynthesis, and consequently its yield. Statistically significant correlation was found among root activity, leaf photosynthetic rate, and grain yield at the developmental stage. The application of N25, N50, and N75 increased grain yield by 1.28%, 2.47%, and 1.58% in 2013 and by 0.62%, 2.77%, and 2.06% in 2014 compared to the N0 treatment. Maximum grain yield of 3238.91 kg ha-1 in 2013 and 3086.87 kg ha-1 in 2014 were recorded for N50 treatment. Grain yield was greater for 2013 than 2014, possibly due to more favorable environmental conditions. This research indicated that applying nitrogen as starter is necessary to increase soybean yield in Sangjiang River Plain in China.	[Gai, Zhijia; Li, Caifeng] Northeast Univ Agr, Dept Agron, Harbin, Heilongjiang, Peoples R China; [Gai, Zhijia; Zhang, Jingtao] Heilongjiang Acad Agr Sci, Jiamusi Branch, Jiamusi, Heilongjiang, Peoples R China	Heilongjiang Academy of Agricultural Sciences	Li, CF (corresponding author), Northeast Univ Agr, Dept Agron, Harbin, Heilongjiang, Peoples R China.	licaifeng@neau.edu.cn	Zhang, Jing/GWZ-7332-2022		National Key Technology Support Program [2014BAD11B01-A02]	National Key Technology Support Program(National Key Technology R&D Program)	This research was supported by National Key Technology Support Program. The grant number is 2014BAD11B01-A02.	Adeli A, 2005, AGRON J, V97, P314, DOI 10.2134/agronj2005.0314; Anten NPR, 2005, ANN BOT-LONDON, V95, P495, DOI 10.1093/aob/mci048; BEARD BH, 1971, AGRON J, V63, P815, DOI 10.2134/agronj1971.00021962006300050051x; BERGERSEN FJ, 1958, J GEN MICROBIOL, V19, P312, DOI 10.1099/00221287-19-2-312; BHAGSARI AS, 1977, CROP SCI, V17, P929, DOI 10.2135/cropsci1977.0011183X001700060028x; Board JE, 1996, AGRON J, V88, P567, DOI 10.2134/agronj1996.00021962008800040012x; Boroomandan P, 2009, Pak J Biol Sci, V12, P378, DOI 10.3923/pjbs.2009.378.382; BRUN WA, 1967, CROP SCI, V7, P451, DOI 10.2135/cropsci1967.0011183X000700050013x; Chen GH, 2010, AGRON J, V102, P1731, DOI 10.2134/agronj2010.0219; DARRAH PR, 1993, PLANT SOIL, V155, P1, DOI 10.1007/BF00024980; Di W, 2010, J NUCL AGR SCI, V24, P612; Dong ShouKun, 2010, Plant Nutrition and Fertilizer Science, V16, P65; DORNHOFF GM, 1970, CROP SCI, V10, P42, DOI 10.2135/cropsci1970.0011183X001000010016x; Du WG, 1988, SOYBEAN SCI, V7, P337; EGLI DB, 1992, AGR FOREST METEOROL, V62, P19, DOI 10.1016/0168-1923(92)90003-M; Fageria N. K., 2006, PHYSL CROP PRODUCTIO; [盖志佳 Gai Zhijia], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P822; HARDY RWF, 1971, PLANT SOIL, P561, DOI 10.1007/BF02661879; Harper J.E., 1987, SOYBEANS IMPROVEMENT, P497; HARPER JE, 1974, CROP SCI, V14, P255, DOI 10.2135/cropsci1974.0011183X001400020026x; HATFIELD JL, 1974, AGRON J, V66, P112, DOI 10.2134/agronj1974.00021962006600010032x; HERBERT SJ, 1982, CROP SCI, V22, P1074, DOI 10.2135/cropsci1982.0011183X002200050044x; HESKETH J D, 1981, Photosynthesis Research, V2, P21, DOI 10.1007/BF00036162; JAYAPAUL P, 1990, INDIAN J AGRON, V35, P329; Jeffery D., 2006, CROP SCI, V46, P52; KRAMER PJ, 1981, BIOSCIENCE, V31, P29, DOI 10.2307/1308175; [刘丽君 Liu Lijun], 2005, [东北农业大学学报, Journal of Northeast Agricultural University], V36, P133; Liu X, 2008, FIELD CROP RES, V105, P157, DOI 10.1016/j.fcr.2007.09.003; Mathew JP, 2000, AGRON J, V92, P1156, DOI 10.2134/agronj2000.9261156x; MUCHOW RC, 1986, FIELD CROP RES, V15, P143, DOI 10.1016/0378-4290(86)90083-3; Osborne SL, 2006, AGRON J, V98, P1569, DOI 10.2134/agronj2006.0089; Oz M, 2008, AFR J BIOTECHNOL, V7, P4464; PEET MM, 1977, CROP SCI, V17, P287, DOI 10.2135/cropsci1977.0011183X001700020014x; Pikul JL, 2001, SOIL TILL RES, V60, P21, DOI 10.1016/S0167-1987(01)00174-X; Purell DE, 1996, J PLANT NUTR, V19, P949; Ray JD, 2006, CROP SCI, V46, P52, DOI 10.2135/cropsci2005.0043; Rotundo JL, 2009, FIELD CROP RES, V110, P147, DOI 10.1016/j.fcr.2008.07.012; Seadh S. E., 2013, Journal of Agronomy, V12, P46, DOI 10.3923/ja.2013.46.52; Serraj R, 1998, PLANT SOIL, V202, P159, DOI 10.1023/A:1004300819535; Setiyono TD, 2008, FIELD CROP RES, V108, P82, DOI 10.1016/j.fcr.2008.03.005; [申晓慧 Shen Xiaohui], 2012, [大豆科学, Soybean Science], V31, P73; SIJ JW, 1979, COMMUN SOIL SCI PLAN, V10, P1451, DOI 10.1080/00103627909366999; Sincik M, 2009, TURK J AGRIC FOR, V33, P111, DOI 10.3906/tar-0807-26; SORENSEN RC, 1978, AGRON J, V70, P213, DOI 10.2134/agronj1978.00021962007000020001x; Starling ME, 1998, AGRON J, V90, P658, DOI 10.2134/agronj1998.00021962009000050015x; STREETER J, 1988, CRIT REV PLANT SCI, V7, P1, DOI 10.1080/07352688809382257; [孙贵荒 Sun Guihuang], 2003, [辽宁农业科学, Liaoning Agricultural sciences], V0, P13; Taylor RS, 2005, CROP SCI, V45, P854, DOI 10.2135/cropsci2003.0344; THOMPSON JA, 1995, CROP SCI, V35, P1575, DOI 10.2135/cropsci1995.0011183X003500060010x; Thompson JA, 1996, PHOTOSYNTH RES, V49, P1, DOI 10.1007/BF00029422; Tian HY, 2007, THESIS NE AGR U CHIN; TOUCHTON JT, 1986, SOIL SCI SOC AM J, V50, P234, DOI 10.2136/sssaj1986.03615995005000010045x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Wan T., 2013, THESIS; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104023; Wang ShuQi, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P1069, DOI 10.3724/SP.J.1011.2009.01069; Wang Xia, 2010, Acta Agronomica Sinica, V36, P1674; Zhang H., 2007, METHANE HYDRATE NEWS, V2007, P1, DOI DOI 10.1007/S11103-006-9072-4; Zhang HengShan, 2001, Soybean Science, V20, P275; Zhang MC, 2014, J INTEGR AGR, V13, P2778, DOI 10.1016/S2095-3119(13)60535-3; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Zhu GJ, 2002, ACTA BOT SIN, V44, P725	62	47	51	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174841	10.1371/journal.pone.0174841	http://dx.doi.org/10.1371/journal.pone.0174841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388620	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800012
J	Lackmann, F; Belikov, S; Wieslander, L				Lackmann, Fredrik; Belikov, Sergey; Wieslander, Lars			Linker 2 of the eukaryotic pre-ribosomal processing factor Mrd1p is an essential interdomain functionally coupled to upstream RNA Binding Domain 2 (RBD2)	PLOS ONE			English	Article							RECOGNITION MOTIF; YEAST; PROTEIN; BIOGENESIS; SUBUNITS; 90S; CELLS; RBM19	Ribosome synthesis is an essential process in all cells. In Sacharomyces cerevisiae, the precursor rRNA, 35S pre-rRNA, is folded and assembled into a 90S pre-ribosomal complex. The 40S ribosomal subunit is processed from the pre-ribosomal complex. This requires concerted action of small nucleolar RNAs, such as U3 snoRNA, and a large number of transacting factors. Mrd1p, one of the essential small ribosomal subunit synthesis factors is required for cleavage of the 35S pre-rRNA to generate 18S rRNA of the small ribosomal subunit. Mrd1p is evolutionary conserved in all eukaryotes and in yeast it contains five RNA Binding Domains (RBDs) separated by linker regions. One of these linkers, Linker 2 between RBD2 and RBD3, is conserved in length, predicted to be structured and contains conserved clusters of amino acid residues. In this report, we have analysed Linker 2 mutations and demonstrate that it is essential for Mrd1p function during pre-ribosomal processing. Extensive changes of amino acid residues as well as specific changes of conserved clusters of amino acid residues were found to be incompatible with synthesis of pre-40S ribosomes and cell growth. In addition, gross changes in primary sequence of Linker 2 resulted in Mrd1p instability, leading to degradation of the N-terminal part of the protein. Our data indicates that Linker 2 is functionally coupled to RBD2 and argues for that these domains constitute a functional module in Mrd1p. We conclude that Linker 2 has an essential role for Mrd1p beyond just providing a defined length between RBD2 and RBD3.	[Lackmann, Fredrik; Belikov, Sergey; Wieslander, Lars] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden	Stockholm University	Wieslander, L (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.	lars.wieslander@su.se	Wieslander, Lars/B-4670-2016	Wieslander, Lars/0000-0003-3271-6946	Swedish Research Council [621-2010-5236]; Carl Tryggers Stiftelse [CTS 15:531]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse	This work was supported by the Swedish Research Council (VR.se) 621-2010-5236 grant to LW; Carl Tryggers Stiftelse, project number CTS 15:531, grant to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bjork P, 2002, MOL BIOL CELL, V13, P3683, DOI 10.1091/mbc.E02-03-0138; Cao YQ, 2011, RES MICROBIOL, V162, P729, DOI 10.1016/j.resmic.2011.05.004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Jin SB, 2002, J BIOL CHEM, V277, P18431, DOI 10.1074/jbc.M112395200; Kallberg Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043786; Lorenzen JA, 2005, GENE EXPR PATTERNS, V6, P45, DOI 10.1016/j.modgep.2005.05.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lundkvist P, 2009, MOL CELL BIOL, V29, P5763, DOI 10.1128/MCB.00428-09; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Segerstolpe A, 2013, NUCLEIC ACIDS RES, V41, P1178, DOI 10.1093/nar/gks1129; Stelter P, 2012, MOL CELL, V47, P788, DOI 10.1016/j.molcel.2012.06.015; Wang B, 2017, NUCLEIC ACIDS RES; Weir M, 2014, METHODS MOL BIOL, V1205, P29, DOI 10.1007/978-1-4939-1363-3_3; WISE JA, 1991, METHOD ENZYMOL, V194, P405; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; YOLOV AA, 1990, NUCLEIC ACIDS RES, V18, P3983, DOI 10.1093/nar/18.13.3983; Zhang J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-115; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175506	10.1371/journal.pone.0175506	http://dx.doi.org/10.1371/journal.pone.0175506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388671	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800063
J	Tu, MC; Lo, CP; Huang, CF; Hsu, YH; Huang, WH; Deng, JF; Lee, YC				Tu, Min-Chien; Lo, Chung-Ping; Huang, Ching-Feng; Hsu, Yen-Hsuan; Huang, Wen-Hui; Deng, Jie Fu; Lee, Yung-Chuan			Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER HYPERINTENSITIES; NATIONAL INSTITUTE; DEMENTIA; DIAGNOSIS; ABNORMALITIES; GUIDELINES; PATHOLOGY; BATTERY; VERSION	Objective To describe and compare diffusion tensor imaging (DTI) parameters between patients with subcortical ischemic vascular disease (SIVD) and Alzheimer's disease (AD) diagnosed using structuralized neuropsychiatric assessments, and investigate potential neuronal substrates related to cognitive performance. Methods Thirty-five patients with SIVD, 40 patients with AD, and 33 cognitively normal control (NC) subjects matched by age and education level were consecutively recruited and underwent cognitive function assessments and DTI examinations. Comparisons among these three subgroups with regards to cognitive performance and DTI parameters including fractional anisotropy (FA) and mean diffusivity (MD) values were performed. Partial correlation analysis after controlling for age and education was used to evaluate associations between cognitive performance and DTI parameters. Results With regards to cognitive performance, the patients with SIVD had lower total scores in frontal assessment battery (FAB) compared to those with AD (p < 0.05) in the context of comparable Mini-Mental Status Examination and Cognitive Abilities Screening Instrument scores. With regards to DTI parameters, there were more regions of significant differences in FA among these three subgroups compared with MD. Compared with NC group, the patients with SIVD had significant global reductions in FA (p < 0.001 similar to 0.05), while significant reductions in FA among the patients with AD were regionally confined within the left superior longitudinal fasciculus, genu and splenium of the corpus callosum, and bilateral forceps major, and the anterior thalamic radiation, uncinate fasciculus, and cingulum of the left side (p < 0.01 similar to 0.05). Analysis of FA values within the left forceps major, left anterior thalamic radiation, and genu of the corpus callosum revealed a 71.8% overall correct classification (p < 0.001) with sensitivity of 69.4%, specificity of 73.8%, positive predictive value of 69.4%, and negative predictive value of 73.8% in discriminating patients with SIVD from those with AD. In combined analysis of the patients with SIVD and AD (n = 75), the total FAB score was positively correlated with FA within the bilateral forceps minor, genu of the corpus callosum, left forceps major, left uncinate fasciculus, and right inferior longitudinal fasciculus (p = 0.001 similar to 0.038), and inversely correlated with MD within the right superior longitudinal fasciculus, genu and body of the corpus callosum, bilateral forceps minor, right uncinate fasciculus, and right inferior longitudinal fasciculus (p = 0.003 similar to 0.040) Conclusions Our findings suggest the effectiveness of DTI measurements in distinguishing patients with early-stage AD from those with SIVD, with discernible changes in spatial distribution and magnitude of significance of the DTI parameters. Strategic FA assessments provided the most robust discriminative power to differentiate SIVD from AD, and FAB may serve as an additional cognitive marker. We also identified the neuronal substrates responsible for FAB performance.	[Tu, Min-Chien; Huang, Ching-Feng; Huang, Wen-Hui; Deng, Jie Fu] Taichung Tzu Chi Hosp, Dept Neurol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Lo, Chung-Ping] Taichung Tzu Chi Hosp, Dept Radiol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Hsu, Yen-Hsuan] Natl Chung Cheng Univ, Dept Psychol, Chiayi, Taiwan; [Lee, Yung-Chuan] Asia Univ, Dept Business Adm, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Chung Cheng University; Asia University Taiwan	Tu, MC (corresponding author), Taichung Tzu Chi Hosp, Dept Neurol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.	tmctmc30@yahoo.com.tvv		Hsu, Yen-Hsuan/0000-0002-2585-3339	 [TTCRD 103-05]		The current study is supported by a research program of our hospital (Project No.: TTCRD 103-05).	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Altamura C, 2016, J CLIN NEUROL, V12, P201, DOI 10.3988/jcn.2016.12.2.201; Alves GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/291658; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Boutoleau-Bretonniere C, 2012, J ALZHEIMERS DIS, V28, P323, DOI 10.3233/JAD-2011-110761; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Chang CC, 2010, J INT NEUROPSYCH SOC, V16, P244, DOI 10.1017/S1355617709991184; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Du AT, 2002, NEUROLOGY, V58, P1635, DOI 10.1212/WNL.58.11.1635; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Fu JL, 2012, ACTA RADIOL, V53, P312, DOI 10.1258/ar.2011.110272; Golden Z, 2005, INT J NEUROSCI, V115, P1569, DOI 10.1080/00207450590957953; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Haller S, 2013, AM J NEURORADIOL, V34, P283, DOI 10.3174/ajnr.A3223; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Kalaria RN, 2016, ACTA NEUROPATHOL, V131, P659, DOI 10.1007/s00401-016-1571-z; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matioli MNPS, 2010, ARQ NEURO-PSIQUIAT, V68, P185, DOI 10.1590/S0004-282X2010000200006; Mayzel-Oreg O, 2007, J NEUROL SCI, V257, P105, DOI 10.1016/j.jns.2007.01.048; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; OBrien JT, 1996, INT J GERIATR PSYCH, V11, P681; Pimentel Érica Maria Lima, 2009, Dement. neuropsychol., V3, P214, DOI 10.1590/S1980-57642009DN30300007; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Snyder S, 2005, AM FAM PHYSICIAN, V72, P1723; Sugihara S, 2004, ACTA RADIOL, V45, P658, DOI 10.1080/02841850410008388; Tu Min-Chien, 2010, Acta Neurol Taiwan, V19, P168; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yuspeh RL, 2002, J CLIN EXP NEUROPSYC, V24, P745, DOI 10.1076/jcen.24.6.745.8399	50	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175143	10.1371/journal.pone.0175143	http://dx.doi.org/10.1371/journal.pone.0175143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388630	Green Published, gold, Green Submitted			2022-12-26	WOS:000399375800024
J	Afreen, S; Shamsi, TN; Baig, MA; Ahmad, N; Fatima, S; Qureshi, MI; Hassan, MI; Fatma, T				Afreen, Sumbul; Shamsi, Tooba Naz; Baig, Mohd Affan; Ahmad, Nadeem; Fatima, Sadaf; Qureshi, M. Irfan; Hassan, Md. Imtaiyaz; Fatma, Tasneem			A novel multicopper oxidase (laccase) from cyanobacteria: Purification, characterization with potential in the decolorization of anthraquinonic dye	PLOS ONE			English	Article							PLEUROTUS-OSTREATUS; PHENOL OXIDASE; EXTRACELLULAR LACCASE; FUNGUS; DEGRADATION; STREPTOMYCES; ISOZYMES; EFFLUENT; CADMIUM; COPPER	A novel extracellular laccase enzyme produced from Spirulina platensis CFTRI was purified by ultrafiltration, cold acetone precipitation, anion exchange and size exclusion chromatography with 51.5% recovery and 5.8 purification fold. The purified laccase was a monomeric protein with molecular mass of similar to 66 kDa that was confirmed by zymogram analysis and peptide mass fingerprinting. The optimum pH and temperature of the enzyme activity was found at 3.0 and 30 degrees C using ABTS as substrate but the enzyme was quite stable at high temperature and alkaline pH. The laccase activity was enhanced by Cu+2, Zn+2 and Mn+2. In addition, the dye decolorization potential of purified laccase was much higher in terms of extent as well as time. The purified laccase decolorized ( 96%) of anthraquinonic dye Reactive blue- 4 within 4 h and its biodegradation studies was monitored by UV visible spectra, FTIR and HPLC which concluded that cyanobacterial laccase can be efficiently used to decolorize synthetic dye and help in waste water treatment.	[Afreen, Sumbul; Ahmad, Nadeem; Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India; [Shamsi, Tooba Naz; Baig, Mohd Affan; Fatima, Sadaf; Qureshi, M. Irfan] Jamia Millia Islamia, Dept Biotechnol, New Delhi, India; [Hassan, Md. Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Jamia Millia Islamia; Jamia Millia Islamia; Jamia Millia Islamia	Fatma, T (corresponding author), Jamia Millia Islamia, Dept Biosci, Cyanobacterial Biotechnol Lab, New Delhi, India.	fatma_cbl@yahoo.com	Shamsi, Tooba/ADE-5752-2022; Hassan, Md Imtaiyaz/G-7072-2017; Hassan, Mohammad/GZA-7507-2022; Qureshi, M Irfan/CAF-0824-2022; Hassan, Imtaiyaz/ABF-6485-2020	Shamsi, Tooba/0000-0001-7164-0791; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Qureshi, M Irfan/0000-0001-9625-0036; Hassan, Imtaiyaz/0000-0002-3663-4940; Baig, Affan/0000-0002-6203-2097; Fatma, Tasneem/0000-0003-3712-8692				Attala MM, 2015, EGYPT PHARM J, V11, P93; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2005, RES MICROBIOL, V156, P670, DOI 10.1016/j.resmic.2005.03.007; Baldrian P, 2000, APPL ENVIRON MICROB, V66, P2471, DOI 10.1128/AEM.66.6.2471-2478.2000; Binz T, 1996, MYCOL RES, V100, P1060, DOI 10.1016/S0953-7562(96)80213-9; BOURBONNAIS R, 1992, APPL MICROBIOL BIOT, V36, P823, DOI 10.1007/BF00172202; Brijwani K, 2010, ENZYM RES; Chefetz B, 1998, APPL ENVIRON MICROB, V64, P3175; Chen CY, 2013, APPL MICROBIOL BIOT, V97, P8977, DOI 10.1007/s00253-013-4727-y; Christiane A., 2013, Journal of Bioremediation and Biodegradation, V4, P206; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; d'Acunzo F, 2004, J MOL CATAL B-ENZYM, V31, P25, DOI 10.1016/j.molcatb.2004.07.001; Das N, 2001, J BASIC MICROB, V41, P261, DOI 10.1002/1521-4028(200110)41:5&lt;261::AID-JOBM261&gt;3.0.CO;2-V; De Souza CGM, 2003, J BASIC MICROB, V43, P278, DOI 10.1002/jobm.200390031; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; Endo K, 2002, MICROBIOL-SGM, V148, P1767, DOI 10.1099/00221287-148-6-1767; Forootanfar H, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-27; Garg N, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-75; Huang YC, 2011, BIORESOURCE TECHNOL, V102, P8117, DOI 10.1016/j.biortech.2011.05.062; Iyer G, 2003, FEMS MICROBIOL LETT, V227, P121, DOI 10.1016/S0378-1097(03)00658-X; Jaiswal N, 2015, INT J BIOL MACROMOL, V72, P326, DOI 10.1016/j.ijbiomac.2014.08.032; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZY, 2010, BIOPROC BIOSYST ENG, V33, P639, DOI 10.1007/s00449-009-0389-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu L, 2007, APPL MICROBIOL BIOT, V74, P1232, DOI 10.1007/s00253-006-0767-x; Mansur M, 2003, MYCOLOGIA, V95, P1013, DOI 10.2307/3761909; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Michniewicz A, 2006, APPL MICROBIOL BIOT, V69, P682, DOI 10.1007/s00253-005-0015-9; Munoz C, 1997, CURR MICROBIOL, V34, P1, DOI 10.1007/s002849900134; Murugesan K, 2006, APPL MICROBIOL BIOT, V72, P939, DOI 10.1007/s00253-006-0403-9; Murugesan K, 2009, J HAZARD MATER, V168, P523, DOI 10.1016/j.jhazmat.2009.02.075; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Olukanni OD, 2010, J HAZARD MATER, V184, P290, DOI 10.1016/j.jhazmat.2010.08.035; Otto B, 2014, PLANTA, V240, P1225, DOI 10.1007/s00425-014-2144-9; Paavol N, 1998, BIOCHEM J, V254, P877; Paavola ML, 2004, ENZYME MICROBIAL TEC, V35, P100; Palanisami S, 2010, WORLD J MICROB BIOT, V26, P63, DOI 10.1007/s11274-009-0143-y; PALMIERI G, 1993, APPL MICROBIOL BIOT, V39, P632, DOI 10.1007/BF00205066; Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006; Parikh A, 2005, BIOTECHNOL LETT, V27, P323, DOI 10.1007/s10529-005-0691-7; Patel H, 2014, 3 BIOTECH, V4, P77, DOI 10.1007/s13205-013-0129-1; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Sadhasivam S, 2008, PROCESS BIOCHEM, V43, P736, DOI 10.1016/j.procbio.2008.02.017; Sahay R, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P2068; Salony, 2006, APPL MICROBIOL BIOT, V71, P646, DOI 10.1007/s00253-005-0206-4; Sathishkumar P, 2014, J MOL CATAL B-ENZYM, V100, P111, DOI 10.1016/j.molcatb.2013.12.008; Semple KT, 1999, FEMS MICROBIOL LETT, V170, P291, DOI 10.1111/j.1574-6968.1999.tb13386.x; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Sheikhi F, 2012, INDIAN J MICROBIOL, V52, P701, DOI 10.1007/s12088-012-0298-3; Soares GMB, 2001, J BIOTECHNOL, V89, P123, DOI 10.1016/S0168-1656(01)00302-9; Somero GN., 2004, COMP BIOCH PHYSL B, V139, P312; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110834; YOUN HD, 1995, FEMS MICROBIOL LETT, V132, P183, DOI 10.1111/j.1574-6968.1995.tb07831.x; Zarrouk C., 1996, THESIS	61	53	54	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175144	10.1371/journal.pone.0175144	http://dx.doi.org/10.1371/journal.pone.0175144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384218	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900100
J	Kawaguchi, T; Yanagihara, T; Yokoyama, T; Suetsugu-Ogata, S; Hamada, N; Harada-Ikeda, C; Suzuki, K; Maeyama, T; Kuwano, K; Nakanishi, Y				Kawaguchi, Tomonobu; Yanagihara, Toyoshi; Yokoyama, Tetsuya; Suetsugu-Ogata, Saiko; Hamada, Naoki; Harada-Ikeda, Chika; Suzuki, Kunihiro; Maeyama, Takashige; Kuwano, Kazuyoshi; Nakanishi, Yoichi			Probucol attenuates hyperoxia-induced lung injury in mice	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; CELL-DEATH; ACTIVATION; APOPTOSIS; PROTECTS	Hyperoxic lung injury is pathologically characterized by alveolar edema, interlobular septal edema, hyaline membrane disease, lung inflammation, and alveolar hemorrhage. Although the precise mechanism by which hyperoxia causes lung injury is not well defined, oxidative stress, epithelial cell death, and proinflammatory cytokines are thought to be involved. Probucol-a commercially available drug for treating hypercholesterolemia-has been suggested to have antioxidant and antiapoptotic effects. This study aimed to assess whether probucol could attenuate hyperoxic lung injury in mice. Mice were exposed to 95% O-2 for 72 h, with or without pre-treatment with 130 mu g/kg probucol intratracheally. Probucol treatment significantly decreased both the number of inflammatory cells in the bronchoalveolar lavage fluid and the degree of lung injury in hyperoxia-exposed mice. Probucol treatment reduced the number of cells positive for 8-hydroxyl-2'-deoxyguanosine or terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and suppressed NF-kappa B activation, Bax expression, and caspase-9 activation in lung tissues from hyperoxia-exposed mice. These results suggest that probucol can reduce oxidative DNA damage, apoptotic cell death, and inflammation in lung tissues. Intratracheal administration of probucol may be a novel treatment for lung diseases induced by oxidative stress, such as hyperoxic lung injury and acute respiratory distress syndrome.	[Kawaguchi, Tomonobu; Yanagihara, Toyoshi; Yokoyama, Tetsuya; Suetsugu-Ogata, Saiko; Hamada, Naoki; Harada-Ikeda, Chika; Suzuki, Kunihiro; Maeyama, Takashige; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan; [Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Div Resp Dis, Dept Internal Med, Tokyo, Japan	Kyushu University; Jikei University	Yanagihara, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan.	yanagiha@kokyu.med.kyushu-u.ac.jp	Yanagihara, Toyoshi/AAI-1037-2020		JSPS [23591150]; Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare	This work was supported by JSPS Grant-in-Aid for Scientific Research (Grant Number 23591150) and the Health and Labor Sciences Research Grants on Diffuse Lung Disease from the Japanese Ministry of Health, Labor and Welfare.	Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Chen H, 2007, EXP MOL PATHOL, V83, P377, DOI 10.1016/j.yexmp.2007.08.016; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308; Jung YS, 2016, ACTA PHARMACOL SIN, V37, P1031, DOI 10.1038/aps.2016.51; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kasai I, 2012, PROBUCOL THERAPY IMP, V220, P463; Kufner S, 2016, JACC-CARDIOVASC INTE, V9, P784, DOI 10.1016/j.jcin.2016.01.009; KUZUYA M, 1991, J LIPID RES, V32, P197; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Mantell LL, 1997, CELL DEATH DIFFER, V4, P600, DOI 10.1038/sj.cdd.4400278; Mao Q, 2008, AM J RESP CELL MOL, V39, P717, DOI 10.1165/rcmb.2008-0052OC; O'Reilly MA, 2000, LAB INVEST, V80, P1845, DOI 10.1038/labinvest.3780195; Petrache I, 1999, AM J PHYSIOL-LUNG C, V277, pL589, DOI 10.1152/ajplung.1999.277.3.L589; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Umeji K, 2006, AM J PHYSIOL-HEART C, V291, pH2522, DOI 10.1152/ajpheart.01198.2005; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Vitiello PF, 2008, FREE RADICAL BIO MED, V44, P367, DOI 10.1016/j.freeradbiomed.2007.09.021; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC	25	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175129	10.1371/journal.pone.0175129	http://dx.doi.org/10.1371/journal.pone.0175129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384256	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900095
J	Kim, YM; Kim, J; Han, Y; Jeon, BH; Cheong, HK; Ahn, K				Kim, Young-Min; Kim, Jihyun; Han, Youngshin; Jeon, Byoung-Hak; Cheong, Hae-Kwan; Ahn, Kangmo			Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea	PLOS ONE			English	Article							DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; UNITED-STATES; PARTICULATE MATTER; CHILDHOOD ASTHMA; RISK-FACTOR; ECZEMA; PREVALENCE; OZONE; EXPOSURE	Introduction The effects of weather and air pollution on the severity and persistence of atopic dermatitis (AD) are important issues that have not been investigated in detail. The objective of our study was to determine the short-term effects of meteorological variables and air pollution on AD symptoms in children. Methods We enrolled 177 AD patients with 5 years or younger from the Seoul Metropolitan Area, Korea, and followed for 17 months between August 2013 and December 2014. Symptoms records of 35,158 person-days, including itching, sleep disturbance, erythema, dry skin, oozing, and edema, were obtained. We estimated the effect of meteorological variables including daily mean temperature, relative humidity (RH), diurnal temperature range (DTR), rainfall and air pollutants including particulate matter with an aerodynamic diameter <= 10 mu m (PM10), nitrogen dioxide (NO2), and tropospheric ozone (O-3) on AD symptoms using a generalized linear mixed model with adjustment for related confounding factors. Results A 5 degrees C increase in outdoor temperature and a 5% increase in outdoor RH was associated with 12.8% (95% confidence intervals (CI): 10.5, 15.2) and 3.3% (95% CI: 1.7, 4.7) decrease in AD symptoms, respectively, on the same day. An increase of rainfall by 5 mm increased AD symptoms by 7.3% (95% CI: 3.6, 11.1) for the days with <40 mm rainfall. The risk of AD symptoms increased by 284.9% (95% CI: 67.6, 784.2) according to a 5 degrees C increase in DTR when it was >14 degrees C. An increase in PM10, NO2, and O3 by 10 units increased the risk of AD symptoms on the same day by 3.2% (95% CI: 1.5, 4.9), 5.0% (95% CI: 1.4, 8.8), and 6.1% (95% CI: 3.2, 9.0), respectively. Conclusion Exposure to meteorological variables and air pollutants are associated with AD symptoms in young children.	[Kim, Young-Min; Kim, Jihyun; Han, Youngshin; Ahn, Kangmo] Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea; [Kim, Young-Min; Kim, Jihyun; Ahn, Kangmo] Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Jeon, Byoung-Hak; Cheong, Hae-Kwan] Sungkyunkwan Univ, Dept Social & Prevent Med, Sch Med, Suwon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Ahn, K (corresponding author), Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea.	kmaped@skku.edu	Jeon, Byoung-Hak/GXM-9445-2022; Ahn, Kangmo/F-4609-2014	Jeon, Byoung-Hak/0000-0001-5246-0357; Cheong, Hae-Kwan/0000-0003-2758-9399	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program" [2013001360002]; Kangmo Ahn at the Department of Pediatrics; Samsung Medical Center, Sungkyunkwan University School of Medicine	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"; Kangmo Ahn at the Department of Pediatrics; Samsung Medical Center, Sungkyunkwan University School of Medicine	This study was funded by the Korea Ministry of Environment (MOE) as "the Environmental Health Action Program" (2013001360002) and was contracted to Kangmo Ahn at the Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boguniewicz M, 2013, J ALLERGY CLIN IMMUN, V132, P511, DOI 10.1016/j.jaci.2013.06.030; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Byremo G, 2006, ALLERGY, V61, P1403, DOI 10.1111/j.1398-9995.2006.01209.x; Chen GH, 2007, INT J CARDIOL, V116, P408, DOI 10.1016/j.ijcard.2006.03.067; Chernyshov PV, 2012, INT J DERMATOL, V51, P290, DOI 10.1111/j.1365-4632.2011.04997.x; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Eberlein-Konig B, 1998, J ALLERGY CLIN IMMUN, V101, P141, DOI 10.1016/S0091-6749(98)70212-X; Ebi KL, 2008, ENVIRON HEALTH PERSP, V116, P1449, DOI 10.1289/ehp.11463; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gao Y, 2013, ATMOS CHEM PHYS, V13, P9607, DOI 10.5194/acp-13-9607-2013; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Harris JM, 2001, BRIT J DERMATOL, V144, P795, DOI 10.1046/j.1365-2133.2001.04135.x; Hashimoto M, 2004, PEDIATR INT, V46, P48, DOI 10.1111/j.1442-200X.2004.01835.x; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacob DJ, 2009, ATMOS ENVIRON, V43, P51, DOI 10.1016/j.atmosenv.2008.09.051; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kim MJ, 2015, ATMOS ENVIRON, V101, P103, DOI 10.1016/j.atmosenv.2014.11.016; Kim YM, 2015, CLIMATIC CHANGE, V128, P71, DOI 10.1007/s10584-014-1290-1; Korea Meteorological Administration (KMA), 2012, KOR PEN CLIM CHANG O; Kramer U, 2005, J INVEST DERMATOL, V124, P514, DOI 10.1111/j.0022-202X.2005.23625.x; Langan SM, 2006, BRIT J DERMATOL, V154, P979, DOI 10.1111/j.1365-2133.2006.07153.x; Lee JY, 2016, ATMOS POLLUT RES, V7, P664, DOI 10.1016/j.apr.2016.02.007; Lee JY, 2016, ATMOS ENVIRON, V127, P100, DOI 10.1016/j.atmosenv.2015.12.020; Lee YL, 2008, J INVEST DERMATOL, V128, P2412, DOI 10.1038/jid.2008.110; Lim YH, 2012, SCI TOTAL ENVIRON, V417, P55, DOI 10.1016/j.scitotenv.2011.12.048; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Suarez-Varela MM, 2008, INT J BIOMETEOROL, V52, P833, DOI 10.1007/s00484-008-0177-0; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Park YM, 2016, ASIAN PAC J ALLERGY, V34, P65, DOI 10.12932/AP0621.34.1.2016; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Sargen MR, 2014, J INVEST DERMATOL, V134, P51, DOI 10.1038/jid.2013.274; Schneider L, 2013, J ALLERGY CLIN IMMUN, V131, P295, DOI 10.1016/j.jaci.2012.12.672; Silverberg JI, 2013, J INVEST DERMATOL, V133, P1752, DOI 10.1038/jid.2013.19; Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x; Song S, 2011, ENVIRON RES, V111, P394, DOI 10.1016/j.envres.2010.10.010; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Stone MR, 2014, PREV MED, V65, P122, DOI 10.1016/j.ypmed.2014.05.008; Tagin MA, 2012, ARCH PEDIAT ADOLESC, V166, P707; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Uekert SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1375, DOI 10.1016/j.jaci.2006.09.008; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Xu ZW, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-12; Yu JS, 2012, J KOREAN MED SCI, V27, P681, DOI 10.3346/jkms.2012.27.6.681	48	49	52	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175229	10.1371/journal.pone.0175229	http://dx.doi.org/10.1371/journal.pone.0175229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384276	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900128
J	Lekander, I; Willers, C; von Euler, M; Lilja, M; Sunnerhagen, KS; Pessah-Rasmussen, H; Borgstrom, F				Lekander, Ingrid; Willers, Carl; von Euler, Mia; Lilja, Mikael; Sunnerhagen, Katharina S.; Pessah-Rasmussen, Helene; Borgstrom, Fredrik			Relationship between functional disability and costs one and two years post stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THROMBECTOMY; SWEDEN; CARE; THROMBOLYSIS; METAANALYSIS; QUALITY; TRIALS; BURDEN	Background and purpose Stroke affects mortality, functional ability, quality of life and incurs costs. The primary objective of this study was to estimate the costs of stroke care in Sweden by level of disability and stroke type (ischemic (IS) or hemorrhagic stroke (ICH)). Method Resource use during first and second year following a stroke was estimated based on a research database containing linked data from several registries. Costs were estimated for the acute and post-acute management of stroke, including direct (health care consumption and municipal services) and indirect (productivity losses) costs. Resources and costs were estimated per stroke type and functional disability categorised by Modified Rankin Scale (mRS). Results The results indicated that the average costs per patient following a stroke were 350,000SEKI 37,000-480,000SEKI 50,000, dependent on stroke type and whether it was the first or second year post stroke. Large variations were identified between different subgroups of functional disability and stroke type, ranging from annual costs of 100,000SEK/10,000-1,100,000SEK/120,000 per patient, with higher costs for patients with ICH compared to IS and increasing costs with more severe functional disability. Conclusion Functional outcome is a major determinant on costs of stroke care. The stroke type associated with worse outcome (ICH) was also consistently associated to higher costs. Measures to improve function are not only important to individual patients and their family but may also decrease the societal burden of stroke.	[Lekander, Ingrid; Willers, Carl] Ivbar Inst AB, Stockholm, Sweden; [Lekander, Ingrid; Borgstrom, Fredrik] Karolinska Inst, Med Management Ctr, LIME, Stockholm, Sweden; [Willers, Carl; von Euler, Mia] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [von Euler, Mia] Karolinska Inst, Stroke Res Network, Sodersjukhuset, Stockholm, Sweden; [Lilja, Mikael] Umea Univ, Ostersund Hosp, Dept Publ Hlth & Clin Med, Unit Res Educ & Dev, Ostersund, Sweden; [Sunnerhagen, Katharina S.] Univ Gothenburg, Inst Neurosci & Physiol, Rehabil Med, Gothenburg, Sweden; [Pessah-Rasmussen, Helene] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Pessah-Rasmussen, Helene] Skane Univ Hosp, Dept Neurol & Rehabil Med, Malmo, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Umea University; University of Gothenburg; Lund University; Lund University; Skane University Hospital	Lekander, I (corresponding author), Ivbar Inst AB, Stockholm, Sweden.; Lekander, I (corresponding author), Karolinska Inst, Med Management Ctr, LIME, Stockholm, Sweden.	ingrid.lekander@ivbar.com	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Willers, Carl/0000-0002-7616-9238; von Euler, Mia/0000-0002-3845-8100	Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care; Forte programme [2012/1688]	Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care; Forte programme	Funding for this research was provided by Sveus, a research collaboration in which seven Swedish regions develop systems for value-based monitoring and reimbursement of health care. Partial funding from Forte programme grant 2012/1688 ("Value and choice") is gratefully acknowledged.	AHLSIO B, 1984, STROKE, V15, P886, DOI 10.1161/01.STR.15.5.886; Aronsson M, 2016, NEUROLOGY, V86, P1053, DOI 10.1212/WNL.0000000000002439; Dawson J, 2007, STROKE, V38, P1893, DOI 10.1161/STROKEAHA.106.472381; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Ehlers L, 2007, STROKE, V38, P85, DOI 10.1161/01.STR.0000251790.19419.a8; Elgendy IY, 2015, J AM COLL CARDIOL, V66, P2498, DOI 10.1016/j.jacc.2015.09.070; Eriksson M, 2007, STROKE, V38, P1384, DOI 10.1161/01.STR.0000260102.97954.9c; Ghatnekar O, 2004, INT J TECHNOL ASSESS, V20, P375, DOI 10.1017/S0266462304001217; Ghatnekar O, 2014, INT J TECHNOL ASSESS, V30, P203, DOI 10.1017/S0266462314000075; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hodgson T, 1982, HEALTH SOC, V60, P429; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Joo H, 2014, J STROKE CEREBROVASC, V23, P1753, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.017; Lindgren P, 2008, EUR J CARDIOV PREV R, V15, P230, DOI 10.1097/HJR.0b013e3282f37a22; Lobotesis K, 2016, J MED ECON, P1; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Penaloza-Ramos MC, 2014, STROKE, V45, P553, DOI 10.1161/STROKEAHA.113.003216; Persson J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-341; Spieler JF, 2004, CEREBROVASC DIS, V17, P134, DOI 10.1159/000075782; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Yarbrough CK, 2015, STROKE, V46, P3177, DOI 10.1161/STROKEAHA.115.009847	21	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174861	10.1371/journal.pone.0174861	http://dx.doi.org/10.1371/journal.pone.0174861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384164	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900043
J	Onofre, T; Oliver, N; Carlos, R; Fellsmino, A; Corte, RC; Silva, E; Bruno, S				Onofre, Tatiana; Oliver, Nicole; Carlos, Renata; Fellsmino, Amanda; Corte, Renata Cristina; Silva, Eliane; Bruno, Selma			Oxygen uptake efficiency slope as a useful measure of cardiorespiratory fitness in morbidly obese women	PLOS ONE			English	Article							HEART-FAILURE; MINUTE VENTILATION; FUNCTIONAL RESERVE; EXERCISE CAPACITY; INDEX; REPRODUCIBILITY; INDIVIDUALS; RESPONSES; VALIDITY; ADULTS	Cardiopulmonary assessment through oxygen uptake efficiency slope (OUES) data has shown encouraging results, revealing that we can obtain important clinical information about functional status. Until now, the use of OUES has not been established as a measure of cardiorespiratory capacity in an obese adult population, only in cardiac and pulmonary diseases or pediatric patients. The aim of this study was to characterize submaximal and maximal levels of OUES in a sample of morbidly obese women and analyze its relationship with traditional measures of cardiorespiratory fitness, anthropometry and pulmonary function. Thirty-three morbidly obese women (age 39.1 +/- 9.2 years) performed Cardiopulmonary Exercise Testing (CPX) on a treadmill using the ramp protocol. In addition, anthropometric measurements and pulmonary function were also evaluated. Maximal and submaximal OUES were measured, being calculated from data obtained in the first 50% (OUES50%) and 75% (OUES75%) of total CPX duration. In one-way ANOVA analysis, OUES did not significantly differ between the three different exercise intensities, as observed through a Bland-Altman concordance of 58.9 mL/min/log(L/min) between OUES75% and OUES100%, and 0.49 mL/kg/min/log(l/min) between OUES/kg75% and OUES/kg100%. A strong positive correlation between the maximal (r = 0.79) and submaximal (r = 0.81) OUES/kg with oxygen consumption at peak exercise (VO2peak) and ventilatory anaerobic threshold (VO2VAT) was observed, and a moderate negative correlation with hip circumference (r = -0.46) and body adiposity index (r = -0.50) was also verified. There was no significant difference between maximal and submaximal OUES, showing strong correlations with each other and oxygen consumption (peak and VAT). These results indicate that OUES can be a useful parameter which could be used as a cardiopulmonary fitness index in subjects with severe limitations to perform CPX, as for morbidly obese women.	[Onofre, Tatiana; Oliver, Nicole; Carlos, Renata; Fellsmino, Amanda; Corte, Renata Cristina] Univ Fed Rio Grande do Norte, Postgrad Phys Therapy Program, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil; [Silva, Eliane] Univ Fed Rio Grande do Norte, Integrated Med Dept, Natal, RN, Brazil; [Bruno, Selma] Univ Fed Rio Grande do Norte, Phys Therapy Dept, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Bruno, S (corresponding author), Univ Fed Rio Grande do Norte, Phys Therapy Dept, Cardiopulm & Metab Rehabil Lab, Natal, RN, Brazil.	selma.bruno@gmail.com	Onofre, Tatiana/AAS-8968-2020	Onofre, Tatiana/0000-0003-4985-1466				Ammenwerth W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102333; Antoine-Jonville S, 2012, MED SCI SPORT EXER, V44, P428, DOI 10.1249/MSS.0b013e31822f8427; Arena R, 2014, PROG CARDIOVASC DIS, V56, P457, DOI 10.1016/j.pcad.2013.08.001; Arena R, 2012, INT J CARDIOL, V154, P384, DOI 10.1016/j.ijcard.2011.11.038; Arena R, 2010, INT J CARDIOL, V144, P101, DOI 10.1016/j.ijcard.2008.12.143; Arena R, 2009, J CARDIOPULM REHABIL, V29, P248, DOI 10.1097/HCR.0b013e3181a3338c; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; Baba R, 1999, J SPORT MED PHYS FIT, V39, P202; Babbo TG, 2008, CHEST, V134, P704, DOI 10.1378/chest.07-1728; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Barron A, 2016, JACC-HEART FAIL, V4, P252, DOI 10.1016/j.jchf.2015.11.003; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bongers BC, 2012, PEDIATR EXERC SCI, V24, P129, DOI 10.1123/pes.24.1.129; Breithaupt PG, 2012, PEDIATR EXERC SCI, V24, P357, DOI 10.1123/pes.24.3.357; Buys R, 2015, EUR J PREV CARDIOL, V22, P356, DOI 10.1177/2047487314547658; Santarem GCDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130268; de Souza SAF, 2005, OBES SURG, V15, P1238, DOI 10.1381/096089205774512627; deJong Adam T, 2008, Prev Cardiol, V11, P100; Di Thommazo-Luporini L, 2012, BRAZ J PHYS THER, V16, P469, DOI 10.1590/S1413-35552012005000036; Evans RA, 2014, CHEST, V146, P81, DOI 10.1378/chest.13-2060; Giardini A, 2009, INT J CARDIOL, V133, P74, DOI 10.1016/j.ijcard.2007.11.092; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Heine M, 2014, J REHABIL MED, V46, P656, DOI 10.2340/16501977-1825; Herdy AH, 2016, ARQ BRAS CARDIOL, V106, P389, DOI 10.5935/abc.20160070; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Hulens M, 2001, SCAND J MED SCI SPOR, V11, P305, DOI 10.1034/j.1600-0838.2001.110509.x; King WC, 2012, SURG OBES RELAT DIS, V8, P48, DOI 10.1016/j.soard.2011.07.003; Kress JP, 1999, AM J RESP CRIT CARE, V160, P883, DOI 10.1164/ajrccm.160.3.9902058; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Lorenzo S, 2013, CHEST, V144, P1330, DOI 10.1378/chest.12-3022; Marinov B, 2003, Acta Physiol Pharmacol Bulg, V27, P59; Miller WM, 2012, OBESITY, V20, P505, DOI 10.1038/oby.2011.262; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Ofir D, 2007, J APPL PHYSIOL, V102, P2217, DOI 10.1152/japplphysiol.00898.2006; Oliver N, 2015, OBES SURG, V25, P1658, DOI 10.1007/s11695-014-1548-8; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Ramos RP, 2014, EUR RESPIR J, V43, P1510, DOI 10.1183/09031936.00167713; Runhaar J, 2011, OBES REV, V12, P1071, DOI 10.1111/j.1467-789X.2011.00916.x; Silva OB, 2003, ARQ BRAS CARDIOL, V81, P42, DOI DOI 10.1590/S0066-782X2003000900004; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Van Laethem C, 2005, AM HEART J, V149, P175, DOI 10.1016/j.ahj.2004.07.004; Van Laethem C, 2009, EUR J CARDIOV PREV R, V16, P493, DOI 10.1097/HJR.0b013e32832c88a8; Wasserman K, 2005, PRINCIPLES EXERCISE; Wasserman K, 1990, CIRCULATION S2, V81, P1114	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0172894	10.1371/journal.pone.0172894	http://dx.doi.org/10.1371/journal.pone.0172894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384329	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900003
J	Simis, SGH; Ylostalo, P; Kallio, KY; Spilling, K; Kutser, T				Simis, Stefan G. H.; Ylostalo, Pasi; Kallio, Kari Y.; Spilling, Kristian; Kutser, Tiit			Contrasting seasonality in optical-biogeochemical properties of the Baltic Sea	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; LIGHT-SCATTERING; CYANOBACTERIAL BLOOMS; SPECTRAL ABSORPTION; PARTICULATE MATTER; MARINE PARTICLES; TRANSITION ZONE; CDOM ABSORPTION; PHYTOPLANKTON; COASTAL	Optical-biogeochemical relationships of particulate and dissolved organic matter are presented in support of remote sensing of the Baltic Sea pelagic. This system exhibits strong seasonality in phytoplankton community composition and wide gradients of chromophoric dissolved organic matter (CDOM), properties which are poorly handled by existing remote sensing algorithms. Absorption and scattering properties of particulate matter reflected the seasonality in biological (phytoplankton succession) and physical (thermal stratification) processes. Inherent optical properties showed much wider variability when normalized to the chlorophyll-a concentration compared to normalization to either total suspended matter dry weight or particulate organic carbon. The particle population had the largest optical variability in summer and was dominated by organic matter in both seasons. The geographic variability of CDOM and relationships with dissolved organic carbon (DOC) are also presented. CDOM dominated light absorption at blue wavelengths, contributing 81% (median) of the absorption by all water constituents at 400 nm and 63% at 442 nm. Consequentially, 90% of water-leaving radiance at 412 nm originated from a layer (z(90)) no deeper than approximately 1.0 m. With water increasingly attenuating light at longer wavelengths, a green peak in light penetration and reflectance is always present in these waters, with z(90) up to 3.0-3.5 m depth, whereas z(90) only exceeds < 5 m at biomass < 5 mg Chla m(-3). High absorption combined with a weakly scattering particle population (despite median phytoplankton biomass of 14.1 and 4.3 mg Chla m(-3) in spring and summer samples, respectively), characterize this sea as a dark water body for which dedicated or exceptionally robust remote sensing techniques are required. Seasonal and regional optical-biogeochemical models, data distributions, and an extensive set of simulated remote-sensing reflectance spectra for testing of remote sensing algorithms are provided as supplementary data.	[Simis, Stefan G. H.] Plymouth Marine Lab, Plymouth, Devon, England; [Simis, Stefan G. H.; Ylostalo, Pasi; Kallio, Kari Y.; Spilling, Kristian] Marine Res Ctr, Finnish Environm Inst SYKE, Helsinki, Finland; [Kutser, Tiit] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	Plymouth Marine Laboratory; Finnish Environment Institute; University of Tartu; Estonian Marine Institute	Simis, SGH (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.; Simis, SGH (corresponding author), Marine Res Ctr, Finnish Environm Inst SYKE, Helsinki, Finland.	stsi@pml.ac.uk	Spilling, Kristian/L-7932-2014; Kutser, Tiit/H-1304-2015	Spilling, Kristian/0000-0002-8390-8270; Ylostalo, Pasi/0000-0003-4702-2840; Simis, Stefan/0000-0002-6296-9146	EOMORE (SYKE); Algalume (Academy of Finland) [132409]; EC FP7 projects PROTOOL [226880]; WaterS [251527]; CoBiOS [263295]; Jerico [262584]; DEVOTES [308392]; BONUS FerryScope; INTERREG IV Central Baltic project GES-REG; LIFE+ MARMONI [LIFE09/NAT/LV/000238]; Estonian Basic Research [SF0180009s11]	EOMORE (SYKE); Algalume (Academy of Finland); EC FP7 projects PROTOOL; WaterS; CoBiOS; Jerico; DEVOTES; BONUS FerryScope; INTERREG IV Central Baltic project GES-REG; LIFE+ MARMONI; Estonian Basic Research	This work was financially supported through projects EOMORE (SYKE), Algalume (Academy of Finland grant 132409), EC FP7 projects PROTOOL (Grant 226880), WaterS (251527), CoBiOS (263295), Jerico (262584), DEVOTES (308392) and BONUS FerryScope, INTERREG IV Central Baltic project GES-REG and LIFE+ MARMONI (LIFE09/NAT/LV/000238), and Estonian Basic Research Grant SF0180009s11.	Aarnos H, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2010JG001633; AHN YH, 1992, DEEP-SEA RES, V39, P1835, DOI 10.1016/0198-0149(92)90002-B; Asmala E, 2013, BIOGEOSCIENCES, V10, P6969, DOI 10.5194/bg-10-6969-2013; Asmala E, 2012, ESTUAR COAST SHELF S, V111, P107, DOI 10.1016/j.ecss.2012.06.015; Attila J, 2013, REMOTE SENS ENVIRON, V128, P138, DOI 10.1016/j.rse.2012.07.009; Babin M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000882; Babin M, 2003, LIMNOL OCEANOGR, V48, P843, DOI 10.4319/lo.2003.48.2.0843; Berthon JF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043227; Boss E, 2001, APPL OPTICS, V40, P5503, DOI 10.1364/AO.40.005503; Bowers DG, 2008, J MARINE SYST, V73, P1, DOI 10.1016/j.jmarsys.2007.07.001; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Bryant D. A., 1986, PHOTOSYNTHETIC PICOP, V214, P423; Darecki M, 2005, INT J REMOTE SENS, V26, P247, DOI 10.1080/01431160410001720298; Darecki M, 2004, REMOTE SENS ENVIRON, V89, P326, DOI 10.1016/j.rse.2003.10.012; Doxaran D, 2009, LIMNOL OCEANOGR, V54, P1257, DOI 10.4319/lo.2009.54.4.1257; Ferrari GM, 1998, ESTUAR COAST SHELF S, V47, P91, DOI 10.1006/ecss.1997.0309; Fleming V, 2006, HYDROBIOLOGIA, V554, P57, DOI 10.1007/s10750-005-1006-7; GORDON HR, 1975, APPL OPTICS, V14, P413, DOI 10.1364/AO.14.000413; Groetsch PMM, 2016, BIOGEOSCIENCES, V13, P4959, DOI 10.5194/bg-13-4959-2016; Groetsch PMM, 2014, J MARINE SYST, V140, P50, DOI 10.1016/j.jmarsys.2014.05.015; Hakanson L, 2005, ECOL MODEL, V189, P130, DOI 10.1016/j.ecolmodel.2005.03.015; Harvey ET, 2015, AMBIO, V44, pS392, DOI 10.1007/s13280-015-0658-4; Haverkamp THA, 2009, ISME J, V3, P397, DOI 10.1038/ismej.2008.118; HELCOM, 2013, APPR METH EUTR TARG; HELCOM, 2013, 5 BALT SEA POLL LOAD; Hojerslev NK, 1996, CONT SHELF RES, V16, P1329, DOI 10.1016/0278-4343(95)00075-5; Hojersley NK, 1988, NATURAL OCCURENCES O; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Johnsen G, 1996, SCI MAR, V60, P47; Kahru M, 2007, MAR ECOL PROG SER, V343, P15, DOI 10.3354/meps06943; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kowalczuk P, 2005, INT J REMOTE SENS, V26, P345, DOI 10.1080/01431160410001720270; Kowalczuk P, 1999, J GEOPHYS RES-OCEANS, V104, P30047, DOI 10.1029/1999JC900198; Kowalczuk P, 2006, MAR CHEM, V101, P1, DOI 10.1016/j.marchem.2005.12.005; Kratzer S, 2003, AMBIO, V32, P577, DOI 10.1639/0044-7447(2003)032[0577:ASAPZD]2.0.CO;2; Kutser T, 2004, LIMNOL OCEANOGR, V49, P2179, DOI 10.4319/lo.2004.49.6.2179; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P303, DOI 10.1016/j.ecss.2005.11.024; Kutser T, 2008, ESTUAR COAST SHELF S, V78, P649, DOI 10.1016/j.ecss.2008.02.024; Kutser T, 2009, BOREAL ENVIRON RES, V14, P305; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Matthews MW, 2013, BIOGEOSCIENCES, V10, P8139, DOI 10.5194/bg-10-8139-2013; Mitchell BG, 1990, OCEAN OPTICS; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Olenina I, 2006, BIOVOLUMES SIZE CLAS, P408; Petzold T.J., 1977, LIGHT SEA, P152; Seppala J, 2005, INT J REMOTE SENS, V26, P387, DOI 10.1080/01431160410001723682; Simis SGH, 2012, LIMNOL OCEANOGR-METH, V10, P214, DOI 10.4319/lom.2012.10.214; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Stedmon CA, 2000, ESTUAR COAST SHELF S, V51, P267, DOI 10.1006/ecss.2000.0645; Stedmon CA, 2010, ESTUAR COAST SHELF S, V87, P156, DOI 10.1016/j.ecss.2009.12.022; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Volten H, 1998, LIMNOL OCEANOGR, V43, P1180, DOI 10.4319/lo.1998.43.6.1180; Whitmire AL, 2010, OPT EXPRESS, V18, P15073, DOI 10.1364/OE.18.015073; YENTSCH CS, 1962, LIMNOL OCEANOGR, V7, P207, DOI 10.4319/lo.1962.7.2.0207; Ylostalo P, 2016, MAR CHEM, V186, P58, DOI 10.1016/j.marchem.2016.07.004; Zhou W, 2012, OPT EXPRESS, V20, P11189, DOI 10.1364/OE.20.011189	57	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173357	10.1371/journal.pone.0173357	http://dx.doi.org/10.1371/journal.pone.0173357			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384157	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000399371900007
J	Ahmad, I; Gribble, A; Murtza, I; Ikram, M; Pop, M; Vitkin, A				Ahmad, Iftikhar; Gribble, Adam; Murtza, Iqbal; Ikram, Masroor; Pop, Mihaela; Vitkin, Alex			Polarization image segmentation of radiofrequency ablated porcine myocardial tissue	PLOS ONE			English	Article							CATHETER ABLATION; SHRINKAGE; VISUALIZATION; POLARIMETRY; LIGHT	Optical polarimetry has previously imaged the spatial extent of a typical radiofrequency ablated (RFA) lesion in myocardial tissue, exhibiting significantly lower total depolarization at the necrotic core compared to healthy tissue, and intermediate values at the RFA rim region. Here, total depolarization in ablated myocardium was used to segment the total depolarization image into three (core, rim and healthy) zones. A local fuzzy thresholding algorithm was used for this multi- region segmentation, and then compared with a ground truth segmentation obtained from manual demarcation of RFA core and rim regions on the histopathology image. Quantitative comparison of the algorithm segmentation results was performed with evaluation metrics such as dice similarity coefficient (DSC = 0.78 +/- 0.02 and 0.80 +/- 0.02), sensitivity (S-n = 0.83 +/- 0.10 and 0.91 +/- 0.08), specificity (S-p = 0.76 +/- 0.17 and 0.72 +/- 0.17) and accuracy (Acc = 0.81 +/- 0.09 and 0.71 +/- 0.10) for RFA core and rim regions, respectively. This automatic segmentation of parametric depolarization images suggests a novel application of optical polarimetry, namely its use in objective RFA image quantification.	[Ahmad, Iftikhar; Ikram, Masroor] PIEAS, Dept Phys & Appl Math, Islamabad, Pakistan; [Gribble, Adam; Vitkin, Alex] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gribble, Adam; Vitkin, Alex] Univ Hlth Network, Princess Margaret Canc Ctr, Div Biophys & Bioimaging, 610 Univ Ave, Toronto, ON, Canada; [Murtza, Iqbal] PIEAS, Dept Comp & Informat Sci, Islamabad, Pakistan; [Pop, Mihaela] Univ Toronto, Sunnybrook Res Inst, Dept Med Biophys, 2075 Bayview Ave, Toronto, ON, Canada; [Vitkin, Alex] Univ Toronto, Dept Radiat Oncol, 610 Univ Ave, Toronto, ON, Canada	Pakistan Institute of Engineering & Applied Science; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Pakistan Institute of Engineering & Applied Science; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Ahmad, I (corresponding author), PIEAS, Dept Phys & Appl Math, Islamabad, Pakistan.	iahmadmp@gmail.com	Pop, Mihaela/AAO-8942-2020; Ahmad, Iftikhar/AAB-7802-2019; Vitkin, Alex/I-8166-2012	Ahmad, Iftikhar/0000-0002-2377-5808; Vitkin, Alex/0000-0001-5495-8888; Murtza, Iqbal/0000-0001-7541-8581	Natural Sciences and Engineering Research Council of Canada (NSERC) [707606790]; Higher Education Commission of Pakistan [HEC/IRSIP-27-PS-21]; IT Endowment and Telecom Fund [ITETF/13579]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IT Endowment and Telecom Fund	This work was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) - http://www.nserc-crsng.gc.ca/index_eng.asp - 707606790 awarded to AV, Higher Education Commission of Pakistan - http://www.hec.gov.pk/english/Pages/Home.aspx - HEC/IRSIP-27-PS-21 awarded to MI, IT Endowment and Telecom Fund - http://www.pieas.edu.pk/admissions/default_ms.cshtml - ITETF/13579 awarded to IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahirwar Anamika, 2013, International Journal of Information Technology and Computer Science, V5, P44, DOI 10.5815/ijitcs.2013.05.06; Ahmad I, 2015, J BIOPHOTONICS, V10, P1; Ahmad I, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.056012; Aja-Fernandez S, 2015, KNOWL-BASED SYST, V83, P1, DOI 10.1016/j.knosys.2015.02.029; Alali S, 2014, BIOMED OPT EXPRESS, V5, P621, DOI 10.1364/BOE.5.000621; Alali S, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003250; Alali S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.086010; Alali S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.045004; Chen CH, 2012, J CHIN MED ASSOC, V75, P109, DOI 10.1016/j.jcma.2012.02.006; Dana N, 2014, HEART RHYTHM, V11, P150, DOI 10.1016/j.hrthm.2013.09.071; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egger J, 2015, IEEE ENG MED BIO, P2423, DOI 10.1109/EMBC.2015.7318883; Eyerly SA, 2010, J CARDIOVASC ELECTR, V21, P557, DOI 10.1111/j.1540-8167.2009.01664.x; Fleming CP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3459134; Fleming CP, 2010, OPT EXPRESS, V18, P3079, DOI 10.1364/OE.18.003079; Fred HL, 2004, TEX HEART I J, V31, P345; Gardner ES, 2001, DERMATOL SURG, V27, P813, DOI 10.1046/j.1524-4725.2001.01017.x; Ghosh N, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3652896; Guo X, 2008, OPT COMMUN, V281, P380, DOI 10.1016/j.optcom.2007.09.043; Herranz D, 2015, BIOMED OPT EXPRESS, V6, P3268, DOI 10.1364/BOE.6.003268; Jacques SL, 2002, J BIOMED OPT, V7, P329, DOI 10.1117/1.1484498; Lardo AC, 2000, CIRCULATION, V102, P698, DOI 10.1161/01.CIR.102.6.698; Lazebnik RS, 2005, ACAD RADIOL, V12, P1491, DOI 10.1016/j.acra.2005.07.011; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106; Manhas S, 2015, OPT EXPRESS, V23, P3047, DOI 10.1364/OE.23.003047; O'Hara GE, 2007, CAN J CARDIOL, V23, p67B, DOI 10.1016/S0828-282X(07)71013-9; Olabarriaga SD, 2001, MED IMAGE ANAL, V5, P127, DOI 10.1016/S1361-8415(00)00041-4; Pang GA, 2015, J CARDIOVASC ELECTR, V26, P339, DOI 10.1111/jce.12584; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pierangelo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046014; Pierangelo A, 2013, OPT EXPRESS, V21, P14120, DOI 10.1364/OE.21.014120; Pierangelo A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066009; Pop M, 2003, PHYS MED BIOL, V48, P2509, DOI 10.1088/0031-9155/48/15/317; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Stevenson WG, 2000, HEART, V84, P553, DOI 10.1136/heart.84.5.553; Stevenson WG, 2010, LANCET, V375, P4, DOI 10.1016/S0140-6736(09)61915-2; Swartling J, 2003, MED BIOL ENG COMPUT, V41, P403, DOI 10.1007/BF02348082; Tata A, 2015, CHEM SCI; Thomsen S, 1999, P SOC PHOTO-OPT INS, V3594, P82, DOI 10.1117/12.348748; Tobias OJ, 2002, IEEE T IMAGE PROCESS, V11, P1457, DOI 10.1109/TIP.2002.806231; Tung R, 2010, CIRCULATION, V122, pE389, DOI 10.1161/CIRCULATIONAHA.110.963371; Wallenburg MA, 2010, J INNOV OPT HEAL SCI, V3, P109, DOI 10.1142/S1793545810000976; Wood MFG, 2011, PHYS MED BIOL, V56, pN115, DOI 10.1088/0031-9155/56/8/N01; Wood MFG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469844; Wright M, 2011, HEART RHYTHM, V8, P304, DOI 10.1016/j.hrthm.2010.10.039; Wu HS, 2000, J MICROSC-OXFORD, V197, P296, DOI 10.1046/j.1365-2818.2000.00653.x; Yeap BH, 2007, ASIAN J SURG, V30, P183, DOI 10.1016/S1015-9584(08)60020-2; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175173	10.1371/journal.pone.0175173	http://dx.doi.org/10.1371/journal.pone.0175173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380013	gold, Green Published, Green Submitted			2022-12-26	WOS:000399353500105
J	Buttelmann, D; Buttelmann, F; Carpenter, M; Call, J; Tomasello, M				Buttelmann, David; Buttelmann, Frances; Carpenter, Melinda; Call, Josep; Tomasello, Michael			Great apes distinguish true from false beliefs in an interactive helping task	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; HUMAN INFANTS; CHILDREN; REPRESENTATION; ATTRIBUTION; IMITATION; IMPLICIT	Understanding the behavior of others in a wide variety of circumstances requires an understanding of their psychological states. Humans' nearest primate relatives, the great apes, understand many psychological states of others, for example, perceptions, goals, and desires. However, so far there is little evidence that they possess the key marker of advanced human social cognition: an understanding of false beliefs. Here we demonstrate that in a nonverbal (implicit) false-belief test which is passed by human 1-year-old infants, great apes as a group, including chimpanzees (Pan troglodytes), bonobos (Pan paniscus), and orangutans (Pongo abelii), distinguish between true and false beliefs in their helping behavior. Great apes thus may possess at least some basic understanding that an agent's actions are based on her beliefs about reality. Hence, such understanding might not be the exclusive province of the human species.	[Buttelmann, David; Carpenter, Melinda; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany; [Buttelmann, David] Univ Bern, Dept Dev Psychol, Fabrikstr 8, Bern, Switzerland; [Buttelmann, Frances] Friedrich Schiller Univ Jena, Dept Dev Psychol, Steiger 3-1, Jena, Germany; [Buttelmann, Frances; Carpenter, Melinda; Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Max Planck Society; University of Bern; Friedrich Schiller University of Jena; University of St Andrews; Duke University	Buttelmann, D (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany.; Buttelmann, D (corresponding author), Univ Bern, Dept Dev Psychol, Fabrikstr 8, Bern, Switzerland.	david.buttelmann@eva.mpg.de		Carpenter, Malinda/0000-0003-3983-2034; Call Balaguer, Josep/0000-0002-8597-8336				[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Buttelmann D, 2008, ANIM COGN, V11, P117, DOI 10.1007/s10071-007-0095-2; Buttelmann D, 2012, ANIM COGN, V15, P1037, DOI 10.1007/s10071-012-0528-4; Buttelmann D, 2009, COGNITION, V112, P337, DOI 10.1016/j.cognition.2009.05.006; Buttelmann D, 2009, DEVELOPMENTAL SCI, V12, P688, DOI 10.1111/j.1467-7687.2008.00802.x; Call J, 1998, J COMP PSYCHOL, V112, P192, DOI 10.1037/0735-7036.112.2.192; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hare B, 1999, ANIM BEHAV, V59, P771; He ZJ, 2011, DEVELOPMENTAL SCI, V14, P292, DOI 10.1111/j.1467-7687.2010.00980.x; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; KRACHUN C., 2010, INT J COMP PSYCHOL, V23, P145; Krachun C, 2009, DEVELOPMENTAL SCI, V12, P521, DOI 10.1111/j.1467-7687.2008.00793.x; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Martin A, 2014, COGNITION, V130, P300, DOI 10.1016/j.cognition.2013.11.016; Myowa-Yamakoshi M, 1999, J COMP PSYCHOL, V113, P128, DOI 10.1037/0735-7036.113.2.128; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Scott RM, 2010, COGNITIVE PSYCHOL, V61, P366, DOI 10.1016/j.cogpsych.2010.09.001; Scott RM, 2009, CHILD DEV, V80, P1172, DOI 10.1111/j.1467-8624.2009.01324.x; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Thoermer C, 2012, BRIT J DEV PSYCHOL, V30, P172, DOI 10.1111/j.2044-835X.2011.02067.x; Tomasello M, 2005, MONOGRAPHS SOC RES C, P70; Trauble B, 2010, INFANCY, V15, P434, DOI 10.1111/j.1532-7078.2009.00025.x; Voelter C, APA HDB COM IN PRESS; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	35	57	58	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173793	10.1371/journal.pone.0173793	http://dx.doi.org/10.1371/journal.pone.0173793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379987	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500024
J	Chen, H; Chen, LJ				Chen, Hai; Chen, Lijun			Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 1 INFECTION; RANDOMIZED CONTROLLED-TRIAL; VIRUS-RELATED CIRRHOSIS; HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; NATURAL-HISTORY; LIVER-DISEASE; FOLLOW-UP; FIBROSIS PROGRESSION	Background All-oral regimens are associated with higher effectiveness and shorter treatment duration for chronic hepatitis C. Given its superior effect and enormous patients in China, clinicians or patients may be compelled to consider delaying treatment for all-oral regimen. Objective To estimate cost-effectiveness of delaying treatment for all-oral regimen in the subsequent years under different assumptions about their price and efficacy compared with standard of care in China. Methods A state-transition Markov model was developed to estimate lifetime costs and quality-adjusted life years (QALYs). Incremental cost-effectiveness ratio (ICER) and net monetary benefit (NB) were calculated. And sensitivity analyses were also performed to assess the impact of uncertainty. Results For treatment naive patients with Genotype 1, immediate treatment with all-oral regimen under assumed cost and efficacy at present was cost-effective compared with peginterferon alpha-2a (PegIFN) regimen at present with an ICER of $12536 per QALY gained and a positive NB of $6832 at a willingness-to-pay threshold of $21209. And it was more than 95% likely to be cost-effective if weekly drug cost was less than $1000. Moreover, patients delaying treatment for all-oral regimen in the 1st year were associated with increase in QALYs of 0.62 and increase in cost of $10114 compared with initiating PegIFN regimen at present, which resulted in a positive NB of $3115. Conclusion From a payer perspective, all-oral regimen is associated with good long-term health and economic benefit for treatment-naive patients infected with HCV genotype 1. Particularly, if all-oral regimen would become available at lower price in the future, delaying treatment for all-oral regimen may be a good choice for patients in China.	[Chen, Hai; Chen, Lijun] Wuxi Ctr Dis Control & Prevent, Dept Infect Dis Control, Wuxi, Jiangsu, Peoples R China		Chen, H (corresponding author), Wuxi Ctr Dis Control & Prevent, Dept Infect Dis Control, Wuxi, Jiangsu, Peoples R China.	dr.chenhai@outlook.com			Scientific Research Program of Jiangsu Province "333" Project [BRA2014042]; Scientific Research Project of Wuxi Health Bureau [Z201304]	Scientific Research Program of Jiangsu Province "333" Project; Scientific Research Project of Wuxi Health Bureau	This work was supported by the Scientific Research Program of Jiangsu Province "333" Project (BRA2014042) and Scientific Research Project of Wuxi Health Bureau (Z201304).	Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chinese Society of Hepatology, 2015, CHINESE HEPATOLOGY, V33, P192; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Deuffic-Burban S, 2014, J HEPATOL, V61, P7, DOI 10.1016/j.jhep.2014.03.011; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Duan ZP, 2014, VALUE HEALTH, V17, pA805, DOI 10.1016/j.jval.2014.08.515; Duan ZP, 2014, J CLIN GASTROENTEROL, V48, P679, DOI 10.1097/MCG.0000000000000109; Feng B, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-47; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hao XG, 2011, J PRACTICAL HEPATOLO, V14, P436; Hiligsmann M, 2009, VALUE HEALTH, V12, P687, DOI 10.1111/j.1524-4733.2008.00497.x; Hu M, 2009, VALUE HEALTH, V12, pS89, DOI 10.1111/j.1524-4733.2009.00636.x; Hui AY, 2002, J CLIN GASTROENTEROL, V34, P569, DOI 10.1097/00004836-200205000-00018; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kuwabara H, 2015, J MED ECON, V18, P502, DOI 10.3111/13696998.2015.1029492; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Li JF, 2014, INT J INFECT DIS, V27, P49, DOI 10.1016/j.ijid.2014.07.003; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Liu JP, 2012, EUR J GASTROEN HEPAT, V24, P186, DOI 10.1097/MEG.0b013e32834dda64; Mao WCW, 2012, CHINA J PHARM EC, V1, P6; Martinot-Peignoux M, 2010, HEPATOLOGY, V51, P1122, DOI 10.1002/hep.23444; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; National Bureau of Statistics of China, CENS DAT; National Bureau of Statistics of China, NAT DAT; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Rao HY, 2012, J GASTROEN HEPATOL, V27, P526, DOI 10.1111/j.1440-1746.2011.06880.x; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Toy M, 2014, HEPATOLOGY, V60, P46, DOI 10.1002/hep.26934; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wang SB, 2012, CHINESE MED J-PEKING, V125, P2157, DOI 10.3760/cma.j.issn.0366-6999.2012.12.014; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Zhang C, 2015, CLIN DRUG INVEST, V35, P197, DOI 10.1007/s40261-015-0273-y; Zhao SH, 2009, INT J CLIN PRACT, V63, P1334, DOI 10.1111/j.1742-1241.2009.02082.x	47	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175189	10.1371/journal.pone.0175189	http://dx.doi.org/10.1371/journal.pone.0175189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380022	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500106
J	Chow, NA; Lindsley, MD; McCotter, OZ; Kangiser, D; Wohrle, RD; Clifford, WR; Yaglom, HD; Adams, LE; Komatsu, K; Durkin, MM; Baker, RJ; Shubitz, LF; Derado, G; Chiller, TM; Litvintseva, AP				Chow, Nancy A.; Lindsley, Mark D.; McCotter, Orion Z.; Kangiser, Dave; Wohrle, Ron D.; Clifford, Wayne R.; Yaglom, Hayley D.; Adams, Laura E.; Komatsu, Kenneth; Durkin, Michelle M.; Baker, Rocky J.; Shubitz, Lisa F.; Derado, Gordana; Chiller, Tom M.; Litvintseva, Anastasia P.			Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species	PLOS ONE			English	Article							WASHINGTON-STATE; IMMITIS; INFECTION; ANIMALS; SEROPREVALENCE; HISTOPLASMIN; SENSITIVITY; ENDEMICITY; CALIFORNIA; SEROLOGY	Coccidioides is a soil-dwelling fungus that causes coccidioidomycosis, a disease also known as Valley fever, which affects humans and a variety of animal species. Recent findings of Coccidioides in new, unexpected areas of the United States have demonstrated the need for a better understanding of its geographic distribution. Large serological studies on animals could provide important information on the geographic distribution of this pathogen. To facilitate such studies, we used protein A/G, a recombinant protein that binds IgG antibodies from a variety of mammalian species, to develop an enzyme immunoassay (EIA) that detects IgG antibodies against Coccidioides in a highly sensitive and high-throughput manner. We showed the potential of this assay to be adapted to multiple animal species by testing a collection of serum and/or plasma samples from dogs, mice, and humans with or without confirmed coccidioidomycosis. We then evaluated the performance of the assay in dogs, using sera from dogs residing in a highly endemic area, and found seropositivity rates significantly higher than those in dogs of non-endemic areas. We further evaluated the specificity of the assay in dogs infected with other fungal pathogens known to cross-react with Coccidioides. Finally, we used the assay to perform a cross-sectional serosurvey investigating dogs from Washington, a state in which infection with Coccidioides has recently been documented. In summary, we have developed a Coccidioides EIA for the detection of antibodies in canines that is more sensitive and has higher throughput than currently available methods, and by testing this assay in mice and humans, we have shown a proof of principle of its adaptability for other animal species.	[Chow, Nancy A.; Lindsley, Mark D.; McCotter, Orion Z.; Chiller, Tom M.; Litvintseva, Anastasia P.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA; [Kangiser, Dave; Wohrle, Ron D.; Clifford, Wayne R.] Washington State Dept Hlth, Off Environm Publ Hlth Sci, Zoonot Dis Program, Olympia, WA USA; [Yaglom, Hayley D.; Adams, Laura E.; Komatsu, Kenneth] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Durkin, Michelle M.] MiraVista Diagnost, Indianapolis, IN USA; [Baker, Rocky J.] Oregon State Univ, Oregon Vet Diagnost Lab, Corvallis, OR 97331 USA; [Shubitz, Lisa F.] Univ Arizona, Valley Fever Ctr Excellence, Tucson, AZ USA; [Derado, Gordana] Ctr Dis Control & Prevent, Biostat & Informat Management Off, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Adams, Laura E.] Ctr Dis Control & Prevent, Field Serv Branch, Div State & Local Readiness, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Arizona Department of Health Services; Oregon State University; University of Arizona; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Chow, NA; Litvintseva, AP (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA.	yln3@cdc.gov; frg8@cdc.gov	Galgiani, John/GLT-7012-2022					Ashburn LL, 1942, ARCH PATHOL, V34, P791; Benedict K, 2015, EMERG INFECT DIS, V21, P1935, DOI 10.3201/eid2111.141950; Bhide MR, 2004, COMP IMMUNOL MICROB, V27, P191, DOI 10.1016/j.cimid.2003.10.001; COWPER H. H., 1953, CALIFORNIA MED, V79, P97; DOTO IL, 1972, AM J EPIDEMIOL, V95, P464, DOI 10.1093/oxfordjournals.aje.a121413; Durkin M, 2008, CLIN INFECT DIS, V47, pE69, DOI 10.1086/592073; EDWARDS PQ, 1957, DIS CHEST, V31, P35, DOI 10.1378/chest.31.1.35; ELIASSON M, 1988, J BIOL CHEM, V263, P4323; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Gautam R, 2013, ZOONOSES PUBLIC HLTH, V60, P174, DOI 10.1111/j.1863-2378.2012.01526.x; Graupmann-Kuzma A, 2008, J AM ANIM HOSP ASSOC, V44, P226, DOI 10.5326/0440226; Grayzel SE, 2016, TRANSBOUND EMERG DIS; Higgins JC, 2005, JAVMA-J AM VET MED A, V226, P1888, DOI 10.2460/javma.2005.226.1888; Huckabone SE, 2015, J WILDLIFE DIS, V51, P295, DOI 10.7589/2014-06-143; HUPPERT M, 1982, MYCOPATHOLOGIA, V78, P107, DOI 10.1007/BF00442634; KAUFMAN L, 1995, J CLIN MICROBIOL, V33, P618, DOI 10.1128/JCM.33.3.618-619.1995; Kirsch EJ, 2012, CLIN VACCINE IMMUNOL, V19, P343, DOI 10.1128/CVI.05631-11; Lindsley MD, 2015, CLIN VACCINE IMMUNOL, V22, P1090, DOI 10.1128/CVI.00375-15; Litvintseva AP, 2015, CLIN INFECT DIS, V60, pE1, DOI 10.1093/cid/ciu681; MADDY K T, 1965, Ariz Med, V22, P281; MADDY KT, 1960, PUBLIC HEALTH REP, V75, P955, DOI 10.2307/4590968; Marsden-Haug N, 2013, CLIN INFECT DIS, V56, P847, DOI 10.1093/cid/cis1028; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; PAPPAGIANIS D, 1990, CLIN MICROBIOL REV, V3, P247, DOI 10.1128/CMR.3.3.247-268.1990; Pappagianis D, 2001, Semin Respir Infect, V16, P242, DOI 10.1053/srin.2001.29315; Shubitz LF, 2005, JAVMA-J AM VET MED A, V226, P1846, DOI 10.2460/javma.2005.226.1846; Shubitz LE, 2007, ANN NY ACAD SCI, V1111, P395, DOI 10.1196/annals.1406.007; SUN SH, 1979, SABOURAUDIA, V17, P265; Wack EE, 2015, CLIN INFECT DIS, V61, P787, DOI 10.1093/cid/civ388; Zhang DL, 2010, CLIN VACCINE IMMUNOL, V17, P485, DOI 10.1128/CVI.00479-09	30	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175081	10.1371/journal.pone.0175081	http://dx.doi.org/10.1371/journal.pone.0175081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380017	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500095
J	Kim, S; Blake, R; Lee, M; Kim, CY				Kim, Sujin; Blake, Randolph; Lee, Minyoung; Kim, Chai-Youn			Audio-visual interactions uniquely contribute to resolution of visual conflict in people possessing absolute pitch	PLOS ONE			English	Article							BINOCULAR-RIVALRY; STOCHASTIC PROPERTIES; FUNCTIONAL-ANATOMY; PLANUM TEMPORALE; PROCESS TONES; PERCEPTION; RECOGNITION; MEMORY; BRAIN; CONNECTIVITY	Individuals possessing absolute pitch (AP) are able to identify a given musical tone or to reproduce it without reference to another tone. The present study sought to learn whether this exceptional auditory ability impacts visual perception under stimulus conditions that provoke visual competition in the form of binocular rivalry. Nineteen adult participants with 3-19 years of musical training were divided into two groups according to their performance on a task involving identification of the specific note associated with hearing a given musical pitch. During test trials lasting just over half a minute, participants dichoptically viewed a scrolling musical score presented to one eye and a drifting sinusoidal grating presented to the other eye; throughout the trial they pressed buttons to track the alternations in visual awareness produced by these dissimilar monocular stimuli. On "pitch-congruent" trials, participants heard an auditory melody that was congruent in pitch with the visual score, on "pitch-incongruent" trials they heard a transposed auditory melody that was congruent with the score in melody but not in pitch, and on "melody-incongruent" trials they heard an auditory melody completely different from the visual score. For both groups, the visual musical scores predominated over the gratings when the auditory melody was congruent compared to when it was incongruent. Moreover, the AP participants experienced greater predominance of the visual score when it was accompanied by the pitch-congruent melody compared to the same melody transposed in pitch; for non-AP musicians, pitch-congruent and pitch-incongruent trials yielded equivalent predominance. Analysis of individual durations of dominance revealed differential effects on dominance and suppression durations for AP and non-AP participants. These results reveal that AP is accompanied by a robust form of bisensory interaction between tonal frequencies and musical notation that boosts the salience of a visual score.	[Kim, Sujin; Lee, Minyoung; Kim, Chai-Youn] Korea Univ, Dept Psychol, Seoul, South Korea; [Blake, Randolph] Vanderbilt Univ, Dept Psychol Sci, Vanderbilt Vis Res Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Blake, Randolph] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea	Korea University; Vanderbilt University; Seoul National University (SNU)	Kim, CY (corresponding author), Korea Univ, Dept Psychol, Seoul, South Korea.	chaikim@korea.ac.kr		Kim, Sujin/0000-0002-1436-3748	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technologies (ICT) and Future Planning [NRF2013R1A1A1010923]; National Institutes of Health [P30-EY008126]; Centennial Professor research funds from Vanderbilt University	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technologies (ICT) and Future Planning; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centennial Professor research funds from Vanderbilt University	This work was supported by NRF2013R1A1A1010923 from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communications Technologies (ICT) and Future Planning, by Core Grant P30-EY008126 from the National Institutes of Health, and by Centennial Professor research funds from Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2015, OXFORD HDB PERCEPTUA, P775; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bermudez P, 2005, J NEUROSCI, V25, P7718, DOI 10.1523/JNEUROSCI.1560-05.2005; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; Breese BB, 1909, PSYCHOL REV, V16, P410, DOI 10.1037/h0075805; Carter OL, 2003, PERCEPTION, V32, P295, DOI 10.1068/p3472; Chang S, 2013, J VISION, V13, DOI 10.1167/13.10.4; Chen Y-C, 2011, FRONT PSYCHOL, P54; Conrad V, 2010, J VISION, V10, DOI 10.1167/10.10.27; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cox D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00722; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Dooley K, 2010, J ACOUST SOC AM, V128, P890, DOI 10.1121/1.3458848; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOX R, 1975, VISION RES, V15, P849, DOI 10.1016/0042-6989(75)90265-5; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hancock S, 2012, I-PERCEPTION, V3, P88, DOI 10.1068/i0486; Hantz EC, 1997, MUSIC PERCEPT, V15, P69; HANTZ EC, 1992, MUSIC PERCEPT, V10, P25; Hantz EC., 1995, PSYCHOMUSICOLOGY, V14, P53; Hasegawa T, 2004, COGNITIVE BRAIN RES, V20, P510, DOI 10.1016/j.cogbrainres.2004.04.005; Hirose H, 2002, NEUROSCI LETT, V330, P247, DOI 10.1016/S0304-3940(02)00812-1; Hoffman Donald D, 2000, VISUAL INTELLIGENCE; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; HOLLINS M, 1980, ATTEN PERCEPT PSYCHO, V27, P550; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; Kang MS, 2009, J VISION, V9, DOI 10.1167/9.2.8; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KLEIN M, 1984, SCIENCE, V223, P1306, DOI 10.1126/science.223.4642.1306; Kogo N, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00111; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee M, 2015, P NATL ACAD SCI USA, V112, P8493, DOI 10.1073/pnas.1509529112; Lepage M, 2003, NEUROSCI LETT, V346, P73, DOI 10.1016/S0304-3940(03)00578-0; Levelt WJM, 1965, BINOCULAR RIVALRY; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Loui P, 2012, NEUROIMAGE, V63, P632, DOI 10.1016/j.neuroimage.2012.07.030; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Lunghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058754; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Miyazaki K, 2004, JPN PSYCHOL RES, V46, P270, DOI 10.1111/j.1468-5584.2004.00260.x; Miyazaki K, 2002, PERCEPT PSYCHOPHYS, V64, P1337, DOI 10.3758/BF03194776; Moore G., 1962, AM I TOO LOUD MEMORI; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; RCore Team, 2020, R LANG ENV STAT COMP; Renninger LB, 2003, MUSIC PERCEPT, V20, P357; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Schulze K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-106; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; WALKER P, 1979, VISION RES, V19, P247, DOI 10.1016/0042-6989(79)90169-X; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; WALKER P, 1978, PSYCHOL BULL, V85, P376, DOI 10.1037/0033-2909.85.2.376; Ward W.D, 1963, SOUND, V2, P33; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson C., 1911, MUSICAL OPINION, V34, P753; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Xu YS, 2006, HUM BRAIN MAPP, V27, P173, DOI 10.1002/hbm.20176; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	81	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175103	10.1371/journal.pone.0175103	http://dx.doi.org/10.1371/journal.pone.0175103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380058	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500098
J	Guimaraes, E; Machado, R; Fonseca, MD; Franca, A; Carvalho, C; Silva, ACAE; Almeida, B; Cassini, P; Hissa, B; Drumond, L; Goncalves, C; Fernandes, G; De Brot, M; Moraes, M; Barcelos, L; Ortega, JM; Oliveira, A; Leite, MF				Guimaraes, Erika; Machado, Rodrigo; Fonseca, Matheus de Castro; Franca, Andressa; Carvalho, Clarissa; Araujo e Silva, Ana Candida; Almeida, Brigida; Cassini, Puebla; Hissa, Barbara; Drumond, Luciana; Goncalves, Carlos; Fernandes, Gabriel; De Brot, Marina; Moraes, Marcio; Barcelos, Luciola; Ortega, Jose Miguel; Oliveira, Andre; Fatima Leite, M.			Inositol 1, 4, 5-trisphosphate-dependent nuclear calcium signals regulate angiogenesis and cell motility in triple negative breast cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NUCLEOPLASMIC CALCIUM; VINCULIN; PROLIFERATION; METASTASIS; MIGRATION; F9; ADHESION; INVASION; DISEASE	Increases in nuclear calcium concentration generate specific biological outcomes that differ from those resulting from increased cytoplasmic calcium. Nuclear calcium effects on tumor cell proliferation are widely appreciated; nevertheless, its involvement in other steps of tumor progression is not well understood. Therefore, we evaluated whether nuclear calcium is essential in other additional stages of tumor progression, including key steps associated with the formation of the primary tumor or with the metastatic cascade. We found that nuclear calcium buffering impaired 4T1 triple negative breast cancer growth not just by decreasing tumor cell proliferation, but also by enhancing tumor necrosis. Moreover, nuclear calcium regulates tumor angiogenesis through a mechanism that involves the upregulation of the anti-angiogenic C-X-C motif chemokine 10 (CXCL10-IP10). In addition, nuclear calcium buffering regulates breast tumor cell motility, culminating in less cell invasion, likely due to enhanced vinculin expression, a focal adhesion structural protein. Together, our results show that nuclear calcium is essential for triple breast cancer angiogenesis and cell migration and can be considered as a promising strategic target for triple negative breast cancer therapy.	[Guimaraes, Erika] Univ Fed Minas Gerais, Dept Mol Med, Belo Horizonte, MG, Brazil; [Guimaraes, Erika; Machado, Rodrigo; Fonseca, Matheus de Castro; Franca, Andressa; Carvalho, Clarissa; Almeida, Brigida; Cassini, Puebla; Drumond, Luciana; Moraes, Marcio; Barcelos, Luciola; Oliveira, Andre; Fatima Leite, M.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Fonseca, Matheus de Castro] Ctr Res Energy & Mat, Brazilian Natl Lab Biosci, Campinas, SP, Brazil; [Araujo e Silva, Ana Candida] Univ Fed Minas Gerais, Dept Pharmacol, Belo Horizonte, MG, Brazil; [Hissa, Barbara] Univ Fed Minas Gerais, Dept Phys, Belo Horizonte, MG, Brazil; [Goncalves, Carlos; Ortega, Jose Miguel] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Fernandes, Gabriel] Univ Catolica Brasilia, Genom Sci & Biotechnol, Brasilia, DF, Brazil; [De Brot, Marina] Univ Fed Minas Gerais, Dept Pathol Anat, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Catolica de Brasilia; Universidade Federal de Minas Gerais	Leite, MF (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	leitemd@ufmg.br	De Brot, Marina/E-2598-2015; Fonseca, Matheus C./O-9213-2019; de Fatima Leite, Maria/AAK-2555-2021; Fonseca, Matheus/GYU-2786-2022; da Rocha Fernandes, Gabriel/A-5383-2010; Ortega, J Miguel/E-8272-2011; da Silva Barcelos, Lucíola/AAP-5595-2021; Moraes, Marcio FD/D-5285-2014; Barcelos, Lucíola S/A-1109-2013; Fonseca, Matheus C./L-8006-2017	Fonseca, Matheus C./0000-0001-9048-9775; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; Ortega, J Miguel/0000-0002-8047-9191; da Silva Barcelos, Lucíola/0000-0001-9133-4011; Moraes, Marcio FD/0000-0002-2034-1836; Barcelos, Lucíola S/0000-0001-9133-4011; Fonseca, Matheus C./0000-0001-9048-9775; Goncalves, Carlos/0000-0003-1222-141X; Carvalho, Luciana/0000-0003-4262-5917; Hissa, Barbara/0000-0001-7618-2689	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes).; The authors acknowledge the technical assistance of Gilson Nogueira and Dr. M. T. Guerra (Yale University, USA) for carefully reading the manuscript. This research was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes).	Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636; Amaya MJ, 2014, HEPATOLOGY, V59, P274, DOI 10.1002/hep.26609; Andrade LM, 2012, J CANC SCI THER, V4, P131, DOI DOI 10.4172/1948-5956.1000127; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Arantes LAM, 2012, J MOL CELL CARDIOL, V53, P475, DOI 10.1016/j.yjmcc.2012.06.017; Arenberg DA, 1996, J EXP MED, V184, P981, DOI 10.1084/jem.184.3.981; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Butler AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072061; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Dobi A, 1998, P NATL ACAD SCI USA, V95, P5981, DOI 10.1073/pnas.95.11.5981; Donnard E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S3; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Feldman AL, 2002, INT J CANCER, V99, P149, DOI 10.1002/ijc.10292; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fontaine JF, 2009, NUCLEIC ACIDS RES, V37, pW141, DOI 10.1093/nar/gkp353; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; GOLDMANN WH, 1995, EXP CELL RES, V221, P311, DOI 10.1006/excr.1995.1380; Gomides LF, 2014, WORLD J HEPATOL, V6, P243, DOI 10.4254/wjh.v6.i4.243; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hissa B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082988; Kawano K, 2012, EXP THER MED, V4, P61, DOI 10.3892/etm.2012.564; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; LIOTTA LA, 1986, CANCER RES, V46, P1; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mehta RR, 2013, CLIN EXP METASTAS, V30, P855, DOI 10.1007/s10585-013-9585-6; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Prewett M, 1999, CANCER RES, V59, P5209; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Quang CT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.14; Resende RR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-14; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Rossari JR, 2012, J ONCOL, V2012, DOI 10.1155/2012/417673; Seo YH, 2015, BIOL PHARM BULL, V38, P389, DOI 10.1248/bpb.b14-00604; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Tao Z, 2014, BREAST CANC EPIDEMIO; Thompson M, 2003, BIOCHEM BIOPH RES CO, V301, P267, DOI 10.1016/S0006-291X(02)03024-3; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wilisch-Neumann A, 2014, J CANCER RES CLIN, V140, P1343, DOI 10.1007/s00432-014-1683-6; Xu WM, 1998, J CELL SCI, V111, P1535; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175041	10.1371/journal.pone.0175041	http://dx.doi.org/10.1371/journal.pone.0175041			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376104	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000036
J	Kim, SY; Kim, S; Bae, DJ; Park, SY; Lee, GY; Park, GM; Kim, IS				Kim, Sang-Yeob; Kim, Soyoun; Bae, Dong-Jun; Park, Seung-Yoon; Lee, Ga-Young; Park, Gyeong-Min; Kim, In-San			Coordinated balance of Rac1 and RhoA plays key roles in determining phagocytic appetite	PLOS ONE			English	Article							CELL CORPSE CLEARANCE; APOPTOTIC CELLS; ACTIN CYTOSKELETON; CAENORHABDITIS-ELEGANS; FAMILY GTPASES; SIRP-ALPHA; ENGULFMENT; MACROPHAGES; PHOSPHATIDYLSERINE; ACTIVATION	The removal of unwanted or damaged cells by phagocytes is achieved via a finely regulated cleaning process called efferocytosis. To characterize the mechanisms through which phagocytes control the intake of apoptotic cells, we investigated how the phagocyte's appetite for engulfed cells may be coordinated by RhoA and Rac1 in the phagocytic cup. We used FRET biosensors to visualize the spatiotemporal dynamics of Rho-family GTPases, and found that RhoA, which is known to be downregulated during phagocytosis, was transiently upregulated at the phagocytic cup immediately prior to ingestion. Conversely, Rac1 was upregulated during the engulfment process and then downregulated prior to phagosomal maturation. Moreover, disturbance of the dynamic activities of RhoA led to uncontrolled engulfment, such as fast and undiscerning eating. Our results reveal that the temporal activity of RhoA GTPase alters the Rac1/RhoA balance at the phagocytic cup prior to ingestion, and that this plays a distinct role in orchestrating efferocytosis, with RhoA modulating the rate of engulfment to ensure that the phagocyte engulfs an appropriate amount of the correct material.	[Kim, Sang-Yeob; Kim, Soyoun; Bae, Dong-Jun; Lee, Ga-Young; Park, Gyeong-Min] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, Sch Med, Daegu, South Korea; [Kim, Sang-Yeob; Bae, Dong-Jun] ASAN Med Ctr, ASAN Inst Life Sci, Seoul, South Korea; [Kim, Sang-Yeob] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Park, Seung-Yoon] Dongguk Univ, Sch Med, Dept Biochem, Gyeongju, South Korea; [Kim, In-San] Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea; [Kim, In-San] Korea Univ, KU KIST Sch, Seoul, South Korea	Kyungpook National University; University of Ulsan; Asan Medical Center; University of Ulsan; Dongguk University; Korea Institute of Science & Technology (KIST); Korea University	Kim, S (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, Sch Med, Daegu, South Korea.; Kim, IS (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul, South Korea.; Kim, IS (corresponding author), Korea Univ, KU KIST Sch, Seoul, South Korea.	soyounki@knu.ac.kr; iskim14@kist.re.kr	Kim, Soyoun/Y-1276-2018	Kim, In-San/0000-0003-1714-4521	National Research Foundation of Korea(NRF) - Korea government [2015R1D1A3A01019018]; National Research Foundation of Korea (NRF) - Korea government [2014R1A5A2009242]; KIST Institutional Program [2E25270]; National Research Foundation of Korea [2014R1A5A2009242]	National Research Foundation of Korea(NRF) - Korea government(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea); KIST Institutional Program(Korea Institute of Science & Technology (KIST)); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government (2015R1D1A3A01019018); by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2014R1A5A2009242); by the KIST Institutional Program (Project No. 2E25270). Author Soyoun Kim received a part of salary from the fund National Research Foundation of Korea (2014R1A5A2009242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henson PM, 2009, CURR BIOL, V19, pR989, DOI 10.1016/j.cub.2009.09.031; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Kinchen JM, 2008, CURR BIOL, V18, pR521, DOI 10.1016/j.cub.2008.04.058; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136801; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liu XW, 2015, J EXP MED, V212, P267, DOI 10.1084/jem.20140508; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; May RC, 2001, J CELL SCI, V114, P1061; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, MOL CELL BIOL, V28, P5288, DOI 10.1128/MCB.01993-07; Park SY, 2008, J BIOL CHEM, V283, P10593, DOI 10.1074/jbc.M709105200; Park SY, 2012, J BIOL CHEM, V287, P11261, DOI 10.1074/jbc.M111.310953; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; WARREN MK, 1985, J IMMUNOL, V134, P982; Williams MJ, 2007, J CELL SCI, V120, P502, DOI 10.1242/jcs.03341; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	44	31	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e174603	10.1371/journal.pone.0174603	http://dx.doi.org/10.1371/journal.pone.0174603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376111	Green Published, gold, Green Submitted			2022-12-26	WOS:000399352000013
J	Rutkowski, R; Zawadzka, D; Suchecka, E; Merta, D				Rutkowski, Robert; Zawadzka, Dorota; Suchecka, Ewa; Merta, Dorota			Conservation genetics of the capercaillie in Poland - Delineation of conservation units	PLOS ONE			English	Article							GROUSE TETRAO-TETRIX; ALLELE FREQUENCY DATA; POPULATION-STRUCTURE; BLACK GROUSE; COMPUTER-PROGRAM; POSTGLACIAL COLONIZATION; NONINVASIVE SAMPLES; MICROSATELLITE LOCI; POLISH POPULATION; FOREST GROUSE	The capercaillie (Tetrao urogallus) is one of Poland's most endangered bird species, with an estimated population of 380-500 individuals in four isolated areas. To study these natural populations in Poland further, more than 900 non-invasive genetic samples were collected, along with samples from 59 birds representing large, continuous populations in Sweden and Russia; and from two centres in Poland breeding capercaillie. Microsatellite polymorphism at nine loci was then analysed to estimate within-population genetic diversity and genetic differentiation among populations. The results confirmed that isolation of populations and recent decreases in their sizes have reduced genetic diversity among capercaillie in Poland, with all the country's natural populations found to be experiencing the genetic after-effects of demographic bottlenecks. The results of analyses of genetic differentiation and structure further suggest the presence of a 'lowland' cluster (encompassing birds of the Augustowska and Solska Primaeval Forests in Poland, and of Sweden and Russia), and a Carpathian cluster. Capercaillie from Sweden and Russia are also found to differ markedly. The Polish lowland populations seem more closely related to birds from Scandinavia. Our genetic analysis also indicates that the stocks at breeding centres are of a high genetic diversity effectively reflecting the origins of founder individuals, though identification of ancestry requires further study in the case of some birds. Overall, the results sustain the conclusion that the Polish populations of capercaillie from the Carpathians and the lowlands should be treated as independent Management Units (MUs). This is to say that the breeding lines associated with these two sources should be maintained separately at breeding centres. The high level of genetic differentiation of birds from the Solska Primaeval Forest suggests that this population should also be assigned the status of independent MU.	[Rutkowski, Robert; Suchecka, Ewa] Polish Acad Sci, Dept Mol & Biometr Tech, Museum & Inst Zool, Warsaw, Poland; [Zawadzka, Dorota] Univ Lodz, Branch Tomaszow Mazowiecki, Inst Forest Sci, Tomaszow Mazowiecki, Poland; [Merta, Dorota] Pedag Univ Cracow, Dept Ecol Wildlife Res & Ecotourism, Krakow, Poland	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Lodz; Pedagogical University of Cracow	Rutkowski, R (corresponding author), Polish Acad Sci, Dept Mol & Biometr Tech, Museum & Inst Zool, Warsaw, Poland.	robertrut@miiz.waw.pl		Merta, Dorota/0000-0002-3311-6830; Rutkowski, Robert/0000-0003-0265-7455	Ministry of Science and Higher Education [N N303 0197 33]; Gorce National Park; Babiogora National Park; Polish Tatra National Park; European Commission, the National Fund for Environmental Protection and Water Management and the Polish State Forests [LIFE11 NAT/PU428]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Gorce National Park; Babiogora National Park; Polish Tatra National Park; European Commission, the National Fund for Environmental Protection and Water Management and the Polish State Forests	The genetic analysis of Polish lowland populations (Augustowska Primeval Forest and Solska Primeval Forest) and farm populations were supported by Ministry of Science and Higher Education (grant N N303 0197 33); the genetic analysis of Carpathian populations were supported by National Parks: Gorce National Park, Babiogora National Park and the Polish Tatra National Park. The genetic analysis of capercaillies from Russia and Sweden were supported by the European Commission, the National Fund for Environmental Protection and Water Management and the Polish State Forests (grant LIFE11 NAT/PU428 "The Active Protection of Lowland Populations of Capercaillie in the Bory DolnoShskie Forest and Augustowska Primeval Forest"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda F, 2011, ANIM CONSERV, V14, P249, DOI 10.1111/j.1469-1795.2010.00425.x; [Anonymous], 2021, LANG ENV STAT COMP; Bajc M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023602; Beshkarev Alexander B., 1995, P12; BirdLife International, TETR UR IUCN RED LIS; Caizergues A, 2003, MOL ECOL, V12, P2297, DOI 10.1046/j.1365-294X.2003.01903.x; Caizergues A, 2001, MOL ECOL NOTES, V1, P36, DOI 10.1046/j.1471-8278.2000.00015.x; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cornuet JM, 1996, GENETICS, V144, P2001; del Hoyo J., 2004, HDB BIRDS WORLD; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Domaniewski J, 1933, ACTA ORN, V2, P63; Olivier D, 2007, CONSERV GENET, V8, P513, DOI 10.1007/s10592-006-9165-2; Dziedzic R, 2008, OCHRONA KURAKOWLE LE, P101; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Glowacinski Z, 2001, POLSKA CZERWONA KSIE, P173; Goudet J., 2001, FSTAT V2 9 3 PROGRAM; Gregersen Finn, 2009, Ornis Norvegica, V32, P179; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoglund J, 2011, ANIM CONSERV, V14, P400, DOI 10.1111/j.1469-1795.2011.00436.x; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Klinga P, 2015, BIOL J LINN SOC, V116, P873, DOI 10.1111/bij.12643; Kobielski J., 2013, Grouse News, V45, P19; Krzywinski Andrzej, 2013, Vogelwelt, V134, P55; Liukkonen-Anttila T, 2004, ANN ZOOL FENN, V41, P619; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Merta D, 2015, EUR J WILDLIFE RES, V61, P299, DOI 10.1007/s10344-015-0899-3; Merta Dorota, 2013, Vogelwelt, V134, P65; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; NEI M, 1978, GENETICS, V89, P583; Pavlovska M, 2015, WILDLIFE BIOL, V21, P283, DOI 10.2981/wlb.00093; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Piotrowska M., 2008, OCHRONA KURAKOW LEAN, P11; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Potapov RL, 1989, HDB VOGEL SOWJETUNIO, V4; Pritchard JK, 2000, GENETICS, V155, P945; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rutkowski R, 2005, ACTA ORNITHOL, V40, P27, DOI 10.3161/068.040.0108; Rutkowski R, 2016, EUR J WILDLIFE RES, V62, P293, DOI 10.1007/s10344-016-1002-4; Rutkowski R, 2012, CENT EUR J BIOL, V7, P759, DOI 10.2478/s11535-012-0051-2; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Rzonca Z., 2015, HODOWLA GLUSZCOW NAD; Sahlsten J, 2008, HEREDITY, V101, P475, DOI 10.1038/hdy.2008.94; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Segelbacher G, 2007, J ORNITHOL, V148, pS269, DOI 10.1007/s10336-007-0153-1; Segelbacher G, 2014, CONSERV GENET, V15, P1183, DOI 10.1007/s10592-014-0610-3; Sirkia S, 2010, BIOL CONSERV, V143, P1540, DOI 10.1016/j.biocon.2010.03.038; SLATKIN M, 1995, GENETICS, V139, P457; Storch I., 2007, GROUSE STATUS SURVEY; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Strzala T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145433; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Vaisfeld M. A., 2014, BALKAN J WILDLIFE RE, V1, P40, DOI [10.15679/bjwr.v1i1.11, DOI 10.15679/BJWR.V1I1.11]; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zawadzka D., 2014, PODRECZNIK NAJLEPSZY; Zawadzka D, 2008, OCHRONA KURAKOW LESN, P25; Zawadzka D, 2003, MONOGRAFIE PRZYRODNI, V11; Zawadzka D, 2015, MONITORING PTAKOW LE, P145; Zawadzki J, 2012, ACTA ORNITHOL, V47, P199, DOI 10.3161/000164512X662322; Zurek Zbigniew, 2011, Studia i Materialy Centrum Edukacji Przyrodniczo-Lesnej, V13, P229	81	14	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174901	10.1371/journal.pone.0174901	http://dx.doi.org/10.1371/journal.pone.0174901			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376095	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000024
J	Ulleryd, MA; Prahl, U; Borsbo, J; Schmidt, C; Nilsson, S; Bergstrom, G; Johanssonl, ME				Ulleryd, Marcus A.; Prahl, Ulrica; Borsbo, Johannes; Schmidt, Caroline; Nilsson, Staffan; Bergstrom, Goran; Johanssonl, Maria E.			The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaques	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEART-RATE-VARIABILITY; BLOOD-CELL COUNT; INTIMA-MEDIA THICKNESS; LEUKOCYTE COUNT; RISK-FACTORS; CORONARY; MARKERS; PROGRESSION; DISEASE	Background Autonomic dysfunction is a risk factor for cardiovascular disease (CVD), however, the exact mechanism linking autonomic dysfunction to cardiovascular disease is not known. In this study we hypothesized that autonomic dysfunction increases inflammation, which subsequently accelerates atherosclerosis. The aim of the current study was to investigate the association between autonomic tone, inflammation and atherosclerosis. Methods 124 men under investigation for carotid atherosclerosis were examined for autonomic function (heart rate variability; HRV and baroreflex sensitivity; BRS), inflammatory markers (white blood cell count; WBCC and C-reactive protein; CRP) and degree of carotid atherosclerosis. The direct or indirect associations between autonomic function, inflammatory parameters and carotid plaque area were investigated with multiple linear regressions. Results Male subjects with prevalent CVD showed larger carotid plaque area, higher WBCC, and reduced BRS compared to subjects with no history of CVD. Further, BRS was inversely associated with carotid plaque area (r = -0.21, p = 0.018) as well as inflammatory parameters WBCC and CRP (r = -0.29, p = 0.001, and r = -0.23, p = 0.009, respectively), whereas HRV only was inversely associated with WBCC (r = -0.22, p = 0.014). To investigate if inflammation could provide a link between autonomic function and carotid atherosclerosis we adjusted the associations accordingly. After adjusting for WBCC and CRP the inverse association between BRS and carotid plaque area was attenuated and did not remain significant, while both WBCC and CRP remained significantly associated with carotid plaque area, indicating that low-grade inflammation can possibly link BRS to atherosclerosis. Also, after adjusting for age, antihypertensive treatment and cardiovascular risk factors, BRS was independently inversely associated with both WBCC and CRP, and HRV independently inversely associated with WBCC. WBCC was the only inflammatory marker independently associated with carotid plaque area after adjustment. Conclusions We demonstrate that autonomic dysfunction is associated with atherosclerosis and that inflammation could play an important role in mediating this relationship.	[Ulleryd, Marcus A.; Borsbo, Johannes; Johanssonl, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Prahl, Ulrica; Schmidt, Caroline; Bergstrom, Goran] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc & Metab Res, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Stat, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Chalmers University of Technology	Johanssonl, ME (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	maria.e.johansson@neuro.gu.se		Nilsson, Staffan/0000-0003-4748-0446; Johansson, Maria/0000-0002-2569-2977; Bergstrom, Goran/0000-0003-4289-5722	Swedish Heart Lung foundation; Swedish Research Council; Swedish Society of Medicine; Magnus Bergvall foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; Lars Hiertas foundation; Ake Wiberg foundation; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells stiftelse; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Sahlgrenska University Hospital	Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Magnus Bergvall foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; Lars Hiertas foundation; Ake Wiberg foundation; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells stiftelse; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Sahlgrenska University Hospital	This work was supported by grants from The Swedish Heart Lung foundation (MJ,GB), The Swedish Research Council (MJ), The Swedish Society of Medicine (MJ), Magnus Bergvall foundation (MJ), Stiftelsen Langmanska kulturfonden (MJ), Stiftelsen Gamla tjanarinnor (MJ), Lars Hiertas foundation (MJ), Ake Wiberg foundation (MJ), OE and Edla Johanssons vetenskapliga stiftelse (MJ), Stiftelsen Tornspiran (MU), Emil and Wera Cornells stiftelse (MJ), Dr. Felix Neuberghs Foundation (MJ), Emelle Foundation (MU,MJ), Wilhelm and Martina Lundgren foundation (MU,MJ) and grants from Sahlgrenska University Hospital (ALF Agreement) (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo F, 2006, INT J CARDIOL, V107, P333, DOI 10.1016/j.ijcard.2005.03.044; Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Blackburn R, 2001, ARTERIOSCL THROM VAS, V21, P1962, DOI 10.1161/hq1201.099433; Burke AP, 2002, CIRCULATION, V105, P2019, DOI 10.1161/01.CIR.0000015507.29953.38; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooper TM, 2015, BRAIN BEHAV IMMUN, V49, P94, DOI 10.1016/j.bbi.2014.12.017; Dehnavi RA, 2008, EUR J INTERN MED, V19, P115, DOI 10.1016/j.ejim.2007.06.011; Eiken A, 2006, CLIN PHYSIOL FUNCT I, V26, P9, DOI 10.1111/j.1475-097X.2005.00644.x; Elias-Smale SE, 2007, ATHEROSCLEROSIS, V195, pE195, DOI 10.1016/j.atherosclerosis.2007.07.006; Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-4; Frostegard J, 2005, ARTERIOSCL THROM VAS, V25, P1776, DOI 10.1161/01.ATV.0000174800.78362.ec; Hamaad Ali, 2005, Clin Cardiol, V28, P570, DOI 10.1002/clc.4960281207; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Herder M, 2013, ARTERIOSCL THROM VAS, V33, P858, DOI 10.1161/ATVBAHA.112.300767; Hjelmgren O, 2013, EUR J VASC ENDOVASC, V46, P21, DOI 10.1016/j.ejvs.2013.03.023; Huang ZS, 2001, ATHEROSCLEROSIS, V158, P431, DOI 10.1016/S0021-9150(01)00445-2; Huikuri HV, 1999, ARTERIOSCL THROM VAS, V19, P1979, DOI 10.1161/01.ATV.19.8.1979; Hunt ME, 2001, AM HEART J, V141, P206, DOI 10.1067/mhj.2001.112488; Janszky I, 2004, J INTERN MED, V256, P421, DOI 10.1111/j.1365-2796.2004.01403.x; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; Lanza GA, 2006, AM J CARDIOL, V97, P1702, DOI 10.1016/j.amjcard.2006.01.029; Libby P, 2006, J AM COLL CARDIOL, V48, pA33, DOI 10.1016/j.jacc.2006.08.011; Lima JAC, 2004, CIRCULATION, V110, P2336, DOI 10.1161/01.CIR.0000145170.22652.51; Loimaala A, 2006, ATHEROSCLEROSIS, V188, P363, DOI 10.1016/j.atherosclerosis.2005.11.021; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Musunuru K, 2008, NAT CLIN PRACT CARD, V5, P621, DOI 10.1038/ncpcardio1322; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; Ortega E, 2012, ATHEROSCLEROSIS, V221, P275, DOI 10.1016/j.atherosclerosis.2011.12.038; Papazafiropoulou A, 2006, DIABETES CARE, V29, P1926, DOI 10.2337/dc06-0154; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Stein PK, 2008, J AM GERIATR SOC, V56, P315, DOI 10.1111/j.1532-5415.2007.01564.x; Temelkova-Kurktschiev T, 2002, CARDIOVASC RES, V56, P277, DOI 10.1016/S0008-6363(02)00547-3; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; van de Ree MA, 2003, ATHEROSCLEROSIS, V166, P129, DOI 10.1016/S0021-9150(02)00316-7; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Wakabayashi I, 2006, CLIN CHIM ACTA, V365, P230, DOI 10.1016/j.cca.2005.08.023; Wallenfeldt K, 2001, J INTERN MED, V250, P492, DOI 10.1046/j.1365-2796.2001.00917.x; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499; Williams TN, 2004, ARTERIOSCL THROM VAS, V24, P61, DOI 10.1161/01.ATV.0000104014.24367.16	45	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174974	10.1371/journal.pone.0174974	http://dx.doi.org/10.1371/journal.pone.0174974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376102	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000031
J	Rah, SY; Lee, YH; Kim, UH				Rah, So-Young; Lee, Young-Hoon; Kim, Uh-Hyun			NAADP-mediated Ca2+ signaling promotes autophagy and protects against LPS-induced liver injury	FASEB JOURNAL			English	Article						calcium; CD38; TFEB; gene expression; hepatocytes	DINUCLEOTIDE PHOSPHATE NAADP; REGULATES AUTOPHAGY; MOBILIZES CA2+; CALCIUM; TRAFFICKING; CONTRIBUTES; CHANNEL; CELLS; FLUX; LC3	LPS has been shown to induce hepatocyte autophagy, but little is known about how LPS is able to do this during acute toxic liver injury. Our aim was to determine the existence of any selective Ca2+ signaling coupling to hepatocyte autophagy in response to LPS. LPS increased the autophagic process in hepatocytes, and CD38 knockdown prevented this response. Ned19, a specific inhibitor for nicotinic acid adenine dinucleotide phosphate (NAADP), prevented LPS-mediated Ca2+ signaling and autophagosome formation in hepatocytes. CD38 over expression protected the liver from LPS/D-galactosamine (Ga1N)-induced injury, and NAADP administration promoted autophagosome formation and protected hepatocytes from injury induced by LPS/Ga1N. Autophagy was promoted by the up-regulation of autophagy-related gene expression via NAADP-mediated Ca2+ signaling in response to LPS. However, CD38-knockout mice displayed down-regulation in hepatocyte gene expression. Ned19 also inhibited the NAADP-stimulated induction of gene expression by inhibiting the LPS-induced nuclear trans location of transcription factor EB (TFEB). Hepatocyte autophagy protects against LPS-induced liver injury via the CD38/NAADP/Ca2+/TFEB pathway. The role of NAADP-mediated Ca2+ signaling in the autophagic process will help elucidate the complexities of autophagy regulation, which is essential toward the discovery of new therapeutic tools against acute liver injury. Rah, S.-Y., Lee, Y.-H., Kim, U.-H. NAADP-mediated Ca2+ signaling promotes autophagy and protects against LPS-induced liver injury.	[Rah, So-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Rah, So-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju, South Korea; [Lee, Young-Hoon] Chonbuk Natl Univ, Sch Dent, Dept Oral Anat, Jeonju, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Korean National Research Foundation [2012R1A3A2026453]	Korean National Research Foundation(National Research Foundation of Korea)	This work was supported by a Korean National Research Foundation Grant 2012R1A3A2026453 (to U.-H.K.). The authors thank Dr. Young June Kim (Indiana University, Bloomington, IN, USA), Dr. Donghee Kim (Rosalind Franklin University, North Chicago, IL, USA), and Chansu Park (Chonbuk National University) for critical reading of the manuscript. The authors declare no conflicts of interest.	Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kim UH, 2014, MESSENGER, V3, P6, DOI [DOI 10.1166/MSR.2014.1030, 10.1166/msr.2014.1030]; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lalazar G, 2016, AM J PHYSIOL-GASTR L, V311, pG377, DOI 10.1152/ajpgi.00124.2016; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mizushima Noboru, 2010, J Cell Biol, V190, P946, DOI 10.1083/jcb.1906pi; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park KH, 2015, J INVEST DERMATOL, V135, P1692, DOI 10.1038/jid.2015.43; Parys JB, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-17; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Rah SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10741; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Wang KW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.14; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang Y, 2014, CARDIOVASC RES, V102, P68, DOI 10.1093/cvr/cvu011	36	27	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3126	3137		10.1096/fj.201601290R	http://dx.doi.org/10.1096/fj.201601290R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386045	Green Published, hybrid			2022-12-26	WOS:000405931000036
J	Pinotsis, N; Waksman, G				Pinotsis, Nikos; Waksman, Gabriel			Structure of the WipA protein reveals a novel tyrosine protein phosphatase effector from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; FEATURES; DOMAIN; PSYCHROPHILE; PATHOGENESIS; BINDING; MOTIF; SH2	Legionnaires' disease is a severe form of pneumonia caused by the bacterium Legionella pneumophila. L. pneumophila pathogenicity relies on secretion of more than 300 effector proteins by a type IVb secretion system. Among these Legionella effectors, WipA has been primarily studied because of its dependence on a chaperone complex, IcmSW, for translocation through the secretion system, but its role in pathogenicity has remained unknown. In this study, we present the crystal structure of a large fragment of WipA, WipA435. Surprisingly, this structure revealed a serine/threonine phosphatase fold that unexpectedly targets tyrosine-phosphorylated peptides. The structure also revealed a sequence insertion that folds into an alpha-helical hairpin, the tip of which adopts a canonical coiledcoil structure. The purified protein was a dimer whose dimer interface involves interactions between the coiled coil of one WipA molecule and the phosphatase domain of another. Given the ubiquity of protein-protein interaction mediated by interactions between coiled-coils, we hypothesize that WipA can thereby transition from a homodimeric state to a heterodimeric state in which the coiled-coil region of WipA is engaged in a protein-protein interaction with a tyrosine-phosphorylated host target. In conclusion, these findings help advance our understanding of the molecular mechanisms of an effector involved in Legionella virulence and may inform approaches to elucidate the function of other effectors.	[Pinotsis, Nikos; Waksman, Gabriel] Inst Struct & Mol Biol, Dept Biol Sci, Malet St, London WC1E 7HX, England; [Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; Birkbeck University London; University College London	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, London WC1E 6BT, England.	g.waksman@ucl.ac.uk	Pinotsis, Nikos/AAD-4013-2019	Pinotsis, Nikos/0000-0002-5096-257X; Waksman, Gabriel/0000-0003-0708-2726	European Research Council [321630]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Grant 321630 (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2016, FEBS J, V283, P1404, DOI 10.1111/febs.13600; Bunney TD, 2015, EBIOMEDICINE, V2, P194, DOI 10.1016/j.ebiom.2015.02.009; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Cutler SJ, 2007, J INFECTION, V54, P313, DOI 10.1016/j.jinf.2006.10.048; Dias AA, 2014, J CHEM EDUC, V91, P1017, DOI 10.1021/ed3006677; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Guasch A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134569; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li YY, 2008, BIOCHEMISTRY-US, V47, P13564, DOI 10.1021/bi8017448; Lin YE, 2011, CURR OPIN INFECT DIS, V24, P350, DOI 10.1097/QCO.0b013e3283486c6e; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; MARRIE TJ, 2008, INFEC AGENT, P133; Mlynek G, 2014, AMINO ACIDS, V46, P1565, DOI 10.1007/s00726-014-1699-x; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tsuruta H, 2005, J BIOCHEM, V137, P69, DOI 10.1093/jb/mvi010; Tsuruta H, 2008, FEBS J, V275, P4317, DOI 10.1111/j.1742-4658.2008.06575.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Walavalkar NM, 2013, J BIOL CHEM, V288, P3419, DOI 10.1074/jbc.M112.431346; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Welte S, 2005, ANAL BIOCHEM, V338, P32, DOI 10.1016/j.ab.2004.11.047; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	47	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9240	9251		10.1074/jbc.M117.781948	http://dx.doi.org/10.1074/jbc.M117.781948			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389563	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000402538900019
J	Tian, XC; Du, HD; Li, LM; Bennett, D; Gao, RQ; Li, SP; Wang, SJ; Guo, Y; Bian, Z; Yang, L; Chen, YP; Chen, JS; Gao, Y; Weng, M; Pang, ZC; Jiang, BF; Chen, ZM				Tian, Xiaocao; Du, Huaidong; Li, Liming; Bennett, Derrick; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Guo, Yu; Bian, Zheng; Yang, Ling; Chen, Yiping; Chen, Junshi; Gao, Yan; Weng, Min; Pang, Zengchang; Jiang, Baofa; Chen, Zhengming		China Kadoorie Biobank Study	Fruit consumption and physical activity in relation to all-cause and cardiovascular mortality among 70,000 Chinese adults with pre-existing vascular disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-INCOME COUNTRIES; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; MEDITERRANEAN DIET; VEGETABLE CONSUMPTION; REGRESSION DILUTION; LIFE-STYLE; RISK; STROKE	Objectives To assess the associations of fresh fruit consumption and total physical activity with all-cause and cardiovascular mortality among Chinese adults who have been diagnosed with cardiovascular disease (CVD) or hypertension. Methods During 2004-08, the China Kadoorie Biobank study recruited 70,047 adults, aged 30-79 years, with physician-diagnosed stroke or transient ischaemic attack, ischemic heart disease, or hypertension. Information on diet and physical activity was collected using an inter-viewer- administered electronic questionnaire. Cox regression was used to yield hazard ratios (HRs) for the independent and joint associations of fresh fruit consumption and total physical activity with mortality. Results At baseline, 32.9% of participants consumed fresh fruit regularly (i.e. > 3 days/week) and the mean total physical activity were 15.8 (SD = 11.8) MET-hr/day. During similar to 7-years follow-up, 6569 deaths occurred with 3563 from CVD. Compared to participants with < 1 day/week fruit consumption, regular consumers had HR (95% CI) of 0.84 (0.79-0.89) for all-cause mortality and 0.79 (0.73-0.86) for CVD mortality. The HRs for the top vs bottom tertile of physical activity were 0.68 (0.64-0.72) and 0.65 (0.60-0.71), respectively, with no clear evidence of reverse causality. After correcting for regression dilution, each 100 g/day usual consumption of fresh fruit or 10 MET-hr/day usual levels of physical activity was associated with 23-29% lower mortality. The combination of regular fruit consumption with top 3(rd) of physical activity (> 16.53 MET-hr/day) was associated with about 40% lower mortality. Conclusion Among Chinese adults with pre-existing vascular disease, higher physical activity and fruit consumption were both independently and jointly associated with lower mortality.	[Tian, Xiaocao; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Tian, Xiaocao; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Pang, Zengchang] Qingdao Ctr Dis Prevent & Control, Qingdao, Shandong, Peoples R China; [Du, Huaidong; Yang, Ling; Chen, Yiping] Univ Oxford, MRC, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford, England; [Du, Huaidong; Bennett, Derrick; Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Du, Huaidong; Bennett, Derrick; Yang, Ling; Chen, Yiping; Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England; [Li, Liming] Peking Univ, Hlth Sci Ctr, Dept Epidemiol, Sch Publ Hlth, Beijing, Peoples R China; [Li, Liming; Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China; [Gao, Yan] Suzhou CDC, Suzhou, Jiangsu, Peoples R China; [Weng, Min] Meilan CDC, Haikou, Hainan, Peoples R China	Shandong University; University of Oxford; University of Oxford; University of Oxford; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China.; Pang, ZC (corresponding author), Qingdao Ctr Dis Prevent & Control, Qingdao, Shandong, Peoples R China.; Du, HD (corresponding author), Univ Oxford, MRC, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford, England.; Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.; Du, HD (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England.	huaidong.du@ctsu.ox.ac.uk; cdcpang@126.com; bjiang@sdu.edu.cn	Bennett, Derrick/AAH-1220-2022; , Bennett/O-7998-2019; Bennett, Derrick/AFL-9254-2022	Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Lv, Jun/0000-0001-7916-3870; Du, Huaidong/0000-0002-9814-0049; Tian, Xiaocao/0000-0002-4275-3719; Kurmi, Om Prakash/0000-0002-9518-4716	Kadoorie Charitable Foundation, Hong Kong; UK Wellcome Trust [088158/Z/09/Z, 104085/Z/14/Z]; Chinese Ministry of Science and Technology [2011BAI09B01]; Chinese National Natural Science Foundation [81390541]; Kadoorie Charitable Foundation in HongKong; British Heart Foundation; UK Medical Research Council; Cancer Research UK; Medical Research Council [MC_UU_12026/2, MC_U137686851] Funding Source: researchfish; MRC [MC_U137686851, MC_UU_12026/2] Funding Source: UKRI	Kadoorie Charitable Foundation, Hong Kong; UK Wellcome Trust(Wellcome Trust); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Kadoorie Charitable Foundation in HongKong; British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported as follows: Baseline survey: Kadoorie Charitable Foundation, Hong Kong. Long-term continuation: UK Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z), Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14), Chinese National Natural Science Foundation (81390541). The baseline survey and the first re-survey were supported by are search grant from the Kadoorie Charitable Foundation in HongKong. The longterm continuation of the project is supported by program grants from the UK Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z, http://www.wellcome.ac.uk/); the Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14); and the Chinese National Natural Science Foundation (81390541, http://www.nsfc.gov.cn/). The British Heart Foundation (https://www.bhf.org.uk/); UK Medical Research Council (http://www.mrc.ac.uk/); and Cancer Research UK (http://www.cancerresearchuk.org/) provide core funding to the Oxford CTSU.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; Barzi F, 2003, EUR J CLIN NUTR, V57, P604, DOI 10.1038/sj.ejcn.1601575; Bennett D, 2015, EUR HEART J, V36, P465; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Booth JN, 2014, AM J CARDIOL, V113, P1933, DOI 10.1016/j.amjcard.2014.03.033; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Du HD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002279; Du HD, 2016, NEW ENGL J MED, V374, P1332, DOI 10.1056/NEJMoa1501451; Du HD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-826; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Greenlund KJ, 2002, STROKE, V33, P565, DOI 10.1161/hs0202.102882; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Jones K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6544; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Larsson SC, 2013, ATHEROSCLEROSIS, V227, P147, DOI 10.1016/j.atherosclerosis.2012.12.022; Lawrence Maggie, 2011, Nurs Stand, V26, P41; Leenders M, 2013, AM J EPIDEMIOL, V178, P590, DOI 10.1093/aje/kwt006; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Li SS, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2659; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nakamura K, 2008, J NUTR, V138, P1129, DOI 10.1093/jn/138.6.1129; Ning M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009836; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trichopoulou A, 2007, EUR J EPIDEMIOL, V22, P871, DOI 10.1007/s10654-007-9190-6; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e173054	10.1371/journal.pone.0173054	http://dx.doi.org/10.1371/journal.pone.0173054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403155	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200004
J	de Boer, R; Musgrave, J; Andersson, N; Lutscher, F				de Boer, Rebecca; Musgrave, Jeffrey; Andersson, Neil; Lutscher, Frithjof			The importance of choice disability and structural intervention in the HIV epidemic in Sub-Saharan Africa	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SOUTHERN AFRICA; SENSITIVITY-ANALYSIS; UNAIDS ESTIMATION; CONDOM USE; RISK; TRANSMISSION; PREVENTION; COUNTRIES; VIOLENCE	Background Despite massive investment in HIV control programs, HIV incidence rates in countries with generalized epidemics have not fallen for most of the last decade. It appears that those at risk are not adopting effective prevention strategies. Those who are unable to implement their prevention preferences are referred to as choice disabled. We examined how and to what extent structural intervention measures that support choice-disabled individuals can reduce HIV transmission and prevalence. Methods A mathematical model was developed to describe HIV transmission among and between choice-disabled and choice-enabled individuals. Data were available from field trials identifying factors and effects of choice disability. The model was used to estimate the potential impact of an intervention strategy in which choice-disabled individuals are enabled to make prevention choices. Several scenarios were considered and compared: supporting only one or both genders; supporting only HIV-individuals or also HIV+ choice-disabled individuals. Results Substantial declines in HIV incidence and prevalence are observed when supportive interventions are included in the model. The magnitude of these declines depends on the scope of the intervention program. The largest positive effect occurs when the support program is offered regardless of HIV status. Conclusions Addressing the effects of choice disability in any HIV intervention program could be crucial to the program's success. Structural intervention programs to support choice-disabled individuals in implementing prevention strategies greatly reduce HIV incidence and prevalence in mathematical models.	[de Boer, Rebecca; Musgrave, Jeffrey; Lutscher, Frithjof] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Andersson, Neil] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Lutscher, Frithjof] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa; McGill University; University of Ottawa	Lutscher, F (corresponding author), Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada.; Lutscher, F (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	flutsche@uottawa.ca	Lutscher, Frithjof/C-9484-2012; Andersson, Neil/G-2248-2011	Lutscher, Frithjof/0000-0001-7380-7647; 	CIET Canada	CIET Canada	This work was supported by CIET Canada http://www.ciet.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson N, 2008, AIDS, V22, pS73, DOI 10.1097/01.aids.0000341778.73038.86; Andersson N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-274; Andersson N, 2012, AIDS BEHAV, V16, P189, DOI 10.1007/s10461-011-9912-3; Bao L, 2012, SEX TRANSM INFECT, V88, pI3, DOI 10.1136/sextrans-2012-050637; Beksinska ME, 1999, SEX TRANSM INFECT, V75, P178, DOI 10.1136/sti.75.3.178; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Cameron M, 2014, AIDS CARE, V26, P1534, DOI 10.1080/09540121.2014.931560; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Duflo E, 2006, ED HIV AIDS PREVENTI; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; Jacquez J.A., 1989, MATH STAT APPROACHES, V83, P301, DOI [10.1007/978-3-642-93454-415, DOI 10.1007/978-3-642-93454-415]; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Malunguza N, 2010, COMPUT MATH METHOD M, V11, P201, DOI 10.1080/17486700903325167; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; UNAIDS, 2016, PREV GAP REP; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175297	10.1371/journal.pone.0175297	http://dx.doi.org/10.1371/journal.pone.0175297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0JS	28399137	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000028
J	He, M; Yang, ZY; Zhang, L; Song, CL; Li, YJ; Zhang, XY				He, Miao; Yang, Zhaoying; Zhang, Le; Song, Changlong; Li, Youjun; Zhang, Xingyi			Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells	PLOS ONE			English	Article							CHELERYTHRINE CHLORIDE; KINASE; SURVIVAL; PATHWAY; STAT3; RESISTANCE; INHIBITOR; APOPTOSIS; GROWTH; BAD	Several studies implicate that lung cancer progression is governed by the interaction between epidermal growth factor receptor (EGFR) signaling and protein kinase C (PKC) pathways. Combined the targeting of EGFR and PKC may have an additive or synergistic effects in lung cancer treatment. The aim of this study is to explore the potential utility by inhibiting these two pathways with the combination of erlotinib and chelerythrine chloride in non-small cell lung cancer (NSCLC) cell lines. The erlotinib-less sensitive cell lines SK-MES- 1 and A549 were treated with erlotinib or chelerythrine by themselves or in combination with each other. The cell viability, clonogenic survival, cell migration, invasion, cell apoptosis effects and immunoblotting were accessed in vitro. Tumor growth was evaluated in vivo. There were additive effects of chelerythrine combined with erlotinib treatment in all NSCLC cell lines, resulting in a significant decrease in cell viability, clonogenicity, migratory and invasive capabilities as well as in the induction of apoptosis. Concordantly, the combined treatment caused a significant delay in tumor growth. The treatment effectively blocked EGFR signaling through decreasing phosphorylation of downstream targets such as STAT3, ERK1/2, p38 MAPK and Bad proteins. Our study supports the functional interaction between the EGFR and PKC pathways in lung cancer and provides a clinically exploitable strategy for erlotinib-less sensitive non-small cell lung cancer patients.	[He, Miao] Jilin Univ, Hosp 2, Dept Anesthesia, Changchun, Peoples R China; [Yang, Zhaoying; Zhang, Le; Song, Changlong] Jilin Univ, China Japan Union Hosp, Dept Breast Surg, Changchun, Peoples R China; [Li, Youjun] Jilin Univ, Norman Bethune Hlth Sci Ctr, Dept Anat, Changchun, Peoples R China; [Zhang, Xingyi] Jilin Univ, Hosp 2, Dept Thorax Surg, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Li, YJ (corresponding author), Jilin Univ, Norman Bethune Hlth Sci Ctr, Dept Anat, Changchun, Peoples R China.; Zhang, XY (corresponding author), Jilin Univ, Hosp 2, Dept Thorax Surg, Changchun, Peoples R China.	youjun.li@yahoo.com; xyzhangjeu@sina.com		Zhang, Le/0000-0003-4622-5750	National Natural Science Foundation of China [81272472, 81372456]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No.81272472; No.81372456).	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Axelrod M, 2013, ONCOTARGET, V4, P622, DOI 10.18632/oncotarget.938; Barre B, 2007, TRENDS MOL MED, V13, P4, DOI 10.1016/j.molmed.2006.11.001; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chiu HC, 2011, BIOCHEM PHARMACOL, V81, P1263, DOI 10.1016/j.bcp.2011.03.003; Chmura SJ, 2000, CLIN CANCER RES, V6, P737; Clark AS, 2003, CANCER RES, V63, P780; Coco S, 2015, TARGET ONCOL, V10, P393, DOI 10.1007/s11523-014-0344-7; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gridelli C, 2007, ONCOLOGIST, V12, P840, DOI 10.1634/theoncologist.12-7-840; Harada D, 2014, CANCERS, V6, P708, DOI 10.3390/cancers6020708; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Liu L, 2011, MOL CANCER THER, V10, P518, DOI 10.1158/1535-7163.MCT-10-0698; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Medvetz D, 2015, MOL CANCER RES, V13, P50, DOI 10.1158/1541-7786.MCR-14-0440; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Poomakkoth N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0768-1; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Wang JH, 2012, ONCOL REP, V27, P1341, DOI 10.3892/or.2012.1677; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yang R, 2008, CLIN CANCER RES, V14, P6396, DOI 10.1158/1078-0432.CCR-07-5113; Yang ZY, 2014, INT J CLIN EXP PATHO, V7, P7563; Zhang L, 2016, ONCOTARGET; Zhang ZF, 2011, ARCH PHARM RES, V34, P791, DOI 10.1007/s12272-011-0513-5	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175466	10.1371/journal.pone.0175466	http://dx.doi.org/10.1371/journal.pone.0175466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399187	gold, Green Submitted, Green Published			2022-12-26	WOS:000399949000041
J	Wang, AS; Gopurenko, D; Wu, HW; Lepschi, B				Wang, Aisuo; Gopurenko, David; Wu, Hanwen; Lepschi, Brendan			Evaluation of six candidate DNA barcode loci for identification of five important invasive grasses in eastern Australia	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; POA POACEAE; RBCL GENE; CHLOROPLAST; PHYLOGENIES; SEQUENCES; EXAMPLE; REGIONS; PLANTS	Invasive grass weeds reduce farm productivity, threaten biodiversity, and increase weed control costs. Identification of invasive grasses from native grasses has generally relied on the morphological examination of grass floral material. DNA barcoding may provide an alternative means to identify co-occurring native and invasive grasses, particularly during early growth stages when floral characters are unavailable for analysis. However, there are no universal loci available for grass barcoding. We herein evaluated the utility of six candidate loci (atpF intron, matK, ndhK-ndhC, psbE-petL, ETS and ITS) for barcode identification of several economically important invasive grass species frequently found among native grasses in eastern Australia. We evaluated these loci in 66 specimens representing five invasive grass species (Chloris gayana, Eragrostis curvula, Hyparrhenia hirta, Nassella neesiana, Nassella trichotoma) and seven native grass species. Our results indicated that, while no single locus can be universally used as a DNA barcode for distinguishing the grass species examined in this study, two plastid loci (atpF and matK) showed good distinguishing power to separate most of the taxa examined, and could be used as a dual locus to distinguish several of the invasive from the native species. Low PCR success rates were evidenced among two nuclear loci (ETS and ITS), and few species were amplified at these loci, however ETS was able to genetically distinguish the two important invasive Nassella species. Multiple loci analyses also suggested that ETS played a crucial role in allowing identification of the two Nassella species in the multiple loci combinations.	[Wang, Aisuo; Gopurenko, David; Wu, Hanwen] Wagga Wagga Agr Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Wang, Aisuo; Gopurenko, David; Wu, Hanwen] Graham Ctr Agr Innovat, An Alliance NSW Dept Primary Ind & Charles Sturt, Wagga Wagga, NSW, Australia; [Lepschi, Brendan] Ctr Australian Natl Biodivers Res, Australian Natl Herbarium, Canberra, ACT, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries	Wang, AS (corresponding author), Wagga Wagga Agr Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.; Wang, AS (corresponding author), Graham Ctr Agr Innovat, An Alliance NSW Dept Primary Ind & Charles Sturt, Wagga Wagga, NSW, Australia.	aisuo.wang@dpi.nsw.gov.au	Gopurenko, David/H-3341-2014; Wu, Hanwen/B-7901-2010	Gopurenko, David/0000-0003-2886-1614; Wu, Hanwen/0000-0001-5157-4977	NSW Weeds Action Programs (WAP)	NSW Weeds Action Programs (WAP)	This work was supported by NSW Weeds Action Programs (WAP).; This study was funded by the NSW Weeds Action Program (WAP). Mr Adam Shephard, Mr Peter Deane, Mr Malcolm Ross, Mr Jeremy Crocker and other Council Weeds Officers provided assistances in field sampling. We thank Dr Pina Milne and Mr Wayne Gebert from the National Herbarium of Victoria for providing herbarium samples (MEL 2375629A and MEL 2330503A). Native grasses were provided by Mr Ian Chivers (Native Seeds Nursery in Melbourne) and Dr Peter Orchard (Charles Sturt University).	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ayres L, 2006, SERRATED TUSSOCK IDE, P44; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Birch JL, 2014, BOT J LINN SOC, V175, P523, DOI 10.1111/boj.12185; Campbell M., 2002, GRASSLANDS SOC NEWSL, V17; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; CRC for Australian Weed Management, 2007, COOL GRASS HYP HIRT; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Diekmann K, 2012, ANN BOT-LONDON, V110, P1327, DOI 10.1093/aob/mcs044; Dong WP, 2015, SCI REPORTS, V5; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gillespie LJ, 2009, AUST SYST BOT, V22, P413, DOI 10.1071/SB09016; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kass E, 1997, PLANT SYST EVOL, V208, P139, DOI 10.1007/BF00985439; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahadani P, 2013, DNA BARCODES, P35; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Starr JR, 2003, INT J PLANT SCI, V164, P213, DOI 10.1086/346168; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Syme AE, 2013, DNA BARCODES, V1, P19; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang A., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0135538; Weller SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22345; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zhang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119921	33	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175338	10.1371/journal.pone.0175338	http://dx.doi.org/10.1371/journal.pone.0175338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399170	gold, Green Submitted, Green Published			2022-12-26	WOS:000399949000033
J	Liu, SW; Du, F; Li, X; Wang, MM; Duan, RX; Zhang, JX; Wu, YR; Zhang, Q				Liu, Shiwei; Du, Fang; Li, Xin; Wang, Mingming; Duan, Ruixue; Zhang, Jiaxin; Wu, Yaru; Zhang, Qi			Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic beta cells	PLOS ONE			English	Article							IMPROVES ENDOTHELIAL FUNCTION; DIFFERENTIATION; MARKERS; PATHWAY; MICE	Pancreatic beta cell dysfunction and reduction due to glucose toxicity play a crucial role in the development of type 2 diabetes mellitus (T2DM). Irisin, a novel exercise-induced myokine, reduces obesity, improves insulin resistance and lowers blood glucose by promoting the browning of white adipose tissue, thereby enhancing thermogenesis and increasing energy expenditure. Recent studies have reported that irisin promotes cell proliferation and protects cells from apoptosis. However, the effects of irisin on pancreatic beta cells are unknown. Thus, the aim of this study was to investigate the effects and the potential underlying mechanisms of irisin on pancreatic beta cell proliferation and apoptosis induced by high glucose. Both in vitro (INS-1 cells) and in vivo ( a T2DM rat model) experiments were conducted. Irisin significantly increased the proliferation of INS-1 cells, with the most significant effect observed at 24 h with 100 ng/ml irisin. Irisin also promoted INS-1 cell proliferation via the ERK and p38 MAPK signaling pathways, protected the cells from high-glucose-induced apoptosis by regulating the expression of caspases, Bad, Bax, Bcl-2 and Bcl-xl, and improved pancreatic beta cell function. Irisin significantly reduced the body weight and blood glucose values and increased the serum insulin levels of the diabetic rats. An oral glucose tolerance test (OGTT) indicated that irisin also improved the glucose tolerance of T2DM rats. Together, these findings suggest that irisin may have applications in the prevention and treatment of T2DM because of its protective effect on the secretion of pancreatic beta cells.	[Liu, Shiwei] Shanxi Med Univ, Dept Endocrinol, Shanxi DAYI Hosp, Taiyuan, Peoples R China; [Du, Fang; Li, Xin; Wang, Mingming; Duan, Ruixue; Zhang, Jiaxin; Wu, Yaru; Zhang, Qi] Shanxi Med Univ, Grad Sch, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University	Liu, SW (corresponding author), Shanxi Med Univ, Dept Endocrinol, Shanxi DAYI Hosp, Taiyuan, Peoples R China.	lswspring6@aliyun.com			National Natural Science Foundation of China [81200591, 81471025]; Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province [2013-251]; International Science and Technology Cooperation Project in Shanxi Province [2015081029]; Research Project Supported Shanxi Scholarship Council of China [2015-109]; Transformation of Scientific and Technological Achievements in Shanxi Province [201604D131003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province; International Science and Technology Cooperation Project in Shanxi Province; Research Project Supported Shanxi Scholarship Council of China; Transformation of Scientific and Technological Achievements in Shanxi Province	This research was supported by the National Natural Science Foundation of China (#81200591&81471025), Fund Program for the Scientific Activities of Selected Return Overseas Professionals in Shanxi Province (#2013-251), International Science and Technology Cooperation Project in Shanxi Province (#2015081029), Research Project Supported Shanxi Scholarship Council of China (#2015-109), Transformation of Scientific and Technological Achievements in Shanxi Province (#201604D131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Han F, 2015, AM J PHYSIOL-HEART C, V309, pH1501, DOI 10.1152/ajpheart.00443.2015; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Wu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134662; Zhu D, 2015, J MOL CELL CARDIOL, V87, P138, DOI 10.1016/j.yjmcc.2015.07.015	13	64	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175498	10.1371/journal.pone.0175498	http://dx.doi.org/10.1371/journal.pone.0175498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394923	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800041
J	Wittmann, F; Marques, MCM; Damasceno, G; Budke, JC; Piedade, MTF; Wittmann, AD; Montero, JC; de Assis, RL; Targhetta, N; Parolin, P; Junk, WJ; Householder, JE				Wittmann, Florian; Marques, Marcia C. M.; Damasceno Junior, Geraldo; Budke, Jean Carlos; Piedade, Maria T. F.; Wittmann, Astrid de Oliveira; Montero, Juan Carlos; de Assis, Rafael L.; Targhetta, Natalia; Parolin, Pia; Junk, Wolfgang J.; Householder, J. Ethan			The Brazilian freshwater wetscape: Changes in tree community diversity and composition on climatic and geographic gradients	PLOS ONE			English	Article							VARZEA FORESTS; SPECIES DISTRIBUTION; DROUGHT SENSITIVITY; ALPHA-DIVERSITY; RIPARIAN FOREST; GLOBAL PATTERNS; BIODIVERSITY; FLOODPLAIN; CONSERVATION; DYNAMICS	Wetlands harbor an important compliment of regional plant diversity, but in many regions data on wetland diversity and composition is still lacking, thus hindering our understanding of the processes that control it. While patterns of broad-scale terrestrial diversity and composition typically correlate with contemporary climate it is not clear to what extent patterns in wetlands are complimentary, or conflicting. To elucidate this, we consolidate data from wetland forest inventories in Brazil and examine patterns of diversity and composition along temperature and rainfall gradients spanning five biomes. We collated 196 floristic inventories covering an area >220 ha and including >260,000 woody individuals. We detected a total of 2,453 tree species, with the Amazon alone accounting for nearly half. Compositional patterns indicated differences in freshwater wetland floras among Brazilian biomes, although biomes with drier, more seasonal climates tended to have a larger proportion of more widely distributed species. Maximal alpha diversity increased with annual temperature, rainfall, and decreasing seasonality, patterns broadly consistent with upland vegetation communities. However, alpha diversity-climate relationships were only revealed at higher diversity values associated with the uppermost quantiles, and in most sites diversity varied irrespective of climate. Likewise, mean biome-level differences in alpha-diversity were unexpectedly modest, even in comparisons of savanna-area wetlands to those of nearby forested regions. We describe attenuated wetland climate-diversity relationships as a shifting balance of local and regional effects on species recruitment. Locally, excessive waterlogging strongly filters species able to colonize from regional pools. On the other hand, increased water availability can accommodate a rich community of drought-sensitive immigrant species that are able to track buffered wetland microclimates. We argue that environmental conditions in many wetlands are not homogeneous with respect to regional climate, and that responses of wetland tree communities to future climate change may lag behind that of non-wetland, terrestrial habitat.	[Wittmann, Florian; Householder, J. Ethan] Karlsruhe Inst Technol, Inst Geog & Geoecol, Dept Floodplain Ecol, Karlsruhe, Germany; [Wittmann, Florian; Piedade, Maria T. F.; de Assis, Rafael L.; Targhetta, Natalia] Inst Nacl Pesquisas Espaciais, MAUA Working Grp, Manaus, Amazonas, Brazil; [Marques, Marcia C. M.] Univ Fed Parana, Curitiba, Parana, Brazil; [Damasceno Junior, Geraldo] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil; [Budke, Jean Carlos] Univ Reg Integrada Alto Uruguai & Missaes, Erechim, RS, Brazil; [Wittmann, Astrid de Oliveira] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Montero, Juan Carlos] Confederac Pueblos Indigenes Bolivia, Gobernanza Recursos Nat, Santa Cruz, Santa Cruz, Bolivia; [de Assis, Rafael L.] Norwegian Univ Life Sci, As, Akershus, Norway; [Parolin, Pia] Univ Hamburg, Bioctr Klein Flottbek, Dept Plant Diversity, Hamburg, Germany; [Junk, Wolfgang J.] Inst Nacl Areas Umidas, Cuiaba, Mato Grosso, Brazil; [Householder, J. Ethan] Bot Res Inst Texas, Ft Worth, TX USA	Helmholtz Association; Karlsruhe Institute of Technology; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal de Amazonas; Norwegian University of Life Sciences; University of Hamburg	Householder, JE (corresponding author), Karlsruhe Inst Technol, Inst Geog & Geoecol, Dept Floodplain Ecol, Karlsruhe, Germany.; Householder, JE (corresponding author), Bot Res Inst Texas, Ft Worth, TX USA.	john.householder@kit.edu	Piedade, Maria Teresa/C-5372-2013; Parolin, Pia/M-8268-2018; Parolin, Pia/AAN-7298-2021; Marques, Marcia Cristina Mendes/F-8699-2012; Damasceno Junior, Geraldo/ABG-2834-2021	Piedade, Maria Teresa/0000-0002-7320-0498; Parolin, Pia/0000-0003-1368-6614; Parolin, Pia/0000-0003-1368-6614; Marques, Marcia Cristina Mendes/0000-0002-1003-9596; 	INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus); Brazilian Council of Science and Technology - CNPq [479599/2008-4]; PELD-MAUA; PRONEX - FAPEAM - CNPq ("Tipologias alagaveis")	INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus); Brazilian Council of Science and Technology - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PELD-MAUA; PRONEX - FAPEAM - CNPq ("Tipologias alagaveis")	Field work from several published inventories in the Amazon was made possible by financial support from the INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus), and the Brazilian Council of Science and Technology-CNPq (Universal 479599/2008-4), PELD-MAUA and PRONEX-FAPEAM-CNPq ("Tipologias alagaveis", 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the National Institute for Amazon Research (INPA) for assistance. Field work from several published inventories in the Amazon was made possible by financial support from the INPA/Max Planck Project (INPA and Max Planck Institute for Chemistry, Manaus), and the Brazilian Council of Science and Technology-CNPq (Universal 479599/2008-4), PELD-MAUA and PRONEX-FAPEAM-CNPq ("Tipologias alagaveis", 2007). Comments from several anonymous reviewers improved the manuscript.	Alroy J, 2015, ECOLOGY, V96, P575, DOI 10.1890/14-0471.1; [Anonymous], 2021, LANG ENV STAT COMP; Assis RL, 2015, PLANT ECOL, V216, P41, DOI 10.1007/s11258-014-0415-y; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Budke JC, 2007, PLANT ECOL, V189, P187, DOI 10.1007/s11258-006-9174-8; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Daly DC, 2000, IMPERFECT BALANCE LA, P391; Damasceno-Junior GA, 2005, FLORA, V200, P119, DOI 10.1016/j.flora.2004.09.002; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; FELFILI JM, 1995, VEGETATIO, V117, P1, DOI 10.1007/BF00033255; Ferreira CS, 2009, AQUAT BOT, V90, P246, DOI 10.1016/j.aquabot.2008.10.006; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; GIULIETTI A. M., 2002, VEGETACAO FLORA CAAT, P103; Gopal B, 2000, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 1, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hamann A, 2013, B AM METEOROL SOC, V94, P1307, DOI 10.1175/BAMS-D-12-00145.1; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Householder JE, 2016, FOREST STRUCTURE FUN, P145; Hsieh TC, 2016, INT SYMP WIREL; Hubbell Stephen P., 2001, V32, pi; IPCC, 2014, IPCC CLIMATE CHANGE; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Junk WJ, 2014, AQUAT CONSERV, V24, P5, DOI 10.1002/aqc.2386; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Kellman M, 1997, J BIOGEOGR, V24, P23, DOI 10.1111/j.1365-2699.1997.tb00047.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Koenker R., 2015, QUANTREG QUANTILE RE, V5, P19; Konar M, 2013, ADV WATER RESOUR, V51, P317, DOI 10.1016/j.advwatres.2012.02.009; Kurzatkowski D, 2015, ACTA OECOL, V69, P21, DOI 10.1016/j.actao.2015.08.002; Latrubesse EM, 2008, GEOMORPHOLOGY, V101, P130, DOI 10.1016/j.geomorph.2008.05.035; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; MAC ARTHUR ROBERT H., 1967; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MEAVE J, 1991, GLOBAL ECOL BIOGEOGR, V1, P69, DOI 10.2307/2997492; Metzger JP, 1997, PLANT ECOL, V133, P135, DOI 10.1023/A:1009791831294; Montero JC, 2014, HYDROBIOLOGIA, V729, P229, DOI 10.1007/s10750-012-1381-9; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Oksanen J, 2022, R PACKAGE VERSION; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Parolin P, 2009, ANN BOT-LONDON, V103, P359, DOI 10.1093/aob/mcn216; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Phillips O, 2002, GLOBAL PATTERNS PLAN; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pitman NCA, 2014, ECOGRAPHY, V37, P902, DOI 10.1111/ecog.00774; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; PRANCE G T, 1975, Acta Amazonica, V5, P207; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Safford HD, 2007, J BIOGEOGR, V34, P1701, DOI 10.1111/j.1365-2699.2007.01732.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Sculthorpe CD, 1985, BIOL AQUATIC VASCULA; Slik JWF, 2015, P NATL ACAD SCI USA, V112, P7472, DOI 10.1073/pnas.1423147112; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Veloso HP, 1991, CLASSIFICAC TEMA UNI; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wittmann F, 2002, J TROP ECOL, V18, P805, DOI 10.1017/S0266467402002523; Wittmann F., 2015, RES REPORTS BIODIVER, V4, P47, DOI [10.2147/rrbs.s64502, DOI 10.2147/RRBS.S64502, 10.2147/RRBS.S64502]; Wittmann F., 2012, MYCORRHIZA OCCURRENC, P223; Wittmann F, 2006, J BIOGEOGR, V33, P1334, DOI 10.1111/j.1365-2699.2006.01495.x; Wittmann F, 2013, ECOGRAPHY, V36, P690, DOI 10.1111/j.1600-0587.2012.07723.x; WORBES M, 1992, J VEG SCI, V3, P553, DOI 10.2307/3235812	81	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175003	10.1371/journal.pone.0175003	http://dx.doi.org/10.1371/journal.pone.0175003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394937	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800013
J	Loux, SC; Scoggin, KE; Bruemmer, JE; Canisso, IF; Troedsson, MHT; Squires, EL; Ball, BA				Loux, Shavahn C.; Scoggin, Kirsten E.; Bruemmer, Jason E.; Canisso, Igor F.; Troedsson, Mats H. T.; Squires, Edward L.; Ball, Barry A.			Evaluation of circulating miRNAs during late pregnancy in the mare	PLOS ONE			English	Article							CELL INVASION; RNA-BINDING; MICRORNAS; STAT3; PROLIFERATION; ACTIVATION; EXPRESSION; BIOMARKERS; DISCOVERY; PATHWAYS	MicroRNAs (miRNAs) are small, non-coding RNAs which are produced throughout the body. Individual tissues tend to have a specific expression profile and excrete many of these miRNAs into circulation. These circulating miRNAs may be diagnostically valuable biomarkers for assessing the presence of disease while minimizing invasive testing. In women, numerous circulating miRNAs have been identified which change significantly during pregnancy -related complications (e.g. chorioamnionitis, eclampsia, recurrent pregnancy loss); however, no prior work has been done in this area in the horse. To identify pregnancy-specific miRNAs, we collected serial whole blood samples in pregnant mares at 8, 9, 10 m of gestation and post-partum, as well as from non-pregnant (diestrous) mares. In total, we evaluated a panel of 178 miRNAs using qPCR, eventually identifying five miRNAs of interest. One miRNA (miR-374b) was differentially regulated through late gestation and four miRNAs (miR-454, miR-133b, miR-486-5p and miR-204b) were differentially regulated between the pregnant and non-pregnant samples. We were able to identify putative targets for the differentially regulated miRNAs using two separate target prediction programs, miRDB and Ingenuity Pathway Analysis. The targets for the miRNAs differentially regulated during pregnancy were predicted to be involved in signaling pathways such as the STAT3 pathway and P13/AKT signaling pathway, as well as more endocrine-based pathways, including the GnRH, prolactin and insulin signaling pathways. In summary, this study provides novel information about the changes occurring in circulating miRNAs during normal pregnancy, as well as attempting to predict the biological effects induced by these miRNAs.	[Loux, Shavahn C.; Scoggin, Kirsten E.; Troedsson, Mats H. T.; Squires, Edward L.; Ball, Barry A.] Univ Kentucky, Dept Vet Sci, Lexington, KY 40506 USA; [Bruemmer, Jason E.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Canisso, Igor F.] Univ Illinois, Coll Vet Med, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Kentucky; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign	Ball, BA (corresponding author), Univ Kentucky, Dept Vet Sci, Lexington, KY 40506 USA.	b.a.ball@uky.edu	Loux, Shavahn C/AAG-9141-2019	Loux, Shavahn C/0000-0001-5193-6675; Scoggin, Kirsten/0000-0003-1348-641X; Ball, Barry/0000-0002-0502-0276; Bruemmer, Jason/0000-0002-4236-756X	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment; Paul Mellon post-doctoral fellowship; Geoffrey Hughes doctoral fellowship	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment; Paul Mellon post-doctoral fellowship; Geoffrey Hughes doctoral fellowship	This work was funded by the Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners (http://www.kentuckybred.org), the Albert Clay Endowment and the Paul Mellon post-doctoral fellowship, and the Geoffrey Hughes doctoral fellowship. Due to their relatively small size, not all funding sources have a website or grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arendt LM, 2015, J MAMMARY GLAND BIOL, V20, P9, DOI 10.1007/s10911-015-9337-0; Backes C, 2016, MOL DIAGNOSIS THERAP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brogaard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21812; Chen CY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131250; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Choi SY, 2013, PLACENTA, V34, P799, DOI 10.1016/j.placenta.2013.06.006; Cretoiu D, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/3851054; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Ghai V, 2016, ARCH TOXICOLOGY; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Hromadnikova I, 2016, THROMB RES, V137, P126, DOI 10.1016/j.thromres.2015.11.032; Kanhoush R, 2010, NUCLEUS-PHILA, V1, P109, DOI 10.4161/nucl.1.1.10857; Klohonatz KM, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142935; Ladomery MR, 2011, INT J MOL EPIDEMIOL, V2, P253; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lim W, 2016, MOL CELL ENDOCRINOL, V428, P28, DOI 10.1016/j.mce.2016.03.018; Llovera M, 2000, ONCOGENE, V19, P4695, DOI 10.1038/sj.onc.1203846; Maegdefessel L, 2014, J INTERN MED, V276, P633, DOI 10.1111/joim.12298; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mouillet JF, 2015, AM J OBSTET GYNECOL, V213, pS163, DOI 10.1016/j.ajog.2015.05.057; Pontes TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129399; Rudolph LM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12405; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Seeliger C, 2016, STEM CELLS DEV, V25, P1261, DOI 10.1089/scd.2016.0133; Sferruzzi-Perri AN, 2016, P NATL ACAD SCI USA, V113, P11255, DOI 10.1073/pnas.1602012113; Singh R, 2016, CANCER LETT, V381, P113, DOI 10.1016/j.canlet.2016.07.002; Suman P, 2014, AM J REPROD IMMUNOL, V72, P65, DOI 10.1111/aji.12248; Unger L, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0224-5; Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Wang Y, 2015, MOL CELL, V60, P118, DOI 10.1016/j.molcel.2015.08.014; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yu LJ, 2015, PLACENTA, V36, P581, DOI 10.1016/j.placenta.2015.02.013; Yu Y, 2015, BIOCHEM BIOPH RES CO, V463, P285, DOI 10.1016/j.bbrc.2015.05.052; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026	43	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175045	10.1371/journal.pone.0175045	http://dx.doi.org/10.1371/journal.pone.0175045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388652	Green Published, gold, Green Submitted			2022-12-26	WOS:000399375800017
J	Savoy, T; Maceda, L; Roy, NK; Peterson, D; Wirgin, I				Savoy, Tom; Maceda, Lorraine; Roy, Nirmal K.; Peterson, Doug; Wirgin, Isaac			Evidence of natural reproduction of Atlantic sturgeon in the Connecticut River from unlikely sources	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS-OXYRINCHUS; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; RE-IMPLEMENTATION; SIBSHIP INFERENCE; ALTAMAHA RIVER; NEW-YORK; N-E; MICROSATELLITE; SOFTWARE	Atlantic Sturgeon is listed under the U.S. Endangered Species Act as five Distinct Population Segments (DPS). The "endangered" New York Bight (NYB) DPS is thought to only harbor two populations; one in the Hudson River and a second smaller one in the Delaware River. Historically, the Connecticut River probably supported a spawning population of Atlantic Sturgeon that was believed extirpated many decades ago. In 2014, we successfully collected pre -migratory juvenile specimens from the lower Connecticut River which were subjected to mitochondrial DNA (mtDNA) control region sequence and microsatellite analyses to determine their genetic relatedness to other populations coastwide. Haplotype and allelic frequencies differed significantly between the Connecticut River collection and all other populations coastwide. Sibship analyses of the microsatellite data indicated that the Connecticut River collection was comprised of a small number of families that were likely the offspring of a limited number of breeders. This was supported by analysis of effective population size (Ne) and number of breeders (Nb). STRUCTURE analysis suggested that there were 11 genetic clusters among the coastwide collections and that from the Connecticut River was distinct from those in all other rivers. This was supported by UPGMA analyses of the microsatellite data. In AMOVA analyses, among region variation was maximized, and among population within regions variation minimized when the Connecticut River collection was separate from the other two populations in the NYB DPS indicating the dissimilarity between the Connecticut River collection and the other two populations in the NYB DPS. Use of mixed stock analysis indicated that the Connecticut River juvenile collection was comprised of specimens primarily of South Atlantic and Chesapeake Bay DPS origins. The most parsimonious explanation for these results is that the Connecticut River hosted successful natural reproduction in 2013 and that its offspring were descendants of a small number of colonizers from populations south of the NYB DPS, most notably the South Atlantic DPS. Our results run contrary to the belief that re -colonizers of extirpated populations primarily originate in proximal populations.	[Savoy, Tom] Connecticut Dept Energy & Environm Protect, Marine Fisheries Div, Hartford, CT USA; [Maceda, Lorraine; Roy, Nirmal K.; Wirgin, Isaac] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10003 USA; [Peterson, Doug] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA	New York University; University System of Georgia; University of Georgia	Wirgin, I (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10003 USA.	issac.wirgin@nyumc.org			Connecticut Sea Grant; Connecticut State Wildlife Grant; National Institute of Environmental Health Sciences Center [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Connecticut Sea Grant; Connecticut State Wildlife Grant; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Connecticut Sea Grant, Connecticut State Wildlife Grant, and a National Institute of Environmental Health Sciences Center Grant ES00260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APOSTLE R, 2013, J INT WILDLIFE LAW P, V16, P170, DOI DOI 10.1080/13880292.2013.805062; [ASSRT Team ASSR], 2007, REP NAT MAR FISH SER; Bain MB, 1997, ENVIRON BIOL FISH, V48, P347, DOI 10.1023/A:1007325814893; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Breece MW, 2016, METHODS ECOL EVOL, V7, P725, DOI 10.1111/2041-210X.12532; Brown JJ, 2010, FISHERIES, V35, P72, DOI 10.1577/1548-8446-35.2.72; Chambers RC, 2012, ENVIRON TOXICOL CHEM, V31, P2324, DOI 10.1002/etc.1953; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; DOVEL WL, 1983, NEW YORK FISH GAME J, V30, P140; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elvira B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145728; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Federal Register, 2012, ENDANGERED THREATENE, V77; Fritts MW, 2016, T AM FISH SOC, V145, P69, DOI 10.1080/00028487.2015.1094131; Galligan J. P., 1960, WILDLIFE CONSERVATIO, V6, P1; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grunwald C, 2008, CONSERV GENET, V9, P1111, DOI 10.1007/s10592-007-9420-1; Hale EA, 2016, T AM FISH SOC, V145, P1193, DOI 10.1080/00028487.2016.1214177; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; HUDSON RR, 1992, GENETICS, V132, P583; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kahn DM, 2012, ENDANGERED ATLANTIC; Kahnle AW, 2007, AM FISH S S, V56, P347; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2008, ONCOR SOFTWARE GENET; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Kinziger AP, 2011, ECOL EVOL, V1, P73, DOI 10.1002/ece3.8; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; MURAWSKI SA, 1977, BIOL FISHERIES DATA; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Leary SJ, 2014, CONSERV GENET, V15, P1173, DOI 10.1007/s10592-014-0609-9; Ong TL, 1996, COPEIA, P464, DOI 10.2307/1446867; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson DL, 2008, T AM FISH SOC, V137, P393, DOI 10.1577/T06-231.1; Peterson Douglas L., 2000, North American Journal of Fisheries Management, V20, P231, DOI 10.1577/1548-8675(2000)020<0231:EODROA>2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, J HEREDITY, V86; Register F., 2016, ENDANGERED THREATENE, V81, P35701; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Savoy T, 2003, T AM FISH SOC, V132, P1, DOI 10.1577/1548-8659(2003)132<0001:MAIHOS>2.0.CO;2; Schueller P, 2010, T AM FISH SOC, V139, P1526, DOI 10.1577/T09-127.1; Secor DH, 1999, AM FISH S S, V23, P203; Smith JA, 2015, T AM FISH SOC, V144, P48, DOI 10.1080/00028487.2014.965344; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Tajima F., 1993, INTRO MOL PALEOPOPUL; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waldman JR, 2013, ESTUAR COAST, V36, P257, DOI 10.1007/s12237-012-9573-0; Waldman JR, 1998, CONSERV BIOL, V12, P631, DOI 10.1046/j.1523-1739.1998.97041.x; Waldman JR, 1996, T AM FISH SOC, V125, P364, DOI 10.1577/1548-8659(1996)125<0364:SCOTNY>2.3.CO;2; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wenzel IV J, 2014, RARE STURGEON FOUND; Wirgin I, 2015, J FISH BIOL, V86, P1251, DOI 10.1111/jfb.12631; Wirgin I, 2000, T AM FISH SOC, V129, P476, DOI 10.1577/1548-8659(2000)129&lt;0476:GSOASP&gt;2.0.CO;2; WIRGIN II, 1990, BIOCHEM GENET, V28, P459, DOI 10.1007/BF00554374; Wirgin I, 2007, N AM J FISH MANAGE, V27, P1214, DOI 10.1577/M06-269.1; Wirgin I, 2015, N AM J FISH MANAGE, V35, P20, DOI 10.1080/02755947.2014.963751; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899; WRIGHT S, 1951, ANN EUGENIC, V15, P323	74	8	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175085	10.1371/journal.pone.0175085	http://dx.doi.org/10.1371/journal.pone.0175085			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388618	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800019
J	Trageser, SJ; Ghose, A; Faisal, M; Mro, P; Mro, P; Rahman, SC				Trageser, Scott J.; Ghose, Animesh; Faisal, Muzaffar; Mro, Passing; Mro, Poroy; Rahman, Shahriar Caesar			Pangolin distribution and conservation status in Bangladesh	PLOS ONE			English	Article								Asian pangolins are a highly-threatened species group, mainly due to the perceived medicinal value of their scales. Increased demand from China has resulted in pangolins being the most trafficked mammal in the world. Three pangolin species are reported to occur in Bangladesh: Manis pentadactyla, M. crassicaudata, and M. javanica. No peer-reviewed studies exist detailing these species' current distribution or status within Bangladesh. A literature review was conducted resulting in the clarification of conflicting reports and misidentified observations and specimen records. In this paper, we also report the current status of pangolins (Manis spp.) in Bangladesh based on semi-structured interviews, camera trapping, media queries, and field surveys employing traditional ecological knowledge and non-randomized transect surveys. Ethnozoological knowledge pertaining to the natural history of M. pentadactyla is also reported from experienced Mro tribal hunters. The critically endangered M. pentadactyla was verified to occur in northwest, northeast, and southeast Bangladesh in natural and degraded habitats. Interviews with the Mro tribe in the southeast indicate that pangolin populations there were likely extirpated in 2014 due to skilled commercial collection beginning in 2010. Evidence of extant M. crassicaudata and M. javanica populations remain unverified and questionable, and historical records of M. crassicaudata and M. javanica are likely a result of misidentification.	[Trageser, Scott J.; Ghose, Animesh; Faisal, Muzaffar; Mro, Passing; Mro, Poroy; Rahman, Shahriar Caesar] Creat Conservat Alliance, Dhaka, Bangladesh		Trageser, SJ (corresponding author), Creat Conservat Alliance, Dhaka, Bangladesh.	trageser.scott@gmail.com	Ghose, Animesh/AAZ-5259-2020		Bangladesh Python Project's International Volunteer Program; Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh; Orianne Society, USA	Bangladesh Python Project's International Volunteer Program; Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh; Orianne Society, USA	This project was supported through the Bangladesh Python Projects International Volunteer Program, the Center for Advanced Research in Natural Resources and Management (CARINAM), Bangladesh, and the Orianne Society, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 1992, MAMMALIAN FAUNA W BE, V3; Ahmed Z.U., 2008, ENCY FLORA FAUNA BAN, V12; Ahmed ZU, 2009, ENCY FLORA FAUNA BAN, V27; Ahsan M. Farid, 2008, Bangladesh Journal of Zoology, V36, P131; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1985, MAMMALS BANGLADESH F; [Anonymous], 2014, IUCN RED LIST THREAT; Athreya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142647; Baillie J, 2014, IUCN RED LIST THREAT; Choudrury Anwaruddin, 2004, Journal of the Bombay Natural History Society, V101, P444; Hansen M. C., 2013, SCIENCE; Heath M. E., 1992, MAMMALIAN SPECIES, V414, P1, DOI DOI 10.2307/3504143; Heath Martha E., 1995, Mammalian Species, V513, P1; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; IUCN Bangladesh, 2003, BANGL BIP BONN PRAN; Katuwal Hem Bahadur, 2015, Journal of Threatened Taxa, V7, P7563; Khan M.M.H., 2008, NISHORGO SUPPORT PRO, P304; Khan MAR, 2010, WILDLIFE BANGLADESH; Lagrada L, 2014, IUCN RED LIST THREAT; Lewin Thomas Herbert, 1869, HILL TRACTS CHITTAGO; Lin J.H., 2011, THESIS; Mahony Stephen, 2008, Hamadryad, V32, P34; Platt SG, 2010, CHELONIAN CONSERV BI, V9, P114, DOI 10.2744/CCB-0813.1; Rasul G, 2007, ENVIRON CONSERV, V34, P153, DOI 10.1017/s0376892907003888; Reza AHMA., 2010, DIVERSITY AMPHIBIANS; WCMC IUCN/SSC TRAFFIC, 1999, REV SIGN TRAD AN SPE; Zhou ZM, 2014, FRONT ECOL ENVIRON, V12, P97, DOI 10.1890/14.WB.001	27	26	26	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175450	10.1371/journal.pone.0175450	http://dx.doi.org/10.1371/journal.pone.0175450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388644	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800056
J	Daimon, M; Kamba, A; Murakami, H; Mizushiri, S; Osonoi, S; Yamaichi, M; Matsuki, K; Sato, E; Tanabe, J; Takayasu, S; Matsuhashi, Y; Yanagimachi, M; Terui, K; Kageyama, K; Tokuda, I; Takahashi, I; Nakaji, S				Daimon, Makoto; Kamba, Aya; Murakami, Hiroshi; Mizushiri, Satoru; Osonoi, Sho; Yamaichi, Masato; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori; Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki			Association between serum prolactin levels and insulin resistance in non-diabetic men	PLOS ONE			English	Article							GROWTH-HORMONE; CELL GROWTH; WEIGHT-LOSS; RISK; RELEASE; GLUCOSE; HYPERPROLACTINEMIA; DIFFERENTIATION; CABERGOLINE; EXPRESSION	Prolactin (PRL) has roles in various physiological functions. Although experimental studies showed that PRL has both beneficial and adverse effects on type 2 diabetes mellitus, clinical findings in subjects with hyperprolactinemia indicate adverse effects on glucose metabolism. However, effects of PRL within the physiological range in human are controversial. A population-based study of 370 Japanese men enrolled in the 2014 Iwaki study (aged 52.0 +/- 14.8 years). In this cross-sectional study, associations between serum PRL levels and homeostatic model assessment (HOMA) indices representing glucose metabolism in a physiological setting were examined using multivariable regression analysis. Although univariate linear regression analyses showed significant associations between serum PRL levels and HOMA indices, adjustment with multiple factors made the association with HOMA-beta (insulin secretion) insignificant, while those with HOMA-R (insulin resistance) remained significant (beta = 0.084, p = 0.035). Non-linear regression analyses showed a regression curve with a peak at serum PRL level, 12.4 ng/mL and a positive association of serum PRL level with HOMA-R below the peak (beta = 0.119, p = 0.004). Higher serum PRL levels within the physiological range seem to be associated with insulin resistance in men.	[Daimon, Makoto; Kamba, Aya; Murakami, Hiroshi; Mizushiri, Satoru; Osonoi, Sho; Yamaichi, Masato; Matsuki, Kota; Sato, Eri; Tanabe, Jutaro; Takayasu, Shinobu; Matsuhashi, Yuki; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan; [Tokuda, Itoyo; Takahashi, Ippei; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Daimon, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan.	mdaimon@hirosaki-u.ac.jp	Takayasu, Shinobu/ABH-9199-2020; Daimon, Makoto/AAY-1289-2020	Daimon, Makoto/0000-0002-3775-1719	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Center of Innovation Program from Japan Science and Technology Agency.	Balbach L, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-12; Baptista T, 2000, PHARMACOPSYCHIATRY, V33, P81, DOI 10.1055/s-2000-8451; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berinder K, 2011, PITUITARY, V14, P199, DOI 10.1007/s11102-010-0277-9; Bouckenooghe T, 2014, BBA-MOL BASIS DIS, V1842, P584, DOI 10.1016/j.bbadis.2013.12.005; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Chirico V, 2013, CLIN ENDOCRINOL, V79, P537, DOI 10.1111/cen.12183; Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001; Ciresi A, 2013, CLIN ENDOCRINOL, V79, P845, DOI 10.1111/cen.12204; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Corona G, 2011, INT J ANDROL, V34, P217, DOI 10.1111/j.1365-2605.2010.01076.x; Corona G, 2014, J SEX MED, V11, P240, DOI 10.1111/jsm.12327; Daimon M, 2016, J CLIN ENDOCR METAB, V101, P889, DOI 10.1210/jc.2015-3568; Doknic M, 2002, EUR J ENDOCRINOL, V147, P77, DOI 10.1530/eje.0.1470077; Silva CMD, 2011, OBESITY, V19, P800, DOI 10.1038/oby.2010.150; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Georgiopoulos GA, 2009, HYPERTENSION, V54, P98, DOI 10.1161/HYPERTENSIONAHA.109.132100; Glintborg D, 2014, HUM REPROD, V29, P1773, DOI 10.1093/humrep/deu133; Greenman Y, 1998, CLIN ENDOCRINOL, V48, P547, DOI 10.1046/j.1365-2265.1998.00403.x; Haring R, 2014, EUR HEART J, V35, P1215, DOI 10.1093/eurheartj/ehs233; Haring R, 2012, ATHEROSCLEROSIS, V221, P570, DOI 10.1016/j.atherosclerosis.2012.01.017; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; KNUDTZON J, 1986, LIFE SCI, V39, P617, DOI 10.1016/0024-3205(86)90042-1; Kok P, 2004, J CLIN ENDOCR METAB, V89, P4445, DOI 10.1210/jc.2003-032184; Kok P, 2006, AM J PHYSIOL-ENDOC M, V290, pE218, DOI 10.1152/ajpendo.00156.2005; Lamos EM, 2016, PRIM CARE DIABETES, V10, P60, DOI 10.1016/j.pcd.2015.10.008; Vicchi FL, 2016, PHARMACOL RES, V109, P74, DOI 10.1016/j.phrs.2015.12.029; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV 2; Nilsson L, 2005, BIOCHEM BIOPH RES CO, V331, P1120, DOI 10.1016/j.bbrc.2005.04.026; Petryk A, 2000, J ENDOCRINOL, V164, P277, DOI 10.1677/joe.0.1640277; Reis FM, 1997, J ENDOCRINOL, V153, P423, DOI 10.1677/joe.0.1530423; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Serri O, 2006, CLIN ENDOCRINOL, V64, P366, DOI 10.1111/j.1365-2265.2006.02469.x; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Wang TG, 2013, DIABETES CARE, V36, P1974, DOI 10.2337/dc12-1893; Zhang LX, 2010, J HYPERTENS, V28, P1400, DOI 10.1097/HJH.0b013e328339f254	40	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175204	10.1371/journal.pone.0175204	http://dx.doi.org/10.1371/journal.pone.0175204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384295	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900119
J	Kolpakova, J; Li, L; Hatcher, JT; Gu, H; Zhang, XG; Chen, J; Cheng, ZXJ				Kolpakova, Jenya; Li, Liang; Hatcher, Jeffrey T.; Gu, He; Zhang, Xueguo; Chen, Jin; Cheng, Zixi Jack			Responses of Nucleus Tractus Solitarius (NTS) early and late neurons to blood pressure changes in anesthetized F344 rats	PLOS ONE			English	Article							VAGAL AFFERENT INNERVATION; BARORECEPTOR REFLEX; HEART-FAILURE; AORTIC-ARCH; RECEPTORS; BAROREFLEX; GLUTAMATE; CHEMORECEPTORS; TRANSMISSION; STIMULATION	Previously, many different types of NTS barosensitive neurons were identified. However, the time course of NTS barosensitive neuronal activity (NA) in response to arterial pressure (AP) changes, and the relationship of NA-AP changes, have not yet been fully quantified. In this study, we made extracellular recordings of single NTS neurons firing in response to AP elevation induced by occlusion of the descending aorta in anesthetized rats. Our findings were that: 1) Thirty-five neurons (from 46 neurons) increased firing, whereas others neurons either decreased firing upon AP elevation, or were biphasic: first decreased firing upon AP elevation and then increased firing during AP decrease. 2) Fourteen neurons with excitatory responses were activated and rapidly increased their firing during the early phase of AP increase (early neurons); whereas 21 neurons did not increase firing until the mean arterial pressure changes (Delta MAP) reached near/after the peak (late neurons). 3) The early neurons had a significantly higher firing rate than late neurons during AP elevation at a similar rate. 4) Early neuron NA-Delta MAP relationship could be well fitted and characterized by the sigmoid logistic function with the maximal gain of 29.3. 5) The increase of early NA correlated linearly with the initial heart rate (HR) reduction. 6) The late neurons did not contribute to the initial HR reduction. However, the late NA could be well correlated with HR reduction during the late phase. Altogether, our study demonstrated that the NTS excitatory neurons could be grouped into early and late neurons based on their firing patterns. The early neurons could be characterized by the sigmoid logistic function, and different neurons may differently contribute to HR regulation. Importantly, the grouping and quantitative methods used in this study may provide a useful tool for future assessment of functional changes of early and late neurons in disease models.	[Kolpakova, Jenya; Li, Liang; Hatcher, Jeffrey T.; Gu, He; Chen, Jin; Cheng, Zixi Jack] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Zhang, Xueguo] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	State University System of Florida; University of Central Florida; Henry Ford Health System; Henry Ford Hospital	Cheng, ZXJ (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	zixi.cheng@ucf.edu	Chen, Jin/M-1837-2019	Chen, Jin/0000-0001-7617-1664	NIH [A21020]; UCF institutional fund; NATIONAL INSTITUTE ON AGING [R01AG021020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCF institutional fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant A21020 and UCF institutional fund to ZC.	Accorsi-Mendonca D, 2013, AUTON NEUROSCI-BASIC, V175, P3, DOI 10.1016/j.autneu.2012.12.002; Al J, 2009, NEUROSCIENCE, V164, P658, DOI 10.1016/j.neuroscience.2009.06.066; Andresen MC, 2004, BRAZ J MED BIOL RES, V37, P549, DOI 10.1590/S0100-879X2004000400012; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; BROWN AM, 1980, CIRC RES, V46, P1, DOI 10.1161/01.RES.46.1.1; Canesin RO, 2000, BRAIN RES, V852, P68, DOI 10.1016/S0006-8993(99)02196-4; Chen MJ, 2014, SCI CHINA LIFE SCI, V57, P502, DOI 10.1007/s11427-014-4649-7; Cheng Z, 1997, J AUTONOM NERV SYST, V67, P1, DOI 10.1016/S0165-1838(97)00085-4; Cheng ZX, 1997, J COMP NEUROL, V381, P1, DOI 10.1002/(SICI)1096-9861(19970428)381:1<1::AID-CNE1>3.0.CO;2-5; Dampney RAL, 2003, CELL MOL NEUROBIOL, V23, P597, DOI 10.1023/A:1025080314925; Deuchars J, 2000, J COMP NEUROL, V417, P233; Gao J, 2014, AM J HYPERTENS, V27, P1248, DOI 10.1093/ajh/hpu044; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; Gu H, 2008, NEUROSCIENCE, V152, P741, DOI 10.1016/j.neuroscience.2007.11.030; Gu H, 2007, AM J PHYSIOL-HEART C, V293, pH2809, DOI 10.1152/ajpheart.00358.2007; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; HINES T, 1994, CIRC RES, V74, P1188, DOI 10.1161/01.RES.74.6.1188; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Li LH, 2010, J COMP NEUROL, V518, P2771, DOI 10.1002/cne.22363; Ma XY, 2002, AM J PHYSIOL-REG I, V283, pR1033, DOI 10.1152/ajpregu.00768.2001; Machado BH, 2000, AM J PHYSIOL-HEART C, V279, pH67, DOI 10.1152/ajpheart.2000.279.1.H67; Mifflin SW, 2001, NEWS PHYSIOL SCI, V16, P266; OHTA H, 1994, AM J PHYSIOL-REG I, V267, pR1065, DOI 10.1152/ajpregu.1994.267.4.R1065; Paton JFR, 2001, ANN NY ACAD SCI, V940, P157; Potts JT, 2002, CLIN EXP PHARMACOL P, V29, P103, DOI 10.1046/j.1440-1681.2002.03613.x; ROGERS RF, 1993, AM J PHYSIOL, V265, pR1355, DOI 10.1152/ajpregu.1993.265.6.R1355; Schreihofer AM, 2002, CLIN EXP PHARMACOL P, V29, P514, DOI 10.1046/j.1440-1681.2002.03665.x; SEAGARD JL, 1990, CIRC RES, V66, P1499, DOI 10.1161/01.RES.66.6.1499; Seagard JL, 2001, ANN NY ACAD SCI, V940, P142; SEAGARD JL, 1995, NEUROSCI LETT, V191, P13, DOI 10.1016/0304-3940(95)11545-1; Seagard JL, 1999, J PHYSIOL-LONDON, V520, P243, DOI 10.1111/j.1469-7793.1999.00243.x; Spitzer, 2008, FUNDAMENTAL NEUROSCI, P829; Wang WZ, 2007, AM J PHYSIOL-REG I, V292, pR1137, DOI 10.1152/ajpregu.00590.2006; Wang WZ, 2006, NEUROSCI LETT, V409, P146, DOI 10.1016/j.neulet.2006.09.032; Zhang J, 2000, J PHYSIOL-LONDON, V529, P431, DOI 10.1111/j.1469-7793.2000.00431.x; Zhang J, 1997, J PHARMACOL EXP THER, V282, P639; Zhang J, 2000, AM J PHYSIOL-REG I, V278, pR1595, DOI 10.1152/ajpregu.2000.278.6.R1595; Zhang XG, 2003, J PHYSIOL-LONDON, V553, P1005, DOI 10.1113/jphysiol.2003.045906; Zhang XG, 2003, AUTON NEUROSCI-BASIC, V103, P19, DOI 10.1016/S1566-0702(02)00145-5	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0169529	10.1371/journal.pone.0169529	http://dx.doi.org/10.1371/journal.pone.0169529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384162	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900002
J	Manz, KM; Clowes, P; Kroidl, I; Kowuor, DO; Geldmacher, C; Ntinginya, NE; Maboko, L; Hoelscher, M; Saathoff, E				Manz, Kirsi M.; Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Geldmacher, Christof; Ntinginya, Nyanda E.; Maboko, Leonard; Hoelscher, Michael; Saathoff, Elmar			Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; EPIDEMIOLOGY; SCHISTOSOMIASIS; METAANALYSIS; VARIABLES; HOOKWORM; AFRICA; DRUGS	Background The intestinal nematode Trichuris trichiura is among the most common causes of human infectious disease worldwide. As for other soil-transmitted nematodes, its reproductive success and thus prevalence and intensity of infection in a given area strongly depend on environmental conditions. Characterization of the influence of environmental factors can therefore aid to identify infection hot spots for targeted mass treatment. Methodology We analyzed data from a cross-sectional survey including 6234 participants from nine distinct study sites in Mbeya region, Tanzania. A geographic information system was used to combine remotely sensed and individual data, which were analyzed using uni- and multivariable Poisson regression. Household clustering was accounted for and when necessary, fractional polynomials were used to capture non-linear relationships between T. trichiura infection prevalence and environmental variables. Principal findings T. trichiura infection was restricted to the Kyela site, close to Lake Nyasa with only very few cases in the other eight sites. The prevalence of T. trichiura infection in Kyela was 26.6% (95% confidence interval (CI) 23.9 to 29.6%). Multivariable models revealed a positive association of infection with denser vegetation (prevalence ratio (PR) per 0.1 EVI units = 2.12, CI 1.28 to 3.50) and inverse associations with rainfall (PR per 100 mm = 0.54, CI 0.44 to 0.67) and elevation (PR per meter = 0.89, CI 0.86 to 0.93) while adjusting for age and previous worm treatment. Slope of the terrain was modelled non-linearly and also showed a positive association with T. trichiura infection (p-value p<0.001). Conclusion/Significance Higher prevalences of T. trichiura infection were only found in Kyela, a study site characterized by denser vegetation, high rainfall, low elevation and flat terrain. But even within this site, we found significant influences of vegetation density, rainfall, elevation and slope on T. trichiura infection. The inverse association of rainfall with infection in Kyela is likely due to the fact, that rainfall in this site is beyond the optimum conditions for egg development. Our findings demonstrate that use of remotely sensed environmental data can aid to predict high-risk areas for targeted helminth control.	[Manz, Kirsi M.] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Manz, Kirsi M.; Clowes, Petra; Kroidl, Inge; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Clowes, Petra; Kroidl, Inge; Kowuor, Dickens O.; Ntinginya, Nyanda E.; Maboko, Leonard; Hoelscher, Michael] NIMR Mbeya Med Res Ctr MMRC, Mbeya, Tanzania; [Kroidl, Inge; Geldmacher, Christof; Hoelscher, Michael; Saathoff, Elmar] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	University of Munich; University of Munich; German Center for Infection Research	Manz, KM (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany.; Manz, KM (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	manz@ibe.med.uni-muenchen.de	Hoelscher, Michael/D-3436-2012	Manz, Kirsi/0000-0002-7740-4076	European Commission [SANTE/2004/078-545/130, SANTE/2006/129-931]; German Science foundation DFG [SA 1878/1-1]; German Federal Ministry of Education and Research BMBF [01 KA 0904]; European Commission's Seventh Framework Programme (EC-GA) [241642]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Science foundation DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); European Commission's Seventh Framework Programme (EC-GA)	The EMINI study was funded by the European Commission (SANTE/2004/078-545/130 & SANTE/2006/129-931). Helminth data collection was supported by the German Science foundation DFG (SA 1878/1-1) and the German Federal Ministry of Education and Research BMBF (01 KA 0904) with additional support from the European Commission's Seventh Framework Programme (EC-GA no 241642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin A, 2010, WIRES COMPUT STAT, V2, P370, DOI 10.1002/wics.84; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; BUNDY DAP, 1989, ADV PARASIT, V28, P107; Chammartin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-152; Cross J.H, 1996, MED MICROBIOLOGY; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Jann B., 2008, NLCHECK STATA MODULE; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Montresor A., 1998, WORLD HLTH ORG; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; NASA Land Processes Distributed Active Archive Center (LP DAAC), 2001, MODIS 11A2 MODIS 13Q; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oluwole AS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003740; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Riess H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002408; Rogers WH, 1993, STATA TECHN B, V13, P19; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 1997, J ROY STAT SOC D-STA, V46, P411; Saathoff E, 2005, TROP MED INT HEALTH, V10, P412, DOI 10.1111/j.1365-3156.2005.01406.x; Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58; Siza JE, 2015, KOREAN J PARASITOL, V53, P525, DOI 10.3347/kjp.2015.53.5.525; Uneke CJ, 2010, TANZAN J HLTH RES, V12, P86; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212	35	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175137	10.1371/journal.pone.0175137	http://dx.doi.org/10.1371/journal.pone.0175137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384306	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000399371900098
J	Mustonen, M; Haimi, J; Kesaniemi, J; Hogmander, H; Knott, KE				Mustonen, Marina; Haimi, Jari; Kesaniemi, Jenni; Hogmander, Harri; Knott, K. Emily			Variation in gene expression within clones of the earthworm Dendrobaena octaedra	PLOS ONE			English	Article							POPULATIONS; LUMBRICIDAE; OLIGOCHAETA; METHYLATION; ADAPTATION; DIVERSITY; RESPONSES; GENOMICS; CADMIUM; COPPER	Gene expression is highly plastic, which can help organisms to both acclimate and adapt to changing environments. Possible variation in gene expression among individuals with the same genotype (among clones) is not widely considered, even though it could impact the results of studies that focus on gene expression phenotypes, for example studies using clonal lines. We examined the extent of within and between clone variation in gene expression in the earthworm Dendrobaena octaedra, which reproduces through apomictic parthenogenesis. Five microsatellite markers were developed and used to confirm that offspring are genetic clones of their parent. After that, expression of 12 genes was measured from five individuals each from six clonal lines after exposure to copper contaminated soil. Variation in gene expression was higher over all genotypes than within genotypes, as initially assumed. A subset of the genes was also examined in the offspring of exposed individuals in two of the clonal lines. In this case, variation in gene expression within genotypes was as high as that observed over all genotypes. One gene in particular (chymotrypsin inhibitor) also showed significant differences in the expression levels among genetically identical individuals. Gene expression can vary considerably, and the extent of variation may depend on the genotypes and genes studied. Ensuring a large sample, with many different genotypes, is critical in studies comparing gene expression phenotypes. Researchers should be especially cautious inferring gene expression phenotypes when using only a single clonal or inbred line, since the results might be specific to only certain genotypes.	[Mustonen, Marina; Haimi, Jari; Knott, K. Emily] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kesaniemi, Jenni] Univ Oulu, Dept Ecol, Oulu, Finland; [Hogmander, Harri] Univ Jyvaskyla, Dept Math & Stat, Jyvaskyla, Finland	University of Jyvaskyla; University of Oulu; University of Jyvaskyla	Mustonen, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	marina.s.mustonen@jyu.fi		Knott, Karelyn Emily/0000-0003-2564-1560; Kesaniemi, Jenni/0000-0001-8328-558X; Haimi, Jari/0000-0003-3582-5697	Maj and Tor Nessling Foundation [2015038]; Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla	Maj and Tor Nessling Foundation; Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla	This work was supported by the Maj and Tor Nessling Foundation (project number 2015038) and the Doctoral Programme in Biological and Environmental Science at University of Jyvaskyla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dudycha JL, 2012, ECOL EVOL, V2, P329, DOI 10.1002/ece3.30; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Fisker KV, 2011, ECOTOXICOLOGY, V20, P563, DOI 10.1007/s10646-011-0610-8; Fisker KV, 2013, COMP BIOCHEM PHYS C, V157, P220, DOI 10.1016/j.cbpc.2012.11.007; Fisker KV, 2011, COMP BIOCHEM PHYS C, V154, P204, DOI 10.1016/j.cbpc.2011.05.009; Grapputo A, 2006, MOL ECOL NOTES, V6, P1177, DOI 10.1111/j.1471-8286.2006.01483.x; Haimi J, 2007, EUR J SOIL BIOL, V43, pS268, DOI 10.1016/j.ejsobi.2007.08.026; Hansen PL, 2006, PEDOBIOLOGIA, V50, P225, DOI 10.1016/j.pedobi.2005.12.001; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HONGELL K, 1989, HEREDITAS, V110, P179, DOI 10.1111/j.1601-5223.1989.tb00440.x; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Knott KE, 2010, HEREDITY, V105, P341, DOI 10.1038/hdy.2010.31; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Loxdale HD, 2003, BIOL J LINN SOC, V79, P3, DOI 10.1046/j.1095-8312.2003.00177.x; Loxdale HD, 2008, AGR FOREST ENTOMOL, V10, P81, DOI 10.1111/j.1461-9563.2008.00364.x; Lukkari T, 2005, ECOTOX ENVIRON SAFE, V62, P35, DOI 10.1016/j.ecoenv.2004.11.012; Mustonen M, 2014, ECOTOXICOLOGY, V23, P1732, DOI 10.1007/s10646-014-1338-z; Nota B, 2013, ENVIRON SCI TECHNOL, V47, P1155, DOI 10.1021/es303983z; Omodeo P., 1955, Caryologia, V8, P135; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Roelofs D, 2008, FUNCT ECOL, V22, P8, DOI 10.1111/j.1365-2435.2007.01312.x; Rosa BA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002678; Rozen A, 2006, SOIL BIOL BIOCHEM, V38, P489, DOI 10.1016/j.soilbio.2005.06.003; Rozen S, 2000, Methods Mol Biol, V132, P365; Rue P, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145549; Schoofs L, 2002, CURR PHARM DESIGN, V8, P483, DOI 10.2174/1381612023395718; Simonsen V, 2008, HEREDITAS, V145, P212, DOI 10.1111/j.0018-0661.2008.02045.x; Simonsen V, 2008, PEDOBIOLOGIA, V52, P51, DOI 10.1016/j.pedobi.2008.02.003; Snoek LB, 2014, SCI REP-UK, V4, DOI 10.1038/srep03912; TERHIVUO J, 1990, PEDOBIOLOGIA, V34, P113; Terhivuo J, 2006, BIOL INVASIONS, V8, P1205, DOI 10.1007/s10530-006-9015-7; Viney M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1104; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wolff GL, 1996, FUND APPL TOXICOL, V29, P176, DOI 10.1006/faat.1996.0019; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	45	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174960	10.1371/journal.pone.0174960	http://dx.doi.org/10.1371/journal.pone.0174960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384196	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900064
J	Xing, H; Mallon, JC; Currie, ML				Xing, Hai; Mallon, Jordan C.; Currie, Margaret L.			Supplementary cranial description of the types of Edmontosaurus regalis (Ornithischia: Hadrosauridae), with comments on the phylogenetics and biogeography of Hadrosaurinae	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; PRINCE CREEK FORMATION; DINOSAURIA HADROSAURIDAE; LAMBEOSAURINE DINOSAUR; NORTH SLOPE; ALBERTA; TAPHONOMY; ORNITHOPODA; BRAINCASE; PROVINCE	The cranial anatomy of the flat-skulled hadrosaurine Edmontosaurus regalis (Ornithischia: Hadrosauridae) is extensively described here, based on the holotype and paratype collected from the middle part of the Horseshoe Canyon Formation in southern Alberta. Focus is given to previously undocumented features of ontogenetic and phylogenetic importance. This description facilitates overall osteological comparisons between E. regalis and other hadrosaurids (especially E. annectens), and revises the diagnosis of E. regalis, to which a new autapomorphy (the dorsal half of the jugal anterior process bearing a sharp posterolateral projection into the orbit) is added. We consider the recently named Ugrunaaluk kuukpikensis from the upper Campanian/lower Maastrichtian of Alaska a nomen dubium, and conservatively regard the Alaskan material as belonging to Edmontosaurus sp.. A phylogenetic analysis of Hadrosauroidea using maximum parsimony further corroborates the sistertaxon relationship between E. regalis and E. annectens. In the strict consensus tree, Hadrosaurus foulkii occurs firmly within the clade comprising all non-lambeosaurine hadrosaurids, supporting the taxonomic scheme that divides Hadrosauridae into Hadrosaurinae and Lambeosaurinae. Within Edmontosaurini, Kerberosaurus is posited as the sister taxon to the clade of Shantungosaurus + Edmontosaurus. The biogeographic reconstruction of Hadrosaurinae in light of the time-calibrated cladogram and probability calculation of ancestral areas for all internal nodes reveals a significantly high probability for the North American origin of the clade. However, the Laramidia-Appalachia dispersals around the Santonian-Campanian boundary, inferred from the biogeographic scenario for the North American origin of Hadrosaurinae, are in conflict with currently accepted paleogeographic models. By contrast, the Asian origin of Hadrosaurinae with its relatively low probability resulting from the biogeographic analysis is worth seriously considering, despite the lack of fossil material from the Santonian and lower Campanian of Asia. Extra fossil collecting in appropriate geographic locations and stratigraphic intervals of Asia and Europe will help to clarify the biogeographic dynamics of hadrosaurine dinosaurs in the near future.	[Xing, Hai] Beijing Acad Sci & Technol, Beijing Museum Nat Hist, Beijing, Peoples R China; [Mallon, Jordan C.; Currie, Margaret L.] Canadian Museum Nat, Palaeobiol, Ottawa, ON, Canada	Beijing Academy of Science & Technology	Xing, H (corresponding author), Beijing Acad Sci & Technol, Beijing Museum Nat Hist, Beijing, Peoples R China.	xinghai@bmnh.org.cn		Mallon, Jordan/0000-0002-8209-8827	National Natural Science Foundation of China [41602006, 41120124002]; Beijing Natural Science Foundation [5174032]; National Basic Research Program of China (973 Program) [2012CB822002]; Youth Backbone Training Plan [201601]; Innovative Team Program of the Beijing Academy of Science and Technology [IG201705N]; Beijing Millions of Talents Project in the New Century; Canadian Museum of Nature; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Youth Backbone Training Plan; Innovative Team Program of the Beijing Academy of Science and Technology; Beijing Millions of Talents Project in the New Century; Canadian Museum of Nature; China Scholarship Council(China Scholarship Council)	Funding was provided by the National Natural Science Foundation of China (No. 41602006 and 41120124002), the Beijing Natural Science Foundation (No. 5174032), the National Basic Research Program of China (973 Program, No. 2012CB822002), the Youth Backbone Training Plan (No. 201601) and Innovative Team Program (No. IG201705N) of the Beijing Academy of Science and Technology, the Beijing Millions of Talents Project in the New Century, the Canadian Museum of Nature, and the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0062; Bell PR, 2014, CURR BIOL, V24, P70, DOI 10.1016/j.cub.2013.11.008; Blakey R., 2009, GLOBAL PALEOGEOGRAPH; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Brett-Surman MK., 1989, THESIS GEORGE WASHIN, P1; Brown CM, 2015, PEERJ, V3, DOI 10.7717/peerj.818; Campione Nicolas E., 2014, P208; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Conrad JE, 1992, US GEOLOGICAL SURV C, V1990C, pC1, DOI DOI 10.1016/J.CRETRES.2015.10.007; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cruzado-Caballero P, 2013, J VERTEBR PALEONTOL, V33, P1367, DOI 10.1080/02724634.2013.772061; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2015, CAN J EARTH SCI, V52, P642, DOI 10.1139/cjes-2014-0184; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fiorillo Anthony R., 2001, Historical Biology, V15, P323, DOI 10.1080/0891296021000037327; Fowler EAF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141304; Gangloff RA, 2010, PALAIOS, V25, P299, DOI 10.2110/palo.2009.p09-103r; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2015, J SYST PALAEONTOL, V13, P711, DOI 10.1080/14772019.2014.950614; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Gilmore CW, 1924, CANADA DEP MINES B G, V43, P13; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; HEATON MJ, 1972, CAN J EARTH SCI, V9, P185, DOI 10.1139/e72-015; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Lambe L. M., 1917, Ottawa Naturalist, V31; Lambe L.M., 1918, OTTAWA NATURALIST, V31, P135; Lambe L.M., 1920, GEOLOGICAL SURVEY CA, V120, P1, DOI [DOI 10.4095/101655, 10.4095/101655]; Langston W., 1960, Fieldiana Geology Memoir, V3, P313; Larson Derek W., 2014, P136; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Lund Eric K., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P263; Maddison WP., 2021, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mori H, 2016, ACTA PALAEONTOL POL, V61, P15, DOI 10.4202/app.00152.2015; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Phillips RL, 2003, CRETACEOUS RES, V24, P499, DOI 10.1016/S0195-6671(03)00068-5; Prieto-Marquez A, 2016, J VERTEBR PALEONTOL, P1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P838, DOI 10.1080/02724631003762971; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Tan Qing-Wei, 2015, Vertebrata Palasiatica, V53, P245; Vanderven E, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0064; Wang RF, 2017, HIST BIOL, V29, P17, DOI 10.1080/08912963.2015.1118688; Xing H, 2014, ACTA GEOL SIN-ENGL, V88, P1623, DOI 10.1111/1755-6724.12334; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160; Zharkov MA, 1998, STRATIGR GEO CORREL+, V6, P209	63	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175253	10.1371/journal.pone.0175253	http://dx.doi.org/10.1371/journal.pone.0175253			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384240	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900139
J	Asadzadeh, M; Ahmad, S; Al-Sweih, N; Khan, Z				Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin			Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait	PLOS ONE			English	Article							ANTIFUNGAL-DRUG-RESISTANCE; BLOOD-STREAM INFECTIONS; FUNGAL-INFECTION; ALBICANS; MECHANISMS; PREVALENCE; FITNESS; SUSCEPTIBILITY; EPIDEMIOLOGY; EVOLUTION	Candida dubliniensis and Candida albicans are two closely related species. Although C. dubliniensis is less pathogenic, it has a higher propensity to develop resistance to fluconazole and some strains exhibit intrinsic resistance to 5-flucytosine (5-FC). All 5-FC-resistant isolates from Kuwait were previously shown to belong to one of seven internal transcribed spacer (ITS) region of rDNA-based haplotypes. This study performed fingerprinting of C. dubliniensis isolates by multilocus sequence typing (MLST) to determine population structure of 5-FC-resistant and -susceptible strains and compared the results with data from a global collection of isolates. Fifty-two C. dubliniensis isolates previously analyzed and 58 additional isolates mostly collected during 2010-2013 and characterized by phenotypic and molecular methods were used. ITS-based haplotypes were identified by haplotype-specific PCR and/or by PCR-DNA sequencing of rDNA. Population structure was determined by 8-loci-based MLST. E-test was used to determine susceptibility to 5-FC, fluconazole, voriconazole and amphotericin B. Five ITS haplotypes (ITSH) were detected among 110 C. dubliniensis isolates. The ITSH1 was most common (n = 80 isolates) followed by ITSH4 (n = 25 isolates). Two isolates each belonged to ITSH5 and ITSH8 while one isolate belonged to ITSH7. MLST identified 16 diploid sequence types (DSTs) including six new DSTs. DST11 (n = 52) and DST14 (n = 25) were dominant genotypes and were confined (together with DST21) to Middle-Eastern countries. Other DSTs (excluding some new DSTs) had a wider global distribution as they were identified from various other countries. Only ITSH4 isolates (n = 25) belonged to DST14, were resistant to 5-FC and contained S29L mutation in CdFCA1. ITSH5, ITSH7 and ITSH8 isolates belonged to different DSTs. Thus, clinical C. dubliniensis isolates in Kuwait exhibited limited genotypic heterogeneity and most isolates belonged to region-specific DSTs. All 5-FC-resistant C. dubliniensis isolates belonged to ITSH4 and MLST-based DST14 genotype. Placement of some isolates into additional ITS haplotypes is also supported by MLST data.	[Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	Zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021	asadzadeh, Mohammad/0000-0002-9151-1505	College of Graduate Studies and Research Sector, Kuwait University [YM10/11, GM01/05, SRUL02/13]	College of Graduate Studies and Research Sector, Kuwait University	This study was funded by the College of Graduate Studies and Research Sector, Kuwait University with grant award numbers YM10/11, GM01/05 and SRUL02/13 to Ziauddin Khan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MED MICROBIOL, V53, P633, DOI 10.1099/jmm.0.05315-0; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-230; Ahmad S, 2012, MED MYCOL, V50, P244, DOI 10.3109/13693786.2011.597446; Al Mosaid A, 2005, J CLIN MICROBIOL, V43, P4026, DOI 10.1128/JCM.43.8.4026-4036.2005; Al-Sweih N, 2005, MYCOSES, V48, P347, DOI 10.1111/j.1439-0507.2005.01143.x; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00247; Ben-Ami R, 2012, VIRULENCE, V3, P95, DOI 10.4161/viru.3.1.18886; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Borecka S, 2011, CAN J MICROBIOL, V57, P416, DOI [10.1139/W11-025, 10.1139/w11-025]; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI S; Cowen LE, 2001, J BACTERIOL, V183, P2971, DOI 10.1128/JB.183.10.2971-2978.2001; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Idelevich EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114834; Joly S, 1999, J CLIN MICROBIOL, V37, P1035, DOI 10.1128/JCM.37.4.1035-1044.1999; Jordan RPC, 2014, MED MYCOL, V52, P254, DOI 10.1093/mmy/myt032; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Khan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032952; Khan ZU, 2004, CLIN MICROBIOL INFEC, V10, P590, DOI 10.1111/j.1469-0691.2004.00923.x; Kolaczkowska A, 2016, J ANTIMICROB CHEMOTH, V71, P1438, DOI 10.1093/jac/dkv445; Loreto ES, 2010, MYCOPATHOLOGIA, V169, P431, DOI 10.1007/s11046-010-9286-5; McManus BA, 2008, J CLIN MICROBIOL, V46, P652, DOI 10.1128/JCM.01574-07; McManus BA, 2014, INFECT GENET EVOL, V21, P166, DOI 10.1016/j.meegid.2013.11.008; McManus BA, 2009, ANTIMICROB AGENTS CH, V53, P4678, DOI 10.1128/AAC.00607-09; Mokaddas E, 2011, MYCOSES, V54, pE29, DOI 10.1111/j.1439-0507.2009.01822.x; Moran Gary P, 2012, Int J Microbiol, V2012, P205921, DOI 10.1155/2012/205921; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Pannanusorn S, 2013, MYCOSES, V56, P264, DOI 10.1111/myc.12014; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pinjon E, 2005, ANTIMICROB AGENTS CH, V49, P1312, DOI 10.1128/AAC.49.4.1312-1318.2005; Pujol C, 2004, ANTIMICROB AGENTS CH, V48, P262, DOI 10.1128/AAC.48.1.262-266.2004; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X; Taj-Aldeen SJ, 2014, MED MYCOL, V52, P549, DOI 10.1093/mmycol/myu016; Tsai MH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.024; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wahab AA, 2014, INT J INFECT DIS, V24, P14, DOI 10.1016/j.ijid.2014.03.1380; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175269	10.1371/journal.pone.0175269	http://dx.doi.org/10.1371/journal.pone.0175269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380072	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500114
J	Carlice-dos-Reis, T; Viana, J; Moreira, FC; Cardoso, GD; Guerreiro, J; Santos, S; Ribeiro-dos-Santos, A				Carlice-dos-Reis, Tania; Viana, Jaime; Moreira, Fabiano Cordeiro; Cardoso, Greice de Lemos; Guerreiro, Joao; Santos, Sidney; Ribeiro-dos-Santos, Andrea			Investigation of mutations in the HBB gene using the 1,000 genomes database	PLOS ONE			English	Article							BETA-CHAIN VARIANT; THALASSEMIA MUTATIONS; MOLECULAR-BASIS; O THALASSEMIA; HEMOGLOBIN; SARDINIA; DISEASE; PROTEIN; CANCER	Mutations in the HBB gene are responsible for several serious hemoglobinopathies, such as sickle cell anemia and 6-thalassemia. Sickle cell anemia is one of the most common mono genic diseases worldwide. Due to its prevalence, diverse strategies have been developed for a better understanding of its molecular mechanisms. In silico analysis has been increasingly used to investigate the genotype-phenotype relationship of many diseases, and the sequences of healthy individuals deposited in the 1,000 Genomes database appear to be an excellent tool for such analysis. The objective of this study is to analyze the variations in the HBB gene in the 1,000 Genomes database, to describe the mutation frequencies in the different population groups, and to investigate the pattern of pathogenicity. The computational tool SNPEFF was used to align the data from 2,504 samples of the 1,000 Genomes database with the HG19 genome reference. The pathogenicity of each amino acid change was investigated using the databases CLINVAR, dbSNP and HbVar and five different predictors. Twenty different mutations were found in 209 healthy individuals. The African group had the highest number of individuals with mutations, and the European group had the lowest number. Thus, it is concluded that approximately 8.3% of phenotypically healthy individuals from the 1,000 Genomes database have some mutation in the HBB gene. The frequency of mutated genes was estimated at 0.042, so that the expected frequency of being homozygous or compound heterozygous for these variants in the next generation is approximately 0.002. In total, 193 subjects had a non-synonymous mutation, which 186 (7.4%) have a deleterious mutation. Considering that the 1,000 Genomes database is representative of the world's population, it can be estimated that fourteen out of every 10,000 individuals in the world will have a hemoglobinopathy in the next generation.	[Carlice-dos-Reis, Tania; Viana, Jaime; Moreira, Fabiano Cordeiro; Cardoso, Greice de Lemos; Guerreiro, Joao; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil; [Viana, Jaime] Fed Rural Univ Amazon, Capanema Campus, Belem, Para, Brazil; [Moreira, Fabiano Cordeiro; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Res Ctr Oncol, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human & Med Genet, Belem, Para, Brazil.; Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Res Ctr Oncol, Belem, Para, Brazil.	akelyufpa@gmail.com	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Moreira, Fabiano/I-2817-2015	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Moreira, Fabiano/0000-0002-2799-3546; dos Reis, Tania Carlice/0000-0001-9209-1971	Rede de Pesquisa em GenOmica Populacional Humana (RPGPH) [3381/2013]; FADESP/PROPESP/UFPA (Universidade Federal do Para); FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa) [ICAAF 083/2013]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq/Produtividade (CNPQ) [304413/2015-1, 305258/2013-3]	Rede de Pesquisa em GenOmica Populacional Humana (RPGPH); FADESP/PROPESP/UFPA (Universidade Federal do Para); FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Produtividade (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Rede de Pesquisa em GenOmica Populacional Humana (RPGPH) - 3381/2013 CAPES-BioComputacional, FADESP/PROPESP/UFPA (Universidade Federal do Para), FAPESPA (Fundacao Amazonia Paraense de Amparo a Pesquisa) ICAAF 083/2013, and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). ANDREA RIBEIRO-DOS-SANTOS supported by CNPq/Produtividade (CNPQ 304413/2015-1); SIDNEY SANTOS supported by CNPq/ Produtividade (CNPq 305258/2013-3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2002, NCBI HDB; AULEHLASCHOLZ C, 1990, HUM GENET, V84, P195; BAUR EW, 1965, HUMANGENETIK, V1, P621; BLACKWELL RQ, 1970, BIOCHIM BIOPHYS ACTA, V214, P396; Carter TE, 2014, AM J TROP MED HYG, V91, P406, DOI 10.4269/ajtmh.13-0572; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; Chassanidis C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157393; CHEHAB FF, 1987, BLOOD, V69, P1141; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; DEIDDA G, 1990, HEMOGLOBIN, V14, P431, DOI 10.3109/03630269009032003; Ghansah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034565; HALL GW, 1991, BRIT J HAEMATOL, V79, P342, DOI 10.1111/j.1365-2141.1991.tb04548.x; HARANO T, 1982, HEMOGLOBIN, V6, P531, DOI 10.3109/03630268209083766; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; IMAMURA T, 1969, J CLIN INVEST, V48, P2341, DOI 10.1172/JCI106200; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KIMURA A, 1983, J BIOL CHEM, V258, P2748; Kulkarni GD, 2012, GENET TEST MOL BIOMA, V16, P138, DOI 10.1089/gtmb.2011.0035; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; LANGDOWN JV, 1994, HEMOGLOBIN, V18, P333, DOI 10.3109/03630269408996199; Lelliott PM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0809-x; Lettre G, 2012, PERSPECT MED, V2, P1; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; MERAULT G, 1986, HEMOGLOBIN, V10, P593, DOI 10.3109/03630268609036564; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Onda M, 2005, BRIT J CANCER, V92, P2216, DOI 10.1038/sj.bjc.6602634; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Orlando GM, 2000, REV BRAS HEMATOL HEM, V22, P111; Pianezze G, 2016, HEMOGLOBIN, V40, P143, DOI 10.3109/03630269.2016.1150292; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saraf SL, 2014, PAEDIATR RESPIR REV, V15, P4, DOI 10.1016/j.prrv.2013.11.003; SCHNEIDER RG, 1968, BLOOD, V32, P250, DOI 10.1182/blood.V32.2.250.250; Singh PK, 2016, GENE, V576, P141, DOI 10.1016/j.gene.2015.09.084; Sirdah MM, 2013, BLOOD CELL MOL DIS, V50, P247, DOI 10.1016/j.bcmd.2012.12.004; Steinberg MH, 2012, AM J HEMATOL, V87, P795, DOI 10.1002/ajh.23232; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; Sultana GNN, 2016, COMPLETE SPECTRUM BE, V3, P1; Torres Lidiane de Souza, 2015, Rev. Bras. Hematol. Hemoter., V37, P120, DOI 10.1016/j.bjhh.2015.02.007; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323	46	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174637	10.1371/journal.pone.0174637	http://dx.doi.org/10.1371/journal.pone.0174637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379995	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500055
J	Gonzalez-Dominguez, B; Studer, MS; Hagedorn, F; Niklaus, PA; Abiven, S				Gonzalez-Dominguez, Beatriz; Studer, Mirjam S.; Hagedorn, Frank; Niklaus, Pascal A.; Abiven, Samuel			Leaching of soils during laboratory incubations does not affect soil organic carbon mineralisation but solubilisation	PLOS ONE			English	Article							NITROGEN MINERALIZATION; MICROBIAL RESPIRATION; MATTER	Laboratory soil incubations provide controlled conditions to investigate carbon and nutrient dynamics; however, they are not free of artefacts. As carbon and nitrogen cycles are tightly linked, we aimed at investigating whether the incubation-induced accumulation of mineral nitrogen (N-min) biases soil organic carbon (SOC) mineralisation. For this, we selected two soils representative of the C: N ratio values found in European temperate forests, and applied two incubation systems: 'closed' beakers and 'open' microlysimeters. The latter allowed leaching the soil samples during the incubation. By the end of the 121-day experiment, the low C: N soil significantly accumulated more N-min in beakers (5.12 g kg(-1) OC) than in microlysimeters (3.00 g kg(-1) OC) but there was not a significant difference in SOC mineralisation at any point of the experiment. On the other hand, N-min did not accumulate in the high C: N soil but, by the end of the experiment, leaching had promoted 33.9% more SOC solubilisation than beakers. Therefore, we did not find evidence that incubation experiments introduce a bias on SOC mineralisation. This outcome strengthens results from soil incubation studies.	[Gonzalez-Dominguez, Beatriz; Studer, Mirjam S.; Abiven, Samuel] Univ Zurich, Dept Geog, Soil Sci & Biogeochem, Zurich, Switzerland; [Gonzalez-Dominguez, Beatriz; Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Hagedorn, Frank] Swiss Fed Inst Snow Forest & Landscape Res WSL, Forest Soils & Biogeochem, Birmensdorf, Switzerland	University of Zurich; University of Zurich	Abiven, S (corresponding author), Univ Zurich, Dept Geog, Soil Sci & Biogeochem, Zurich, Switzerland.	samuel.abiven@geo.uzh.ch	Niklaus, Pascal A/G-5786-2010; Abiven, Samuel/J-5328-2013	Niklaus, Pascal A/0000-0002-2360-1357; Abiven, Samuel/0000-0002-5663-0912; Gonzalez-Dominguez, Beatriz/0000-0002-2428-3119; Hagedorn, Frank/0000-0001-5218-7776	Swiss National Science Foundation [143026, 68]; Geography Department of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Geography Department of the University of Zurich	This study was funded by the Swiss National Science Foundation (project-no. 143026) in the frame of the National Research Programme 68. (hip //www.nrp68.ch/en). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Geography Department of the University of Zurich for their support. We also thank the Swiss Federal Institute for Forest, Snow and Landscape Research, their team on the Long-term Forest Ecosystem Research Programme and specially Lorenz Walthert and Stephan Zimmermann, for giving us access to the research sites and to the database.We thank Rebecca Navarro, Rene Husi and Miguel Jales Hon for their technical assistance. Finally, we thank two anonymous reviewers for their helpful comments on this manuscript.	Andresen LC, 2016, SOIL DISCUSS, V2016, P1; [Anonymous], 2016, SOIL DISCUSS, V2016, P1, DOI DOI 10.1039/C6GC01133K'; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2016, 14239 ISODIS; Bracho R, 2016, SOIL BIOL BIOCHEM, V97, P1, DOI 10.1016/j.soilbio.2016.02.008; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Gonzalez-Dominguez B, 2017, DATABASE LEACHING SO; Hagedorn F, 2004, EUR J SOIL SCI, V55, P91, DOI 10.1046/j.1365-2389.2003.00578.x; Hopkins DW, 2006, SOIL BIOL BIOCHEM, V38, P3130, DOI 10.1016/j.soilbio.2006.01.012; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Kim H, 2011, J MICROBIOL, V49, P369, DOI 10.1007/s12275-011-0421-x; Lavoie M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001629; Lorenz W, 2013, SWISS FEDERAL I FORE; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; NADELHOFFER KJ, 1990, SOIL SCI SOC AM J, V54, P411, DOI 10.2136/sssaj1990.03615995005400020019x; Niklewski B, 1912, ZENTRALBLATT BAKTERI, V32, P209; Paul E., 2001, ASSESSMENT METHODS S, V14, P193; Persson T, 2000, ECOL STU AN, V142, P14; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, SOIL BIOL BIOCHEM, V42, P2336, DOI 10.1016/j.soilbio.2010.08.032; Recous S, 1995, SOIL BIOL BIOCHEM, V27, P1529, DOI 10.1016/0038-0717(95)00096-W; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; TIPPING E, 1991, J SOIL SCI, V42, P437, DOI 10.1111/j.1365-2389.1991.tb00421.x; Walthert L, 2004, GRUNDLAGEN REGION JA, V1; WOLLUM AG, 1970, ECOLOGY, V51, P555	29	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174725	10.1371/journal.pone.0174725	http://dx.doi.org/10.1371/journal.pone.0174725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380005	Green Accepted, Green Published, gold			2022-12-26	WOS:000399353500061
J	Karoubi, N; Leibovich, T; Segevl, R				Karoubi, Naomi; Leibovich, Tali; Segevl, Ronen			Symbol-value association and discrimination in the archerfish	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; NUMERICAL COMPETENCE; ORDINAL JUDGMENTS; NUMBER; CHIMPANZEES; SUMMATION; FISH; COGNITION; QUANTITY; MONKEYS	One of the most important aspects of mathematical cognition in humans is the ability to symbolically represent magnitudes and quantities. In the last 20 years it has been shown that not only humans but also other primates, birds and dolphins can use symbolic representation of quantities. However, it remains unclear to what extent this ability is spread across the animal kingdom. Here, by training archerfish to associate variable amounts of rewards with different geometric shapes, we show for the first time that lower vertebrates can also associate a value with a symbol and make a decision that maximizes their food intake based on this information. In addition, the archerfish is able to understand up to four different quantities and organize them mentally in an ordinal manner, similar to observations in higher vertebrates. These findings point in the direction of the existence of an approximate magnitude system in fish.	[Karoubi, Naomi; Segevl, Ronen] Ben Gurion Univ Negev, Life Sci Dept, Beer Sheva, Israel; [Karoubi, Naomi; Segevl, Ronen] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Leibovich, Tali] Univ Western Ontario, Psychol Dept, London, ON, Canada; [Leibovich, Tali] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada	Ben Gurion University; Ben Gurion University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Segevl, R (corresponding author), Ben Gurion Univ Negev, Life Sci Dept, Beer Sheva, Israel.; Segevl, R (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel.	ronensgv@bgu.ac.il		Segev, Ronen/0000-0002-8109-1076; Leibovich-Raveh, Tali/0000-0002-8692-9480	Israel Science Foundation [211/15]; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev	Israel Science Foundation(Israel Science Foundation); Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev	We gratefully acknowledge financial support from the Israel Science Foundation (grant No. 211/15), and the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev.r We thank Gustavo Glusman and Asya Mikhaylov for technical assistance and Zvika Abramsky for his valuable suggestions. We gratefully acknowledge financial support from the Israel Science Foundation (grant No. 211/15), and the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Initiative of Ben-Gurion University of the Negev.	Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Beran MJ, 2005, J EXP PSYCHOL-ANIM B, V31, P351, DOI 10.1037/0097-7403.31.3.351; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Biro D, 2001, Anim Cogn, V4, P193, DOI 10.1007/s100710100086; Bisazza A, 2014, J EXP BIOL, V217, P1902, DOI 10.1242/jeb.101683; Bouton ME, 2004, NEUROSCI BIOBEHAV R, V28, P663, DOI 10.1016/j.neubiorev.2004.09.001; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Boysen ST, 1999, ANNU REV PSYCHOL, V50, P683, DOI 10.1146/annurev.psych.50.1.683; Brysbaert M, 1998, COGNITION, V66, P51, DOI 10.1016/S0010-0277(98)00006-7; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Dehaene S, 1997, THE NUMBER SENSE HOW; DeLong CM, 2016, BEHAV PROCESSES; Fechner G., 1965, ELEMENTS PSYCHOPHYSI; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FERSTER CB, 1964, SCI AM, V210, P98, DOI 10.1038/scientificamerican0564-98; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Jordan KE, 2006, ANIM COGN, V9, P159, DOI 10.1007/s10071-006-0017-8; Katz MW, 2013, AM NAT, V181, P381, DOI 10.1086/669156; Kilian A, 2003, LEARN BEHAV, V31, P133; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Leibovich T, 2014, Q J EXP PSYCHOL, V67, P899, DOI 10.1080/17470218.2013.837940; Leibovich T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00375; Lucon-Xiccato T, 2017, BEHAV PROCESS, V141, P184, DOI 10.1016/j.beproc.2017.01.015; Lucon-Xiccato T, 2016, ANIM COGN, V19, P733, DOI 10.1007/s10071-016-0969-2; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Mamuneas D, 2015, BEHAV ECOL, V26, P91, DOI 10.1093/beheco/aru160; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; Merkley R, 2015, Q J EXP PSYCHOL, V68, P1860, DOI 10.1080/17470218.2014.994538; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Olthof A, 2000, J COMP PSYCHOL, V114, P158, DOI 10.1037/0735-7036.114.2.158; Olthof A, 1997, J EXP PSYCHOL ANIM B, V23, P325, DOI 10.1037/0097-7403.23.3.325; Pepperberg IM, 2006, ANIM COGN, V9, P377, DOI 10.1007/s10071-006-0034-7; Pepperberg IM, 2012, COGNITION, V125, P219, DOI 10.1016/j.cognition.2012.07.003; Pepperberg IM, 2012, ANIM COGN, V15, P711, DOI [10.1007/s10071-012-0470-5, 10.1007/s10071-012-0476-5]; Petrazzini MEM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15497; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Spaepen E, 2011, P NATL ACAD SCI USA, V108, P3163, DOI 10.1073/pnas.1015975108; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x; Wilson ML, 2002, P ROY SOC B-BIOL SCI, V269, P1107, DOI 10.1098/rspb.2001.1926; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174044	10.1371/journal.pone.0174044	http://dx.doi.org/10.1371/journal.pone.0174044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379988	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500029
J	Pang, KH; Rosario, DJ; Morgan, SL; Catto, JWF				Pang, Karl H.; Rosario, Derek J.; Morgan, Susan L.; Catto, James W. F.			Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies	PLOS ONE			English	Article							PCA3; ANTIGEN; RISK; IDENTIFICATION; EXPRESSION; MICRORNAS; OUTCOMES	Background Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of PCA3. Here we test the ability of this ncRNA to predict the presence of cancer in men with a biopsy without PCa. Methods We selected men whose initial biopsy did not identify PCa and selected matched cohorts whose subsequent biopsies revealed PCa or benign tissue. We extracted RNA from the initial biopsy and measured PCA3-shRNA2, PCA3 and PSA (qRT-PCR). Results We identified 116 men with and 94 men without an eventual diagnosis of PCa in 2-5 biopsies (mean 26 months), collected from 2002-2008. The cohorts were similar for age, PSA and surveillance period. We detected PSA and PCA3-shRNA2 RNA in all samples, and PCA3 RNA in 90% of biopsies. The expression of PCA3 and PCA3-shRNA2 were correlated (Pearson's r = 0.37, p<0.01). There was upregulation of PCA3 (2.1-fold, t-test p = 0.02) and PCA3-shRNA2 (1.5-fold) in men with PCa on subsequent biopsy, although this was not significant for the latter RNA (p = 0.2). PCA3 was associated with the future detection of PCa (C-index 0.61, p = 0.01). This was not the case for PCA3-shRNA2 (C-index 0.55, p = 0.2). Conclusions PCA3 and PCA3-shRNA2 expression are detectable in historic biopsies and their expression is correlated suggesting co-expression. PCA3 expression was upregulated in men with PCa diagnosed at a future date, the same did not hold for PCA3-shRNA2. Futures studies should explore expression in urine and look at a time course between biopsy and PCa detection.	[Pang, Karl H.; Rosario, Derek J.; Catto, James W. F.] Univ Sheffield, Dept Oncol & Human Metab, Acad Urol Unit, Sheffield, S Yorkshire, England; [Pang, Karl H.; Rosario, Derek J.; Catto, James W. F.] Univ Sheffield, Dept Oncol & Human Metab, Acad Unit Mol Oncol, Sheffield, S Yorkshire, England; [Morgan, Susan L.] Royal Hallamshire Hosp, Dept Histopathol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Catto, JWF (corresponding author), Univ Sheffield, Dept Oncol & Human Metab, Acad Urol Unit, Sheffield, S Yorkshire, England.; Catto, JWF (corresponding author), Univ Sheffield, Dept Oncol & Human Metab, Acad Unit Mol Oncol, Sheffield, S Yorkshire, England.	j.catto@sheffield.acuk	Rosario, Derek/C-2028-2017	Rosario, Derek/0000-0002-9086-3592; catto, james/0000-0003-2787-8828	Royal College of Surgeons of England; Urology Foundation	Royal College of Surgeons of England; Urology Foundation	KHP received a Research Fellowship from the Royal College of Surgeons of England (https.//www.rcseng.ac.uk/standards-and-research/research/fellowships-awards-grants/fellowships/current-and-past/one year-fellowships 2013-2014/), and a Research Scholarship from The Urology Foundation (http.//wwwtheurologyfoundation.org/professionals/our-programmes/research-programmes/220-tufcurrent-projects).	Aakula A, 2016, EUR UROL, V69, P1120, DOI 10.1016/j.eururo.2015.09.019; Alinezhad S, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.12.014; Bokhorst LP, 2015, EUR UROL, V68, P814, DOI 10.1016/j.eururo.2015.06.012; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Catto JWF, 2009, CLIN CANCER RES, V15, P3150, DOI 10.1158/1078-0432.CCR-08-1960; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; de Kok JB, 2002, CANCER RES, V62, P2695; Djavan B, 2001, J UROLOGY, V166, P1679, DOI 10.1016/S0022-5347(05)65652-2; Drayton RM, 2015, CANCER EPIDEM BIOMAR, V24, P268, DOI 10.1158/1055-9965.EPI-14-0377; Gandaglia G, 2016, EUR UROL, V69, P998, DOI 10.1016/j.eururo.2015.05.046; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; Herawi M, 2006, J UROLOGY, V175, P121, DOI 10.1016/S0022-5347(05)00064-9; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Klecka J, 2010, ANTICANCER RES, V30, P665; Miah S, 2012, BRIT J CANCER, V107, P123, DOI 10.1038/bjc.2012.221; Mottet N, 2016, EUR UROL; Paziewska A, 2014, BRIT J CANCER, V111, P781, DOI 10.1038/bjc.2014.337; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Salagierski M, 2010, PROSTATE, V70, P70, DOI 10.1002/pros.21040; Schroder FH, 2014, UROLOGY, V83, P613, DOI 10.1016/j.urology.2013.12.005; Svoronos AA, 2016, CANCER RES, V76, P3666, DOI 10.1158/0008-5472.CAN-16-0359; Tomlins SA, 2016, EUR UROL, V70, P45, DOI 10.1016/j.eururo.2015.04.039; Vedder MM, 2014, EUR UROL, V66, P1109, DOI 10.1016/j.eururo.2014.08.011	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175070	10.1371/journal.pone.0175070	http://dx.doi.org/10.1371/journal.pone.0175070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380027	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500093
J	Ziaukas, P; Alabdulgader, A; Vainoras, A; Navickas, Z; Ragulskis, M				Ziaukas, Pranas; Alabdulgader, Abdullah; Vainoras, Alfonsas; Navickas, Zenonas; Ragulskis, Minvydas			New approach for visualization of relationships between RR and JT intervals	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; QT INTERVAL	This paper presents the concept of perfect matrices of Lagrange differences which are used to analyze relationships between RR and JT intervals during the bicycle ergometry exercise. The concept of the perfect matrix of Lagrange differences, its parameters, the construction of the load function and the corresponding optimization problem, the introduction of internal and external smoothing, embedding of the scalar parameter time series into the phase plane all these computational techniques allow visualization of complex dynamical processes taking place in the cardiovascular system during the load and the recovery processes. Detailed analysis is performed with one person's RR and JT records only but the presented techniques open new possibilities for novel interpretation of the dynamics of the cardiovascular system.	[Ziaukas, Pranas; Navickas, Zenonas; Ragulskis, Minvydas] Kaunas Univ Technol, Res Grp Math & Numer Anal Dynam Syst, Kaunas, Lithuania; [Alabdulgader, Abdullah] Prince Sultan Cardiac Ctr, Al Hasa, Al Hofuf, Saudi Arabia; [Vainoras, Alfonsas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania	Kaunas University of Technology; Prince Sultan Cardiac Center; Lithuanian University of Health Sciences	Ragulskis, M (corresponding author), Kaunas Univ Technol, Res Grp Math & Numer Anal Dynam Syst, Kaunas, Lithuania.	minvydas.ragulskis@ktu.it	Ragulskis, Minvydas/A-1546-2008	Ragulskis, Minvydas/0000-0002-3348-9717; Alabdulagader, Abdullah/0000-0002-5425-460X; Navickas, Zenonas/0000-0002-8725-3005; Vainoras, Alfonsas/0000-0002-5732-8520	Lithuanian University of Health Sciences; Lithuanian Science Council [MIP078=15]	Lithuanian University of Health Sciences(Research Council of Lithuania (LMTLT)); Lithuanian Science Council(Research Council of Lithuania (LMTLT))	Lithuanian University of Health Sciences is acknowledged for covering the open access publication fee. Financial support from the Lithuanian Science Council under project no. MIP078=15 is acknowledged.	AHNVE S, 1985, AM HEART J, V109, P568, DOI 10.1016/0002-8703(85)90564-2; Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bieri T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152693; Bonomini MP, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-15; Camm AJ, 1996, CIRCULATION, V93, P1043; Cysarz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019400; Djousse L, 2005, J AM COLL CARDIOL, V45, P1716, DOI 10.1016/j.jacc.2005.01.060; Erem B, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042218; Gargasas L, 2006, 6 NORD C EHEALTH TEL, P255; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Gomes RL, 2016, INT J CLIN EXP MED, V9, P2047; Henriques TS, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0252-0; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; Korsakas S, 1997, BIOMED TECH, P114; Malik M, 2002, HEART, V87, P220, DOI 10.1136/heart.87.3.220; Misigoj-Durakovic M, 2016, ANN NONINVAS ELECTRO, V21, P595, DOI 10.1111/anec.12374; Mukherjee S, 2015, PHYSICA A, V439, P93, DOI 10.1016/j.physa.2015.07.030; Orfanidis SJ, 2009, INTRO SIGNAL PROCESS; Ragulskis M, 2009, NEUROCOMPUTING, V72, P2618, DOI 10.1016/j.neucom.2008.10.010; Rautaharju PM, 2004, AM J CARDIOL, V93, P1017, DOI 10.1016/j.amjcard.2003.12.055; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schuldberg D, 2015, NONLIN DYNAM PSYCHOL, V19, P553; Slapikas R, 1997, VI ASIAN-PACIFIC SYMPOSIUM ON CARDIAC PACING AND ELECTROPHYSIOLOGY, P405; Vainoras A, 1997, P 26 INT C EL EL 97, P253; Vazquez P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00037; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZHOU SH, 1993, J ELECTROCARDIOL, V25, P131, DOI 10.1016/0022-0736(92)90079-F; Zywietz Ch, 1994, ANN KAUNAS I CARDIOL, V1, P66	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174279	10.1371/journal.pone.0174279	http://dx.doi.org/10.1371/journal.pone.0174279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379976	Green Submitted, gold, Green Published			2022-12-26	WOS:000399353500039
J	Brackley, AD; Sarrami, S; Gomez, R; Guerrero, KA; Jeske, NA				Brackley, Allison Doyle; Sarrami, Shayda; Gomez, Ruben; Guerrero, Kristi A.; Jeske, Nathaniel A.			Identification of a signaling cascade that maintains constitutive delta-opioid receptor incompetence in peripheral sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); G-protein-coupled receptor (GPCR); neuron; opiate opioid; pain; phosphorylation; protein kinase A (PKA); GRK2; opioid	DEPENDENT PROTEIN-KINASE; ANCHORING PROTEIN; FUNCTIONAL COMPETENCE; REGULATORY SUBUNIT; TRIGEMINAL NOCICEPTORS; AKAP150-ANCHORED PKA; SKELETAL-MUSCLE; CHRONIC PAIN; PHOSPHORYLATION; ACTIVATION	mu-Opioid receptor (MOR) agonists are often used to treat severe pain but can result in adverse side effects. To circumvent systemic side effects, targeting peripheral opioid receptors is an attractive alternative treatment for severe pain. Activation of the delta-opioid receptor (DOR) produces similar analgesia with reduced side effects. However, until primed by inflammation, peripheral DOR is analgesically incompetent, raising interest in the mechanism. We recently identified a novel role for G-protein-coupled receptor kinase 2 (GRK2) that renders DOR analgesically incompetent at the plasma membrane. However, the mechanism that maintains constitutive GRK2 association with DOR is unknown. Protein kinase A (PKA) phosphorylation of GRK2 at Ser-685 targets it to the plasma membrane. Protein kinase A-anchoring protein 79/150 (AKAP), residing at the plasma membrane in neurons, scaffolds PKA to target proteins to mediate downstream signal. Therefore, we sought to determine whether GRK2-mediated DOR desensitization is directed by PKA via AKAP scaffolding. Membrane fractions from cultured rat sensory neurons following AKAP siRNA transfection and from AKAP-knock-out mice had less PKA activity, GRK2 Ser-685 phosphorylation, and GRK2 plasma membrane targeting than controls. Site-directed mutagenesis revealed that GRK2 Ser-685 phosphorylation drives the association of GRK2 with plasma membrane-associated DOR. Moreover, overexpression studies with AKAP mutants indicated that impaired AKAP-mediated PKA scaffolding significantly reduces DOR-GRK2 association at the plasma membrane and consequently increases DOR activity in sensory neurons without a priming event. These findings suggest that AKAP scaffolds PKA to increase plasma membrane targeting and phosphorylation of GRK2 to maintain DOR analgesic incompetence in peripheral sensory neurons.	[Brackley, Allison Doyle; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Sarrami, Shayda; Gomez, Ruben; Guerrero, Kristi A.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Oral & Maxillofacial Surg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Jeske@uthscsa.edu		Dietert, Kristi/0000-0003-2338-7968; Brackley, Allison/0000-0002-9552-3159	NINDS, National Institutes of Health (NIH) [RO1 NS082746]; NIDCR, NIH [T32 DE14318, F31 DE025551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318, F31DE025551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082746] Funding Source: NIH RePORTER	NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health (NIH), Grant RO1 NS082746 (to N. A. J.); NIDCR, NIH, Grant T32 DE14318 (to A. D. B.); and NIDCR, NIH, Grant F31 DE025551 (to A. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarado LT, 2007, J ENDODONT, V33, P1167, DOI 10.1016/j.joen.2007.06.018; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Brackley AD, 2016, CELL REP, V16, P2686, DOI 10.1016/j.celrep.2016.07.084; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Buzas B, 1997, J NEUROCHEM, V68, P610; Byun SW, 2012, CANCER LETT, V326, P96, DOI 10.1016/j.canlet.2012.07.032; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; CORBIN JD, 1975, J BIOL CHEM, V250, P218; CORBIN JD, 1973, J BIOL CHEM, V248, P1813; CORBIN JD, 1977, J BIOL CHEM, V252, P910; Edwards HV, 2012, BIOCHEM J, V446, P437, DOI 10.1042/BJ20120570; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GOLDENBERG SSS, 1983, J NEUROBIOL, V14, P195, DOI 10.1002/neu.480140304; Gomez R, 2011, PAIN, V152, P1548, DOI 10.1016/j.pain.2011.02.044; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00123; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; LAW PY, 1995, J PHARMACOL EXP THER, V272, P322; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060558; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Pettinger L, 2013, J NEUROSCI, V33, P10762, DOI 10.1523/JNEUROSCI.0123-13.2013; POTTER RL, 1979, J BIOL CHEM, V254, P2413; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Rowan MP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-50; Rowan MP, 2009, EUR J PHARMACOL, V602, P283, DOI 10.1016/j.ejphar.2008.11.028; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Stein C, 2001, Curr Opin Pharmacol, V1, P62, DOI 10.1016/S1471-4892(01)00005-4; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vanderah TW, 2010, CLIN J PAIN, V26, pS10, DOI 10.1097/AJP.0b013e3181c49e3a; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Xu W, 2013, LIFE SCI, V92, P1101, DOI 10.1016/j.lfs.2013.04.006; Zhao ZH, 2016, EMBO REP, V17, P739, DOI 10.15252/embr.201541532	46	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8762	8772		10.1074/jbc.M117.776799	http://dx.doi.org/10.1074/jbc.M117.776799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381559	Green Published, hybrid			2022-12-26	WOS:000402153900022
J	Chen, L; Paquette, N; Mamoor, S; Rus, F; Nandy, A; Leszyk, J; Shaffer, SA; Silverman, N				Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Leszyk, John; Shaffer, Scott A.; Silverman, Neal			Innate immune signaling in Drosophila is regulated by transforming growth factor beta (TGF beta)-activated kinase (Tak1)-triggered ubiquitin editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); Drosophila; mass spectrometry (MS); NF-B (NF-B); phosphorylation; ubiquitylation (ubiquitination); Imd; Tak1; ubiquitin editing	NF-KAPPA-B; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; IMD-PATHWAY; PGRP-LC; ACTIVATION; PEPTIDOGLYCAN; E2; BINDING; TAK1	Coordinated regulation of innate immune responses is necessary in all metazoans. In Drosophila the Imd pathway detects Gram-negative bacterial infections through recognition of diaminopimelic acid (DAP)-type peptidoglycan and activation of the NF-kappa B precursor Relish, which drives robust antimicrobial peptide gene expression. Imd is a receptor-proximal adaptor protein homologous to mammalian RIP1 that is regulated by proteolytic cleavage and Lys-63-polyubiquitination. However, the precise events and molecular mechanisms that control the post-translational modification of Imd remain unclear. Here, we demonstrate that Imd is rapidly Lys-63-polyubiquitinated at lysine residues 137 and 153 by the sequential action of two E2 enzymes, Ubc5 and Ubc13-Uev1a, in conjunction with the E3 ligase Diap2. Lys-63-ubiquitination activates the TGF beta-activated kinase (Tak1), which feeds back to phosphorylate Imd, triggering the removal of Lys-63 chains and the addition of Lys-48 polyubiquitin. This ubiquitin-editing process results in the proteasomal degradation of Imd, which we propose functions to restore homeostasis to the Drosophila immune response.	[Chen, Li; Paquette, Nicholas; Mamoor, Shahan; Rus, Florentina; Nandy, Anubhab; Silverman, Neal] Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA; [Leszyk, John; Shaffer, Scott A.] Univ Massachusetts, Med Sch, Prote & Mass Spectrometry Facil, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), Univ Massachusetts, Med Sch, Div Infect Dis, Dept Med, 364 Plantat St, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu		Mamoor, Shahan/0000-0003-4150-0936	National Institutes of Health [AI060025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, T32AI095213, R56AI060025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant AI060025 (to N. S.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Bergmann A, 2010, CELL DEATH DIFFER, V17, P61, DOI 10.1038/cdd.2009.70; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guntermann S, 2009, DEV COMP IMMUNOL, V33, P127, DOI 10.1016/j.dci.2008.07.021; Jones D, 2002, GENOME BIOL, V3; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Khush RS, 2002, CURR BIOL, V12, P1728, DOI 10.1016/S0960-9822(02)01214-9; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhuang ZH, 2006, CELL SIGNAL, V18, P964, DOI 10.1016/j.cellsig.2005.08.020	47	20	22	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8738	8749		10.1074/jbc.M117.788158	http://dx.doi.org/10.1074/jbc.M117.788158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377500	Green Published, hybrid			2022-12-26	WOS:000402153900020
J	Yaakov, N; Barak, Y; Pereman, I; Christie, PJ; Elbaum, M				Yaakov, Noga; Barak, Yoav; Pereman, Idan; Christie, Peter J.; Elbaum, Michael			Direct fluorescence detection of VirE2 secretion by Agrobacterium tumefaciens	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; BINDING PROTEIN VIRE2; T-DNA; PLANT TRANSFORMATION; NUCLEAR-LOCALIZATION; DIRECT VISUALIZATION; HOST-CELLS; CROWN-GALL; ARABIDOPSIS; VIRULENCE	VirE2 is a ssDNA binding protein essential for virulence in Agrobacterium tumefaciens. A tetracysteine mutant (VirE2-TC) was prepared for in vitro and in vivo fluorescence imaging based on the ReAsH reagent. VirE2-TC was found to be biochemically active as it binds both ssDNA and the acidic secretion chaperone VirE1. It was also biologically functional in complementing virE2 null strains transforming Arabidopsis thaliana roots and Nicotiana tabacum leaves. In vitro experiments demonstrated a two-color fluorescent complex using VirE2-TC/ReAsH and Alexa Fluor 488 labeled ssDNA. In vivo, fluorescent VirE2-TC/ReAsH was detected in bacteria and in plant cells at time frames relevant to transformation.	[Yaakov, Noga; Elbaum, Michael] Weizmann Inst Sci, Dept Mat & Interfaces, Rehovot, Israel; [Barak, Yoav] Weizmann Inst Sci, Chem Res Support Dept, Rehovot, Israel; [Pereman, Idan] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Christie, Peter J.] UT Houston Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of Texas System; University of Texas Health Science Center Houston	Elbaum, M (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, Rehovot, Israel.	michael.elbaum@weizmann.ac.il			European Research Council TRACTAR project; US-Israel Binational Agricultural Research and Development Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048746] Funding Source: NIH RePORTER	European Research Council TRACTAR project; US-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the European Research Council TRACTAR project, and by a grant from the US-Israel Binational Agricultural Research and Development Fund to PC and ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Avilov SV, 2012, VACCINE, V30, P7411, DOI 10.1016/j.vaccine.2012.09.077; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; BARKER RF, 1983, PLANT MOL BIOL, V2, P335, DOI 10.1007/BF01578595; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bharat TAM, 2013, STRUCTURE, V21, P1158, DOI 10.1016/j.str.2013.04.027; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Citovsky V, 1997, J MOL BIOL, V271, P718, DOI 10.1006/jmbi.1997.1230; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; CITOVSKY V, 1994, P NATL ACAD SCI USA, V91, P3210, DOI 10.1073/pnas.91.8.3210; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Crivat G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022975; DAS A, 1988, P NATL ACAD SCI USA, V85, P2909, DOI 10.1073/pnas.85.9.2909; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; Dym O, 2008, P NATL ACAD SCI USA, V105, P11170, DOI 10.1073/pnas.0801525105; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Estevez JM, 2006, BIOTECHNIQUES, V41, P569, DOI 10.2144/000112264; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Frenkiel-Krispin D, 2007, J BIOL CHEM, V282, P3458, DOI 10.1074/jbc.M605270200; Fullner KJ, 1996, J BACTERIOL, V178, P1498, DOI 10.1128/jb.178.6.1498-1504.1996; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; Gelvin SB, 2006, BIOTECHNOL AGRIC FOR, V58, P195; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; GIETL C, 1987, P NATL ACAD SCI USA, V84, P9006, DOI 10.1073/pnas.84.24.9006; Grange W, 2008, PLOS BIOL, V6, P343, DOI 10.1371/journal.pbio.0060044; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guralnick B, 1996, PLANT CELL, V8, P363, DOI 10.1105/tpc.8.3.363; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Li XY, 2014, PLANT J, V77, P487, DOI 10.1111/tpj.12397; LICHTENSTEIN C, 1985, DNA CLONING, V2, P67; Maes M, 2014, PROTEIN ENG DES SEL, V27, P439, DOI 10.1093/protein/gzu036; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; Nickerson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100589; OTTEN L, 1984, MOL GEN GENET, V195, P159, DOI 10.1007/BF00332739; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; ROSSI L, 1993, MOL GEN GENET, V239, P345, DOI 10.1007/BF00276932; Rossi L, 1996, P NATL ACAD SCI USA, V93, P126, DOI 10.1073/pnas.93.1.126; Sakalis PA, 2014, MICROBIOLOGYOPEN, V3, P104, DOI 10.1002/mbo3.152; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Ward DV, 2001, P NATL ACAD SCI USA, V98, P385, DOI 10.1073/pnas.98.2.385; Yang QH, 2017, P NATL ACAD SCI USA, V114, P2982, DOI 10.1073/pnas.1612098114; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07; Zupan JR, 1996, P NATL ACAD SCI USA, V93, P2392, DOI 10.1073/pnas.93.6.2392	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175273	10.1371/journal.pone.0175273	http://dx.doi.org/10.1371/journal.pone.0175273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403156	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200046
J	Munkhammar, J; Mattsson, L; Ryden, J				Munkhammar, Joakim; Mattsson, Lars; Ryden, Jesper			Polynomial probability distribution estimation using the method of moments	PLOS ONE			English	Article							HANKEL-MATRICES; MODELS	We suggest a procedure for estimating Nth degree polynomial approximations to unknown (or known) probability density functions (PDFs) based on N statistical moments from each distribution. The procedure is based on the method of moments and is setup algorithmically to aid applicability and to ensure rigor in use. In order to show applicability, polynomial PDF approximations are obtained for the distribution families Normal, Log-Normal, Weibull as well as for a bimodal Weibull distribution and a data set of anonymized household electricity use. The results are compared with results for traditional PDF series expansion methods of Gram-Charlier type. It is concluded that this procedure is a comparatively simple procedure that could be used when traditional distribution families are not applicable or when polynomial expansions of probability distributions might be considered useful approximations. In particular this approach is practical for calculating convolutions of distributions, since such operations become integrals of polynomial expressions. Finally, in order to show an advanced applicability of the method, it is shown to be useful for approximating solutions to the Smoluchowski equation.	[Munkhammar, Joakim] Uppsala Univ, BEESG, Dept Engn Sci, Uppsala, Sweden; [Mattsson, Lars] KTH Royal Inst Technol, NORDITA, SE-10691 Stockholm, Sweden; [Mattsson, Lars] Stockholm Univ, SE-10691 Stockholm, Sweden; [Ryden, Jesper] Uppsala Univ, Dept Math, SE-75106 Uppsala, Sweden; [Munkhammar, Joakim] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden	Uppsala University; Nordic Institute for Theoretical Physics; Royal Institute of Technology; Stockholm University; Uppsala University; Uppsala University	Munkhammar, J (corresponding author), Uppsala Univ, BEESG, Dept Engn Sci, Uppsala, Sweden.; Munkhammar, J (corresponding author), Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden.	joakim.munkhammar@angstrom.uu.se		Ryden, Jesper/0000-0002-5451-4563; Munkhammar, Joakim/0000-0003-0051-4098	Lundstrom-Amans scholarship; Swedish Energy Agency; mathematical department at Uppsala university; Swedish Research Council [2015-04505]	Lundstrom-Amans scholarship; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); mathematical department at Uppsala university; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Joakim Munkhammar was funded primarily by the Swedish Energy Agency, and Lundstrom-Amans scholarship. Jesper Ryden was funded by the mathematical department at Uppsala university. Lars Mattsson was funded by the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) with grant number 2015-04505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Prof. Svante Janson, Prof. Rolf Larsson and Dr. Johan Bjorklund at the department of mathematics at Uppsala University for discussions on the method presented in this paper. This work was partially funded by the Lundstrom-Amans scholarship.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldous DJ, 1999, BERNOULLI, V5, P3, DOI 10.2307/3318611; BARTON DE, 1952, BIOMETRIKA, V39, P425, DOI 10.1093/biomet/39.3-4.425; Casella G, 2002, STATISTICAL INFERENC; Chabrier G., 2013, GALACTIC STELLAR AND, V114, P763; CHOI MD, 1983, AM MATH MON, V90, P301, DOI 10.2307/2975779; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; DasGupta A, 2008, SPRINGER TEXTS STAT, P1; Fasino D, 1995, J COMPUT APPL MATH, V65, P145, DOI 10.1016/0377-0427(95)00108-5; Gallier Jean, 1999, CURVES SURFACES GEOM; Golovin A., 1963, GEOPHYS SER, V5, P482; Gupta A.K., 2011, INT ENCY STAT SCI, P144; Hollands KGT, 2013, SOL ENERGY, V96, P103, DOI 10.1016/j.solener.2013.07.007; Jeffreys H., 1988, METHODS MATH PHYS, P446; Jondeau E, 2001, J ECON DYN CONTROL, V25, P1457, DOI 10.1016/S0165-1889(99)00082-2; Kendall M, 1987, KENDALLS ADVANCED TH, V1; Kolassa J.E., 2006, SERIES APPROXIMATION; Kotz S, 1985, ENCYCLOPEDIA OF STAT, V5; Kotz S, 1982, ENCYCLOPEDIA OF STAT, V1; Mattsson L, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201015572; MITA K, 1989, J BIOMED ENG, V11, P315, DOI 10.1016/0141-5425(89)90066-6; Monahan AH, 2007, J CLIMATE, V20, P5798, DOI 10.1175/2007JCLI1609.1; Munkhammar J, 2014, APPL ENERG, V135, P382, DOI 10.1016/j.apenergy.2014.08.093; Ochi MK, 1991, OCEAN WAVES THE STOC; Ochi MK, 1992, APPLIED PROBABILITY; Partington JR, 1988, LMS STUDENT TEXTS, V13; Runge C, 1901, Z MATH PHYS, V46, P224, DOI DOI 10.2307/2323093; Shohat JA, 1943, MATH SURVEYS, V1; Smoluchowski M., 1916, Z PHYS, V17, P557; Titterington DM, 1985, STAT ANAL; TRENCH WF, 1965, J SOC IND APPL MATH, V13, P1102, DOI 10.1137/0113078; Wand MP., 1994, KERNEL SMOOTHING; Weierstrass K., 1885, UBER U DIE ANALYTISC; Yim JZ, 2000, ATMOS ENVIRON, V34, P1583, DOI 10.1016/S1352-2310(99)00414-8; Zimmermann JP, 2009, REPORT	35	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174573	10.1371/journal.pone.0174573	http://dx.doi.org/10.1371/journal.pone.0174573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394949	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800004
J	Georgi, E; Walter, MC; Pfalzgraf, MT; Northoff, BH; Holdt, LM; Scholz, HC; Zoeller, L; Zange, S; Antwerpen, MH				Georgi, Enrico; Walter, Mathias C.; Pfalzgraf, Marie-Theres; Northoff, Bernd H.; Holdt, Lesca M.; Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine; Antwerpen, Markus H.			Whole genome sequencing of Brucella melitensis isolated from 57 patients in Germany reveals high diversity in strains from Middle East	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; RPOB GENE; BIOVAR 1; MLVA; EVOLUTION; ALIGNMENT	Brucellosis, a worldwide common bacterial zoonotic disease, has become quite rare in Northern and Western Europe. However, since 2014 a significant increase of imported infections caused by Brucella (B.) melitensis has been noticed in Germany. Patients predominantly originated from Middle East including Turkey and Syria. These circumstances afforded an opportunity to gain insights into the population structure of Brucella strains. Brucella-isolates from 57 patients were recovered between January 2014 and June 2016 with culture confirmed brucellosis by the National Consultant Laboratory for Brucella. Their whole genome sequences were generated using the Illumina MiSeq platform. A whole genome-based SNP typing assay was developed in order to resolve geographically attributed genetic clusters. Results were compared to MLVA typing results, the current gold-standard of Brucella typing. In addition, sequences were examined for possible genetic variation within target regions of molecular diagnostic assays. Phylogenetic analyses revealed spatial clustering and distinguished strains from different patients in either case, whereas multiple isolates from a single patient or technical replicates showed identical SNP and MLVA profiles. By including WGS data from the NCBI database, five major genotypes were identified. Notably, strains originating from Turkey showed a high diversity and grouped into seven subclusters of genotype II. MLVA analysis congruently clustered all isolates and predominantly matched the East Mediterranean genetic clade. This study confirms whole-genome based SNP-analysis as a powerful tool for accurate typing of B. melitensis. Furthermore it allows special allocation and therefore provides useful information on the geographic origin for trace-back analysis. However, the lack of reliable metadata in public databases often prevents a resolution below geographic regions or country levels and corresponding precise trace-back analysis. Once this obstacle is resolved, WGS-derived bacterial typing adds an important method to complement epidemiological surveys during outbreak investigations. This is the first report of a detailed genetic investigation of an extensive collection of B. melitensis strains isolated from human cases in Germany.	[Georgi, Enrico; Walter, Mathias C.; Pfalzgraf, Marie-Theres; Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine; Antwerpen, Markus H.] Bundeswehr Inst Microbiol, Munich, Germany; [Northoff, Bernd H.; Holdt, Lesca M.] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Scholz, Holger C.; Zoeller, Lothar; Zange, Sabine] Natl Consultant Lab Brucella, Munich, Germany	Bundeswehr Institute of Microbiology (IMB); University of Munich	Antwerpen, MH (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	markusantwerpen@bundeswehr.org	Walter, Mathias/AGP-4944-2022	Walter, Mathias/0000-0003-3012-2626; Zange, Sabine/0000-0001-8721-9248; Antwerpen, Markus/0000-0003-4013-8808; Northoff, Bernd/0000-0002-7333-3231	German Ministry of Defence Medical Service [57-2014-03]	German Ministry of Defence Medical Service	This study was supported by internal funding of the German Ministry of Defence Medical Service as part of project no. 57-2014-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab H, 2011, SCAND J INFECT DIS, V43, P536, DOI 10.3109/00365548.2011.562531; Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; [Anonymous], 2016, MBIO; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Azam S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/3034756; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Massis F, 2015, TRANSBOUND EMERG DIS, V62, P463, DOI 10.1111/tbed.12397; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Foster JT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-110; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Garofolo Giuliano, 2016, BMC Res Notes, V9, P277, DOI 10.1186/s13104-016-2074-7; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Gyuranecz M, 2016, VET MICROBIOL, V186, P8, DOI 10.1016/j.vetmic.2016.02.009; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Ke YH, 2012, J BACTERIOL, V194, P5489, DOI 10.1128/JB.01293-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Musallam II, 2016, EPIDEMIOL INFECT, V144, P671, DOI 10.1017/S0950268815002575; Osterman B., 2006, INT J SYST EVOL MICR, V56, P1173, DOI [DOI 10.1099/IJS.0.64349-0, DOI 10.1099/ijs.0.64349-0]; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Sayan M, 2009, JPN J INFECT DIS, V62, P160; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scholz HC, 2013, REV SCI TECH OIE, V32, P149; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Scholz HC, 2008, J MED MICROBIOL, V57, P64, DOI 10.1099/jmm.0.47507-0; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Tan KK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1294-x; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Vollmar P, 1946, DEUT MED WOCHENSCHR, V141, P1014; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00	45	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175425	10.1371/journal.pone.0175425	http://dx.doi.org/10.1371/journal.pone.0175425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388689	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800052
J	Kucuker, MA; Wieczorek, N; Kuchta, K; Copty, NK				Kucuker, Mehmet Ali; Wieczorek, Nils; Kuchta, Kerstin; Copty, Nadim K.			Biosorption of neodymium on Chlorella vulgaris in aqueous solution obtained from hard disk drive magnets	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; NDFEB MAGNETS; ION-EXCHANGE; METAL-IONS; ADSORPTION; RECOVERY; REMOVAL; EQUILIBRIUM; COPPER(II); LANTHANUM	In recent years, biosorption is being considered as an environmental friendly technology for the recovery of rare earth metals (REE). This study investigates the optimal conditions for the biosorption of neodymium (Nd) from an aqueous solution derived from hard drive disk magnets using green microalgae (Chlorella vulgaris). The parameters considered include solution pH, temperature and biosorbent dosage. Best-fit equilibrium as well as kinetic biosorption models were also developed. At the optimal pH of 5, the maximum experimental Nd uptakes at 21, 35 and 50 degrees C and an initial Nd concentration of 250 mg/L were 126.13, 157.40 and 77.10 mg/g, respectively. Analysis of the optimal equilibrium sorption data showed that the data fitted well (R-2 = 0.98) to the Langmuir isotherm model, with maximum monolayer coverage capacity (q(max)) of 188.68 mg/g, and Langmuir isotherm constant (K-L) of 0.029 L/mg. The corresponding separation factor (R-L) is 0.12 indicating that the equilibrium sorption was favorable. The sorption kinetics of Nd ion follows well a pseudo-second order model (R-2 > 0.99), even at low initial concentrations. These results show that Chlorella vulgaris has greater biosorption affinity for Nd than activated carbon and other algae types such as: A. Gracilis, Sargassum sp. and A. Densus.	[Kucuker, Mehmet Ali; Wieczorek, Nils; Kuchta, Kerstin] Hamburg Univ Technol TUHH, Inst Environm Technol & Energy Econ, Waste Resources Management, Hamburg, Germany; [Copty, Nadim K.] Bogazici Univ, Inst Environm Sci, Istanbul, Turkey	Hamburg University of Technology; Bogazici University	Kuchta, K (corresponding author), Hamburg Univ Technol TUHH, Inst Environm Technol & Energy Econ, Waste Resources Management, Hamburg, Germany.	kuchta@tuhh.de	Copty, Nadim K/Q-2749-2015; Kucuker, Mehmet Ali/ABG-6276-2020	Copty, Nadim K/0000-0002-4807-7790; Kucuker, Mehmet Ali/0000-0001-9648-8925; Wieczorek, Nils/0000-0001-8392-3772	BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )" [1DL14004]; Scientific and Technological Research Council of Turkey (TUBITAK) [113Y011]	BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )"(Federal Ministry of Education & Research (BMBF)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The authors acknowledge the financial support from BMBF (The Federal Ministry of Education and Research) through the project "Biotechnological Approach For Recovery Of Rare Earth Elements And Precious Metals From E-Waste - (BIOREEs )", Project Number :1DL14004. Nadim K. Copty gratefully acknowledges the financial support provided by the Scientific and Technological Research Council of Turkey (TUBITAK, project no. 113Y011).	AjayKumar A.V., 2009, WORLD APPL SCI J, V5, P32; Aksu Z, 2005, PROCESS BIOCHEM, V40, P3031, DOI 10.1016/j.procbio.2005.02.004; Bhalara PD, 2014, J ENVIRON CHEM ENG, V2, P1621, DOI 10.1016/j.jece.2014.06.007; Carrillo PFR, 2014, ENV TECHNOL, V35; Dada A., 2012, IOSR J APPL CHEM, V3, P38, DOI [10.9790/5736-0313845, DOI 10.9790/5736-0313845]; Das N, 2013, J RARE EARTH, V31, P933, DOI 10.1016/S1002-0721(13)60009-5; Das N, 2010, HYDROMETALLURGY, V103, P180, DOI 10.1016/j.hydromet.2010.03.016; Diniz V, 2005, WATER RES, V39, P2229, DOI 10.1016/j.watres.2005.04.004; Ramos SND, 2015, IND CROP PROD, V74, P357, DOI 10.1016/j.indcrop.2015.05.022; Donmez GC, 1999, PROCESS BIOCHEM, V34, P885; Dziwulska U, 2004, ANAL LETT, V37, P2189, DOI 10.1081/AL-200026696; Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fomina M, 2014, BIORESOURCE TECHNOL, V160, P3, DOI 10.1016/j.biortech.2013.12.102; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Fujiwara K, 2007, J HAZARD MATER, V146, P39, DOI 10.1016/j.jhazmat.2006.11.049; Gautam R.K., 2013, WASTEWATER REUSE MAN, P305, DOI [DOI 10.1007/978-94-007-4942-9_10, 10.1007/978-94-007-4942-9_10]; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ho YS, 2006, POL J ENVIRON STUD, V15, P81; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2001, SEPAR SCI TECHNOL, V36, P241, DOI 10.1081/SS-100001077; HOSEA M, 1986, INORG CHIM A-BIOINOR, V123, P161, DOI 10.1016/S0020-1693(00)86339-2; Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9; Kucuker M.A., 2016, INT J PLANT ANIM ENV, V2016, P197; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lodeiro P, 2006, J HAZARD MATER, V137, P244, DOI 10.1016/j.jhazmat.2006.01.061; Mohan SV, 1997, ENVIRON POLLUT, V97, P183, DOI 10.1016/S0269-7491(97)00025-0; Moldoveanu GA, 2012, HYDROMETALLURGY, V117, P71, DOI 10.1016/j.hydromet.2012.02.007; Onoda H, 2014, J ENVIRON CHEM ENG, V2, P1186, DOI 10.1016/j.jece.2014.04.019; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Palmieri MC, 2002, HYDROMETALLURGY, V67, P31, DOI 10.1016/S0304-386X(02)00133-0; Palmieri MC, 2000, PROCESS BIOCHEM, V36, P441, DOI 10.1016/S0032-9592(00)00236-3; Palmieri MC, 2003, 15 INT BIOH S HELL; Cazon JP, 2013, J ENVIRON MANAGE, V129, P423, DOI 10.1016/j.jenvman.2013.07.011; REES LVC, 1986, ZEOLITES, V6, P201, DOI 10.1016/0144-2449(86)90048-5; Riano S, 2015, GREEN CHEM, V17, P2931, DOI 10.1039/c5gc00230c; Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biortech.2006.09.026; Sag Y, 2000, BIOCHEM ENG J, V6, P145, DOI 10.1016/S1369-703X(00)00083-8; Saini AS, 2013, BIORESOURCE TECHNOL, V149, P155, DOI 10.1016/j.biortech.2013.09.034; Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n; Sekomo CB, 2012, WATER AIR SOIL POLL, V223, P533, DOI 10.1007/s11270-011-0880-z; Sert S, 2008, HYDROMETALLURGY, V90, P13, DOI 10.1016/j.hydromet.2007.09.006; Smith J.M., 1981, CHEM ENG KINETICS; Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114858; Takeda O, 2005, J ALLOY COMPD, V392, P206, DOI 10.1016/j.jallcom.2004.09.020; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Tang JW, 2010, CHEM GEOL, V279, P120, DOI 10.1016/j.chemgeo.2010.10.011; Tangaromsuk J, 2002, BIORESOURCE TECHNOL, V85, P103, DOI 10.1016/S0960-8524(02)00066-4; TING YP, 1995, J APPL PHYCOL, V7, P97, DOI 10.1007/BF00003557; Tuncuk A, 2012, MINER ENG, V25, P28, DOI 10.1016/j.mineng.2011.09.019; VAISHNAV V, 2011, INT J SCI ENG RES, V2, P2229; Vander Hoogerstraete T, 2014, RSC ADV, V4, P64099, DOI 10.1039/c4ra13787f; Varsihini CJS, 2014, J RARE EARTH, V32, P745, DOI 10.1016/S1002-0721(14)60136-8; Vijayaraghavan K, 2014, ENVIRON PROG SUSTAIN, V33, P147, DOI 10.1002/ep.11770; Vijayaraghavan K, 2011, DESALINATION, V265, P54, DOI 10.1016/j.desal.2010.07.030; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; VOLESKY B, 1987, TRENDS BIOTECHNOL, V5, P96, DOI 10.1016/0167-7799(87)90027-8; Volesky B., 2003, SORPTION BIOSORPTION; WANG JL, 2009, BIOTECHNOL ADV, V27, P195, DOI DOI 10.1016/J.BIOTECHADV.2008.11.002; Wieczorek N, 2014, APPL ENERG, V132, P108, DOI 10.1016/j.apenergy.2014.07.003; Yang XL, 2015, SEP PURIF TECHNOL, V142, P203, DOI 10.1016/j.seppur.2014.11.050	62	47	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175255	10.1371/journal.pone.0175255	http://dx.doi.org/10.1371/journal.pone.0175255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388641	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800031
J	Rodriguez-Hidalgo, R; Perez-Otanez, X; Garces-Carrera, S; Vanwambeke, SO; Madder, M; Benitez-Ortiz, W				Rodriguez-Hidalgo, Richar; Perez-Otanez, Ximena; Garces-Carrera, Sandra; Vanwambeke, Sophie O.; Madder, Maxime; Benitez-Ortiz, Washington			The current status of resistance to alpha-cypermethrin, ivermectin, and amitraz of the cattle tick (Rhipicephalus microplus) in Ecuador	PLOS ONE			English	Article							BOOPHILUS-MICROPLUS; ACARICIDE RESISTANCE; UNITED-STATES; IXODIDAE; TESTS; BIOASSAY; BIOLOGY; BRAZIL	Rhipicephalus microplus is widely distributed in tropical and subtropical areas of the world where livestock is a principal activity with great veterinary and economic importance. In Ecuador, this hematophagous ectoparasite has been observed between 0 and 2600 masl. One of the main tick control measures is the use of acaricides, which have been indiscriminately used worldwide and in Ecuador. In this country, no studies on acaricide resistance in Rhipicephalus microplus have been published. The current study aims to characterise the level of resistance of R. microplus against three main acaricides commonly used in Ecuador i.e. amitraz, alpha-cypermethrin and ivermectin to determine the level and pattern of dose-responses for R. microplus in 12 field populations (farms). The level of acaricide resistance was evaluated using three different bioassays: adult immersion test (AIT), larval package test (LPT) and larval immersion test (LIT), as recommended by the FAO. The predictive dose-responses were analysed by binomial logistics regression of the larval survival rate (resistance). In general, we found resistance of 67% for amitraz; 50% for alpha-cypermethrin and from 25 to 42% for ivermectin in the twelve field populations analysed. Resistance levels were studied in larval and adult bioassays, respectively, which were slightly modified for this study. For larval bioassays based on corrected mortality i.e. high (above 51%), medium (2150%) and low (1120%) resistance, percentages less than 10% were considered as susceptible. For the adult test, two resistance levels were used i.e. high (more than 76%) and medium (51 to 75%) resistance. Percentages lower than 50% were considered as susceptible. In this context, for larval bioassays, amitraz showed 21%, 38% and 8% for high, medium and low resistance, respectively. Alpha-cypermethrin presented 8%, 4 and 38% for high, medium and low resistance, respectively. Ivermectin presented 8%, 25% and 8% for high, medium and low resistance, respectively. For adult tests with amitraz 50% and 17% of the field populations showed average and high resistance, with evidences of average resistance to alpha-cypermethrin in 50% of the samples and average resistance against ivermectin in 25% of the farms. No statistical difference amongst the three bioassays was found and acaricide resistance was confirmed by logistic regression analysis; hence resistance (dose-responses) in each field populations differed, depending on the choice of the acaricide, frequent usage, frequency of treatment and farm management. The effective estimated dose needed to eliminate 99% of ticks is higher than dose recommended by the manufacturer. In conclusion, amitraz showed the highest resistance followed by ivermectin and alpha-cypermethrin and reveals differences on resistance in each individual field population. This information is important in order to establish the monitoring of resistance on each farm individually, contributing to the rational use of acaricides included in an integrated control program for R. microplus.	[Rodriguez-Hidalgo, Richar; Benitez-Ortiz, Washington] Univ Cent Ecuador, Inst Invest Salud Publ & Zoonosis, Quito, Ecuador; [Rodriguez-Hidalgo, Richar; Perez-Otanez, Ximena; Benitez-Ortiz, Washington] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [Garces-Carrera, Sandra] Inst Nacl Invest Agr, Quito, Ecuador; [Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Louvain La Neuve, Belgium; [Madder, Maxime] Inst Trop Med, Antwerp, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa	Universidad Central del Ecuador; Universidad Central del Ecuador; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); University of Pretoria	Rodriguez-Hidalgo, R (corresponding author), Univ Cent Ecuador, Inst Invest Salud Publ & Zoonosis, Quito, Ecuador.; Rodriguez-Hidalgo, R (corresponding author), Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador.	rrodriguez@uce.edu.ec		Vanwambeke, Sophie/0000-0001-6620-6173; Perez Otanez, Ximena/0000-0001-8688-6487; Rodriguez-Hidalgo, Richar/0000-0002-9338-1062	Central University of Ecuador, Research Program [17]; SENESCYTECUADOR postdoctoral fellowship [AR2Q-7446]; Academie de Recherche et d'Enseignement superior (ARES)	Central University of Ecuador, Research Program; SENESCYTECUADOR postdoctoral fellowship; Academie de Recherche et d'Enseignement superior (ARES)	This work was supported by the Central University of Ecuador, Research Program No.17; SENESCYTECUADOR postdoctoral fellowship AR2Q-7446; Academie de Recherche et d'Enseignement superior (ARES) for the publication payment.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas RZ, 2014, VET PARASITOL, V203, P6, DOI 10.1016/j.vetpar.2014.03.006; Alonso-Diaz MA, 2006, ARCH MED VET, V38, P105, DOI 10.4067/S0301-732X2006000200003; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Andreotti R, 2011, REV BRAS PARASITOL V, V20, P127, DOI 10.1590/S1984-29612011000200007; Araque Alejandra, 2014, rev.udcaactual.divulg.cient., V17, P161; Barros-Battesti D.M., 2006, VOXICTTD3BUTANTAN; Santos TRB, 2013, REV BRAS PARASITOL V, V22, P495, DOI 10.1590/S1984-29612013000400008; Bravo Maribel J, 2008, Zootecnia Trop., V26, P41; Busch JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-188; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Castro-Janer E, 2011, VET PARASITOL, V178, P148, DOI 10.1016/j.vetpar.2010.12.035; Cooley RA., 1946, NATL I HEAL B, V187; Coronado A., 1997, GAC CIEN CIAS VETERN, V25, P5; Cortes Vecino AJ, 2010, CORPORACION COLOMB I, V11, P73; CUPP EW, 1991, VET CLIN N AM-SMALL, V21, P1, DOI 10.1016/S0195-5616(91)50001-2; DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130; EDIFARM, 2011, VAD VET, P208; FAO, 2004, TICKS AC RES DIAGN M, P1; ffrench Constant RH, 1990, PESTICIDE RESISTANCE, P4; Food and Agriculture Organization, 1984, PRACTICAL FIELD MANU, VVolume I, P299; Gallardo S., 1999, SCIENCE, V11, P77; Gonzalez-Coloma A, 2013, DESARROLLO METODOS B, P58; Guillen N, 2013, ESTUDIO TAXONOMICO N; Veiga LPHN, 2012, REV BRAS PARASITOL V, V21, P133, DOI 10.1590/S1984-29612012000200011; Jonsson NN, 2007, VET PARASITOL, V146, P307, DOI 10.1016/j.vetpar.2007.02.031; Junte RD, 2008, ACARICIDE RESISTANCE, P41; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; Ojeda-Chi MM, 2011, REV MEX CIENC PECU, V2, P177; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Mekonnen S, 2003, J S AFR VET ASSOC, V74, P41; Mekonnen S, 2002, J VET; Mendes MC, 2011, VET PARASITOL, V178, P383, DOI 10.1016/j.vetpar.2011.01.006; Muyobela J, 2015, TROP ANIM HEALTH PRO, V47, P1599, DOI 10.1007/s11250-015-0906-4; NARI A.E.C., 2003, RESISTENCIA ANTIPARA; Otero JS, 2002, INTRO DISENO EXPT, P4; Pavon-Leyva J., 2014, CIENC TECNOL, V18, P50; Perez-Otanez X, 2016, RESISTENCIA ALFA CIP; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ritz C, 2009, ENVIRON TOXICOL CHEM, V28, P2009, DOI 10.1897/08-480.1; Rivera G, 2009, 27 REUN CIENT TECN F; Rosario-Cruz R, 2009, PARASITOL RES, V105, P1145, DOI 10.1007/s00436-009-1539-1; Soberanes Cespedes N., 2002, Tecnica Pecuaria en Mexico, V40, P81; Stone NE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0456-z; Valencia GL, 2010, CES MED VET ZOOTEC, V4, P57; Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1023/B:APPA.0000049223.92326.02; Vargas V. M., 2006, Agronomia Costarricense, V30, P101; Whitlock C, 2009, ANAL BIOL DATA, P231	48	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174652	10.1371/journal.pone.0174652	http://dx.doi.org/10.1371/journal.pone.0174652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388639	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800008
J	Olariu, V; Nilsson, J; Jonsson, H; Peterson, C				Olariu, Victor; Nilsson, Julia; Jonsson, Henrik; Peterson, Carsten			Different reprogramming propensities in plants and mammals: Are small variations in the core network wirings responsible?	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; NANOG AUTOREPRESSION; GENE-EXPRESSION; SHOOT; PLURIPOTENCY; WUSCHEL; ARABIDOPSIS; MERISTEM; INDUCTION; COMPLEX	Although the plant and animal kingdoms were separated more than 1,6 billion years ago, multicellular development is for both guided by similar transcriptional, epigenetic and post-transcriptional machinery. One may ask to what extent there are similarities and differences in the gene regulation circuits and their dynamics when it comes to important processes like stem cell regulation. The key players in mouse embryonic stem cells governing pluripotency versus differentiation are Oct4, Sox2 and Nanog. Correspondingly, the WUSCHEL and CLAVATA3 genes represent a core in the Shoot Apical Meristem regulation for plants. In addition, both systems have designated genes that turn on differentiation. There is very little molecular homology between mammals and plants for these core regulators. Here, we focus on functional homologies by performing a comparison between the circuitry connecting these players in plants and animals and find striking similarities, suggesting that comparable regulatory logics have been evolved for stem cell regulation in both kingdoms. From in silico simulations we find similar differentiation dynamics. Further when in the differentiated state, the cells are capable of regaining the stem cell state. We find that the propensity for this is higher for plants as compared to mammalians. Our investigation suggests that, despite similarity in core regulatory networks, the dynamics of these can contribute to plant cells being more plastic than mammalian cells, i.e. capable to reorganize from single differentiated cells to whole plants-reprogramming. The presence of an incoherent feed-forward loop in the mammalian core circuitry could be the origin of the different reprogramming behaviour.	[Olariu, Victor; Nilsson, Julia; Jonsson, Henrik; Peterson, Carsten] Lund Univ, Computat Biol & Biol Phys, Lund, Sweden; [Olariu, Victor] Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Copenhagen, Denmark; [Jonsson, Henrik] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Jonsson, Henrik] Univ Cambridge, DAMTP, Cambridge, England	Lund University; University of Copenhagen; Niels Bohr Institute; University of Cambridge; University of Cambridge	Jonsson, H; Peterson, C (corresponding author), Lund Univ, Computat Biol & Biol Phys, Lund, Sweden.; Jonsson, H (corresponding author), Univ Cambridge, Sainsbury Lab, Cambridge, England.; Jonsson, H (corresponding author), Univ Cambridge, DAMTP, Cambridge, England.	Henrik.Jonsson@slcu.cam.ac.uk; Carsten.Peterson@thep.lu.se			Swedish Research Council [VR 621-2013-4547, VR 621-2013-4632]; Swedish Foundation for Strategic Research [A3 04 159p]; Gatsby Charitable Foundation (GB) [GAT3395-PR4]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Gatsby Charitable Foundation (GB)	This work was supported Swedish Research Council, grant VR 621-2013-4547 to CP; the Swedish Foundation for Strategic Research, grant A3 04 159p to CP; the Gatsby Charitable Foundation (GB), grant GAT3395-PR4 to HJ and the Swedish Research Council, grant VR 621-2013-4632 to HJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchabke-Coussa O, 2013, PLANT CELL REP, V32, P675, DOI 10.1007/s00299-013-1402-9; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kornet N, 2008, COLD SPRING HARB S Q; Laux T, 1996, DEVELOPMENT, V122, P87; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Livigni A, 2013, CURR BIOL, V23, P2233, DOI 10.1016/j.cub.2013.09.048; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Olariu V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25438; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pikaard CS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019315; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Sun B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00017; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas P., 2011, J CHEM PHYS, V135; Tsai SY, 2011, STEM CELLS, V29, P964, DOI 10.1002/stem.649; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126	53	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175251	10.1371/journal.pone.0175251	http://dx.doi.org/10.1371/journal.pone.0175251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384293	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900137
J	Yang, KL; Chang, WT; Hong, MY; Hung, KC; Chuang, CC				Yang, Kun-Lin; Chang, Wen-Teng; Hong, Ming-Yuan; Hung, Kuo-Chen; Chuang, Chia-Chang			Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative antioxidant through suppression of ROS, inflammation and hepatic stellate cells activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ANTRODIA-CAMPHORATA; IN-VITRO; INHIBITION; PROMOTER; GENE; OVEREXPRESSION; EXPRESSION; TGF-BETA-1; INDUCTION	Current anti-fibrotic effect of antioxidants in vivo is disappointing due probably to the fact that once liver fibrogenesis is established it is too advanced to be reversed by anti-oxidation mechanism. We consider antioxidant may only act on the early phase of fibrogenesis. Thus, we had previously established an early liver fibrosis animal model using an inducible expression vector (pPK9a), which contains TGF-beta gene and was hydro-dynamically transferred into mice to induce a transient liver fibrosis. TGF-beta 1 has been well documented to up-regulate the expression of alpha 2(1) collagen (Col 1A2) gene in the liver via the reactive oxygen species (ROS); the process triggers inflammation, leading to hepatic stellate cells (HSC) activation and liver fibrogenesis. Using our animal model and ROS, cyclooxygenase-2 (Cox-2) and Col 1A2 promoter assays as screening targets, we report here that a maleic acid derivative isolated from the Antrodia camphorata mycelium strongly decreases ROS production, promoter activity of Cox-2 and Col 1A2, intracellular calcium, expression of alpha-smooth muscle actin (alpha-SMA), Smad4-p-Smad2/3 co-localization in cell nucleus and the DNA binding activity of Sp1. Our results suggest that the maleic acid derivative prevents liver fibrosis at an early phase both in vitro and in vivo through the inhibition of ROS, inflammation and the activation of HSC.	[Yang, Kun-Lin] Natl Pei Men Senior Agr & Ind Vocat Sch, Dept Anim Sci, Tainan, Taiwan; [Yang, Kun-Lin] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Chang, Wen-Teng] Chung Hwa Univ Med Technol, Dept Biol Sci & Technol, Tainan, Taiwan; [Hong, Ming-Yuan; Chuang, Chia-Chang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Coll Med, Tainan, Taiwan; [Hung, Kuo-Chen] Yuans Gen Hosp, Dept Gen Surg, Kaohsiung, Taiwan	National Kaohsiung Normal University; Chung Hua University; National Cheng Kung University; National Cheng Kung University Hospital	Chuang, CC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Coll Med, Tainan, Taiwan.	chuanger@mail.ncku.edu.tw		Hong, Ming-Yuan/0000-0003-0320-1484	National Science Council, Taiwan [NSC 93-2622-B-006-002-CC3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by a grant from the National Science Council, Taiwan (NSC 93-2622-B-006-002-CC3). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthemanuscript.	Chang WT, 2004, J BIOL CHEM, V279, P14542, DOI 10.1074/jbc.M309825200; Chang WW, 2003, J HEPATOL, V39, P834, DOI 10.1016/S0168-8278(03)00389-1; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen RH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134887; Cho JH, 2002, CARCINOGENESIS, V23, P1163, DOI 10.1093/carcin/23.7.1163; Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Grant MB, 2000, INVEST OPHTH VIS SCI, V41, P2296; Hseu YC, 2005, INT IMMUNOPHARMACOL, V5, P1914, DOI 10.1016/j.intimp.2005.06.013; Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Kobayashi N, 2005, ADV DRUG DELIVER REV, V57, P713, DOI 10.1016/j.addr.2004.12.006; Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1016/S0022-4804(02)00037-9; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mori Y, 2000, EXP CELL RES, V258, P374, DOI 10.1006/excr.2000.4930; SAMUEL SK, 1992, EMBO J, V11, P1599, DOI 10.1002/j.1460-2075.1992.tb05205.x; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Song TY, 2002, J AGR FOOD CHEM, V50, P3322, DOI 10.1021/jf011671z; Swart PJ, 1999, J HEPATOL, V31, P1034, DOI 10.1016/S0168-8278(99)80316-X; Vogel S, 2000, J LIPID RES, V41, P882; Yang Kun-Lin, 2007, Comp Hepatol, V6, P9, DOI 10.1186/1476-5926-6-9; Yang KL, 2008, BIOCHEM BIOPH RES CO, V373, P219, DOI 10.1016/j.bbrc.2008.05.192; Yang KL, 2008, BIOCHEM BIOPH RES CO, V365, P484, DOI 10.1016/j.bbrc.2007.10.203; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003	27	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174008	10.1371/journal.pone.0174008	http://dx.doi.org/10.1371/journal.pone.0174008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384213	Green Published, gold			2022-12-26	WOS:000399371900011
J	Casos, K; Ferrer-Curriu, G; Soler-Ferrer, P; Perez, ML; Permanyer, E; Blasco-Lucas, A; Gracia-Baena, JM; Castro, MA; Sureda, C; Barquinero, J; Galinanes, M				Casos, Kelly; Ferrer-Curriu, Gemma; Soler-Ferrer, Paula; Perez, Maria L.; Permanyer, Eduard; Blasco-Lucas, Arnau; Manuel Gracia-Baena, Juan; Castro, Miguel A.; Sureda, Carlos; Barquinero, Jordi; Galinanes, Manuel			Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; OXIDATIVE STRESS; FREE-RADICALS; ESTROGEN; COMPLICATIONS; CHANNEL	Background The diseased human myocardium is highly susceptible to ischemia/reoxygenation (I/R)induced injury but its response to protective interventions such as ischemic preconditioning (IPreC) is unclear. Cardiac and other pre-existing clinical conditions as well as previous or ongoing medical treatment may influence the myocardial response to I/R injury and protection. This study investigated the effect of both on myocardial susceptibility to I/R-induced injury and the protective effects of IPreC. Methods and results Atrial myocardium from cardiac surgery patients (n = 300) was assigned to one of three groups: aerobic control, I/R alone, and IPreC. Lactate dehydrogenase leakage, as a marker of cell injury, and cell viability were measured. The basal redox status was determined in samples from 90 patients. The response to I/R varied widely. Myocardium from patients with aortic valve disease was the most susceptible to injury whereas myocardium from dyslipidemia patients was the least susceptible. Tissue from females was better protected than tissue from males. Myocardium from patients with mitral valve disease was the least responsive to IPreC. The basal redox status was altered in the myocardium from patients with mitral and aortic valve disease. Conclusions The response of the myocardium to I/R and IPreC is highly variable and influenced by the underlying cardiac pathology, dyslipidemia, sex, and the basal redox status. These results should be taken into account in the design of future clinical studies on the prevention of I/R injury and protection.	[Casos, Kelly; Ferrer-Curriu, Gemma; Soler-Ferrer, Paula; Perez, Maria L.; Galinanes, Manuel] Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Vall dHebron Res Inst VHIR, Reparat Therapy Heart, Barcelona, Spain; [Permanyer, Eduard; Blasco-Lucas, Arnau; Manuel Gracia-Baena, Juan; Castro, Miguel A.; Sureda, Carlos; Galinanes, Manuel] Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Dept Cardiac Surg, Barcelona, Spain; [Barquinero, Jordi] UAB, Gene & Cell & Therapy Lab VHIR, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Galinanes, M (corresponding author), Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Vall dHebron Res Inst VHIR, Reparat Therapy Heart, Barcelona, Spain.; Galinanes, M (corresponding author), Autonomous Univ Barcelona UAB, Univ Hosp Vall dHebron, Dept Cardiac Surg, Barcelona, Spain.	manuel.galinanes@gmail.com	Barquinero, Jordi/F-6979-2011; Blasco-Lucas, Arnau/AFL-9427-2022; Llusa-Perez, Manuel/ABF-6891-2021; Blasco-Lucas, Arnau/AAH-1531-2022	Barquinero, Jordi/0000-0002-1677-9851; Llusa-Perez, Manuel/0000-0003-2807-563X; Gracia Baena, Juan Manuel/0000-0001-5277-3847; Ferrer Curriu, Gemma/0000-0002-2651-649X	Institute de Salud Carlos III (FIS) [12/00119]	Institute de Salud Carlos III (FIS)	This study was supported by the Institute de Salud Carlos III (FIS) [grant number 12/00119].	Adams KF, 1999, CIRCULATION, V99, P1816, DOI 10.1161/01.CIR.99.14.1816; ALLARD MF, 1994, J MOL CELL CARDIOL, V26, P1551, DOI 10.1006/jmcc.1994.1175; ANDERSON PG, 1990, CIRC RES, V67, P948, DOI 10.1161/01.RES.67.4.948; Cao YK, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187940; Carluccio E, 2000, INT J CARDIOL, V74, P177, DOI 10.1016/S0167-5273(00)00264-3; Cavalca V, 2013, INTERACT CARDIOV TH, V17, P923, DOI 10.1093/icvts/ivt386; Chandrashekhar Y, 2009, LANCET, V374, P1271, DOI 10.1016/S0140-6736(09)60994-6; Correale M, 2012, CURR VASC PHARMACOL, V12, P873; Csonka C, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3863726; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Fernandez-Jimenez R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001218; Ferrara AL, 2003, NUTR METAB CARDIOVAS, V13, P126, DOI 10.1016/S0939-4753(03)80171-0; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Galinanes M, 2004, CARDIOVASC RES, V61, P512, DOI 10.1016/j.cardiores.2003.11.028; Genereux P, 2014, J AM COLL CARDIOL, V64, P2605, DOI 10.1016/j.jacc.2014.08.052; Hawkes AL, 2006, VASC HEALTH RISK MAN, V2, P477, DOI 10.2147/vhrm.2006.2.4.477; He F, 2015, INT J MOL SCI, V16, P27770, DOI 10.3390/ijms161126059; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Juranek I, 2005, GEN PHYSIOL BIOPHYS, V24, P263; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lee TM, 2000, J MOL CELL CARDIOL, V32, P1147, DOI 10.1006/jmcc.2000.1167; Linares-Palomino J, J PHYSL, V588, P2173; Malek LA, 2012, EUR J RADIOL, V81, pE177, DOI 10.1016/j.ejrad.2011.01.088; MENASCHE P, 1985, AM HEART J, V110, P1204, DOI 10.1016/0002-8703(85)90014-6; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Schwarzenberger JC, 2003, CRIT CARE MED, V31, P689, DOI 10.1097/01.CCM.0000055442.84685.4D; SINK JD, 1981, J THORAC CARDIOV SUR, V81, P865; Skyschally A, 2003, AM J PHYSIOL-HEART C, V284, pH698, DOI 10.1152/ajpheart.00693.2002; SPEECHLYDICK ME, 1995, CIRC RES, V77, P1030, DOI 10.1161/01.RES.77.5.1030; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tritto I, 1997, CIRC RES, V80, P743, DOI 10.1161/01.RES.80.5.743; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang MJ, 2006, J MOL CELL CARDIOL, V40, P205, DOI 10.1016/j.yjmcc.2005.06.019; Zhai PY, 2000, AM J PHYSIOL-HEART C, V279, pH2766, DOI 10.1152/ajpheart.2000.279.6.H2766; Zhang JG, 2000, CARDIOVASC RES, V45, P93; Zuo Li, 2013, [Frontiers in Biology, 生物学前沿], V8, P305; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174588	10.1371/journal.pone.0174588	http://dx.doi.org/10.1371/journal.pone.0174588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380047	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500053
J	Chehelcheraghi, M; van Leeuwen, C; Steur, E; Nakatani, C				Chehelcheraghi, Mojtaba; van Leeuwen, Cees; Steur, Erik; Nakatani, Chie			A neural mass model of cross frequency coupling	PLOS ONE			English	Article							SYNCHRONIZED GAMMA-OSCILLATIONS; NEURONAL OSCILLATIONS; PHASE SYNCHRONIZATION; INTERNEURON NETWORKS; SYNAPTIC INHIBITION; MATHEMATICAL-MODEL; HIPPOCAMPUS; MODULATION; RHYTHMS; BRAIN	Electrophysiological signals of cortical activity show a range of possible frequency and amplitude modulations, both within and across regions, collectively known as cross-frequency coupling. To investigate whether these modulations could be considered as manifestations of the same underlying mechanism, we developed a neural mass model. The model provides five out of the theoretically proposed six different coupling types. Within model components, slow and fast activity engage in phase-frequency coupling in conditions of low ambient noise level and with high noise level engage in phase-amplitude coupling. Between model components, these couplings can be coordinated via slow activity, giving rise to more complex modulations. The model, thus, provides a coherent account of cross-frequency coupling, both within and between components, with which regional and crossregional frequency and amplitude modulations could be addressed.	[Chehelcheraghi, Mojtaba; van Leeuwen, Cees; Steur, Erik; Nakatani, Chie] Katholieke Univ Leuven, Brain & Cognit Res Unit, Leuven, Belgium; [van Leeuwen, Cees] TU Kaiserslautern, Ctr Cognit Sci, Kaiserslautern, Germany; [Steur, Erik] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Steur, Erik] Eindhoven Univ Technol, Dept Mech Engn, Eindhoven, Netherlands	KU Leuven; University of Kaiserslautern; Eindhoven University of Technology; Eindhoven University of Technology	Nakatani, C (corresponding author), Katholieke Univ Leuven, Brain & Cognit Res Unit, Leuven, Belgium.	chie.nakatani@kuleuven.be	van Leeuwen, Cees/AAB-9525-2022; van Leeuwen, Cees/G-2644-2010; Nakatani, Chie/I-9183-2017	van Leeuwen, Cees/0000-0002-4441-2440; van Leeuwen, Cees/0000-0002-4441-2440; Nakatani, Chie/0000-0001-6743-4709	Odysseus grant from the Flemish organizations for science (FWO)	Odysseus grant from the Flemish organizations for science (FWO)	This research is founded by an Odysseus grant from the Flemish organizations for science (FWO) awarded to Cees van Leeuwen.; This research was supported by an Odysseus grant from the Flemish organizations for science (FWO) awarded to Cees van Leeuwen.	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bekisz M, 1999, NEUROREPORT, V10, P3589, DOI 10.1097/00001756-199911260-00023; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunner C., 2013, BIOMED ENG BIOMED TE; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chehelcheraghi M, 2017, ZENODO; Chehelcheraghi M, MATH MODEL IN PRESS; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cona F, 2014, J COMPUT NEUROSCI, V37, P125, DOI 10.1007/s10827-013-0493-1; Cona F, 2011, NEUROIMAGE, V57, P1045, DOI 10.1016/j.neuroimage.2011.05.007; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Davis J., 1994, LARGE SCALE NEURONAL; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garnier A, 2015, NEURAL COMPUT, V27, P329, DOI 10.1162/NECO_a_00696; Goodfellow M, 2011, NEUROIMAGE, V55, P920, DOI 10.1016/j.neuroimage.2010.12.074; Huang G, 2011, NEUROCOMPUTING, V74, P1026, DOI 10.1016/j.neucom.2010.11.019; Hyafil A, 2015, TRENDS NEUROSCI, V38, P725, DOI 10.1016/j.tins.2015.09.001; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Lefebvre J, 2015, J NEUROSCI, V35, P2895, DOI 10.1523/JNEUROSCI.3609-14.2015; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mina F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00094; Moran R, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00057; Nakhnikian A, 2016, J NEUROSCI METH, V269, P61, DOI 10.1016/j.jneumeth.2016.04.019; Neymotin SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076285; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Park H, 2011, BRAIN CONNECT, V1, P460, DOI 10.1089/brain.2011.0046; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Sen Bhattacharya B, 2011, NEURAL NETWORKS, V24, P631, DOI 10.1016/j.neunet.2011.02.009; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Ursino M, 2010, NEUROIMAGE, V52, P1080, DOI 10.1016/j.neuroimage.2009.12.084; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang XJ, 1996, J NEUROSCI, V16, P6402; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Youssofzadeh V, 2015, NEUROIMAGE, V108, P364, DOI 10.1016/j.neuroimage.2014.12.067	66	12	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173776	10.1371/journal.pone.0173776	http://dx.doi.org/10.1371/journal.pone.0173776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380064	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500022
J	Pitt, JI; Lange, L; Lacey, AE; Vuong, D; Midgley, DJ; Greenfield, P; Bradbury, MI; Lacey, E; Busk, PK; Pilgaard, B; Chooi, YH; Piggott, AM				Pitt, John I.; Lange, Lene; Lacey, Alastair E.; Vuong, Daniel; Midgley, David J.; Greenfield, Paul; Bradbury, Mark I.; Lacey, Ernest; Busk, Peter K.; Pilgaard, Bo; Chooi, Yit-Heng; Piggott, Andrew M.			Aspergillus hancockii sp nov., a biosynthetically talented fungus endemic to southeastern Australian soils	PLOS ONE			English	Article							ACID BIOSYNTHESIS; TRICHOTHECENE BIOSYNTHESIS; OXINDOLE ALKALOIDS; GENE-CLUSTER; KOJIC ACID; CLASSIFICATION; IDENTIFICATION; CONSTITUTION; SPERADINE; RESOURCE	Aspergillus hancockii sp. nov., classified in Aspergillus subgenus Circumdati section Flavi, was originally isolated from soil in peanut fields near Kumbia, in the South Burnett region of southeast Queensland, Australia, and has since been found occasionally from other substrates and locations in southeast Australia. It is phylogenetically and phenotypically related most closely to A. leporis States and M. Chr., but differs in conidial colour, other minor features and particularly in metabolite profile. When cultivated on rice as an optimal substrate, A. hancockii produced an extensive array of 69 secondary metabolites. Eleven of the 15 most abundant secondary metabolites, constituting 90% of the total area under the curve of the HPLC trace of the crude extract, were novel. The genome of A. hancockii, approximately 40 Mbp, was sequenced and mined for genes encoding carbohydrate degrading enzymes identified the presence of more than 370 genes in 114 gene clusters, demonstrating that A. hancockii has the capacity to degrade cellulose, hemicellulose, lignin, pectin, starch, chitin, cutin and fructan as nutrient sources. Like most Aspergillus species, A. hancockii exhibited a diverse secondary metabolite gene profile, encoding 26 polyketide synthase, 16 nonribosomal peptide synthase and 15 nonribosomal peptide synthase-like enzymes.	[Pitt, John I.; Midgley, David J.; Greenfield, Paul; Bradbury, Mark I.] CSIRO, N Ryde, NSW, Australia; [Lange, Lene; Busk, Peter K.; Pilgaard, Bo] Tech Univ Denmark, Dept Chem & Biochem Engn, Lyngby, Denmark; [Lacey, Alastair E.; Vuong, Daniel; Lacey, Ernest] Microbial Screening Technol, Smithfield, Australia; [Chooi, Yit-Heng] Univ Western Australia, Sch Chem & Biochem, Crawley, Australia; [Piggott, Andrew M.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Technical University of Denmark; University of Western Australia; Macquarie University	Pitt, JI (corresponding author), CSIRO, N Ryde, NSW, Australia.; Piggott, AM (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.	John.Pitt@csiro.au; andrew.piggott@mq.edu.au	Midgley, David/GOV-4218-2022; Chooi, Yit Heng/D-4338-2013; Piggott, Andrew M/G-9259-2012; Kamp Busk, Peter/Q-8145-2016	Chooi, Yit Heng/0000-0001-7719-7524; Piggott, Andrew M/0000-0002-5308-5314; Vuong, Daniel/0000-0002-2451-3148; Pilgaard, Bo/0000-0002-8697-6041; Bradbury, Mark/0000-0002-3727-9055; Kamp Busk, Peter/0000-0003-1920-636X	Austrailian Research Council [FT130100142]; Macquarie University; CSIRO; Microbial Screening Technologies; Technical University of Denmark; University of Western Austrailia	Austrailian Research Council; Macquarie University; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Microbial Screening Technologies; Technical University of Denmark; University of Western Austrailia	This work was supported in part by the Austrailian Research Council (FT130100142), Macquarie University, CSIRO, Microbial Screening Technologies, Technical University of Denmark and University of Western Austrailia. The funders provided support in the form of salaries for authors LL, AEL, DV, DJM, PG, MIB, EL, PKB, BP, Y-HC and AMP but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ali H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098212; [Anonymous], 2003, MICROBIOL AUST; BENTLEY R, 1962, J BIOL CHEM, V237, P859; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; Busk PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114138; Busk PK, 2013, APPL ENVIRON MICROB, V79, P3380, DOI 10.1128/AEM.03803-12; Busk PK, 2012, Patent application, Patent No. [PCT/EP2012/051099, 2012051099]; Cacho RA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00774; Cardoza RE, 2011, APPL ENVIRON MICROB, V77, P4867, DOI 10.1128/AEM.00595-11; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Clutterbuck PW, 1935, BIOCHEM J, V29, P871, DOI 10.1042/bj0290871; da Silva JV, 2013, NAT PROD RES, V27, P9, DOI 10.1080/14786419.2011.647021; Fujita T, 2004, BIOSCI BIOTECH BIOCH, V68, P820, DOI 10.1271/bbb.68.820; Fujita T, 2002, BIOSCI BIOTECH BIOCH, V66, P1697, DOI 10.1271/bbb.66.1697; Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085; Greenfield P, 2014, BIOINFORMATICS, V30, P2723, DOI 10.1093/bioinformatics/btu368; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hornbogen T, 2007, CHEMBIOCHEM, V8, P1048, DOI 10.1002/cbic.200700076; Hu X, 2014, CHEM PHARM BULL, V62, P942, DOI 10.1248/cpb.c14-00312; Hu X, 2014, HETEROCYCLES, V89, P1662, DOI 10.3987/COM-14-13004; JACOBSEN JP, 1978, TETRAHEDRON LETT, P1081; Kato N, 2011, CHEMBIOCHEM, V12, P1376, DOI 10.1002/cbic.201000672; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kornerup A, 1978, METHUEN HDB COLOUR, DOI DOI 10.1093/NAR/GKV437; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacey HJ, 2016, AUST J CHEM, V69, P152, DOI 10.1071/CH15488; Li SM, 2011, J ANTIBIOT, V64, P45, DOI 10.1038/ja.2010.128; Ma XH, 2015, TETRAHEDRON, V71, P3522, DOI 10.1016/j.tet.2015.03.050; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; MAYERL F, 1993, J ANTIBIOT, V46, P1082, DOI 10.7164/antibiotics.46.1082; McCormick SP, 1999, APPL ENVIRON MICROB, V65, P5252; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mundt K, 2012, CHEMBIOCHEM, V13, P2583, DOI 10.1002/cbic.201200523; Perez-Victoria I, 2012, J NAT PROD, V75, P1210, DOI 10.1021/np3000987; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Semeiks J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-590; Seshime Y, 2009, BIOORG MED CHEM LETT, V19, P3288, DOI 10.1016/j.bmcl.2009.04.073; SHOJI JI, 1989, J ANTIBIOT, V42, P1729, DOI 10.7164/antibiotics.42.1729; STATES JS, 1966, MYCOLOGIA, V58, P738, DOI 10.2307/3756848; Sussmuth R, 2011, NAT PROD REP, V28, P99, DOI 10.1039/c001463j; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEPASKE MR, 1991, TETRAHEDRON LETT, V32, P5687, DOI 10.1016/S0040-4039(00)93530-5; TERUI Y, 1990, J ANTIBIOT, V43, P1245, DOI 10.7164/antibiotics.43.1245; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tokuoka M, 2015, BIOSCI BIOTECH BIOCH, V79, P2081, DOI 10.1080/09168451.2015.1065167; Tsuda M, 2003, TETRAHEDRON, V59, P3227, DOI 10.1016/S0040-4020(03)00413-7; Varga J, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.69.05; Velkov T, 2011, CHEM BIOL, V18, P464, DOI 10.1016/j.chembiol.2011.01.017; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Wang D, 2015, CHEM NAT COMPD+, V51, P733, DOI 10.1007/s10600-015-1395-4; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Yabuta T, 1924, J CHEM SOC, V125, P575, DOI 10.1039/ct9242500575; YAMAZAKI M, 1971, CHEM PHARM BULL, V19, P1739, DOI 10.1248/cpb.19.1739; Yang XL, 2014, CHEMBIOCHEM, V15, P1578, DOI 10.1002/cbic.201402172; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang SG, 2007, FUNGAL GENET BIOL, V44, P1342, DOI 10.1016/j.fgb.2007.06.005; Zhu HC, 2015, CHEM BIODIVERS, V12, P1547, DOI 10.1002/cbdv.201400412	64	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0170254	10.1371/journal.pone.0170254	http://dx.doi.org/10.1371/journal.pone.0170254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379953	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500002
J	Rohena-Rivera, K; Sanchez-Vazquez, MM; Aponte-Colon, DA; Forestier-Roman, IS; Quintero-Aguilo, ME; Martinez-Ferrer, M				Rohena-Rivera, Krizia; Sanchez-Vazquez, Maria M.; Aponte-Colon, Diana A.; Forestier-Roman, Ingrid S.; Quintero-Aguilo, Mario E.; Martinez-Ferrer, Magaly			IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; NEUTROPHIL ELASTASE; REACTIVE STROMA; INTERLEUKIN-15; BREAST; CELLS; ADIPONECTIN; PROGRESSION; CHEMOKINES; INHIBITION	Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer. In the United States it is second leading cause of cancer related deaths in men. PCa is often treated via radical prostatectomy (RP). However, 15-30% of the patients develop biochemical recurrence (i. e. increased serum prostate specific antigen (PSA) levels). Interleukin-15 (IL-15) is a secreted cytokine found over expressed in patients with recurrence-free survival after RP. In our study, we aim to determine the role of IL-15 in PCa using in vitro and in vivo models, and gene expression analysis. PC3 (androgen-independent) and 22RV1 (androgen- dependent) cell lines were treated with IL-15 at 0.0013 ng/mL and 0.1 ng/mL. Tumor growth was evaluated using an orthotopic xenograft model. The anterior prostate lobes of SCID mice were injected with 250,000 22RV1 cells and IL-15 was administered bi-weekly with intraperitoneal (IP) injections during 4 weeks. Tumor tissue was collected for immunohistochemical and gene expression analysis. To study changes in gene expression, we looked at "Tumor Metastasis" and "PI3K pathway" using commercially available PCR arrays. In addition, we employed a microarray approach using the Affymetrix Hugene 2.0 ST array chip followed by analysis with Ingenuity Pathways Analysis (IPA) software. In vitro studies showed that IL-15 decreased PCa cell motility at both concentrations. In vivo studies showed that IL-15 increased neutrophil infiltration, and the expression of adiponectin, desmin and alpha smooth muscle actin (a-sma) in the tumor tissue. Angiogenesis analysis, using CD31 immunohistochemistry, showed that IL-15 decreased the number of blood vessels. Gene expression analysis identified Cancer, Cell Death, Immune Response and Lipid Metabolism as the major diseases and functions altered in tumors treated with IL-15. This suggests that IL-15 causes inflammation and changes in stroma that can promote decreased tumor cell proliferation.	[Rohena-Rivera, Krizia; Forestier-Roman, Ingrid S.; Martinez-Ferrer, Magaly] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Rohena-Rivera, Krizia; Sanchez-Vazquez, Maria M.; Aponte-Colon, Diana A.; Forestier-Roman, Ingrid S.; Quintero-Aguilo, Mario E.; Martinez-Ferrer, Magaly] Univ Puerto Rico, Comprehens Canc Ctr San Juan, San Juan, PR 00936 USA; [Martinez-Ferrer, Magaly] Univ Puerto Rico, Sch Pharm San Juan, Dept Pharmaceut Sci, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico	Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA.; Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Comprehens Canc Ctr San Juan, San Juan, PR 00936 USA.; Martinez-Ferrer, M (corresponding author), Univ Puerto Rico, Sch Pharm San Juan, Dept Pharmaceut Sci, San Juan, PR 00936 USA.	magaly.martinez1@upr.edu			NIH [K01 CA140711]; MBRS-RISE grant [R25GM061838]; NIH MARC grants [5T34GM007821-35, 5T34GM007821-36]; University of Puerto Rico Comprehensive Cancer Center; School of Pharmacy; RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus) [8G12-MD007600, NIMHDG: 12RR0305]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MBRS-RISE grant; NIH MARC grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico Comprehensive Cancer Center; School of Pharmacy; RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by NIH grant K01 CA140711, MBRS-RISE grant R25GM061838, NIH MARC grants 5T34GM007821-35 and 5T34GM007821-36, and Institutional funds from the University of Puerto Rico Comprehensive Cancer Center and the School of Pharmacy.; Special thanks to Dr. Carmen Cadilla and Jessica Renta of the RCMI Center for Genomics in Health Disparities and Rare Diseases (RCMI, Medical Science Campus, grants 8G12-MD007600 and NIMHDG: 12RR0305) for their aid with microarray experiments.	Alva A, 2014, CURR TREAT OPTION ON, V15, P127, DOI 10.1007/s11864-013-0272-2; Assi K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-42; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Barb D, 2007, ENDOCR-RELAT CANCER, V14, P995, DOI 10.1677/ERC-06-0091; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bickers B, 2009, ANTICANCER RES, V29, P3289; Blum DL, 2008, CLIN CANCER RES, V14, P7790, DOI 10.1158/1078-0432.CCR-08-1716; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716; Bub JD, 2006, BIOCHEM BIOPH RES CO, V340, P1158, DOI 10.1016/j.bbrc.2005.12.103; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cassatella MA, 2000, CURR OPIN HEMATOL, V7, P174, DOI 10.1097/00062752-200005000-00008; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Fu GP, 2012, J IMMUNOL, V189, P2326, DOI 10.4049/jimmunol.1103458; Garratt LW, 2015, EUR RESPIR J, V46, P384, DOI 10.1183/09031936.00212114; Goktas S, 2005, UROLOGY, V65, P1168, DOI 10.1016/j.urology.2004.12.053; Hammond ME, 1950, J IMMUNOL, V155, p1428 ; Huber RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057793; ISAACS JT, 1988, PROSTATE, V13, P165; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu Ai-jun, 2007, Journal of Zhejiang University-Science B, V8, P853, DOI 10.1631/jzus.2007.B0853; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Marchion DC, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.004; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Meyer K, 2015, MOL CELL BIOL, V35, P2991, DOI 10.1128/MCB.01149-14; Morris JC, 2014, GENE THER, V21, P393, DOI 10.1038/gt.2014.10; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Oliveros J. C., INTERACTIVE TOOL COM; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Pourmand Gholamreza, 2007, Urol J, V4, P95; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Serrano-Pertierra E, 2014, J LEUKOCYTE BIOL, V95, P487, DOI 10.1189/jlb.0613316; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skvortsov S, 2014, BRIT J CANCER, V110, P2677, DOI 10.1038/bjc.2014.221; Stanelle J, 2010, BLOOD, V116, P4202, DOI 10.1182/blood-2010-01-265827; Steel JC, 2012, TRENDS PHARMACOL SCI, V33, P35, DOI 10.1016/j.tips.2011.09.004; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Takaku M, 2015, GENE EXPRESSION, V16, P163, DOI 10.3727/105221615X14399878166113; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Van de Walle I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11171; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Waldmann TA, 2014, EXPERT REV CLIN IMMU, V10, P1689, DOI 10.1586/1744666X.2014.973856; Wang C, 2015, CURR OPIN IMMUNOL, V37, P6, DOI 10.1016/j.coi.2015.08.001; Wang J, 2013, EUR REV MED PHARMACO, V17, P596; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wu JP, 2014, ASIAN J ANDROL, V16, P710, DOI 10.4103/1008-682X.129131; Xie B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149199; Yu P, 2012, P NATL ACAD SCI USA, V109, P6187, DOI 10.1073/pnas.1203479109; Zabransky DJ, 2012, PROSTATE, V72, P487, DOI 10.1002/pros.21449; Zhang W. C., 2010, 2010 IEEE 3rd International Nanoelectronics Conference (INEC 2010), P1, DOI 10.1109/INEC.2010.5425054	63	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172786	10.1371/journal.pone.0172786	http://dx.doi.org/10.1371/journal.pone.0172786			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379958	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500009
J	Domingos, JA; Soares, LS; Bandeira, LM; Bonin, CM; Vicente, ACP; Zanella, L; Puga, MAM; Tozetti, IA; Motta-Castro, ARC; da Cunha, RV				Domingos, Joao Americo; Soares, Luana Silva; Bandeira, Larissa M.; Bonin, Camila Mareti; Vicente, Ana C. P.; Zanella, Louise; Moreira Puga, Marco Antonio; Tozetti, Ines Aparecida; Coimbra Motta-Castro, Ana Rita; da Cunha, Rivaldo Venancio			Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil	PLOS ONE			English	Article							MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; VIRUS TYPE-1 HTLV-1; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; ASYMPTOMATIC CARRIERS; GENE-EXPRESSION; T-CELLS; NEUROLOGICAL MANIFESTATIONS; DIAGNOSTIC-CRITERIA; CLINICAL-FEATURES	The lifetime risk of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development differs among ethnic groups. To better understand these differences, this prospective cohort study was conducted to investigate the cytokine profile and the HTLV-1 proviral load (PVL) in Japanese and non-Japanese populations with HAM/TSP and asymptomatic carriers (ACs). The serum IL-2, IL-4, IL-6, IL-10, IL-17, TNF-alpha, and IFN-Y levels were quantified using the Cytometric Bead Array in 40 HTLV-1-infected patients (11 HAM/ TSP and 29 ACs) and 18 healthy controls (HCs) in Brazil. Among ACs, 15 were Japanese descendants and 14 were non-Japanese. Of 11 patients with HAM/TSP, only one was a Japanese descendant. The HTLV-1 PVL was quantified by real-time PCR. The HTLV-1 PVL was 2.7-fold higher in HAM/TSP patients than ACs. Regardless of the clinical outcome, the PVL was significantly higher in patients younger than 60 years than older patients. The HAM/TSP and ACs had higher IL-10 serum concentrations than that of HCs. The ACs also showed higher IL-6 serum levels than those of HCs. According to age, the IL-10 and IL-6 levels were higher in ACs non-Japanese patients older than 60 years. HAM/TSP patients showed a positive correlation between IL-6 and IL-17 and a negative correlation between the PVL and IL-17 and IFN-Y. In the all ACs, a significant positive correlation was observed between IL-2 and IL-17 and a negative correlation was detected between IL-10 and TNF-a. Only 6.25% of the Japanese patients were symptomatic carriers, compared with 41.67% of the non-Japanese patients. In conclusion, this study showed that high levels of HTLV-1 PVL was intrinsicaly associated with the development of HAM/TSP. A higher HTLV-1 PVL and IL10 levels found in non-Japanese ACs over 60 years old, which compared with the Japanese group depicts that the ethnic background may interfere in the host immune status. More researches also need to be undertaken regarding the host genetic background to better understand the low frequency of HAM/TSP in Japanese HTLV-1-infected individuals.	[Domingos, Joao Americo; Soares, Luana Silva; Bandeira, Larissa M.; Bonin, Camila Mareti; Moreira Puga, Marco Antonio; Tozetti, Ines Aparecida; Coimbra Motta-Castro, Ana Rita; da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil; [Vicente, Ana C. P.; Zanella, Louise] Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Coimbra Motta-Castro, Ana Rita; da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Motta-Castro, ARC (corresponding author), Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.; Motta-Castro, ARC (corresponding author), Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.	anacastro@fiocruz.br	motta-castro, ana rita c/O-2075-2017; Soares, Luana/AAL-1909-2020; Zanella, Louise/AAT-2292-2021	Soares, Luana/0000-0001-5924-1691; Zanella, Louise/0000-0001-8891-6002; Bandeira, Larissa/0000-0003-1015-0187; Tozetti, Ines/0000-0003-3936-8729; Motta-Castro, Ana Rita/0000-0003-3070-1337				Aggarwal S, 2016, J LEUKOCYTE BIOL, V71, P1; Annunziato F, 2010, EUR J IMMUNOL, V40, P3312, DOI 10.1002/eji.201041145; Araujo AQC, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0459-0; Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Bandeira LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003691; Starling ALB, 2015, BIOMARKERS, V20, P502, DOI 10.3109/1354750X.2015.1094141; Starling ALB, 2013, ACTA TROP, V125, P75, DOI 10.1016/j.actatropica.2012.09.012; Furtado MDBS, 2012, J MED VIROL, V84, P664, DOI 10.1002/jmv.23227; Brito-Melo GEA, 2007, CLIN EXP IMMUNOL, V147, P35, DOI 10.1111/j.1365-2249.2006.03252.x; Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001; Casseb J, 2008, CLIN INFECT DIS, V47, P728, DOI 10.1086/590969; Catalan-Soares BC., 2001, REV BRAS EPIDEMIOL, V4, P81, DOI [10.1590/S1415-790X2001000200003, DOI 10.1590/S1415-790X2001000200003]; Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027; Costa-Silva MF, 2014, MOL IMMUNOL, V57, P74, DOI 10.1016/j.molimm.2013.08.008; Dias GAD, 2016, MICROB PATHOGENESIS, V92, P72, DOI 10.1016/j.micpath.2015.11.018; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; Demontis MA, 2013, AIDS RES HUM RETROV, V29, P359, DOI [10.1089/AID.2012.0132, 10.1089/aid.2012.0132]; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Espindola OM, 2015, INTERVIROLOGY, V58, P106, DOI 10.1159/000371766; Fuzii HT, 2014, LIFE SCI, V104, P9, DOI 10.1016/j.lfs.2014.03.025; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173, DOI 10.1056/NEJM199304223281608; Hollsberg P, 1999, MICROBIOL MOL BIOL R, V63, P308; Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848; Jeffery KJM, 2000, J IMMUNOL, V165, P7278, DOI 10.4049/jimmunol.165.12.7278; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kubota R, 1998, J IMMUNOL, V161, P482; LAGRENADE L, 1990, LANCET, V336, P1345; LAL RB, 1991, BLOOD, V78, P571; Lin HH, 2014, GENOMICS, V104, P490, DOI 10.1016/j.ygeno.2014.10.003; Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011; Mariette X, 2000, CLIN EXP RHEUMATOL, V18, P341; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Montanheiro PA, 2009, SCAND J IMMUNOL, V70, P403, DOI 10.1111/j.1365-3083.2009.02291.x; Nishimura M, 2003, HUM IMMUNOL, V64, P453, DOI 10.1016/S0198-8859(02)00829-7; NISHIOKA K, 1989, LANCET, V1, P441; Nishiura Y, 1996, TOHOKU J EXP MED, V179, P227, DOI 10.1620/tjem.179.227; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010; Osame M, 1997, J NEUROVIROL, V3, pS50; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; Pinto MT, 2012, REV INST MED TROP SP, V54, P123, DOI 10.1590/S0036-46652012000300002; Pique C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00378; Puccioni-Sohler M, 2001, NEUROLOGY, V57, P725, DOI 10.1212/WNL.57.4.725; Quaresma JAS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010005; Grassi MFR, 2011, J MED VIROL, V83, P1269, DOI 10.1002/jmv.22087; Rosadas C, 2013, J VIROL METHODS, V193, P536, DOI 10.1016/j.jviromet.2013.07.040; ROWE P., 2007, ESSENCIAL STAT PHAMA, P364; Santos S.B., 2009, GAZ MED BAHIA, V79, P11; Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7; Santos SB, 2012, J MED VIROL, V84, P1809, DOI 10.1002/jmv.23341; Sarkis S, 2013, J CLIN VIROL, V58, P295, DOI 10.1016/j.jcv.2013.05.006; Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46; Shirdel A, 2013, IRAN J BASIC MED SCI, V16, P258; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; Talledo M, 2010, J MED VIROL, V82, P460, DOI 10.1002/jmv.21675; Tanajura D, 2015, CLIN INFECT DIS, V61, P49, DOI 10.1093/cid/civ229; Taylor GP., 2015, CLIN INFECT DIS ADV, V01, P1; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; Trevino A, 2013, J NEUROL, V260, P2551, DOI 10.1007/s00415-013-7014-z; UMEHARA F, 1994, J NEUROPATH EXP NEUR, V53, P72, DOI 10.1097/00005072-199401000-00009; Vakili R, 2013, IRAN J BASIC MED SCI, V16, P268; Vallinoto ACR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/804167; VILLIGER PM, 1991, J IMMUNOL, V146, P550; WALTON GW, 1993, J UROLOGY, V150, P930, DOI 10.1016/S0022-5347(17)35652-5; Watanabe T, 2011, INT J HEMATOL, V94, P430, DOI 10.1007/s12185-011-0934-4; Yasuma K, 2016, J NEUROVIROL, V22, P416, DOI 10.1007/s13365-015-0407-2	69	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174869	10.1371/journal.pone.0174869	http://dx.doi.org/10.1371/journal.pone.0174869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376092	Green Submitted, gold, Green Published			2022-12-26	WOS:000399352000023
J	Vrielink, ASO; Vance, TDR; de Jong, AM; Davies, PL; Voets, IK				Vrielink, Anneloes S. Oude; Vance, Tyler D. R.; de Jong, Arthur M.; Davies, Peter L.; Voets, Ilja K.			Unusually high mechanical stability of bacterial adhesin extender domains having calcium clamps	PLOS ONE			English	Article							SINGLE-MOLECULE FORCE; MARINE BACTERIUM; PROTEIN; BONDS; SPECTROSCOPY; ISOPEPTIDE; PILI; ICE; MODULES; TITIN	To gain insight into the relationship between protein structure and mechanical stability, single molecule force spectroscopy experiments on proteins with diverse structure and topology are needed. Here, we measured the mechanical stability of extender domains of two bacterial adhesins MpAFP and MhLap, in an atomic force microscope. We find that both proteins are remarkably stable to pulling forces between their N-and C-terminal ends. At a pulling speed of 1 mu m/s, the MpAFP extender domain fails at an unfolding force F-u = 348 +/- 37 pN and MhLap at F-u = 306 +/- 51 pN in buffer with 10 mM Ca2+. These forces place both extender domains well above the mechanical stability of many other beta-sandwich domains in mechanostable proteins. We propose that the increased stability of MpAFP and MhLap is due to a combination of both hydrogen bonding between parallel terminal strands and intramolecular coordination of calcium ions.	[Vrielink, Anneloes S. Oude; de Jong, Arthur M.; Voets, Ilja K.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Vrielink, Anneloes S. Oude; Voets, Ilja K.] Eindhoven Univ Technol, Dept Chem Engn & Chem, Lab Macromol & Organ Chem, Eindhoven, Netherlands; [Vance, Tyler D. R.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [de Jong, Arthur M.] Eindhoven Univ Technol, Dept Appl Phys, Lab Mol Biosensing Med Diagnost, Eindhoven, Netherlands; [Voets, Ilja K.] Eindhoven Univ Technol, Dept Chem Engn & Chem, Lab Phys Chem, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Queens University - Canada; Eindhoven University of Technology; Eindhoven University of Technology	Voets, IK (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.; Voets, IK (corresponding author), Eindhoven Univ Technol, Dept Chem Engn & Chem, Lab Macromol & Organ Chem, Eindhoven, Netherlands.; Voets, IK (corresponding author), Eindhoven Univ Technol, Dept Chem Engn & Chem, Lab Phys Chem, Eindhoven, Netherlands.	I.voets@tue.nl	Voets, Ilja/E-3604-2014; Voets, Ilja/AAG-7502-2021	Voets, Ilja/0000-0003-3543-4821; Voets, Ilja/0000-0003-3543-4821	CIHR [106612]; NSERC (discovery grant) [RGPIN-2016-04810]; European Union (ERC-2014-StG) [635928]; Dutch Ministry of Education, Culture and Science [024.001.035]	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC (discovery grant)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union (ERC-2014-StG); Dutch Ministry of Education, Culture and Science	This work was supported by CIHR (operating grant 106612); NSERC (discovery grant RGPIN-2016-04810); European Union (ERC-2014-StG Contract No. 635928); and Dutch Ministry of Education, Culture and Science (Gravity Program 024.001.035). The funders had no role in study de sign, data collect ion and analysis, decision to publish, or preparation of the manuscript.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07; Cao Y, 2006, ANGEW CHEM, V118, P658; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez Mariano, 2006, V10, P163; Chyan CL, 2004, BIOPHYS J, V87, P3995, DOI 10.1529/biophysj.104.042754; Cieplak M., 2007, J PHYS CONDENS MATT, V19; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dufrene YF, 2015, TRENDS MICROBIOLOGY; Echelman DJ, 2016, P NATL ACAD SCI USA, V113, P2490, DOI 10.1073/pnas.1522946113; El-Kirat-Chatel S, 2014, ACS CHEM BIOL, V9, P485, DOI 10.1021/cb400794e; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Grimaud R, 2012, J BACTERIOL, V194, P3539, DOI 10.1128/JB.00500-12; Guo SQ, 2013, FEBS J, V280, P5919, DOI 10.1111/febs.12518; Guo SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048805; Guzman DL, 2010, P NATL ACAD SCI USA, V107, P1989, DOI 10.1073/pnas.0905796107; Hoffmann T, 2013, PHYS CHEM CHEM PHYS, V15, P15767, DOI 10.1039/c3cp52142g; Hoffmann T, 2012, CHEM SOC REV, V41, P4781, DOI 10.1039/c2cs35033e; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klein B, 2010, BIOTECHNOL BIOENG, V105, P461, DOI 10.1002/bit.22577; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lv C, 2014, NATURE COMMUNICATION, V5; Ramanujam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094513; Rounsevell R, 2004, METHODS, V34, P100, DOI 10.1016/j.ymeth.2004.03.007; Sikora M, 2011, NUCLEIC ACIDS RES, V39, pD443, DOI 10.1093/nar/gkq851; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vance TDR, 2014, BIOSCIENCE REP, V34, P357, DOI 10.1042/BSR20140083; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174682	10.1371/journal.pone.0174682	http://dx.doi.org/10.1371/journal.pone.0174682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376122	Green Submitted, Green Published, gold			2022-12-26	WOS:000399352000015
J	Ho, CH; Tsai, SF				Ho, Ching-Huang; Tsai, Shih-Feng			Functional and biochemical characterization of a T cell-associated anti-apoptotic protein, GIMAP6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; P-TYPE ATPASES; GTPASE ACTIVITIES; HUMAN ORTHOLOG; ATP-BINDING; IAN FAMILY; ACTIVATION; EXPRESSION; DEATH; DIFFERENTIATION	GTPases of immunity-associated proteins (GIMAPs) are expressed in lymphocytes and regulate survival/death signaling and cell development within the immune system. We found that human GIMAP6 is expressed primarily in T cell lines. By sorting human peripheral blood mononuclear cells and performing quantitative RT-PCR, GIMAP6 was found to be expressed in CD3+ cells. In Jurkat cells that had been knocked down for GIMAP6, treatment with hydrogen peroxide, FasL, or okadaic acid significantly increased cell death/apoptosis. Exogenous expression of GMAP6 protected Huh-7 cells from apoptosis, suggesting that GIMAP6 is an anti-apoptotic protein. Furthermore, knockdown of GIMAP6 not only rendered Jurkat cells sensitive to apoptosis but also accelerated T cell activation under phorbol 12-myristate 13-acetate/ionomycin treatment conditions. Using this experimental system, we also observed a down-regulation of p65 phosphorylation (Ser-536) in GIMAP6 knockdown cells, indicating that GIMAP6 might display antiapoptotic function through NF-kappa B activation. The conclusion from the study on cultured T cells was corroborated by the analysis of primary CD3+ T cells, showing that specific knockdown of GIMAP6 led to enhancement of phorbol 12-myristate 13-acetate/ionomycin-mediated activation signals. To characterize the biochemical properties of GIMAP6, we purified the recombinant GIMAP6 to homogeneity and revealed that GIMAP6 had ATPase as well as GTPase activity. We further demonstrated that the hydrolysis activity of GIMAP6 was not essential for its anti-apoptotic function inHuh-7cells. Combining the expression data, biochemical properties, and cellular features, we conclude that GIMAP6 plays a role in modulating immune function and that it does this by controlling cell death and the activation of T cells.	[Ho, Ching-Huang; Tsai, Shih-Feng] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Ho, Ching-Huang; Tsai, Shih-Feng] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli 350, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Tsai, SF (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.; Tsai, SF (corresponding author), Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan.; Tsai, SF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli 350, Taiwan.	petsai@nhri.org.tw			Intramural Grant of the National Health Research Institutes, Taiwan [MG-105-PP-01]; Taiwan's Ministry of Health and Welfare [106-0324-01-10-05, 106-0324-01-10-07]	Intramural Grant of the National Health Research Institutes, Taiwan; Taiwan's Ministry of Health and Welfare	This work was supported by Intramural Grant MG-105-PP-01 of the National Health Research Institutes, Taiwan, and two extramural grants from Taiwan's Ministry of Health and Welfare (106-0324-01-10-05 and Advance Medical Plan 106-0324-01-10-07). The authors declare that they have no conflicts of interest with the contents of this article.	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; BREITMAN TR, 1980, EXP CELL RES, V126, P494, DOI 10.1016/0014-4827(80)90296-7; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Cambot M, 2002, BLOOD, V99, P3293, DOI 10.1182/blood.V99.9.3293; Datta P, 2017, EUR J IMMUNOL, V47, P84, DOI 10.1002/eji.201646599; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Filen JJ, 2009, MOL CELL PROTEOMICS, V8, P32, DOI 10.1074/mcp.M800139-MCP200; GALLAGHER R, 1979, BLOOD, V54, P713; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Heinonen MT, 2015, IMMUNOL CELL BIOL, V93, P158, DOI 10.1038/icb.2014.86; Hildeman DA, 2003, P NATL ACAD SCI USA, V100, P15035, DOI 10.1073/pnas.1936213100; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Kadare G, 1996, J VIROL, V70, P8169; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Krucken J, 2005, J CELL BIOCHEM, V96, P339, DOI 10.1002/jcb.20552; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kuhlbrandt W, 1998, CURR OPIN STRUC BIOL, V8, P510, DOI 10.1016/S0959-440X(98)80130-9; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Moore-Carrasco R, 2009, ANTICANCER RES, V29, P1315; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Park J, 2001, J MOL BIOL, V307, P929, DOI 10.1006/jmbi.2001.4526; Pascall JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077782; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SATISHCHANDRAN C, 1992, BIOCHEMISTRY-US, V31, P11684, DOI 10.1021/bi00162a003; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Schmitz I, 2003, J IMMUNOL, V171, P2930, DOI 10.4049/jimmunol.171.6.2930; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Sharma S, 2002, J IMMUNOL, V169, P3120, DOI 10.4049/jimmunol.169.6.3120; Shiao YM, 2008, LUNG CANCER, V62, P287, DOI 10.1016/j.lungcan.2008.03.021; Stamm O, 2002, GENE, V282, P159, DOI 10.1016/S0378-1119(01)00837-X; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Sugimoto K, 1998, BLOOD, V91, P1407, DOI 10.1182/blood.V91.4.1407; Uno T, 2010, BIOL LETTERS, V6, P379, DOI 10.1098/rsbl.2009.0878; URITANI M, 1988, J BIOCHEM-TOKYO, V103, P522, DOI 10.1093/oxfordjournals.jbchem.a122302; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webb LMC, 2016, J IMMUNOL, V196, P207, DOI 10.4049/jimmunol.1501582; Weiss Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-400; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200; Zenz T, 2004, GENES IMMUN, V5, P109, DOI 10.1038/sj.gene.6364044	55	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9305	9319		10.1074/jbc.M116.768689	http://dx.doi.org/10.1074/jbc.M116.768689			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381553	hybrid, Green Published			2022-12-26	WOS:000402538900025
J	Arnold, D; Tomaschek, F; Sering, K; Lopez, F; Baayen, RH				Arnold, Denis; Tomaschek, Fabian; Sering, Konstantin; Lopez, Florence; Baayen, R. Harald			Words from spontaneous conversational speech can be recognized with human-like accuracy by an error-driven learning algorithm that discriminates between meanings straight from smart acoustic features, bypassing the phoneme as recognition unit	PLOS ONE			English	Article							MODEL; REPRESENTATION; ACQUISITION; LANGUAGE; SPARSE; SIGNAL	Sound units play a pivotal role in cognitive models of auditory comprehension. The general consensus is that during perception listeners break down speech into auditory words and subsequently phones. Indeed, cognitive speech recognition is typically taken to be computationally intractable without phones. Here we present a computational model trained on 20 hours of conversational speech that recognizes word meanings within the range of human performance (model 25%, native speakers 20-44%), without making use of phone or word form representations. Our model also generates successfully predictions about the speed and accuracy of human auditory comprehension. At the heart of the model is a 'wide' yet sparse two-layer artificial neural network with some hundred thousand input units representing summaries of changes in acoustic frequency bands, and proxies for lexical meanings as output units. We believe that our model holds promise for resolving longstanding theoretical problems surrounding the notion of the phone in linguistic theory.	[Arnold, Denis; Tomaschek, Fabian; Sering, Konstantin; Lopez, Florence; Baayen, R. Harald] Eberhard Karls Univ Tubingen, Quantitat Linguist, Seminar Sprachwissensch, Tubingen, Germany; [Arnold, Denis] Inst Deutsch Sprache, Mannheim, Germany	Eberhard Karls University of Tubingen; Institut fur Deutsche Sprache (IDS)	Arnold, D (corresponding author), Eberhard Karls Univ Tubingen, Quantitat Linguist, Seminar Sprachwissensch, Tubingen, Germany.; Arnold, D (corresponding author), Inst Deutsch Sprache, Mannheim, Germany.	denis.arnold@uni-tuebingen.de		Baayen, Harald/0000-0003-3178-3944; Arnold, Denis/0000-0003-0540-3872	Alexander von Humboldt Chair	Alexander von Humboldt Chair	This paper was funded by the Alexander von Humboldt Chair awarded to R. H. Baayen.	[Anonymous], 2021, LANG ENV STAT COMP; Arnold D., 2017, ACOUSTICNDLCODER COD; Baayen H., 2005, CORPUS LINGUIST LING, V1       (2), P183, DOI [10.1515/cllt.2005.1.2.183, DOI 10.1515/CLLT.2005.1.2.183]; Baayen H, 2017, J MEM LANG, V94, P206, DOI 10.1016/j.jml.2016.11.006; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Baayen RH, 2015, COMPREHENSION SEGMEN; BROAD DJ, 1970, J ACOUST SOC AM, V47, P1572, DOI 10.1121/1.1912090; Brockwell P.J., 1991, TIME SERIES DATA ANA, Vsecond; Burgess C, 1998, COGNITIVE DYNAMICS C, P117; Charniak E., 1993, STAT LANGUAGE PROCES; Cucchiarini C., 2003, P ICPHS, P347; Cutler Anne, 2012, NATIVE LISTENING LAN; Ellis DPW, 2005, ONL WEB RES; Ernestus M, 2002, BRAIN LANG, V81, P162, DOI 10.1006/brln.2001.2514; Gaskell MG, 1996, J EXP PSYCHOL HUMAN, V22, P144, DOI 10.1037/0096-1523.22.1.144; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hannun A., 2014, ARXIV E PRINTS; Hay J, 2010, LINGUISTICS, V48, P865, DOI 10.1515/LING.2010.027; Hendrix P, 2016, NOTE 2 LAYER N UNPUB; Jackson, 1953, COMMUN THEORY, P486; Johnson Keith., 2004, SPONTANEOUS SPEECH D, P29; Junqua J.-C., 2012, ROBUSTNESS AUTOMATIC, V341; Kemps R, 2004, BRAIN LANG, V90, P117, DOI 10.1016/S0093-934X(03)00425-5; Kitaoka N, 2014, COMPUT SPEECH LANG, V28, P769, DOI 10.1016/j.csl.2013.09.009; Kohler K.J., 1990, SPEECH PRODUCTION SP, P21; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lippmann RP, 1997, SPEECH COMMUN, V22, P1, DOI 10.1016/S0167-6393(97)00021-6; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Mbu Nyamsi Ruben G., 1994, Bioacoustics, V5, P187; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Milin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171935; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Nearey T., 2003, PAPERS LAB PHONOLOGY, P197; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Nusbaum H. C., 1985, 11 IND U; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Port RF, 2005, LANGUAGE, V81, P927, DOI 10.1353/lan.2005.0195; Port RF, 2006, 2 LANGUAGE SPEECH LE; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; RAPHAEL LJ, 1972, J ACOUST SOC AM, V51, P1296, DOI 10.1121/1.1912974; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Scharenborg O, 2005, COGNITIVE SCI, V29, P867, DOI 10.1207/s15516709cog0000_37; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schweitzer A, 2013, P INT 2013 LYON; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; ten Bosch L, 2014, INTERSPEECH, P462; ten Bosch L, 2009, FUND INFORM, V90, P229, DOI 10.3233/FI-2009-0016; Tomaschek F., 2013, P INT LYON, P1302; Tomaschek F., 2014, P 10 ISSP COL, P425; Trimmer PC, 2012, J THEOR BIOL, V302, P39, DOI 10.1016/j.jtbi.2012.02.014; Tuske Z, 2014, INTERSPEECH, P890; van den Oord A., 2016, SSW; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; ZERLIN S, 1969, J ACOUST SOC AM, V46, P1011, DOI 10.1121/1.1911792	62	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174623	10.1371/journal.pone.0174623	http://dx.doi.org/10.1371/journal.pone.0174623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET0LV	28394938	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800005
J	Okumura, F; Joo-Okumura, A; Nakatsukasa, K; Kamura, T				Okumura, Fumihiko; Joo-Okumura, Akiko; Nakatsukasa, Kunio; Kamura, Takumi			Hypoxia-inducible factor-2a stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2	PLOS ONE			English	Article							PROLYL HYDROXYLATION; CELL CARCINOMA; GENE-EXPRESSION; HIF-ALPHA; COMPLEX; BINDING; FAMILY; CANCER; DESTRUCTION; PROTEOLYSIS	Ubiquitin ligase von Hippel-Lindau tumor suppressor (pVHL) negatively regulates protein levels of hypoxia-inducible factor-alpha (HIF-alpha). Loss of pVHL causes HIF-alpha accumulation, which contributes to the pathogenesis of von Hippel-Lindau (VHL) disease. In contrast, v-Myb avian myeloblastosis viral oncogene homolog-like 2 (MYBL2; B-Myb), a transcription factor, prevents VHL pathogenesis by regulating gene expression of HIF-independent pathways. Both HIF-alpha and B-Myb are targets of pVHL-mediated polyubiquitination and proteasomal degradation. Here, we show that knockdown of HIF-2 alpha induces downregulation of BMyb in 786-O cells, which are deficient in pVHL, and this downregulation is prevented by proteasome inhibition. In the presence of pVHL and under hypoxia-like conditions, B-Myb and HIF-2 alpha are both upregulated, and the upregulation of B-Myb requires expression of HIF-2 alpha. We also show that HIF-2 alpha and B-Myb interact in the nucleus, and this interaction is mediated by the central region of HIF-2 alpha and the C-terminal region of B-Myb. These data indicate that oncogenic HIF-2 alpha stabilizes B-Myb to suppress VHL pathogenesis.	[Okumura, Fumihiko; Joo-Okumura, Akiko; Nakatsukasa, Kunio; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi, Japan	Nagoya University	Okumura, F; Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi, Japan.	okumura.fumihiko@a.mbox.nagoya-u.ac.jp; z47617a@nucc.cc.nagoya-u.ac.jp			Japan society for the promotion of science (JSPS) KAKENHI [25291023, 25860043, 24112006, 15K14474, 25870312, 15K18503, 13J40160]; Uehara Memorial Foundation; Inamori Foundation	Japan society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Inamori Foundation	This work was supported by the Japan society for the promotion of science (JSPS) KAKENHI Grant Numbers 25291023 (to F.O. and T. K.), 25860043 (to F.O.), 24112006 and 15K14474 (to T.K.), 25870312 and 15K18503 (to K.N.), 13J40160 (to A.J.O), and the Uehara Memorial Foundation (to F.O.) and the Inamori Foundation (to F.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Khatua S, 2003, CANCER RES, V63, P1865; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Liu MY, 2003, CANCER RES, V63, P2675; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Okumura F, 2016, MOL CELL BIOL; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Oppici E, 2015, BBA-PROTEINS PROTEOM, V1854, P1212, DOI 10.1016/j.bbapap.2014.12.029; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Ryther RCC, 2004, ENDOCRINOLOGY, V145, P2988, DOI 10.1210/en.2003-1724; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175593	10.1371/journal.pone.0175593	http://dx.doi.org/10.1371/journal.pone.0175593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394947	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800044
J	Pan, CL; Li, QF; Lu, YQ; Zhang, JP; Yang, XM; Li, XQ; Li, LH; Liu, WH				Pan, Cuili; Li, Qingfeng; Lu, Yuqing; Zhang, Jinpeng; Yang, Xinming; Li, Xiuquan; Li, Lihui; Liu, Weihua			Chromosomal localization of genes conferring desirable agronomic traits from Agropyron cristatum chromosome 1P	PLOS ONE			English	Article							TRITICUM-AESTIVUM L; ADDITION LINES; MOLECULAR MARKERS; BREAD WHEAT; DURUM-WHEAT; IDENTIFICATION; TRANSLOCATION; RESISTANCE; 6P; GENOME	Agropyron cristatum (L.) Gaertn. (2n = 4x = 28, PPPP), a wild relative of common wheat, possesses many potentially valuable genes for wheat breeding. To transfer these genes into wheat, a series of wheat-A. cristatum derivatives have been obtained in our laboratory. In this study, a wheat-A. cristatum derivative II-3-1 was obtained, which was proven to contain a 1P (1A) disomic substitution and 2P disomic addition line with 40 wheat chromosomes and two pairs of A. cristatum chromosomes by genomic in situ hybridization (GISH) and molecular markers analysis. By further backcrossing with the wheat parent Fukuhokomugi (Fukuho) and self-fertilization, three different lines were separated from II-3-1, including wheat-A. cristatum 1P disomic addition line II-3-1a, 2P disomic addition line II-3-1b and 1P (1A) disomic substitution line II-3-1c. Because 2P addition line had been reported before, we aimed to investigate 1P disomic addition line II-3-1a and wheat-A. cristatum 1P (1A) disomic substitution line II-3-1c. Analysis of different genetic populations demonstrated that 1P chromosome harbored multiple agronomic traits, such as elevated spike length, increased tillering ability, reduced plant height and spikelet density. Besides, bristles on the glume ridges as an important morphological marker was located on 1P chromosome. Therefore, the novel 1P addition and substitution lines will be used as important genetic materials to widen the genetic resources of wheat.	[Pan, Cuili; Li, Qingfeng; Lu, Yuqing; Zhang, Jinpeng; Yang, Xinming; Li, Xiuquan; Li, Lihui; Liu, Weihua] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China; [Li, Qingfeng] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Northwest A&F University - China	Li, LH; Liu, WH (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing, Peoples R China.	lilihui@caas.cn; liuweihua@caas.cn			National Key Technology Support Program of China [2013BAD01B02]; National Natural Science Foundation of China [31271714]; National Key Research and Development Program of China [2016YFD0100102, 2016YFD0100302]	National Key Technology Support Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was funded by the National Key Technology Support Program of China (No.2013BAD01B02) [http://www.most.gov.cn/kjjh/gjkjjh/] to LHL; the National Natural Science Foundation of China (No. 31271714), [http://www.most.gov.cn/kjjh/gjkjjh/] to YQL; and the National Key Research and Development Program of China (2016YFD0100102) [http://www.most.gov.cn/kjjh/gjkjjh/] to WHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was funded by the National Key Research and Development Program of China (2016YFD0100102 and 2016YFD0100302).	AHMAD F, 1991, PLANT BREEDING, V106, P275, DOI 10.1111/j.1439-0523.1991.tb00512.x; ANAMTHAWATJONSSON K, 1995, GENOME, V38, P814, DOI 10.1139/g95-104; Bayat H, 2016, ARCH AGRON SOIL SCI, V62, P769, DOI 10.1080/03650340.2015.1094182; BLANCO A, 1987, THEOR APPL GENET, V74, P328, DOI 10.1007/BF00274714; CHEN Q, 1990, GENOME, V33, P663, DOI 10.1139/g90-098; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dewey DR, 1984, GENOMIC SYSTEM CLASS; Dobrovolskaya OB, 2009, RUSS J GENET+, V45, P1368, DOI 10.1134/S1022795409110118; Du WL, 2013, MOL BREEDING, V31, P879, DOI 10.1007/s11032-013-9841-0; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Han HM, 2017, PLANTA, V245, P425, DOI 10.1007/s00425-016-2616-1; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; ISLAM AKMR, 1981, GENET RES, V37, P215, DOI 10.1017/S0016672300020188; Jauhar PP, 2006, PLANT BREEDING, V125, P19, DOI 10.1111/j.1439-0523.2006.01176.x; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; LARKIN PJ, 1995, GENOME, V38, P385, DOI 10.1139/g95-050; Li GR, 2016, PLANTA, V244, P865, DOI 10.1007/s00425-016-2554-y; Li HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145928; Li L.H., 1997, ACTA GENET SIN, V24, P154; LI LH, 1991, THEOR APPL GENET, V81, P312, DOI 10.1007/BF00228669; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li QF, 2016, CROP SCI, V56, P2390, DOI 10.2135/cropsci2015.10.0638; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; Lin ZS, 2006, PLANT BREEDING, V125, P114, DOI 10.1111/j.1439-0523.2006.01167.x; Liu Shu-hui, 2008, Xibei Zhiwu Xuebao, V28, P1554; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Lu MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159577; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; Mullan DJ, 2005, GENOME, V48, P811, DOI 10.1139/g05-040; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Ren TH, 2009, EUPHYTICA, V169, P207, DOI 10.1007/s10681-009-9924-5; Schneider A, 2016, THEOR APPL GENET, V129, P1045, DOI 10.1007/s00122-016-2682-6; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Song LQ, 2016, THEOR APPL GENET, V129, P1023, DOI 10.1007/s00122-016-2680-8; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Sourdille P, 1998, HEREDITAS, V128, P41, DOI 10.1111/j.1601-5223.1998.00041.x; Taketa S, 2001, BREEDING SCI, V51, P199, DOI 10.1270/jsbbs.51.199; Uhrin A, 2012, EUPHYTICA, V186, P45, DOI 10.1007/s10681-011-0483-1; VILLAREAL RL, 1991, PLANT BREEDING, V106, P77, DOI 10.1111/j.1439-0523.1991.tb00482.x; Wang YH, 2016, J GENET GENOMICS, V43, P45, DOI 10.1016/j.jgg.2015.10.004; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Wu M, 2010, EUPHYTICA, V172, P363, DOI 10.1007/s10681-009-0033-2; Ye XL, 2015, THEOR APPL GENET, V128, P797, DOI 10.1007/s00122-015-2466-4; Zhang J, 2016, PLANTA, V244, P853, DOI 10.1007/s00425-016-2550-2; Zhang JP, 2015, GENOMICS, V106, P129, DOI 10.1016/j.ygeno.2015.04.003	47	10	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175265	10.1371/journal.pone.0175265	http://dx.doi.org/10.1371/journal.pone.0175265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394901	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800023
J	Hsu, CH; Soong, K				Hsu, Chia-Hsuan; Soong, Keryea			Mechanisms causing size differences of the land hermit crab Coenobita rugosus among eco-islands in Southern Taiwan	PLOS ONE			English	Article							COMMERCIAL PENAEID PRAWNS; BODY-SIZE; BEHAVIORAL ECOLOGY; GROWTH; POPULATIONS; PREDATION; RESOURCE; DISTRIBUTIONS; QUEENSLAND; CARNIVORES	Numerous environmental factors can influence body size. Comparing populations in different ecological contexts is one potential approach to elucidating the most critical of such factors. In the current study, we found that the body size of the land hermit crab Coenobita rugosus was significantly larger on Dongsha Island in the South China Sea than on other eco-islands around Southern Taiwan. We hypothesized that this could be due to differences in (1) shell resources, (2) parasite impact, (3) competition, (4) predation, and (5) food. We found no supporting evidence for the first three hypotheses; the shells used by the hermit crabs on Dongsha were in poorer condition than were those used elsewhere, extremely few individuals in the region had ectoparasites, and the density of hermit crabs varied considerably among localities within each island. However, significantly higher percentages of C. rugosus reached age 3 years on Dongsha than at Siziwan bay in Taiwan. Two growth rate indices inferred from size structures suggested faster growth on Dongsha than at Siziwan. The condition index (i. e., the body mass/shield length ratio of C. rugosus) was also greater on Dongsha than at Siziwan. Therefore, Dongsha hermit crabs seem to have superior diet and growth performance. Seagrass debris accumulation at the shore of Dongsha was considerable, whereas none was observed at Siziwan or on the other islands, where dicot leaves were the dominant food item for the vegetarian hermit crabs. We then experimentally evaluated the possible role of seagrass as food for C. rugosus. The crabs on Dongsha preferred seagrass to dicot leaves, and their growth increment was faster when they fed on seagrass than when they fed on dicot leaves; no such differences were found in the Siziwan hermit crabs. The aforementioned results are compatible with the food hypothesis explaining the size differences among the islands. The predator hypothesis could explain the greater life span but not the other findings. Populations of C. rugosus on islands with seagrass debris piles probably contribute more to the gene pool of the species because higher proportions of these populations could achieve high fecundity. The fate of these terrestrial hermit crabs may rely on the health of underwater seagrass ecosystems that are under threat from global change.	[Hsu, Chia-Hsuan; Soong, Keryea] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan	National Sun Yat Sen University	Soong, K (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	keryea@gmail.com		Soong, Keryea/0000-0002-4371-7103; Hsu, Chia-Hsuan/0000-0002-5128-5902	Marine National Park for a graduate-student fellowship; Ministry of Science and Technology, Taiwan, through Asian-Pacific Ocean Research Center of National SunYat-sen University [105-2811-M-110-001]; Asian Pacific Ocean Research Center; National Sun Yat-senUniversity, Taiwan	Marine National Park for a graduate-student fellowship; Ministry of Science and Technology, Taiwan, through Asian-Pacific Ocean Research Center of National SunYat-sen University; Asian Pacific Ocean Research Center; National Sun Yat-senUniversity, Taiwan	The authors would like to thank Marine National Park for a graduate-student fellowship to CH. Financial support from Ministry of Science and Technology, Taiwan, 105-2811-M-110-001, http:// web1.most.gov.tw/ROC, through Asian-Pacific Ocean Research Center of National SunYat-sen University to KS made this study possible; Asian Pacific Ocean Research Center, National Sun Yat-senUniversity, Taiwan, No grantnumber, http://top.nsysu.edu.tw/files/13-1201-40630.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2007, J ANIM ECOL, V76, P289, DOI 10.1111/j.1365-2656.2007.01210.x; ALEXANDER HGL, 1979, PHILOS T ROY SOC B, V286, P241, DOI 10.1098/rstb.1979.0031; Amarillo-Suarez AR, 2011, ECOL EVOL, V1, P1, DOI 10.1002/ece3.1; Barber I, 2008, BEHAVIOUR, V145, P647, DOI 10.1163/156853908792451403; Barnes DKA, 2005, MAR BIOL, V146, P625, DOI 10.1007/s00227-004-1451-2; Barnes DKA, 2003, MAR BIOL, V142, P549, DOI 10.1007/s00227-002-0968-5; Barnes DKA, 2002, FUNCT ECOL, V16, P714, DOI 10.1046/j.1365-2435.2002.00677.x; BERTNESS MD, 1981, CRUSTACEANA, V40, P197, DOI 10.1163/156854081X00598; BERTNESS MD, 1982, J EXP MAR BIOL ECOL, V64, P159, DOI 10.1016/0022-0981(82)90151-4; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; BOUDREAU PR, 1989, CAN J FISH AQUAT SCI, V46, P614, DOI 10.1139/f89-078; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Buck TL, 2003, J EXP MAR BIOL ECOL, V292, P103, DOI 10.1016/S0022-0981(03)00146-1; CHILDRESS JR, 1972, ECOLOGY, V53, P960, DOI 10.2307/1934316; COLES RG, 1987, AUST J MAR FRESH RES, V38, P103; Damuth J., 2005, BODY SIZE MAMMALIAN; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Elwood RW, 1995, J EXP MAR BIOL ECOL, V193, P41, DOI 10.1016/0022-0981(95)00109-3; FOTHERINGHAM N, 1976, J EXP MAR BIOL ECOL, V23, P299, DOI 10.1016/0022-0981(76)90027-7; Gause GF, 1932, Q REV BIOL, V7, P27, DOI 10.1086/394394; Green SO, 2003, B MAR SCI, V73, P443; Grudemo J, 1999, J EXP MAR BIOL ECOL, V239, P167, DOI 10.1016/S0022-0981(98)00198-1; HAZLETT B A, 1970, Zeitschrift fuer Tierpsychologie, V27, P369; HAZLETT BA, 1981, ANNU REV ECOL SYST, V12, P1, DOI 10.1146/annurev.es.12.110181.000245; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hsu C-H, 2015, TESTING MECH CAUSING; Jorgensen C, 2013, J SEA RES, V75, P8, DOI 10.1016/j.seares.2012.04.003; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kharlamenko VI, 2001, MAR ECOL PROG SER, V220, P103, DOI 10.3354/meps220103; King M, 2007, FISHERIES BIOL ASSES, P189; KUHLMANN ML, 1992, J EXP MAR BIOL ECOL, V157, P143, DOI 10.1016/0022-0981(92)90159-8; Latham ADM, 2002, MAR BIOL, V141, P1131, DOI 10.1007/s00227-002-0913-7; Lively CM, 2002, EVOL ECOL RES, V4, P219; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; McLaughlin PA, 2007, CATALOG HERMIT CRABS; Morgan BJ, 2003, J ZOOL, V259, P337, DOI 10.1017/S0952836902003291; Morrison LW, 2006, J BIOGEOGR, V33, P314, DOI 10.1111/j.1365-2699.2005.01399.x; Pechenik JA, 2015, MAR ECOL PROG SER, V529, P171, DOI 10.3354/meps11298; Peters RH, 1986, ECOLOGICAL IMPLICATI; Roche DG, 2012, AUST J ZOOL, V60, P330, DOI 10.1071/ZO12130; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Stahlschmidt ZR, 2015, COMP BIOCHEM PHYS A, V187, P1, DOI 10.1016/j.cbpa.2015.04.007; Vasilakopoulos P, 2011, ICES J MAR SCI, V68, P1525, DOI 10.1093/icesjms/fsr075; WATSON RA, 1993, AUST J MAR FRESH RES, V44, P211; Wolverton S, 2009, AM MIDL NAT, V162, P403, DOI 10.1674/0003-0031-162.2.403; Yom-Tov Y, 2003, FUNCT ECOL, V17, P323, DOI 10.1046/j.1365-2435.2003.00735.x	46	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174319	10.1371/journal.pone.0174319	http://dx.doi.org/10.1371/journal.pone.0174319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388638	Green Submitted, gold, Green Published			2022-12-26	WOS:000399375800005
J	Nilsson, A; Wahlin-Larsson, B; Kadi, F				Nilsson, Andreas; Wahlin-Larsson, Britta; Kadi, Fawzi			Physical activity and not sedentary time per se influences on clustered metabolic risk in elderly community-dwelling women	PLOS ONE			English	Article							UNITED-STATES; SITTING TIME; BREAKING; ASSOCIATION; BEHAVIOR; METAANALYSIS; PATTERNS; ADULTS	Introduction Whether amount of time spent in sedentary activities influences on clustered metabolic risk in elderly, and to what extent such an influence is independent of physical activity behavior, remain unclear. Therefore, the aim of the study was to examine cross-sectional associations of objectively assessed physical activity and sedentary behavior on metabolic risk outcomes in a sample of elderly community-dwelling women. Methods Metabolic risk outcomes including waist circumference, systolic and diastolic blood pressures, fasting levels of plasma glucose, HDL-cholesterol and triglycerides were assessed in 120 community-dwelling older women (65-70 yrs). Accelerometers were used to retrieve daily sedentary time, breaks in sedentary time, daily time in light (LPA) and moderate-to-vigorous physical activity (MVPA), and total amount of accelerometer counts. Multivariate regression models were used to examine influence of physical activity and sedentary behavior on metabolic risk outcomes including a clustered metabolic risk score. Results When based on isotemporal substitution modeling, replacement of a 10-min time block of MVPA with a corresponding time block of either LPA or sedentary activities was associated with an increase in clustered metabolic risk score (beta = 0.06 to 0.08, p < 0.05), and an increase in waist circumference (beta = 1.78 to 2.19 p < 0.01). All associations indicated between sedentary time and metabolic risk outcomes were lost once variation in total accelerometer counts was adjusted for. Conclusions Detrimental influence of a sedentary lifestyle on metabolic health is likely explained by variations in amounts of physical activity rather than amount of sedentary time per se. Given our findings, increased amounts of physical activity with an emphasis on increased time in MVPA should be recommended in order to promote a favorable metabolic health profile in older women.	[Nilsson, Andreas; Wahlin-Larsson, Britta; Kadi, Fawzi] Univ Orebro, Sch Hlth Sci, Orebro, Sweden	Orebro University	Nilsson, A (corresponding author), Univ Orebro, Sch Hlth Sci, Orebro, Sweden.	andreas.nilsson@oru.se		Nilsson, Andreas/0000-0003-3793-335X; kadi, fawzi/0000-0002-9831-0896	Swedish National Centre for Research [P2012/102, P2014-117, P2015-120]	Swedish National Centre for Research	This work was supported by grants from the Swedish National Centre for Research (P2012/102, P2014-117 and P2015-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Carr LJ, 2012, J OBES, V2012, DOI 10.1155/2012/460271; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0361-2; Keadle SK, 2016, PREV MED, V89, P37, DOI 10.1016/j.ypmed.2016.05.009; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118078; Latouche C, 2013, J APPL PHYSIOL, V114, P453, DOI 10.1152/japplphysiol.00978.2012; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Maher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086403; Pate RR, 2010, EXERCISE SPORT SCI R, V38, P105; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Schmid D, 2016, MED SCI SPORT EXER, V48, P1312, DOI 10.1249/MSS.0000000000000913; Shiroma EJ, 2013, JAMA-J AM MED ASSOC, V310, P2562, DOI 10.1001/jama.2013.278896; Strandberg E, 2015, J APPL PHYSIOL, V119, P918, DOI 10.1152/japplphysiol.00066.2015; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	34	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175496	10.1371/journal.pone.0175496	http://dx.doi.org/10.1371/journal.pone.0175496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388679	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800060
J	Nolte, L; Tinne, N; Schulze, J; Heinemann, D; Antonopoulos, GC; Meyer, H; Nothwang, HG; Lenarz, T; Heisterkamp, A; Warnecke, A; Ripken, T				Nolte, Lena; Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Antonopoulos, Georgios C.; Meyer, Heiko; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo			Scanning laser optical tomography for in toto eimaging of the murine cochlea	PLOS ONE			English	Article							AIDED 3-DIMENSIONAL RECONSTRUCTION; 3D RECONSTRUCTION; CONFOCAL MICROSCOPY; IMAGE-ANALYSIS; SECTIONS; PLATFORM; HEARING	The mammalian cochlea is a complex macroscopic structure due to its helical shape and the microscopic arrangements of the individual layers of cells. To improve the outcomes of hearing restoration in deaf patients, it is important to understand the anatomic structure and composition of the cochlea ex vivo. Hitherto, only one histological technique based on confocal laser scanning microscopy and optical clearing has been developed for in toto optical imaging of the murine cochlea. However, with a growing size of the specimen, e.g., human cochlea, this technique reaches its limitations. Here, we demonstrate scanning laser optical tomography (SLOT) as a valuable imaging technique to visualize the murine cochlea in toto without any physical slicing. This technique can also be applied in larger specimens up to cm 3 such as the human cochlea. Furthermore, immunolabeling allows visualization of inner hair cells (otoferlin) or spiral ganglion cells (neurofilament) within the whole cochlea. After image reconstruction, the 3D dataset was used for digital segmentation of the labeled region. As a result, quantitative analysis of position, length and curvature of the labeled region was possible. This is of high interest in order to understand the interaction of cochlear implants (CI) and cells in more detail.	[Nolte, Lena; Tinne, Nadine; Heinemann, Dag; Antonopoulos, Georgios C.; Meyer, Heiko; Heisterkamp, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Ind & Biomed Opt Dept, Hannover, Germany; [Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo] Cluster Excellence Hearing4all, Hannover, Germany; [Tinne, Nadine; Schulze, Jennifer; Heinemann, Dag; Nothwang, Hans Gerd; Lenarz, Thomas; Heisterkamp, Alexander; Warnecke, Athanasia; Ripken, Tammo] Cluster Excellence Hearing4all, Oldenburg, Germany; [Schulze, Jennifer; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Meyer, Heiko; Lenarz, Thomas; Heisterkamp, Alexander; Ripken, Tammo] Biofabricat NIFE, Hannover, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Neurogenet, Oldenburg, Germany; [Heisterkamp, Alexander] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany	Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Leibniz University Hannover	Nolte, L (corresponding author), Laser Zentrum Hannover eV, Ind & Biomed Opt Dept, Hannover, Germany.	l.nolte@lzh.de	Warnecke, Athanasia/HHC-6174-2022; Heinemann, Dag/AAZ-9970-2021; Heinemann, Dag/A-2861-2019; Heisterkamp, Alexander/V-5376-2017	Heinemann, Dag/0000-0003-3506-1762; Heisterkamp, Alexander/0000-0001-8770-0859; Nothwang, Hans Gerd/0000-0001-7695-6437	DFG Cluster of Excellence [EXC 1077/1]; Ministry of Lower Saxony; VolkswagenStiftung (both BIOFABRICATION FOR NIFE) [VWZN2860]	DFG Cluster of Excellence(German Research Foundation (DFG)); Ministry of Lower Saxony; VolkswagenStiftung (both BIOFABRICATION FOR NIFE)	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (https://hearing4all.eu/) and the Ministry of Lower Saxony and the VolkswagenStiftung (both BIOFABRICATION FOR NIFE: VWZN2860, http:// bidabrication.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 2010, MICROSC SCI TECHNOL, V2, P1356; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; ARIYASU L, 1989, OTOLARYNG HEAD NECK, V100, P87, DOI 10.1177/019459988910000201; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Christensen GE, 2003, ACAD RADIOL, V10, P988, DOI 10.1016/S1076-6332(03)00121-1; Coleman B, 2009, J NEUROSCI METH, V176, P144, DOI 10.1016/j.jneumeth.2008.09.007; Eaton J.W., 2021, GNU OCTAVE VERSION 6; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Hardie NA, 2004, BRAIN RES, V1000, P200, DOI 10.1016/j.brainres.2003.10.071; Heidrich M, 2011, BIOMED OPT EXPRESS, V2, P2982, DOI 10.1364/BOE.2.002982; Kawano A, 1996, ANN OTO RHINOL LARYN, V105, P701, DOI 10.1177/000348949610500906; Kellner M, 2012, J APPL PHYSIOL, V113, P975, DOI 10.1152/japplphysiol.00026.2012; Korsawe J., 2012, MATLAB CENTRAL FILE; Kraemer R., 2015, OTOLARYNGOL ONLINE J, V5, P39; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lorbeer RA, 2011, OPT EXPRESS, V19, P5419, DOI 10.1364/OE.19.005419; MacDonald GH, 2008, HEARING RES, V243, P1, DOI 10.1016/j.heares.2008.05.009; Manji SSM, 2012, AM J PATHOL, V180, P1560, DOI 10.1016/j.ajpath.2011.12.034; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; PLASSMANN W, 1987, BRAIN BEHAV EVOLUT, V30, P82, DOI 10.1159/000118639; Poznyakovskiy AA, 2008, HEARING RES, V243, P95, DOI 10.1016/j.heares.2008.06.008; Santi PA, 2009, BIOTECHNIQUES, V46, P287, DOI 10.2144/000113087; Sato M, 1999, HEARING RES, V135, P29, DOI 10.1016/S0378-5955(99)00086-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Tinne N, 2016, SPIE P, V9689; Voie AH, 2002, HEARING RES, V171, P119, DOI 10.1016/S0378-5955(02)00493-8; Voie AH, 1993, J MICROSC-OXFORD, P170; Wada H, 1998, HEARING RES, V120, P1, DOI 10.1016/S0378-5955(98)00007-0; Yoo SK, 2000, IEEE T BIO-MED ENG, V47, P1392, DOI 10.1109/10.871413; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175431	10.1371/journal.pone.0175431	http://dx.doi.org/10.1371/journal.pone.0175431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388662	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800053
J	Molli, AEI; Panero, J; Dos Santos, PC; Gonzalez, CD; Vilarino, J; Sereday, M; Cerrone, GE; Slavutsky, I; Frechtel, GD				Iglesias Molli, Andrea E.; Panero, Julieta; Dos Santos, Patricia C.; Gonzalez, Claudio D.; Vilarino, Jorge; Sereday, Marta; Cerrone, Gloria E.; Slavutsky, Irma; Frechtel, Gustavo D.			Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome	PLOS ONE			English	Article							UNHEALTHY NORMAL-WEIGHT; PERIPHERAL-BLOOD CELLS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; RISK; ASSOCIATION; STRESS; DIET; AGE	Introduction Obesity is the principal component in the Metabolic Syndrome (MetS) that determines the progression of metabolic complications. Metabolically healthy obese (MHO) individuals seem to be protected against those complications. Telomere length (TL) as a novel marker of cellular aging had a complex relationship to the MetS. The principal aim of this study was to investigate the TL in MHO, and to study the association between TL and the worsening of the metabolic condition. Material and methods We have determined the absolute TL (aTL) in 400 women (mean age of 46.76 +/- 15.47 years; range: 18-86 years), grouped according to the metabolic condition in three groups: metabolically healthy non-obese women (MHNO), MHO and obese women with MetS (MSO); and grouped according to the number of components of MetS. Results We found that MHO displays significantly higher aTL than MSO (p = 0.033; r = -4.63; 95% CI r = -8.89/-0.37), but did not differ from MHNO. A decrease in aTL with the progressive increase in the number of MetS components was also observed (p < 0.001; r = -2.06; 95% CI r = -3.13/-0.99). In this way, our results indicate that aTL is influenced by the presence of MetS, but it is not affected by the presence of obesity. Discussion We found that shorter aTL is not associated with MHO, but is related to MetS and with the increased number of metabolic abnormalities.	[Iglesias Molli, Andrea E.; Frechtel, Gustavo D.] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Lab Diabet & Metab, Buenos Aires, DF, Argentina; [Panero, Julieta; Dos Santos, Patricia C.; Slavutsky, Irma] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Lab Genet Neoplasias Linfoides, Buenos Aires, DF, Argentina; [Gonzalez, Claudio D.] Univ Buenos Aires, Fac Med, Dept Farmacol, Catedra 2, Buenos Aires, DF, Argentina; [Vilarino, Jorge] Hosp FLENI, Dept Cardiol, Buenos Aires, DF, Argentina; [Sereday, Marta] Hosp Fiorito, Serv Endocrinol, Buenos Aires, DF, Argentina; [Cerrone, Gloria E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol, Catedra Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Molli, AEI (corresponding author), Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Lab Diabet & Metab, Buenos Aires, DF, Argentina.	andrea.iglesiasmolli@gmail.com		Gonzalez, Claudio/0000-0002-3772-8850	Sanofi Aventis Laboratory	Sanofi Aventis Laboratory	This work was financially supported by an unrestricted grant of Sanofi Aventis Laboratory to Gustavo D. Frechtel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002; Gao X, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0095-9; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1749, DOI 10.1093/ije/dyv171; Mathew H, 2016, METABOLISM, V65, P73, DOI 10.1016/j.metabol.2015.10.019; Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521; Njajou OT, 2012, INT J OBESITY, V36, P1176, DOI 10.1038/ijo.2011.196; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Panero J, 2015, MOL BIOTECHNOL, V57, P155, DOI 10.1007/s12033-014-9811-8; Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188; Revesz D, 2014, J CLIN ENDOCR METAB, V99, P1; Revesz D, 2015, J CLIN ENDOCR METAB, V100, P3050, DOI 10.1210/JC.2015-1995; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Satoh H, 1996, JPN J HUM GENET, V41, P413, DOI 10.1007/BF01876332; Satoh M, 2008, ATHEROSCLEROSIS, V198, P347, DOI 10.1016/j.atherosclerosis.2007.09.040; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Shaharyar S, 2015, J OBES, V2015, DOI 10.1155/2015/178526; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Verde Z, 2015, ENVIRON RES, V140, P488, DOI 10.1016/j.envres.2015.05.008; Vilarino J, 2015, REVISTA ALAD, V4, P140; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174945	10.1371/journal.pone.0174945	http://dx.doi.org/10.1371/journal.pone.0174945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384193	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900060
J	Ludington, WB; Seher, TD; Applegate, O; Li, XD; Kliegman, JI; Langelier, C; Atwill, ER; Harter, T; DeRisi, JL				Ludington, William B.; Seher, Thaddeus D.; Applegate, Olin; Li, Xunde; Kliegman, Joseph I.; Langelier, Charles; Atwill, Edward R.; Harter, Thomas; DeRisi, Joseph L.			Assessing biosynthetic potential of agricultural groundwater through metagenomic sequencing: A diverse anammox community dominates nitrate-rich groundwater	PLOS ONE			English	Article							SHALLOW GROUNDWATER; ANAEROBIC AMMONIUM; CENTRAL VALLEY; GENERATION; OXIDATION; QUALITY; BLAST; WATER; METABOLISM; BACTERIAL	Background Climate change produces extremes in both temperature and precipitation causing increased drought severity and increased reliance on groundwater resources. Agricultural practices, which rely on groundwater, are sensitive to but also sources of contaminants, including nitrate. How agricultural contamination drives groundwater geochemistry through microbial metabolism is poorly understood. Methods On an active cow dairy in the Central Valley of California, we sampled groundwater from three wells at depths of 4.3 m (two wells) and 100 m (one well) below ground surface (bgs) as well as an effluent surface water lagoon that fertilizes surrounding corn fields. We analyzed the samples for concentrations of solutes, heavy metals, and USDA pathogenic bacteria of the Escherichia coli and Enterococcus groups as part of a long term groundwater monitoring study. Whole metagenome shotgun sequencing and assembly revealed taxonomic composition and metabolic potential of the community. Results Elevated nitrate and dissolved organic carbon occurred at 4.3m but not at 100m bgs. Metagenomics confirmed chemical observations and revealed several Planctomycete genomes, including a new Brocadiaceae lineage and a likely Planctomycetes OM190, as well novel diversity and high abundance of nano-prokaryotes from the Candidate Phyla Radiation (CPR), the Diapherotrites, Parvarchaeota, Aenigmarchaeota, Nanoarchaeota, Nanohaloarchaea (DPANN) and the Thaumarchaeota, Aigarchaeota, Crenarchaeota, Korarchaeota (TACK) superphyla. Pathway analysis suggests community interactions based on complimentary primary metabolic pathways and abundant secondary metabolite operons encoding antimicrobials and quorum sensing systems. Conclusions The metagenomes show strong resemblance to activated sludge communities from a nitrogen removal reactor at a wastewater treatment plant, suggesting that natural bioremediation occurs through microbial metabolism. Elevated nitrate and rich secondary metabolite biosynthetic capacity suggest incomplete remediation and the potential for novel pharmacologically active compounds.	[Ludington, William B.; Seher, Thaddeus D.] Univ Calif Berkeley, Mol Cell Biol Dept, Berkeley, CA 94720 USA; [Applegate, Olin; Harter, Thomas] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Li, Xunde; Atwill, Edward R.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Li, Xunde; Atwill, Edward R.] Univ Calif Davis, Western Inst Food Safety & Secur, Davis, CA 95616 USA; [Kliegman, Joseph I.; Langelier, Charles; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Seher, Thaddeus D.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Merced	Ludington, WB (corresponding author), Univ Calif Berkeley, Mol Cell Biol Dept, Berkeley, CA 94720 USA.	will.ludington@berkeley.edu	Harter, Thomas/AAB-7355-2020	Harter, Thomas/0000-0001-8526-3843; Kliegman, Joseph/0000-0002-7362-6085	California State Water Resources Control Board [03-244-555-01, 04-184-555-0, 11-168-150]; Howard Hughes Medical Institute; NIH [1DP50D017851, 5K12HL119997-04]; UC Berkeley Bowes Fellows Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017851] Funding Source: NIH RePORTER	California State Water Resources Control Board; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley Bowes Fellows Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for our research projects was provided by the late Henry "Sam" Wheeler (WBL, JIK, JLD), the California State Water Resources Control Board (swrcb.ca.gov) contracts 03-244-555-01, 04-184-555-0, and 11-168-150 (ERA, XL, OA, TH), the Howard Hughes Medical Institute (hhmi.org) (JLD), NIH (nih.gov) grant 1DP50D017851 (WBL), NIH grant 5K12HL119997-04 (CL), and the UC Berkeley Bowes Fellows Program (WBL). The funders played no role in the research.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burton CA, 2012, 20115218 CALI GAMA P, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Clark ML, 2006, WATER QUALITY CHARAC, P2006; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Hafner SC, 2016, J ENVIRON QUAL, V45, P480, DOI 10.2134/jeq2015.05.0251; Harpole WS, 2016, NATURE, V537, P93, DOI 10.1038/nature19324; Harter T, 2002, J CONTAM HYDROL, V55, P287, DOI 10.1016/S0169-7722(01)00189-9; Harter T, 2012, ADDRESSING NITRATE C, P1; Harter T, 2003, GROUNDWATER SAMPLING; Harter T, 2014, GROUNDWATER, V52, P126, DOI 10.1111/gwat.12222; Hill VR, 2005, APPL ENVIRON MICROB, V71, P6878, DOI 10.1128/AEM.71.11.6878-6884.2005; Hu ZY, 2013, APPL ENVIRON MICROB, V79, P2807, DOI 10.1128/AEM.03987-12; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jetten MSM, 2003, APPL MICROBIOL BIOT, V63, P107, DOI 10.1007/s00253-003-1422-4; Jewell TNM, 2016, ISME J, V10, P2106, DOI 10.1038/ismej.2016.25; Jurgens BC, 2010, GROUND WATER, V48, P913, DOI 10.1111/j.1745-6584.2009.00635.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kiparsky M, 2016, DESIGNING EFFECTIVE, P1; Krasnv J, 2007, GROUNDWATER FRACTURE; Laczny CC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0066-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li X, 2013, ENVIRON MONIT ASSESS, V186, P1253; Li XD, 2015, J ENVIRON QUAL, V44, P1435, DOI 10.2134/jeq2015.03.0139; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; MURTHY GK, 1967, J DAIRY SCI, V50, P818, DOI 10.3168/jds.S0022-0302(67)87527-1; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ransom KM, 2016, WATER RESOUR RES, V52, P5577, DOI 10.1002/2015WR018523; Ruby JG, 2013, PRICE SOFTWARE TARGE; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shen LD, 2014, APPL ENVIRON MICROB, V80, P7611, DOI 10.1128/AEM.02379-14; Smith MB, 2015, MBIO, V6, DOI 10.1128/mBio.00326-15; Speth DR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11172; Speth DR, 2012, FRONTIERS MICROBIOLO, V3; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Thorgersen MP, 2015, APPL ENVIRON MICROB; Unc A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010775; Villanueva L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weber T., 2015, NUCL ACIDS RES; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	61	13	13	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174930	10.1371/journal.pone.0174930	http://dx.doi.org/10.1371/journal.pone.0174930			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384184	Green Published, gold			2022-12-26	WOS:000399371900056
J	Wei, JY; Liu, GY; Liu, DB; Chen, YY				Wei, Junya; Liu, Guoyin; Liu, Debing; Chen, Yeyuan			Influence of irrigation during the growth stage on yield and quality in mango (Mangifera indica L)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; DEFICIT IRRIGATION; FRUIT-GROWTH; PHOTOSYNTHESIS; PHYSIOLOGY	Although being one of the few drought-tolerant plants, mango trees are irrigated to ensure optimum and consistent productivity in China. In order to better understand the effects of soil water content on mango yield and fruit quality at fruit growth stage, irrigation experiments were investigated and the object was to determine the soil water content criteria at which growth and quality of mango would be optimal based on soil water measured by RHD-JS water-saving irrigation system through micro-sprinkling irrigation. Five soil water content treatments (relative to the percentage of field water capacity) for irrigation (T1:79%-82%, T2:75%-78%, T3:71%-74%, T4:65%-70%, T5:63%-66%) were compared in 2013. Amount of applied irrigation water for different treatments varied from 2.93m(3) to 1.08 m(3). The results showed that mango fruit production and quality at fruit growth stage were significantly affected under different irrigation water amounts. Variation in soil water content not only had effects on fruit size, but also on fruit yield. The highest fruit yield and irrigation water use efficiency were obtained from the T4 treatment. Irrigation water amount also affected fruit quality parameters like fruit total soluble solids, soluble sugar, starch, titratable acid and vitamin C content. Comprehensive evaluation of the effect of indexs of correlation on irrigation treatment by subordinate function showed that when the soil moisture content were controlled at about 65-70% of the field water moisture capacity, water demand in the growth and development of mango could be ensured, and maximum production efficiency of irrigation and the best quality of fruit could be achieved. In conclusion, treatment T4 was the optimum irrigation schedule for growing mango, thus achieving efficient production of mango in consideration of the compromise among mango yield, fruit quality and water use efficiency.	[Wei, Junya; Liu, Guoyin; Liu, Debing] Hainan Univ, Appl Sci & Technol Coll, Haikou, Hainan, Peoples R China; [Wei, Junya; Chen, Yeyuan] Chinese Acad Trop Agr Sci, Natl Trop Fruit Improvement Ctr, Hainan Trop Fruit Cultivat Engn Technol Res Ctr, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences	Liu, DB (corresponding author), Hainan Univ, Appl Sci & Technol Coll, Haikou, Hainan, Peoples R China.	ldebing@126.com			National Nonprofit Institute Research Grant of CATAS-TCGRI [163003201206, 0315137]; Science and technology project of Hainan Province [ZDXM2015016]	National Nonprofit Institute Research Grant of CATAS-TCGRI; Science and technology project of Hainan Province	The study was conducted under the support of National Nonprofit Institute Research Grant of CATAS-TCGRI(163003201206, 0315137; Science and technology project of Hainan Province (ZDXM2015016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHBOUDIAN MH, 1994, SCI HORTIC-AMSTERDAM, V60, P89, DOI 10.1016/0304-4238(94)90064-7; BLANCO MJS, 1989, PLANT SOIL, V120, P299, DOI 10.1007/BF02377080; Cao J., 2007, EXPT GUIDANCE POSTHA; CASPARI HW, 1994, J AM SOC HORTIC SCI, V119, P383, DOI 10.21273/JASHS.119.3.383; Chen Y. Y., 2006, TROPICAL TROPICAL S; CRISOSTO CH, 1994, HORTSCIENCE, V29, P1169, DOI 10.21273/HORTSCI.29.10.1169; Doorenbos J., 1979, 24 UNFAO; Dumas Y, 2006, ACTA HORTIC, P235, DOI 10.17660/ActaHortic.2006.724.29; Huang XM, 2000, SCI HORTIC-AMSTERDAM, V83, P227, DOI 10.1016/S0304-4238(99)00083-7; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kato Y, 2009, FIELD CROP RES, V113, P328, DOI 10.1016/j.fcr.2009.06.010; Lechaudel M, 2005, J SCI FOOD AGR, V85, P251, DOI 10.1002/jsfa.1968; Liu D. B., 2012, J S CHINA FRUITS, V41, P83; Liu DB, 2011, 3RD CONFERENCE ON KEY TECHNOLOGY OF HORTICULTURE, CKTH 2011, P132; Liu Debing, 2011, S CHINA FRUITS, V40, P64; Liu G. Y., 2014, JIANGSU AGR SCI J, V42, P124; Liu H., 2008, THESIS; Liu Z.T., 2007, J CHINA TROP AGR, V1, P32; Madigu NO, 2009, ACTA HORTIC, V837, P299, DOI 10.17660/ActaHortic.2009.837.40; Nagle M, 2010, SCI HORTIC-AMSTERDAM, V125, P771, DOI 10.1016/j.scienta.2010.04.044; Pavel EW, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.646.7; Singh Z, 2005, J PLANT NUTR, V28, P1723, DOI 10.1080/01904160500250771; Spreer W, 2009, ACTA HORTIC, V820, P357; Tezara W, 2002, J EXP BOT, V53, P1781, DOI 10.1093/jxb/erf021	24	17	18	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174498	10.1371/journal.pone.0174498	http://dx.doi.org/10.1371/journal.pone.0174498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384647	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900018
J	Newman, LE; Schiavon, CR; Zhou, CJ; Kahn, RA				Newman, Laura E.; Schiavon, Cara R.; Zhou, Chengjing; Kahn, Richard A.			The abundance of the ARL2 GTPase and its GAP, ELMOD2, at mitochondria are modulated by the fusogenic activity of mitofusins and stressors	PLOS ONE			English	Article							RIBOSYLATION FACTOR FAMILY; SACCHAROMYCES-CEREVISIAE; PDE-DELTA; ENDOPLASMIC-RETICULUM; FARNESYLATED CARGO; ACTIVATING PROTEIN; DISTINCT FUNCTIONS; STRUCTURAL BASIS; MAMMALIAN-CELLS; COFACTOR-D	Mitochondria are essential, dynamic organelles that respond to a number of stressors with changes in morphology that are linked to several mitochondrial functions, though the mechanisms involved are poorly understood. We show that the levels of the regulatory GTPase ARL2 and its GAP, ELMOD2, are specifically increased at mitochondria in immortalized mouse embryo fibroblasts deleted for Mitofusin 2 (MFN2), but not MFN1. Elevated ARL2 and ELMOD2 in MEFs deleted for MFN2 could be reversed by re-introduction of MFN2, but only when the mitochondrial fragmentation in these MEFs was also reversed, demonstrating that reversal of elevated ARL2 and ELMOD2 requires the fusogenic activity of MFN2. Other stressors with links to mitochondrial morphology were investigated and several, including glucose or serum deprivation, also caused increases in ARL2 and ELMOD2. In contrast, a number of pharmacological inhibitors of energy metabolism caused increases in ARL2 without affecting ELMOD2 levels. Together we interpret these data as evidence of two ARL2-sensitive pathways in mitochondria, one affecting ATP levels that is independent of ELMOD2 and the other leading to mitochondrial fusion involving MFN2 that does involve ELMOD2.	[Newman, Laura E.; Schiavon, Cara R.; Zhou, Chengjing; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; , PEP-MX Core/AGV-4051-2022	Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X; Schiavon, Cara/0000-0002-9311-2145	National Institutes of Health [P30NS055077, 5R01GM090158, 1F31GM111047]; American Heart Association [14PRE18840040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institutes of Health [https://www.nih.gov/] P30NS055077, 5R01GM090158 to RAK, 1F31GM111047 to LEN; and the American Heart Association [http://www.heart.org/HEARTORG/] 14PRE18840040 to LEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fansa EK, 2016, SMALL GTPASES, P1; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2016, J BIOL CHEM, V291, P20766, DOI 10.1074/jbc.M116.741827; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LEE JUN BONG, 2014, [Journal of IFA, Korea, 조세학술논집], V30, P1, DOI 10.9725/kstle.2014.30.1.1; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Newman Laura E, 2016, Cell Logist, V6, pe1247939, DOI 10.1080/21592799.2016.1247939; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; STEARNS T, 1990, GENETICS, V124, P251; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Watzlich D, 2013, EMBO REP, V14, P465, DOI 10.1038/embor.2013.37; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WICK AN, 1957, J BIOL CHEM, V224, P963; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	66	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175164	10.1371/journal.pone.0175164	http://dx.doi.org/10.1371/journal.pone.0175164			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380071	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500104
J	Stratford, JK; Yan, F; Hill, RA; Major, MB; Graves, LM; Der, CJ; Yeh, JJ				Stratford, Jeran K.; Yan, Feng; Hill, Rebecca A.; Major, Michael B.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen			Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; NEGATIVE BREAST-CANCER; DUCTAL ADENOCARCINOMA; MPS1 KINASE; KINETOCHORE LOCALIZATION; MITOTIC CHECKPOINT; TPR DOMAIN; EXPRESSION; ANEUPLOIDY; PROTEIN	Pancreatic ductal adenocarcinoma, which accounts for the majority of pancreatic cancers, is a lethal disease with few therapeutic options. Genomic profiling of pancreatic ductal adenocarcinoma has identified a complex and heterogeneous landscape. Understanding the molecular characteristics of pancreatic ductal adenocarcinoma will facilitate the identification of potential therapeutic strategies. We analyzed the gene expression profiles of primary tumors from patients compared to normal pancreas and identified high co-overexpression of core components of the spindle assembly checkpoint, including the protein kinase TTK (also known as MPS-1). We found overexpression of TTK protein in a subset of pancreatic ductal adenocarcinoma primary tumors and cell lines. siRNA-mediated depletion or catalytic inhibition of TTK resulted in an aberrant cell cycle profile, multi-and micro-nucleation, induction of apoptosis, and decreased cell proliferation and transformed growth. Selective catalytic inhibition of TTK caused override of the spindle assembly checkpoint-induced cell cycle arrest. Interestingly, we identified ubiquitin specific peptidase 16 (Usp16), an ubiquitin hydrolase, as a phosphorylation substrate of TTK. Usp16 regulates chromosomal condensation and G2/M progression by deubiquitinating histone H2A and polo-like kinase 1. Phosphomimetic mutants of Usp16 show enhanced proteosomal degradation and may prolong the G2/M transition allowing for correction of replication errors. Taken together, our results suggest a critical role for TTK in preventing aneuploidyinduced cell death in pancreatic cancer.	[Stratford, Jeran K.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen] Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Stratford, Jeran K.; Hill, Rebecca A.; Major, Michael B.; Graves, Lee M.; Der, Channing J.; Yeh, Jen Jen] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yan, Feng; Major, Michael B.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Major, Michael B.] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Yeh, JJ (corresponding author), Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA.	jjyeh@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022	Der, Channing/0000-0002-7751-2747; Major, Michael/0000-0002-6753-8513; Stratford, Jeran/0000-0003-4305-1468	National Institutes of Health [R01-CA042978, R01-CA14024, T32CA071341, 5F31CA165623-02]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA193650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institutes of Health R01-CA042978 (CJD), R01-CA14024 (JJY), T32CA071341 (JKS), and 5F31CA165623-02 (JKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.14; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gotoh M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/780836; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; GOWER WR, 1994, IN VITRO CELL DEV-AN, V30A, P151, DOI 10.1007/BF02631438; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Heidenblad M, 2004, CANCER RES, V64, P3052, DOI 10.1158/0008-5472.CAN-03-3159; Hennrich ML, 2013, J PROTEOME RES, V12, P2214, DOI 10.1021/pr400074f; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang YS, 2009, LASERS ELECTRO-OPT R, P1; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jemaa M, 2013, CELL DEATH DIFFER; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kaistha BP, 2014, BRIT J CANCER, V111, P1780, DOI 10.1038/bjc.2014.460; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee S, 2012, J BIOL CHEM, V287, P5988, DOI 10.1074/jbc.M111.307355; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Maachani UB, 2015, MOL CANCER RES, V13, P852, DOI 10.1158/1541-7786.MCR-14-0462-T; Maia ARR, 2015, ANN ONCOL, V26, P2180, DOI 10.1093/annonc/mdv293; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Moskovitz AH, 2003, GENE CHROMOSOME CANC, V37, P201, DOI 10.1002/gcc.10189; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schreiner B, 2003, GENE CHROMOSOME CANC, V38, P240, DOI 10.1002/gcc.10285; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slee RB, 2014, MOL CANCER THER, V13, P307, DOI 10.1158/1535-7163.MCT-13-0324; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tannous BA, 2013, J NATL CANC I; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thykjaer T, 2001, CANCER RES, V61, P2492; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Von Hoff DD, 2014, NEW ENGL J MED, V370, P479, DOI 10.1056/NEJMc1314761; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zhuo XL, 2015, J CELL BIOL, V210, P727, DOI 10.1083/jcb.201502044	85	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174863	10.1371/journal.pone.0174863	http://dx.doi.org/10.1371/journal.pone.0174863			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380042	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500070
J	Ghatak, S; Markwald, RR; Hascall, VC; Dowling, W; Lottes, RG; Baatz, JE; Beeson, G; Beeson, CC; Perrella, MA; Thannickal, VJ; Misra, S				Ghatak, Shibnath; Markwald, Roger R.; Hascall, Vincent C.; Dowling, William; Lottes, Robyn Grayson; Baatz, John E.; Beeson, Gyada; Beeson, Craig C.; Perrella, Mark A.; Thannickal, Victor J.; Misra, Suniti			Transforming growth factor 1 (TGF1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); CD44; early growth response protein 1 (EGR1); extracellular-signal-regulated kinase (ERK); signaling	SMOOTH-MUSCLE-CELLS; SHORT-INTERFERING RNAS; NF-KAPPA-B; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN-CELLS; CANCER-CELLS; TRANSCRIPTION FACTORS; MULTIDRUG-RESISTANCE; LEVEL EXPRESSION	The appearance of myofibroblasts is generally thought to be the underlying cause of the fibrotic changes that underlie idiopathic pulmonary fibrosis. However, the cellular/molecular mechanisms that account for the fibroblast-myofibroblast differentiation/activation in idiopathic pulmonary fibrosis remain poorly understood. We investigated the functional role of hyaluronan receptor CD44V6 (CD44 containing variable exon 6 (v6)) for differentiation of lung fibroblast to myofibroblast phenotype. Increased hyaluronan synthesis and CD44 expression have been detected in numerous fibrotic organs. Previously, we found that the TGF1/CD44V6 pathway is important in lung myofibroblast collagen-1 and -smooth-muscle actin synthesis. Because increased EGR1 (early growth response-1) expression has been shown to appear very early and nearly coincident with the expression of CD44V6 found after TGF1 treatment, we investigated the mechanism(s) of regulation of CD44V6 expression in lung fibroblasts by TGF1. TGF1-mediated CD44V6 up-regulation was initiated through EGR1 via ERK-regulated transcriptional activation. We showed that TGF1-induced CD44V6 expression is through EGR1-mediated AP-1 (activator protein-1) activity and that the EGR1- and AP-1-binding sites in the CD44v6 promoter account for its responsiveness to TGF1 in lung fibroblasts. We also identified a positive-feedback loop in which ERK/EGR1 signaling promotes CD44V6 splicing and found that CD44V6 then sustains ERK signaling, which is important for AP-1 activity in lung fibroblasts. Furthermore, we identified that HAS2-produced hyaluronan is required for CD44V6 and TGFRI co-localization and subsequent CD44V6/ERK1/EGR1 signaling. These results demonstrate a novel positive-feedback loop that links the myofibroblast phenotype to TGF1-stimulated CD44V6/ERK/EGR1 signaling.	[Ghatak, Shibnath; Markwald, Roger R.; Dowling, William; Misra, Suniti] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Dowling, William] Coll Charleston, Charleston, SC 29424 USA; [Lottes, Robyn Grayson; Baatz, John E.] Med Univ South Carolina, Dept Pediat Neonatol, Charleston, SC 29425 USA; [Beeson, Gyada; Beeson, Craig C.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Perrella, Mark A.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Perrella, Mark A.] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [Perrella, Mark A.] Harvard Med Sch, Boston, MA 02115 USA; [Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	Medical University of South Carolina; Cleveland Clinic Foundation; College of Charleston; Medical University of South Carolina; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham	Ghatak, S; Misra, S (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health (NIH) [1R03CA167722-01A1]; NIH [1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, 1P20 GM103444, 1 R01HL113325, 1 P01HL107147]; pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina [5P30GM103339-03]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756, R01HL113325, P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, P20GM103444, P20GM103499, P20GM103542, P30GM103339] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant 1R03CA167722-01A1 (to S. M. and S. G.); NIH Grants 1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, and 1P20 GM103444 (to S. M., S. G., and R. R. M.); NIH Grants 1 R01HL113325 and 1 P01HL107147 (to V. C. H.); and a pilot project award (to S. M.) from the COBRE in Lipidomics and Pathobiology (NIH Grant 5P30GM103339-03) at the Medical University of South Carolina. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu T, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-15; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Fitzner B, 2004, INT J COLORECTAL DIS, V19, P414, DOI 10.1007/s00384-003-0565-1; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Foster LC, 1998, J BIOL CHEM, V273, P20341, DOI 10.1074/jbc.273.32.20341; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Ghatak S., 2015, INT J CELL BIOL; Ghatak S, 2017, J BIOL CHEM, V292, P10490, DOI 10.1074/jbc.M116.752469; Ghatak S, 2014, J BIOL CHEM, V289, P7856, DOI 10.1074/jbc.M113.505065; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; Goodchild A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-40; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hebbard L, 2000, J CELL SCI, V113, P2619; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; HOFMANN M, 1993, CANCER RES, V53, P1516; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Kane S, 2002, ANTICANCER RES, V22, P1433; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Lo LW, 2001, J CELL PHYSIOL, V188, P304, DOI 10.1002/jcp.1124; Maltzman JS, 1996, J EXP MED, V183, P1747, DOI 10.1084/jem.183.4.1747; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Monaghan M, 2000, J PATHOL, V192, P519; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Parra E, 2011, INT J ONCOL, V39, P345, DOI 10.3892/ijo.2011.1047; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Recio JA, 2003, CANCER RES, V63, P1576; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Varga J, 2002, ARTHRITIS RHEUM-US, V46, P1703, DOI 10.1002/art.10413; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhao Y, 2000, EXP MOL PATHOL, V69, P67, DOI 10.1006/exmp.2000.2319	91	30	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10465	10489		10.1074/jbc.M116.752451	http://dx.doi.org/10.1074/jbc.M116.752451			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28389562	hybrid, Green Published			2022-12-26	WOS:000404115400012
J	Machado, LESF; Shen, TL; Page, R; Peti, W				Machado, Luciana E. S. F.; Shen, Tun-Li; Page, Rebecca; Peti, Wolfgang			The KIM-family protein-tyrosine phosphatases use distinct reversible oxidation intermediates: Intramolecular or intermolecular disulfide bond formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; enzyme inactivation; nuclear magnetic resonance (NMR); oxidation-reduction (redox); tyrosine-protein phosphatase (tyrosine phosphatase)	REDOX REGULATION; HYDROGEN-PEROXIDE; IN-VIVO; NMR-SPECTROSCOPY; CATALYTIC DOMAIN; 1B; INHIBITION; P38-ALPHA; CYSTEINE; ALPHA	The kinase interaction motif (KIM) family of protein-tyrosine phosphatases (PTPs) includes hematopoietic protein-tyrosine phosphatase (HePTP), striatal-enriched protein-tyrosine phosphatase (STEP), and protein-tyrosine phosphatase receptor type R (PTPRR). KIM-PTPs bind and dephosphorylate mitogen-activated protein kinases (MAPKs) and thereby critically modulate cell proliferation and differentiation. PTP activity can readily be diminished by reactive oxygen species (ROS), e.g. H2O2, which oxidize the catalytically indispensable active-site cysteine. This initial oxidation generates an unstable sulfenic acid intermediate that is quickly converted into either a sulfinic/sulfonic acid (catalytically dead and irreversible inactivation) or a stable sulfenamide or disulfide bond intermediate (reversible inactivation). Critically, our understanding of ROS-mediated PTP oxidation is not yet sufficient to predict the molecular responses of PTPs to oxidative stress. However, identifying distinct responses will enable novel routes for PTP-selective drug design, important for managing diseases such as cancer and Alzheimer's disease. Therefore, we performed a detailed biochemical and molecular study of all KIM-PTP family members to determine their H2O2 oxidation profiles and identify their reversible inactivation mechanism(s). We show that despite having nearly identical 3D structures and sequences, each KIM-PTP family member has a unique oxidation profile. Furthermore, we also show that whereas STEP and PTPRR stabilize their reversibly oxidized state by forming an intramolecular disulfide bond, HePTP uses an unexpected mechanism, namely, formation of a reversible intermolecular disulfide bond. In summary, despite being closely related, KIM-PTPs significantly differ in oxidation profiles. These findings highlight that oxidation protection is critical when analyzing PTPs, for example, in drug screening.	[Machado, Luciana E. S. F.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Shen, Tun-Li; Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Page, Rebecca] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	Brown University; Brown University; Brown University; University of Arizona	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.; Peti, W (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	wolfgangpeti@email.arizona.edu	Machado, Luciana Elena Souza Fraga/D-3737-2017	Machado, Luciana Elena Souza Fraga/0000-0002-2475-9324	American Diabetes Association Pathway to Stop Diabetes [1-14-ACN-31]; National Institutes of Health [R01NS091336]; Brazil Initiative Brown University grant; National Institutes of Health Grant [R01GM098482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazil Initiative Brown University grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Diabetes Association Pathway to Stop Diabetes Grant 1-14-ACN-31, National Institutes of Health Grant R01NS091336, a Brazil Initiative Brown University grant (to W. P.), and National Institutes of Health Grant R01GM098482 (to R. P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Brito PM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00082; Buhrman G, 2005, BIOCHEMISTRY-US, V44, P5307, DOI 10.1021/bi047449f; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Critton DA, 2011, J MOL BIOL, V405, P619, DOI 10.1016/j.jmb.2010.11.020; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Francis DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091934; Francis DM, 2014, BIOMOL NMR ASSIGN, V8, P185, DOI 10.1007/s12104-013-9480-8; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Francis DM, 2013, STRUCTURE, V21, P1612, DOI 10.1016/j.str.2013.07.003; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Groen A, 2008, FEBS J, V275, P2597, DOI 10.1111/j.1742-4658.2008.06407.x; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; Jeeves M, 2008, BIOMOL NMR ASSIGN, V2, P101, DOI 10.1007/s12104-008-9095-7; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Lee CU, 2015, ANGEW CHEM INT EDIT, V54, P13796, DOI 10.1002/anie.201506338; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Parsons ZD, 2013, BIOCHEMISTRY-US, V52, P6412, DOI 10.1021/bi400451m; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Peti W, 2016, METHODS MOL BIOL, V1447, P181, DOI 10.1007/978-1-4939-3746-2_11; Roeser J, 2010, ANAL BIOANAL CHEM, V397, P3441, DOI 10.1007/s00216-010-3471-8; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xu J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001923; Xu J, 2012, ADV PHARMACOL, V64, P303, DOI 10.1016/B978-0-12-394816-8.00009-X; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; ZANKE B, 1994, LEUKEMIA, V8, P236	49	12	12	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8786	8796		10.1074/jbc.M116.774174	http://dx.doi.org/10.1074/jbc.M116.774174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28389559	Green Published, hybrid			2022-12-26	WOS:000402153900024
J	Beall, T; Massiot, E; Arsenault, JE; Smith, MR; Hijmans, RJ				Beall, Ty; Massiot, Eric; Arsenault, Joanne E.; Smith, Matthew R.; Hijmans, Robert J.			Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes	PLOS ONE			English	Article							FOOD BALANCE SHEETS; PREDICTED PREVALENCE; VILLAGE POPULATIONS; IRON-ABSORPTION; NUTRITION; BIOAVAILABILITY; CHILDREN; ZINC; BIOFORTIFICATION; AGRICULTURE	Understanding dietary patterns is vital to reducing the number of people experiencing hunger (about 795 million), micronutrient deficiencies (2 billion), and overweight or obesity (2.1 billion). We characterize global trends in dietary quality by estimating micronutrient density of the food supply, prevalence of inadequate intake of 14 micronutrients, and average prevalence of inadequate intake of these micronutrients for all countries between 1961 and 2011. Over this 50-year period, the estimated prevalence of inadequate intakes of micronutrients has declined in all regions due to increased total production of food and/or micronutrient density. This decline has been particularly strong in East and Southeast Asia and weaker in South Asia and sub-Saharan Africa. Sub-Saharan Africa is the only region where dietary micronutrient density has declined over this 50-year period. At the global level, micronutrients with the lowest levels of adequate estimated intake are calcium, iron, vitamin A, and zinc, but there are strong differences between countries and regions. Fortification has reduced the estimated prevalence of inadequate micronutrient intakes in all low-income regions, except South Asia. The food supply in many countries is still far below energy requirements, which suggests a need to increase the availability and accessibility of nutritious foods. Countries where the food energy supply is adequate show a very large variation in dietary quality, and in many of these countries people would benefit from more diverse diets with a greater proportion of micronutrient-dense foods. Dietary quality can be improved through fortification, biofortification, and agricultural diversification, as well as efforts to improve access to and use of micronutrient-dense foods and nutritional knowledge. Reducing poverty and increasing education, especially of women, are integral to sustainably addressing malnutrition.	[Beall, Ty; Massiot, Eric; Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Beall, Ty; Arsenault, Joanne E.; Hijmans, Robert J.] Univ Calif Davis, Program Int & Community Nutr, Davis, CA 95616 USA; [Arsenault, Joanne E.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Smith, Matthew R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health	Beall, T (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.; Beall, T (corresponding author), Univ Calif Davis, Program Int & Community Nutr, Davis, CA 95616 USA.	tbeal@ucdavis.edu		Smith, Matthew/0000-0001-5207-2370; Beal, Ty/0000-0002-0398-9825	Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development [AID-OOA-L-14-00006]; National Science Foundation Graduate Research Fellowship Program [1650042]	Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development(United States Agency for International Development (USAID)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	Funding for this project was provided by the Feed the Future Sustainable Intensification Innovation Lab through the United States Agency for International Development received by RJH (grant # AID-OOA-L-14-00006) (http://www.k-state.edu/siil/). This work was also supported by the National Science Foundation Graduate Research Fellowship Program received by TB (grant # 1650042) (https://www.nsfgrfp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2001, STATE FOOD INWORLD; [Anonymous], 1998, DIET REF INT THIAM R; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Arimond M, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P41, DOI 10.1079/9781845937140.0041; Arsenault JE, 2015, FOOD SECUR, V7, P693, DOI 10.1007/s12571-015-0452-y; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Beaton G.H, 1994, CRITERIA ADEQUATE DI, P1491; Biesalski HK, 2016, WORLD REV NUTR DIET; CALLOWAY DH, 1993, AM J CLIN NUTR, V58, P376, DOI 10.1093/ajcn/58.3.376; Cotruvo J., 2009, CALCIUM MAGNESIUM DR; DeFries R, 2015, SCIENCE, V349, P238, DOI 10.1126/science.aaa5766; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; FAO, 2001, FOOD BAL SHEETS HDB; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; Frison EA, 2011, SUSTAINABILITY-BASEL, V3, P238, DOI 10.3390/su3010238; Ghavami A, 2012, BRIT J NUTR, V107, P1350, DOI 10.1017/S000711451100451X; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Haas J, 2014, FASEB J S, V28; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1979, SCAND J GASTROENTERO, V14, P769, DOI 10.3109/00365527909181403; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; icddrb  UNICEF  Global Alliance for Improved Nutrition, 2013, NAT MICR STAT SURV 2; Institute of Medicine Panel on Macronutrients Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT EN CARB; Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; Institute of Medicine (US), 2001, DIET REF INT VIT C V; Joint FAO/WHO Expert Consultation, 2005, VIT MIN REQ HUM NUTR; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Kumssa DB, 2015, CROP PASTURE SCI, V66, P1278, DOI 10.1071/CP15096; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Low JW, 2007, J NUTR, V137, P1320; Mark HE, 2016, ASIA PAC J CLIN NUTR, V25, P368, DOI 10.6133/apjcn.2016.25.2.11; Matthews R.H., 1975, FOOD YIELDS SUMMARIZ; Miller LV, 2007, J NUTR, V137, P135, DOI 10.1093/jn/137.1.135; Moshfegh A., 2005, WHAT WE EAT AM NHANE; MURPHY SP, 1992, AM J CLIN NUTR, V56, P565, DOI 10.1093/ajcn/56.3.565; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Olney DK, 2015, J NUTR, V145, P1317, DOI 10.3945/jn.114.203539; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Pourkhalili A, 2013, SCI WORLD J, DOI 10.1155/2013/374030; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Sahni S, 2010, J BONE MINER RES, V25, P2494, DOI 10.1002/jbmr.194; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Schmid A, 2011, CRIT REV FOOD SCI, V51, P50, DOI 10.1080/10408390903044636; Serra-Majem L, 2003, J EPIDEMIOL COMMUN H, V57, P74, DOI 10.1136/jech.57.1.74; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Stadlmayr B., 2012, W AFRICAN FOOD COMPO; Svedberg P, 1999, WORLD DEV, V27, P2081, DOI 10.1016/S0305-750X(99)00102-3; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; United Nations, 2014, ESAPWP235 UN; University of California at Berkeley International Minilist, WORLDFOOD DIET ASS S; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; von Grebmer K, 2015, 2015 GLOBAL HUNGER I; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050565; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zijp IM, 2000, CRIT REV FOOD SCI, V40, P371, DOI 10.1080/10408690091189194	62	147	151	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175554	10.1371/journal.pone.0175554	http://dx.doi.org/10.1371/journal.pone.0175554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399168	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000048
J	Blazquez, E; Rodriguez, C; Rodenas, J; de Rozas, AP; Segales, J; Pujols, J; Polo, J				Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Perez de Rozas, Ana; Segales, Joaquim; Pujols, Joan; Polo, Javier			Ultraviolet (UV-C) inactivation of Enterococcus faecium, Salmonella choleraesuis and Salmonella typhimurium in porcine plasma	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; WEANLING PIGS; LIGHT; MODEL; FOOD; MICROORGANISMS; VALIDATION; RADIATION; EFFICACY; CURVES	The objective of this study was to assess the effectiveness of an ultraviolet (UV-C, 254 nm) irradiation system on reducing the load of Salmonella typhimurium (S. typhimurium), Salmonella choleraesuis (S. choleraesuis) resistant to streptomycin and Enterococcus faecium (E. faecium) inoculated in sterile porcine plasma and then subjected to different UV-C irradiation doses (750, 1500, 3000, 6000 and 9000 J/L) using a pilot plant UV-C device working under turbulent flow. Results indicated that UV-C treatment induced a viability reduction of 0.38, 1.18, 3.59, 4.72 and 5.06 log10 S. typhimurium when irradiated at 750, 1500, 3000, 6000 and 9000 J/L, respectively. The observed log10 reduction of S. choleraesuis was 1.44, 2.68, 5.55, 7.07 and 7.97 at 750, 1500, 3000, 6000 and 9000 J/L, respectively. The best-fit inactivation for S. choleraesuis was the Weibull distribution curve, while the best-fit curve for S. typhimurium was the Weibull plus tail model, indicating that around 10 2 cfu/mL resistant S. typhimurium was detected when the liquid plasma was UV-C irradiated at doses up to 9000 J/L. Viability reduction for E. faecium was 0.44, 1.01, 3.70, 5.61 and 6.22 log10 when irradiated at 750, 1500, 3000, 6000 and 9000 J/L, respectively, with no bacterial resistance observed with UV-C doses of 6000 J/L or higher. The biphasic model was the best fit model for the inactivation curve for E. faecium. For the three microorganisms tested, about a 4 log-unit reduction was achieved when the liquid plasma was irradiated at 3000J/L. Overall results demonstrate the usefulness of the UV-C system to inactivate bacteria in liquid plasma before spray-drying. We conclude that the UV-C system can provide an additional biosafety feature that can be incorporated into the manufacturing process for spray-dried animal plasma.	[Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier] APC EUROPE SA, Pol Ind Congost, Granollers, Spain; [Blazquez, Elena; Perez de Rozas, Ana; Pujols, Joan] Campus Univ Autanoma Barcelona, IRTA, Ctr Rec Sanitat Anim CReSA IRTA UAB, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Ctr Rec Sanitat Anim CReSA IRTA UAB, Barcelona, Spain	IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Polo, J (corresponding author), APC EUROPE SA, Pol Ind Congost, Granollers, Spain.	Javier.polo@apc-europe.com	Pujols, Joan/S-1141-2018; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020; Pujols, Joan/AAV-6427-2020	Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Pujols, Joan/0000-0002-6940-1529; Blazquez Salvador, Elena/0000-0001-8115-3225; Polo, Javier/0000-0003-0990-2230	APC Europe, S.A., Granollers, Spain; de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya [2014 DI 066]; CERCA Programme/Generalitat de Catalunya; APC EUROPE	APC Europe, S.A., Granollers, Spain; de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; CERCA Programme/Generalitat de Catalunya; APC EUROPE	Funding for this study was provided in part by APC Europe, S.A., Granollers, Spain. This study was partly supported by Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya (2014 DI 066) to EB. The funding from CERCA Programme/Generalitat de Catalunya to IRTA is also acknowledged. APC EUROPE provided support in the form of salaries for authors EB, CR, JR and JPolo retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Baysal AH, 2013, INT J FOOD MICROBIOL, V166, P494, DOI 10.1016/j.ijfoodmicro.2013.08.015; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Boyen F, 2008, VET MICROBIOL, V130, P1, DOI 10.1016/j.vetmic.2007.12.017; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Cerf O, 1977, J APPL MICROBIOL, V42, P92; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; Gebreyes WA, 2004, J FOOD PROTECT, V67, P698, DOI 10.4315/0362-028X-67.4.698; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; GRAY JT, 1995, VET MICROBIOL, V47, P43, DOI 10.1016/0378-1135(95)00060-N; Groenewald WH, 2013, J NEW GENER SCI, V11, P19; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jagger J., 1967, INTRO RES ULTRAVIOLE; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Kopit LM, 2014, APPL ENVIRON MICROB, V80, P1899, DOI 10.1128/AEM.03859-13; Lin CH, 2012, J HAZARD MATER, V30, P209; Luksiene Z, 2007, J APPL MICROBIOL, V103, P1545, DOI 10.1111/j.1365-2672.2007.03403.x; Ma L, 2007, J FOOD PROTECT, V70, P952, DOI 10.4315/0362-028X-70.4.952; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Matak KE, 2005, J FOOD PROTECT, V68, P2212, DOI 10.4315/0362-028X-68.10.2212; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2002, P 48 INT C MEAT SCI, V1, P194; Polo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133008; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; PUJOLS J, 2007, P AM ASS SWIN VET AM, P281; Pujols J, 2011, VET J, V190, P16; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Shama G, 1992, ENCY FOOD MICROBIOLO, V3, P2208; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Simmons MJH, 2012, INNOV FOOD SCI EMERG, V14, P122, DOI 10.1016/j.ifset.2011.11.006; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131	37	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175289	10.1371/journal.pone.0175289	http://dx.doi.org/10.1371/journal.pone.0175289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399166	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000027
J	Li, YJ; Su, J; Li, FF; Chen, X; Zhang, GY				Li, Yongjian; Su, Juan; Li, Fangfang; Chen, Xiang; Zhang, Guiying			MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1 alpha and VEGFA: Implications for psoriasis treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OVER-EXPRESSION; UP-REGULATION; MICRORNAS; ANGIOGENESIS; SKIN; INFLAMMATION; RNAS	Psoriasis is a common and chronic autoimmune skin disease which affects 2 to 3% of the world population. Abnormal proliferation of human keratinocytes is an important feature of psoriasis, along with local hypoxia and vascular abnormal growth. To leverage recent molecular findings into the personalized treatment of psoriasis, we need a strategy that integrates clinical stratification with molecular phenotyping. MicroRNAs (miRNAs) are a large family of small non-coding RNA which regulates diverse biological process, including cell proliferation, by modulating gene expression at the posttranscriptional level. In the present study, we indicated that miR-150 specifically down-regulated expressed in psoriatic skin lesions, and could inhibit HaCaT cells and primary adult human keratinocytes (HKCs)' proliferation in either normal or hypoxia conditions; by direct targeting, miR-150 could also regulate the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor A (VEGFA). In addition, we found that HIF-1 alpha and VEGFA were highly expressed in the lesional psoriatic skin compared with the non-lesional psoriatic skin, and negatively correlated with miR-150 expression. Taken together, we indicated miR-150 regulates human keratinocytes' proliferation in hypoxic conditions through targeting HIF-1 alpha and VEGFA in psoriasis for the first time, and provide diagnostic markers and a novel target for psoriasis treatment.	[Li, Yongjian] Nanhua Univ, Affiliated Hosp 2, Dept Dermatol, Hengyang, Hunan, Peoples R China; [Su, Juan; Li, Fangfang] Cent S Univ, XiangYa Hosp, Dept Dermatol, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China; [Chen, Xiang] Cent S Univ, XiangYa Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Zhang, Guiying] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China	University of South China; Central South University; Central South University; Central South University	Zhang, GY (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China.	Zhangguiying67@aliyun.com			Science and Technology Plan Project of Hunan [2013FJ3131]	Science and Technology Plan Project of Hunan	This work was supported by the Science and Technology Plan Project of Hunan (2013FJ3131) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; [Anonymous], 2016, T AUTOM SCI ENG, DOI DOI 10.1038/ONCSIS.2016.35; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Campanati A, 2009, INT J IMMUNOPATH PH, V22, P371, DOI 10.1177/039463200902200214; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gu X, 2010, P63 AND EPITHELIAL H; Hawkes JE, 2016, J INVEST DERMATOL, V136, P365, DOI 10.1038/JID.2015.409; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jimenez SA, 2013, AUTOIMMUN REV, V12, P1046, DOI 10.1016/j.autrev.2013.04.004; Jinnin Masatoshi, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P439; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kim J, 2015, PLOS ONE, V10; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Lambert JLW, 2015, BRIT J DERMATOL, V173, P323, DOI 10.1111/bjd.13837; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li W, 2014, DISCOV MED, V18, P97; Li Y., 2014, J BIOMATER TISS ENG, V4, P1; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Meki ARMA, 2014, J CLIN LAB ANAL, V28, P496, DOI 10.1002/jcla.21717; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Schon MP, 2005, LANCET, V366, P1333, DOI 10.1016/S0140-6736(05)67542-3; Simonetti O, 2006, INT J IMMUNOPATH PH, V19, P751, DOI 10.1177/039463200601900405; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sun JJ, 2016, MOL MED REP, V13, P4499, DOI 10.3892/mmr.2016.5066; Tao J, 2008, J DERMATOL SCI, V51, P203, DOI 10.1016/j.jdermsci.2008.04.012; Torales-Cardena A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607363; Tovar-Castillo LE, 2007, INT J DERMATOL, V46, P239, DOI 10.1111/j.1365-4632.2006.02962.x; Vasilopoulos Y, 2013, CYTOKINE, V62, P38, DOI 10.1016/j.cyto.2013.02.029; Wang M, 2016, ONCOTARGET; Wang R, 2014, FEBS LETT, V588, P4438, DOI 10.1016/j.febslet.2014.09.045; Wu ZH, 2016, ONCOL REP, V35, P1696, DOI 10.3892/or.2015.4529; Yu ZY, 2013, MOL MED REP, V8, P287, DOI 10.3892/mmr.2013.1493	35	28	28	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175459	10.1371/journal.pone.0175459	http://dx.doi.org/10.1371/journal.pone.0175459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399173	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000039
J	Sartakhti, JS; Manshaei, MH; Basanta, D; Sadeghi, M				Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Basanta, David; Sadeghi, Mehdi			Evolutionary emergence of angiogenesis in avascular tumors using a spatial public goods game	PLOS ONE			English	Article							CANCER; COOPERATION; DYNAMICS; NORMALIZATION; HETEROGENEITY; VASCULATURE; COMPETITION; MECHANISMS; RESISTANCE; DIFFUSION	Natural selection in cancer often results in the emergence of increasingly malignant tumor cells that display many if not all of the hallmarks of cancer. One of the most important traits acquired during cancer progression is angiogenesis. Tumor cells capable of secreting pro-angiogenic factors can be seen as cooperators where the improved oxygenation, nutrient delivery and waste disposal resulting from angiogenesis could be seen as a public good. Under this view, the relatively costly secretion of molecular signals required to orchestrate angiogenesis would be undertaken exclusively by cooperating tumor cells but the benefits of angiogenesis would be felt by neighboring tumor cells regardless of their contribution to the process. In this work we detail a mathematical model to better understand how clones capable of secreting pro-angiogenic factors can emerge in a tumor made of non-cooperative tumor cells. Given the importance of the spatial configuration of the tumor in determining the efficacy of the secretion of pro-angiogenic factors as well as the benefits of angiogenesis we have developed a spatial game theoretic approach where interactions and public good diffusion are described by graphs. The results show that structure of the population affects the evolutionary dynamics of the pro-angiogenic clone. Specifically, when the benefit of angiogenesis is represented by sigmoid function with regards to the number of pro-angiogenic clones then the probability of the coexistence of pro-angiogenic and angiogenesis-neutral clones increases. Our results demonstrate that pro-angiogenic clone equilibrates into clusters that appear from surrounding vascular tissues towards the center of tumor. These clusters appear notably less dense after anti-angiogenic therapy.	[Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan 8415683111, Iran; [Basanta, David] H Lee Moffitt Canc Ctr & Res Inst, Integrated Math Oncol, Tampa, FL 33612 USA; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Sadeghi, Mehdi] Inst Res Fundamental Sci, Sch Biol Sci, Tehran, Iran	Isfahan University of Technology; H Lee Moffitt Cancer Center & Research Institute	Manshaei, MH (corresponding author), Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan 8415683111, Iran.	manshaei@cc.iut.ac.ir		Basanta, David/0000-0002-8527-0776				Ahmad SA, 2002, SEMIN CANCER BIOL, V12, P105, DOI 10.1006/scbi.2001.0418; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2016, J THEOR BIOL, V396, P191, DOI 10.1016/j.jtbi.2016.02.027; Archetti M, 2015, P NATL ACAD SCI USA, V112, P1833, DOI 10.1073/pnas.1414653112; Archetti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108526; Archetti M, 2014, J THEOR BIOL, V341, P1, DOI 10.1016/j.jtbi.2013.09.017; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Bach LA, 2001, EUR J CANCER, V37, P2116, DOI 10.1016/S0959-8049(01)00246-5; Bejan A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606555; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bickel ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091992; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; Csikasz-Nagy A, 2013, SEMIN CANCER BIOL, V23, P293, DOI 10.1016/j.semcancer.2013.05.009; Dobay A, 2014, J EVOLUTION BIOL, V27, P1869, DOI 10.1111/jeb.12437; Eichhorn ME, 2007, LANGENBECK ARCH SURG, V392, P371, DOI 10.1007/s00423-007-0150-0; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gibbs MN, 2000, IEEE T NEURAL NETWOR, V11, P1458, DOI 10.1109/72.883477; GIMBRONE MA, 1976, JNCI-J NATL CANCER I, V56, P305, DOI 10.1093/jnci/56.2.305; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goymer P, 2008, NATURE, V454, P1047, DOI 10.1038/4541046a; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jana BK, 2010, IMPACT OF CLIMATE CHANGE ON NATURAL RESOURCE MANAGEMENT, P1, DOI 10.1007/978-90-481-3581-3; JOUANNEAU J, 1994, P NATL ACAD SCI USA, V91, P286, DOI 10.1073/pnas.91.1.286; Julou T, 2013, P NATL ACAD SCI USA, V110, P12577, DOI 10.1073/pnas.1301428110; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Loeschcke, 2003, J THEORETICAL MED, P5, DOI [10.1080/10273660310001630443, DOI 10.1080/10273660310001630443]; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Nagy JD, 2004, B MATH BIOL, V66, P663, DOI 10.1016/j.bulm.2003.10.001; Nagy JD, 2012, MATH BIOSCI ENG, V9, P843, DOI 10.3934/mbe.2012.9.843; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sartakhti JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168856; Shoham Y., 2008, MULTIAGENT SYSTEMS A, DOI DOI 10.1017/CBO9780511811654; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Tomlinson IPM, 1997, BRIT J CANCER, V75, P157, DOI 10.1038/bjc.1997.26; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Ziyad Safiyyah, 2011, Genes Cancer, V2, P1085, DOI 10.1177/1947601911432334; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	52	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175063	10.1371/journal.pone.0175063	http://dx.doi.org/10.1371/journal.pone.0175063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399181	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000018
J	Du, HX; Yang, JJ; Bai, JY; Ming, K; Shi, JT; Yao, FK; Zhang, W; Yu, Y; Chen, Y; Xiong, W; Wu, Y; Wang, DY; Hu, YL; Liu, JG				Du, Hongxu; Yang, Jingjing; Bai, Jingying; Ming, Ke; Shi, Jintong; Yao, Fangke; Zhang, Wei; Yu, Yang; Chen, Yun; Xiong, Wen; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo			A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type	PLOS ONE			English	Article							OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; LIVER-INJURY; CELL-DEATH; MEDICINE; SEROTYPE; PROTEIN	The principal target organ of duck hepatitis A virus type 1 (DHAV-1) is duckling liver, which is an energy-intensive organ and plays important roles in body's energy metabolism and conversion. As the "power house" of the hepatocytes, mitochondria provide more than 90% of the energy. However, mitochondria are much vulnerable to the oxidative stress for their rich in polyunsaturated fatty acids. Although previous researches have demonstrated that DHAV-1 could induce the oxidative stress in the serum of the infected ducklings, no related study on the mitochondria during the pathological process of DVH has been reported by far. To address this issue, we examined the HE stained tissue pathological slices, detected the hepatic SOD, CAT and GPX activities and MDA contents and analyzed the ATP content, mitochondrial ultrastructure and the mitochondrial SOD, GPX activities and MDA content in the liver tissues. The results showed that the hepatic redox status was significantly disturbed so that causing the mitochondrial dysfunction, ATP depletion and mitochondrial oxidative stress during the process of the DHAV-1 infection, and a prescription formulated with Hypericum japonicum flavone, Radix Rehmanniae Recens polysaccharide and Salvia plebeia flavone (HRS), which had been demonstrated with good anti-oxidative activity in serum, could effectively alleviate the hepatic injury and the oxidative stress in liver tissue induced by DHAV-1 thus alleviating the mitochondrial injury and oxidative stress. In a word, this research discovers the oxidative stress induced mitochondrial dysfunction and oxidative stress during the DVH pathological process and demonstrates HRS exerts good anti-oxidative activity in liver tissue to protect mitochondria against reactive oxygen species (ROS).	[Du, Hongxu; Yang, Jingjing; Bai, Jingying; Ming, Ke; Shi, Jintong; Yao, Fangke; Zhang, Wei; Yu, Yang; Chen, Yun; Xiong, Wen; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Peoples R China	Nanjing Agricultural University	Liu, JG (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Peoples R China.	liujiaguo@njau.edu.cn			National Natural Science Foundation of China [31172355, 31572557]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest [201303040, 201403051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest	This work was supported by the National Natural Science Foundation of China (grant no. 31172355, 31572557, URLs: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), Project Funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Special Funds for Agro-scientific Research of Public Interest (201303040 and 201403051, URLs: http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016; Al-Qabandi W, 2012, MED PRIN PRACT, V21, P264, DOI 10.1159/000334491; Arakawa S, 2015, BIOCHEM BIOPH RES CO, V467, P1006, DOI 10.1016/j.bbrc.2015.10.022; ASPLIN FD, 1965, VET REC, V77, P1529; Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040; Bacchetta R, 2016, ENVIRON RES, V148, P376, DOI 10.1016/j.envres.2016.04.028; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chen Y, 2015, VIRUS RES, V204, P58, DOI 10.1016/j.virusres.2015.04.013; Chen Y, 2014, INT J BIOL MACROMOL, V66, P186, DOI 10.1016/j.ijbiomac.2014.02.038; Chen ZG, 2015, J ETHNOPHARMACOL, V162, P287, DOI 10.1016/j.jep.2015.01.002; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Clark R, 2005, J INVEST DERMATOL, V125, P629, DOI 10.1111/j.0022-202X.2005.23856.x; Du HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146046; Gui SY, 2005, WORLD J GASTROENTERO, V11, P2984, DOI 10.3748/wjg.v11.i19.2984; HAIDER SA, 1979, AVIAN DIS, V23, P715, DOI 10.2307/1589748; Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; LEVINE PP, 1950, CORNELL VET, V40, P71; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Liu P, 2005, WORLD J GASTROENTERO, V11, P2892, DOI 10.3748/wjg.v11.i19.2892; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Polo M, 2015, BRIT J PHARMACOL, V172, P1713, DOI 10.1111/bph.13018; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Sanz A, 2016, BBA-BIOENERGETICS, V1857, P1116, DOI 10.1016/j.bbabio.2016.03.018; Sekine S, 2015, TOXICOL APPL PHARM, V282, P237, DOI 10.1016/j.taap.2014.12.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang YH, 2012, FOOD CHEM TOXICOL, V50, P1194, DOI 10.1016/j.fct.2012.02.008; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; Wiesenfeld PW, 2006, FOOD CHEM TOXICOL, V44, P579, DOI 10.1016/j.fct.2005.09.005; Zeng T, 2008, TOXICOLOGY, V252, P86, DOI 10.1016/j.tox.2008.07.062; Zhang R, 2010, FOOD CHEM TOXICOL, V48, P922, DOI 10.1016/j.fct.2010.01.001	39	3	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175495	10.1371/journal.pone.0175495	http://dx.doi.org/10.1371/journal.pone.0175495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394931	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800039
J	Rozani, V; Giladi, N; El-Ad, B; Gurevich, T; Tsamir, J; Hemo, B; Peretz, C				Rozani, Violetta; Giladi, Nir; El-Ad, Baruch; Gurevich, Tanya; Tsamir, Judith; Hemo, Beatriz; Peretz, Chava			Statin adherence and the risk of Parkinson's disease: A population-based cohort study	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; SERUM-CHOLESTEROL; SIMVASTATIN; THERAPY; PREVENTS	Background While experimental data provided some compelling evidence on the benefits of statins on dopaminergic neurons, observational studies reported conflicting results regarding the potential of statins to effect the risk of Parkinson's disease (PD). Objectives To evaluate the association between changes in statin adherence over time and PD risk. Methods A population-based cohort of new statin users (ages 40-79, years 1999-2012) was derived from a large Israeli healthcare services organization. Data included history of statin purchases and low density lipoprotein cholesterol (LDL-C) levels. Personal statin adherence was measured annually by the proportion of days covered (PDC). PD was detected employing a drug-tracer approach. Stratified (by sex, LDL-C levels at baseline and age) Cox proportional hazards models with time-dependent covariates were used to compute adjusted Hazard Ratio (HR) with 95%Cl. Results The cohort included 232,877 individuals, 49.3% men. Mean age at first statin purchase was 56.5 (9.8) years for men and 58.7 (9.2) years for women. PDC distribution for the whole follow up period differed between men and women: medians 58.3% and 54.1% respectively. During a mean follow up of 7.6 (3.4) years, 2,550 (1.1%) PD cases were identified. In a 1 year lagged analysis, we found no association between annual statin adherence and PD risk in all age-groups regardless of statin type and potency. Age-pooled HR (95%C1) for men and women with LDL-C levels at baseline <160mg/dL were: 0.99 (0.99-1.01), 1.01 (1.00-1.02); and for men and women with LDL-C >160mg/dL levels: 0.99 (0.98-1.01), 0.97 (0.98-1.01). Conclusions Our findings suggest that statin adherence over time does not affect PD risk. Future studies should use large-scale cohorts and refining assessments of long-term profiles in statin adherence.	[Rozani, Violetta; Peretz, Chava] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol, Sackler Fac Med, Tel Aviv, Israel; [Giladi, Nir; Gurevich, Tanya] Tel Aviv Med Ctr & Sch Med, Neurol Inst, Tel Aviv, Israel; [Giladi, Nir; Gurevich, Tanya] Tel Aviv Univ, Sagol Sch Neurosci, Sackler Fac Med, Tel Aviv, Israel; [El-Ad, Baruch; Tsamir, Judith; Hemo, Beatriz] Maccabi Healthcare Serv, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Giladi, N (corresponding author), Tel Aviv Med Ctr & Sch Med, Neurol Inst, Tel Aviv, Israel.; Giladi, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Sackler Fac Med, Tel Aviv, Israel.	nirg@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522; Rozani, Dr. Violetta/0000-0001-6306-6267	Teva Pharmaceutical Industries Ltd; Israeli National Network of Excellence in Neuroscience (NNE); MHS	Teva Pharmaceutical Industries Ltd(Teva Pharmaceutical Industries); Israeli National Network of Excellence in Neuroscience (NNE); MHS	Teva Pharmaceutical Industries Ltd. provided funding in the form of a scholarship to author VR as part of the Israeli National Network of Excellence in Neuroscience (NNE). The MHS provided support in the form of salaries for authors [BE; JT; BH]. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agouridis AP, 2016, CURR PHARM DESIGN, V22, P18, DOI 10.2174/1381612822666151109111511; [Anonymous], 2015, WHO COLL CTR DRUG ST; Arfe A, 2016, J CLIN EPIDEMIOL, V4356, P300; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bijlsma MJ, 2016, PHARMACOEPIDEM DR S, V25, P325, DOI 10.1002/pds.3935; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Bykov K, 2016, PHARMACOEPIDEM DR S, V16, P4049; Chillag-Talmor O, 2011, J PARKINSON DIS, V1, P35, DOI 10.3233/JPD-2011-11024; Chodick G, 2008, CLIN THER, V30, P2167, DOI 10.1016/j.clinthera.2008.11.012; Claassen DO, 2010, NEUROLOGY, V75, P494, DOI 10.1212/WNL.0b013e3181ec7fac; de Lau LML, 2007, MOVEMENT DISORD, V22, P1985, DOI 10.1002/mds.21582; Friedman B, 2013, AM J MANAG CARE, V19, P626; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Howe Chanelle J, 2015, Curr Epidemiol Rep, V2, P162; Huang XM, 2015, MOVEMENT DISORD, V30, P552, DOI 10.1002/mds.26152; Korhonen MJ, 2011, EUR J CLIN PHARMACOL, V67, P925, DOI 10.1007/s00228-011-1019-2; Korhonen MJ, 2009, EUR J CLIN PHARMACOL, V65, P1167, DOI 10.1007/s00228-009-0701-0; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Rajanikant GK, 2007, CURR MED CHEM, V14, P103, DOI 10.2174/092986707779313462; Ritz B, 2010, MOVEMENT DISORD, V25, P1210, DOI 10.1002/mds.23102; Samii A, 2008, J CLIN NEUROSCI, V15, P1272, DOI 10.1016/j.jocn.2008.01.016; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Tabenkin H, 2013, CLIN GUIDELINES ISRA; Tan EK, 2013, NEUROLOGY, V81, P406, DOI 10.1212/WNL.0b013e31829d87bb; U. S. Department of Health and Human Services National Institutes of Health National Heart Lung and Blood, 2005, YOUR GUID LOW YOUR C; Ubeda-Bannon I, 2014, BRAIN STRUCT FUNCT, V219, P1513, DOI 10.1007/s00429-013-0651-2; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wolkewitz M, 2012, J CLIN EPIDEMIOL, V65, P1171, DOI 10.1016/j.jclinepi.2012.04.008; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175054	10.1371/journal.pone.0175054	http://dx.doi.org/10.1371/journal.pone.0175054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388626	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800018
J	Zhang, J; Liu, C; Huang, RZ; Chen, HF; Liao, ZX; Sung, JY; Xia, XK; Wang, FX				Zhang, Jing; Liu, Chao; Huang, Ri-Zhen; Chen, Hui-Feng; Liao, Zhi-Xin; Sun, Jin-Yue; Xia, Xue-Kui; Wang, Feng-Xiang			Three new C-27-carboxylated-lupane-triterpenoid derivatives from Potentilla discolor Bunge and their in vitro antitumor activities	PLOS ONE			English	Article							MEDICINAL-PLANTS; TRITERPENOIDS; APOPTOSIS; CELLS; EXTRACTS; GROWTH; ACID	Three new lupane-triterpenoids (1-3) along with six known compounds (4-9) were isolated from the ethanolic extract of whole plant of Potentilla discolor Bunge. The structures of Compounds 1-3 were established by extensive 1D and 2D NMR together with other spectrum analysis, indicating that their C-27 positions were highly oxygenated, which were rarely found in nature. Their in vitro anti-proliferative activities against HepG-2, MCF-7 and T-84 cell lines were evaluated by Cell Counting Kit-8 (CCK-8) assay, and the results showed different activities for three cell lines with IC50 values ranging from 17.84 to 40.64 mu M. In addition, the results from Hoechst 33258 and AO/EB staining as well as annexinV-FITC assays exhibited Compound 1 caused a markedly increased HepG-2 cellular apoptosis in a dose-dependent manner. The further mechanisms of Compound 1-induced cellular apoptosis were confirmed that 1 induced the production of ROS and the alteration of pro-and anti-apoptotic proteins, which led to the dysfunction of mitochondria and activation of caspase-9 and caspase-3 and finally caused cellular apoptosis. These results would be useful in search for new potential antitumor agents and for developing semisynthetic lupane-triterpenoid derivatives with high antitumor activity.	[Zhang, Jing; Huang, Ri-Zhen; Chen, Hui-Feng; Liao, Zhi-Xin] Southeast Univ, Sch Chem & Chem Engn, Dept Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing; Liu, Chao; Sun, Jin-Yue] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Peoples R China; [Xia, Xue-Kui] Shandong Acad Sci, Biotechnol Ctr, Jinan, Peoples R China; [Wang, Feng-Xiang] Inst Shandong River Wetlands, Laiwu, Peoples R China	Southeast University - China; Shandong Academy of Agricultural Sciences; Qilu University of Technology	Liao, ZX (corresponding author), Southeast Univ, Sch Chem & Chem Engn, Dept Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.; Sung, JY (corresponding author), Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Jinan, Peoples R China.	zxliao@seu.edu.cn; moon_s731@hotmail.com			Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) [CMEMR2016-B06]; Priority Academic Program Development of Jiangsu Higher Education Institutions [1107047002]; Taishan Overseas Talents Introduction Program of Shandong, China [tshw20120747]	Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University); Priority Academic Program Development of Jiangsu Higher Education Institutions; Taishan Overseas Talents Introduction Program of Shandong, China	This study was supported by Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) (CMEMR2016-B06 to ZXL), the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 1107047002 to ZXL), and the Taishan Overseas Talents Introduction Program of Shandong, China (No. tshw20120747 to JYS).	[Anonymous], 2015, MON POT DISC, VI, P383; [Anonymous], 2017, MON TORM RHIZ TORM T, P1542; Chen KL, 2005, J ETHNOPHARMACOL, V96, P201, DOI 10.1016/j.jep.2004.09.020; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cheng L, 2010, HELV CHIM ACTA, V93, P2263, DOI 10.1002/hlca.201000131; Connolly JD, 1996, NAT PROD REP, V13, P151, DOI 10.1039/np9961300151; Editorial Committee of Chinese Flora, 1985, FLOR CHIN, P291; Garner DL, 1999, MOL REPROD DEV, V53, P222, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;222::AID-MRD11&gt;3.0.CO;2-L; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Han JH, 2015, J NAT PROD, V78, P1005, DOI 10.1021/np5009174; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Hua SX, 2015, EUR J MED CHEM, V95, P435, DOI 10.1016/j.ejmech.2015.03.051; Ibrahim M, 2014, ASIAN J CHEM, V26, P1011, DOI 10.14233/ajchem.2014.15765; Jang Dae Sik, 2006, Agricultural Chemistry and Biotechnology, V49, P48; Jang DaeSik, 2007, Natural Product Sciences, V13, P160; Jiangsu New Medical College, 1975, DICT CHIN MAT MED, P2705; Jin Quan, 2011, Chinese Journal of Natural Medicines, V9, P61, DOI 10.1016/S1875-5364(11)60022-8; KHAC DD, 1990, PHYTOCHEMISTRY, V29, P251, DOI 10.1016/0031-9422(90)89044-A; Konoshima T, 1996, BIOL PHARM BULL, V19, P962, DOI 10.1248/bpb.19.962; Li C. L., 2003, FLORA CHINA, V9, P291; Li J., 2013, MED FLORA SHANDONG, P283; Li YL, 2008, MOLECULES, V13, P1931, DOI 10.3390/molecules13081931; Liu C, 2014, PLANTA MED, V80, P936, DOI 10.1055/s-0034-1368612; Lu MY, 2013, FITOTERAPIA, V85, P119, DOI 10.1016/j.fitote.2013.01.006; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; McCutcheon AR, 1995, J ETHNOPHARMACOL, V49, P101, DOI 10.1016/0378-8741(95)90037-3; Mei QX, 2016, CHIN HERB MED, V8, P75, DOI 10.1016/S1674-6384(16)60011-4; [孟令云 Meng Lingyun], 2004, [中国药理学通报, Chinese Pharmacological Bulletin], V20, P588; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Oikonomakos NG, 2002, CURR PROTEIN PEPT SC, V3, P561, DOI 10.2174/1389203023380422; Ovesna Z, 2004, NEOPLASMA, V51, P327; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Quan ZW, 2010, CANCER LETT, V295, P252, DOI 10.1016/j.canlet.2010.03.008; Spiridonov NA, 2005, PHYTOTHER RES, V19, P428, DOI 10.1002/ptr.1616; Sun HX, 2006, BIOORGAN MED CHEM, V14, P1189, DOI 10.1016/j.bmc.2005.09.043; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Tosun A, 2006, TURK J PHARM SCI, V3, P167; Wada S, 1998, BIOORG MED CHEM LETT, V8, P2829, DOI 10.1016/S0960-894X(98)00515-0; Webster D, 2008, J ETHNOPHARMACOL, V115, P140, DOI 10.1016/j.jep.2007.09.014; Xue PF, 2006, BIOCHEM SYST ECOL, V34, P825, DOI 10.1016/j.bse.2006.07.003; [薛培凤 Xue Peifeng], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1052; Yang J, 2008, MAGN RESON CHEM, V46, P794, DOI 10.1002/mrc.2253; Zhang JY, 2007, CANCER BIOL THER, V6, P1413; Zhang N, 2014, CHIN HERB MED, V6, P164, DOI 10.1016/S1674-6384(14)60026-5; Zhang ZhongLi, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1490	47	12	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e175502	10.1371/journal.pone.0175502	http://dx.doi.org/10.1371/journal.pone.0175502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388692	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800061
J	Guo, WY; Cai, YQ; Zhang, HX; Yang, YF; Yang, G; Wang, XJ; Zhao, JY; Lin, JT; Zhu, JF; Li, WQ; Lv, LX				Guo, Weiyun; Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Zhao, Jingyuan; Lin, Juntang; Zhu, Jinfu; Li, Wenqiang; Lv, Luxian			Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; LINKED MENTAL-RETARDATION; GENOME-WIDE ASSOCIATION; P190 RHOGAP; NEURODEVELOPMENTAL HYPOTHESIS; RHOA ACTIVITY; MIGRATION; COMPLEX; GENE; SUSCEPTIBILITY	Numerous developmental genes have been linked to schizophrenia (SZ) by case-control and genome-wide association studies, suggesting that neurodevelopmental disturbances are major pathogenic mechanisms. However, no neurodevelopmental deficit has been definitively linked to SZ occurrence, likely due to disease heterogeneity and the differential effects of various gene variants across ethnicities. Hence, it is critical to examine linkages in specific ethnic populations, such as Han Chinese. The newly identified RhoGAP ARH-GAP18 is likely involved in neurodevelopment through regulation of RhoA/C. Here we describe four single nucleotide polymorphisms (SNPs) in ARHGAP18 associated with SZ across a cohort of >2000 cases and controls from the Han population. Two SNPs, rs7758025 and rs9483050, displayed significant differences between case and control groups both in genotype (P = 0.0002 and P = 7.54x10(-6)) and allelic frequencies (P = 4.36x10(-5) and P = 5.98x10(-7)), respectively. The AG haplotype in rs7758025-rs9385502 was strongly associated with the occurrence of SZ (P = 0.0012, OR = 0.67, 95% CI = 0.48 - 0.93), an association that still held following a 1000-times random permutation test (P = 0.022). In an independently collected validation cohort, rs9483050 was the SNP most strongly associated with SZ. In addition, the allelic frequencies of rs12197901 remained associated with SZ in the combined cohort (P = 0.021), although not in the validation cohort alone (P = 0.251). Collectively, our data suggest the ARHGAP18 may confer vulnerability to SZ in the Chinese Han population, providing additional evidence for the involvement of neurodevelopmental dysfunction in the pathogenesis of schizophrenia.	[Guo, Weiyun; Lin, Juntang] Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China; [Guo, Weiyun; Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Lin, Juntang; Li, Wenqiang; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Cai, Yaqi; Zhang, Hongxing; Yang, Yongfeng; Yang, Ge; Wang, Xiujuan; Zhao, Jingyuan; Li, Wenqiang; Lv, Luxian] Xinxiang Med Univ, Henan Mental Hosp, Dept Psychiat, Affiliated Hosp 2, Xinxiang, Peoples R China; [Lin, Juntang; Zhu, Jinfu] Friedrich Schiller Univ Jena, Inst Anat 1, Jena, Germany; [Zhu, Jinfu] Xinxiang Med Univ, Dept Psychol, Xinxiang, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Friedrich Schiller University of Jena; Xinxiang Medical University	Li, WQ; Lv, LX (corresponding author), Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China.; Li, WQ; Lv, LX (corresponding author), Xinxiang Med Univ, Henan Mental Hosp, Dept Psychiat, Affiliated Hosp 2, Xinxiang, Peoples R China.	lwq781603@163.com; lvx928@126.com			National Natural Science Foundation of China [81201040, U1404811, 81571315]; Natural Science Foundation of Henan [122300413212, 162102310488, 132102310164]; Scientific Research Fund of Xinxiang Medical University [ZD2011-20, 2013QN102]; Open Fund of Henan Key lab of Biological Psychiatry [ZDSYS2014002]; Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Scientific Research Fund of Xinxiang Medical University; Open Fund of Henan Key lab of Biological Psychiatry; Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University	This work was supported by the following: (1) the National Natural Science Foundation of China (to WL, 81201040; to YY, U1404811; to HZ, 81571315), http://www.nsfc.gov.cn/. (2) the Natural Science Foundation of Henan (to WL, 122300413212; to WG, 162102310488; to J. Zhu, 132102310164), http://www.hnkjt.gov.cn/. (3) the Scientific Research Fund of Xinxiang Medical University (to WL, ZD2011-20; to YY, 2013QN102), http://www.xxmu.edu.cn/. (4) the Open Fund of Henan Key lab of Biological Psychiatry (to WG, ZDSYS2014002). (5) the support project for the Disciplinary group of Psychology and Neuroscience to Xinxiang Medical University, http://www.haedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2015, GENE, V558, P220, DOI 10.1016/j.gene.2014.12.064; Azzarelli R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4405; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Cannon TD, 2015, TRENDS COGN SCI, V19, P744, DOI 10.1016/j.tics.2015.09.009; Chang Garry H K, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.975002; Datta D, 2015, BIOL PSYCHIAT, V78, P775, DOI 10.1016/j.biopsych.2015.03.030; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Foletta VC, 2002, MOL BRAIN RES, V107, P65, DOI 10.1016/S0169-328X(02)00448-5; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hu XF, 2013, PROG NEURO-PSYCHOPH, V43, P197, DOI 10.1016/j.pnpbp.2012.12.007; Katayama KI, 2013, DEVELOPMENT, V140, P3139, DOI 10.1242/dev.092585; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Kitaoka Y, 2004, BRAIN RES, V1018, P111, DOI 10.1016/j.brainres.2004.05.070; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Li WQ, 2011, PROG NEURO-PSYCHOPH, V35, P1505, DOI 10.1016/j.pnpbp.2011.04.007; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Ma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057865; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Mulherkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067015; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Sakurai T, 2015, PROG NEUROBIOL, V134, P178, DOI 10.1016/j.pneurobio.2015.09.010; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Schaefer L, 1997, GENOMICS, V46, P268, DOI 10.1006/geno.1997.5040; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Voineskos AN, 2015, SCHIZOPHR RES, V161, P50, DOI 10.1016/j.schres.2014.03.034; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	48	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175209	10.1371/journal.pone.0175209	http://dx.doi.org/10.1371/journal.pone.0175209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384650	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900120
J	Oguma, T; Nagaoka, T; Kurahashi, M; Kobayashi, N; Yamamori, S; Tsuji, C; Takiguchi, H; Niimi, K; Tomomatsu, H; Tomomatsu, K; Hayama, N; Aoki, T; Urano, T; Magatani, K; Takeda, S; Abe, T; Asano, K				Oguma, Tsuyoshi; Nagaoka, Takashi; Kurahashi, Muneshige; Kobayashi, Naofumi; Yamamori, Shinji; Tsuji, Chizuko; Takiguchi, Hiroto; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Aoki, Takuya; Urano, Tetsuya; Magatani, Kazushige; Takeda, Sunao; Abe, Tadashi; Asano, Koichiro			Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer	PLOS ONE			English	Article							BREATH; JAPAN; COPD	Background Exhaled volatile organic compounds (VOC) are being considered as biomarkers for various lungs diseases, including cancer. However, the accurate measurement of extremely low concentrations of VOC in expired air is technically challenging. We evaluated the clinical contribution of exhaled VOC measured with a new, double cold-trap method in the diagnosis of lung cancer. Methods Breath samples were collected from 116 patients with histologically confirmed lung cancer and 37 healthy volunteers (controls) after inspiration of purified air, synthesized through a cold-trap system. The exhaled VOC, trapped in the same system, were heat extracted. We analyzed 14 VOC with gas chromatography. Results The concentrations of exhaled cyclohexane and xylene were significantly higher in patients with lung cancer than in controls (p = 0.002 and 0.0001, respectively), increased significantly with the progression of the clinical stage of cancer (both p < 0.001), and decreased significantly after successful treatment of 6 patients with small cell lung cancer (p = 0.06 and 0.03, respectively). Conclusion Measurements of exhaled VOCs by a double cold-trap method may help diagnose lung cancer and monitor its progression and regression.	[Oguma, Tsuyoshi; Takiguchi, Hiroto; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Aoki, Takuya; Urano, Tetsuya; Abe, Tadashi; Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa, Japan; [Nagaoka, Takashi; Takeda, Sunao] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Kurahashi, Muneshige; Kobayashi, Naofumi; Yamamori, Shinji] Nihon Kohden Corp, Ogino Mem Lab, Tokyo, Japan; [Tsuji, Chizuko] Tokai Univ, Sch Med, Dept Physiol, Hiratsuka, Kanagawa, Japan; [Magatani, Kazushige] Tokai Univ, Sch Engn, Dept Elect & Elect Engn, Hiratsuka, Kanagawa, Japan	Tokai University; Waseda University; Nihon Kohden Corporation; Tokai University; Tokai University	Oguma, T (corresponding author), Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa, Japan.	tyoguma@tokai-u.jp		Nagaoka, Takashi/0000-0002-7460-5008				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Buszewski B, 2009, BIOMED CHROMATOGR, V23, P551, DOI 10.1002/bmc.1141; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Fuchs D, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027101; Gasparri R, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/1/016007; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Mazzone PJ, 2012, J THORAC ONCOL, V7, P137, DOI 10.1097/JTO.0b013e318233d80f; Nagaoka T, 2015, ADV BIOMED ENG, V4, P112, DOI 10.14326/abe.4.112; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Poli Diana, 2008, Acta Biomed, V79 Suppl 1, P64; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Solano-Serena F, 1998, BIODEGRADATION, V9, P319, DOI 10.1023/A:1008305906032; Song G, 2010, LUNG CANCER, V67, P227, DOI 10.1016/j.lungcan.2009.03.029; Stock TH, 2004, ENV HLTH PERSPECT, V112, P1386; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; van de Kant KDG, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-117	18	27	33	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174802	10.1371/journal.pone.0174802	http://dx.doi.org/10.1371/journal.pone.0174802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384298	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900038
J	Paal, P; Bukki, J				Paal, Piret; Buekki, Johannes			"If I had stayed back home, I would not be alive any more..." - Exploring end-of-life preferences in patients with migration background	PLOS ONE			English	Article							PALLIATIVE CARE; UNITED-KINGDOM; ETHNIC-GROUPS; PHYSICIANS; MIGRANTS	Background In patients with life-limiting conditions and a history of migration, a higher risk of not dying at home and limited access to palliative care services has been reported. Aim To explore the views and end-of-life preferences of patients with a migration history in Germany and to identify migration specific themes. Design Two-armed study using Kaufmann's 'understanding interview' ('focused interview') method and grounded theory approach. Thematic content analysis was applied using MaxQDA 12 software. Setting/Participants Migrant and non-migrant adult patients with far advanced, life-limiting disease receiving palliative care in different specialist level settings (specialist home palliative care, palliative care inpatient unit, inpatient hospice). Results The 37 interviewees (19 native Germans and 18 patients from Europe and the U.S., Israel, Turkey, and Indonesia) expressed eleven themes covering health care-and patient-related issues, of which four emerged to be specific for migrants: worse survival in home country; the perception of an altered identity and 'not belonging'; language skills as prerequisite to survive; and longing for 'home' while being attached to Germany. From these categories, three overarching themes were derived: (1) a limited understanding of the concept of 'palliative care'; (2) the suppression of end of life discussions for its association with suffering and loss of autonomy; and (3) the significance of complex individual migration histories. Conclusions Based on these findings, the concept of a 'double home' experience is proposed. Barriers to access to palliative care should be minimized for all patients while cultural stereotyping has to be avoided.	[Paal, Piret; Buekki, Johannes] Hospice Care DaSein, Dept Res & Dev, Munich, Germany; [Buekki, Johannes] Paracelsus Med Univ, Inst Nursing Sci & Palliat Care, Salzburg, Austria	Paracelsus Private Medical University	Bukki, J (corresponding author), Hospice Care DaSein, Dept Res & Dev, Munich, Germany.	dr.j.buekki@hospiz-da-sein.de	Paal, Piret/J-4565-2019; Bukki, Johannes/D-4980-2015	Bukki, Johannes/0000-0003-1232-1103; Paal, Piret/0000-0002-1341-3248	Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege) [VI 5/33454/20/15]; Bavarian Ministry of Health officials	Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege); Bavarian Ministry of Health officials	This work has been kindly funded by the Bavarian Ministry of Health (Bayerisches Staatsministerium fur Gesundheit und Pflege https://www.stmgp.bayern.de), grant number: VI 5/33454/20/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to Iemkje Stiemer and Iryna Tretiakova who diligently conducted the transcriptions, and to the Bavarian Ministry of Health officials who generously supported this research project and provided administrative advice.	Bade KJ, 2010, CYCLOPEDIA MIGRATION; Bosma H, 2010, PALLIATIVE MED, V24, P510, DOI 10.1177/0269216309351380; Briggs C. L., 1986, LEARNING ASK; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; Burt RS, 2005, BROKERAGE CLOSURE IN; Ceuterick M, 2017, SOC SCI MED, V177, P43, DOI 10.1016/j.socscimed.2017.01.026; Coupland VH, 2011, PALLIATIVE MED, V25, P314, DOI 10.1177/0269216310395986; Crawley LaVera M, 2005, J Palliat Med, V8 Suppl 1, pS58; de Graaff Fuusje M, 2010, BMC Palliat Care, V9, P19, DOI 10.1186/1472-684X-9-19; Epner DE, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds086; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Gunaratnam Y, 2014, SUBJECTIVITY, V7, P74, DOI 10.1057/sub.2013.21; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Holloway I., 2003, QUAL RES, V3, P345, DOI [https://doi.org/10.1177/1468794103033004, DOI 10.1177/1468794103033004, 10.1177/1468794103033004]; Jansky M, 2015, PALLIATIVE HOSPICE C; Jansky M, 2017, BUNDESGESUNDHEITSBLA, V60, P45, DOI 10.1007/s00103-016-2473-x; Kars MC, 2016, PALLIATIVE MED, V30, P533, DOI 10.1177/0269216315616759; Kaufmann Jean-Claude, 1999, UNDERSTANDING INTERV; LeBlanc TW, 2013, J ONCOL PRACT, V9, P277, DOI 10.1200/JOP.2013.000996; Milberg A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165452; Razum O, 2016, BUNDESGESUNDHEITSBLA, V59, P259, DOI 10.1007/s00103-015-2286-3; Salis Gross C, 2014, PALLIATIVE CARE SENS; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; Taylor B, 2011, QUAL HEALTH RES, V21, P1576, DOI 10.1177/1049732311415288; Torres S, 2016, J INTERCULT STUD, V37, P103, DOI 10.1080/07256868.2016.1141756; United Nations Department of Economic and Social Affairs report, 2016, TRENDS INT MIGRANT S; Vaismoradi M, 2016, J NUR ED PR, V6, P100, DOI DOI 10.5430/JNEP.V6N5P100; van Dijk TA, 2006, DISCOURSE STUD, V8, P159, DOI 10.1177/1461445606059565; Venkatasalu MR, 2014, PALLIATIVE MED, V28, P264, DOI 10.1177/0269216313506765; Volker Deborah L, 2005, Am J Hosp Palliat Care, V22, P442, DOI 10.1177/104990910502200610	30	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175314	10.1371/journal.pone.0175314	http://dx.doi.org/10.1371/journal.pone.0175314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384309	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900154
J	Walton, Z; Samelius, G; Odden, M; Willebrand, T				Walton, Zea; Samelius, Gustaf; Odden, Morten; Willebrand, Tomas			Variation in home range size of red foxes Vulpes vulpes along a gradient of productivity and human landscape alteration	PLOS ONE			English	Article							INTRA-SPECIFIC VARIATION; POPULATION-DENSITY; URBAN FOXES; HABITAT USE; SPACE-USE; TERRITORIALITY; PATTERNS; MOVEMENTS; MODEL; FOOD	Home range size is a fundamental concept for understanding animal dispersion and ecological needs, and it is one of the most commonly reported ecological attributes of free-ranging mammals. Previous studies indicate that red foxes Vulpes vulpes display great variability in home range size. Yet, there has been little consensus regarding the reasons why home range sizes of red foxes vary so extensively. In this study, we examine possible causes of variation in red fox home range sizes using data from 52 GPS collared red foxes from four study areas representing a gradient of landscape productivity and human landscape alteration in Norway and Sweden. Using 90% Local Convex Hull home range estimates, we examined how red fox home range size varied in relation to latitude, elevation, vegetation zone, proportion of agricultural land and human settlement within a home range, and sex and age. We found considerable variation in red fox home range sizes, ranging between 0.95 km(2) to 44 km(2) (LoCoH 90%) and 2.4 km(2) to 358 km(2) (MCP 100%). Elevation, proportion of agricultural land and sex accounted for 50% of the variation in home range size found amongst foxes, with elevation having the strongest effect. Red foxes residing in more productive landscapes (those in more southern vegetation zones), had home ranges approximately four times smaller than the home ranges of foxes in the northern boreal vegetation zone. Our results indicate that home range size was influenced by a productivity gradient at both the landscape (latitude) and the local (elevation) scale. The influence of the proportion of agriculture land on home range size of foxes illustrates how human landscape alteration can affect the space use and distribution of red foxes. Further, the variation in home range size found in this study demonstrates the plasticity of red foxes to respond to changing human landscape alteration as well as changes in landscape productivity, which may be contributing to red fox population increases and northern range expansions.	[Walton, Zea; Odden, Morten; Willebrand, Tomas] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Campus Evenstad, Koppang, Norway; [Samelius, Gustaf] Snow Leopard Trust, Seattle, WA USA	Inland Norway University of Applied Sciences	Walton, Z (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Campus Evenstad, Koppang, Norway.	zea.walton@inn.no		Walton, Zea/0000-0003-3859-3676	Swedish Nature Protection Board [DNR 15/155]; Swedish Hunters Association [5861/2016]; Karl Erik Onnesjos Stiftelse, Sweden; Norwegian Directorate for Nature Management [13F6CC7, 15SA0283, 16SA3A43]; Gotaas Fund, Norway [13/00282]	Swedish Nature Protection Board; Swedish Hunters Association; Karl Erik Onnesjos Stiftelse, Sweden; Norwegian Directorate for Nature Management; Gotaas Fund, Norway	Funding for this study was provided by the Swedish Nature Protection Board (DNR 15/155), Swedish Hunters Association (5861/2016), Karl Erik Onnesjos Stiftelse, Sweden, and the Norwegian Directorate for Nature Management (grant numbers: 13F6CC7, 15SA0283, 16SA3A43) and the Gotaas Fund, Norway (13/00282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES ED, 1969, J MAMMAL, V50, P108, DOI 10.2307/1378635; Andren H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120570; ANGELSTAM P, 1985, HOLARCTIC ECOL, V8, P285; Aronsson M, 2016, ECOL EVOL, V6, P2957, DOI 10.1002/ece3.2032; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Barton, 2009, MUMIN MULTIMODEL INT; Barton KA, 2007, GLOBAL ECOL BIOGEOGR, V16, P281, DOI 10.1111/j.1466-8238.2007.00299.x; Bastille-Rousseau G, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0080-y; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Buchmann CM, 2011, OIKOS, V120, P106, DOI 10.1111/j.1600-0706.2010.18556.x; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham KP, 1998, INTRO MODEL SELECTIO, P1; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; COMAN BJ, 1991, WILDLIFE RES, V18, P215, DOI 10.1071/WR9910215; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; DONCASTER CP, 1991, J ANIM ECOL, V60, P423, DOI 10.2307/5288; Duncan C, 2015, REMOTE SENS ECOL CON, V1, P39, DOI 10.1002/rse2.6; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; ESRI, 2011, ARCGIS REL 10 ARCGIS REL 10; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Goszczynski J, 2002, ACTA THERIOL, V47, P103, DOI 10.1007/BF03192482; Hagen D, 2013, ECOL SOC, V18, DOI 10.5751/ES-05891-180434; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; HARRISON DJ, 1989, J WILDLIFE MANAGE, V53, P181, DOI 10.2307/3801327; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; JONES DM, 1982, CAN J ZOOL, V60, P807, DOI 10.1139/z82-111; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kreeger T. J., 2012, HDB WILDLIFE CHEM IM, V4th; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Lucherini M, 1996, BEHAV PROCESS, V36, P103, DOI 10.1016/0376-6357(95)00018-6; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; MAJOR JT, 1987, J WILDLIFE MANAGE, V51, P606, DOI 10.2307/3801278; Maletzke BT, 2014, ECOL EVOL, V4, P2178, DOI 10.1002/ece3.1089; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Meia JS, 1995, CAN J ZOOL, V73, P1960, DOI 10.1139/z95-230; Moen A., 1998, NASJONALATLAS NORGE; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Nilsen EB, 2007, ECOLOGICAL RES, V23, P635; Panzacchi M, 2010, FOREST ECOL MANAG, V259, P1536, DOI 10.1016/j.foreco.2010.01.030; Pearce F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2122; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rotem G, 2011, J WILDLIFE MANAGE, V75, P132, DOI 10.1002/jwmg.9; Rydin H., 1999, SWEDISH PLANT GEOGRA; Saeki M, 2007, J MAMMAL, V88, P1098, DOI 10.1644/06-MAMM-A-208R1.1; Said S, 2009, OIKOS, V118, P1299, DOI 10.1111/j.1600-0706.2009.17346.x; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sinclair ARE, 2005, WILDLIFE ECOLOGY CON; STGEORGES M, 1995, CAN J ZOOL, V73, P755, DOI 10.1139/z95-089; TRAVAINI A, 1993, ACTA THERIOL, V38, P427, DOI 10.4098/AT.arch.93-33; Tsukada H, 1997, J ETHOL, V15, P27, DOI 10.1007/BF02767323; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; VOIGT D R, 1984, Acta Zoologica Fennica, V171, P261; White G.C., 1990, ANAL WILDLIFE RADIO	74	52	53	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175291	10.1371/journal.pone.0175291	http://dx.doi.org/10.1371/journal.pone.0175291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384313	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900147
J	Dorji, P; Fearns, P				Dorji, Passang; Fearns, Peter			Impact of the spatial resolution of satellite remote sensing sensors in the quantification of total suspended sediment concentration: A case study in turbid waters of Northern Western Australia	PLOS ONE			English	Article							DIFFUSE ATTENUATION COEFFICIENT; 250 M IMAGERY; PARTICULATE MATTER; COASTAL WATERS; ATMOSPHERIC CORRECTION; ENVIRONMENTAL IMPACTS; TAMPA-BAY; MODIS; LANDSAT; QUALITY	The impact of anthropogenic activities on coastal waters is a cause of concern because such activities add to the total suspended sediment (TSS) budget of the coastal waters, which have negative impacts on the coastal ecosystem. Satellite remote sensing provides a powerful tool in monitoring TSS concentration at high spatiotemporal resolution, but coastal managers should be mindful that the satellite-derived TSS concentrations are dependent on the satellite sensor's radiometric properties, atmospheric correction approaches, the spatial resolution and the limitations of specific TSS algorithms. In this study, we investigated the impact of different spatial resolutions of satellite sensor on the quantification of TSS concentration in coastal waters of northern Western Australia. We quantified the TSS product derived from MODerate resolution Imaging Spectroradiometer (MODIS)-Aqua, Landsat-8 Operational Land Image (OLI), and WorldView-2 (WV2) at native spatial resolutions of 250 m, 30 m and 2 m respectively and coarser spatial resolution (resampled up to 5 km) to quantify the impact of spatial resolution on the derived TSS product in different turbidity conditions. The results from the study show that in the waters of high turbidity and high spatial variability, the high spatial resolution WV2 sensor reported TSS concentration as high as 160 mg L-1 while the low spatial resolution MODIS-Aqua reported a maximum TSS concentration of 23.6 mg L-1. Degrading the spatial resolution of each satellite sensor for highly spatially variable turbid waters led to variability in the TSS concentrations of 114.46%, 304.68% and 38.2% for WV2, Landsat-8 OLI and MODIS-Aqua respectively. The implications of this work are particularly relevant in the situation of compliance monitoring where operations may be required to restrict TSS concentrations to a pre-defined limit.	[Dorji, Passang; Fearns, Peter] Curtin Univ, Remote Sensing & Satellite Res Grp, Perth, WA, Australia	Curtin University	Dorji, P (corresponding author), Curtin Univ, Remote Sensing & Satellite Res Grp, Perth, WA, Australia.	dorji.passang@postgrad.curtin.edu.au		Dorji, Passang/0000-0002-1130-0581	Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project [2/3]; Curtin University	Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project; Curtin University	This study was funded by the Western Australian Marine Science Institute (WAMSI) through the Dredging Science Node Project 2/3. Also, Curtin University provided a postgraduate research scholarship to PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021852; Australia P, 2014, DREDG AUSTR PORTS SU; Binding CE, 2005, REMOTE SENS ENVIRON, V94, P373, DOI 10.1016/j.rse.2004.11.002; Binding CE, 2003, INT J REMOTE SENS, V24, P3791, DOI 10.1080/0143116021000024131; Brando VE, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020150; Brewin RJW, 2015, REMOTE SENS ENVIRON, V162, P271, DOI 10.1016/j.rse.2013.09.016; Brezonik P, 2005, LAKE RESERV MANAGE, V21, P373, DOI 10.1080/07438140509354442; Bureau of Meteorology, 2015, CLIM STAT AUSTR LOC; Burenkov VI, 2001, OCEANOLOGY+, V41, P622; Chen J, 2014, REMOTE SENS ENVIRON, V140, P78, DOI 10.1016/j.rse.2013.08.031; Chen XL, 2010, INT J APPL EARTH OBS, V12, pS203, DOI 10.1016/j.jag.2009.10.002; Chen ZQ, 2007, REMOTE SENS ENVIRON, V109, P207, DOI 10.1016/j.rse.2006.12.019; Chevron, 2014, WSO000HESRPTCVX00000; Dekker AG, 2002, INT J REMOTE SENS, V23, P15, DOI 10.1080/01431160010006917; DigitalGlobe, 2017, RES SAT INF DIGITALG; Dorji P, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070556; Doxaran D, 2002, REMOTE SENS ENVIRON, V81, P149, DOI 10.1016/S0034-4257(01)00341-8; Doxaran D, 2006, INT J REMOTE SENS, V27, P2303, DOI 10.1080/01431160500396865; Doxaran D, 2009, ESTUAR COAST SHELF S, V81, P321, DOI 10.1016/j.ecss.2008.11.013; Ekercin S, 2007, WATER AIR SOIL POLL, V183, P239, DOI 10.1007/s11270-007-9373-5; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Eugenio F, 2013, 2013 PROCEEDINGS OF THE 21ST EUROPEAN SIGNAL PROCESSING CONFERENCE (EUSIPCO); Feldman G.C., 2010, L2GEN OCEAN COLOR SE; Fettweis M, 2007, CONT SHELF RES, V27, P1568, DOI 10.1016/j.csr.2007.01.017; Forkuor G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170478; Gernez P, 2015, REMOTE SENS-BASEL, V7, P9507, DOI 10.3390/rs70809507; Glover D. M., 2011, MODELING METHODS MAR; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Hanley JR, 2011, APPEA J, V2011, P273; Havens KE, 2011, J PLANKTON RES, V33, P1081, DOI 10.1093/plankt/fbr002; Hu CM, 2004, REMOTE SENS ENVIRON, V93, P423, DOI 10.1016/j.rse.2004.08.007; Islam M. S., 2007, J COMPUTER SCI, V1, P15; Kallio K, 2008, ENVIRON MANAGE, V42, P511, DOI 10.1007/s00267-008-9146-y; Kloiber SN, 2002, REMOTE SENS ENVIRON, V82, P38, DOI 10.1016/S0034-4257(02)00022-6; Koponen S, 2002, REMOTE SENS ENVIRON, V79, P51, DOI 10.1016/S0034-4257(01)00238-3; Koponen S, 2007, CONT SHELF RES, V27, P228, DOI 10.1016/j.csr.2006.10.006; Kotchenova SY, 2006, APPL OPTICS, V45, P6762, DOI 10.1364/AO.45.006762; Kratzer S, 2008, REMOTE SENS ENVIRON, V112, P2284, DOI 10.1016/j.rse.2007.10.006; Lee ZP, 1999, APPL OPTICS, P38; Li J, 2010, ACTA OCEANOL SIN, V29, P38, DOI 10.1007/s13131-010-0049-4; Martin J, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010037; Miller RL, 2011, REMOTE SENS-BASEL, V3, P962, DOI 10.3390/rs3050962; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Min JE, 2012, MAR POLLUT BULL, V64, P382, DOI 10.1016/j.marpolbul.2011.10.025; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; Mostafa YE, 2012, AIN SHAMS ENG J, V3, P1, DOI 10.1016/j.asej.2011.12.004; Myint SW, 2002, INT J REMOTE SENS, V23, P3229, DOI 10.1080/01431160110104700; Odermatt D, 2008, SENSORS-BASEL, V8, P4582, DOI 10.3390/s8084582; Ody A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030245; Olmanson LG, 2008, REMOTE SENS ENVIRON, V112, P4086, DOI 10.1016/j.rse.2007.12.013; Onderka M, 2008, SCI TOTAL ENVIRON, V397, P238, DOI 10.1016/j.scitotenv.2008.02.044; Ostlund C, 2001, SCI TOTAL ENVIRON, V268, P139, DOI 10.1016/S0048-9697(00)00683-5; Ouillon S, 2005, OPT EXPRESS, V13, P2531, DOI 10.1364/OPEX.13.002531; Passang D, 2016, SEMIANALYTIC MODEL E; Petus C, 2010, CONT SHELF RES, V30, P379, DOI 10.1016/j.csr.2009.12.007; Ruddick K., 2000, APPL OPTICS, V39, P912; Sanderson PG, 2001, AMBIO, V30, P43, DOI 10.1639/0044-7447(2001)030[0043:TAOSRS]2.0.CO;2; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40326; Shi K, 2014, REMOTE SENS ENVIRON, V140, P365, DOI 10.1016/j.rse.2013.09.013; SKM Sinclair Knight Merz Pty Ltd., 2013, IMPR DREDG MAT MAN G; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sun DY, 2013, IEEE T GEOSCI REMOTE, V51, P3871, DOI 10.1109/TGRS.2012.2227976; Tang SL, 2013, INT J REMOTE SENS, V34, P6562, DOI 10.1080/01431161.2013.804222; URS, 2014, ONSL WAT INFR UPGR P; Vanhellemont Q, 2015, REMOTE SENS ENVIRON, V161, P89, DOI 10.1016/j.rse.2015.02.007; Vanhellemont Q, 2014, REMOTE SENS ENVIRON, V145, P105, DOI 10.1016/j.rse.2014.01.009; WA EPA, 2011, ENV ASS GUID MAR DRE; WAMSI, 2014, DREDG SCI NOD W AUST; Wang F, 2009, ENVIRON GEOL, V56, P1093, DOI 10.1007/s00254-008-1209-0; Wang JJ, 2010, SCI TOTAL ENVIRON, V408, P1131, DOI 10.1016/j.scitotenv.2009.11.057; Wang JJ, 2009, EARTH SURF PROC LAND, V34, P1082, DOI 10.1002/esp.1795; Wang MH, 2009, REMOTE SENS ENVIRON, V113, P635, DOI 10.1016/j.rse.2008.11.005; WAPC, 2011, ONSL REG HOTSP LAND; Wu GF, 2008, INT J REMOTE SENS, V29, P2183, DOI 10.1080/01431160701422254; Wu M, 2009, ENVIRON MONIT ASSESS, V148, P255, DOI 10.1007/s10661-008-0156-2; Yueh MF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037705, 10.1371/journal.pone.0043606]; Zhang MW, 2010, REMOTE SENS ENVIRON, V114, P392, DOI 10.1016/j.rse.2009.09.016; Zhao WJ, 2001, REMOTE SENS ENVIRON, V76, P202, DOI 10.1016/S0034-4257(00)00204-2; Zhou W, 2006, INT J REMOTE SENS, V27, P1177, DOI 10.1080/01431160500353825	79	31	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175042	10.1371/journal.pone.0175042	http://dx.doi.org/10.1371/journal.pone.0175042			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380059	Green Submitted, gold, Green Published			2022-12-26	WOS:000399353500090
J	Hansen, J; Asberg, S; Kumlien, E; Zelano, J				Hansen, Julia; Asberg, Signild; Kumlien, Eva; Zelano, Johan			Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort study	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; RISK-FACTORS; SEIZURES; LEVETIRACETAM; CARBAMAZEPINE; MONOTHERAPY; VALIDATION; PREDICTORS; INPATIENT; REGISTER	The risk of death is increased for persons with epilepsy. The literature on causes of death in epilepsy is based mainly on cohorts with epilepsy of mixed aetiologies. For clinical purposes and improved understanding of mortality in different epilepsies, more information is needed on mortality in epilepsies of specific causes. In poststroke epilepsy (PSE), seizures occur in a setting of vascular disease and high mortality rates. The extent to which epilepsy contributes to mortality in this patient group is poorly understood. We therefore aimed to describe causes of death (COD) in PSE on a national scale. A previously identified cohort of 7740 patients with epilepsy or seizures after a stroke in 2005-2010 was investigated. A total of 4167 deaths occurred before the end of 2014. The standardized mortality ratio for the study cohort was 3.56 (95% CI: 3.45-3.67). The main underlying causes of death were disorders of the circulatory system (60%) followed by neoplasms (12%). Diseases of the nervous system were the sixth leading underlying COD (3%), and epilepsy or status epilepticus was considered the underlying COD in approximately a similar proportion of cases as neurodegenerative disorders (0.9% and 1.1%, respectively). Epilepsy was considered a contributing COD in 14% of cases. Our findings highlight the importance of optimal management of vascular morbidity in patients with PSE. The large proportion of patients with epilepsy as a contributing COD indicate the need of high ambitions also regarding the management of seizures in patients with PSE.	[Hansen, Julia; Zelano, Johan] Univ Gothenburg, Dept Neurol, Sahlgrenska Univ Hosp, Gothenburg, Sweden; [Hansen, Julia; Zelano, Johan] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Asberg, Signild] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Kumlien, Eva] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Uppsala University; Uppsala University	Zelano, J (corresponding author), Univ Gothenburg, Dept Neurol, Sahlgrenska Univ Hosp, Gothenburg, Sweden.; Zelano, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	johan.zelano@neuro.gu.se	Åsberg, Signild/AAU-8162-2020; Zelano, Johan/AAF-1708-2021	Åsberg, Signild/0000-0001-8693-1014; Zelano, Johan/0000-0001-9445-4545	Swedish Society of Medicine, Jeanssons foundation; Gbteborg Medical Society; Sahlgrenska university hospital	Swedish Society of Medicine, Jeanssons foundation; Gbteborg Medical Society; Sahlgrenska university hospital	This project was funded by Swedish Society of Medicine, Jeanssons foundation, The Gbteborg Medical Society, and Sahlgrenska university hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Belcastro V, 2008, EPILEPSY RES, V82, P223, DOI 10.1016/j.eplepsyres.2008.08.008; Consoli D, 2012, CEREBROVASC DIS, V34, P282, DOI 10.1159/000342669; Ferlazzo E, 2016, EPILEPSIA, V57, P1205, DOI 10.1111/epi.13448; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Gilad R, 2007, CLIN NEUROPHARMACOL, V30, P189, DOI 10.1097/WNF.0B013E3180333069; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; Jungehulsing GJ, 2013, ACTA NEUROL SCAND, V127, P427, DOI 10.1111/ane.12070; Keezer MR, 2016, NEUROLOGY, V86, P704, DOI 10.1212/WNL.0000000000002390; Kutlu G, 2008, EPILEPSY BEHAV, V13, P542, DOI 10.1016/j.yebeh.2008.04.025; Lindsten H, 2000, EPILEPSIA, V41, P1469, DOI 10.1111/j.1528-1157.2000.tb00124.x; Loiseau J, 1999, EPILEPSIA, V40, P1388, DOI 10.1111/j.1528-1157.1999.tb02010.x; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mattsson P, 2010, NEUROLOGY, V74, P295, DOI 10.1212/WNL.0b013e3181cbcd5c; Nevalainen O, 2016, EUR J EPIDEMIOL, V31, P445, DOI 10.1007/s10654-015-0095-5; Nevalainen O, 2012, EPILEPSIA, V53, pe212, DOI 10.1111/epi.12006; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; Rafnsson V, 2001, NEUROEPIDEMIOLOGY, V20, P232, DOI 10.1159/000054795; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Socialstyrelsen, 2010, PROD TILLF RLITL KOM; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Trinka E, 2013, EPILEPSIA, V54, P495, DOI 10.1111/epi.12014; Zelano J, 2016, EUR STROKE J, V1, P272, DOI 10.1177/2396987316669000; Zelano J, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.366	25	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174659	10.1371/journal.pone.0174659	http://dx.doi.org/10.1371/journal.pone.0174659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380003	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500056
J	Ishiguro, S; Uppalapati, D; Goldsmith, Z; Robertson, D; Hodge, J; Holt, H; Nakashima, A; Turner, K; Tamura, M				Ishiguro, Susumu; Uppalapati, Deepthi; Goldsmith, Zachary; Robertson, Dana; Hodge, Jacob; Holt, Hayley; Nakashima, Arashi; Turner, Katie; Tamura, Masaaki			Exopolysaccharides extracted from Parachlorella kessleri inhibit colon carcinoma growth in mice via stimulation of host antitumor immune responses	PLOS ONE			English	Article							UNICELLULAR GREEN-ALGAE; CHLORELLA-VULGARIS; ATTENUATES GROWTH; CELL-WALL; TUMOR; POLYSACCHARIDES; GLYCOPROTEIN; RESISTANCE; LIPOPOLYSACCHARIDE; STRAIN	The newly purified extracellular polysaccharides (exopolysaccharides) from Parachlorella kessleri (PCEPS) were evaluated on their antitumor and immunomodulatory effects in cell culture and mouse colon carcinoma peritoneal dissemination model. In two-dimensional cell culture, the PCEPS treatment inhibited cell growth of both murine and human colon carcinoma cells in a dose- and time-dependent manner. In contrast, the growth of mouse splenocytes (SPLs) and bone marrow cells (BMCs) were stimulated by the treatment with PCEPS. The treatment with PCEPS also increased specific subpopulations of the cells in BMCs: antigen presenting cells (CD19(+) B cells, 33D1(+) dendritic cells and CD68(+) macrophage) and CD8(+) cytotoxic T cells. In three-dimensional spheroid culture, spheroid growth of CT26 cells co-cultured with HL-60 human neutrophilic promyeloblasts and Jurkat cells (human lymphoblasts), but not THP1 human monocyte/macrophage was significantly attenuated by PCEPS treatment. In a mouse CT26 colon carcinoma peritoneal dissemination model, intraperitoneal injection of PCEPS (10 mg/kg, twice per week) significantly attenuated the growth of CT26 colon carcinoma in syngeneic mice. The present study suggests that PCEPS inhibits colon carcinoma growth via direct cell growth inhibition and a stimulation of the host antitumor immune responses. Taken together, the current study suggests that exopolysaccharides derived from Parachlorella kessleri contain significant bioactive materials that inhibit colon carcinoma growth.	[Tamura, Masaaki] Kansas State Univ, Coll Vet Med, Dept Anat, Manhattan, KS 66506 USA; Kansas State Univ, Coll Vet Med, Dept Physiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Tamura, M (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat, Manhattan, KS 66506 USA.	mtamura@vet.ksu.edu		Tamura, Masaaki/0000-0003-4863-3379; Ishiguro, Susumu/0000-0002-3268-7754	Kansas State University Johnson Cancer Research Center [2011JCRCEQ, 2014CRA, 2015CRA, 2016CRA]; College of Veterinary Medicine Dean's funds [2010CVM-EQ]; NIH [P20 RR017686]	Kansas State University Johnson Cancer Research Center; College of Veterinary Medicine Dean's funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by funds from Kansas State University Johnson Cancer Research Center 2011JCRCEQ (MT), 2014CRA (ZG and MT), 2015CRA (JH, HH, AN and MT), 2016CRA (HH and MT), College of Veterinary Medicine Dean's funds 2010CVM-EQ (MT), and NIH grant P20 RR017686 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, COLORECTAL CANCER FA; Armstrong MT, 2006, FASEB J, V20, P2145, DOI 10.1096/fj.05-5484fje; Armstrong PB, 2002, BIOL BULL, V203, P203, DOI 10.2307/1543397; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buono S, 2014, FOOD FUNCT, V5, P1669, DOI [10.1039/C4FO00125G, 10.1039/c4fo00125g]; Coragliotti A. FS, 2012, Microalgal polysaccharide compositions. United States patent US, Patent No. 20120202768; Raposo MFD, 2013, MAR DRUGS, V11, P233, DOI 10.3390/md11010233; Doi C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-67; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; El-Sheekh MM, 2012, IRAN J ENVIRON HEALT, V9, DOI 10.1186/1735-2746-9-10; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Hasegawa T, 2002, INT IMMUNOPHARMACOL, V2, P579, DOI 10.1016/S1567-5769(02)00002-4; HASEGAWA T, 1995, INT J IMMUNOPHARMACO, V17, P505, DOI 10.1016/0192-0561(95)00035-Z; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; IBUSUKI K, 1990, NAT IMMUN CELL GROW, V9, P121; Ishiguro S, 2016, PHARM RES-DORDR, V33, P2517, DOI 10.1007/s11095-016-1976-3; Ishiguro S, 2015, CANCER BIOL THER, V16, P307, DOI 10.1080/15384047.2014.1002357; Justo GZ, 2001, IMMUNOPHARM IMMUNOT, V23, P119, DOI 10.1081/IPH-100102573; Kawabata A, 2012, CANCER BIOL THER, V13, P880, DOI 10.4161/cbt.20840; Kawakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084704; KONISHI F, 1985, CANCER IMMUNOL IMMUN, V19, P73; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li P, 2001, Biotechnol Genet Eng Rev, V18, P375; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Matsuzuka T, 2010, LUNG CANCER, V70, P28, DOI 10.1016/j.lungcan.2010.01.003; Merchant Randall E., 2002, Journal of Medicinal Food, V5, P141, DOI 10.1089/10966200260398170; MIKHEYSKAYA LV, 1977, J BACTERIOL, V130, P1; MIYAZAWA Y, 1988, J ETHNOPHARMACOL, V24, P135, DOI 10.1016/0378-8741(88)90145-6; Mohamed ZA, 2008, ECOTOXICOLOGY, V17, P504, DOI 10.1007/s10646-008-0204-2; Noda K, 1996, PLANTA MED, V62, P423, DOI 10.1055/s-2006-957931; Ohta N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123756; OKAMOTO K, 1978, JPN HEART J, V19, P622; OSBORN MJ, 1964, SCIENCE, V145, P783, DOI 10.1126/science.145.3634.783; Ou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087223; PANAC CO. LTD, 2014, Japan patent, Patent No. [JP2014-025035A, 2014025035]; Ramos AL, 2010, NUTR CANCER, V62, P1170, DOI 10.1080/01635581.2010.513801; Royce CL, 1996, J ENDOTOXIN RES, V3, P437, DOI 10.1177/096805199600300601; SANO T, 1987, ARTERY, V14, P76; SANO T, 1988, ARTERY, V15, P217; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEMPLE TU, 1978, CANCER RES, V38, P1345; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; TANAKA K, 1984, CANCER IMMUNOL IMMUN, V17, P90, DOI 10.1007/BF00200042; TANAKA K, 1990, IMMUNOPHARM IMMUNOT, V12, P277, DOI 10.3109/08923979009019673; Tanaka K, 1998, CANCER IMMUNOL IMMUN, V45, P313, DOI 10.1007/s002620050448; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Zheng WF, 2006, INT IMMUNOPHARMACOL, V6, P1093, DOI 10.1016/j.intimp.2006.01.020	49	17	17	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175064	10.1371/journal.pone.0175064	http://dx.doi.org/10.1371/journal.pone.0175064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380056	Green Published, gold			2022-12-26	WOS:000399353500091
J	Kjaergaard, M; Thiele, M; Jansen, C; Madsen, BS; Gortzen, J; Strassburg, C; Trebicka, J; Krag, A				Kjaergaard, Maria; Thiele, Maja; Jansen, Christian; Madsen, Bjom Staehr; Goertzen, Jan; Strassburg, Christian; Trebicka, Jonel; Krag, Aleksander			High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PORTAL-HYPERTENSION; FIBROSIS; RELIABILITY; CIRRHOSIS; VIRUS	Food intake increases liver stiffness, but it is believed that liver stiffness returns to baseline two hours after a meal. The aim of this study was to investigate the impact of different sized meals on liver stiffness. Liver and spleen stiffness was measured with transient elastography (TE) and real-time 2-dimensional shear wave elastography (2D-SWE). Patients ingested a 625 kcal and a 1250 kcal liquid meal on two consecutive days. We measured liver and spleen elasticity, Controlled attenuation parameter (CAP) and portal flow at baseline and after 20, 40, 60, 120 and 180 minutes. Sixty patients participated, 83% with alcoholic liver disease. Twenty-eight patients had METAVIR fibrosis score F0-3 and 32 patients had cirrhosis. Liver stiffness, spleen stiffness and CAP increased after both meals for all stages of fibrosis. False positive 2D-SWE liver stiffness measurements caused 36% and 52% of patients with F0-3 fibrosis to be misclassified with higher stages of fibrosis after the moderate and high caloric meal. Likewise, 10% and 13% of compensated cirrhosis patients were misclassified with clinically significant portal hypertension after the two meals. We observed similar misclassification rates with TE. After three hours, liver stiffness remained elevated more than 20% from baseline in up to 50% of patients. In conclusion: Liver stiffness, spleen stiffness and CAP increase after a meal across all stages of fibrosis and across elastography techniques. Up to half of patients may be misclassified with higher stages of fibrosis, if they are assessed after less than three hours fasting period.	[Kjaergaard, Maria; Thiele, Maja; Madsen, Bjom Staehr; Trebicka, Jonel; Krag, Aleksander] Odense Univ Hosp, Dept & Gastroenterol & Hepatol, Odense, Denmark; [Kjaergaard, Maria; Thiele, Maja; Madsen, Bjom Staehr] OPEN, Odense, Denmark; [Thiele, Maja; Madsen, Bjom Staehr; Trebicka, Jonel; Krag, Aleksander] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Jansen, Christian; Goertzen, Jan; Strassburg, Christian; Trebicka, Jonel] Univ Klinikum Bonn, Dept Internal Med 1, Bonn, Germany; [Trebicka, Jonel] European Fdn Study Chron Liver Failure EF Clif, Barcelona, Spain	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Bonn	Kjaergaard, M (corresponding author), Odense Univ Hosp, Dept & Gastroenterol & Hepatol, Odense, Denmark.; Kjaergaard, M (corresponding author), OPEN, Odense, Denmark.	maria.kjaergaard@rsyd.dk	Krag, Aleksander/ABH-9649-2020; Thiele, Maja/AAD-2353-2019	Krag, Aleksander/0000-0002-9598-4932; Thiele, Maja/0000-0003-1854-1924; Kjaergaard, Maria/0000-0001-8452-1820	National Advanced Technology Foundation/Innovation Fund Denmark; University of Southern Denmark; Region of Southern Denmark; A. P. Moeller Foundation; Toyota Foundation; Deutsche Forschungsgemeinschaft [SFB TRR57]; H. J. AMP; W. Hector Stiftung [M60.2]; National Advanced Technology Foundation/Innovation Fund Denmark; University of Southern Denmark; Region of Southern Denmark; A. P. Moeller Foundation; Toyota Foundation; Deutsche Forschungsgemeinschaft [SFB TRR57]; H. J. AMP; W. Hector Stiftung [M60.2]	National Advanced Technology Foundation/Innovation Fund Denmark; University of Southern Denmark; Region of Southern Denmark; A. P. Moeller Foundation; Toyota Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. J. AMP; W. Hector Stiftung; National Advanced Technology Foundation/Innovation Fund Denmark; University of Southern Denmark; Region of Southern Denmark; A. P. Moeller Foundation; Toyota Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. J. AMP; W. Hector Stiftung	The study was funded by the National Advanced Technology Foundation/Innovation Fund Denmark, University of Southern Denmark, Region of Southern Denmark, the A. P. Moeller Foundation, the Toyota Foundation, Deutsche Forschungsgemeinschaft (SFB TRR57) and H. J. & W. Hector Stiftung (M60.2). Nestle Denmark provided the liquid meals free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2015, GASTROENT HEPAT-BARC, V38, P431, DOI 10.1016/j.gastrohep.2015.01.009; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arena U, 2013, HEPATOLOGY, V58, P65, DOI 10.1002/hep.26343; Barone M, 2015, SCAND J GASTROENTERO, V50, P560, DOI 10.3109/00365521.2014.1003396; Berzigotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058742; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; Elkrief L, 2015, RADIOLOGY, V275, P589, DOI 10.1148/radiol.14141210; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Herrmann E, 2015, J HEPATOL, V62, pS199, DOI 10.1016/S0168-8278(15)30026-X; Jansen C, 2016, LIVER INT OFFICIAL J; Jansen C, 2016, GUT, V65, P1057, DOI 10.1136/gutjnl-2016-311536; Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Procopet B, 2015, J HEPATOL, V62, P1068, DOI 10.1016/j.jhep.2014.12.007; Staugaard B., 2016, SCAND J GASTROENTERO, V16, P1; Tangpradabkiet Warisara, 2014, Journal of the Medical Association of Thailand, V97, P1033; Thiele M, 2016, EUROPEAN J ULTRASOUN; Thiele M, 2016, GASTROENTEROLOGY, V150, P123, DOI 10.1053/j.gastro.2015.09.040; Tsochatzis EA, 2014, HEPATOLOGY, V60, P832, DOI 10.1002/hep.27296	25	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0173992	10.1371/journal.pone.0173992	http://dx.doi.org/10.1371/journal.pone.0173992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376114	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000003
J	Uekusa, Y; Takatsuki, S; Tsutsumi, T; Akiyama, H; Matsuda, R; Teshima, R; Hachisuka, A; Watanabe, T				Uekusa, Yoshinori; Takatsuki, Satoshi; Tsutsumi, Tomoaki; Akiyama, Hiroshi; Matsuda, Rieko; Teshima, Reiko; Hachisuka, Akiko; Watanabe, Takahiro			Determination of polychlorinated biphenyls in marine fish obtained from tsunami-stricken areas of Japan	PLOS ONE			English	Article							COMMERCIAL PCB FORMULATIONS; DIOXIN-LIKE PCBS; GAS; RISK; FOOD	We determined the polychlorinated biphenyl (PCB) congeners in 101 marine fish obtained from tsunami-stricken areas following the Great East Japan Earthquake in 2011. In particular, to determine the degree of PCB contamination in the fish, we investigated the concentration of total PCB (Sigma PCB) and the proportions of 209 individual PCB congeners by high-resolution gas chromatography/high-resolution mass spectrometry. The Sigma PCB concentration was 1.7-33 ng/g in fat greenling (n = 29), 0.44-25 ng/g in flounder (n = 36), and 1.6-86 ng/g in mackerel (n = 36), all values being much lower than the provisional regulatory limit in Japan. In the congener analysis, tetra-, penta-, hexa-, and hepta-chlorinated PCB congeners dominated in all samples (comprising over 86% of the Sigma PCB). The proportions of the chlorinated PCB congeners were similar to the contamination patterns derived from Kanechlor in the environment, implying that the marine fish were not contaminated with fresh PCBs.	[Uekusa, Yoshinori; Takatsuki, Satoshi; Tsutsumi, Tomoaki; Akiyama, Hiroshi; Matsuda, Rieko; Teshima, Reiko; Hachisuka, Akiko; Watanabe, Takahiro] Natl Inst Hlth Sci, Setagaya Ku, Tokyo, Japan; [Uekusa, Yoshinori] Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan	National Institute of Health Sciences - Japan; Keio University	Uekusa, Y (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, Tokyo, Japan.; Uekusa, Y (corresponding author), Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan.	uekusa@nihs.go.jp		Uekusa, Yoshinori/0000-0003-1654-5403	Health Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan	Health Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan	This work was supported by a Health Sciences Research Grant from the Ministry of Health, Labour, and Welfare of Japan (http://www,/mhlw.go. jp/seisakunitsuite/bunya/hokabonya/kenkyuligyou/holokin-koubo-h24/gaiyo/25 html, no grant number) to AH and TW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2015, TOXICOL LETT, V234, P13, DOI 10.1016/j.toxlet.2015.02.001; Akutsu K, 2005, J FOOD HYG SOC JPN, V46, P99, DOI 10.3358/shokueishi.46.99; Anezaki K, 2015, ENVIRON SCI POLLUT R, V22, P14478, DOI 10.1007/s11356-014-2985-6; [Anonymous], 2010, SPEC STAND FOODS FOO; ATSDR, 2000, TOX PROF POL BIPH PC; Bhavsar SP, 2007, ENVIRON SCI TECHNOL, V41, P3096, DOI 10.1021/es062402y; Bhavsar SP, 2007, ENVIRON TOXICOL CHEM, V26, P1622, DOI 10.1897/06-621R.1; Bird WA, 2011, ENVIRON HEALTH PERSP, V119, pA290, DOI 10.1289/ehp.119-a290; Mehmet C, 2006, ENVIRON INT, V32, P775, DOI 10.1016/j.envint.2006.03.015; EFSA, 2005, EFSA J, V263, P1, DOI DOI 10.2903/J.EFSA.2005.284; ELSKUS AA, 1994, ENVIRON SCI TECHNOL, V28, P401, DOI 10.1021/es00052a010; Ferrante MC, 2016, J FOOD SCI, V81, pT1024, DOI 10.1111/1750-3841.13259; Georgieva S, 2013, SCRIPTA SCI MEDICA, V45, P14; Hori T, 2008, ANN REP FUKUOKA I HL, V33, P77; Kim KS, 2004, CHEMOSPHERE, V55, P539, DOI 10.1016/j.chemosphere.2003.11.056; Matsumoto R, 2014, MAR POLLUT BULL, V85, P549, DOI 10.1016/j.marpolbul.2014.04.021; Matsumura C, 2002, J ENV CHEM, V12, P855, DOI DOI 10.5985/JEC.12.855; Ministry for Primary Industries of New Zealand, 2012, CHEM CONT IMP DRIED; Ministry of Health Labour and Welfare (MHLW), 2014, LEV RAD CONT FOODS T; Ministry of the Environment of Japan, 2010, REP ENV SURV MON CHE; Ministry of the Environment of Japan, 2011, REP ENV SURV MON CHE; Ministry of the Environment of Japan, 2014, REP ENV SURV MON CHE; Ministry of the Environment of Japan, 2013, REP ENV SURV MON CHE; Ministry of the Environment of Japan, 2012, REP ENV SURV MON CHE; Okayama Prefectural Institute for Environmental Science and Public Health, 2002, ANN REP OK PREF I EN, V26, P65; Perugini M, 2004, CHEMOSPHERE, V57, P391, DOI 10.1016/j.chemosphere.2004.04.034; Smith AG, 2002, FOOD CHEM TOXICOL, V40, P767, DOI 10.1016/S0278-6915(02)00046-7; Takasuga T, 2006, CHEMOSPHERE, V62, P469, DOI 10.1016/j.chemosphere.2005.04.034; Tsutsumi T, 2001, CHEMOSPHERE, V45, P1129, DOI 10.1016/S0045-6535(01)00151-5; Uekusa Y, 2015, FOOD HYG SAFE SCI, V56, P49, DOI 10.3358/shokueishi.56.49; Uekusa Y, 2014, FOOD HYG SAFE SCI, V55, P177, DOI 10.3358/shokueishi.55.177	31	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174961	10.1371/journal.pone.0174961	http://dx.doi.org/10.1371/journal.pone.0174961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376117	Green Submitted, gold, Green Published			2022-12-26	WOS:000399352000029
J	Zhou, Y; Zhang, XT; Zhang, JJ; Fang, JY; Ge, ZZ; Li, XB				Zhou, Ying; Zhang, Xintian; Zhang, Jingjing; Fang, Jingyuan; Ge, Zhizheng; Li, Xiaobo			LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation	PLOS ONE			English	Article							EXPRESSION; BETA; GENES; BIOMARKERS; CARCINOMA; SERUM; ANGIOGENESIS; GLYCOPROTEIN; GROWTH	Leucine-rich-alpha-2-glycoprotein 1 (LRG1) has been shown to be involved in various human malignancies. Whether it plays a role in colorectal cancer (CRC) development remains unclear. Here, we investigated whether and through what mechanism LRG1 functions in human CRC cells. The plasma level of LRG1 was significantly increased in CRC patients, but it was remarkably decreased in patients with resected colorectal cancers. Meanwhile, both mRNA and protein levels of LRG1 were remarkable overexpressed in CRC tissues than normal tissues. The knockdown of LRG1 significantly inhibited cell proliferation, induced cell cycle arrest at the G0/G1 phase, and promoted apoptosis in SW480 and HCT116 cells in vitro. In addition, LRG1 silencing led to the downregulation of the levels of key cell cycle factors, such as cyclin D1, B, and E and anti-apoptotic B-cell lymphoma-2(Bcl-2). However, it up-regulated the expression of pro-apoptotic Bax and cleaved caspase-3. Furthermore, RUNX1 could be induced by LRG1 in a concentration-dependent manner, while the knockdown of RUNX1 blocked the promotion of the proliferation and inhibition of apoptosis induced by LRG1. Collectively, these findings indicate that LRG1 plays a crucial role in the proliferation and apoptosis of CRC by regulating RUNX1 expression. Thus, LRG1 may be a potential detection biomarker as well as a marker for monitoring recurrence and therapeutic target for CRC.	[Li, Xiaobo] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Key Lab Gastroenterol & Hepatol, Minist Hlth,Renji Hosp,Sch Med, Shanghai, Peoples R China; Shanghai Inst Digest Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University	Li, XB (corresponding author), Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Key Lab Gastroenterol & Hepatol, Minist Hlth,Renji Hosp,Sch Med, Shanghai, Peoples R China.	lxb_1969@163.com			Innovation Program of Shanghai Municipal Education Commission [16ZR1420400]	Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This study was supported by Innovation Program of Shanghai Municipal Education Commission. (No.16ZR1420400)	Anglin Ian, 2004, Cancer Treat Res, V119, P189; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Cameron ER, 2003, BLOOD CELL MOL DIS, V30, P194, DOI 10.1016/S1079-9796(03)00031-7; Choi JW, 2013, PROTEOMICS, V13, P2361, DOI 10.1002/pmic.201200550; Coffman JA, 2009, J CELL BIOCHEM, V107, P194, DOI 10.1002/jcb.22143; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Furukawa K, 2015, PANCREAS, V44, P93, DOI 10.1097/MPA.0000000000000205; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; He X, 2014, NEOPLASMA, V61, P17, DOI 10.4149/neo_2014_001; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hutter G, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-29; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ito Y, 2003, Ann Acad Med Singap, V32, pS6; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kara M, 2015, GENE, V567, P81, DOI 10.1016/j.gene.2015.04.065; Kentsis A, 2012, ANN EMERG MED, V60, P78, DOI 10.1016/j.annemergmed.2011.12.015; Kidwai F, 2016, STEM CELLS, V22; Ladd JJ, 2012, CANCER PREV RES, P655; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Liu HP, 2015, EUR J IMMUNOL, V45, P1010, DOI 10.1002/eji.201444726; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Lund AH, 2002, CANCER CELL, V1, P213, DOI 10.1016/S1535-6108(02)00049-1; Mu WP, 2014, ONCOTARGETS THER, V7, P1237, DOI 10.2147/OTT.S62103; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Simpson DJ, 2001, CARCINOGENESIS, V22, P1801, DOI 10.1093/carcin/22.11.1801; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Suarez-Villanueva S, 2015, GENET MOL RES, V14, P15505, DOI 10.4238/2015.November.30.28; Uen YH, 2013, J PROTEOMICS, V83, P197, DOI 10.1016/j.jprot.2013.03.007; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Wu J, 2013, J PROTEOME RES, V12, P3342, DOI 10.1021/pr400169n; Wu RSC, 2012, HUM EXP TOXICOL, V31, P771, DOI 10.1177/0960327111429137; Zhang JJ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0306-2; Zhong D, 2015, ACTA HISTOCHEM, V117, P551, DOI 10.1016/j.acthis.2015.05.001; Zhong D, 2015, TUMOR BIOL, V36, P4271, DOI 10.1007/s13277-015-3065-3	39	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175122	10.1371/journal.pone.0175122	http://dx.doi.org/10.1371/journal.pone.0175122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376129	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000039
J	Chen, Y; Zeng, C; Zhan, Y; Wang, H; Jiang, X; Li, W				Chen, Y.; Zeng, C.; Zhan, Y.; Wang, H.; Jiang, X.; Li, W.			Aberrant low expression of p85 alpha in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b	ONCOGENE			English	Article							PHOSPHOINOSITIDE 3-KINASES; TUMOR-SUPPRESSOR; PI3K PATHWAY; TGF-BETA; ACQUISITION; GROWTH; TUMORIGENESIS; TRANSITIONS; ACTIVATION; MUTATIONS	P85 alpha, which acts as a tumour suppressor, is frequently found to be downregulated in various human cancers. However, the role of p85 alpha in the tumour microenvironment is unknown. Here, we report that aberrantly low expression of p85 alpha in breast cancer stroma is clinically relevant to breast cancer disease progression. Stromal fibroblasts can acquire the hallmarks of cancer-associated fibroblasts (CAFs) as a result of the loss of p85 alpha expression. Paracrine Wnt10b from p85 alpha-deficient fibroblasts can promote cancer progression via epithelial-to-mesenchymal transition (EMT) induced by the canonical Wnt pathway. Moreover, exosomes have a key role in paracrine Wnt10b transport from fibroblasts to breast cancer epithelial cells. Our results reveal that p85 alpha expression in stromal fibroblasts haves a crucial role in regulating breast cancer tumourigenesis and progression by modifying stromal-epithelial crosstalk and remodelling the tumour microenvironment. Therefore, p85 alpha can function as a tumour suppressor and represent a new candidate for diagnosis, prognosis and targeted therapy.	[Chen, Y.; Zeng, C.; Zhan, Y.; Wang, H.; Li, W.] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China; [Jiang, X.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Sinofrance Lab Drug Screening, Key Lab Mol Biophys,Minist Educ, Wuhan, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Li, W (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.	whli@whu.edu.cn			National Basic Research Program of China [2014CB910603]; National Natural Science Foundation of China [81472684, 81072151]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0436]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	We thank Professor Lewis C Cantley for the gift of the knockout cell lines. This study was supported by National Basic Research Program of China (2014CB910603), the National Natural Science Foundation of China (81472684, 81072151) and Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0436).	Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Gong K, 2012, J BIOL CHEM, V287, P35576, DOI 10.1074/jbc.M112.370585; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352; Hu HM, 2013, FASEB J, V27, P163, DOI 10.1096/fj.12-216622; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Klarenbeek S, 2013, MOL ONCOL, V7, P146, DOI 10.1016/j.molonc.2013.02.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shannon KM, 2012, CANCER J, V18, P310, DOI 10.1097/PPO.0b013e318260946f; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Spaeth EL, 2013, CANCER RES, V73, P5347, DOI 10.1158/0008-5472.CAN-13-0087; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Weinberg RA, 2008, NAT GENET, V40, P494, DOI 10.1038/ng0508-494; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Ye K, 2016, NAT MED, V22, P97, DOI 10.1038/nm.4002; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	56	70	75	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4692	4705		10.1038/onc.2017.100	http://dx.doi.org/10.1038/onc.2017.100			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394344	Green Published, hybrid			2022-12-26	WOS:000407702400003
J	Lin, QH; Parker, MJ; Taguchi, AT; Ravichandran, K; Kim, A; Kang, G; Shao, JM; Drennan, CL; Stubbe, J				Lin, Qinghui; Parker, Mackenzie J.; Taguchi, Alexander T.; Ravichandran, Kanchana; Kim, Albert; Kang, Gyunghoon; Shao, Jimin; Drennan, Catherine L.; Stubbe, JoAnne			Glutamate 52-beta at the alpha/beta subunit interface of Escherichia coli class Ia ribonucleotide reductase is essential for conformational gating of radical transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; SITE-SPECIFIC INCORPORATION; 2-AZIDO-2-DEOXYURIDINE 5-DIPHOSPHATE; DIPHOSPHATE REDUCTASE; PROPAGATION PATHWAY; CATALYTIC-ACTIVITY; KINETIC-ANALYSIS; PROTEIN; INTERMEDIATE; INHIBITION	Ribonucleotide reductases (RNRs) catalyze the conversion of nucleoside diphosphate substrates (S) to deoxynucleotides with allosteric effectors (e) controlling their relative ratios and amounts, crucial for fidelity of DNA replication and repair. Escherichia coli class Ia RNR is composed of alpha and beta subunits that form a transient, active alpha 2 beta 2 complex. The E. coli RNR is rate- limited by S/e- dependent conformational change(s) that trigger the radical initiation step through a pathway of 35 angstrom across the subunit (alpha/beta) interface. The weak subunit affinity and complex nucleotide- dependent quaternary structures have precluded a molecular understanding of the kinetic gating mechanism( s) of the RNR machinery. Using a docking model of alpha 2 beta 2 created from X- ray structures of alpha and beta and conserved residues from a new subclassification of the E. coli Ia RNR (Iag), we identified and investigated four residues at the alpha/beta interface (Glu(350) and Glu(52) in beta 2 and Arg(329) and Arg(639) in alpha 2) of potential interest in kinetic gating. Mutation of each residue resulted in loss of activity and with the exception of E52Q-beta 2, weakened subunit affinity. An RNR mutant with 2,3,5- trifluorotyrosine radical (F3Y122 center dot) replacing the stable Tyr122(center dot) in WT-beta 2, a mutation that partly overcomes conformational gating, was placed in the E52Q background. Incubation of this double mutant with His(6)-alpha 2/S/e resulted in anRNRcapable of catalyzing pathway- radical formation (Tyr(356 center dot) -beta 2), 0.5 eq of dCDP/F3Y122 center dot, and formation of an alpha 2 beta 2 complex that is isolable in pulldown assays over 2 h. Negative stainEMimages with S/e (GDP/TTP) revealed the uniformity of the alpha 2 beta 2 complex formed.	[Lin, Qinghui; Shao, Jimin] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Parker, Mackenzie J.; Taguchi, Alexander T.; Ravichandran, Kanchana; Kim, Albert; Kang, Gyunghoon; Drennan, Catherine L.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.; Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Zhejiang University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Stubbe, J (corresponding author), 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu; stubbe@mit.edu			National Institutes of Health [GM29595]; National Natural Science Foundation of China [81372138]; Foundation of Zhejiang University for International Cooperation and Exchanges; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Zhejiang University for International Cooperation and Exchanges; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29595 (to J.S.), National Natural Science Foundation of China Grant 81372138 and Foundation of Zhejiang University for International Cooperation and Exchanges (to J.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; CLIMENT I, 1991, BIOCHEMISTRY-US, V30, P5164, DOI 10.1021/bi00235a008; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; Ekberg M, 1998, J BIOL CHEM, V273, P21003, DOI 10.1074/jbc.273.33.21003; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Hassan AQ, 2008, BIOORG MED CHEM LETT, V18, P5923, DOI 10.1016/j.bmcl.2008.08.048; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Minnihan EC, 2011, J AM CHEM SOC, V133, P15942, DOI 10.1021/ja207719f; Minnihan EC, 2011, J AM CHEM SOC, V133, P9430, DOI 10.1021/ja201640n; Nick TU, 2015, J AM CHEM SOC, V137, P289, DOI 10.1021/ja510513z; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Persson AL, 1997, J BIOL CHEM, V272, P31533, DOI 10.1074/jbc.272.50.31533; Ravichandran K. R., 2016, THESIS; Ravichandran K, 2017, BIOCHEMISTRY-US, V56, P856, DOI 10.1021/acs.biochem.6b01145; Ravichandran KR, 2017, J AM CHEM SOC, V139, P2994, DOI 10.1021/jacs.6b11011; Ravichandran KR, 2016, J AM CHEM SOC, V138, P13706, DOI 10.1021/jacs.6b08200; Ravichandran KR, 2015, J AM CHEM SOC, V137, P14387, DOI 10.1021/jacs.5b09189; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; SALOWE S, 1993, BIOCHEMISTRY-US, V32, P12749, DOI 10.1021/bi00210a026; SALOWE SP, 1987, BIOCHEMISTRY-US, V26, P3408, DOI 10.1021/bi00386a024; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15748, DOI 10.1021/ja076459b; Seyedsayamdost MR, 2007, NAT PROTOC, V2, P1225, DOI 10.1038/nprot.2007.159; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; Seyedsayamdost MR, 2009, METHOD ENZYMOL, V462, P45, DOI 10.1016/S0076-6879(09)62003-6; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, P NATL ACAD SCI USA, V95, P2723, DOI 10.1073/pnas.95.6.2723; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; Worsdorfer B, 2013, J AM CHEM SOC, V135, P8585, DOI 10.1021/ja401342s; Yokoyama K, 2011, J AM CHEM SOC, V133, P18420, DOI 10.1021/ja207455k; Yokoyama K, 2010, J AM CHEM SOC, V132, P15368, DOI 10.1021/ja1069344; Yokoyama K, 2010, J AM CHEM SOC, V132, P8385, DOI 10.1021/ja101097p; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141	50	23	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9229	9239		10.1074/jbc.M117.783092	http://dx.doi.org/10.1074/jbc.M117.783092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377505	hybrid, Green Published			2022-12-26	WOS:000402538900018
J	Hintsa, S; Dube, L; Abay, M; Angesom, T; Workicho, A				Hintsa, Solomon; Dube, Lamessa; Abay, Mebrahtu; Angesom, Teklit; Workicho, Abdulhalik			Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; COMPLICATIONS	Background Diabetic nephropathy is the most serious complication of diabetes which leads to end-stage renal failure and other complication of diabetes mellitus. Determinants of Diabetic nephropathy are not consistent in different studies and associated factors to chronic complications of diabetes are not specific and there are limited studies specific to diabetic nephropathy. Thus, the aim of this study is to identify determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia. Methods A case-control study was conducted from February 14 to May 8 2016. Diabetic patients who developed nephropathy in the last two years were the cases and diabetic patients free of nephropathy were controls. Cases and controls were identified detailed review of the chronic care follow up chart. Then simple random sampling was used to select sample of 420 ( with control to case ratio of 4: 1) resulting in 84 cases and 336 controls. Record review and interviewer administered questionnaire were used to collect data. Data was coded and entered in to Epi-Data version 3.1 and then exported to STATA 12 for analysis. Variables with P-values< 0.25 in Bivariate logistic regression were selected for multiple logistic regressions to determine independent determinants of diabetic nephropathy. OR was calculated with 95% CI to show strength of association. Result The mean age (+/- Standard deviation) for the cases and the controls were 52( SD: +/- 1.34) and 42.4( SD: +/- 0.8) respectively. In multiple logistic regressions age of patient ( AOR: 1.037 95% CI: 1.01 - 1.064), duration of diabetes after diagnosis ( AOR for one year increase: 1.09 95% CI: 1.036 - 1.15), not-adhered to blood glucose measurement at home ( AOR: 6.81 95% CI: 1.15 - 40.24), having Systolic Hypertension ( AOR; 2.13 ( 1.002 - 4.51), poor glycemic control (AOR; 2.71 95% CI: ( 1.49 - 4.95), being overweight( AOR; 2.7( 1.47 - 4.96) were the independent predictors of diabetic nephropathy. Conclusion In the light of these findings, targeted interventions should be designed at the follow up clinic to address the risk of developing diabetic nephropathy among the risk groups.	[Hintsa, Solomon; Abay, Mebrahtu; Angesom, Teklit] Aksum Univ Ksum, Coll Hlth Sci, Dept Publ Hlth, Aksum, Ethiopia; [Dube, Lamessa; Workicho, Abdulhalik] Jimma Univ, Coll Hlth Sci, Dept Epidemiol, Jimma, Ethiopia	Jimma University	Hintsa, S (corresponding author), Aksum Univ Ksum, Coll Hlth Sci, Dept Publ Hlth, Aksum, Ethiopia.	solomonhintsa2013@gmail.com		angesom, teklit/0000-0002-7216-8617; Hintsa, Solomon/0000-0003-1270-4817; Workicho, Abdulhalik/0000-0001-8422-1983; Abay, Mebrahtu/0000-0002-3307-0588	Ayder Referral Hospital	Ayder Referral Hospital	We sincerely thank, to Jimma University, for giving us the chance to do this research work and Ayder Referral Hospital for their support in collecting the actual data. We would also like to thank the data collectors and study participants for their participation.	Abejew AA, 2015, DIABETIC COMPLICATIO, V2015; Ahn JH, 2014, DIABETES METAB J, V38, P109, DOI 10.4093/dmj.2014.38.2.109; Amogne W, 2011, ETHIOP J HEALTH DEV, V25, P17; [Anonymous], 2005, DIABETES CARE, V28, P164; [Anonymous], 2015, PUBLIC HEAL ACTION, VI, P74; Care M, 2003, DIABETES CARE, V26, ps33; Chowdhury TA, 1999, CLIN SCI, V96, P221, DOI 10.1042/CS19980331; de Luis DA, 2005, J DIABETES COMPLICAT, V19, P42, DOI 10.1016/j.jdiacomp.2003.12.003; Effective health care program, 2014, EV BAS PRACT CTR SYS, P1; Ferreira SRG, 1997, BRAZ J MED BIOL RES, V30, P735, DOI 10.1590/S0100-879X1997000600006; Fleiss, 1981, STAT METHODS RATES P, P38; George L, 2015, PATIENT INFORM DIABE; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Heydari I, 2010, INT J DIABET MELLIT, V2, P61; ISAK, 2001, INT STAND ANTHR ASS; LESTER FT, 1984, DIABETES CARE, V7, P6, DOI 10.2337/diacare.7.1.6; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Noubiap JJN, 2015, WORLD J DIABETES, V6, P759, DOI 10.4239/wjd.v6.i5.759; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Seifu W, 2015, MOJ PUBLIC HEAL, V2; Shera AS, PREVALENCE CHR UNPUB; Tefera G., 2014, ADV DIABETES METAB, V2, P48; Tesfaye S, 2011, AFRICAN J DIABETES M, V19; Viswanathan V, 2012, INDIAN J MED RES, V136, P46; Worku D, 2010, ETHIOP J HEALTH SCI, V20, P33	26	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173566	10.1371/journal.pone.0173566	http://dx.doi.org/10.1371/journal.pone.0173566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403160	Green Submitted, Green Published, gold			2022-12-26	WOS:000399955200007
J	Kroon, F; Streten, C; Harries, S				Kroon, Frederieke; Streten, Claire; Harries, Simon			A protocol for identifying suitable biomarkers to assess fish health: A systematic review	PLOS ONE			English	Review							FLOUNDER PLATICHTHYS-FLESUS; BASS DICENTRARCHUS-LABRAX; BARRAMUNDI LATES-CALCARIFER; MUMMICHOGS FUNDULUS-HETEROCLITUS; ENVIRONMENTAL RISK-ASSESSMENT; TISSUE-SPECIFIC ACCUMULATION; OXIDATIVE STRESS BIOMARKERS; TURBOT SCOPHTHALMUS-MAXIMUS; ADVERSE OUTCOME PATHWAYS; SOLE SOLEA-SENEGALENSIS	Background Biomarkers have been used extensively to provide the connection between external levels of contaminant exposure, internal levels of tissue contamination, and early adverse effects in organisms. Objectives To present a three-step protocol for identifying suitable biomarkers to assess fish health in coastal and marine ecosystems, using Gladstone Harbour (Australia) as a case study. Methods Prior to applying our protocol, clear working definitions for biomarkers were developed to ensure consistency with the global literature on fish health assessment. First, contaminants of concern were identified based on the presence of point and diffuse sources of pollution and available monitoring data for the ecosystem of interest. Second, suitable fish species were identified using fisheries dependent and independent data, and prioritised based on potential pathways of exposure to the contaminants of concern. Finally, a systematic and critical literature review was conducted on the use of biomarkers to assess the health of fish exposed to the contaminants of concern. Results/Discussion We present clear working definitions for bioaccumulation markers, biomarkers of exposure, biomarkers of effect and biomarkers of susceptibility. Based on emission and concentration information, seven metals were identified as contaminants of concern for Gladstone Harbour. Twenty out of 232 fish species were abundant enough to be potentially suitable for biomarker studies; five of these were prioritised based on potential pathways of exposure and susceptibility to metals. The literature search on biomarkers yielded 5,035 articles, of which 151met the inclusion criteria. Based on our review, the most suitable biomarkers include bioaccumulation markers, biomarkers of exposure (CYP1A, EROD, SOD, LPOX, HSP, MT, DNA strand breaks, micronuclei, apoptosis), and biomarkers of effect (histopathology, TAG: ST). Conclusion Our protocol outlines a clear pathway to identify suitable biomarkers to assess fish health in coastal and marine ecosystems, which can be applied to biomarker studies in aquatic ecosystems around the world.	[Kroon, Frederieke] Australian Inst Marine Sci, Townsville, Qld, Australia; [Streten, Claire; Harries, Simon] Australian Inst Marine Sci, Arafura Timor Res Facil, Brinkin, NT, Australia	Australian Institute of Marine Science; Australian Institute of Marine Science	Kroon, F (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	f.kroon@aims.gov.au	Harries, Simon J/F-2543-2017; Kroon, Frederieke J/G-1072-2010	Harries, Simon J/0000-0002-3270-6206; Kroon, Frederieke J/0000-0001-8771-6543	Glad stone Healthy Harbour Partnership	Glad stone Healthy Harbour Partnership	This study was supported by the Glad stone Healthy Harbour Partnership. The funders had no role in study design, data collection and analysis ,decision to publish, or preparation of the manuscript.	Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Almroth BC, 2008, MAR ENVIRON RES, V66, P271, DOI 10.1016/j.marenvres.2008.04.002; Anastasi Amie, 2010, Australasian Journal of Ecotoxicology, V16, P119; Andersen L, 2005, METAL BIOACCUMULATIO; Angel BM, 2012, METAL CONCENTRATIONS; Angel BM, 2010, MAR FRESHWATER RES, V61, P170, DOI 10.1071/MF09046; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Annabi A, 2012, AQUAT BIOL, V17, P285, DOI 10.3354/ab00482; [Anonymous], 1987, Environ Health Perspect, V74, P3; [Anonymous], 1993, ECOLOGICAL RISK ASSE; ANZECC/ARMCANZ, 2000, 4 ANZECCARMCANZ; Apte S, 2006, CONTGAMINANT PATHWAY; Apte S, 2005, CONTAMINANTS PORT CU; Arango C, 2013, POSTFLOOD WATER QUAL; Australian Department of the Environment and Energy, 2016, NAT POLL INV; Australian Department of the Environment Water Heritage and the Arts, 2009, WAT HER ARTS NAT ASS; Barbee NC, 2014, AQUAT TOXICOL, V152, P244, DOI 10.1016/j.aquatox.2014.04.012; Beg MU, 2015, MAR POLLUT BULL, V100, P662, DOI 10.1016/j.marpolbul.2015.07.058; Benedetti M, 2012, ENVIRON INT, V38, P17, DOI 10.1016/j.envint.2011.08.003; Benhamed S, 2016, TOXICOL REP, V3, P364, DOI 10.1016/j.toxrep.2016.02.006; Beyer J, 1996, AQUAT TOXICOL, V36, P75, DOI 10.1016/S0166-445X(96)00798-9; Beyer J, 2013, MAR POLLUT BULL, V69, P28, DOI 10.1016/j.marpolbul.2013.01.001; Cao L, 2012, ENVIRON TOXICOL PHAR, V33, P16, DOI 10.1016/j.etap.2011.10.003; Cao L, 2010, COMP BIOCHEM PHYS C, V151, P386, DOI 10.1016/j.cbpc.2010.01.004; Cavanagh JE, 2000, MAR POLLUT BULL, V41, P377, DOI 10.1016/S0025-326X(00)00135-1; Chen MH, 1999, MAR POLLUT BULL, V39, P239, DOI 10.1016/S0025-326X(99)00027-2; Chen MH, 2002, MAR POLLUT BULL, V44, P703, DOI 10.1016/S0025-326X(02)00066-8; Codi S, 2004, ENVIRON TOXICOL CHEM, V23, P2737, DOI 10.1897/03-499; Connolly RM, 2006, INTERTIDAL WETLANDS; Corsi I, 2003, MAR POLLUT BULL, V46, P203, DOI 10.1016/S0025-326X(02)00359-4; Costa PM, 2008, MUTAT RES-GEN TOX EN, V654, P29, DOI 10.1016/j.mrgentox.2008.04.007; Costa PM, 2012, ENVIRON POLLUT, V161, P107, DOI 10.1016/j.envpol.2011.10.010; Costa PM, 2011, ENVIRON RES, V111, P25, DOI 10.1016/j.envres.2010.09.011; Cotou E, 2012, CHEMOSPHERE, V89, P1091, DOI 10.1016/j.chemosphere.2012.05.075; Dang F, 2009, AQUAT TOXICOL, V95, P248, DOI 10.1016/j.aquatox.2009.09.013; De Domenico E, 2013, ECOTOX ENVIRON SAFE, V97, P114, DOI 10.1016/j.ecoenv.2013.07.015; De Domenico E, 2011, AQUAT TOXICOL, V105, P688, DOI 10.1016/j.aquatox.2011.08.026; de Mora S, 2004, MAR POLLUT BULL, V49, P410, DOI 10.1016/j.marpolbul.2004.02.029; Machado AAD, 2013, AQUAT TOXICOL, V138, P60, DOI 10.1016/j.aquatox.2013.04.009; Deng DF, 2008, SCI TOTAL ENVIRON, V407, P197, DOI 10.1016/j.scitotenv.2008.08.028; Dutton J, 2010, AQUAT BIOL, V10, P211, DOI 10.3354/ab00276; Edwards JW, 2001, MAR POLLUT BULL, V42, P389, DOI 10.1016/S0025-326X(00)00168-5; Eyckmans M, 2013, AQUAT TOXICOL, V126, P373, DOI 10.1016/j.aquatox.2012.09.004; Fasulo S, 2010, ECOTOX ENVIRON SAFE, V73, P873, DOI 10.1016/j.ecoenv.2009.12.025; Faucher K, 2008, ENVIRON POLLUT, V151, P148, DOI 10.1016/j.envpol.2007.02.017; Fernandes C, 2007, ECOTOX ENVIRON SAFE, V66, P426, DOI 10.1016/j.ecoenv.2006.02.007; Ferreira M, 2008, SCI TOTAL ENVIRON, V407, P638, DOI 10.1016/j.scitotenv.2008.07.058; Fonseca VF, 2015, ECOL INDIC, V58, P335, DOI 10.1016/j.ecolind.2015.05.064; Fonseca VF, 2014, MAR ENVIRON RES, V96, P45, DOI 10.1016/j.marenvres.2013.10.011; Fonseca VF, 2011, AQUAT TOXICOL, V102, P216, DOI 10.1016/j.aquatox.2011.01.018; GHD Pty Ltd, 2009, GLADST PORT CORP REP; Gladstone Healthy Harbour Partnership, 2015, TECHNICAL REPORT; Gladstone Port Corporation, 2012, CURT COAST COAST MAR; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; Gorbi S, 2005, ARCH ENVIRON CON TOX, V49, P62, DOI 10.1007/s00244-004-0150-9; Granek EF, 2010, CONSERV BIOL, V24, P207, DOI 10.1111/j.1523-1739.2009.01355.x; Gravato C, 2010, ECOTOX ENVIRON SAFE, V73, P524, DOI 10.1016/j.ecoenv.2009.11.009; Great Barrier Reef Marine Park Authority, 2014, GREAT BARR REEF OUTL; Groen S., ENV ECOSYSTEMS CASE; Handy RD, 2003, ECOTOXICOLOGY, V12, P331, DOI 10.1023/A:1022527432252; Hanson N, 2013, BIOMARKERS ENV MONIT; Hariharan G, 2016, ENVIRON TOXICOL, V31, P24, DOI 10.1002/tox.22019; Hartl MGJ, 2007, MAR ENVIRON RES, V64, P191, DOI 10.1016/j.marenvres.2007.01.002; Henry F, 2012, J ENVIRON MONITOR, V14, P3211, DOI 10.1039/c2em30765k; Hook SE, 2017, ENVIRON TOXICOL CHEM, V36, P103, DOI 10.1002/etc.3505; Hook SE, 2014, INTEGR ENVIRON ASSES, V10, P327, DOI [10.1002/ieam.1530, 10]; Humphrey CA, 2007, MAR POLLUT BULL, V54, P1569, DOI 10.1016/j.marpolbul.2007.06.004; Isani G, 2009, ECOTOXICOL ENVIRON S; Isani G, 2011, FISH SHELLFISH IMMUN, V31, P1051, DOI 10.1016/j.fsi.2011.09.005; Jara-Marini ME, 2009, CHEMOSPHERE, V77, P1366, DOI 10.1016/j.chemosphere.2009.09.025; Jeffree RA, 2006, SCI TOTAL ENVIRON, V368, P839, DOI 10.1016/j.scitotenv.2006.03.026; Jezierska B, 2006, NATO SCI S SS IV EAR, V69, P107; Jia R, 2016, COMP BIOCHEM PHYS C, V181, P40, DOI 10.1016/j.cbpc.2016.01.002; Jimenez-Tenorio N, 2007, ENVIRON INT, V33, P474, DOI 10.1016/j.envint.2006.11.009; Jones HJ, 2014, ESTUAR COAST SHELF S, V137, P14, DOI 10.1016/j.ecss.2013.11.024; Jones MA, 2005, MAR POLLUT BULL, V51, P448, DOI 10.1016/j.marpolbul.2004.10.021; Kailola P.J., 1993, FISHERIES RESOURCES; Kalantzi I, 2014, SCI TOTAL ENVIRON, V470, P742, DOI 10.1016/j.scitotenv.2013.10.020; Kelada SN, 2001, AM J EPIDEMIOL, V154, P1, DOI 10.1093/aje/154.1.1; Kerambrun E, 2013, CHEMOSPHERE, V91, P498, DOI 10.1016/j.chemosphere.2012.12.010; Kerambrun E, 2012, ECOTOX ENVIRON SAFE, V80, P45, DOI 10.1016/j.ecoenv.2012.02.010; Kerambrun E, 2012, ECOL INDIC, V19, P161, DOI 10.1016/j.ecolind.2011.06.035; Kerambrun E, 2012, AQUAT TOXICOL, V108, P130, DOI 10.1016/j.aquatox.2011.07.016; Kerambrun E, 2011, COMP BIOCHEM PHYS C, V154, P187, DOI 10.1016/j.cbpc.2011.05.006; Kessabi K, 2012, J ENVIRON MONITOR, V14, P2254, DOI 10.1039/c2em30329a; KIME DE, 1995, REV FISH BIOL FISHER, V5, P52, DOI 10.1007/BF01103366; Kroon F.J., 2015, IDENTIFICATION IMPAC; Kroon FJ, 2015, ENVIRON TOXICOL CHEM, V34, P1881, DOI 10.1002/etc.3011; Kroon FJ, 2015, MAR ENVIRON RES, V104, P51, DOI 10.1016/j.marenvres.2015.01.002; Kroon FJ, 2014, ENVIRON TOXICOL CHEM, V33, P1607, DOI 10.1002/etc.2594; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kuiter R. H., 1993, COASTAL FISHES S E A; Le KT, 2014, AQUACULTURE, V433, P229, DOI 10.1016/j.aquaculture.2014.06.021; Leaver MJ, 2010, AQUAT TOXICOL, V96, P234, DOI 10.1016/j.aquatox.2009.10.025; Lee JW, 2015, J ENVIRON SCI, V35, P115, DOI 10.1016/j.jes.2015.05.002; Liu K, 2015, AQUAT TOXICOL, V165, P120, DOI 10.1016/j.aquatox.2015.05.013; Liu XJ, 2011, ECOTOX ENVIRON SAFE, V74, P1156, DOI 10.1016/j.ecoenv.2011.02.015; LIVINGSTONE DR, 1992, MAR ECOL PROG SER, V91, P97, DOI 10.3354/meps091097; Loro VL, 2014, COMP BIOCHEM PHYS C, V166, P96, DOI 10.1016/j.cbpc.2014.07.004; Maharajan A., 2016, J BASIC APPL ZOOL, V77, P21, DOI DOI 10.1016/J.JOBAZ.2016.02.001; Martinez-Gomez C, 2012, MAR ENVIRON RES, V77, P50, DOI 10.1016/j.marenvres.2012.02.002; McCarty LS, 2002, HUM ECOL RISK ASSESS, V8, P159, DOI 10.1080/20028091056791; Migliarini B, 2005, GEN COMP ENDOCR, V142, P241, DOI 10.1016/j.ygcen.2004.12.012; Minghetti M, 2008, COMP BIOCHEM PHYS C, V147, P450, DOI 10.1016/j.cbpc.2008.01.014; Mohammed A, 2012, MAR POLLUT BULL, V64, P169, DOI 10.1016/j.marpolbul.2011.10.036; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mortimer M, 2013, POSTFLOOD WATER QUAL; Mzimela HM, 2003, MAR POLLUT BULL, V46, P659, DOI 10.1016/S0025-326X(03)00088-2; Nel L, 2015, MAR POLLUT BULL, V101, P878, DOI 10.1016/j.marpolbul.2015.11.015; Oliva M, 2014, COMP BIOCHEM PHYS C, V166, P134, DOI 10.1016/j.cbpc.2014.07.010; Oliva M, 2012, MAR POLLUT BULL, V64, P2097, DOI 10.1016/j.marpolbul.2012.07.017; Oliva M, 2012, ECOTOX ENVIRON SAFE, V75, P151, DOI 10.1016/j.ecoenv.2011.08.017; Oliveira BL, 2014, NEOTROP ICHTHYOL, V12, P845, DOI 10.1590/1982-0224-20140040; Oliveira M, 2010, MAR ENVIRON RES, V69, P227, DOI 10.1016/j.marenvres.2009.10.012; Olvera-Nestor CG, 2016, B ENVIRON CONTAM TOX, V96, P326, DOI 10.1007/s00128-015-1721-3; Omar WA, 2016, ECOTOXICOLOGY, V25, P253, DOI 10.1007/s10646-015-1584-8; Omar WA, 2012, MUTAT RES-GEN TOX EN, V746, P7, DOI 10.1016/j.mrgentox.2012.01.013; Padmini E, 2009, ECOTOXICOLOGY, V18, P304, DOI 10.1007/s10646-008-0282-1; Padmini E, 2009, SCI TOTAL ENVIRON, V407, P4533, DOI 10.1016/j.scitotenv.2009.04.005; Pamplona JH, 2010, ECOTOX ENVIRON SAFE, V74, P342; Papetti P, 2009, ENVIRON MONIT ASSESS, V159, P589, DOI 10.1007/s10661-008-0725-4; PEAKALL DB, 1994, ECOTOXICOLOGY, V3, P173, DOI 10.1007/BF00117082; PEAKALL DB, 1994, ECOTOXICOLOGY, V3, P157, DOI 10.1007/BF00117080; Pereira P, 2010, ECOTOX ENVIRON SAFE, V73, P805, DOI 10.1016/j.ecoenv.2010.02.020; Pereira P, 2010, MAR ENVIRON RES, V69, P53, DOI 10.1016/j.marenvres.2009.08.003; Peters GM, 1999, MAR ENVIRON RES, V47, P491, DOI 10.1016/S0141-1136(99)00027-6; Piva F, 2011, CHEMOSPHERE, V83, P475, DOI 10.1016/j.chemosphere.2010.12.064; Platten JR, 2004, HIST TRENDS RECREATI; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Qiu YW, 2015, ESTUAR COAST SHELF S, V163, P7, DOI 10.1016/j.ecss.2015.05.036; Qiu YW, 2011, ECOTOX ENVIRON SAFE, V74, P284, DOI 10.1016/j.ecoenv.2010.10.008; Queensland Department of Agriculture, 2016, QUEENSL FISH QFISH; Queensland Department of Agriculture, 2012, COMM CATCH KEY SPEC; Queensland Department of Agriculture and Fisheries, 2016, SHARK CATCH NUMB; Queensland Department of Environment and Heritage Protection, 2017, SEW TREATM FAC MON P; Queensland Department of Environment and Heritage Protection, 2012, UPD QUAL SED PORT CU; Queensland Department of Environment and Resource Management, 2011, WAT QUAL PORT CURT T; Queensland Department of the Environment and Heritage Protection, 2012, 11 UPD WAT QUAL PORT; Queensland Government, 2016, COMM FISH LOGB MAPS; Rajeshkumar S, 2011, CHEMOSPHERE, V83, P415, DOI 10.1016/j.chemosphere.2010.12.086; Ransberry VE, 2015, AQUAT TOXICOL, V161, P242, DOI 10.1016/j.aquatox.2015.02.013; Ribecco C, 2011, AQUAT TOXICOL, V104, P308, DOI 10.1016/j.aquatox.2011.05.005; Rodrigues RV, 2011, AQUACULTURE, V322, P223, DOI 10.1016/j.aquaculture.2011.09.040; Rose WL, 2006, AQUAT TOXICOL, V80, P298, DOI 10.1016/j.aquatox.2006.09.007; Rowling K, 2010, STATUS FISHERIES RES; Sawynok B, 2014, ASSESSING TRENDS REC; Sawynok B, 2012, ASSESSING TRENDS REC; Sawynok B, 2015, CALLIOPE RIVER FISH; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schipper CA, 2009, ICES J MAR SCI, V66, P2089, DOI 10.1093/icesjms/fsp194; Schlenk D, 1999, MAR POLLUT BULL, V39, P48, DOI 10.1016/S0025-326X(99)00015-6; Schmidt V, 2003, HELGOLAND MAR RES, V57, P262, DOI 10.1007/s10152-003-0159-x; Seafood Standards, 2016, 53002015 AS; Serafim A, 2012, ECOL INDIC, V19, P215, DOI 10.1016/j.ecolind.2011.08.009; Simpson S.L., 2013, CSIRO LAND WATER, P132, DOI DOI 10.4225/08/5894C6184320C; Siscar R, 2013, MAR POLLUT BULL, V77, P90, DOI 10.1016/j.marpolbul.2013.10.026; Smit MGD, 2009, ENVIRON TOXICOL CHEM, V28, P1104, DOI 10.1897/08-464.1; Soto-Jimenez MF, 2008, MAR ENVIRON RES, V66, P451, DOI 10.1016/j.marenvres.2008.07.009; Souza IC, 2013, ENVIRON POLLUT, V180, P136, DOI 10.1016/j.envpol.2013.05.017; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Taylor AM, 2010, OCEANOGR OCEAN ENG, P1; Tigano C, 2009, ECOTOX ENVIRON SAFE, V72, P1278, DOI 10.1016/j.ecoenv.2008.09.028; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Traven L, 2013, ENVIRON MONIT ASSESS, V185, P9009, DOI 10.1007/s10661-013-3230-3; Tsangaris C, 2011, ARCH ENVIRON CON TOX, V61, P482, DOI 10.1007/s00244-010-9629-8; Tse CY, 2010, FISH PHYSIOL BIOCHEM, V36, P141, DOI 10.1007/s10695-008-9243-0; van Bussel CGJ, 2014, AQUACULT ENG, V61, P35, DOI 10.1016/j.aquaeng.2014.05.003; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; vanGestel CAM, 1996, ECOTOXICOLOGY, V5, P217, DOI 10.1007/BF00118992; Vethaak AD, 1996, ENVIRON HEALTH PERSP, V104, P1218, DOI 10.2307/3432916; Vicente-Beckett V, 2006, METAL POLYCYCLIC ARO; Vicente-Martorell JJ, 2009, J HAZARD MATER, V162, P823, DOI 10.1016/j.jhazmat.2008.05.106; Vision Environment QLD, 2011, PORT CURT EC HLTH RE; Waltham NJ, 2011, J ENVIRON MONITOR, V13, P3409, DOI 10.1039/c1em10664c; Wang T, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/783021; Waters D.K., 2014, MODELLING REDUCTIONS; Weis JS, 2003, MAR ENVIRON RES, V55, P27, DOI 10.1016/S0141-1136(02)00204-0; Weis JS, 2001, CAN J FISH AQUAT SCI, V58, P1442, DOI 10.1139/cjfas-58-7-1442; WHO (World Health Organization), 1993, BIOM RISK ASS CONC P; Williams TD, 2014, CHEMOSPHERE, V108, P152, DOI 10.1016/j.chemosphere.2014.01.028; Wilson S, 2012, ARROW LNG PLANT SUPP; Zhang L, 2005, AQUAT TOXICOL, V73, P353, DOI 10.1016/j.aquatox.2005.04.001; Zhang L, 2015, MAR POLLUT BULL, V101, P930, DOI 10.1016/j.marpolbul.2015.10.041; Zhu SQ, 2008, MAR ENVIRON RES, V65, P315, DOI 10.1016/j.marenvres.2007.11.007; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS322, DOI 10.1016/j.marenvres.2006.04.058	185	60	62	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174762	10.1371/journal.pone.0174762	http://dx.doi.org/10.1371/journal.pone.0174762			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403149	Green Published, Green Submitted, gold			2022-12-26	WOS:000399955200020
J	Szoeke, C; Dang, C; Lehert, P; Hickey, M; Morris, ME; Dennerstein, L; Campbell, S				Szoeke, Cassandra; Dang, Christa; Lehert, Philippe; Hickey, Martha; Morris, Meg E.; Dennerstein, Lorraine; Campbell, Stephen			Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LIFE-STYLE; AUSTRALIAN WOMEN; ADULT-POPULATION; FACTOR REDUCTION; FOLLOW-UP; PREVENTION; HEALTH; PREVALENCE	Objectives Vascular disease remains a leading cause of death. There are several vascular risk factors identified that can mitigate development of disease in ageing. We examine reported rates of modifiable risk factors in women responding to an online health questionnaire advertised by popular media. Methods A sample of 26 620 women aged over 18 was examined in 2015 with a cross-sectional health questionnaire. The questionnaire included self-reported health, mood, lifestyle and vascular risk factors. Results There remains high rates of modifiable risk factors present in women. The vast majority of women (80%) reported not eating enough fruit and vegetables. Compared to the guidelines for health, the majority did not perform enough weekly physical activity (70%) and more than half the participants were overweight (54%). Sufficient fruit, vegetables, fish, legumes and physical activity were reported in less than 30% of women! Conclusions Women continue to report low rates of physical activity, fruit and vegetable intake and higher BMI than recommended for good health, despite worldwide health promotion activities aimed at changing these lifestyle factors. Programs to support healthy living need to be reviewed and revised to reduce the burden of vascular disease and dementia in women. Previous guidelines are not having the important impact they should, particularly in women.	[Szoeke, Cassandra; Dang, Christa; Hickey, Martha; Dennerstein, Lorraine] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Szoeke, Cassandra] Australian Catholic Univ, Inst Hlth & Ageing, Melbourne, Vic, Australia; [Lehert, Philippe] Univ Mons, Dept Math & Stat, Mons, Belgium; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Campbell, Stephen] Melbourne Hlth, Melbourne, Vic, Australia	University of Melbourne; Australian Catholic University; University of Mons; La Trobe University	Szoeke, C (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia.; Szoeke, C (corresponding author), Australian Catholic Univ, Inst Hlth & Ageing, Melbourne, Vic, Australia.	cszoeke@unimelb.edu.au	Szoeke, Cassandra/AAI-8631-2021; Szoeke, CAssandra/AAE-8715-2019	Szoeke, Cassandra/0000-0002-3698-2590; Dang, Christa/0000-0003-0905-282X; Morris, Meg/0000-0002-0114-4175	National Health and Medical Research Council [547500]; Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne	CS received funding from the National Health and Medical Research Council (grant 547500), https//www.nhmrc.gov.au/. CS received funding from the Department of Medicine - Royal Melbourne Hospital, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, http://www.medrmhwh.unimelb.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AA, 2014, ALZH DIS FACTS FIG I; ABS, 2008, CAUS DEATH AUSTR 200; ABS, ABS PUBLIC; AIHW, 2010, WOM HEART DIS CARD P; Anderson R, 2010, MATURITAS, V67, P151, DOI 10.1016/j.maturitas.2010.06.007; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Institute of Health andWelfare (AIHW), 2011, CARD DIS AUSTR FACTS; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Booth-Kewley S, 2007, COMPUT HUM BEHAV, V23, P463, DOI 10.1016/j.chb.2004.10.020; Brown WJ, 2000, RES Q EXERCISE SPORT, V71, P206, DOI 10.1080/02701367.2000.10608901; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Dobson R., 2008, BRIT MED J; DOH, 2008, PUTTING PREVENTION F; DOHA, 2010, NAT WOM HLTH POL, P69; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Ferretti F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141834; Goldman L, 2001, J AM COLL CARDIOL, V38, P1012, DOI 10.1016/S0735-1097(01)01512-1; Graham IM, 2005, CURR OPIN CARDIOL, V20, P430, DOI 10.1097/01.hco.0000176405.56119.54; Hammond Jean, 2007, Aust Crit Care, V20, P53, DOI 10.1016/j.aucc.2007.02.001; HASKELL WL, 1994, CIRCULATION, V89, P975, DOI 10.1161/01.CIR.89.3.975; Hendrie G, 2016, CSIRO HLTH DIET SCOR, V2016; Hung J., 2008, MED J AUSTRALIA, V184, P206; Huxley RR, 2015, CIRC J, V79, P1662, DOI 10.1253/circj.CJ-15-0661; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kopjar B, 2005, PREV CHRONIC DIS, V2, pA18; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Magarey A, 2006, AUST NZ J PUBL HEAL, V30, P32, DOI 10.1111/j.1467-842X.2006.tb00083.x; McPherson K, 2002, CORONARY HEART DIS E; Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mosca L, 2013, CIRCULATION, V127, P1254, DOI 10.1161/CIR.0b013e318287cf2f; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Mosca L, 2010, CIRC-CARDIOVASC QUAL, V3, P120, DOI 10.1161/CIRCOUTCOMES.109.915538; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; Rose G., 1992, STRATEGY PREVENTIVE; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Seib C, 2014, WOMEN HEALTH ISS, V24, pE43, DOI 10.1016/j.whi.2013.11.004; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Smith-DiJulio K, 2009, HEALTH CARE WOMEN IN, V30, P1111, DOI 10.1080/07399330903104524; Taskforce NPH, 2008, AUSTRALIA HEALTHIEST; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Wenger NK, 2013, ADV CHRONIC KIDNEY D, V20, P419, DOI 10.1053/j.ackd.2013.02.006; Yeats B., 2008, WOMEN CARDIOVASCULAR	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173603	10.1371/journal.pone.0173603	http://dx.doi.org/10.1371/journal.pone.0173603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403144	Green Published, gold			2022-12-26	WOS:000399955200008
J	Toledo, RD; Martins, FDC; Ferreira, FP; de Almeida, JC; Ogawa, L; dos Santos, HLEPL; dos Santos, MM; Pinheiro, FA; Navarro, IT; Garcia, JL; Freire, RL				Toledo, Roberta dos Santos; Cardoso Martins, Felippe Danyel; Ferreira, Fernanda Pinto; de Almeida, Jonatas Campos; Ogawa, Liza; Peruch Lemos dos Santos, Hannah Lia Ettiene; dos Santos, Maira Moreira; Pinheiro, Filipe Aguera; Navarro, Italmar Teodorico; Garcia, Joao Luis; Freire, Roberta Lemos			Cryptosporidium spp. and Giardia spp. in feces and water and the associated exposure factors on dairy farms	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DUODENALIS GENOTYPES; GENETIC-CHARACTERIZATION; PROTOZOAN PARASITES; SUBTYPE ANALYSES; PARVUM OOCYSTS; SURFACE-WATER; BEEF-CALVES; PREVALENCE; CATTLE	The aims of this study were to verify the prevalence of Cryptosporidium spp. and Giardia spp. in animal feces and drinking water on dairy farms and to identify a possible relation between the exposure factors and the presence of these parasites. Fecal samples from cattle and humans and water samples were collected on dairy farms in Parana A, Brazil. Analysis of (oo) cysts in the feces was performed by the modified Ziehl-Neelsen staining and centrifugal flotation in zinc sulfate. Test-positive samples were subjected to nested PCR amplification of the 18SSU ribosomal RNA gene for identification of Cryptosporidium and Giardia and of the gp60 gene for subtyping of Cryptosporidium. Microbiological analysis of water was carried out by the multiple-tube method and by means of a chromogenic substrate, and parasitological analysis was performed on 31 samples by direct immunofluorescence and nested PCR of the genes mentioned above. Identification of the species of Cryptosporidium was performed by sequencing and PCR with analysis of restriction fragment length polymorphisms. The prevalence of Giardia and Cryptosporidium was higher in calves than in adults. Among the samples of cattle feces, Cryptosporidium parvum was identified in 41 (64%), C. ryanae in eight (12.5%), C. bovis in four (6.3%), C. andersoni in five (7.8%), and a mixed infection in 20 samples (31.3%). These parasites were not identified in the samples of human feces. Thermotolerant coliform bacteria were identified in 25 samples of water (45.5%). Giardia duodenalis and C. parvum were identified in three water samples. The gp60 gene analysis of C. parvum isolates revealed the presence of two strains (IIaA20G1R1 and IIaA17G2R2) in the fecal samples and one (IIaA17G2R1) in the water samples. The presence of coliforms was associated with the water source, structure and degradation of springs, rain, and turbidity. The prevalence of protozoa was higher in calves up to six months of age. C. parvum and G. duodenalis were identified in the water of dairy farms, as were thermotolerant coliforms; these findings point to the need for guidance on handling of animals, preservation of water sources, and water treatment.	[Toledo, Roberta dos Santos; Cardoso Martins, Felippe Danyel; Ferreira, Fernanda Pinto; de Almeida, Jonatas Campos; Peruch Lemos dos Santos, Hannah Lia Ettiene; dos Santos, Maira Moreira; Pinheiro, Filipe Aguera; Navarro, Italmar Teodorico; Garcia, Joao Luis; Freire, Roberta Lemos] Univ Estadual Londrina, DMVP, Londrina, Parana, Brazil; [Ogawa, Liza] UENP, Ctr Ciencias Agr, Bandeirantes, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual do Norte do Parana (UENP)	Toledo, RD (corresponding author), Univ Estadual Londrina, DMVP, Londrina, Parana, Brazil.	betatoledo@yahoo.com.br	ALMEIDA, JONATAS/AAB-4140-2020; Garcia, Joao Luis/Y-8864-2019; Martins, Felippe Danyel Cardoso/T-5710-2019; Garcia, João Luis/X-4279-2019; Luis, João/AAE-9252-2019	ALMEIDA, JONATAS/0000-0002-2282-4268; Garcia, Joao Luis/0000-0002-5736-7511; Garcia, João Luis/0000-0003-1826-7582; Moreira Santos, Maira/0000-0002-2483-9009; Ogawa, Liza/0000-0002-2509-386X	Araucaria Foundation [24/2012]; Araucaria Foundation of the Universal Program of Basic and Applied Research [196/2014]	Araucaria Foundation(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Araucaria Foundation of the Universal Program of Basic and Applied Research(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This work was funded by the Araucaria Foundation to support the scientific and technological development of Parana, after approval of funding in the call for projects 24/2012 of the Universal Program of Basic and Applied Research. The agreement was established under number 196/2014. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Andrade J, 2005, ESPACO ENERGIA, V3, P6; Appelbee AJ, 2003, VET PARASITOL, V112, P289, DOI 10.1016/S0304-4017(02)00422-3; Lima RCA, 2013, SEMIN-CIENC AGRAR, V34, P3747, DOI 10.5433/1679-0359.2013v34n6Supl2p3747; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Branco N, 2012, VECTOR-BORNE ZOONOT, V12, P410, DOI 10.1089/vbz.2011.0679; Brasil Ministerio da Saude., 2013, MAN PRAT AN AG; Brasil Ministerio do Planejamento Orcamento e Instituto Brasileiro de Geografia e Estatistica -IBGE, 2012, PESQ NAC AM DOM PNAD; Budu-Amoako E, 2012, J VET INTERN MED, V26, P668, DOI 10.1111/j.1939-1676.2012.00930.x; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Cama V, 2006, EMERG INFECT DIS, V12, P1025, DOI 10.3201/eid1206.060015; CANTUSIO NETO R, 2004, HIGIENE ALIMENTAR, V18, P52, DOI DOI 10.1007/S00436-009-1440-Y; Capp N., 2012, Geografia Ensino & Pesquisa, V16, P77; Cardoso Jose Marcio S, 2008, Rev Bras Parasitol Vet, V17 Suppl 1, P239; Chalmers RM, 2011, EPIDEMIOL INFECT, V139, P700, DOI 10.1017/S0950268810001688; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Collier Sarah A., 2011, Morbidity and Mortality Weekly Report, V60, P918; Del Coco VF, 2014, RES VET SCI, V96, P311, DOI 10.1016/j.rvsc.2013.12.010; Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036; Faust E.C., 1939, Journal of Parasitology Urbana, V25, P241, DOI 10.2307/3272508; Fayer R, 2005, J PARASITOL, V91, P624, DOI 10.1645/GE-3435; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Feitosa Francisco Leydson Formiga, 2004, Cienc. Rural, V34, P189, DOI 10.1590/S0103-84782004000100029; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Franco RM., 2007, REV PANAM INFECTOL, V9, P36; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2012, VET PARASITOL, V190, P383, DOI 10.1016/j.vetpar.2012.06.039; Geurden T, 2010, EXP PARASITOL, V124, P98, DOI 10.1016/j.exppara.2009.03.001; Heller L., 2004, EPIDEMIOL SERV SAUDE, V13, P79, DOI [10.5123/S1679-49742004000200002, DOI 10.5123/S1679-49742004000200002]; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Huetink REC, 2001, VET PARASITOL, V102, P53, DOI 10.1016/S0304-4017(01)00514-3; Karanis P, 1998, WATER SCI TECHNOL, V37, P9, DOI 10.1016/S0273-1223(98)00046-8; Karanis P, 1996, ZBL BAKT-INT J MED M, V284, P107; Karanis P, 1998, PARASITOL RES, V84, P442, DOI 10.1007/s004360050427; Karanis P, 1996, ZBL BAKT-INT J MED M, V284, P302; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Kaupke A, 2015, PARASITOL RES, V114, P4709, DOI 10.1007/s00436-015-4719-1; Koehler AV, 2013, ELECTROPHORESIS, V34, P1720, DOI 10.1002/elps.201300100; Lalonde LF, 2009, VET PARASITOL, V160, P185, DOI 10.1016/j.vetpar.2008.11.022; Langoni H., 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P313, DOI 10.1590/S1413-95962004000500004; Martins-Vieira MBC, 2009, ARQ BRAS MED VET ZOO, V61, P1454, DOI 10.1590/S0102-09352009000600030; McAllister TA, 2005, CAN VET J, V46, P47; Meireles MV, 2011, PARASITOL RES, V109, P949, DOI 10.1007/s00436-011-2336-1; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Neta EDM, 2010, REV BRAS MED VET, V32, P201; Nishi L, 2009, VECTOR-BORNE ZOONOT, V9, P543, DOI 10.1089/vbz.2008.0021; Nolan MJ, 2009, ELECTROPHORESIS, V30, P2640, DOI 10.1002/elps.200900071; O'Handley RM, 2000, VET PARASITOL, V90, P193, DOI 10.1016/S0304-4017(00)00235-1; O'Handley RM, 2003, VET PARASITOL, V113, P89, DOI 10.1016/S0304-4017(03)00059-1; Oliveira JP, 2007, PESQUI VET BRASIL, V27, P419, DOI 10.1590/S0100-736X2007001000006; Ortolani E. L., 2003, Parasitologia Latinoamericana, V58, P122; OUCHENE N, 2014, J PARASITOL VECTOR B, V6, P61; Silva FMPE, 2013, REV BRAS PARASITOL V, V22, P22, DOI 10.1590/S1984-29612013005000010; Paz e Silva FM, 2012, FOLIA PARASIT, V59, P15; Plutzer J, 2010, LETT APPL MICROBIOL, V50, P82, DOI 10.1111/j.1472-765X.2009.02758.x; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Plutzer J, 2016, WATER RES, V101, P318, DOI 10.1016/j.watres.2016.05.085; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Redlinger T, 2002, AM J TROP MED HYG, V66, P794, DOI 10.4269/ajtmh.2002.66.794; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Santin M, 2009, VET PARASITOL, V162, P40, DOI 10.1016/j.vetpar.2009.02.008; Seva AD, 2010, REV BRAS PARASITOL V, V19, P249; Silva CV, 2012, ENG SANIT AMBIENT, V17, P293; Silverlas C, 2013, INT J PARASITOL, V43, P155, DOI 10.1016/j.ijpara.2012.10.009; Smith RP, 2014, VET PARASITOL, V204, P111, DOI 10.1016/j.vetpar.2014.05.022; Swaffer BA, 2014, WATER RES, V67, P310, DOI 10.1016/j.watres.2014.08.055; Taylor R, 2004, FEMS MICROBIOL ECOL, V49, P17, DOI 10.1016/j.femsec.2004.02.018; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Thompson RCA, 2004, VET PARASITOL, V126, P15, DOI 10.1016/j.vetpar.2004.09.008; Thompson RCA, 2004, ADV PARASIT, V58, P69, DOI 10.1016/S0065-308X(04)58002-8; Tomazic ML, 2013, VET PARASITOL, V198, P382, DOI 10.1016/j.vetpar.2013.09.022; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Trout JM, 2007, VET PARASITOL, V147, P205, DOI 10.1016/j.vetpar.2007.05.014; Trout JM, 2006, VET PARASITOL, V140, P217, DOI 10.1016/j.vetpar.2006.03.025; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Trout JM, 2005, VET PARASITOL, V130, P177, DOI 10.1016/j.vetpar.2005.03.032; Vargas SF, 2014, PESQUI VET BRASIL, V34, P749, DOI 10.1590/S0100-736X2014000800007; Vaz L, 2012, 21 ENC NAC GEOGR AGR, V21, P1; VESEY G, 1993, J APPL BACTERIOL, V75, P82, DOI 10.1111/j.1365-2672.1993.tb03412.x; Wells B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0684-x; Wilkes G, 2013, APPL ENVIRON MICROB, V79, P434, DOI 10.1128/AEM.01924-12; World Health Organization, 2009, DIARRH WHY CHILDR AR; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	96	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175311	10.1371/journal.pone.0175311	http://dx.doi.org/10.1371/journal.pone.0175311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403147	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200050
J	Leon-Ortega, M; Jimenez-Franco, MV; Martinez, JE; Calvo, JF				Leon-Ortega, Mario; Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.			Factors influencing territorial occupancy and reproductive success in a Eurasian Eagle-owl (Bubo bubo) population	PLOS ONE			English	Article							SPECIES OCCURRENCE DYNAMICS; CALIFORNIA SPOTTED OWL; CLIFF-NESTING RAPTORS; BREEDING PERFORMANCE; HIERAAETUS-PENNATUS; AQUILA-CHRYSAETOS; SPATIAL-PATTERNS; MULTIPLE STATES; SITE FIDELITY; LARGE-SCALE	Modelling territorial occupancy and reproductive success is a key issue for better understanding the population dynamics of territorial species. This study aimed to investigate these ecological processes in a Eurasian Eagle-owl (Bubo bubo) population in south-eastern Spain during a seven-year period. A multi-season, multi-state modelling approach was followed to estimate the probabilities of occupancy and reproductive success in relation to previous state, time and habitat covariates, and accounting for imperfect detection. The best estimated models showed past breeding success in the territories to be the most important factor determining a high probability of reoccupation and reproductive success in the following year. In addition, alternative occupancy models suggested the positive influence of crops on the probability of territory occupation. By contrast, the best reproductive model revealed strong interannual variations in the rates of breeding success, which may be related to changes in the abundance of the European Rabbit, the main prey of the Eurasian Eagle-owl. Our models also estimated the probabilities of detecting the presence of owls in a given territory and the probability of detecting evidence of successful reproduction. Estimated detection probabilities were high throughout the breeding season, decreasing in time for unsuccessful breeders but increasing for successful breeders. The probability of detecting reproductive success increased with time, being close to one in the last survey. These results suggest that reproduction failure in the early stages of the breeding season is a determinant factor in the probability of detecting occupancy and reproductive success.	[Leon-Ortega, Mario; Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.] Univ Murcia, Fac Biol, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Jose E.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain; [Jimenez-Franco, Maria V.] Univ Miguel Hernandez Elche, Area Ecol, Elche, Spain	University of Murcia; Universidad Miguel Hernandez de Elche	Calvo, JF (corresponding author), Univ Murcia, Fac Biol, Dept Ecol & Hidrol, Murcia, Spain.	ifcalvo@um.es	Jiménez-Franco, Maria Victoria/M-2041-2014; Calvo, José Francisco/C-7076-2009	Jiménez-Franco, Maria Victoria/0000-0002-7254-0431; Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795	FPU grant from the Spanish Ministry of Educationand Science [AP2009-2073]	FPU grant from the Spanish Ministry of Educationand Science(German Research Foundation (DFG))	MVJ-F was partially supported by a FPU grant (reference AP2009-2073) from the Spanish Ministry of Educationand Science (http://www.mecd.gob.es/educacion-mecd/areas-educacion/profesorado/universitarios/becas-ayudas/formacion.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bionda R, 2012, J ORNITHOL, V153, P167, DOI 10.1007/s10336-011-0721-2; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Boughton DA, 2000, AM NAT, V156, P131, DOI 10.1086/303380; Bouvier JC, 2014, ACTA ORNITHOL, V49, P23, DOI 10.3161/000164514X682869; Brambilla M, 2013, ORNIS FENNICA, V90, P50; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Carrete M, 2005, OIKOS, V108, P125, DOI 10.1111/j.0030-1299.2005.12942.x; Casado E, 2008, IBIS, V150, P788, DOI 10.1111/j.1474-919X.2008.00862.x; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Donazar J.A., 1988, Ardeola, V35, P233; DONAZAR JA, 1990, J ORNITHOL, V131, P439, DOI 10.1007/BF01639820; Espin S, 2014, SCI TOTAL ENVIRON, V470, P1132, DOI 10.1016/j.scitotenv.2013.10.063; Fernandez-de-Simon J, 2014, ACTA OECOL, V60, P1, DOI 10.1016/j.actao.2014.06.006; Fisher JT, 2014, CONSERV BIOL, V28, P1249, DOI 10.1111/cobi.12302; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gomez-Rodriguez C, 2012, DIVERS DISTRIB, V18, P260, DOI 10.1111/j.1472-4642.2011.00837.x; Grady MJ, 2017, IBIS, V159, P285; Guillod N, 2016, J AVIAN BIOL, V47, P697, DOI 10.1111/jav.00990; Hines JE., 2006, PRESENCESOFTWARE EST; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Jimenez-Franco MV, 2014, J ZOOL, V292, P64, DOI 10.1111/jzo.12085; Jimenez-Franco MV, 2013, J ORNITHOL, V154, P311, DOI 10.1007/s10336-012-0895-2; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; Kaisanlahti-Jokimaki ML, 2008, ORNIS FENNICA, V85, P2; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kruger SC, 2015, CONDOR, V117, P94, DOI 10.1650/CONDOR-14-121.1; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Lee DE, 2012, CONDOR, V114, P792, DOI 10.1525/cond.2012.110147; Leon-Ortega M, 2016, EUR J WILDLIFE RES, V62, P643, DOI 10.1007/s10344-016-1036-7; Leon-Ortega M, 2014, ARDEOLA, V61, P45, DOI 10.13157/arla.61.1.2014.45; Linkhart BD, 2007, AUK, V124, P264, DOI 10.1642/0004-8038(2007)124[264:RRFADI]2.0.CO;2; Lohmus A, 2004, J AVIAN BIOL, V35, P455, DOI 10.1111/j.0908-8857.2004.03228.x; Lopez-Lopez P, 2009, BIODIVERS CONSERV, V18, P1389, DOI 10.1007/s10531-008-9469-2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2011, METHODS ECOL EVOL, V2, P612, DOI 10.1111/j.2041-210X.2011.00110.x; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Marchesi L, 2002, IBIS, V144, pE164, DOI 10.1046/j.1474-919X.2002.t01-2-00094_2.x; Margalida A, 2011, ANIM CONSERV, V14, P167, DOI 10.1111/j.1469-1795.2010.00412.x; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; MARTIN K, 1995, AM ZOOL, V35, P340; Martinez JA, 2003, ECOGRAPHY, V26, P21, DOI 10.1034/j.1600-0587.2003.03368.x; Martinez Jose Antonio, 2002, Ardeola, V49, P1; Martinez JE, 2008, ORNIS FENNICA, V85, P13; Martinez JE, 2006, IBIS, V148, P807, DOI 10.1111/j.1474-919X.2006.00586.x; Martinez Jose Enrique, 2000, Ardeola, V47, P215; Martinez-Abrain A., 2002, Animal Biodiversity and Conservation, V25, P47; Martinez-Marti C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33838; Mcintyre CL, 2012, IBIS, V154, P124, DOI 10.1111/j.1474-919X.2011.01181.x; Millon A, 2008, J ZOOL, V275, P349, DOI 10.1111/j.1469-7998.2008.00447.x; Neteler M., 2013, OPEN SOURCE GIS GRAS; Newton I., 1998, POPULATION LIMITATIO; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Ortego J, 2004, ARDEOLA, V51, P385; Ortego J, 2007, ORNIS FENNICA, V84, P78; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Penteriani V, 2001, ARDEA, V89, P331; Penteriani V, 2010, ORNIS FENNICA, V87, P135; Penteriani V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003014; Peterson SL, 2014, CONDOR, V116, P527, DOI 10.1650/CONDOR-14-45.1; Sadoti G, 2014, WILDLIFE BIOL, V20, P97, DOI 10.2981/wlb.13056; Schmidt KA, 2004, ECOL LETT, V7, P176, DOI 10.1111/j.1461-0248.2003.00565.x; Seamans M., 2010, J ORNITHOL, DOI DOI 10.1007/S10336-010-0544-6; Seamans ME, 2007, CONDOR, V109, P566, DOI 10.1650/8352.1; Serrano D, 2001, J ANIM ECOL, V70, P568, DOI 10.1046/j.1365-2656.2001.00512.x; Steenhof Karen, 2007, P181; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Switzer PV, 1997, BEHAV ECOL SOCIOBIOL, V40, P307, DOI 10.1007/s002650050346; Tempel DJ, 2013, CONSERV BIOL, V27, P1087, DOI 10.1111/cobi.12074; Tingley MW, 2016, METHODS ECOL EVOL, V7, P508, DOI 10.1111/2041-210X.12500; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	77	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175597	10.1371/journal.pone.0175597	http://dx.doi.org/10.1371/journal.pone.0175597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399175	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000053
J	Heuch, I; Heuch, I; Hagen, K; Zwart, JA				Heuch, Ingrid; Heuch, Ivar; Hagen, Knut; Zwart, John-Anker			Physical activity level at work and risk of chronic low back pain: A follow-up in the Nord-Trondelag Health Study	PLOS ONE			English	Article							TRONDELAG-HEALTH; LEISURE-TIME; PROSPECTIVE COHORT; POPULATION; PREDICTORS; ASSOCIATION; NORWAY; DISABILITY; EDUCATION; VALIDITY	Background Physical activity in leisure time seems to reduce the risk of low back pain, but it is not known whether occupational activity, as recorded in a representative working population, produces a higher or lower risk. Objective To study associations between physical activity level at work and risk of chronic low back pain. Methods Associations were examined in a Norwegian prospective study using data from the HUNT2 and HUNT3 surveys carried out in the whole county of Nord-Tremptysetndelag. Participants were 7580 women and 7335 men who supplied information about physical activity level at work. Levels considered were sedentary work, work involving walking but no heavy lifting, work involving walking and heavy lifting, and particularly strenuous physical work. Nobody in the cohort was affected by chronic low back pain at baseline. After 11 years, participants reported whether they suffered from chronic low back pain. Generalized linear modelling with adjustment for potential confounders was applied to assess associations with risk factors. Results In age-adjusted analyses both women and men showed statistically significant associations between physical activity at work and risk of chronic low back pain, suggesting positive relationships. For particularly strenuous physical work the relative risk of chronic low back pain was 1.30 (95% CI: 1.00-1.71) in women and 1.36 (95% CI 1.17-1.59) in men, compared to sedentary work. Women still showed a general association with activity level after adjustment for education, leisure time physical activity, BMI, smoking and occupational category. In men, the higher risk was only maintained for particularly strenuous work. Conclusion In this cohort, women had a higher risk of chronic low back pain with work involving walking and heavy lifting or particularly strenuous work, compared to sedentary work. Men participating in particularly strenuous work also experienced a higher risk of chronic low back pain.	[Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Heuch, Ivar] Univ Bergen, Dept Math, Bergen, Norway; [Hagen, Knut] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Hagen, Knut] St Olavs Hosp, Dept Neurol, Norwegian Natl Headache Ctr, Trondheim, Norway; [Zwart, John-Anker] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Heuch, I (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.; Heuch, I (corresponding author), Oslo Univ Hosp, FORMI, Oslo, Norway.	ingrid.heuch@ous-hf.no	Heuch, Ivar/A-4510-2008	Heuch, Ivar/0000-0003-3386-9688				Andersen JH, 2007, ARTHRITIS RHEUM-US, V56, P1355, DOI 10.1002/art.22513; BERGENUDD H, 1988, SPINE, V13, P58, DOI 10.1097/00007632-198801000-00014; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Bogduk N, 2004, MED J AUSTRALIA, V180, P79, DOI 10.5694/j.1326-5377.2004.tb05805.x; Chen SM, 2009, INT ARCH OCC ENV HEA, V82, P797, DOI 10.1007/s00420-009-0410-0; Coenen P, 2014, OCCUP ENVIRON MED, V71, P871, DOI 10.1136/oemed-2014-102346; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631; Hagen KB, 2006, SOC SCI MED, V63, P1267, DOI 10.1016/j.socscimed.2006.03.041; Hagen KB, 2002, SPINE, V27, P1790, DOI 10.1097/00007632-200208150-00019; Hartvigsen J, 2000, SCAND J PUBLIC HEALT, V28, P230, DOI 10.1177/14034948000280030201; Hartvigsen J, 2001, SPINE, V26, P1788, DOI 10.1097/00007632-200108150-00011; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heuch I, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2970-8; Heuch I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141268; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2013, INT ARCH OCC ENV HEA, V86, P463, DOI 10.1007/s00420-012-0781-5; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Keogh E, 2006, J MENS HLTH GEND, V3, P236, DOI DOI 10.1016/J.JMHG.2006.03.006; Keogh E, 2006, PAIN, V123, P275, DOI 10.1016/j.pain.2006.03.004; Kopec JA, 2004, SPINE, V29, P70, DOI 10.1097/01.BRS.0000103942.81227.7F; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kujala UM, 1996, EUR J APPL PHYSIOL O, V73, P452, DOI 10.1007/BF00334423; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Kwon BK, 2011, OCCUP MED-OXFORD, V61, P541, DOI 10.1093/occmed/kqr092; Leboeuf-Yde C, 1999, SPINE, V24, P1463, DOI 10.1097/00007632-199907150-00012; Liebers F, 2013, BUNDESGESUNDHEITSBLA, V56, P367, DOI 10.1007/s00103-012-1619-8; Macfarlane GJ, 1997, SPINE, V22, P1143, DOI 10.1097/00007632-199705150-00015; Miranda H, 2008, SCAND J WORK ENV HEA, V34, P411, DOI 10.5271/sjweh.1290; National Education Association, 2010, FOC AM IND AL NAT, P2; Roffey DM, 2010, SPINE J, V10, P639, DOI 10.1016/j.spinee.2010.04.028; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Sterud T, 2013, OCCUP ENVIRON MED, V70, P296, DOI 10.1136/oemed-2012-101116	39	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175086	10.1371/journal.pone.0175086	http://dx.doi.org/10.1371/journal.pone.0175086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394896	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800016
J	Maesato, K; Ohtake, T; Mochida, Y; Ishioka, K; Oka, M; Moriya, H; Hidaka, S; Kobayashi, S				Maesato, Kyoko; Ohtake, Takayasu; Mochida, Yasuhiro; Ishioka, Kunihiro; Oka, Machiko; Moriya, Hidekazu; Hidaka, Sumi; Kobayashi, Shuzo			Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SMALL-VESSEL DISEASE; CEREBRAL-BLOOD-FLOW; COGNITIVE IMPAIRMENT; HOMOCYSTEINE LEVELS; ALZHEIMERS-DISEASE; FOLIC-ACID; ATHEROSCLEROSIS; DIALYSIS; BRAIN	Background Cognitive impairment is one of the important critical issues in hemodialysis (HD) patients. However, the associating factors of brain atrophy in HD patients have not been fully elucidated. Purpose and methods Brain magnetic resonance imaging (MRI) was performed in 34 of total 72 HD outpatients in our dialysis center. These MRI images were analyzed by an application software; Voxel-based Specific Regional Analysis System for Alzheimer's Disease (VSRAD). VSRAD quantitatively calculates the extent of brain atrophy (percent of volume reduction) comparing with a MRI imaging database of 80 age-matched healthy controls. The extent of both hippocampal and whole-brain atrophy was evaluated with possible contributing factors. Results In all patients, the mean extent of hippocampal atrophy was 27.3%, and the mean extent of whole-brain atrophy was 11.2%. The extent of hippocampal atrophy was significantly correlated with low body mass index (BMI), total serum homocysteine (tHcy) levels, and brachialankle pulse wave velocity (baPWV). The extent of whole-brain atrophy showed significant correlations with age, hypoalbuminemia, and baPWV. Based on the multiple regression analysis, tHcy was an independent determinant of hippocampal atrophy (beta = 0.460, R-2 = 0.189, P<0.01); while age was an independent determinant of whole-brain atrophy (beta = 0.594, R-2 = 0.333, P<0.01). Conclusions In this exploratory pilot study, hippocampal atrophy was significantly correlated with hyperhomocysteinemia in HD patients.	[Maesato, Kyoko] Shonan Kamakura Gen Hosp, Dept Kidney Dis, Kamakura, Kanagawa, Japan; Shonan Kamakura Gen Hosp, Transplant Ctr, Kamakura, Kanagawa, Japan		Maesato, K (corresponding author), Shonan Kamakura Gen Hosp, Dept Kidney Dis, Kamakura, Kanagawa, Japan.	kyoko.maesato@tokushukai.jp						Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Balla S, 2013, CURR OPIN PHARMACOL, V13, P192, DOI 10.1016/j.coph.2012.12.001; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Cacciapuoti F, 2013, J THROMB THROMBOLYS, V36, P258, DOI 10.1007/s11239-012-0856-x; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Huang RFS, 2001, LIFE SCI, V68, P2799, DOI 10.1016/S0024-3205(01)01066-9; Isshiki R, 2014, THER APHER DIAL, V18, P291, DOI 10.1111/1744-9987.12107; Jardine MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3533; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Kampoli AM, 2012, CURR MED CHEM, V19, P2521, DOI 10.2174/092986712800493039; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kobayashi S, 2014, HYPERTENS RES, V37, P636, DOI 10.1038/hr.2014.57; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Post JB, 2012, AM J NEPHROL, V35, P120, DOI 10.1159/000334871; Righetti M, 2012, CURR MED CHEM, V19, P3502, DOI 10.2174/092986712801323261; RODGERS GM, 1990, BLOOD, V75, P895; Shimomura T, 2011, EUR J CLIN INVEST, V41, P751, DOI 10.1111/j.1365-2362.2010.02464.x	20	8	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175102	10.1371/journal.pone.0175102	http://dx.doi.org/10.1371/journal.pone.0175102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394902	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800017
J	Zhang, L; Gan, XQ; He, YT; Zhu, ZL; Zhu, JF; Yu, HY				Zhang, Ling; Gan, Xueqi; He, Yuting; Zhu, Zhuoli; Zhu, Junfei; Yu, Haiyang			Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; MC3T3-E1 CELLS; TNF-ALPHA; DIFFERENTIATION; ACTIVATION; DRP1; BLOCKADE; DIVISION; OXIDANTS	Although previous studies have implicated pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), to be detrimental for osteogenic activity, the related regulatory mechanisms are not yet fully validated. Since mitochondria host several essential metabolic processes and play a pivotal role in cellular functions, whether and how mitochondrial function contributes to inflammation-induced bone destruction needs further exploration. Our findings revealed that TNF-alpha impaired osteoblast function, including decreased mRNA levels of osteogenic markers, suppressed ALP expression and activity, and compromised cellular viability. Moreover, increased reactive oxygen species (ROS)mediated oxidative stress in the TNF-alpha-treated group enhanced excessive mitochondrial fragmentation and disrupted mitochondrial function. However, treatment with antioxidant N-acetyl cysteine (NAC) or mitochondrial division inhibitor Mdivi-1 protected the cells from these adverse phenomena. These findings provide new insights into the role of the Drp1-dependent mitochondrial pathway in the osteogenic dysfunction during inflammation, indicating that this pathway may be a target for the development of new therapeutic approaches for the prevention and treatment of inflammation-induced bone destruction.	[Zhang, Ling; Gan, Xueqi; He, Yuting; Zhu, Zhuoli; Zhu, Junfei; Yu, Haiyang] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China	Sichuan University	Yu, HY (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China.	yhyang6812@scu.edu.cn			Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province [2014SZ0037]; National Natural Science Foundation of China [81400483]; National Key Research and Development Project [2016YFC1102704]	Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was sponsored by the Provincial Key Technology Research and Development Program of the Ministry of Science and Technology of Sichuan Province (no. 2014SZ0037), the National Natural Science Foundation of China (no. 81400483) and the National Key Research and Development Project (no. 2016YFC1102704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2013, BIOMED RES-TOKYO, V34, P161, DOI 10.2220/biomedres.34.161; Arias-Loza PA, 2013, PFLUG ARCH EUR J PHY, V465, P739, DOI 10.1007/s00424-013-1247-7; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Choi EM, 2012, INFLAMMATION, V35, P1204, DOI 10.1007/s10753-012-9430-0; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duarte PM, 2009, CLIN ORAL IMPLAN RES, V20, P514, DOI 10.1111/j.1600-0501.2008.01680.x; Durhuus JA, 2015, MITOCHONDRION, V20, P7, DOI 10.1016/j.mito.2014.10.004; Gan XQ, 2015, BIOCHEM BIOPH RES CO, V468, P719, DOI 10.1016/j.bbrc.2015.11.022; Gan XQ, 2014, FREE RADICAL BIO MED, V75, P230, DOI 10.1016/j.freeradbiomed.2014.07.021; Gan XQ, 2014, BONE, V62, P67, DOI 10.1016/j.bone.2014.01.018; Gan XQ, 2014, BBA-MOL BASIS DIS, V1842, P220, DOI 10.1016/j.bbadis.2013.11.009; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; Grcevic D, 2001, CROAT MED J, V42, P384; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Kawai VK, 2012, CURR OPIN RHEUMATOL, V24, P576, DOI 10.1097/BOR.0b013e328356d212; Kitaura H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/181849; Kozawa O, 1997, J BIOL CHEM, V272, P25099, DOI 10.1074/jbc.272.40.25099; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Niedzwiedzki T, 2015, J MOL ENDOCRINOL, V55, pR23, DOI 10.1530/JME-15-0067; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith SS, 2009, TOXICOL IN VITRO, V23, P60, DOI 10.1016/j.tiv.2008.10.011; Stock M, 2013, ARTHRITIS RHEUM-US, V65, P2310, DOI 10.1002/art.38054; Takei H, 2000, J BIOMED MATER RES, V52, P382, DOI 10.1002/1097-4636(200011)52:2<382::AID-JBM19>3.0.CO;2-V; Thapa D, 2015, J MOL CELL CARDIOL, V79, P212, DOI 10.1016/j.yjmcc.2014.11.008; Wang YW, 2015, J CRANIOFAC SURG, V26, P2081, DOI 10.1097/SCS.0000000000001971; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang L, 2016, BIOCHEM BIOPH RES CO, V470, P510, DOI 10.1016/j.bbrc.2016.01.120	40	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175262	10.1371/journal.pone.0175262	http://dx.doi.org/10.1371/journal.pone.0175262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388678	Green Published, gold, Green Submitted			2022-12-26	WOS:000399375800032
J	Ansari, FA; Ali, SN; Arif, H; Khan, AA; Mahmood, R				Ansari, Fariheen Aisha; Ali, Shaikh Nisar; Arif, Hussain; Khan, Aijaz Ahmed; Mahmood, Riaz			Acute oral dose of sodium nitrite induces redox imbalance, DNA damage, metabolic and histological changes in rat intestine	PLOS ONE			English	Article							PROTEIN CROSS-LINKS; CARBOHYDRATE-METABOLISM; CATALASE INACTIVATION; ANTIOXIDANT POWER; OXIDATIVE STRESS; REACTIVE OXYGEN; OXIDE; GLUTATHIONE; ACID; METHEMOGLOBINEMIA	Industrialization and unchecked use of nitrate/nitrite salts for various purposes has increased human exposure to high levels of sodium nitrite (NaNO2) which can act as a pro-oxidant and pro-carcinogen. Oral exposure makes the gastrointestinal tract particularly susceptible to nitrite toxicity. In this work, the effect of administration of a single acute oral dose of NaNO2 on rat intestine was studied. Animals were randomly divided into four groups and given single doses of 20, 40, 60 and 75 mg NaNO2/kg body weight. Untreated animals served as the control group. An NaNO2 dose-dependent decline in the activities of brush border membrane enzymes, increase in lipid peroxidation, protein oxidation, hydrogen peroxide levels and decreased thiol content was observed in all treated groups. The activities of various metabolic and antioxidant defense enzymes were also altered. NaNO2 induced a dose-dependent increase in DNA damage and DNA-protein crosslinking. Histopathological studies showed marked morphological damage in intestinal cells. The intestinal damage might be due to nitrite-induced oxidative stress, direct action of nitrite anion or chemical modification by reaction intermediates.	[Ansari, Fariheen Aisha; Ali, Shaikh Nisar; Arif, Hussain; Mahmood, Riaz] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, Dept Anat, Jawaharlal Nehru Med Coll, Fac Med, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India.	riazmahmood2002@Yahoo.co.in		Mahmood, Riaz/0000-0001-6726-157X; Arif, Hussain/0000-0002-7596-343X	University Grants Commission, India (SAP-DRS III); Department of Science and Technology (DST-FIST), India	University Grants Commission, India (SAP-DRS III)(University Grants Commission, India); Department of Science and Technology (DST-FIST), India(Department of Science & Technology (India))	This work was supported by the University Grants Commission, India (SAP-DRS III) and the Department of Science and Technology (DST-FIST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Gayyar MMH, 2016, REDOX REP, V21, P50, DOI 10.1179/1351000215Y.0000000035; Ansari FA, 2016, CELL BIOL INT, V40, P887, DOI 10.1002/cbin.10628; Archer MC, 2012, NUTR TOXICOL, V1, P327; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Barrett KE, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1931; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bryan NS, 2011, NUTR HEALTH SER, P279, DOI 10.1007/978-1-60761-616-0_17; Buege J A, 1978, Methods Enzymol, V52, P302; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chui JSW, 2005, ANAESTHESIA, V60, P496, DOI 10.1111/j.1365-2044.2004.04076.x; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; CRANE RK, 1953, J BIOL CHEM, V203, P273; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; Escobar JA, 1996, FREE RADICAL BIO MED, V20, P285, DOI 10.1016/0891-5849(95)02037-3; Evans GA, 1990, CELL, V61, P17, DOI DOI 10.1016/0092-8674(90)90210-6; Farooq N, 2004, NUTR RES, V24, P407, DOI 10.1016/j.nutres.2004.01.004; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; GLOSSMANN H, 1972, FEBS LETT, V19, P340, DOI 10.1016/0014-5793(72)80075-9; GOLDMANN DR, 1976, BIOCHIM BIOPHYS ACTA, V419, P251, DOI 10.1016/0005-2736(76)90351-5; Gui Guan, 2016, Yaoxue Xuebao, V51, P59, DOI 10.16438/j.0513-4870.2015-0551; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HARTMAN Z, 1994, ENVIRON MOL MUTAGEN, V24, P168, DOI 10.1002/em.2850240305; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hord NG, 2011, CURR ATHEROSCLER REP, V13, P484, DOI 10.1007/s11883-011-0209-9; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Jia R, 2015, AQUAT TOXICOL, V169, P1, DOI 10.1016/j.aquatox.2015.09.016; KAPLAN A, 1990, S AFR MED J, V77, P300; Katabami K, 2016, CASE REP EMERG MED, V2016; KEMPSON SA, 1979, AM J PHYSIOL, V237, pE465, DOI 10.1152/ajpendo.1979.237.5.E465; Khundmiri SJ, 2004, J NEPHROL, V17, P377; Lawniczak AE, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5167-9; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCA D, 1987, MUTAT RES, V189, P333, DOI 10.1016/0165-1218(87)90065-6; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; McNally B, 2016, MOL NUTR FOOD RES, V60, P67, DOI 10.1002/mnfr.201500153; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Mithieux G, 2014, DIABETES RES CLIN PR, V105, P295, DOI 10.1016/j.diabres.2014.04.008; MOHRENWEISER HW, 1982, AM J HUM GENET, V34, P425; Montenegro MF, 2012, N-S ARCH PHARMACOL, V385, P509, DOI 10.1007/s00210-011-0712-0; Montenegro MF, 2011, FREE RADICAL BIO MED, V51, P144, DOI 10.1016/j.freeradbiomed.2011.04.005; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; National Toxicology Program, 2001, Natl Toxicol Program Tech Rep Ser, V495, P7; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; Ohshima H, 1998, FREE RADICAL BIO MED, V25, P1057, DOI 10.1016/S0891-5849(98)00141-5; Ozen H, 2014, EXP TOXICOL PATHOL, V66, P367, DOI 10.1016/j.etp.2014.05.003; Payne CM, 1999, ANTIOXID REDOX SIGN, V1, P449, DOI 10.1089/ars.1999.1.4-449; Penhoat A, 2014, METABOLISM, V63, P104, DOI 10.1016/j.metabol.2013.09.005; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rubenchik BL, 1990, J ENVIRON PATHOL TOX, V10, P6; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Sherif IO, 2013, EUR CYTOKINE NETW, V24, P114, DOI 10.1684/ecn.2013.0341; Shingles R, 1997, J BIOENERG BIOMEMBR, V29, P611, DOI 10.1023/A:1022491220299; SHONK CE, 1964, CANCER RES, V24, P709; Singh M, 2012, NITRIC OXIDE-BIOL CH, V26, P61, DOI 10.1016/j.niox.2011.12.002; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Slaoui M, 2011, METHODS MOL BIOL, V691, P69, DOI 10.1007/978-1-60761-849-2_4; Sohn CH, 2014, CLIN TOXICOL, V52, P44, DOI 10.3109/15563650.2013.863327; Spencer JPE, 2000, FREE RADICAL BIO MED, V28, P1039, DOI 10.1016/S0891-5849(00)00190-8; Tamir S, 1996, CHEM RES TOXICOL, V9, P821, DOI 10.1021/tx9600311; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Titov VY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P627, DOI 10.1023/A:1024609624652; WHO (World Health Organization), 2011, NITR NITR DRINK WAT, P1; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Zhao KC, 2001, METHOD ENZYMOL, V335, P296; ZHITKOVICH A, 1992, CARCINOGENESIS, V13, P1485, DOI 10.1093/carcin/13.8.1485; Zhou L, 2016, NUTR CANCER, V68, P105, DOI 10.1080/01635581.2016.1102298	81	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175196	10.1371/journal.pone.0175196	http://dx.doi.org/10.1371/journal.pone.0175196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384248	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900117
J	Balaguier, R; Madeleine, P; Rose-Dulcina, K; Vuillerme, N				Balaguier, Romain; Madeleine, Pascal; Rose-Dulcina, Kevin; Vuillerme, Nicolas			Trunk kinematics and low back pain during pruning among vineyard workers-A field study at the Chateau Larose-Trintaudon	PLOS ONE			English	Article							FLEXION-RELAXATION RESPONSE; RISK-FACTORS; PRESSURE PAIN; MUSCULOSKELETAL DISORDERS; LUMBAR FLEXION; POSTURES; EPIDEMIOLOGY; PREVALENCE; EXERCISE; INCLINOMETRY	The prevalence of low back disorders is dramatically high in viticulture. Field measurements that objectively quantify work exposure can provide information on the relationship between the adopted trunk postures and low back pain. The purposes of the present study were three-fold (1) to carry out a kinematics analysis of vineyard-workers' pruning activity by extracting the duration of bending and rotation of the trunk, (2) to question separately the relationship between the duration of forward bending or trunk rotation with low back pain intensity and pressure pain sensitivity and (3) to question the relationship between the combined duration of forward bending and trunk rotation on low back pain intensity and pressure pain sensitivity. Fifteen vineyard-workers were asked to perform pruning activity for 12 minutes with a wireless triaxial accelerometer placed on their trunk. Kinematic analysis of the trunk showed that vineyard-workers spent more than 50% of the time with the trunk flexed greater than 30 degrees and more than 20% with the trunk rotated greater than 10 degrees. These results show that pruning activity lead to the adoption of forward bended and rotated trunk postures that could significantly increase the risk of work related musculoskeletal disorders in the low back. However, this result was mitigated by the observation of an absence of significant association between the duration of forward bending and trunk rotation with low back pain intensity or pressure pain sensitivity. Even if prospective field measurements and studies assessing the effects of low back pain confounders are needed, this field study provides new genuine information on trunk kinematics during pruning activity.	[Balaguier, Romain; Rose-Dulcina, Kevin; Vuillerme, Nicolas] Univ Grenoble Alpes, AGEIS, Grenoble, France; [Balaguier, Romain; Madeleine, Pascal; Rose-Dulcina, Kevin; Vuillerme, Nicolas] Aalborg Univ, Dept Hlth Sci & Technol, SMI, Phys Act & Human Performance Grp, Aalborg, Denmark; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Aalborg University; Institut Universitaire de France	Vuillerme, N (corresponding author), Univ Grenoble Alpes, AGEIS, Grenoble, France.; Vuillerme, N (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, SMI, Phys Act & Human Performance Grp, Aalborg, Denmark.; Vuillerme, N (corresponding author), Inst Univ France, Paris, France.	nicolas.vuillerme@agim.eu	Madeleine, Pascal/AAD-3201-2021; Balaguier, Romain/ABD-8496-2020; VUILLERME, Nicolas/U-5767-2019	Rose-Dulcina, Kevin/0000-0002-8698-3268; Balaguier, Romain/0000-0001-6393-1556; VUILLERME, Nicolas/0000-0003-3773-393X	grant from the French Ministry of Higher Education and Research; French National Research Agency in the framework of the "Investissements d'avenir" program [ANR-10-AIRT-05]; Blaland French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Denmark)	grant from the French Ministry of Higher Education and Research; French National Research Agency in the framework of the "Investissements d'avenir" program(French National Research Agency (ANR)); Blaland French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Denmark)	This work is part of a joint PhD project financed by a grant from the French Ministry of Higher Education and Research. *This work was also supported by the French National Research Agency in the framework of the "Investissements d'avenir" program (ANR-10-AIRT-05).*EWS project has benefited from support from the Blaland French-Danish scientific cooperation program (Institut Francais du Danemark), the Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France) and Aalborg University (Denmark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to sincerely thank all the Larose-Trintaudon vineyard-workers for their active participation and their patience in this study. The authors are also grateful to Franck Bijon and Mathieu Maudet for their trust and their help during the implementation of this study. The authors would like to thank anonymous reviewers for helpful comments and suggestions. The presented work is also part of a larger pluri-disciplinary project called 'EWS' (Ergonomics at Work and in Sports). EWS project has benefited from support from the Blatand French-Danish scientific cooperation program (Institut Francais du Danemark), the Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France) and Aalborg University (Denmark).	Afshari D, 2014, APPL ERGON, V45, P278, DOI 10.1016/j.apergo.2013.04.015; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Balaguier R, 2014, INT S HUM FACT ORG D, P965; Balaguier R, 2016, BMC MUSCULOSKEL DIS, V17, P1; Balaguier R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160866; Bernard C, 2011, J OCCUP HEALTH, V53, P297, DOI 10.1539/joh.10-0031-OA; Bevan S, 2009, FIT WORK MUSCULOSKEL, P1; Binderup AT, 2010, EUR J PAIN, V14, P705, DOI 10.1016/j.ejpain.2009.11.001; Brumitt J, 2011, J AGROMEDICINE, V16, P72, DOI 10.1080/1059924X.2011.534041; Burrows NJ, 2014, OSTEOARTHR CARTILAGE, V22, P407, DOI 10.1016/j.joca.2013.12.023; Coenen P, 2016, ERGONOMICS, V59, P1182, DOI 10.1080/00140139.2015.1130862; Coenen P, 2015, APPL ERGON, V51, P322, DOI 10.1016/j.apergo.2015.06.005; Coenen P, 2013, J OCCUP REHABIL, V23, P11, DOI 10.1007/s10926-012-9375-z; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; De Rui M, 2015, GERODONTOLOGY, V32, P274, DOI 10.1111/ger.12117; de Zwart BCH, 2001, INT ARCH OCC ENV HEA, V74, P21; de la Morena JMD, 2013, J STRENGTH COND RES, V27, P3045, DOI 10.1519/JSC.0b013e31828bf2c9; Farioli A, 2014, SCAND J WORK ENV HEA, V40, P36, DOI 10.5271/sjweh.3381; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Freitag S, 2007, ANN OCCUP HYG, V51, P385, DOI 10.1093/annhyg/mem018; Ge HY, 2014, BMC MUSCULOSKEL DIS, V15, P1; Hansson GA, 2001, SCAND J WORK ENV HEA, V27, P30, DOI 10.5271/sjweh.584; Hendershot B, 2011, CLIN BIOMECH, V26, P250, DOI 10.1016/j.clinbiomech.2010.09.019; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Hoozemans MJM, 2001, SCAND J WORK ENV HEA, V27, P125, DOI 10.5271/sjweh.599; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jansen JP, 2001, SCAND J WORK ENV HEA, V27, P373, DOI 10.5271/sjweh.629; Jansen JP, 2004, OCCUP ENVIRON MED, V61, P972, DOI 10.1136/oem.2003.012245; Jorgensen MB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-213; Kato AE, 2006, J AGRIC SAF HEALTH, V12, P17, DOI 10.13031/2013.20199; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lagersted-Olsen J, 2016, SCAND J WORK ENV HEA, V42, P528, DOI 10.5271/sjweh.3591; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Meyers James M, 2004, J Agromedicine, V9, P433; Milosavljevic S, 2007, APPL ERGON, V38, P299, DOI 10.1016/j.apergo.2006.04.026; Ning XP, 2011, CLIN BIOMECH, V26, P35, DOI 10.1016/j.clinbiomech.2010.08.012; Oakman J, 2016, INT ARCH OCC ENV HEA, V89, P1127, DOI 10.1007/s00420-016-1149-z; Osborne A, 2012, AM J IND MED, V55, P143, DOI 10.1002/ajim.21033; Panjabi MM, 2006, EUR SPINE J, V15, P668, DOI 10.1007/s00586-005-0925-3; Prairie J, 2014, APPL ERGON, V45, P895, DOI 10.1016/j.apergo.2013.11.006; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Ramond-Roquin A, 2015, SPINE J, V15, P559, DOI 10.1016/j.spinee.2013.05.040; Roquelaure Y, 2002, INT ARCH OCC ENV HEA, V75, P591, DOI 10.1007/s00420-002-0366-9; Roquelaure Y, 2004, APPL ERGON, V35, P179, DOI 10.1016/j.apergo.2003.11.006; Schneider E, 2010, OSH FIGURES WORK REL; Shan XH, 2013, EUR SPINE J, V22, P1972, DOI 10.1007/s00586-013-2784-7; Solomonow M, 2004, J ELECTROMYOGR KINES, V14, P49, DOI 10.1016/j.jelekin.2003.09.011; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; Solomonow M, 2003, CLIN BIOMECH, V18, P273, DOI 10.1016/S0268-0033(03)00024-X; Spielholz P, 2001, ERGONOMICS, V44, P588, DOI 10.1080/00140130118050; Teschke K, 2009, ERGONOMICS, V52, P1067, DOI 10.1080/00140130902912811; Thomas JS, 2008, EUR SPINE J, V17, P97, DOI 10.1007/s00586-007-0532-6; Vaegter HB, 2016, CLIN J PAIN, V32, P58, DOI 10.1097/AJP.0000000000000223; van den Heuvel SG, 2004, SCAND J WORK ENV HEA, V30, P459, DOI 10.5271/sjweh.835; Villumsen M, 2017, APPL ERGON, V58, P273, DOI 10.1016/j.apergo.2016.06.017; Villumsen M, 2015, ERGONOMICS, V58, P246, DOI 10.1080/00140139.2014.969783; Wai EK, 2010, SPINE J, V10, P76, DOI 10.1016/j.spinee.2009.06.005; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666; Widanarko B, 2012, APPL ERGON, V43, P727, DOI 10.1016/j.apergo.2011.11.004; Zwambag DP, 2016, J ELECTROMYOGR KINES, V30, P38, DOI 10.1016/j.jelekin.2016.05.008	63	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175126	10.1371/journal.pone.0175126	http://dx.doi.org/10.1371/journal.pone.0175126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384277	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900094
J	Gahring, LC; Myers, EJ; Dunn, DM; Weiss, RB; Rogers, SW				Gahring, Lorise C.; Myers, Elizabeth J.; Dunn, Diane M.; Weiss, Robert B.; Rogers, Scott W.			Nicotinic alpha 7 receptor expression and modulation of the lung epithelial response to lipopolysaccharide	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; NEUROEPITHELIAL BODIES; PULMONARY-FIBROSIS; GENE-EXPRESSION; STEM-CELLS; ACTIVATION; MOUSE; DYSFUNCTION; MECHANISMS; SURFACTANT	Nicotine modulates multiple inflammatory responses in the lung through the nicotinic acetylcholine receptor subtype alpha7 (alpha 7). Previously we reported that alpha 7 modulates both the hematopoietic and epithelium responses in the lung to the bacterial inflammogen, lipopolysaccharide (LPS). Here we apply immunohistochemistry, flow cytometry and RNA-Seq analysis of isolated distal lung epithelium to further define alpha 7-expression and function in this tissue. Mouse lines were used that co-express a bicistronic tau-green fluorescent protein (tGFP) as a reporter of alpha 7 (alpha 7(G)) expression and that harbor an alpha 7 with a specific point mutation (alpha 7(E260A:G)) that selectively uncouples it from cell calcium-signaling mechanisms. The tGFP reporter reveals strong cell-specific alpha 7-expression by alveolar macrophages (AM), Club cells and ATII cells. Ciliated cells do not express detectible tGFP, but their numbers decrease by one-third in the alpha 7(E260A:G) lung compared to controls. Transcriptional comparisons (RNA-Seq) between alpha 7(G) and a7(E260A:G) enriched lung epithelium 24 hours after challenge with either intra-nasal (i.n.)saline or LPS reveals a robust alpha 7-genotype impact on both the stasis and inflammatory response of this tissue. Overall the alpha 7(E260A:G) lung epithelium exhibits reduced inflammatory cytokine/chemokine expression to i.n. LPS. Transcripts specific to Club cells (e.g., CC10, secretoglobins and Muc5b) or to ATII cells (e.g., surfactant proteins) were constitutively decreased in in the alpha 7(E260A:G) lung, but they were strongly induced in response to i.n. LPS. Protein analysis applying immunohistochemistry and ELISA also revealed alpha 7-associated differences suggested by RNA-Seq including altered mucin protein 5b ( Muc5b) accumulation in the alpha 7(E260A:G) bronchia, that in some cases appeared to form airway plugs, and a substantial increase in extracellular matrix deposits around alpha 7(E260A:G) airway bronchia linings that was not seen in controls. Our results show that alpha 7 is an important modulator of normal gene expression stasis and the response to an inhaled inflammogen in the distal lung epithelium. Further, when normal alpha 7 signaling is disrupted, changes in lung gene expression resemble those associated with long-term lung pathologies seen in humans who use inhaled nicotine products.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA; [Gahring, Lorise C.; Myers, Elizabeth J.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Dunn, Diane M.; Weiss, Robert B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Gahring, LC; Rogers, SW (corresponding author), Salt Lake City Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84148 USA.; Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Rogers, SW (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Lorise.Gahring@hsc.utah.edu; Scott.Rogers@hsc.utah.edu			VA MERIT REVIEW AWARD [101BX001798]; National Heart, Lung, and Blood Institute [R01 HL135610]; National Cancer Institute [5P01CA098262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	VA MERIT REVIEW AWARD(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the VA MERIT REVIEW AWARD, 101BX001798 to LCG; the National Heart, Lung, and Blood Institute, R01 HL135610 to LCG and SWR; and the National Cancer Institute, 5P01CA098262 to RBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen D, 1998, CELL TISSUE RES, V293, P395, DOI 10.1007/s004410051131; Adriaensen D, 2006, J APPL PHYSIOL, V101, P960, DOI 10.1152/japplphysiol.00267.2006; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araz O, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-74; Barnes FA, 2008, AM J RESP CELL MOL, V38, P377, DOI 10.1165/rcmb.2007-0388TR; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brasch F, 2004, EUR RESPIR J, V24, P426, DOI 10.1183/09031936.04.00076403; Brass David M, 2007, Proc Am Thorac Soc, V4, P92, DOI 10.1513/pats.200607-147JG; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eddins D, 2002, AM J PHYSIOL-CELL PH, V282, pC796, DOI 10.1152/ajpcell.00453.2001; Enioutina EY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121128; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103861; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Gahring LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-38; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Horiguchi K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/jnr.22102; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurosawa N, 1996, J BIOL CHEM, V271, P15109, DOI 10.1074/jbc.271.25.15109; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Lee MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112666; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2011, J PHARMACOL EXP THER, V339, P62, DOI 10.1124/jpet.111.184671; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Makinde TO, 2013, EXP MOL PATHOL, V94, P45, DOI 10.1016/j.yexmp.2012.05.009; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Nakano Y, 2016, AM J RESP CRIT CARE, V193, P464, DOI 10.1164/rccm.201509-1872LE; Noguchi M, 2015, CELL REP, V13, P2679, DOI 10.1016/j.celrep.2015.11.058; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2014, BIOCH PHARM; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Reynolds PR, 2005, J BIOL CHEM, V280, P32548, DOI 10.1074/jbc.M502231200; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; Ritzenthaler JD, 2013, ALCOHOL CLIN EXP RES, V37, P914, DOI 10.1111/acer.12044; Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Volckaert T, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-8; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wongtrakool C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109602; Wright JR, 2003, J CLIN INVEST, V111, P1453, DOI 10.1172/JCI200318650; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Zia S, 1997, RES COMMUN MOL PATH, V97, P243; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	82	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175367	10.1371/journal.pone.0175367	http://dx.doi.org/10.1371/journal.pone.0175367			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384302	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900163
J	Kurczab, R; Bojarski, AJ				Kurczab, Rafal; Bojarski, Andrzej J.			The influence of the negative-positive ratio and screening database size on the performance of machine learning-based virtual screening	PLOS ONE			English	Article							CLASSIFICATION; DIVERSITY	The machine learning-based virtual screening of molecular databases is a commonly used approach to identify hits. However, many aspects associated with training predictive models can influence the final performance and, consequently, the number of hits found. Thus, we performed a systematic study of the simultaneous influence of the proportion of negatives to positives in the testing set, the size of screening databases and the type of molecular representations on the effectiveness of classification. The results obtained for eight protein targets, five machine learning algorithms (SMO, Naive Bayes, Ibk, J48 and Random Forest), two types of molecular fingerprints (MACCS and CDK FP) and eight screening databases with different numbers of molecules confirmed our previous findings that increases in the ratio of negative to positive training instances greatly influenced most of the investigated parameters of the ML methods in simulated virtual screening experiments. However, the performance of screening was shown to also be highly dependent on the molecular library dimension. Generally, with the increasing size of the screened database, the optimal training ratio also increased, and this ratio can be rationalized using the proposed cost-effectiveness threshold approach. To increase the performance of machine learning-based virtual screening, the training set should be constructed in a way that considers the size of the screening database.	[Kurczab, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland	Polish Academy of Sciences	Kurczab, R (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, Krakow, Poland.	kurczab@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022	Kurczab, Rafal/0000-0002-9555-3905; Bojarski, Andrzej/0000-0003-1417-6333	 [2011/03/N/NZ2/02478];  [Pol-Nor/198887/73/2013]	; 	The following grants supported the research: 2011/03/N/NZ2/02478 and Pol-Nor/198887/73/2013.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Chuprina A, 2010, J CHEM INF MODEL, V50, P470, DOI 10.1021/ci900464s; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Heikamp K, 2013, J CHEM INF MODEL, V53, P1595, DOI 10.1021/ci4002712; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kalliokoski T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061007; Krier M, 2006, J CHEM INF MODEL, V46, P512, DOI 10.1021/ci050352v; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Ma XH, 2008, J CHEM INF MODEL, V48, P1227, DOI 10.1021/ci800022e; Melville JL, 2009, COMB CHEM HIGH T SCR, V12, P332, DOI 10.2174/138620709788167980; Mitchell TM, 1997, MACHINE LEARNING ANN; Petrova T, 2012, MEDCHEMCOMM, V3, P571, DOI 10.1039/c2md00302c; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Provost F, 2000, P AAAI 2000 WORK IMB; Qiong Wei, 2013, PLOS ONE, P8; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Smusz S, 2013, CHEMOMETR INTELL LAB, V128, P89, DOI 10.1016/j.chemolab.2013.08.003; Smusz S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-17; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Voigt JH, 2001, J CHEM INF COMP SCI, V41, P702, DOI 10.1021/ci000150t; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175410	10.1371/journal.pone.0175410	http://dx.doi.org/10.1371/journal.pone.0175410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384344	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900169
J	Paquin-Proulx, D; Greenspun, BC; Costa, EAS; Segurado, AC; Kallas, EG; Nixon, DF; Leal, FE				Paquin-Proulx, Dominic; Greenspun, Benjamin C.; Costa, Emanuela A. S.; Segurado, Aluisio C.; Kallas, Esper G.; Nixon, Douglas F.; Leal, Fabio E.			MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; HTLV-I; PROVIRAL LOAD; CYTOKINE EXPRESSION; INTERFERON-GAMMA; LEUKEMIA-VIRUS; HIV-INFECTION; TUBERCULOSIS; METABOLITES; ACTIVATION	HTLV-1 infection is associated with several inflammatory disorders, including the neurode-generative condition HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It is unclear why a minority of infected subjects develop HAM/TSP. The cellular immune response has been implicated in the development of inflammatory alterations in these patients; however the pathogenic mechanisms for disease progression remain unclear. Furthermore, HTLV-1-infected individuals have an increase incidence of Mycobacterium tuberculosis (Mtb) infection, suggesting that immunological defect are associated with HTLV-1 infection. Evidence suggests an important role for Mucosal-associated invariant T (MAIT) cells in the early control of Mtb infection. Chronic viral infections like HIV and HCV have been associated with decreased frequency and functionality of MAIT cells. We hypothesized that HTLV-1 infection is associated with similar perturbations in MAIT cells. We investigated MAIT cell frequency, phenotype, and function by flow cytometry in a cohort of 10 asymptomatic and 10 HAM/TSP HTLV-1 infected patients. We found that MAIT cells from HTLV-1-infected subjects were reduced and showed high co-expression of the activation markers CD38 and HLA-DR but normal levels of CCR6 and CD127. MAIT cells had a lower expression of the transcription factor PLZF in HAM/TSP patients. Unlike Tax-specific CD8+T cells, which are hyperfunctional, MAIT cells from HTLV-1-infected subjects had a poor IFN gamma response following antigen stimulation. MAIT cell perturbations in HTLV-1 infection were not associated with HTLV-1 proviral load and MAIT cells were not infected by HTLV-1 in vivo. Rather, MAIT cells loss was associated with immune activation. Overall, our results do not support a role for MAIT cells in HAM/TSP pathogenesis but reduced numbers of MAIT cells, together with their poor functionality, could contribute to the increased susceptibility of HTLV-1-infected individuals to other infectious agents.	[Paquin-Proulx, Dominic; Greenspun, Benjamin C.; Nixon, Douglas F.; Leal, Fabio E.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Costa, Emanuela A. S.; Segurado, Aluisio C.; Kallas, Esper G.] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil	George Washington University; Universidade de Sao Paulo	Paquin-Proulx, D (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	dpaquin_proulx@gwu.edu	Nixon, Douglas/AAU-5734-2020; Paquin-Proulx, Dominic/AFS-1852-2022; Segurado, Aluisio C/K-2229-2012	Nixon, Douglas/0000-0002-2801-1786; Paquin-Proulx, Dominic/0000-0003-1407-3414; Segurado, Aluisio C/0000-0002-6311-8036; Kallas, Esper/0000-0003-2026-6925	NIH [AI117970]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI117970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been facilitated by the services and resources provided by the District of Columbia Center for AIDS Research, an NIH funded program (AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0; Azakami K, 2009, BLOOD, V114, P3208, DOI 10.1182/blood-2009-02-203042; Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bastos MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-199; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brito-Melo GEA, 2007, CLIN EXP IMMUNOL, V147, P35, DOI 10.1111/j.1365-2249.2006.03252.x; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1; Dias J, 2016, J LEUKOCYTE BIOL, V100, P233, DOI 10.1189/jlb.4TA0815-391RR; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Furuya T, 1999, J NEUROIMMUNOL, V95, P185, DOI 10.1016/S0165-5728(98)00263-X; Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871; Gerart S, 2013, BLOOD, V121, P614, DOI 10.1182/blood-2012-09-456095; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goon PKC, 2004, J IMMUNOL, V172, P1735, DOI 10.4049/jimmunol.172.3.1735; Greene JM, 2016, MUCOSAL IMMUNOL; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; Hengst J, 2016, EUR J IMMUNOL; Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2016, NAT IMMUNOL; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Marinho J, 2005, JAIDS-J ACQ IMM DEF, V40, P625, DOI 10.1097/01.qai.0000174252.73516.7a; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943; MORGAN OS, 1989, LANCET, V2, P1184; Nakamura H, 1997, ANN RHEUM DIS, V56, P167, DOI 10.1136/ard.56.3.167; Ndhlovu LC, 2009, CLIN EXP IMMUNOL, V158, P294, DOI 10.1111/j.1365-2249.2009.04019.x; Ndhlovu LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001030; NISHIOKA K, 1989, LANCET, V1, P441; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; Grassi MFR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1428-z; Rocha MC, 2012, TISSUE ANTIGENS, V80, P143, DOI 10.1111/j.1399-0039.2012.01887.x; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Salou M, 2016, CLIN IMMUNOL, V166, P1, DOI 10.1016/j.clim.2016.03.014; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00503; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	50	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175345	10.1371/journal.pone.0175345	http://dx.doi.org/10.1371/journal.pone.0175345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384290	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900161
J	Chang, YF; Broyles, CN; Brook, FA; Davies, MJ; Turtle, CW; Nagai, T; Daniels, MJ				Chang, Yu-Fen; Broyles, Connor N.; Brook, Frances A.; Davies, Mark J.; Turtle, Cameron W.; Nagai, Takeharu; Daniels, Matthew J.			Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics	PLOS ONE			English	Article							GENETICALLY ENCODED CALCIUM; IN-VIVO; CA2+ INDICATORS; LIGHT; ELECTROPHYSIOLOGY; ARRHYTHMIAS; SECRETION; CHANNELS; ATRIAL; MUSCLE	Identification of drug induced electrical instability of the heart curtails development, and introduction, of potentially proarrhythmic drugs. This problem usually requires complimentary contact based approaches such as patch-clamp electrophysiology combined with field stimulation electrodes to observe and control the cell. This produces data with high signal to noise but requires direct physical contact generally preventing high-throughput, or prolonged, phenotyping of single cells or tissues. Combining genetically encoded optogenetic control and spectrally compatible calcium indicator tools into a single adenoviral vector allows the analogous capability for cell control with simultaneous cellular phenotyping without the need for contact. This combination can be applied to single rodent primary adult cardiomyocytes, and human stem cell derived cardiomyocytes, enabling contactless small molecule evaluation for inhibitors of sodium, potassium and calcium channels suggesting it may be useful for early toxicity work. In pancreatic beta-cells it reveals the effects of glucose and the KATP inhibitor gliclazide.	[Chang, Yu-Fen; Broyles, Connor N.; Brook, Frances A.; Davies, Mark J.; Turtle, Cameron W.; Daniels, Matthew J.] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Nagai, Takeharu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Nagai, Takeharu] Osaka Univ, Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Dept Biomol Sci & Engn, Ibaraki, Osaka, Japan; [Daniels, Matthew J.] Oxford Univ NHS Hosp Trust, Dept Cardiol, Oxford, England; [Daniels, Matthew J.] Univ Oxford, BHF Ctr Regenerat Med, Oxford, England; [Chang, Yu-Fen] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Turtle, Cameron W.] BridgeBio Pharmaceut, Pala Alto, CA USA	University of Oxford; Osaka University; Osaka University; Osaka University; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Taipei Veterans General Hospital	Daniels, MJ (corresponding author), Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England.; Daniels, MJ (corresponding author), Oxford Univ NHS Hosp Trust, Dept Cardiol, Oxford, England.; Daniels, MJ (corresponding author), Univ Oxford, BHF Ctr Regenerat Med, Oxford, England.	matthew.daniels@cardiov.ox.ac.uk		Nagai, Takeharu/0000-0003-2650-9895; Daniels, Matthew/0000-0002-9250-6214	Wellcome Trust [WT098519MA]; BHF Centre of Excellence award to Oxford University [RE/08/004/23915, RE/13/1/30181]; 'JSTSENTAN'; MEXT Scientific Research on Innovative Areas [3306]; JSPS Core-to Core Program	Wellcome Trust(Wellcome TrustEuropean Commission); BHF Centre of Excellence award to Oxford University; 'JSTSENTAN'(Japan Science & Technology Agency (JST)); MEXT Scientific Research on Innovative Areas; JSPS Core-to Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Work in MJD's lab is supported by the Wellcome Trust (WT098519MA) YFC was supported by a pump priming grant from the BHF Centre of Excellence award to Oxford University (RE/08/004/23915 & RE/13/1/30181). CT was a Rhodes Scholar. Mark Davies is an NIHR clinical academic trainee. TN is supported by 'JSTSENTAN', the MEXT Scientific Research on Innovative Areas, 'Spying minority in biological phenomena' (No. 3306) and the JSPS Core-to Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; ATTWELL D, 1981, J PHYSIOL-LONDON, V313, P439, DOI 10.1113/jphysiol.1981.sp013675; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Bingen BO, 2014, CARDIOVASC RES, V104, P194, DOI 10.1093/cvr/cvu179; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Burton RAB, 2015, NAT PHOTONICS, V9, P813, DOI [10.1038/NPHOTON.2015.196, 10.1038/nphoton.2015.196]; Chen Z, 2016, EUR HEART J; Colatsky T, 2016, J PHARM TOXICOL METH; Dempsey GT, 2016, J PHARM TOXICOL METH; Doss MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040288; Du DTM, 2015, BIOPHYS J, V108, P1, DOI 10.1016/j.bpj.2014.11.008; Gassanov N, 2008, DIFFERENTIATION, V76, P971, DOI 10.1111/j.1432-0436.2008.00283.x; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Harmer SC, 2016, BIOL CHEM, V397, P679, DOI 10.1515/hsz-2015-0306; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Inagaki S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42398; Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; Kushibiki T, 2015, GENE THER, V22, P553, DOI 10.1038/gt.2015.23; Levy RL, 1922, J AMER MED ASSOC, V79, P1108, DOI 10.1001/jama.1922.02640140020008; Leyton-Mange JS, 2014, STEM CELL REP, V2, P163, DOI 10.1016/j.stemcr.2014.01.003; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nussinovitch U, 2015, NAT BIOTECHNOL, V33, P750, DOI 10.1038/nbt.3268; Reinbothe TM, 2014, ISLETS, V6, DOI 10.4161/isl.28095; Rodriguez B, 2015, EUROPACE; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schwartz PJ, 2016, J AM COLL CARDIOL, V67, P1639, DOI 10.1016/j.jacc.2015.12.063; Shinnawi R, 2015, STEM CELL REP, V5, P582, DOI 10.1016/j.stemcr.2015.08.009; Sinnecker D, 2014, PHARMACOL THERAPEUT, V143, P246, DOI 10.1016/j.pharmthera.2014.03.004; Spencer CI, 2014, STEM CELL REP, V3, P269, DOI 10.1016/j.stemcr.2014.06.003; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yajuan Xiao, 2012, Curr Chem Genomics, V6, P87, DOI 10.2174/1875397301206010087; Yu JZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16542; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174181	10.1371/journal.pone.0174181	http://dx.doi.org/10.1371/journal.pone.0174181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379974	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500036
J	Kos, S; Blagus, T; Cemazar, M; Filipic, G; Sersa, G; Cvelbar, U				Kos, Spela; Blagus, Tanja; Cemazar, Maja; Filipic, Gregor; Sersa, Gregor; Cvelbar, Uros			Safety aspects of atmospheric pressure helium plasma jet operation on skin: In vivo study on mouse skin	PLOS ONE			English	Article							BARRIER DISCHARGE; MEDICINE; SURFACE	Biomedical applications of plasma require its efficacy for specific purposes and equally importantly its safety. Herein the safety aspects of cold plasma created with simple atmospheric pressure plasma jet produced with helium gas and electrode discharge are evaluated in skin damage on mouse, at different duration of exposure and gas flow rates. The extent of skin damage and treatments are systematically evaluated using stereomicroscope, labelling with fluorescent dyes, histology, infrared imaging and optical emission spectroscopy. The analyses reveal early and late skin damages as a consequence of plasma treatment, and are attributed to direct and indirect effects of plasma. The results indicate that direct skin damage progresses with longer treatment time and increasing gas flow rates which reflect changes in plasma properties. With increasing flow rates, the temperature on treated skin grows and the RONS formation rises. The direct effects were plasma treatment dependent, whereas the disclosed late D secondary effects were more independent on discharge parameters and related to diffusion of RONS species. Thermal effects and skin heating are related to plasma-coupling properties and are separated from the effects of other RONS. It is demonstrated that cumulative topical treatment with helium plasma jet could lead to skin damage. How these damages can be mitigated is discussed in order to provide guidance, when using atmospheric pressure plasma jets for skin treatments.	[Kos, Spela; Blagus, Tanja; Cemazar, Maja; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Filipic, Gregor; Cvelbar, Uros] Jozef Stefan Inst, Ljubljana, Slovenia	Institute of Oncology - Slovenia; University of Primorska; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Cvelbar, U (corresponding author), Jozef Stefan Inst, Ljubljana, Slovenia.	gsersa@onko-i.si; uros.cvelbar@ijs.si	Cvelbar, Uros/AAE-7916-2019; Filipič, Gregor/T-4900-2018	Filipič, Gregor/0000-0003-0153-5181; Cvelbar, Uros/0000-0002-1957-0789	Javna Agencija za Raziskovalno Dejavnost RS [P3-0003]; Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization [SPS.984555]; Javna Agencija za Raziskovalno Dejavnost [N3-0059]; Flanders (FWO)	Javna Agencija za Raziskovalno Dejavnost RS(Slovenian Research Agency - Slovenia); Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization(NATO (North Atlantic Treaty Organisation)); Javna Agencija za Raziskovalno Dejavnost; Flanders (FWO)(FWO)	This work was supported by Javna Agencija za Raziskovalno Dejavnost RS (P3-0003); Javna Agencija za Raziskovalno Dejavnost (Uros Cvelbar); North Atlantic Treaty Organization (SPS.984555); Flanders (FWO) and Javna Agencija za Raziskovalno Dejavnost (N3-0059).	Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Brisset JL, 2012, PLASMA CHEM PLASMA P, V32, P655, DOI 10.1007/s11090-012-9384-x; Buxadera-Palomero J, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4913376; Chernets N, 2015, PLASMA PROCESS POLYM, V12, P1400, DOI 10.1002/ppap.201500140; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Dunnill C, 2015, INT WOUND J; Duval A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083001; Foletto M, 2014, IEEE T PLASMA SCI, V42, P2436, DOI 10.1109/TPS.2014.2331393; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Isbary G, 2013, CLIN PLASMA MED, V1, P36, DOI 10.1016/j.cpme.2012.10.001; Judee F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21421; Kalghatgi S, 2009, TOXICITY DIRECT NONT, P1124; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/033001; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Kong M. G., 2009, NEW J PHYS, V11; Kuo SP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115016; Laroussi M, 2007, PLASMA PROCESS POLYM, V4, P777, DOI 10.1002/ppap.200700066; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Park GY, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/043001; Pei X, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/3/035013; Potter MJ, 2007, ANN PLAS SURG, V58, P608, DOI 10.1097/01.sap.0000252481.84134.fe; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Robert E, 2014, PLASMA SOURCES SCI T, V23; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rumbach P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8248; Van der Paal J, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/15/155202; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Winter J., 2014, J PHYS D, V47; Yonemori S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/125401; Zaplotnik R, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/25001; Zaplotnik R, 2015, SPECTROCHIM ACTA B, V103, P124, DOI 10.1016/j.sab.2014.12.004; Zhou RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155584	43	36	37	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174966	10.1371/journal.pone.0174966	http://dx.doi.org/10.1371/journal.pone.0174966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379998	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500080
J	Matyash, M; Zabiegalov, O; Wendt, S; Matyash, V; Kettenmannl, H				Matyash, Marina; Zabiegalov, Oleksandr; Wendt, Stefan; Matyash, Vitali; Kettenmannl, Helmut			The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain	PLOS ONE			English	Article							NEURONAL NMDA RECEPTORS; NEUTROPHIL CHEMOTAXIS; INDUCE RAMIFICATION; EXTRACELLULAR ATP; DOWN-REGULATION; RELEASE; EXPRESSION; REVEALS; CELLS; MODEL	Microglial cells invade the brain as amoeboid precursors and acquire a highly ramified morphology in the postnatal brain. Microglia express all essential purinergic elements such as receptors, nucleoside transporters and ecto-enzymes, including CD39 (NTPDase1) and CD73 (5'-nucleotidase), which sequentially degrade extracellular ATP to adenosine. Here, we show that constitutive deletion of CD39 and CD73 or both caused an inhibition of the microglia ramified phenotype in the brain with a reduction in the length of processes, branching frequency and number of intersections with Sholl spheres. In vitro, unlike wild-type microglia, cd39(-/-) and cd73(-/-) microglial cells were less complex and did not respond to ATP with the transformation into a more ramified phenotype. In acute brain slices, wild-type microglia retracted approximately 50% of their processes within 15 min after slicing of the brain, and this phenomenon was augmented in cd39(-/-) mice; moreover, the elongation of microglial processes towards the source of ATP or towards a laser lesion was observed only in wild-type but not in cd39(-/-) microglia. An elevation of extracellular adenosine 1) by the inhibition of adenosine transport with dipyridamole, 2) by application of exogenous adenosine or 3) by degradation of endogenous ATP/ADP with apyrase enhanced spontaneous and ATP-induced ramification of cd39(-/-) microglia in acute brain slices and facilitated the transformation of cd39(-/-) and cd73(-/-) microglia into a ramified process-bearing phenotype in vitro. These data indicate that under normal physiological conditions, CD39 and CD73 nucleotidases together with equilibrative nucleoside transporter 1 (ENT1) control the fate of extracellular adenosine and thereby the ramification of microglial processes.	[Matyash, Marina; Zabiegalov, Oleksandr; Wendt, Stefan; Matyash, Vitali; Kettenmannl, Helmut] Helmholtz Assoc, Cellular Neurosci, Max Delbruck Ctr Mol Med, Berlin, Germany; [Matyash, Vitali] Charite, Dept Neuropathol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kettenmannl, H (corresponding author), Helmholtz Assoc, Cellular Neurosci, Max Delbruck Ctr Mol Med, Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021	Wendt, Stefan/0000-0002-8754-2464; Kettenmann, Helmut/0000-0001-8208-0291	Deutsche Forschungsgemeinscaft [FOR 748]; NeuroCure	Deutsche Forschungsgemeinscaft(German Research Foundation (DFG)); NeuroCure	This work was supported by Deutsche Forschungsgemeinscaft FOR 748 and NeuroCure.	Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Bai AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9819; Balakumar P, 2014, PHARMACOL RES, V87, P144, DOI 10.1016/j.phrs.2014.05.008; Bhattarai S, 2015, J MED CHEM, V58, P6248, DOI 10.1021/acs.jmedchem.5b00802; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Bulavina L, 2013, PURINERG SIGNAL, V9, P199, DOI 10.1007/s11302-012-9339-y; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Cattaneo M, 2010, CIRCULATION, V121, P171, DOI 10.1161/CIRCULATIONAHA.109.853069; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cunha RA, 1998, J NEUROSCI, V18, P1987; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; dos Santos-Rodrigues A, 2014, NEUROCHEM INT, V73, P229, DOI 10.1016/j.neuint.2014.03.014; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Eder C, 1999, EUR J NEUROSCI, V11, P4251, DOI 10.1046/j.1460-9568.1999.00852.x; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Farber K, 2008, GLIA, V56, P331, DOI 10.1002/glia.20606; Fredholm BB, 1997, TRENDS PHARMACOL SCI, V18, P79, DOI 10.1016/S0165-6147(96)01038-3; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Guzman SJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1207393; Hao F, 2013, NEUROCHEM RES, V38, P1002, DOI 10.1007/s11064-013-1010-7; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Hinzman JM, 2015, BIOSENS BIOELECTRON, V74, P512, DOI 10.1016/j.bios.2015.06.074; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; JAMES S, 1993, J NEUROCHEM, V60, P219, DOI 10.1111/j.1471-4159.1993.tb05841.x; Junger WG, 2008, CELL MOL LIFE SCI, V65, P2528, DOI 10.1007/s00018-008-8095-1; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Koso H, 2016, GLIA, V64, P2005, DOI 10.1002/glia.23038; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Lana D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00322; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noto D, 2014, NEUROPATH APPL NEURO, V40, P697, DOI 10.1111/nan.12086; Ohgidani M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04957; Ohsawa K, 2012, J NEUROCHEM, V121, P217, DOI 10.1111/j.1471-4159.2012.07693.x; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perez-Pouchoulen M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0036-15.2015; Rio-Hortega Pd., 1919, B SOC ESP BIOL, V9, P51; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Salimi K, 2002, BRAIN RES, V946, P283, DOI 10.1016/S0006-8993(02)02896-2; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Sloka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-89; Socodato R, 2015, GLIA, V63, P497, DOI 10.1002/glia.22767; STAFFORD A, 1967, NATURE, V214, P390, DOI 10.1038/214390a0; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Volonte C, 2009, FEBS J, V276, P318, DOI 10.1111/j.1742-4658.2008.06793.x; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wogram E, 2016, EUR J NEUROSCI, V43, P1523, DOI 10.1111/ejn.13256; Wollmer MA, 2001, J NEUROIMMUNOL, V115, P19, DOI 10.1016/S0165-5728(01)00257-0; Yagi R, 1999, GLIA, V28, P49, DOI 10.1002/(SICI)1098-1136(199910)28:1<49::AID-GLIA6>3.0.CO;2-V; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4; Zusso M, J NEUROSCIENCE OFFIC	77	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175012	10.1371/journal.pone.0175012	http://dx.doi.org/10.1371/journal.pone.0175012			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376099	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000399352000034
J	Hu, PS; Xia, QS; Wu, F; Li, DK; Qi, YJ; Hu, Y; Wei, ZZ; Li, SS; Tian, NY; Wei, QF; Shen, LJ; Yin, B; Jiang, T; Yuan, JG; Qiang, BQ; Han, W; Peng, XZ				Hu, P-S; Xia, Q-S; Wu, F.; Li, D-K; Qi, Y-J; Hu, Y.; Wei, Z-Z; Li, S-S; Tian, N-Y; Wei, Q-F; Shen, L-J; Yin, B.; Jiang, T.; Yuan, J-G; Qiang, B-Q; Han, W.; Peng, X-Z			NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma	ONCOGENE			English	Article							SIDE POPULATION; POLYCOMB GENE; COMPLEX 1; BMI1; GROWTH; IDENTIFICATION; MAINTENANCE; ASTROCYTES; EXPRESSION; REGULATOR	Polycomb group (PcG) proteins play an important role in development and stem cell maintenance, and their dysregulation have been closely linked to oncogenesis and cancer stem cell phenotypes. Here, we found that nervous system polycomb 1 (NSPc1) was highly expressed in stem cell-like glioma cells (SLCs). Knockdown of NSPc1 in SLCs resulted in impaired neurosphere formation and self-renewal abilities, down-regulated expression of stemness markers such as NESTIN, CD133 and SOX2, and decreased capacity to propagate subcutaneous xenografts. In contrast, glioma cells overexpressing NSPc1 exhibited a stem cell-like phenotype, upregulated expression of stemness markers NESTIN, CD133 and SOX2, and an enhanced capacity to propagate subcutaneous xenografts. Furthermore, we identified that NSPc1 epigenetically repressed the expression of retinol dehydrogenase 16 (RDH16) by directly binding to a region upstream (-1073 to -823) of the RDH16 promoter. Next, we confirmed that RDH16 is a stemness suppressor that partially rescues SLCs from the NSPc1-induced increase in neurosphere formation. Finally, we showed that ATRA partly reversed the NSPc1-induced stemness enhancement in SLCs, through mechanisms correlated with an ATRA-dependent decrease in the expression of NSPc1. Thus, our results demonstrate that NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of ATRA via targeting RDH16 and may provide novel targets for glioma treatment in the future.	[Hu, P-S; Xia, Q-S; Wu, F.; Li, D-K; Qi, Y-J; Hu, Y.; Wei, Z-Z; Li, S-S; Tian, N-Y; Wei, Q-F; Shen, L-J; Yin, B.; Yuan, J-G; Qiang, B-Q; Han, W.; Peng, X-Z] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Dept Mol Biol & Biochem,Sch Basic Med,Peking Unio, Inst Basic Med Sci,Med Primate Res Ctr,Neurosci C, Beijing, Peoples R China; [Jiang, T.] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University	Han, W; Peng, XZ (corresponding author), Chinese Acad Med Sci, State Key Lab Med Mol Biol, Dept Mol Biol & Biochem, Inst Basic Med Sci,Med Primate Res Ctr,Neurosci C, Beijing 100005, Peoples R China.; Han, W; Peng, XZ (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.	hanweijx2002@163.com; pengxiaozhong@pumc.edu.cn		wei, zhizhong/0000-0002-9840-1878	National Key Research and Development Plan [2016YFC0902502, 2016YFA0100702]; 973 project [2013CB531304]; National Sciences Foundation of China [31671316, 31301152, 31370789, 31670789]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-001, 2016-I2M-2-001, 2016-I2M-1-004]	National Key Research and Development Plan; 973 project(National Basic Research Program of China); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	This work was supported by grants from The National Key Research and Development Plan (2016YFC0902502, 2016YFA0100702), 973 project No. 2013CB531304, National Sciences Foundation of China (31671316, 31301152, 31370789, 31670789), CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, CIFMS, 2016-I2M-2-001, 2016-I2M-1-004). We thank Dr Zeper Abliz and Ruiping Zhang from the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, for assistance with retinoid quantification.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Aguilar-Gallardo C, 2013, SEMIN REPROD MED, V31, P5, DOI 10.1055/s-0032-1331792; Ahmed AU, 2013, EXPERT REV NEUROTHER, V13, P545, DOI [10.1586/ern.13.42, 10.1586/ERN.13.42]; Chen H, 2011, HEAD NECK-J SCI SPEC, V33, P1115, DOI 10.1002/hed.21576; Chockalingam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083877; Choschzick I, 2014, NEUROSCIENCE, V279, P44, DOI 10.1016/j.neuroscience.2014.07.078; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Gong YH, 2006, NUCLEIC ACIDS RES, V34, P6158, DOI 10.1093/nar/gkl834; Gong YH, 2005, FEBS LETT, V579, P115, DOI 10.1016/j.febslet.2004.11.056; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; ISHIDA A, 1993, GENE, V129, P249, DOI 10.1016/0378-1119(93)90275-8; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jiang T, 2016, CANCER LETT, V375, P263, DOI 10.1016/j.canlet.2016.01.024; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Jurcic Joseph G, 2007, Curr Oncol Rep, V9, P337, DOI 10.1007/s11912-007-0045-9; Kimura M, 2011, CANCER SCI, V102, P983, DOI 10.1111/j.1349-7006.2011.01891.x; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li H, 2013, BIOCHEM BIOPH RES CO, V440, P527, DOI 10.1016/j.bbrc.2013.09.095; Liang Y, 2015, FRONT MED-PRC, V9, P57, DOI 10.1007/s11684-015-0389-8; Lorie EP, 2009, ARCH DERMATOL RES, V301, P475, DOI 10.1007/s00403-009-0937-7; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Moon JH, 2008, BIOCHEM BIOPH RES CO, V371, P267, DOI 10.1016/j.bbrc.2008.04.068; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Nunes M, 2001, MECH DEVELOP, V102, P219, DOI 10.1016/S0925-4773(01)00288-X; Oliviero G, 2015, SCI REP-UK, V5, DOI 10.1038/srep18388; Ostrom QT, 2015, CANCER TREAT RES, V163, P1, DOI 10.1007/978-3-319-12048-5_1; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Ross K, 2012, BLOOD, V119, P4152, DOI 10.1182/blood-2011-09-382390; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sher F, 2011, CELL REPROGRAM, V13, P1, DOI 10.1089/cell.2010.0052; Siddikuzzaman, 2011, IMMUNOPHARM IMMUNOT, V33, P241, DOI 10.3109/08923973.2010.521507; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Udali S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0077-1; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Wang HX, 2015, NEOPLASIA, V17, P239, DOI 10.1016/j.neo.2015.02.002; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yin CL, 2014, FRONT BIOSCI-LANDMRK, V19, P818, DOI 10.2741/4249; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang P, 2009, CANCER LETT, V277, P227, DOI 10.1016/j.canlet.2008.12.015	54	25	26	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4706	4718		10.1038/onc.2017.34	http://dx.doi.org/10.1038/onc.2017.34			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394339				2022-12-26	WOS:000407702400004
J	Stern, E; Ruf-Zamojski, F; Zalepa-King, L; Pincas, H; Choi, SG; Peskin, CS; Hayot, F; Turgeon, JL; Sealfon, SC				Stern, Estee; Ruf-Zamojski, Frederique; Zalepa-King, Lisa; Pincas, Hanna; Choi, Soon Gang; Peskin, Charles S.; Hayot, Fernand; Turgeon, Judith L.; Sealfon, Stuart C.			Modeling and high-throughput experimental data uncover the mechanisms underlying Fshb gene sensitivity to gonadotropin-releasing hormone pulse frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIFUSED L-BETA-T2 CELLS; BETA GENE; RECEPTOR DESENSITIZATION; DIFFERENTIAL REGULATION; DICTYOSTELIUM CELLS; MATHEMATICAL-MODEL; SINGLE-CELL; EXPRESSION; GNRH; TRANSCRIPTION	Neuroendocrine control of reproduction by brain-secreted pulses of gonadotropin-releasing hormone (GnRH) represents a longstanding puzzle about extracellular signal decoding mechanisms. GnRH regulates the pituitary gonadotropin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers specified by unique beta subunits (FSH beta/LH beta). Contrary to Lhb, Fshb gene induction has a preference for low-frequency GnRH pulses. To clarify the underlying regulatory mechanisms, we developed three biologically anchored mathematical models: 1) parallel activation of Fshb inhibitory factors (e.g. inhibin alpha and VGF nerve growth factor-inducible), 2) activation of a signaling component with a refractory period (e.g. Gprotein), and 3) inactivation of a factor needed for Fshb induction (e.g. growth differentiation factor 9). Simulations with all three models recapitulated the Fshb expression levels obtained in pituitary gonadotrope cells perifused with varying GnRH pulse frequencies. Notably, simulations altering average concentration, pulse duration, and pulse frequency revealed that the apparent frequency-dependent pattern of Fshb expression in model 1 actually resulted from variations in average GnRH concentration. In contrast, models 2 and 3 showed "true" pulse frequency sensing. To resolve which components of this GnRH signal induce Fshb, we developed a high-throughput parallel experimental system. We analyzed over 4,000 samples in experiments with varying near-physiological GnRH concentrations and pulse patterns. Whereas Egr1 and Fos genes responded only to variations in average GnRH concentration, Fshb levels were sensitive to both average concentration and true pulse frequency. These results provide a foundation for understanding the role of multiple regulatory factors in modulating Fshb gene activity.	[Stern, Estee; Ruf-Zamojski, Frederique; Zalepa-King, Lisa; Pincas, Hanna; Choi, Soon Gang; Hayot, Fernand; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Ctr Adv Res Diagnost Assays, New York, NY 10029 USA; [Peskin, Charles S.] NYU, Courant Inst Math Sci, 251 Mercer St, New York, NY 10012 USA; [Peskin, Charles S.] NYU, Ctr Neural Sci, 550 1St Ave, New York, NY 10012 USA; [Turgeon, Judith L.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Endocrinol, Davis, CA 95616 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; New York University; University of California System; University of California Davis	Sealfon, SC (corresponding author), Icahn Sch Med Mt Sinai, Annenberg 14-44,Box 1137,One Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	choi, soon gang/AAE-3187-2019; Ruf-Zamojski, Frederique/N-5718-2015	choi, soon gang/0000-0003-0314-3958; Ruf-Zamojski, Frederique/0000-0002-2451-8598; SEALFON, Stuart/0000-0001-5791-1217	National Institutes of Health [DK46943]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943, R56DK046943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK46943. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Alarid ET, 1996, DEVELOPMENT, V122, P3319; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bedecarrats GY, 2003, P NATL ACAD SCI USA, V100, P9348, DOI 10.1073/pnas.1633592100; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bertram R, 2008, B MATH BIOL, V70, P2211, DOI 10.1007/s11538-008-9341-2; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; Choi SG, 2016, J BIOL CHEM, V291, P21322, DOI 10.1074/jbc.M116.740365; Choi SG, 2014, J BIOL CHEM, V289, P16164, DOI 10.1074/jbc.M113.537696; Choi SG, 2012, J BIOL CHEM, V287, P21550, DOI 10.1074/jbc.M112.348607; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; DAVIDSON JS, 1995, MOL CELL ENDOCRINOL, V107, P241, DOI 10.1016/0303-7207(94)03449-4; Dode C, 2009, EUR J HUM GENET, V17, P139, DOI 10.1038/ejhg.2008.206; FARNWORTH PG, 1995, J ENDOCRINOL, V145, P387, DOI 10.1677/joe.0.1450387; FLANAGAN CA, 1994, J BIOL CHEM, V269, P22636; Fletcher PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095613; Jonak CR, 2017, J BIOL CHEM, V292, P2646, DOI 10.1074/jbc.M116.771808; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; Kitanovic S, 2001, MOL ENDOCRINOL, V15, P390, DOI 10.1210/me.15.3.390; LI YX, 1990, J THEOR BIOL, V146, P355, DOI 10.1016/S0022-5193(05)80746-5; LI YX, 1989, BIOPHYS J, V55, P125, DOI 10.1016/S0006-3495(89)82785-7; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magill JC, 2013, MATH BIOSCI, V246, P38, DOI 10.1016/j.mbs.2013.09.006; MARSHALL JC, 1991, RECENT PROG HORM RES, V47, P155; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; McNeilly AS, 2003, REPRODUCTION, P463; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nicol L, 2004, J MOL ENDOCRINOL, V32, P467, DOI 10.1677/jme.0.0320467; Pincas H, 2014, MOL CELL ENDOCRINOL, V385, P56, DOI 10.1016/j.mce.2013.08.015; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purwana IN, 2011, BIOL REPROD, V84, P996, DOI 10.1095/biolreprod.110.088526; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Wang Q, 2013, MOL ENDOCRINOL, V27, P224, DOI 10.1210/me.2012-1310; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Xie HM, 2015, MOL ENDOCRINOL, V29, P842, DOI 10.1210/me.2014-1279; Yuen T, 2002, MOL ENDOCRINOL, V16, P1145, DOI 10.1210/me.16.6.1145; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; ZHOU W, 1995, J BIOL CHEM, V270, P18853, DOI 10.1074/jbc.270.32.18853	50	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9815	9829		10.1074/jbc.M117.783886	http://dx.doi.org/10.1074/jbc.M117.783886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28385888	Green Published, hybrid			2022-12-26	WOS:000403113000029
J	Martinez-Marin, D; Jarvis, C; Nelius, T; de Riese, W; Volpert, OV; Filleur, S				Martinez-Marin, Dalia; Jarvis, Courtney; Nelius, Thomas; de Riese, Werner; Volpert, Olga V.; Filleur, Stephanie			PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INTEGRIN-ASSOCIATED PROTEIN; ENDOGENOUS THROMBOSPONDIN-1; GENE-EXPRESSION; PHAGOCYTOSIS; SURVIVAL; INFILTRATION; RECEPTOR; SURFACE; CD47	Background Although inflammation and prostate cancer (PCa) have been linked, the molecular interactions between macrophages and PCa cells are poorly explored. Pigment Epithelium-Derived Factor (PEDF) is an anti-angiogenic and anti-tumor factor. We previously showed that PEDF induces macrophages recruitment in vitro, correlates with macrophages density in human prostate, and stimulates macrophages polarization towards the classically activated pathway. Here, we demonstrate that PEDF modulates the interaction between macrophages and PCa cells through a bidirectional signalling leading to tumor cell apoptosis and phagocytosis. Methods RAW 264.7 and THP-1 cells, and BMDMs were grown in vitro as mono-or co-cultures with PC3 or CL1 tumor cells. The effects of PEDF and its derived P18 peptide were measured on macrophages differentiation, migration, and superoxide production, and tumor cell apoptosis and phagocytosis. PEDF receptors (ATP5B, PNPLA2, and LRP6) and CD47 mRNA and protein expression were quantified in macrophages and tumor cells by quantitative RTPCR, western blot, immunofluorescence and flow cytometry. Results We found that PEDF induced the migration of macrophages towards tumor 3D spheroids and 2D cultures. In co-culture, PEDF increased PCa cells phagocytosis through an indirect apoptosis-dependent mechanism. Moreover, PEDF stimulated the production of superoxide by macrophages. Conditioned media from macrophages exposed to PEDF induced tumor cells apoptosis in contrast to control conditioned media suggesting that ROS may be D involved in tumor cells apoptosis. ATP5B and PNPLA2 PEDF receptors on macrophages and CD47 on tumor cells were respectively up-and down-regulated by PEDF. As PEDF, blocking CD47 induced phagocytosis. Inhibiting ATP5B reduced phagocytosis. Inversely, PNPLA2 inhibition blocks differentiation but maintains phagocytosis. CD47-induced phagocytosis was partially reverted by ATP5B inhibition suggesting a complementary action. Similar effects were observed with P18 PEDF-derived peptide. Conclusions These data established that modulating the molecular interactions between macrophages and PCa cells using PEDF may be a promising strategy for PCa treatment.	[Martinez-Marin, Dalia; Jarvis, Courtney; Nelius, Thomas; de Riese, Werner; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA; [Jarvis, Courtney; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA; [Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Volpert, Olga V.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Northwestern University; Feinberg School of Medicine; University of Texas System; UTMD Anderson Cancer Center	Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA.; Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA.	Stephanie.filleur@ttuhsc.edu		Filleur, Stephanie/0000-0002-3420-5536	NIH/NCI grant [R15 CA161634]; CH Foundation; South Plains Foundation (Lubbock, TX)	NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CH Foundation; South Plains Foundation (Lubbock, TX)	The present study was performed with the financial support of the NIH/NCI grant R15 CA161634, The CH Foundation and South Plains Foundation (Lubbock, TX).	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bergstrom SE, 2015, IMMUNOLOGY, V144, P687, DOI 10.1111/imm.12424; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Craword SE, 2013, EXPERT OPIN DRUG DIS, V8, P769, DOI 10.1517/17460441.2013.794781; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; de Coana YP, 2015, TRENDS MOL MED, V21, P482, DOI 10.1016/j.molmed.2015.05.005; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Deshpande M, INT J ONCOLOGY, V41, P219; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Hu H, 2016, TUMOUR BIOL J INT SO; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Jinushi M, 2015, BIOCH BIOPHYSICA ACT; Jinushi M, 2014, CANCER METAST REV, V33, P737, DOI 10.1007/s10555-014-9501-9; Jung KY, 2015, J PATHOL TRANSL MED, V49, P318, DOI 10.4132/jptm.2015.06.01; Krishnan AV, 2007, J BONE MINER RES, V22, pV74, DOI 10.1359/JBMR.07S213; Kubler K, 2014, GYNECOL ONCOL, V135, P176, DOI 10.1016/j.ygyno.2014.08.028; Li J, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9368; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, P449, DOI 10.1016/j.urolonc.2013.10.012; Lin L, 2015, ONCOTARGET, V6, P34758, DOI 10.18632/oncotarget.5325; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Mirochnik Y, 2009, CLIN CANCER RES, V15, P1655, DOI 10.1158/1078-0432.CCR-08-2113; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Moransard M, 2010, GLIA, V58, P559, DOI 10.1002/glia.20945; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Nelius T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.180; Nelius T, 2013, PROSTATE, V73, P549, DOI 10.1002/pros.22595; Nilsson A, 2012, BIOCHEM BIOPH RES CO, V417, P1304, DOI 10.1016/j.bbrc.2011.12.137; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Park JY, 2015, CLIN RES HEPATOLOGY; Perri SR, 2007, FASEB J, V21, P3928, DOI 10.1096/fj.07-8158com; Principe DR, 2016, ONCOTARGET, V7, P28218, DOI 10.18632/oncotarget.8587; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Shimura S, 2000, CANCER RES, V60, P5857; Soto-Pantoja DR, 2013, EXPERT OPIN THER TAR, V17, P89, DOI 10.1517/14728222.2013.733699; Stern M, 1996, AM J PATHOL, V149, P911; Stukes S, 2016, J IMMUNOL, V197, P1252, DOI 10.4049/jimmunol.1501855; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Tso CL, 2000, CANCER J, V6, P220; Wagner BJ, 2011, J CELL SCI, V124, P1644, DOI 10.1242/jcs.078907; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134122; Xu L, 2014, ANN SURG ONCOL, V21, P3142, DOI 10.1245/s10434-014-3601-1; Xuan QJ, 2014, PATHOL ONCOL RES, V20, P619, DOI 10.1007/s12253-013-9740-z; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zhang H, 2015, GASTRIC CANCER, V18, P740, DOI 10.1007/s10120-014-0422-7; Zhang MY, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-19; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	75	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174968	10.1371/journal.pone.0174968	http://dx.doi.org/10.1371/journal.pone.0174968			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403150	gold, Green Submitted, Green Published			2022-12-26	WOS:000399955200026
J	Nagara, Y; Takada, T; Nagata, Y; Kado, S; Kushiro, A				Nagara, Yusuke; Takada, Toshihiko; Nagata, Yuriko; Kado, Shoichi; Kushiro, Akira			Microscale spatial analysis provides evidence for adhesive monopolization of dietary nutrients by specific intestinal bacteria	PLOS ONE			English	Article							AMYLOMAIZE STARCH GRANULES; RESISTANT STARCH; GUT MICROBIOTA; BIFIDOBACTERIA; IDENTIFICATION; BIOSTRUCTURE; AMYLOPECTIN; DIVERSITY	Each species of intestinal bacteria requires a nutritional source to maintain its population in the intestine. Dietary factors are considered to be major nutrients; however, evidence directly explaining the in situ utilization of dietary factors is limited. Microscale bacterial distribution would provide clues to understand bacterial lifestyle and nutrient utilization. However, the detailed bacterial localization around dietary factors in the intestine remains uninvestigated. Therefore, we explored microscale habitats in the murine intestine by using histology and fluorescent in situ hybridization, focusing on dietary factors. This approach successfully revealed several types of bacterial colonization. In particular, bifidobacterial colonization and adhesion on granular starch was frequently and commonly observed in the jejunum and distal colon. To identify the bacterial composition of areas around starch granules and areas without starch, laser microdissection and next-generation sequencing-based 16S rRNA microbial profiling was performed. It was found that Bifidobacteriaceae were significantly enriched by 4.7 fold in peri-starch areas compared to ex- starch areas. This family solely consisted of Bifidobacterium pseudolongum. In contrast, there was no significant enrichment among the other major families. This murine intestinal B. pseudolongum had starchdegrading activity, confirmed by isolation from the mouse feces and in vitro analysis. Collectively, our results demonstrate the significance of starch granules as a major habitat and potential nutritional niche for murine intestinal B. pseudolongum. Moreover, our results suggest that colonizing bifidobacteria effectively utilize starch from the closest location and maintain the location. This may be a bacterial strategy to monopolize solid dietary nutrients. We believe that our analytical approach could possibly be applied to other nutritional factors, and can be a powerful tool to investigate in vivo relationships between bacteria and environmental factors in the intestine.	[Nagara, Yusuke; Takada, Toshihiko; Kushiro, Akira] Yakult Cent Inst, Dept Microbiol Res, Tokyo, Japan; [Nagata, Yuriko; Kado, Shoichi] Yakult Cent Inst, Safety Res Dept, Tokyo, Japan	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited	Nagara, Y (corresponding author), Yakult Cent Inst, Dept Microbiol Res, Tokyo, Japan.	yusuke-nagara@yakult.co.jp		Takada, Toshihiko/0000-0002-9914-8253	Yakult Central Institute	Yakult Central Institute	This work was funded by Yakult Central Institute (http://institute.yakult.co.jp/). All authors are employees of the funder, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrit.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Bird A R, 2000, Curr Issues Intest Microbiol, V1, P25; Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Brown IL, 1998, FOOD AUST, V50, P603; Cameron EA, 2014, MBIO, V5, DOI 10.1128/mBio.01441-14; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen P, 2011, CARBOHYD POLYM, V83, P1975, DOI 10.1016/j.carbpol.2010.11.001; Cockburn DW, 2015, MOL MICROBIOL, V95, P209, DOI 10.1111/mmi.12859; Crittenden R, 2001, APPL ENVIRON MICROB, V67, P3469, DOI 10.1128/AEM.67.8.3469-3475.2001; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Duranti S, 2014, APPL ENVIRON MICROB, V80, P6080, DOI 10.1128/AEM.01993-14; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kleessen B, 1997, J ANIM SCI, V75, P2453; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Leitch ECM, 2007, ENVIRON MICROBIOL, V9, P667, DOI 10.1111/j.1462-2920.2006.01186.x; Liu SL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0362-3; MACFARLANE GT, 1986, J APPL BACTERIOL, V60, P195, DOI 10.1111/j.1365-2672.1986.tb01073.x; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; Mitsouka T., 1984, BIFIDOBACTERIA MICRO, P11, DOI DOI 10.12938/BIFIDUS1982.3.1_; Morikawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163607; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Ryan SM, 2006, APPL ENVIRON MICROB, V72, P5289, DOI 10.1128/AEM.00257-06; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang X, 2002, J APPL MICROBIOL, V93, P390, DOI 10.1046/j.1365-2672.2002.01704.x; Wang X, 1999, APPL ENVIRON MICROB, V65, P4848; Wang X, 1999, J APPL MICROBIOL, V87, P631, DOI 10.1046/j.1365-2672.1999.00836.x; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; YUKI N, 1999, J INTEST MICROBIOL, V12, P97; Ze XL, 2015, MBIO, V6, DOI 10.1128/mBio.01058-15; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4	43	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175497	10.1371/journal.pone.0175497	http://dx.doi.org/10.1371/journal.pone.0175497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394924	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800040
J	Chu, HW; Sun, P; Yin, JH; Liu, GM; Wang, YW; Zhao, PY; Zhu, YZ; Yang, XH; Zheng, TZ; Zhou, XZ; Jin, WL; Sun, CK				Chu, Hongwei; Sun, Pin; Yin, Jiahui; Liu, Guangming; Wang, Yiwei; Zhao, Pengyao; Zhu, Yizhun; Yang, Xiaohan; Zheng, Tiezheng; Zhou, Xuezhong; Jin, Weilin; Sun, Changkai			Integrated network analysis reveals potentially novel molecular mechanisms and therapeutic targets of refractory epilepsies	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENE ONTOLOGY; INTERNATIONAL-LEAGUE; ANTIEPILEPTIC DRUGS; COMMON EPILEPSIES; DISEASE-GENES; WEB SERVER; SEIZURES; DALFAMPRIDINE; DETERMINANTS	Epilepsy is a complex neurological disorder and a significant health problem. The pathogenesis of epilepsy remains obscure in a significant number of patients and the current treatment options are not adequate in about a third of individuals which were known as refractory epilepsies (RE). Network medicine provides an effective approach for studying the molecular mechanisms underlying complex diseases. Here we integrated 1876 disease-gene associations of RE and located those genes to human protein-protein interaction (PPI) network to obtain 42 significant RE-associated disease modules. The functional analysis of these disease modules showed novel molecular pathological mechanisms of RE, such as the novel enriched pathways (e.g., "presynaptic nicotinic acetylcholine receptors", "signaling by insulin receptor"). Further analysis on the relationships between current drug targets and the RE-related disease genes showed the rational mechanisms of most antiepileptic drugs. In addition, we detected ten potential novel drug targets (e.g., KCNA1, KCNA4-6, KCNC3, KCND2, KCNMA1, CAMK2G, CACNB4 and GRM1) located in three RE related disease modules, which might provide novel insights into the new drug discovery for RE therapy.	[Chu, Hongwei; Sun, Changkai] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China; [Chu, Hongwei; Wang, Yiwei; Yang, Xiaohan; Zheng, Tiezheng; Sun, Changkai] Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China; [Sun, Pin] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China; [Yin, Jiahui] Tongji Univ, Coll Elect & Informat Engn, Shanghai, Peoples R China; [Liu, Guangming; Zhao, Pengyao; Zhou, Xuezhong] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Liu, Guangming; Zhao, Pengyao; Zhou, Xuezhong] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Mining, Beijing, Peoples R China; [Zhu, Yizhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Sch Elect Informat & Elect Engn,Minist Educ, Dept Instrument Sci & Engn,Key Lab Thin Film & Mi, Shanghai, Peoples R China; [Sun, Changkai] Dalian Univ Technol, Res Ctr Control Engn Translat Precis Med, Dalian, Peoples R China; [Sun, Changkai] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian, Peoples R China	Dalian University of Technology; Dalian Medical University; Fudan University; Tongji University; Beijing Jiaotong University; Beijing Jiaotong University; Fudan University; Shanghai Jiao Tong University; Dalian University of Technology; Dalian University of Technology	Sun, CK (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China.; Sun, CK (corresponding author), Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China.; Zhou, XZ (corresponding author), Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China.; Zhou, XZ (corresponding author), Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Mining, Beijing, Peoples R China.; Jin, WL (corresponding author), Shanghai Jiao Tong Univ, Inst Nano Biomed & Engn, Sch Elect Informat & Elect Engn,Minist Educ, Dept Instrument Sci & Engn,Key Lab Thin Film & Mi, Shanghai, Peoples R China.; Sun, CK (corresponding author), Dalian Univ Technol, Res Ctr Control Engn Translat Precis Med, Dalian, Peoples R China.; Sun, CK (corresponding author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian, Peoples R China.	xzzhou@bjtu.edu.cn; weiliniin@yahoo.com; cksun110@vip.sina.com	ZHOU, XUE/F-6129-2013; SUN, CHANG/GXM-3680-2022; Jin, Wei-Lin/A-8355-2013; Zhou, Xuezhong/AAZ-5025-2021; Zhu, Yi Zhun/ABG-8449-2021; Zhou, Xuezhong/I-4101-2014	Jin, Wei-Lin/0000-0001-8011-2405; Zhu, Yi Zhun/0000-0001-7700-8041; Zhou, Xuezhong/0000-0002-4713-3594	National Science and Technology Major Projects Subject [2012ZX09503-001-003]; National Natural Science Foundation of China [61105055, 81230086]; Special program of Traditional Chinese medicine [201407001]; Tsung-Dao Lee Chinese Undergraduate Research Endowment [14032]	National Science and Technology Major Projects Subject; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special program of Traditional Chinese medicine; Tsung-Dao Lee Chinese Undergraduate Research Endowment	The study is supported by National Science and Technology Major Projects Subject (No. 2012ZX09503-001-003) to Changkai Sun (http//wwwrnost.gov.cn/), National Natural Science Foundation of China (Nos. 61105055, 81230086) to Xuezhong Zhou (https//isisn.nsfc.gov.cn/), Special program of Traditional Chinese medicine (No. 201407001) to Xuezhong Zhou, and Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment (No.14032) to Pin Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; [Anonymous], 1998, COLLECTIVEDYNAMICS S, P440; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beck H, 2012, ANTIEPILEPTOGENESIS; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ERN.11.51, 10.1586/ern.11.51]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chang HR, 2008, J MED CHEM, V51, P1534, DOI 10.1021/jm0706618; Che FY, 2015, SEIZURE-EUR J EPILEP, V25, P178, DOI 10.1016/j.seizure.2014.09.014; Chu H, 2014, NETWORK BASED DETECT, P132; Cormen Thomas H., 2009, INTRO ALGORITHMS; Delahaye-Duriez A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1097-7; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Dunn J, 2011, CURR MED RES OPIN, V27, P1415, DOI 10.1185/03007995.2011.583229; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ghaffarpour M, 2014, ARCH NEUROSCI, V1, DOI 10.5812/archneurosci.14182; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guo LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12939; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He D, 2011, BMC GENOMICS, V12, P813; Hung CL, 2014, DRUG DEVELOP RES, V75, P412, DOI 10.1002/ddr.21222; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin SH, 2015, EPILEPSIA, V56, P772, DOI 10.1111/epi.12966; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kerr M, 2014, EPILEPSIA, V55, P1902, DOI 10.1111/epi.12848; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Ladino LD, 2014, EPILEPSY RES, V108, P765, DOI 10.1016/j.eplepsyres.2014.01.024; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Liu CC, 2014, NUCLEIC ACIDS RES, V42, pW137, DOI 10.1093/nar/gku412; Liu TT, 2014, AM J TRANSL RES, V6, P625; Liu Y, 2012, EUR REV MED PHARMACO, V16, P867; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MANCANO MA, 2013, HOSP PHARM, V48, P725, DOI DOI 10.1310/hpj4809-725; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Murphy JV, 2005, EXPERT REV MED DEVIC, V2, P175, DOI 10.1586/17434440.2.2.175; Musto AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116543; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Najjar S, 2011, NEUROLOGIST, V17, P249, DOI 10.1097/NRL.0b013e31822aad04; Nelson M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0277-x; Nobili P, 2014, SEIZURE INDUCED PATH; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ostendorf AP, 2015, CNS DRUGS, V29, P91, DOI 10.1007/s40263-014-0223-x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; [彭毓棻 PENG Yufen], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1230; Porto Juliana Antola, 2010, J. epilepsy clin. neurophysiol., V16, P26, DOI 10.1590/S1676-26492010000100006; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Quek AML, 2012, ARCH NEUROL-CHICAGO, V69, P582, DOI 10.1001/archneurol.2011.2985; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074; Rong LL, 2014, EPILEPSY BEHAV, V31, P210, DOI 10.1016/j.yebeh.2013.11.022; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Sharma A, 2013, MOL CELL PROTEOMICS, V12, P3398, DOI 10.1074/mcp.M112.024851; Shu-Qiu W, 2014, PLOS ONE, V9; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Steinlein OK, 2002, CNS NEUROL DISORD-DR, V1, P443, DOI 10.2174/1568007023339193; Striano P, 2012, ARCH NEUROL-CHICAGO, V69, P322, DOI 10.1001/archneurol.2011.1999; Sudhop T, 1999, EPILEPSIA, V40, P480, DOI 10.1111/j.1528-1157.1999.tb00744.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tadmouri A, 2012, EMBO J, V31, P3730, DOI 10.1038/emboj.2012.226; Tan H, 2014, J PEDIATR ENDOCR MET, V18, P985; Van Poucke M, 2012, NEUROMUSCULAR DISORD, V22, P558, DOI 10.1016/j.nmd.2012.01.008; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang GF, 2015, GENE DEV, V29, P1535, DOI 10.1101/gad.260869.115; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Wassenaar M, 2013, EPILEPSY RES, V106, P301, DOI 10.1016/j.eplepsyres.2013.06.013; Welch KA, 2014, J NEUROL NEUROSUR PS, V85, P593, DOI 10.1136/jnnp-2013-306267; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yoon HJ, 2014, TOXICOL LETT, V225, P147, DOI 10.1016/j.toxlet.2013.12.002; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	86	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174964	10.1371/journal.pone.0174964	http://dx.doi.org/10.1371/journal.pone.0174964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388656	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800015
J	Kumssa, DB; Joy, EJM; Young, SD; Odee, DW; Ander, EL; Broadleyl, MR				Kumssa, Diriba B.; Joy, Edward J. M.; Young, Scott D.; Odee, David W.; Ander, E. Louise; Broadleyl, Martin R.			Variation in the mineral element concentration of Moringa oleifera Lam. and M-stenopetala (Bak. f.) Cuf.: Role in human nutrition	PLOS ONE			English	Article							WILD EDIBLE PLANTS; UNDERUTILIZED CROPS; LEAVES; SELENIUM; NUTRIENT; EXTRACTION; CHILDREN; VALLEY; PODS; TREE	Background Moringa oleifera (MO) and M. stenopetala (MS) (family Moringaceae; order Brassicales) are multipurpose tree/shrub species. They thrive under marginal environmental conditions and produce nutritious edible parts. The aim of this study was to determine the mineral composition of different parts of MO and MS growing in their natural environments and their potential role in alleviating human mineral micronutrient deficiencies (MND) in sub-Saharan Africa. Methods Edible parts of MO (n = 146) and MS (n = 50), co-occurring cereals/vegetables and soils (n = 95) underneath their canopy were sampled from localities in southern Ethiopia and Kenya. The concentrations of seven mineral elements, namely, calcium (Ca), copper (Cu), iodine (I), iron (Fe), magnesium (Mg), selenium (Se), and zinc (Zn) in edible parts and soils were determined using inductively coupled plasma-mass spectrometry. Results In Ethiopian crops, MS leaves contained the highest median concentrations of all elements except Cu and Zn, which were greater in Enset (a.k.a., false banana). In Kenya, Mo flowers and MS leaves had the highest median Se concentration of 1.56 mg kg(-1) and 3.96 mg kg(-1), respectively. The median concentration of Se in MS leaves was 7-fold, 10-fold, 23-fold, 117-fold and 147-fold more than that in brassica leaves, amaranth leaves, baobab fruits, sorghum grain and maize grain, respectively. The median Se concentration was 78-fold and 98-fold greater in MO seeds than in sorghum and maize grain, respectively. There was a strong relationship between soil total Se and potassium dihydrogen phosphate (KH2PO4)-extractable Se, and Se concentration in the leaves of MO and MS. Conclusion This study confirms previous studies that Moringa is a good source of several of the measured mineral nutrients, and it includes the first wide assessment of Se and I concentrations in edible parts of MO and MS grown in various localities. Increasing the consumption of MO and MS, especially the leaves as a fresh vegetable or in powdered form, could reduce the prevalence of MNDs, most notably Se deficiency.	[Kumssa, Diriba B.; Young, Scott D.; Broadleyl, Martin R.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Kumssa, Diriba B.; Ander, E. Louise] British Geol Survey, Ctr Environm Geochem, Keyworth, Notts, England; [Kumssa, Diriba B.] Univ Nottingham Malaysia Campus, Crops Future, Semenyih, Selangor, Malaysia; [Joy, Edward J. M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Odee, David W.] Kenya Forestry Res Inst, Nairobi, Kenya; [Odee, David W.] Ctr Ecol & Hydrol, Bush Estate, Penicuik, Midlothian, Scotland	University of Nottingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham Malaysia; University of London; London School of Hygiene & Tropical Medicine; UK Centre for Ecology & Hydrology (UKCEH)	Broadleyl, MR (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	Broadley, Martin/AAW-4638-2021; Kumssa, Diriba/AAR-7547-2020; Kumssa, Diriba B/C-3774-2017; broadley, martin r/E-9081-2011; Ander, E.L./D-2009-2013	Broadley, Martin/0000-0003-3964-7226; Kumssa, Diriba/0000-0002-5869-4864; Kumssa, Diriba B/0000-0002-5869-4864; broadley, martin r/0000-0003-3964-7226; Ander, E.L./0000-0003-3901-1949	Crops for the Future; NERC [nigl010001, ceh020005] Funding Source: UKRI; Natural Environment Research Council [nigl010001, ceh020005] Funding Source: researchfish	Crops for the Future; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Crops for the Future (http://www.cropsforthefuture.org/) funded DBK's studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2003, East Afr Med J, V80, P247; Ahmed T, 2010, P I CIVIL ENG-WAT M, V163, P381, DOI 10.1680/wama.900080; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; Anjorin TS, 2010, INT J AGRIC BIOL, V12, P431; [Anonymous], [No title captured]; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Aslam M., 2005, ASIAN J PLANT SCI, V4, P417, DOI [10.3923/ajps.2005.417.421, DOI 10.3923/AJPS.2005.417.421]; Balemie K, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-53; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chilimba A. D. C., 2015, BMC NUTR, V1, P42, DOI DOI 10.1186/S40795-015-0036-4; Chilimba ADC, 2012, FIELD CROP RES, V125, P118, DOI 10.1016/j.fcr.2011.08.014; da Conceicao VM, 2015, CAN J CHEM ENG, V93, P37, DOI 10.1002/cjce.22101; Debela E, 2013, AGROFOREST SYST, V87, P1147, DOI 10.1007/s10457-013-9626-9; Degefu DM, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1719-6; Devi NS, 2007, ACTA HORTIC, P367, DOI 10.17660/ActaHortic.2007.752.64; Forster N, 2015, FOOD CHEM, V166, P456, DOI 10.1016/j.foodchem.2014.06.043; Foidl N, POTENTIAL MORINGA OL; Freiberger CE, 1998, PLANT FOOD HUM NUTR, V53, P57, DOI 10.1023/A:1008080508028; Gashu D, 2016, EUR J CLIN NUTR, V70, P929, DOI 10.1038/ejcn.2016.27; Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z; Gidamis AB, 2003, ECOL FOOD NUTR, V42, P399, DOI 10.1080/03670240390268857; Guo L, 2014, SELENIUM ENV HUMAN H, P86; IOM, 2003, DIET REF INT APPL DI, P248; JAHN SA, 1991, AMBIO, V20, P244; Jiru D., 2006, LEAF YIELD NUTR VALU; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Kifleyohannes Tsegabirhan, 2014, BMC Res Notes, V7, P390, DOI 10.1186/1756-0500-7-390; Kumssa DB, 2015, CROP PASTURE SCI, V66, P1278, DOI 10.1071/CP15096; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Kushwaha S, 2014, J FOOD SCI TECH MYS, V51, P3464, DOI 10.1007/s13197-012-0859-9; Leone A, 2015, INT J MOL SCI, V16, P18923, DOI 10.3390/ijms160818923; Lim TK., 2012, EDIBLE MED NONMEDICI, P453; Limmatvapirat C, 2015, INDIAN J PHARM SCI, V77, P485, DOI 10.4103/0250-474X.164782; Mabhaudhi T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040302; Matshediso PG, 2015, FOOD CHEM, V172, P423, DOI 10.1016/j.foodchem.2014.09.047; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; Melesse A, 2012, AGROFOREST SYST, V86, P505, DOI 10.1007/s10457-012-9514-8; MORTON JF, 1991, ECON BOT, V45, P318, DOI 10.1007/BF02887070; Moyo B, 2011, AFR J BIOTECHNOL, V10, P12925; Nouman W, 2013, TURK J AGRIC FOR, V37, P410, DOI 10.3906/tar-1206-29; NRC, 2006, MOR LOST CROPS AFR V, VII, P377; Ocho DL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-30; Odee D., 1998, DRYLAND BIODIVERSITY, V2, P7; Ogbe AO, 2011, J MICROB BIOTEC FOOD, V1, P296; Ogunsina BS, 2014, J FOOD SCI TECH MYS, V51, P503, DOI 10.1007/s13197-011-0519-5; Olson ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159782; Olson ME, 2001, BOT J LINN SOC, V135, P315, DOI 10.1111/j.1095-8339.2001.tb00786.x; Padulosi S., 2008, P605, DOI 10.1079/9781845930998.0605; Popoola JO, 2013, J ETHNOPHARMACOL, V150, P682, DOI 10.1016/j.jep.2013.09.043; Price ML., MORINGA TREE 2007; Ritu Paliwal, 2011, Asian Journal of Biotechnology, V3, P317, DOI 10.3923/ajbkr.2011.317.328; Roskov Y., 2014, SPECIES 2000 ITIS CA; Shahzad U, 2013, CONSERV GENET, V14, P1161, DOI 10.1007/s10592-013-0503-x; Smolen S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00730; Stroud JL, 2012, INT J ENVIRON AN CH, V92, P222, DOI 10.1080/03067310903111661; Teklehaymanot T, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-23; Tesfaye EB, 2014, J APPL POULTRY RES, V23, P614, DOI 10.3382/japr.2013-00920; Toma Alemayehu, 2014, BMC Complement Altern Med, V14, P180, DOI 10.1186/1472-6882-14-180; Undie U. L., 2013, EUR J AGR FOR RES, V1, P17; Valdez-Solana MA, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/860381; Virchow D., 2008, 5th International Symposium on New Crops and Uses: their role in a rapidly changing world, University of Southampton, Southampton, UK, 3-4 September 2007, P79; White PJ, 2016, ANN BOT-LONDON, V117, P217, DOI 10.1093/aob/mcv180; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Zaffer M, 2014, PAK J PHARM SCI, V27, P1857	64	24	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175503	10.1371/journal.pone.0175503	http://dx.doi.org/10.1371/journal.pone.0175503			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388674	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000399375800062
J	Lee, SJ; Leem, YE; Go, GY; Choi, Y; Song, YJ; Kim, I; Kim, DY; Kim, YK; Seo, DW; Kang, JS; Bae, GU				Lee, Sang-Jin; Leem, Young-Eun; Go, Ga-Yeon; Choi, Younhee; Song, Yoo Jin; Kim, Insol; Kim, Do Yoon; Kim, Yong Kee; Seo, Dong-Wan; Kang, Jong-Sun; Bae, Gyu-Un			Epicatechin elicits MyoD-dependent myoblast differentiation and myogenic conversion of fibroblasts	PLOS ONE			English	Article							SKELETAL-MUSCLE; SIGNALING PATHWAYS; GENE-EXPRESSION; (-)-EPICATECHIN; RESTRICTION; SARCOPENIA; PROMOTER; TEA	Prevention of age-associated reduction in muscle mass and function is required to manage a healthy life. Supplemental (-)-Epicatechin (EC) appears to act as a potential regulator for muscle growth and strength. However, its cellular and molecular mechanisms as a potential muscle growth agent have not been studied well. In the current study, we investigated a role of EC in differentiation of muscle progenitors to gain the molecular insight into how EC regulates muscle growth. EC enhanced myogenic differentiation in a dose-dependent manner through stimulation of promyogenic signaling pathways, p38MAPK and Akt. EC treatment elevated MyoD activity by enhancing its heterodimerization with E protein. Consistently, EC also positively regulated myogenic conversion and differentiation of fibroblasts. In conclusion, EC has a potential as a therapeutic or nutraceutical remedy to treat degenerative muscle diseases or age-related muscle weakness.	[Lee, Sang-Jin; Go, Ga-Yeon; Choi, Younhee; Song, Yoo Jin; Kim, Insol; Kim, Do Yoon; Kim, Yong Kee; Bae, Gyu-Un] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul, South Korea; [Leem, Young-Eun; Kang, Jong-Sun] Sungkyunkwan Univ, Dept Mol Cell Biol, Single Cell Network Res Ctr, Sch Med, Suwon, South Korea; [Seo, Dong-Wan] Dankook Univ, Coll Pharm, Cheonan, South Korea	Sookmyung Women's University; Sungkyunkwan University (SKKU); Dankook University	Bae, GU (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul, South Korea.	gbae@sookmyung.ac.kr		Seo, Dong-Wan/0000-0003-4971-834X	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2011-0030074, 2015R1A2A1A15056117, 2016R1A2134014868]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2011-0030074, 2015R1A2A1A15056117 and 2016R1A2134014868).	Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Gutierrez-Salmean G, 2014, J NUTR BIOCHEM, V25, P91, DOI 10.1016/j.jnutbio.2013.09.007; Hemdan DII, 2009, J MED INVESTIG, V56, P26, DOI 10.2152/jmi.56.26; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Kwik-Uribe C, 2008, ASIA PAC J CLIN NUTR, V17, P280; Ludolph DC, 1995, FASEB J, V9, P1595, DOI 10.1096/fasebj.9.15.8529839; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892; Rondanelli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524948; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sousa-Victor P, 2016, MOL ASPECTS MED, Vxxx, pyy_zz; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TONIN PN, 1991, CANCER RES, V51, P5100; Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Zeng XB, 2014, PHYTOMEDICINE, V21, P217, DOI 10.1016/j.phymed.2013.08.026	30	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175271	10.1371/journal.pone.0175271	http://dx.doi.org/10.1371/journal.pone.0175271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384253	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900144
J	Lin, JT; Cheng, DC				Lin, Jui-Teng; Cheng, Da-Chuan			Modeling the efficacy profiles of UV-light activated corneal collagen crosslinking	PLOS ONE			English	Article							STROMAL DEMARCATION LINE; RIBOFLAVIN; ULTRAVIOLET; PHOTOPOLYMERIZATION; OPTIMIZATION; ABSORPTION; STANDARD; KINETICS; SAFETY; LAW	Objective Analysis of the crosslink time, depth and efficacy profiles of UV-light-activated corneal collagen crosslinking (CXL). Methods A modeling system described by a coupled dynamic equations are numerically solved and analytic formulas are derived for the crosslinking time (T*) and crosslinking depth (z*). The z-dependence of the CXL efficacy is numerically produced to show the factors characterizing the profiles. Results Optimal crosslink depth (z*) and maximal CXL efficacy (Ceff) have opposite trend with respective to the UV light intensity and RF concentration, where z* is a decreasing function of the riboflavin concentration (C-o). In comparison, Ceff is an increasing function of C-o and the UV exposure time (for a fixed UV dose), but it is a decreasing function of the UV light intensity. CXL efficacy is a nonlinear increasing function of [C-o/I-o](- 0.5) and more accurate than that of the linear theory of Bunsen Roscoe law. Depending on the UV exposure time and depth, the optimal intensity ranges from 3 to 30 mW/cm(2) for maximal CXL efficacy. For steady state (with long exposure time), low intensity always achieves high efficacy than that of high intensity, when same dose is applied on the cornea. Conclusions The crosslinking depth (z*) and the crosslinking time (T*) have nonlinear dependence on the UV light dose and the efficacy of corneal collagen crosslinking should be characterized by both z* and the efficacy profiles. A nonlinear scaling law is needed for more accurate protocol.	[Lin, Jui-Teng] New Vis Inc, Taipei, Taiwan; [Cheng, Da-Chuan] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan	China Medical University Taiwan	Cheng, DC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	dccheng@mail.cmu.edu.tw		Lin, Jui-Teng/0000-0003-0890-4234	Ministry of Science and Technology (MOST), Taiwan [MOST 105-0221-E-039-006]; New Vision Inc	Ministry of Science and Technology (MOST), Taiwan; New Vision Inc	The second author (DC Cheng) thanks the partial financial support from Ministry of Science and Technology (MOST), Taiwan, under the grant number MOST 105-0221-E-039-006. The company (New Vision Inc) provided support in the form of salaries for the author JT Lin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The second author (DCC) thanks the partial financial support from Ministry of Science and Technology (MOST), Taiwan, under the grant number MOST 105-0221-E-039-006.	Afnawaiseh M, 2015, CORNEA, V34, P1427; Gatzioufas Z, 2016, J CATARACT REFR SURG, V42, P804, DOI 10.1016/j.jcrs.2016.02.043; Hafezi F, CORNEAL COLLAGEN CRO; Kamaev P, 2012, INVEST OPHTH VIS SCI, V53, P2360, DOI 10.1167/iovs.11-9385; Kling S, 2017, J REFRACT SURG, V33, P128, DOI 10.3928/1081597X-20161206-01; Koppen C, 2010, EYE CONTACT LENS, V36, P77, DOI 10.1097/ICL.0b013e3181d0b74b; Kymionis GD, 2014, J CATARACT REFR SURG, V40, P736, DOI 10.1016/j.jcrs.2013.10.029; Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0; Lin J-T, 2016, OPHTHALMOLOGY RES, P1, DOI [10.9734/OR/2016/28712, DOI 10.9734/OR/2016/28712]; Lin JT, 2016, J POLYM RES, V23, DOI 10.1007/s10965-016-0934-4; Lin JT, 2015, INVEST OPHTH VIS SCI, V56, P5740, DOI 10.1167/iovs.15-17537; Lin JT, 2014, POLYMERS-BASEL, V6, P1489, DOI 10.3390/polym6051489; Lin JT, 2014, POLYMERS-BASEL, V6, P552, DOI 10.3390/polym6020552; [Lin Juiteng 林瑞騰], 2015, [中华眼视光学与视觉科学杂志, Chinese Journal of Optometry Ophthalmology and Visual Science], V17, P140; Martin JW, 2003, PROG ORG COAT, V47, P292, DOI 10.1016/j.porgcoat.2003.08.002; Mita M, 2014, J CATARACT REFR SURG, V40, P1032, DOI 10.1016/j.jcrs.2013.12.014; Moramarco A, 2015, J CATARACT REFR SURG, V41, P2546, DOI 10.1016/j.jcrs.2015.04.033; Richoz O, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.7.6; Schumacher S, 2012, INVEST OPHTH VIS SCI, V53, P762, DOI 10.1167/iovs.11-8059; Schumacher S, 2012, J REFRACT SURG, V28, P91, DOI 10.3928/1081597X-20120117-01; Schumacher S, 2011, INVEST OPHTH VIS SCI, V52, P9048, DOI 10.1167/iovs.11-7818; Semchishen A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1403, DOI 10.1111/php.12498; Sorkin N, 2014, OPHTHALMOLOGICA, V232, P10, DOI 10.1159/000357979; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wernli J, 2013, INVEST OPHTH VIS SCI, V54, P1176, DOI 10.1167/iovs.12-11409; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1786, DOI 10.1016/S0886-3350(03)00343-2	26	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175002	10.1371/journal.pone.0175002	http://dx.doi.org/10.1371/journal.pone.0175002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384251	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900071
J	Moss, JA; Baum, MM; Easley, JT; Cox, DM; Smith, TJ				Moss, John A.; Baum, Marc M.; Easley, Jeremiah T.; Cox, Darren M.; Smith, Thomas J.			An intravaginal ring for real-time evaluation of adherence to therapy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HIV-PREVENTION TRIALS; PREEXPOSURE PROPHYLAXIS; SUSTAINED DELIVERY; AFRICAN WOMEN; VAGINAL RING; PHARMACOKINETICS; INFECTION; SAFETY; DRUGS	Two recent Phase III clinical trials to investigate an intravaginal ring for preventing HIV infection demonstrated that adherence to prescribed device use was a primary driver of efficacy. Surrogate methods for determining adherence in the studies were limited in their inability to monitor temporal patterns of use and allow deconvolution of the effects of adherence and device efficacy on HIV infection rates. To address this issue, we have developed functionality in an intravaginal ring to continuously monitor when the device is being used and maintain a log of adherence that can be accessed by clinicians after it is removed. An electronic module fabricated with common, inexpensive electronic components was encapsulated in a silicone intravaginal ring. The device uses temperature as a surrogate measure of periods of device insertion and removal, and stores a record of the data for subsequent retrieval. The adherence-monitoring intravaginal ring accurately recorded the device status over 33 simulated IN-OUT cycles and more than 1000 measurement cycles in vitro. Following initial in vitro testing in a temperature-controlled chamber, the device was evaluated in vivo in sheep using a predetermined insertion/removal pattern to simulate intravaginal ring use. After insertion into the vaginal cavity of a sheep, the logged data correctly indicated the device status over 29 hours of continuous measurement including three cycles of insertion and removal. The device described here is a promising, low-cost method for real-time adherence assessment in clinical trials involving medicated intravaginal rings or other intravaginal devices.	[Moss, John A.; Baum, Marc M.; Cox, Darren M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA; [Easley, Jeremiah T.] Colorado State Univ, Preclin Surg Res Lab, Ft Collins, CO 80523 USA; [Smith, Thomas J.] Auritec Pharmaceut Inc, Pasadena, CA USA	Colorado State University	Moss, JA (corresponding author), Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA.	j.moss@oak-crest.org		Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH) [1R41AI104549]; NIH Small Business Technology Transfer (STTR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI104549] Funding Source: NIH RePORTER	National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH); NIH Small Business Technology Transfer (STTR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute for Allergies and Infectious Diseases of the National Institutes of Health (NIH) under grant 1R41AI104549 (JM). The funder provided support in the form of salaries for authors [JM, MB, JE, DC, and TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. TS is an employee of Auritec Pharmaceuticals, a for profit pharmaceutical company that was the private sector partner in the NIH Small Business Technology Transfer (STTR) grant funding this work. The specific roles of the authors are articulated in the 'author contributions' section.	Agot K, 2015, AIDS BEHAV, V19, P743, DOI 10.1007/s10461-014-0859-z; Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9; Auritec Pharmaceuticals, 2000, AURITEC PHARMACEUTIC; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, NEW ENGL J MED; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Boyd P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125682; Brown E., 2016, 21 INT AIDS C AIDS 2; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2014, J PHARM SCI-US, V103, P3611, DOI 10.1002/jps.24154; Gunawardana M, 2014, ANTIMICROB AGENTS CH, V58, P2262, DOI 10.1128/AAC.02542-13; Hillier S., 2016, RINGS AND THINGS; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151; MacQueen KM, 2014, J INT AIDS SOC S2, V17, P19158, DOI DOI 10.7448/IAS.17.3.19158; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Quittner AL, 2000, J CLIN PSYCHOL MED S, V7, P41, DOI 10.1023/A:1009545319673; RAND CS, 1994, AM J RESP CRIT CARE, V149, pS69, DOI 10.1164/ajrccm/149.2_Pt_2.S69; Rand CS, 1998, HDB HLTH BEHAV CHANG, P114; Reece W. O., 2009, FUNCTIONAL ANATOMY P; Riekert KA, 2002, J CLIN PSYCHOL MED S, V9, P25, DOI 10.1023/A:1014131928789; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174729	10.1371/journal.pone.0174729	http://dx.doi.org/10.1371/journal.pone.0174729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384179	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000399371900031
J	Khaliq, A; Ravindran, R; Hussainy, SF; Krishnan, VV; Ambreen, A; Yusuf, NW; Irum, S; Rashid, A; Jamil, M; Zaffar, F; Chaudhry, MN; Gupta, PK; Akhtar, MW; Khan, IH				Khaliq, Aasia; Ravindran, Resmi; Hussainy, Syed Fahadulla; Krishnan, Viwanathan V.; Ambreen, Atiqa; Yusuf, Noshin Wasim; Irum, Shagufta; Rashid, Abdul; Jamil, Muhammad; Zaffar, Fareed; Chaudhry, Muhammad Nawaz; Gupta, Puneet K.; Akhtar, Muhammad Waheed; Khan, Imran H.			Field evaluation of a blood based test for active tuberculosis in endemic settings	PLOS ONE			English	Article							PLASMA ANTIBODY PROFILES; SPUTUM SMEAR MICROSCOPY; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; ASSAY; SERODIAGNOSIS; ANTIGENS; AMPLIFICATION; BIOMARKERS; RESPONSES	Over 9 million new active tuberculosis (TB) cases emerge each year from an enormous pool of 2 billion individuals latently infected with Mycobacterium tuberculosis (M. tb.) worldwide. About 3 million new TB cases per year are unaccounted for, and 1.5 million die. TB, however, is generally curable if diagnosed correctly and in a timely manner. The current diagnostic methods for TB, including state-of-the-art molecular tests, have failed in delivering the capacity needed in endemic countries to curtail this ongoing pandemic. Efficient, cost effective and scalable diagnostic approaches are critically needed. We report a multiplex TB serology panel using microbead suspension array containing a combination of 11 M. tb. antigens that demonstrated overall sensitivity of 91% in serum/plasma samples from TB patients confirmed by culture. Group wise sensitivities for sputum smear positive and negative patients were 95%, and 88%, respectively. Specificity of the test was 96% in untreated COPD patients and 91% in general healthy population. The sensitivity of this test is superior to that of the frontline sputum smear test with a comparable specificity (30-70%, and 9399%, respectively). The multiplex serology test can be performed with scalability from 1 to 360 patients per day, and is amenable to automation for higher (1000s per day) throughput, thus enabling a scalable clinical work flow model for TB endemic countries. Taken together, the above results suggest that well defined antibody profiles in blood, analyzed by an appropriate technology platform, offer a valuable approach to TB diagnostics in endemic countries.	[Khaliq, Aasia; Chaudhry, Muhammad Nawaz] Univ Punjab, Coll Earth & Environm Sci, Lahore, Pakistan; [Ravindran, Resmi; Krishnan, Viwanathan V.; Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Hussainy, Syed Fahadulla; Zaffar, Fareed] Lahore Univ Management Sci, Sch Sci & Engn, Dept Comp Sci, Lahore, Pakistan; [Krishnan, Viwanathan V.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Ambreen, Atiqa; Rashid, Abdul; Jamil, Muhammad] Gulab Devi Chest Hosp, Lahore, Pakistan; [Yusuf, Noshin Wasim; Irum, Shagufta] Allama lqbal Med Coll, Dept Pathol, Lahore, Pakistan; [Gupta, Puneet K.] NextGen Vitro Diagnost, New Delhi, India; [Akhtar, Muhammad Waheed] Univ Punjab, Sch Biol Sci, Lahore, Pakistan	University of Punjab; University of California System; University of California Davis; Lahore University of Management Sciences; California State University System; California State University Fresno; University of Punjab	Khan, IH (corresponding author), Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA.; Akhtar, MW (corresponding author), Univ Punjab, Sch Biol Sci, Lahore, Pakistan.	mwa.sbs@pu.edu.pk; ihkhan@ucdavis.edu	Khan, Imran Ali/GVT-0232-2022; Gupta, Puneet K/H-2841-2016; Nadeem, Muhammad Shahid/H-2372-2017; Khan, imran/GQQ-2176-2022	Khan, Imran Ali/0000-0002-8774-2896; Gupta, Puneet K/0000-0003-1108-5903; Nadeem, Muhammad Shahid/0000-0003-4112-0925; Khaliq, Aasia/0000-0003-1833-0940	NextGen In Vitro Diagnostics	NextGen In Vitro Diagnostics	The funder (NextGen In Vitro Diagnostics) provided support in the form of salary for author PG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Al Zahrani K, 2000, AM J RESP CRIT CARE, V162, P1323, DOI 10.1164/ajrccm.162.4.9912115; [Anonymous], 2006, DIAGNOSTICS TUBERCUL; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1999, NEURAL COMPUT, V11, P1493, DOI 10.1162/089976699300016106; Brusasca PN, 2003, COMPARATIVE MED, V53, P165; Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Faisel A, 2006, SEX TRANSM INFECT, V82, P307, DOI 10.1136/sti.2005.018762; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10; Kanaujia GV, 2003, COMPARATIVE MED, V53, P602; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kumar P, 2014, J INFECTION, V69, P607, DOI 10.1016/j.jinf.2014.08.017; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1226; Lyashchenko KP, 2007, CLIN VACCINE IMMUNOL, V14, P1158, DOI 10.1128/CVI.00230-07; Mani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116262; MARTIN ME, 1968, APPL MICROBIOL, V16, P506, DOI 10.1128/AEM.16.3.506-508.1968; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mulcahy GM, 1996, J CLIN MICROBIOL, V34, P1348, DOI 10.1128/JCM.34.5.1348-1349.1996; Ohta S, 2008, J NETW SYST MANAG, V16, P399, DOI 10.1007/s10922-008-9102-4; Organization WH, 2011, COMMERCIAL SERODIAGN; Organization WH, 2010, WHO END NEW RAP TUB; Organization WH, 2009, PATHW BETT DIAGN TUB; Organization WH, US TUB INT GAMM REL; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ravindran R, 2014, J MED PRIMATOL, V43, P59, DOI 10.1111/jmp.12097; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; ROELSGAARD E, 1957, Bull World Health Organ, V17, P187; Safianowska Aleksandra, 2012, Pneumonol Alergol Pol, V80, P6; Saitoh H, 1999, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, V10, P103; Saqib Muhammad An, 2011, BMC Res Notes, V4, P165, DOI 10.1186/1756-0500-4-165; Singh S, 2011, INDIAN J MED RES, V134, P384, DOI 10.4103/0971-5916.90980; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195; WHO, 2015, GLOB TUB REP; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Zhou Jin-song, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P830; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173359	10.1371/journal.pone.0173359	http://dx.doi.org/10.1371/journal.pone.0173359			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380055	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500018
J	Tang, C; Zhou, X; Nguyen, PT; Zhang, YX; Hu, ZT; Zhang, CX; Yarov-Yarovoy, V; DeCaen, PG; Liang, SP; Liu, ZH				Tang, Cheng; Zhou, Xi; Phuong Tran Nguyen; Zhang, Yunxiao; Hu, Zhaotun; Zhang, Changxin; Yarov-Yarovoy, Vladimir; DeCaen, Paul G.; Liang, Songping; Liu, Zhonghua			A novel tarantula toxin stabilizes the deactivated voltage sensor of bacterial sodium channel	FASEB JOURNAL			English	Article						peptide toxin; deactivated state; Ns(v)Ba	PROTEIN-PROTEIN DOCKING; CRYSTAL-STRUCTURE; DOMAIN-II; MOLECULAR DETERMINANTS; CONFORMATIONAL-CHANGE; SELECTIVITY FILTER; FAST INACTIVATION; JINGZHAOTOXIN-I; K+ CHANNEL; ACTIVATION	Voltage-gated sodium channels (Na(V)s) are activated by transiting the voltage sensor from the deactivated to the activated state. The crystal structures of several bacterial Na(V)s have captured the voltage sensor module (VSM) in an activated state, but structure of the deactivated voltage sensor remains elusive. In this study, we sought to identify peptide toxins stabilizing the deactivated VSM of bacterial Na(V)s. We screened fractions from several venoms and characterized a cystine knot toxin called JZTx-27 from the venom of tarantula Chilobrachys jingzhao as a high-affinity antagonist of the prokaryotic Na(V)s NsyBa (nonselective voltage-gated Bacillus alcalophilus) and NaChBac (bacterial sodium channel from Bacillus halodurans) (IC50 = 112 nM and 30 nM, respectively). JZTx-27 was more efficacious at weaker depolarizing voltages and significantly slowed the activation but accelerated the deactivation of NsyBa, whereas the local anesthetic drug lidocaine was shown to antagonize NsyBa without affecting channel gating. Mutation analysis confirmed that JZTx-27 bound to S34 linker of NsyBa, with F98 being the critical residue in determining toxin affinity. All electrophysiological data and in silico analysis suggested that JZTx-27 trapped VSM of NsyBa in one of the deactivated states. In mammalian Na(V)s, JZTx-27 preferably inhibited the inactivation of Nay1.5 by targeting the fourth transmembrane domain. To our knowledge, this is the first report of peptide antagonist for prokaryotic Na(V)s. More important, we proposed that JZTx-27 stabilized the NsyBa VSM in the deactivated state and may be used as a probe to determine the structure of the deactivated VSM of Na(V)s. Tang, C., Zhou, X., Nguyen, P. T., Zhang, Y., Hu, Z., Zhang, C., Yarov-Yarovoy, V., DeCaen, P. G., Liang, S., Liu, Z. A novel tarantula toxin stabilizes the deactivated voltage sensor of bacterial sodium channel.	[Tang, Cheng; Zhou, Xi; Zhang, Yunxiao; Hu, Zhaotun; Zhang, Changxin; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China; [Phuong Tran Nguyen; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [DeCaen, Paul G.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA	Hunan Normal University; University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine	Liang, SP; Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; liuzh@hunnu.edu.cn	Yarov-Yarovoy, Vladimir/ABE-5454-2020; Nguyen, Phuong T./AAT-6194-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; tang, cheng/0000-0002-5848-2458	National Basic Research Program of China (973 Program) [2010CB529801]; National Science Foundation [31370783, 31370817]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This work was supported by the National Basic Research Program of China (973 Program; Grant 2010CB529801); the National Science Foundation Project (Grants 31370783 and 31370817 to Z.L.); and the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (Grant 20134486). The authors declare no conflicts of interest.	Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bagneris C., 2014, P NATL ACAD SCI US; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Corry Ben, 2014, Handb Exp Pharmacol, V221, P251, DOI 10.1007/978-3-642-41588-3_12; DeCaen PG, 2014, ELIFE, V3, DOI 10.7554/eLife.04387; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee S, 2012, CHANNELS, V6, P403, DOI 10.4161/chan.21807; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Martin LJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003688; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Naylor CE, 2016, EMBO J, V35, P820, DOI 10.15252/embj.201593285; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Qu YX, 1997, J PROTEIN CHEM, V16, P565, DOI 10.1023/A:1026314722607; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Scheuer Todd, 2014, Handb Exp Pharmacol, V221, P269, DOI 10.1007/978-3-642-41588-3_13; Sheets MF, 2003, J GEN PHYSIOL, V121, P163, DOI 10.1085/jgp.20028651; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Struyk AF, 2000, J NEUROSCI, V20, P8610; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Tang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09241; Tao H, 2013, TOXICON, V63, P129, DOI 10.1016/j.toxicon.2012.12.001; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terahara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046248; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	60	5	5	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3167	3178		10.1096/fj.201600882R	http://dx.doi.org/10.1096/fj.201600882R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28400471	Green Submitted, Bronze			2022-12-26	WOS:000405931000039
J	Rotwein, P				Rotwein, Peter			Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING-PROTEINS; FACTOR-I; POSTNATAL-GROWTH; HOMOZYGOUS MUTATION; RECEPTOR; STATURE; PATIENT; AXIS; GENE; EVOLUTION	The insulin-like growth factors IGF1 and IGF2 are closely related proteins that are essential for normal growth and development in humans and other species and play critical roles in many physiological and pathophysiological processes. IGF actions are mediated by transmembrane receptors and modulated by IGF-binding proteins. The importance of IGF actions in human physiology is strengthened by the rarity of inactivating mutations in their genes and by the devastating impact caused by such mutations on normal development and somatic growth. Large-scale genome sequencing has the potential to provide new insights into human variation and disease susceptibility. Toward this end, the availability of DNA sequence data from 60,706 people through the Exome Aggregation Consortium has prompted the analyses presented here. Results reveal a broad range of potential missense and other alterations in the coding regions of every IGF family gene, but the vast majority of predicted changes were uncommon. The total number of different alleles detected per gene in the population varied over an similar to 15fold range, from 57 for IGF1 to 872 for IGF2R, although when corrected for protein length the rate ranged from 0.22 to 0.59 changes/codon among the 11 genes evaluated. Previously characterized disease-causing mutations in IGF2, IGF1R, IGF2R, or IGFALS all were found in the general population but with allele frequencies of < 1: 30,000. A few new highly prevalent amino acid polymorphisms were also identified. Collectively, these data provide a wealth of opportunities to understand the intricacies of IGF signaling and action in both physiological and pathological contexts.	[Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA		Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748-26]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grant R01 DK042748-26 (to P.R.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Bach LA, 2015, PEDIATR ENDOCR REV P, V13, P521; Bach LA, 2015, BEST PRACT RES CL EN, V29, P713, DOI 10.1016/j.beem.2015.06.002; Bahcall OG, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.121; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Baserga R, 2013, J CELL PHYSIOL, V228, P675, DOI 10.1002/jcp.24217; Batey L, 2014, J CLIN ENDOCR METAB, V99, pE153, DOI 10.1210/jc.2013-3106; Baxter RC, 2001, HORM RES, V55, P68, DOI 10.1159/000063479; Baxter RC, 2001, BEST PRACT RES CL EN, V15, P421, DOI 10.1053/beem.2001.0161; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bikle DD, 2015, BONE, V80, P79, DOI 10.1016/j.bone.2015.04.036; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Burkhardt S, 2015, J PEDIATR ENDOCR MET, V28, P217, DOI 10.1515/jpem-2014-0132; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Dauber A, 2014, J CLIN ENDOCR METAB, V99, P3080, DOI 10.1210/jc.2014-1506; David A, 2012, J MOL ENDOCRINOL, V49, P213, DOI 10.1530/JME-12-0086; DESOUZA AT, 1995, NAT GENET, V11, P447, DOI 10.1038/ng1295-447; Domene HM, 2011, BEST PRACT RES CL EN, V25, P101, DOI 10.1016/j.beem.2010.08.010; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fuqua JS, 2012, HORM RES PAEDIAT, V78, P59, DOI 10.1159/000337249; Gannage-Yared MH, 2013, EUR J ENDOCRINOL, V168, pK1, DOI 10.1530/EJE-12-0701; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hoeflich A, 2015, BEST PRACT RES CL EN, V29, P685, DOI 10.1016/j.beem.2015.07.002; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Killian JK, 2001, HUM MUTAT, V18, P25, DOI 10.1002/humu.1146; Klammt J, 2011, BEST PRACT RES CL EN, V25, P191, DOI 10.1016/j.beem.2010.09.012; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kruger RP, 2016, CELL, V167, P289, DOI 10.1016/j.cell.2016.09.040; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Netchine I, 2011, BEST PRACT RES CL EN, V25, P181, DOI 10.1016/j.beem.2010.08.005; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Poukoulidou T, 2014, HORM RES PAEDIAT, V81, P422, DOI 10.1159/000358329; Prontera P, 2015, HUM MUTAT, V36, P1043, DOI 10.1002/humu.22853; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; Ranke MB, 2015, BEST PRACT RES CL EN, V29, P701, DOI 10.1016/j.beem.2015.06.003; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Savage MO, 2010, CLIN ENDOCRINOL, V72, P721, DOI 10.1111/j.1365-2265.2009.03775.x; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; Scott CD, 2015, BEST PRACT RES CL EN, V29, P723, DOI 10.1016/j.beem.2015.08.001; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; van Duyvenvoorde HA, 2010, J CLIN ENDOCR METAB, V95, pE363, DOI 10.1210/jc.2010-0511; Vattathil S, 2015, CELL, V163, P281, DOI 10.1016/j.cell.2015.09.042; Walenkamp MJE, 2013, ENDOCR DEV, V24, P128, DOI 10.1159/000342841; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zou J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13293	67	17	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9252	9261		10.1074/jbc.M117.783639	http://dx.doi.org/10.1074/jbc.M117.783639			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389567	hybrid, Green Published			2022-12-26	WOS:000402538900020
J	Awad, F; Assrawi, E; Jumeau, C; Georgin-Lavialle, S; Cobret, L; Duquesnoy, P; Piterboth, W; Thomas, L; Stankovic-Stojanovic, K; Louvrier, C; Giurgea, I; Grateau, G; Amselem, S; Karabina, SA				Awad, Fawaz; Assrawi, Eman; Jumeau, Claire; Georgin-Lavialle, Sophie; Cobret, Laetitia; Duquesnoy, Philippe; Piterboth, William; Thomas, Lucie; Stankovic-Stojanovic, Katia; Louvrier, Camille; Giurgea, Irina; Grateau, Gilles; Amselem, Serge; Karabina, Sonia-Athina			Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN CASPASE-4; INTERLEUKIN-1-ALPHA SECRETION; AUTOINFLAMMATORY DISORDER; DIFFERENTIAL REQUIREMENT; IL-1-BETA RELEASE; HOST-DEFENSE; RECEPTOR; PROTEIN; MECHANISMS	Inflammasomes are multiprotein complexes nucleating around an NLR (Nucleotide-binding domain and Leucine-rich Repeat containing protein), which regulate the secretion of the pro-inflammatory interleukin (IL)-1 beta and IL-18 cytokines. Monocytes and macrophages, the main cells expressing the inflammasome genes, adapt to their surrounding micro environment by a phenotypic polarization towards a pro-inflammatory M1 phenotype that promotes inflammation or an anti-inflammatory M2 phenotype important for resolution of inflammation. Despite the importance of inflammasomes in health and disease, little is known about inflammasome gene expression in relevant human cells and the impact of monocyte and macrophage polarization in inflammasome gene expression. We examined the expression of several members of the NLR, caspase and cytokine family, and we studied the activation of the well-described NLRP3 inflammasome in an experimental model of polarized human primary monocytes and monocyte-derived macrophages (M1/M2 phenotypes) before and after activation with LPS, a well-characterized microbial pattern used in inflammasome activation studies. Our results show that the differentiation of monocytes to macrophages alters NLR expression. Polarization using IFN-gamma (M1 phenotype), induces among the NLRs studied, only the expression of NOD2. One of the key results of our study is that the induction of NLRP3 expression by LPS is inhibited in the presence of IL-4+IL-13 (M2 phenotype) at both mRNA and protein level in monocytes and macrophages. Unlike caspase-3, the expression of inflammasome-related CASP1 (encodes caspase-1) and CASP4 (encodes caspase-4) is up-regulated in M1 but not in M2 cells. Interestingly, the presence of LPS marginally influenced IL18 mRNA expression and secretion, unlike its impact on IL1B. Our data provide the basis for a better understanding of the role of different inflammasomes within a given environment (M1 and M2) in human cells and their impact in the pathophysiology of several important inflammatory disorders.	[Awad, Fawaz; Assrawi, Eman; Cobret, Laetitia; Duquesnoy, Philippe; Piterboth, William; Thomas, Lucie; Louvrier, Camille; Giurgea, Irina; Amselem, Serge; Karabina, Sonia-Athina] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Trousseau,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France; [Georgin-Lavialle, Sophie; Stankovic-Stojanovic, Katia; Grateau, Gilles] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Tenon,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Karabina, SA (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, Hop Trousseau,Publ Hopitaux Paris,UMR S 933,Serv, Paris, France.	sonia.karabina@upmc.fr	AWAD, Fawaz/AAB-1825-2019; Giurgea, Irina/AGX-6879-2022	Giurgea, Irina/0000-0002-5035-2958; Awad, Fawaz/0000-0002-8214-394X	French government, Palestine; Fondation pour la Recherche Medicale [FDT20130928419]; Alquds University, Palestine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER	French government, Palestine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Alquds University, Palestine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Fawaz Awad was supported from a grant from the French government and Alquds University, Palestine and from the "Fondation pour la Recherche Medicale" (FDT20130928419). Eman Assrawi is supported from a grant from the French government and An-Najah University, Palestine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Ferrari D, 1997, J IMMUNOL, V159, P1451; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Haverkamp MH, 2014, CLIN EXP IMMUNOL, V177, P720, DOI 10.1111/cei.12361; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huai WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5738; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Jeru I, 2010, ARTHRITIS RHEUM-US, V62, P1176, DOI 10.1002/art.27326; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Murray P. J., 2016, ANNU REV PHYSIOL; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Pegorier S, 2006, ATHEROSCLEROSIS, V188, P433, DOI 10.1016/j.atherosclerosis.2005.11.015; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Qu Y, 2016, J EXP MED; Rosengren S, 2005, ANN RHEUM DIS, V64, P708, DOI 10.1136/ard.2004.025577; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tuncer S, 2014, J LEUKOC BIOL; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293	59	106	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175336	10.1371/journal.pone.0175336	http://dx.doi.org/10.1371/journal.pone.0175336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403163	gold, Green Published, Green Submitted			2022-12-26	WOS:000399955200052
J	Chang, YT; Shiu, JH; Huang, CH; Chen, YC; Chen, CY; Chang, YS; Chuang, WJ				Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chang, Yung-Sheng; Chuang, Woei-Jer			Effects of the RGD loop and C-terminus of rhodostomin on regulating integrin alpha IIb beta 3 recognition	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; SNAKE-VENOM DISINTEGRINS; INDUCED BINDING-SITE; BETA 3 INTEGRINS; PICHIA-PASTORIS; MELANOMA-CELLS; VIPER VENOMS; ECHISTATIN; FIBRINOGEN; RECEPTOR	Rhodostomin (Rho) is a medium disintegrin containing a (48)PRGDMP motif. We here showed that Rho proteins with P48A, M52W, and P53N mutations can selectively inhibit integrin alpha IIb beta 3. To study the roles of the RGD loop and C-terminal region in disintegrins, we expressed Rho (48)PRGDMP and (48)ARGDWN mutants in Pichia pastoris containing P-65, (PR)-P-65, (PRYH)-P-65, (65)PRNGLYG, and (65)PRNPWNG C-terminal sequences. The effect of C-terminal region on their integrin binding affinities was alpha IIb beta 3 > alpha v beta 3 >= alpha 5 beta 1, and the (48)ARGDWN-(65)PRNPWNG protein was the most selective integrin alpha IIb beta 3 mutant. The (48)ARGDWN-(PRYH)-P-65, (48)ARGDWN-(65)PRNGLYG, and (48)ARGDWN-(65)PRNPWNG mutants had similar activities in inhibiting platelet aggregation and the binding of fibrinogen to platelet. In contrast, (48)ARGDWN-(PRYH)-P-65 and (48)ARGDWN-(65)PRNGLYG exhibited 2.9- and 3.0-fold decreases in inhibiting cell adhesion in comparison with that of (48)ARGDWN-(65)PRNPWNG. Based on the results of cell adhesion, platelet aggregation and the binding of fibrinogen to platelet inhibited by ARGDWN mutants, integrin alpha IIb beta 3 bound differently to immobilized and soluble fibrinogen. NMR structural analyses of (48)ARGDWN-(PRYH)-P-65, (48)ARGDWN-(65)PRNGLYG, and (48)ARGDWN-(65)PRNPWNG mutants demonstrated that their C-terminal regions interacted with the RGD loop. In particular, the W52 sidechain of (48)ARGDWN interacted with H68 of (PRYH)-P-65, L69 of (65)PRNGLYG, and N70 of (65)PRNPWNG, respectively. The docking of the (48)ARGDWN-(65)PRNPWNG mutant into integrin alpha IIb beta 3 showed that the N70 residue formed hydrogen bonds with the alpha IIb D159 residue, and the W69 residue formed cation-pi interaction with the beta 3 K125 residue. These results provide the first structural evidence that the interactions between the RGD loop and C- terminus of medium disintegrins depend on their amino acid sequences, resulting in their functional differences in the binding and selectivity of integrins.	[Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chuang, Woei-Jer] Inst Basic Med Sci, Tainan, Taiwan; [Chang, Yao-Tsung; Shiu, Jia-Hau; Huang, Chun-Hao; Chen, Yi-Chun; Chen, Chiu-Yueh; Chuang, Woei-Jer] Dept Biochem & Mol Biol, Tainan, Taiwan; [Chang, Yung-Sheng; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan, Taiwan; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Chuang, WJ (corresponding author), Inst Basic Med Sci, Tainan, Taiwan.; Chuang, WJ (corresponding author), Dept Biochem & Mol Biol, Tainan, Taiwan.; Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan, Taiwan.; Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.	wjcnmr@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan, Republic of China [MOST-105-2325-6-006-004]	Ministry of Science and Technology, Taiwan, Republic of China	NMR spectra were obtained at National Cheng Kung University or from the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine. We are grateful to Drs. Wen-Mei Fu, Wenya Huang, and Tur-Fu Huang for helpful discussions. This work was supported by the research grants from the Ministry of Science and Technology (MOST-105-2325-6-006-004), Taiwan, Republic of China (https://www.most.gov.tw/).; NMR spectra were obtained at National Cheng Kung University or from the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine. We are grateful to Drs. Wen-Mei Fu, Wenya Huang, and Tur-Fu Huang for helpful discussions. This work was supported by the research grants from the Ministry of Science and Technology (MOST-105-2325-B-006-004), Taiwan, Republic of China.	Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Calvete JJ, 2003, BIOCHEM J, V372, P725, DOI 10.1042/BJ20021739; Chen CY, 2009, PROTEINS, V76, P808, DOI 10.1002/prot.22387; Chen CY, 2006, PROTEINS, V62, P279, DOI 10.1002/prot.20742; Chen YC, 2012, TOXICON, V60, P1342, DOI 10.1016/j.toxicon.2012.08.009; Cheng CH, 2012, PROTEIN SCI, V21, P1872, DOI 10.1002/pro.2169; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Guo RT, 2001, PROTEINS, V43, P499, DOI 10.1002/prot.1061; HUANG TF, 1987, J BIOL CHEM, V262, P16157; HUANG TF, 1991, J BIOCHEM-TOKYO, V109, P328; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; Mas-Moruno C, 2010, ANTI-CANCER AGENT ME, V10, P753, DOI 10.2174/187152010794728639; McLane MA, 2001, HAEMOSTASIS, V31, P177; MCLANE MA, 1994, BIOCHEM J, V301, P429, DOI 10.1042/bj3010429; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; McLane MA, 2005, PATHOPHYSIOL HAEMO T, V34, P164, DOI 10.1159/000092417; McLane Mary Ann, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P327, DOI 10.2174/1568006043335880; Monleon D, 2005, BIOCHEM J, V387, P57, DOI 10.1042/BJ20041343; Mousa SA, 1999, DRUG DISCOV TODAY, V4, P552, DOI 10.1016/S1359-6446(99)01394-X; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Rahman S, 1998, BIOCHEM J, V335, P247, DOI 10.1042/bj3350247; SAVAGE B, 1995, J BIOL CHEM, V270, P28812, DOI 10.1074/jbc.270.48.28812; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Shiu JH, 2004, PROTEINS, V57, P839, DOI 10.1002/prot.20269; Shiu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028833; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; Yahalom D, 2002, BIOCHEMISTRY-US, V41, P8321, DOI 10.1021/bi025690t; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175321	10.1371/journal.pone.0175321	http://dx.doi.org/10.1371/journal.pone.0175321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399159	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000030
J	Huang, HQ; Roh, J; Davis, CD; Wang, TTY				Huang, Haiqiu; Roh, Jamin; Davis, Cindy D.; Wang, Thomas T. Y.			An improved method to quantitate mature plant microRNA in biological matrices using modified periodate treatment and inclusion of internal controls	PLOS ONE			English	Article							MIRNAS; RNAS; BIOAVAILABILITY; QUANTIFICATION; IDENTIFICATION; BIOGENESIS; PCR	MicroRNAs (miRNAs) ubiquitously exist in microorganisms, plants, and animals, and appear to modulate a wide range of critical biological processes. However, no definitive conclusion has been reached regarding the uptake of exogenous dietary small RNAs into mammalian circulation and organs and cross-kingdom regulation. One of the critical issues is our ability to assess and distinguish the origin of miRNAs. Although periodate oxidation has been used to differentiate mammalian and plant miRNAs, validation of treatment efficiency and the inclusion of proper controls for this method were lacking in previous studies. This study aimed to address: 1) the efficiency of periodate treatment in a plant or mammalian RNA matrix, and 2) the necessity of inclusion of internal controls. We designed and tested spike-in synthetic miRNAs in various plant and mammalian matrices and showed that they can be used as a control for the completion of periodate oxidation. We found that overloading the reaction system with high concentration of RNA resulted in incomplete oxidation of unmethylated miRNA. The abundant miRNAs from soy and corn were analyzed in the plasma, liver, and fecal samples of C57BL/6 mice fed a corn and soy-based chow diet using our improved methodology. The improvement resulted in the elimination of the false positive detection in the liver, and we did not detect plant miRNAs in the mouse plasma or liver samples. In summary, an improved methodology was developed for plant miRNA detection that appears to work well in different sample matrices.	[Huang, Haiqiu; Roh, Jamin; Wang, Thomas T. Y.] USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Huang, Haiqiu; Davis, Cindy D.] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA	United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA	Wang, TTY (corresponding author), USDA ARS, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA.	Tom.Wang@ars.usda.gov	Huang, Haiqiu/J-8856-2012	Huang, Haiqiu/0000-0003-1543-3901	U.S. department of Agriculture appropriated fund [8040-51530-056-00D]; Office of Dietary Supplements Interagency Reimbursable Agreement [8040-51530-056-20-I]	U.S. department of Agriculture appropriated fund; Office of Dietary Supplements Interagency Reimbursable Agreement	Support was provided by the U.S. department of Agriculture appropriated fund #8040-51530-056-00D; and by the Office of Dietary Supplements Interagency Reimbursable Agreement #8040-51530-056-20-I.	Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beatty M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-933; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chiang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128089; Chin AR, 2016, CELL RES; Rosas-Cardenas FD, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-4; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146145; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang Y, 2010, MOL BIOL REP, V37, P3171, DOI 10.1007/s11033-009-9897-4; KEITH G, 1974, BIOCHEMISTRY-US, V13, P3601, DOI 10.1021/bi00714a031; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Liang HW, 2015, J NUTR BIOCHEM, V26, P505, DOI 10.1016/j.jnutbio.2014.12.002; Masotti A, 2009, BIOMED RES INT, V2009; Mico V, 2016, PLANT FOOD HUM NUTR, V71, P102, DOI 10.1007/s11130-016-0534-9; Ohara T, 2007, NATURE STRUCTURAL MO, V14; Philip A, 2015, MOL NUTR FOOD RES, V59, P1962, DOI 10.1002/mnfr.201500137; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ranjha R, 2013, INFLAMM RES, V62, P343, DOI 10.1007/s00011-013-0600-9; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Witwer KW, 2015, J NUTR BIOCHEM, V26, P1685, DOI 10.1016/j.jnutbio.2015.09.004; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137516; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2010, METHODS MOL BIOL, V592, P137, DOI 10.1007/978-1-60327-005-2_10; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	41	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175429	10.1371/journal.pone.0175429	http://dx.doi.org/10.1371/journal.pone.0175429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399134	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000037
J	Skert, C; Perucca, S; Chiarini, M; Giustini, V; Sottini, A; Ghidini, C; Martellos, S; Cattina, F; Rambaldi, B; Cancelli, V; Malagola, M; Turra, A; Polverelli, N; Bernardi, S; Imberti, L; Russo, D				Skert, Cristina; Perucca, Simone; Chiarini, Marco; Giustini, Viviana; Sottini, Alessandra; Ghidini, Claudia; Martellos, Stefano; Cattina, Federica; Rambaldi, Benedetta; Cancelli, Valeria; Malagola, Michele; Turra, Alessandro; Polverelli, Nicola; Bernardi, Simona; Imberti, Luisa; Russo, Domenico			Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation	PLOS ONE			English	Article							THYMIC FUNCTION; ACUTE GVHD; MEMORY; RECONSTITUTION; INFILTRATION; DEFICIENCY; RECIPIENTS; DIAGNOSIS; RECOVERY; NUMBERS	T and B lymphocyte subsets have been not univocally associated to Graft-versus-host disease (GVHD) and relapse of hematological malignancies after stem cell transplantation (SCT). Their sequential assessment together with B and T cell neogenesis indexes has been not thoroughly analysed in relation to these changing and interrelated immunologic/clinic events yet. Lymphocyte subsets in peripheral blood (PB) and B and T cell neogenesis indexes were analysed together at different time points in a prospective study of 50 patients. Principal component analysis (PCA) was used as first step of multivariate analysis to address issues related to a high number of variables versus a relatively low number of patients. Multivariate analysis was completed by Fine-Gray proportional hazard regression model. PCA identified 3 clusters of variables (PC1-3), which correlated with acute GVHD: PC1 (pre-SCT: KRECs >= 6608/ml, unswitched memory B <2.4%, CD4+T-CM cells <45%; HR 0.5, p = 0.001); PC2 (at aGVHD onset: CD4+>44%, CD8+T-CM cells>4%; HR 1.9, p = 0.01), and PC3 (at aGVHD onset: CD4+TEMRA <1, total Treg<4, Treg(EM) <2 cells/mu l; HR 0.5, p = 0.002). Chronic GVHD was associated with one PC (Treg(EM) <2 cells/mu l at day+28, CD8+TEMRA <43% at day+90, immature B cells<6 cells/mu l and KRECs<11710/ml at day+180; HR 0.4, P = 0.001). Two PC correlated with relapse: PC1 (pre-SCT: CD4+ <269, CD4+TCM <120, total Treg <18, Treg(CM) <8 cells/mu l; HR 4.0, p = 0.02); PC2 (pre-SCT mature CD19+ >69%, switched memory CD19+ = 0 cells and KRECs<6614/ml at +90; HR 0.1, p = 0.008). All these immunologic parameters were independent indicators of chronic GVHD and relapse, also considering the possible effect of previous steroid-therapy for acute GVHD. Specific time-varying immunologic profiles were associated to GVHD and relapse. Pre-SCT host immune- microenvironment and changes of B cell homeostasis could influence GVH- and Graft-versus-Tumor reactions. The paradoxical increase of EM Treg in PB of patients with GVHD could be explained by their compartmentalization outside lymphoid tissues, which are of critical relevance for regulation of GVH reactions.	[Skert, Cristina; Cattina, Federica; Rambaldi, Benedetta; Cancelli, Valeria; Malagola, Michele; Turra, Alessandro; Polverelli, Nicola; Russo, Domenico] Univ Brescia, Stem Cell Transplantat Unit, Chair Haematol, Brescia, Italy; [Perucca, Simone; Chiarini, Marco; Giustini, Viviana; Sottini, Alessandra; Ghidini, Claudia; Bernardi, Simona; Imberti, Luisa] Spedali Civili Brescia, Ctr Ric Ematooncol AIL CREA, Brescia, Italy; [Martellos, Stefano] Univ Trieste, Dept Life Sci, Res Unit Biodivers Informat, Trieste, Italy	University of Brescia; Hospital Spedali Civili Brescia; University of Trieste	Skert, C (corresponding author), Univ Brescia, Stem Cell Transplantat Unit, Chair Haematol, Brescia, Italy.	cristina_skert@yahoo.it	Giustini, Viviana/AAC-5242-2022; Polverelli, Nicola/AAJ-3718-2021	Polverelli, Nicola/0000-0001-6297-9697; Martellos, Stefano/0000-0001-5201-8948; Malagola, Michele/0000-0003-0907-130X; Imberti, Luisa/0000-0002-2075-8391; Bernardi, Simona/0000-0002-3494-2624				Alho AC, 2016, BLOOD, V127, P646, DOI 10.1182/blood-2015-10-672345; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bremm M, 2011, J IMMUNOL METHODS, V373, P36, DOI 10.1016/j.jim.2011.07.018; Clark FJ, 2004, BLOOD, V103, P2410, DOI 10.1182/blood-2003-06-2073; Clave E, 2005, BLOOD, V105, P2608, DOI 10.1182/blood-2004-04-1667; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dohner H, 2013, HAEMATOLOGICA, V98, P233, DOI 10.3324/haematol.2012.072264; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fujioka T, 2013, BONE MARROW TRANSPL, V48, P859, DOI 10.1038/bmt.2012.232; Glauzy S, 2014, BLOOD, V124, P2459, DOI 10.1182/blood-2014-05-573303; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Greinix HT, 2008, BIOL BLOOD MARROW TR, V14, P208, DOI 10.1016/j.bbmt.2007.10.009; Greinix HT, 2015, BIOL BLOOD MARROW TR, V21, P250, DOI 10.1016/j.bbmt.2014.11.010; Gress RE, 2013, BIOL BLOOD MARROW TR, V19, P1537, DOI 10.1016/j.bbmt.2013.08.010; Hilgendorf I, 2012, TRANSPL INT, V25, P87, DOI 10.1111/j.1432-2277.2011.01388.x; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Khoder A, 2014, BLOOD, V124, P2034, DOI 10.1182/blood-2014-04-571125; Kuzmina Z, 2011, BLOOD, V117, P2265, DOI 10.1182/blood-2010-07-295766; Lee J, 2015, INT J RHEUM DIS, V18, P200, DOI 10.1111/1756-185X.12432; Lu SY, 2011, CLIN EXP IMMUNOL, V165, P264, DOI 10.1111/j.1365-2249.2011.04418.x; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Matsuoka K, 2010, J CLIN INVEST, V120, P1479, DOI 10.1172/JCI41072; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mensen A, 2014, BLOOD, V124, P963, DOI 10.1182/blood-2013-11-539031; Mensen A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-188; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Pidala J, 2014, BONE MARROW TRANSPL, V49, P324, DOI 10.1038/bmt.2013.97; Podgorny PJ, 2014, BIOL BLOOD MARROW TR, V20, P450, DOI 10.1016/j.bbmt.2014.01.002; Poutsiaka DD, 2011, BONE MARROW TRANSPL, V46, P300, DOI 10.1038/bmt.2010.112; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Saglio F, 2015, BIOL BLOOD MARROW TR, V21, P1099, DOI 10.1016/j.bbmt.2015.02.010; Sarantopoulos S, 2015, BIOL BLOOD MARROW TR, V21, P16, DOI 10.1016/j.bbmt.2014.10.029; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwarz A, 2013, J IMMUNOL, V190, P4965, DOI 10.4049/jimmunol.1203224; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Segalen I, 2011, AUTOIMMUN REV, V10, P218, DOI 10.1016/j.autrev.2010.10.005; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Skert C, 2009, BONE MARROW TRANSPL, V44, P729, DOI 10.1038/bmt.2009.80; Sottini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034493; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Tedder TF, 2009, NAT REV RHEUMATOL, V5, P572, DOI 10.1038/nrrheum.2009.184; Ukena SN, 2011, ANN HEMATOL, V90, P213, DOI 10.1007/s00277-010-1068-0; Vincent K, 2011, BLOOD, V118, P2951, DOI 10.1182/blood-2011-04-350868; Wang GC, 2014, TRANSL MED UNISA, V9, P1; Xhaard A, 2014, BONE MARROW TRANSPL, V49, P1089, DOI 10.1038/bmt.2014.105; Yakoub-Agha I, 2006, LEUKEMIA, V20, P1557, DOI 10.1038/sj.leu.2404308; Yakoub-Agha I, 2009, BIOL BLOOD MARROW TR, V15, P496, DOI 10.1016/j.bbmt.2008.11.038; Zhai ZM, 2007, TRANSPL INT, V20, P440, DOI 10.1111/j.1432-2277.2007.00462.x	51	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175337	10.1371/journal.pone.0175337	http://dx.doi.org/10.1371/journal.pone.0175337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399164	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000032
J	Ferreira, J; Carvalho, E; Ferreira, BV; de Souza, C; Suhara, Y; Pentland, A; Pessin, G				Ferreira Junior, Jair; Carvalho, Eduardo; Ferreira, Bruno V.; de Souza, Cleidson; Suhara, Yoshihiko; Pentland, Alex; Pessin, Gustavo			Driver behavior profiling: An investigation with different smartphone sensors and machine learning	PLOS ONE			English	Article								Driver behavior impacts traffic safety, fuel/energy consumption and gas emissions. Driver behavior profiling tries to understand and positively impact driver behavior. Usually driver behavior profiling tasks involve automated collection of driving data and application of computer models to generate a classification that characterizes the driver aggressiveness profile. Different sensors and classification methods have been employed in this task, however, low-cost solutions and high performance are still research targets. This paper presents an investigation with different Android smartphone sensors, and classification algorithms in order to assess which sensor/method assembly enables classification with higher performance. The results show that specific combinations of sensors and intelligent methods allow classification performance improvement.	[Ferreira Junior, Jair; Carvalho, Eduardo; Ferreira, Bruno V.; de Souza, Cleidson; Pessin, Gustavo] Inst Tecnol Vale, Appl Comp Lab, Belem, PA, Brazil; [Ferreira Junior, Jair; de Souza, Cleidson; Pessin, Gustavo] Fed Univ Para, Inst Exact & Nat Sci, Belem, PA, Brazil; [Carvalho, Eduardo; Ferreira, Bruno V.] SENAI Inst Innovat Mineral Technol, Belem, PA, Brazil; [Suhara, Yoshihiko] Recruit Inst Technol, Mountain View, CA USA; [Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal do Para; Massachusetts Institute of Technology (MIT)	Pessin, G (corresponding author), Inst Tecnol Vale, Appl Comp Lab, Belem, PA, Brazil.; Pessin, G (corresponding author), Fed Univ Para, Inst Exact & Nat Sci, Belem, PA, Brazil.	gustavo.pessin@itv.org	Pessin, Gustavo/A-8524-2013; de Souza, Cleidson R B/J-4409-2014	Pessin, Gustavo/0000-0002-7411-9229; de Souza, Cleidson R B/0000-0003-3240-3122; da Silva Ferreira Junior, Jair/0000-0003-0921-6660	MCTI/CT-Info/CNPq [277440880/2013-0]	MCTI/CT-Info/CNPq	This work was supported by MCTI/CT-Info/CNPq, process 277440880/2013-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P1005, DOI 10.1109/IVS.2012.6232304; Ben-Gal I, 2008, BAYESIAN NETWORKS; Blincoe Lawrence, 2015, EC SOC IMPACT MOTOR; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Castignani G, 2015, IEEE INTEL TRANSP SY, V7, P91, DOI 10.1109/MITS.2014.2328673; Castignani G, 2013, IEEE INT C INTELL TR, P552, DOI 10.1109/ITSC.2013.6728289; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dai J, 2010, P 4 INT ICST C PERV, P1, DOI DOI 10.1097/MPA.0B013E3181F7E09F; Domingos P., 2015, MASTER ALGORITHM QUE, DOI 10.5555/3217330; Engelbrecht J, 2015, IET INTELL TRANSP SY, V9, P924, DOI 10.1049/iet-its.2014.0248; Eren H, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P234, DOI 10.1109/IVS.2012.6232298; Evans L., 2004, TRAFFIC SAFETY; Fan Xiaoqiu, 2011, 2011 International Conference on Measuring Technology and Mechatronics Automation (ICMTMA), P370, DOI 10.1109/ICMTMA.2011.379; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fazeen M, 2012, IEEE T INTELL TRANSP, V13, P1462, DOI 10.1109/TITS.2012.2187640; Handel P, 2014, IEEE SYST J, V8, P1238, DOI 10.1109/JSYST.2013.2292721; Haworth N, 2001, P ROAD SAF RES POL E, P7; Haykin S., 2009, NEURAL NETWORKS LEAR, Vthird; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Johnson DA, 2011, IEEE INT C INTELL TR, P1609, DOI 10.1109/ITSC.2011.6083078; Mohan P, 2008, SENSYS'08: PROCEEDINGS OF THE 6TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS, P323; Paefgen J, 2012, ACM; Saiprasert C, 2013, PROCEEDINGS OF THE 2; Saiprasert C, 2014, INT CONF CONNECT VEH, P552, DOI 10.1109/ICCVE.2014.7297609; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Skog I, 2013, IEEE GLOB CONF SIG, P1135, DOI 10.1109/GlobalSIP.2013.6737098; Song H, 2009, TRANSP RES BOARD 88; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Van Mierlo J, 2004, P I MECH ENG D-J AUT, V218, P43, DOI 10.1243/095440704322829155; Vapnik V., 2000, STAT ENG INFORM SCI, DOI [DOI 10.1007/978-1-4757-3264-1, 10.1007/978-1-4757-3264-1]; Wahlstrom J, 2015, IEEE T INTELL TRANSP, V16, DOI 10.1109/TITS.2015.2431293; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; White J, 2011, MOBILE NETW APPL, V16, P285, DOI 10.1007/s11036-011-0304-8; Zhao CH, 2012, ENG APPL ARTIF INTEL, V25, P1677, DOI 10.1016/j.engappai.2012.09.018	37	107	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174959	10.1371/journal.pone.0174959	http://dx.doi.org/10.1371/journal.pone.0174959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394925	Green Published, gold			2022-12-26	WOS:000399954800010
J	Lv, JJ; Zhang, LT; Liu, P; Li, JA				Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian			Transcriptomic variation of eyestalk reveals the genes and biological processes associated with molting in Portunus trituberculatus	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; DIFFERENTIALLY EXPRESSED GENES; CRAYFISH PROCAMBARUS-CLARKII; PIGMENT-DISPERSING HORMONE; CENTRAL-NERVOUS-SYSTEM; SHORT NEUROPEPTIDE F; RNA-SEQ DATA; UCA-PUGILATOR; LITOPENAEUS-VANNAMEI; INHIBITING HORMONE	Background Molting is an essential biological process throughout the life history of crustaceans, which is regulated by many neuropeptide hormones expressed in the eyestalk. To better understand the molting mechanism in Portunus trituberculatus, we used digital gene expression (DGE) to analyze single eyestalk samples during the molting cycle by high-throughput sequencing. Results We obtained 14,387,942, 12,631,508 and 13,060,062 clean sequence reads from inter-molt (InM), pre-molt (PrM) and post-molt (PoM) cDNA libraries, respectively. A total of 1,394 molt-related differentially expressed genes (DEGs) were identified. GO and KEGG enrichment analysis identified some important processes and pathways with key roles in molting regulation, such as chitin metabolism, peptidase inhibitor activity, and the ribosome. We first observed a pattern associated with the neuromodulator-related pathways during the molting cycle, which were up-regulated in PrM and down-regulated in PoM. Four categories of important molting-related transcripts were clustered and most of them had similar expression patterns, which suggests that there is a connection between these genes throughout the molt cycle. Conclusion Our work is the first molt-related investigation of P. trituberculatus focusing on the eyestalk at the whole transcriptome level. Together, our results, including DEGs, identification of molting-related biological processes and pathways, and observed expression patterns of important genes, provide a novel insight into the function of the eyestalk in molting regulation.	[Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China; [Lv, Jianjian; Zhang, Longtao; Liu, Ping; Li, Jian] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Li, JA (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China.; Li, JA (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Peoples R China.	lijian@ystri.ac.cn	LI, RUIJIAN/GYJ-0470-2022		National Natural Science Foundation of China [41576147]; Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project [LJNY2015002]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology	This research was supported by the National Natural Science Foundation of China (No. 41576147), Efficient Eco Agriculture Innovation Project of Taishan Leading Talent Project (No. LJNY2015002) and The Scientific and Technological Innovation Project financially supported by Qingdao National Laboratory for Marine Science and Technology (No. 2015ASKJ02).	Anders S., 2010, MOL BIOL; Andersen SO, 1999, COMP BIOCHEM PHYS A, V123, P203, DOI 10.1016/S1095-6433(99)00051-3; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; [Anonymous], 2008, ECDYSTEROID RECEPTOR; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Covi JA, 2012, INVERTEBR REPROD DEV, V56, P33, DOI 10.1080/07924259.2011.588009; DeKleijn DPV, 1995, COMP BIOCHEM PHYS B, V112, P573, DOI 10.1016/0305-0491(95)00126-3; Duangprom S, 2017, AQUACULTURE, V468, P481, DOI 10.1016/j.aquaculture.2016.11.008; Durica DS, 1999, AM ZOOL, V39, P758; Ernst J, THE SHORT TIME SERIE; FINGERMAN M, 1974, GEN PHARMACOL-VASC S, V5, P299, DOI 10.1016/S0306-3623(74)80042-X; GIRARDIE J, 1987, INSECT BIOCHEM, V17, P977, DOI 10.1016/0020-1790(87)90106-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hill RJ, 2012, ADV INSECT PHYSIOL, V43, P299, DOI 10.1016/B978-0-12-391500-9.00004-8; Hirano M, 2008, EXPRESSION ANAL ECDY; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Huang S.-W., 2015, SCI REPORTS, V5; Jie S, 2011, J FISH CHINA, P1481; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Junzeng X, 1997, DONGHAI MARIN E SCIE, V15, P60; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kuballa AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-147; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loh JT, 2001, MOL MICROBIOL, V41, P1357, DOI 10.1046/j.1365-2958.2001.02603.x; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; Manfrin C, 2015, GENE, V557, P28, DOI 10.1016/j.gene.2014.12.001; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Ollivaux C, 2002, J COMP NEUROL, V444, P1, DOI 10.1002/cne.1426; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Pitts NL, 2017, COMP BIOCHEM PHYS A, V203, P328, DOI 10.1016/j.cbpa.2016.10.012; Qian ZY, 2014, COMP BIOCHEM PHYS A, V172, P10, DOI 10.1016/j.cbpa.2014.02.011; Ren Q, 2014, AQUACULTURE, V434, P108, DOI 10.1016/j.aquaculture.2014.08.008; Robert A, 2016, AQUAT TOXICOL, V175, P192, DOI 10.1016/j.aquatox.2016.03.025; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; Shyamal S, 2015, GEN COMP ENDOCR, V211, P39, DOI 10.1016/j.ygcen.2014.11.006; Skinner DM., 1985, INTEGUMENT PIGMENTS, P43; Stewart MJ, 2013, COMP BIOCHEM PHYS A, V164, P276, DOI 10.1016/j.cbpa.2012.10.029; Suwansa-ard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123848; Tan SH, 2000, MAR BIOTECHNOL, V2, P126; Techa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117278; Techa S, 2013, GENE, V527, P139, DOI 10.1016/j.gene.2013.05.035; Tom M, 2014, J EXP BIOL, V217, P4193, DOI 10.1242/jeb.109009; Cahansky AV, 2011, COMP BIOCHEM PHYS A, V158, P126, DOI 10.1016/j.cbpa.2010.09.016; Wang ChunJian, 2013, Acta Hydrobiologica Sinica, V37, P22; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Webster S. E., 2015, PHYSIOLOGY, P1; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xie X, 2016, COMP BIOCHEM PHYS B, V200, P69, DOI 10.1016/j.cbpb.2016.06.004; Xu ZQ, 2015, GENE, V569, P280, DOI 10.1016/j.gene.2015.05.075; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang SY, 2014, COMP BIOCHEM PHYS B, V167, P30, DOI 10.1016/j.cbpb.2013.09.009; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zou EM, 2004, COMP BIOCHEM PHYS C, V139, P225, DOI 10.1016/j.cca.2004.11.003	72	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175315	10.1371/journal.pone.0175315	http://dx.doi.org/10.1371/journal.pone.0175315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394948	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800026
J	Bosch, X; Monclus, E; Escoda, O; Guerra-Garcia, M; Moreno, P; Guasch, N; Lopez-Soto, A				Bosch, Xavier; Monclus, Esther; Escoda, Ona; Guerra-Garcia, Mar; Moreno, Pedro; Guasch, Neus; Lopez-Soto, Alfons			Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients	PLOS ONE			English	Article							QUICK DIAGNOSIS UNITS; POTENTIALLY SEVERE DISEASES; SPANISH HEALTH-CARE; CONVENTIONAL HOSPITALIZATION; DELIVERY MODEL; CANCER; POPULATION; VALIDATION; REFERRALS; ANEMIA	Background Whereas there are numerous studies on unintentional weight loss (UWL), these have been limited by small sample sizes, short or variable follow-up, and focus on older patients. Although some case series have revealed that malignancies escaping early detection and uncovered subsequently are exceptional, reported follow-ups have been too short or unspecified and necropsies seldom made. Our objective was to examine the etiologies, characteristics, and long-term outcome of UWL in a large cohort of outpatients. Methods We prospectively enrolled patients referred to an outpatient diagnosis unit for evaluation of UWL as a dominant or isolated feature of disease. Eligible patients underwent a standard baseline evaluation with laboratory tests and chest X-ray. Patients without identifiable causes 6 months after presentation underwent a systematic follow-up lasting for 60 further months. Subjects aged >= 65 years without initially recognizable causes underwent an oral cavity examination, a videofluoroscopy or swallowing study, and a depression and cognitive assessment. Results Overall, 2677 patients (mean age, 64.4 [14.7] years; 51% males) were included. Predominant etiologies were digestive organic disorders (nonmalignant in 17% and malignant in 16%). Psychosocial disorders explained 16% of cases. Oral disorders were second to nonhematologic malignancies as cause of UWL in patients aged >= 65 years. Although 375 (14%) patients were initially diagnosed with unexplained UWL, malignancies were detected in only 19 (5%) within the first 28 months after referral. Diagnosis was established at autopsy in 14 cases. Conclusion This investigation provides new information on the relevance of follow-up in the long-term clinical outcome of patients with unexplained UWL and on the role of age on this entity. Although unexplained UWL seldom constitutes a short-term medical alert, malignancies may be undetectable until death. Therefore, these patients should be followed up regularly (eg yearly visits) for longer than reported periods, and autopsies pursued when facing unsolved deaths.	[Bosch, Xavier; Monclus, Esther; Escoda, Ona; Guerra-Garcia, Mar; Guasch, Neus] Univ Barcelona, Hosp Clin, Quick Diag Unit, Adult Day Care Ctr, Barcelona, Spain; [Bosch, Xavier; Monclus, Esther; Escoda, Ona; Moreno, Pedro; Lopez-Soto, Alfons] Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, Quick Diag Unit, Adult Day Care Ctr, Barcelona, Spain.; Bosch, X (corresponding author), Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain.	xavbasch@clinic.ub.es		Monclus Cols, Ester/0000-0001-5064-2632				Baicus C, 2006, EUR J INTERN MED, V17, P28, DOI 10.1016/j.ejim.2005.07.009; Baicus C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095286; Bilbao-Garay J, 2002, Eur J Intern Med, V13, P240, DOI 10.1016/S0953-6205(02)00032-8; BLAZER D, 1980, AM J PSYCHIAT, V137, P439; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Bosch X, 2015, HEALTH POLICY, V119, P107, DOI 10.1016/j.healthpol.2014.10.020; Bosch X, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000095; Bosch X, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-75; Bosch X, 2014, INT J HEALTH SERV, V44, P25, DOI 10.2190/HS.44.1.c; Bosch X, 2013, AM J EMERG MED, V31, P114, DOI 10.1016/j.ajem.2012.06.013; Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Bosch X, 2012, ONCOLOGY-BASEL, V83, P283, DOI 10.1159/000341658; Bosch X, 2012, J HOSP MED, V7, P41, DOI 10.1002/jhm.931; Bosch X, 2012, EUR J INTERN MED, V23, P159, DOI 10.1016/j.ejim.2011.02.013; Bosch X, 2009, MED J AUSTRALIA, V191, P496, DOI 10.5694/j.1326-5377.2009.tb02912.x; Bouras EP, 2001, MAYO CLIN PROC, V76, P923; Brito-Zeron P, 2014, EUR J CLIN INVEST, V44, P707, DOI 10.1111/eci.12287; Campbell J, 2001, J ROY SOC MED, V94, P628, DOI 10.1177/014107680109401206; Capell S, 2004, MED CLIN-BARCELONA, V123, P247, DOI 10.1157/13065197; CarrLopez SM, 1996, DRUG AGING, V9, P221, DOI 10.2165/00002512-199609040-00001; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SP, 2010, ARCH GERONTOL GERIAT, V50, pS27, DOI 10.1016/S0167-4943(10)70008-X; Clarkston WK, 1997, AM J PHYSIOL-REG I, V272, pR243, DOI 10.1152/ajpregu.1997.272.1.R243; Evans AT, 2016, APPROACH PATIENT UNI; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Gaddey HL, 2014, AM FAM PHYSICIAN, V89, P718; Goldeberg RJ, 2005, LONG TERM CARE INTER, V6, P20; Gupta S, 2014, J HOSP MED, V9, P54, DOI 10.1002/jhm.2129; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Loser C, 2007, DABI, V104, pA3411; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Organisation for Economic Cooperation and Development, HLTH GLANC EUR 2014; Payette H, 2000, J CLIN EPIDEMIOL, V53, P579, DOI 10.1016/S0895-4356(99)00186-9; Pericas JM, 2013, EUR J CLIN INVEST, V43, P602, DOI 10.1111/eci.12087; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; ROBBINS LJ, 1989, GERIATRICS, V44, P31; Rubio-Rivas M, 2008, REV CLIN ESP, V208, P561, DOI 10.1016/S0014-2565(08)76034-X; Sanchez JLA, 2004, MED CLIN-BARCELONA, V122, P653; Sanclemente-Anso C, 2016, EUR J INTERN MED, V30, P11, DOI 10.1016/j.ejim.2015.12.015; Sanclemente-Anso C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1070-2; Sanclemente-Anso C, 2013, POL ARCH MED WEWN, V123, P582, DOI 10.20452/pamw.1966; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith HA, 2000, AGE AGEING, V29, P495, DOI 10.1093/ageing/29.6.495; Stajkovic S, 2011, CAN MED ASSOC J, V183, P443, DOI 10.1503/cmaj.101471; SULLIVAN DH, 1993, J AM GERIATR SOC, V41, P725, DOI 10.1111/j.1532-5415.1993.tb07461.x; Teran CMS, 2002, MED CLIN-BARCELONA, V118, P157; THOMPSON MP, 1991, J AM GERIATR SOC, V39, P497, DOI 10.1111/j.1532-5415.1991.tb02496.x; Vanderschueren Steven, 2005, Eur J Intern Med, V16, P160, DOI 10.1016/j.ejim.2005.01.004; WISE GR, 1994, POSTGRAD MED, V95, P143, DOI 10.1080/00325481.1994.11945824; Wong CJ, 2014, MED CLIN N AM, V98, P625, DOI 10.1016/j.mcna.2014.01.012	57	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175125	10.1371/journal.pone.0175125	http://dx.doi.org/10.1371/journal.pone.0175125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388637	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800021
J	Trillo, PA; Narvaez, AE; Ron, SR; Hoke, KL				Trillo, Paula A.; Narvaez, Andrea E.; Ron, Santiago R.; Hoke, Kim L.			Mating patterns and post-mating isolation in three cryptic species of the Engystomops petersi species complex	PLOS ONE			English	Article							PHYSALAEMUS-PETERSI; GENUS ENGYSTOMOPS; MATE CHOICE; FROGS; ANURA; DIVERSITY; DNA; INTROGRESSION; DIVERGENCE; SPECIATION	Determining the extent of reproductive isolation in cryptic species with dynamic geographic ranges can yield important insights into the processes that generate and maintain genetic divergence in the absence of severe geographic barriers. We studied mating patterns, propensity to hybridize in nature and subsequent fertilization rates, as well as survival and development of hybrid F-1 offspring for three nominal species of the Engystomops petersi species complex in Yasuni A National Park, Ecuador. We found at least two species in four out of six locations sampled, and 14.3% of the wild pairs genotyped were mixed-species (heterospecific) crosses. We also found reduced fertilization rates in hybrid crosses between E. petersi females and E. "magnus" males, and between E. "magnus" females and E. "selva" males but not in the reciprocal crosses, suggesting asymmetric reproductive isolation for these species. Larval development times decreased in F1 hybrid crosses compared to same species (conspecific) crosses, but we did not find significant reduction in larval survival or early metamorph survival. Our results show evidence of post-mating isolation for at least two hybrid crosses of the cryptic species we studied. The general decrease in fertilization rates in heterospecific crosses suggests that sexual selection and reinforcement might have not only contributed to the pattern of call variation and behavioral isolation we see between species today, but they may also contribute to further signal divergence and behavioral evolution, especially in locations where hybridization is common and fertilization success is diminished.	[Trillo, Paula A.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima, Peru; [Trillo, Paula A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Trillo, Paula A.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA; [Narvaez, Andrea E.; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [Narvaez, Andrea E.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Hoke, Kim L.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Universidad Nacional Mayor de San Marcos; Smithsonian Institution; Smithsonian Tropical Research Institute; Gettysburg College; Pontificia Universidad Catolica del Ecuador; La Trobe University; Colorado State University	Trillo, PA (corresponding author), Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima, Peru.; Trillo, PA (corresponding author), Smithsonian Trop Res Inst, Balboa, Ancon, Panama.; Trillo, PA (corresponding author), Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA.	ptrillo@gettysburg.edu	Ron, Santiago/J-4203-2019	Ron, Santiago/0000-0001-6300-9350; Trillo, Paula/0000-0001-5994-5189; Narvaez, Andrea/0000-0002-5953-9233	National Science Foundation [IOS-0940466]; UNESCO-L'Oreal-CONCYTEC L'Oreal fellowship [001-2009]; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative); Pontificia Universidad Catolica del Ecuador(PUCE-DGA)	National Science Foundation(National Science Foundation (NSF)); UNESCO-L'Oreal-CONCYTEC L'Oreal fellowship; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative); Pontificia Universidad Catolica del Ecuador(PUCE-DGA)	This research was funded-by a National Science Foundation IOS-0940466 grant to KH and a UNESCO-L'Oreal-CONCYTEC 001-2009-L'Oreal fellowship to PAT. Laboratory work was funded by grants from the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT,ArcadeNoeAInitiative) and a Pontificia Universidad Catolica del Ecuador(PUCE-DGA) grant to SRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2014, SYST BIOL, V63, P518, DOI 10.1093/sysbio/syu017; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Boul KE, 2004, COPEIA, P624, DOI 10.1643/CH-03-153R2; CANNATELLA DC, 1984, COPEIA, P902, DOI 10.2307/1445335; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Drummond AJ, 2010, GENEIOUS V5 1; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; Elmer KR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-59; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Funk WC, 2007, MOL PHYLOGENET EVOL, V44, P825, DOI 10.1016/j.ympev.2007.01.012; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Funk WC, 2008, HERPETOLOGICA, V64, P290, DOI 10.1655/08-019.1; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Guerra MA, 2008, BEHAV ECOL, V19, P1128, DOI 10.1093/beheco/arn098; Guerra MA, 2014, COPEIA, P123, DOI 10.1643/CG-13-051; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hotz H, 1999, P NATL ACAD SCI USA, V96, P2171, DOI 10.1073/pnas.96.5.2171; Jimenez de la Espada M, 1872, ANALES SOC ESPANOLA; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Lourenco LB, 1999, CAN J ZOOL, V77, P624, DOI 10.1139/cjz-77-4-624; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Romero-Carvajal A, 2009, DEV DYNAM, V238, P1444, DOI 10.1002/dvdy.21952; Ron SR, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.229.3580; Ron SR, 2006, MOL PHYLOGENET EVOL, V39, P392, DOI 10.1016/j.ympev.2005.11.022; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sanzo D, 2006, ENVIRON POLLUT, V140, P247, DOI 10.1016/j.envpol.2005.07.013; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Targueta CP, 2009, MOL PHYLOGENETICS EV; Teran-Valdez Andrea, 2009, PHYLLOMEDUSA, V8, P105; Touchon JC, 2013, ECOLOGY, V94, P850, DOI 10.1890/12-0194.1; Trillo PA, 2013, J EVOLUTION BIOL, V26, P216, DOI 10.1111/jeb.12041; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Warkentin KM, 1999, BEHAV ECOL, V10, P251, DOI 10.1093/beheco/10.3.251; Willink B, 2014, EVOL ECOL, V28, P103, DOI 10.1007/s10682-013-9661-z; Zwickl DJ, 2006, GARLI GENETIC ALGORI	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174743	10.1371/journal.pone.0174743	http://dx.doi.org/10.1371/journal.pone.0174743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388628	Green Published, gold			2022-12-26	WOS:000399375800010
J	Li, ZJ; Chakraborty, S; Xu, GZ				Li, Zhijie; Chakraborty, Sayan; Xu, Guozhou			Differential CLE peptide perception by plant receptors implicated from structural and functional analyses of TDIF-TDR interactions	PLOS ONE			English	Article							STEM-CELL FATE; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; COMPLEX; KINASE; ACTIVATION; PROTEIN; POLYPEPTIDE; RECOGNITION; INHIBITOR	Tracheary Element Differentiation Inhibitory Factor (TDIF) belongs to the family of post-translationally modified CLE (CLAVATA3/embryo surrounding region (ESR)-related) peptide hormones that control root growth and define the delicate balance between stem cell proliferation and differentiation in SAM (shoot apical meristem) or RAM (root apical meristem). In Arabidopsis, Tracheary Element Differentiation Inhibitory Factor Receptor (TDR) and its ligand TDIF signaling pathway is involved in the regulation of procambial cell proliferation and inhibiting its differentiation into xylem cells. Here we present the crystal structures of the extracellular domains (ECD) of TDR alone and in complex with its ligand TDIF resolved at 2.65 angstrom and 2.75 angstrom respectively. These structures provide insights about the ligand perception and specific interactions between the CLE peptides and their cognate receptors. Our in vitro biochemical studies indicate that the interactions between the ligands and the receptors at the C-terminal anchoring site provide conserved binding. While the binding interactions occurring at the N-terminal anchoring site dictate differential binding specificities between different ligands and receptors. Our studies will open different unknown avenues of TDR-TDIF signaling pathways that will enhance our knowledge in this field highlighting the receptor ligand interaction, receptor activation, signaling network, modes of action and will serve as a structure function relationship model between the ligand and the receptor for various similar leucine-rich repeat receptor-like kinases (LRR-RLKs).	[Li, Zhijie; Chakraborty, Sayan; Xu, Guozhou] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Xu, GZ (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	gxu3@ncsu.edu	Chakraborty, Sayan/AAC-4933-2021	Chakraborty, Sayan/0000-0002-2580-5097	North Carolina State University; Dr. Xu's NCSU Faculty Research and Development award	North Carolina State University; Dr. Xu's NCSU Faculty Research and Development award	This work was supported by the new faculty start-up funds of North Carolina State University and Dr. Xu's NCSU Faculty Research and Development award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etchells JP, 2010, DEVELOPMENT, V137, P767, DOI 10.1242/dev.044941; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Goad DM, 2016, NEW PHYTOL; Han ZF, 2014, CURR OPIN PLANT BIOL, V20, P55, DOI 10.1016/j.pbi.2014.04.008; Hastwell AH, 2015, J EXP BOT, V66, P5271, DOI 10.1093/jxb/erv351; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kinoshita A, 2007, PLANT CELL PHYSIOL, V48, P1821, DOI 10.1093/pcp/pcm154; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kondo T, 2008, BIOCHEM BIOPH RES CO, V377, P312, DOI 10.1016/j.bbrc.2008.09.139; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukoglu M, 2015, PHYSIOL PLANTARUM, V155, P74, DOI 10.1111/ppl.12358; Lease KA, 2006, PLANT PHYSIOL, V142, P831, DOI 10.1104/pp.106.086041; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Morita J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12383; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Reid DE, 2013, J EXP BOT, V64, P1575, DOI 10.1093/jxb/ert008; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song XF, 2013, PLANT PHYSIOL, V161, P1076, DOI 10.1104/pp.112.211029; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tabata R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00311; Tang J, 2015, CELL RES, V25, P110, DOI 10.1038/cr.2014.161; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Wang GD, 2010, PROTOPLASMA, V240, P33, DOI 10.1007/s00709-009-0095-y; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang HQ, 2016, CELL RES, V26, P543, DOI 10.1038/cr.2016.45; Zhang Z, 2013, J INTEGR PLANT BIOL, V55, P1212, DOI 10.1111/jipb.12080	45	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175317	10.1371/journal.pone.0175317	http://dx.doi.org/10.1371/journal.pone.0175317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384649	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900155
J	Rademaker, RL; de Ven, VGV; Tong, F; Sack, AT				Rademaker, Rosanne L.; de Ven, Vincent G. van; Tong, Frank; Sack, Alexander T.			The impact of early visual cortex transcranial magnetic stimulation on visual working memory precision and guess rate	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FEATURE-BASED ATTENTION; NEURAL MECHANISMS; STATE-DEPENDENCY; PARIETAL CORTEX; CAPACITY LIMIT; CONSOLIDATION; REPRESENTATIONS; INFORMATION; REVEALS	Neuroimaging studies have demonstrated that activity patterns in early visual areas predict stimulus properties actively maintained in visual working memory. Yet, the mechanisms by which such information is represented remain largely unknown. In this study, observers remembered the orientations of 4 briefly presented gratings, one in each quadrant of the visual field. A 10Hz Transcranial Magnetic Stimulation (TMS) triplet was applied directly at stimulus offset, or midway through a 2-second delay, targeting early visual cortex corresponding retinotopically to a sample item in the lower hemifield. Memory for one of the four gratings was probed at random, and participants reported this orientation via method of adjustment. Recall errors were smaller when the visual field location targeted by TMS over-lapped with that of the cued memory item, compared to errors for stimuli probed diagonally to TMS. This implied topographic storage of orientation information, and a memory-enhancing effect at the targeted location. Furthermore, early pulses impaired performance at all four locations, compared to late pulses. Next, response errors were fit empirically using a mixture model to characterize memory precision and guess rates. Memory was more precise for items proximal to the pulse location, irrespective of pulse timing. Guesses were more probable with early TMS pulses, regardless of stimulus location. Thus, while TMS administered at the offset of the stimulus array might disrupt early-phase consolidation in a non-topographic manner, TMS also boosts the precise representation of an item at its targeted retinotopic location, possibly by increasing attentional resources or by injecting a beneficial amount of noise.	[Rademaker, Rosanne L.] Univ Calif San Diego, Psychol Dept, San Diego, CA 92103 USA; [Rademaker, Rosanne L.; de Ven, Vincent G. van; Sack, Alexander T.] Maastricht Univ, Cognit Neurosci Dept, Maastricht, Netherlands; [Tong, Frank] Vanderbilt Univ, Psychol Dept, Nashville, TN USA	University of California System; University of California San Diego; Maastricht University; Vanderbilt University	Rademaker, RL (corresponding author), Univ Calif San Diego, Psychol Dept, San Diego, CA 92103 USA.	rosanne.rademaker@gmail.com		Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience) [NWO 22.001.036]; European Research Council; ERC Grant [263472]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience); European Research Council(European Research Council (ERC)European Commission); ERC Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RLR was supported by a grant from the Netherlands Organization for Scientific Research (Graduate School for Cognitive and Clinical Neuroscience, NWO 22.001.036). ATS was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013) / ERC Grant agreement n [263472].	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2015, TRENDS COGN SCI, V19, P431, DOI 10.1016/j.tics.2015.06.004; Bays PM, 2014, J NEUROSCI, V34, P3632, DOI 10.1523/JNEUROSCI.3204-13.2014; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; BERLUCCHI G, 1968, SCIENCE, V159, P308, DOI 10.1126/science.159.3812.308; Bettencourt KC, 2016, NAT NEUROSCI, V19, P150, DOI 10.1038/nn.4174; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cattaneo Z, 2009, EUR J NEUROSCI, V30, P1393, DOI 10.1111/j.1460-9568.2009.06911.x; Chen YZ, 2012, NEURON, V74, P557, DOI 10.1016/j.neuron.2012.03.033; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Graaf TA, 2014, NEUROSCI BIOBEHAV R, V45, P295, DOI 10.1016/j.neubiorev.2014.06.017; De Weerd P, 2012, J NEUROSCI, V32, P1981, DOI 10.1523/JNEUROSCI.3712-11.2011; Duecker F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073813; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Emrich SM, 2013, J NEUROSCI, V33, P6516, DOI 10.1523/JNEUROSCI.5732-12.2013; Ester EF, 2015, NEURON, V87, P893, DOI 10.1016/j.neuron.2015.07.013; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Ester EF, J COG NEUROSCI, V25, P754; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hollingworth A, 2006, J EXP PSYCHOL LEARN, V32, P58, DOI 10.1037/0278-7393.32.1.58; Jacobs C, 2014, CORTEX, V59, P1, DOI 10.1016/j.cortex.2014.06.017; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee SH, 2013, NAT NEUROSCI, V16, P997, DOI 10.1038/nn.3452; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Ling S, 2009, CURR BIOL, V19, P1458, DOI 10.1016/j.cub.2009.06.069; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Matthews PBC, 1999, J PHYSIOL-LONDON, V518, P867, DOI 10.1111/j.1469-7793.1999.0867p.x; Pasternak T, 2003, J NEUROPHYSIOL, V90, P2757, DOI 10.1152/jn.00422.2003; Pooresmaeili A, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.007; Pratte MS, 2017, J EXP PSYCHOL HUMAN, V43, P6, DOI 10.1037/xhp0000302; Pratte MS, 2014, J VISION, V14, DOI 10.1167/14.3.22; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Silvanto J, 2012, NEUROIMAGE, V59, P840, DOI 10.1016/j.neuroimage.2011.07.062; Silvanto J, 2010, NEUROIMAGE, V50, P1683, DOI 10.1016/j.neuroimage.2010.01.021; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sneve MH, 2015, NEUROPSYCHOLOGIA, V66, P1, DOI 10.1016/j.neuropsychologia.2014.11.004; Soto D, 2012, J NEUROSCI, V32, P3447, DOI 10.1523/JNEUROSCI.6243-11.2012; Sreenivasan KK, 2014, J COGNITIVE NEUROSCI, V26, P1141, DOI 10.1162/jocn_a_00556; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; van Bergen RS, 2015, NAT NEUROSCI, V18, P1728, DOI 10.1038/nn.4150; van de Ven V, 2012, J NEUROSCI, V32, P4, DOI 10.1523/JNEUROSCI.3261-11.2012; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123; Woodman GF, 2012, VIS COGN, V20, P1, DOI 10.1080/13506285.2011.630694; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zaksas D, 2001, J NEUROPHYSIOL, V86, P912, DOI 10.1152/jn.2001.86.2.912; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	76	19	19	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175230	10.1371/journal.pone.0175230	http://dx.doi.org/10.1371/journal.pone.0175230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384347	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900129
J	Reimer, C; Deike, K; Graf, M; Reimer, P; Wiestler, B; Floca, RO; Kickingereder, P; Schlemmer, HP; Wick, W; Bendszus, M; Radbruch, A				Reimer, Caroline; Deike, Katerina; Graf, Markus; Reimer, Peter; Wiestler, Benedikt; Floca, Ralf Omar; Kickingereder, Philipp; Schlemmer, Heinz-Peter; Wick, Wolfgang; Bendszus, Martin; Radbruch, Alexander			Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; HIGH-GRADE GLIOMAS; ADJUVANT TEMOZOLOMIDE; IMAGING BIOMARKER; MALIGNANT GLIOMAS; TUMOR PROGRESSION; TRUE PROGRESSION; BRAIN-TUMOR; RADIOTHERAPY; CONCOMITANT	Purpose The purpose of this study was to investigate whether a voxel-wise analysis of apparent diffusion coefficient (ADC) values may differentiate between progressive disease (PD) and pseudoprogression (PsP) in patients with high-grade glioma using the parametric response map, a newly introduced postprocessing tool. Methods Twenty-eight patients with proven PD and seven patients with PsP were identified in this retrospective feasibility study. For all patients ADC baseline and follow-up maps on four subsequent MRIs were available. ADC maps were coregistered on contrast enhanced T1-weighted follow-up images. Subsequently, enhancement in the follow-up contrast enhanced T1-weighted image was manually delineated and a reference region of interest (ROI) was drawn in the contralateral white matter. Both ROIs were transferred to the ADC images. Relative ADC (rADC) (baseline)/reference ROI values and rADC (follow up)/reference ROI values were calculated for each voxel within the ROI. The corresponding voxels of rADC (follow up) and rADC (baseline) were subtracted and the percentage of all voxels within the ROI that exceeded the threshold of 0.25 was quantified. Results rADC voxels showed a decrease of 59.2% (1 st quartile (Q1) 36.7; 3rd quartile (Q3) 78.6) above 0.25 in patients with PD and 18.6% (Q1 3.04; Q3 26.5) in patients with PsP (p = 0.005). Receiver operating characteristic curve analysis showed the optimal decreasing rADC cut-off value for identifying PD of > 27.05% (area under the curve 0.844 +/- 0.065, sensitivity 0.86, specificity 0.86, p = 0.014). Conclusion This feasibility study shows that the assessment of rADC using parametric response maps might be a promising approach to contribute to the differentiation between PD and PsP. Further research in larger patient cohorts is necessary to finally determine its clinical utility.	[Reimer, Caroline; Wiestler, Benedikt; Kickingereder, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany; [Deike, Katerina; Graf, Markus; Floca, Ralf Omar; Schlemmer, Heinz-Peter; Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany; [Reimer, Peter] Univ Freiburg, Acad Teaching Hosp, Klinikum Karlsruhe, Inst Diagnost & Intervent Radiol, Karlsruhe, Germany; [Wiestler, Benedikt] Tech Univ Munich, Dept Neuroradiol, Munich, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Dept Neurol, Med Ctr, Heidelberg, Germany; [Radbruch, Alexander] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, German Canc Consortium DKTK, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Municipal Hospital Karlsruhe; University of Freiburg; Technical University of Munich; Ruprecht Karls University Heidelberg; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany.; Radbruch, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany.; Radbruch, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.; Radbruch, A (corresponding author), Deutsch Krebsforschungszentrum DKFZ, German Canc Consortium DKTK, Heidelberg, Germany.	a.radbruch@dkfz.de	Radbruch, Alexander/ABA-6277-2021; Wick, Wolfgang/AAA-2545-2020; Vollmuth, Philipp/AAK-3267-2021; Reimer, Peter/AAO-7052-2020	Wick, Wolfgang/0000-0002-6171-634X; Deike, Katerina/0000-0002-4319-0428; Radbruch, Alexander/0000-0001-6238-6525; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Wiestler, Benedikt/0000-0002-2963-7772	grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram	grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram	The study was sponsored by a grant of the German Cancer Research Center (DKFZ), Intramurales Forderprogram.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Deike K, 2015, J NEUROONCOL; Dessouky BAM, 2010, EGYPT J RADIOL NUC M, V41, P441, DOI 10.1016/j.ejrnm.2010.08.005; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Gahramanov S, 2011, INT J RADIAT ONCOL, V79, P514, DOI 10.1016/j.ijrobp.2009.10.072; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Galldiks N, 2015, EUR J NUCL MED MOL I, V42, P685, DOI 10.1007/s00259-014-2959-4; Ganser KA, 1998, BILDVERABEITUNG MED, P422; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Kickingereder P, 2016, RADIOLOGY, V279, P542, DOI 10.1148/radiol.2015151172; Lee WJ, 2012, ACAD RADIOL, V19, P1353, DOI 10.1016/j.acra.2012.06.011; Lemasson B, 2013, TRANSL ONCOL, V6, P554, DOI 10.1593/tlo.13532; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Radbruch A, 2015, NEURO-ONCOLOGY, V17, P151, DOI 10.1093/neuonc/nou129; Shah AH, 2013, J NEURO-ONCOL, V112, P141, DOI 10.1007/s11060-013-1059-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008; Verma N, 2013, NEURO-ONCOLOGY, V15, P515, DOI 10.1093/neuonc/nos307; Wang S, 2015, AJNR AM J NEURORADIO; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Young RJ, 2011, NEUROLOGY, V76, P1918, DOI 10.1212/WNL.0b013e31821d74e7; Yun TJ, 2015, RADIOLOGY, V274, P830, DOI 10.1148/radiol.14132632	39	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174620	10.1371/journal.pone.0174620	http://dx.doi.org/10.1371/journal.pone.0174620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384170	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900022
J	Urano-Morisawa, E; Takami, M; Suzawa, T; Matsumoto, A; Osumi, N; Baba, K; Kamijo, R				Urano-Morisawa, Eri; Takami, Masamichi; Suzawa, Tetsuo; Matsumoto, Akifumi; Osumi, Noriko; Baba, Kazuyoshi; Kamijo, Ryutaro			Induction of osteoblastic differentiation of neural crest-derived stem cells from hair follicles	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; OSTEOCLAST DIFFERENTIATION; STROMAL CELLS; MOUSE EMBRYOS; REGENERATION; MARROW; GENE; MAINTENANCE; RENEWAL	The neural crest (NC) arises near the neural tube during embryo development. NC cells migrate throughout the embryo and have potential to differentiate into multiple cell types, such as peripheral nerves, glial, cardiac smooth muscle, endocrine, and pigment cells, and craniofacial bone. In the present study, we induced osteoblast-like cells using whisker follicles obtained from the NC of mice. Hair follicle cells derived from the NC labeled with enhanced green fluorescent protein (EGFP) were collected from protein zero-Cre/floxedEGFP double transgenic mice and cultured, then treated and cultured in stem cell growth medium. After growth for 14 days, results of flow cytometry analysis showed that 95% of the EGFP-positive (EGFP(+)) hair follicle cells derived from the NC had proliferated and 76.2% of those expressed mesenchymal stem cells markers, such as platelet-derived growth factor a and stem cell antigen-1, and also showed constitutive expression of Runx2 mRNA. Cells stimulated with bone morphogenetic protein-2 expressed osteocalcin, osterix, and alkaline phosphatase mRNA, resulting in production of mineralized matrices, which were detected by von Kossa and alizarin red staining. Moreover, EGFP+ hair follicle cells consistently expressed macrophage colony-stimulating factor and osteoprotegerin (OPG). Addition of 1 alpha, 25-dihydroxyvitamin D-3 [1,25(OH) D-2(3)] (10(-8) M) to the cultures suppressed OPG expression and induced RANKL production in the cells. Furthermore, multinucleated osteoclasts appeared within 6 days after starting co-cultures of bone marrow cells with EGFP(+) cells in the presence of 1,25(OH) D-2(3) and PGE(2). These results suggest that NC-derived hair follicle cells possess a capacity for osteoblastic differentiation and may be useful for developing new bone regenerative medicine therapies.	[Urano-Morisawa, Eri; Takami, Masamichi; Suzawa, Tetsuo; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo, Japan; [Urano-Morisawa, Eri; Matsumoto, Akifumi; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Tokyo, Japan; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo, Japan; [Osumi, Noriko] Tohoku Univ, Div Dev Neurosci, Grad Sch Med, Sendai, Miyagi, Japan	Showa University; Showa University; Showa University; Tohoku University	Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Tokyo, Japan.; Takami, M (corresponding author), Showa Univ, Sch Dent, Dept Pharmacol, Tokyo, Japan.	takami@dent.showa-u.ac.jp	Baba, Kazuyoshi/AAY-2304-2021; Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; Baba, Kazuyoshi/0000-0001-8025-2168; Takami, Masamichi/0000-0002-4506-3975	JSPS KAKENHI [24659830, 26293398]; Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT [S1411009, S1201014, S0801016]; Grants-in-Aid for Scientific Research [17K19372] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant numbers 24659830, 26293398 and by Industry to Support Private Universities Building up Their Foundations of Strategic Research of MEXT (S1411009, S1201014, S0801016). These funders supported equipment purchase, data collection and analysis, decision to publish, and preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401; Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267; COULY GF, 1993, DEVELOPMENT, V117, P409; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Ebraheim N A, 2001, J Am Acad Orthop Surg, V9, P210; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fish JL, 2014, DEVELOPMENT, V141, P674, DOI 10.1242/dev.100107; Gazdag, 1995, J Am Acad Orthop Surg, V3, P1; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Hagiwara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084072; HARRIS WH, 1969, NEW ENGL J MED, V280, P253, DOI 10.1056/NEJM196901302800507; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; HOTZ G, 1994, INT J ORAL MAX SURG, V23, P413, DOI 10.1016/S0901-5027(05)80033-5; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kaku M, 2015, J PROSTHODONT RES, V59, P96, DOI 10.1016/j.jpor.2015.02.001; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kellner JC, 2009, CELL STEM CELL, V5, P569, DOI 10.1016/j.stem.2009.11.010; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; LEDOUARIN NM, 1984, CELL, V38, P353, DOI 10.1016/0092-8674(84)90490-2; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Shim JH, 2013, STEM CELLS DEV, V22, P1264, DOI 10.1089/scd.2012.0244; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Suda T, 2012, ARCH BIOCHEM BIOPHYS, V523, P22, DOI 10.1016/j.abb.2011.11.011; Suzuki J, 2013, NEUROSCI RES, V75, P112, DOI 10.1016/j.neures.2012.11.005; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581; Zhang XY, 2013, INT J MOL MED, V31, P913, DOI 10.3892/ijmm.2013.1272	73	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174940	10.1371/journal.pone.0174940	http://dx.doi.org/10.1371/journal.pone.0174940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384239	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900059
J	Yokoyama, A; Katada, C; Yokoyama, T; Yano, T; Kaneko, K; Oda, I; Shimizu, Y; Doyama, H; Koike, T; Takizawa, K; Hirao, M; Okada, H; Yoshii, T; Konishi, K; Yamanouchi, T; Tsuda, T; Omori, T; Kobayashi, N; Suzuki, H; Tanabe, S; Hori, K; Nakayama, N; Kawakubo, H; Ishikawa, H; Muto, M				Yokoyama, Akira; Katada, Chikatoshi; Yokoyama, Tetsuji; Yano, Tomonori; Kaneko, Kazuhiro; Oda, Ichiro; Shimizu, Yuichi; Doyama, Hisashi; Koike, Tomoyuki; Takizawa, Kohei; Hirao, Motohiro; Okada, Hiroyuki; Yoshii, Takako; Konishi, Kazuo; Yamanouchi, Takenori; Tsuda, Takashi; Omori, Tai; Kobayashi, Nozomu; Suzuki, Haruhisa; Tanabe, Satoshi; Hori, Keisuke; Nakayama, Norisuke; Kawakubo, Hirofumi; Ishikawa, Hideki; Muto, Manabu			Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ENDOSCOPIC MUCOSAL RESECTION; ALDEHYDE DEHYDROGENASE-2 GENOTYPES; UPPER AERODIGESTIVE TRACT; LUGOL-VOIDING LESIONS; NECK-CANCER; GENETIC POLYMORPHISMS; SUBMUCOSAL DISSECTION; PHARYNGEAL CANCER; APPRAISAL MODELS	Background Alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2) and the presence of multiple esophageal Lugol-voiding lesions (LVLs; dysplasia) are strong predictors for multiple development of esophageal squamous cell carcinoma (ESCC) in East Asians. We invented a health risk appraisal (HRA) model for predicting the risk of ESCC based on drinking, smoking, dietary habits, and alcohol flushing, i.e., past or present facial flushing after drinking a glass of beer, a surrogate marker for inactive ALDH2. Methods Prospective follow-up examinations (median follow-up time, 50.3 months) were performed in 278 Japanese men after endoscopic mucosectomy for early ESCC (UMIN Clinical Trials Registry ID: UMIN000001676). Results Sixty-four subjects developed metachronous ESCC. A receiver operating characteristic curve showed that HRA scores >= 12 best predicted the development of metachronous ESCC. The ESCC detection rate per 100 person-years was 9.8 in the high-HRA-score group (n = 104) and 4.5 in the low-HRA-score group (n = 174), and the risk of development of metachronous ESCC was higher in the high-HRA-score group than in the low-HRA-score group (adjusted hazard ratio: 2.00 [95% CI: 1.12-3.30]). Multiple LVLs was a very strong predictor of the development of metachronous SCC, but high HRA scores predicted it independently. The cumulative incidences of metachronous ESCC decreased after drinking cessation in the high-HRA-score drinker group (adjusted hazard ratio: 0.37 [0.14-0.97]). Conclusions Both the HRA model that included alcohol flushing and the multiple LVL grade predicted the development of metachronous ESCC in Japanese men after endoscopic mucosectomy for ESCC. Drinking cessation in the high-HRA-score drinker group reduced the rate of metachronous ESCC.	[Yokoyama, Akira] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan; [Katada, Chikatoshi] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Yano, Tomonori; Kaneko, Kazuhiro; Hori, Keisuke] Natl Canc Ctr Hosp East, Dept Gastroenterol & Endoscopy, Chiba, Japan; [Oda, Ichiro; Suzuki, Haruhisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Shimizu, Yuichi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Kokkaido, Japan; [Doyama, Hisashi] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Koike, Tomoyuki] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi, Japan; [Takizawa, Kohei] Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan; [Hirao, Motohiro] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Okada, Hiroyuki] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yoshii, Takako; Nakayama, Norisuke] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Kanagawa, Japan; [Konishi, Kazuo] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan; [Yamanouchi, Takenori] Kumamoto Reg Med Ctr, Dept Gastroenterol, Kumamoto, Japan; [Tsuda, Takashi] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Omori, Tai] Kawasaki Municipal Ida Hosp, Endoscopy Ctr, Kawasaki, Kanagawa, Japan; [Kobayashi, Nozomu] Tochigi Canc Ctr, Dept Diagnost Imaging, Utsunomiya, Tochigi, Japan; [Tanabe, Satoshi] Kitasato Univ, Res & Dev Ctr New Frontiers, Sch Med, Sagamihara, Kanagawa, Japan; [Kawakubo, Hirofumi] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan; [Ishikawa, Hideki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan; [Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Kyoto, Japan	Kitasato University; National Institute of Public Health - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hokkaido University; Ishikawa Prefectural Central Hospital; Tohoku University; Shizuoka Cancer Center; Osaka National Hospital; Okayama University; Kanagawa Prefectural Cancer Center; Showa University; Saint Marianna University; Tochigi Prefectural Cancer Center; Kitasato University; Keio University; Kyoto Prefectural University of Medicine; Kyoto University	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan.	a_yokoyama@kurihama1.hosp.go.jp	Kobayashi, Nozomu/ABB-8025-2020		National Cancer Center (NCC) Research and Development Fund 36 - Ministry of Health, Labor and Welfare of Japan	National Cancer Center (NCC) Research and Development Fund 36 - Ministry of Health, Labor and Welfare of Japan	Support was provided by the grant of National Cancer Center (NCC) Research and Development Fund 36 by the Ministry of Health, Labor and Welfare of Japan.	[Anonymous], 2010, IARC MONOGRAPHS EVAL; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Bosetti C, 2006, ORAL ONCOL, V42, P957, DOI 10.1016/j.oraloncology.2006.03.007; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Higuchi K, 2013, GASTROINTEST ENDOSC, V78, P704, DOI 10.1016/j.gie.2013.04.182; Hori K, 2011, AM J GASTROENTEROL, V106, P858, DOI 10.1038/ajg.2010.489; Jarl J, 2012, ADDICTION, V107, P1234, DOI 10.1111/j.1360-0443.2011.03772.x; Jin J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05229; Kagemoto K, 2016, CANCER MED-US, V5, P1397, DOI 10.1002/cam4.705; Katada C, 2010, ENDOSCOPY, V42, P185, DOI 10.1055/s-0029-1243963; Katada C, 2016, GASTROENTEROLOGY, V15; Katada C, 2012, LARYNGOSCOPE, V122, P1291, DOI 10.1002/lary.23249; Lachenmeier DW, 2008, FOOD CHEM TOXICOL, V46, P2903, DOI 10.1016/j.fct.2008.05.034; Makuuchi H, 2001, Gastrointest Endosc Clin N Am, V11, P445; Matsubara T, 2003, J CLIN ONCOL, V21, P4336, DOI 10.1200/JCO.2003.12.074; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Shimizu Y, 2003, ENDOSCOPY, V35, P322, DOI 10.1055/s-2003-38151; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Wang YL, 2011, ASIAN PAC J CANCER P, V12, P2065; Yamaji T, 2008, INT J CANCER, V123, P1935, DOI 10.1002/ijc.23744; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yokoyama A, 2006, ALCOHOL CLIN EXP RES, V30, P491, DOI 10.1111/j.1530-0277.2006.00053.x; Yokoyama A, 2013, DIS ESOPHAGUS, V26, P148, DOI 10.1111/j.1442-2050.2012.01343.x; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2002, CANCER EPIDEM BIOMAR, V11, P895; Yokoyama A, 1996, CANCER EPIDEM BIOMAR, V5, P99; Yokoyama A, 1996, CANCER-AM CANCER SOC, V77, P1986, DOI 10.1002/(SICI)1097-0142(19960515)77:10<1986::AID-CNCR4>3.0.CO;2-F; Yokoyama A, 2008, CANCER SCI, V99, P1164, DOI 10.1111/j.1349-7006.2008.00807.x; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2009, CANCER EPIDEM BIOMAR, V18, P651, DOI 10.1158/1055-9965.EPI-08-0758; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Yokoyama T, 2008, CANCER EPIDEM BIOMAR, V17, P2846, DOI 10.1158/1055-9965.EPI-08-0397	42	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175182	10.1371/journal.pone.0175182	http://dx.doi.org/10.1371/journal.pone.0175182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384229	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900111
J	Carlson, DE; Hedin, M				Carlson, David E.; Hedin, Marshal			Comparative transcriptomics of Entelegyne spiders (Araneae, Entelegynae), with emphasis on molecular evolution of orphan genes	PLOS ONE			English	Article							MULTI-TISSUE TRANSCRIPTOMICS; RNA-SEQ DATA; POSITIVE SELECTION; CAVE SPIDERS; WEB SPIDER; ALIGNMENT; SEQUENCE; REVEALS; SILK; ACCURACY	Next-generation sequencing technology is rapidly transforming the landscape of evolutionary biology, and has become a cost-effective and efficient means of collecting exome information for non-model organisms. Due to their taxonomic diversity, production of interesting venom and silk proteins, and the relative scarcity of existing genomic resources, spiders in particular are excellent targets for next-generation sequencing (NGS) methods. In this study, the transcriptomes of six entelegyne spider species from three genera (Cicurina travisae, C. vibora, Habronattus signatus, H. ustulatus, Nesticus bishopi, and N. cooperi) were sequenced and de novo assembled. Each assembly was assessed for quality and completeness and functionally annotated using gene ontology information. Approximately 100 transcripts with evidence of homology to venom proteins were discovered. After identifying more than 3,000 putatively orthologous genes across all six taxa, we used comparative analyses to identify 24 instances of positively selected genes. In addition, between 550 and 1,100 unique orphan genes were found in each genus. These unique, uncharacterized genes exhibited elevated rates of amino acid substitution, potentially consistent with lineage-specific adaptive evolution. The data generated for this study represent a valuable resource for future phylogenetic and molecular evolutionary research, and our results provide new insight into the forces driving genome evolution in taxa that span the root of entelegyne spider phylogeny.	[Carlson, David E.; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Carlson, David E.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	California State University System; San Diego State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carlson, DE (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Carlson, DE (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	david.carison@stonybrook.edu		Carlson, Dave/0000-0002-6987-9493	United States Fish and Wildlife Service [F13PX00770]; San Diego State University Grants Program	United States Fish and Wildlife Service(US Fish & Wildlife Service); San Diego State University Grants Program	This study was funded by a grant to MH from the United States Fish and Wildlife Service (contract #F13PX00770). https.//v/ww.fv/s.govi. This study was also funded by support to MH from the San Diego State University Grants Program (https llnewscenter sdsu eduiresearchaffairsiugp aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Agnarsson I, 2013, J ZOOL SYST EVOL RES, V51, P100, DOI 10.1111/jzs.12007; Andrews S., 2010, FASTQC QUALITY CONTR; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arruda AP, 2007, BBA-BIOMEMBRANES, V1768, P1498, DOI 10.1016/j.bbamem.2007.03.016; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Brewer MS, 2015, EVOLUTION, V69, P162, DOI 10.1111/evo.12563; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Clarke TH, 2015, GENOME BIOL EVOL, V7, P1856, DOI 10.1093/gbe/evv110; Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Croucher PJP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-862; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Duan ZG, 2013, J PROTEOMICS, V78, P416, DOI 10.1016/j.jprot.2012.10.011; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Garrison NL, 2016, PEERJ, V4, DOI 10.7717/peerj.1719; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant J.R., 2012, PROTIST GENOMICS, V1, P3; Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a; Griswold CE, 1999, J ARACHNOL, V27, P53; Griswold CE., 1987, REVISION JUMPING SPI; Griswold Charles E., 2005, Proceedings of the California Academy of Sciences, V56, P1; Haney RA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-366; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081357; Hedin M, 2015, MOL ECOL, V24, P346, DOI 10.1111/mec.13036; Hedin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042888; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Jiang LP, 2013, TOXICON, V73, P23, DOI 10.1016/j.toxicon.2013.07.005; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Karashima T, 2000, DEVELOPMENT, V127, P1069; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Markova-Raina P, 2011, GENOME RES, V21, P863, DOI 10.1101/gr.115949.110; Mattila TM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-70; Miller JA, 2010, MOL PHYLOGENET EVOL, V55, P786, DOI 10.1016/j.ympev.2010.02.021; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Niu JZ, 2012, INSECT MOL BIOL, V21, P422, DOI 10.1111/j.1365-2583.2012.01148.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Palmieri N, 2014, ELIFE, V3, DOI 10.7554/eLife.01311; Paquin P, 2009, ZOOTAXA, P1; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Posnien N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104885; Prabh N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1102-x; Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Prpic NM, 2004, DEV GENES EVOL, V214, P296, DOI 10.1007/s00427-004-0393-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; Riesgo A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-33; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Santoferrara LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101418; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Silva DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143959; Sun W, 2015, FEBS LETT, V589, P2731, DOI 10.1016/j.febslet.2015.08.008; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Venables WN, 2008, INTRO R; Voit R, 2000, J BIOL CHEM, V275, P39339, DOI 10.1074/jbc.M005442200; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wheeler W.C., 2016, CLADISTICS; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yim KM, 2014, J HERED, V105, P771, DOI 10.1093/jhered/esu043; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286; Zhao YJ, 2014, INSECT SCI, V21, P687, DOI 10.1111/1744-7917.12068	117	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174102	10.1371/journal.pone.0174102	http://dx.doi.org/10.1371/journal.pone.0174102			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379977	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500031
J	Faulkner, KT; Robertson, MP; Rouget, M; Wilson, JRU				Faulkner, Katelyn T.; Robertson, Mark P.; Rouget, Mathieu; Wilson, John R. U.			Prioritising surveillance for alien organisms transported as stowaways on ships travelling to South Africa	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; BALLAST-WATER; RISK-ASSESSMENT; PLANT PESTS; MARINE; PATHWAYS; MODEL; MECHANISMS; HABITATS	The global shipping network facilitates the transportation and introduction of marine and terrestrial organisms to regions where they are not native, and some of these organisms become invasive. South Africa was used as a case study to evaluate the potential for shipping to contribute to the introduction and establishment of marine and terrestrial alien species (i.e. establishment debt) and to assess how this varies across shipping routes and seasons. As a proxy for the number of species introduced (i.e. 'colonisation pressure') shipping movement data were used to determine, for each season, the number of ships that visited South African ports from foreign ports and the number of days travelled between ports. Seasonal marine and terrestrial environmental similarity between South African and foreign ports was then used to estimate the likelihood that introduced species would establish. These data were used to determine the seasonal relative contribution of shipping routes to South Africa's marine and terrestrial establishment debt. Additionally, distribution data were used to identify marine and terrestrial species that are known to be invasive elsewhere and which might be introduced to each South African port through shipping routes that have a high relative contribution to establishment debt. Shipping routes from Asian ports, especially Singapore, have a particularly high relative contribution to South Africa's establishment debt, while among South African ports, Durban has the highest risk of being invaded. There was seasonal variation in the shipping routes that have a high relative contribution to the establishment debt of the South African ports. The presented method provides a simple way to prioritise surveillance effort and our results indicate that, for South Africa, port-specific prevention strategies should be developed, a large portion of the available resources should be allocated to Durban, and seasonal variations and their consequences for prevention strategies should be explored further.	[Faulkner, Katelyn T.; Wilson, John R. U.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Invas Species Programme, Claremont, South Africa; [Faulkner, Katelyn T.; Robertson, Mark P.] Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, Hatfield, South Africa; [Rouget, Mathieu] CIRAD, UMR PVBMT, St Clotilde, La Reunion, France; [Wilson, John R. U.] Stellenbosch Univ, Dept Bot & Zool, Ctr Invas Biol, Matieland, South Africa	South African National Biodiversity Institute; University of Pretoria; CIRAD; Stellenbosch University	Faulkner, KT (corresponding author), South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Invas Species Programme, Claremont, South Africa.; Faulkner, KT (corresponding author), Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, Hatfield, South Africa.	katelynfaulkner@gmail.com	Wilson, John/B-4101-2008	Wilson, John/0000-0003-0174-3239; Faulkner, Katelyn/0000-0002-3955-353X; Rouget, Mathieu/0000-0002-6172-3152	South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme; DST-NRF Centre for Invasion Biology; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa	South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme; DST-NRF Centre for Invasion Biology(Department of Science & Technology (India)); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by the South African National Department of Environment Affairs through its funding of the South African National Biodiversity Institute's Invasive Species Programme. Additional funding was provided by the DST-NRF Centre for Invasion Biology. MR acknowledges funding from the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areal FJ, 2008, J ENVIRON MANAGE, V89, P300, DOI 10.1016/j.jenvman.2007.06.017; Australian Department of Agriculture and Water Resources, 2016, AUSTR BALL WAT MAN R; Australian Department of Agriculture and Water Resources, 2015, BIOS ACT 2015; Australian Government, 2009, NAT BIOF MAN GUID CO; Azmi F, 2015, ICES J MAR SCI, V72, P1078, DOI 10.1093/icesjms/fsu236; Azmi F, 2015, ICES J MAR SCI, V72, P1069, DOI 10.1093/icesjms/fsu150; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Bailey SA, 2011, ENVIRON SCI TECHNOL, V45, P2554, DOI 10.1021/es102655j; Barry SC, 2008, ICES J MAR SCI, V65, P121, DOI 10.1093/icesjms/fsn004; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bivand R.S., 2014, MAPTOOLS TOOLS READI; Botes L, 2003, GLOBALLAST MON SER, V7; Bradie J, 2015, BIOL INVASIONS, V17, P3455, DOI 10.1007/s10530-015-0970-8; Briski E, 2014, LIMNOL OCEANOGR, V59, P2068, DOI 10.4319/lo.2014.59.6.2068; Briski E, 2014, DIVERS DISTRIB, V20, P236, DOI 10.1111/ddi.12154; Briski E, 2013, LIMNOL OCEANOGR, V58, P1361, DOI 10.4319/lo.2013.58.4.1361; Briski E, 2011, LIMNOL OCEANOGR, V56, P1929, DOI 10.4319/lo.2011.56.5.1929; Briski E, 2011, DIVERS DISTRIB, V17, P593, DOI 10.1111/j.1472-4642.2011.00763.x; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; CARLTON JT, 1987, B MAR SCI, V41, P452; Costello C, 2007, J ENVIRON ECON MANAG, V54, P262, DOI 10.1016/j.jeem.2007.06.001; Crafton RE, 2015, HYDROBIOLOGIA, V746, P349, DOI 10.1007/s10750-014-2027-x; Crawley M.J., 2007, R BOOK; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P433, DOI 10.1111/j.1467-842X.2004.tb00025.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Dytham C., 2011, CHOOSING USING STAT; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Faulkner KT, 2016, BIOL INVASIONS, V18, P73, DOI 10.1007/s10530-015-0990-4; Faulkner KT, 2014, BIOL CONSERV, V179, P25, DOI 10.1016/j.biocon.2014.08.014; Faulkner KT, 2015, ASSESSMENT INFORM CO, P45; Gollasch Stephan, 2007, Aquatic Invasions, V2, P313, DOI 10.3391/ai.2007.2.4.3; Gray DR, 2010, ECOL APPL, V20, P2300, DOI 10.1890/09-1540.1; Griffiths Charles L., 2009, V204, P393; Hewitt CL, 2007, MAR POLLUT BULL, V55, P395, DOI 10.1016/j.marpolbul.2007.01.005; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hijmans RJ., 2015, GEOSPHERE SPHERICAL; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; JUPP PG, 1992, J AM MOSQUITO CONTR, V8, P321; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lo VB, 2012, MAR POLLUT BULL, V64, P295, DOI 10.1016/j.marpolbul.2011.11.016; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1, DOI [10.1182/bloo d-2011-06-357442, DOI 10.1182/BLOOD-2011-06-357442]; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; MacIsaac HJ, 2002, CAN J FISH AQUAT SCI, V59, P1245, DOI 10.1139/F02-090; McClay T, 2015, VESSEL BIOFOULING PR; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; McGeoch MA, 2016, BIOL INVASIONS, V18, P299, DOI 10.1007/s10530-015-1013-1; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Mitchell M, 2014, CIVIL ENG, V22, P74; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Neuwirth E, 2011, RCOLORBREWER COLORBR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Oksanen J., 2020, VEGAN COMMUNITY ECOL; R Core Team, 2021, R LANGUAGE ENV STAT; Rouget M, 2016, DIVERS DISTRIB, V22, P445, DOI 10.1111/ddi.12408; Ruiz GM, 1997, AM ZOOL, V37, P621; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Seebens H, 2016, P NATL ACAD SCI USA, V113, P5646, DOI 10.1073/pnas.1524427113; Sink K.J., 2011, SPATIAL PLANNING IDE; Smit AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082381; Sprent P., 2007, APPL NONPARAMETRIC S; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Surkov IV, 2008, AGR ECON-BLACKWELL, V38, P363, DOI 10.1111/j.1574-0862.2008.00306.x; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Wilson JR, 2016, DETECTING RESPONDING; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Zweng M. M., 2013, SALINITY, V2, DOI DOI 10.1182/BLOOD-2011-06-357442	79	18	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173340	10.1371/journal.pone.0173340	http://dx.doi.org/10.1371/journal.pone.0173340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379957	Green Published, gold			2022-12-26	WOS:000399353500017
J	Tsujii, N; Mikawa, W; Tsujimoto, E; Adachi, T; Niwa, A; Ono, H; Shirakawa, O				Tsujii, Noa; Mikawa, Wakako; Tsujimoto, Emi; Adachi, Toru; Niwa, Atsushi; Ono, Hisae; Shirakawa, Osamu			Reduced left precentral regional responses in patients with major depressive disorder and history of suicide attempts	PLOS ONE			English	Article							VERBAL-FLUENCY TASK; TRANSPORTER BINDING-CAPACITY; NEAR-INFRARED SPECTROSCOPY; JAPANESE VERSION; BIPOLAR DISORDER; BRAIN-SEROTONIN; ACTIVATION; BEHAVIOR; SCHIZOPHRENIA; VULNERABILITY	Previous neuroimaging studies have revealed frontal and temporal functional abnormalities in patients with major depressive disorder (MDD) and a history of suicidal behavior. However, it is unknown whether multi-channel near-infrared spectroscopy (NIRS) signal changes among individuals with MDD are associated with a history of suicide attempts and a diathesis for suicidal behavior (impulsivity, hopelessness, and aggression). Therefore, we aimed to explore frontotemporal hemodynamic responses in depressed patients with a history of suicide attempts using 52-channel NIRS. We recruited 30 patients with MDD and a history of suicidal behavior (suicide attempters; SAs), 38 patient controls without suicidal behavior (non-attempters; NAs), and 40 healthy controls (HCs) matched by age, gender ratio, and estimated IQ. Regional hemodynamic responses during a verbal fluency task (VFT) were monitored using NIRS. Our results showed that severities of depression, impulsivity, aggression, and hopelessness were similar between SAs and NAs. Both patient groups had significantly reduced activation compared with HCs in the bilateral frontotemporal regions. Post hoc analyses revealed that SAs exhibited a smaller hemodynamic response in the left precentral gyrus than NAs and HCs. Furthermore, the reduced response in the left inferior frontal gyrus was negatively correlated with impulsivity level and hemodynamic responses in the right middle frontal gyrus were negatively associated with hopelessness and aggression in SAs but not in NAs and HCs. Our findings suggest that MDD patients with a history of suicide attempts demonstrate patterns of VFT-induced NIRS signal changes different from those demonstrated by individuals without a history of suicidal behaviors, even in cases where clinical symptoms are similar. NIRS has a relatively high time resolution, which may help visually differentiate SAs from NAs.	[Tsujii, Noa; Mikawa, Wakako; Tsujimoto, Emi; Adachi, Toru; Niwa, Atsushi; Shirakawa, Osamu] Kindai Univ, Fac Med, Dept Neuropsychiat, Osaka, Osaka, Japan; [Tsujimoto, Emi; Ono, Hisae] Kwansei Gakuin Univ, Grad Sch Humanities, Dept Psychol Sci, Nishinomiya, Hyogo, Japan	Kindai University (Kinki University); Kwansei Gakuin University	Tsujii, N (corresponding author), Kindai Univ, Fac Med, Dept Neuropsychiat, Osaka, Osaka, Japan.	tujiinoa@med.kindai.ac.jp		ONO, HISAE/0000-0001-7099-3798; Tsujii, Noa/0000-0003-3434-6280	Japan Society for the Promotion of Science [25461792, 25380965, 16K10229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25461792, No. 25380965, No. 16K10229).	Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; Aman MG, 2009, J AM ACAD CHILD PSY, V48, P1143, DOI 10.1097/CHI.0b013e3181bfd669; Ando A, 1999, JPN J PSYCHOL, V70, P384, DOI 10.4992/jjpsy.70.384; Audenaert K, 2002, NUCL MED COMMUN, V23, P907, DOI 10.1097/00006231-200209000-00015; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; BARTFAI A, 1990, SUICIDE LIFE-THREAT, V20, P254; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Cope M, 1988, Adv Exp Med Biol, V222, P183; Ding Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.1; Ehlis AC, 2014, NEUROIMAGE, V85, P478, DOI 10.1016/j.neuroimage.2013.03.067; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Herrmann MJ, 2003, BRAIN RES BULL, V61, P51, DOI 10.1016/S0361-9230(03)00066-2; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Inada T, 2015, PSYCHIAT CLIN NEUROS, V69, P440, DOI 10.1111/pcn.12275; Jha A, 2015, CEREB CORTEX, V25, P4392, DOI 10.1093/cercor/bhv027; Jollant F, 2008, AM J PSYCHIAT, V165, P740, DOI 10.1176/appi.ajp.2008.07081239; Jollant F, 2011, WORLD J BIOL PSYCHIA, V12, P319, DOI 10.3109/15622975.2011.556200; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kobashi M, 2013, J PSYCHOL RISSHO U, V4, P53; Lindstrom MB, 2004, EUR NEUROPSYCHOPHARM, V14, P295, DOI 10.1016/S0924-977X(03)00218-9; Mann JJ, 2005, CRISIS, V26, P101, DOI 10.1027/0227-5910.26.3.101; Mann JJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0537; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Noda T, 2012, J PSYCHIATR RES, V46, P905, DOI 10.1016/j.jpsychires.2012.04.001; Ohtani T, 2015, J AFFECT DISORDERS, V176, P78, DOI 10.1016/j.jad.2015.01.042; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oquendo MA, 2003, ARCH GEN PSYCHIAT, V60, P14, DOI 10.1001/archpsyc.60.1.14; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Papmeyer M, 2015, BIOL PSYCHIAT, V78, P58, DOI 10.1016/j.biopsych.2014.10.018; Peng DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120704; Pu SH, 2015, J AFFECT DISORDERS, V181, P9, DOI 10.1016/j.jad.2015.04.010; Pu S, 2013, PSYCHIAT RES-NEUROIM, V214, P73, DOI 10.1016/j.pscychresns.2013.05.011; Reisch T, 2010, J AFFECT DISORDERS, V126, P321, DOI 10.1016/j.jad.2010.03.005; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Ryding E, 2006, PSYCHIAT RES-NEUROIM, V148, P195, DOI 10.1016/j.pscychresns.2006.06.001; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Sublette ME, 2013, ARCH SUICIDE RES, V17, P434, DOI 10.1080/13811118.2013.801813; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; Tomioka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120828; Tsujii N, 2016, PSYCHIAT RES; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; van Heeringen K, 2017, J PSYCHIATR RES, V84, P243, DOI 10.1016/j.jpsychires.2016.10.011; van Heeringen K, 2014, CRISIS, V35, P1, DOI 10.1027/0227-5910/a000213; Wagner G, 2012, J PSYCHIATR RES, V46, P1449, DOI 10.1016/j.jpsychires.2012.07.013; Willeumier K, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.28; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Zhang XC, 2012, J AFFECT DISORDERS, V136, P443, DOI 10.1016/j.jad.2011.11.005	58	29	32	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175249	10.1371/journal.pone.0175249	http://dx.doi.org/10.1371/journal.pone.0175249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380030	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500110
J	Jiang, H; Shen, SM; Yin, J; Zhang, PP; Shi, Y				Jiang, Hao; Shen, Si-mei; Yin, Jie; Zhang, Peng-peng; Shi, Yi			Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATION; PATHOGENESIS; VIRULENCE; DISEASE; S1P(1)	Background Influenza A virus infection and its complications effect a large population worldwide. Endothelial cells are an important component in lung inflammation caused by influenza A virus infection. The roles of endothelial sphingosine 1-phophate receptor 1 (S1PR1) in the regulation of molecules involved in leukocyte recruitment during influenza A virus infection still remain unknown. In this report, we tested our hypothesis that S1PR1 agonist CYM5442 inhibits expression of intracellular adhesion molecules 1 (ICAM1) in endothelial cells infected with influenza A virus. Methods Human pulmonary microvascular endothelial cells (HPMEC) were infected with influenza A virus H1N1. Expression of cytokines, chemokines, interferons, and cellular adhesion molecules was measured by q-PCR. Expression of ICAM1 was further tested by Western Blotting. A S1PR1 agonist CYM5442 was added to the culture media to assess CYM5442's inhibitory effects during virus infection. Results HPMEC could be infected with H1N1 and responded to produce pro-inflammatory cytokines, chemokines, type I interferons, and cellular adhesion molecules. Addition of CYM5442 in culture media reduced the production of ICAM1 via a dosage-and time-dependent manner. CYM5442 inhibited the activation of nuclear factor (NF)-kappa B. The regulatory effects of CYM5442 were beta-arrestin2-dependent. Conclusion Activated S1PR1 signaling regulates the production of cellular adhesion molecules by inhibiting NF-kappa B activation via a beta-arrestin2-dependent manner.	[Jiang, Hao; Shen, Si-mei; Yin, Jie; Zhang, Peng-peng; Shi, Yi] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Jiang, Hao] Southeast Univ, Affiliated Hosp 2, Dept Emergency Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Southeast University - China	Shi, Y (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China.	yishi201607@163.com			National Natural Science Foundation of China [81470206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China (81470206, to Dr. Yi Shi). The funder did not have any role in the experiment design, data collection and analysis, decision to publish, or manuscript preparation.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Gao W., 2012, PLOS ONE, V7; Ishiguro N, 2004, ARCH VIROL, V149, P17, DOI 10.1007/s00705-003-0208-4; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luyt Charles-Edouard, 2011, Presse Med, V40, pe561, DOI 10.1016/j.lpm.2011.05.027; McCaughey Conall, 2010, Ulster Med J, V79, P46; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Obinata H, 2014, J LIPID RES, V55, P2665, DOI 10.1194/jlr.P054163; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ramsey C, 2011, CURR OPIN CRIT CARE, V17, P64, DOI 10.1097/MCC.0b013e3283427259; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175188	10.1371/journal.pone.0175188	http://dx.doi.org/10.1371/journal.pone.0175188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399143	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000022
J	Quesada, A; Segarra, AB; Montoro-Molina, S; de Gracia, MD; Osuna, A; O'Valle, F; Gomez-Guzman, M; Vargas, F; Wangensteen, R				Quesada, Andres; Belen Segarra, Ana; Montoro-Molina, Sebastian; del Carmen de Gracia, Maria; Osuna, Antonio; O'Valle, Francisco; Gomez-Guzman, Manuel; Vargas, Felix; Wangensteen, Rosemary			Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; BIOMARKER DISCOVERY; MEMBRANE; NEPHROTOXICITY; PROTEOMICS; VESICLES; DISEASE; PLASMA	Purpose The aim of this work was to investigate if the content of glutamyl aminopeptidase (GluAp) in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats. Methods Urine samples were collected 24 hours after injection of cisplatin (7 mg/kg, n = 10) or saline serum (n = 10), and they were subjected to differential centrifugation at 1.000, 17.000 and 200.000 g to obtain microvesicular and exosomal fractions. GluAp was measured with a commercial ELISA kit in both fractions. Serum creatinine (SCr) and body weight were measured 15 days after treatment. We analyzed if early excretion of GluAp in microsomal and exosomal fractions was correlated with final SCr and body weight increase. In a second experiment, enzymatic activities of GluAp and alanyl aminopeptidase (AlaAp) in urine, microvesicular and exosomal fractions were measured three days after injection. We analyzed the correlation of both markers with SCr determined at this point. Finally, we studied the expression of GluAp and extracellular vesicles markers Alix and tumor susceptibility gene (TSG101) in both fractions by immunoblotting. Results GluAp excretion was increased in all fractions of urine after cisplatin treatment, even if data were normalized per mg of creatinine, per body weight or per total protein content of each fraction. We found significant predictive correlations with SCr concentration, and inverse correlations with body weight increase determined 15 days later. Three days after injection, amino-peptidasic activities were markedly increased in all fractions of urine in cisplatin-treated rats. The highest correlation coefficient with SCr was found for GluAp in microvesicular fraction.Increase of GluAp in microvesicular and exosomal fractions from cisplatin-treated rats was confirmed by immunoblotting. Alix and TSG101 showed different patterns of expression in each fraction. Conclusions Determination of GluAp content or its enzymatic activity in microvesicular and exosomal fractions of urine is an early and predictive biomarker of renal dysfunction in cisplatin-induced nephrotoxicity. Measurement of GluAp in these fractions can serve to detect proximal tubular damage independently of glomerular filtration status.	[Quesada, Andres; del Carmen de Gracia, Maria; Osuna, Antonio] FIBAO, Hosp Virgen Nieves, Unidad Nefrol, Granada, Spain; [Belen Segarra, Ana; Montoro-Molina, Sebastian; Gomez-Guzman, Manuel; Wangensteen, Rosemary] Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain; [O'Valle, Francisco] Univ Granada, IBIMER, Dept Anat Patol, Granada, Spain; [Vargas, Felix] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain	Hospital Universitario Virgen de las Nieves; Universidad de Jaen; University of Granada; University of Granada	Wangensteen, R (corresponding author), Univ Jaen, Dept Ciencias Salud, Area Fisiol, Jaen, Spain.	rwangens@ujaen.es	Segarra, Ana Belén/C-6219-2017; Belen, Segarra Ana/T-2002-2019; OValle, Francisco/AAA-9151-2019; Gómez-Guzmán, M/E-3341-2012; Wangensteen Fuentes, Rosemary/M-9856-2015	Segarra, Ana Belén/0000-0002-9409-6052; Gómez-Guzmán, M/0000-0003-2452-9286; Wangensteen Fuentes, Rosemary/0000-0001-7161-9925; Quesada, Andres/0000-0002-9584-5756; Montoro-Molina, Sebastian/0000-0003-3683-3357	Carlos III Health Institute of Spain [PI13/02743, PI13/02384]; Red de Investigacion Renal REDinREN [RD16/0009/0033]	Carlos III Health Institute of Spain(Instituto de Salud Carlos III); Red de Investigacion Renal REDinREN	This study was supported by the grants PI13/02743 (AO) and PI13/02384 (RW) from the Carlos III Health Institute of Spain, and the Red de Investigacion Renal REDinREN RD16/0009/0033 (AO). "FEDER una manera de hacer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2013, TRANSPL P, V45, P3719, DOI 10.1016/j.transproceed.2013.08.079; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Gamez-Valero A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00006; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Jayachandran M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0021-2; Kawai Y, 2009, J PHARMACOL SCI, V111, P433, DOI 10.1254/jphs.09185FP; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Lisowska-Myjak B, 2010, BLOOD PURIFICAT, V29, P357, DOI 10.1159/000309421; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Montoro-Molina S, 2015, PROTEOM CLIN APPL, V9, P630, DOI 10.1002/prca.201400096; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Murakami T, 2014, PLOS ONE, V2; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Palmisano G, 2012, MOL CELL PROTEOMICS, V11, P230, DOI 10.1074/mcp.M111.012732; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Quesada A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040402; Salih M, 2014, AM J PHYSIOL-RENAL, V306, pF1251, DOI 10.1152/ajprenal.00128.2014; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vinuela-Berni V, 2015, CLIN EXP IMMUNOL, V180, P442, DOI 10.1111/cei.12598; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175462	10.1371/journal.pone.0175462	http://dx.doi.org/10.1371/journal.pone.0175462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399178	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000040
J	Zhu, KJ; Spaink, HP; Durston, AJ				Zhu, Kongju; Spaink, Herman P.; Durston, Antony J.			Collinear Hox-Hox interactions are involved in patterning the vertebrate anteroposterior (A-P) axis	PLOS ONE			English	Article							GENE-EXPRESSION; SPEMANN ORGANIZER; BITHORAX COMPLEX; HOMEOTIC GENES; DROSOPHILA; SPACE; TIME; MAINTENANCE; MESODERM; SPECIFICATION	Investigating regulation and function of the Hox genes, key regulators of positional identity in the embryo, opened a new vista in developmental biology. One of their most striking features is collinearity: the temporal and spatial orders of expression of these clustered genes each match their 3 ' to 5 ' order on the chromosome. Despite recent progress, the mechanisms underlying collinearity are not understood. Here we show that ectopic expression of 4 different single Hox genes predictably induces and represses expression of others, leading to development of different predictable specific sections of the body axis. We use ectopic expression in wild-type and noggin-dorsalised (Hox-free) Xenopus embryos, to show that two Hox-Hox interactions are important. Posterior induction (induction of posterior Hox genes by anterior ones: PI), drives Hox temporal collinearity (Hox timer), which itself drives anteroposterior (A-P) patterning. Posterior prevalence (repression of anterior Hox genes by posterior ones: PP) is important in translating temporal to spatial collinearity. We thus demonstrate for the first time that two collinear Hox interactions are important for vertebrate axial patterning. These findings considerably extend and clarify earlier work suggesting the existence and importance of PP and PI, and provide a major new insight into genesis of the body axis.	[Zhu, Kongju; Spaink, Herman P.; Durston, Antony J.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Durston, AJ (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	a.j.durston@gmail.com	Spaink, Herman P./S-3586-2017; Zhu, Kongju/GNM-6714-2022	Spaink, Herman P./0000-0003-4128-9501; Zhu, Kongju/0000-0002-9720-8128				Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Almirantis Y, 2013, CURR GENOMICS, V14, P279, DOI 10.2174/13892029113149990003; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Durston AJ, 2015, SEMIN CELL DEV BIOL, V42, P86, DOI 10.1016/j.semcdb.2015.06.001; Durston AJ, 2015, SEMIN CELL DEV BIOL, V42, P66, DOI 10.1016/j.semcdb.2015.05.005; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; FAIELLA A, 1994, P NATL ACAD SCI USA, V91, P5335, DOI 10.1073/pnas.91.12.5335; Gestri G, 2005, DEVELOPMENT, V132, P2401, DOI 10.1242/dev.01814; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; Hashiguchi M, 2013, DEVELOPMENT, V140, P1970, DOI 10.1242/dev.088104; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hooiveld MHW, 1999, INT J DEV BIOL, V43, P665; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; Kikuta H, 2003, DEV DYNAM, V228, P433, DOI 10.1002/dvdy.10409; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Miller DFB, 2001, MECH DEVELOP, V102, P3, DOI 10.1016/S0925-4773(01)00301-X; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; NIEUWKOOP P, 1994, NORMAL TABLE OF XENO; Noordermeer D, 2014, ELIFE, P3; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zaghloul NA, 2007, DEV BIOL, V306, P222, DOI 10.1016/j.ydbio.2007.03.017; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	50	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175287	10.1371/journal.pone.0175287	http://dx.doi.org/10.1371/journal.pone.0175287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399140	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000026
J	Resende, TP; Marthaler, DG; Vannucci, FA				Resende, Talita P.; Marthaler, Douglas G.; Vannucci, Fabio A.			A novel RNA-based in situ hybridization to detect Seneca Valley virus in neonatal piglets and sows affected with vesicular disease	PLOS ONE			English	Article							NUCLEIC-ACID; PIGS; INFECTION; PICORNAVIRUS; PATHOGENESIS; EXPRESSION; BRAZIL	Seneca Valley virus (SVV) is the causative agent of an emerging vesicular disease in swine, which is clinically indistinguishable from other vesicular diseases such as foot- and-mouth disease. In addition, SVV has been associated with neonatal mortality in piglets. While a commercial SVV qRT-PCR is available, commercial antibodies are lacking to diagnose SVV infections by immunohistochemistry (IHC). Thus, a novel in situ hybridization technique-RNAscope (ISH) was developed to detect SVVRNA in infected tissues. From a total of 78 samples evaluated, 30 were positive by qRT-PCR and ISH-RNA, including vesicular lesions of affected sows, ulcerative lesions in the tongue of piglets and various other tissues with no evidence of histological lesions. Nineteen samples were negative for SVV by qRT-PCR and ISH-RNA. The Ct values of the qRT-PCR from ISH-RNA positive tissues varied from 12.0 to 32.6 ( 5.12 x 10(6) to 5.31 RNA copies/g, respectively). The ISH-RNA technique is an important tool in diagnosing and investigating the pathogenesis of SVV and other emerging pathogens.	[Resende, Talita P.] Univ Minnesota, Dept Vet & Biomed Sci, Coll Vet Med, St Paul, MN 55108 USA; [Marthaler, Douglas G.; Vannucci, Fabio A.] Univ Minnesota, Vet Diagnost Lab, Coll Vet Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Resende, TP (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Coll Vet Med, St Paul, MN 55108 USA.	resen023@umm.edu	Resende, Talita Pilar/AGZ-6654-2022	Resende, Talita Pilar/0000-0002-7705-714X; Marthaler, Douglas/0000-0001-8574-2473	CAPES-Brazil	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	TPR was supported by CAPES - Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank all employees at histology and immunohistochemistry laboratories in MNVDL for the help during the ISH activities. TPR was supported by CAPES-Brazil.	Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Canning P, 2016, TRANSBOUND EMERG DIS; Chang SY, 2015, HUM PATHOL, V46, P1592, DOI 10.1016/j.humpath.2015.07.012; Gaynor AM, 2016, VET PATHOL, V53, P567, DOI 10.1177/0300985815594852; Joshi LR, 2016, J GEN VIROL, V97, P3267, DOI 10.1099/jgv.0.000631; Joshi LR, 2016, J CLIN MICROBIOL, V54, P1536, DOI 10.1128/JCM.03390-15; Leme RA, 2016, J COMP PATHOL, V155, P145, DOI 10.1016/j.jcpa.2016.06.011; Leme RA, 2015, TRANSBOUND EMERG DIS, V62, P603, DOI 10.1111/tbed.12430; Leme RA, 2016, EMERG INFECT DIS, V22, P1238, DOI 10.3201/eid2207.151583; Luff J, 2016, VET PATHOL; Maes RK, 2014, VET PATHOL, V51, P238, DOI 10.1177/0300985813505878; Marthaler D, 2012, VIROLOGY, V433, P85, DOI 10.1016/j.virol.2012.07.006; Montiel N, 2016, EMERG INFECT DIS, V22, P1246, DOI 10.3201/eid2207.151863; Palinski RM, 2016, J GEN VIROL, V97, P281, DOI 10.1099/jgv.0.000343; Palmer MV, 2015, J COMP PATHOL, V153, P150, DOI 10.1016/j.jcpa.2015.06.004; POTEL K, 1967, WISS Z KARLMARX U LP, V16, P153; Reddy PS, 2007, J NATL CANCER I, V99, P1623, DOI 10.1093/jnci/djm198; Tubbs RR, 2013, AM J CLIN PATHOL, V140, P736, DOI 10.1309/AJCPJTWK07FSABRJ; Vannucci FA, 2015, TRANSBOUND EMERG DIS, V62, P589, DOI 10.1111/tbed.12410; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wu Q, 2016, GENOME ANNOUNC, P4	21	23	32	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0173190	10.1371/journal.pone.0173190	http://dx.doi.org/10.1371/journal.pone.0173190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394893	gold, Green Published, Green Submitted			2022-12-26	WOS:000399954800002
J	Yuan, CW; Liu, WX; Wang, YB; Hou, JL; Zhang, LG; Wang, GQ				Yuan, Chaowen; Liu, Wenxin; Wang, Yingbo; Hou, Jinlong; Zhang, Liguo; Wang, Guoqing			Homologous recombination is a force in the evolution of canine distemper virus	PLOS ONE			English	Article							HEMAGGLUTININ GENES; MEASLES-VIRUS; PROTEIN GENE; CDV; FUSION; CORONAVIRUS; PROPAGATION; EMERGENCE; SEQUENCES; DISEASE	Canine distemper virus (CDV) is the causative agent of canine distemper (CD) that is a highly contagious, lethal, multisystemic viral disease of receptive carnivores. The prevalence of CDV is a major concern in susceptible animals. Presently, it is unclear whether intragenic recombination can contribute to gene mutations and segment reassortment in the virus. In this study, 25 full-length CDV genome sequences were subjected to phylogenetic and recombinational analyses. The results of phylogenetic analysis, intragenic recombination, and nucleotide selection pressure indicated that mutation and recombination occurred in the six individual genes segment (H, F, P, N, L, M) of the CDV genome. The analysis also revealed pronounced genetic diversity in the CDV genome according to the geographically distinct lineages (genotypes), namely Asia-1, Asia-2, Asia-3, Europe, America-1, and America-2. The six recombination events were detected using SimPlot and RDP programs. The analysis of selection pressure demonstrated that a majority of the nucleotides in the CDV individual gene were under negative selection. Collectively, these data suggested that homologous recombination acts as a key force driving the genetic diversity and evolution of canine distemper virus.	[Yuan, Chaowen; Wang, Yingbo; Hou, Jinlong; Wang, Guoqing] Northeastern Univ, Coll life & Hlth Sci, Shenyang, Liaoning, Peoples R China; [Liu, Wenxin] Affiliated Hosp Guangdong Med Coll, Hematol Lab, Guangzhou, Peoples R China; [Zhang, Liguo] Ctr Anim Dis Emergency Liaoning Prov, Shenyang, Liaoning, Peoples R China	Northeastern University - China; Guangdong Medical University	Wang, GQ (corresponding author), Northeastern Univ, Coll life & Hlth Sci, Shenyang, Liaoning, Peoples R China.	wangguoqing@mail.neu.edu.cn			Natural Science Foundation of China [31272615]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financed by the Natural Science Foundation of China (No.31272615). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aris-Brosou S, 2003, SYST BIOL, V52, P781, DOI 10.1080/10635150390258949; Bolt G, 1997, J GEN VIROL, V78, P367, DOI 10.1099/0022-1317-78-2-367; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Bruen TC, 2007, VIROLOGY, V364, P362, DOI 10.1016/j.virol.2007.03.023; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Cong YY, 2013, VIRUS GENES, V47, P66, DOI 10.1007/s11262-013-0926-y; Demeter Z, 2010, VET MICROBIOL, V142, P420, DOI 10.1016/j.vetmic.2009.10.017; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Han GZ, 2008, VIRUS RES, V136, P198, DOI 10.1016/j.virusres.2008.04.022; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; He HB, 2010, TALANTA, V82, P1562, DOI 10.1016/j.talanta.2010.07.055; Herrewegh AAPM, 1998, J VIROL, V72, P4508, DOI 10.1128/JVI.72.5.4508-4514.1998; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lan NT, 2006, VET MICROBIOL, V118, P177, DOI 10.1016/j.vetmic.2006.07.015; Lan NT, 2009, J VET MED SCI, V71, P155, DOI 10.1292/jvms.71.155; Lan NT, 2005, VET MICROBIOL, V110, P197, DOI 10.1016/j.vetmic.2005.07.016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lednicky JA, 2004, J VIROL METHODS, V118, P147, DOI 10.1016/j.jviromet.2004.02.004; Lednicky JA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-2; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2007, VET MICROBIOL, V122, P32, DOI 10.1016/j.vetmic.2007.01.005; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936, DOI 10.1128/JCM.37.9.2936-2942.1999; Pardo IDR, 2005, J CLIN MICROBIOL, V43, P5009, DOI 10.1128/JCM.43.10.5009-5017.2005; Phillips ML, 1999, PEDIATRICS, V104, P1095, DOI 10.1542/peds.104.5.1095; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaben M, 2010, J VIROL, V84, P7880, DOI 10.1128/JVI.00486-10; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SIDHU MS, 1993, VIROLOGY, V193, P66, DOI 10.1006/viro.1993.1103; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang Fu-Xu, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P862	45	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175416	10.1371/journal.pone.0175416	http://dx.doi.org/10.1371/journal.pone.0175416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394936	Green Submitted, gold, Green Published			2022-12-26	WOS:000399954800033
J	Martinez-Monino, AB; Zapata-Perez, R; Garcia-Saura, AG; Gil-Ortiz, F; Perez-Gilabert, M; Sanchez-Ferrer, A				Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Gil-Ortiz, Fernando; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro			Characterization and mutational analysis of a nicotinamide mononucleotide deamidase from Agrobacterium tumefaciens showing high thermal stability and catalytic efficiency	PLOS ONE			English	Article							PYRIDINE-NUCLEOTIDE CYCLE; SALMONELLA-TYPHIMURIUM; ADENINE-DINUCLEOTIDE; AMIDOHYDROLASE; HOMEOSTASIS; METABOLISM; MECHANISM; SIRTUINS; MUTANTS; REVEALS	NAD(+) has emerged as a crucial element in both bioenergetic and signaling pathways since it acts as a key regulator of cellular and organismal homeostasis. Among the enzymes involved in its recycling, nicotinamide mononucleotide (NMN) deamidase is one of the key players in the bacterial pyridine nucleotide cycle, where it catalyzes the conversion of NMN into nicotinic acid mononucleotide (NaMN), which is later converted to NAD+ in the PreissHandler pathway. The biochemical characteristics of bacterial NMN deamidases have been poorly studied, although they have been investigated in some firmicutes, gamma-proteobacteria and actinobacteria. In this study, we present the first characterization of an NMN deamidase from an alphaproteobacterium, Agrobacterium tumefaciens (AtCinA). The enzyme was active over a broad pH range, with an optimum at pH 7.5. Moreover, the enzyme was quite stable at neutral pH, maintaining 55% of its activity after 14 days. Surprisingly, AtCinA showed the highest optimal (80 degrees C) and melting (85 C) temperatures described for an NMN deamidase. The above described characteristics, together with its high catalytic efficiency, make AtCinA a promising biocatalyst for the production of pure NaMN. In addition, six mutants (C32A, S48A, Y58F, Y58A, T105A and R145A) were designed to study their involvement in substrate binding, and two (S31A and K63A) to determine their contribution to the catalysis. However, only four mutants (C32A, S48A Y58F and T105A) showed activity, although with reduced catalytic efficiency. These results, combined with a thermal and structural analysis, reinforce the Ser/Lys catalytic dyad mechanism as the most plausible among those proposed.	[Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro] Univ Murcia, Fac Biol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain; [Belen Martinez-Monino, Ana; Zapata-Perez, Ruben; Gines Garcia-Saura, Antonio; Perez-Gilabert, Manuela; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Gil-Ortiz, Fernando] CELLS ALBA Synchrotron Light Source, Barcelona, Spain	University of Murcia	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Fac Biol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain.; Sanchez-Ferrer, A (corresponding author), Murcia Biomed Res Inst IMIB, Murcia, Spain.	alvaro@um.es	Pérez-Gilabert, Manuela/E-5676-2016; Zapata-Perez, Ruben/AAA-9782-2020; Sánchez-Ferrer, Alvaro/M-1631-2014	Pérez-Gilabert, Manuela/0000-0002-3706-5786; Zapata-Perez, Ruben/0000-0003-4432-9652; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Gil-Ortiz, Fernando/0000-0001-5897-2724	Spanish grants from MINECO-FEDER [B102013-45336-R]; Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia [19893/GERM/15]	Spanish grants from MINECO-FEDER; Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia	This study was partially supported by Spanish grants from MINECO-FEDER (B102013-45336-R) and from the Ayudas a los Grupos y Unidades de Excelencia Cientffica de la Region de Murcia, Fundacion Seneca-Agenda de Ciencia y Tecnologia de la Region de Murcia(19893/GERM/15, Programa de Apoyo a la Investigacion 2014).	Auerbach G, 1997, STRUCTURE, V5, P1475, DOI 10.1016/S0969-2126(97)00297-9; Butepage M, 2015, CELLS-BASEL, V4, P569, DOI 10.3390/cells4040569; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Covington JD, 2016, MOL NUTR FOOD RES, V60, P79, DOI 10.1002/mnfr.201500340; FOSTER JW, 1980, J BACTERIOL, V142, P1032, DOI 10.1128/JB.142.3.1032-1035.1980; FOSTER JW, 1979, J BACTERIOL, V137, P1165, DOI 10.1128/JB.137.3.1165-1175.1979; FRIEDMANN HC, 1973, BIOCHEM BIOPH RES CO, V50, P54, DOI 10.1016/0006-291X(73)91062-0; FYFE JA, 1969, J BIOL CHEM, V244, P1659; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; Imanaka T, 2011, P JPN ACAD B-PHYS, V87, P587, DOI 10.2183/pjab.87.587; Garcia-Garcia MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096976; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; Karuppiah V, 2014, J BIOL CHEM, V289, P33187, DOI 10.1074/jbc.M114.608448; KINNEY DM, 1979, J BACTERIOL, V140, P607, DOI 10.1128/JB.140.2.607-611.1979; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kupis W, 2016, J PHYSIOL BIOCHEM, V72, P371, DOI 10.1007/s13105-016-0492-6; Lespinet O, 2005, SCIENCE, V307, P42; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROBINSON CR, 1993, PROTEIN SCI, V2, P826, DOI 10.1002/pro.5560020512; Ruggieri S, 2015, BBA-PROTEINS PROTEOM, V1854, P1138, DOI 10.1016/j.bbapap.2015.02.021; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082705; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056727; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sorci L, 2014, DNA REPAIR, V23, P17, DOI 10.1016/j.dnarep.2014.07.014; Sorci L, 2014, FEBS LETT, V588, P1016, DOI 10.1016/j.febslet.2014.01.063; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Verheugd P, 2016, CURR PROTEIN PEPT SC, V17, P654, DOI 10.2174/1389203717666160419144846; Yang Y, 2016, BIOCH BIOPHYS ACTA	40	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174759	10.1371/journal.pone.0174759	http://dx.doi.org/10.1371/journal.pone.0174759			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388636	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800011
J	Berry, RS; Kulmatiski, A				Berry, Ryan S.; Kulmatiski, Andrew			A savanna response to precipitation intensity	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; UNITED-STATES; TERRESTRIAL ECOSYSTEMS; RAINFALL VARIABILITY; SOUTH-AFRICA; GRASSLAND; MODEL; MANIPULATION; VEGETATION; EXTREMES	As the atmosphere warms, precipitation events are becoming less frequent but more intense. A three-year experiment in Kruger National Park, South Africa, found that fewer, more intense precipitation events encouraged woody plant encroachment. To test whether or not these treatment responses persisted over time, here, we report results from all five years of that experiment. Grass growth, woody plant growth, total fine root number and area and hydrologic tracer uptake by grasses and woody plants were measured in six treated plots (8 m by 8 m) and six control plots. Treatment effects on soil moisture were measured continuously in one treated and one control plot. During the fourth year, increased precipitation intensity treatments continued to decrease water flux in surface soils (0-10 cm), increase water flux in deeper soils (20+ cm), decrease grass growth and increase woody plant growth. Greater root numbers at 20-40 cm and greater woody plant uptake of a hydrological tracer from 45-60 cm suggested that woody plants increased growth by increasing root number and activity (but not root area) in deeper soils. During the fifth year, natural precipitation events were large and intense so treatments had little effect on precipitation intensity or plant available water. Consistent with this effective treatment removal, there was no difference in grass or woody growth rates between control and treated plots, although woody plant biomass remained higher in treated than control plots due to treatment effects in the previous four years. Across the five years of this experiment, we found that 1) small increases in precipitation intensity can result in large increases in deep (20-130 cm) soil water availability, 2) plant growth responses to precipitation intensity are rapid and disappear quickly, and 3) because woody plants accumulate biomass, occasional increases in precipitation intensity can result in long-term increases in woody plant biomass (i.e., shrub encroachment). While results are likely to be site-specific, they provide experimental evidence of large ecohydrological responses to small changes in precipitation intensity.	[Kulmatiski, Andrew] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu	kulmatiski, andrew/J-2072-2015	kulmatiski, andrew/0000-0001-9977-5508	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University [8965]	Andrew Mellon Foundation; Utah Agricultural Experiment Station, Utah State University	This research was supported by the Andrew Mellon Foundation and the Utah Agricultural Experiment Station, Utah State University and approved as journal paper #8965. Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This research was supported by the Andrew Mellon Foundation and the Utah Agricultural Experiment Station, Utah State University and approved as journal paper #8965. We thank Kruger National Park and Isaak Smit for access to land and logistic support. Also a special thanks to our field crew: Isaac Lekgotla, Rudolph Sibuyi, Vhelaphi Sibuyi and Wisani Mashele.	Beier C, 2012, ECOL LETT; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; Buitenwerf R, 2014, KOEDOE, V56; Du Toit J, 2004, KRUGER EXPERIENCE EC; EMERMAN SH, 1995, J HYDROL, V171, P23, DOI 10.1016/0022-1694(95)02735-8; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; February EC, 2013, ECOLOGY, V94, P1155, DOI 10.1890/12-0540.1; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hewitson BC, 2006, INT J CLIMATOL, V26, P1315, DOI 10.1002/joc.1314; Higgins RW, 2013, J HYDROMETEOROL, V14, P105, DOI 10.1175/JHM-D-12-062.1; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huang J, 2013, CATENA, V104, P93, DOI 10.1016/j.catena.2012.10.013; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kulmatiski A, 2013, NAT CLIM CHANGE, V3, P833, DOI [10.1038/nclimate1904, 10.1038/NCLIMATE1904]; Kulmatiski A, 2013, OECOLOGIA, V171, P25, DOI 10.1007/s00442-012-2390-0; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Laprise R, 2013, CLIM DYNAM, V41, P3219, DOI 10.1007/s00382-012-1651-2; Lauenroth WK, 2009, ECOHYDROLOGY, V2, P173, DOI 10.1002/eco.53; Lett MS, 2005, AM MIDL NAT, V153, P217, DOI 10.1674/0003-0031(2005)153[0217:WPEARI]2.0.CO;2; Mazzacavallo MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144300; Molnar P, 2015, HYDROL EARTH SYST SC, V19, P1753, DOI 10.5194/hess-19-1753-2015; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Petrie MD, 2015, ECOHYDROLOGY, V8, P1614, DOI 10.1002/eco.1614; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Schenk HJ, 2008, VADOSE ZONE J, V7, P1119, DOI 10.2136/vzj2007.0119; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Smith NG, 2016, J APPL ECOL, V53, P579, DOI 10.1111/1365-2664.12593; Smith NG, 2014, REV GEOPHYS, V52, P412, DOI 10.1002/2014RG000458; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Thomas BF, 2016, WATER-SUI, V8, DOI 10.3390/w8030090; Tietjen B, 2016, ECOL MODEL, V326, P13, DOI 10.1016/j.ecolmodel.2015.06.013; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Tsiko CT, 2012, PHYS CHEM EARTH, V47-48, P122, DOI 10.1016/j.pce.2011.06.009; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; Warren CP, 2015, J ARID ENVIRON, V121, P67, DOI 10.1016/j.jaridenv.2015.06.001; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilcox BP, 2010, ECOHYDROLOGY, V3, P126, DOI 10.1002/eco.104; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Yan H, 2015, PLOS ONE, V10; Zambatis N., 2006, African Journal of Range & Forage Science, V23, P85, DOI 10.2989/10220110609485891; Zeng G, 2008, NEW PHYTOL, V177, P549, DOI 10.1111/j.1469-8137.2007.02271.x; Zhang DH, 2016, J HYDROL, V543, P270, DOI 10.1016/j.jhydrol.2016.10.003	51	28	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175402	10.1371/journal.pone.0175402	http://dx.doi.org/10.1371/journal.pone.0175402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388640	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800050
J	Ajabnoor, GMA; Bahijri, S; Sheik, NA; Borai, A; Alamoudi, AA; Al-Aama, JY; Chrousos, GP				Ajabnoor, Ghada M. A.; Bahijri, Suhad; Sheik, Noor Ahmad; Borai, Anwar; Alamoudi, Aliaa A.; Al-Aama, Jumana Y.; Chrousos, George P.			Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GAMMA-GLUTAMYL-TRANSFERASE; CIRCADIAN CLOCK; CARDIOVASCULAR RISK; ATHEROGENIC INDEX; PLASMA-PROTEIN; SLEEP DEBT; ADIPONECTIN; RESTRICTION; DISEASE	Background During the fasting month of Ramadan, practicing Saudis develop severe disturbances in sleeping and feeding patterns. Concomitantly, cortisol circadian rhythm is abolished, diurnal cortisol levels are elevated and circulating levels of several adipokines are altered favouring insulin resistance. Aim To examine changes in the expression of CLOCK and glucocorticoid-controlled genes, such as DUSP1 and IL-1 alpha in Saudi adults before and during Ramadan, and to investigate possible associations with selected cardiometabolic risk factors. Methods Healthy young volunteers (5 females, 18 males; mean age +SEM = 23.2 + 1.2 years) were evaluated before Ramadan and two weeks into it. Blood samples were collected at 9 am (+/- 1 hour) and twelve hours later for determination of serum lipid profile, high sensitivity CRP (hsCRP), and adiponectin. The expression of CLOCK, DUSP1 and IL-1 alpha was evaluated in circulating leukocytes. Results Mean levels of GGT and morning adiponectin decreased, while those of LDL-c/HDL-c and atherogenic index (AI) increased significantly in Ramadan compared to Shabaan. There was no significant difference between morning and evening adiponectin during Ramadan, while the diurnal rhythm of hsCRP was lost. CLOCK gene expression mean was significantly higher in morning than in evening during Shabaan. Mean morning and evening DUSP1 mRNA levels showed significant increase during Ramadan compared to Shabaan, however, its diurnal rhythm was maintained. Morning IL-1 alpha mRNA expression remained significantly higher than in the evening during Ramadan, but was markedly decreased compared to Shabaan. Discussion Ramadan fasting in Saudi Arabia is associated with improvements in some cardiometabolic risk factors, such as circulating GGT and hsCRP and leukocyte expression of IL-1 alpha mRNA, suggesting that intermittent fasting might have a beneficial component. These benefits may be offset by the previously reported dysregulation in the circadian rhythm, excess glucocorticoid levels and action, and insulin resistance, explaining increased prevalence of cardiometabolic disorders and type 2 diabetes mellitus.	[Ajabnoor, Ghada M. A.; Bahijri, Suhad; Alamoudi, Aliaa A.] King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah, Saudi Arabia; [Ajabnoor, Ghada M. A.; Bahijri, Suhad; Borai, Anwar; Alamoudi, Aliaa A.; Al-Aama, Jumana Y.; Chrousos, George P.] King Abdulaziz Univ, King Fand Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah, Saudi Arabia; [Sheik, Noor Ahmad; Al-Aama, Jumana Y.] King Abdulaziz Univ, Dept Genet Med, Fac Med, Jeddah, Saudi Arabia; [Sheik, Noor Ahmad; Al-Aama, Jumana Y.] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Borai, Anwar] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Coll Med, KAIMRC, Jeddah, Saudi Arabia; [Chrousos, George P.] Univ Athens, Med Sch, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Bahijri, S (corresponding author), King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah, Saudi Arabia.; Bahijri, S (corresponding author), King Abdulaziz Univ, King Fand Med Res Ctr, Saudi Diabet Study Res Grp, Jeddah, Saudi Arabia.	sbahijri@gmail.com	Bahijri, Suhad M/AAF-4141-2020; Al-aama, Jumana/AAA-8653-2021	Bahijri, Suhad M/0000-0001-6674-5409; alamoudi, aliaa/0000-0001-5428-8853	Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia [HiCi/1432-6-2]	Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia	The funding body is Deanship of Scientific Research, (DSR) at King Abdulaziz University - Jeddah - Kingdom of Saudi Arabia under grant number (HiCi/1432-6-2), URL:http:// dsr.kau.edu.sa/Default.aspx?Site_ID=305&Lng= AR. Given that no individuals employed or contracted by the funder, other than the authors, were involved in these tasks and the authors had unrestricted access to the data, we declared that the funders had no role in study design, data collection and analysis, decisiont to publish, or preparation of the manuscript.	Ajabnoor GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096500; Bahijri S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060917, 10.1371/annotation/8d92315c-9944-4470-9bbb-806a26b0809b]; Bahijri SM, 2015, THER ADV ENDOCRINOL, V6, P223, DOI 10.1177/2042018815594527; Balachandran JS, 2012, AM J CARDIOL, V109, P140, DOI 10.1016/j.amjcard.2011.07.071; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kocc M, 2011, TURK KARDIYOL DERN A, V39, P568, DOI 10.5543/tkda.2011.01649; Koc M, 2010, TEX HEART I J, V37, P42; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Liu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048878; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Nematy M, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-69; Nwagha UI, 2010, AFR HEALTH SCI, V10, P248; OIbrahim NK, 2010, INTRNET J CARDIOVASC, V7; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; POCKNEE RC, 1978, J NUTR, V108, P1266, DOI 10.1093/jn/108.8.1266; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shimada K, 2004, CLIN CHIM ACTA, V344, P1, DOI 10.1016/j.cccn.2004.02.020; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2003, REV NEUROL-FRANCE, V159, pS11; Takata M, 2002, JPN J PHARMACOL, V90, P263, DOI 10.1254/jjp.90.263; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Yang MY, 2011, J BIOL RHYTHM, V26, P136, DOI 10.1177/0748730410395527; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007	50	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174342	10.1371/journal.pone.0174342	http://dx.doi.org/10.1371/journal.pone.0174342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384165	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900016
J	Avansini, SH; Lima, BPD; Secolin, R; Santos, ML; Coan, AC; Vieira, AS; Torres, FR; Carvalho, BS; Alvim, MKM; Morita, ME; Yasuda, CL; Pimentel-Silva, LR; Dogini, DB; Rogerio, F; Cendes, F; Lopes-Cendes, I				Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Coan, Ana Carolina; Vieira, Andre S.; Torres, Fabio R.; Carvalho, Benilton S.; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Dogini, Danyella B.; Rogerio, Fabio; Cendes, Fernando; Lopes-Cendes, Iscia			MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy	PLOS ONE			English	Article							HIPPOCAMPAL SCLEROSIS; NONEPILEPTIC SEIZURES; MISDIAGNOSIS; CANCER; CLASSIFICATION; EXPRESSION; DISEASE; PLASMA	Epilepsy is misdiagnosed in up to 25% of patients, leading to serious and long-lasting consequences. Recently, circulating microRNAs have emerged as potential biomarkers in a number of clinical scenarios. The purpose of this study was to identify and to validate circulating microRNAs that could be used as biomarkers in the diagnosis of epilepsy. Quantitative real-time PCR was used to measure plasma levels of three candidate microRNAs in two phases of study: an initial discovery phase with 14 patients with mesial temporal lobe epilepsy (MTLE), 13 with focal cortical dysplasia (FCD) and 16 controls; and a validation cohort constituted of an independent cohort of 65 patients with MTLE and 83 controls. We found hsa-miR-134 downregulated in patients with MTLE (p = 0.018) but not in patients with FCD, when compared to controls. Furthermore, hsa-miR-134 expression could be used to discriminate MTLE patients with an area under the curve (AUC) of 0.75. To further assess the robustness of hsa-miR-134 as a biomarker for MTLE, we studied an independent cohort of 65 patients with MTLE, 27 of whom MTLE patients were responsive to pharmacotherapy, and 38 patients were pharmacoresistant and 83 controls. We confirmed that hsa-miR-134 was significantly downregulated in the plasma of patients with MTLE when compared with controls (p < 0.001). In addition, hsa-miR-134 identified patients with MTLE regardless of their response to pharmacotherapy or the presence of MRI signs of hippocampal sclerosis. We revealed that decreased expression of hsa-miR-134 could be a potential non-invasive biomarker to support the diagnosis of patients with MTLE.	[Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Vieira, Andre S.; Torres, Fabio R.; Dogini, Danyella B.; Lopes-Cendes, Iscia] Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil; [Avansini, Simoni H.; de Sousa Lima, Beatriz Pereira; Secolin, Rodrigo; Santos, Marilza L.; Coan, Ana Carolina; Vieira, Andre S.; Torres, Fabio R.; Carvalho, Benilton S.; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Dogini, Danyella B.; Rogerio, Fabio; Cendes, Fernando; Lopes-Cendes, Iscia] Brazilian Inst Neurosci & Neurotechnol BRAIN, Campinas, SP, Brazil; [Coan, Ana Carolina; Alvim, Marina K. M.; Morita, Marcia E.; Yasuda, Clarissa L.; Pimentel-Silva, Luciana R.; Cendes, Fernando] Univ Estadual Campinas, UNICAMP, Dept Neurol, Campinas, SP, Brazil; [Carvalho, Benilton S.] Univ Estadual Campinas, UNICAMP, Inst Math Stat & Sci Comp, Dept Stat, Campinas, SP, Brazil; [Rogerio, Fabio] Univ Estadual Campinas, UNICAMP, Dept Anat Pathol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Lopes-Cendes, I (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Med Genet, Campinas, SP, Brazil.; Lopes-Cendes, I (corresponding author), Brazilian Inst Neurosci & Neurotechnol BRAIN, Campinas, SP, Brazil.	icendes@unicamp.br	Secolin, Rodrigo/AAG-2115-2019; yasuda, clarissa l/B-7934-2013; Lopes-Cendes, Iscia/B-9416-2013; Secolin, Rodrigo/G-1738-2010; Carvalho, Benilton/L-9329-2019; Torres, Fabio/H-8289-2014; Avansini, Simoni H/J-9269-2017; Dogini, Danyella/AAC-4900-2021; Coan, Ana Carolina/F-4982-2012; Rogerio, Fabio/B-9391-2013; Cendes, Fernando/C-1301-2012; yasuda, clarissa lin/D-4599-2018; Dogini, Danyella B/A-4520-2013; Pimentel-Silva, Luciana Ramalho/AAB-4792-2021; Coan, Ana Carolina/AAA-7887-2020; Schwambach Vieira, Andre/A-3819-2013	Secolin, Rodrigo/0000-0002-2485-9560; yasuda, clarissa l/0000-0001-9084-7173; Lopes-Cendes, Iscia/0000-0002-6221-6822; Secolin, Rodrigo/0000-0002-2485-9560; Carvalho, Benilton/0000-0001-5122-5646; Avansini, Simoni H/0000-0002-2490-7438; Dogini, Danyella/0000-0002-0757-3982; Coan, Ana Carolina/0000-0002-2888-929X; Cendes, Fernando/0000-0001-9336-9568; yasuda, clarissa lin/0000-0001-9084-7173; Dogini, Danyella B/0000-0002-0757-3982; Pimentel-Silva, Luciana Ramalho/0000-0001-5045-9512; Coan, Ana Carolina/0000-0002-2888-929X; Schwambach Vieira, Andre/0000-0001-5318-8957	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil [2013/07559-3, 2013/00099-7]; Conselho Nacional de Pesquisa, CNPq, Brazil; Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Brazil, 2013/07559-3 and 2013/00099-7; Conselho Nacional de Pesquisa, CNPq, Brazil; and Coordenacao de Aperfeicoamento de Pessoalde Nivel Superior, CAPES, Brazil.	[Anonymous], 2014, R LANG ENV STAT COMP; Avansini SH, FOCAL CORTICAL DYSPL; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bodde NMG, 2009, CLIN NEUROL NEUROSUR, V111, P1, DOI 10.1016/j.clineuro.2008.09.028; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Coan AC, 2014, AM J NEURORADIOL, V35, P77, DOI 10.3174/ajnr.A3640; de Boer HC, 2013, EUR HEART J, V34, P3451, DOI 10.1093/eurheartj/eht007; De Timary P, 2002, SEIZURE-EUR J EPILEP, V11, P193, DOI 10.1053/seiz.2001.0617; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Ferrie CD, 2006, ARCH DIS CHILD, V91, P206, DOI 10.1136/adc.2005.088906; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; JACKSON GD, 1994, NEUROLOGY, V44, P42, DOI 10.1212/WNL.44.1.42; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Juarez-Garcia A, 2006, SEIZURE-EUR J EPILEP, V15, P598, DOI 10.1016/j.seizure.2006.08.005; Mathern GW, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2009.02294.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Simon N, 2011, J STAT SOFTW, V39, P1; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Sun JJ, 2016, MOL MED REP, V14, P5318, DOI 10.3892/mmr.2016.5906; Surges R, 2016, BIOCHEM BIOPH RES CO, V481, P13, DOI 10.1016/j.bbrc.2016.11.029; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Uldall P, 2006, ARCH DIS CHILD, V91, P219, DOI 10.1136/adc.2004.064477; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10201; Wang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09522; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808	31	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173060	10.1371/journal.pone.0173060	http://dx.doi.org/10.1371/journal.pone.0173060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384161	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900004
J	Gracia, JCM; Van den Hoecke, S; Saelens, X; Van Reeth, K				Gracia, Jose Carlos Mancera; Van den Hoecke, Silvie; Saelens, Xavier; Van Reeth, Kristien			Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine	PLOS ONE			English	Article							A VIRUSES; RECEPTOR SPECIFICITY; GENETIC-CHARACTERIZATION; INTERNAL GENES; HOST-RANGE; TRANSMISSION; REPLICATION; HEMAGGLUTININ; EVOLUTION; CHINA	H9N2 avian influenza viruses are endemic in poultry in Asia and the Middle East. These viruses sporadically cause dead-end infections in pigs and humans raising concerns about their potential to adapt to mammals or reassort with human or swine influenza viruses. We performed ten serial passages with an avian H9N2 virus (A/quail/Hong Kong/G1/1997) in influenza naive pigs to assess the potential of this virus to adapt to swine. Virus replication in the entire respiratory tract and nasal virus excretion were examined after each passage and we deep sequenced viral genomic RNA of the parental and passage four H9N2 virus isolated from the nasal mucosa and lung. The parental H9N2 virus caused a productive infection in pigs with a predominant tropism for the nasal mucosa, whereas only 50% lung samples were virus-positive. In contrast, inoculation of pigs with passage four virus resulted in viral replication in the entire respiratory tract. Subsequent passages were associated with reduced virus replication in the lungs and infectious virus was no longer detectable in the upper and lower respiratory tract of inoculated pigs at passage ten. The broader tissue tropism after four passages was associated with an amino acid residue substitution at position 225, within the receptor-binding site of the hemagglutinin. We also compared the parental H9N2, passage four H9N2 and the 2009 pandemic H1N1 (pH1N1) virus in a direct contact transmission experiment. Whereas only one out of six contact pigs showed nasal virus excretion of the wild-type H9N2 for more than four days, all six contact animals shed the passage four H9N2 virus. Nevertheless, the amount of excreted virus was significantly lower when compared to that of the pH1N1, which readily transmitted and replicated in all six contact animals. Our data demonstrate that serial passaging of H9N2 virus in pigs enhances its replication and transmissibility. However, full adaptation of an avian H9N2 virus to pigs likely requires an extensive set of mutations.	[Gracia, Jose Carlos Mancera; Van Reeth, Kristien] Univ Ghent, Dept Virol Parasitol & Immunol, Lab Virol, Fac Vet Med, Merelbeke, Belgium; [Van den Hoecke, Silvie; Saelens, Xavier] VIB, Ctr Med Biotechnol, Ghent, Belgium; [Van den Hoecke, Silvie; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Van Reeth, K (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Lab Virol, Fac Vet Med, Merelbeke, Belgium.	kristien.vanreeth@ugent.be	Saelens, Xavier/N-5728-2015	, Xavier/0000-0002-3861-6965	EU FLUPIG project [FP7-GA 258084]; Fonds voor Wetenschappelijk Onderzoek [3G052412]	EU FLUPIG project; Fonds voor Wetenschappelijk Onderzoek(FWO)	JCMG was supported by the EU FLUPIG project (FP7-GA 258084). SVDH was supported by Fonds voor Wetenschappelijk Onderzoek (3G052412).; The authors would like to express their gratitude to Dr. John Nicholls for providing the H9N2 influenza viruses and Lieve Sys, Melanie Bauwens, Nele Dennequin and Laura Van Driessche for excellent technical assistance. This study was supported by the EU FLUPIG project (FP7-GA 258084). Silvie Van den Hoecke is supported by Fonds voor Wetenschappelijk Onderzoek (3G052412).	Baranovich T, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.75; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; De Vleeschauwer A, 2009, J INFECT DIS, V200, P1884, DOI 10.1086/648475; Dlugolenski D, 2011, ARCH VIROL, V156, P565, DOI 10.1007/s00705-010-0891-x; Gu M, 2014, VET MICROBIOL, V174, P309, DOI 10.1016/j.vetmic.2014.09.029; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Kahn RE, 2014, CURR TOP MICROBIOL, V385, P205, DOI 10.1007/82_2014_392; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Lakdawala SS, 2015, NATURE, V526, P122, DOI 10.1038/nature15379; Lewis NS, 2016, ELIFE, V5, DOI 10.7554/eLife.12217; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu QF, 2014, J VIROL, V88, P8153, DOI 10.1128/JVI.00894-14; Matrosovich M, 2015, TOP CURR CHEM, V367, P1, DOI 10.1007/128_2013_466; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Matsuoka Y, 2009, CURR PROTOC MICROBIO; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Qiao CL, 2012, J GEN VIROL, V93, P2337, DOI 10.1099/vir.0.044040-0; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; Romero-Tejeda A, 2013, INFLUENZA OTHER RESP, V7, P4, DOI 10.1111/irv.12075; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shichinohe S, 2013, VIROLOGY, V444, P404, DOI 10.1016/j.virol.2013.07.007; Slomka MJ, 2013, VET MICROBIOL, V162, P530, DOI 10.1016/j.vetmic.2012.11.013; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Sun YP, 2015, PROTEIN CELL, V6, P18, DOI 10.1007/s13238-014-0111-7; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van den Hoecke S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1284-z; Van Poucke S, 2013, INFLUENZA OTHER RESP, V7, P151, DOI 10.1111/j.1750-2659.2012.00376.x; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang J, 2016, J VIROL, V90, P3506, DOI 10.1128/JVI.02605-15; Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; World Health Organization, 2016, ANT GEN CHAR ZOON IN; World Health Organization, INFLUENZA AT THE HUM; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Yu H, 2011, VET MICROBIOL, V149, P254, DOI 10.1016/j.vetmic.2010.11.008; Zaraket H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7553; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhou P, 2014, J MED VIROL, V86, P597, DOI 10.1002/jmv.23869	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175267	10.1371/journal.pone.0175267	http://dx.doi.org/10.1371/journal.pone.0175267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384328	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900143
J	Ye, Q; Yin, WL; Zhang, L; Xiao, HJ; Qi, YM; Liu, SY; Qian, BX; Wang, FM; Han, T				Ye, Qing; Yin, Weili; Zhang, Lei; Xiao, Huijuan; Qi, Yumei; Liu, Shuye; Qian, Baoxin; Wang, Fengmei; Han, Tao			The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; ADVANCED LIVER-DISEASE; BODY-COMPOSITION; MASS-SPECTROMETRY; MALNUTRITION; SARCOPENIA; TRANSPLANTATION; MANAGEMENT; PROGNOSIS; UPLC/MS	The liver is essential for the regulation of energy, protein and amino acids, as well as in other aspects of metabolism. To identify efficient indexes for evaluation of nutritional status and metabolic characteristics during different Child-Pugh stages of hepatitis B cirrhosis, 83 patients and 35 healthy individuals were enrolled in our study. We found that grip strength, triceps skinfold thickness (TSF), body fat and skeletal muscle of the patients were reduced compared to the control group (P< 0.05). Ultra-high-performance liquid chromatography data combined with mass spectrometry (UPLC-MS) showed that levels of a variety of metabolites, including lysophosphatidylcholines (LysoPCs), glycerophosphocholine, ornithine and glucuronic acid were reduced in the serum of patients with hepatitis B cirrhosis (P< 0.001). However, glycerophosphoserine and taurocholic acid levels were higher than in the control group (P< 0.001). Moreover, grip strength was correlated with the Child-Pugh score (P< 0.05). Serum albumin, total cholesterol, LDL, LysoPCs, glycerophosphocholine, ornithine, glucuronic acid, glycerophosphoserine and taurocholic acid were correlated with the Child-Pugh score (P< 0.01). These findings suggested that grip strength and the above small molecular substances might be considered as sensitive and important indexes for evaluating nutritional status and metabolic characteristics of patients with hepatitis B cirrhosis, which may help assess prognosis and adjust nutritional treatment.	[Ye, Qing; Yin, Weili; Xiao, Huijuan; Qian, Baoxin; Wang, Fengmei; Han, Tao] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China; [Ye, Qing; Yin, Weili; Qian, Baoxin; Wang, Fengmei; Han, Tao] Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Dept Gastroenterol & Hepatol, Tianjin Key Lab Artificial Cells, Tianjin, Peoples R China; [Zhang, Lei; Liu, Shuye] Tianjin Third Cent Hosp, Clin Lab, Tianjin, Peoples R China; [Xiao, Huijuan; Qi, Yumei] Tianjin Third Cent Hosp, Dept Nutriol, Tianjin, Peoples R China	Tianjin Medical University	Han, T (corresponding author), Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China.; Han, T (corresponding author), Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Dept Gastroenterol & Hepatol, Tianjin Key Lab Artificial Cells, Tianjin, Peoples R China.	hantaomd@126.com			Tianjin Science and Technology Commission Foundation Project [13RCGFSY19200]	Tianjin Science and Technology Commission Foundation Project	This study was supported by the Tianjin Science and Technology Commission Foundation Project (No.13RCGFSY19200) to TH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; Carretero A, 2014, ANAL BIOANAL CHEM, V406, P5465, DOI 10.1007/s00216-014-7983-5; Carvalho Luciana, 2006, Arq. Gastroenterol., V43, P269, DOI 10.1590/S0004-28032006000400005; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; CSoIDaPaCSoHoCM. A, 2000, CHIN J HEPATOL, P324; Drzazga A, 2014, ACTA POL PHARM, V71, P887; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Fernandes SA, 2016, WORLD J HEPATOL, V8, P1205, DOI 10.4254/wjh.v8.i29.1205; Figueiredo FAF, 2005, J GASTROEN HEPATOL, V20, P209, DOI 10.1111/j.1440-1746.2004.03544.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005; Haverkort EB, 2015, EUR J CLIN NUTR, V69, P3, DOI 10.1038/ejcn.2014.203; Huisman EJ, 2011, EUR J GASTROEN HEPAT, V23, P982, DOI 10.1097/MEG.0b013e32834aa4bb; Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027; Kahraman A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-191; Kalaitzakis E, 2006, SCAND J GASTROENTERO, V41, P1464, DOI 10.1080/00365520600825117; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Matoori S, 2015, ADV DRUG DELIVER REV, V90, P55, DOI 10.1016/j.addr.2015.04.009; Mattar J A, 1996, New Horiz, V4, P493; Memon N, 2016, PEDIATR RES, V79, P378, DOI 10.1038/pr.2015.247; Merli M, 2010, LIVER INT, V30, P208, DOI 10.1111/j.1478-3231.2009.02135.x; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; Nie CY, 2014, J VIRAL HEPATITIS, V21, P53, DOI 10.1111/jvh.12122; Park HW, 2015, YONSEI MED J, V56, P95, DOI 10.3349/ymj.2015.56.1.95; Park JY, 2006, YONSEI MED J, V47, P817, DOI 10.3349/ymj.2006.47.6.817; Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009; Pirlich M, 2000, HEPATOLOGY, V32, P1208, DOI 10.1053/jhep.2000.20524; Putadechakum Supanee, 2012, ISRN Gastroenterol, V2012, P690402, DOI 10.5402/2012/690402; Rachakonda V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159142; Rahimi RS, 2015, CLIN GERIATR MED, V31, P539, DOI 10.1016/j.cld.2015.04.008; Ritter Luciana, 2006, Arq. Gastroenterol., V43, P66, DOI 10.1590/S0004-28032006000100016; Ruiz-Margain A, 2015, DIGEST LIVER DIS, V47, P309, DOI 10.1016/j.dld.2014.12.015; Seijo S, 2016, LIVER INT, V36, P1051, DOI 10.1111/liv.12972; Subbaiah P V, 1986, Methods Enzymol, V129, P790; Tietge UJF, 1998, HEPATO-GASTROENTEROL, V45, P2255; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Tsai YW, 2015, EUR J CLIN NUTR, V69, P34, DOI 10.1038/ejcn.2014.66; Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Xiong J, 2015, CLINICS, V70, P563, DOI 10.6061/clinics/2015(08)06; Yan TM, 2015, PHARM RES-DORDR, V32, P1141, DOI 10.1007/s11095-014-1525-x; Zhao YY, 2014, CHEM-BIOL INTERACT, V220, P181, DOI 10.1016/j.cbi.2014.06.029	43	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175165	10.1371/journal.pone.0175165	http://dx.doi.org/10.1371/journal.pone.0175165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384211	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900106
J	Zhao, J; Chen, WC; Huang, XS; Peng, SM; Zhu, TH; Deng, ZH; Liang, P; Chang, H; Fan, BJ				Zhao, Jun; Chen, Wenchieh; Huang, Xiaosheng; Peng, Shiming; Zhu, Tianhui; Deng, Zhihui; Liang, Ping; Chang, Hui; Fan, Bao Jian			Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; GLUCOSE-6-PHOSPHATE ISOMERASE; AQUEOUS-HUMOR; CELLS; EXPRESSION; AUTOIMMUNITY; DYSFUNCTION; ARTHRITIS; DISEASE; GAMMA	Posner-Schlossman syndrome (PSS) shares some clinical features with uveitis and open angle glaucoma. Cytokines and autoantibodies have been associated with uveitis and open angle glaucoma. However, the role of serum cytokines and autoantibodies in the pathogenesis of PSS remains unknown. This study aimed to evaluate the associations of type 1 T helper (Th1) and Th17 related cytokines and autoantibodies with PSS. Peripheral blood serum samples were collected from 81 patients with PSS and 97 gender-and age-matched healthy blood donors. Th1 and Th17 related cytokines, including interleukin-1 beta (IL-1 beta), IL-12, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma. (IFN-gamma), IL-6 and IL-17, and glucose-6-phosphate isomerase (GPI) were determined by double antibody sandwich ELISA. Antinuclear antibody (ANA), anti-keratin antibody (AKA) and anti-neutrophil cytoplasmic antibody (ANCA) were detected by indirect immunofluorescence assay. Anti-cardiolipin antibody (ACA)-IgG, ACA-IgM, ACA-IgA, anti-double stranded DNA (anti-dsDNA) and anti-cyclic citrullinated peptide antibody (anti-CCP) were detected by indirect ELISA. Serum levels of IL-1 beta, IL-12 and IL-6 in PSS patients were significantly lower than those in controls (P < 0.003), and these associations survived the Bonferroni correction (P-c < 0.018). There was no significant difference in serum levels of TNF-alpha, IFN-gamma and IL-17 between the PSS and control groups (P-c > 0.12). Positive rate of serum anti-dsDNA in PSS patients was significantly higher than that in the control group (P = 0.002, P-c = 0.018), while positive rates of serum ANA, AKA, ANCA, ACA-IgG, ACA-IgM, ACA-IgA, GPI and anti-CCP in the PSS group were not significantly different from those in the control group (P-c > 0.09). These results suggest that anti-dsDNA may contribute to the pathogenesis of PSS, while Th1 and Th17 related cytokines and other autoantibodies may not be major contributors to PSS.	[Zhao, Jun; Chen, Wenchieh; Huang, Xiaosheng; Peng, Shiming; Zhu, Tianhui; Chang, Hui] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Zhao, Jun; Liang, Ping] Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China; [Deng, Zhihui] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen, Guangdong, Peoples R China; [Fan, Bao Jian] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Jinan University; Shenzhen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Zhao, J (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China.; Zhao, J (corresponding author), Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China.; Fan, BJ (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA.	dotorzhaojun@163.com; baojian_fan@meei.harvard.edu		deng, zhihui/0000-0002-2046-1467; Fan, Baojian/0000-0002-6851-2737	Shenzhen Science & Technology Project, China [GJHZ20160229170608241, CXZZ20140418182638764]	Shenzhen Science & Technology Project, China	This work was supported by Shenzhen Science & Technology Project, China (No. GJHZ20160229170608241; No. CXZZ20140418182638764). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Chen W, 2015, CURR MOL MED, V15, P543, DOI 10.2174/1566524015666150731100012; Enriquez-de-Salamanca A, 2010, MOL VIS, V16, P862; Fan LY, 2010, CLIN CHIM ACTA, V411, P2049, DOI 10.1016/j.cca.2010.08.043; Fleisher LN, 2000, EXP EYE RES, V70, P271, DOI 10.1006/exer.1999.0787; Grajewski RS, 2008, J IMMUNOL, V181, P4791, DOI 10.4049/jimmunol.181.7.4791; Huang P, 2010, J GLAUCOMA, V19, P324, DOI 10.1097/IJG.0b013e3181b4cac7; Jap A, 2001, OPHTHALMOLOGY, V108, P913, DOI 10.1016/S0161-6420(01)00551-6; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Li J., 2012, THESCIENTIFICWORLDJO, V2012, P7, DOI [10.1100/2012/154939, DOI 10.1100/2012/154939]; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Megaw R, 2016, SURV OPHTHALMOL; Nikitina EY, 2005, CANCER RES, V65, P4309, DOI 10.1158/0008-5472.CAN-04-3119; Ohira S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147080; POSNER A, 1948, ARCH OPHTHALMOL-CHIC, V39, P517; Rodier-Bonifas C, 2011, J FR OPHTALMOL, V34, P24, DOI 10.1016/j.jfo.2010.10.008; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; Seri Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13041; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Shen SC, 2010, INVEST OPHTH VIS SCI, V51, P272, DOI 10.1167/iovs.09-3849; Shin MS, 2013, J IMMUNOL, V190, P1407, DOI 10.4049/jimmunol.1201195; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; Vasiliauskiene L, 2001, ANN RHEUM DIS, V60, P459, DOI 10.1136/ard.60.5.459; Wang ZG, 2016, J MED VIROL, V88, P852, DOI 10.1002/jmv.24391; Wong MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122184; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu YZ, 2010, MOL VIS, V16, P1689; Yamagami H, 2003, INVEST OPHTH VIS SCI, V44, P514, DOI 10.1167/iovs.02-0498; Yokoi H, 1997, EUR J IMMUNOL, V27, P641, DOI 10.1002/eji.1830270310; Yong PH, 2010, MOL VIS, V16, P2524; Zhang HY, 2016, SOFT ROBOT, V3, P3, DOI 10.1089/soro.2015.0017; Zhang MF, 2000, CURR EYE RES, V21, P913, DOI 10.1076/ceyr.21.6.913.6986; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132179; Zong M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0619-0	37	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175519	10.1371/journal.pone.0175519	http://dx.doi.org/10.1371/journal.pone.0175519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384257	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900174
J	Ye, Y; Wagner, MM; Cooper, GF; Ferraro, JP; Su, H; Gesteland, PH; Haug, PJ; Millett, NE; Aronis, JM; Nowalk, AJ; Ruiz, VM; Pineda, AL; Shi, LY; Van Bree, R; Ginter, T; Tsui, F				Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Ferraro, Jeffrey P.; Su, Howard; Gesteland, Per H.; Haug, Peter J.; Millett, Nicholas E.; Aronis, John M.; Nowalk, Andrew J.; Ruiz, Victor M.; Pineda, Arturo Lopez; Shi, Lingyun; Van Bree, Rudy; Ginter, Thomas; Tsui, Fuchiang			A study of the transferability of influenza case detection systems between two large healthcare systems	PLOS ONE			English	Article							INFECTIOUS-DISEASES; MODELS	Objectives This study evaluates the accuracy and transferability of Bayesian case detection systems (BCD) that use clinical notes from emergency department (ED) to detect influenza cases. Methods A BCD uses natural language processing (NLP) to infer the presence or absence of clinical findings from ED notes, which are fed into a Bayesain network classifier (BN) to infer patients' diagnoses. We developed BCDs at the University of Pittsburgh Medical Center (BCDUPMC) and Intermountain Healthcare in Utah (BCDIH). At each site, we manually built a rule-based NLP and trained a Bayesain network classifier from over 40,000 ED encounters between Jan. 2008 and May. 2010 using feature selection, machine learning, and expert debiasing approach. Transferability of a BCD in this study may be impacted by seven factors: development (source) institution, development parser, application (target) institution, application parser, NLP transfer, BN transfer, and classification task. We employed an ANOVA analysis to study their impacts on BCD performance. Results Both BCDs discriminated well between influenza and non-influenza on local test cases (AUCs > 0.92). When tested for transferability using the other institution's cases, BCDUPMC discriminations declined minimally (AUC decreased from 0.95 to 0.94, p< 0.01), and BCDIH discriminations declined more (from 0.93 to 0.87, p< 0.0001). We attributed the BCDIH decline to the lower recall of the IH parser on UPMC notes. The ANOVA analysis showed five significant factors: development parser, application institution, application parser, BN transfer, and classification task. Conclusion We demonstrated high influenza case detection performance in two large healthcare systems in two geographically separated regions, providing evidentiary support for the use of automated case detection from routinely collected electronic clinical notes in national influenza surveillance. The transferability could be improved by training Bayesian network classifier locally and increasing the accuracy of the NLP parser.	[Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Su, Howard; Millett, Nicholas E.; Aronis, John M.; Ruiz, Victor M.; Shi, Lingyun; Tsui, Fuchiang] Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance Lab, Pittsburgh, PA USA; [Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.; Tsui, Fuchiang] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA; [Ferraro, Jeffrey P.; Gesteland, Per H.; Haug, Peter J.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Ferraro, Jeffrey P.; Gesteland, Per H.; Haug, Peter J.; Van Bree, Rudy] Intermt Healthcare, Salt Lake City, UT USA; [Gesteland, Per H.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Nowalk, Andrew J.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Pineda, Arturo Lopez] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Ginter, Thomas] VA Salt Lake City Healthcare Syst, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; US Department of Veterans Affairs	Tsui, F (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance Lab, Pittsburgh, PA USA.; Tsui, F (corresponding author), Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA.	tsui2@pitt.edu	Ye, Ye/T-2154-2019; Pineda, Arturo Lopez/B-1610-2015	Pineda, Arturo Lopez/0000-0002-3409-1815; Nowalk, Andrew/0000-0002-1374-3167; Ye, Ye/0000-0002-1138-9846	National Library of Medicine [R01LM011370]; NATIONAL LIBRARY OF MEDICINE [R01LM011370, T15LM007059] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Research reported in this publication was supported by grant R01LM011370 from the National Library of Medicine, https.//www.nih.gov/. YY, MMW, GFC, JPF, PHG, PJH, NEM, JMA, RVB, TG, and FT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A., 2007, PROC 7 IEEE INT C DA, P77, DOI DOI 10.1109/ICDMW.2007.109; Aue A., 2005, P RECENT ADV NATURAL, V1, P1; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Chang W, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P1120; Chapman W.W., 2005, ANN EMERG MED, V46, P445; Chute Christopher G, 2011, AMIA Annu Symp Proc, V2011, P248; Ciaramita M, 2010, PROCEEDINGS OF THE 2, P1; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Cooper GF, 2015, J BIOMED INFORM, V53, P15, DOI 10.1016/j.jbi.2014.08.011; Dai Wenyuan, 2007, AAAI, P540; Draper AJ, 2014, P ANN FALL S AM MED; Druzdzel MJ, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P902; DUCZMAL L, 2005, MMWR CDC S, V54, P187; Elkin PL, 2012, ANN INTERN MED, V156, P11, DOI 10.7326/0003-4819-156-1-201201030-00003; Espino JU, 2001, J AM MED INFORM ASSN, P164; Finkel Jenny Rose, 2009, P HUM LANG TECHN 200, P602, DOI DOI 10.3115/1620754.1620842; Gerbier-Colomban S, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-101; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Grant I., 1987, TEACH STAT, V9, P15; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hripcsak G, 1998, METHOD INFORM MED, V37, P1; Hripcsak G, 2015, OBSERVATIONAL HLTH D, P15; Huang J., 2006, ADV NEURAL INFORM PR, P601, DOI DOI 10.7551/MITPRESS/7503.003.0080; Inc SI, 2011, SAS STAT 9 3 US GUID; Ivanov Oleg, 2003, AMIA Annu Symp Proc, P318; Jiang J., 2008, DOMAIN ADAPTATION NA; Jiang Jing, 2007, P 16 ACM C INF KNOWL, P401; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1999, STAT IND TECHNOL, P303; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Lenert Leslie, 2012, Am J Public Health, V102, pe1, DOI 10.2105/AJPH.2011.300542; Lu J, 2015, KNOWL-BASED SYST, V80, P14, DOI 10.1016/j.knosys.2015.01.010; Neubauer AS, 1997, CLIN CHEM, V43, P594; Ni X, 2010, PROC 19 INT C WORLD, P751; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Pan SJ, 2011, IEEE T NEURAL NETWOR, V22, P199, DOI 10.1109/TNN.2010.2091281; Panackal AA, 2002, EMERG INFECT DIS, V8, P685, DOI 10.3201/eid0807.010493; Pineda AL, 2015, J BIOMED INFORM, V58, P60, DOI 10.1016/j.jbi.2015.08.019; Qin GS, 2008, STAT METHODS MED RES, V17, P207, DOI 10.1177/0962280207087173; Rexit R, 2015, INFORM SYST, V48, P151, DOI 10.1016/j.is.2014.05.008; Roy DM, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2599; Ruiz VM, 2014, THESIS; Ruiz VM, 2015, P ANN FALL S AM MED; Satpal S, 2007, LECT NOTES ARTIF INT, V4702, P224; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shapiro DE, 1999, STAT METHODS MED RES, V8, P113, DOI 10.1177/096228029900800203; Skvortsov A, 2010, P 13 INT C INF FUS F, P1; Steininger C, 2009, CLIN MICROBIOL INFEC, V15, P267, DOI 10.1111/j.1469-0691.2008.02674.x; Tan SB, 2009, LECT NOTES COMPUT SC, V5478, P337; Tsui F, 2011, ONLINE J PUBLIC HLTH, V3, P22; Tsui F-C, 2010, AUTOMATED INFLUENZA; Villamarin R., 2011, EMERG HLTH THREATS J, V4, ps57; Wagner M, 2011, ONLINE J PUBLIC HLTH, V3, P22; Wagner Michael M, 2004, MMWR Suppl, V53, P28; Wagner Michael M, 2004, MMWR Suppl, V53, P40; Ye Y, 2014, J AM MED INFORM ASSN, V21, P815, DOI 10.1136/amiajnl-2013-001934; Zeng D, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P106; Zhang JC, 2003, IEEE SENSOR, P748, DOI 10.1109/ICSENS.2003.1279041	68	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174970	10.1371/journal.pone.0174970	http://dx.doi.org/10.1371/journal.pone.0174970			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380048	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500081
J	Jiang, YH; Kuo, HC				Jiang, Yuan-Hong; Kuo, Hann-Chorng			Video-urodynamic characteristics of nonneurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction	PLOS ONE			English	Article							DETRUSOR UNDERACTIVITY; SYMPTOMS; DYSFUNCTION; NECK; AGE	Objective Underactive bladder is frequently encountered in elderly patients. It may result from detrusor underactivity (DU) or low detrusor contractility due to a urethral sphincter inhibitory effect. This study analyzed the video-urodynamic study (VUDS) characteristics of patients with underactive bladder in a large cohort of men with lower urinary tract symptoms (LUTS). Methods Male patients with LUTS who had failed the initial treatment were consecutively enrolled. All patients underwent detailed urological investigations including prostate measurement, free uroflowmetry, post-void residual volume (PVR) measurement, cystoscopy and VUDS. The VUDS characteristics of the men with underactive bladder were analyzed and compared with those of men with bladder outlet obstruction and normal tracing. Results A total of 1329 men who underwent VUDS were included in this retrospective analysis. After VUDS, the final diagnosis was DU in 165 patients, poor relaxation of external sphincter (PRES) in 525, bladder outlet obstruction in 501, and normal tracing in 138. VUDS findings in DU patients showed a slowly increased detrusor pressure, intermittent detrusor contractions, or early decline of detrusor contraction, resulting in a low maximum flow rate (Qmax), and large PVR. In comparison with the PRES groups, DU patients were older, had reduced bladder sensation, lower detrusor pressure (Pdet), lower Qmax, larger PVR volume, and lower voiding efficiency. Patients with urodynamic PRES also had low-pressure-low-flow tracings, but their bladder sensation was similar to that with normal tracing. DU patients with very low Pdet also had low detrusor tonicity, and more medical co-morbidities than the other groups did. Conclusion Idiopathic underactive bladder in elderly men could be attributed to urodynamic DU and PRES. DU is associated with old age, reduced bladder sensation, low voiding efficiency, and medical co-morbidities.	[Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; Tzu Chi Univ, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw; redeemer1019@yahoo.com.tw						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Andersson KE, 2014, CURR OPIN UROL, V24, P363, DOI 10.1097/MOU.0000000000000059; Andersson KE, 2010, J UROLOGY, V184, P1829, DOI 10.1016/j.juro.2010.08.048; Birder LA, 2012, NEUROUROL URODYNAM, V31, P293, DOI 10.1002/nau.22195; Chancellor MB, 1995, PRACTICAL NEUROUROLO, P25; Cucchi A, 2009, J UROLOGY, V181, P225, DOI 10.1016/j.juro.2008.09.018; Jamzadeh AE, 2014, WORLD J UROL, V32, P469, DOI 10.1007/s00345-013-1134-z; Kanai A, 2010, J UROLOGY, V183, P1288, DOI 10.1016/j.juro.2009.12.060; Kaplan SA, 1996, UROLOGY, V47, P836, DOI 10.1016/S0090-4295(96)00038-6; Karami H, 2011, NEUROUROL URODYNAM, V30, P1580, DOI 10.1002/nau.21095; Ke QS, 2015, LUTS, V7, P143, DOI 10.1111/luts.12067; Kuo HC, 2007, UROLOGY, V70, P272, DOI 10.1016/j.urology.2007.03.063; Meng NH, 2010, ARCH PHYS MED REHAB, V91, P1105, DOI 10.1016/j.apmr.2010.03.017; Miyazato Minoru, 2013, Rev Urol, V15, P11; Nitti VW, 1999, J UROLOGY, V161, P1535, DOI 10.1016/S0022-5347(05)68947-1; Osman NI, 2014, NAT REV UROL, V11, P87, DOI 10.1038/nrurol.2013.277; Reitz A, 2003, NEUROUROL URODYNAM, V22, P597, DOI 10.1002/nau.10134; RESNICK NM, 1989, NEW ENGL J MED, V320, P1, DOI 10.1056/NEJM198901053200101; Smith PP, 2010, NEUROUROL URODYNAM, V29, P408, DOI 10.1002/nau.20765; Taylor JA, 2006, J AM GERIATR SOC, V54, P1920, DOI 10.1111/j.1532-5415.2006.00917.x; Thomas AW, 2004, BJU INT, V93, P745, DOI 10.1111/j.1464-410X.2003.04719.x; Ueda T, 1997, J UROLOGY, V157, P590	22	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174593	10.1371/journal.pone.0174593	http://dx.doi.org/10.1371/journal.pone.0174593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376105	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000010
J	Keel, S; Lee, PY; Foreman, J; van Wijngaarden, P; Taylor, HR; Dirani, M				Keel, Stuart; Lee, Pei Ying; Foreman, Joshua; van Wijngaarden, Peter; Taylor, Hugh R.; Dirani, Mohamed			Participant referral rate in the National Eye Health Survey (NEHS)	PLOS ONE			English	Article							VISUAL IMPAIRMENT; DIABETIC-RETINOPATHY; INDIGENOUS AUSTRALIANS; VISION LOSS; PREVALENCE; POPULATION; BLINDNESS; TRACHOMA; PROGRAM; CARE	Purpose To present the rates of referral of participants in the National Eye Health Survey (NEHS) for further eye care. Materials & methods A national sample of 3098 non-Indigenous Australians aged 50-98 and 1738 Indigenous Australians aged 40-92 years living in 30 randomly selected sites was recruited using a door-to-door approach. Participants completed a general questionnaire and a series of eye tests, including vision and anterior segment assessment, intra-ocular pressure measurement, visual field testing and fundus photography. A predefined protocol was used to guide the referral of participants for follow up eye care. An ophthalmologist was on-call to assist with the triaging of participants. Results Of the total sample, 32.1% (994/3098) of non-Indigenous participants and 43.6% (757/1738) of Indigenous participants were referred for further eye care (p<0.001). A significant difference in referral rates for Indigenous Australians was observed between regions of differing geographic remoteness [ range = 32.2% (Inner Regional)-60.4% (Very Remote), p <0.001]. After adjusting for covariates, males (OR = 1.24, 95% CI: 1.06-1.46), older age (OR = 1.02 per year, 95% CI: 1.01, 1.02) and longer time since previous eye examination (OR = 1.15 per year, 95% CI: 1.12, 1.19) were associated with higher rates of eye care referral in the non-Indigenous population. In the Indigenous population, older age (OR = 1.02 per year, 95% CI: 1.01-1.03), self-reported diabetes (OR = 1.70, 95% CI: 1.37-2.12), greater geographical remoteness (OR = 1.19, 95% CI: 1.09-1.29) and longer time since previous eye examination (OR = 1.10 per year, 95% CI: 1.07, 1.13) were associated with a higher rate of referral after multivariate adjustments. A total of 25 participants (1.4%) were referred for urgent follow-up of potentially sight threatening conditions. Conclusions Our data has identified several high risk groups that required ophthalmic referral including older Australians, non-Indigenous men, Indigenous Australians with self-reported diabetes and those residing in very remote populations who may benefit from improvements in the provision and/or uptake of eye health services. Future longitudinal research is warranted to evaluate the feasibility and efficacy of implementing a referral protocol within a populationbased research setting.	[Keel, Stuart; Lee, Pei Ying; Foreman, Joshua; van Wijngaarden, Peter; Dirani, Mohamed] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Foreman, Joshua; van Wijngaarden, Peter] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; [Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Indigenous Eye Hlth Unit, Melbourne, Vic, Australia	Centre for Eye Research Australia; University of Melbourne; University of Melbourne; University of Melbourne	Dirani, M (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mdirani@unimelb.edu.au		Foreman, Joshua/0000-0002-3685-4054; van Wijngaarden, Peter/0000-0002-8800-7834	Department of Health of the Australian Government; NHMRC Career Development Fellowship [1090466]; Novartis Australia; Australian Postgraduate Award scholarship	Department of Health of the Australian Government(Australian GovernmentDepartment of Health & Ageing); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Novartis Australia(Novartis); Australian Postgraduate Award scholarship	The National Eye Health Survey was funded by the Department of Health of the Australian Government, and also received financial contributions from Novartis Australia and in-kind support from our industry and sector partners, OPSM, Carl Zeiss, Designs for Vision, the Royal Flying Doctor Service, Optometry Australia and the Brien Holden Vision Institute. We would like to specifically acknowledge OPSM, who kindly donated sunglasses valued at $130 for each study participant. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. The Principal Investigator, Dr Mohamed Dirani, is supported by a NHMRC Career Development Fellowship (#1090466). The PhD student, Joshua Foreman is supported by an Australian Postgraduate Award scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Dabasia PL, 2013, OPTOM PRACT, V14, P147; Friedman DS, 2013, OPHTHAL EPIDEMIOL, V20, P201, DOI 10.3109/09286586.2013.789533; Gracey M, 2006, ASIA PAC J CLIN NUTR, V15, P178; group Tedpr, 2004, EPIDEMIOLOGY, V122, P477; Gruen RL, 2002, J EPIDEMIOL COMMUN H, V56, P517, DOI 10.1136/jech.56.7.517; Jaross N, 2003, CLIN EXP OPHTHALMOL, V31, P32, DOI 10.1046/j.1442-9071.2003.00596.x; Jung Jenny, 2014, Infectious Disorders - Drug Targets, V14, P219; Keeffe J, 1998, LOW VISION KIT; Kiely PM, 2011, CLIN EXP OPTOM, V94, P468, DOI 10.1111/j.1444-0938.2011.00590.x; Kivela T, 2003, INVEST OPHTH VIS SCI, V44, P3288, DOI 10.1167/iovs.02-1328; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Looker HC, 2014, BRIT J OPHTHALMOL, V98, P790, DOI 10.1136/bjophthalmol-2013-303948; Noel CW, 2015, JAMA OPHTHALMOL, V133, P455, DOI 10.1001/jamaophthalmol.2014.6113; Patel KH, 2013, EYE, V27, P664, DOI 10.1038/eye.2013.31; Pollack AL, 1998, OPHTHALMOLOGY, V105, P382, DOI 10.1016/S0161-6420(98)93718-6; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533; Tapp RJ, 2013, DIABETIC MED, V30, P1145, DOI 10.1111/dme.12215; Taylor H, 2004, IOVS, V45, P25; Taylor HR, 2005, MED J AUSTRALIA, V182, P565, DOI 10.5694/j.1326-5377.2005.tb06815.x; Taylor HR, 1997, AM J OPHTHALMOL, V123, P328, DOI 10.1016/S0002-9394(14)70128-X; Taylor HR, 2015, ROADMAP CLOSE GAP VI; Taylor HR, 2010, MED J AUSTRALIA, V192, P312, DOI 10.5694/j.1326-5377.2010.tb03529.x; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; World Health Organization, 2012, GLOBAL DATA VISUAL I; Xie J, 2011, CLIN EXP OPHTHALMOL, V39, P487, DOI 10.1111/j.1442-9071.2011.02502.x	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174867	10.1371/journal.pone.0174867	http://dx.doi.org/10.1371/journal.pone.0174867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376091	Green Published, gold			2022-12-26	WOS:000399352000022
J	Yang, J; Liu, K; Yang, J; Jin, B; Chen, H; Zhan, X; Li, Z; Wang, L; Shen, X; Li, M; Yu, W; Mao, Z				Yang, J.; Liu, K.; Yang, J.; Jin, B.; Chen, H.; Zhan, X.; Li, Z.; Wang, L.; Shen, X.; Li, M.; Yu, W.; Mao, Z.			PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; HEMI-METHYLATED DNA; HUMAN-DIPLOID FIBROBLASTS; HISTONE H3 TAIL; STRUCTURAL BASIS; SRA DOMAIN; METHYLTRANSFERASE DNMT1; EPIGENETIC INHERITANCE; TRANSGENIC MICE; PROTEIN UHRF1	PIM1 is a proto-oncogene, encoding a serine/threonine protein kinase that regulates cell proliferation, survival, differentiation and apoptosis. Previous reports suggest that overexpression of PIM1 can induce cellular senescence. However, the molecular mechanism underlying this process is not fully understood. Here we report that UHRF1 is a novel substrate of PIM1 kinase, which could be phosphorylated at Ser311 and therefore promoted to degradation. Our data demonstrates that PIM1 destabilizes UHRF1, leading to DNA hypomethylation, which consequently results in genomic instability, increased p16 expression and subsequent induction of cellular senescence. Taken together, our results suggest that down-regulation of UHRF1 is an important mechanism of PIM1-mediated cellular senescence.	[Yang, J.; Liu, K.; Chen, H.; Zhan, X.; Li, Z.; Wang, L.; Shen, X.; Li, M.; Yu, W.; Mao, Z.] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Sch Basic Med Sci, 38 Xueyuan Rd, Beijing 100083, Peoples R China; [Yang, J.] Qingdao Univ, Affiliated Hosp, Dept Cadre Hlth Care, Qingdao, Peoples R China; [Jin, B.] Peking Univ, Dept Clin Lab, Hosp 1, Beijing, Peoples R China	Peking University; Qingdao University; Peking University	Yu, W; Mao, Z (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Sch Basic Med Sci, 38 Xueyuan Rd, Beijing 100083, Peoples R China.	yuwenhua@hsc.pku.edu.cn; zbmao@bjmu.edu.cn		, Jiong/0000-0001-9698-0338	National Basic Research Programs of China [2013CB530801]; Natural Science Foundation of China [81471406, 81541066]; National Natural Science Foundation of China [81471406, 81541066, 81641183]	National Basic Research Programs of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Programs of China (Grant number 2013CB530801) and the Natural Science Foundation of China (Grant number 81471406 and Grant number 81541066). This work was supported by the National Basic Research Programs of China (Grant Number 2013CB530801) and the National Natural Science Foundation of China (Grant Number 81471406, 81641183 and 81541066).	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Acton D, 1992, Curr Top Microbiol Immunol, V182, P293; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; BREUER M, 1991, CANCER RES, V51, P958; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen H, 2013, MOL CELL BIOL, V33, P1139, DOI 10.1128/MCB.01191-12; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Chu J, 2012, MOL BIOL CELL, V23, P59, DOI 10.1091/mbc.E11-06-0487; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; CUYPERS HT, 1984, CELL, V37, P141; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Fang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11197; Fang ZY, 2009, CELL IMMUNOL, V257, P80, DOI 10.1016/j.cellimm.2009.03.001; Feldman BJ, 1997, ONCOGENE, V15, P2735, DOI 10.1038/sj.onc.1201670; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Harrison JS, 2016, ELIFE, V5, DOI 10.7554/eLife.17101; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; HOLLIDAY R, 1986, EXP CELL RES, V166, P543, DOI 10.1016/0014-4827(86)90499-4; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Jin B, 2014, AGING CELL, V13, P879, DOI 10.1111/acel.12249; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Miura M, 2001, EXP CELL RES, V263, P202, DOI 10.1006/excr.2000.5115; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Narlik-Grassow M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060277; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Ramesh V, 2016, GENE DEV, V30, P2199, DOI 10.1101/gad.284992.116; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shay KP, 2005, MOL CANCER RES, V3, P170; TANG ZQ, 1994, MECH AGEING DEV, V73, P57, DOI 10.1016/0047-6374(94)90038-8; Tauber M, 2015, NUCLEUS-PHILA, V6, P123, DOI 10.1080/19491034.2015.1026022; Tittle RK, 2011, DEV BIOL, V350, P50, DOI 10.1016/j.ydbio.2010.11.009; Trotzier MA, 2004, BIOCHEM BIOPH RES CO, V319, P590, DOI 10.1016/j.bbrc.2004.05.028; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Vogt M, 1998, CELL GROWTH DIFFER, V9, P139; von Meyenn F, 2016, MOL CELL, V62, P848, DOI 10.1016/j.molcel.2016.04.025; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Wang Z, 2001, J Vet Sci, V2, P167; Wei S, 1999, CANCER RES, V59, P1539; WELLER EM, 1993, CELL PROLIFERAT, V26, P45, DOI 10.1111/j.1365-2184.1993.tb00005.x; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zhao JL, 2016, J SENSORS, V2016, DOI 10.1155/2016/3270916; Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387	98	26	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 24	2017	36	34					4828	4842		10.1038/onc.2017.96	http://dx.doi.org/10.1038/onc.2017.96			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FE5EI	28394343				2022-12-26	WOS:000408234400002
J	Giess, RM; Pfuhl, C; Behrens, JR; Rasche, L; Freitag, E; Khalighy, N; Otto, C; Wuerfel, J; Brandt, AU; Hofmann, J; Eberspacher, B; Bellmann-Strobl, J; Paul, F; Ruprecht, K				Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Khalighy, Nima; Otto, Carolin; Wuerfel, Jens; Brandt, Alexander U.; Hofmann, Joerg; Eberspaecher, Bettina; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens			Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis	PLOS ONE			English	Article							IMMUNE-RESPONSE; EBV; INFECTION; RISK; MS; MRI; REACTIVATION; ATROPHY; ANTIGEN; TITERS	Objective To investigate the association of Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) and viral capsid antigen (VCA) immunoglobulin (Ig) G antibodies in serum as well as EBV DNA load in saliva with radiological and clinical disease activity in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS). Methods EBNA-1 and VCA immunoglobulin (Ig) G antibodies were determined in serum of 100 patients with CIS/early RRMS and 60 healthy controls. EBV DNA load was measured in saliva of 48 patients and 50 controls. Patients underwent clinical assessment with the Expanded Disability Status Scale (EDSS) and 3 Tesla magnetic resonance imaging at baseline and after a median of 20 months of follow-up (n = 63 for MRI, n = 71 for EDSS). The association of EBV parameters with occurrence of a second relapse, indicating conversion to clinically definite MS (CDMS), was evaluated over a median of 35 months of follow-up after the first clinical event (n = 89). Results EBNA-1 IgG antibody frequency (p = 0.00005) and EBNA-1 and VCA IgG antibody levels (p<0.0001 for both) were higher in patients than in controls. EBV DNA load in saliva did not differ between groups. Neither EBV antibody levels nor DNA load in saliva were associated with baseline or follow-up number or volume of T2-weighted (T2w) or contrast enhancing lesions, number of Barkhof criteria or the EDSS, or with the number of new T2w lesions, T2w lesion volume change or EDSS change on follow-up. Likewise, levels of EBV IgG antibodies in serum and DNA load in saliva were not associated with conversion to CDMS. Conclusions While these findings confirm the association of EBV infection with early MS, neither EBNA-1 nor VCA IgG antibodies in serum nor EBV DNA load in saliva were associated with radiological or clinical disease activity in patients with CIS/early RRMS. These data are compatible with the concept that EBV may be a trigger for MS acting very early during the development of the disease.	[Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Khalighy, Nima; Paul, Friedemann; Ruprecht, Klemens] Charite, Dept Neurol, Berlin, Germany; [Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Wuerfel, Jens; Brandt, Alexander U.; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Giess, Rene M.; Pfuhl, Catherina; Behrens, Janina R.; Rasche, Ludwig; Freitag, Erik; Brandt, Alexander U.; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens] Charite, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Otto, Carolin] St Josefs Hosp, Potsdam, Germany; [Wuerfel, Jens] Univ Basel, MIAC AG, Basel, Switzerland; [Wuerfel, Jens] Univ Basel, Dept Biomed Engn, Basel, Switzerland; [Hofmann, Joerg; Eberspaecher, Bettina] Lab Berlin Charite Vivantes GmbH, Berlin, Germany; [Hofmann, Joerg] Charite, Inst Med Virol, Berlin, Germany; [Eberspaecher, Bettina] Vivantes Klinikum Neukolln, Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Basel; Labor Berlin - Charite Vivantes GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; VIivantes Klinikum Neukolln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ruprecht, K (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Ruprecht, K (corresponding author), Charite, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany.	klemens.ruprecht@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Hofmann, Joerg/0000-0003-3966-515X; Wuerfel, Jens/0000-0002-0034-8053; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Ministry of Education and Research [01G11312]; Charite Research Fund	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Charite Research Fund	Support was provided by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis, grant number 01G11312) and the Charite Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JH and BE are affiliated to Labor Berlin Charite-Vivantes GmbH but do not receive salaries from Labor Berlin Charite-Vivantes GmbH. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section."	Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; Cocuzza CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094497; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Deuschle K, 2013, MULT SCLER J, V19, P1242, DOI 10.1177/1352458512472751; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Franciotta D, 2009, ACTA NEUROL BELG, V109, P277; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Hollsberg P, 2005, ACTA NEUROL SCAND, V112, P395, DOI 10.1111/j.1600-0404.2005.00516.x; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Ingram G, 2010, EUR J NEUROL, V17, P1386, DOI 10.1111/j.1468-1331.2010.03083.x; Kuhle J., 2015, MULT SCLER; Kvistad S., 2014, MULT SCLER; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Latham LB, 2016, ACTA NEUROL SCAND, V133, P17, DOI 10.1111/ane.12417; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lindsey JW, 2010, EUR J NEUROL, V17, P1263, DOI 10.1111/j.1468-1331.2010.03005.x; Lucas RM, 2011, NEUROLOGY, V77, P371, DOI 10.1212/WNL.0b013e318227062a; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Montalban X., 2014, MULT SCLER RELAT DIS, V3, P764; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Munger KL, 2015, NEUROLOGY, V85, P1694, DOI 10.1212/WNL.0000000000002099; Niesters HGM, 2000, J CLIN MICROBIOL, V38, P712, DOI 10.1128/JCM.38.2.712-715.2000; Otto C, 2016, MED HYPOTHESES, V91, P109, DOI 10.1016/j.mehy.2016.04.025; Pakpoor J, 2013, MULT SCLER J, V19, P162, DOI 10.1177/1352458512449682; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ruprecht K, 2008, NERVENARZT, V79, P399, DOI 10.1007/s00115-007-2335-8; Ruprecht K, 2014, J NEUROIMMUNOL, V272, P56, DOI 10.1016/j.jneuroim.2014.04.005; Schlemm L, 2016, J NEUROIMMUNOL, V297, P56, DOI 10.1016/j.jneuroim.2016.05.012; Simpson S, 2014, ACTA NEUROL SCAND, V130, P328, DOI 10.1111/ane.12268; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thorley-Lawson DA, 2005, EPSTEIN-BARR VIRUS, P309; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Yea C, 2013, NEUROLOGY, V81, P1392, DOI 10.1212/WNL.0b013e3182a841e4; Zivadinov R, 2009, J NEUROL NEUROSUR PS, V80, P620, DOI 10.1136/jnnp.2008.154906; Zivadinov R, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000190; Zivadinov R, 2014, J NEUROIMMUNOL, V273, P58, DOI 10.1016/j.jneuroim.2014.04.012; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	44	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175279	10.1371/journal.pone.0175279	http://dx.doi.org/10.1371/journal.pone.0175279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388676	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000399375800034
J	Mazuel, L; Blanc, J; Repond, C; Bouchaud, V; Raffard, G; Deglon, N; Bonvento, G; Pellerin, L; Bouzier-Sore, AK				Mazuel, Leslie; Blanc, Jordy; Repond, Cendrine; Bouchaud, Veronique; Raffard, Gerard; Deglon, Nicole; Bonvento, Gilles; Pellerin, Luc; Bouzier-Sore, Anne-Karine			A neuronal MCT2 knockdown in the rat somatosensory cortex reduces both the NMR lactate signal and the BOLD response during whisker stimulation	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; MONOCARBOXYLATE TRANSPORTER MCT2; INSULIN-RECEPTOR EXPRESSION; ADULT-MOUSE BRAIN; IN-VIVO; PYRUVATE-CARBOXYLASE; CONFOCAL MICROSCOPY; MAGNETIC-RESONANCE; AEROBIC GLYCOLYSIS; DOWN-REGULATION	Although several in vitro and ex vivo evidence support the existence of lactate exchange between astrocytes and neurons, a direct demonstration in vivo is still lacking. In the present study, a lentiviral vector carrying a short hairpin RNA (shRNA) was used to downregulate the expression of the monocarboxylate transporter type 2 (MCT2) in neurons of the rat somatosensory cortex (called Si BF) by -25%. After one hour of whisker stimulation, HRMAS 1H-NMR spectroscopy analysis of S-IBF perchloric acid extracts showed that while an increase in lactate content is observed in both uninjected and shRNA-control injected extracts, such an effect was abrogated in shMCT2 injected rats. A 13C -incorporation analysis following [1-13C]glucose infusion during the stimulation confirmed that the elevated lactate observed during activation originates from newly synthesized [3-13C]lactate, with blood derived [1-13C]glucose being the precursor. Moreover, the analysis of the 13C -labeling of glutamate in position C3 and C4 indicates that upon activation, there is an increase in TCA cycle velocity for control rats while a decrease is observed for MCT2 knockdown animals. Using in vivo localized 1H-NMR spectroscopy, an increase in lactate levels is observed in the S-IBF area upon whisker stimulation for shRNA-control injected rats but not for MCT2 knockdown animals. Finally, while a robust BOLD fMRI response was evidenced in control rats, it was absent in MCT2 knockdown rats. These data not only demonstrate that glucose derived lactate is locally produced following neuronal activation but also suggest that its use by neurons via MCT2 is probably essential to maintain synaptic activity within the barrel cortex.	[Mazuel, Leslie; Blanc, Jordy; Pellerin, Luc; Bouzier-Sore, Anne-Karine] Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, 146 Rue Leo Saignat, Bordeaux, France; [Pellerin, Luc] Dept Physiol, 7 Rue Bugnon, Lausanne, Switzerland; [Deglon, Nicole] Univ Lausanne Hosp, Dept Clin Neurosci, Lab Cellular & Mol Neurotherapies LCMN, Lausanne, Switzerland; [Deglon, Nicole] Univ Lausanne Hosp, Neurosci Res Ctr CRN, LCMN, Lausanne, Switzerland; [Deglon, Nicole; Bouzier-Sore, Anne-Karine] Univ Paris Saclay, CNRS UMR 9199, Univ Paris Sud, Mol Imaging Ctr MIRCen, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Bouzier-Sore, AK (corresponding author), Univ Bordeaux, CNRS, UMR 5536, Ctr Resonance Magnet Syst Biol, 146 Rue Leo Saignat, Bordeaux, France.	akb@rmsb.u-bordeaux2.fr	Bonvento, Gilles/F-6023-2013; Deglon, Nicole/A-2265-2012; Pellerin, Luc/A-8912-2017	Bonvento, Gilles/0000-0002-2886-4228; Deglon, Nicole/0000-0003-4475-9476; Pellerin, Luc/0000-0002-1016-1970; Bouzier-Sore, Anne-Karine/0000-0002-3470-0940; Mazuel, Leslie/0000-0002-0180-871X	French State in the context of the "Investments for the future" Programme IdEx; LabEx TRAIL [ANR-10-IDEX, ANR-10-LABX-57]; international French (ANR)/Swiss (FNS) grant [ANR-15-CE37-0012]; FNS [310030E-16427]	French State in the context of the "Investments for the future" Programme IdEx; LabEx TRAIL; international French (ANR)/Swiss (FNS) grant(French National Research Agency (ANR)); FNS(Swiss National Science Foundation (SNSF))	Anne-Karine Bouzier-Sore has received financial support from the French State in the context of the "Investments for the future" Programme IdEx and the LabEx TRAIL, reference ANR-10-IDEX and ANR-10-LABX-57. Anne-Karine Bouzier-Sore and Luc Pellerin have received financial support from an international French (ANR)/Swiss (FNS) grant, references ANR-15-CE37-0012 and FNS no 310030E-16427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; BRAND A, 1992, BIOCHIMIE, V74, P941, DOI 10.1016/0300-9084(92)90078-S; Brix B, 2012, J NEUROSCI, V32, P9727, DOI 10.1523/JNEUROSCI.0879-12.2012; Chiry O, 2008, BRAIN RES, V1226, P61, DOI 10.1016/j.brainres.2008.06.025; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Dobbins RL, 2003, CURR OPIN CLIN NUTR, V6, P501, DOI 10.1097/00075197-200309000-00003; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FREEMAN R, 1981, J MAGN RESON, V42, P341, DOI 10.1016/0022-2364(81)90227-4; Grillo CA, 2007, PHYSIOL BEHAV, V92, P691, DOI 10.1016/j.physbeh.2007.05.043; Grillo CA, 2011, BEHAV BRAIN RES, V222, P230, DOI 10.1016/j.bbr.2011.03.052; Hassel B, 2000, J CEREBR BLOOD F MET, V20, P327, DOI 10.1097/00004647-200002000-00014; Kacem K, 1998, GLIA, V23, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mangia S, 2007, J NEUROSCI RES, V85, P3340, DOI 10.1002/jnr.21371; Marcillac F, 2011, GLIA, V59, P1987, DOI 10.1002/glia.21240; Merienne N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00106; Merle M, 2002, J NEUROCHEM, V82, P47, DOI 10.1046/j.1471-4159.2002.00924.x; Mosso A, 1884, ATTI REALE ACAD SFMN, VXIX, P531; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Robinet C, 2011, NEUROSCIENCE, V192, P155, DOI 10.1016/j.neuroscience.2011.06.059; Robinet C, 2010, J CEREBR BLOOD F MET, V30, P286, DOI 10.1038/jcbfm.2009.208; Rodrigues Tiago B, 2013, Front Neuroenergetics, V5, P9, DOI 10.3389/fnene.2013.00009; ROTHMAN DL, 1985, P NATL ACAD SCI USA, V82, P1633, DOI 10.1073/pnas.82.6.1633; Roy C S, 1890, J Physiol, V11, P85; Samoylova TI, 2002, J NEUROIMMUNOL, V127, P13, DOI 10.1016/S0165-5728(02)00071-1; Sampol Denys, 2013, Front Neuroenergetics, V5, P5, DOI 10.3389/fnene.2013.00005; Sandrone S, 2014, BRAIN, V137, P621, DOI 10.1093/brain/awt091; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Serres S, 2005, J NEUROSCI RES, V79, P19, DOI 10.1002/jnr.20277; Serres S, 2003, NMR BIOMED, V16, P430, DOI 10.1002/nbm.838; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Zimmer ER, 2017, NATURE NEUROSCIENCE	56	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174990	10.1371/journal.pone.0174990	http://dx.doi.org/10.1371/journal.pone.0174990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388627	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800016
J	Nauffal, V; Zhang, YY; Tanawuttiwat, T; Blasco-Colmenares, E; Rickard, J; Marine, JE; Butcher, B; Norgard, S; Dickfeld, TM; Ellenbogen, KA; Guallar, E; Tomaselli, GF; Cheng, AA				Nauffal, Victor; Zhang, Yiyi; Tanawuttiwat, Tanyanan; Blasco-Colmenares, Elena; Rickard, John; Marine, Joseph E.; Butcher, Barbara; Norgard, Sanaz; Dickfeld, Timm-Michael; Ellenbogen, Kenneth A.; Guallar, Eliseo; Tomaselli, Gordon F.; Cheng, Alan			Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD	PLOS ONE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVERTER-DEFIBRILLATOR; BROAD-SPECTRUM; PACEMAKER; ANEMIA; DYSFUNCTION; PREDICTOR; MORBIDITY	Background Cardiac resynchronization therapy (CRT) devices reduce mortality through pacing-induced cardiac resynchronization and implantable cardioverter defibrillator (ICD) therapy for ventricular arrhythmias (VAs). Whether certain factors can predict if patients will benefit more from implantation of CRT pacemakers (CRT-P) or CRT defibrillators (CRT-D) remains unclear. Methods and results We followed 305 primary prevention CRT-D recipients for the two primary outcomes of HF hospitalization and ICD therapy for VAs. Serum biomarkers, electrocardiographic and clinical variables were collected prior to implant. Multivariable analysis using Cox-proportional hazards model was used to fit the final models. Among 282 patients with follow-up outcome data, 75 (26.6%) were hospitalized for HF and 31 (11%) received appropriate ICD therapy. Independent predictors of HF hospitalization were atrial fibrillation (HR = 1.8 (1.1,2.9)), NYHA class III/IV (HR = 2.2 (1.3,3.6)), ejection fraction < 20% (HR = 1.7 (1.1,2.7)), HS-IL6 > 4.03pg/ml (HR = 1.7 (1.1,2.9)) and hemoglobin (< 12g/dl) (HR = 2.2 (1.3,3.6)). Independent predictors of appropriate therapy included BUN > 20mg/dL (HR = 3.0 (1.3,7.1)), HS-CRP > 9.42mg/L (HR = 2.3 (1.1,4.7)), no beta blocker therapy (HR = 3.2 (1.4,7.1)) and hematocrit >= 38% (HR = 2.7 (1.03,7.0)). Patients with 0-1 risk factors for appropriate therapy (IR 1 per 100 person-years) and >= 3 risk factors for HF hospitalization (IR 23 per 100-person-years) were more likely to die prior to receiving an appropriate ICD therapy. Conclusions Clinical and biomarker data can risk stratify CRT patients for HF progression and VAs. These findings may help characterize subgroups of patients that may benefit more from the use of CRT-P vs. CRT-D systems.	[Nauffal, Victor; Tanawuttiwat, Tanyanan; Rickard, John; Marine, Joseph E.; Butcher, Barbara; Norgard, Sanaz; Tomaselli, Gordon F.; Cheng, Alan] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Zhang, Yiyi; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Dickfeld, Timm-Michael] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Ellenbogen, Kenneth A.] Virginia Commonwealth Univ, Dept Med, Med Coll Virginia Campus, Richmond, VA 23298 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Virginia Commonwealth University	Cheng, AA (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	alcheng@jhmi.edu	Ellenbogen, Kenneth/AAJ-3992-2021; Tanawuttiwat, Tanyanan/AAA-5694-2020		National Institutes of Health [R01 HL091062, R01 HL103946]; Johns Hopkins Murex Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Murex Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health R01 HL091062 to GT and National Institutes of Health R01 HL103946 to AC. VN was supported by the Johns Hopkins Murex Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Bogale N, 2012, EUR J HEART FAIL, V14, P61, DOI 10.1093/eurjhf/hfr158; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cheng A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000083; Choi EY, 2012, AM HEART J, V164, P251, DOI 10.1016/j.ahj.2012.05.010; Ellenbogen KA, 2010, CIRCULATION, V122, P2660, DOI 10.1161/CIRCULATIONAHA.110.992552; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Hjalmarson A, 1999, LANCET, V353, P2001; Kleijn L, 2012, HEART, V98, P1237, DOI 10.1136/heartjnl-2012-301954; Looi KL, 2014, HEART, V100, P794, DOI 10.1136/heartjnl-2014-305537; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Michelucci A, 2007, J CARD FAIL, V13, P207, DOI 10.1016/j.cardfail.2006.11.013; Morani G, 2013, EUROPACE, V15, P1273, DOI 10.1093/europace/eut032; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nauffal V, 2015, J AM COLL CARDIOL, V66, P2911, DOI 10.1016/j.jacc.2015.10.048; O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Rao RK, 2007, CIRCULATION, V115, P2136, DOI 10.1161/CIRCULATIONAHA.106.634444; Santini M, 2011, J AM COLL CARDIOL, V57, P167, DOI 10.1016/j.jacc.2010.08.624; Saxon LA, 2006, CIRCULATION, V114, P2766, DOI 10.1161/CIRCULATIONAHA.106.642892; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Singh JP, 2011, CIRCULATION, V123, P1159, DOI 10.1161/CIRCULATIONAHA.110.000646; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Theuns DAMJ, 2012, PACE, V35, P275, DOI 10.1111/j.1540-8159.2011.03289.x; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; van Bommel RJ, 2010, EUR HEART J, V31, P2783, DOI 10.1093/eurheartj/ehq252; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wu KC, 2012, CIRC-CARDIOVASC IMAG, V5, P178, DOI 10.1161/CIRCIMAGING.111.968024	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							0175205	10.1371/journal.pone.0175205	http://dx.doi.org/10.1371/journal.pone.0175205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388657	Green Submitted, gold, Green Published			2022-12-26	WOS:000399375800028
J	Chen, L; Yang, J; Xing, ZH; Yuan, F; Shu, Y; Zhang, YH; Kong, XY; Huang, T; Li, HP; Cai, YD				Chen, Lei; Yang, Jing; Xing, Zhihao; Yuan, Fei; Shu, Yang; Zhang, YunHua; Kong, XiangYin; Huang, Tao; Li, HaiPeng; Cai, Yu-Dong			An integrated method for the identification of novel genes related to oral cancer	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; GROWTH-FACTOR; SHORTEST-PATH; C-MYC; PROTEIN-INTERACTION; GASTRIC-CANCER; CLINICOPATHOLOGICAL FEATURES	Cancer is a significant public health problem worldwide. Complete identification of genes related to one type of cancer facilitates earlier diagnosis and effective treatments. In this study, two widely used algorithms, the random walk with restart algorithm and the shortest path algorithm, were adopted to construct two parameterized computational methods, namely, an RWR-based method and an SP-based method; based on these methods, an integrated method was constructed for identifying novel disease genes. To validate the utility of the integrated method, data for oral cancer were used, on which the RWR-based and SP-based methods were trained, thereby building two optimal methods. The integrated method combining these optimal methods was further adopted to identify the novel genes of oral cancer. As a result, 85 novel genes were inferred, among which eleven genes (e.g., MYD88, FGFR2, NF-kappa BIA) were identified by both the RWR-based and SP-based methods, 70 genes (e.g., BMP4, IFNG, KITLG) were discovered only by the RWR-based method and four genes (L1R1, MCM6, NOG and CXCR3) were predicted only by the SP-based method. Extensive analyses indicate that several novel genes have strong associations with cancers, indicating the effectiveness of the integrated method for identifying disease genes.	[Chen, Lei; Yang, Jing; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Xing, Zhihao; Shu, Yang; Kong, XiangYin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Yuan, Fei] Binzhou Med Univ Hosp, Dept Sci & Technol, Binzhou, Shandong, Peoples R China; [Zhang, YunHua] Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China; [Li, HaiPeng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Binzhou Medical University; Anhui Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.; Li, HP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai, Peoples R China.	tohuangtao@126.com; lihaipeng@picb.ac.cn; cai_yud@126.com	Chen, Lei/A-2275-2011; Zhang, Yu-Hang/AAQ-9012-2021; Xing, Zhihao/AAH-6061-2020	Chen, Lei/0000-0003-3068-1583; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335]; Natural Science Foundation of Shanghai [17ZR1412500]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (31371335), Natural Science Foundation of Shanghai (17ZR1412500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2008, IARC PUBL, VIX, P1; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BLANKENSTEIN T, 1991, J EXP MED, V173, P1047, DOI 10.1084/jem.173.5.1047; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Cai YD, 2017, J PROTEOME RES, V16, P1027, DOI 10.1021/acs.jproteome.6b00950; Cambien B, 2009, BRIT J CANCER, V100, P1755, DOI 10.1038/sj.bjc.6605078; Care MA, 2009, HUM MUTAT, V30, P485, DOI 10.1002/humu.20917; Chang BL, 2004, CANCER RES, V64, P1997, DOI 10.1158/0008-5472.CAN-03-2340; Chang PY, 2013, CLIN CHEM LAB MED, V51, P1291, DOI 10.1515/cclm-2012-0504; Chen L, 2016, PROTEIN PEPTIDE LETT, V23, P1081, DOI 10.2174/0929866523666161021165506; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29849; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen LJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0521-1; Chen X, 2016, THEOR COMPUT SCI, V623, P146, DOI 10.1016/j.tcs.2015.12.006; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elcin AE, 2017, EXP CELL RES; Elgizouli M, 2016, CLIN EXP IMMUNOL, V183, P221, DOI 10.1111/cei.12706; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao YF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/891945; Gormen T. H., 1990, INTRO ALGORITHMS; Gozgit JM, 2013, CANCER CHEMOTH PHARM, V71, P1315, DOI 10.1007/s00280-013-2131-z; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Groeger S, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0185-5; Gu B, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P3532; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haroun F, 2015, CANCER CHEMOTH PHARM, V75, P207, DOI 10.1007/s00280-014-2632-4; Haudenschild DR, 2004, CANCER RES, V64, P8276, DOI 10.1158/0008-5472.CAN-04-2251; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MF, 1999, ORAL ONCOL, V35, P296, DOI 10.1016/S1368-8375(98)00119-5; ISHITOYA J, 1989, BRIT J CANCER, V59, P559, DOI 10.1038/bjc.1989.113; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Karamouzis MV, 2012, CRIT REV ONCOL HEMAT, V84, P8, DOI 10.1016/j.critrevonc.2012.02.010; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohavi R., 1995, INT JOINT C ART INT, V14; Koontongkaew S, 2000, ORAL ONCOL, V36, P334, DOI 10.1016/S1368-8375(99)00093-7; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LAHAV J, 1993, BIOCHIM BIOPHYS ACTA, V1182, P1, DOI 10.1016/0925-4439(93)90146-R; Laimer K, 2007, CANCER, V110, P326, DOI 10.1002/cncr.22813; Lang T, 2016, BIOMED PHARMACOTHER, V84, P1967, DOI 10.1016/j.biopha.2016.11.002; LARGEY JS, 1993, CANCER, V71, P1933, DOI 10.1002/1097-0142(19930315)71:6<1933::AID-CNCR2820710602>3.0.CO;2-D; LAURI D, 1991, JNCI-J NATL CANCER I, V83, P1321, DOI 10.1093/jnci/83.18.1321; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li YN, 2015, LUNG CANCER, V89, P232, DOI 10.1016/j.lungcan.2015.06.009; Liao RG, 2013, CANCER RES, V73, P5195, DOI 10.1158/0008-5472.CAN-12-3950; Lin C.-B., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/967182; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Lucenteforte E, 2009, ORAL ONCOL, V45, P461, DOI 10.1016/j.oraloncology.2008.09.002; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Mitchell KO, 2000, CANCER RES, V60, P6318; Miyamoto R, 2003, ORAL ONCOL, V39, P610, DOI 10.1016/S1368-8375(03)00048-4; Muller M, 2015, CLIN EXP IMMUNOL, V182, P90, DOI 10.1111/cei.12668; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagatsuka H, 2001, ORAL ONCOL, V37, P599, DOI 10.1016/S1368-8375(01)00051-3; Nanda MS, 2011, ASIAN PAC J CANCER P, V12, P67; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nishiyama H, 2008, INT J CLIN ONCOL, V13, P282, DOI 10.1007/s10147-008-0815-x; Noda M, 1999, Jpn J Clin Oncol, V29, P592; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pal SK, 2016, J ORAL PATHOL MED, V1, P1; Patel BP, 2005, J SURG ONCOL, V90, P81, DOI 10.1002/jso.20240; Pavia M, 2006, AM J CLIN NUTR, V83, P1126, DOI 10.1093/ajcn/83.5.1126; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Pradelli E, 2009, INT J CANCER, V125, P2586, DOI 10.1002/ijc.24665; Pranzatelli MR, 2013, CLIN EXP IMMUNOL, V172, P427, DOI 10.1111/cei.12065; QIN ZH, 1993, J EXP MED, V178, P355, DOI 10.1084/jem.178.1.355; Sakata K, 1996, J ORAL PATHOL MED, V25, P302, DOI 10.1111/j.1600-0714.1996.tb00266.x; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Shang ZJ, 2006, INT J ORAL MAX SURG, V35, P533, DOI 10.1016/j.ijom.2005.09.006; Shiraki M, 2005, MODERN PATHOL, V18, P1482, DOI 10.1038/modpathol.3800455; Shridhar K, 2016, ORAL ONCOL, V53, P1, DOI 10.1016/j.oraloncology.2015.11.012; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Su R, 2016, J MICROSC-OXFORD, V264, P127, DOI 10.1111/jmi.12421; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Tang W, 2016, ONCOTARGET, V7, P85613, DOI 10.18632/oncotarget.12828; Traer E, 2012, LEUKEMIA, V26, P1140, DOI 10.1038/leu.2011.325; Tsantoulis PK, 2007, ORAL ONCOL, V43, P523, DOI 10.1016/j.oraloncology.2006.11.010; Tucci M, 2014, EXPERT REV CLIN IMMU, V10, P1395, DOI 10.1586/1744666X.2014.955851; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; Walser TC, 2007, J IMMUNOTHER, V30, P490, DOI 10.1097/CJI.0b013e318031b551; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Wang GH, 2016, TUMOR BIOL, V37, P12597, DOI 10.1007/s13277-016-5126-7; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Warnakulasuriya S, 2005, ORAL ONCOL, V41, P244, DOI 10.1016/j.oraloncology.2004.08.010; Wei LY, 2017, IEEE T NANOBIOSCI, V16, P240, DOI 10.1109/TNB.2017.2661756; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Wei LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122118; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; WENZEL CT, 1995, ARCH OTOLARYNGOL, V121, P1279; Werkmeister R, 2000, ORAL ONCOL, V36, P100, DOI 10.1016/S1368-8375(99)00069-X; Wu YW, 2015, ACTA PHARMACOL SIN, V36, P1395, DOI 10.1038/aps.2015.91; Xi SC, 2006, JNCI-J NATL CANCER I, V98, P181, DOI 10.1093/jnci/djj020; Xia WY, 1997, CLIN CANCER RES, V3, P3; Xiang W, 2015, REV NEUROSCIENCE, V26, P407, DOI 10.1515/revneuro-2014-0067; Yao L, 2000, ORAL ONCOL, V36, P539, DOI 10.1016/S1368-8375(00)00048-8; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481; Zeigler-Johnson C, 2004, CANCER RES, V64, P8461, DOI 10.1158/0008-5472.CAN-04-1651; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zhang JR, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/7604641; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhao XQ, 2007, CANCER RES, V67, P4443, DOI 10.1158/0008-5472.CAN-07-0185; Zhou HF, 2016, BIOMED PHARMACOTHER, V82, P479, DOI 10.1016/j.biopha.2016.04.069; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5	142	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175185	10.1371/journal.pone.0175185	http://dx.doi.org/10.1371/journal.pone.0175185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384236	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900113
J	Hernandes, FR; Canziani, MEF; Barreto, FC; Santos, RO; Moreira, VD; Rochitte, CE; Carvalho, AB				Hernandes, Fabiana Rodrigues; Fernandes Canziani, Maria Eugenia; Barreto, Fellype Carvalho; Santos, Rodrigo Oliveira; Moreira, Valeria de Melo; Rochitte, Carlos Eduardo; Carvalho, Aluizio Barbosa			The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CORONARY CALCIFICATION; ARTERIAL CALCIFICATIONS; ALL-CAUSE; MORTALITY; IMPACT; RISK	Parathyroidectomy (PTX) may cause low levels of PTH, leading to an excessive reduction of bone turnover, which is associated with poor outcomes in dialysis patients, including vascular calcification (VC). We aimed to prospectively investigate the impact of PTX on bone remodeling and its potential consequence on the progression of VC in hemodialysis patients. In this prospective study, 19 hemodialysis patients with severe secondary hyperparathyroidism (sHPT) were evaluated. All patients underwent laboratorial tests and coronary tomography at baseline and, 6 and 12 months after PTX; bone biopsy was performed at baseline and 12-month. At baseline, all patients had increased PTH levels up to 2500 pg/mL and high turnover bone disease in their bone biopsies. Fourteen (74%) patients had VC. During the follow-up, there was a significant decrease of PTH at 6 and 12-month. At 12-month, 90% of the patients evolved to low turnover bone disease. During the period of the hungry bone syndrome (first 6 months), no change of coronary calcium score was observed. However, calcium score increased significantly thereafter (12(th) month). There was an association between VC progression and the severity of low turnover bone disease. In conclusion, the shift from high to low turnover bone disease after PTX occurs in parallel to VC progression, contributing to the understanding of the complex pathophysiology involving mineral metabolism and cardiovascular disease in hemodialysis patients.	[Hernandes, Fabiana Rodrigues; Fernandes Canziani, Maria Eugenia; Carvalho, Aluizio Barbosa] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil; [Barreto, Fellype Carvalho] Univ Fed Parana, Nephrol Div, Curitiba, Parana, Brazil; [Santos, Rodrigo Oliveira] Univ Fed Sao Paulo, Head & Neck Surg Div, Sao Paulo, Brazil; [Moreira, Valeria de Melo; Rochitte, Carlos Eduardo] Univ Sao Paulo, Cardiol Div, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Carvalho, AB (corresponding author), Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil.	aluizio@uol.com.br	Barreto, Fellype C/C-6517-2012; Canziani, Maria E F/AGI-3240-2022	Barreto, Fellype C/0000-0002-6394-9227; Santos, Rodrigo/0000-0003-1172-4621	National Counsel of Technological and Scientific Development (CNPq)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author (FRH) received financial support National Counsel of Technological and Scientific Development (CNPq).; Financial support: National Counsel of Technological and Scientific Development (CNPq).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ammirati AL, 2007, PERITON DIALYSIS INT, V27, P340; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Custódio Melani Ribeiro, 2013, Braz. J. Nephrol., V35, P308, DOI 10.5935/0101-2800.20130050; Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fotheringham J, 2011, NEPHRON CLIN PRACT, V119, pC113, DOI 10.1159/000326683; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Histomorphometry Nomenclature Committee, 2013, J BONE MINER RES, V28, P1; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, KIDNEY INT S, pS70; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Malluche HH, 1986, METHODOLOGY MINERALI, P17; McCullagh P, 2019, GEN LINEAR MODELS, DOI [10.1201/9780203753736, DOI 10.1007/978-1-4899-3242-6, DOI 10.1201/9780203753736]; MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS125; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Santos RO, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/631243; Savazzi G M, 1993, Eur J Med, V2, P363; Spiegel DM, 2007, NEPHROL DIAL TRANSPL, V22, P3568, DOI 10.1093/ndt/gfm424; Tomiyama C, 2010, J BONE MINER RES, V25, P499, DOI 10.1359/jbmr.090735; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126	30	21	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174811	10.1371/journal.pone.0174811	http://dx.doi.org/10.1371/journal.pone.0174811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384171	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900040
J	Ribeiro, MM; Piotti, A; Ricardo, A; Gaspar, D; Costa, R; Parducci, L; Vendramin, GG				Ribeiro, Maria Margarida; Piotti, Andrea; Ricardo, Alexandra; Gaspar, Daniel; Costa, Rita; Parducci, Laura; Vendramin, Giovanni Giuseppe			Genetic diversity and divergence at the Arbutus unedo L. (Ericaceae) westernmost distribution limit	PLOS ONE			English	Article							PINE PINUS-PINASTER; STRAWBERRY TREE; POPULATION-GENETICS; MARKERS; FIRE; CONSERVATION; CHLOROPLAST; HISTORY; VARIABILITY; ECOSYSTEMS	Mediterranean forests are fragile ecosystems vulnerable to recent global warming and reduction of precipitation, and a long-term negative effect is expected on vegetation with increasing drought and in areas burnt by fires. We investigated the spatial distribution of genetic variation of Arbutus unedo in the western Iberia Peninsula, using plastid markers with conservation and provenance regions design purposes. This species is currently undergoing an intense domestication process in the region, and, like other species, is increasingly under the threat from climate change, habitat fragmentation and wildfires. We sampled 451 trees from 15 natural populations from different ecological conditions spanning the whole species' distribution range in the region. We applied Bayesian analysis and identified four clusters ( north, centre, south, and a single-population cluster). Hierarchical AMOVA showed higher differentiation among clusters than among populations within clusters. The relatively low within-clusters differentiation can be explained by a common postglacial history of nearby populations. The genetic structure found, supported by the few available palaeobotanical records, cannot exclude the hypothesis of two independent A. unedo refugia in western Iberia Peninsula during the Last Glacial Maximum. Based on the results we recommend a conservation strategy by selecting populations for conservation based on their allelic richness and diversity and careful seed transfer consistent with current species' genetic structure.	[Ribeiro, Maria Margarida; Ricardo, Alexandra] Inst Politecn Castelo Branco, Escola Super Agr, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal; [Ribeiro, Maria Margarida; Parducci, Laura] Uppsala Univ, Plant Ecol Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden; [Ribeiro, Maria Margarida; Costa, Rita] Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal; [Piotti, Andrea; Vendramin, Giovanni Giuseppe] CNR, Inst Biosci & BioResources, Via Madonna del Piano 10, Florence, Italy; [Gaspar, Daniel; Costa, Rita] Inst Nacl Invest Agr Vet IP, INIAV, Av Republ, Quinta Do Marques Oeiras, Portugal	Polytechnic Institute of Castelo Branco; Uppsala University; Universidade de Lisboa; Forest Research Centre; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV)	Ribeiro, MM (corresponding author), Inst Politecn Castelo Branco, Escola Super Agr, Dept Recursos Nat & Desenvolvimento Sustentavel, Castelo Branco, Portugal.; Ribeiro, MM (corresponding author), Uppsala Univ, Plant Ecol Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden.; Ribeiro, MM (corresponding author), Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal.	mataide@ipcb.pt	Parducci, Laura/B-8918-2012; Ribeiro, Maria Margarida/O-7373-2019; Costa, Rita L/B-5190-2016; Costa, Rita Lourenco/Q-4564-2019; Ribeiro, Maria Margarida/M-4235-2013; Piotti, Andrea/C-1304-2009; Parducci, Laura/H-9355-2019	Parducci, Laura/0000-0003-1956-4757; Ribeiro, Maria Margarida/0000-0003-4684-1262; Costa, Rita L/0000-0001-9503-6126; Costa, Rita Lourenco/0000-0001-9503-6126; Ribeiro, Maria Margarida/0000-0003-4684-1262; Piotti, Andrea/0000-0002-3324-5325; Parducci, Laura/0000-0003-1956-4757	Fundacao para a Ciencia e a Tecnologia [PTDC/AGR-FOR/3746/2012, UID/AGR/00239/2013, SFRH/BSAB/113895/2015]; Fundação para a Ciência e a Tecnologia [UID/AGR/00239/2013, PTDC/AGR-FOR/3746/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Fundacao para a Ciencia e a Tecnologia grant PTDC/AGR-FOR/3746/2012 funded MMR, RC, AR and DG. Grants UID/AGR/00239/2013 and SFRH/BSAB/113895/2015 additionally funded MMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Celikel G, 2008, SCI HORTIC-AMSTERDAM, V118, P115, DOI 10.1016/j.scienta.2008.05.028; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dury M, 2011, IFOREST, V4, P82, DOI 10.3832/ifor0572-004; ELKASSABY YA, 1995, TREE PHYSIOL, V15, P545, DOI 10.1093/treephys/15.7-8.545; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fady B, 2012, ANN FOREST SCI, V69, P421, DOI 10.1007/s13595-012-0219-y; FAO, 2010, 2 FAO; Figueiral I, 2002, QUATERNARY SCI REV, V21, P549, DOI 10.1016/S0277-3791(01)00022-1; Fletcher WJ, 2007, HOLOCENE, V17, P481, DOI 10.1177/0959683607077027; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Garcia Couto MA, 2011, IBERIAN CLIMATE ATLA; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gomes F, 2016, MYCORRHIZA, V26, P177, DOI 10.1007/s00572-015-0656-1; Gomes F, 2013, J FORESTRY RES, V24, P227, DOI 10.1007/s11676-012-0302-0; Gomes F, 2010, NEW BIOTECHNOL, V27, P882, DOI 10.1016/j.nbt.2010.02.009; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Heuertz M, 2010, J BIOGEOGR, V37, P541, DOI 10.1111/j.1365-2699.2009.02223.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Lefevre F, 2004, FOREST ECOL MANAG, V197, P257, DOI 10.1016/j.foreco.2004.05.017; Lefevre F, 2014, ANN FOREST SCI, V71, P723, DOI 10.1007/s13595-013-0272-1; Lopes L, 2012, SCI HORTIC-AMSTERDAM, V142, P57, DOI 10.1016/j.scienta.2012.04.031; Lopez GA, 2001, SILVAE GENET, V50, P244; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Mateus J, 1992, THESIS; MESLEARD F, 1989, OECOLOGIA, V80, P127, DOI 10.1007/BF00789941; Miguel MG, 2014, MOLECULES, V19, P15799, DOI 10.3390/molecules191015799; Nei M., 1987, MOL EVOLUTIONARY GEN; Feliner GN, 2014, PERSPECT PLANT ECOL, V16, P265, DOI 10.1016/j.ppees.2014.07.002; Oliveira SLJ, 2012, INT J WILDLAND FIRE, V21, P48, DOI 10.1071/WF10131; Ouborg NJ, 2006, J ECOL, V94, P1233, DOI 10.1111/j.1365-2745.2006.01167.x; Panagos P, 2012, LAND USE POLICY, V29, P329, DOI 10.1016/j.landusepol.2011.07.003; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pausas JG, 2014, NEW PHYTOL, V204, P55, DOI 10.1111/nph.12921; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedro J.G., 1994, PORTUGAL ATLAS AMBIE; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Queiroz PF, 2011, PTDCCTEGEX712982006; R Core Team, 2013, R LANG ENV STAT COMP; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Ribeiro MM, 2001, THEOR APPL GENET, V102, P97, DOI 10.1007/s001220051623; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Santiso X, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw003; Santiso X, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01264; Santos L, 2003, HOLOCENE, V13, P459, DOI 10.1191/0959683603hl638rp; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SEALY JR, 1949, J ECOL, V37, P365, DOI 10.2307/2256613; Takrouni MM, 2012, SCI HORTIC-AMSTERDAM, V146, P92, DOI 10.1016/j.scienta.2012.08.005; Takrouni MM, 2010, SCI HORTIC-AMSTERDAM, V126, P330, DOI 10.1016/j.scienta.2010.07.031; Torres JA, 2002, PLANT ECOL, V160, P207, DOI 10.1023/A:1015864821706; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vendramin GG, 1998, THEOR APPL GENET, V97, P456, DOI 10.1007/s001220050917; Vincenzi S, 2014, PLANT ECOL, V215, P689, DOI 10.1007/s11258-014-0342-y; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; White T. L., 2007, FOREST GENETICS	60	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175239	10.1371/journal.pone.0175239	http://dx.doi.org/10.1371/journal.pone.0175239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384294	Green Published, gold			2022-12-26	WOS:000399371900132
J	Galizia, G; Lieto, E; Auricchio, A; Cardella, F; Mabilia, A; Diana, A; Castellano, P; De Vita, F; Orditura, M				Galizia, Gennaro; Lieto, Eva; Auricchio, Annamaria; Cardella, Francesca; Mabilia, Andrea; Diana, Anna; Castellano, Paolo; De Vita, Ferdinando; Orditura, Michele			Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; 7TH EDITION; TOTAL GASTRECTOMY; D2 GASTRECTOMY; END-POINTS; SURVIVAL; CLASSIFICATION; LYMPHADENECTOMY; UNION; SPLENECTOMY	Background In gastric cancer, the current AJCC numeric-based lymph node staging does not provide information on the anatomical extent of the disease and lymphadenectomy. A new anatomical location-based node staging, proposed by Choi, has shown better prognostic performance, thus soliciting Western world validation. Study design Data from 284 gastric cancers undergoing radical surgery at the Second University of Naples from 2000 to 2014 were reviewed. The lymph nodes were reclassified into three groups (lesser and greater curvature, and extraperigastric nodes); presence of any metastatic lymph node in a given group was considered positive, prompting a new N and TNM stage classification. Receiver-operating-characteristic (ROC) curves for censored survival data and bootstrap methods were used to compare the capability of the two models to predict tumor recurrence. Results More than one third of node positive patients were reclassified into different N and TNM stages by the new system. Compared to the current staging system, the new classification significantly correlated with tumor recurrence rates and displayed improved indices of prognostic performance, such as the Bayesian information criterion and the Harrell C-index. Higher values at survival ROC analysis demonstrated a significantly better stratification of patients by the new system, mostly in the early phase of the follow-up, with a worse prognosis in more advanced new N stages, despite the same current N stage. Conclusions This study suggests that the anatomical location-based classification of lymph node metastasis may be an important tool for gastric cancer prognosis and should be considered for future revision of the TNM staging system.	[Galizia, Gennaro; Lieto, Eva; Auricchio, Annamaria; Cardella, Francesca; Mabilia, Andrea; Castellano, Paolo] Univ Campania Luigi Vanvitelli, Sch Med, Dept Surg Sci, Div Surg Oncol, Naples, Italy; [Diana, Anna; De Vita, Ferdinando; Orditura, Michele] Univ Campania Luigi Vanvitelli, Sch Med, F Magrassi Dept Clin & Expt Med & Surg, Div Med Oncol, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Galizia, G (corresponding author), Univ Campania Luigi Vanvitelli, Sch Med, Dept Surg Sci, Div Surg Oncol, Naples, Italy.	gennaro.galizia@unina2.it	Diana, Anna/AAJ-3588-2021; Galizia, Gennaro/A-3924-2010	GALIZIA, Gennaro/0000-0002-6897-0391; diana, anna/0000-0003-1131-8690				Ajani JA., 2017, AJCC CANC STAGING MA, P203, DOI [10.1007/978-3-319-40618-3_17, DOI 10.1007/978-3-319-40618-3_17]; [Anonymous], 1997, P AM STAT ASS BIOM S; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Birgisson H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-438; Chae S, 2011, GASTRIC CANCER, V14, P166, DOI 10.1007/s10120-011-0024-6; Choi YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149555; Choi YY, 2016, GASTRIC CANCER, V19, P206, DOI 10.1007/s10120-015-0472-5; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Fang WL, 2011, WORLD J SURG, V35, P2723, DOI 10.1007/s00268-011-1275-4; Galizia G, 2015, SURGERY, V157, P285, DOI 10.1016/j.surg.2014.09.012; Gertler R, 2011, ANN SURG, V253, P689, DOI 10.1097/SLA.0b013e31821111b5; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hayashi H, 2000, SURGERY, V127, P129, DOI 10.1067/msy.2000.102171; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hermanek P, 1987, UICC TNM CLASSIFICAT; Ichikura T, 1999, CANCER-AM CANCER SOC, V86, P553, DOI 10.1002/(SICI)1097-0142(19990815)86:4<553::AID-CNCR2>3.0.CO;2-D; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jiang L, 2013, J SURG ONCOL, V107, P807, DOI 10.1002/jso.23325; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Kim DH, 2012, J SURG ONCOL, V105, P26, DOI 10.1002/jso.22026; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Koziol JA, 2009, BIOMETRICAL J, V51, P467, DOI 10.1002/bimj.200800228; Lee KG, 2016, ANN SURG ONCOL, V23, P1234, DOI 10.1245/s10434-015-4980-7; Lonjon G, 2014, ANN SURG, V259, P18, DOI 10.1097/SLA.0000000000000256; Lowenfeld L, 2015, ANN SURG ONCOL, V22, pS863, DOI 10.1245/s10434-015-4677-y; Marrelli D, 2015, WORLD J GASTROENTERO, V21, P7954, DOI 10.3748/wjg.v21.i26.7954; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; Oba K, 2013, JNCI-J NATL CANCER I, V105, P1600, DOI 10.1093/jnci/djt270; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reim D, 2013, J CLIN ONCOL, V31, P263, DOI 10.1200/JCO.2012.44.4315; Sano T, 2017, ANN SURG, V265, P277, DOI 10.1097/SLA.0000000000001814; Sano T, 2017, GASTRIC CANCER, V20, P217, DOI 10.1007/s10120-016-0601-9; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Sobin LH., 2010, TNM CLASSIFICATION M; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; UICC, 2017, TNM CLASSIFICATION M; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Watanabe M, 2016, WORLD J SURG, V40, P1165, DOI 10.1007/s00268-015-3362-4; Wood M., 2004, SIGNIFICANCE, V1, P180, DOI DOI 10.1111/J.1740-9713.2004.00067.X; Xiao LB, 2011, WORLD J GASTROENTERO, V17, P5123, DOI 10.3748/wjg.v17.i46.5123; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018; Zhao FM, 2016, J CLIN ONCOL, V34, P1436, DOI 10.1200/JCO.2016.66.4581	48	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173619	10.1371/journal.pone.0173619	http://dx.doi.org/10.1371/journal.pone.0173619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380037	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500020
J	Sasai, K; Takao-Rikitsu, E; Sukezane, T; Yanagita, E; Nakagawa, H; Itoh-Yagi, M; Izumi, Y; Itoh, T; Akagi, T				Sasai, Ken; Takao-Rikitsu, Etsuko; Sukezane, Taiko; Yanagita, Emmy; Nakagawa, Harumi; Itoh-Yagi, Machiko; Izumi, Yukina; Itoh, Tomoo; Akagi, Tsuyoshi			Engineering cancer stem-like cells from normal human lung epithelial cells	PLOS ONE			English	Article							ORIGIN; ADENOCARCINOMA; SUBPOPULATIONS; IDENTIFICATION; REGENERATION; EXPRESSION; VITRO	It has been proposed that a subpopulation of tumour cells with stem cell-like characteristics, known as cancer stem cells (CSCs), drives tumour initiation and generates tumour heterogeneity, thus leading to cancer metastasis, recurrence, and drug resistance. Although there has been substantial progress in CSC research into many solid tumour types, an understanding of the biology of CSCs in lung cancer remains elusive, mainly because of their heterogeneous origins and high plasticity. Here, we demonstrate that engineered lung cancer cells derived from normal human airway basal epithelial cells possessed CSC-like characteristics in terms of multilineage differentiation potential and strong tumour-initiating ability. Moreover, we established an in vitro 3D culture system that allowed the in vivo differentiation process of the CSC-like cells to be recapitulated. This engineered CSC model provides valuable opportunities for studying the biology of CSCs and for exploring and evaluating novel therapeutic approaches and targets in lung CSCs.	[Sasai, Ken; Takao-Rikitsu, Etsuko; Sukezane, Taiko; Nakagawa, Harumi; Itoh-Yagi, Machiko; Izumi, Yukina; Akagi, Tsuyoshi] KAN Res Inst Inc, Kobe, Hyogo, Japan; [Yanagita, Emmy; Itoh, Tomoo] Kobe Univ, Div Diagnost Pathol, Grad Sch Med, Kobe, Hyogo, Japan	KAN Research Institute; Kobe University	Akagi, T (corresponding author), KAN Res Inst Inc, Kobe, Hyogo, Japan.	t-akagi@kan.eisai.co.jp		Yagi, Machiko/0000-0001-5880-5766	Eisai Inc.	Eisai Inc.(Eisai Co Ltd)	Our institute is the subsidiary of Eisai Inc., and the funding for the work was from the research and development budget of Eisai Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunuru S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.93; Akunuru S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016951; Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fukui T, 2013, EUR RESPIR J, V42, P1332, DOI 10.1183/09031936.00144012; Hardavella G, 2016, TRANSL LUNG CANCER R, V5, P272, DOI 10.21037/tlcr.2016.02.01; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Radyuk SN, 2003, BIOCHEM BIOPH RES CO, V305, P624, DOI 10.1016/S0006-291X(03)00830-1; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sasai K, 2008, AM J SURG PATHOL, V32, P1220, DOI 10.1097/PAS.0b013e318164c3f0; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Schilders KAA, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0358-z; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Templeton Amanda K, 2014, Stem Cell Investig, V1, P9, DOI 10.3978/j.issn.2306-9759.2014.03.06; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Xu X, 2014, GENE DEV, V28, P1929, DOI 10.1101/gad.243717.114; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175147	10.1371/journal.pone.0175147	http://dx.doi.org/10.1371/journal.pone.0175147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380052	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500102
J	Lu, W; Cheng, F; Yan, W; Li, X; Yao, X; Song, W; Liu, M; Shen, X; Jiang, H; Chen, J; Li, J; Huang, J				Lu, W.; Cheng, F.; Yan, W.; Li, X.; Yao, X.; Song, W.; Liu, M.; Shen, X.; Jiang, H.; Chen, J.; Li, J.; Huang, J.			Selective targeting p53(WT) lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA	ONCOGENE			English	Article							CYCLOPHILIN-A; ACQUIRED-RESISTANCE; ISOMERASE ACTIVITY; COMPLEX PROMOTES; CYCLOSPORINE-A; MUTANT P53; CISPLATIN; BINDING; SUPPRESSION; ACTIVATION	TP53 plays essential roles in tumor initiation and progression, and is frequently mutated in cancer. However, pharmacological stabilization and reactivation of p53 have not been actively explored for targeted cancer therapies. Herein, we identify a novel Cyclophilin A (CypA) small molecule inhibitor (HL001) that induces non-small cell lung cancer (NSCLC) cell cycle arrest and apoptosis via restoring p53 expression. We find that HL001 stabilizes p53 through inhibiting the MDM2-mediated p53 ubiquitination. Further mechanistic studies reveal that the downregulation of G3BP1 and the induction of reactive oxygen species and DNA damage by HL001 contribute to p53 stabilization. Surprisingly, HL001 selectively suppresses tumor growth in p53 wildtype NSCLC harboring Arg72 homozygous alleles (p53-72R) through disrupting interaction between MDM2 and p53-72R in a CypA-dependent manner. Moreover, combining HL001 with cisplatin synergistically enhance tumor regression in orthotopic NSCLC mouse model. Collectively, this study demonstrates that pharmacologic inhibition of CypA offers a potential therapeutic strategy via specific activation of p53-72R in NSCLC.	[Lu, W.; Yan, W.; Li, X.; Yao, X.; Shen, X.; Jiang, H.; Li, J.; Huang, J.] East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China; [Lu, W.; Liu, M.] East China Univ Sci & Technol, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China; [Lu, W.; Liu, M.] East China Univ Sci & Technol, Sch Life Sci, Shanghai, Peoples R China; [Cheng, F.] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Cheng, F.] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China; [Song, W.; Chen, J.] Vanderbilt Univ, Sch Med, Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Shen, X.; Jiang, H.] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, CAS Key Lab Receptor Res, Shanghai, Peoples R China; [Chen, J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Chen, J.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Chen, J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Cheng, F.] Harvard Med Sch, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA USA; [Cheng, F.] Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA	East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; Sichuan University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northeastern University	Li, J; Huang, J (corresponding author), East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai 200237, Peoples R China.	jianli@ecust.edu.cn; huangjin@ecust.edu.cn		huang, jin/0000-0002-0698-1693; XUE, YAO/0000-0002-1806-7372; Cheng, Feixiong/0000-0002-1736-2847; Chen, Jin/0000-0002-5557-2079	National Natural Science Foundation of China [21222211, 31371485, 81402482, 91313303, 81573020]; CAS Key Laboratory of Receptor Research; Shanghai Committee of Science and Technology [14ZR1411100, 15431902000]; China Postdoctoral Science Foundation [2014M551361, 2015T80415]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Key Laboratory of Receptor Research; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We are grateful to Mr Lianbiao Cheng, Miss Jiaqian Pu and Miss Ningning Dong (all from Jin Huang lab) for material and intellectual help with the design and execution of some of these experiments. The authors thank Professor Jose M Cuezva (Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid, Madrid, Spain) for providing G3BP1 plasmid; Professor Xiangshi Tan (Department of Chemistry, Fudan University, Shanghai, China) for providing the pMAL-c2x-derived MBPHT-Cherry2 vector; Professor Yi Yang (Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China) for providing H23, H838, H1703 and H2126 lung cancer cell lines. The work is supported by the National Natural Science Foundation of China (21222211, 31371485, 81402482, 91313303 and 81573020), CAS Key Laboratory of Receptor Research, the Shanghai Committee of Science and Technology (14ZR1411100 and 15431902000), China Postdoctoral Science Foundation Grant (2014M551361 and 2015T80415).	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Arnedos M, 2015, NAT REV CLIN ONCOL, V12, P693, DOI 10.1038/nrclinonc.2015.123; Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Baum N, 2009, ONCOGENE, V28, P3915, DOI 10.1038/onc.2009.248; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bonfils C, 2010, BIOCHEM BIOPH RES CO, V393, P325, DOI 10.1016/j.bbrc.2010.01.135; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cheng FX, 2017, TRENDS IMMUNOL, V38, P77, DOI 10.1016/j.it.2016.11.007; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Choudhury R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4078; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Hamilton G, 2014, CURR CANCER DRUG TAR, V14, P46, DOI 10.2174/15680096113136660109; Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Klein DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6800; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; MUTCH DG, 1992, GYNECOL ONCOL, V47, P28, DOI 10.1016/0090-8258(92)90070-Y; Ni SS, 2009, J MED CHEM, V52, P5295, DOI 10.1021/jm9008295; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Puente XS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-15; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang HR, 2007, BIOCHEM BIOPH RES CO, V361, P763, DOI 10.1016/j.bbrc.2007.07.085; Zhu D, 2015, NAT MED, V21, P572, DOI 10.1038/nm.3867; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	44	13	13	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4719	4731		10.1038/onc.2017.41	http://dx.doi.org/10.1038/onc.2017.41			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394340	Green Published, hybrid			2022-12-26	WOS:000407702400005
J	Antonopoulos, CG; Baptista, MS				Antonopoulos, Chris G.; Baptista, Murilo S.			Maintaining extensivity in evolutionary multiplex networks	PLOS ONE			English	Article							CHARACTERISTIC EXPONENTS; CHAOS; LIMIT; LAW	In this paper, we explore the role of network topology on maintaining the extensive property of entropy. We study analytically and numerically how the topology contributes to maintaining extensivity of entropy in multiplex networks, i.e. networks of subnetworks (layers), by means of the sum of the positive Lyapunov exponents, HKS, a quantity related to entropy. We show that extensivity relies not only on the interplay between the coupling strengths of the dynamics associated to the intra (short-range) and inter (long-range) interactions, but also on the sum of the intra-degrees of the nodes of the layers. For the analytically treated networks of size N, among several other results, we show that if the sum of the intra-degrees (and the sum of inter-degrees) scales as N theta+1,theta> 0, extensivity can be maintained if the intra-coupling (and the inter-coupling) strength scales as N-theta, when evolution is driven by the maximisation of HKS. We then verify our analytical results by performing numerical simulations in multiplex networks formed by electrically and chemically coupled neurons.	[Antonopoulos, Chris G.] Univ Essex, Dept Math Sci, Wivenhoe Pk, Colchester, Essex, England; [Baptista, Murilo S.] Univ Aberdeen, Inst Complex Sci & Math Biol, SUPA, Aberdeen, Scotland	University of Essex; University of Aberdeen	Antonopoulos, CG (corresponding author), Univ Essex, Dept Math Sci, Wivenhoe Pk, Colchester, Essex, England.	canton@essex.ac.uk	Antonopoulos, Chris G./A-2354-2015; baptista, murilo s/B-7277-2008	Antonopoulos, Chris G./0000-0001-7195-6892; 	Engineering and Physical Sciences Research Council (EPSRC) [EP/I032606/1]; EPSRC [EP/I032606/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032606/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C. G. A. and M. S. B. acknowledge financial support provided by the Engineering and Physical Sciences Research Council (EPSRC) (https://www.epsrc.ac.uk/) Ref: EP/I032606/1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr N. Rubido for discussions about the extensive character of complex networks, and Dr Rodrigo F. Pereira for valuable discussions, especially with regard to the finite nature of super-extensive behaviour. This work was performed using both the Maxwell high performance computing cluster and the ICSMB cluster of the University of Aberdeen. Both authors acknowledge financial support provided by the EPSRC Ref: EP/I032606/1 grant. C. G. A. contributed to this work while working at the University of Aberdeen and then, when working at the University of Essex.	Antonopoulos CG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004372; Baptista M, 2013, SCI REPORTS, V6, P1; Baptista MS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026205; Baptista MS, 2011, PHYS LETT A, V375, P1309, DOI 10.1016/j.physleta.2011.01.054; Baptista MS, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036203; Barreira L, 2002, LYAPUNOV EXPONENTS S, V23; Benettin G., 1980, MECCANICA, V15, P21, DOI [10.1007/BF02128237, DOI 10.1007/BF02128237]; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; CHATE H, 1992, PROG THEOR PHYS, V87, P1, DOI 10.1143/PTP.87.1; Chung F.R., 1997, AM MATH SOC, V92, DOI DOI 10.1038/s41467-018-03133-y; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Giorgilli A., 1980, MECCANICA, V15, P9, DOI 10.1007/BF02128236; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; KANEKO K, 1990, PHYS REV LETT, V65, P1391, DOI 10.1103/PhysRevLett.65.1391; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; LIVI R, 1986, J PHYS A-MATH GEN, V19, P2033, DOI 10.1088/0305-4470/19/11/012; Luccioli S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.138103; Martin-Hernandez J, 2014, PHYSICA A, V404, P92, DOI 10.1016/j.physa.2014.02.043; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Newman M.E.J., 2010, NETWORKS INTRO; Paul MR, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045203; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Pesin YB, 1976, IZV AKAD NAUK SSSR M, V40, P1332; PIKOVSKY AS, 1994, PHYS REV LETT, V72, P1644, DOI 10.1103/PhysRevLett.72.1644; RUELLE D, 1982, COMMUN MATH PHYS, V87, P287, DOI 10.1007/BF01218566; Ruelle D., 1978, BOL SOC BRAS MAT, V9, P83, DOI DOI 10.1007/BF02584795; Skokos C, 2010, LECT NOTES PHYS, V790, P63, DOI 10.1007/978-3-642-04458-8_2; Sole-Ribalta A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032807; Takeuchi KA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.124101; Takeuchi KA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.154103; Van Mieghem P., 2010, GRAPH SPECTRA COMPLE; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175389	10.1371/journal.pone.0175389	http://dx.doi.org/10.1371/journal.pone.0175389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403162	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000399955200058
J	Han, BY; Li, Y; Han, HT; Zhao, YF; Pan, QJ; Ren, LM				Han, Binyue; Li, Yan; Han, Haitang; Zhao, Yaofeng; Pan, Qingjie; Ren, Liming			Three IgH isotypes, IgM, IgA and IgY are expressed in Gentoo penguin and zebra finch	PLOS ONE			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; RAINBOW-TROUT; EXTENSIVE DIVERSIFICATION; GENES; LOCUS; REGION; BIRDS; EVOLUTION; IDENTIFICATION; REPERTOIRE	Previous studies on a limited number of birds suggested that the IgD-encoding gene was absent in birds. However, one of our recent studies showed that the gene was definitely expressed in the ostrich and emu. Interestingly, we also identified subclass diversification of IgM and IgY in these two birds. To better understand immunoglobulin genes in birds, in this study, we analyzed the immunoglobulin heavy chain genes in the zebra finch (Taeniopygia guttata) and Gentoo penguin (Pygoscelis papua), belonging respectively to the order Passeriformes, the most successful bird order in terms of species diversity and numbers, and Sphenisciformes, a relatively primitive avian order. Similar to the results obtained in chickens and ducks, only three genes encoding immunoglobulin heavy chain isotypes, IgM, IgA and IgY, were identified in both species. Besides, we detected a transcript encoding a short membrane-bound IgA lacking the last two CH exons in the Gentoo penguin. We did not find any evidence supporting the presence of IgD gene or subclass diversification of IgM/IgY in penguin or zebra finch. The obtained data in our study provide more insights into the immunoglobulin heavy chain genes in birds and may help to better understand the evolution of immunoglobulin genes in tetrapods.	[Han, Binyue; Han, Haitang; Zhao, Yaofeng; Ren, Liming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Li, Yan; Pan, Qingjie] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Ren, LM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Pan, QJ (corresponding author), Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China.	qjpan@126.com; renim@cau.edu.cn						AMEMIYA CT, 1989, NUCLEIC ACIDS RES, V17, P5388, DOI 10.1093/nar/17.13.5388; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Cheng G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2317; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi JW, 2010, VET IMMUNOL IMMUNOP, V136, P248, DOI 10.1016/j.vetimm.2010.03.014; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Han BY, 2016, J IMMUNOL, V196, P5138, DOI 10.4049/jimmunol.1600307; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Huang T, 2016, DEV COMP IMMUNOL, V60, P160, DOI 10.1016/j.dci.2016.02.024; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; Li LX, 2012, J IMMUNOL, V189, P3995, DOI 10.4049/jimmunol.1200188; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Olivieri DN, 2016, MOL IMMUNOL, V72, P81, DOI 10.1016/j.molimm.2016.03.003; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARVARI R, 1987, EMBO J, V6, P97, DOI 10.1002/j.1460-2075.1987.tb04724.x; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Ramirez-Gomez F, 2012, J IMMUNOL, V188, P1341, DOI 10.4049/jimmunol.1101938; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROMAN T, 1995, EUR J IMMUNOL, V25, P269, DOI 10.1002/eji.1830250144; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469	39	4	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0173334	10.1371/journal.pone.0173334	http://dx.doi.org/10.1371/journal.pone.0173334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403146	gold, Green Published, Green Submitted			2022-12-26	WOS:000399955200005
J	Lin, WH; Lee, SS; Wu, JY; Kuo, YH; Hsieh, TF				Lin, Wenhsu; Lee, Shangsen; Wu, Jengyuan; Kuo, Yuhung; Hsieh, Tengfu			5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; FOLLOW-UP; FINASTERIDE; EFFICACY; RISK; HYPERPLASIA; VALIDATION; INCREASES; STROKE	Background This study investigated the risk of transurethral resection of prostate (TURP) and acute urine retention (AUR) in relation to 5-alpha-reductase inhibitor (5ARI) therapy. Methods We identified 22,687 patients who were newly diagnosed with PE and low urinary tract symptoms (LUTS) between January 1, 2002 and December 31, 2011. We further classified study subjects who had moderate to severe LUTS and a maximum uroflow rate of less than 15ml/sec into three groups by their defined daily dose (DDD) of 5ARI used. The control group consisted of 7-28 cumulative DDD (cDDD) 5ARI users, while the short-term treatment group was 29-179cDDD 5ARI users, and the long-term treatment group was users of more than 180cDDD 5ARI. Each patient was monitored to identify those who subsequently developed TURP and AUR. Results TURP and AUR are detected in 5.6% of control group, 7.6% of short-term treatment group and 5.5% of long-term treatment group during 10-year follow up. Compared with the control group, there was no difference in the risk of TURP and AUR in the short-term and long-term treatment groups (HR = 1.41, 95% CI 0.76 to 2.62 and HR = 0.81, 95% CI 0.42 to 1.56, respectively). Conclusion 5ARI therapy did not change the risk of TURP and AUR events in patients with PE, moderate to severe LUTS and a maximum uroflow rate of less than 15 ml/sec in 10 years of followup. But long-term 5ARI used can postpone AUR and TURP for 8.16 months.	[Lin, Wenhsu] Minist Hlth & Welf, Nantou Hosp, Dept Urol, Nantou, Taiwan; [Lee, Shangsen; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Urol, Taichung, Taiwan; [Lee, Shangsen; Wu, Jengyuan; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Surg, Taichung, Taiwan; [Lee, Shangsen; Wu, Jengyuan; Hsieh, Tengfu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wu, Jengyuan; Kuo, Yuhung; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Urol, Taichung, Taiwan.; Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Surg, Taichung, Taiwan.; Hsieh, TF (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan.	hdf95@yahoo.com.tw						Armitage JN, 2007, BRIT MED J, V335, P1199, DOI 10.1136/bmj.39377.617269.55; Cathcart P, 2006, J UROLOGY, V176, P200, DOI 10.1016/S0022-5347(06)00509-X; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Chen JS, 2012, BJU INT, V110, pE896, DOI 10.1111/j.1464-410X.2012.11471.x; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Cindolo L, 2013, INT UROLOGY NEPHROLO; Ekman P, 1998, EUR UROL, V33, P312, DOI 10.1159/000019566; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Hsieh TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119694; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; Lee SS, 2015, PROSTATE; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu HY, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1423-8; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Silva J, 2014, CURR OPIN UROL, V24, P21, DOI 10.1097/MOU.0000000000000007; Wu C, 2011, PROSTATE CANCER P D, V14, P326, DOI 10.1038/pcan.2011.28	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175356	10.1371/journal.pone.0175356	http://dx.doi.org/10.1371/journal.pone.0175356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394903	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800030
J	Hosaka, T; Sugimoto, K; Numata, S				Hosaka, Tetsuro; Sugimoto, Koun; Numata, Shinya			Effects of childhood experience with nature on tolerance of urban residents toward hornets and wild boars in Japan	PLOS ONE			English	Article							ECOSYSTEM DISSERVICES; LETHAL CONTROL; ACCEPTABILITY; ATTITUDES; SERVICES; CONSERVATION; PERCEPTIONS; EXTINCTION; CONFLICTS; BENEFITS	Urban biodiversity conservation often aims to promote the quality of life for urban residents by providing ecosystem services as well as habitats for diverse wildlife. However, biodiversity inevitably brings some disadvantages, including problems and nuisances caused by wildlife. Although some studies have reported that enhancement of nature interaction among urban children promotes their affective attitude toward of favorable animals, its effect on tolerance toward problem-causing wildlife is unknown. In this study, we assessed the tolerance of 1,030 urban residents in Japan toward hornets and wild boar, and analyzed the effects of childhood experience with nature on tolerance using a structural equation model. The model used sociodemographic factors and childhood nature experience as explanatory variables, affective attitude toward these animals as a mediator, and tolerance as a response variable. The public tolerance toward hornets and boars was low; over 60% of the respondents would request the removal of hornets and wild boar from nearby green spaces by government services, even when the animals had not caused any damage. Tolerance was lower in females and elderly respondents. Childhood experience with nature had a greater influence on tolerance than did sociodemographic factors in the scenario where animals have not caused any problems; however, its effect was only indirect via promoting positive affective attitude toward wildlife when the animals have caused problems. Our results suggest that increasing people's direct experience with nature is important to raise public tolerance, but its effect is limited to cases where wildlife does not cause any problems. To obtain wider support for conservation in urban areas, conservationists, working together with municipal officials, educators and the media, should provide relevant information on the ecological functions performed by problem-causing wildlife and strategies for avoiding the problems that wildlife can cause.	[Hosaka, Tetsuro; Sugimoto, Koun; Numata, Shinya] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, 1-1 Minami Osawa, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Hosaka, T (corresponding author), Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Tourism Sci, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.	tetsurau@yahoo.co.jp	Hosaka, Tetsuro/I-2847-2018		Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government	Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government	This study was supported by the Advanced Research Program of Asian Human Research Fund by Tokyo Metropolitan Government.	Azmy MM, 2016, URBAN FOR URBAN GREE, V18, P117, DOI 10.1016/j.ufug.2016.05.014; Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; Barendse Mariska., 2015, PACKAGE LAVAAN; Bezak P, 2008, ENVIRON SCI-TOKYO, V5, P161, DOI [DOI 10.1080/15693430802055524, 10.1080/15693430802055524]; Bixler RD, 1997, ENVIRON BEHAV, V29, P443, DOI 10.1177/001391659702900401; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Butler JS, 2003, WILDLIFE SOC B, V31, P1027; Cheng JCH, 2012, ENVIRON BEHAV, V44, P31, DOI 10.1177/0013916510385082; Choi MB, 2012, ENTOMOL RES, V42, P308, DOI 10.1111/j.1748-5967.2012.00472.x; Conway TM, 2016, LANDSCAPE URBAN PLAN, V153, P1, DOI 10.1016/j.landurbplan.2016.04.016; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Gore ML, 2009, J WILDLIFE MANAGE, V73, P1407, DOI 10.2193/2008-343; Hosaka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30911; Jacobs M., 2009, HUM DIMENS WILDL, V14, P1, DOI [10.1080/10871200802545765, DOI 10.1080/10871200802545765]; Jacobs MH, 2014, EUR J WILDLIFE RES, V60, P589, DOI 10.1007/s10344-014-0823-2; Jacobs MH, 2014, J NAT CONSERV, V22, P377, DOI 10.1016/j.jnc.2014.03.005; Jiji Kyodo, 2014, JAPAN TIMES; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Kamihogi A., 2009, TOWN DEV BASED LOCAL; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Kansky R, 2014, CONSERV BIOL, V28, P924, DOI 10.1111/cobi.12275; Kawahara AY, 2013, MANAGEMENT OF INSECTS IN RECREATION AND TOURISM, P138; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Kobe City, 2009, WILD BOARS; Lyytimaki J, 2015, ECOSYST SERV, V12, P136, DOI 10.1016/j.ecoser.2014.11.008; Lyytimaki J, 2009, URBAN FOR URBAN GREE, V8, P309, DOI 10.1016/j.ufug.2009.09.003; Macromill, 2016, QUAL CONTR POL MACR; Macromill, 2013, SURV LIF MACR MON; Matsuura M., 1988, WHY DO HORNETS STING; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Ministry of Agriculture Forestry and Fisheries, 2012, STAT AGR DAM CAUS WI; Ministry of Health Labor and Welfare, 2014, JAP FIG; Nakamura M., 2007, VESPA URBAN INVASION; Saito M, 2013, PLOS ONE, V31; Sakurai R., 2014, Human Dimensions of Wildlife, V19, P88, DOI 10.1080/10871209.2014.842026; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Siemer W. F., 2009, Human Dimensions of Wildlife, V14, P185, DOI 10.1080/10871200902856138; Sijtsma MTJ, 2012, SOC NATUR RESOUR, V25, P1308, DOI 10.1080/08941920.2012.684850; Soga M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060529; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soulsbury CD, 2015, WILDLIFE RES, V42, P541, DOI 10.1071/WR14229; van der Ploeg J, 2011, CONSERV LETT, V4, P313, DOI 10.1111/j.1755-263X.2011.00181.x; Vaske J., 2008, SURVEY RES ANAL APPL; von Dohren P, 2015, ECOL INDIC, V52, P490, DOI 10.1016/j.ecolind.2014.12.027; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Wieczorek Hudenko Heather, 2010, P21; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011	53	15	17	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175243	10.1371/journal.pone.0175243	http://dx.doi.org/10.1371/journal.pone.0175243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388643	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800030
J	Imboden, MT; Welch, WA; Swartz, AM; Montoye, AHK; Finch, HW; Herber, MP; Kaminsky, LA				Imboden, Mary T.; Welch, Whitney A.; Swartz, Ann M.; Montoye, Alexander H. K.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.			Reference standards for body fat measures using GE dual energy x-ray absorptiometry in Caucasian adults	PLOS ONE			English	Article							GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; BEAM INSTRUMENTS; MASS INDEX; WOMEN; LUNAR; DXA; WEIGHT; BONE; MEN	Background Dual energy x-ray absorptiometry (DXA) is an established technique for the measurement of body composition. Reference values for these variables, particularly those related to fat mass, are necessary for interpretation and accurate classification of those at risk for obesity related health complications and in need of lifestyle modifications (diet, physical activity, etc.). Currently, there are no reference values available for GE-Healthcare DXA systems and it is known that whole-body and regional fat mass measures differ by DXA manufacturer. Objective To develop reference values by age and sex for DXA-derived fat mass measurements with GE-Healthcare systems. Methods A de-identified sample of 3,327 participants (2,076 women, 1,251 men) was obtained from Ball State University's Clinical Exercise Physiology Laboratory and University of Wisconsin Milwaukee's Physical Activity & Health Research Laboratory. All scans were completed using a GE Lunar Prodigy or iDXA and data reported included percent body fat (%BF), fat mass index (FMI), and ratios of android-to-gynoid (A/G), trunk/limb, and trunk/leg fat measurements. Percentiles were calculated and a factorial ANOVA was used to determine differences in the mean values for each variable between age and sex. Results Normative reference values for fat mass variables from DXA measurements obtained from GE-Healthcare DXA systems are presented as percentiles for both women and men in 10 year age groups. Women had higher (p<0.01) mean %BF and FMI than men, whereas men had higher (p<0.01) mean ratios of A/G, trunk/limb, and trunk/leg fat measurements than women. Conclusion These reference values provide clinicians and researchers with a resource for interpretation of DXA-derived fat mass measurements specific to use with GE-Healthcare DXA systems.	[Imboden, Mary T.; Montoye, Alexander H. K.; Finch, Holmes W.; Herber, Matthew P.; Kaminsky, Leonard A.] Ball State Univ, Muncie, IN 47306 USA; [Welch, Whitney A.; Swartz, Ann M.] Univ Wisconsin, Milwaukee, WI 53201 USA	Ball State University; University of Wisconsin System; University of Wisconsin Milwaukee	Imboden, MT (corresponding author), Ball State Univ, Muncie, IN 47306 USA.	Mstuttle2@bsu.edu			NCI NIH HHS [T32 CA193193] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA193193] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aasen G, 2006, SCAND J CLIN LAB INV, V66, P659, DOI 10.1080/00365510600898214; Fan B, 2014, J CLIN DENSITOM, V17, P344, DOI 10.1016/j.jocd.2013.08.019; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Genton L, 2006, CLIN NUTR, V25, P428, DOI 10.1016/j.clnu.2005.11.002; Gillette-Guyonnet S, 2003, MECH AGEING DEV, V124, P317, DOI 10.1016/S0047-6374(02)00199-9; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hong S, 2011, J KOREAN MED SCI, V26, P1599, DOI 10.3346/jkms.2011.26.12.1599; Kamel EG, 1999, INT J OBESITY, V23, P686, DOI 10.1038/sj.ijo.0800904; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Kirchengast S, 2008, COLLEGIUM ANTROPOL, V32, P1079; Kirschner MM, 2011, MED SCI SPORT EXER, V43, P317, DOI 10.1249/01.MSS.0000400874.39385.50; Ramos RML, 2012, RADIOLOGIA-MADRID, V54, P410, DOI 10.1016/j.rx.2011.09.023; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Malouf J, 2013, J CLIN DENSITOM, V16, P212, DOI 10.1016/j.jocd.2012.04.003; Min KB, 2015, CLIN ENDOCRINOL, V82, P377, DOI 10.1111/cen.12505; PAFFENBARGER RS, 1986, ACTA MED SCAND, P85; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Pescatello LS., 2014, ACSMS GUIDELINES EXE, P62; Plank LD, 2005, CURR OPIN CLIN NUTR, V8, P305, DOI 10.1097/01.mco.0000165010.31826.3d; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Shepherd JA, 2012, J BONE MINER RES, V27, P2208, DOI 10.1002/jbmr.1654; Stults-Kolehmainen MA, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.5; Tothill P, 2000, ANN NY ACAD SCI, V904, P63; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wells JCK, 2010, INT J OBESITY, V34, P649, DOI 10.1038/ijo.2009.249; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804	31	51	52	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175110	10.1371/journal.pone.0175110	http://dx.doi.org/10.1371/journal.pone.0175110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388669	Green Published, gold, Green Submitted			2022-12-26	WOS:000399375800020
J	Zhai, L; Liu, M; Wang, TT; Zhang, HY; Li, S; Guo, YL				Zhai, Li; Liu, Min; Wang, Tingting; Zhang, Hongyan; Li, Shan; Guo, Yunliang			Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; NADPH OXIDASE; STROKE; STRESS; NEUROPROTECTION; ACTIVATION; THERAPY; KINASE	Background and purpose Thrombolysis is used to improve cerebral circulation; at the same time, neuroprotective drugs such as antioxidants should also be used. The aim of these experiments was to explore the protective mechanism of an antioxidant, picroside II, on the blood-brain barrier (BBB) after cerebral ischemia-reperfusion (CI/R) injury. Methods To observe the antagonistic effect of picroside II on CI/R damage, the neurological deficit score and the infarct volume were measured. To detect the protective effect of picroside II on nerve cells and the BBB, the morphology and structure of cortical brain tissue were observed, respectively. To investigate the antioxidant effect and mechanism of picroside II, reactive oxygen species (ROS) content, the activity of Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), and the protein levels of Nox2 and Rac-1 were detected. To investigate the protective mechanism of picroside II on the BBB, the levels of ROCK, MLCK, MMP-2 and claudin-5 were tested. Results A higher neurological score, bigger cortex infarction, more damaged neuron structure and injured BBB, increased content of ROS and activity of NADPH oxidase, higher protein levels of Nox2, Rac-1, ROCK, MLCK and MMP-2 and lower levels of claudin-5 were observed in the model group. In the picroside group, the neurological score, neuronal damage, BBB injury, ROS content and NADPH oxidase activity were reduced (P< 0.05), and the protein levels of Rac-1, Nox2, ROCK, MLCK and MMP-2 were down-regulated (P< 0.05), while the expression of claudin-5 was up-regulated (P< 0.05). Conclusions Picroside II could protect the nervous system possibly through reducing the content of ROS by down-regulating the expression of Rac-1 and Nox2 and could protect the BBB through reducing the expression of ROCK, MLCK, and MMP-2, while enhancing the expression of claudin-5.	[Zhai, Li; Wang, Tingting] Qingdao Univ, Clin Med Coll 3, Dept Pharm, Qingdao, Shandong, Peoples R China; [Zhang, Hongyan; Li, Shan; Guo, Yunliang] Qingdao Univ, Affiliated Hosp, Inst Cerebrovasc Dis, Qingdao, Shandong, Peoples R China	Qingdao University; Qingdao University	Guo, YL (corresponding author), Qingdao Univ, Affiliated Hosp, Inst Cerebrovasc Dis, Qingdao, Shandong, Peoples R China.	guogdsd@163.com	wang, tingting/AAK-2640-2020					Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Camire RB, 2014, J PHARMACOL EXP THER, V351, P654, DOI 10.1124/jpet.114.218339; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Enns GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100001; Fleenor BS, 2012, AGING CELL, V11, P269, DOI 10.1111/j.1474-9726.2011.00783.x; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Gu YT, 2013, NEUROPHARMACOLOGY, V75, P407, DOI 10.1016/j.neuropharm.2013.08.004; Guell K, 2014, EXPERT REV NEUROTHER, V14, P1287, DOI 10.1586/14737175.2014.964210; Guellich A, 2013, AM J PHYSIOL-HEART C, V304, pH1505, DOI 10.1152/ajpheart.00669.2012; Guliani A, 2015, IET NANOBIOTECHNOL, V10, P114; Jaffer H, 2011, DRUG DELIV TRANSL RE, V1, P409, DOI 10.1007/s13346-011-0046-y; Kahles T, 2013, ANTIOXID REDOX SIGN, V18, P1400, DOI 10.1089/ars.2012.4721; Kim YH, 2016, J STROKE, V18, P129, DOI 10.5853/jos.2016.00234; Lee JC, 2014, ANAT CELL BIOL, V47, P101, DOI [10.5115/acb.2014.47.2.101, 10.5115/acb.2014.47.3.149]; Li HY, 2014, TRANSL STROKE RES, V5, P618, DOI 10.1007/s12975-014-0354-x; Li Ting-ting, 2010, Zhongguo Yaolixue Yu Dulixue Zazhi, V24, P307; Liu K, 2011, INT J MOL SCI, V12, P1222, DOI 10.3390/ijms12021222; Luscher TF, 2016, EUR HEART J, V37, P857, DOI 10.1093/eurheartj/ehw084; Ma QL, 2013, TRENDS CARDIOVAS MED, V23, P179, DOI 10.1016/j.tcm.2012.11.002; McCann SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110602; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muir SW, 2008, STROKE, V39, P3303, DOI 10.1161/STROKEAHA.108.519793; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Ren YX, 2015, INT J NEUROSCI, V125, P555, DOI 10.3109/00207454.2014.959121; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Tang XN, 2011, ANN NEUROL, V70, P606, DOI 10.1002/ana.22476; Thompson JW, 2012, CURR NEUROPHARMACOL, V10, P354, DOI 10.2174/157015912804143577; Verma PC, 2009, CURR PHARM BIOTECHNO, V10, P641, DOI 10.2174/138920109789069314; Wang JJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/572729; Wang TT, 2015, J MOL NEUROSCI, V57, P335, DOI 10.1007/s12031-015-0623-5; Wang TT, 2015, CLIN EXP PHARMACOL P, V42, P930, DOI 10.1111/1440-1681.12445; Wang TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124099; Wu SM, 2014, INT J STROKE, V9, P101, DOI 10.1111/ijs.12163; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; [张树红 Zhang Shuhong], 2015, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V40, P612; Zhang Y, 2014, RHEUMATOL INT, V20, P20	39	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174414	10.1371/journal.pone.0174414	http://dx.doi.org/10.1371/journal.pone.0174414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388666	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800006
J	Anders, F; Teister, J; Liu, A; Funke, S; Grus, FH; Thanos, S; von Pein, HD; Pfeiffer, N; Prokosch, V				Anders, Fabian; Teister, Julia; Liu, Aiwei; Funke, Sebastian; Grus, Franz H.; Thanos, Solon; von Pein, Harald D.; Pfeiffer, Norbert; Prokosch, Verena			Intravitreal injection of beta-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; HEAT-SHOCK PROTEINS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; OPTIC-NERVE; DBA/2J MICE; AXONAL REGENERATION; INHERITED GLAUCOMA; GENE-EXPRESSION; IRIS ATROPHY	Purpose of this study was to investigate firstly specific proteomic changes within the retina in the course of an animal glaucoma model and to identify secondly new approaches for neuroprotective, therapeutic options in glaucoma by addressing those specific changes. Intraocular pressure was elevated through cauterization of episcleral veins in adult Sprague Dawley rats. Molecular and morphological changes were surveyed using mass spectrometry, optical coherence tomography as well as immunohistochemical cross section- and flat mount stainings. By quantifying more than 1500 retinal proteins, it was found that the HspB5 protein and numerous beta-crystallins showed a uniform and unique shifting expression pattern as a result of different periods of elevated IOP exposure. Crystallins showed a significant downregulation (p<0.05) after 3 weeks of elevated IOP and an upregulation after 7 weeks. Counteracting those typical changes, an intravitreal injection of beta-crystallin B2 at the time of IOP elevation was found to reduce retinal ganglion cell loss (p<0.05), decrease of the retinal nerve fiber layer (p<0.05) and impairment of the optic nerve. Ultimately, proteomic data revealed that beta-crystallin B2 might influence calcium-depended cell signaling pathways with severe effect on apoptosis and gene regulation. In this context especially annexin A5, calcium-transporting ATPase 1 and various histone proteins seem to play a major role.	[Anders, Fabian; Teister, Julia; Liu, Aiwei; Funke, Sebastian; Grus, Franz H.; Pfeiffer, Norbert; Prokosch, Verena] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany; [Thanos, Solon] Westfalian Wilhelms Univ Munster, Sch Med, Inst Expt Ophthalmol, Munster, Germany; [von Pein, Harald D.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neuropathol, Mainz, Germany	Johannes Gutenberg University of Mainz; University of Munster; Johannes Gutenberg University of Mainz	Prokosch, V (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany.	vprokosch@gmx.de	Pfeiffer, Norbert/AAO-7586-2020	Liu, Aiwei/0000-0001-6656-3576	Deutsche Forschungsgemeinschaft (DFG) [PR1569/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant PR1569/1-1 to VP).	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Bohm MRR, 2015, CELL TRANSPLANT, V24, P1829, DOI 10.3727/096368914X684583; Bohm MRR, 2013, GRAEF ARCH CLIN EXP, V251, P63, DOI 10.1007/s00417-012-2157-7; Bohm MRR, 2012, INVEST OPHTH VIS SCI, V53, P8265, DOI 10.1167/iovs.12-10334; Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Flammer J, 1999, J GLAUCOMA, V8, P212; Furuyoshi N, 2000, OPHTHALMOLOGICA, V214, P24, DOI 10.1159/000027470; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Ghaffariyeh A, 2011, OPTOMETRY VISION SCI, V88, P80, DOI 10.1097/OPX.0b013e3181fc329f; HEAD MW, 1993, AM J PATHOL, V143, P1743; HEYWOOD R, 1975, BRIT VET J, V131, P213, DOI 10.1016/S0007-1935(17)35342-3; Hitchings R A, 1995, Curr Opin Ophthalmol, V6, P67; Jha P, 2011, MOL IMMUNOL, V48, P2151, DOI 10.1016/j.molimm.2011.07.012; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Jung KH, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00002; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Konishi Y, 2004, BIOCHEM BIOPH RES CO, V313, P977, DOI 10.1016/j.bbrc.2003.12.032; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; McMonnies CW, 2008, OPTOMETRY VISION SCI, V85, P1018, DOI 10.1097/OPX.0b013e3181890e91; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Naskar R, 2006, MOL VIS, V12, P1199; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Piri N, 2016, PROG RETIN EYE RES, V52, P22, DOI 10.1016/j.preteyeres.2016.03.001; Piri N, 2013, MOL NEUROBIOL, V48, P819, DOI 10.1007/s12035-013-8470-2; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Quigley HA, 1996, NUMBER, V80, P389; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Schallenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033593; Schwartz M, 2000, INVEST OPHTH VIS SCI, V41, P349; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Thanos S, 2004, EXP EYE RES, V79, P119, DOI 10.1016/j.exer.2004.02.005; Tomita G, 2000, Curr Opin Ophthalmol, V11, P116, DOI 10.1097/00055735-200004000-00009; Ueda J, 1998, JPN J OPHTHALMOL, V42, P337, DOI 10.1016/S0021-5155(98)00026-4; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; WATANABE H, 1989, CURR EYE RES, V8, P479, DOI 10.3109/02713688909000028	57	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175451	10.1371/journal.pone.0175451	http://dx.doi.org/10.1371/journal.pone.0175451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384305	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900170
J	Brodska, B; Kracmarova, M; Holoubek, A; Kuzelova, K				Brodska, Barbora; Kracmarova, Marketa; Holoubek, Ales; Kuzelova, Katerina			Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NUCLEOLAR PROTEIN B23; FAVORABLE PROGNOSIS; NORMAL KARYOTYPE; GENE-MUTATIONS; ARF; EXPRESSION; OLIGOMERIZATION; DOMAIN	Mutations of the gene for nucleophosmin (NPM1) are the most frequent genetic aberration in patients with acute myeloid leukemia (AML). The mechanism of leukemic transformation in this leukemia subtype is not fully understood, but aberrant cytoplasmic localization of mutated NPM (NPMmut) is widely considered as an important factor for leukemia manifestation. We analyzed the subcellular localization of three types of NPM with a C-terminal mutation (A, B and E). Genes for the individual NPM forms were fused with a gene for one of fluorescent protein variants in plasmids, which were transfected into three cell lines with different endogenous NPM expression. Subcellular localization of the fluorescent proteinlabeled NPM was further correlated with the relative expression of all NPM forms. We confirmed a high cytoplasmic expression of NPMmutA and NPMmutB whereas a substantial fraction of NPMmutE was found to be localized in nucleoli. Moreover, we revealed that the localization of fluorescently labeled NPM is affected by the interaction between various forms of the protein.	[Brodska, Barbora; Kracmarova, Marketa; Holoubek, Ales; Kuzelova, Katerina] Inst Hematol & Blood Transfus, Prague 2, Czech Republic	Institute of Hematology Prague	Brodska, B (corresponding author), Inst Hematol & Blood Transfus, Prague 2, Czech Republic.	brodska@uhkt.cz	Kuzelova, Katerina/ADE-8303-2022; Kráčmarová, Markéta/T-8185-2017	Kuzelova, Katerina/0000-0002-9628-6255; Kráčmarová, Markéta/0000-0002-9001-9594; Brodska, Barbora/0000-0002-3703-594X	Ministry of Health, CzechRepublic [00023736, 163 0268A]	Ministry of Health, CzechRepublic(Ministry of Health, Czech RepublicCzech Republic Government)	This work was supported by the Ministry of Health, CzechRepublic (www.mzcr.cz): Project for conceptual development of research organization No.00023736 and Grant No163 0268A. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Alpermann T, 2016, HAEMATOLOGICA, V101, pE55, DOI 10.3324/haematol.2015.133819; Alpermann T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.51.51; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Braoudaki M, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-41; Brodska B, 2016, J CELL BIOCHEM, V117, P1319, DOI 10.1002/jcb.25420; Chou SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049769; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, LEUKEMIA, V21, P2052, DOI 10.1038/sj.leu.2404839; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V108, P1999, DOI 10.1182/blood-2006-03-007013; Falini B, 2011, BLOOD, V117, P1109, DOI 10.1182/blood-2010-08-299990; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Gruszka AM, 2010, BLOOD, V116, P2096, DOI 10.1182/blood-2010-01-266908; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Huang M, 2013, LEUKEMIA, V27, P1970, DOI 10.1038/leu.2013.222; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Janke H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089560; Koh Y, 2009, INT J HEMATOL, V90, P1, DOI 10.1007/s12185-009-0350-1; Kurki S, 2004, CELL CYCLE, V3, P976; Kuzelova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127637; Liu YF, 2014, MOL CLIN ONCOL, V2, P275, DOI 10.3892/mco.2013.222; Macville M, 1999, CANCER RES, V59, P141; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Prinos Panagiotis, 2011, Int J Biochem Mol Biol, V2, P24; Rashid NU, 2014, BLOOD, V124, P3110, DOI 10.1182/blood-2014-04-569327; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Schnittger S, 2011, LEUKEMIA, V25, P615, DOI 10.1038/leu.2010.299; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168	40	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175175	10.1371/journal.pone.0175175	http://dx.doi.org/10.1371/journal.pone.0175175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384310	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900110
J	Frappe, P; Cogneau, J; Gaboreau, Y; Abenhaim, N; Bayen, M; Calafiore, M; Guichard, C; Jacquet, JP; Lacoin, F; Bertoletti, L				Frappe, Paul; Cogneau, Joel; Gaboreau, Yoann; Abenhaim, Nathan; Bayen, Marc; Calafiore, Matthieu; Guichard, Claude; Jacquet, Jean-Pierre; Lacoin, Francois; Bertoletti, Laurent		CACAO Study Investigators	Areas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; DABIGATRAN; WARFARIN; RISK; THROMBOEMBOLISM; CARE	Background Real-world studies on anticoagulants are mostly performed on health insurance databases, limited to reported events, and sometimes far from every-day issues in family practice. We assess the presence of data for safe monitoring of oral anticoagulants in general practice, and compare patients' knowledge of taking an anticoagulant between vitamin K antagonists (VKA) and direct anticoagulants (DOAC), and the general practitioner's perception of their adherence to anticoagulation. Methods The CACAO study is a national cohort study, conducted by general practitioners on ambulatory patients under oral anticoagulant. In the first phase, investigators provided safety data available from medical records at inclusion. They also evaluated patients' knowledge about anticoagulation and graded their perception of patients' adherence. Results Between April and December 2014, 463 general practitioners included 7154 patients. Renal and hepatic function tests were respectively unavailable in 109 (7.5%) and 359 (24.7%) DOAC patients. Among patients with atrial fibrillation, 345 patients (6.9%) had a questionable indication of anticoagulant (CHA2DS2-Vasc< 2). One hundred and thirty-three VKA patients (2.3%) and 70 DOAC patients (4.9%) answered they took no anticoagulant (p< 0.0001). According to general practitioners' perception, 430 patients (6.1%) were classified as "not very " or " not adherent ", with no difference between groups. Conclusions Our results highlight the efforts needed to improve anticoagulant safety in daily practice: decreasing the rate of unknown biological data in patients with DOACs or the rate of patients with VKA with no strong indication of anticoagulation, and improving patient knowledge with regard to their anticoagulant. Patients' adherence seems highly over-estimated by the general practitioners.	[Frappe, Paul] Univ St Etienne, Dept Gen Practice, St Etienne, France; [Frappe, Paul; Bertoletti, Laurent] Univ St Etienne, INSERM, U1059, Sainbiose DVH, St Etienne, France; [Frappe, Paul; Bertoletti, Laurent] CIC EC 1408, St Etienne, France; [Cogneau, Joel; Abenhaim, Nathan; Guichard, Claude; Lacoin, Francois] Inst Rech Med Gen, Paris, France; [Gaboreau, Yoann; Jacquet, Jean-Pierre] Grenoble Alpes Univ, Dept Gen Practice, Grenoble, France; [Gaboreau, Yoann] Grenoble Aloes Univ, TIMC IMAG UMR 5525, Grenoble, France; [Bayen, Marc; Calafiore, Matthieu] Univ Lille, Dept Gen Practice, Lille, France; [Bertoletti, Laurent] CHU St Etienne, Dept Vasc Med & Therapeut, St Etienne, France	Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; Universite de Lille; CHU de St Etienne	Frappe, P (corresponding author), Univ St Etienne, Dept Gen Practice, St Etienne, France.; Frappe, P (corresponding author), Univ St Etienne, INSERM, U1059, Sainbiose DVH, St Etienne, France.; Frappe, P (corresponding author), CIC EC 1408, St Etienne, France.	paul.frappe@univ-st-etienne.ir	CALAFIORE, Matthieu/AAY-6286-2021; Bayen, Marc/Q-8802-2019; Gaboreau, Yoann/P-1069-2019; Bertoletti, Laurent/X-1319-2019	CALAFIORE, Matthieu/0000-0002-4755-5172; Bayen, Marc/0000-0002-9355-3434; Gaboreau, Yoann/0000-0002-8198-099X; Bertoletti, Laurent/0000-0001-8214-3010; COGNEAU, Joel/0000-0003-1673-7528	French government	French government	The CACAO study was supported by the French government (continuing professional development of investigators).	Agence Nationale de Se A curite A du Me A dicament (ANSM), AN VENT MED FRANC 20; Agence Nationale de Securite du Medicament et des Produits de Sante, RAPP ANT FRANC 2014; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bertoletti L, 2016, PHARM RES; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Davidson BL, 2014, JAMA INTERN MED, V174, P947, DOI 10.1001/jamainternmed.2014.946; Douketis J, 2014, CAN FAM PHYSICIAN, V60, P989; Douketis J, 2014, CAN FAM PHYSICIAN, V60, P997; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Kane-Gill SL, 2010, ANN PHARMACOTHER, V44, P983, DOI 10.1345/aph.1M726; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Kodani E, 2016, CIRC J, V80, P843, DOI 10.1253/circj.CJ-16-0066; Laporte S, 2016, PHARM RES; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rodriguez RA, 2013, J THROMB HAEMOST, V11, P390, DOI 10.1111/jth.12086; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Seeger JD, 2015, THROMB HAEMOSTASIS, V114, P1277, DOI 10.1160/TH15-06-0497; ten Cate V, 2016, NETH HEART J, V24, P574, DOI 10.1007/s12471-016-0874-y; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Villines TC, 2015, THROMB HAEMOSTASIS, V114, P1290, DOI 10.1160/TH15-06-0453	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175167	10.1371/journal.pone.0175167	http://dx.doi.org/10.1371/journal.pone.0175167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384199	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900107
J	Krishnappa, G; Singh, AM; Chaudhary, S; Ahlawat, AK; Singh, SK; Shukla, RB; Jaiswal, JP; Singh, GP; Solanki, IS				Krishnappa, Gopalareddy; Singh, Anju Mahendru; Chaudhary, Swati; Ahlawat, Arvind Kumar; Singh, Santosh Kumar; Shukla, Ram Bihari; Jaiswal, Jai Prakash; Singh, Gyanendra Pratap; Solanki, Ishwar Singh			Molecular mapping of the grain iron and zinc concentration, protein content and thousand kernel weight in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; QTL ANALYSIS; QUALITY TRAITS; DENSITY; ENVIRONMENT; POPULATION; GENOTYPE; IMPROVE; YIELD; LINES	Genomic regions responsible for accumulation of grain iron concentration (Fe), grain zinc concentration (Zn), grain protein content (PC) and thousand kernel weight (TKW) were investigated in 286 recombinant inbred lines (RILs) derived from a cross between an old Indian wheat variety WH542 and a synthetic derivative (Triticum dicoccon PI94624/Aegilops squarrosa [409]//BCN). RILs were grown in six environments and evaluated for Fe, Zn, PC, and TKW. The population showed the continuous distribution for all the four traits, that for pooled Fe and PC was near normal, whereas, for pooled Zn, RILs exhibited positively skewed distribution. A genetic map spanning 2155.3cM was constructed using microsatellite markers covering the 21 chromosomes and used for QTL analysis. 16 quantitative trait loci (QTL) were identified in this study. Four QTLs (QGFe. iari-2A, QGFe. iari-5A, QGFe. iari-7A and QGFe. iari-7B) for Fe, five QTLs (QGZn. iari-2A, QGZn. iari-4A, QGZn. iari-5A, QGZn. iari-7A and QGZn. iari-7B) for Zn, two QTLs (QGpc. iari-2A and QGpc. iari-3A) for PC, and five QTLs (QTkw. iari-1A, QTkw. iari-2A, QTkw. iari-2B, QTkw. iari-5B and QTkw. iari-7A) for TKW were identified. The QTLs together explained 20.0%, 32.0%, 24.1% and 32.3% phenotypic variation, respectively, for Fe, Zn, PC and TKW. QGpc. iari-2A was consistently expressed in all the six environments, whereas, QGFe. iari-7B and QGZn. iari-2A were identified in two environments each apart from pooled mean. QTkw. iari-2A and QTkw. iari-7A, respectively, were identified in four and three environments apart from pooled mean. A common region in the interval of Xgwm359-Xwmc407 on chromosome 2A was associated with Fe, Zn, and PC. One more QTL for TKW was identified on chromosome 2A but in a different chromosomal region (Xgwm382-Xgwm359). Two more regions on 5A (Xgwm126-Xgwm595) and 7A (Xbarc49-Xwmc525) were found to be associated with both Fe and Zn. A QTL for TKW was identified (Xwmc525-Xbarc222) in a different chromosomal region on the same chromosome (7A). This reflects at least a partly common genetic basis for the four traits. It is concluded that fine mapping of the regions of the three chromosomes of A genome involved in determining the accumulation of Fe, Zn, PC, and TKW in this mapping population may be rewarding.	[Krishnappa, Gopalareddy; Singh, Anju Mahendru; Chaudhary, Swati; Ahlawat, Arvind Kumar; Singh, Santosh Kumar; Shukla, Ram Bihari; Singh, Gyanendra Pratap] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Krishnappa, Gopalareddy] ICAR Indian Inst Wheat & Barley Res, Div Crop Improvement, Karnal, Haryana, India; [Jaiswal, Jai Prakash] Govind Ballabh Pant Univ Agr & Technol, Pantnagar, Uttarakhand, India; [Solanki, Ishwar Singh] ICAR Indian Agr Res Inst, Reg Stn, Samastipur, Bihar, India; [Singh, Santosh Kumar] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Singh, Gyanendra Pratap] ICAR Indian Inst Wheat & Barley Res, Karnal, Haryana, India; [Solanki, Ishwar Singh] Indian Council Agr Res, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Morehouse School of Medicine; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR)	Singh, AM (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	anju_mahendru@yahoo.co.in			DBT [BT/AGR/Wheat Bioforti/PH-II/2010]	DBT(Department of Biotechnology (DBT) India)	This work is a part outcome of a DBT funded project (BT/AGR/Wheat Bioforti/PH-II/2010) granted to AMS.; This work is a part outcome of a DBT funded project (BT/AGR/Wheat Bioforti/PH-II/2010) granted to AMS. Collaboration of HarvestPlus in calibration of the XRF machine and provision of glass based standards is also acknowledged.	[Anonymous], 2014, OPEN J GENET, DOI DOI 10.4236/OJGEN.2014.43024; Badakhshan H., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P57; Bouis HE, 2003, P NUTR SOC, V62, P403, DOI 10.1079/PNS2003262; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; de Benoist Bruno, 2008, WORLDWIDE PREVALENCE, V7; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Erba D, 2011, J CEREAL SCI, V54, P250, DOI 10.1016/j.jcs.2011.06.011; FAO, 2003, FOOD OUTL; Ficco DBM, 2009, FIELD CROP RES, V111, P235, DOI 10.1016/j.fcr.2008.12.010; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Gomez-Becerra HF, 2010, EUPHYTICA, V171, P39, DOI 10.1007/s10681-009-9987-3; Gonzalez-Hernandez JL, 2004, EUPHYTICA, V139, P217, DOI 10.1007/s10681-004-3157-4; Gopalareddy K, 2015, INDIAN J GENET PL BR, V75, P307, DOI 10.5958/0975-6906.2015.00048.6; Grusak MA, 2005, BIOL SCI SER, P265; Gupta V.S., 2011, J WHEAT RES, V3, P14; Hao YF, 2014, MOL BREEDING, V34, P1893, DOI 10.1007/s11032-014-0147-7; HarvestPlus, 2011, HARVESTPLUS ANN REPO; Horton S, 2008, CHALLENGE HUNGER MAL, P3; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; JANSEN RC, 1994, GENETICS, V136, P1447; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Kulwal Pawan, 2005, Functional & Integrative Genomics, V5, P254, DOI 10.1007/s10142-005-0136-3; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lincoln SE, 1993, CONSTRUCTING GENETIC; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Mergoum M., 2013, Journal of Plant Breeding and Genetics, V1, P19; Morgounov A, 2007, EUPHYTICA, V155, P193, DOI 10.1007/s10681-006-9321-2; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nezhad KZ, 2012, EUPHYTICA, V186, P127, DOI 10.1007/s10681-011-0559-y; Oury FX, 2006, EUR J AGRON, V25, P177, DOI 10.1016/j.eja.2006.04.011; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; PETERSON CJ, 1986, CEREAL CHEM, V63, P183; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Pu ZE, 2014, J INTEGR AGR, V13, P2322, DOI 10.1016/S2095-3119(13)60640-1; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Roder MS, 1998, GENETICS, V149, P2007; Roshanzamir H., 2013, IRAN J GENET PLANT B, V2, P551; Saleem N., 2015, Scientific Research and Essays, V10, P260; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; Solomons NW., 2003, ENCY FOOD SCI; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Srinivasa J, 2014, THEOR APPL GENET, V127, P1643, DOI 10.1007/s00122-014-2327-6; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Surma M, 2012, PLANT PROD SCI, V15, P192, DOI 10.1626/pps.15.192; Tiwari C, 2016, EUPHYTICA, V207, P563, DOI 10.1007/s10681-015-1544-7; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Velu G, 2012, FIELD CROP RES, V137, P261, DOI 10.1016/j.fcr.2012.07.018; Welch RM, 2005, J TRACE ELEM MED BIO, V18, P299, DOI 10.1016/j.jtemb.2005.03.001; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; Xu YF, 2012, FIELD CROP RES, V138, P57, DOI 10.1016/j.fcr.2012.09.017; Yasmin Z, 2014, CROP SCI, V54, P255, DOI 10.2135/cropsci2013.04.0214; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang H, 2016, CROP J, V4, P220, DOI 10.1016/j.cj.2016.01.007	61	48	48	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174972	10.1371/journal.pone.0174972	http://dx.doi.org/10.1371/journal.pone.0174972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384292	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900065
J	Kristen, AV; Maurer, MS; Rapezzi, C; Mundayat, R; Suhr, OB; Damy, T				Kristen, Arnt V.; Maurer, Mathew S.; Rapezzi, Claudio; Mundayat, Rajiv; Suhr, Ole B.; Damy, Thibaud		THAOS Investigators	Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)	PLOS ONE			English	Article							SENILE SYSTEMIC AMYLOIDOSIS; BRAIN NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; FIBRIL COMPOSITION; DISEASE SEVERITY; TROPONIN-T; WILD-TYPE; HEREDITARY; CARDIOMYOPATHY; SURVIVAL	Aim: Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin amyloidosis (ATTR) are lacking. Methods and results: Patients (n = 1617) with any of the following cardiac biomarkers, BNP (n = 1079), NT-proBNP (n = 550), troponin T (n = 274), and troponin I (n = 108), available at baseline in the Transthyretin Amyloidosis Outcomes Survey (THAOS) were analyzed for differences between genotypes and phenotypes and their association with survival. Median level of BNP was 68.0 pg/mL (IQR 30.5-194.9), NT-proBNP 337.9 pg/mL (IQR 73.0-2584.0), troponin T 0.03 mu g/L (IQR 0.01-0.05), and troponin I 0.08 mu g/L (IQR 0.04-0.13). NT-proBNP and BNP were higher in wild-type than mutant-type ATTR, troponin T and I did not differ, respectively. Non-Val30Met patients had higher BNP, NT-proBNP and troponin T levels than Val30Met patients, but not troponin I. Late-onset Val30Met was associated with higher levels of troponin I and troponin T compared with early-onset. 115 patients died during a median follow-up of 1.2 years. Mortality increased with increasing quartiles (BNP/NT-proBNP Q1 = 1.7%, Q2 = 5.2%, Q3 = 21.7%, Q4 = 71.3%; troponin T/I Q1 = 6.5%, Q2 = 14.5%, Q3 = 33.9%, Q4 = 45.2%). Three-year overall-survival estimates for BNP/NT-proBNP and troponin T/I quartiles differed significantly (p<0.001). Stepwise risk stratification was achieved by combining NT-proBNP/BNP and troponin T/I. From Cox proportional hazards model, age, modified body mass index, mutation (Val30Met vs. Non-Val30Met) and BNP/NT-proBNP (Q1-Q3 pooled vs. Q4) were identified as independent predictors of survival in patients with mutant-type ATTR. Conclusions: In this ATTR patient cohort, cardiac biomarkers were abnormal in a substantial percentage of patients irrespective of genotype. Along with age, mBMI, and mutation (Val30Met vs. Non-Val30Met), cardiac biomarkers were associated with surrogates of disease severity with BNP/NT-proBNP identified as an independent predictor of survival in ATTR.	[Kristen, Arnt V.] Heidelberg Univ, Dept Cardiol, Amyloidosis Ctr, Heidelberg, Germany; [Maurer, Mathew S.] Columbia Univ, Ctr Adv Cardiac Care, Med Ctr, New York, NY USA; [Rapezzi, Claudio] Univ Bologna, Inst Cardiol, Bologna, Italy; [Rapezzi, Claudio] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Mundayat, Rajiv] Pfizer Inc, New York, NY USA; [Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Damy, Thibaud] CHU Henri Mondor, Dept Cardiol, Amyloidosis Network, Creteil, France	Ruprecht Karls University Heidelberg; Columbia University; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Pfizer; Umea University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Kristen, AV (corresponding author), Heidelberg Univ, Dept Cardiol, Amyloidosis Ctr, Heidelberg, Germany.	Arnt_Kristen@med.uni-heidelberg.de	Conceicao, Isabel/AAC-6075-2022; Hazenberg, Bouke/I-2866-2016	Conceicao, Isabel/0000-0003-0934-9631; Judge, Daniel/0000-0002-3407-0248; Hazenberg, Bouke/0000-0003-1827-0482; Shah, Sanjiv/0000-0002-5655-8201	Pfizer Inc	Pfizer Inc(Pfizer)	THAOS registry is funded by Pfizer Inc. Data collection and analysis in THAOS were supported by Pfizer Inc. Pfizer Inc. provided financial support to enable the development and hosting of THAOS by a database vendor and provided compensation to survey sites for data reporting and quality of life assessment. A Scientific Board comprising participating physicians, clinical experts, and a medical representative of the sponsor gave a dviceon scientific and policy decisions and over saw data review and analysis. The funder provided statistical support, and the statistician participated as an author, but other than this, the funder had no role in the decision to publish, in the interpretation of the findings, or in the writing of the manuscript. Assistance in preparing the manuscript for submission (editing and formatting of tables and text) was provided by Shuang Li, PhD, at Engage Scientific and was funded by Pfizer Inc. The authors take full responsibility for the content of the article.	Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Benson MD, 2012, AMYLOID, V19, P14, DOI 10.3109/13506129.2012.668501; Coelho T, 2013, CURR MED RES OPIN, V29, P63, DOI 10.1185/03007995.2012.754348; Connors LH, 2011, AMYLOID, V18, P157, DOI 10.3109/13506129.2011.574354059; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Damy T, 2013, AMYLOID, V20, P212, DOI 10.3109/13506129.2013.825240; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Dispenzieri A, 2003, LANCET, V361, P1787, DOI 10.1016/S0140-6736(03)13396-X; Dungu JN, 2012, HEART, V98, P1546, DOI 10.1136/heartjnl-2012-301924; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hund E, 2001, NEUROLOGY, V56, P431, DOI 10.1212/WNL.56.4.431; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Jacobson DR, 1997, HUM MUTAT, V9, P83, DOI 10.1002/(SICI)1098-1004(1997)9:1<83::AID-HUMU19>3.0.CO;2-L; Kristen AV, 2013, INT J CARDIOL, V164, P179, DOI 10.1016/j.ijcard.2011.06.123; Kristen AV, 2010, BLOOD, V116, P2455, DOI 10.1182/blood-2010-02-267708; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lobato L, 2012, CLIN J AM SOC NEPHRO, V7, P1337, DOI 10.2215/CJN.08720811; Palladini G, 2003, CIRCULATION, V107, P2440, DOI 10.1161/01.CIR.0000068314.02595.B2; Plante-Bordeneuve V, 2013, CURR MED RES OPIN, V29, P77, DOI 10.1185/03007995.2012.754349; Rapezzi C, 2009, CIRCULATION, V120, P1203, DOI 10.1161/CIRCULATIONAHA.108.843334; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ruberg FL, 2012, AM HEART J, V164, P222, DOI 10.1016/j.ahj.2012.04.015; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; Steen H, 2006, J AM COLL CARDIOL, V48, P2192, DOI 10.1016/j.jacc.2006.06.002; Suhr OB, 2003, J INTERN MED, V254, P225, DOI 10.1046/j.1365-2796.2003.01173.x; Suhr OB, 2008, J INTERN MED, V263, P294, DOI 10.1111/j.1365-2796.2007.01888.x; Suhr OB, 2012, AMYLOID, V19, P78, DOI 10.3109/13506129.2012.673139; Westermark P, 2003, AMYLOID, V10, P48; Zand Parsa Amir Farhang, 2012, Indian Heart J, V64, P479, DOI 10.1016/j.ihj.2012.08.003	31	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173086	10.1371/journal.pone.0173086	http://dx.doi.org/10.1371/journal.pone.0173086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384285	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900005
J	Garcia-Morante, B; Segales, J; Fraile, L; Llarden, G; Coll, T; Sibila, M				Garcia-Morante, Beatriz; Segales, Joaquim; Fraile, Lorenzo; Llarden, Gemma; Coll, Teresa; Sibila, Marina			Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions	PLOS ONE			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; PULMONARY-LESIONS; INFECTED-PIGS; RISK-FACTORS; SWINE; PNEUMONIA; SLAUGHTER; SEROCONVERSION; DURATION; DISEASE	Immunopathological events are key for the development of enzootic pneumonia (EP), which is macroscopically observed as cranioventral pulmonary consolidation (CVPC). This study aimed to investigate the putative association between the humoral immune response against Mycoplasma hyopneumoniae (M. hyopneumoniae) and prevalence and extension of CVPC in 1) experimentally infected pigs, 2) slaughtered pigs and 3) sequentially necropsied pigs in a longitudinal study. CVPC was scored by means of the European Pharmacopoeia recommended methodology. Specific IgG, IgG1 and IgG2 antibodies were assessed in serum. In addition, mucosal IgG and IgA antibodies were analyzed in broncho-alveolar lavage fluid (BALF) from experimentally challenged pigs. The systemic humoral immune response in experimentally infected pigs was delayed in onset whereas humoral respiratory mucosal immune response appeared more rapidly but declined earlier. Although low, BALF IgG antibodies showed the highest correlation with CVPC scores (r = 0.49, p<0.05). In slaughter-aged pigs, both percentage of lungs with CVPC and mean lung lesion score were significantly higher in M. hyopneumoniae seropositive farms compared to the seronegative ones (p<0.001). Similarly, seropositive sequentially necropsied pigs showed more severe CVPC than seronegative ones. Overall, mean serological values might help to forecast prevalence and severity of EP-like lung lesions using a population based approach. Remarkably, the specific systemic humoral immune response was found to be predominated by the IgG2 subclass, suggesting a dominant Th1mediated immune response to M. hyopneumoniae.	[Garcia-Morante, Beatriz; Llarden, Gemma; Sibila, Marina] IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Garcia-Morante, Beatriz] Boehringer Ingelheim Espana SA, Sant Cugat Del Valles, Spain; [Segales, Joaquim] UAB, Ctr Recerca Sanitat Anim, IRTA UAB, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Segales, Joaquim] Fac Vet, Dept Sanitat & Anat Anim, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Fraile, Lorenzo] Univ Lleida, Dept Ciencia Anim, ETSEA, Lleida, Spain; [Coll, Teresa] Boehringer Ingelheim Vet Res Ctr GmbH&Co, Hannover, Germany	Autonomous University of Barcelona; IRTA; Boehringer Ingelheim; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Universitat de Lleida; Boehringer Ingelheim	Sibila, M (corresponding author), IRTA UAB, Ctr Recerca Sanitat Anim, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain.	marina.sibila@irta.cat	Segalés, Joaquim/A-4933-2011; Garcia Morante, Beatriz/AAV-4930-2020; Fraile, Lorenzo/AGE-2172-2022; Fraile, Lorenzo/GQQ-8989-2022; Fraile, Lorenzo/A-1142-2009; Segalés, Joaquim/AAB-4815-2020	Segalés, Joaquim/0000-0002-1539-7261; Garcia Morante, Beatriz/0000-0002-5610-9932; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Fraile, Lorenzo/0000-0002-8980-5862; Segalés, Joaquim/0000-0002-1539-7261; Sibila, Marina/0000-0003-3867-1988	Boehringer Ingelheim; Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate) [DI2013-0039]	Boehringer Ingelheim(Boehringer Ingelheim); Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate)	This work was supported by a collaborative agreement for independent research from Boehringer Ingelheim and a grant from Secretaria del Departament d'Economia i Creixement de la Generalitat de Catalunya (Industrial Doctorate: DI2013-0039). Boehringer Ingelheim provided support in the form of salaries for authors BGM and TC. The specific roles of BGM and TC are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen M, 2001, PREV VET MED, V52, P147, DOI 10.1016/S0167-5877(01)00242-2; Chase C.C., 2012, DIS SWINE, VTenth, P264; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; DAVIS JK, 1985, INFECT IMMUN, V50, P647, DOI 10.1128/IAI.50.3.647-654.1985; Fano E, 2005, CAN J VET RES, V69, P223; Feng ZX, 2014, VET J, V202, P128, DOI 10.1016/j.tvjl.2014.06.019; Fraile L, 2010, VET J, V184, P326, DOI 10.1016/j.tvjl.2009.03.029; Furesz SE, 1998, VACCINE, V16, P1971, DOI 10.1016/S0264-410X(98)00120-0; Garcia-Morante B, 2016, J COMP PATHOL, V154, P125, DOI 10.1016/j.jcpa.2015.11.003; Garcia-Morante B, 2016, VET RES, V47, DOI 10.1186/s13567-016-0340-2; HANNAN PCT, 1982, RES VET SCI, V33, P76, DOI 10.1016/S0034-5288(18)32364-6; Katayama M, 2011, ASIAN AUSTRAL J ANIM, V24, P889, DOI 10.5713/ajas.2011.10391; KOBISCH M, 1993, VET RES, V24, P67; Madec F, 1982, J RECH PORCINE FRANC, V14, P405; Merialdi G, 2012, VET J, V193, P234, DOI 10.1016/j.tvjl.2011.11.009; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; MORRIS CR, 1995, PREV VET MED, V21, P323, DOI 10.1016/0167-5877(94)00384-U; Muneta Y, 2008, J VET MED SCI, V70, P1065, DOI 10.1292/jvms.70.1065; Nathues H, 2014, TRANSBOUND EMERG DIS, V61, P316, DOI 10.1111/tbed.12033; NOYES EP, 1990, J AM VET MED ASSOC, V197, P1025; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Park SC, 2002, INFECT IMMUN, V70, P2502, DOI 10.1128/IAI.70.5.2502-2506.2002; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Raymond BBA, 2016, P 4 VETPATH C PATH B; Raymond CR, 2004, VACCINE, V22, P1016, DOI 10.1016/j.vaccine.2003.08.026; Redondo E, 2009, J COMP PATHOL, V140, P260, DOI 10.1016/j.jcpa.2008.12.008; Sarradell J, 2003, VET PATHOL, V40, P395, DOI 10.1354/vp.40-4-395; Sibila M, 2007, VET MICROBIOL, V122, P97, DOI 10.1016/j.vetmic.2007.01.010; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Sitjar M., 1996, Swine Health and Production, V4, P273; Sorensen V, 1997, VET MICROBIOL, V54, P23, DOI 10.1016/S0378-1135(96)01266-7; SUTER M, 1985, INFECT IMMUN, V49, P615, DOI 10.1128/IAI.49.3.615-620.1985; Thacker EL., 2019, DIS SWINE, P779; VANTIL LD, 1991, CAN J VET RES, V55, P347; Vranckx K, 2012, VET MICROBIOL, V156, P315, DOI 10.1016/j.vetmic.2011.11.007; Walker J, 1996, VET IMMUNOL IMMUNOP, V54, P197, DOI 10.1016/S0165-2427(96)05709-1; WALLGREN P, 1994, J VET MED B, V41, P441, DOI 10.1111/j.1439-0450.1994.tb00249.x; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875; YAGIHASHI T, 1993, VET MICROBIOL, V34, P155, DOI 10.1016/0378-1135(93)90169-8	39	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175034	10.1371/journal.pone.0175034	http://dx.doi.org/10.1371/journal.pone.0175034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380065	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500089
J	Nooij, SAE; Pretto, P; Oberfeld, D; Hecht, H; Bulthoff, HH				Nooij, Suzanne A. E.; Pretto, Paolo; Oberfeld, Daniel; Hecht, Heiko; Buelthoff, Heinrich H.			Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories	PLOS ONE			English	Article							CALCULATING CORRELATION-COEFFICIENTS; OPTOKINETIC DRUM; POSTURAL INSTABILITY; SIMULATOR SICKNESS; PERIPHERAL-VISION; CIRCULAR VECTION; MIXED-MODEL; NYSTAGMUS; SEVERITY; FIELD	This study investigated the role of vection (i.e., a visually induced sense of self-motion), optokinetic nystagmus (OKN), and inadvertent head movements in visually induced motion sickness (VIMS), evoked by yaw rotation of the visual surround. These three elements have all been proposed as contributing factors in VIMS, as they can be linked to different motion sickness theories. However, a full understanding of the role of each factor is still lacking because independent manipulation has proven difficult in the past. We adopted an integrative approach to the problem by obtaining measures of potentially relevant parameters in four experimental conditions and subsequently combining them in a linear mixed regression model. To that end, participants were exposed to visual yaw rotation in four separate sessions. Using a full factorial design, the OKN was manipulated by a fixation target (present/absent), and vection strength by introducing a conflict in the motion direction of the central and peripheral field of view (present/absent). In all conditions, head movements were minimized as much as possible. Measured parameters included vection strength, vection variability, OKN slow phase velocity, OKN frequency, the number of inadvertent head movements, and inadvertent head tilt. Results show that VIMS increases with vection strength, but that this relation varies among participants (R-2 = 0.48). Regression parameters for vection variability, head and eye movement parameters were not significant. These results may seem to be in line with the Sensory Conflict theory on motion sickness, but we argue that a more detailed definition of the exact nature of the conflict is required to fully appreciate the relationship between vection and VIMS.	[Nooij, Suzanne A. E.; Pretto, Paolo; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Oberfeld, Daniel; Hecht, Heiko] Johannes Gutenberg Univ Mainz, Dept Expt Psychol, Mainz, Germany	Max Planck Society; Johannes Gutenberg University of Mainz	Nooij, SAE (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	suzanne.nooij@tuebingen.mpg.de	Oberfeld, Daniel/A-7997-2008; Hecht, Heiko/H-3106-2011; Pretto, Paolo/AAZ-8895-2021; Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Oberfeld, Daniel/0000-0002-6710-3309; Hecht, Heiko/0000-0001-9418-862X; Bülthoff, Heinrich H/0000-0003-2568-0607; Pretto, Paolo/0000-0003-3922-3108	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are very grateful to Daniel Diers for programming the visual stimuli, and to two anonymous reviewers for comments on an earlier version of this manuscript. This study was funded by the Max Planck Society.	Becker W, 2002, EXP BRAIN RES, V144, P554, DOI 10.1007/s00221-002-1104-y; BEHRENS F, 1992, VISION RES, V32, P889, DOI 10.1016/0042-6989(92)90031-D; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Bonato F, 2006, PERCEPTION, V35, P53, DOI 10.1068/p5062; Bonato F, 2005, AVIAT SPACE ENVIR MD, V76, P823; Bonato F, 2004, AVIAT SPACE ENVIR MD, V75, P306; Bonato F, 2008, PRESENCE-TELEOP VIRT, V17, P283, DOI 10.1162/pres.17.3.283; Bonato F, 2015, AEROSP MED HUM PERF, V86, P440, DOI 10.3357/AMHP.4105.2015; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Bubka A, 2003, AVIAT SPACE ENVIR MD, V74, P315; Bubka A, 2006, AVIAT SPACE ENVIR MD, V77, P811; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; CRAMPTON GH, 1953, J COMP PHYSIOL PSYCH, V46, P451, DOI 10.1037/h0058423; DICHGANS J, 1973, ACTA OTO-LARYNGOL, V76, P339, DOI 10.3109/00016487309121519; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; EBENHOLTZ SM, 1994, AVIAT SPACE ENVIR MD, V65, P1032; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Faugloire E, 2007, EXP BRAIN RES, V177, P520, DOI 10.1007/s00221-006-0700-7; Fischer MH, 1930, J PSYCHOL NEUROL, V41, P273; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; Flanagan MB, 2002, AVIAT SPACE ENVIR MD, V73, P1067; Fouladi RT, 2004, COMMUN STAT-SIMUL C, V33, P807, DOI 10.1081/SAC-200033260; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Golding JF, 2009, AVIAT SPACE ENVIR MD, V80, P516, DOI 10.3357/ASEM.2433.2009; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Hu SQ, 1997, AVIAT SPACE ENVIR MD, V68, P306; HU SQ, 1989, AVIAT SPACE ENVIR MD, V60, P411; Hu SQ, 1998, AVIAT SPACE ENVIR MD, V69, P1162; HU SQ, 1991, AVIAT SPACE ENVIR MD, V62, P308; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Keshavarz B., 2015, FRONT PSYCHOL, V6; Keshavarz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101016; Keshavarz B, 2011, DISPLAYS, V32, P181, DOI 10.1016/j.displa.2011.05.009; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Palmisano S, 2007, AVIAT SPACE ENVIR MD, V78, P951, DOI 10.3357/ASEM.2079.2007; Prothero JD, 1999, AVIAT SPACE ENVIR MD, V70, P277; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Skene SS, 2010, STAT MED, V29, P2825, DOI 10.1002/sim.4073; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; STERN RM, 1985, AVIAT SPACE ENVIR MD, V56, P1074; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; Stern RM, 1987, GASTROENTEROLOGY, V92, P92, DOI 10.1016/0016-5085(87)90843-2; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Webb NA, 2003, AVIAT SPACE ENVIR MD, V74, P622; Webb NA, 2002, AVIAT SPACE ENVIR MD, V73, P351; Welsch R, 1980, REGRESSION DIAGNOSTI; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; YANG TD, 1991, AVIAT SPACE ENVIR MD, V62, P141; YOUNG LR, 1975, AVIAT SPACE ENVIR MD, V46, P264	60	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175305	10.1371/journal.pone.0175305	http://dx.doi.org/10.1371/journal.pone.0175305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380077	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500116
J	Rosenholm, M; Paro, E; Antila, H; Voikar, V; Rantamaki, T				Rosenholm, Marko; Paro, Emmi; Antila, Hanna; Voikar, Vootele; Rantamaki, Tomi			Repeated brief isoflurane anesthesia during early postnatal development produces negligible changes on adult behavior in male mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; REPEATED MATERNAL SEPARATION; EARLY EXPOSURE; APOPTOTIC NEURODEGENERATION; SEVOFLURANE ANESTHESIA; PREPULSE INHIBITION; DEVELOPING BRAIN; NEONATAL-RATS; MOUSE STRAINS; BIRTH COHORT	Brain development is a complex process regulated by genetic programs and activity-dependent neuronal connectivity. Anesthetics profoundly alter neuronal excitability, and anesthesia during early brain development has been consistently associated with neuroapoptosis, altered synaptogenesis, and persistent behavioral abnormalities in experimental animals. However, the depth, and even more the duration and developmental time point(s) of exposure to anesthesia determine the neuropathological and long-term behavioral consequences of anesthetics. Here, we have investigated adulthood phenotypic changes induced by repeated but brief (30 min) isoflurane anesthesia delivered during two distinct developmental periods in male mice. A set of animals were subjected to anesthesia treatments at postnatal days 7, 8 and 9 (P7-9) when the animals are susceptible to anesthesia-induced neuroapoptosis and reduced synaptogenesis. To control the potential influence of (handling) stress, a separate group of animals underwent repeated maternal separations of similar durations. Another set of animals were exposed to the same treatments at postnatal days 15, 16 and 17 (P15-17), a developmental time period when anesthetics have been shown to increase synaptogenesis. Starting from postnatal week 9 the mouse phenotype was evaluated using a battery of behavioral tests that assess general locomotor activity (home cage activity, open field), learning and memory (water maze) and depression- (saccharin preference, forced swim test), anxiety- (light-dark box, stress-induced hyperthermia) and schizophrenia- (nesting, prepulse inhibition) related endophenotypes. Apart from mild impairment in spatial navigation memory, exposure to anesthesia treatments during P7-9 did not bring obvious behavioral alterations in adult animals. Importantly, maternal separation during the same developmental period produced a very similar phenotype during the water maze. Mice exposed to anesthesia during P15-17 showed mild hyperactivity and risk-taking behavior in adulthood, but were otherwise normal. We conclude that significantly longer administration periods are needed in order for early-life repeated exposures to anesthetics to produce behavioral alterations in adult mice.	[Rosenholm, Marko; Paro, Emmi; Rantamaki, Tomi] Univ Helsinki, Lab Neurotherapeut, Div Physiol & Neurosci, Fac Biol & Environm Sci,Dept Biosci, Helsinki, Finland; [Antila, Hanna; Voikar, Vootele] Univ Helsinki, Neurosci Ctr, Helsinki Inst Life Sci, Helsinki, Finland	University of Helsinki; University of Helsinki	Rantamaki, T (corresponding author), Univ Helsinki, Lab Neurotherapeut, Div Physiol & Neurosci, Fac Biol & Environm Sci,Dept Biosci, Helsinki, Finland.	tomi.rantamaki@heisinki.fi	Voikar, Vootele/V-4542-2019	Voikar, Vootele/0000-0003-4201-8666; Antila, Hanna/0000-0001-8317-4564; Rosenholm, Marko/0000-0002-5437-8282; Rantamaki, Tomi/0000-0002-0052-1434	Academy of Finland [276333, 284569]; Biocenter Finland; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Biocenter Finland; Jane and Aatos Erkko Foundation	This study has been supported by the Academy of Finland (T.R.; grant numbers 276333, 284569). Animal phenotyping was conducted at the Mouse Phenotypic Core Facility (Neuroscience Center, University of Helsinki, Finland) supported by Biocenter Finland and Jane and Aatos Erkko Foundation (V.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; Ben-Ari Y, 2013, HDB CLIN NEUROLOGY; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cao WG, 2012, ANESTHESIOLOGY, V117, P791, DOI 10.1097/ALN.0b013e318266c62d; Creeley CE, 2010, ANESTH ANALG, V110, P442, DOI 10.1213/ANE.0b013e3181c6b9ca; Darbra S, 2013, PSYCHONEUROENDOCRINO, V38, P1397, DOI 10.1016/j.psyneuen.2012.12.007; De Roo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007043; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jeevakumar V, 2015, BEHAV BRAIN RES, V282, P165, DOI 10.1016/j.bbr.2015.01.010; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; JL. Response to neonatal anesthesia, 2008, NEUROSCIENCE, V152, P959; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kohtala S, 2016, ACS CHEM NEUROSCI; Lee B.H., 2014, PLOS ONE, V9; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Mehta M, 2011, BEHAV NEUROSCI, V125, P29, DOI 10.1037/a0021952; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Pedersen CS, 2014, BEHAV BRAIN RES, V273, P63, DOI 10.1016/j.bbr.2014.07.023; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Qiu L, 2016, TOXICOL SCI, V149, P121, DOI 10.1093/toxsci/kfv219; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shen XF, 2013, NEUROTOXICOLOGY, V39, P45, DOI 10.1016/j.neuro.2013.08.007; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tagawa T, 2014, J ANESTH, V28, P815, DOI 10.1007/s00540-014-1822-x; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu CQ, 2015, PSYCHONEUROENDOCRINO, V60, P173, DOI 10.1016/j.psyneuen.2015.06.016; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099171; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	44	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175258	10.1371/journal.pone.0175258	http://dx.doi.org/10.1371/journal.pone.0175258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380075	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500113
J	Weng, SF; Reps, J; Kai, J; Garibaldi, JM; Qureshi, N				Weng, Stephen F.; Reps, Jenna; Kai, Joe; Garibaldi, Jonathan M.; Qureshi, Nadeem			Can machine-learning improve cardiovascular risk prediction using routine clinical data?	PLOS ONE			English	Article							CORONARY EVENTS; VALIDATION; MODELS; REGRESSION; DISEASE; MUNSTER; PROFILE; WOMEN; MEN	Background Current approaches to predict cardiovascular risk fail to identify many people who would benefit from preventive treatment, while others receive unnecessary intervention. Machinelearning offers opportunity to improve accuracy by exploiting complex interactions between risk factors. We assessed whether machine-learning can improve cardiovascular risk prediction. Methods Prospective cohort study using routine clinical data of 378,256 patients from UK family practices, free from cardiovascular disease at outset. Four machine-learning algorithms (random forest, logistic regression, gradient boosting machines, neural networks) were compared to an established algorithm (American College of Cardiology guidelines) to predict first cardiovascular event over 10-years. Predictive accuracy was assessed by area under the 'receiver operating curve' (AUC); and sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) to predict 7.5% cardiovascular risk (threshold for initiating statins). Findings 24,970 incident cardiovascular events (6.6%) occurred. Compared to the established risk prediction algorithm (AUC 0.728, 95% CI 0.723-0.735), machine-learning algorithms improved prediction: random forest + 1.7% (AUC 0.745, 95% CI 0.739-0.750), logistic regression + 3.2% (AUC 0.760, 95% CI 0.755-0.766), gradient boosting + 3.3% (AUC 0.761, 95% CI 0.755-0.766), neural networks + 3.6% (AUC 0.764, 95% CI 0.759-0.769). The highest achieving (neural networks) algorithm predicted 4,998/7,404 cases (sensitivity 67.5%, PPV 18.4%) and 53,458/75,585 non-cases (specificity 70.7%, NPV 95.7%), correctly predicting 355 (+ 7.6%) more patients who developed cardiovascular disease compared to the established algorithm. Conclusions Machine-learning significantly improves accuracy of cardiovascular risk prediction, increasing the number of patients identified who could benefit from preventive treatment, while avoiding unnecessary treatment of others.	[Weng, Stephen F.; Kai, Joe; Qureshi, Nadeem] Univ Nottingham, NIHR Sch Primary Care Res, Nottingham, England; [Weng, Stephen F.; Kai, Joe; Qureshi, Nadeem] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [Reps, Jenna; Garibaldi, Jonathan M.] Univ Nottingham, Adv Data Anal Ctr, Nottingham, England; [Reps, Jenna; Garibaldi, Jonathan M.] Univ Nottingham, Sch Comp Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Weng, SF (corresponding author), Univ Nottingham, NIHR Sch Primary Care Res, Nottingham, England.; Weng, SF (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England.	stephen.weng@nottingham.ac.uk		Kai, Joe/0000-0001-9040-9384; Qureshi, Nadeem/0000-0003-4909-0644; Weng, Stephen/0000-0002-5281-9590	National Institute for Health Research School for Primary Care Research (NIHR SPCR); National Institute for Health Research [SPCR-098] Funding Source: researchfish	National Institute for Health Research School for Primary Care Research (NIHR SPCR); National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR): personal training fellowship award for SW from 2015-2018. URL:https//www.spcr.nihr.ac.uk/trainees. The views expressed are those of the authors and not necessarily those of the NIHR, the NHS, or the Department of Health.; This paper presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR): post-doctoral training fellowship award (URL: https://www.spcr.nihr.ac.uk/trainees). The views expressed are those of the authors and not necessarily those of the NIHR, the NHS, or the Department of Health.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Batista GEAPA, 2003, APPL ARTIF INTELL, V17, P519, DOI 10.1080/08839510390219309; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Berglund E, 2013, PATIENT EDUC COUNS, V91, P105, DOI 10.1016/j.pec.2012.11.001; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32333; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Goff DC, 2013, CIRCULATION, V135, P1; Hagan M.T., 2014, NEURAL NETWORK DESIG; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kennedy EH, 2013, MED CARE, V51, P251, DOI 10.1097/MLR.0b013e31827da594; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Mason Jennifer E, 2010, Prev Cardiol, V13, P36, DOI 10.1111/j.1751-7141.2009.00054.x; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; NHS England Board, 2015, PERS MED STRAT; NICE (National Institute for Health and Care Excellence), 2014, CARD DIS RISK ASS RE; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9; Osborn DPJ, 2015, JAMA PSYCHIAT, V72, P143, DOI 10.1001/jamapsychiatry.2014.2133; Precision Medicine Initiative (PMI) Working Group, 2015, PREC MED IN COH PROG; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253; Waljee AK, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.19; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557; Weng SF, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000272; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	43	439	455	6	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174944	10.1371/journal.pone.0174944	http://dx.doi.org/10.1371/journal.pone.0174944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376093	Green Published, gold, Green Submitted			2022-12-26	WOS:000399352000025
J	Mulinta, R; Yao, SYM; Ng, AML; Cass, CE; Young, JD				Mulinta, Ras; Yao, Sylvia Y. M.; Ng, Amy M. L.; Cass, Carol E.; Young, James D.			Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GLUTAMATE RESIDUES; CRYSTAL-STRUCTURE; NUCLEOBASE TRANSPORT; MECHANISTIC INSIGHTS; MOLECULAR-CLONING; RECOMBINANT HUMAN; NA+; IDENTIFICATION; PURINE; EXPRESSION	The human SLC28 family of concentrative nucleoside transporter (CNT) proteins has three members: hCNT1, hCNT2, and hCNT3. Na+-coupled hCNT1 and hCNT2 transport pyrimidine and purine nucleosides, respectively, whereas hCNT3 transports both pyrimidine and purine nucleosides utilizing Na+ and/or H+ electrochemical gradients. Escherichia coli CNT family member NupC resembles hCNT1 in permeant selectivity but is H+-coupled. Using heterologous expression in Xenopus oocytes and the engineered cysteine-less hCNT3 protein hCNT3(C-), substituted cysteine accessibility method analysis with the membrane-impermeant thiol reactive reagent p-chloromercuribenzene sulfonate was performed on the transport domain (interfacial helix 2, hairpin 1, putative transmembrane domain (TM) 7, and TM8), as well as TM9 of the scaffold domain of the protein. This systematic scan of the entire C-terminal half of hCNT3(C-) together with parallel studies of the transport domain of wild-type hCNT1 and the corresponding TMs of cysteine-less NupC(C-) yielded results that validate the newly developed structural homology model of CNT membrane architecture for human CNTs, revealed extended conformationally mobile regions within transport-domain TMs, identified porelining residues of functional importance, and provided evidence of an emerging novel elevator-type mechanism of transporter function.	[Mulinta, Ras; Yao, Sylvia Y. M.; Ng, Amy M. L.; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Young, JD (corresponding author), Univ Alberta, Dept Physiol, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Wellcome Trust.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; CHE MX, 1995, J BIOL CHEM, V270, P13596, DOI 10.1074/jbc.270.23.13596; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Johnson ZL, 2014, ELIFE, V3, DOI 10.7554/eLife.03604; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; McCoy JG, 2016, STRUCTURE, V24, P956, DOI 10.1016/j.str.2016.04.003; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Mulligan C, 2016, NAT STRUCT MOL BIOL, V23, P256, DOI 10.1038/nsmb.3166; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Slugoski MD, 2009, J BIOL CHEM, V284, P17266, DOI 10.1074/jbc.M109.009613; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Vergara-Jaque A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00183; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wohlert D, 2015, ELIFE, V4, DOI 10.7554/eLife.09375; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao S. Y. M., 2000, MEMBRANE TRANSPORT P; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	58	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9505	9522		10.1074/jbc.M116.743997	http://dx.doi.org/10.1074/jbc.M116.743997			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28385889	Green Published, hybrid			2022-12-26	WOS:000403113000006
J	Jacob, H; Pouil, S; Lecchini, D; Oberhansli, F; Swarzenski, P; Metian, M				Jacob, Hugo; Pouil, Simon; Lecchini, David; Oberhaensli, Francois; Swarzenski, Peter; Metian, Marc			Trophic transfer of essential elements in the clownfish Amphiprion ocellaris in the context of ocean acidification	PLOS ONE			English	Article							MARINE ORGANISMS; METAL; LARVAE; FISH; RADIONUCLIDES; PH	Little information exists on the effects of ocean acidification (OA) on the digestive and post-digestive processes in marine fish. Here, we investigated OA impacts (Delta pH = 0.5) on the trophic transfer of select trace elements in the clownfish Amphiprion ocellaris using radiotracer techniques. Assimilation efficiencies of three essential elements (Co, Mn and Zn) as well as their other short-term and long-term kinetic parameters in juvenile clownfish were not affected by this experimental pH change. In complement, their stomach pH during digestion were not affected by the variation in seawater pH. Such observations suggest that OA impacts do not affect element assimilation in these fish. This apparent pCO(2) tolerance may imply that clownfish have the ability to self-regulate pH shifts in their digestive tract, or that they can metabolically accommodate such shifts. Such results are important to accurately assess future OA impacts on diverse marine biota, as such impacts are highly species specific, complex, and may be modulated by species-specific metabolic processes.	[Jacob, Hugo; Pouil, Simon; Oberhaensli, Francois; Swarzenski, Peter; Metian, Marc] IAEA, Environm Labs, 4a Quai Antoine 1er, Monaco, Monaco; [Jacob, Hugo; Lecchini, David] Univ Perpignan, CNRS EPHE UPVD, USR 3278, PSL, Via Domitia, Perpignan, France; [Pouil, Simon] Univ La Rochelle, CNRS, Littoral Environm & Societes LIENSs, UMR 7266, 2 Rue Olympe Gouges, La Rochelle, France; [Lecchini, David] Lab Excellence CORAIL, Moorea, French Polynesi, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Metian, M (corresponding author), IAEA, Environm Labs, 4a Quai Antoine 1er, Monaco, Monaco.	m.metian@iaea.org	Swarzenski, Peter/AAD-8562-2022; Pouil, Simon/J-6839-2019; Metian, Marc/F-8010-2018	Pouil, Simon/0000-0003-1531-0362; Metian, Marc/0000-0003-1485-5029; Jacob, Hugo/0000-0002-3376-8425; Swarzenski, Peter/0000-0003-0116-0578	IAEA; CNRS-EPHE-UPVD [USR 3278]; IAEA by the Government of the Principality of Monaco	IAEA(International Atomic Energy Agency); CNRS-EPHE-UPVD; IAEA by the Government of the Principality of Monaco	The work was supported by funds from IAEA and USR 3278 CNRS-EPHE-UPVD. The IAEA is grateful for the support provided to its Environment Laboratories by the Government of the Principality of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank IAEA OA-ICC team and especially Jean-Louis Teyssie A for their very useful help in the experimental design of the experiments. The work was supported by funds from IAEA and USR 3278 CNRS-EPHE-UPVD. The IAEA is grateful for the support provided to its Environment Laboratories by the Government of the Principality of Monaco.	Bignami S, 2013, GLOBAL CHANGE BIOL, V19, P996, DOI 10.1111/gcb.12133; BREMNER I, 1981, PHILOS T R SOC B, V294, P75, DOI 10.1098/rstb.1981.0090; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Deguara S, 2003, J FISH BIOL, V62, P1033, DOI 10.1046/j.1095-8649.2003.00094.x; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gattuso J.-P., 2015, COMPREHENSIVE R ARCH; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Heuer RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34480; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Heuer RM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P450, DOI 10.1086/667617; Hurst TP, 2012, AQUAT BIOL, V17, P247, DOI 10.3354/ab00483; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Ivanina AV, 2015, CURR ZOOL, V61, P653, DOI 10.1093/czoolo/61.4.653; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Metian M, 2010, MAR POLLUT BULL, V61, P576, DOI 10.1016/j.marpolbul.2010.06.035; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Norin T, 2016, J FISH BIOL, V88, P122, DOI 10.1111/jfb.12796; Perry DM, 2015, ECOL EVOL, V5, P4187, DOI 10.1002/ece3.1678; Perry SF, 2006, RESP PHYSIOL NEUROBI, V154, P199, DOI 10.1016/j.resp.2006.04.010; Pimentel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134082; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Pouil S, 2016, MAR ECOL PROG SER, V550, P207, DOI 10.3354/meps11716; Pouil S, 2015, J ENVIRON RADIOACTIV, V150, P189, DOI 10.1016/j.jenvrad.2015.08.016; Reinardy HC, 2011, SCI TOTAL ENVIRON, V409, P3771, DOI 10.1016/j.scitotenv.2011.06.057; Rosa R, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2840-z; Rosa R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1738; Wallace WG, 2003, MAR ECOL PROG SER, V257, P125, DOI 10.3354/meps257125; Wang WX, 1999, SCI TOTAL ENVIRON, V238, P459; Warnau M, 1996, MAR ECOL PROG SER, V141, P83, DOI 10.3354/meps141083; Welch MJ, 2016, CORAL REEFS, V35, P485, DOI 10.1007/s00338-015-1385-9; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Yufera M, 2004, MAR BIOL, V144, P863, DOI 10.1007/s00227-003-1255-9	37	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174344	10.1371/journal.pone.0174344	http://dx.doi.org/10.1371/journal.pone.0174344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399186	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000009
J	Li, YZ; Fan, XW; Chen, Q; Zhong, H				Li, You-Zhi; Fan, Xian-Wei; Chen, Qiang; Zhong, Hao			A photoperiod-responsive protein compendium and conceptual proteome roadmap outline in maize grown in growth chambers with controlled conditions	PLOS ONE			English	Article							CAT3 CATALASE GENE; CIRCADIAN REGULATION; ARABIDOPSIS; SENSITIVITY; PLANTS; LEAVES; COINCIDENCE; TRANSITION; EXPRESSION; TOLERANCE	Maize (Zea mays L.) is one of the major staple food crops of the world. However, high photoperiod sensitivity, especially for tropical germplasms, impedes attempts to improve maize agronomical traits by integration of tropical and temperate maize germplasms. Physiological and phenotypic responses of maize to photoperiod have widely been investigated based on multi-site field observations; however, proteome-based responsive mechanisms under controlled photoperiod regimes, nutrient and moisture soils are not yet well understood. In the present study, we sequenced and analyzed six proteomes of tropically-adapted and photo-period-sensitive M9 inbred line at the vegetative 3 stage and proteomes from tropically-adapted and photoperiod-sensitive Shuang M9 (SM9) inbred line at the vegetative-tasseling stage. All plants were grown in growth chambers with controlled soil and temperature and three photoperiod regimes, a short photoperiod (SP) of 10 h light/14 h dark, a control neutral photoperiod (NP) of 12 h light/12 h dark, and a long photoperiod (LP) of 16 h light/8 h dark for a daily cycle. We identified 4,395 proteins of which 401 and 425 differentially-expressed proteins (DPs) were found in abundance in M9 leaves and in SM9 leaves as per SP/LP vs. NP, respectively. Some DPs showed responses to both SP and LP while some only responded to either SP or LP, depending on M9 or SM9. Our study showed that the photoperiodic response pathway, circadian clock rhythm, and high light density/intensity crosstalk with each other, but apparently differ from dark signaling routes. Photoperiod response involves light-responsive or dark-responsive proteins or both. The DPs positioned on the signaling routes from photoperiod changes to RNA/DNA responses involve the mago nashi homolog and glycine-rich RNA-binding proteins. Moreover, the cell-to-cell movement of ZCN14 through plasmodesmata is likely blocked under a 16-h-light LP. Here, we propose a photoperiodic model based on our findings and those from previous studies.	[Li, You-Zhi; Fan, Xian-Wei; Chen, Qiang; Zhong, Hao] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China	Guangxi University	Li, YZ (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China.	dyzl@gxu.edu.cn			State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; High-Quality Teaching Project of Guangxi High Education -Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China	State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; High-Quality Teaching Project of Guangxi High Education -Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China	The State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, and the High-Quality Teaching Project of Guangxi High Education 2016-Subproject of Advantageous and Characteristic Specialty (Excellent Undergraduate Major), China.	Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; BOLDT R, 1995, PLANT J, V7, P989, DOI 10.1046/j.1365-313X.1995.07060989.x; BROADWATER AH, 1993, GENE, V131, P227, DOI 10.1016/0378-1119(93)90297-G; Chen Q, 2015, PLANT CELL ENVIRON, V38, P1479, DOI 10.1111/pce.12361; Clarke JH, 1999, PLANT J, V20, P493, DOI 10.1046/j.1365-313x.1999.00623.x; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Dell'Amico J, 2001, PLANT SCI, V160, P481, DOI 10.1016/S0168-9452(00)00409-X; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; Dodd IC, 2008, PLANT CELL ENVIRON, V31, P1263, DOI 10.1111/j.1365-3040.2008.01831.x; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Gouesnard B, 2002, GENET RESOUR CROP EV, V49, P471, DOI 10.1023/A:1020982827604; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Grundy J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00648; Gulyas Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-91; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Han X, 2016, MOL PLANT, V9, P46, DOI 10.1016/j.molp.2015.08.015; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kellogg EA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00250; Lewis RS, 2003, THEOR APPL GENET, V107, P798, DOI 10.1007/s00122-003-1341-x; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; REDINBAUGH MG, 1990, P NATL ACAD SCI USA, V87, P6853, DOI 10.1073/pnas.87.17.6853; Sager R, 2014, J EXP BOT, V65, P6337, DOI 10.1093/jxb/eru365; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; Shim JS, 2015, BIOCHEMISTRY-US, V54, P157, DOI 10.1021/bi500922q; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Voss I, 2013, PLANT BIOLOGY, V15, P713, DOI 10.1111/j.1438-8677.2012.00710.x; Wang CL, 2008, THEOR APPL GENET, V117, P1129, DOI 10.1007/s00122-008-0851-y; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang W, 2006, ACTA HISTOCHEM, V108, P395, DOI 10.1016/j.acthis.2006.06.003; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Xu J, 2012, J INTEGR PLANT BIOL, V54, P358, DOI 10.1111/j.1744-7909.2012.01128.x; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Zhao DZ, 2009, SEX PLANT REPROD, V22, P221, DOI 10.1007/s00497-009-0106-3	44	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174003	10.1371/journal.pone.0174003	http://dx.doi.org/10.1371/journal.pone.0174003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399169	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000007
J	Park, JW; Park, KH; Jung, EY; Choi, SH; Jang, JA; Yoo, HN				Park, Jeong Woo; Park, Kyo Hoon; Jung, Eun Young; Choi, Soo-Hyun; Jang, Ji Ae; Yoo, Ha-Na			Short cervical lengths initially detected in mid-trimester and early in the third trimester in asymptomatic twin gestations: Association with histologic chorioamnionitis and preterm birth	PLOS ONE			English	Article							INTRAAMNIOTIC INFECTION; PLACENTAL HISTOLOGY; AMNIOTIC-FLUID; PREGNANCIES; PREDICTION; METAANALYSIS; WOMEN; RISK; MORBIDITY; LABOR	Objective To determine whether short cervical lengths (<= 20 mm) that were initially detected in mid- trimester and early in the third trimester are independently associated with increased risks of subsequent histologic chorioamnionitis and spontaneous preterm birth (SPTB, defined as a delivery before 34 weeks) in asymptomatic women with twin pregnancies. Material and methods This is a prospective study including 292 consecutive asymptomatic women with twin gestations. Cervical length measurements were carried out at 20 to 24 weeks' gestation and at 28 to 32 weeks' gestation. Both placentas of each twin pair were examined histologically after delivery. The generalized estimation equations models and logistic regression analysis were used for statistical analyses. Results Multivariable generalized estimation equations analysis revealed that short cervical length at mid-trimester was independently associated with an increased risk for subsequent histologic chorioamnionitis, whereas short cervical length initially detected early in the third trimester was not. By using the likelihood of SPTB as an outcome variable, multivariable logistic regression analysis indicated that short mid- trimester cervical length and histologic chorioamnionitis were independently associated with a greater risk for SPTB. Similarly, based on the multivariable analysis, a short third trimester cervical length was independently and significantly associated with a greater risk for SPTB. Conclusions In asymptomatic women with twin pregnancies, a short mid-trimester cervical length is independently associated with an increased risk of both subsequent histologic chorioamnionitis and SPTB, whereas a short cervical length initially detected early in the third trimester is independently associated with preterm delivery, but not subsequent histologic chorioamnionitis.	[Park, Jeong Woo] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Obstet & Gynecol, Gyeonggi, South Korea; [Park, Jeong Woo; Park, Kyo Hoon] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Kyo Hoon; Jung, Eun Young; Choi, Soo-Hyun; Jang, Ji Ae; Yoo, Ha-Na] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org		Park, Jeong Woo/0000-0001-6499-0814	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HI 14C1798).	Bartmann C, 2014, AM J REPROD IMMUNOL, V71, P109, DOI 10.1111/aji.12185; Cho SH, 2017, J KOREAN MED SCI, V32, P488, DOI 10.3346/jkms.2017.32.3.488; Conde-Agudelo A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.064; Dulay AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.040; Ehsanipoor RM, 2012, ULTRASOUND OBST GYN, V40, P81, DOI 10.1002/uog.10130; Esplin MS, 2014, CLIN OBSTET GYNECOL, V57, P518, DOI 10.1097/GRF.0000000000000037; Fuchs F, 2016, SEMIN FETAL NEONAT M, V21, P113, DOI 10.1016/j.siny.2015.12.010; Fujita MM, 2002, ACTA OBSTET GYN SCAN, V81, P856, DOI 10.1034/j.1600-0412.2002.810910.x; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1047, DOI 10.1016/S0002-9378(96)80051-2; Guzman ER, 1999, AM J OBSTET GYNECOL, V181, P793, DOI 10.1016/S0002-9378(99)70303-0; Hassan S, 2006, J PERINAT MED, V34, P13, DOI 10.1515/JPM.2006.002; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Jams JD., 1997, AM J OBSTET GYNECOL, V176, pS6; Kalan AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.013; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Kindinger LM, 2016, BJOG-INT J OBSTET GY, V123, P877, DOI 10.1111/1471-0528.13575; Langston C, 1997, ARCH PATHOL LAB MED, V121, P449; Lim AC, 2011, ULTRASOUND OBST GYN, V38, P10, DOI 10.1002/uog.9013; Martin JA, 2011, NATL VITAL STAT REP, V60, P1; Mazor M, 1996, ACTA OBSTET GYN SCAN, V75, P624, DOI 10.3109/00016349609054686; Meath AI, 2005, AM J OBSTET GYNECOL, V192, P1410, DOI 10.1016/j.ajog.2005.01.033; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Oncel MY, 2013, ARCH GYNECOL OBSTET, V287, P893, DOI 10.1007/s00404-012-2678-7; Pelaez LM, 2010, J PERINAT MED, V38, P485, DOI [10.1515/JPM.2010.077, 10.1515/jpm.2010.077]; Phung DT, 2002, AM J OBSTET GYNECOL, V186, P1041, DOI 10.1067/mob.2002.122449; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P757, DOI 10.1016/0002-9378(90)91063-I; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Saccone G, 2015, ACTA OBSTET GYN SCAN, V94, P352, DOI 10.1111/aogs.12600; Suh YH, 2007, J KOREAN MED SCI, V22, P89, DOI 10.3346/jkms.2007.22.1.89; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; van der Ven AJ, 2015, EUR J OBSTET GYN R B, V188, P12, DOI 10.1016/j.ejogrb.2015.02.032; Vayssiere C, 2005, ULTRASOUND OBST GYN, V26, P707, DOI 10.1002/uog.2616; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	34	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175455	10.1371/journal.pone.0175455	http://dx.doi.org/10.1371/journal.pone.0175455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399138	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000038
J	Jirsova, D; Stefka, J; Jirku, M				Jirsova, Dagmar; Stefka, Jan; Jirku, Miloslav			Discordant population histories of host and its parasite: A role for ecological permeability of extreme environment?	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; GENETIC DIVERSITY; CESTODA CARYOPHYLLIDEA; HAEMONCHUS-CONTORTUS; DIVERGENT SELECTION; MITOCHONDRIAL-DNA; MALARIA PARASITES; LOCAL ADAPTATION; FAUNAL TURNOVER; CICHLID FISHES	Biogeographical and ecological barriers strongly affect the course of micro-evolutionary processes in free living organisms. Here we assess the impact of a recently emerged barrier on populations of limnic fauna. Genetic diversity and population structure in a host-parasite system (Wenyonia virilis tapeworm, Synodontis schall catfish) are analyzed in the recently divided Turkana and Nile basins. The two basins, were repeatedly connected during the Holocene wet/dry climatic oscillations, following late Pleistocene dessication of the Turkana basin. Mitochondrial DNA sequences for cytochrome oxidase I gene (cox I) and a whole genome scanning method amplified fragment length polymorphism (AFLP) were employed. A total of 347 cox I sequences (representing 209 haplotypes) and 716 AFLP fragments, as well as 120 cox I sequences (20 haplotypes) and 532 AFLP fragments were obtained from parasites and hosts, respectively. Although results indicate that host and parasite populations share some formative traits (bottlenecks, Nilotic origin), their population histories/patterns differ markedly. Mitochondrial analysis revealed that parasite populations evolve significantly faster and show remarkably higher genetic variability. Analyses of both markers confirmed that the parasites undergo lineage fission, forming new clusters specific for either freshwater or saline parts of Lake Turkana. In congruence with the geological history, these clusters apparently indicate multiple colonisations of Lake Turkana from the Nile. In contrast, the host population pattern indicates fusion of different colonisation waves. Although fish host populations remain connected, saline habitats in Lake Turkana (absent in the Nile), apparently pose a barrier to the gene flow in the parasite, possibly due to its multihost lifecycle, which involves freshwater annelids. Despite partially corroborating mitochondrial results, AFLP data was not sufficiently informative for analyzing populations with recently mixed biogeographic histories.	[Jirsova, Dagmar; Stefka, Jan] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Jirsova, Dagmar; Stefka, Jan; Jirku, Miloslav] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Jirsova, D (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Jirsova, D (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.	dasa.jirsova@gmail.com	Štefka, Jan/G-9267-2014; Jirku, Miloslav/G-7823-2014; Štefka, Jan/N-3924-2019	Štefka, Jan/0000-0002-1283-9730; Jirku, Miloslav/0000-0002-4258-6543; Štefka, Jan/0000-0002-1283-9730; Jirsova, Dagmar/0000-0002-1099-8076				Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Barrows TT, 2014, GEOLOGY, V42, P163, DOI 10.1130/G35238.1; Beerli P, 1997, MIGRATE DOCUMENTATIO; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Berg PR, 2015, GENOME BIOL EVOL, V7, P1644, DOI 10.1093/gbe/evv093; Best A, 2009, AM NAT, V173, P779, DOI 10.1086/598494; Bloszies C, 2015, GLOBAL PLANET CHANGE, V132, P64, DOI 10.1016/j.gloplacha.2015.06.006; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Camberlin P, 2009, MONOGR BIOL, V89, P307; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Day T, 2007, P ROY SOC B-BIOL SCI, V274, P2685, DOI 10.1098/rspb.2007.0809; de Gruijter JM, 2006, MOL CELL PROBE, V20, P317, DOI 10.1016/j.mcp.2006.03.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumont HJ, 2009, MONOGR BIOL, V89, P1; Elmer KR, 2009, P NATL ACAD SCI USA, V106, P13404, DOI 10.1073/pnas.0902299106; Emerson BC, 2014, MOL ECOL, V23, P5132, DOI 10.1111/mec.12951; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folkertsma RT, 1996, MOL PLANT MICROBE IN, V9, P47, DOI 10.1094/MPMI-9-0047; FRANK SA, 1993, EVOLUTION, V47, P1721, DOI 10.2307/2410216; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Froese R, 2014, FISHBASE INTERNET VE; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Garrick RC, 2014, MOL ECOL, V23, P5276, DOI 10.1111/mec.12919; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; Goodier SAM, 2011, PLOS ONE, P6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HARVEY CPD, 1982, GEOGR J, V148, P327, DOI 10.2307/633150; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hopson A, 1982, 19721975 OV DEV ADM, V1-6; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson KP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2174; Johnson T. C., 2009, LAKE TURKANA ITS LIN, P287; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kautt AF, 2012, MOL ECOL, V21, P4770, DOI 10.1111/j.1365-294X.2012.05738.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan Shahid M., 2013, Evolution Medicine and Public Health, P3, DOI 10.1093/emph/eos003; Koop JAH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0255; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lundberg J.G., 1998, PHYLOGENY CLASSIFICA, P603; MACKIEWICZ JS, 1972, EXP PARASITOL, V31, P417, DOI 10.1016/0014-4894(72)90103-8; Mariaux J, 2008, ZOOL J LINN SOC-LOND, V152, P367, DOI 10.1111/j.1096-3642.2007.00332.x; Martinelli A, 2004, MOL BIOCHEM PARASIT, V136, P117, DOI 10.1016/j.molbiopara.2004.02.011; Mattersdorfer K, 2012, MOL ECOL, V21, P3531, DOI 10.1111/j.1365-294X.2012.05634.x; Matthee CA, 2004, P ROY SOC B-BIOL SCI, V271, P1967, DOI 10.1098/rspb.2004.2806; McKee JK, 2001, PALEOBIOLOGY, V27, P500, DOI 10.1666/0094-8373(2001)027<0500:FTRAMB>2.0.CO;2; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Nejsum P, 2006, VET PARASITOL, V139, P203, DOI 10.1016/j.vetpar.2006.02.025; NYAMWERU C, 1989, GEOGR J, V155, P179, DOI 10.2307/635059; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otero O, 2001, PALAEOGEOGR PALAEOCL, V165, P141, DOI 10.1016/S0031-0182(00)00158-9; Otsen M, 2001, INT J PARASITOL, V31, P1138, DOI 10.1016/S0020-7519(01)00225-9; Patra KP, 2007, EXP PARASITOL, V116, P59, DOI 10.1016/j.exppara.2006.11.011; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinton A, 2013, MOL PHYLOGENET EVOL, V66, P1027, DOI 10.1016/j.ympev.2012.12.009; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Ricketts RD, 1998, LIMNOL OCEANOGR, V43, P811, DOI 10.4319/lo.1998.43.5.0811; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos MH, 2004, INT J PARASITOL, V34, P109, DOI 10.1016/j.ijpara.2003.10.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sambrook J, 2001, MOLECULAR CLONING SA; Schaeffner BC, 2011, SYST PARASITOL, V79, P83, DOI 10.1007/s11230-011-9290-2; Scholz T., 1998, TAPEWORMS GENUS PROT; Scholz T, 2011, FOLIA PARASIT, V58, P197, DOI 10.14411/fp.2011.020; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Simo G, 2008, EXP PARASITOL, V118, P172, DOI 10.1016/j.exppara.2007.07.010; Spurgin LG, 2014, MOL ECOL, V23, P1028, DOI 10.1111/mec.12672; Stefka J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-284; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; Tandon R, 2005, INT J PARASITOL, V35, P813, DOI 10.1016/j.ijpara.2005.02.004; van der Veer M, 2003, EXP PARASITOL, V104, P70, DOI 10.1016/S0014-4894(03)00116-4; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wagner CE, 2014, ECOL LETT, V17, P583, DOI 10.1111/ele.12260; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3; Xu DD, 2013, MAR BIOTECHNOL, V15, P221, DOI 10.1007/s10126-012-9480-1; Zwickl D.J., 2006, THESIS, P115	95	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175286	10.1371/journal.pone.0175286	http://dx.doi.org/10.1371/journal.pone.0175286			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394904	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800025
J	Liu, IW; Ho, BL; Chen, CF; Han, K; Lin, CJ; Sheng, WY; Hu, HH; Chao, AC				Liu, I-Wen; Ho, Bo-Lin; Chen, Chien-Fu; Han, Ke; Lin, Chung-Jung; Sheng, Wen-Yung; Hu, Han-Hwa; Chao, A-Ching			Vertebral artery terminating in posterior inferior cerebellar artery: A normal variation with clinical significance	PLOS ONE			English	Article							CEREBRAL VASOMOTOR REACTIVITY; VASCULAR DEMENTIA; ISCHEMIC-STROKE; HYPOPLASIA; OCCLUSION; ULTRASONOGRAPHY; MANIPULATION; CIRCULATION; NECK	A vertebral artery (VA) terminating in a posterior inferior cerebellar artery (PICA) is often considered to be a normal variation associated with VA hypoplasia. We aimed to investigate the clinical significance of this cerebrovascular variant. A total of 80 patients with clinically evident cerebrovascular events in posterior circulation were examined by duplex sonography and magnetic resonance angiography (MRA). Eighty healthy subjects who had MRA check-up were recruited as controls. PICA termination of the VA (PICA-VA) was identified as the VA not communicating with the basilar artery (BA) but ending into a PICA. We compared the prevalence of PICA-VA and associated hemodynamic parameters between the patients with and without PICA-VA, and investigated their relationships with VA hypoplasia. The prevalence of PICA-VA was higher in the patient group than in the controls (18.7% vs. 6.3%, p = 0.015). Most measurements (73.3%) of PICA-VA did not fit the criteria of VA hypoplasia. In comparison with the non-PICA-terminating group, the PICA-VA has a smaller diameter (3.7 +/- 0.7 mm vs. 3.0 +/- 0.5 mm, p < 0.001), lower mean velocity (241 +/- 100 mm/ sec vs. 164 +/- 88 mm/ sec, p < 0.01), and higher pulsatility index (1.3 +/- 0.5 vs. 1.9 +/- 0.6, p < 0.001). Moreover, a smaller diameter of the BA (3.2 +/- 0.5 mm vs. 2.5 +/- 0.9 mm, p = 0.004) and the posterior cerebral artery (PCA) (2.0 +/- 0.1 mm vs. 1.6 +/- 0.1 mm, p = 0.006) were also noted in the PICA-VA group. The higher prevalence of PICA-VA in the patient group with smaller diameter of VA, BA and PCA reflected its clinical significance, suggesting that PICA-VA may have a detrimental impact on cerebral hemodynamics. However, the sample is small, and further studies are needed with larger sample size for confirmation.	[Liu, I-Wen; Sheng, Wen-Yung; Hu, Han-Hwa] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Ho, Bo-Lin; Chen, Chien-Fu; Chao, A-Ching] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Ho, Bo-Lin] Kaohsiung Municipal Gangshan Hosp, Dept Neurol, Kaohsiung, Taiwan; [Han, Ke] Jilin Univ, Dept Neurol, Hosp 1, Changchun, Kagawa, Peoples R China; [Han, Ke] Jilin Univ, Neurosci Ctr, Hosp 1, Changchun, Kagawa, Peoples R China; [Lin, Chung-Jung] Natl Yang Ming Univ, Dept Radiol, Taipei Vet Gen Hosp, Sch Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ & Hosp, Coll Med, Dept Neurol, Taipei, Taiwan; [Chao, A-Ching] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan	Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Jilin University; Jilin University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University	Chao, AC (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Chao, AC (corresponding author), Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan.	achch@cc.kmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST104-2314-B-037-029]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST104-2314-B-037-029).	Asil T, 2005, J ULTRAS MED, V24, P1065, DOI 10.7863/jum.2005.24.8.1065; Brandt T, 2005, NEUROLOGY, V65, P1156, DOI 10.1212/01.wnl.0000183154.93624.ac; Chen YY, 2010, ULTRASOUND MED BIOL, V36, P38, DOI 10.1016/j.ultrasmedbio.2009.08.012; Chuang YM, 2006, EUR NEUROL, V55, P193, DOI 10.1159/000093868; FRISONI GB, 1991, STROKE, V22, P1452, DOI 10.1161/01.STR.22.11.1452; Greenberg MS, 2010, HDB NEUROSURGERY, P102; Jeng JS, 2004, ULTRASOUND MED BIOL, V30, P605, DOI 10.1016/j.ultrasmedbio.2004.03.004; Marti S, 2008, J NEUROL, V255, P663, DOI 10.1007/s00415-008-0773-2; MEHALIC T, 1974, SURG NEUROL, V2, P125; MULLER M, 1995, STROKE, V26, P96, DOI 10.1161/01.STR.26.1.96; Noh Y, 2011, J NEUROL, V258, P1775, DOI 10.1007/s00415-011-6005-1; Park JH, 2007, J NEUROL NEUROSUR PS, V78, P954, DOI 10.1136/jnnp.2006.105767; Perren F, 2007, NEUROLOGY, V68, P65, DOI 10.1212/01.wnl.0000250258.76706.98; Saito K, 2004, STROKE, V35, P1068, DOI 10.1161/01.STR.0000125857.63427.59; SCHELLHAS KP, 1980, JAMA-J AM MED ASSOC, V244, P1450, DOI 10.1001/jama.244.13.1450; Siclari F, 2007, AM J NEURORADIOL, V28, P1185, DOI 10.3174/ajnr.A0498; Strupp M, 2000, NEUROLOGY, V54, P1376, DOI 10.1212/WNL.54.6.1376; Tsivgoulis G, 2014, J ALZHEIMERS DIS, V42, pS251, DOI 10.3233/JAD-132441; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; Yeh Ju-Fen, 2005, Acta Neurol Taiwan, V14, P69; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	22	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e175264	10.1371/journal.pone.0175264	http://dx.doi.org/10.1371/journal.pone.0175264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394897	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800022
J	Tolnai, S; Beutelmann, R; Klump, GM				Tolnai, Sandra; Beutelmann, Rainer; Klump, Georg M.			Exploring binaural hearing in gerbils (Meriones unguiculatus) using virtual headphones	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; MEDIAL SUPERIOR OLIVE; SOUND LOCALIZATION; BEHAVIORAL SENSITIVITY; MONGOLIAN GERBIL; COINCIDENCE DETECTION; DIRECTIONAL HEARING; LATERAL POSITION; DUPLEX THEORY; SPATIAL CUES	The Mongolian gerbil (Meriones unguiculatus) has become a key species in investigations of the neural processing of sound localization cues in mammals. While its sound localization has been tested extensively under free-field stimulation, many neurophysiological studies use headphones to present signals with binaural localization cues. The gerbil's behavioral sensitivity to binaural cues, however, is unknown for the lack of appropriate stimulation paradigms in awake behaving gerbils. We close this gap in knowledge by mimicking a head-phone stimulation; we use free-field loudspeakers and apply cross-talk cancellation techniques to present pure tones with binaural cues via "virtual headphones" to gerbils trained in a sound localization task. All gerbils were able to lateralize sounds depending on the inter-aural time or level difference (ITD and ILD, respectively). For ITD stimuli, reliable responses were seen for frequencies <= 2.9 kHz, the highest frequency tested with ITD stimuli. ITD sensitivity was frequency-dependent with the highest sensitivity observed at 1 kHz. For stimuli with ITD outside the gerbil's physiological range, responses were cyclic indicating the use of phase information when lateralizing narrow-band sounds. For ILD stimuli, reliable responses were obtained for frequencies >= 2 kHz. The comparison of ITD and ILD thresholds with ITD and ILD thresholds derived from gerbils' free-field performance suggests that ongoing ITD information is the main cue for sound localization at frequencies <2kHz. At 2 kHz, ITD and ILD cues are likely used in a complementary way. Verification of the use of the virtual headphones suggests that they can serve as a suitable substitute for conventional headphones particularly at frequencies <= 2 kHz.	[Tolnai, Sandra; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Cluster Excellence Hearing4all, Dept Neurosci,Sch Med & Hlth Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Tolnai, S (corresponding author), Carl von Ossietzky Univ Oldenburg, Anim Physiol & Behav Grp, Cluster Excellence Hearing4all, Dept Neurosci,Sch Med & Hlth Sci, Oldenburg, Germany.	sandra.tolnai@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft); Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft); A*MIDEX grant - French Government "Investissements d'Avenir" program [ANR-11-IDEX-0001-02]	CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft); Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft); A*MIDEX grant - French Government "Investissements d'Avenir" program(French National Research Agency (ANR))	Support was provided by CRC/Transregio 31 "The Active Auditory System" (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/) (to GMK); and Cluster of Excellence "Hearing4all" EXC1077 (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/) (to GMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Lena Wallbach, Janna Henrike Mrozek, Linda Arfmann, and Jeremy Giroud for their contribution to data collection and excellent care of the animals during the time of data collection. Jeremy Giroud was supported by the A*MIDEX grant (no ANR-11-IDEX-0001-02) funded by the French Government "Investissements d'Avenir" program. We also wish to thank the two anonymous reviewers for their valuable and appreciated	Akeroyd MA, 2007, J ACOUST SOC AM, V121, P1056, DOI 10.1121/1.2404625; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Bungert-Kahl P., 2004, Zeitschrift fur Audiologie, V43, P48; Carney LH, 2011, HEARING RES, V275, P89, DOI 10.1016/j.heares.2010.12.006; DAMASKE P, 1971, J ACOUST SOC AM, V50, P1109, DOI 10.1121/1.1912742; Dietz M, 2014, J NEUROPHYSIOL, V111, P1973, DOI 10.1152/jn.00681.2013; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; DON M, 1972, J NEUROPHYSIOL, V35, P493, DOI 10.1152/jn.1972.35.4.493; Ebert CS, 2008, HEARING RES, V235, P134, DOI 10.1016/j.heares.2007.11.003; Feinkohl A, 2016, HEARING RES, V332, P238, DOI 10.1016/j.heares.2015.04.001; Franken TP, 2015, NAT NEUROSCI, V18, P444, DOI 10.1038/nn.3948; Gai Y, 2014, J NEUROPHYSIOL, V112, P802, DOI 10.1152/jn.00044.2013; Gourevitch B, 2012, J ACOUST SOC AM, V132, P9, DOI 10.1121/1.4726052; Green D, 2000, SIGNAL DETECTION THE; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; HOUBEN D, 1979, J ACOUST SOC AM, V66, P1057, DOI 10.1121/1.383377; Keating P, 2014, EUR J NEUROSCI, V39, P197, DOI 10.1111/ejn.12402; Keating P, 2013, JARO-J ASSOC RES OTO, V14, P561, DOI 10.1007/s10162-013-0390-3; Klinge A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026124; KLUMPP RG, 1956, J ACOUST SOC AM, V28, P859, DOI 10.1121/1.1908493; Laumen G, 2016, HEARING RES, V337, P46, DOI 10.1016/j.heares.2016.04.009; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; Maier JK, 2006, J ACOUST SOC AM, V119, P1029, DOI 10.1121/1.2159429; Maki K, 2005, J ACOUST SOC AM, V118, P872, DOI 10.1121/1.1944647; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Plauska A, 2016, J NEUROPHYSIOL, V115, P2950, DOI 10.1152/jn.01146.2015; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Saberi K, 1998, P NATL ACAD SCI USA, V95, P6465, DOI 10.1073/pnas.95.11.6465; SAYERS BM, 1964, J ACOUST SOC AM, V36, P923, DOI 10.1121/1.1919121; SHACKLETON TM, 1991, Q J EXP PSYCHOL-A, V43, P503, DOI 10.1080/14640749108400984; Stange A, 2013, NAT NEUROSCI, V16, P1840, DOI 10.1038/nn.3548; Sumner CJ, 2012, EUR J NEUROSCI, V36, P2428, DOI 10.1111/j.1460-9568.2012.08151.x; Takeuchi T, 2001, J ACOUST SOC AM, V109, P958, DOI 10.1121/1.1349539; Tolnai S, 2017, EUR J NEUROSCI, V45, P460, DOI 10.1111/ejn.13491; TRAHIOTIS C, 1989, J ACOUST SOC AM, V86, P1285, DOI 10.1121/1.398743; van der Heijden M, 2013, NEURON, V78, P936, DOI 10.1016/j.neuron.2013.04.028; Versteegh CPC, 2011, JARO-J ASSOC RES OTO, V12, P301, DOI 10.1007/s10162-010-0255-y; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WAKEFORD OS, 1974, J ACOUST SOC AM, V55, P649, DOI 10.1121/1.1914577; Welch TE, 2011, J ACOUST SOC AM, V130, P2293, DOI 10.1121/1.3628335; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; YOST WA, 1981, J ACOUST SOC AM, V70, P397, DOI 10.1121/1.386775; Young ED, 1996, J ACOUST SOC AM, V99, P3064, DOI 10.1121/1.414883; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175142	10.1371/journal.pone.0175142	http://dx.doi.org/10.1371/journal.pone.0175142			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394906	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000399954800018
J	Yamane, H; Takakura, A; Shimadzu, Y; Kodama, T; Lee, JW; Isogai, Y; Ishizuya, T; Takao-Kawabata, R; Iimura, T				Yamane, Hiroshi; Takakura, Aya; Shimadzu, Yukari; Kodama, Toshiyuki; Lee, Ji-Won; Isogai, Yukihiro; Ishizuya, Toshinori; Takao-Kawabata, Ryoko; Iimura, Tadahiro			Acute development of cortical porosity and endosteal naive bone formation from the daily but not weekly short-term administration of PTH in rabbit	PLOS ONE			English	Article							OVARIECTOMIZED CYNOMOLGUS MONKEYS; HUMAN PARATHYROID HORMONE(1-34); POSTMENOPAUSAL WOMEN; FIBROUS DYSPLASIA; MARROW FIBROSIS; DISTAL RADIUS; MECHANICAL-PROPERTIES; VERTEBRAL FRACTURES; TURNOVER MARKERS; THINNER CORTICES	Teriparatide [human parathyroid hormone (1-34)], which exerts an anabolic effect on bone, is used for the treatment of osteoporosis in patients who are at a high risk for fracture. That the once-daily administration of teriparatide causes an increase in cortical porosity in animal models and clinical studies has been a matter of concern. However, it is not well documented that the frequency of administration and/or the total dose of teriparatide affect the cortical porosity. The present study developed 4 teriparatide regimens [20 mu g/kg/day (D20), 40 mu g/kg/day (D40), 140 mu g/kg/week (W140) and 280 mu g/kg/week (W280)] in the rabbit as a model animal with a well-developed Haversian system and osteons. The total weekly doses were equivalent in the low-dose groups (D20 and W140) and in the high-dose groups (D40 and W280). After the short-term (1 month) administration of TPDT, micro-CT, histomorphometry and three-dimensional second harmonic generation (3D-SHG) imaging to visualize the bone collagen demonstrated that daily regimens but not weekly regimens were associated with the significant development of cortical porosity and endosteal naive bone formation by marrow fibrosis. We concomitantly monitored the pharmacokinetics of the plasma teriparatide levels as well as the temporal changes in markers of bone formation and resorption. The analyses in the present study suggested that the daily repeated administration of teriparatide causes more deleterious changes in the cortical microarchitecture than the less frequent administration of higher doses. The findings of the present study may have some implications for use of teriparatide in clinical treatment.	[Yamane, Hiroshi; Takakura, Aya; Shimadzu, Yukari; Isogai, Yukihiro; Ishizuya, Toshinori; Takao-Kawabata, Ryoko] Asahi Kasei Pharma Corp, Pharmaceut Res Ctr, Lab Pharmacol, Shizuoka, Japan; [Takakura, Aya; Iimura, Tadahiro] Ehime Univ, Grad Sch Med, Div Analyt Biomed, Toon City, Ehime, Japan; [Kodama, Toshiyuki] Asahi Kasei Pharma Corp, Lab Safety Assessment & ADME, Pharmaceut Res Ctr, Shizuoka, Japan; [Lee, Ji-Won; Iimura, Tadahiro] Ehime Univ, Div Bioimaging Proteosci Ctr PROS, Toon City, Ehime, Japan; [Isogai, Yukihiro] Asahi Kasei Pharma Corp, Pharmaceut Business Adm Div, Med Affairs Dept, Tokyo, Japan; [Iimura, Tadahiro] Ehime Univ, Div Analyt Biomed, Adv Res Support Ctr ADRES, Toon City, Ehime, Japan; [Iimura, Tadahiro] Ehime Univ Hosp, Artificial Joint Integrated Ctr, Toon City, Ehime, Japan	Asahi Kasei Pharma Corporation; Ehime University; Asahi Kasei Pharma Corporation; Ehime University; Asahi Kasei Pharma Corporation; Ehime University; Ehime University	Takao-Kawabata, R (corresponding author), Asahi Kasei Pharma Corp, Pharmaceut Res Ctr, Lab Pharmacol, Shizuoka, Japan.; Iimura, T (corresponding author), Ehime Univ, Grad Sch Med, Div Analyt Biomed, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ, Div Bioimaging Proteosci Ctr PROS, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ, Div Analyt Biomed, Adv Res Support Ctr ADRES, Toon City, Ehime, Japan.; Iimura, T (corresponding author), Ehime Univ Hosp, Artificial Joint Integrated Ctr, Toon City, Ehime, Japan.	takao.rb@om.asahi-kasei.co.jp; iimura@m.ehime-u.ac.jp	Iimura, Tadahiro/P-3550-2018	Iimura, Tadahiro/0000-0002-1431-0689; Takao-Kawabata, Ryoko/0000-0002-6811-7526	Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project [2014-241]; Asahi Kasei Pharma Corporation;  [16K20412];  [26293392]	Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project; Asahi Kasei Pharma Corporation; ; 	This study was funded by the Asahi Kasei Pharma Corporation. The funder provided support in the form of salaries for authors [HY, AT, YS, TK, YI, Tol, and RT-K], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was also partly supported by Grant Numbers 16K20412 and 26293392 to J-WL and Tal, respectively. This work was also partly supported by The Institute of Medical Science, The University of Tokyo: IMSUT Joint Research Project (2014-241) to Tal.	Bala Y, 2015, CURR OPIN RHEUMATOL, V27, P406, DOI 10.1097/BOR.0000000000000183; Bandeira L, 2016, F1000RES, P5; Black DM, 2008, J CLIN ENDOCR METAB, V93, P2166, DOI 10.1210/jc.2007-2781; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Burr DB, 2001, J BONE MINER RES, V16, P157, DOI 10.1359/jbmr.2001.16.1.157; Chen PQ, 2005, J BONE MINER RES, V20, P962, DOI 10.1359/JBMR.050105; Diab T, 2006, BONE, V38, P427, DOI 10.1016/j.bone.2005.09.002; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Fox J, 2006, CALCIFIED TISSUE INT, V79, P262, DOI 10.1007/s00223-006-0108-1; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Glorieux FH, 2006, J BONE MINER RES, V21, pP110, DOI 10.1359/JBMR.06S221; Hansen MF, 2006, J BONE MINER RES, V21, pP58, DOI 10.1359/JBMR.06S211; Hansen S, 2013, J BONE MINER RES, V28, P736, DOI 10.1002/jbmr.1784; Hirano T, 2000, CALCIFIED TISSUE INT, V66, P456, DOI 10.1007/s002230010091; Hirano T, 1999, J BONE MINER RES, V14, P536, DOI 10.1359/jbmr.1999.14.4.536; Inoue J, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P409; Jee W. S. S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P232; Jerome CP, 2001, BONE, V28, P150, DOI 10.1016/S8756-3282(00)00430-0; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Lotinun S, 2005, ENDOCRINOLOGY, V146, P4074, DOI 10.1210/en.2005-0480; Marie PJ, 1997, AM J PATHOL, V150, P1059; Miller MA, 2008, BONE, V42, P1175, DOI 10.1016/j.bone.2008.01.029; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Rubin MR, 2002, OSTEOPOROSIS INT, V13, P267, DOI 10.1007/s001980200026; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Shigdel R, 2015, BONE, V81, P1, DOI 10.1016/j.bone.2015.06.016; Stein EM, 2013, J BONE MINER RES, V28, P1029, DOI 10.1002/jbmr.1841; Sugimoto T, 2014, OSTEOPOROSIS INT, V25, P1173, DOI 10.1007/s00198-013-2516-1; Takakura A, 2017, BONE RESEARCH FORTHC; Takao-Kawabata R, 2015, CALCIFIED TISSUE INT, V97, P156, DOI 10.1007/s00223-015-9998-0; UZAWA T, 1995, BONE, V16, P477; Weinstein LS, 2006, J BONE MINER RES, V21, pP120, DOI 10.1359/JBMR.06S223; Yamamoto T, 2016, ENDOCRINOLOGY, V157, P2604, DOI 10.1210/en.2015-2028; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175329	10.1371/journal.pone.0175329	http://dx.doi.org/10.1371/journal.pone.0175329			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394900	gold, Green Published, Green Submitted			2022-12-26	WOS:000399954800028
J	Hwang, DJ; Lee, KM; Park, MS; Choi, SH; Park, JI; Cho, JH; Park, KH; Woo, SJ				Hwang, Duck Jin; Lee, Kyoung Min; Park, Moon Seok; Choi, Sung Hee; Park, Ji In; Cho, Joon Hee; Park, Kyu Hyung; Woo, Se Joon			Association between diabetic foot ulcer and diabetic retinopathy	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; RISK-FACTORS; PREVALENCE; NEUROPATHY; EPIDEMIOLOGY; PREDICTION; AMPUTATION; MORBIDITY; PRESSURE; MELLITUS	Purpose We aimed to investigate the prevalence of diabetic retinopathy (DR) in patients with diabetic foot ulcer (DFU) and elucidate the association between DR and DFU severities and their shared risk factors. Methods A retrospective review was conducted on DFU patients who underwent ophthalmic and vascular examinations within 6 months; 100 type 2 diabetic patients with DFU were included. The medical records of 2496 type 2 diabetic patients without DFU served as control data. DR prevalence and severity were assessed in DFU patients. DFU patients were compared with the control group regarding each clinical variable. Additionally, DFU patients were divided into two groups according to DR severity and compared. Results Out of 100 DFU patients, 90 patients (90%) had DR and 55 (55%) had proliferative DR (PDR). There was no significant association between DR and DFU severities (R = 0.034, p = 0.734). A multivariable analysis comparing type 2 diabetic patients with and without DFUs showed that the presence of DR [OR, 226.12; 95% confidence interval (CI), 58.07-880.49; p < 0.001] and proliferative DR [OR, 306.27; 95% CI, 64.35-1457.80; p < 0.001), higher HbA1c (%, OR, 1.97, 95% CI, 1.46-2.67; p < 0.001), higher serum creatinine (mg/dL, OR, 1.62, 95% CI, 1.06-2.50; p = 0.027), older age (years, OR, 1.12; 95% CI, 1.06-1.17; p < 0.001), higher pulse pressure (mmHg, OR, 1.03; 95% CI, 1.00-1.06; p = 0.025), lower cholesterol (mg/dL, OR, 0.94; 95% CI, 0.92-0.97; p < 0.001), lower BMI (kg/m(2), OR, 0.87, 95% CI, 0.75-1.00; p = 0.044) and lower hematocrit (%, OR, 0.80, 95% CI, 0.74-0.87; p < 0.001) were associated with DFUs. In a subgroup analysis of DFU patients, the PDR group had a longer duration of diabetes mellitus, higher serum BUN, and higher serum creatinine than the non-PDR group. In the multivariable analysis, only higher serum creatinine was associated with PDR in DFU patients (OR, 1.37; 95% CI, 1.05-1.78; p = 0.021). Conclusions Diabetic retinopathy is prevalent in patients with DFU and about half of DFU patients had PDR. No significant association was found in terms of the severity of these two diabetic complications. To prevent blindness, patients with DFU, and especially those with high serum creatinine, should undergo retinal examinations for timely PDR diagnosis and management.	[Hwang, Duck Jin; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea; [Hwang, Duck Jin] HanGil Eye Hosp, Dept Ophthalmol, Incheon, South Korea; [Lee, Kyoung Min; Park, Moon Seok] Seoul Natl Univ, Dept Orthoped Surg, Bundang Hosp, Seongnam, South Korea; [Choi, Sung Hee] Seoul Natl Univ, Bundang Hosp, Dept Endocrinol, Coll Med, Seongnam, South Korea; [Park, Ji In] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Cho, Joon Hee] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Kyu Hyung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University Hospital; Hallym University; Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.	sejoon1@snu.ac.kr	; Woo, Se Joon/I-7357-2013	Park, Ji In/0000-0003-4662-3759; Woo, Se Joon/0000-0003-3692-7169; Hwang, Daniel Duck-Jin/0000-0003-1808-3169	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2016R1D1A11303934724]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant 2016R1D1A11303934724 funded by the Korean government (MSIP). The funding organization had no role in the design or conduct of this research.	Apelqvist J, 2000, DIABETES-METAB RES, V16, pS75, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR139>3.0.CO;2-8; BORSSEN B, 1990, DIABETIC MED, V7, P438, DOI 10.1111/j.1464-5491.1990.tb01420.x; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Brod M, 1998, QUAL LIFE RES, V7, P365; Brooks B, 2001, DIABETIC MED, V18, P528, DOI 10.1046/j.1464-5491.2001.00493.x; Carrington AL, 1996, DIABETES RES CLIN PR, V32, P19, DOI 10.1016/0168-8227(96)01198-9; Clark N, 2003, DIABETES CARE, V26, P3333; Cohen JA, 1998, MUSCLE NERVE, V21, P72, DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2; Coyne KS, 2004, FAM PRACT, V21, P447, DOI 10.1093/fampra/cmh417; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; Harrison ML, 2011, BLOOD PRESS MONIT, V16, P138, DOI 10.1097/MBP.0b013e328346a839; Jiang YF, 2015, WOUND REPAIR REGEN, V23, P222, DOI 10.1111/wrr.12263; Khandekar R, 2003, BRIT J OPHTHALMOL, V87, P1061, DOI 10.1136/bjo.87.9.1061; Liu CB, 2015, INT J LOW EXTR WOUND, V14, P28, DOI 10.1177/1534734614568375; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Monami M, 2009, DIABETES CARE, V32, P897, DOI 10.2337/dc08-1679; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; OHARE JA, 1994, IRISH J MED SCI, V163, P132, DOI 10.1007/BF02965972; Pinto A, 2008, METABOLISM, V57, P676, DOI 10.1016/j.metabol.2008.01.004; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Sampson CJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0006-6; Shahbazian H, 2013, PAK J MED SCI, V29, P730, DOI 10.12669/pjms.293.3473; Sharma Sanjay, 2005, Curr Opin Ophthalmol, V16, P155, DOI 10.1097/01.icu.0000161227.21797.3d; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tennvall GR, 2000, J DIABETES COMPLICAT, V14, P235; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Vileikyte L, 2001, DIABETES-METAB RES, V17, P246, DOI 10.1002/dmrr.216; Wagner F W Jr, 1981, Foot Ankle, V2, P64; WAGNER FW, 1987, ORTHOPEDICS, V10, P163; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5	31	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175270	10.1371/journal.pone.0175270	http://dx.doi.org/10.1371/journal.pone.0175270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388680	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800033
J	Ariane, M; Allouche, MH; Bussone, M; Giacosa, F; Bernard, F; Barigou, M; Alexiadis, A				Ariane, Mostapha; Allouche, Mohamed Hatem; Bussone, Marco; Giacosa, Fausto; Bernard, Frederic; Barigou, Mostafa; Alexiadis, Alessio			Discrete multi-physics: A mesh-free model of blood flow in flexible biological valve including solid aggregate formation	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; SMOOTHED PARTICLE HYDRODYNAMICS; COMPLEX NETWORK; MOLECULAR-DYNAMICS; TIME-SERIES; TRANSPORT	We propose a mesh-free and discrete (particle-based) multi-physics approach for modelling the hydrodynamics in flexible biological valves. In the first part of this study, the method is successfully validated against both traditional modelling techniques and experimental data. In the second part, it is further developed to account for the formation of solid aggregates in the flow and at the membrane surface. Simulations of various types of aggregates highlight the main benefits of discrete multi-physics and indicate the potential of this approach for coupling the hydrodynamics with phenomena such as clotting and calcification in biological valves.	[Ariane, Mostapha; Barigou, Mostafa; Alexiadis, Alessio] Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England; [Allouche, Mohamed Hatem] Univ Euromediterraneenne Fes, INSA Euromediterranee, Fes, Morocco; [Bussone, Marco; Giacosa, Fausto] LivaNova Sorin, Saluggia, Vercelli, Italy; [Bernard, Frederic] Univ Bourgogne Franche Comte, Lab Interdisciplinaire Carnot Bourgogne, Dijon, France	University of Birmingham; Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM)	Ariane, M; Alexiadis, A (corresponding author), Univ Birmingham, Sch Chem Engn, Birmingham, W Midlands, England.	mxa437@bham.ac.uk; A.Alexiadis@bham.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/N033698/1]; EPSRC [EP/N033698/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N033698/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) grant number: EP/N033698/1.	Alexiadis A, 2017, COMPUT BIOL MED, V81, P188, DOI 10.1016/j.compbiomed.2017.01.003; Alexiadis A., 2015, LUT S DYN CAPS VES C, P80; Alexiadis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124678; Alexiadis A, 2014, INT J NUMER METH ENG, V100, P713, DOI 10.1002/nme.4782; Alexiadis A, 2014, INT J NUMER METH ENG, V98, P534, DOI 10.1002/nme.4646; Bajd F, 2013, BIOPHYS J, V104, P1181, DOI 10.1016/j.bpj.2013.01.029; Bavo AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154517; De Hart J, 2000, J BIOMECH, V33, P1079, DOI 10.1016/S0021-9290(00)00068-3; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Gray JP, 2001, COMPUT METHOD APPL M, V190, P6641, DOI 10.1016/S0045-7825(01)00254-7; Halevi R, 2015, J BIOMECH, V48, P489, DOI 10.1016/j.jbiomech.2014.12.004; Harrison SE, 2008, PROG COMPUT FLUID DY, V8, P121, DOI 10.1504/PCFD.2008.018084; Hosseini SM, 2009, CHEM ENG SCI, V64, P4488, DOI 10.1016/j.ces.2008.11.028; Hou GN, 2012, COMMUN COMPUT PHYS, V12, P337, DOI 10.4208/cicp.291210.290411s; Ledesma-Alonso R, 2014, J FLUID MECH, V739, P338, DOI 10.1017/jfm.2013.611; Liu GR, 2016, PARTICLE METHODS MUL; Lobovsky L., 2007, APPL COMPUT MECH, V1, P521; Marom G, 2015, ARCH COMPUT METHOD E, V22, P595, DOI 10.1007/s11831-014-9133-9; Narracott Andrew, 2005, J Artif Organs, V8, P56, DOI 10.1007/s10047-004-0274-8; Panteleev MA, 2015, THROMB RES, V136, P699, DOI 10.1016/j.thromres.2015.07.025; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Sinnott MD, 2012, COMPUT BIOL MED, V42, P492, DOI 10.1016/j.compbiomed.2012.01.002; van Loon R, 2006, J COMPUT PHYS, V217, P806, DOI 10.1016/j.jcp.2006.01.032; van Loon R, 2004, INT J NUMER METH FL, V46, P533, DOI 10.1002/fld.775	28	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174795	10.1371/journal.pone.0174795	http://dx.doi.org/10.1371/journal.pone.0174795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384341	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900036
J	Okumura, M; Ishikawa, A; Aoyama, T; Yamada, S; Uwabe, C; Imai, H; Matsuda, T; Yoneyama, A; Takeda, T; Takakuwa, T				Okumura, Misaki; Ishikawa, Aoi; Aoyama, Tomoki; Yamada, Shigehito; Uwabe, Chigako; Imai, Hirohiko; Matsuda, Tetsuya; Yoneyama, Akio; Takeda, Tohoru; Takakuwa, Tetsuya			Cartilage formation in the pelvic skeleton during the embryonic and early-fetal period	PLOS ONE			English	Article							HUMAN VERTEBRAL COLUMN; HUMAN HIP-JOINT; SEX-DIFFERENCES; PROPER	The pelvic skeleton is formed via endochondral ossification. However, it is not known how the normal cartilage is formed before ossification occurs. Furthermore, the overall timeline of cartilage formation and the morphology of the cartilage in the pelvis are unclear. In this study, cartilage formation in the pelvic skeletons of 25 human fetuses (crown-rump length [CRL] = 11.9-75.0 mm) was observed using phase-contrast computed tomography and 7T magnetic resonance imaging. The chondrification center of the ilium, ischium, and pubis first appeared simultaneously at Carnegie stage (CS) 18, was located around the acetabulum, and grew radially in the later stage. The iliac crest formed at CS20 while the iliac body's central part remained chondrified. The iliac body formed a discoid at CS22. The growth rate was greater in the ilium than in the sacrum-coccyx, pubis, and ischium. Connection and articulation formed in a limited period, while the sacroiliac joint formed at CS21. The articulation of the pubic symphysis, connection of the articular column in the sacrum, and Y-shape connection of the three parts of the hip bones to the acetabulum were observed at CS23; the connection of the ischium and pubic ramus was observed at the early-fetal stage. Furthermore, the degree of connection at the center of the sacrum varied among samples. Most of the pelvimetry data showed a high correlation with CRL. The transverse and antero-posterior lengths of the pelvic inlet of the lesser pelvis varied among samples (R-2 = 0.11). The subpubic angle also varied (65-90 degrees) and was not correlated with CRL (R-2 = 0.22). Moreover, cartilaginous structure formation appeared to influence bone structure. This study provides valuable information regarding the morphogenesis of the pelvic structure.	[Okumura, Misaki; Ishikawa, Aoi; Aoyama, Tomoki; Yamada, Shigehito; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito; Uwabe, Chigako] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Imai, Hirohiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan; [Yoneyama, Akio; Takeda, Tohoru] Kitasato Univ, Allied Hlth Sci, Sagamihara, Kanagawa, Japan	Kyoto University; Kyoto University; Kyoto University; Kitasato University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yamada, Shigehito/G-2061-2010; Yoneyama, Akio/ABH-5357-2020	Yamada, Shigehito/0000-0002-8194-6927; Yoneyama, Akio/0000-0001-6925-6723	Japan Society for the Promotion of Science [26220004, 15H01119, 15K15014, 16K15535, 15K08134, 15H05270, 15H01121]; Grants-in-Aid for Scientific Research [17H05296, 16H03167, 15H01121] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants 26220004, 15H01119, 15K15014, 16K15535, 15K08134, 15H05270, and 15H01121 from the Japan Society for the Promotion of Science.	ANDERSEN H, 1962, ACTA ANAT, V48, P258, DOI 10.1159/000141844; BADGLEY CE, 1949, J BONE JOINT SURG AM, V31-A, P341, DOI 10.2106/00004623-194931020-00011; Bardeen CR, 1905, AM J ANAT, V4, P265, DOI 10.1002/aja.1000040302; BARDEEN CR, 1908, ANAT REC, V2, P99; Biwasaka H, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2011.11.032; Blechscmidt E., 1961, THE STAGES OF HUMAN; BOUCHER BJ, 1957, AM J PHYS ANTHROPOL, V15, P581, DOI 10.1002/ajpa.1330150409; COLEMAN WH, 1969, AM J PHYS ANTHROPOL, V31, P125, DOI 10.1002/ajpa.1330310202; Drake R, 2019, GRAYS ANATOMY STUDEN; GARDNER E, 1970, AM J ANAT, V129, P121, DOI 10.1002/aja.1001290202; GARDNER E, 1950, AM J ANAT, V87, P163, DOI 10.1002/aja.1000870202; GLENISTER TW, 1954, J ANAT, V88, P413; Haque M, 2016, J CLIN DIAGN RES, V10, pAC1, DOI 10.7860/JCDR/2016/17699.7051; Khomiakovlu S, 1987, ARKH ANAT GISTOL EMB, V93, P47; LAURENSON RD, 1964, ANAT RECORD, V148, P197, DOI 10.1002/ar.1091480209; Lee W, 2010, ULTRASOUND OBST GYN, V35, P163, DOI 10.1002/uog.7477; Magee J, 2012, J ANAT, V221, P240, DOI 10.1111/j.1469-7580.2012.01535.x; Momose A, 2001, NUCL INSTRUM METH A, V467, P917, DOI 10.1016/S0168-9002(01)00523-X; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; NOBACK CR, 1951, AM J ANAT, V89, P1, DOI 10.1002/aja.1000890102; Nowlan NC, 2015, EUR CELLS MATER, V29, P1; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; O'Rahilly R. R, 2006, EMBRYONIC HUMAN BRAI; ORAHILLY R, 1972, AM J ANAT, V134, P291, DOI 10.1002/aja.1001340303; ORAHILLY R, 1990, J ANAT, V168, P95; ORAHILLY R, 1979, ANAT EMBRYOL, V157, P167, DOI 10.1007/BF00305157; Schaefer Maureen, 2009, JUVENILE OSTEOLOGY L; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; SINGH S, 1978, J ANAT, V125, P619; Strayer L M, 1943, Yale J Biol Med, V16, P13; STRAYER LM, 1971, CLIN ORTHOP RELAT R, P221; STREETER GL, 1949, CONTRIB EMBRYOL, V33, P151; TANAKA O, 1976, Okajimas Folia Anatomica Japonica, V53, P173; Weinstein SL, 1997, CLIN ORTHOP RELAT R, P227; Yamada S, 2004, BIRTH DEFECTS RES A, V70, P495, DOI 10.1002/bdra.20048; Yoneyama A, 2004, NUCL INSTRUM METH A, V523, P217, DOI 10.1016/j.nima.2003.12.008; Yoneyama A, 2011, ADVANCED BIOMEDICAL ENGINEERING-BOOK, P107	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173852	10.1371/journal.pone.0173852	http://dx.doi.org/10.1371/journal.pone.0173852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384153	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900009
J	Baker, LA; Kirkpatrick, B; Rosa, GJM; Gianola, D; Valente, B; Sumner, JP; Baltzer, W; Hao, ZL; Binversie, EE; Volstad, N; Piazza, A; Sample, SJ; Muir, P				Baker, Lauren A.; Kirkpatrick, Brian; Rosa, Guilherme J. M.; Gianola, Daniel; Valente, Bruno; Sumner, Julia P.; Baltzer, Wendy; Hao, Zhengling; Binversie, Emily E.; Volstad, Nicola; Piazza, Alexander; Sample, Susannah J.; Muir, Peter			Genome-wide association analysis in dogs implicates 99 loci as risk variants for anterior cruciate ligament rupture	PLOS ONE			English	Article							ACL RECONSTRUCTION; INJURY RISK; GENE; MODEL; ANGIOGENESIS; NEWFOUNDLAND; PREVALENCE; EXPRESSION; OUTCOMES; PACKAGE	Anterior cruciate ligament (ACL) rupture is a common condition that can be devastating and life changing, particularly in young adults. A non-contact mechanism is typical. Second ACL ruptures through rupture of the contralateral ACL or rupture of a graft repair is also common. Risk of rupture is increased in females. ACL rupture is also common in dogs. Disease prevalence exceeds 5% in several dog breeds, similar to 100 fold higher than human beings. We provide insight into the genetic etiology of ACL rupture by genome-wide association study (GWAS) in a high-risk breed using 98 case and 139 control Labrador Retrievers. We identified 129 single nucleotide polymorphisms (SNPs) within 99 risk loci. Associated loci (P< 5E-04) explained approximately half of phenotypic variance in the ACL rupture trait. Two of these loci were located in uncharacterized or non-coding regions of the genome. A chromosome 24 locus containing nine genes with diverse functions met genome-wide significance (P = 3.63E-0.6). GWAS pathways were enriched for c-type lectins, a gene set that includes aggrecan, a gene set encoding antimicrobial proteins, and a gene set encoding membrane transport proteins with a variety of physiological functions. Genotypic risk estimated for each dog based on the risk contributed by each GWAS locus showed clear separation of ACL rupture cases and controls. Power analysis of the GWAS data set estimated that similar to 172 loci explain the genetic contribution to ACL rupture in the Labrador Retriever. Heritability was estimated at 0.48. We conclude ACL rupture is a moderately heritable highly polygenic complex trait. Our results implicate c-type lectin pathways in ACL homeostasis.	[Baker, Lauren A.; Hao, Zhengling; Binversie, Emily E.; Volstad, Nicola; Piazza, Alexander; Sample, Susannah J.; Muir, Peter] Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Kirkpatrick, Brian; Rosa, Guilherme J. M.; Gianola, Daniel; Valente, Bruno] Univ Wisconsin Madison, Dept Anim Sci, Coll Agr & Life Sci, Madison, WI USA; [Valente, Bruno] Univ Wisconsin Madison, Dept Dairy Sci, Coll Agr & Life Sci, Madison, WI USA; [Sumner, Julia P.] Louisiana State Univ, Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA; [Baltzer, Wendy] Oregon State Univ, Dept Clin Sci, Coll Vet Med, Corvalis, OR USA; [Sumner, Julia P.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Oregon State University; Cornell University	Muir, P (corresponding author), Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	peter.muir@wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005; Piazza, Alexander/0000-0002-4637-8442; Binversie, Emily/0000-0003-1991-0867; Baltzer, Wendy/0000-0001-5295-9641; Sumner, Julia/0000-0003-4635-9791	Morris Animal Foundation [D13CA-020]; Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison; Melita Grunow Family Professorship in Companion Animal Health; National Institutes of Health [T32OD10999, K01OD019743-01A1]; NLM training grant [NLM5T15LM007359]; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019743] Funding Source: NIH RePORTER	Morris Animal Foundation; Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison; Melita Grunow Family Professorship in Companion Animal Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Morris Animal Foundation (D13CA-020, www.morrisanimalfoundation.org), the Robert Draper Technology Innovation Fund from the University of Wisconsin-Madison and the Melita Grunow Family Professorship in Companion Animal Health. Lauren Baker received support from the National Institutes of Health (T32OD10999) and is supported by an NLM training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM5T15LM007359). Susannah Sample received support from the National Institutes of Health (K01OD019743-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AEG, 2014, ANIM GENET, V45, P542, DOI 10.1111/age.12162; Baird AEG, 2014, CONNECT TISSUE RES, V55, P275, DOI 10.3109/03008207.2014.910199; Beynnon BD, 2006, AM J SPORT MED, V34, P757, DOI 10.1177/0363546505282624; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Brophy RH, 2012, AM J SPORT MED, V40, P2517, DOI 10.1177/0363546512459476; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Dohrn MF, 2013, J NEUROL, V260, P3093, DOI 10.1007/s00415-013-7124-7; Flynn RK, 2005, AM J SPORT MED, V33, P23, DOI 10.1177/0363546504265678; Gerard HC, 2001, ARTHRITIS RHEUM-US, V44, P1689, DOI 10.1002/1529-0131(200107)44:7<1689::AID-ART293>3.0.CO;2-K; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Gregory MH, 2012, ARTHRITIS, V2012, DOI DOI 10.1155/2012/764621; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Halper J, 2014, ADV EXP MED BIOL, V802, P49, DOI 10.1007/978-94-007-7893-1_4; HARNER CD, 1994, AM J SPORT MED, V22, P37, DOI 10.1177/036354659402200107; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; Hoffman GE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Khoschnau S, 2008, AM J SPORT MED, V36, P2432, DOI 10.1177/0363546508320805; Kitayama K, 2009, EXP CELL RES, V315, P206, DOI 10.1016/j.yexcr.2008.10.028; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Liao WJ, 2015, ONCOTARGET, V6, P24132, DOI 10.18632/oncotarget.4432; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malila S, 2011, GENET MOL RES, V10, P4158, DOI 10.4238/2011.October.31.1; Mannion S, 2014, BRIT J SPORT MED, V48, P1640, DOI 10.1136/bjsports-2013-093201; Miur P, 2007, MICROB PATHOGENESIS, V42, P47, DOI 10.1016/j.micpath.2006.10.002; Miyasaka K. C., 1991, AM J KNEE SURG, V4, P3; Muir P, 1997, COMP CONT EDUC PRACT, V19, P1149; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Nielen ALJ, 2001, AM J VET RES, V62, P1198, DOI 10.2460/ajvr.2001.62.1198; O'Connell K, 2015, EUR J SPORT SCI, V15, P341, DOI 10.1080/17461391.2014.936324; Obeidat M, 2014, AM J PHYSIOL-RENAL, V307, pF623, DOI 10.1152/ajprenal.00070.2014; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Personnic N, 2014, FEBS J, V281, P2977, DOI 10.1111/febs.12836; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; Posthumus M, 2012, SCAND J MED SCI SPOR, V22, P523, DOI 10.1111/j.1600-0838.2010.01270.x; Posthumus M, 2010, BRIT J SPORT MED, V44, P1160, DOI 10.1136/bjsm.2009.060756; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Proffen BL, 2013, THE ACL HANDBOOK; Rahim M, 2014, J ORTHOP RES, V32, P1612, DOI 10.1002/jor.22705; Reif U, 2004, VET SURG, V33, P368, DOI 10.1111/j.1532-950X.2004.04053.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Schierding W, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00039; September AV, 2007, BRIT J SPORT MED, V41, P241, DOI 10.1136/bjsm.2006.033035; Spicer AP, 2003, J BIOL CHEM, V278, P21083, DOI 10.1074/jbc.M213100200; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Sutton KM, 2013, J AM ACAD ORTHOP SUR, V21, P41, DOI 10.5435/JAAOS-21-01-41; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Varoga D, 2006, J PATHOL, V209, P166, DOI 10.1002/path.1974; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Waggett AD, 2006, EUR J CELL BIOL, V85, P1145, DOI 10.1016/j.ejcb.2006.06.002; Webster KE, 2014, AM J SPORT MED, V42, P641, DOI 10.1177/0363546513517540; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Wright RW, 2011, J BONE JOINT SURG AM, V93A, P1159, DOI [10.2106/JBJS.J.00898, 10.2106/JBJSJ.00898]; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Young NJ, 2009, MATRIX BIOL, V28, P311, DOI 10.1016/j.matbio.2009.05.002; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	71	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173810	10.1371/journal.pone.0173810	http://dx.doi.org/10.1371/journal.pone.0173810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379989	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500025
J	Gervais, O; Pong-Wong, R; Navarro, P; Haley, CS; Nagamine, Y				Gervais, Olivier; Pong-Wong, Ricardo; Navarro, Pau; Haley, Chris S.; Nagamine, Yoshitaka			Antagonistic genetic correlations for milking traits within the genome of dairy cattle	PLOS ONE			English	Article							WIDE ASSOCIATION; LOCI; VARIANCE; NUCLEOTIDE; RESISTANCE; SELECTION; YIELD; TOOL; QTL	Genome-wide association studies can be applied to identify useful SNPs associated with complex traits. Furthermore, regional genomic mapping can be used to estimate regional variance and clarify the genomic relationships within and outside regions but has not previously been applied to milk traits in cattle. We applied both single SNP analysis and regional genomic mapping to investigate SNPs or regions associated with milk yield traits in dairy cattle. The deregressed breeding values of three traits, total yield (kg) of milk (MLK), fat (FAT), and protein (PRT) in 305 days, from 2,590 Holstein sires in Japan were analyzed. All sires were genotyped with 40,646 single-nucleotide polymorphism (SNP) markers. A genome-wide significant region (P < 0.01) common to all three traits was identified by regional genomic mapping on chromosome (BTA) 14. In contrast, single SNP analysis identified significant SNPs only for MLK and FAT (P < 0.01), but not PRT in the same region. Regional genomic mapping revealed an additional significant region (P < 0.01) for FAT on BTA5 that was not identified by single SNP analysis. The additive whole-genomic effects estimated in the regional genomic mapping analysis for the three traits were positively correlated with one another (0.830-0.924). However, the regional genomic effects obtained by using a window size of 20 SNPs for FAT on BTA14 were negatively correlated (P < 0.01) with the regional genomic effect for MLK (-0.940) and PRT (-0.878). The BTA14 regional effect for FAT also showed significant negative correlations (P < 0.01) with the whole genomic effects for MLK (-0.153), FAT (-0.172), and PRT (-0.181). These negative genomic correlations between loci are consistent with the negative linkage disequilibrium expected for traits under directional selection. Such antagonistic correlations may hamper the fixation of the FAT increasing alleles on BTA14. In summary, regional genomic mapping found more regions associated with milk production traits than did single SNP analysis. In addition, the existence of non-zero covariances between regional and whole genomic effects may influence the detection of regional effects, and antagonistic correlations could hamper the fixation of major genes under intensive selection.	[Gervais, Olivier] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Pong-Wong, Ricardo; Haley, Chris S.] Univ Edinburgh, Roslin Inst & RDSVS, Edinburgh, Midlothian, Scotland; [Navarro, Pau; Haley, Chris S.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC,Human Genet Unit, Edinburgh, Midlothian, Scotland; [Nagamine, Yoshitaka] Nihon Univ, Bioresource Sci, Fujisawa, Kanagawa, Japan	Kyoto University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Nihon University	Nagamine, Y (corresponding author), Nihon Univ, Bioresource Sci, Fujisawa, Kanagawa, Japan.	nagamine.yoshitaka@nihon-u.ac.Jp	Navarro, Pau/AAJ-8091-2021	Navarro, Pau/0000-0001-5576-8584; Pong-Wong, Ricardo/0000-0001-9808-2742; Haley, Chris/0000-0002-9811-0210	Biotechnology and Biological Sciences Research Council [BBS/E/D/30002275] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696] Funding Source: researchfish; BBSRC [BBS/E/D/20211553, BB/J002844/1, BBS/E/D/20211550] Funding Source: UKRI; MRC [MC_PC_U127592696] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002844/1, BBS/E/D/20211550, BBS/E/D/20211553] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Caballero A, 2015, GENETICS, V201, P1601, DOI 10.1534/genetics.115.177220; Canela-Xandri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10162; George AW, 2000, GENETICS, V156, P2081; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Henderson C. R, 1984, APPL LINEAR MODELS A; ITOH Y, 1991, GENET SEL EVOL, V23, P301, DOI 10.1051/gse:19910404; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Matika O, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0191-3; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENETICS, V157, P1819; Nagamine Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remington DL, 2015, EVOLUTION, V69, P3025, DOI 10.1111/evo.12775; Riggio V, 2013, HEREDITY, V110, P420, DOI 10.1038/hdy.2012.90; Rowe SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081189; Thaller G, 2003, J ANIM SCI, V81, P1911; Uemoto Yoshinobu, 2013, Frontiers in Genetics, V4, P232, DOI 10.3389/fgene.2013.00232; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175105	10.1371/journal.pone.0175105	http://dx.doi.org/10.1371/journal.pone.0175105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380033	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500099
J	Labeit, AM; Peinemann, F				Labeit, Alexander Michael; Peinemann, Frank			Determinants of a GP visit and cervical cancer screening examination in Great Britain	PLOS ONE			English	Article							HEALTH-CARE; DEMAND; BREAST; MODEL; ATTENDANCE; SMOKING	Objective In the UK, women are requested to attend a cervical cancer test every 3 years as part of the NHS Cervical Screening Programme. This analysis compares the determinants of a cervical cancer screening examination with the determinants of a GP visit in the same year and investigates if cervical cancer screening participation is more likely for women who visit their GP. Methods A recursive probit model was used to analyse the determinants of GP visits and cervical cancer screening examinations. GP visits were considered to be endogenous in the cervical cancer screening examination. The analysed sample consisted of 52,551 observations from 8,386 women of the British Household Panel Survey. Results The analysis showed that a higher education level and a worsening self-perceived health status increased the probability of a GP visit, whereas smoking decreased the probability of a GP visit. GP visits enhanced the uptake of a cervical cancer screening examination in the same period. The only variables which had the same positive effect on both dependent variables were higher education and living with a partner. The probability of a cervical cancer screening examination increased also with previous cervical cancer screening examinations and being in the recommended age groups. All other variables had different results for the uptake of a GP visit or a cervical cancer screening examination. Conclusions Most of the determinants of visiting a GP and cervical cancer screening examination differ from each other and a GP visit enhances the uptake of a smear test.	[Labeit, Alexander Michael] Univ Sheffield, Sch Hlth & Related Sci, Sheffield, S Yorkshire, England; [Peinemann, Frank] FOM Univ Appl Sci Econ & Management, Essen, Germany; [Peinemann, Frank] Univ Hosp Cologne, Childrens Hosp, Cologne, Germany	University of Sheffield; University of Cologne	Labeit, AM (corresponding author), Univ Sheffield, Sch Hlth & Related Sci, Sheffield, S Yorkshire, England.	alabeit.publications@gmail.com	Labeit, Alexander/AAB-2707-2019; Peinemann, Frank/H-2800-2019	Peinemann, Frank/0000-0002-4727-1313; Labeit, Alexander Michael/0000-0002-4709-4767				BANGJENSEN J, 2012, J PUBLIC HLTH OXF, P1; Biewenga P, 2011, CANCER-AM CANCER SOC, V117, P768, DOI 10.1002/cncr.25658; Brice J., 2010, BRIT HOUSEHOLD PANEL; Carrieri V, 2013, APPL ECON, V45, P239, DOI 10.1080/00036846.2011.597729; Challier B, 2000, CANCER CAUSE CONTROL, V11, P157, DOI 10.1023/A:1008998322628; Contoyannis P, 2004, J APPL ECONOMET, V19, P473, DOI 10.1002/jae.755; CROPPER ML, 1977, J POLIT ECON, V85, P1273, DOI 10.1086/260637; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Government Statistical Service, 2002, CERV STAT B CERV SCR; Greene WH, 1998, J ECON EDUC, V29, P291, DOI 10.2307/1182919; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Jenkins S. P., 2010, ISER WORKING PAPER S, V2010-33; JEPSON R, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4140; KENKEL DS, 1994, APPL ECON, V26, P313, DOI 10.1080/00036849400000078; Kenkel DS, 2000, HANDB ECON, V17, P1675; KULIK JA, 1987, HEALTH PSYCHOL, V6, P15, DOI 10.1037/0278-6133.6.1.15; Labeit A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003387; Labeit A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02362; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; Lairson DR, 2005, SOC SCI MED, V61, P1608, DOI 10.1016/j.socscimed.2005.03.015; Lin SJ, 2008, J R SOC PROMO HEALTH, V128, P327, DOI 10.1177/1466424007092802; Macmillan Cancer Support, CERV SCREEN; MAJEED FA, 1994, BRIT MED J, V308, P1272, DOI 10.1136/bmj.308.6939.1272; Manderbacka K, 1998, INT J EPIDEMIOL, V27, P208, DOI 10.1093/ije/27.2.208; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Marra G, 2011, CAN J STAT, V39, P259, DOI 10.1002/cjs.10100; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; NHS, CERV SCREEN PROGR; NHS, NHS CHOIC CERV SCREE; Office for National Statistics, 2014, CERV CANC IS MOST CO; Patnick J, 2002, BUILDING EXPERIENCE; Peckham Stephen, 2011, Qual Prim Care, V19, P317; PERKINS KA, 1993, HEALTH PSYCHOL, V12, P410, DOI 10.1037/0278-6133.12.5.410; Pfeifer C., 2012, NORDIC J HLTH EC, V1, P135, DOI DOI 10.5617/NJHE.195; Polisson M., 2011, WORKING PAPER; Public Health England, CERV SCREEN PROGR; Public Health England, UKNSC POL DAT UK NSC; Rodvall Y, 2005, EUR J CANCER PREV, V14, P459, DOI 10.1097/01.cej.0000178078.21910.da; Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032; Scholes D, 1999, CANCER CAUSE CONTROL, V10, P339, DOI 10.1023/A:1008993619060; Scott A, 2000, HANDB ECON, V17, P1175; SELDEN TM, 1993, J HEALTH ECON, V12, P109, DOI 10.1016/0167-6296(93)90043-E; Vesco KK, 2011, SCREENING CERVICAL C; VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733; Wacker M, 2013, BMC HEALTH SERV RES, P13; Zweifel P., 2009, HEALTH ECON	47	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174363	10.1371/journal.pone.0174363	http://dx.doi.org/10.1371/journal.pone.0174363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379990	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500044
J	Perisic, T; Zhang, ZY; Foehr, P; Hopfner, U; Klutz, K; Burgkart, RH; Slobodianski, A; Goeldner, M; Machens, HG; Schilling, AF				Perisic, Tatjana; Zhang, Ziyang; Foehr, Peter; Hopfner, Ursula; Klutz, Kathrin; Burgkart, Rainer H.; Slobodianski, Alexei; Goeldner, Moritz; Machens, Hans-Gunther; Schilling, Arndt F.			Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for geneticallymodified fibroblasts	PLOS ONE			English	Article							ECTOPIC BONE-FORMATION; OSTEOCLASTIC BIORESORPTION; DELIVERY; THERAPY; CELLS; RECONSTRUCTION; SYSTEM; CANCER; GENERATION; FRACTURE	Recent advances in gene delivery into cells allow improved therapeutic effects in gene therapy trials. To increase the bioavailability of applied cells, it is of great interest that transfected cells remain at the application site and systemic spread is minimized. In this study, we tested clinically used biodegradable poly(lactic acid-co-glycolic acid) (PLGA) scaffolds (Vicryl & Ethisorb) as transient carriers for genetically modified cells. To this aim, we used human fibroblasts and examined attachment and proliferation of untransfected cells on the scaffolds in vitro, as well as the mechanical properties of the scaffolds at four time points (1, 3, 6 and 9 days) of cultivation. Furthermore, the adherence of cells transfected with green fluorescent protein (GFP) and vascular endothelial growth factor (VEGF165) and also VEGF165 protein secretion were investigated. Our results show that human fibroblasts adhere on both types of PLGA scaffolds. However, proliferation and transgene expression capacity were higher on Ethisorb scaffolds most probably due to a different architecture of the scaffold. Additionally, cultivation of the cells on the scaffolds did not alter their biomechanical properties. The results of this investigation could be potentially exploited in therapeutic regiments with areal delivery of transiently transfected cells and may open the way for a variety of applications of cell-based gene therapy, tissue engineering and regenerative medicine.	[Perisic, Tatjana; Hopfner, Ursula; Klutz, Kathrin; Slobodianski, Alexei; Machens, Hans-Gunther; Schilling, Arndt F.] Tech Univ Munich, Klinikum Rechts Isar, Expt Plast Surg, Dept Plast Surg & Hand Surg, Munich, Germany; [Zhang, Ziyang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China; [Foehr, Peter; Burgkart, Rainer H.] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed & Sportsorthopaed, Munich, Germany; [Goeldner, Moritz] Johnson & Johnson Med GmbH, Norderstedt, Germany; [Schilling, Arndt F.] Univ Med Ctr Gottingen, Klin Unfallchirurg Orthopadie & Plast Chirurg, Gottingen, Germany; [Goeldner, Moritz] Hamburg Univ Technol, Inst Technol & Innovat Management, Hamburg, Germany	Technical University of Munich; Huazhong University of Science & Technology; Technical University of Munich; Johnson & Johnson; University of Gottingen; Hamburg University of Technology	Schilling, AF (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Expt Plast Surg, Dept Plast Surg & Hand Surg, Munich, Germany.; Schilling, AF (corresponding author), Univ Med Ctr Gottingen, Klin Unfallchirurg Orthopadie & Plast Chirurg, Gottingen, Germany.	arndt.schilling@med.uni-goettingen.de		Foehr, Peter/0000-0003-1042-546X	National Natural Science Foundation of China [81401538]; Johnson & Johnson Medical GmbH, Norderstedt, Germany; Johnson & Johnson Medical GmbH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Johnson & Johnson Medical GmbH, Norderstedt, Germany; Johnson & Johnson Medical GmbH	This work was partly supported by a grant to Dr. Ziyang Zhang from National Natural Science Foundation of China (Grant No. No. 81401538). This study was also partly supported by an unrestricted the grant of Johnson & Johnson Medical GmbH, Norderstedt, Germany. Johnson & Johnson Medical GmbH provided support in the form of salaries for author MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barbolt TA, 2001, NEUROL RES, V23, P813, DOI 10.1179/016164101101199405; Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228; Buchel P, 2005, J ORAL MAXIL SURG, V63, P646, DOI 10.1016/j.joms.2004.11.013; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Chang H-I, TECH; Chmielewski M, 2014, IMMUNOL REV, V257, P83, DOI 10.1111/imr.12125; Conde J, 2016, NAT MATER, V15, P1128, DOI [10.1038/nmat4707, 10.1038/NMAT4707]; Conde J, 2016, NAT MATER, V15, P353, DOI [10.1038/nmat4497, 10.1038/NMAT4497]; Conde J, 2015, ADV FUNCT MATER, V25, P4183, DOI 10.1002/adfm.201501283; Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]; Das D, 2012, ADV BIOCHEM ENG BIOT, V126, P317, DOI 10.1007/10_2011_119; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; Hadjipanayi E, 2013, J CONTROL RELEASE, V169, P91, DOI 10.1016/j.jconrel.2013.04.008; Hadjipanayi E, 2012, J CONTROL RELEASE, V161, P852, DOI 10.1016/j.jconrel.2012.04.048; Hadjipanayi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135618; Hadjipanayi E, 2013, ORGANOGENESIS, V9, P261, DOI 10.4161/org.25970; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81; Jensen SA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006839; Keller J, 2012, PLOS ONE, V7; Korenkov M, 2005, Hernia, V9, P252, DOI 10.1007/s10029-005-0341-y; Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9; Lee JB, 2012, NAT MATER, V11, P316, DOI [10.1038/nmat3253, 10.1038/NMAT3253]; Lohmeyer JA, 2011, LANGENBECK ARCH SURG, V396, P543, DOI 10.1007/s00423-011-0761-3; Manabe T, 2003, CLIN CANCER RES, V9, P3158; Newman MI, 2010, AESTHET PLAST SURG, V34, P297, DOI 10.1007/s00266-010-9498-6; Pape SA, 2000, J BURN CARE REHABIL, V21, P390; Pendegrass CJ, 2006, J BONE JOINT SURG BR, V88B, P1245, DOI 10.1302/0301-620X.88B9.17748; Perisic T, 2015, GENE THER MOL BIOL, V17, P42; Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267; Riss TL, 2004, CELL VIABILITY ASSAY; Seidl RO, 2000, HNO, V48, P753, DOI 10.1007/s001060050654; Spanholtz TA, 2011, J SURG RES, V171, P329, DOI 10.1016/j.jss.2010.03.033; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Spiro AS, 2010, J ORTHOP RES, V28, P785, DOI 10.1002/jor.21044; Stone GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007334; Weiss RA, 2000, J INFECTION, V40, P21, DOI 10.1053/jinf.1999.0604; Winkler T, 2010, ACTA BIOMATER, V6, P4127, DOI 10.1016/j.actbio.2010.04.015; Winkler T, 2010, INT J ARTIF ORGANS, V33, P198, DOI 10.1177/039139881003300404; Wittenburg G, 2014, BRIT J ORAL MAX SURG, V52, P409, DOI 10.1016/j.bjoms.2014.02.023; Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037; Wunsch L, 2005, EUR J PEDIATR SURG, V15, P164, DOI 10.1055/s-2004-830356; Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019192; Zhang ZY, 2011, BIOMATERIALS, V32, P4109, DOI 10.1016/j.biomaterials.2011.02.036	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174860	10.1371/journal.pone.0174860	http://dx.doi.org/10.1371/journal.pone.0174860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380080	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500069
J	Tanaka, N; Yamashita, T; Sato, A; Vogel, V; Tanaka, Y				Tanaka, Nobuyuki; Yamashita, Tadahiro; Sato, Asako; Vogel, Viola; Tanaka, Yo			Simple agarose micro-confinement array and machine-learning-based classification for analyzing the patterned differentiation of mesenchymal stem cells	PLOS ONE			English	Article							CYTOSKELETAL TENSION; MATRIX ELASTICITY; GEOMETRIC CONTROL; HIGH-THROUGHPUT; FATE; SHAPE; HYDROGELS; GROWTH; FORCE; MECHANOTRANSDUCTION	The geometrical confinement of small cell colonies gives differential cues to cells sitting at the periphery versus the core. To utilize this effect, for example to create spatially graded differentiation patterns of human mesenchymal stem cells (hMSCs) in vitro or to investigate underpinning mechanisms, the confinement needs to be robust for extended time periods. To create highly repeatable micro-fabricated structures for cellular patterning and high-throughput data mining, we employed here a simple casting method to fabricate more than 800 adhesive patches confined by agarose micro-walls. In addition, a machine learning based image processing software was developed (open code) to detect the differentiation patterns of the population of hMSCs automatically. Utilizing the agarose walls, the circular patterns of hMSCs were successfully maintained throughout 15 days of cell culture. After staining lipid droplets and alkaline phosphatase as the markers of adipogenic and osteogenic differentiation, respectively, the mega-pixels of RGB color images of hMSCs were processed by the software on a laptop PC within several minutes. The image analysis successfully showed that hMSCs sitting on the more central versus peripheral sections of the adhesive circles showed adipogenic versus osteogenic differentiation as reported previously, indicating the compatibility of patterned agarose walls to conventional microcontact printing. In addition, we found a considerable fraction of undifferentiated cells which are preferentially located at the peripheral part of the adhesive circles, even in differentiation-inducing culture media. In this study, we thus successfully demonstrated a simple framework for analyzing the patterned differentiation of hMSCs in confined microenvironments, which has a range of applications in biology, including stem cell biology.	[Tanaka, Nobuyuki; Sato, Asako; Tanaka, Yo] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Yamashita, Tadahiro; Vogel, Viola] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland; [Tanaka, Yo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; Swiss Federal Institutes of Technology Domain; ETH Zurich; Osaka University	Tanaka, Y (corresponding author), RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.; Tanaka, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yo.tanaka@riken.jp	Tanaka, Nobuyuki/AAM-4278-2020; Tanaka, Yo/ABE-5075-2020; Vogel, Viola/O-8025-2015	Tanaka, Nobuyuki/0000-0002-4698-5867; Tanaka, Yo/0000-0003-1034-5718; Vogel, Viola/0000-0003-2898-7671; Yamashita, Tadahiro/0000-0003-2168-9567	JSPS Bilateral Programs; JSPS KAKENHI [25709081, 15K18004]; ERC Advanced Grant from the European Research Council [233157]; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI [25709081, 15K18004]; Grants-in-Aid for Scientific Research [15K18004] Funding Source: KAKEN	JSPS Bilateral Programs; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ERC Advanced Grant from the European Research Council; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 233157, https://erc.europa.eu/projects-and-results/erc-funded-projects/project/mechanochem-switches; JSPS Postdoctoral Fellowships for Research Abroad, http://www.jsps.go.jp/english/e-ab/index.html; JSPS KAKENHI Grant Number 25709081, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25709081/, and 15K18004, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K18004/; and JSPS Bilateral Programs, http://www.jsps.go.jp/english/e-bilat/index.html.; The authors would like to thank Prof. Sandra Hoffman and Prof. Ralph Muller for kindly providing us the bone marrow-derived hMSCs, Dr. Melanie Burkhardt for discussions on experimental protocols, and Dr. H. R. Ueda for useful discussions. The study was partially supported by the ERC Advanced Grant (233157) from the European Research Council (VV), Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (TY), JSPS KAKENHI Grant Number 25709081 (YT) and 15K18004 (NT), and JSPS Bilateral Programs.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bellas E, 2014, CURR OPIN CELL BIOL, V31, P92, DOI 10.1016/j.ceb.2014.09.006; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cho WK, 2010, BIOMATERIALS, V31, P9565, DOI 10.1016/j.biomaterials.2010.08.037; Ciresan D, 2012, DEEP NEURAL NETWORKS, P1; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]; Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; LONZA, POIET HUM BON MARR; Mammoto T, 2013, ANNU REV CELL DEV BI, V29, P27, DOI 10.1146/annurev-cellbio-101512-122340; Mason B. N., 2012, ENG BIOMATERIALS REG, DOI [10.1007/978-1-4614-1080-5, DOI 10.1007/978-1-4614-1080-5_2]; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Raschka Sebastian, DOES DEEP LEARNING W; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sandra H, 2007, BIOMATERIALS, V28, P1152; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001; Strulson MK, 2012, LANGMUIR, V28, P4318, DOI 10.1021/la2035533; Sugio Y, 2004, SENSOR ACTUAT B-CHEM, V99, P156, DOI 10.1016/S0925-4005(03)00550-1; Tanaka N, 2016, RSC ADV, V6, P54754, DOI 10.1039/c6ra11563b; Tanaka N, 2014, BIOMATERIALS, V35, P9802, DOI 10.1016/j.biomaterials.2014.08.043; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Vahey MD, 2014, CURR OPIN CELL BIOL, V26, P60, DOI 10.1016/j.ceb.2013.10.001; Vedula SRK, 2014, METHOD CELL BIOL, V120, P235, DOI 10.1016/B978-0-12-417136-7.00016-1; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Willaert Ronnie G., 2015, Fermentation-Basel, V1, P38, DOI 10.3390/fermentation1010038	48	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173647	10.1371/journal.pone.0173647	http://dx.doi.org/10.1371/journal.pone.0173647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380036	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500021
J	Wang, YB; Lin, MJ; Gao, X; Pedram, P; Du, JL; Vikram, C; Gulliver, W; Zhang, HW; Sun, G				Wang, Yongbo; Lin, Meiju; Gao, Xiang; Pedram, Pardis; Du, Jianling; Vikram, Chandurkar; Gulliver, Wayne; Zhang, Hongwei; Sun, Guang			High dietary selenium intake is associated with less insulin resistance in the Newfoundland population	PLOS ONE			English	Article							BETA-CELL FUNCTION; OXIDATIVE STRESS; SERUM SELENIUM; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; GLUCOSE-METABOLISM; TOENAIL SELENIUM; CENTRAL OBESITY; ADIPOSE-TISSUE; TRACE-ELEMENTS	As an essential nutrient, Selenium (Se) is involved in many metabolic activities including mimicking insulin function. Data on Se in various biological samples and insulin resistance are contradictory, moreover there is no large study available regarding the relationship of dietary Se intake with insulin resistance in the general population. To investigate the association between dietary Se intake and variation of insulin resistance in a large population based study, a total of 2420 subjects without diabetes from the CODING (Complex Diseases in the Newfoundland Population: Environment and Genetics) study were assessed. Dietary Se intake was evaluated from the Willett Food Frequency questionnaire. Fasting blood samples were used for the measurement of glucose and insulin. Insulin resistance was determined with the homeostasis model assessment (HOMA-IR). Body composition was measured using dual energy X-ray absorptiometry. Analysis of covariance showed that high HOMA-IR groups in both males and females had the lowest dietary Se intake (fag/kg/ day) (p < 0.01), being 18% and 11% lower than low HOMA-IR groups respectively. Insulin resistance decreased with the increase of dietary Se intake in females but not in males after controlling for age, total calorie intake, physical activity level, serum calcium, serum magnesium, and body fat percentage (p < 0.01). Partial correlation analysis showed that dietary Se intake was negatively correlated with HOMA-IR after adjusting for the Se confounding factors in subjects whose dietary Se intake was below 1.6 mu g/kg/day (r = -0.121 for males and -0.153 for females, p < 0.05). However, the negative correlation was no longer significant when dietary Se intake was above 1.6 pg/kg/day. Our findings suggest that higher dietary Se intake is beneficially correlated with lower insulin resistance when total dietary Se intake was below 1.6 pg/kg/day. Above this cutoff, this beneficial effect disappears.	[Wang, Yongbo; Du, Jianling] Dalian Med Univ, Dept Endocrinol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Lin, Meiju] Dalian Univ, Dept Biliary Minimally Invas Surg, Affiliated Zhongshan Hosp, Dalian, Liaoning, Peoples R China; [Gao, Xiang; Pedram, Pardis; Gulliver, Wayne; Zhang, Hongwei; Sun, Guang] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Vikram, Chandurkar] Mem Univ Newfoundland, Fac Med, Div Endocrinol, St John, NF, Canada	Dalian Medical University; Dalian University; Memorial University Newfoundland; Memorial University Newfoundland	Gulliver, W; Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada.	WGulliver@newlabresearch.com; gain@mun.ca			Canadian Institutes of Health Research (CIHR) [MOP192552]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project has been funded by a Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2012, ANN NUTR METAB, V60, P157, DOI 10.1159/000335470; Arganini C, 2012, GENDER DIFFERENCES I; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Azab SFA, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-20; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Becker DJ, 1996, DIABETOLOGIA, V39, P3, DOI 10.1007/BF00400407; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Brigelius-Flohe R, 2004, ARCH BIOCHEM BIOPHYS, V423, P66, DOI 10.1016/j.abb.2003.12.008; Cahill F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058278; Chen L, 2014, FERTIL STERIL, V102, P1167, DOI 10.1016/j.fertnstert.2014.06.027; Chen ZH, 2014, DIABETES CARE, V37, P3294, DOI 10.2337/dc14-1433; Combs GF, 2009, AM J CLIN NUTR, V89, P1808, DOI 10.3945/ajcn.2008.27356; Coudray C, 1997, J AM COLL NUTR, V16, P584; Dhanya BL, 2014, BIOL TRACE ELEM RES, V161, P107, DOI 10.1007/s12011-014-0076-7; EZAKI O, 1990, J BIOL CHEM, V265, P1124; Farinha JB, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0011-2; Faure P, 2004, EUR J CLIN INVEST, V34, P475, DOI 10.1111/j.1365-2362.2004.01362.x; Faure P, 2007, J TRACE ELEM MED BIO, V21, P113, DOI 10.1016/j.jtemb.2006.12.005; Fontaine-Bisson B, 2014, AM J CLIN NUTR, V99, P384, DOI 10.3945/ajcn.113.073387; Furnsinn C, 1996, LIFE SCI, V59, P1989, DOI 10.1016/S0024-3205(96)00550-4; Gao H, 2014, DIABETIC MED, V31, P787, DOI 10.1111/dme.12429; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Green KK, 2010, CLIN MED INSIGHTS-EN, V3, P25; Hamasaki H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/526201; Hei YJ, 1998, MOL CELL BIOCHEM, V178, P367, DOI 10.1023/A:1006819906820; Honek J, 2014, P NATL ACAD SCI USA, V111, P14906, DOI 10.1073/pnas.1415825111; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; Jamilian M, 2015, CLIN ENDOCRINOL, V82, P885, DOI 10.1111/cen.12699; Kim HN, 2014, BIOL TRACE ELEM RES, V158, P152, DOI 10.1007/s12011-014-9934-6; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mao S, 2014, ENDOCRINE, V47, P758, DOI 10.1007/s12020-014-0298-7; Marucci A, 2015, ACTA DIABETOL, V52, P991, DOI 10.1007/s00592-015-0804-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattmiller SA, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.17; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; MCNEILL JH, 1991, DIABETES, V40, P1675, DOI 10.2337/diabetes.40.12.1675; Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006; Ozkaya M, 2009, BIOL TRACE ELEM RES, V128, P144, DOI 10.1007/s12011-008-8263-z; Park K, 2012, DIABETES CARE, V35, P1544, DOI 10.2337/dc11-2136; Puchau B, 2010, BIOL TRACE ELEM RES, V133, P304, DOI 10.1007/s12011-009-8443-5; Rajpathak S, 2005, J AM COLL NUTR, V24, P250, DOI 10.1080/07315724.2005.10719472; Rayman MP, 2013, FREE RADICAL BIO MED, V65, P1557, DOI 10.1016/j.freeradbiomed.2013.04.003; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Razavi M, 2016, HORM METAB RES, V48, P185, DOI 10.1055/s-0035-1559604; Rocourt CRB, 2013, NUTRIENTS, V5, P1349, DOI 10.3390/nu5041349; Rotter I, 2015, INT J ENV RES PUB HE, V12, P3944, DOI 10.3390/ijerph120403944; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Stranges S, 2011, ATHEROSCLEROSIS, V217, P274, DOI 10.1016/j.atherosclerosis.2011.03.027; Stranges S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-564; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Tanguy S, 2012, MOL NUTR FOOD RES, V56, P1106, DOI 10.1002/mnfr.201100766; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Wang XD, 2008, DIABETOLOGIA, V51, P1515, DOI 10.1007/s00125-008-1055-3; Wang XH, 2014, AASRI PROC, V6, P2, DOI 10.1016/j.aasri.2014.05.002; Wang Y., 2016, NUTRIENTS, V8; Wei J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0007-2; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yoshimura Eiichi, 2011, Obes Res Clin Pract, V5, pe79, DOI 10.1016/j.orcp.2011.01.001	70	35	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174149	10.1371/journal.pone.0174149	http://dx.doi.org/10.1371/journal.pone.0174149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380029	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500032
J	Romer, D; Bollazzi, M; Roces, F				Roemer, Daniela; Bollazzi, Martin; Roces, Flavio			Carbon dioxide sensing in an obligate insect-fungus symbiosis: CO2 preferences of leaf-cutting ants to rear their mutualistic fungus	PLOS ONE			English	Article							ATTA-VOLLENWEIDERI; ACROMYRMEX-HEYERI; NEST ARCHITECTURE; LEAFCUTTER ANTS; CENTRAL-AMERICA; GROWING ANTS; FORMICIDAE; GROWTH; HYMENOPTERA; RESPIRATION	Defense against biotic or abiotic stresses is one of the benefits of living in symbiosis. Leaf-cutting ants, which live in an obligate mutualism with a fungus, attenuate thermal and desiccation stress of their partner through behavioral responses, by choosing suitable places for fungus-rearing across the soil profile. The underground environment also presents hypoxic (low oxygen) and hypercapnic (high carbon dioxide) conditions, which can negatively influence the symbiont. Here, we investigated whether workers of the leaf-cutting ant Acromyrmex lundii use the CO2 concentration as an orientation cue when selecting a place to locate their fungus garden, and whether they show preferences for specific CO2 concentrations. We also evaluated whether levels preferred by workers for fungus-rearing differ from those selected for themselves. In the laboratory, CO2 preferences were assessed in binary choices between chambers with different CO2 concentrations, by quantifying number of workers in each chamber and amount of relocated fungus. Leaf-cutting ants used the CO2 concentration as a spatial cue when selecting places for fungus-rearing. A. lundii preferred intermediate CO2 levels, between 1 and 3%, as they would encounter at soil depths where their nest chambers are located. In addition, workers avoided both atmospheric and high CO2 levels as they would occur outside the nest and at deeper soil layers, respectively. In order to prevent fungus desiccation, however, workers relocated fungus to high CO2 levels, which were otherwise avoided. Workers' CO2 preferences for themselves showed no clear-cut pattern. We suggest that workers avoid both atmospheric and high CO2 concentrations not because they are detrimental for themselves, but because of their consequences for the symbiotic partner. Whether the preferred CO2 concentrations are beneficial for symbiont growth remains to be investigated, as well as whether the observed preferences for fungus-rearing influences the ants' decisions where to excavate new chambers across the soil profile.	[Roemer, Daniela; Roces, Flavio] Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol, Wurzburg, Germany; [Roemer, Daniela; Bollazzi, Martin] Univ Republica, Fac Agron, Dept Protecc Vegetal, Unidad Entomol, Montevideo, Uruguay	University of Wurzburg; Universidad de la Republica, Uruguay	Romer, D (corresponding author), Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol, Wurzburg, Germany.; Romer, D (corresponding author), Univ Republica, Fac Agron, Dept Protecc Vegetal, Unidad Entomol, Montevideo, Uruguay.	Daniela.Roemer@uni-wuerzburg.de		Bollazzi, Martin/0000-0003-3361-5602; Romer, Daniela/0000-0002-7437-2195; Roces, Flavio/0000-0001-9258-3079	German Research Foundation (DFG) [SFB 554, TP E1]; German Excellence Initiative to the Graduate School of Life Sciences; University of Wurzburg (PostDoc Plus funding program); postdoctoral fellowship of the Agencia Nacional de Investigacion e Innovation (ANII), Uruguay [PD_NAC_2015_1_108641]; German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences; University of Wurzburg (PostDoc Plus funding program); postdoctoral fellowship of the Agencia Nacional de Investigacion e Innovation (ANII), Uruguay; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was partially supported by funds from the German Research Foundation (DFG, grant SFB 554, TP E1, httplAww.dfoxie/), FR. Daniela Rbmer was also in part supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg (PostDoc Plus funding program, \http://www.graduateschools.uni-wuerzburg.de/life sciences/startseite/, DR) and a postdoctoral fellowship of the Agencia Nacional de Investigacion e Innovation (ANII), Uruguay (PD_NAC_2015_1_108641, http://www anii.org. uy/, DR). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowski D, 2011, INSECT SOC, V58, P65, DOI 10.1007/s00040-010-0117-y; Angilletta MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000258; [Anonymous], THESIS; Arenas A, 2016, J EXP BIOL, V219, P2490, DOI 10.1242/jeb.139568; BACON CW, 1975, APPL MICROBIOL, V29, P553, DOI 10.1128/AEM.29.4.553-556.1975; Bekele A, 2007, FOREST ECOL MANAG, V242, P587, DOI 10.1016/j.foreco.2007.01.088; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; Bollazzi M, 2010, J ETHOL, V28, P399, DOI 10.1007/s10164-010-0207-3; Bouchebti S, 2015, INSECT SOC, V62, P97, DOI 10.1007/s00040-014-0378-y; Buehlmann C, 2012, CURR BIOL, V22, P645, DOI 10.1016/j.cub.2012.02.029; Bursell E., 1964, PHYSIOL INSECT, VI, P323; Cherrett J. M., 1989, ECOSYSTEMS WORLD B, P473; CLAY K, 1985, OECOLOGIA, V66, P1, DOI 10.1007/BF00378545; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; CURRIE JA, 1984, J SOIL SCI, V35, P1, DOI 10.1111/j.1365-2389.1984.tb00253.x; DEREU JC, 1995, APPL MICROBIOL BIOT, V43, P908; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Gauslaa Y, 2001, OECOLOGIA, V126, P462, DOI 10.1007/s004420000541; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Hamada Y, 2001, HYDROL PROCESS, V15, P1829, DOI 10.1002/hyp.242; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Herz H, 2008, BEHAV ECOL, V19, P575, DOI 10.1093/beheco/arn016; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; Hillel D., 1998, ENV SOIL PHYS; JANZEN D H, 1973, Biotropica, V5, P15, DOI 10.2307/2989677; JANZEN DH, 1967, ECOLOGY, V48, P26, DOI 10.2307/1933414; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jilkova V, 2014, EUR J SOIL BIOL, V60, P44, DOI 10.1016/j.ejsobi.2013.11.003; JONES OT, 1978, ENTOMOL EXP APPL, V24, P472, DOI 10.1007/BF02385099; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; Kojima W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141733; Lapointe SL, 1998, ENVIRON ENTOMOL, V27, P636, DOI 10.1093/ee/27.3.636; Lehane M. J., 2005, BIOL BLOOD SUCKING I, P27; LIGHTON JRB, 1989, FUNCT ECOL, V3, P523, DOI 10.2307/2389566; MCNAUGHTON SJ, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P548; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; MOSER JOHN C., 1963, ANN ENTOMOL SOC AMER, V56, P286, DOI 10.1093/aesa/56.3.286; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2011, P NATL ACAD SCI USA, V108, P4053, DOI 10.1073/pnas.1015806108; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Nielsen MG, 2006, PHYSIOL ENTOMOL, V31, P120, DOI 10.1111/j.1365-3032.2005.00492.x; Nielsen MG, 2003, AUST J ENTOMOL, V42, P357, DOI 10.1046/j.1440-6055.2003.00372.x; OMER SM, 1971, ENTOMOL EXP APPL, V14, P251, DOI 10.1111/j.1570-7458.1971.tb00162.x; Pielstrom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095658; Piersanti S, 2016, ZOOLOGY, V119, P137, DOI 10.1016/j.zool.2016.01.003; PORTER SD, 1993, BEHAV ECOL SOCIOBIOL, V32, P321, DOI 10.1007/BF00183787; POTTS LR, 1984, INSECT SOC, V31, P335, DOI 10.1007/BF02223616; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1979, ECOL ENTOMOL, V4, P151, DOI 10.1111/j.1365-2311.1979.tb00570.x; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; Richard FJ, 2007, J CHEM ECOL, V33, P2281, DOI 10.1007/s10886-007-9385-z; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; Romer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097872; Romer D., 2014, THESIS; Rosenberg N.J., 1983, MICROCLIMATE BIOL EN; Sands W. A., 1969, P495; Lopes JFS, 2011, SOCIOBIOLOGY, V58, P593; Saverschek N, 2011, ANIM BEHAV, V82, P453, DOI 10.1016/j.anbehav.2011.05.015; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; SCHWARTZ DM, 1973, OECOLOGIA, V12, P161, DOI 10.1007/BF00345515; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Suarez AV, 1998, BIOTROPICA, V30, P480, DOI 10.1111/j.1744-7429.1998.tb00083.x; Tschinkel WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059911; Verza SS, 2007, INSECT SOC, V54, P303, DOI 10.1007/s00040-007-0943-8; Vieira-Neto EHM, 2006, INSECT SOC, V53, P326, DOI 10.1007/s00040-006-0876-7; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; WELLS JM, 1970, PHYTOPATHOLOGY, V60, P50, DOI 10.1094/Phyto-60-50; Zolessi LC., 1978, REV FAC HUMAN CIENC, V1, P9	82	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174597	10.1371/journal.pone.0174597	http://dx.doi.org/10.1371/journal.pone.0174597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376107	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000011
J	Takahashi, A; Kono, S; Wada, A; Oshima, S; Abel, K; Imaizumi, H; Fujita, M; Hayashi, M; Okai, K; Miura, I; Yabe, H; Ohira, H				Takahashi, Atsushi; Kono, Soichi; Wada, Akira; Oshima, Sachie; Abel, Kazumichi; Imaizumi, Hiromichi; Fujita, Masashi; Hayashi, Manabu; Okai, Ken; Miura, Itaru; Yabe, Hirooki; Ohira, Hiromasa			Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy	PLOS ONE			English	Article							VERBAL FLUENCY TASK; QUALITY-OF-LIFE; DEPRESSION; ACTIVATION; STEATOHEPATITIS; SCHIZOPHRENIA; SEVERITY; ANXIETY; SLEEP; DIET	Patients with non-alcoholic fatty liver disease (NAFLD) have impaired health-related quality of life including physical and mental state. Near-infrared spectroscopy (NIRS) is a useful tool for evaluation of brain activity and depressive state. This study aimed to determine the brain activity of female NAFLD patients using NIRS. Cerebral oxygenated hemoglobin (oxy-Hb) concentration during a verbal fluency task (VFT) was measured using NIRS in 24 female NAFLD patients and 15 female healthy controls. The Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire was administered to both groups before NIRS. There was no significant difference in CES-D score between groups. However, the oxyHb concentration and number of words during the VFT were less in NAFLD compared to healthy controls. The mean value of oxy-Hb concentration during 0-60 s VFT in the frontal lobe was also smaller in NAFLD patients compared to healthy controls (0.082 +/- 0.126 vs. 0.183 +/- 0.145, P < 0.001). Cerebral oxygen concentration is poorly reactive in response to VFT in female NAFLD patients. This may indicate an association between decreased brain activity and NAFLD regardless of depression.	[Takahashi, Atsushi; Abel, Kazumichi; Imaizumi, Hiromichi; Fujita, Masashi; Hayashi, Manabu; Okai, Ken; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan; [Kono, Soichi; Oshima, Sachie; Miura, Itaru; Yabe, Hirooki] Fukushima Med Univ, Neuropsychiat, Sch Med, Fukushima, Japan; [Wada, Akira] Tokyo Univ Hosp, Dept Neuropsychiat, Tokyo, Japan	Fukushima Medical University; Fukushima Medical University; University of Tokyo	Takahashi, A (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan.	junior@fmu.ac.jp		Takahashi, Atsushi/0000-0003-0568-8361				Abe K, 2016, HEPATOL RES; Buysse D J, 1989, Psychiatry Res, V28, P193; Chawla KS, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2015-000069; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; Dan AA, 2007, ALIMENT PHARM THER, V26, P815, DOI 10.1111/j.1365-2036.2007.03426.x; David K, 2009, HEPATOLOGY, V49, P1904, DOI 10.1002/hep.22868; Elwing JE, 2006, PSYCHOSOM MED, V68, P563, DOI 10.1097/01.psy.0000221276.17823.df; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Imaizumi H, 2015, OBESITY FACTS, V8, P234, DOI 10.1159/000436997; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Klumpp H, 2010, INT J PSYCHOPHYSIOL, V75, P77, DOI 10.1016/j.ijpsycho.2009.10.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee K, 2013, PSYCHOSOMATICS, V54, P52, DOI 10.1016/j.psym.2012.09.005; Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; Nakanishi H, 2014, HEPATOL RES, V44, P319, DOI 10.1111/hepr.12127; Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338; Obrig H, 1996, J APPL PHYSIOL, V81, P1174, DOI 10.1152/jappl.1996.81.3.1174; Sassaroli A, 2006, NEUROIMAGE, V33, P505, DOI 10.1016/j.neuroimage.2006.07.006; Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Surdea-Blaga Teodora, 2011, Rom J Intern Med, V49, P273; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; Tomeno W, 2015, J GASTROEN HEPATOL, V30, P1009, DOI 10.1111/jgh.12897; Weinstein AA, 2011, PSYCHOSOMATICS, V52, P127, DOI 10.1016/j.psym.2010.12.019; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Youssef NA, 2013, LIVER INT, V33, P1062, DOI 10.1111/liv.12165	32	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174169	10.1371/journal.pone.0174169	http://dx.doi.org/10.1371/journal.pone.0174169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IO	28376101	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000005
J	Colicchia, V; Petroni, M; Guarguaglini, G; Sardina, F; Sahun-Roncero, M; Carbonari, M; Ricci, B; Heil, C; Capalbo, C; Belardinilli, F; Coppa, A; Peruzzi, G; Screpanti, I; Lavia, P; Gulino, A; Giannini, G				Colicchia, V.; Petroni, M.; Guarguaglini, G.; Sardina, F.; Sahun-Roncero, M.; Carbonari, M.; Ricci, B.; Heil, C.; Capalbo, C.; Belardinilli, F.; Coppa, A.; Peruzzi, G.; Screpanti, I.; Lavia, P.; Gulino, A.; Giannini, G.			PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma	ONCOGENE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; N-MYC; METASTATIC NEUROBLASTOMA; THERAPEUTIC STRATEGY; GENOMIC INSTABILITY; COMBINATION THERAPY; DNA-REPLICATION; FORK REVERSAL; C-MYC; CELLS	High-risk and MYCN-amplified neuroblastomas are among the most aggressive pediatric tumors. Despite intense multimodality therapies, about 50% of these patients succumb to their disease, making the search for effective therapies an absolute priority. Due to the important functions of poly (ADP-ribose) polymerases, PARP inhibitors have entered the clinical settings for cancer treatment and are being exploited in a variety of preclinical studies and clinical trials. PARP inhibitors based combination schemes have also been tested in neuroblastoma preclinical models with encouraging results. However, the expression of PARP enzymes in human neuroblastoma and the biological consequences of their inhibition remained largely unexplored. Here, we show that high PARP1 and PARP2 expression is significantly associated with high-risk neuroblastoma cases and poor survival, highlighting its previously unrecognized prognostic value for human neuroblastoma. In vitro, PARP1 and 2 are abundant in MYCN amplified and MYCN-overexpressing cells. In this context, PARP inhibitors with high 'PARP trapping' potency, such as olaparib or talazoparib, yield DNA damage and cell death preceded by intense signs of replication stress. Notwithstanding the activation of a CHK1-CDC25A replication stress response, PARP-inhibited MYCN amplified and overexpressing cells fail to sustain a prolonged checkpoint and progress through mitosis in the presence of damaged DNA, eventually undergoing mitotic catastrophe. CHK1-targeted inhibition of the replication stress checkpoint exacerbated this phenotype. These data highlight a novel route for cell death induction by PARP inhibitors and support their introduction, together with CHK1 inhibitors, in therapeutic approaches for neuroblastomas with high MYC(N) activity.	[Colicchia, V.; Sardina, F.; Sahun-Roncero, M.; Ricci, B.; Heil, C.; Capalbo, C.; Belardinilli, F.; Screpanti, I.; Gulino, A.; Giannini, G.] Univ Roma La Sapienza, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy; [Petroni, M.; Peruzzi, G.] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Guarguaglini, G.; Lavia, P.] Univ Roma La Sapienza, Inst Mol Biol & Pathol, CNR, Rome, Italy; [Carbonari, M.] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy; [Coppa, A.] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Giannini, G.] Univ Roma La Sapienza, Dept Mol Med, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Giannini, G (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Viale Regina Elena 291, I-00161 Rome, Italy.	giuseppe.giannini@uniroma1.it	petroni, marialaura/AAB-8637-2019; coppa, anna/N-3274-2016; Lavia, Patrizia/J-5793-2019; Lavia, Patrizia/AAL-3982-2021; Sardina, Francesca/AAC-2143-2022; Giannini, Giuseppe/B-5672-2013; Ricci, Biancamaria/AAT-9935-2021	petroni, marialaura/0000-0002-6021-1657; Lavia, Patrizia/0000-0003-3310-6701; Giannini, Giuseppe/0000-0003-0299-4056; Ricci, Biancamaria/0000-0003-1574-6043; Peruzzi, Giovanna/0000-0002-6517-9107; coppa, anna/0000-0001-9758-5444; Belardinilli, Francesca/0000-0003-4966-7044	Associazione Italiana per la Ricerca sul Cancro [IG17734, IG14723, IG14535]; AIRC [MFAG13350, 5XMILLE]; Ministry of University and Research (FIRB and PRIN); Italian Institute of Technology; FIRC	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministry of University and Research (FIRB and PRIN)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); FIRC(Fondazione AIRC per la ricerca sul cancro)	Time-lapse experiments were performed at the Nikon Reference Center for Central-Southern Italy at IBPM-CNR. Financial Support: This work was supported by grants from: Associazione Italiana per la Ricerca sul Cancro IG17734 (G. Giannini), IG14723 (A. Gulino) and IG14535 (P. Lavia); AIRC MFAG13350 (G. Guarguaglini); AIRC 5XMILLE (A. Gulino); Ministry of University and Research (FIRB and PRIN projects) (A. Gulino and G. Giannini); Italian Institute of Technology (A. Gulino). M.P. has been recipient of a FIRC fellowship David Raffaelli.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Canete A, 2009, J CLIN ONCOL, V27, P1014, DOI 10.1200/JCO.2007.14.5839; Carbonari M, 2016, CYTOM PART A, V89A, P498, DOI 10.1002/cyto.a.22823; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chayka O, 2015, J BIOL CHEM, V290, P2198, DOI 10.1074/jbc.M114.624056; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Daniel RA, 2009, CLIN CANCER RES, V15, P1241, DOI 10.1158/1078-0432.CCR-08-1095; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Ferrao PT, 2012, ONCOGENE, V31, P1661, DOI 10.1038/onc.2011.358; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Judware R, 1995, ONCOGENE, V11, P2599; Kuzyk A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014373; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lupo B, 2014, BBA-REV CANCER, V1846, P201, DOI 10.1016/j.bbcan.2014.07.004; Lutz W, 1996, ONCOGENE, V13, P803; Massimi I, 2013, MOL CARCINOGEN, V52, P526, DOI 10.1002/mc.21887; McCluskey AG, 2012, J NUCL MED, V53, P1146, DOI 10.2967/jnumed.111.095943; McNeil EM, 2013, DNA REPAIR, V12, P1000, DOI 10.1016/j.dnarep.2013.08.017; Mueller S, 2013, ANTICANCER RES, V33, P755; Murai J, 2014, J PHARMACOL EXP THER, V349, P408, DOI 10.1124/jpet.113.210146; Murai J, 2014, MOL CANCER THER, V13, P433, DOI 10.1158/1535-7163.MCT-13-0803; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Neiman PE, 2006, ONCOGENE, V25, P6325, DOI 10.1038/sj.onc.1209646; Norris RE, 2014, PEDIATR BLOOD CANCER, V61, P145, DOI 10.1002/pbc.24697; Petroni M, 2016, CELL DEATH DIFFER, V23, P197, DOI 10.1038/cdd.2015.81; Petroni M, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00141; Petroni M, 2011, MOL CANCER RES, V9, P67, DOI 10.1158/1541-7786.MCR-10-0227; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rohban S, 2015, BBA-GENE REGUL MECH, V1849, P517, DOI 10.1016/j.bbagrm.2014.04.008; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Srinivasan SV, 2013, CELL REP, V3, P1629, DOI 10.1016/j.celrep.2013.04.002; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Veschi V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.68; Veschi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049139; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099	50	52	52	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4682	4691		10.1038/onc.2017.40	http://dx.doi.org/10.1038/onc.2017.40			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394338				2022-12-26	WOS:000407702400002
J	Conceicao, T; de Lencastre, H; Aires-de-Sousa, M				Conceicao, Teresa; de Lencastre, Herminia; Aires-de-Sousa, Marta			Frequent isolation of methicillin resistant Staphylococcus aureus (MRSA) ST398 among healthy pigs in Portugal	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; HIGH PREVALENCE; CC398; BACTERIA; PATTERNS	Background Although livestock-associated ST398 methicillin-resistant Staphylococcus aureus (MRSA) has been widely reported in different geographic regions, MRSA carriage studies among healthy pigs in Portugal are very limited. Methods and findings In total, 101 swine nasal samples from two Portuguese farms were screened for MRSA. In addition five swine workers (including one veterinary and one engineer) and four household members were nasally screened. The isolates were characterized by spa typing, SCCmec typing and MLST. All isolates were tested for antimicrobial susceptibility, presence of mecA and mecC genes, and virulence determinants. MRSA prevalence in swine was 99% (100/101), 80% (4/5) in swine workers and 25% (1/4) in household members. All isolates belonged to ST398 distributed over two spa types-t011 (57%) and t108 (42%). SCCmec type V was present in most of the isolates (n = 95; 82%) while 21 isolates amplified the mecA gene only and were classified as nontypeable. The majority of the isolates were resistant to tetracycline (100%), clindamycin (97%), erythromycin (96%), chloramphenicol (84%) and gentamycin (69%). Notably, 12% showed resistance to quinupristin-dalfopristin (MICs 3-8 mu g/mL). Beta-hemolysin (81%) and gamma-hemolysin (74%) were the unique virulence determinants detected. None of the isolates harboured PVL or mecC gene. Conclusions This study showed a massive occurrence of ST398-MRSA in two independent swine farms, highlighting its establishment among healthy pigs in Portugal.	[Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier ITQB, Lab Mol Genet, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10021 USA; [Aires-de-Sousa, Marta] ESSCVP, Lisbon, Portugal	Universidade Nova de Lisboa; Rockefeller University	Aires-de-Sousa, M (corresponding author), ESSCVP, Lisbon, Portugal.	msousa@esscvp.eu	; Conceicao, Teresa/M-3449-2014	Aires-de-Sousa, Marta/0000-0001-5036-2446; /0000-0001-6816-8932; Conceicao, Teresa/0000-0002-9818-2767	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/DTP-EPI/0842/2014]; FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT, Portugal [SFRH/BPD/72422/2010]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by project PTDC/DTP-EPI/0842/2014 from FCT - Fundacao para a Ciencia e a Tecnologia, Portugal and by project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI). TC was supported by grant SFRH/BPD/72422/2010 from FCT, Portugal.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812; Couto N, 2015, J ANTIMICROB CHEMOTH, V70, P2483, DOI 10.1093/jac/dkv141; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Dierikx CM, 2016, J ANTIMICROB CHEMOTH, V71, P2414, DOI 10.1093/jac/dkw190; ECDC, 2017, ANTIMICROBIAL RESIST, DOI DOI 10.2900/6928; Hershberger E, 2004, CLIN INFECT DIS, V38, P92, DOI 10.1086/380125; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; Li BB, 2013, J ANTIMICROB CHEMOTH, V68, P1251, DOI 10.1093/jac/dkt015; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Peeters LEJ, 2015, VET MICROBIOL, V180, P151, DOI 10.1016/j.vetmic.2015.08.018; Pomba C, 2010, J ANTIMICROB CHEMOTH, V65, P2479, DOI 10.1093/jac/dkq330; Pomba CA, 2009, INT J ANTIMICROB AG, V34, P193, DOI 10.1016/j.ijantimicag.2009.02.019; Pyorala S, 2014, VET J, V200, P230, DOI 10.1016/j.tvjl.2014.02.028; van Alen S, 2017, VET MICROBIOL, V200, P19, DOI 10.1016/j.vetmic.2016.01.021; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	24	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175340	10.1371/journal.pone.0175340	http://dx.doi.org/10.1371/journal.pone.0175340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399155	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000034
J	Moon, SJ; Ahn, CH; Cho, YM				Moon, Sun Joon; Ahn, Chang Ho; Cho, Young Min			Effect of prescribing metformin according to eGFR instead of serum creatinine level: A study based on Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2014	PLOS ONE			English	Article							LACTIC-ACIDOSIS; RENAL-DISEASE; TYPE-2; EQUATION; YOUNG; HYPERGLYCEMIA; MANAGEMENT; CLEARANCE; THERAPY; VALUES	Background The metformin label has recently been changed from serum creatinine (sCr)-based to estimated glomerular filtration rate (eGFR)-based indication, which is expected to expand its use for patients with mild renal insufficiency. However, because the sCr level is lower in Asians than in Caucasians at the same level of renal function, this change might not expand metformin use in the Asian population. We investigated the effect of this change among Korean patients with diabetes. Methods Data from the Korean National Health and Nutrition Examination Survey 2009 to 2014 were used and included 4,127 adult patients with diabetes. The metformin eligibility was assessed by the sCr level (1.4 mg/dL for women and 1.5 mg/dL for men) or by eGFR categories (contraindicated, <30; indeterminate, >= 30, <45; likely safe, >= 45 mL/min/1.73 m(2)) calculated by various eGFR equations including MDRD equation. We designated the 'expanding' and 'contracting' population as those who are likely safe according to eGFR among sCr-ineligible patients and those contraindicated according to eGFR among sCr-eligible patients, respectively. Results were weighted to the whole Korean adult population. Results All eGFR equations showed expansion in the population for whom metformin is likely safe, ranging from 14.3% to 19.9% of the sCr-ineligible population. With the MDRD equation, the expanding population was 15,264 (15.8%) and the contracting population was 0 (0.0%). Male sex and younger age were significantly associated with the expanding population. Conclusions Contrary to our concern, prescribing metformin according to eGFR substantially expanded the indication of its use among the Korean diabetic patients.	[Moon, Sun Joon; Ahn, Chang Ho; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU)	Cho, YM (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ymchomd@snu.ac.kr		Cho, Young Min/0000-0002-2331-6126				Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Canadian Diabetes Association, 2013, CLIN PRACT GUID; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COHEN RD, 1973, DIABETOLOGIA, V9, P43, DOI 10.1007/BF01225999; Couchoud C, 1999, KIDNEY INT, V55, P1878, DOI 10.1046/j.1523-1755.1999.00411.x; Du Bois D, 1989, Nutrition, V5, P303; Ezzati T M, 1992, Vital Health Stat 2, P1; Friesecke S, 2010, CRITICAL CARE, V14, P1; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; Holstein A, 2005, DIABETOLOGIA, V48, P2454, DOI 10.1007/s00125-005-0026-1; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Jung JH, 2015, DIABETES METAB J, V39, P307, DOI 10.4093/dmj.2015.39.4.307; Kalantar-Zadeh K, 2016, DIABETES CARE, V39, P1281, DOI 10.2337/dc15-2327; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee EK, 2009, DIABETES RES CLIN PR, V83, P44, DOI 10.1016/j.diabres.2008.09.047; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lipska KJ, 2011, DIABETES CARE, V34, P1431, DOI 10.2337/dc10-2361; Misbin RI, 2004, DIABETES CARE, V27, P1791, DOI 10.2337/diacare.27.7.1791; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Institute for Health and Care Excellence, 2015, NICE GUID MAN TYP 2; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003; Tuot DS, 2015, DIABETES CARE, V38, P2059, DOI 10.2337/dc15-0542; U.S. Food and Drug Administration, 1994, METF HYDR TABL; US Food and Drug Administration. FDA drug safety communication, 2016, FDA REV WARN REG US; Yeung RO, 2014, LANCET DIABETES ENDO, V2, P935, DOI 10.1016/S2213-8587(14)70137-8	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175334	10.1371/journal.pone.0175334	http://dx.doi.org/10.1371/journal.pone.0175334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399132	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000031
J	Zhang, M; Liu, BX				Zhang, Mei; Liu, Baoxiu			Identification of a rice metal tolerance protein OsMTP11 as a manganese transporter	PLOS ONE			English	Article							DIFFUSION FACILITATOR FAMILY; HEAVY-METAL; TRANSCRIPTIONAL ACTIVATION; YEAST; GENE; ARABIDOPSIS; EXPRESSION; PATHWAY; STRESS; TRANSFORMATION	Metal tolerance proteins (MTPs) are a gene family of cation efflux transporters that occur widely in plants and might serve an essential role in metal homeostasis and tolerance. Our research describes the identification, characterization, and localization of OsMTP11, a member of the MTP family from rice. OsMTP11 was expressed constitutively and universally in different tissues in rice plant. Heterologous expression in yeast showed that OsMTP11 complemented the hypersensitivity of mutant strains to Mn, and also complemented yeast mutants to other metals, including Co and Ni. Real time RT-PCR analysis demonstrated OsMTP11 expression was substantially enhanced following 4 h under Cd, Zn, Ni, and Mn treatments, suggesting possible roles of OsMTP11 involvement in heavy metal stress responses. Promoter analysis by transgenic assays with GUS as a reporter gene and mRNA in situ hybridization experiments showed that OsMTP11 was expressed specifically in conducting tissues in rice. DNA methylation assays of genomic DNA in rice treated with Cd, Zn, Ni, and Mn revealed that decreased DNA methylation levels were present in the OsMTP11 promoter region, which was consistent with OsMTP11 induced-expression patterns resulting from heavy metal stress. This result suggested that DNA methylation is one of major factors regulating expression of OsMTP11 through epigenetic mechanisms. OsMTP11 fused to green fluorescent protein (GFP) localized to the entire onion epidermal cell cytoplasm, while vacuolar membrane exhibited increased GFP signals, consistent with an OsMTP11 function in cation sequestration. Our results indicated that OsMTP11 might play vital roles in Mn and other heavy metal transportation in rice.	[Zhang, Mei; Liu, Baoxiu] Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China; [Liu, Baoxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, M (corresponding author), Chinese Acad Sci, South China Bot Garden, Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China.	zhangmei@scbg.ac.cn		Zhang, Mei/0000-0003-0976-3867	National Natural Sciences Foundation of China [31271702, 31570257]; Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	This research was supported by the National Natural Sciences Foundation of China (Grant nos. 31271702 and 31570257) and Knowledge Innovation Project for Young Scientists of the South China Botanical Garden, awarded to M.Zhang. The funders had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript.	Aichinger E, 2010, METHODS MOL BIOL, V655, P433, DOI 10.1007/978-1-60761-765-5_29; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BACHHAWAT AK, 1993, YEAST, V9, P175, DOI 10.1002/yea.320090208; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Erbasol I, 2013, BIOMETALS, V26, P795, DOI 10.1007/s10534-013-9658-7; Fei Y, 2016, PROTOPLASMA; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Graham LA, 1995, J BIOL CHEM; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Meyer P, 2011, FEBS LETT, V585, P2008, DOI 10.1016/j.febslet.2010.08.017; Migocka M, 2014, J EXP BOT, V65, P5367, DOI 10.1093/jxb/eru295; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muthukumar B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-32; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Porto MS, 2014, MOL BIOTECHNOL, V56, P38, DOI 10.1007/s12033-013-9713-1; Qi XT, 2007, PLANT PHYSIOL, V143, P50, DOI 10.1104/pp.106.080283; Searle P F, 1987, Experientia Suppl, V52, P407; Sharma SS, 2016, PLANT CELL ENVIRON, V39, P1112, DOI 10.1111/pce.12706; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh S, 2015, FRONT PLANT SCI, P6; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Ueno D, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.170, 10.1038/nplants.2015.170]; van der Zaal BJ, 1999, PLANT PHYSIOL, V119, P1047, DOI 10.1104/pp.119.3.1047; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang Y, 2005, CELL RES, V15, P604, DOI 10.1038/sj.cr.7290330; Wimalarathna RN, 2012, BIOCHEM BIOPH RES CO, V422, P658, DOI 10.1016/j.bbrc.2012.05.047; Xu J, 2009, PLANT CELL REP, V28, P1235, DOI 10.1007/s00299-009-0723-1; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9	50	40	44	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174987	10.1371/journal.pone.0174987	http://dx.doi.org/10.1371/journal.pone.0174987			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394944	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800011
J	Jeng, JS; Hsieh, FI; Yeh, HL; Chen, WH; Chiu, HC; Tang, SC; Liu, CH; Lin, HJ; Hsu, SP; Lo, YK; Chan, L; Chen, CH; Lin, RT; Chen, YW; Lee, JT; Yeh, CH; Sun, MH; Lai, TC; Sun, Y; Sun, MC; Chen, PL; Chiang, TR; Lin, SK; Yip, BS; Chen, CI; Bai, CH; Chen, ST; Chiou, HY; Lien, LM; Hsu, CY				Jeng, Jiann-Shing; Hsieh, Fang-I; Yeh, Hsu-Ling; Chen, Wei-Hung; Chiu, Hou-Chang; Tang, Sung-Chun; Liu, Chung-Hsiang; Lin, Huey-Juan; Hsu, Shih-Pin; Lo, Yuk-Keung; Chan, Lung; Chen, Chih-Hung; Lin, Ruey-Tay; Chen, Yu-Wei; Lee, Jiunn-Tay; Yeh, Chung-Hsin; Sun, Ming-Hui; Lai, Ta-Chang; Sun, Yu; Sun, Mu-Chien; Chen, Po-Lin; Chiang, Tsuey-Ru; Lin, Shinn-Kuang; Yip, Bak-Sau; Chen, Chin-I; Bai, Chi-Huey; Chen, Sien-Tsong; Chiou, Hung-Yi; Lien, Li-Ming; Hsu, Chung Y.		Taiwan Stroke Registry Investigato	Impact of MCA stenosis on the early outcome in acute ischemic stroke patients	PLOS ONE			English	Article							CEREBRAL-ARTERY STENOSIS; INTRACRANIAL ATHEROSCLEROTIC STROKE; OCCLUSIVE CEREBROVASCULAR-DISEASE; TRANSCRANIAL DOPPLER ULTRASOUND; MAGNETIC-RESONANCE ANGIOGRAPHY; NORTHERN MANHATTAN STROKE; RISK-FACTORS; METABOLIC SYNDROME; CHINESE PATIENTS; TAIWAN	Background Asians have higher frequency of intracranial arterial stenosis. The present study aimed to compare the clinical features and outcomes of ischemic stroke patients with and without middle cerebral artery (MCA) stenosis, assessed by transcranial sonography (TCS), based on the Taiwan Stroke Registry (TSR). Methods Patients with acute ischemic stroke or transient ischemic attack registered in the TSR, and received both carotid duplex and TCS assessment were categorized into those with stenosis (>= 50%) and without (< 50%) in the extracranial internal carotid artery (ICA) and MCA,respectively. Logistic regression analysis, Kaplan-Meier method and Cox proportional hazard model were applied to assess relevant variables between groups. Results Of 6003 patients, 23.3% had MCA stenosis, 10.1% ICA stenosis, and 3.9% both MCA and ICA stenosis. Patients with MCA stenosis had greater initial NIHSS, higher likelihood of stroke-in-evolution, and more severe disability than those without (all p < 0.001). Patients with MCA stenosis had higher prevalence of hypertension, diabetes and hypercholesterolemia. Patients with combined MCA and extracranial ICA stenosis had even higher NIHSS, worse functional outcome, higher risk of stroke recurrence or death (hazard ratio, 2.204; 95% confidence intervals, 1.440-3.374; p < 0.001) at 3 months after stroke than those without MCA stenosis. Conclusions In conclusion, MCA stenosis was more prevalent than extracranial ICA stenosis in ischemic stroke patients in Taiwan. Patients with MCA stenosis, especially combined extracranial ICA stenosis, had more severe neurological deficit and worse outcome.	[Jeng, Jiann-Shing; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hsieh, Fang-I; Chiou, Hung-Yi] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei, Taiwan; [Yeh, Hsu-Ling; Chen, Wei-Hung; Chiu, Hou-Chang; Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Liu, Chung-Hsiang] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Huey-Juan] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hsu, Shih-Pin] E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lo, Yuk-Keung] Kaohsiung Vet Gen Hosp, Neurol Sect, Kaohsiung, Taiwan; [Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chen, Chih-Hung] Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan, Taiwan; [Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chen, Yu-Wei] Landseed Hosp, Dept Neurol, Taoyuan, Taiwan; [Lee, Jiunn-Tay] Tri Serv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yeh, Chung-Hsin] Yuan Rung Hosp, Dept Neurol, Changhua, Taiwan; [Sun, Ming-Hui] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lai, Ta-Chang] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Chen, Po-Lin] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Chiang, Tsuey-Ru] Cathay Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Shinn-Kuang] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei Branch, New Taipei, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Dept Neurol, Hsinchu Branch, Hsinchu, Taiwan; [Chen, Chin-I] Taipei Med Univ, Wan Fang Hosp, Dept Neurol, Taipei, Taiwan; [Bai, Chi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan; [Chen, Sien-Tsong] Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan; [Hsu, Chung Y.] China Med Univ & Hosp, Grad Inst Clin Med Sci, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chi Mei Hospital; E-Da Hospital; Kaohsiung Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tri-Service General Hospital; Cheng Hsin General Hospital; Changhua Christian Hospital; Taichung Veterans General Hospital; Cathay General Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lien, LM (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan.; Lien, LM (corresponding author), Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan.	limingmd@ms28.hinet.net	Chan, Lung/AAM-3231-2021; Chan, Lung/AAI-6349-2020	Chan, Lung/0000-0001-5795-4460; Chiou, Hung Yi/0000-0002-4545-9697; JENG, JIANN-SHING/0000-0002-1456-3686; Hsu, Chung Y./0000-0002-5632-2733; Tang, Sung-Chun/0000-0003-3731-5973; Yip, Bak-Sau/0000-0001-7942-8293	Bureau of Health Promotion; Department of Health Taiwan Stroke Registry grant [DOH-9598-HP-1102]; Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Center of Excellence for Clinical Trial and Research in Neuroscience, Taiwan [DOH102-TD-B-111-003]; Ministry of Health and Welfare, Taiwan [MOHW105-TDU-B-212-133018]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325B-039 -006]; Taiwan Ministry of Science and Technology [MOST 105-2314-B-341-004]; Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302103-DR-17]; Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Bureau of Health Promotion; Department of Health Taiwan Stroke Registry grant; Department of Health Clinical Trial and Research Center of Excellence; Center of Excellence for Clinical Trial and Research in Neuroscience, Taiwan; Ministry of Health and Welfare, Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Taiwan Ministry of Science and Technology; Shin Kong Wu Ho-Su Memorial Hospital; Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This project was funded by the Bureau of Health Promotion, Department of Health Taiwan Stroke Registry grant (DOH-9598-HP-1102); Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), Center of Excellence for Clinical Trial and Research in Neuroscience (DOH102-TD-B-111-003), Taiwan; the Ministry of Health and Welfare (MOHW105-TDU-B-212-133018), Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB Stroke Clinical Trial Consortium (MOST 103-2325B-039 -006); Taiwan Ministry of Science and Technology (MOST 105-2314-B-341-004); Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302103-DR-17); Dr. Chi-Chin Huang Stroke Research Center, Taipei, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Battistella V, 2014, EUR J NEUROL, V21, P956, DOI 10.1111/ene.12385; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; De Silva DA, 2007, STROKE, V38, P2592, DOI 10.1161/STROKEAHA.107.484584; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Hao Q, 2010, J NEUROIMAGING, V20, P122, DOI 10.1111/j.1552-6569.2008.00337.x; Holzer Katrin, 2009, BMC Med Imaging, V9, P13, DOI 10.1186/1471-2342-9-13; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129; JENG JS, 1994, STROKE, V25, P1989, DOI 10.1161/01.STR.25.10.1989; Kappelle IJ, 1999, STROKE, V30, P282, DOI 10.1161/01.STR.30.2.282; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Lee SJ, 2003, ARCH NEUROL-CHICAGO, V60, P1561, DOI 10.1001/archneur.60.11.1561; Liu HM, 1996, STROKE, V27, P650, DOI 10.1161/01.STR.27.4.650; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Nahab F, 2008, STROKE, V39, P1039, DOI 10.1161/STROKEAHA.107.499475; Navarro JC, 2007, CEREBROVASC DIS, V23, P325, DOI 10.1159/000099130; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; Qureshi AI, 2014, LANCET, V383, P984, DOI 10.1016/S0140-6736(13)61088-0; Rincon F, 2009, CEREBROVASC DIS, V28, P65, DOI 10.1159/000219299; ROTHER J, 1994, CEREBROVASC DIS, V4, P273, DOI 10.1159/000108494; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Stelagowski M, 2010, ANN VASC SURG, V24, P786, DOI 10.1016/j.avsg.2010.02.033; Tang SC, 2005, J ULTRAS MED, V24, P451, DOI 10.7863/jum.2005.24.4.451; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; Wang YJ, 2014, STROKE, V45, P663, DOI 10.1161/STROKEAHA.113.003508; Weimar C, 2006, ARCH NEUROL-CHICAGO, V63, P1287, DOI 10.1001/archneur.63.9.1287; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Zhao LM, 2011, STROKE, V42, P3429, DOI 10.1161/STROKEAHA.111.621235	40	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175434	10.1371/journal.pone.0175434	http://dx.doi.org/10.1371/journal.pone.0175434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388675	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800055
J	Kanari, K; Sakamoto, K; Kaneko, H				Kanari, Kei; Sakamoto, Kiyomi; Kaneko, Hirohiko			Effect of visual attention on the properties of optokinetic nystagmus	PLOS ONE			English	Article							MOTION STIMULI; EYE-MOVEMENTS; MICROSACCADES; STATIONARY; SMOOTH; TARGET	It has been demonstrated that optokinetic nystagmus (OKN) gain increases through attention to peripheral motion when the central visual field is occluded. However, how the properties of OKN change when two areas containing motion in different directions are presented in the peripheral visual field is still unclear. In this study, we investigated whether OKN corresponding to the attended motion in the periphery occurred while the observer was maintaining fixation at the center. We presented two areas with different directions of motion arranged on the left and right, top and bottom, or center and surrounding (concentric) areas in the display. Observers counted targets appearing on the attended area in the stimulus to maintain their attention on it. The results indicate that attention enhances the gain and frequency of OKN corresponding to the attended motion even in the case of stimuli having several areas with different directions of motion.	[Kanari, Kei; Kaneko, Hirohiko] Tokyo Inst Technol, Sch Engn, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan; [Sakamoto, Kiyomi] Panasonic Corp, Groupwide CTO Off, Tech Informat Serv Dept, Kadoma, Osaka, Japan	Tokyo Institute of Technology; Panasonic	Kanari, K (corresponding author), Tokyo Inst Technol, Sch Engn, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan.	kei.kanari@ip.titech.ac.jp	Kanari, Kei/AAY-5764-2020	Kanari, Kei/0000-0003-4379-5758	Japan Science and Technology Agency [AS2621022H]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by A-STEP FS (no. AS2621022H) from Japan Science and Technology Agency. URL: https://www.jst.go.jp/EN/index.html. Grant Recipient: HK. Panasonic Corporation provided support in the form of salaries for authors [KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abadi RV, 2005, PERCEPTION, V34, P1015, DOI 10.1068/p5251b; BARNES GR, 1985, EXP BRAIN RES, V59, P548; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carpenter RHS, 1991, EYE MOVEMENTS; CHENG M, 1975, EXP BRAIN RES, V23, P129; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Dichgans J., 1977, CONTROL GAZE BRAIN S, P261; DUBOIS MFW, 1979, VISION RES, V19, P1105, DOI 10.1016/0042-6989(79)90005-1; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; GRESTY M, 1979, ACTA OTO-LARYNGOL, V87, P477, DOI 10.3109/00016487909126455; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; HOWARD IP, 1987, VISION RES, V27, P1807, DOI 10.1016/0042-6989(87)90109-X; Kleiner M, 2007, PERCEPTION, V36, P14; KOWLER E, 1984, VISION RES, V24, P1789, DOI 10.1016/0042-6989(84)90010-5; Maruyama M, 2003, EXP BRAIN RES, V151, P411, DOI 10.1007/s00221-003-1497-2; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; MURASUGI CM, 1989, EXP BRAIN RES, V77, P183; MURASUGI CM, 1986, VISION RES, V26, P1155, DOI 10.1016/0042-6989(86)90049-0; MURPHY BJ, 1975, VISION RES, V15, P1263, DOI 10.1016/0042-6989(75)90172-8; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Posner MI, CHRONOMETRIC EXPLORA, P197; Rubinstein NJ, 2011, INVEST OPHTH VIS SCI, V52, P462, DOI 10.1167/iovs.10-6016; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072041; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; van Die G, 1982, Hum Neurobiol, V1, P111; VANDENBERG AV, 1988, EXP BRAIN RES, V70, P597, DOI 10.1007/BF00247608; VIRSU V, 1979, EXP BRAIN RES, V37, P475; Williams IM, 2006, J CLIN NEUROSCI, V13, P828, DOI 10.1016/j.jocn.2005.10.010	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175453	10.1371/journal.pone.0175453	http://dx.doi.org/10.1371/journal.pone.0175453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388668	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800057
J	Neves, RAF; Fernandes, T; dos Santos, LN; Nascimento, SM				Neves, Raquel A. F.; Fernandes, Taina; dos Santos, Luciano Neves; Nascimento, Silvia M.			Toxicity of benthic dinoflagellates on grazing, behavior and survival of the brine shrimp Artemia salina	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; HARMFUL ALGAL BLOOMS; PARALYTIC SHELLFISH TOXINS; PROROCENTRUM-LIMA; ALEXANDRIUM-FUNDYENSE; DINOPHYCEAE; PHYTOPLANKTON; PALYTOXIN; RESPONSES; COPEPODS	Harmful algae may differently affect their primary grazers, causing sub-lethal effects and/ or leading to their death. The present study aim to compare the effects of three toxic benthic dinoflagellates on clearance and grazing rates, behavioral changes, and survival of Artemia salina. Feeding assays consisted in 1-h incubations of brine shrimps with the toxic Prorocentrum lima, Gambierdiscus excentricus and Ostreopsis cf. ovata and the non-toxic Tetraselmis sp. Brine shrimps fed unselectively on all toxic and non-toxic algal preys, without significant differences in clearance and ingestion rates. Acute toxicity assays were performed with dinoflagellate cells in two growth phases during 7-h to assess differences in cell toxicity to A. salina. Additionally, exposure to cell-free medium was performed to evaluate its effects on A. salina survival. The behavior of brine shrimps significantly changed during exposure to the toxic dinoflagellates, becoming immobile at the bottom by the end of the trials. Dinoflagellates significantly affected A. salina survival with 100% mortality after 7-h exposure to cells in exponential phase (all treatments) and to P. lima in stationary phase. Mortality rates of brine shrimps exposed to O. cf. ovata and G. excentricus in stationary phase were 91% and 75%, respectively. However, incubations of the brine shrimps with cell-free medium did not affect A. salina survivorship. Significant differences in toxic effects between cell growth phases were only found in the survival rates of A. salina exposed to G. excentricus. Acute exposure to benthic toxic dinoflagellates induced harmful effects on behavior and survival of A. salina. Negative effects related to the toxicity of benthic dinoflagellates are thus expected on their primary grazers making them more vulnerable to predation and vectors of toxins through the marine food webs.	[Neves, Raquel A. F.; Fernandes, Taina; Nascimento, Silvia M.] Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Microalgas Marinhas, Rio De Janeiro, Brazil; [dos Santos, Luciano Neves] Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Ictiol Teor & Aplicada, Rio De Janeiro, Brazil; [dos Santos, Luciano Neves; Nascimento, Silvia M.] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop PPGBIO, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	dos Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Ecol & Recursos Marinhos, Lab Ictiol Teor & Aplicada, Rio De Janeiro, Brazil.; dos Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop PPGBIO, Rio De Janeiro, Brazil.	luciano.santos@unirio.br	Neves, Raquel A. F./D-5128-2015; Nascimento, Silvia M/G-4460-2013; Santos, Luciano/M-4377-2015	Neves, Raquel A. F./0000-0002-2627-9666; Nascimento, Silvia M/0000-0002-5149-4181; Santos, Luciano/0000-0002-5279-5672	Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ [E-26/203.493/2015]	Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Partial funding was provided by the Graduate Course in Neotropical Biodiversity (PPGBIO-UNIRIO) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (grant n<SUP>o</SUP> E-26/203.493/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoroni Stefano, 2016, Advances in Oceanography and Limnology, V7, P1, DOI 10.4081/aiol.2016.5591; Ajuzie CC, 2007, J APPL PHYCOL, V19, P513, DOI 10.1007/s10811-007-9164-9; Aligizaki K, 2009, P 7 INT C MOLL SHELL, P1; Aligizaki K, 2011, TOXICON, V57, P390, DOI 10.1016/j.toxicon.2010.11.014; [Anonymous], 2012, GLOBAL ECOLOGY OCEAN; Bagoien E, 1996, MAR BIOL, V126, P361, DOI 10.1007/BF00354618; Basti L, 2009, AQUACULTURE, V291, P41, DOI 10.1016/j.aquaculture.2009.02.029; Beattie KA, 2003, AQUAT TOXICOL, V62, P219, DOI 10.1016/S0166-445X(02)00091-7; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; Demaret A, 1995, P 6 INT C TOX MAR PH, P427; Engstrom-Ost J, 2002, J EXP MAR BIOL ECOL, V276, P95, DOI 10.1016/S0022-0981(02)00241-1; Faimali M, 2012, MAR ENVIRON RES, V76, P97, DOI 10.1016/j.marenvres.2011.09.010; Fleming L. E., 1998, HARMFUL ALGAE, P245; FORWARD RB, 1993, J PLANKTON RES, V15, P693, DOI 10.1093/plankt/15.6.693; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Furlan M, 2013, HARMFUL ALGAE, V21-22, P20, DOI 10.1016/j.hal.2012.11.004; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Gayoso AM, 2002, J SHELLFISH RES, V21, P461; Giussani V, 2016, HARMFUL ALGAE, V57, P49, DOI 10.1016/j.hal.2016.05.005; Graneli E., 2002, 10 INT C HARMF ALG S, P113; Graneli E, 2011, HARMFUL ALGAE, V10, P165, DOI 10.1016/j.hal.2010.09.002; Guerrini F, 2010, TOXICON, V55, P211, DOI 10.1016/j.toxicon.2009.07.019; Guillard R.R.L., 1995, MANUAL HARMFUL MARIN, P45; Guisande C, 2002, MAR ECOL PROG SER, V240, P105, DOI 10.3354/meps240105; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hegaret H, 2007, J SHELLFISH RES, V26, P549, DOI 10.2983/0730-8000(2007)26[549:DFROFS]2.0.CO;2; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Holland WC, 2013, TOXICON, V65, P15, DOI 10.1016/j.toxicon.2012.12.016; Hoppenrath M, 2013, HARMFUL ALGAE, V27, P1, DOI 10.1016/j.hal.2013.03.006; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hwang BS, 2013, BIOORG MED CHEM LETT, V23, P3023, DOI 10.1016/j.bmcl.2013.03.020; Issam E, 2010, ECOTOX ENVIRON SAFE, V73, P762, DOI 10.1016/j.ecoenv.2009.12.015; KELLY AM, 1992, ENVIRON BIOL FISH, V33, P275, DOI 10.1007/BF00005871; Koike K, 1998, TOXICON, V36, P2039, DOI 10.1016/S0041-0101(98)00132-9; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lasley-Rasher RS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0176; Lawrence J. E., 1998, HARMFUL ALGAE, P78; Lee KW, 2014, HARMFUL ALGAE, V37, P62, DOI 10.1016/j.hal.2014.05.007; Leps J, 2003, MULTIVARIATE ANAL EC; Lincoln JA, 2001, HYDROBIOLOGIA, V453, P107, DOI 10.1023/A:1013163816771; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; Lopes VM, 2014, AQUAT TOXICOL, V146, P205, DOI 10.1016/j.aquatox.2013.11.011; Mangialajo L, 2008, MAR POLLUT BULL, V56, P1209, DOI 10.1016/j.marpolbul.2008.02.028; Marcoval MA, 2013, ESTUAR COAST SHELF S, V131, P235, DOI 10.1016/j.ecss.2013.05.034; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MURATA M, 1982, B JPN SOC SCI FISH, V48, P549; Nascimento SM, 2016, HARMFUL ALGAE, V57, P39, DOI 10.1016/j.hal.2016.05.006; Nascimento SM, 2012, HARMFUL ALGAE, V13, P1, DOI 10.1016/j.hal.2011.09.008; Nascimento SM, 2015, PHYCOLOGIA, V54, P628, DOI 10.2216/15-61.1; Nascimento SM, 2005, TOXICON, V45, P633, DOI 10.1016/j.toxicon.2004.12.023; Neves RAF, 2015, AQUAT TOXICOL, V160, P96, DOI 10.1016/j.aquatox.2015.01.010; Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037; OHMAN MD, 1991, BIOL BULL, V181, P500, DOI 10.2307/1542370; Pezzolesi L, 2012, WATER RES, V46, P82, DOI 10.1016/j.watres.2011.10.029; Ramos V, 2010, MAR DRUGS, V8, P2021, DOI 10.3390/md8072021; Rhodes L., 2008, P 6 INT C MOLL SHELL, P168; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Samson JC, 2008, J FISH BIOL, V72, P168, DOI 10.1111/j.1095-8649.2007.01698.x; Shears NT, 2009, HARMFUL ALGAE, V8, P916, DOI 10.1016/j.hal.2009.05.003; Shumway SE, 2006, HARMFUL ALGAE, V5, P442, DOI 10.1016/j.hal.2006.04.013; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Silva NJ, 2013, J PLANKTON RES, V35, P855, DOI 10.1093/plankt/fbt026; Sopanen S, 2011, J PLANKTON RES, V33, P1564, DOI 10.1093/plankt/fbr052; Tan ZJ, 2007, BIOMED ENVIRON SCI, V20, P235; Tubaro A, 2011, TOXICON, V57, P478, DOI 10.1016/j.toxicon.2011.01.005; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; Turner JT, 1998, MAR ECOL-P S Z N I, V19, P195, DOI 10.1111/j.1439-0485.1998.tb00462.x; Vasconcelos V, 2010, MAR DRUGS, V8, P59, DOI 10.3390/md8010059; Wu Zhen-Xing, 2006, Acta Ecologica Sinica, V26, P3942	70	25	25	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175168	10.1371/journal.pone.0175168	http://dx.doi.org/10.1371/journal.pone.0175168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388672	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800026
J	Aklilu, E; Gebresilassie, A; Yared, S; Kindu, M; Tekie, H; Balkew, M; Warburg, A; Hailu, A; Gebre-Michael, T				Aklilu, Esayas; Gebresilassie, Araya; Yared, Solomon; Kindu, Mizan; Tekie, Habte; Balkew, Meshesha; Warburg, Alon; Hailu, Asrat; Gebre-Michael, Teshome			Studies on sand fly fauna and ecological analysis of Phlebotomus orientalis in the highland and lowland foci of kala-azar in northwestern Ethiopia	PLOS ONE			English	Article							VISCERAL-LEISHMANIASIS; POTENTIAL DISTRIBUTION; POPULATION-DYNAMICS; SPECIES COMPOSITION; DOMESTIC HABITATS; BERGEROTI DIPTERA; BREEDING SITES; ENDEMIC FOCUS; AMHARA REGION; PSYCHODIDAE	Background Visceral leishmaniasis (VL) also known as kala-azar is a growing health problem in Ethiopia with an estimated annual VL incidence between 3700 and 7400. The disease is mainly endemic in northwestern parts of the country. The aim of the current study was to determine the sand fly fauna and ecology of Phlebotomus orientalis in two endemic and ecologically distinct areas of northwestern Ethiopia. Methods Sand flies were collected using CDC light traps, sticky traps and pyrethrum spray catches from peri-domestic, mixed forest, farm field and indoor habitats from both Libo-Kemkem (May 2011-April 2012) and Metema (October 2012-September 2013) districts. Results A total of 51,411 sand fly specimens were collected and identified (10,776 from highland and 40, 635 from the lowland areas). Seven species were found in the highland area: two Phlebotomus spp. (P. orientalis and P. rodhaini) and five Sergentomyia species. Whereas 19 species were found in the lowland area: six Phlebotomus (P. orientalis, P. rodhaini, P. Phle-geroti, P. duboscqi, P. papatasi and P. martini) and 13 Sergentomyia species. Of the Phlebotomus spp., P. orientalis was the predominant species in both the highland (99.9%) and lowland (93.7%) areas. Indoor collections using pyrethrum spray catches and sticky traps indicated that P. orientalis has a strong exophilic and exophagic behaviors in both districts. In both areas, this species showed seasonal occurrence and showing abundance during the dry months (March-May/June) of the year and increasing in numbers till the rain season, when numbers dropped dramatically. Mean density of P. orientalis in the two areas had positive and significant correlation with mean temperature in light trap collections (P<0.05). However, mean density of P. orientalis in the two areas in sticky trap collections had positive and insignificant association with the temperature (P>0.05). Regarding the rainfall pattern, density of P. orientalis had negative and statistically insignificant correlation (for light trap collections for both areas) and significant correlation (for sticky trap collections for lowland area). Conclusions The current study indicated the variation in sand fly fauna between the highland and lowland districts, wherein, P. orientalis was found to be the most abundant Phlebotomus species. The study also determined that P. orientalis exhibits distinct seasonality, where its abundance increases during the dry season and disappears when the rainy period starts in both study areas. This entomological observation on the bionomics of P. orientalis provides significant evidence for considering vector control or preventive measures in the areas studied.	[Aklilu, Esayas; Kindu, Mizan] Mada Walabu Univ, Dept Biol, Bale, Ethiopia; [Gebresilassie, Araya; Yared, Solomon] Jigjiga Univ, Dept Biol, Jigjiga, Ethiopia; [Tekie, Habte] Univ Addis Ababa, Dept Zool Sci, Addis Ababa, Ethiopia; [Balkew, Meshesha; Gebre-Michael, Teshome] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Warburg, Alon] Hebrew Univ Jerusalem, Hadassah Med Sch, Fac Med,Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet,Inst Med Res Israel Ca, Jerusalem, Israel; [Hailu, Asrat] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Hebrew University of Jerusalem; Addis Ababa University	Aklilu, E (corresponding author), Mada Walabu Univ, Dept Biol, Bale, Ethiopia.	reyeesayas@gmail.com	Warburg, Alon/ABE-9946-2020; Hailu, Asrat/AAM-6982-2020; Yared, Solomon/AAX-2429-2021	Warburg, Alon/0000-0001-7929-3114; Yared, Solomon/0000-0003-1510-8316; Maasho, Habte Tekie/0000-0003-2228-5249	Bill and Melinda Gates Foundation Global Health Program [OPPGH5336]	Bill and Melinda Gates Foundation Global Health Program(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) provided financial support.; Authors are grateful to the people of Libo-Kemkem and Metema districts for their determined support during the study. We also thank our field and laboratory assistant Mr. Gashaw Mihiret for his helps in carrying out this study. The Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) provided financial support.	Abonnenc E, 1965, MEM OFF RECH SCI TEC, V5, P1; Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x; Alvar J, 2007, AM J TROP MED HYG, V77, P275; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ASHFORD RW, 1992, T ROY SOC TROP MED H, V86, P379, DOI 10.1016/0035-9203(92)90229-6; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Elnaiem DA, 1998, ANN TROP MED PARASIT, V92, P229, DOI 10.1080/00034989860085; Elnaiem DA, 1997, ANN TROP MED PARASIT, V91, P307, DOI 10.1080/00034989761157; Gebre-Michael T, 2007, ANN TROP MED PARASIT, V101, P367, DOI 10.1179/136485907X176382; Gebre-Michael T, 2004, ACTA TROP, V90, P73, DOI 10.1016/j.actatropica.2003.09.021; Gebre-Michael T, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-6; GEBREMICHAEL T, 1993, T ROY SOC TROP MED H, V87, P10, DOI 10.1016/0035-9203(93)90399-B; GebreMichael T, 1997, J MED ENTOMOL, V34, P383, DOI 10.1093/jmedent/34.4.383; GebreMichael T, 1996, MED VET ENTOMOL, V10, P53, DOI 10.1111/j.1365-2915.1996.tb00082.x; Gebresilassie A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0849-7; Gemetchu T., 1983, Sinet (Addis Ababa), V6, P65; Guernaoui S, 2006, ACTA TROP, V97, P346, DOI 10.1016/j.actatropica.2006.01.001; Gupta A, 2013, INT J TROP DIS HLTH, V3, P73; Hailu A., 2006, EPIDEMIOLOGY ECOLOGY, P615, DOI DOI 10.1186/1756-3305-2-60; Heip Carlo H. R., 1998, Oceanis, V24, P61; HOOGSTRAAL H, 1969, AM J TROP MED HYG, V18, P1091, DOI 10.4269/ajtmh.1969.18.1091; JANINI R, 1995, J MED ENTOMOL, V32, P822, DOI 10.1093/jmedent/32.6.822; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Lambert M, 2002, ANN TROP MED PARASIT, V96, P631, DOI 10.1179/000349802125001474; LANE RP, 1986, SYST ENTOMOL, V11, P439, DOI 10.1111/j.1365-3113.1986.tb00535.x; Lemma W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-359; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; Moncaz A, 2014, ACTA TROP, V139, P5, DOI 10.1016/j.actatropica.2014.06.013; Moncaz A, 2014, ACTA TROP, V137, P88, DOI 10.1016/j.actatropica.2014.05.005; Ozbel Y, 2011, J VECTOR ECOL, V36, pS99, DOI 10.1111/j.1948-7134.2011.00118.x; PERKINS PV, 1988, T ROY SOC TROP MED H, V82, P695, DOI 10.1016/0035-9203(88)90204-0; QUATE LAURENCE W., 1964, J MED ENTOMOL, V1, P213, DOI 10.1093/jmedent/1.3.213; Seblova V, 2013, PLOS NEG TROPL DIS, V4, P2187; Service M. W., 1993, FIELD SAMPLING METHO; Shabtai IA, 2014, SOIL TILL RES, V136, P19, DOI 10.1016/j.still.2013.09.007; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x; Wheeler AS, 1996, MED VET ENTOMOL, V10, P295, DOI 10.1111/j.1365-2915.1996.tb00747.x; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, 2010, WHO TECH REP SER, V949, P1	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175308	10.1371/journal.pone.0175308	http://dx.doi.org/10.1371/journal.pone.0175308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384307	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900152
J	Dar, QA; Schott, EM; Catheline, SE; Maynard, RD; Liu, ZY; Kamal, F; Farnsworth, CW; Ketz, JP; Mooney, RA; Hilton, MJ; Jonason, JH; Prawitt, J; Zuscik, MJ				Dar, Qurratul-Ain; Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Liu, Zhaoyang; Kamal, Fadia; Farnsworth, Christopher W.; Ketz, John P.; Mooney, Robert A.; Hilton, Matthew J.; Jonason, Jennifer H.; Prawitt, Janne; Zuscik, Michael J.			Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis	PLOS ONE			English	Article							HYALURONIC-ACID SYNTHESIS; II COLLAGEN; KNEE OSTEOARTHRITIS; CHONDROITIN SULFATE; GLUCOSAMINE SULFATE; THERAPEUTIC AGENTS; INDUCED ARTHRITIS; ANIMAL-MODELS; CARTILAGE; RATS	Osteoarthritis (OA) is a degenerative joint disease for which there are no disease modifying therapies. Thus, strategies that offer chondroprotective or regenerative capability represent a critical unmet need. Recently, oral consumption of a hydrolyzed type 1 collagen (hCol1) preparation has been reported to reduce pain in human OA and support a positive influence on chondrocyte function. To evaluate the tissue and cellular basis for these effects, we examined the impact of orally administered hCol1 in a model of posttraumatic OA (PTOA). In addition to standard chow, male C57BL/6J mice were provided a daily oral dietary supplement of hCol1 and a meniscal-ligamentous injury was induced on the right knee. At various time points post-injury, hydroxyproline (hProline) assays were performed on blood samples to confirm hCol1 delivery, and joints were harvested for tissue and molecular analyses were performed, including histomorphometry, OARSI and synovial scoring, immunohistochemistry and mRNA expression studies. Confirming ingestion of the supplements, serum hProline levels were elevated in experimental mice administered hCol1. In the hCol1 supplemented mice, chondroprotective effects were observed in injured knee joints, with dose-dependent increases in cartilage area, chondrocyte number and proteoglycan matrix at 3 and 12 weeks post-injury. Preservation of cartilage and increased chondrocyte numbers correlated with reductions in MMP13 protein levels and apoptosis, respectively. Supplemented mice also displayed reduced synovial hyperplasia that paralleled a reduction in Tnf mRNA, suggesting an anti-inflammatory effect. These findings establish that in the context of murine knee PTOA, daily oral consumption of hCol1 is chondroprotective, anti-apoptotic in articular chondrocytes, and anti-inflammatory. While the underlying mechanism driving these effects is yet to be determined, these findings provide the first tissue and cellular level information explaining the already published evidence of symptom relief supported by hCol1 in human knee OA. These results suggest that oral consumption of hCol1 is disease modifying in the context of PTOA.	[Dar, Qurratul-Ain; Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Liu, Zhaoyang; Kamal, Fadia; Farnsworth, Christopher W.; Ketz, John P.; Mooney, Robert A.; Jonason, Jennifer H.; Zuscik, Michael J.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Dar, Qurratul-Ain] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Schott, Eric M.; Catheline, Sarah E.; Maynard, Robert D.; Farnsworth, Christopher W.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Kamal, Fadia; Ketz, John P.; Jonason, Jennifer H.; Zuscik, Michael J.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Hilton, Matthew J.] Duke Univ, Orthopaed Cellular Dev & Genome Labs, Durham, NC USA; [Prawitt, Janne] Rousselot BVBA, Ghent, Belgium	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Duke University	Zuscik, MJ (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.; Zuscik, MJ (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA.	michael_zuscik@urmc.rochester.edu	Kamal, Fadia/AAP-1798-2021	Zuscik, Michael/0000-0003-0461-8708; Hilton, Matthew/0000-0003-3165-267X; Liu, Zhaoyang/0000-0002-8032-1167; Catheline, Sarah/0000-0003-3550-7699	Rousselot BVBA [057066]; NIH/NIAMS [5P50 AR054041-5471, 5R01 AR063071, 5T32 AR053459, 1P30 AR069655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063071, P30AR069655] Funding Source: NIH RePORTER	Rousselot BVBA; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Rousselot BVBA contract number 057066 (MJZ, study design, data collection, data analysis, data interpretation, writing), NIH/NIAMS 5P50 AR054041-5471 (MJZ, study design, data interpretation, writing), NIH/NIAMS 5R01 AR063071 (MJH, study design), NIH/NIAMS 5T32 AR053459 (data collection, data analysis, data interpretation), and NIH/NIAMS Core Center Grant 1P30 AR069655 (data collection).	Asserin J, 2015, J COSMET DERMATOL-US, V14, P291, DOI 10.1111/jocd.12174; Blaker CL, 2016, J ORTHOP RES; Bottegoni C, 2014, CARBOHYD POLYM, V109, P126, DOI 10.1016/j.carbpol.2014.03.033; Bruyere O, 2006, ANN RHEUM DIS, V65, P1050, DOI 10.1136/ard.2005.045914; Bruyere O, 2007, DRUG AGING, V24, P573, DOI 10.2165/00002512-200724070-00005; Bruyere O, 2016, SEMIN ARTHRITIS RHEU, V45, pS12, DOI 10.1016/j.semarthrit.2015.11.011; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Christgau S, 2004, CLIN EXP RHEUMATOL, V22, P36; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Deal CL, 1999, RHEUM DIS CLIN N AM, V25, P379, DOI 10.1016/S0889-857X(05)70074-0; Deparle LA, 2005, J VET PHARMACOL THER, V28, P385, DOI 10.1111/j.1365-2885.2005.00668.x; FDA, 1975, DAT SEL COMM GRAS SU; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Goldring MB., 2015, POSTRAUMATIC ARTHRIT, P201; Golightly Y. M., 2015, POSTTRAUMATIC ARTHRI, P317; Guillerminet F, 2010, BONE, V46, P827, DOI 10.1016/j.bone.2009.10.035; Gupta RC, 2009, J VET PHARMACOL THER, V32, P577, DOI 10.1111/j.1365-2885.2009.01079.x; Hamada D, 2015, ARTHRITIS RHEUMATOLO; Hamada D, 2014, METHODS MOL BIOL, V1130, P61, DOI 10.1007/978-1-62703-989-5_5; Henrotin Y, 2014, SEMIN ARTHRITIS RHEU, V43, P579, DOI 10.1016/j.semarthrit.2013.10.005; Hunter DJ, 2014, BEST PRACT RES CL RH, V28, P61, DOI 10.1016/j.berh.2014.01.007; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Jiang JX, 2014, AGRO FOOD IND HI TEC, V25, P19; Kawaguchi T, 2012, BIOL PHARM BULL, V35, P422, DOI 10.1248/bpb.35.422; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lugo JP, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0130-8; Malfait AM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0747-6; Matsuda N, 2006, J NUTR SCI VITAMINOL, V52, P211, DOI 10.3177/jnsv.52.211; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Mevel E, 2014, DRUG DISCOV TODAY, V19, P1649, DOI 10.1016/j.drudis.2014.06.012; Mooney RA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3529; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; NAGLERANDERSON C, 1986, P NATL ACAD SCI USA, V83, P7443, DOI 10.1073/pnas.83.19.7443; Nakatani S, 2009, OSTEOARTHR CARTILAGE, V17, P1620, DOI 10.1016/j.joca.2009.07.001; Nomura Y, 2005, NUTRITION, V21, P1120, DOI 10.1016/j.nut.2005.03.007; Oesser S, 1999, J NUTR, V129, P1891, DOI 10.1093/jn/129.10.1891; Oesser S, 2003, CELL TISSUE RES, V311, P393, DOI 10.1007/s00441-003-0702-8; Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Raabe O, 2010, HISTOCHEM CELL BIOL, V134, P545, DOI 10.1007/s00418-010-0760-4; Ragle RL, 2012, DRUG AGING, V29, P717, DOI 10.1007/s40266-012-0006-3; Ramadass SK, 2016, EUR J PHARM SCI, V91, P216, DOI 10.1016/j.ejps.2016.05.015; Salmon JH, 2016, OSTEOARTHR CARTILAGE, V24, P1500, DOI 10.1016/j.joca.2016.03.012; Sampson ER, 2011, J ORTHOP RES, V29, P1145, DOI 10.1002/jor.21368; Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214; Shigemura Y, 2014, FOOD CHEM, V159, P328, DOI 10.1016/j.foodchem.2014.02.091; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Van Vijven JPJ, 2012, OSTEOARTHR CARTILAGE, V20, P809, DOI 10.1016/j.joca.2012.04.008; Watanabe-Kamiyama M, 2010, J AGR FOOD CHEM, V58, P835, DOI 10.1021/jf9031487; Yoshinari O, 2013, J MED FOOD, V16, P1039, DOI 10.1089/jmf.2013.2911; Yu SPC, 2015, EXPERT OPIN EMERG DR, V20, P361, DOI 10.1517/14728214.2015.1037275; Zhang LZ, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.37; Zhang YZ, 2010, J NUTR SCI VITAMINOL, V56, P208, DOI 10.3177/jnsv.56.208; ZHANG ZYJ, 1990, J IMMUNOL, V145, P2489	64	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174705	10.1371/journal.pone.0174705	http://dx.doi.org/10.1371/journal.pone.0174705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384173	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900027
J	Dobierzewska, A; Soman, S; Iilanes, SE; Morris, AJ				Dobierzewska, Aneta; Soman, Sony; Iilanes, Sebastian E.; Morris, Andrew J.			Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; PLACENTAL SYNCYTIOTROPHOBLAST; EXTRAVILLOUS TROPHOBLAST; IN-VITRO; PREGNANCY; SPHINGOSINE-1-PHOSPHATE; METABOLISM; APOPTOSIS; CERAMIDE; RISK	Introduction Preeclampsia (PE) is a gestational disorder, manifested in the second half of pregnancy by maternal hypertension, proteinuria and generalized edema. PE is a major cause of maternal and fetal morbidity and mortality, accounting for nearly 40% of all premature births worldwide. Bioactive sphingolipids are emerging as key molecules involved in etiopathogenesis of PE, characterized by maternal angiogenic imbalance and symptoms of metabolic syndrome. The aim of this study was to compare the cross-gestational profile of circulating bioactive sphingolipids in maternal plasma from preeclamptic (PE) versus normotensive control (CTL) subjects with the goal of identifying sphingolipids as candidate first trimester biomarkers of PE for early prediction of the disease. Methods A prospective cohort of patients was sampled at the first, second and third trimester of pregnancy for each patient (11-14, 22-24, and 32-36 weeks A gestation). A retrospective stratified study design was used to quantify different classes of sphingolipids in maternal plasma. We used a reverse-phase high-performance liquid chromatography-tandem mass spectrometry (HPLC-ESI-MS/MS) approach for determining different sphingolipid molecular species (sphingosine- 1-phosphate (S1P), dihydro-sphingosine-1-phosphate (DH-S1P), sphingomyelins (SM) and ceramides (Cer)) in cross-gestational samples of human plasma from PE (n = 7, 21 plasma samples across pregnancy) and CTL (n = 7, 21 plasma samples across pregnancy) patients. Results Plasma levels of angiogenic S1P did not change significantly in control and in preeclamptic patients A group across gestation. DH-S1P was significantly decreased in second trimester plasma of PE patients in comparison to their first trimester, which could contribute to reduced endothelial barrier observed in PE. The major ceramide species (Cer 16: 0 and Cer 24: 0) tended to be up-regulated in plasma of control and PE subjects across gestation. The levels of a less abundant plasma ceramide species (Cer 14: 0) were significantly lower in first trimester plasma of PE patients when compared with their gestational-matched control samples (p = 0.009). Major plasma sphingomyelin species (SM 16: 0, SM 18: 1 and SM 24: 0) tended to be higher in control pregnancies across gestation. However, in PE patients, SM 16: 0, SM 18: 0 and SM 18: 1 showed significant up-regulation across gestation, pointing to atherogenic properties of the sphingomyelins and particularly the potential contribution of SM 18: 0 to the disease development. In addition, two major sphingomyelins, SM 16: 0 and SM 18: 0, were significantly lower in first trimester plasma of PE patients versus first trimester samples of respective controls (p = 0.007 and p = 0.002, respectively). Conclusions Cross-gestational analysis of maternal plasma of preeclamptic and normotensive women identifies differences in the biochemical profile of major sphingolipids (DH-S1P, sphingomyelins and ceramides) between these two groups. In addition, first trimester maternal plasma sphingolipids (Cer 14: 0, SM 16: 0 and SM 18: 0) may serve in the future as early biomarkers of PE occurrence and development.	[Dobierzewska, Aneta; Iilanes, Sebastian E.] Univ Los Andes, Dept Obstet & Gynecol, Fac Med, Santiago, Chile; [Dobierzewska, Aneta; Iilanes, Sebastian E.] Univ Los Andes, Lab Reprod Biol, Fac Med, Santiago, Chile; [Soman, Sony; Morris, Andrew J.] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY USA; [Soman, Sony; Morris, Andrew J.] Univ Kentucky, Coll Med, Gill Heart Inst, Lexington, KY USA; [Soman, Sony; Morris, Andrew J.] US Dept Vet Affairs, Med Ctr Lexington, Lexington, KY USA	Universidad de los Andes - Chile; Universidad de los Andes - Chile; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Dobierzewska, A (corresponding author), Univ Los Andes, Dept Obstet & Gynecol, Fac Med, Santiago, Chile.; Dobierzewska, A (corresponding author), Univ Los Andes, Lab Reprod Biol, Fac Med, Santiago, Chile.	adobierzewska@uandes.cl		Illanes, Sebastian/0000-0001-5433-9315	FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; NIH; Department of Veterans Affairs; Veterans Affairs [I01CX001550, IS1BX003153] Funding Source: NIH RePORTER	FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by FAI Inicacion grant (Fondo de Ayuda a la Investigacion Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia" to AD and grants from the NIH and Department of Veterans Affairs to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Brown SHJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163972; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Dobierzewska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157221; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Grammatikos G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138130; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Huppertz B, 2003, PLACENTA, V24, P181, DOI 10.1053/plac.2002.0903; Huppertz B, 1999, LAB INVEST, V79, P1687; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kaneko-Tarui T, 2007, BIOL REPROD, V77, P658, DOI 10.1095/biolreprod.107.061044; Kemp B, 2002, HISTOCHEM CELL BIOL, V117, P401, DOI 10.1007/s00418-002-0396-0; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Korkes HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110747; Lagana AS, 2016, J MATERN-FETAL NEO M, V29, P3019, DOI 10.3109/14767058.2015.1113522; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mikat B., 2012, ISRN OBSTET GYNECOL, V2012; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Newhouse SM, 2007, PLACENTA, V28, P999, DOI 10.1016/j.placenta.2007.04.008; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Romanowicz L, 2010, MOL CELL BIOCHEM, V340, P81, DOI 10.1007/s11010-010-0403-z; Romanowicz L, 2009, CLIN BIOCHEM, V42, P1719, DOI 10.1016/j.clinbiochem.2009.07.011; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Singh AT, 2012, MOL CELL ENDOCRINOL, V362, P48, DOI 10.1016/j.mce.2012.05.009; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Skaznik-Wikiel ME, 2006, BIOL REPROD, V74, P569, DOI 10.1095/biolreprod.105.046714; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Wu Zhexue, 2014, J Lifestyle Med, V4, P17, DOI 10.15280/jlm.2014.4.1.17; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zhao YY, 2014, INT REV CEL MOL BIO, V313, P1, DOI 10.1016/B978-0-12-800177-6.00001-3	45	20	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175118	10.1371/journal.pone.0175118	http://dx.doi.org/10.1371/journal.pone.0175118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384202	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900091
J	Irwin, J; Ferguson, E; Simms, LA; Hanigan, K; Carbonnel, F; Radford-Smith, G				Irwin, James; Ferguson, Emma; Simms, Lisa A.; Hanigan, Katherine; Carbonnel, Franck; Radford-Smith, Graham			A rolling phenotype in Crohn's disease	PLOS ONE			English	Article							WORKING PARTY; MAINTENANCE; GASTROENTEROLOGY; CLASSIFICATION; METHOTREXATE; REMISSION; THERAPY; COHORT	Background and aim The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn's disease complications, the rolling phenotype. As is commonly observed in clinical practice, this definition allows progression to a more severe phenotype (stricturing, penetrating) but also, regression to a less severe behaviour (inflammatory, or remission) over time. Methods All patients diagnosed with Crohn's Disease between 01/01/1994 and 01/03/2008, managed at a single centre and observed for a minimum of 5 years, had development and resolution of all complications recorded. A rolling phenotype was defined at each time point based on all observed complications in the three years prior to the time point. Phenotype was defined as B1, B2, B3, or B23 (penetrating and stenotic). The progression over time of the rolling phenotype was compared to that of the cumulative Montreal phenotype. Results 305 patients were observed a median of 10.0 (Intraquartile range 7.3-13.7) years. Longitudinal progression of rolling phenotype demonstrated a consistent proportion of patients with B1 (70%), B2 (20%), B3 (5%) and B23 (5%) phenotypes. These proportions were observed regardless of initial phenotype. In contrast, the cumulative Montreal phenotype progressed towards a more severe phenotype with time (B1 (39%), B2 (26%), B3(35%) at 10 years). Conclusion A rolling phenotype provides an alternative view of the longitudinal burden of intra-abdominal complications in Crohn's disease. From this viewpoint, 70% of patients have durable freedom from complication over time (>3 years).	[Irwin, James; Ferguson, Emma; Simms, Lisa A.; Hanigan, Katherine; Radford-Smith, Graham] QIMR Berghofer Med Res Inst, Inflammatory Bowel Dis Res Grp, Brisbane, Qld, Australia; [Irwin, James; Radford-Smith, Graham] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia; [Irwin, James; Ferguson, Emma; Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Carbonnel, Franck] Hop Univ Paris Sud, Site Bicetre Assistance Publ Hop Paris, Serv Gastroenterol, Paris, France; [Carbonnel, Franck] Univ Paris Saclay, Fac Med, Univ Paris Sud, UVSQ,INSERM,CESP, Villejuif, France	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Irwin, J (corresponding author), QIMR Berghofer Med Res Inst, Inflammatory Bowel Dis Res Grp, Brisbane, Qld, Australia.; Irwin, J (corresponding author), Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia.; Irwin, J (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	James.Irwin@midcentraldhb.govt.nz	Radford-Smith, Graham/H-2792-2013; Radford-Smith, Graham L/G-5749-2017	Radford-Smith, Graham/0000-0002-2047-6239; Radford-Smith, Graham L/0000-0002-2047-6239; Irwin, James/0000-0002-6804-1752; Simms, Lisa/0000-0002-5387-7397				Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GREENSTEIN AJ, 1988, GUT, V29, P588, DOI 10.1136/gut.29.5.588; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Magro F, 2014, AM J GASTROENTEROL, V109, P1026, DOI 10.1038/ajg.2014.97; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Pearson DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000067; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramadas AV, 2010, GUT, V59, P1200, DOI 10.1136/gut.2009.202101; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Sandborn WJ, 1996, COCHRANE DATABASE SY; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Tang LY, 2006, CLIN GASTROENTEROL H, V4, P1130, DOI 10.1016/j.cgh.2006.06.021; Tarrant KM, 2008, AM J GASTROENTEROL, V103, P3082, DOI 10.1111/j.1572-0241.2008.02212.x	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174954	10.1371/journal.pone.0174954	http://dx.doi.org/10.1371/journal.pone.0174954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384331	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900063
J	Jansen, JM; Wartchow, C; Jahnke, W; Fong, SS; Tsang, T; Pfister, K; Zavorotinskaya, T; Bussiere, D; Cheng, JM; Crawford, K; Dai, YM; Dove, J; Fang, E; Feng, Y; Florent, JM; Fuller, J; Gossert, AD; Hekmat-Nejad, M; Henry, C; Klopp, J; Lenahan, WP; Lingel, A; Ma, S; Meyer, A; Mishina, Y; Narberes, J; Pardee, G; Ramurthy, S; Rieffel, S; Stuart, D; Subramanian, S; Tandeske, L; Widger, S; Widmer, A; Winterhalter, A; Zaror, I; Hardy, S				Jansen, Johanna M.; Wartchow, Charles; Jahnke, Wolfgang; Fong, Susan; Tsang, Tiffany; Pfister, Keith; Zavorotinskaya, Tatiana; Bussiere, Dirksen; Cheng, Jan Marie; Crawford, Kenneth; Dai, Yumin; Dove, Jeffrey; Fang, Eric; Feng, Yun; Florent, Jean-Michel; Fuller, John; Gossert, Alvar D.; Hekmat-Nejad, Mohammad; Henry, Chrystele; Klopp, Julia; Lenahan, William P.; Lingel, Andreas; Ma, Sylvia; Meyer, Arndt; Mishina, Yuji; Narberes, Jamie; Pardee, Gwynn; Ramurthy, Savithri; Rieffel, Sebastien; Stuart, Darrin; Subramanian, Sharadha; Tandeske, Laura; Widger, Stephania; Widmer, Armin; Winterhalter, Aurelie; Zaror, Isabel; Hardy, Stephen			Inhibition of prenylated KRAS in a lipid environment	PLOS ONE			English	Article							STATE 1(T) INHIBITORS; ONCOGENIC K-RAS; H-RAS; EFFECTOR INTERACTIONS; NUCLEOTIDE EXCHANGE; DYNAMIC PROPERTIES; PLASMA-MEMBRANE; PROTEIN-KINASE; ACTIVATED RAS; BINDING-SITE	RAS mutations lead to a constitutively active oncogenic protein that signals through multiple effector pathways. In this chemical biology study, we describe a novel coupled biochemical assay that measures activation of the effector BRAF by prenylated KRAS(G12V) in a lipid-dependent manner. Using this assay, we discovered compounds that block biochemical and cellular functions of KRAS(G12V) with low single-digit micromolar potency. We characterized the structural basis for inhibition using NMR methods and showed that the compounds stabilized the inactive conformation of KRAS(G12V). Determination of the biophysical affinity of binding using biolayer interferometry demonstrated that the potency of inhibition matches the affinity of binding only when KRAS is in its native state, namely post-translationally modified and in a lipid environment. The assays we describe here provide a first-time alignment across biochemical, biophysical, and cellular KRAS assays through incorporation of key physiological factors regulating RAS biology, namely a negatively charged lipid environment and prenylation, into the in vitro assays. These assays and the ligands we discovered are valuable tools for further study of KRAS inhibition and drug discovery.	[Jansen, Johanna M.; Pfister, Keith; Zavorotinskaya, Tatiana; Dai, Yumin; Fang, Eric; Feng, Yun; Gossert, Alvar D.; Ma, Sylvia; Rieffel, Sebastien; Zaror, Isabel] Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA USA; [Fong, Susan; Fuller, John; Henry, Chrystele] Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland; [Cheng, Jan Marie; Fuller, John; Hekmat-Nejad, Mohammad] Novartis Inst BioMed Res, Dept Oncol, Emeryville, CA USA; [Dai, Yumin; Fuller, John; Hekmat-Nejad, Mohammad; Henry, Chrystele; Lenahan, William P.; Lingel, Andreas] Novartis Inst BioMed Res, Dept Oncol, Cambridge, MA USA	Novartis; Novartis; Novartis; Novartis	Jansen, JM (corresponding author), Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA USA.	johanna.jansen@novartis.com	Fang, Eric/GXV-4491-2022; Wartchow, Charles A./W-4985-2019; Lingel, Andreas/AAP-5078-2021	Wartchow, Charles/0000-0002-0123-1455; Gossert, Alvar/0000-0001-7732-495X; Jansen, Johanna/0000-0003-3937-6243	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	This research was funded by Novartis Institutes for BioMedical Research. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gillette WK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15916; Gossert AD, 2011, J AM CHEM SOC, V133, P210, DOI 10.1021/ja108383x; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Hocker HJ, 2013, P NATL ACAD SCI USA, V110, P10201, DOI 10.1073/pnas.1300016110; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Howell BA, 2009, LANGMUIR, V25, P12056, DOI 10.1021/la901644h; Huynh MV, 2016, MINI-REV MED CHEM, V16, P383, DOI 10.2174/1389557515666151001154352; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Kalbitzer HR, 2013, ENZYMES, V33, P69, DOI 10.1016/B978-0-12-416749-0.00004-X; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Kovacs H, 2014, J BIOMOL NMR, V58, P101, DOI 10.1007/s10858-013-9808-9; Kuroda S, 1996, J BIOL CHEM, V271, P14680, DOI 10.1074/jbc.271.25.14680; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin E, 2011, NOVARTIS EVALUATION, P223; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; McDonald CB, 2010, ARCH BIOCHEM BIOPHYS, V494, P216, DOI 10.1016/j.abb.2009.12.011; Okada T, 1996, J BIOL CHEM, V271, P4671; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prakash P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004469; Rosnizeck IC, 2014, BIOCHEMISTRY-US, V53, P3867, DOI 10.1021/bi401689w; Rosnizeck IC, 2012, ANGEW CHEM INT EDIT, V51, P10647, DOI 10.1002/anie.201204148; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schuffenhauer A, 2005, CURR TOP MED CHEM, V5, P751, DOI 10.2174/1568026054637700; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Upadhyaya P, 2015, ANGEW CHEM INT EDIT, V54, P7602, DOI 10.1002/anie.201502763; van Hattum H, 2014, CHEM BIOL, V21, P1185, DOI 10.1016/j.chembiol.2014.08.001; Wang WR, 2012, BIOORG MED CHEM LETT, V22, P5766, DOI 10.1016/j.bmcl.2012.07.082; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t; Wittinghofer A, 2000, ANGEW CHEM INT EDIT, V39, P4193, DOI 10.1002/1521-3773(20001201)39:23<4192::AID-ANIE4192>3.0.CO;2-Y; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	58	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174706	10.1371/journal.pone.0174706	http://dx.doi.org/10.1371/journal.pone.0174706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384226	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900028
J	Liao, J; Wang, KY; Yao, WR; Yi, XF; Yan, HH; Chen, M; Lan, XP				Liao, Jian; Wang, Kaiyu; Yao, Weirong; Yi, Xunfei; Yan, Huihui; Chen, Min; Lan, Xiaopeng			Cloning, expression and antioxidant activity of a thioredoxin peroxidase from Branchiostoma belcheri tsingtaunese	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; AMPHIOXUS; PEROXIREDOXINS; CELL; EVOLUTION; REDUCTASE; PROTEIN	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes that catalyze the thioredoxindependent reduction of hydroperoxides. In this study, a novel thioredoxin peroxidase (Bbt-TPx1), a member of the peroxiredoxin superfamily, was found by EST sequence analysis of a cDNA library of Branchiostoma belcheri tsingtaunese ovary. The sequence of a full-length cDNA clone contained an open reading frame encoding a polypeptide of 198 amino acid residues, with a calculated molecular weight of 22,150 Da. The expression patterns of the protein at different developmental stages and adult amphioxus tissues indicate that this enzyme may play important roles in anti-oxidation and innate immunity. The recombinant Bbt-TPx1 protein was expressed with a polyhistidine-tag in Escherichia coli and purified using Ni chromatography followed by SP cation exchange chromatography. The rBbt-TPx1 protein existed as a dimer under non-reducing conditions, and was dissociated into monomers by dithiothreitol (DTT); it might predominantly exist in oligomeric form. The rBbt-TPx1 protein showed a significant thiol-dependent peroxidase activity, removing hydrogen peroxide in the presence of dithiothreitol (DTT), but not glutathione (GSH). Protection of plasmid DNA and the thiol-protein from damage by metal-catalyzed oxidation (MCO) in vitro was also revealed.	[Liao, Jian; Wang, Kaiyu; Yi, Xunfei; Yan, Huihui; Chen, Min; Lan, Xiaopeng] Fuzhou Gen Hosp Nanjing Command, Inst Lab Med, Fuzhou, Fujian Province, Peoples R China; [Yao, Weirong] First Hosp Longhai, Clin Lab, Zhangzhou, Fujian Province, Peoples R China		Chen, M; Lan, XP (corresponding author), Fuzhou Gen Hosp Nanjing Command, Inst Lab Med, Fuzhou, Fujian Province, Peoples R China.	fzcmin@qq.com; lanxp@sina.com			Key Project of Science and Technology of Fujian Province [2012Y0058]	Key Project of Science and Technology of Fujian Province	This work was supported by the Key Project of Science and Technology of Fujian Province(No.2012Y0058).	Bhattacharyya S, 2015, SCAND J IMMUNOL, V82, P477, DOI 10.1111/sji.12350; Camejo D, 2015, J PROTEOMICS, V119, P112, DOI 10.1016/j.jprot.2015.01.022; Choi J, 2013, BIOCHEM BIOPH RES CO, V435, P634, DOI 10.1016/j.bbrc.2013.05.035; Dip PV, 2014, BBA-BIOENERGETICS, V1837, P1932, DOI 10.1016/j.bbabio.2014.08.007; Du JC, 2004, DEV COMP IMMUNOL, V28, P961, DOI 10.1016/j.dci.2004.04.001; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Holland LZ, 2013, SEMIN CELL DEV BIOL, V24, P101, DOI 10.1016/j.semcdb.2012.12.007; Huang CY, 2014, MOL BIOL REP, V41, P155, DOI 10.1007/s11033-013-2848-0; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lian FM, 2012, J BIOL CHEM, V287, P17077, DOI 10.1074/jbc.M112.357368; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; LIM YS, 1994, BIOCHEM BIOPH RES CO, V199, P199, DOI 10.1006/bbrc.1994.1214; Minguillon C, 2003, DEVELOPMENT, V130, P5903, DOI 10.1242/dev.00811; Mizohata E, 2005, J MOL BIOL, V354, P317, DOI 10.1016/j.jmb.2005.09.006; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428	17	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175162	10.1371/journal.pone.0175162	http://dx.doi.org/10.1371/journal.pone.0175162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384204	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900105
J	Petrichella, S; Johnson, N; He, B				Petrichella, Sara; Johnson, Nessa; He, Bin			The influence of corticospinal activity on TMS-evoked activity and connectivity in healthy subjects: A TMS-EEG study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DIRECTED TRANSFER-FUNCTION; CORTICAL FUNCTIONAL CONNECTIVITY; PRIMARY MOTOR CORTEX; HIGH-RESOLUTION EEG; STIMULUS-INTENSITY; COIL ORIENTATION; BRAIN; RESPONSES; VARIABILITY	Combined transcranial magnetic stimulation (TMS) and electroencephalography (EEG) can be used to analyze cortical reactivity and connectivity. However, the effects of corticospinal and peripheral muscle activity on TMS-evoked potentials (TEPs) are not well understood. The aim of this paper is to evaluate the relationship between cortico-spinal activity, in the form of peripheral motor-evoked potentials (MEPs), and the TEPs from motor areas, along with the connectivity among activated brain areas. TMS was applied to left and right motor cortex (M1), separately, at motor threshold while multi-channel EEG responses were recorded in 17 healthy human subjects. Cortical excitability and source imaging analysis were performed for all trials at each stimulation location, as well as comparing trials resulting in MEPs to those without. Connectivity analysis was also performed comparing trials resulting in MEPs to those without. Cortical excitability results significantly differed between the MEP and no-MEP conditions for left M1 TMS at 60 ms (CP1, CP3, C1) and for right M1 TMS at 54 ms (CP6, C6). Connectivity analysis revealed higher outflow and inflow between M1 and somatosensory cortex bi-directionally for trials with MEPs than those without for both left M1 TMS (at 60, 100, 164 ms) and right M1 TMS (at 54, 100, and 164 ms). Both TEP amplitudes and connectivity measures related to motor and somatosensory areas ipsilateral to the stimulation were shown to correspond with peripheral MEP amplitudes. This suggests that cortico-spinal activation, along with the resulting somatosensory feedback, affects the cortical activity and dynamics within motor areas reflected in the TEPs. The findings suggest that TMS-EEG, along with adaptive connectivity estimators, can be used to evaluate the cortical dynamics associated with sensorimotor integration and proprioceptive manipulation along with the influence of peripheral muscle feedback.	[Petrichella, Sara; Johnson, Nessa; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Petrichella, Sara] Univ Campus Biomed, Dept Comp Sci & Comp Engn, Rome, Italy; [He, Bin] Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University Campus Bio-Medico - Rome Italy; University of Minnesota System; University of Minnesota Twin Cities	He, B (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	binhe@umn.edu		Johnson, Nessa/0000-0002-1020-6091	National Science Foundation [CBET 1264782]; National Institutes of Health, NIH [NIH EY023101, NIH EB008389]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Science Foundation, CBET 1264782 [B.H.], www.nsf.gov; National Institutes of Health, NIH EY023101 [B.H.], NIH EB008389 [B.H.], www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P401, DOI 10.1016/0168-5597(89)90029-4; [Anonymous], [No title captured]; Arnold M, 1998, IEEE T BIO-MED ENG, V45, P553, DOI 10.1109/10.668741; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; Astolfi L, 2005, CLIN NEUROPHYSIOL, V116, P920, DOI 10.1016/j.clinph.2004.10.012; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Casula EP, 2014, NEUROIMAGE, V98, P225, DOI 10.1016/j.neuroimage.2014.04.065; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Ding M., 2013, NEURAL ENG, P545; Edelman BJ, 2015, ENGINEERING-PRC, V1, P292, DOI [10.15302/J-ENG-2015078, 10.15302/j-eng-2015078]; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Ferreri F, 2016, CLIN NEUROPHYSIOL, V127, pe330; Ferreri F, 2016, HUM BRAIN MAPP; Ferreri F, 2014, HUM BRAIN MAPP, V35, P1969, DOI 10.1002/hbm.22306; Ferreri F, 2012, J NEUROPHYSIOL, V108, P314, DOI 10.1152/jn.00796.2011; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Giambattistelli F, 2013, HUM BRAIN MAPP; Gomez LJ, 2015, IEEE T BIO-MED ENG, V62, P361, DOI 10.1109/TBME.2014.2353993; Guo T, 2015, IEEE T BIOMED ENG, V62, P2532; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Huber R, 2008, J NEUROSCI, V28, P7911, DOI 10.1523/JNEUROSCI.1636-08.2008; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Johnson MD, 2013, IEEE T BIO-MED ENG, V60, P610, DOI 10.1109/TBME.2013.2244890; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Klein-Flugge MC, 2013, J NEUROSCI, V33, P5564, DOI 10.1523/JNEUROSCI.2448-12.2013; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Lee WH, 2015, IEEE T BIO-MED ENG, V62, P2095, DOI 10.1109/TBME.2015.2425406; Lu M, 2015, IEEE T BIO-MED ENG, V62, P2911, DOI 10.1109/TBME.2015.2452261; Maki H, 2010, NEUROSCI LETT, V478, P24, DOI 10.1016/j.neulet.2010.04.059; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Nikouline V, 1999, CLIN NEUROPHYSIOL, V110, P1325, DOI 10.1016/S1388-2457(99)00070-X; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROSSINI PM, 1991, BRAIN RES, V567, P111, DOI 10.1016/0006-8993(91)91442-4; Schulz H, 2014, CEREB CORTEX, V24, P1708, DOI 10.1093/cercor/bht024; ter Braack EM, 2015, BRAIN TOPOGR, V28, P520, DOI 10.1007/s10548-013-0312-z; Tiitinen H, 1999, CLIN NEUROPHYSIOL, V110, P982, DOI 10.1016/S1388-2457(99)00038-3; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Ziemann U, 2000, J CLIN NEUROPHYSIOL, V17, P397, DOI 10.1097/00004691-200007000-00005	57	33	34	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174879	10.1371/journal.pone.0174879	http://dx.doi.org/10.1371/journal.pone.0174879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384197	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900048
J	Ranucci, M; Porta, A; Bari, V; Pistuddi, V; La Rovere, MT				Ranucci, Marco; Porta, Alberto; Bari, Vlasta; Pistuddi, Valeria; La Rovere, Maria Teresa			Baroreflex sensitivity and outcomes following coronary surgery	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ARTERY-BYPASS SURGERY; ATRIAL-FIBRILLATION; CARDIAC-SURGERY; MYOCARDIAL-INFARCTION; AUTONOMIC DYSFUNCTION; RISK STRATIFICATION; RENAL DYSFUNCTION; FAILURE PATIENTS; VAGUS NERVE	Postoperative atrial fibrillation, acute kidney dysfunction and low cardiac output following coronary surgery are associated with morbidity and mortality. The purpose of this study is to determine if the preoperative autonomic control is a determinant of these postoperative complications. This is a prospective cohort study on 150 adult patients undergoing surgical coronary revascularization with cardiopulmonary bypass. The patients received an autonomic control assessment after the induction of anesthesia. Baroreflex sensitivity was computed by spectral analysis and expressed as BRSaHF and BRSaLF for measure respectively in the high and low frequency domains. Atrial fibrillation was adjudicated at any postoperative time during the hospital stay. Acute kidney dysfunction was defined as any increase of serum creatinine levels from preoperative values within the first 48 hours after surgery, and acute kidney injury was adjudicated at a 50% increase. Low cardiac ouput syndrome was defined as the need for inotropic support > 48 hours. Thirty-eight (26.4%) patients experienced postoperative atrial fibrillation; 32 (22.2%) had acute kidney dysfunction and 5 (3.5%) acute kidney injury; 14(10%) had a low cardiac output state. No indices of baroreflex sensitivity were associated with atrial fibrillation or acute kidney injury. A low value of BRS alpha LF was associated with acute kidney dysfunction and low cardiac output state. A BRS alpha LF < 3 msec/mmHg was an independent risk factor for acute kidney dysfunction (odds ratio 3.0, 95% confidence interval 1.02-8.8, P = 0.045) and of low cardiac output state (odds ratio 17.0, 95% confidence interval 2.9-99, P = 0.002). Preoperative baroreflex sensitivity is linked to postoperative complications through a number of possible mechanisms, including an autonomic nervous system-mediated vasoconstriction, a poor response to hypotension, and an increased inflammatory reaction.	[Ranucci, Marco; Porta, Alberto; Bari, Vlasta; Pistuddi, Valeria] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [La Rovere, Maria Teresa] IRCCS Ist Clin Sci Maugeri, Dept Cardiol, Ist Montescano, Pavia, Italy	IRCCS Policlinico San Donato; University of Milan; Istituti Clinici Scientifici Maugeri IRCCS	Ranucci, M (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy.	cardioanestesia@virgilio.it	Bari, Vlasta/J-8591-2016; Pistuddi, Valeria/J-9047-2016; La Rovere, Maria Teresa/D-6796-2019; Ranucci, Marco/K-1040-2016	Bari, Vlasta/0000-0002-5346-2677; Pistuddi, Valeria/0000-0002-5781-3972; La Rovere, Maria Teresa/0000-0002-1884-5058; Ranucci, Marco/0000-0002-4915-3572	IRCCS Policlinico San Donato, a Clinical Research Hospital; Italian Ministry of Health	IRCCS Policlinico San Donato, a Clinical Research Hospital; Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by the IRCCS Policlinico San Donato, a Clinical Research Hospital partially funded by the Italian Ministry of Health.	Ackland GL, 2016, CRIT CARE MED, V44, pE614, DOI 10.1097/CCM.0000000000001606; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; BASELLI G, 1987, INT J BIOMED COMPUT, V20, P51, DOI 10.1016/0020-7101(87)90014-6; Bauernschmitt R, 2007, PACE, V30, P77, DOI 10.1111/j.1540-8159.2007.00568.x; Chamchad D, 2006, ANESTH ANALG, V103, P1109, DOI 10.1213/01.ane.0000239330.45658.76; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9; De Ferrari GM, 2007, J AM COLL CARDIOL, V50, P2285, DOI 10.1016/j.jacc.2007.08.043; Deschamps A, 2013, J CARDIOTHOR VASC AN, V27, P485, DOI 10.1053/j.jvca.2012.07.016; Dimmer C, 1998, AM J CARDIOL, V82, P22, DOI 10.1016/S0002-9149(98)00231-8; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Gouveia S, 2015, CLIN SCI, V129, P1163, DOI 10.1042/CS20150341; Hakala T, 2002, SCAND CARDIOVASC J, V36, P167, DOI 10.1080/cdv.36.3.167.171; Hogue CW, 1998, CIRCULATION, V98, P429, DOI 10.1161/01.CIR.98.5.429; Inoue T, 2016, KIDNEY INT, V90, P462, DOI 10.1016/j.kint.2016.07.009; Jideus L, 2001, SCAND CARDIOVASC J, V35, P238; Johns EJ, 2011, COMPR PHYSIOL, V1, P731, DOI 10.1002/cphy.c100043; Katsube Y, 1996, AM J CARDIOL, V78, P1007, DOI 10.1016/S0002-9149(96)00525-5; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; La Rovere MT, 2014, ANN NONINVAS ELECTRO, V19, P303, DOI 10.1111/anec.12170; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; La Rovere MT, 1998, LANCET, V351, P478; Landolina M, 1997, J AM COLL CARDIOL, V29, P568, DOI 10.1016/S0735-1097(96)00533-5; Lankhorst S, 2015, ANAESTHESIA, V70, P336, DOI 10.1111/anae.12904; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x; Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pinna GD, 2005, J AM COLL CARDIOL, V46, P1314, DOI 10.1016/j.jacc.2005.06.062; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Provenchere S, 2003, ANESTH ANALG, V96, P1258, DOI 10.1213/01.ANE.0000055803.92191.69; Shen FM, 2004, SHOCK, V21, P556, DOI 10.1097/01.shk.0000126647.51109.5c; Simula S, 2013, CLIN PHYSIOL FUNCT I, V33, P70, DOI 10.1111/j.1475-097X.2012.01165.x; Smith ML, 1992, J CARDIOVASC ELECTR, V2, P441; Stammers AN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007250; Toner A, 2016, BRIT J ANAESTH, V117, P324, DOI 10.1093/bja/aew257; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	42	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175008	10.1371/journal.pone.0175008	http://dx.doi.org/10.1371/journal.pone.0175008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384188	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900072
J	Shelomi, M				Shelomi, Matan			De novo transcriptome analysis of the excretory tubules of Carausius morosus (Phasmatodea) and possible functions of the midgut 'appendices'	PLOS ONE			English	Article							MALPIGHIAN TUBULES; STICK INSECT; RNA-SEQ; DIGESTIVE-SYSTEM; ACTIVE-TRANSPORT; ORTHOPTERA; REVEALS; WATER; ELIMINATION; EXPRESSION	The Malpighian tubules are the insect excretory organs, responsible for ion and water homeostasis and elimination of nitrogenous wastes. Post-genomic assays suggest they also metabolize and detoxify xenobiotic compounds and have antimicrobial properties. The Phasmatodea have an additional, unique set of excretory organs referred to predominantly as midgut appendices. Their function and how it compares to phasmid and other insect Malpighian tubules is unknown. Hypotheses include carbonic anhydrase activity, calcium and metal cation sequestration, and xenobiotic transport. This work presents the first comparative transcriptomic analysis of the Phasmatodean excretory organs, using the model insect Carausius morosus. I produced de novo transcriptomes of the midgut appendices, midgut wall, and Malpighian tubules, and looked for differentially expressed genes associated with putative organ functions. The appendices differentially and highly express lipid transport and metabolism proteins, and the biomineralization gene otopetrin. The Malpighian tubules differentially and highly express acid phosphatases and multiple transporter types, while appendices express fat-soluble vitamin and peptide transporters. Many defense proteins such as multidrug resistance proteins, ABC transporters, cytochrome P450's, and glutathione- S-transferases were differentially expressed in specific excretory organs. I hypothesize that the appendices and Malpighian tubules both have defensive / xenobiotic metabolism functions, but each likely target different substrates. Phasmid Malpighian tubules excrete as in other insects, while the appendices may predominantly regulate amino acids, fats, and fat-soluble compounds. Lipid metabolism in insects is poorly understood, and the Phasmatodea may thus serve as a model for studying this further.	[Shelomi, Matan] Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan; [Shelomi, Matan] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Thuringen, Germany	National Taiwan University; Max Planck Society	Shelomi, M (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan.; Shelomi, M (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Jena, Thuringen, Germany.	mshelomi@ntu.edu.tw	Shelomi, Matan/AAF-6194-2020	Shelomi, Matan/0000-0003-4413-4097	National Science Foundation (USA) Postdoctoral Research Fellowship in Biology [DBI-1402883]; Max Planck Society (Germany)	National Science Foundation (USA) Postdoctoral Research Fellowship in Biology; Max Planck Society (Germany)(Max Planck Society)	This research was funded by the National Science Foundation (USA) Postdoctoral Research Fellowship in Biology, GrantNo. DBI-1402883, and by the Max Planck Society (Germany) through David Heckel of the Max Planck Institute for Chemical Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; ANESHANSLEY DJ, 1989, J INSECT PHYSIOL, V35, P41, DOI 10.1016/0022-1910(89)90034-6; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; ATZBACHER U, 1974, J INSECT PHYSIOL, V20, P1989, DOI 10.1016/0022-1910(74)90106-1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bordas L, 1897, B MUSEUM HIST NATURE, V2, P378; Bradler Sven, 2015, Entomologie Heute, V27, P1; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Sinety R., 1901, CELLULE, V19, P117, DOI [10.5962/bhl.part.17087, DOI 10.5962/BHL.PART.17087]; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Heymons R, 1897, SITZUNGSBERICHTE KON, V16, P363; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lison L, 1937, CELL TISSUE RES, V28, P179; Lison L., 1942, RECHERCHES HISTOPHYS; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Maddrell S, 2004, J EXP BIOL, V207, P894, DOI 10.1242/jeb.00846; MADDRELL SH, 1974, J EXP BIOL, V61, P357; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; MADDRELL SHP, 1992, J EXP BIOL, V172, P417; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; MEULEMANS W, 1992, J CELL SCI, V101, P349; Monteiro EC, 2014, ARTHROPOD STRUCT DEV, V43, P123, DOI 10.1016/j.asd.2013.11.005; MOSCONA A, 1950, Q J MICROSC SCI, V91, P183; NIJHOUT HF, 1975, J EXP BIOL, V62, P221; O'Donnell MJ, 2009, J EXP BIOL, V212, P363, DOI 10.1242/jeb.023739; O'Donnell M, 2008, ADV INSECT PHYSIOL, V35, P1, DOI 10.1016/S0065-2806(08)00001-5; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Palm N. B., 1952, Arkiv for Zoologi Stockholm (NS), V3, P195; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pantel J, 1919, CR HEBD ACAD SCI, V168, P242; RAMSAY JA, 1955, J EXP BIOL, V32, P200; RAMSAY JA, 1954, J EXP BIOL, V31, P104; RAMSAY JA, 1958, J EXP BIOL, V35, P871; RAMSAY JA, 1956, J EXP BIOL, V33, P697; RAMSAY JA, 1952, J EXP BIOL, V29, P110; RAMSAY JA, 1955, J EXP BIOL, V32, P183; SAVAGE AA, 1962, Q J MICROSC SCI, V103, P417; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; SHAPIRO JP, 1988, ANNU REV ENTOMOL, V33, P297, DOI 10.1146/annurev.en.33.010188.001501; Sharpe ML, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2006-2; Shelomi Matan, 2015, Journal of Orthoptera Research, V24, P29; Shelomi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-917; Shelomi M, 2014, J MORPHOL, V275, P623, DOI 10.1002/jmor.20243; Strauss AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098637; TAYLOR HH, 1971, Z ZELLFORSCH MIK ANA, V122, P411, DOI 10.1007/BF00936077; TAYLOR HH, 1971, Z ZELLFORSCH MIK ANA, V118, P333, DOI 10.1007/BF00331192; TAYLOR HH, 1973, Z ZELLFORSCH MIK ANA, V141, P479, DOI 10.1007/BF00307119; TAYLOR HH, 1974, COMP BIOCHEM PHYSIOL, V47, P1129, DOI 10.1016/0300-9629(74)90087-5; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang GX, 2014, DIABETES, V63, P1340, DOI 10.2337/db13-1139; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157783; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yi SX, 2001, ARCH INSECT BIOCHEM, V46, P152, DOI 10.1002/arch.1025; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16; Zhu JS, 2010, INSECT BIOCHEM MOLEC, V40, P23, DOI 10.1016/j.ibmb.2009.12.004	69	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174984	10.1371/journal.pone.0174984	http://dx.doi.org/10.1371/journal.pone.0174984			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384348	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900068
J	Wang, KA; Wang, JC; Lin, CL; Tseng, CH				Wang, Kevin A.; Wang, Jia-Chi; Lin, Cheng-Li; Tseng, Chun-Hung			Association between fibromyalgia syndrome and peptic ulcer disease development	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; HELICOBACTER-PYLORI; MITOCHONDRIAL DYSFUNCTION; INTESTINAL PERMEABILITY; OXIDATIVE STRESS; GASTRIC-MUCOSA; CHRONIC PAIN; MECHANISMS	Purpose The correlation of fibromyalgia syndrome (FMS) with peptic ulcer disease (PUD) is unclear. We therefore conducted a cohort study to investigate whether FMS is correlated with an increased risk of PUD. Methods In this study, we established an FMS cohort comprising 26068 patients aged more than 20 years who were diagnosed with FMS from 2000 to 2011. Furthermore, we established a control cohort by randomly choosing 104269 people without FMS who were matched to the FMS patients by gender, age, and index year. All patients were free of PUD at the baseline. Cox proportional hazard regressions were performed to compute the hazard ratio of PUD after adjustment for demographic characteristics and comorbidities. Results The prevalence of comorbidities was significantly higher in the FMS patients than in the controls. The incidence of PUD was 29.8 and 19.4 per 1000 person-years in the FMS and control cohorts, respectively. In addition, the FMS cohort exhibited a 1.40-fold higher risk of PUD (95% confidence interval = 1.35-1.45) compared with the control cohort. After control for confounding factors, the medications (selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and antidepressants) taken by the FMS patients did not increase the risk of PUD. Conclusion FMS patients exhibit a higher risk of PUD than that of patients without FMS.	[Wang, Kevin A.] Shin Kong Mem Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Wang, Kevin A.] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Wang, Jia-Chi] Natl Yang Ming Univ, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Jia-Chi] Taipei Vet Gen Hosp, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tseng, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.	Tseng.nm@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019, MOHW106-TDU-B-212-113004]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005, MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); the Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital; the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bazzichi L, 2016, CLIN EXP RHEUMATOL, V34, pS145; Bellato E, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/426130; Calandre EP, 2015, EXPERT OPIN PHARMACO, V16, P1347, DOI 10.1517/14656566.2015.1047343; Calvino-Fernandez M, 2010, REV ESP ENFERM DIG, V102, P41, DOI 10.4321/s1130-01082010000100006; Chang L, 1998, EUR J SURG, V164, P32, DOI 10.1080/11024159850191210; Chen CH, 2016, ONCOTARGET, V7, P64380, DOI 10.18632/oncotarget.9062; Chen HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003670; Cordero MD, 2010, NEUROENDOCRINOL LETT, V31, P169; Dall M, 2011, SCAND J GASTROENTERO, V46, P1039, DOI 10.3109/00365521.2011.580100; Erin Lawson E, 2015, FIBROMYALGIA CLIN GU, P1; Goebel A, 2008, RHEUMATOLOGY, V47, P1223, DOI 10.1093/rheumatology/ken140; Itatsu T, 2011, INTERNAL MED, V50, P713, DOI 10.2169/internalmedicine.50.4644; Jacobson SA, 2015, AGING CLIN EXP RES, V27, P75, DOI 10.1007/s40520-014-0238-7; Jong JCF, 2003, BR J CLIN PHARM, V55, P591; Lauche R, 2015, EVID-BASED COMPL ALT, V2015, P610; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Liao CH, 2014, J PSYCHOSOM RES, V77, P541, DOI 10.1016/j.jpsychores.2014.08.005; MARTIN LF, 1982, SURGERY, V92, P337; MASI AT, 1994, BAILLIERE CLIN RHEUM, V8, P957, DOI 10.1016/S0950-3579(05)80056-1; Meeus M, 2013, EXPERT OPIN THER TAR, V17, P1081, DOI 10.1517/14728222.2013.818657; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oliveira Paula J., 2012, PSYCHOSOCIAL FACTORS; Pimentel M, 2004, ANN RHEUM DIS, V63, P450, DOI 10.1136/ard.2003.011502; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Ruiz-Cabello P, 2016, J ACAD NUTR DIET; Sanchez-Dominguez B, 2015, MITOCHONDRION, V21, P69, DOI 10.1016/j.mito.2015.01.010; SATO N, 1978, BIOCHIM BIOPHYS ACTA, V538, P236, DOI 10.1016/0304-4165(78)90351-3; Slim M, 2015, RHEUMATOL INT, V35, P433, DOI 10.1007/s00296-014-3109-9; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Stisi S, 2008, REUMATISMO, V60, P25, DOI 10.4081/reumatismo.2008.1s.25; Thieme Kati, 2009, Curr Rheumatol Rep, V11, P443; Torpy DJ, 1996, BAILLIERE CLIN RHEUM, V10, P181; TRIADAFILOPOULOS G, 1991, DIGEST DIS SCI, V36, P59, DOI 10.1007/BF01300088; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VERIM S, 2016, J BACK MUSCULOSKELET; Vincent A, 2013, PAIN MANAG NURS, V14, P228, DOI 10.1016/j.pmn.2011.05.001; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; Wallace Daniel J, 2004, Curr Pain Headache Rep, V8, P364; Wolfe F, 2013, EUR J PAIN, V17, P581, DOI 10.1002/j.1532-2149.2012.00234.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarandi SS, 2016, J NEUROGASTROENTEROL, V22, P201, DOI 10.5056/jnm15146; Zhang C, 2014, HELICOBACTER, V19, P330, DOI 10.1111/hel.12138	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175370	10.1371/journal.pone.0175370	http://dx.doi.org/10.1371/journal.pone.0175370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384332	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900164
J	Dharmayanthi, AB; Terai, Y; Sulandari, S; Zein, MSA; Akiyama, T; Satta, Y				Dharmayanthi, Anik Budhi; Terai, Yohei; Sulandari, Sri; Zein, M. Syamsul Arifin; Akiyama, Toyoko; Satta, Yoko			The origin and evolution of fibromelanosis in domesticated chickens: Genomic comparison of Indonesian Cemani and Chinese Silkie breeds	PLOS ONE			English	Article							SELECTION; NUMBER; PIGMENTATION; HITCHHIKING; FRAMEWORK; PATTERNS; REVEALS; ALLELE; LOCI; SNP	Like Chinese Silkie, Indonesian Ayam Cemani exhibits fibromelanosis or dermal hyperpigmentation and possesses complex segmental duplications on chromosome 20 that involve the endothelin 3 gene, EDN3. A genomic region, DR1 of 127 kb, together with another region, DR2 of 171 kb, was duplicated by unequal crossing over, accompanied by inversion of one DR2. Quantitative PCR and copy number variation analyses on the Cemani genome sequence confirmed the duplication of EDN3. These genetic arrangements are identical in Cemani and Silkie, indicating a single origin of the genetic cause of Fm. The two DR1s harbor two distinct EDN3 haplotypes in a form of permanent heterozygosity, although they remain allelic in the ancestral Red Jungle Fowl population and some domesticated chicken breeds, with their allelic divergence time being as recent as 0.3 million years ago. In Cemani and Silkie breeds, artificial selection favoring the Fm phenotype has left an unambiguous record for selective sweep that extends in both directions from tandemly duplicated EDN3 loci. This highly homozygous tract is different in length between Cemani and Silkie, reflecting their distinct breeding histories. It is estimated that the Fm phenotype came into existence at least 6600-9100 years ago, prior to domestication of Cemani and Silkie, and that throughout domestication there has been intense artificial selection with strength s > 50% in each breed.	[Dharmayanthi, Anik Budhi; Terai, Yohei; Satta, Yoko] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Dharmayanthi, Anik Budhi; Sulandari, Sri; Zein, M. Syamsul Arifin] Indonesian Inst Sci LIPI, Museum Zool Bogoriense, Cibinong, Indonesia; [Akiyama, Toyoko] Keio Univ, Dept Biol, Yokohama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan; Bogor Zoology Museum; Indonesian Institute of Sciences; Keio University	Satta, Y (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	sattayk@soken.ac.jp		Dharmayanthi, Anik Budhi/0000-0003-4635-6099; Satta, Yoko/0000-0002-5305-493X	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. Naoyuki Takahata for helpful discussion and critical reading of early versions of this manuscript and Drs. Monty Slatkin and Wen-Hsiung Li for comments and suggestions. We are deeply grateful to the ABRC in Nagoya University, and to the JSAC for providing us with chickens as well as blood and DNA samples. We are grateful for the support of SOKENDAI and LIPI throughout this project. ABD expresses her sincere thanks to the MEXT for a scholarship. SS passed away before the completion of this study. YS is responsible for the integrity and validity of the data collected by the deceased author.	Akiyama T, 2013, SKIN PIGMENTATION, P175; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Bateson W, 1911, J GENET, V1, P185, DOI 10.1007/BF02981551; Bellwood PS, 1979, MANS CONQUEST PACIFI; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brodkorb P., 1964, Bulletin of the Florida State Museum Biological Sciences, V8, P195; Charlesworth B, 2012, ELEMENTS EVOLUTIONAR; Chen H, 2015, THEOR POPUL BIOL, V99, P18, DOI 10.1016/j.tpb.2014.11.001; Chen H, 2013, G3-GENES GENOM GENET, V3, P1429, DOI 10.1534/g3.113.006197; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; HUDSON RR, 1987, GENETICS, V116, P153; Hutt F.B., 1949, GENETICS OF THE FOWL; Johnsson M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12950; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; KAPLAN NL, 1989, GENETICS, V123, P887; LAHAV R, 1994, DIFFERENTIATION, V58, P133; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lambrecht K., 1933, HDB PALAOMITHOLOGIE; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Liang M, 2014, GENETICS, V197, P953, DOI 10.1534/genetics.114.162362; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mugal CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-86; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pritchard JK, 2000, GENETICS, V155, P945; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Shinomiya A, 2011, GENETICS, V111; Slatkin M, 2008, GENET RES, V90, P129, DOI 10.1017/S0016672307008944; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smyth Jr JR, 1994, MELANIN PIGMENTATION; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Xiang H, 2014, P NATL ACAD SCI USA, V111, P17564, DOI 10.1073/pnas.1411882111; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80	56	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173147	10.1371/journal.pone.0173147	http://dx.doi.org/10.1371/journal.pone.0173147			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379963	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500012
J	Motzik, A; Amir, E; Erlich, T; Wang, J; Kim, BG; Han, JM; Kim, JH; Nechushtan, H; Guo, M; Razin, E; Tshori, S				Motzik, A.; Amir, E.; Erlich, T.; Wang, J.; Kim, B-G; Han, J. M.; Kim, J. H.; Nechushtan, H.; Guo, M.; Razin, E.; Tshori, S.			Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells	ONCOGENE			English	Article							TRANSFER-RNA SYNTHETASE; MAST-CELLS; TUMOR-SUPPRESSOR; AXONAL NEUROPATHY; GENE-EXPRESSION; GASTRIC-CANCER; PROTEIN; MICROPHTHALMIA; MECHANISM; NEUROMYOTONIA	Microphthalmia transcription factor (MITF) is a basic helix-loop-helix leucine zipper (bHLH-Zip) DNA-binding protein. This transcription factor plays a crucial role in the physiological and pathological functions of distinct cell types. MITF transcriptional activity is inhibited by the histidine triad nucleotide-binding protein 1 (HINT1) through direct binding. We previously reported that this association is disrupted by the binding of the second messenger Ap4A to HINT1. Ap4A is mainly produced in the mammalian cells by S207-phosphorylated Lysyl-tRNA synthetase. In this study, we found first that HINT1 was subjected to K21 acetylation and Y109 phosphorylation in activated mast cells, together with the Ap4A-triggered HINT1 dissociation from MITF. Mutational analysis confirmed that these modifications promote MITF transcriptional and oncogenic activity in melanoma cell lines, derived from human melanoma patients. Thus, we provided here an example that manipulation of the LysRS-Ap4A-HINT1-MITF signalling pathway in melanoma through post-translational modifications of HINT1 can affect the activity of the melanoma oncogene MITF.	[Motzik, A.; Amir, E.; Erlich, T.; Razin, E.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel; [Wang, J.] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai, Peoples R China; [Kim, B-G] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea; [Han, J. M.] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul, South Korea; [Han, J. M.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, J. H.] Yonsei Univ, Coll Pharm, Seoul, South Korea; [Nechushtan, H.] Hadassah Hebrew Univ Med Ctr, Oncol Dept, Jerusalem, Israel; [Guo, M.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Tshori, S.] Kaplan Med Ctr, Dept Nucl Med, Rehovot, Israel	Hebrew University of Jerusalem; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Yonsei University; Hebrew University of Jerusalem; Scripps Research Institute; Hebrew University of Jerusalem; Kaplan Medical Center	Razin, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	ehudr@ekmd.huji.ac.il	nechushtan, hovav/Z-3564-2019; Amir, Eitan/L-6052-2019	Han, Jung Min/0000-0003-3372-7575; Wang, Jing/0000-0002-7566-1212; Erlich, Tal/0000-0003-0601-2574	National Institute of Health [GM100136]; American Asthma Foundation [AAF15-0080]; National Research Foundation of Singapore (Hebrew University of Jerusalem-Campus for Research Excellence and Technological Enterprise); Israel Science Foundation; Israel Cancer Association, Boca Grove Fellowship Fund	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; National Research Foundation of Singapore (Hebrew University of Jerusalem-Campus for Research Excellence and Technological Enterprise); Israel Science Foundation(Israel Science Foundation); Israel Cancer Association, Boca Grove Fellowship Fund	We thank Prof Norman Grover from the Hebrew University for conducting the statistical analysis. Patient-derived cutaneous metastatic melanoma cells (line TC-2514) were kindly provided by Dr John Wunderlich (Surgery Branch National Cancer Institute). This work was supported in part by grants from the National Institute of Health GM100136 and American Asthma Foundation AAF15-0080 to MG, and National Research Foundation of Singapore (Hebrew University of Jerusalem-Campus for Research Excellence and Technological Enterprise) and Israel Science Foundation to ER and the Israel Cancer Association, Boca Grove Fellowship Fund to ER.	Aminkeng F, 2013, CLIN GENET, V83, P31, DOI 10.1111/cge.12030; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Carmi-Levy I, 2008, MOL CELL BIOL, V28, P5777, DOI 10.1128/MCB.00106-08; Carmi-Levy I, 2011, MOL CELL BIOL, V31, P2111, DOI 10.1128/MCB.01159-10; Chen Q, 2008, SCHIZOPHR RES, V106, P200, DOI 10.1016/j.schres.2008.08.006; Dolot R, 2016, INT J BIOL MACROMOL, V87, P62, DOI 10.1016/j.ijbiomac.2016.02.047; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Huang HY, 2011, INT J ONCOL, V38, P1557, DOI 10.3892/ijo.2011.994; Jackson KJ, 2011, PHARMACOGENOMICS J, V11, P251, DOI 10.1038/tpj.2010.41; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Li HY, 2008, J CELL BIOL, V183, P253, DOI 10.1083/jcb.200711150; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nechushtan H, 2002, MOL IMMUNOL, V38, P1177, DOI 10.1016/S0161-5890(02)00059-7; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; RANDERATH K, 1966, BIOCHEM BIOPH RES CO, V24, P98, DOI 10.1016/0006-291X(66)90416-5; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Sonnenblick A, 2005, J IMMUNOL, V175, P1450, DOI 10.4049/jimmunol.175.3.1450; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; Tang TY, 2016, ANTICANCER RES, V36, P3229; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; YANG DCH, 1985, CURR TOP CELL REGUL, V26, P325; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Yuan BZ, 2004, NEOPLASIA, V6, P412, DOI 10.1593/neo.03490; Zimon M, 2012, NAT GENET, V44, P1080, DOI 10.1038/ng.2406; Zuk K, 2012, ONCOL LETT, V3, P219, DOI 10.3892/ol.2011.456	37	25	25	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4732	4738		10.1038/onc.2017.81	http://dx.doi.org/10.1038/onc.2017.81			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394346				2022-12-26	WOS:000407702400006
J	Teramoto, T; Balasubramanian, A; Choi, KH; Padmanabhan, R				Teramoto, Tadahisa; Balasubramanian, Anuradha; Choi, Kyung H.; Padmanabhan, Radhakrishnan			Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LINKER REGION; TYPE-2; POLYMERASE; HELICASE; METHYLTRANSFERASE; PROTEASE; 5'-TRIPHOSPHATASE; TRIPHOSPHATASE; FLEXIBILITY	Four serotypes of mosquito-borne dengue virus (DENV), evolved from a common ancestor, are human pathogens of global significance for which there is no vaccine or antiviral drug available. The N-terminal domain of DENV NS5 has guanylyltransferase and methyltransferase (MTase), and the C-terminal region has the polymerase (POL), all of which are important for 5 '-capping and RNA replication. The crystal structure of NS5 shows it as a dimer, but the functional evidence for NS5 dimer is lacking. Our studies showed that the substitution of DENV2 NS5 MTase or POL for DENV4 NS5 within DENV2 RNA resulted in a severe attenuation of replication in the transfected BHK-21 cells. A replication-competent species was evolved with the acquired mutations in the DENV2 and DENV4 NS5 MTase or POL domain or in the DENV2 NS3 helicase domain in the DENV2 chimera RNAs by repeated passaging of infected BHK-21 or mosquito cells. The linker region of seven residues in NS5, rich in serotype-specific residues, is important for the recovery of replication fitness in the chimera RNA. Our results, taken together, provide genetic evidence for a serotype-specific interaction between NS3 and NS5 as well as specific interdomain interaction within NS5 required for RNA replication. Genome-wide RNAseq analysis revealed the distribution of adaptive mutations in RNA quasispecies. Those within NS3 and NS5 are located at the surface and/or within the NS5 dimer interface, providing a functional significance to the crystal structure NS5 dimer.	[Teramoto, Tadahisa; Balasubramanian, Anuradha; Padmanabhan, Radhakrishnan] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Georgetown University; University of Texas System; University of Texas Medical Branch Galveston	Padmanabhan, R (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.	rp55@georgetown.edu			National Institutes of Health [R01 AI087856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI087856 (to K. H. C. and R. P). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Borderia AV, 2016, CURR TOP MICROBIOL, V392, P303, DOI 10.1007/82_2015_483; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fishman SL, 2009, INFECT GENET EVOL, V9, P1158, DOI 10.1016/j.meegid.2009.07.011; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Furio V, 2005, P NATL ACAD SCI USA, V102, P10233, DOI 10.1073/pnas.0501062102; Gebhard LG, 2014, NUCLEIC ACIDS RES, V42, P11668, DOI 10.1093/nar/gku812; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010; Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Padmanabhan R, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P13; Padmanabhan R, 2015, METHODS, V91, P20, DOI 10.1016/j.ymeth.2015.08.002; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Tan CSE, 2013, J GEN VIROL, V94, P1961, DOI 10.1099/vir.0.054395-0; Teramoto T, 2014, J BIOL CHEM, V289, P22385, DOI 10.1074/jbc.M114.584466; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006; Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08; Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15; Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682	48	10	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9465	9479		10.1074/jbc.M117.775643	http://dx.doi.org/10.1074/jbc.M117.775643			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28396347	Green Published, hybrid			2022-12-26	WOS:000403113000003
J	Huertas, I; Jesus, S; Garcia-Gomez, FJ; Lojo, JA; Bernal-Bernal, I; Bonilla-Toribio, M; Martin-Rodriguez, JF; Garcia-Solis, D; Gomez-Garre, P; Mir, P				Huertas, Ismael; Jesus, Silvia; Javier Garcia-Gomez, Francisco; Antonio Lojo, Jose; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Francisco Martin-Rodriguez, Juan; Garcia-Solis, David; Gomez-Garre, Pilar; Mir, Pablo			Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease	PLOS ONE			English	Article							GLUCOCEREBROSIDASE MUTATIONS; DOPAMINE; APOE; SUSCEPTIBILITY; POLYMORPHISM; ASSOCIATION; COGNITION; COHORT; SPECT; MOTOR	The dual syndrome hypothesis for cognitive impairment in Parkinson's disease (PD) establishes a dichotomy between a frontrostriatal dopamine-mediated syndrome, which leads to executive deficits, and a posterior cortical syndrome, which leads to dementia. Certain genes have been linked to these syndromes although the exact contribution is still controversial. The study's objective was to investigate the role of APOE, MAPT, COMT, SNCA and GBA genes in the dual syndromes. We genotyped APOE (rs429358 and rs7412), MAPT (rs9468), COMT (rs4680) and SNCA (rs356219) risk polymorphisms and sequenced GBA in a cohort of 298 PD patients. The degree of dopaminergic depletion was investigated with [I-123] FP-CIT SPECTs and the presence of dementia was ascertained with a long-term review based on established criteria. The association between genetic and imaging parameters was studied with linear regression, and the relationship with dementia onset with Cox regression. We found that APOE2 allele (P-put = 0.002; P-cau = 0.01), the minor allele 'G' in SNCA polymorphism (P-put = 0.02; P-cau = 0.006) and GBA deleterious variants in (P-put = 0.01; P-cau = 0.001) had a detrimental effect on striatal [I-123] FP-CIT uptake in PD. Conversely, Met/Met carriers in COMT polymorphism had increased caudate uptake (Pcau = 0.03). The development of dementia was influenced by APOE4 allele (HR = 1.90; P = 0.03) and GBA deleterious variants (HR = 2.44; P = 0.01). Finally, we observed no role of MAPT locus in any of the syndromes. As a conclusion, APOE2, SNCA, COMT and GBA influence frontostriatal dysfunction whereas APOE4 and GBA influence the development of dementia, suggesting a double-edged role of GBA. The dichotomy of the dual syndromes may be driven by a broad dichotomy in these genetic factors.	[Huertas, Ismael; Jesus, Silvia; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Francisco Martin-Rodriguez, Juan; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, Hosp Univ Virgen Rocio, CSIC,Unidad Trastornos Movimiento, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain; [Javier Garcia-Gomez, Francisco; Antonio Lojo, Jose; Garcia-Solis, David] Hosp Univ Virgen Rocio, UDIM, Serv Med Nucl, Seville, Spain; [Garcia-Solis, David; Gomez-Garre, Pilar; Mir, Pablo] Ctr Invest Biorned Red Enfermedades Neurodegenera, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Mir, P (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, CSIC,Unidad Trastornos Movimiento, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain.; Mir, P (corresponding author), Ctr Invest Biorned Red Enfermedades Neurodegenera, Madrid, Spain.	pmir@us.es	Gómez-Garre, Pilar/AAG-8048-2020; Garcia Gomez, Francisco Javier/D-2553-2015	Gómez-Garre, Pilar/0000-0002-0437-6182; Garcia Gomez, Francisco Javier/0000-0001-9307-5017; Martin Rodriguez, Juan Francisco/0000-0003-1392-8775; Lojo Ramirez, Jose Antonio/0000-0003-4945-8250; JESUS MAESTRE, SILVIA/0000-0002-1874-4628; BERNAL, INMACULADA/0000-0002-4207-1208; Huertas, Ismael/0000-0002-4317-0662	Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) [PI14/01823, PI16/01575]; Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013]; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; PFIS doctoral programme from the ISCIII-FEDER [FI4/00497]; Rio Hortega programme from the ISCIII-FEDER; Sara Borrell programme from the ISCIII-FEDER; Miguel Servet programme from the ISCIII-FEDER	Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); PFIS doctoral programme from the ISCIII-FEDER; Rio Hortega programme from the ISCIII-FEDER; Sara Borrell programme from the ISCIII-FEDER; Miguel Servet programme from the ISCIII-FEDER	This work was supported by grants from the Institute de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) [PI14/01823, PI16/01575], the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685], the Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013], the Sociedad Andaluza de Neurologia, the Fundacion Alicia Koplowitz and the Fundacion Mutua Madrilena. Ismael Huertas was supported by the PFIS doctoral programme [FI4/00497], Silvia Jesus by the Rio Hortega programme, Juan Francisco Martin Rodriguez by the Sara Borrell programme, and Pilar Gomez-Garre by the Miguel Servet programme, all from the ISCIII-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2011, CURR NEUROL NEUROSCI, V11, P371, DOI 10.1007/s11910-011-0203-1; Alcalay RN, 2015, BRAIN, V138, P2648, DOI 10.1093/brain/awv179; Brockmann K, 2015, MOVEMENT DISORD, V30, P407, DOI 10.1002/mds.26071; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; de la Fuente-Fernandez R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00090; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Ezquerra M, 2008, NEUROSCI LETT, V448, P20, DOI 10.1016/j.neulet.2008.10.018; Federoff M, 2012, NEUROBIOL DIS, V46, P389, DOI 10.1016/j.nbd.2012.02.002; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Goker-Alpan O, 2012, BRAIN, V135, P2440, DOI 10.1093/brain/aws174; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Huertas-Fernandez I, 2015, EUR J NUCL MED MOL I, V42, P112, DOI 10.1007/s00259-014-2882-8; Jesus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167749; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; Mata IF, 2016, MOVEMENT DISORD, V31, P95, DOI 10.1002/mds.26359; Mata IF, 2014, JAMA NEUROL, V71, P1405, DOI 10.1001/jamaneurol.2014.1455; McNeill A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069190; Mollenhauer B, 2014, MOVEMENT DISORD, V29, P622, DOI 10.1002/mds.25846; Muellner J, 2015, PARKINSONISM RELAT D, V21, P471, DOI 10.1016/j.parkreldis.2015.02.009; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nombela C, 2014, BRAIN, V137, P2743, DOI 10.1093/brain/awu201; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pagonabarraga J, 2010, MOVEMENT DISORD, V25, P440, DOI 10.1002/mds.22877; Pihlstrom L, 2011, NEUROGENETICS, V12, P283, DOI 10.1007/s10048-011-0292-7; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Robbins TW, 2014, MOVEMENT DISORD, V29, P597, DOI 10.1002/mds.25853; Schillaci O, 2005, EUR J NUCL MED MOL I, V32, P1452, DOI 10.1007/s00259-005-1922-9; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Williams-Gray CH, 2009, J NEUROL, V256, P493, DOI 10.1007/s00415-009-0119-8; Winder-Rhodes SE, 2013, BRAIN, V136, P392, DOI 10.1093/brain/aws318; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157	34	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175560	10.1371/journal.pone.0175560	http://dx.doi.org/10.1371/journal.pone.0175560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399184	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000050
J	Nakao, M; Yamauchi, K; Ishihara, Y; Omori, H; Solongo, B; Ichinnorov, D				Nakao, Motoyuki; Yamauchi, Keiko; Ishihara, Yoko; Omori, Hisamitsu; Solongo, Bandi; Ichinnorov, Dashtseren			Prevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: Cross-sectional studies	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC-BRONCHITIS; LUNG-FUNCTION; COPD; SMOKING; POLLUTION; HEALTH; BURDEN; ASTHMA	The burden of chronic obstructive pulmonary disease ( COPD) is expected to increase in the coming decades. In Ulaanbaatar, Mongolia, air pollution, which has been suggested to correlate with COPD, is a growing concern. However, the COPD prevalence in Ulaanbaatar is currently unknown. This study aims to estimate the prevalence of airflow limitation and investigate the association between airflow limitation and putative risk factors in the Mongolian population. Five cross-sectional studies were carried out in Ulaanbaatar. Administration of a self-completed questionnaire, body measurements, and medical examination including spirometry were performed in 746 subjects aged 40 to 79 years living in Ulaanbaatar. The age-and sex-standardized prevalence of airflow limitation in Ulaanbaatar varied widely from 4.0 to 10.9% depending on the criteria for asthma. Age, body mass index (BMI), and smoking habit were independent predictors for airflow limitation while residential area and household fuel type were not significant. In conclusion, prevalence of putative COPD was 10.0% when subjects with physician-diagnosed asthma were excluded from COPD. Older age, lower BMI, and current smoking status were putative risk factors for airflow limitation. This prevalence was consistent with reports from Asian countries.	[Nakao, Motoyuki; Yamauchi, Keiko; Ishihara, Yoko] Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka, Japan; [Omori, Hisamitsu] Kumamoto Univ, Fac Life Sci, Dept Biomed Lab Sci, Kumamoto, Japan; [Solongo, Bandi; Ichinnorov, Dashtseren] Mongolian Natl Univ Med Sci, Dept Resp Med, Ulaanbaatar, Mongolia	Kurume University; Kumamoto University; Mongolian National University of Medical Sciences	Ishihara, Y (corresponding author), Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka, Japan.	blackcat@med.kurume-u.a.c.jp			Ministry of Education, Culture, Sports, Science, and Technology [20406001, 23406001, 26340053]; Ministry of Education, Culture, Sports, Science, and Technology MEXT Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology MEXT Program for the Strategic Research Foundation at Private Universities	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (B) 20406001 YI; Ministry of Education, Culture, Sports, Science, and Technology (B) 23406001 to YI; Ministry of Education, Culture, Sports, Science, and Technology (C) 26340053 to YI; Ministry of Education, Culture, Sports, Science, and Technology MEXT-Supported Program for the Strategic Research Foundation at Private Universities to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Amarsaikhan D., 2014, J GEOSCI ENV PROT, V2, P123, DOI [10.4236/gep.2014.22017, DOI 10.4236/GEP.2014.22017]; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Berend N, 2016, RESPIROLOGY, V21, P237, DOI 10.1111/resp.12644; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD and Asthma-COPD Overlap Syndrome (ACOS), 2015, BAS GLOB STRAT ASTHM; Ezzati M, 2005, LANCET, V366, P104, DOI 10.1016/S0140-6736(05)66845-6; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Harik-Khan RI, 2002, CHEST, V121, P370, DOI 10.1378/chest.121.2.370; Hu GP, 2015, J THORAC DIS, V7, P59, DOI 10.3978/j.issn.2072-1439.2014.12.47; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Kessler R, 2011, EUR RESPIR J, V37, P264, DOI 10.1183/09031936.00051110; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Laniado-Laborin R, 2009, INT J ENV RES PUB HE, V6, P209, DOI 10.3390/ijerph6010209; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray RP, 1998, J CLIN EPIDEMIOL, V51, P1317, DOI 10.1016/S0895-4356(98)00120-6; Park H, 2015, KOREAN J FAM MED, V36, P128, DOI 10.4082/kjfm.2015.36.3.128; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; United Nations Economic and Social Commission for Asia and the Pacific ESCAP Statistical Database, 2014, ESCAP STAT DAT STAT; van den Boom G, 1998, EUR RESPIR J, V11, P67, DOI 10.1183/09031936.98.11010067; van Schayck C P Onno, 2006, Prim Care Respir J, V15, P81, DOI 10.1016/j.pcrj.2006.01.006; Viinanen A, 2005, ALLERGY, V60, P1370, DOI 10.1111/j.1398-9995.2005.00877.x; World Health Organization, AMBIENT OUTDOOR AIR; World Health Organization, TOP 10 CAUS DEATH; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou Y., 2013, CURR BIOMARK FIND, V3, P1, DOI DOI 10.1155/2013/706156	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175557	10.1371/journal.pone.0175557	http://dx.doi.org/10.1371/journal.pone.0175557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399185	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000049
J	Potvin, J; Werth, AJ				Potvin, Jean; Werth, Alexander J.			Oral cavity hydrodynamics and drag production in Balaenid whale suspension feeding	PLOS ONE			English	Article							BOWHEAD WHALE; FLOW; FILTRATION; MECHANISMS; ENGULFMENT; KINEMATICS	Balaenid whales feed on large aggregates of small and slow-moving prey (predominantly copepods) through a filtration process enabled by baleen. These whales exhibit continuous filtration, namely, with the mouth kept partially opened and the baleen exposed to oncoming prey-laden waters while fluking. The process is an example of crossflow filtration (CFF) in which most of the particulates (prey) are separated from the substrate (water) without ever coming into contact with the filtering surface (baleen). This paper discusses the simulation of baleen filtration hydrodynamics based on a type of hydraulic circuit modeling commonly used in microfluidics, but adapted to the much higher Reynolds number flows typical of whale hydrodynamics. This so-called Baleen Hydraulic Circuit (BHC) model uses as input the basic characteristics of the flows moving through a section of baleen observed in a previous flume study by the authors. The model has low-spatial resolution but incorporates the effects of fluid viscosity, which doubles or more a whale's total body drag in comparison to non-feeding travel. Modeling viscous friction is crucial here since exposing the baleen system to the open ocean ends up tripling a whale's total wetted surface area. Among other findings, the BHC shows how CFF is enhanced by a large filtration surface and hence large body size; how it is carried out via the establishment of rapid anteroposterior flows transporting most of the prey-water slurry towards the oropharyngeal wall; how slower intra-baleen flows manage to transfer most of the substrate out of the mouth, all the while contributing only a fraction to overall oral cavity drag; and how these anteroposterior and intra-baleen flows lose speed as they approach the oropharyngeal wall.	[Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA; [Werth, Alexander J.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA	Saint Louis University	Potvin, J (corresponding author), St Louis Univ, Dept Phys, St Louis, MO 63103 USA.	potvinj@slu.edu		Werth, Alexander/0000-0002-7777-478X	Hampden-Sydney College; Virginia Foundation for Independent Colleges	Hampden-Sydney College; Virginia Foundation for Independent Colleges	JP did not get funding for the work performed in this manuscript. AJW acknowledges intramural funding provided by faculty grants from Hampden-Sydney College, and Mednick and Harris Awards from the Virginia Foundation for Independent Colleges.	Abbott IH., 1959, THEORY WING SECTIONS; [Anonymous], 1954, PIP FRICT MAN; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Berthier J, 2010, ARTECH HSE INTEGR MI, P1; Blevins R. D., 1992, APPL FLUID DYNAMICS; Denny M., 1993, AIR WATER; Eppler R., 1990, AIRFOIL DESIGN DATA; Fish FE, 1998, J EXP BIOL, V201, P2867; Fontaine P-H., 2007, WHALES SEALS BIOL EC; Fox RW, 1978, INTRO FLUID MECH; Goldbogen JA, 2017, ANNU REV MAR SCI, V9, P367, DOI 10.1146/annurev-marine-122414-033905; Goldbogen JA, 2016, CRC MAR BIOL SER, P3; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Hain JHW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054340; Hertel H., 1966, STRUCTURE FORM MOVEM; KENNEY RD, 1986, MAR MAMMAL SCI, V2, P1, DOI 10.1111/j.1748-7692.1986.tb00024.x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Kooyman G. L., 1989, DIVERSE DIVERS; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; McGregor AE Nousek, 2010, THESIS; Nguyen L. A., 2011, THESIS; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; Paig-Tran EWM, 2013, J MORPHOL, V274, P1026, DOI 10.1002/jmor.20160; Potvin J, 2015, 23 AIAA AER DEC SYST; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Rae Jr WH, 1984, LOW SPEED WIND TUNNE, V2nd; Riedeberger D., 2012, HIGH PERFORMANCE COM, V32, P379; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; Sanderson S. Laurie, 1993, P37; SANDERSON SL, 1990, SCI AM, V262, P96, DOI 10.1038/scientificamerican0390-96; Shadwick RE, 2013, J EXP BIOL, V216, P2691, DOI 10.1242/jeb.081752; Shyy W, 2008, CAMB AERO SER, P1; Simon M, 2009, P ROY SOC B-BIOL SCI, V276, P3819, DOI 10.1098/rspb.2009.1135; van der Hoop JM, 2015, MARINE MAMMAL SCI; van der Hoop JM, 2013, MARINE MAMMAL SCI; Vogel S., 2003, COMP BIOMECHANICS LI; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth AJ, 2016, J MORPHOL, V277, P453, DOI 10.1002/jmor.20510; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Werth Alexander J., 2012, International Journal of Ecology, P1; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; Wilcox DC., 2006, TURBULENCE MODELING, V3	45	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175220	10.1371/journal.pone.0175220	http://dx.doi.org/10.1371/journal.pone.0175220			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399142	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000023
J	Zeng, P; Tan, QP; Meng, XK; Shao, ZM; Xie, QZ; Yan, Y; Cao, W; Xu, JJ				Zeng, Ping; Tan, Qingping; Meng, Xiankai; Shao, Zeming; Xie, Qinzheng; Yan, Ying; Cao, Wei; Xu, Jianjun			A multi-pattern hash-binary hybrid algorithm for URL matching in the HTTP protocol	PLOS ONE			English	Article								In this paper, based on our previous multi-pattern uniform resource locator (URL) binary-matching algorithm called HEM, we propose an improved multi-pattern matching algorithm called MH that is based on hash tables and binary tables. The MH algorithm can be applied to the fields of network security, data analysis, load balancing, cloud robotic communications, and so on-all of which require string matching from a fixed starting position. Our approach effectively solves the performance problems of the classical multi-pattern matching algorithms. This paper explores ways to improve string matching performance under the HTTP protocol by using a hash method combined with a binary method that transforms the symbol-space matching problem into a digital-space numerical-size comparison and hashing problem. The MH approach has a fast matching speed, requires little memory, performs better than both the classical algorithms and HEM for matching fields in an HTTP stream, and it has great promise for use in real-world applications.	[Zeng, Ping; Tan, Qingping; Meng, Xiankai; Shao, Zeming; Xie, Qinzheng; Yan, Ying; Xu, Jianjun] Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China; [Zeng, Ping; Tan, Qingping] Natl Univ Def Technol, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Cao, Wei] Changsha Univ Sci & Technol, Sch Comp & Commun Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China; Changsha University of Science & Technology	Tan, QP (corresponding author), Natl Univ Def Technol, Coll Comp, Changsha, Hunan, Peoples R China.; Tan, QP (corresponding author), Natl Univ Def Technol, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	eric_tan@nudt.edu.cn			Scientific Research Fund of the Hunan Provincial Education Department [15A007]; National Natural Science Foundation of China [61202116]	Scientific Research Fund of the Hunan Provincial Education Department(Hunan Provincial Education Department); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Scientific Research Fund of the Hunan Provincial Education Department (No. 15A007) and National Natural Science Foundation of China (No. 61202116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Al-Ssulami AM, 2015, J INF SCI, V41, P82, DOI 10.1177/0165551514555668; Aldwairi M, 2015, 2015 2ND WORLD SYMPOSIUM ON WEB APPLICATIONS AND NETWORKING (WSWAN); Allauzen C, 1999, 9911 U MARN LA VALL; Baykan E, 2011, ACM T WEB, V5, DOI 10.1145/1993053.1993057; Ben-Kiki O, 2011, LEIBNIZ INT PR INFOR, V13, P423, DOI 10.4230/LIPIcs.FSTTCS.2011.423; Bremler-Barr A, 2016, 2016 IFIP NETWORKING CONFERENCE (IFIP NETWORKING) AND WORKSHOPS, P467, DOI 10.1109/IFIPNetworking.2016.7497218; Cantone D, 2010, LECT NOTES COMPUT SC, V6129, P288, DOI 10.1007/978-3-642-13509-5_26; Cantone D, 2010, LECT NOTES COMPUT SC, V6099, P166, DOI 10.1007/978-3-642-13122-6_18; Changsheng Miao, 2010, Proceedings of the 2010 Fourth International Conference on Genetic and Evolutionary Computing (ICGEC 2010), P582, DOI 10.1109/ICGEC.2010.149; Dogmus Z, 2015, ROBOT CIM-INT MANUF, V33, P100, DOI 10.1016/j.rcim.2014.08.010; Durian B, 2010, LECT NOTES COMPUT SC, V6049, P129, DOI 10.1007/978-3-642-13193-6_12; Faro Simone, 2012, Implementation and Application of Automata. Proceedings of the 17th International Conference (CIAA 2012), P149, DOI 10.1007/978-3-642-31606-7_13; Faro S., 2013, P 15 M ALGORITHM ENG, P113, DOI [DOI 10.1137/1.9781611972931.10, 10.1137/1.9781611972931.10]; Fielding R, 1997, RFC2068; He Long-Tao, 2005, Journal of Software, V16, P676, DOI 10.1360/jos160676; He SQ, 2006, APPL ELECT TECHNIQUE, V7, P30; Hlayel AA, 2014, J INF SCI, V40, P357, DOI 10.1177/0165551513519039; Kamei K, 2012, IEEE NETWORK, V26, P28, DOI 10.1109/MNET.2012.6201213; Kuffner J., 2010, HUMANOID ROBOTS HUMA, P519; Li Xiao-Ming, 2004, Journal of Software, V15, P179; [刘燕兵 Liu Yanbing], 2014, [计算机学报, Chinese Journal of Computers], V37, P1159; Navarro G, 2000, ACM J EXPT ALGORITHM, V5, P4, DOI DOI 10.1145/351827.384246; Ou W, 2007, MICROPROCESSORS, V28, P59; Peltola H, 2011, PROCEEDINGS OF THE PRAGUE STRINGOLOGY CONFERENCE 2011, P3; Wu S., 1994, TR9417 U AR DEP COMP; [薛颂东 XUE SongDong], 2008, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V21, P177; Zeng P, 2015, 5 INT C COMM SYST NE, P2015; Zhang Heng, 2014, Application Research of Computers, V31, P2567, DOI 10.3969/j.issn.1001-3695.2014.09.002; Zhou X, 2010, PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON LOGISTICS SYSTEMS AND INTELLIGENT MANAGEMENT, VOLS 1-3, P1, DOI 10.1109/ICLSIM.2010.5461480	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175500	10.1371/journal.pone.0175500	http://dx.doi.org/10.1371/journal.pone.0175500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399157	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000043
J	Cao, GQ; Cheng, DZ; Ye, LC; Pan, YY; Yang, F; Lyu, SX				Cao, Guoquan; Cheng, Dezhi; Ye, Lechi; Pan, Yiyuan; Yang, Fan; Lyu, Shixu			Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; LUNG METASTASES; RADIOFREQUENCY ABLATION; CARCINOMA; SURVIVAL; RECURRENCE	Objective To analyze the benefits and prognostic factors after surgical resection of pulmonary metastases from colorectal cancer (CRC). Methods From Jan. 2004 to Jan. 2015, continuous 88 cases diagnosed with pulmonary metastases from CRC, including 15 cases of synchronous metastases and 73 metachronous metastases, were analyzed in the retrospective study. Results All of these 88 cases underwent curative pulmonary resection including 8 cases of simultaneous surgery. The one-year, three-year and five-year survival of the 88 cases were 93.4%, 60.2% and 35.7%, respectively. 63 patients just have one metastasis, and 25 patients have more than one metastasis. Additionally, the one-year, three-year and five-year survival was 98.1%, 70.2% and 40.3% respectively in one metastasis group, while 80.1%, 37.9% and 22.5% respectively in more than one metastasis group (p = 0.003). DFS of 37 metachronous metastases were equal or greater than 18 months, and DFS of 36 metachronous metastases were less than 18 months. The one-year, three-year and five-year survival was 97.8%, 77.9% and 41.4% respectively in the DFS >= 18 month group, while 88.2%, 44.6% and 28.1% respectively in the DFS<18 month group ( p = 0.01). Conclusion Surgical resection of pulmonary metastases from colorectal cancer can improve survival rate in selected patients. It seems that the number of metastases is an independence prognostic factor in surgical treatment. Furthermore, longer DFI implies longer survival for resectable CRC pulmonary metastases.	[Cao, Guoquan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Peoples R China; [Cheng, Dezhi] Wenzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ye, Lechi; Pan, Yiyuan; Yang, Fan; Lyu, Shixu] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Lyu, SX (corresponding author), Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China.	1059647116@qq.corn	Pan, Yi/AAJ-2341-2021		zhejiang provincial natural science foundation [LY15H160058, LY15H030016]; Wenzhou city science and technology projects [2015Y0452]	zhejiang provincial natural science foundation(Natural Science Foundation of Zhejiang Province); Wenzhou city science and technology projects	This work was supported by LY15H160058, http://www.zjnsf.gov.cn/, zhejiang provincial natural science foundation, Lechi Ye. Decision to publish; LY15H030016, http://www.zinsf.gov.cn/, zhejiang provincial natural science foundation, Guoquan Cao. Data collection and analysis; 2015Y0452, Wenzhou city science and technology projects, Shixu Lyu. Study design.	Abdelnour-Berchtold E, 2016, WORLD J SURG, V40, P373, DOI 10.1007/s00268-015-3254-7; Cho JH, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0621-7; Cho S, 2013, INTERACT CARDIOV TH, V17, P303, DOI 10.1093/icvts/ivt164; Hachimaru A, 2016, INTERACT CARDIOV TH, V22, P826, DOI 10.1093/icvts/ivv382; Ibrahim Tony, 2016, J Gastrointest Cancer, V47, P223, DOI 10.1007/s12029-016-9818-4; Iizasa T, 2006, ANN THORAC SURG, V82, P254, DOI 10.1016/j.athoracsur.2006.02.027; Kolodziejski L, 1999, EUR J SURG ONCOL, V25, P410, DOI 10.1053/ejso.1999.0667; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; Maeda R, 2016, WORLD J SURG, V40, P1318, DOI 10.1007/s00268-016-3424-2; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Nakajima Jun, 2008, Interact Cardiovasc Thorac Surg, V7, P212; Osoegawa A, 2016, ANN THORAC CARDIOVAS, V22, P6, DOI 10.5761/atcs.oa.14-00345; Pennathur A, 2009, ANN THORAC SURG, V87, P1030, DOI 10.1016/j.athoracsur.2008.12.061; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Rotolo N, 2007, SURG ONCOL, V16, pS141, DOI 10.1016/j.suronc.2007.10.007; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Shiono S, 2005, ANN THORAC SURG, V79, P278, DOI 10.1016/j.athoracsur.2004.06.096; Takakura Y, 2010, COLORECTAL DIS, V12, pE68, DOI 10.1111/j.1463-1318.2009.02070.x; Treasure T, 2008, EUR J CARDIO-THORAC, V33, P300, DOI 10.1016/j.ejcts.2007.10.015; Vogelsang H, 2004, BRIT J SURG, V91, P1066, DOI 10.1002/bjs.4602; Vogl TJ, 2008, EUR RADIOL, V18, P2449, DOI 10.1007/s00330-008-1056-0; WEISS L, 1986, J PATHOL, V150, P195, DOI 10.1002/path.1711500308	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175284	10.1371/journal.pone.0175284	http://dx.doi.org/10.1371/journal.pone.0175284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394911	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800024
J	Tian, FW; Yu, LL; Zhai, QX; Xiao, Y; Shi, Y; Jiang, JC; Liu, XM; Zhao, JX; Zhang, H; Chen, W				Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Xiao, Yue; Shi, Ying; Jiang, Jinchi; Liu, Xiaoming; Zhao, Jianxin; Zhang, Hao; Chen, Wei			The therapeutic protection of a living and dead Lactobacillus strain against aluminum-induced brain and liver injuries in C57BL/6 mice	PLOS ONE			English	Article							INDUCED EXPERIMENTAL COLITIS; LACTIC-ACID BACTERIA; OXIDATIVE STRESS; PLANTARUM CCFM8610; ALZHEIMERS-DISEASE; CADMIUM TOXICITY; NITRIC-OXIDE; RATS; INFLAMMATION; BEHAVIOR	Our previous study found that Lactobacillus plantarum CCFM639 had the ability to alleviate acute aluminum (Al) toxicity when the strain was introduced simultaneously with Al exposure. This research was designed to elucidate the therapeutic effects of living and dead L. plantarum CCFM639 against chronic Al toxicity and to gain insight into the protection modes of this strain. Animals were assigned into control, Al only, Al + living CCFM639, and Al + dead CCFM639 groups. The Al exposure model was established by drinking water for the first 4 weeks. The strain was given after Al exposure by oral gavage at 10(9) colony-forming units once per day for 12 weeks. The results show that the Al binding ability of dead CCFM639 was similar to that of living CCFM639 in vitro. The ingestion of living or dead CCFM639 has similar effects on levels of Al and trace element in tissues, but living strains led to more significant amelioration of oxidative stress and improvement of memory deficits in Al-exposed mice. In conclusion, in addition to intestinal Al sequestration, CCFM639 treatment offers direct protection against chronic Al toxicity by alleviation of oxidative stress. Therefore, L. plantarum CCFM639 has a potential as dietary supplement ingredient that provides protection against Al-induced injury.	[Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Xiao, Yue; Shi, Ying; Jiang, Jinchi; Liu, Xiaoming; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Tian, Fengwei; Yu, Leilei; Zhai, Qixiao; Zhang, Hao; Chen, Wei] UK China Joint Ctr Probiot Bacteria, Norwich, Norfolk, England; [Chen, Wei] Beijing Technol Business Univ, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China	Jiangnan University; Beijing Technology & Business University	Chen, W (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Chen, W (corresponding author), UK China Joint Ctr Probiot Bacteria, Norwich, Norfolk, England.; Chen, W (corresponding author), Beijing Technol Business Univ, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.	chenwei66@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Zhang, Hao/HHM-1940-2022		National Natural Science Foundation of China [31371721, 31601452, 31470161]; National Natural Science Foundation of China Key Program [31530056]; National Natural Science Foundation of Jiangsu Province [BK20160175]; BBSRC Newton Fund Joint Centre Award; Self-determined Research Program of Jiangnan University [JUSRP 115A23]; Grain Industry Research Special Funds for Public Welfare Projects [201513006-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China Key Program(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); BBSRC Newton Fund Joint Centre Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Self-determined Research Program of Jiangnan University; Grain Industry Research Special Funds for Public Welfare Projects	This work was supported by the National Natural Science Foundation of China [grant number 31371721]; the National Natural Science Foundation of China Key Program [grant numbers 31530056]; the National Natural Science Foundation of China [grant numbers 31601452]; the National Natural Science Foundation of China [grant numbers 31470161]; the National Natural Science Foundation of Jiangsu Province [grant number BK20160175]; BBSRC Newton Fund Joint Centre Award, the Self-determined Research Program of Jiangnan University [grant numbers JUSRP 115A23]; Grain Industry Research Special Funds for Public Welfare Projects [grant numbers 201513006-03].	Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P809, DOI 10.1007/s00253-012-4241-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Belkhelfa M, 2014, J INTERF CYTOK RES, V34, P839, DOI 10.1089/jir.2013.0085; Benchabane S, 2016, INT J IMMUNOPATH PH, V29, P386, DOI 10.1177/0394632016651273; Bharathi, 2006, BRAIN RES REV, V52, P275, DOI 10.1016/j.brainresrev.2006.04.003; Bhasin P, 2014, ENVIRON TOXICOL, V29, P320, DOI 10.1002/tox.21760; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Ding R, 2010, BRAIN RES, V1324, P96, DOI 10.1016/j.brainres.2010.02.024; Do TKL, 2009, ASIA PAC J CLIN NUTR, V18, P326; Exley C, 1996, J TOXICOL ENV HEALTH, V48, P569, DOI 10.1080/009841096161078; Gareau MG, ADV EXP MED BIOL, P357; Gilgun-Sherki Y, 2003, J MOL NEUROSCI, V21, P1, DOI 10.1385/JMN:21:1:1; Guo CH, 2011, CLIN BIOCHEM, V44, P1309, DOI 10.1016/j.clinbiochem.2011.08.1132; Halttunen T, 2008, LETT APPL MICROBIOL, V46, P160, DOI 10.1111/j.1472-765X.2007.02276.x; Javed H, 2011, BRAIN RES, V1389, P133, DOI 10.1016/j.brainres.2011.02.072; Kumar A, 2009, BEHAV BRAIN RES, V205, P384, DOI 10.1016/j.bbr.2009.07.012; Kumar V, 2009, ARCH TOXICOL, V83, P965, DOI 10.1007/s00204-009-0455-6; Li M, 2015, TOXICOL RES-UK, V4, P1366, DOI 10.1039/c5tx00050e; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Linardaki ZI, 2013, FOOD CHEM TOXICOL, V52, P163, DOI 10.1016/j.fct.2012.11.016; Mahieu S, 2009, TOXICOL LETT, V190, P9, DOI 10.1016/j.toxlet.2009.06.852; Malhi H, 2008, REGEN MED, V3, P165, DOI 10.2217/17460751.3.2.165; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Naruszewicz M, 2002, AM J CLIN NUTR, V76, P1249, DOI 10.1093/ajcn/76.6.1249; Ohland CL, 2013, PSYCHONEUROENDOCRINO, V38, P1738, DOI 10.1016/j.psyneuen.2013.02.008; Ozcelik D, 2003, BIOL TRACE ELEM RES, V96, P209, DOI 10.1385/BTER:96:1-3:209; Park EJ, 2015, ARCH TOXICOL, V89, P371, DOI 10.1007/s00204-014-1256-0; Park EJ, 2014, ARCH TOXICOL, V88, P323, DOI 10.1007/s00204-013-1134-1; Prakash D, 2013, NEUROMOL MED, V15, P192, DOI 10.1007/s12017-012-8210-1; Ribes D, 2008, EXP NEUROL, V214, P293, DOI 10.1016/j.expneurol.2008.08.017; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Sethi P, 2009, PHARMACOL BIOCHEM BE, V93, P31, DOI 10.1016/j.pbb.2009.04.005; Shrivastava S, 2015, J ENVIRON PATHOL TOX, V34, P11, DOI 10.1615/JEnvironPatholToxicolOncol.2015011778; Sivakumar S, 2012, ENVIRON TOXICOL PHAR, V34, P791, DOI 10.1016/j.etap.2012.09.007; Songisepp E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-22; Stacchiotti A, 2008, EXP GERONTOL, V43, P330, DOI 10.1016/j.exger.2008.01.009; Toumi R, 2014, INT J IMMUNOPATH PH, V27, P615, DOI 10.1177/039463201402700418; Toumi R, 2013, IMMUNOPHARM IMMUNOT, V35, P403, DOI 10.3109/08923973.2013.790413; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079734; Yang Y, 2016, BIOL TRACE ELEM RES; Yokel RA, 2002, BRAIN RES, V930, P101, DOI 10.1016/S0006-8993(02)02234-5; Yu LL, 2017, BIOL TRACE ELEM RES, V176, P342, DOI 10.1007/s12011-016-0843-8; Yu LL, 2016, APPL MICROBIOL BIOT, V100, P1891, DOI 10.1007/s00253-015-7135-7; Zatta P, 2002, COORDIN CHEM REV, V228, P271, DOI 10.1016/S0010-8545(02)00074-7; Zhai QX, 2014, APPL ENVIRON MICROB, V80, P4063, DOI 10.1128/AEM.00762-14; Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12; Zhang C, 2013, PLOS ONE, V8; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147; Zhu YZ, 2012, FOOD CHEM TOXICOL, V50, P2911, DOI 10.1016/j.fct.2012.05.041	53	14	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175398	10.1371/journal.pone.0175398	http://dx.doi.org/10.1371/journal.pone.0175398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388664	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800049
J	Britten, L; Coats, R; Ichiyama, R; Raza, W; Jamil, F; Astill, S				Britten, Laura; Coats, Rachel; Ichiyama, Ronaldo; Raza, Wajid; Jamil, Firas; Astill, Sarah			Bimanual reach to grasp movements after cervical spinal cord injury	PLOS ONE			English	Article							TO-GRASP; PREHENSION MOVEMENTS; KINEMATIC CHARACTERISTICS; QUADRIPLEGIC PATIENTS; OBJECT DISTANCE; 2 HANDS; COORDINATION; ARM; PLASTICITY; PATTERNS	Injury to the cervical spinal cord results in bilateral deficits in arm/hand function reducing functional independence and quality of life. To date little research has been undertaken to investigate control strategies of arm/hand movements following cervical spinal cord injury (cSCI). This study aimed to investigate unimanual and bimanual coordination in patients with acute cSCI using 3D kinematic analysis as they performed naturalistic reach to grasp actions with one hand, or with both hands together (symmetrical task), and compare this to the movement patterns of uninjured younger and older adults. Eighteen adults with a cSCI (mean 61.61 years) with lesions at C4-C8, with an American Spinal Injury Association (ASIA) grade B to D and 16 uninjured younger adults (mean 23.68 years) and sixteen uninjured older adults (mean 70.92 years) were recruited. Participants with a cSCI produced reach-to-grasp actions which took longer, were slower, and had longer deceleration phases than uninjured participants. These differences were exacerbated during bimanual reach-to-grasp tasks. Maximal grasp aperture was no different between groups, but reached earlier by people with cSCI. Participants with a cSCI were less synchronous than younger and older adults but all groups used the deceleration phase for error correction to end the movement in a synchronous fashion. Overall, this study suggests that after cSCI a level of bimanual coordination is retained. While there seems to be a greater reliance on feedback to produce both the reach to grasp, we observed minimal disruption of the more impaired limb on the less impaired limb. This suggests that bimanual movements should be integrated into therapy.	[Britten, Laura; Ichiyama, Ronaldo; Astill, Sarah] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Coats, Rachel] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds, W Yorkshire, England; [Raza, Wajid; Jamil, Firas] Pinderfields Gen Hosp, Yorkshire Reg Spinal Injuries Ctr, Wakefield, England	University of Leeds; University of Leeds; Pinderfields Hospital	Britten, L (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	L.E.Britten@leeds.ac.uk	Coats, Rachel/AAH-6980-2019; Astill, Sarah/Z-3237-2019	Coats, Rachel/0000-0003-4415-408X; Britten, Laura/0000-0002-1010-5135; Astill, Sarah/0000-0002-9443-6934; Ichiyama, Ronaldo/0000-0002-7640-8032	University of Leeds; NHS Yorkshire; North West Spinal Injuries Centres	University of Leeds; NHS Yorkshire; North West Spinal Injuries Centres	We are grateful for the support from The University of Leeds and NHS Yorkshire and North West Spinal Injuries Centres and would also like to thank all of the participants involved within the study.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Cacho EWA, 2011, INT J REHABIL RES, V34, P65, DOI 10.1097/MRR.0b013e32833d6cf3; Backus D, 2014, ARCH PHYS MED REHAB, V95, P1447, DOI 10.1016/j.apmr.2014.03.011; Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; Barreca S, 2006, PHYSIOTHER CAN, V58, P148, DOI DOI 10.3138/PTC.58.2.148; Bingham GP, 2008, EXP BRAIN RES, V184, P283, DOI 10.1007/s00221-007-1107-9; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Calabro FJ, 2016, J NEUROPHYSIOL, V115, P157, DOI 10.1152/jn.00692.2015; Coats RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047222; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; FOWLER B, 1991, Q J EXP PSYCHOL-A, V43, P205, DOI 10.1080/14640749108400967; GENTILUCCI M, 1992, BEHAV BRAIN RES, V47, P71, DOI 10.1016/S0166-4328(05)80253-0; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Hoffman Larisa, 2013, Top Spinal Cord Inj Rehabil, V19, P288, DOI 10.1310/sci1904-288; Hoffman LR, 2010, J NEUROL PHYS THER, V34, P193, DOI 10.1097/NPT.0b013e3181fbe692; Hoffmann G, 2006, NEUROSCIENCE, V139, P749, DOI 10.1016/j.neuroscience.2005.12.018; Hoffmann G, 2002, CAH PSYCHOL COGN, V21, P305; Jackson GM, 1999, BRIT J PSYCHOL, V90, P247, DOI 10.1348/000712699161396; Jacquier-Bret J, 2008, IEEE ENG MED BIO, P5366, DOI 10.1109/IEMBS.2008.4650427; Jeannerod M., 1984, J MOTOR BEHAV; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; Koshland GF, 2005, EXP BRAIN RES, V164, P133, DOI 10.1007/s00221-005-2218-9; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Laffont I, 2000, SPINAL CORD, V38, P354, DOI 10.1038/sj.sc.3100999; Marsh BC, 2011, BRAIN RES BULL, V84, P327, DOI 10.1016/j.brainresbull.2010.07.011; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Mason AH, 2013, EXP BRAIN RES, V231, P153, DOI 10.1007/s00221-013-3678-y; Mason AH, 2009, HUM MOVEMENT SCI, V28, P48, DOI 10.1016/j.humov.2008.09.002; Mateo S, 2013, SPINAL CORD, V51, P144, DOI 10.1038/sc.2012.101; Mateo S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-9; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Reft J, 2002, SPINAL CORD, V40, P186, DOI 10.1038/sj.sc.3101277; Riek S, 2003, EXP BRAIN RES, V153, P59, DOI 10.1007/s00221-003-1581-7; Spooren AIF, 2009, J REHABIL MED, V41, P497, DOI 10.2340/16501977-0387; Stahl VA, 2014, EXPT BRAIN RES, P1; Thibaudier Y, 2014, J NEUROPHYSIOL, V112, P2006, DOI 10.1152/jn.00236.2014; Thompson C, 2014, J SPINAL CORD MED; Trombly CA, 1999, AM J OCCUP THER, V53, P333, DOI 10.5014/ajot.53.4.333; Waller SM, 2008, NEUROREHABILITATION, V23, P29	44	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175457	10.1371/journal.pone.0175457	http://dx.doi.org/10.1371/journal.pone.0175457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384247	gold, Green Published			2022-12-26	WOS:000399371900171
J	Chan, M; Chiang, CL; Lee, V; Cheung, S; Leung, R; Wong, M; Lee, F; Blanck, O				Chan, Mark; Chiang, Chi Leung; Lee, Venus; Cheung, Steven; Leung, Ronnie; Wong, Matthew; Lee, Frankle; Blanck, Oliver			Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas	PLOS ONE			English	Article							BODY RADIATION-THERAPY; LUNG-CANCER PATIENTS; TRANSARTERIAL CHEMOEMBOLIZATION; CT; MOTION; TUMOR; SBRT; STRATEGIES; GUIDANCE	Background Aim of this study was to comparatively evaluate the accuracy of respiration-correlated (4D) and uncorrelated (3D) cone beam computed tomography (CBCT) in localizing lipiodolized hepatocellular carcinomas during stereotactic body radiotherapy (SBRT). Methods 4D-CBCT scans of eighteen HCCs were acquired during free-breathing SBRT following trans-arterial chemo-embolization (TACE) with lipiodol. Approximately 1320 x-ray projections per 4D-CBCT were collected and phase-sorted into ten bins. A 4D registration work-flow was followed to register the reconstructed time-weighted average CBCT with the planning mid-ventilation (MidV) CT by an initial bone registration of the vertebrae and then tissue registration of the lipiodol. For comparison, projections of each 4D-CBCT were combined to synthesize 3D-CBCT without phase-sorting. Using the lipiodolized tumor, uncertainties of the treatment setup estimated from the absolute and relative lipiodol position to bone were analyzed separately for 4D-and 3D-CBCT. Results Qualitatively, 3D-CBCT showed better lipiodol contrast than 4D-CBCT primarily because of a tenfold increase of projections used for reconstruction. Motion artifact was observed to subside in 4D-CBCT compared to 3D-CBCT. Group mean, systematic and random errors estimated from 4D-and 3D-CBCT agreed to within 1 mm in the cranio-caudal (CC) and 0.5 mm in the anterior-posterior (AP) and left-right (LR) directions. Systematic and random errors are largest in the CC direction, amounting to 4.7 mm and 3.7 mm from 3D-CBCT and 5.6 mm and 3.8 mm from 4D-CBCT, respectively. Safety margin calculated from 3D-CBCT and 4D-CBCT differed by 2.1, 0.1 and 0.0 mm in the CC, AP, and LR directions. Conclusions 3D-CBCT is an adequate alternative to 4D-CBCT when lipoid is used for localizing HCC during free-breathing SBRT. Similar margins are anticipated with 3D- and 4D-CBCT.	[Chan, Mark; Blanck, Oliver] Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Kiel, Germany; [Chiang, Chi Leung; Lee, Venus; Cheung, Steven; Leung, Ronnie; Wong, Matthew; Lee, Frankle] Tuen Mun Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chiang, Chi Leung; Lee, Venus] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chiang, Chi Leung] Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Kiel; Schleswig Holstein University Hospital; Tuen Mun Hospital; University of Hong Kong; University of Hong Kong	Chan, M (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Radiat Oncol, Kiel, Germany.	markkhchan@yahoo.com	Chan, Mark/ABF-5313-2021; Leung, Ronnie/CAG-2088-2022	Chan, Mark/0000-0002-0187-2703; Chiang, Chi-Leung/0000-0002-9836-6478; Blanck, Oliver/0000-0003-1391-1308				Case RB, 2009, INT J RADIAT ONCOL, V75, P302, DOI 10.1016/j.ijrobp.2009.03.058; Chan MKH, 2016, STRAHLENTHER ONKOL, V192, P92, DOI 10.1007/s00066-015-0929-9; Chan MKH, 2013, J APPL CLIN MED PHYS, V14; Choi BO, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-351; Dawson LA, 2006, ACTA ONCOL, V45, P856, DOI 10.1080/02841860600936369; Hoogeman MS, 2005, RADIOTHER ONCOL, V74, P177, DOI 10.1016/j.radonc.2004.12.010; Hugo GD, 2007, INT J RADIAT ONCOL, V69, P1634, DOI 10.1016/j.ijrobp.2007.08.023; Jones BL, 2014, J PHYS CONF SER, V489, DOI 10.1088/1742-6596/489/1/012035; Koo JE, 2010, INT J RADIAT ONCOL, V78, P180, DOI 10.1016/j.ijrobp.2009.07.1730; Lagendijk JJW, 2008, RADIOTHER ONCOL, V86, P25, DOI 10.1016/j.radonc.2007.10.034; Lee A, 2012, INT J RADIAT ONCOL, V84, pS333, DOI 10.1016/j.ijrobp.2012.07.876; Li W, 2015, INT J RADIAT ONCOL, V93, pE182, DOI 10.1016/j.ijrobp.2015.07.1014; Lu B, 2010, J APPL CLIN MED PHYS, V11, P231, DOI 10.1120/jacmp.v11i3.3274; Rit S, 2011, RADIOTHER ONCOL, V100, P356, DOI 10.1016/j.radonc.2011.08.018; Seppenwoolde Y, 2011, PHYS MED BIOL, V56, P5445, DOI 10.1088/0031-9155/56/17/001; Sonke JJ, 2009, INT J RADIAT ONCOL, V74, P567, DOI 10.1016/j.ijrobp.2008.08.004; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Sweeney RA, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-81; Velec M, 2014, PRACT RADIAT ONCOL, V4, P160, DOI 10.1016/j.prro.2013.07.001; Wolthaus JWH, 2008, MED PHYS, V35, P3998, DOI 10.1118/1.2966347; Wolthaus JWH, 2008, INT J RADIAT ONCOL, V70, P1229, DOI 10.1016/j.ijrobp.2007.11.042; Yang J, 2014, INT J RADIAT ONCOL, V90, P952, DOI 10.1016/j.ijrobp.2014.07.028; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460; Zhong R, 2012, RADIOTHER ONCOL; Zhong RM, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-77	26	7	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174929	10.1371/journal.pone.0174929	http://dx.doi.org/10.1371/journal.pone.0174929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384187	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900055
J	Chen, HC; Chung, CH; Wang, CH; Lin, JC; Chang, WK; Lin, FH; Tsao, CH; Wu, YF; Chien, WC				Chen, Hsin-Chien; Chung, Chi-Hsiang; Wang, Chih-Hung; Lin, Jung-Chun; Chang, Wei-Kuo; Lin, Fu -Huang; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien			Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection	PLOS ONE			English	Article							B-VIRUS; C-VIRUSES; TAIWAN; EPIDEMIOLOGY; VACCINATION; COMMUNITY	The etiology of sudden sensorineural hearing loss (SSNHL) remains unclear. Possible causes of SSNHL include vascular diseases, viral infection, and autoimmune disorders. Therefore, we investigated whether hepatitis virus infection is correlated with the risk of SSNHL. Using data from the Taiwan Longitudinal Health Insurance Database, we conducted a retrospective matched-cohort study to compare patients diagnosed with hepatitis B or C virus (HBV/HCV) infections from January 1, 2000, to December 31, 2010, (N = 170,942) with frequency-matched controls (N = 512,826) at a ratio of 1: 3 by sex, age, and index year. We followed each patient until the end of 2010 and evaluated the incidence of SSNHL. At the end of the follow-up period, 647 (0.38%, 647/170,942) patients developed SSNHL in the HBV/HCV group compared with 978 (0.19%, 978/512,826) in the control groups, with a statistical significance of P < 0.001 (using the log-rank test). The incidence rate ratio of SSNHL was 5.743-fold higher in the HBV/HCV group than in the control group (283.17 vs. 49.31 per 100,000 person-years, P < 0.001). The risk of SSNHL increased with HBV/HCV infection, and an adjusted hazard ratio of 5.103 (95% CI, 4.585-5.678) was determined using Cox proportional hazards regression. This study contributes to the awareness of the increased risk of SSNHL in HBV/HCV-infected populations. Our findings suggest that an underlying viral infection contributes to the development of SSNHL.	[Chen, Hsin-Chien; Wang, Chih-Hung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chung, Chi-Hsiang; Tsao, Chang-Huei; Wu, Yung-Fu; Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu -Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, Jung-Chun; Chang, Wei-Kuo] Natl Def Med Ctr, Triserv Gen Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.	doc30459@gmail.com	Wang, Chih-Hung/AAR-9766-2020; Chung, Chi-Hsiang/AAY-3386-2021		Ministry of Science and Technology, Taiwan [MOST 103-2314-B-016 -018 -MY2, MOST 103-2314-B-016-018 -MY2]; Tri-Service General Hospital [TSGH-C105-008]; National Defense Medical Research grants, Taiwan, ROC [MAB-104-058, MAB-105-019]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Defense Medical Research grants, Taiwan, ROC	This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-016 -018 -MY2 to HC Chen), Tri-Service General Hospital (TSGH-C105-008 to HC Chen), National Defense Medical Research grants, Taiwan, ROC (MAB-104-058 and MAB-105-019 to HC Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-016-018 -MY2 to HC Chen); Tri-Service General Hospital (TSGH-C105-108 to HC Chen); and National Defense Medical Research grants, Taiwan, ROC (MAB-104-058 and MAB-105-019 to HC Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuShakra M, 1997, LUPUS, V6, P543, DOI 10.1177/096120339700600612; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Chang MC, 2014, WORLD J GASTROENTERO, V20, P5060, DOI 10.3748/wjg.v20.i17.5060; Chen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002276; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gozdas HT, 2015, INDIAN J PHARMACOL, V47, P121, DOI 10.4103/0253-7613.150377; Hagr A, 2011, SAUDI J GASTROENTERO, V17, P114, DOI 10.4103/1319-3767.77240; Huang CC, 2009, OTOLARYNG HEAD NECK, V141, P659, DOI 10.1016/j.otohns.2009.05.006; Mendes-Correa MCJ, 2011, BRAZ J INFECT DIS, V15, P87, DOI [10.1590/S1413-86702011000100017, 10.1016/S1413-8670(11)70147-7]; Joglekar S, 2010, AM J OTOLARYNG, V31, P221, DOI 10.1016/j.amjoto.2009.02.006; KOIDE J, 1988, ACTA OTO-LARYNGOL, P21; Lin C, 2013, JAMA OTOLARYNGOL, V139, P251, DOI 10.1001/jamaoto.2013.1709; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Masuda M, 2012, OTOL NEUROTOL, V33, P1142, DOI 10.1097/MAO.0b013e3182635417; Mentel R, 2004, J MED VIROL, V72, P625, DOI 10.1002/jmv.20014; Nasab Mohamad Shayani, 2012, Oman Med J, V27, P418, DOI 10.5001/omj.2012.103; Orlando MP, 1997, ANN NY ACAD SCI, V830, P319, DOI 10.1111/j.1749-6632.1997.tb51903.x; Pacher BM, 2015, REV SOC BRAS MED TRO, V48, P603, DOI 10.1590/0037-8682-0058-2015; Qureshi MO, 2012, JCPSP-J COLL PHYSICI, V22, P632, DOI 10.2012/JCPSP.632634; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; So H, 2007, JARO-J ASSOC RES OTO, V8, P338, DOI 10.1007/s10162-007-0084-9; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Wu CS, 2006, AUDIOL NEURO-OTOL, V11, P151, DOI 10.1159/000091198; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5	29	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175266	10.1371/journal.pone.0175266	http://dx.doi.org/10.1371/journal.pone.0175266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384326	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900142
J	Cho, D; Shin, TJ; Ham, J; Choi, DH; Kim, S; Jeong, S; Kim, HI; Kim, JG; Lee, B				Cho, Dongrae; Shin, Teo Jeon; Ham, Jinsil; Choi, Dong-Hyuk; Kim, Seonghyun; Jeong, Seongwook; Kim, Hyoung-Ihl; Kim, Jae Gwen; Lee, Boreom			Differential modulation of thalamo-parietal interactions by varying depths of isoflurane anesthesia	PLOS ONE			English	Article							INFORMATION INTEGRATION; INDUCED UNCONSCIOUSNESS; IMPAIRED CONSCIOUSNESS; ATTENTIONAL MODULATION; ALPHA OSCILLATIONS; RETICULAR NUCLEUS; BRAIN; MECHANISMS; NEURONS; MODEL	The thalamus is thought to relay peripheral sensory information to the somatosensory cortex in the parietal lobe. Long-range thalamo-parietal interactions play an important role in inducing the effect of anesthetic. However, whether these interaction changes vary with different levels of anesthesia is not known. In the present study, we investigated the influence of different levels of isoflurane-induced anesthesia on the functional connectivity between the thalamus and the parietal region. Microelectrodes were implanted in rats to record local field potentials (LFPs). The rats underwent different levels of isoflurane anesthesia [deep anesthesia: isoflurane (ISO) 2.5 vol%, light anesthesia (ISO 1 vol%), awake, and recovery state] and LFPs were recorded from four different brain areas (left parietal, right parietal, left thalamus, and right thalamus). Partial directed coherence (PDC) was calculated for these areas. With increasing depth of anesthesia, the PDC in the thalamus-to-parietal direction was significantly increased mainly in the high frequency ranges; however, in the parietal-to-thalamus direction, the increase was mainly in the low frequency band. For both directions, the PDC changes were prominent in the alpha frequency band. Functional interactions between the thalamus and parietal area are augmented proportionally to the anesthesia level. This relationship may pave the way for better understanding of the neural processing of sensory inputs from the periphery under different levels of anesthesia.	[Cho, Dongrae; Ham, Jinsil; Choi, Dong-Hyuk; Kim, Seonghyun; Kim, Hyoung-Ihl; Kim, Jae Gwen; Lee, Boreom] Gwangju Inst Sci & Technol, Inst Integrated Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Shin, Teo Jeon] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul, South Korea; [Shin, Teo Jeon] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jeong, Seongwook] Chonnam Natl Univ, Dept Anesthesiol & Pain Med, Sch Med, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Seoul National University (SNU); Chonnam National University	Kim, JG; Lee, B (corresponding author), Gwangju Inst Sci & Technol, Inst Integrated Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.	jaekim@gist.ac.kr; leebr@gist.ac.kr		Cho, Dongrae/0000-0002-3741-3410; Kim, Jae/0000-0002-1010-7712	GIST Research Institute (GRI); Biomedical Integrated Technology Research" Project through a grant provided by GIST; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2016R1D1A1B03933840]	GIST Research Institute (GRI); Biomedical Integrated Technology Research" Project through a grant provided by GIST; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education	This work was supported by the GIST Research Institute (GRI) in 2017. It was also supported by Biomedical Integrated Technology Research Project through a grant provided by GIST and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (2016R1D1A1B03933840).	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boly M, 2013, THE JOURNAL OF NEURO, V32, P7082; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gottschalk A, 2009, ANESTHESIOLOGY, V110, P996, DOI 10.1097/ALN.0b013e31819db923; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Liu XL, 2013, ANESTHESIOLOGY, V118, P59, DOI 10.1097/ALN.0b013e318277a801; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Mashour GA, 2013, ANESTHESIOLOGY, V118, P13, DOI 10.1097/ALN.0b013e318277a9c6; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Pratt JA, 2015, J PSYCHOPHARMACOL, V29, P127, DOI 10.1177/0269881114565805; R Core Team, 2013, R LANG ENV STAT COMP; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shin TJ, 2016, NEUROSCI LETT, V627, P18, DOI 10.1016/j.neulet.2016.05.045; Sun Y, 2009, IEEE T BIO-MED ENG, V56, P2721, DOI 10.1109/TBME.2009.2025966; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Tononi G, 2010, ARCH ITAL BIOL, V148, P299; Tzovara A, 2015, BRAIN, V138, P1160, DOI 10.1093/brain/awv041; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Vijayan S, 2012, P NATL ACAD SCI USA, V109, P18553, DOI 10.1073/pnas.1215385109; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Xu X, 2015, WORLD J NEUROSCIENCE, V5, P99	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175191	10.1371/journal.pone.0175191	http://dx.doi.org/10.1371/journal.pone.0175191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384227	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900115
J	Chu, CL; Dui, QL; Li, CQ; Zhang, LL; Zhou, XY; Zuo, F; Zhang, YM; Li, F; Xie, GF; Li, YQ				Chu, Chuanlian; Dui, Quanlin; Li, Changqing; Zhang, Linlu; Zhou, Xiaoyan; Zuo, Fang; Zhang, Yanmin; Li, Fang; Xie, Guofeng; Li, Yanqing			Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn	PLOS ONE			English	Article							DILATED INTERCELLULAR SPACES; MINIMAL CHANGE ESOPHAGITIS; GASTROESOPHAGEAL-REFLUX; NORMAL VALUES; SYMPTOM ANALYSIS; ACID; POPULATION; CLASSIFICATION; ASSOCIATION; MULTICENTER	Aims To assess the contribution of 24-h esophageal multichannel intraluminal impedance and pH (MII-pH) monitoring and high resolution endoscopy (HRE) with i-scan imaging in differentiating non erosive reflux disease (NERD) from functional heartburn (FH). Methods This is a retrospective cohort study of patients with heartburn from the Endoscopy Unit. NERD patients and FH patients were defined by 24-h MII-pH monitoring and white light endoscopy. Minimal mucosal changes were assessed by HRE with i-scan imaging. Results Total of 156 consecutive patients with heartburn but without esophageal mucosal erosions were studied. Forty-eight of these subjects had NERD, with increased acid exposure time (AET) and positive SAP and/or SI. Eighteen had FH with normal AET and negative SAP and SI. When compared to FH patients and healthy controls, NERD patients had significantly increased number of total acid reflux episodes, as well as increased number of weakly acidic reflux episodes (p<0.01). The rate of proximal reflux episodes in NERD patients was higher than that of FH patients and healthy controls (p<0.01). Irregular or blurring of the Z-line (58.3%) and white mucosal turbidity (47.9%) were the most common endoscopic findings of minimal mucosal changes observed in this study. NERD patients had more prevalent minimal changes than FH patients and the controls (87.5% vs. 66.6% vs. 61.9%; p = 0.004) with sensitivity of 87.5%. Histopathological evaluation showed that NERD patients had significantly higher average scores of intercellular spaces dilation (2.82 +/- 0.9 vs. 1.2 +/- 0.6, p = 0.005) and papillae elongation (2.65 +/- 1.0 vs. 1.5 +/- 0.8, p = 0.014), but not for basal cell proliferation (1.6 +/- 1.3 vs. 1.0 +/- 0.9, p = 0.070). The histological scores of the NERD patients were 7.1 +/- 1.2, which were higher than those of FH patients (3.4 +/- 1.0, p = 0.004). Conclusions Minimal mucosal changes could be useful markers to support clinical diagnosis of NERD. Combination of 24-h MII-pH monitoring and i-scan high resolution endoscopy can distinguish patients with NERD from those with FH.	[Chu, Chuanlian; Dui, Quanlin; Zhang, Linlu; Zhou, Xiaoyan; Zuo, Fang; Zhang, Yanmin; Li, Fang] Shandong Univ, Jinan Cent Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Li, Changqing; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Xie, Guofeng] Univ Maryland, Sch Med, Maryland VA Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; University System of Maryland; University of Maryland Baltimore	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn			Science Technology Development Project of Shangdong Province [2013G0021804]; Science Technology Development Project of Jinan City [201121001]	Science Technology Development Project of Shangdong Province; Science Technology Development Project of Jinan City	This work was supported by grants from the Science Technology Development Projects of Shangdong Province and Jinan City, award ID number 2013G0021804 and 201121001, respectively (CC and YL).	Altorki NK, 2008, ANN SURG, V247, P434, DOI 10.1097/SLA.0b013e318163a2ff; Calabrese C, 2003, ALIMENT PHARM THER, V18, P525, DOI 10.1046/j.1365-2036.2003.01713.x; Calabrese C, 2005, AM J GASTROENTEROL, V100, P537, DOI 10.1111/j.1572-0241.2005.40476.x; Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023; Caviglia R, 2005, AM J GASTROENTEROL, V100, P543, DOI 10.1111/j.1572-0241.2005.40978.x; Choung RS, 2012, NEUROGASTROENT MOTIL, V24, P229, DOI 10.1111/j.1365-2982.2011.01845.x; Chu CL, 2012, AM J GASTROENTEROL, V107, P864, DOI 10.1038/ajg.2012.44; Edebo A, 2007, ENDOSCOPY, V39, P195, DOI 10.1055/s-2006-945112; Frazzoni M, 2016, J GASTROENTEROLOGY; Galmiche JP, 2006, GASTROENTEROLOGY, V130, P1459, DOI 10.1053/j.gastro.2005.08.060; Hongo M, 2006, J GASTROENTEROL, V41, P95, DOI 10.1007/s00535-006-1775-4; Hongo M, 2008, J GASTROENTEROL, V43, P448, DOI 10.1007/s00535-008-2186-5; Hoshihara Yoshio, 2004, Nihon Rinsho, V62, P1459; Joh T, 2007, J GASTROENTEROL, V42, P444, DOI 10.1007/s00535-007-2022-3; JOHNSTON BT, 1995, SCAND J GASTROENTERO, V30, P1, DOI 10.3109/00365529509093228; Kandulski A, 2013, ALIMENT PHARM THER, V38, P643, DOI 10.1111/apt.12428; Kandulski A, 2015, CLIN GASTROENTEROL H, V13, P1075, DOI 10.1016/j.cgh.2014.11.033; Kim JH, 2011, ENDOSCOPY, V43, P190, DOI 10.1055/s-0030-1256101; Kim MS, 2011, CLIN ENDOSC, V44, P27, DOI 10.5946/ce.2011.44.1.27; Lei WY, 2012, DIGESTION, V85, P27, DOI 10.1159/000334715; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Luo X, 2016, WORLD J GASTROENTERO, V22, P3845, DOI 10.3748/wjg.v22.i14.3845; Manner H, 2008, AM J GASTROENTEROL, V103, P2589, DOI 10.1111/j.1572-0241.2008.02083.x; Netinatsunton N, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0417-4; Pehl C, 2004, EUR J GASTROEN HEPAT, V16, P375, DOI 10.1097/00042737-200404000-00002; Rey JW, 2016, DIS ESOPHAGUS, V29, P185, DOI 10.1111/dote.12308; Savarino E, 2013, J GASTROENTEROL, V48, P473, DOI 10.1007/s00535-012-0672-2; Savarino E, 2012, J GASTROENTEROL, V47, P159, DOI 10.1007/s00535-011-0480-0; Savarino E, 2011, DIGEST LIVER DIS, V43, P940, DOI 10.1016/j.dld.2011.07.014; Savarino E, 2011, DIGEST LIVER DIS, V43, P542, DOI 10.1016/j.dld.2011.01.016; Shay S, 2004, AM J GASTROENTEROL, V99, P1037, DOI 10.1111/j.1572-0241.2004.04172.x; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Slaughter JC, 2011, CLIN GASTROENTEROL H, V9, P868, DOI 10.1016/j.cgh.2011.07.009; Tack J, 2005, GUT, V54, P1370, DOI 10.1136/gut.2004.053355; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vela MF, 2011, AM J GASTROENTEROL, V106, P844, DOI 10.1038/ajg.2010.476; WEUSTEN BLAM, 1994, GASTROENTEROLOGY, V107, P1741, DOI 10.1016/0016-5085(94)90815-X; Xiao YL, 2009, DIGESTION, V79, P109, DOI 10.1159/000209220; Zentilin P, 2006, DIGEST LIVER DIS, V38, P226, DOI 10.1016/j.dld.2005.12.011; Zerbib F, 2006, AM J GASTROENTEROL, V101, P1956, DOI 10.1111/j.1572-0241.2006.00711.x; Zerbib Frank, 2012, Curr Gastroenterol Rep, V14, P181, DOI 10.1007/s11894-012-0255-7	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175263	10.1371/journal.pone.0175263	http://dx.doi.org/10.1371/journal.pone.0175263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384225	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900141
J	Dobrakowski, P; Bogocz, M; Cholewa, K; Rajchel, M; Kapica-Topczewska, K; Wawrzyniak, S; Bartosik-Psujek, H; Kulakowska, A; Koziarska, D; Adamczyk-Sowa, M				Dobrakowski, Pawel; Bogocz, Michel; Cholewa, Kamil; Rajchel, Mateusz; Kapica-Topczewska, Katarzyna; Wawrzyniak, Slawomir; Bartosik-Psujek, Halina; Kulakowska, Aline; Koziarska, Dorota; Adamczyk-Sowa, Monika			Month of birth and level of insolation as risk factors for multiple sclerosis in Poland	PLOS ONE			English	Article							VITAMIN-D; DIAGNOSTIC-CRITERIA; HEWITTS TEST; SEASON; POPULATION	Introduction Many studies have shown that people born in the spring are at a higher risk of developing multiple sclerosis (MS). This may be associated with lower levels of sun exposure, and consequently, lower levels of vitamin D3 during pregnancy. However, these relationships have not been verified thus far in any countries in Central Europe. Objective The aim of our study was to determine the frequency distribution of births for each calendar month in patients suffering from MS in Poland. Methods We analyzed data for 2574 patients diagnosed with MS (1758 women, 816 men) living in Poland for an extended period. We added corrections resulting from the frequency distribution of births for the years in which the patients were born. We applied the Hewitt test for seasonality with Rogerson modification for 3-, 4-, or 6-month pulses or periods. Moreover, we examined the average number hours of sunshine in every month of the year. Results The rank-sums for successive 3- and 4-month segments indicated the period from September to December and from October to December as having a significantly lower incidence (p = 0.027 and p = 0.054, respectively). We did not find a correlation between with hours of sunshine in the first trimester of pregnancy, the child's birth month, and the child developing MS. Conclusions We were able to confirm a seasonal variation in the risk of MS in Poland. However, these findings did not correlate with hours of sunshine during the first trimester of pregnancy.	[Dobrakowski, Pawel; Bogocz, Michel; Cholewa, Kamil; Rajchel, Mateusz; Adamczyk-Sowa, Monika] Med Univ Silesia, Dept Neurol Zabrze, Zabrze, Poland; [Kapica-Topczewska, Katarzyna; Kulakowska, Aline] Med Univ Bialystok, Dept Neurol, Bialystok, Poland; [Wawrzyniak, Slawomir] 10th Mil Hosp Policlin, Dept Neurol, Bydgoszcz, Poland; [Bartosik-Psujek, Halina] Rzeszow State Hosp 2, Dept Clin Neurol, Rzeszow, Poland; [Koziarska, Dorota] Pomeranian Med Univ, Dept Neurol, Szczecin, Poland	Medical University Silesia; Medical University of Bialystok; Pomeranian Medical University	Dobrakowski, P (corresponding author), Med Univ Silesia, Dept Neurol Zabrze, Zabrze, Poland.	paweldobrakowski@interia.pl	kapica-topczewska, katarzyna/ABD-9114-2020	Adamczyk-Sowa, Monika/0000-0002-6894-9891; Bartosik-Psujek, Halina/0000-0002-2860-6456				Akhtar S, 2015, MULT SCLER J, V21, P147, DOI 10.1177/1352458514541578; Balbuena LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155181; Barros P, 2013, CLIN NEUROL NEUROSUR, V115, P1762, DOI 10.1016/j.clineuro.2013.04.007; Bayes HK, 2010, EUR NEUROL, V63, P36, DOI 10.1159/000268163; Becker J, 2013, J NEUROL SCI, V329, P6, DOI 10.1016/j.jns.2013.03.001; Cendrowski W, 2012, MED BIOL SCI, V26, P39; Cendrowski W, 2014, AKTUAL NEUROL, V14, P16, DOI 10.15557/AN.2014.0001; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; de Abreu DAF, 2009, MULT SCLER J, V15, P1146, DOI 10.1177/1352458509106780; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Fiddes B, 2013, ANN NEUROL, V73, P714, DOI 10.1002/ana.23925; Givon U, 2012, NEUROEPIDEMIOLOGY, V38, P64, DOI 10.1159/000334437; Grytten N, 2013, MULT SCLER J, V19, P1028, DOI 10.1177/1352458512471094; HEWITT D, 1971, BRIT J PREV SOC MED, V25, P174; Hintzen R, 2013, NAT REV NEUROL, V9, P489, DOI 10.1038/nrneurol.2013.156; JAMES WH, 1995, ACTA NEUROL SCAND, V92, P430; Kimura T, 1983, MED BIOL; Munger KL, 2016, JAMA NEUROL, V73, P515, DOI 10.1001/jamaneurol.2015.4800; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Rogerson PA, 1996, INT J EPIDEMIOL, V25, P644, DOI 10.1093/ije/25.3.644; Saastamoinen KP, 2012, MULT SCLER J, V18, P563, DOI 10.1177/1352458511426814; SADOVNICK AD, 1994, ACTA NEUROL SCAND, V89, P190; Salemi G, 2000, ACTA NEUROL SCAND, V101, P381, DOI 10.1034/j.1600-0404.2000.90336.x; Salzer J, 2010, ACTA NEUROL SCAND, V121, P20, DOI 10.1111/j.1600-0404.2009.01181.x; Sidhom Y, 2015, MULT SCLER RELAT DIS, V4, P491, DOI 10.1016/j.msard.2015.08.002; Sotgiu S, 2006, J NEUROL, V253, P38, DOI 10.1007/s00415-005-0917-6; Staples J, 2010, BMJ-BRIT MED J, V29, P340; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Torkildsen O, 2012, ACTA NEUROL SCAND, V126, P58, DOI 10.1111/ane.12040; TROMP SW, 1977, PROGR BIOMETEOROLO 2, V1, P164; Verheul F, 2013, ACTA NEUROL SCAND, V127, P301, DOI 10.1111/ane.12007; WALTER SD, 1980, J EPIDEMIOL COMMUN H, V34, P147, DOI 10.1136/jech.34.2.147; Wiberg MA, 1994, J ORTHOMOL MED, V9, P71; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63	36	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175156	10.1371/journal.pone.0175156	http://dx.doi.org/10.1371/journal.pone.0175156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384281	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900104
J	Eckstrand, CD; Sparger, EE; Pitt, KA; Murphy, BG				Eckstrand, C. D.; Sparger, E. E.; Pitt, K. A.; Murphy, B. G.			Peripheral and central immune cell reservoirs in tissues from asymptomatic cats chronically infected with feline immunodeficiency virus	PLOS ONE			English	Article							T-CELLS; OX40; PHASE; CD134; FIV; IMMUNOPHENOTYPE; TRANSMISSION; SUBSETS; BLOOD; CD4+	Feline immunodeficiency virus (FIV) infection in cats results in life-long viral persistence and progressive immunopathology. We have previously described a cohort of experimentally infected cats demonstrating a progressive decline of peripheral blood CD4+ T-cell over six years in the face of apparent peripheral viral latency. More recently we reported findings from this same cohort that revealed popliteal lymph node tissue as sites for ongoing viral replication suggesting that tissue reservoirs are important in FIV immunopathogenesis during the late asymptomatic phase of infection. Results reported herein characterize important tissue reservoirs of active viral replication during the late asymptomatic phase by examining biopsied specimens of spleen, mesenteric lymph node (MLN), and intestine from FIV-infected and uninfected control cats. Peripheral blood collected coincident with harvest of tissues demonstrated severe CD4+ T-cell depletion, undetectable plasma viral gag RNA and rarely detectable peripheral blood mononuclear cell (PBMC)-associated viral RNA (vRNA) by real-time PCR. However, vRNA was detectable in all three tissue sites from three of four FIV-infected cats despite the absence of detectable vRNA in plasma. A novel in situ hybridization assay identified B cell lymphoid follicular domains as microanatomical foci of ongoing FIV replication. Additionally, we demonstrated that CD4+ leukocyte depletion in tissues, and CD4+ and CD21+ leukocytes as important cellular reservoirs of ongoing replication. These findings revealed that tissue reservoirs support foci of ongoing viral replication, in spite of highly restricted viral replication in blood. Lentiviral eradication strategies will need address tissue viral reservoirs.	[Eckstrand, C. D.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Sparger, E. E.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Pitt, K. A.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Murphy, B. G.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA USA	Washington State University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Eckstrand, CD (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	ceckstrand@vetmed.wsu.edu	Eckstrand, Chrissy/C-8743-2018	Eckstrand, Chrissy/0000-0002-6844-0251	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis [2014-16-F]; Bernice Barbour Foundation; Peter C. Kennedy Endowed Fellowship in Anatomic Pathology; Graduate Student Support System; Graduate Studies Dissertation Year Fellowship; Northern California Chapter of the ARCS Foundation	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); Bernice Barbour Foundation; Peter C. Kennedy Endowed Fellowship in Anatomic Pathology; Graduate Student Support System; Graduate Studies Dissertation Year Fellowship; Northern California Chapter of the ARCS Foundation	This work was funded by the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis (Grant number 2014-16-F, http://www.vetmed.ucdavis.edu/ccah/index.cfm) and the Bernice Barbour Foundation (http://bemicebarbour.org/). Graduate student funding was provided by the Peter C. Kennedy Endowed Fellowship in Anatomic Pathology (SVM, UCD), the Graduate Student Support System (SVM, UCD), the Graduate Studies Dissertation Year Fellowship (UCD), and the Northern California Chapter of the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; Bienzle D, 2003, VET IMMUNOL IMMUNOP, V96, P19, DOI 10.1016/S0165-2427(03)00132-6; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; BROWN PJ, 1991, J COMP PATHOL, V104, P345, DOI 10.1016/S0021-9975(08)80145-4; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; DOW SW, 1990, J ACQ IMMUN DEF SYND, V3, P658; Eckstrand CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146285; Eckstrand CD, 2016, VET SCI, V3; Endo Y, 1997, J VET MED SCI, V59, P739, DOI 10.1292/jvms.59.739; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Hartmann K, 2011, VET IMMUNOL IMMUNOP, V143, P190, DOI 10.1016/j.vetimm.2011.06.003; Howard KE, 2005, J IMMUNOL METHODS, V302, P36, DOI 10.1016/j.jim.2005.04.019; Howard KE, 2007, AIDS RES HUM RETROV, V23, P720, DOI 10.1089/aid.2006.0025; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McDonnel SJ, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-69; McDonnel SJ, 2012, VIRUSES-BASEL, V4, P878, DOI 10.3390/v4050878; Murphy B, 2014, VIRUS RES, V179, P34, DOI 10.1016/j.virusres.2013.11.017; Murphy B, 2012, VIRUS RES, V169, P117, DOI 10.1016/j.virusres.2012.07.017; Murphy B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-12; Murphy KM., 2016, JANEWAYS IMMUNOBIOLO, V9, DOI DOI 10.1201/9781315533247; Raskin RE., 2015, CANINE FELINE CYTOLO; Rogers AB, 1998, J INFECT DIS, V178, P960, DOI 10.1086/515692; Rogers AB, 2002, AM J PATHOL, V161, P1143, DOI 10.1016/S0002-9440(10)64391-X; Schmitz JE, 2011, IMMUNOBIOLOGY, V98, P3757; Shacklett BL, 2003, J VIROL, V77, P5621, DOI 10.1128/JVI.77.10.5621-5631.2003; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Siliciano JD, METHODS MOL BIOL, P3; Sparger EE, 1987, FIV MODEL HIV OVERVI, P149; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Vahlenkamp TW, 2004, J IMMUNOL, V172, P4752, DOI 10.4049/jimmunol.172.8.4752; Willett BJ, 2007, J VIROL, V81, P9665, DOI 10.1128/JVI.01020-07	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175327	10.1371/journal.pone.0175327	http://dx.doi.org/10.1371/journal.pone.0175327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384338	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900158
J	Li, HT; Wang, YG; Liu, ZM; Yuan, Y; Huang, WT; Zhang, N; He, AN; Shen, Z; Sun, YJ; Yao, Y				Li, Hongtao; Wang, Yonggang; Liu, Zimei; Yuan, Yuan; Huang, Wentao; Zhang, Na; He, Aina; Shen, Zan; Sun, Yuanjue; Yao, Yang			Lack of association between platelet indices and disease stage in osteosarcoma at diagnosis	PLOS ONE			English	Article							VOLUME/PLATELET COUNT RATIO; STUDY-GROUP PROTOCOLS; GASTRIC-CANCER; PROGNOSTIC-FACTORS; TUMOR PROGRESSION; SURVIVAL; METASTASIS; EXTREMITY; SARCOMA; VOLUME	Purpose The purpose of this study was to investigate the relationship between platelet indices [ mean platelet volume (MPV), platelet count (PLT), platelet distribution width (PDW) and plateletcrit (PCT)] at diagnosis in osteosarcoma. Methods The information of 233 patients with osteosarcoma at diagnosis between 2007 and 2015 was retrospectively reviewed. Clinical parameters such as gender, age, size and site of tumor, and tumor necrosis rate after neoadjuvant chemotherapy were analyzed. Results No significant difference was noted in the mean values of MPV, PLT, PDW and PCT among stage I, II and III patients. In localized patients, the median disease-free survival (DFS) values were 42 and 22 months in the PLT<300x10(9) /L and >= 300x10(9) /L groups, respectively, but the difference was not statistically significant (P = 0.2611). No difference in the DFS among the three different levels of MPV was observed. Conclusion No significantly different platelet indices were noted among the different stages. Although a shorter median DFS was found in localized patients with PLT >= 300x10(9) /L, there was still a lack of strong evidence to demonstrate the association between platelet indices and osteosarcoma.	[Li, Hongtao; Wang, Yonggang; Liu, Zimei; Yuan, Yuan; He, Aina; Shen, Zan; Yao, Yang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai, Peoples R China; [Huang, Wentao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Pathol, Shanghai, Peoples R China; [Zhang, Na; Sun, Yuanjue] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp South Campus 6, Dept Oncol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yao, Y (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai, Peoples R China.	sunyuanjue@163.com; yangyao_6@hotmail.com		Li, Hongtao/0000-0001-6532-2092	National Natural Scientific Foundation of China (NSFC) [81102038, 81172105]	National Natural Scientific Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (NSFC) (No. 81102038, 81172105). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2008, INT J LAB HEMATOL, V30, P214, DOI 10.1111/j.1751-553X.2007.00947.x; Alsweedan SA, 2008, J PEDIAT HEMATOL ONC, V30, P953, DOI 10.1097/MPH.0b013e318182e7a9; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Cho SY, 2013, PLATELETS, V24, P375, DOI 10.3109/09537104.2012.701028; Eppert K, 2005, MODERN PATHOL, V18, P388, DOI 10.1038/modpathol.3800265; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gu M, 2015, BREAST CANC; Heras P, 2010, SCAND J GASTROENTERO, V45, P1005, DOI 10.3109/00365521003797221; Hernandez-Rodriguez NA, 2002, INT J BIOL MARKER, V17, P189, DOI 10.1177/172460080201700308; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.020; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kebapcilar L, 2009, ARCH GYNECOL OBSTET, V280, P187, DOI 10.1007/s00404-008-0884-0; Kilincalp S, 2014, PLATELETS, V25, P592, DOI 10.3109/09537104.2013.783689; Kumagai S, 2015, MOL CLIN ONCOL, V3, P197, DOI 10.3892/mco.2014.436; Li JY, 2014, ASIAN PAC J CANCER P, V15, P10501, DOI 10.7314/APJCP.2014.15.23.10501; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Maraz A, 2013, ANTICANCER RES, V33, P1725; Matowicka-Karna J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/401623; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Nakamura T, 2013, BONE JOINT J, V95B, P411, DOI 10.1302/0301-620X.95B3.30344; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Osada J, 2010, NEOPLASMA, V57, P145, DOI 10.4149/neo_2010_02_145; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Riedl J, 2014, THROMB HAEMOSTASIS, V111, P670, DOI 10.1160/TH13-07-0603; Rutkowski P, 2003, J SURG ONCOL, V84, P151, DOI 10.1002/jso.10305; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Takagi S, 2014, CANCER SCI, V105, P983, DOI 10.1111/cas.12464; THOMPSON CB, 1988, BLOOD, V72, P1; Vazquez-Santiago M, 2016, COMPUT BIOL MED, V69, P226, DOI 10.1016/j.compbiomed.2015.12.023; Xiao H, 2014, TUMOR BIOL, V35, P1023, DOI 10.1007/s13277-013-1136-x	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174668	10.1371/journal.pone.0174668	http://dx.doi.org/10.1371/journal.pone.0174668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384168	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900025
J	Miranda, P; Gil-Santana, L; Oliveira, MG; Mesquita, EDD; Silva, E; Rauwerdink, A; Cobelens, F; Oliveira, MM; Andrade, BB; Kritski, A				Miranda, Pryscila; Gil-Santana, Leonardo; oliveira, Marina G.; Mesquita, Eliene D. D.; Silva, Elisangela; Rauwerdink, Anneloek; Cobelens, Frank; Oliveira, Martha M.; Andrade, Bruno B.; Kritski, Afranio			Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HOUSEHOLD CONTACTS; IRON; BIOMARKERS; THERAPY; INFECTION; DISEASE; MARKERS; ANEMIA; COHORT	Background Clinical trials that evaluate new anti-tubercular drugs and treatment regimens take years to complete due to the slow clearance of Mycobacterium tuberculosis infection and the lack of early biomarkers that predict treatment outcomes. Host Inflammation markers have been associated with tuberculosis (TB) pathogenesis. In the present study, we tested if circulating levels of C-reactive protein (CRP) and ferritin reflect mycobacterial loads and inflammation in pulmonary TB (PTB) patients undergoing anti-tuberculous therapy (ATT). Methods Prospective measurements of CRP and ferritin, used as readouts of systemic inflammation, were performed in cryopreserved serum samples from 165 Brazilian patients with active PTB initiating ATT. Associations between levels of these laboratory parameters with mycobacterial loads in sputum as well as with sputum conversion at day 60 of ATT were tested. Results Circulating levels of both ferritin and CRP gradually decreased over time on ATT. At pretreatment, concentrations of these parameters were unable to distinguish patients with positive from those with negative acid-fast bacilli (AFB) in sputum cultures. However, patients who remained with positive cultures at day 60 of ATT exhibited heightened levels of these inflammatory markers compared to those with negative cultures at that time point. Conclusions CRP and Ferritin levels in serum may be useful to identify patients with positive cultures at day 60 of ATT.	[Miranda, Pryscila; oliveira, Marina G.; Kritski, Afranio] Univ Fed Rio de Janeiro, TB Acad Program, Med Sch, Rio De Janeiro, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Andrade, Bruno B.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil; [Mesquita, Eliene D. D.] State Secretary Hlth Rio de Janeiro, Ary Parreira Inst, Rio De Janeiro, Brazil; [Silva, Elisangela] State Univ North Fluminense Darcy Ribeiro, Recognize Biol Lab, Ctr Biosci & Biotechnol, Rio De Janeiro, Brazil; [Silva, Elisangela; Oliveira, Martha M.; Andrade, Bruno B.; Kritski, Afranio] Rede Brasileira Pesquisas TB Rede TB, Rio De Janeiro, Brazil; [Rauwerdink, Anneloek; Cobelens, Frank] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Oliveira, Martha M.] Fundacao Oswaldo Cruz, Dev Ctr Technol Hlth CDTS, Rio De Janeiro, Brazil; [Andrade, Bruno B.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Andrade, Bruno B.] Laureate Int Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Amsterdam; Academic Medical Center Amsterdam; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Escola Bahiana de Medicina e Saude Publica; Universidade Salvador (UNIFACS)	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.	bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020; Silva, Elisangela/AAW-5193-2020; Kritski, Afranio/I-6760-2016	Silva, Elisangela/0000-0001-9833-1825; kritski, afranio/0000-0002-5900-6007; Andrade, Bruno/0000-0001-6833-3811; Cobelens, Frank/0000-0002-4367-1133	CNPq /INCT [573548/2008-0]; Faperj [E-26/110.974/2011]; CNPq (produtividade em pesquisa); FAPERJ (Cientistas do Nosso Estado); Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Fundacao Oswaldo Cruz (FIOCRUZ)	CNPq /INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (produtividade em pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Cientistas do Nosso Estado)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by CNPq /INCT 573548/2008-0; Faperj Process: Processo - E-26/110.974/2011. AK is the recipient of a career award from CNPq (produtividade em pesquisa) and FAPERJ (Cientistas do Nosso Estado). LG-S received scientific initiation fellowship from Fundacao de Amparo a Pesquisa da Bahia (FAPESB) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	El Idrissi HB, 2015, NUTR HOSP, V32, P2848, DOI 10.3305/nh.2015.32.6.9827; Clifford V, 2015, TUBERCULOSIS, V95, P217, DOI 10.1016/j.tube.2015.01.003; Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Jacobs R, 2016, CYTOKINE, V81, P50, DOI 10.1016/j.cyto.2016.02.004; Koethe JR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-19; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Kuznetsov IA, 2013, B EXP BIOL MED+, V154, P618, DOI 10.1007/s10517-013-2013-8; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48; Minchella PA, 2015, TUBERCULOSIS, V95, P288, DOI 10.1016/j.tube.2015.02.042; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Oliveira MG, 2014, J BRAS PNEUMOL, V40, P403, DOI 10.1590/S1806-37132014000400008; Petersen E, 2015, LANCET INFECT DIS, V15, P6, DOI 10.1016/S1473-3099(14)71055-2; Plit ML, 1998, INT J TUBERC LUNG D, V2, P590; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Sivakolundu S, 2013, T ROY SOC TROP MED H, V107, P43, DOI 10.1093/trstmh/trs005; Subbian S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/385402; Tacke F, 2016, CRIT CARE MED, V44, P1049, DOI 10.1097/CCM.0000000000001607; Tanaka M, 2015, BONE MARROW TRANSPL, V50, P727, DOI 10.1038/bmt.2015.17; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Walzl G, 2014, COLD SPRING HARB PER, V5; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, FACT SHEETS TUB	26	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175278	10.1371/journal.pone.0175278	http://dx.doi.org/10.1371/journal.pone.0175278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384354	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900145
J	Oguchi, ME; Noguchi, K; Fukuda, M				Oguchi, Mai E.; Noguchi, Kenta; Fukuda, Mitsunori			TBC1 D12 is a novel Rab11-binding protein that modulates neurite outgrowth of PC12 cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; RAB SMALL GTPASES; BINDING-PROTEIN; AMPA RECEPTORS; TRAFFICKING; IDENTIFICATION; MELANOCYTES; DOMAIN; GAPS; ENDOSOMES	Recycling endosomes are generally thought to play a central role in endocytic recycling, but recent evidence has indicated that they also participate in other cellular events, including cytokinesis, autophagy, and neurite outgrowth. Rab small GTPases are key regulators in membrane trafficking, and although several Rab isoforms, e.g., Rab11, have been shown to regulate recycling endosomal trafficking, the precise mechanism by which these Rabs regulate recycling endosomes is not fully understood. In this study, we focused on a RabGTPase-activating protein (Rab-GAP), one of the key regulators of Rabs, and comprehensively screened 43 mammalian Tre-2/Bub2/Cdc16 (TBC)/Rab-GAP-domain-containing proteins (TBC proteins) for proteins that specifically localize on recycling endosomes in mouse embryonic fibroblasts (MEFs). Four of the 43 mammalian TBC proteins screened, i.e., TBC1 D11, TBC1 D12, TBC1 D14, and EVI5, were found to colocalize well with transferrin receptor, a well-known recycling endosome marker. We further investigated the biochemical properties of TBC1 D12, a previously uncharacterized TBC protein. The results showed that TBC1 D12 interacted with active Rab11 through its middle region and that it did not display Rab11-GAP activity in vitro. The recycling endosomal localization of TBC1 D12 was found to depend on the expression of Rab11. We also found that TBC1 D12 expression had no effect on common Rab11-dependent cellular events, e.g., transferrin recycling, in MEFs and that it promoted neurite outgrowth, a specialized Rab11-dependent cellular event, of PC12 cells independently of its GAP activity. These findings indicated that TBC1 D12 is a novel Rab11binding protein that modulates neurite outgrowth of PC12 cells.	[Oguchi, Mai E.; Noguchi, Kenta; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan [15H04367]; Grants-in-Aid for Scientific Research [17H05682] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (grant number 15H04367 to M. F.). There was no additional external funding received for this study.	Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Frasa MAM, 2010, CURR BIOL, V20, P198, DOI 10.1016/j.cub.2009.12.053; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Homma Y, 2016, MOL BIOL CELL, V27, P2107, DOI 10.1091/mbc.E16-02-0091; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kobayashi Hotaka, 2015, Methods Mol Biol, V1298, P207, DOI 10.1007/978-1-4939-2569-8_18; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Lamb CA, 2016, EMBO J, V35, P281, DOI 10.15252/embj.201592695; Longatti A, 2012, AUTOPHAGY, V8, P1682, DOI 10.4161/auto.21486; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Marubashi S, 2016, J BIOL CHEM, V291, P1427, DOI 10.1074/jbc.M115.684043; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104	45	11	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174883	10.1371/journal.pone.0174883	http://dx.doi.org/10.1371/journal.pone.0174883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384198	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900049
J	Simonetto, C; Azizova, TV; Barjaktarovic, Z; Bauersachs, J; Jacob, P; Kaiser, JC; Meckbach, R; Schollnberger, H; Eidemuller, M				Simonetto, Cristoforo; Azizova, Tamara V.; Barjaktarovic, Zarko; Bauersachs, Johann; Jacob, Peter; Kaiser, Jan Christian; Meckbach, Reinhard; Schollnberger, Helmut; Eidemuller, Markus			A mechanistic model for atherosclerosis and its application to the cohort of Mayak workers	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PRODUCTION-ASSOCIATION; INFLAMMATORY RESPONSE; IONIZING-RADIATION; CARCINOGENESIS; MACROPHAGE; RISK; CANCER; ATHEROGENESIS; INSTABILITY	We propose a stochastic model for use in epidemiological analysis, describing the age-dependent development of atherosclerosis with adequate simplification. The model features the uptake of monocytes into the arterial wall, their proliferation and transition into foam cells. The number of foam cells is assumed to determine the health risk for clinically relevant events such as stroke. In a simulation study, the model was checked against the age-dependent prevalence of atherosclerotic lesions. Next, the model was applied to incidence of atherosclerotic stroke in the cohort of male workers from the Mayak nuclear facility in the Southern Urals. It describes the data as well as standard epidemiological models. Based on goodness-of-fit criteria the risk factors smoking, hypertension and radiation exposure were tested for their effect on disease development. Hypertension was identified to affect disease progression mainly in the late stage of atherosclerosis. Fitting mechanistic models to incidence data allows to integrate biological evidence on disease progression into epidemiological studies. The mechanistic approach adds to an understanding of pathogenic processes, whereas standard epidemiological methods mainly explore the statistical association between risk factors and disease outcome. Due to a more comprehensive scientific foundation, risk estimates from mechanistic models can be deemed more reliable. To the best of our knowledge, such models are applied to epidemiological data on cardiovascular diseases for the first time.	[Simonetto, Cristoforo; Barjaktarovic, Zarko; Jacob, Peter; Kaiser, Jan Christian; Meckbach, Reinhard; Schollnberger, Helmut; Eidemuller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.] Southern Urals Biophys Inst, Ozyorsk, Chelyabinsk Reg, Russia; [Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Jacob, Peter] RADRISK, Schliersee, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute; Hannover Medical School	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	cristoforo.simonetto@helmholtz-muenchen.de	Simonetto, Cristoforo/AAE-7124-2020; Azizova, Tamara V./R-5295-2019; Schöllnberger, Helmut/K-1446-2016	Simonetto, Cristoforo/0000-0003-4816-3514; Azizova, Tamara V./0000-0001-6954-2674; Schöllnberger, Helmut/0000-0002-4398-6565	Federal Ministry of Education and Research (BMBF) [02NUK026]; Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Federal Office for Radiation Protection (BfS) [3611S30022]; EU [295823]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Federal Office for Radiation Protection (BfS); EU(European Commission)	This work was supported by the Federal Ministry of Education and Research (BMBF, www.bmbf.de) with contract number 02NUK026 (PASSOS). Furthermore, it was supported by the Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety and the Federal Office for Radiation Protection (BfS, www.bfs.de, contract 3611S30022) and by the EU Seventh Framework (ec.europa.eu/research/fp7) project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Bulelzai MAK, 2012, J THEOR BIOL, V297, P1, DOI 10.1016/j.jtbi.2011.11.023; Chien A, 2011, AM J NEURORADIOL, V32, P1249, DOI 10.3174/ajnr.A2483; Cilia M, 2013, J R SOC INTERFACE, V11; Cohen A, 2014, B MATH BIOL, V76, P1117, DOI 10.1007/s11538-014-9948-4; DAVIES MJ, 1993, BRIT HEART J, V69, P377; DAVIES RB, 1977, BIOMETRIKA, V64, P247, DOI 10.2307/2335690; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Eidemuller M, 2015, MUTAT RES-FUND MOL M, V775, P1, DOI 10.1016/j.mrfmmm.2015.03.002; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Heidenreich WF, 2007, RADIAT RES, V168, P750, DOI 10.1667/RR0919.1; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Hinkle Janice L, 2007, J Neurosci Nurs, V39, P285; Ibragimov AI, 2005, MATH MED BIOL, V22, P305, DOI 10.1093/imammb/dqi011; James F., 2004, MINUIT USERS GUIDE; Jeon J, 2008, MATH BIOSCI, V213, P56, DOI 10.1016/j.mbs.2008.02.006; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kaiser JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111024; Kreuzer M, 2015, MUTAT RES-REV MUTAT, V764, P90, DOI 10.1016/j.mrrev.2015.03.002; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Kruglov A., 2002, HIST SOVIET ATOMIC I; Le Gallic C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128539; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Little M.P., 2015, CARDIO ONCOLOGY, V1, P1, DOI DOI 10.1186/S40959-015-0007-6; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Ougrinovskaia A, 2010, B MATH BIOL, V72, P1534, DOI 10.1007/s11538-010-9509-4; Parton A, 2015, BRIEF BIOINFORMATICS; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; ROSS R, 1977, AM J PATHOL, V86, P675; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Santoro F, 2014, CLIN RES CARDIOL, V103, P955, DOI 10.1007/s00392-014-0718-y; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Shuryak I, 2010, RADIAT RES, V174, P357, DOI 10.1667/RR2143.1; Simonetto C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125904; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Stary HC, 2000, AM J CLIN NUTR, V72, p1297S, DOI 10.1093/ajcn/72.5.1297s; Stewart FA, 2013, CLIN ONCOL-UK, V25, P617, DOI 10.1016/j.clon.2013.06.012; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takahashi I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000654; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Tan WY, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-26; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Vasilenko EK, 2010, AAHP SPEC SESS HLTH; Xu JP, 2013, INTERV NEUROL, V2, P183, DOI 10.1159/000363068; ZHANG S, 2013, DISCRETE CONT S NOV, P825; Zollner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126238	69	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175386	10.1371/journal.pone.0175386	http://dx.doi.org/10.1371/journal.pone.0175386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384359	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900167
J	Zhang, HR; Xin, HN; Li, XW; Li, HJ; Li, MF; Lu, W; Bai, LQ; Wang, XH; Liu, JM; Jin, Q; Gao, L				Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Lu, Wei; Bai, Liqiong; Wang, Xinhua; Liu, Jianmin; Jin, Qi; Gao, Lei			A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; ASSOCIATION; PREVALENCE; REACTIVITY; EXPOSURE	Objectives China has high burden on both of tuberculosis (TB) and tobacco use. This study aims to explore the potential link between smoking and TB infection using baseline survey data of a large-scale population-based prospective study in rural China Methods Between July 1 and Sept 30, 2013, based on the baseline survey of a population-based, prospective study in rural China, the relationship between smoking and TB infection, assessed by interferon-gamma release assays (IGRA), was investigated among the total study population and only among those smokers, respectively. Results A total of 21,008 eligible rural registered residents (>= 5 years old) from 4 rural sites were included in the analysis. Ever-smokers were more likely to be QuantiFERON-TB Gold InTube (QFT) positive than never smokers with an adjusted odds ratio (OR) of 1.34 (95% confidence interval (CI): 1.21-1.49). Among ever smokers, a significant linear dose-response relation was observed between duration of smoking (by years) and QFT positivity (p < 0.001). Stratified analysis suggested that such an association was not influenced by gender and age. Evidence for interaction of smoking status with age was found. Conclusions Our results provide further evidence to support smoking might increase host susceptibility to TB infection. Populations under high risk of infection, such as elderly smokers, should be prior to TB infection controlling under a premise of community level intervention.	[Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Chinese Acad Med Sci, Ctr TB, Beijing, Peoples R China; [Zhang, Haoran; Xin, Henan; Li, Xiangwei; Li, Hengjing; Li, Mufei; Jin, Qi; Gao, Lei] Peking Union Med Coll, Beijing, Peoples R China; [Lu, Wei] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Bai, Liqiong] Hunan Prov Inst TB Prevent & Control, Changsha, Hunan, Peoples R China; [Wang, Xinhua] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Liu, Jianmin] Sixth Peoples Hosp Zhengzhou, Zhengzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jiangsu Provincial Center for Disease Control & Prevention	Gao, L (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China.; Gao, L (corresponding author), Chinese Acad Med Sci, Ctr TB, Beijing, Peoples R China.; Gao, L (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	gaolei@ipbcams.ac.cn	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Science and Technology Major Project of China [2013ZX10003004-002, 2014ZX10003001-001]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT13007]; Sanming Project of Medicine in Shenzhen [GCZX2015043015340574]	National Science and Technology Major Project of China; Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sanming Project of Medicine in Shenzhen	This work was supported by the National Science and Technology Major Project of China (grant number: 2013ZX10003004-002, 2014ZX10003001-001), and the Program for Changjiang Scholars and Innovative Research Team in University of China (grant number: IRT13007) and the Sanming Project of Medicine in Shenzhen (GCZX2015043015340574). The content is solely the responsibility of the authors and the funding sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; and decision to submit the article for publication.	Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; Aryanpur M, 2016, INT J TUBERC LUNG D, V20, P679, DOI 10.5588/ijtld.15.0662; Aryanpur Mahshid, 2016, Tanaffos, V15, P17; Bai KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156677; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Gao L, 2016, EUR RESPIR J, V48, P168, DOI 10.1183/13993003.00235-2016; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; He GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124097; Horne DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049050; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Loddenkemper R, 2016, PNEUMOLOGIE, V70, P17, DOI 10.1055/s-0041-109601; Matsunaga K, 2002, J INFECT DIS, V185, P229, DOI 10.1086/338449; McCurdy SA, 1997, AM J IND MED, V32, P600, DOI 10.1002/(SICI)1097-0274(199712)32:6&lt;600::AID-AJIM5&gt;3.0.CO;2-T; Ministry of Health of the Peoples Republic of China, 2013, WST4282013 MIN HLTH; NISAR M, 1993, THORAX, V48, P1257, DOI 10.1136/thx.48.12.1257; Oni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047072; Patra J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001835; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Solsona J, 2001, EUR J EPIDEMIOL, V17, P123, DOI 10.1023/A:1017580329538; Wei XL, 2015, T ROY SOC TROP MED H, V109, P545, DOI 10.1093/trstmh/trv063; World Health Organization, 2007, WHO THE UN MON TB TO; Zhang XL, 2011, TROP MED INT HEALTH, V16, P1511, DOI 10.1111/j.1365-3156.2011.02869.x	33	43	47	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175183	10.1371/journal.pone.0175183	http://dx.doi.org/10.1371/journal.pone.0175183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384350	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900112
J	Skirgard, H; Roberts, SG; Yencken, L				Skirgard, Hedvig; Roberts, Sean G.; Yencken, Lars			Why are some languages confused for others? Investigating data from the Great Language Game	PLOS ONE			English	Article							TONOGENESIS; PERCEPTION; SUPPORT; DANISH	In this paper we explore the results of a large-scale online game called 'the Great Language Game', in which people listen to an audio speech sample and make a forced-choice guess about the identity of the language from 2 or more alternatives. The data include 15 million guesses from 400 audio recordings of 78 languages. We investigate which languages are confused for which in the game, and if this correlates with the similarities that linguists identify between languages. This includes shared lexical items, similar sound inventories and established historical relationships. Our findings are, as expected, that players are more likely to confuse two languages that are objectively more similar. We also investigate factors that may affect players' ability to accurately select the target language, such as how many people speak the language, how often the language is mentioned in written materials and the economic power of the target language community. We see that non-linguistic factors affect players' ability to accurately identify the target. For example, languages with wider ` global reach' are more often identified correctly. This suggests that both linguistic and cultural knowledge influence the perception and recognition of languages and their similarity.	[Skirgard, Hedvig] Australian Natl Univ, Coll Asia & Pacific, Sch Culture Hist & Language,Dept Linguist, Wellsprings Linguist Diver Laureate Project, Acton, ACT, Australia; [Roberts, Sean G.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Gelderland, Netherlands	Australian National University; Max Planck Society	Roberts, SG (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Gelderland, Netherlands.	sean.roberts@mpi.nl		Skirgard, Hedvig/0000-0002-7748-2381; Roberts, Sean/0000-0001-5990-9161	Max Planck society; ERC Advanced Grant [269484]	Max Planck society(Max Planck SocietyFoundation CELLEX); ERC Advanced Grant(European Research Council (ERC))	SGR is supported by the Max Planck society and an ERC Advanced Grant No. 269484 INTERACT to Stephen Levinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SR is supported by the Max Planck society and an ERC Advanced Grant No. 269484 INTERACT to Stephen Levinson. Many thanks to our reviewers for thorough feedback, Siva Kalyan and Harald Hammarstrom for very helpful comments and Mikael Parkvall for sharing information on GDP from the countries involved in the study.	[Anonymous], 2014, ETHNOLOGUE LANGUAGES; Bakker P, 2011, J PIDGIN CREOLE LANG, V26, P5, DOI 10.1075/jpcl.26.1.02bak; Becker RA, 2016, R PACKAGE VERSION 3; Beekes R., 1995, COMPARATIVE INDO EUR; Bentz C, 2013, LANG DYN CHANG, V3, P1, DOI 10.1163/22105832-13030105; Blanc Haim, 1965, FIELD YIDDISH, P185; Borcard D, 2012, ECOLOGY, V93, P1473; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Central Intelligence Agency, 2012, WORLD FACTBOOK; Clopper C., 2004, THESIS; Clopper CG, 2012, J AUTISM DEV DISORD, V42, P740, DOI 10.1007/s10803-011-1305-y; Clopper CG, 2009, J PHONETICS, V37, P436, DOI 10.1016/j.wocn.2009.07.004; Cojocaru Dana, 2003, ROMANIAN GRAMMAR; Croft W., 2000, EXPLAINING LANGUAGE; Dennis Preston, 1999, HANDBOOK OF PERCEPTU; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Garde M, 2015, THE 46TH ANNUAL CONF; Georg S, 1999, J LINGUIST, V35, P65, DOI 10.1017/S0022226798007312; Good J, 2013, LANGUOID DOCULECT AN; Gooskens C, 2006, AVT PUBL, V23, P101; Gooskens C, 2010, SPEECH COMMUN, V52, P1022, DOI 10.1016/j.specom.2010.06.005; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Hammarstro H, 2015, GLOTTOLOG 2 4; Harmon Luke J, 2010, POOR STATISTICAL PER, V64, P2173; Haspelmath M, 2008, WORLD ATLAS OF LANGU; Hay J, 2007, ANNU REV ANTHROPOL, V36, P89, DOI 10.1146/annurev.anthro.34.081804.120633; Hay J, 2006, LINGUIST REV, V23, P351, DOI 10.1515/TLR.2006.014; HOLM S, 1979, SCAND J STAT, V6, P65; Holman EricW., 2007, LINGUIST TYPOL, V11, P393, DOI [DOI 10.1515/LINGTY.2007.027, 10.1515/lingty.2007.027]; Hothorn T, 2012, PARTY A LABORATORY F; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jager G, 2016, THE EVOLUTION OF LAN; Kang Y, 2013, LINGUA, V134, P62, DOI 10.1016/j.lingua.2013.06.002; Kirby JP, 2014, J PHONETICS, V43, P69, DOI 10.1016/j.wocn.2014.02.001; Kirk NW, 2013, 54TH ANNUAL MEETING; Larsen AB, 1917, NABOOPPOSISJON D KNO, P97; Lebenswerd P. J., 2012, THESIS; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Lewis MP, THE PROBLEM OF LANGU; Maddieson I, 2013, TONE; Matisoff JA, 1973, SOUTHERN CALIFORNIA, V1; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; McNamara T., 2005, LANG POLICY-NETH, V4, P351, DOI [10.1007/s10993-005-2886-0, DOI 10.1007/S10993-005-2886-0]; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Miles J., 2014, TOLERANCE AND VARIAN; MORAN STEVEN, 2014, PHOIBLE ONLINE; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Robbeets M, 2005, IS JAPANESE RELATED; Roberts G, 2010, INTERACT STUD, V11, P138, DOI 10.1075/is.11.1.o6rob; Rubin DL, 1992, NONLANGUAGE FACTORS, V4, P511; Schrijver P., 1999, THE CELTIC CONTRIBUT; Schuppert A, 2015, LINGUISTICS, V53, P375, DOI 10.1515/ling-2015-0003; Spruit M. R., 2006, Literary & Linguistic Computing, V21, P493, DOI 10.1093/llc/fql043; Strongman T, 1967, STEREOTYPED REACTION, V6, P164; Thurston William R., 1987, PROCESSES OF CHANGE; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Wagner L, 2014, J CHILD LANG, V41, P1062, DOI 10.1017/S0305000913000330; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wichmann S, 2013, THE ASJP DATABASE VE; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011	65	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0165934	10.1371/journal.pone.0165934	http://dx.doi.org/10.1371/journal.pone.0165934			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ES2JD	28379970	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500001
J	Wei, ZW; Hui, XL; Li, XH; Zhang, YZ; Jiang, LC; Li, J; Guan, ZB; Cai, YJ; Liao, XR				Wei, Zhiwen; Hui, Xiaolong; Li, Xunhang; Zhang, Yanzhou; Jiang, Leichun; Li, Jing; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru			The rhizospheric microbial community structure and diversity of deciduous and evergreen forests in Taihu Lake area, China	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PYROSEQUENCING-BASED ANALYSIS; BACTERIAL COMMUNITY; COMPARATIVE METAGENOMICS; COOCCURRENCE PATTERNS; RARE BIOSPHERE; SOIL-PH; IMPACT; BIOGEOGRAPHY; ENVIRONMENT	Soil bacteria are important drivers of biogeochemical cycles and participate in many nutrient transformations in the soil. Meanwhile, bacterial diversity and community composition are related to soil physic-chemical properties and vegetation factors. However, how the soil and vegetation factors affect the diversity and community composition of bacteria is poorly understood, especially for bacteria associated with evergreen and deciduous trees in subtropical forest ecosystems. In the present paper, the microbial communities of rhizospheric soils associated with different types of trees were analyzed by Illumina MiSeq sequencing the V3-V4 region of the 16S rRNA gene. A total of 121,219 effective 16S rRNA gene sequences were obtained, which were classified into 29 bacterial phyla and 2 archaeal phyla. The dominant phyla across all samples (>5% of good-quality sequences in each sample) were Proteobacteria, Acidobacteria, Firmicutes and Bacteroidetes. The bacterial community composition and diversity were largely affected by both soil pH and tree species. The soil pH was the key factor influencing bacterial diversity, with lower pH associated with less diverse communities. Meanwhile, the contents of NO3 were higher in evergreen tree soils than those associated with deciduous trees, while less NH4+ than those associated with deciduous trees, leading to a lower pH and indirectly influencing the diversity and composition of the bacteria. The co-occurrence patterns were assessed by network analysis. A total of 415 pairs of significant and robust correlations (co-occurrence and negative) were identified from 89 genera. Sixteen hubs of co-occurrence patterns, mainly under the phyla Acidobacteria, Proteobacteria, Firmicutes and Bacteroidetes, may play important roles in sustaining the stability of the rhizospheric microbial communities. In general, our results suggested that local environmental conditions and soil pH were important in shaping the bacterial community of the Taihu Lake zone in east China.	[Wei, Zhiwen; Li, Jing; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Wei, Zhiwen] Jiangsu Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou, Jiangsu, Peoples R China; [Hui, Xiaolong] Zhengzhou Univ Light Ind, Sch Food & Biol Engn, Zhengzhou, Henan, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang, Jiangxi, Peoples R China; [Zhang, Yanzhou] Yancheng Teachers Univ, Sch Marine & Biol Engn, Yancheng, Jiangsu, Peoples R China; [Jiang, Leichun] Wuxi Plum Garden & Hengshan Scen Area, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangsu Normal University; Zhengzhou University of Light Industry; Jiangxi Agricultural University; Yancheng Teachers University	Liao, XR (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.	laoxiangru@163.com	Hui, XIAO/GZH-2322-2022		Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province [BY2014023-28]; Agricultural Support Project, Wuxi Science & Technology Development [CLEO1N1310]; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou [13021ry08]	Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province; Agricultural Support Project, Wuxi Science & Technology Development; Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou	This study was supported by Collaborative Innovation Involving Production, Teaching & Research funds of Jiangsu Province (BY2014023-28); Agricultural Support Project, Wuxi Science & Technology Development (CLEO1N1310); the Program of Marine Biological Resources Exploitation and Utilization of Science and Technology Innovation Team of Taizhou (no. 13021ry08).	[Anonymous], 1999, LYT1237 STAT FOR ADM; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Augusto L, 2002, ANN FOREST SCI, V59, P233, DOI 10.1051/forest:2002020; Baek Dong-Heon, 2007, International Journal of Oral Biology, V32, P75; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Barra Caracciolo A., 2011, CHEM ECOL, V27, P43, DOI DOI 10.1080/02757540.2016.53408; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Coates JD, 2002, APPL ENVIRON MICROB, V68, P2445, DOI 10.1128/AEM.68.5.2445-2452.2002; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Cristobal HA, 2015, FOLIA MICROBIOL, V60, P183, DOI 10.1007/s12223-014-0351-1; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dokulil M., 2000, AQUAT ECOSYST HEALTH, V3, P81, DOI DOI 10.1016/S1463-4988(99)00067-6; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Eilers KG, 2010, SOIL BIOL BIOCHEM, V42, P896, DOI 10.1016/j.soilbio.2010.02.003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Guo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086881; HALL A, 1993, APPL GEOCHEM, V8, P101, DOI 10.1016/0883-2927(93)90059-P; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Han D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086887; Harrell JFE, 2008, HMISC HARREL MISCELL; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hjort K, 2014, APPL MICROBIOL BIOT, V98, P2819, DOI 10.1007/s00253-013-5287-x; Hu XL, 2016, APPL ENVIRON MICROB, V82, P2506, DOI 10.1128/AEM.03409-15; Huang QY, 2013, FEMS MICROBIOL ECOL, V85, P452, DOI 10.1111/1574-6941.12134; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Kanokratana P, 2011, MICROB ECOL, V61, P518, DOI 10.1007/s00248-010-9766-7; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee KCY, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0099-5; Lee SH, 2013, J MICROBIOL, V51, P484, DOI 10.1007/s12275-013-3312-5; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu GS, 1996, SOIL PHYS CHEM ANAL, P166; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Livermore JA, 2013, ENVIRON SCI TECHNOL, V47, P7672, DOI 10.1021/es4012788; Llado S, 2016, BIOL FERT SOILS, V52, P251, DOI 10.1007/s00374-015-1072-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Massenssini AM, 2015, APPL SOIL ECOL, V91, P8, DOI 10.1016/j.apsoil.2015.02.009; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pankhurst C, 1997, BIOL INDICATORS SOIL; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rose NL, 2004, J PALEOLIMNOL, V32, P41, DOI 10.1023/B:JOPL.0000025282.06961.42; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Spatharis S, 2011, ECOL INDIC, V11, P697, DOI 10.1016/j.ecolind.2010.09.009; Stratford JP, 2014, BIORESOURCE TECHNOL, V156, P84, DOI 10.1016/j.biortech.2014.01.041; Su WZ, 2010, LANDSCAPE URBAN PLAN, V95, P61, DOI 10.1016/j.landurbplan.2009.12.003; Sul WJ, 2013, SOIL BIOL BIOCHEM, V65, P33, DOI 10.1016/j.soilbio.2013.05.007; Taha M, 2015, APPL BIOCHEM BIOTECH, V175, P3709, DOI 10.1007/s12010-015-1539-9; Tao Y, 2014, APPL ENVIRON MICROB, V80, P2254, DOI 10.1128/AEM.04070-13; TARAS MJ, 1950, ANAL CHEM, V22, P1020, DOI 10.1021/ac60044a014; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Uren NC, 2007, RHIZOSPHERE BIOCH OR, P1, DOI [10.1201/9781420005585.ch1, DOI 10.1201/9781420005585.CH1]; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; van Beek TA, 1998, FITOTERAPIA, V69, P195; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wang J, 2013, CHALLENGING ICT APPL, P48, DOI DOI 10.4018/978-1-4666-1999-9; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Wu FY, 2012, INT J PHYTOREMEDIAT, V14, P543, DOI 10.1080/15226514.2011.604691; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yin Yun-long, 2002, Journal of Plant Resources and Environment, V11, P46; Yuan HZ, 2014, ENVIRON EARTH SCI, V71, P783, DOI 10.1007/s12665-013-2480-2; [张彪 Zhang Biao], 2010, [水土保持研究, Research of Soil and Water Conservation], V17, P96; Zhang Y., 2011, ANAL TUTORIAL SOIL W, P66; Zhang Y, 2012, B ENVIRON CONTAM TOX, V89, P1009, DOI 10.1007/s00128-012-0784-7; Zhao DY, 2014, APPL MICROBIOL BIOT, V98, P9119, DOI 10.1007/s00253-014-5920-3; Zhao HX, 2013, CHINESE GEOGR SCI, V23, P203, DOI 10.1007/s11769-013-0593-x; Zimmermann J, 2006, ANTON LEEUW INT J G, V89, P203, DOI 10.1007/s10482-005-9020-3	104	37	39	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174411	10.1371/journal.pone.0174411	http://dx.doi.org/10.1371/journal.pone.0174411			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379996	gold, Green Submitted, Green Published			2022-12-26	WOS:000399353500046
J	Chen, CL; Chen, JT; Liang, CM; Tai, MC; Lu, DW; Chen, YH				Chen, Ching-Long; Chen, Jiann-Torng; Liang, Chang-Min; Tai, Ming-Cheng; Lu, Da-Wen; Chen, Yi-Hao			Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BACTERIAL-ENDOTOXIN; MESSENGER-RNA; LEWIS RATS; TNF-ALPHA; EXPRESSION; INHIBITION; LIPOPOLYSACCHARIDE	Uveitis, an intraocular inflammatory disease, occurs mostly in young people and can result in the loss of socioeconomic capabilities. Silibinin has been shown to exert anti-inflammatory effects in human retinal pigment epithelial (RPE) cells. The present study investigated the anti-inflammatory effect of silibinin pretreatment on endotoxin-induced uveitis (EIU) in rats and the mechanisms by which it exerts these effects. Uveitis was induced via injection of lipopolysaccharides (LPS) into Lewis rats. Twenty-four hours after the LPS injection, histological examination showed that silibinin decreased inflammatory cell infiltration in the anterior segment of the eyes of LPS-treated rats. Analyses of the aqueous humor showed that silibinin decreased cell infiltration, protein concentration, nitric oxide (NO), and prostaglandin (PG)-E2 production. Western blot analysis indicated that silibinin decreased the expression of inducible NO synthase (iNOS), cyclooxygenase (COX-2), and phosphorylated IkB in the iris-ciliary body (ICB). Immunohistochemistry showed that silibinin decreased intercellular adhesion molecule (ICAM-1) expression in the ICB. In addition, western blot analysis showed that silibinin attenuated the expression of iNOS, COX-2, ICAM-1, and nuclear p65 in LPS-treated RAW cells. In conclusion, silibinin pretreatment prevents EIU and the subsequent production of proinflammatory mediators and ICAM-1, at least in part, by blocking the NF-kappa B-dependent signaling pathway both in vivo and in vitro. These effects may contribute to the silibinin-mediated preventive effects on intraocular inflammatory diseases such as acute uveitis.	[Chen, Ching-Long; Chen, Jiann-Torng; Liang, Chang-Min; Lu, Da-Wen; Chen, Yi-Hao] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Ching-Long; Chen, Jiann-Torng; Liang, Chang-Min; Tai, Ming-Cheng; Lu, Da-Wen; Chen, Yi-Hao] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chen, YH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, YH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	keane@ms18.url.com.tw			National Science Council [NSC102-2314-B-016-046-MY3, NSC-102-2314-B-016-047]; Ministry of Science and Technology, Taiwan, [MOST103-2314-B-016-015, MOST 104-2314-B-016-035, MOST 105-2314-B-016-045]; Tri-Service General Hospital [TSGH-C102-097]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan,(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This work was supported by National Science Council, NSC102-2314-B-016-046-MY3 (Jiann-Torng Chen); National Science Council, NSC-102-2314-B-016-047 (Ching -Long Chen); Ministry of Science and Technology, Taiwan, MOST103-2314-B-016-015 (Ching -Long Chen); Ministry of Science and Technology, Taiwan, MOST 104-2314-B-016-035 (Yi-Hao Chen), Ministry of Science and Technology, Taiwan, MOST 105-2314-B-016-045 (Jiann-Torng Chen);and Tri-Service General Hospital, TSGH-C102-097 (Ching-Long Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BECKER B, 1963, JAMA-J AM MED ASSOC, V185, P884, DOI 10.1001/jama.1963.03060110088027; Becker MD, 2001, INVEST OPHTH VIS SCI, V42, P2563; Bellot JL, 1996, INFLAMM RES, V45, P203, DOI 10.1007/BF02285162; BHATTACHERJEE P, 1983, INVEST OPHTH VIS SCI, V24, P196; CAO CY, 1995, BRAIN RES, V697, P187, DOI 10.1016/0006-8993(95)00839-I; Chang YH, 2008, INVEST OPHTH VIS SCI, V49, P5441, DOI 10.1167/iovs.08-1784; Chen JT, 2006, INVEST OPHTH VIS SCI, V47, P664, DOI 10.1167/iovs.05-1008; Chen Y, 2014, J ASIAN NAT PROD RES, V19, P1, DOI DOI 10.1155/2014/701395; da Silva PS, 2011, MOL VIS, V17, P1310; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P1100; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; GOUREAU O, 1995, J IMMUNOL, V154, P6518; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; HOWES EL, 1970, ARCH OPHTHALMOL-CHIC, V84, P360, DOI 10.1001/archopht.1970.00990040362017; Ichitani Y, 2001, CELL TISSUE RES, V303, P235, DOI 10.1007/s004410000296; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jacquemin E, 1996, INVEST OPHTH VIS SCI, V37, P1187; Kamata K, 2003, PHARMACOL RES, V47, P485, DOI 10.1016/S1043-6618(03)00057-4; Kanagawa T, 1996, JPN J OPHTHALMOL, V40, P174; KOGISO M, 1992, JPN J OPHTHALMOL, V36, P281; Lemaitre C, 2001, INVEST OPHTH VIS SCI, V42, P2022; MANDAI M, 1994, INVEST OPHTH VIS SCI, V35, P3673; Marie O, 1999, INVEST OPHTH VIS SCI, V40, P2275; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Mitchell JA, 1999, BRIT J PHARMACOL, V128, P1121, DOI 10.1038/sj.bjp.0702897; Noh EJ, 2006, LIFE SCI, V79, P695, DOI 10.1016/j.lfs.2006.02.020; OKUMURA A, 1990, INT OPHTHALMOL, V14, P31, DOI 10.1007/BF00131166; Pavesio CE, 2008, BRIT J OPHTHALMOL, V92, P455, DOI 10.1136/bjo.2007.132621; Qin YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103995; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sahnoun Z, 1998, THERAPIE, V53, P315; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Siddique SS, 2011, EXPERT OPIN INV DRUG, V20, P1497, DOI 10.1517/13543784.2011.617741; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Surai PF, 2015, ANTIOXIDANTS-BASEL, V4, P204, DOI 10.3390/antiox4010204; THOMAS L, 1954, ANNU REV PHYSIOL, V16, P467, DOI 10.1146/annurev.ph.16.030154.002343; TILTON RG, 1994, INVEST OPHTH VIS SCI, V35, P3278; Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P2387, DOI 10.1016/j.ophtha.2014.07.007; WHITCUP SM, 1995, EXP EYE RES, V60, P597, DOI 10.1016/S0014-4835(05)80001-6; WHITCUP SM, 1992, ARCH OPHTHALMOL-CHIC, V110, P662, DOI 10.1001/archopht.1992.01080170084029; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yadav Umesh C S, 2013, Methods Mol Biol, V1031, P155, DOI 10.1007/978-1-62703-481-4_18; Yang PZ, 1996, INVEST OPHTH VIS SCI, V37, P77; YOSHIDA M, 1994, INVEST OPHTH VIS SCI, V35, P1107	51	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174971	10.1371/journal.pone.0174971	http://dx.doi.org/10.1371/journal.pone.0174971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376126	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000030
J	Liu, WF; Wu, JP; Fan, HB; Duan, HL; Li, Q; Yuan, YH; Zhang, H				Liu, Wenfei; Wu, Jianping; Fan, Houbao; Duan, Honglang; Li, Qiang; Yuan, Yinghong; Zhang, Hao			Estimations of evapotranspiration in an age sequence of Eucalyptus plantations in subtropical China	PLOS ONE			English	Article							WATER-USE; UROPHYLLA PLANTATIONS; CARBON STORAGE; FOREST; TRANSPIRATION; BALANCE; GROWTH; GRANDIS; PLANT; CAMALDULENSIS	Eucalyptus species are widely planted for reforestation in subtropical China. However, the effects of Eucalyptus plantations on the regional water use remain poorly understood. In an age sequence of 2-, 4- and 6-year-old Eucalyptus plantations, the tree water use and soil evaporation were examined by linking model estimations and field observations. Results showed that annual evapotranspiration of each age sequence Eucalyptus plantations was 876.7, 944.1 and 1000.7 mm, respectively, accounting for 49.81%, 53.64% and 56.86% of the annual rainfall. In addition, annual soil evaporations of 2-, 4- and 6-year-old were 318.6, 336.1, and 248.7 mm of the respective Eucalyptus plantations. Our results demonstrated that Eucalyptus plantations would potentially reduce water availability due to high evapotranspiration in subtropical regions. Sustainable management strategies should be implemented to reduce water consumption in Eucalyptus plantations in the context of future climate change scenarios such as drought and warming.	[Liu, Wenfei; Wu, Jianping; Fan, Houbao; Duan, Honglang; Yuan, Yinghong; Zhang, Hao] Nanchang Inst Technol, Jiangxi Prov Key Lab Restorat Degraded Ecosyst &, Nanchang, Jiangxi, Peoples R China; [Li, Qiang] Univ British Columbia Okanagan, Dept Earth Environm & Geog Sci, Kelowna, BC, Canada	Nanchang Institute Technology; University of British Columbia; University of British Columbia Okanagan	Fan, HB (corresponding author), Nanchang Inst Technol, Jiangxi Prov Key Lab Restorat Degraded Ecosyst &, Nanchang, Jiangxi, Peoples R China.	hbfan@nit.edu.cn	Fan, houbao/GQZ-7022-2022	Li, Qiang/0000-0003-2221-6905	National Science Foundation of China [31160153]; Jiangxi Provincial Department of Education [KJLD12097, GJJ14744]; Gan-po 555 Talent Project; Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines [20162BCB22021]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Department of Education; Gan-po 555 Talent Project; Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines	This work was financially supported by the National Science Foundation of China (No. 31160153), Jiangxi Provincial Department of Education (KJLD12097; GJJ14744), Gan-po 555 Talent Project and Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines (20162BCB22021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the editor and all anonymous reviewers for their helpful comments on the manuscript. We thank Yingchun Liao for her field help. This work was financially supported by the National Science Foundation of China (No. 31160153), Jiangxi Provincial Department of Education (KJLD12097; GJJ14744), Gan-po 555 Talent Project and Jiangxi Provincial Fund for Academic and Technical Leadership of Major Disciplines (20162BCB22021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; [Anonymous], 2001, CHINESE SOIL TAXOMOM; Benyon RG, 1999, AGR WATER MANAGE, V39, P229, DOI 10.1016/S0378-3774(98)00080-8; Bren L, 2010, J HYDROL, V384, P52, DOI 10.1016/j.jhydrol.2010.01.007; Cabral OMR, 2010, J HYDROL, V388, P208, DOI 10.1016/j.jhydrol.2010.04.041; Chen H, 1995, ADV WATERENCE; Chen JM, 2013, J FUJIAN FORESTRY SC, V40, P6; Chen YQ, 2015, FORESTS, V6, P794, DOI 10.3390/f6030794; Cramer VA, 1999, AGR WATER MANAGE, V39, P187, DOI 10.1016/S0378-3774(98)00078-X; Cui XiangHui, 2006, Scientia Silvae Sinicae, V42, P8; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Dye P, 2013, FOREST ECOL MANAG, V301, P51, DOI 10.1016/j.foreco.2012.08.027; DYE PJ, 1993, PLANT CELL ENVIRON, V16, P45, DOI 10.1111/j.1365-3040.1993.tb00843.x; Engel V, 2005, WATER RESOUR RES, V41, P3053; Fan HB, 2015, PLANT SOIL, V392, P127, DOI 10.1007/s11104-015-2444-2; [冯建设 Feng Jianshe], 2011, [应用气象学报, Journal of Applied Meteorolgical Science], V22, P766; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Forrester DI, 2010, FOREST ECOL MANAG, V259, P1754, DOI 10.1016/j.foreco.2009.04.023; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIGATION DRAINAG, V129, P187; Hua Lei, 2014, Yingyong Shengtai Xuebao, V25, P1639; Hubbard RM, 2010, FOREST ECOL MANAG, V259, P1714, DOI 10.1016/j.foreco.2009.10.028; HULME M, 1992, CLIM DYNAM, V7, P57, DOI 10.1007/BF00209609; IPCC, 2007, CLIM CHANG 2007 PHYS; Kallarackal J, 1997, TREE PHYSIOL, V17, P195; Li Q, 2014, AGR ECOSYST ENVIRON, V196, P114, DOI 10.1016/j.agee.2014.06.028; LIMA W P, 1984, IPEF (Instituto de Pesquisas e Estudos Florestais), P11; Liu XD, 2015, ECOHYDROLOGY, V8, P1037, DOI 10.1002/eco.1561; Morris J, 2004, TREE PHYSIOL, V24, P1035, DOI 10.1093/treephys/24.9.1035; Myers BJ, 1996, TREE PHYSIOL, V16, P211; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Roberts S, 2001, FOREST ECOL MANAG, V143, P153, DOI 10.1016/S0378-1127(00)00514-4; Rodriguez-Suarez JA, 2011, J HYDROL, V396, P321, DOI 10.1016/j.jhydrol.2010.11.027; Sankarasubramanian A, 2001, WATER RESOUR RES, V37, P1771, DOI 10.1029/2000WR900330; Scott DF, 1998, WATER SA, V24, P187; Scott DF, 2008, WATER RESOUR RES, V44, P297; Shi ZhongJie, 2009, Scientia Silvae Sinicae, V45, P135; Soares JV, 2001, J HYDROL, V253, P130, DOI 10.1016/S0022-1694(01)00477-2; Stape JL, 2010, FOREST ECOL MANAG, V259, P1684, DOI 10.1016/j.foreco.2010.01.012; STATE FOREST RESOURCES ADMINISTRATIONPRC'S MINISTRY OF FORESTRY [Guojia linyeju senlin ziyuan guanglisi], 2010, FOREST RESOURCES MAN, V1, P1; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Wang FM, 2013, PLANT SOIL, V364, P207, DOI 10.1007/s11104-012-1353-x; Wang FM, 2010, RESTOR ECOL, V18, P313, DOI 10.1111/j.1526-100X.2009.00642.x; Wang HF, 2011, NEW FOREST, V42, P101, DOI 10.1007/s11056-010-9240-x; White DA, 2014, FOREST ECOL MANAG, V331, P272, DOI 10.1016/j.foreco.2014.08.020; Wu JP, 2015, ENVIRON MANAGE, V56, P1244, DOI 10.1007/s00267-015-0578-x; Wu JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06262; [闫俊华 Yan Junhua], 2003, [生态学报, Acta Ecologica Sinica], V23, P2359; Yang MS, 2011, RES EUCALYPTUS CHINA; Yu Z. Y., 1985, TROPICAL SUBTROPICAL, V3, P97, DOI DOI 10.1111/NPH.14119; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang Ning-Nan, 2007, Forest Research, V20, P1; Zhao CJ, 2015, ACTA ECOLOGICA SINIC, V35, P692; [赵从举 Zhao Congju], 2015, [生态学报, Acta Ecologica Sinica], V35, P1734; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128	57	17	19	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174208	10.1371/journal.pone.0174208	http://dx.doi.org/10.1371/journal.pone.0174208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399174	Green Submitted, gold, Green Published			2022-12-26	WOS:000399949000008
J	Pironti, A; Pfeifer, N; Walter, H; Jensen, BEO; Zazzi, M; Gomes, P; Kaiser, R; Lengauer, T				Pironti, Alejandro; Pfeifer, Nico; Walter, Hauke; Jensen, Bjorn-Erik O.; Zazzi, Maurizio; Gomes, Perpetua; Kaiser, Rolf; Lengauer, Thomas			Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; COMPUTATIONAL MODELS; PHENOTYPIC RESISTANCE; HIV-INFECTION; MUTATIONS; PROTEASE; RECOMMENDATIONS; PERFORMANCE; ZIDOVUDINE	Antiretroviral treatment history and past HIV-1 genotypes have been shown to be useful predictors for the success of antiretroviral therapy. However, this information may be unavailable or inaccurate, particularly for patients with multiple treatment lines often attending different clinics. We trained statistical models for predicting drug exposure from current HIV-1 genotype. These models were trained on 63,742 HIV-1 nucleotide sequences derived from patients with known therapeutic history, and on 6,836 genotype-phenotype pairs (GPPs). The mean performance regarding prediction of drug exposure on two test sets was 0.78 and 0.76 (ROC-AUC), respectively. The mean correlation to phenotypic resistance in GPPs was 0.51 (PhenoSense) and 0.46 (Antivirogram). Performance on prediction of therapy-success on two test sets based on genetic susceptibility scores was 0.71 and 0.63 (ROC-AUC), respectively. Compared to geno2pheno[resistance], our novel models display a similar or superior performance. Our models are freely available on the internet via www.geno2pheno.org. They can be used for inferring which drug compounds have previously been used by an HIV-1-infected patient, for predicting drug resistance, and for selecting an optimal antiretroviral therapy. Our data-driven models can be periodically retrained without expert intervention as clinical HIV-1 databases are updated and therefore reduce our dependency on hard-to-obtain GPPs.	[Pironti, Alejandro; Pfeifer, Nico; Lengauer, Thomas] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Walter, Hauke] Med Infektiol Zentrum Berlin, Berlin, Germany; [Walter, Hauke] Med Lab Stendal, Stendal, Germany; [Jensen, Bjorn-Erik O.] Univ Clin Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Gomes, Perpetua] HEM Ctr Hosp Lisboa Ocidental, SPC, LMCBM, Lab Biol Mol, Lisbon, Portugal; [Gomes, Perpetua] Inst Super Ciencias Saude Sul, CiiEM, Caparica, Portugal; [Kaiser, Rolf] Univ Clin Cologne, Inst Virol, Cologne, Germany	Max Planck Society; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Siena; University of Cologne	Pironti, A (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	apironti@mpi-inf.mpg.de	Pfeifer, Nico/G-1559-2016; Zazzi, Maurizio/K-3422-2018; Gomes, Perpetua/I-5652-2012	Zazzi, Maurizio/0000-0002-0344-6281; Walter, Henrik/0000-0002-9403-6121; Lengauer, Thomas/0000-0003-3801-2640; Gomes, Perpetua/0000-0003-3271-8255	Bundesminiterium fur Gesundheit, HIV-HEP-MASTER [IIA5-2013-2514AUK375]; German Health Ministry [MASTER/HIV-HEP]	Bundesminiterium fur Gesundheit, HIV-HEP-MASTER; German Health Ministry [MASTER/HIV-HEP]	This work was supported by Bundesminiterium fur Gesundheit, HIV-HEP-MASTER (IIA5-2013-2514AUK375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Health Ministry [MASTER/HIV-HEP].	Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bickel S, 2008, MULTITASK LEARNING H, P56; Bogojeska J, 2012, P 15 INT C ART INT S, P118; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Faria NR, 2013, INFECT GENET EVOL J; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hachiya A, 2012, J BIOL CHEM, V287, P29988, DOI 10.1074/jbc.M112.351551; Hanna GJ, 2001, CLIN INFECT DIS, V32, P774, DOI 10.1086/319231; Hastie T., 2009, UNSUPERVISED LEARNIN; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kantor Rami, 2003, AIDS Reviews, V5, P25; Kempf DJ, 1997, ANTIMICROB AGENTS CH, V41, P654, DOI 10.1128/AAC.41.3.654; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lundgren J, 2014, GUIDELINES VERSION 7; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Obermeier M, 2012, INTERVIROLOGY, V55, P102, DOI 10.1159/000331999; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pironti A., 2016, THESIS; Platt J., PROBABILISTIC OUTPUT, P61; Prosperi MCF, 2012, AIDS REV, V14, P145; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013753; R Core Team, 2021, R LANGUAGE ENV STAT; Revell AD, 2014, HIV MED, V15, P442, DOI 10.1111/hiv.12156; Revell AD, 2014, J ANTIMICROB CHEMOTH, V69, P1104, DOI 10.1093/jac/dkt447; Revell AD, 2011, AIDS, V25, P1855, DOI 10.1097/QAD.0b013e328349a9c2; Rhee SY, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-13; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Saigo H, 2011, STAT APPL GENET MOL, P10; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Scherrer AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037983; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh K, 2014, VIRUSES-BASEL, V6, P3535, DOI 10.3390/v6093535; Svicher V, 2010, NEW MICROBIOL, V33, P195; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Theys K, 2013, FUTURE MICROBIOL, V8, P303, DOI [10.2217/FMB.13.10, 10.2217/fmb.13.10]; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wainberg MA, 2012, MOL BIOL INT, V2012, P1; Wang K, 2004, ANTIVIR THER, V9, P703; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4; Zaccarelli M, 2009, ANTIVIR THER, V14, P285; Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x; Zazzi M, 2012, INTERVIROLOGY, V55, P123, DOI 10.1159/000332008	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174992	10.1371/journal.pone.0174992	http://dx.doi.org/10.1371/journal.pone.0174992			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394945	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800012
J	Bilal, A; Dai, WH; Larson, M; Beebo, QN; Xie, QC				Bilal, Ahmed; Dai, Wenhong; Larson, Magnus; Beebo, Qaid Naamo; Xie, Qiancheng			Qualitative simulation of bathymetric changes due to reservoir sedimentation: A Japanese case study	PLOS ONE			English	Article							TRANSPORT; RAINFALL; RUNOFF; BASIN; FLOW; DAM	Sediment-dynamics modeling is a useful tool for estimating a dam's lifespan and its cost-benefit analysis. Collecting real data for sediment-dynamics analysis from conventional field survey methods is both tedious and expensive. Therefore, for most rivers, the historical record of data is either missing or not very detailed. Available data and existing tools have much potential and may be used for qualitative prediction of future bathymetric change trend. This study shows that proxy approaches may be used to increase the spatiotemporal resolution of flow data, and hypothesize the river cross-sections and sediment data. Sediment-dynamics analysis of the reach of the Tenryu River upstream of Sakuma Dam in Japan was performed to predict its future bathymetric changes using a 1D numerical model (HEC-RAS). In this case study, only annually-averaged flow data and the river's longitudinal bed profile at 5-year intervals were available. Therefore, the other required data, including river cross-section and geometry and sediment inflow grain sizes, had to be hypothesized or assimilated indirectly. The model yielded a good qualitative agreement, with an R-2 ( coefficient of determination) of 0.8 for the observed and simulated bed profiles. A predictive simulation demonstrated that the useful life of the dam would end after the year 2035 (+/- 5 years), which is in conformity with initial detailed estimates. The study indicates that a sedimentdynamic analysis can be performed even with a limited amount of data. However, such studies may only assess the qualitative trends of sediment dynamics.	[Bilal, Ahmed; Dai, Wenhong; Xie, Qiancheng] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Dai, Wenhong] State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Dai, Wenhong] Natl Engn Res Ctr Water Resources Efficient Utili, Nanjing, Jiangsu, Peoples R China; [Larson, Magnus; Beebo, Qaid Naamo] Lund Univ, Dept Water Resources Engn, Lund, Sweden	Hohai University; Lund University	Dai, WH (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.; Dai, WH (corresponding author), State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.; Dai, WH (corresponding author), Natl Engn Res Ctr Water Resources Efficient Utili, Nanjing, Jiangsu, Peoples R China.	wdai@hhu.edu.cn	Bilal, Ahmed/J-6971-2019	Bilal, Ahmed/0000-0002-6903-1126; Xie, Qiancheng/0000-0003-0820-617X	National Natural Science Foundation of China [51479071]; "111 Project" [B12032]; Jiangsu Colleges and Universities Academic Building Engineering Project [YS11001];  [2016YFC0402501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111 Project"(Ministry of Education, China - 111 Project); Jiangsu Colleges and Universities Academic Building Engineering Project; 	This research is supported by the funding received by National Key R&D Program of China (No.2016YFC0402501) to WD, National Natural Science Foundation of China (51479071) to WD, the "111 Project" (B12032) to WD and the Jiangsu Colleges and Universities Academic Building Engineering Project (YS11001) to WD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2015, HYDROL EARTH SYST SC, V19, P631, DOI 10.5194/hess-19-631-2015; Brunner G, 2010, HEC RAS RIVER ANAL S; Cheng PD, 2013, J HYDRODYN, V25, P620, DOI 10.1016/S1001-6058(11)60404-7; Fang NF, 2011, GEOMORPHOLOGY, V135, P158, DOI 10.1016/j.geomorph.2011.08.013; Gomez B, 2009, GLOBAL PLANET CHANGE, V67, P153, DOI 10.1016/j.gloplacha.2009.02.002; Hobgen SE, 2014, GEOGR ANN A, V96, P513, DOI 10.1111/geoa.12076; Huang G, 2011, WORLD J MECH, V01, P115; Ishibashi K, 2004, ANN GEOPHYS-ITALY, V47, P339; JCLD, 2009, DAMS JAP PAST PRES F; Jimenez JA, 2003, J WATERW PORT C-ASCE, V129, P70, DOI 10.1061/(ASCE)0733-950X(2003)129:2(70); Jin ZW, 2016, J HYDRODYN, V28, P153, DOI 10.1016/S1001-6058(16)60616-9; Kail J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130228; Khan MS, 2012, LIFE SCI J, V9, P221; Lopez P, 2016, SCI TOTAL ENVIRON, V540, P158, DOI 10.1016/j.scitotenv.2015.06.033; Maswood M, 2016, INT J RIVER BASIN MA, V14, P103, DOI 10.1080/15715124.2015.1089250; Melesse AM, 2011, AGR WATER MANAGE, V98, P855, DOI 10.1016/j.agwat.2010.12.012; Micic V, 2013, SCI TOTAL ENVIRON, V458, P90, DOI 10.1016/j.scitotenv.2013.03.102; Ministry of Land Insfrastructure Transport and Tourism (MLIT), 2008, WAT RES JAP; MLIT, 2007, TABL MAJ RIV JAP; Mohammad ME, 2016, SEDIMENT MOSUL DAM R, P235; Morris G.L., 1998, RESERVOIR SEDIMENTAT; Paskett CJ, 1982, WATER INT, V7, P59; Sato S, 2008, COMPREHENSIVE STUDY; Sumil T, 2004, RESERVOIR SEDIMENTAT; Swenson JB, 2005, J GEOPHYS RES-EARTH, V110, P1, DOI 10.1029/2004JF000265; Tigrek S., 2011, RESERVOIR SEDIMENT M; Toffaleti F.B., 1968, PROCEDURE COMPUTATIO; Tuset J, 2016, SCI TOTAL ENVIRON, V540, P114, DOI 10.1016/j.scitotenv.2015.07.075; Van Rijn LC, 1989, HDB SEDIMENT TRANSPO; Wang C, 2015, J HYDRODYN, V27, P24, DOI 10.1016/S1001-6058(15)60453-X; Wang F, 2015, SCI TOTAL ENVIRON, V508, P166, DOI 10.1016/j.scitotenv.2014.11.055; Zeleke Takele, 2013, Lakes & Reservoirs Research and Management, V18, P366, DOI 10.1111/lre.12047	32	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174931	10.1371/journal.pone.0174931	http://dx.doi.org/10.1371/journal.pone.0174931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384361	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900057
J	Gautschi, I; van Bemmelen, MX; Schild, L				Gautschi, Ivan; van Bemmelen, Miguel Xavier; Schild, Laurent			Proton and non-proton activation of ASIC channels	PLOS ONE			English	Article							SENSING ION CHANNELS; NA+ CHANNEL	The Acid-Sensing Ion Channels (ASIC) exhibit a fast desensitizing current when activated by pH values below 7.0. By contrast, non-proton ligands are able to trigger sustained ASIC currents at physiological pHs. To analyze the functional basis of the ASIC desensitizing and sustained currents, we have used ASIC1a and ASIC2a mutants with a cysteine in the pore vestibule for covalent binding of different sulfhydryl reagents. We found that ASIC1a and ASIC2a exhibit two distinct currents, a proton-induced desensitizing current and a sustained current triggered by sulfhydryl reagents. These currents differ in their pH dependency, their sensitivity to the sulfhydryl reagents, their ionic selectivity and their relative magnitude. We propose a model for ASIC1 and ASIC2 activity where the channels can function in two distinct modes, a desensitizing mode and a sustained mode depending on the activating ligands. The pore vestibule of the channel represents a functional site for binding non-proton ligands to activate ASIC1 and ASIC2 at neutral pH and to prevent channel desensitization.	[Gautschi, Ivan; van Bemmelen, Miguel Xavier; Schild, Laurent] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Laurent.Schild@unil.ch			Swiss National Fund [310030_135378]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Fund (www.snf.ch), grant number 310030_135378 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Browne LE, 2014, P NATL ACAD SCI USA, V111, P521, DOI 10.1073/pnas.1318582111; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Roy S, 2013, FASEB J; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; van Bemmelen MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135191; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175293	10.1371/journal.pone.0175293	http://dx.doi.org/10.1371/journal.pone.0175293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384246	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900148
J	Gretscher, H; Tempelmann, S; Haun, DBM; Liebal, K; Kaminski, J				Gretscher, Heinz; Tempelmann, Sebastian; Haun, Daniel B. M.; Liebal, Katja; Kaminski, Juliane			Prelinguistic human infants and great apes show different communicative strategies in a triadic request situation	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; GESTURAL COMMUNICATION; AUDITORY INFORMATION; POINT; ATTENTION; EYES; EVOLUTION; IMPACT; OTHERS; ACT	In the present research, we investigate the communicative strategies of 20 month old human infants and great apes when requesting rewards from a human experimenter. Infants and apes both adapted their signals to the attentional state of the experimenter as well as to the location of the reward. Yet, while infants frequently positioned themselves in front of the experimenter and pointed towards a distant reward, apes either remained in the experimenter's line of sight and pointed towards him or moved out of sight and pointed towards the reward. Further, when pointing towards a reward that was placed at a distance from the experimenter, only the infants, and not the apes, took the experimenter's attentional state into account. These results demonstrate that prelinguistic human infants and nonhuman apes use different means when guiding others' attention to a location; indicating that differing cognitive mechanisms may underlie their pointing gestures.	[Gretscher, Heinz; Kaminski, Juliane] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Tempelmann, Sebastian] Univ Appl Sci & Arts Northwestern Switzerland, Liestal, Switzerland; [Tempelmann, Sebastian; Liebal, Katja] Free Univ Berlin, Cluster Languages Emot, Berlin, Germany; [Haun, Daniel B. M.] Univ Leipzig, Leipzig Res Ctr Early Child Dev, Leipzig, Germany; [Haun, Daniel B. M.] Univ Leipzig, Dept Early Child Dev & Culture, Leipzig, Germany; [Kaminski, Juliane] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England	Max Planck Society; Free University of Berlin; Leipzig University; Leipzig University; University of Portsmouth	Gretscher, H (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	heinz.gretscher@gmx.de	Liebal, Katja/AAQ-7910-2020	Liebal, Katja/0000-0003-2447-8327	VolkswagenStiftung, Germany	VolkswagenStiftung, Germany(Volkswagen)	This research is part of the project 'Evolutionary Roots of Human Social Interaction (ROSI),' which was funded by the VolkswagenStiftung, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONCOHEN S, 1989, BRIT J DEV PSYCHOL, V7, P113, DOI 10.1111/j.2044-835X.1989.tb00793.x; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Bates D, LME4 LINEAR MIXED EF; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Brauer J, 2008, ANIM COGN, V11, P175, DOI 10.1007/s10071-007-0097-0; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Camaioni L., 1993, NEW PERSPECTIVES EAR, P82; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; D'Entremont B, 2007, CHILD DEV, V78, P723, DOI 10.1111/j.1467-8624.2007.01026.x; Deak GO, 2000, DEV PSYCHOL, V36, P511, DOI 10.1037/0012-1649.36.4.511; Douglas PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13999; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gomez J, 2005, GESTURE, V5, P91, DOI [10.1075/gest.5.1-2.08gom, DOI 10.1075/GEST.5.1.08GOM, DOI 10.1075/GEST.5.1-2.08GOM]; Grosse G, 2010, DEV PSYCHOL, V46, P1710, DOI 10.1037/a0020727; Halina M, 2016, APE POINTING M UNPUB; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hobaiter C, 2014, J COMP PSYCHOL, V128, P82, DOI 10.1037/a0033757; Hopkins WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079338; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Knudsen B, 2013, J COGN DEV, V14, P424, DOI 10.1080/15248372.2012.689387; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 2015, CHILD DEV, V86, P1623, DOI 10.1111/cdev.12404; Leavens DA, 2011, J COGN EDUC PSYCHOL, V10, P9, DOI 10.1891/1945-8959.10.1.9; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Legerstee M., 2008, FIRST LANG, V28, P281, DOI DOI 10.1177/0142723708091045; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Liszkowski U, 2007, J CHILD LANG, V34, P1, DOI 10.1017/S0305000906007689; Liszkowski U, 2011, J COGN EDUC PSYCHOL, V10, P32, DOI 10.1891/1945-8959.10.1.32; Liszkowski U, 2009, PSYCHOL SCI, V20, P654, DOI 10.1111/j.1467-9280.2009.02346.x; Lyn H, 2010, PSYCHOL SCI, V21, P360, DOI 10.1177/0956797610362218; Melis AP, 2006, J COMP PSYCHOL, V120, P154, DOI 10.1037/0735-7036.120.2.154; Melis AP, 2010, DEVELOPMENTAL SCI, V13, P479, DOI 10.1111/j.1467-7687.2009.00892.x; Menzel E. W., 1973, PRECULTURAL PRIMATE, P192; Moll H, 2004, DEVELOPMENTAL SCI, V7, pF1, DOI 10.1111/j.1467-7687.2004.00315.x; Moll H, 2014, J COGN DEV, V15, P12, DOI 10.1080/15248372.2012.710865; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Plooij FX., 1978, ACTION GESTURE SYMBO, P111; Povinelli DJ, 1996, MONOGR SOC RES CHILD, V61, P1, DOI 10.1111/j.1540-5834.1996.tb00481.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rivas E, 2005, J COMP PSYCHOL, V119, P404, DOI 10.1037/0735-7036.119.4.404; Roberts AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4088; Russell JL, 2005, ANIM COGN, V8, P263, DOI 10.1007/s10071-005-0253-3; Shwe HI, 1997, DEV PSYCHOL, V33, P630, DOI 10.1037/0012-1649.33.4.630; Tempelmann S, 2013, INTERACT STUD, V14, P7, DOI 10.1075/is.14.1.02tem; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Tomasello M, 1997, HUM DEV, V40, P7, DOI 10.1159/000278540; Tomasello M, 2007, CHILD DEV, V78, P705, DOI 10.1111/j.1467-8624.2007.01025.x; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van der Goot MH, 2014, CHILD DEV, V85, P444, DOI 10.1111/cdev.12141; Weatherall D., 2006, USE NONHUMAN PRIMATE; Williamson RA, 2015, J COGN DEV, V16, P252, DOI 10.1080/15248372.2013.824884; Zimmermann F, 2009, ANIM COGN, V12, P347, DOI 10.1007/s10071-008-0194-8	66	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175227	10.1371/journal.pone.0175227	http://dx.doi.org/10.1371/journal.pone.0175227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384300	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900127
J	Hinnouho, GM; Singh-Manoux, A; Gueguen, A; Matta, J; Lemogne, C; Goldberg, M; Zins, M; Czernichow, S				Hinnouho, Guy-Marino; Singh-Manoux, Archana; Gueguen, Alice; Matta, Joane; Lemogne, Cedric; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien			Metabolically healthy obesity and depressive symptoms: 16-year follow-up of the Gazel cohort study	PLOS ONE			English	Article							RISK; OVERWEIGHT; ASSOCIATION; ADOLESCENTS; MORTALITY; DISEASE; WEIGHT; PEOPLE	Aims The health correlates of the metabolically healthy obese (MHO) phenotype, particularly in relation to depressive symptoms remains unclear. Accordingly, we examined the risk of depressive symptoms in this phenotype using a 16-year follow-up prospective study. Methods A sample of 14 475 participants (75% men), aged 44-59 years in 1996, was drawn from the Gazel cohort. Obesity was defined as body mass index (BMI) >= 30 kg/m(2) and metabolic health as having none of the self-reported following cardiovascular risk factors: hypertension, type 2 diabetes and dyslipidemia. Depressive symptoms were assessed by the Center for Epidemiologic Studies Depression (CES-D) scale in 1996, 1999, 2002, 2005, 2008 and 2012. Generalized Estimating Equations (GEE) were used to estimate the risk of depressive symptoms during a follow-up of 16 years. Results In multivariate analyses, metabolically unhealthy normal weight [Odds Ratio (OR) = 1.37; 95% Confidence Interval (CI): 1.25-1.51], overweight [1.44 (1.31-1.59)] and obese [1.30 (1.10-1.54)] but not MHO participants [1.04 (0.81-1.32)] had higher risk of depressive symptoms at the start of follow-up compared to metabolically healthy normal weight individuals. Depressive symptoms decreased over time in metabolically healthy normal weight individuals [0.52 (0.50-0.55)], this decrease was less marked only in metabolically unhealthy obese participants [1.22 (1.07-1.40)]. Compared to MHO participants, metabolically unhealthy obese individuals were at increased risk of depression at the start of follow-up, but with a similar reduction of this risk over time. Conclusion Poor metabolic health, irrespective of BMI was associated with greater depressive symptoms at the start of follow-up, whereas a poorer course of depressive symptoms over time was observed only in those with both obesity and poor metabolic health.	[Hinnouho, Guy-Marino; Gueguen, Alice; Matta, Joane; Goldberg, Marcel; Zins, Marie; Czernichow, Sebastien] INSERM, UMS 011, Villejuif, France; [Hinnouho, Guy-Marino; Singh-Manoux, Archana] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Hinnouho, Guy-Marino; Singh-Manoux, Archana; Goldberg, Marcel; Zins, Marie] Univ Versailles St Quentin Yvelines, Versailles, France; [Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Matta, Joane] Holy Spirit Univ, Dept Nutr, Jounieh, Lebanon; [Lemogne, Cedric; Czernichow, Sebastien] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Lemogne, Cedric] Hop Univ Paris Ouest, AP HP, Serv Psychiat Adulte & Sujet Age, Paris, France; [Lemogne, Cedric] Inserm U894, Ctr Psychiat & Neurosci, Paris, France; [Czernichow, Sebastien] Hop Europeen Georges Pompidou, Dept Nutr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Czernichow, S (corresponding author), INSERM, UMS 011, Villejuif, France.; Czernichow, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France.; Czernichow, S (corresponding author), Hop Europeen Georges Pompidou, Dept Nutr, Paris, France.	sebastien.czernichow@aphp.fr	Zins, Marie/AAX-6551-2021; Singh-Manoux, Archana/F-6804-2013; Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019	Singh-Manoux, Archana/0000-0002-1244-5037; Goldberg, Marcel/0000-0002-6161-5880; 	Electricite de France-Gaz de France; INSERM; 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); EDF-GDF (Electricite De France-Gaz De France); INSERM (Institut National de la Sante et de la Recherche Medicale)	Electricite de France-Gaz de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); EDF-GDF (Electricite De France-Gaz De France); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The GAZEL Cohort Study was funded by Electricite de France-Gaz de France and INSERM, and received grants from the 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).; The authors express their thanks to EDF-GDF (Electricite De France-Gaz De France), especially to the Service General de Medecine de Controle, and to the "Caisse centrale d'action sociale du personnel des industries electrique et gaziere". We also wish to acknowledge the Population-based Cohort Unit, UMS 011 INSERM Versailles St-Quentin University responsible for the GAZEL database management. The GAZEL Cohort Study was funded by EDF-GDF (Electricite De France-Gaz De France) and INSERM (Institut National de la Sante et de la Recherche Medicale), and received grants from the 'Cohortes Sante' TGIR Program' Agence nationale de la recherche' (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET).	Akbaraly TN, 2009, DIABETES CARE, V32, P499, DOI 10.2337/dc08-1358; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Despres JP, 2012, J CLIN ENDOCR METAB, V97, P2283, DOI 10.1210/jc.2012-2081; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Hamer M, 2012, MOL PSYCHIATR, V17, P940, DOI 10.1038/mp.2012.30; Hinnouho GM, 2014, EUR HEART J; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Jokela M, 2013, MOL PSYCHIAT; Koenigsberg HW, 2004, J PSYCHIATR RES, V38, P503, DOI 10.1016/j.jpsychires.2004.03.006; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melchior M, 2010, PSYCHIAT RES, V177, P92, DOI 10.1016/j.psychres.2009.08.002; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y	31	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174678	10.1371/journal.pone.0174678	http://dx.doi.org/10.1371/journal.pone.0174678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384219	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900026
J	Hoopes, SL; Gruzdev, A; Edin, ML; Graves, JP; Bradbury, JA; Flake, GP; Lih, FB; DeGraff, LM; Zeldin, DC				Hoopes, Samantha L.; Gruzdev, Artiom; Edin, Matthew L.; Graves, Joan P.; Bradbury, J. Alyce; Flake, Gordon P.; Lih, Fred B.; DeGraff, Laura M.; Zeldin, Darryl C.			Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; CYTOCHROME-P450 EPOXYGENASES; HYPERPOLARIZING FACTORS; IDENTIFICATION; ANGIOGENESIS; METHYLATION; RECOVERY; HEART; ACIDS	Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid into epoxyeicosatrienoic acids (EETs), which play an important role in blood pressure regulation, protection against ischemia-reperfusion injury, angiogenesis, and inflammation. Epoxide hydrolases metabolize EETs to their corresponding diols (dihydroxyeicosatrienoic acids; DHETs) which are biologically less active. Microsomal epoxide hydrolase (EPHX1, mEH) and soluble epoxide hydrolase (EPHX2, sEH) were identified >30 years ago and are capable of hydrolyzing EETs to DHETs. A novel epoxide hydrolase, EPHX3, was recently identified by sequence homology and also exhibits epoxide hydrolase activity in vitro with a substrate preference for 9,10-epoxyoctadecamonoenoic acid (EpOME) and 11,12-EET. EPHX3 is highly expressed in the skin, lung, stomach, esophagus, and tongue; however, its endogenous function is unknown. Therefore, we investigated the impact of genetic disruption of Ephx3 on fatty acid epoxide hydrolysis and EET-related physiology in mice. Ephx3(-/-) mice were generated by excising the promoter and first four exons of the Ephx3 gene using Cre-LoxP methodology. LC-MS/MS analysis of Ephx3(-/-) heart, lung, and skin lysates revealed no differences in endogenous epoxide: diol ratios compared to wild type (WT). Ephx3(-/-) mice also exhibited no change in plasma levels of fatty acid epoxides and diols relative to WT. Incubations of cytosolic and microsomal fractions prepared from Ephx3(-/-) and WT stomach, lung, and skin with synthetic 8,9-EET, 11,12-EET, and 9,10-EpOME revealed no significant differences in rates of fatty acid diol formation between the genotypes. Ephx3(-/-) hearts had similar functional recovery compared to WT hearts following ischemia/reperfusion injury. Following intranasal lipopolysaccharide (LPS) exposure, Ephx3(-/-) mice were not different from WT in terms of lung histology, bronchoalveolar lavage fluid cell counts, or fatty acid epoxide and diol levels. We conclude that genetic disruption of Ephx3 does not result in an overt phenotype and has no significant effects on the metabolism of EETs or EpOMEs in vivo.	[Hoopes, Samantha L.; Gruzdev, Artiom; Edin, Matthew L.; Graves, Joan P.; Bradbury, J. Alyce; Flake, Gordon P.; Lih, Fred B.; DeGraff, Laura M.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, POB 12233, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	National Institute of Environmental Health Sciences [Z01ES025034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES103005, ZIAES025034, Z01ES025034, ZICES102546, ZIAES103005] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (Z01ES025034 to D.C.Z.).	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Arand M, 2003, DRUG METAB REV, V35, P365, DOI 10.1081/DMR-120026498; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Decker M, 2012, J LIPID RES, V53, P2038, DOI 10.1194/jlr.M024448; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Harris TR, 2008, ARCH BIOCHEM BIOPHYS, V472, P139, DOI 10.1016/j.abb.2008.01.016; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Larsen BT, 2008, CIRC RES, V102, P59, DOI 10.1161/CIRCRESAHA.107.159129; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175348	10.1371/journal.pone.0175348	http://dx.doi.org/10.1371/journal.pone.0175348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384353	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900162
J	Ma, GW; Chu, YK; Zhang, WJ; Qin, FY; Xu, SS; Yang, H; Rong, EG; Du, ZQ; Wang, SZ; Li, H; Wang, N				Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Yang, Hua; Rong, En-Guang; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning			Polymorphisms of FST gene and their association with wool quality traits in Chinese Merino sheep	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; FOLLISTATIN; IDENTIFICATION; EXPRESSION; ACTIVINS; PATTERNS; DEFECTS; PROTEIN; BRAIN	Follistatin (FST) is involved in hair follicle morphogenesis. However, its effects on hair traits are not clear. This study was designed to investigate the effects of FSTgene single nucleotide polymorphisms (SNP) on wool quality traits in Chinese Merino sheep (Junken Type). We performed gene expression analysis, SNP detection, and association analysis of FST gene with sheep wool quality traits. The real-time RT-PCR analysis showed that FSTgene was differentially expressed in adult skin between Chinese Merino sheep (Junken Type) and Suffolk sheep. Immunostaining showed that FST was localized in inner root sheath (IRS) and matrix of hair follicle (HF) in both SF and Suffolk sheep. Sequencing analysis identified a total of seven SNPs (termed SNPs 1-7) in the FSTgene in Chinese Merino sheep (Junken Type). Association analysis showed that SNP2 (Chr 16. 25,633,662 G>A) was significantly associated with average wool fiber diameter, wool fineness SD, and wool crimp (P < 0.05). SNP4 (Chr 16. 25,633,569 C>T) was significantly associated with wool fineness SD and CV of fiber diameter (P < 0.05). Similarly, the haplotypes derived from these seven identified SNPs were also significantly associated with average wool fiber diameter, wool fineness SD, CV of fiber diameter, and wool crimp (P < 0.05). Our results suggest that FST influences wool quality traits and its SNPs 2 and 4 might be useful markers for marker-assisted selection and sheep breeding.	[Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Ma, Guang-Wei; Chu, Yan-Kai; Zhang, Wen-Jian; Qin, Fei-Yue; Xu, Song-Song; Du, Zhi-Qiang; Wang, Shou-Zhi; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Yang, Hua] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi, Peoples R China; [Rong, En-Guang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University	Wang, N (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.	wangning@neau.edu.cn			Domain Specific projects for transgenic biological breeding [2014ZX08009-002, 2009ZX08009-160B]; National High Technology Research and Development Program of China (863 program) [2013AA102506]; Postgraduate Technology Innovation Project of Northeast Agricultural University [yjscx14006]	Domain Specific projects for transgenic biological breeding; National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Postgraduate Technology Innovation Project of Northeast Agricultural University	This study was supported by Domain Specific projects for transgenic biological breeding (2014ZX08009-002 and 2009ZX08009-160B), The National High Technology Research and Development Program of China (863 program) (grant no. 2013AA102506) and Postgraduate Technology Innovation Project of Northeast Agricultural University (yjscx14006).	Chen HY, 2011, INDIAN J ANIM SCI, V81, P391; Correa AM, 2016, GENETICS AND MOLECUL, V15; Cottle D., 2010, INT SHEEP WOOL HDB, VVolume 1, P711; De Marco P, 2006, BIRTH DEFECTS RES A, V76, P86, DOI 10.1002/bdra.20225; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gan W, 2015, GENET MOL RES, V14, P6699, DOI 10.4238/2015.June.18.14; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Jakubauskiene E, 2012, FEBS LETT, V586, P3698, DOI 10.1016/j.febslet.2012.08.028; Jhaveri S, 1998, MOL CELL NEUROSCI, V12, P206, DOI 10.1006/mcne.1998.0710; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; KONDO S, 1989, BIOCHEM BIOPH RES CO, V161, P1267, DOI 10.1016/0006-291X(89)91379-X; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lembeye F, 2014, ARCH MED VET, V46, P103, DOI 10.4067/S0301-732X2014000100014; Ling YH, 2014, GENET MOL RES, V13, P5617, DOI 10.4238/2014.July.25.17; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Michael RG, 2014, MOL CLONING LAB MANU; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; NAYLOR GRS, 1995, WOOL TECH SHEEP BREE, V43, P254; Patel K, 1998, INT J BIOCHEM CELL B, V30, P1087, DOI 10.1016/S1357-2725(98)00064-8; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rong EG, 2015, J ANIM SCI, V93, P4601, DOI 10.2527/jas.2015-8963; Shi G. Q., 2010, GRASS FEED LIVEST, V2, P4; Strucken EM, 2014, J ANIM SCI, V92, P1939, DOI 10.2527/jas.2013-7247; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Zhang YR, 2014, GENET MOL RES, V13, P8105, DOI 10.4238/2014.October.7.5; Zhou H, 2015, J ANIM BREED GENET, V132, P301, DOI 10.1111/jbg.12138; Zou C, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080203	32	15	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174868	10.1371/journal.pone.0174868	http://dx.doi.org/10.1371/journal.pone.0174868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384189	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900046
J	Nijland, H; Gerbers, JG; Bulstra, SK; Overbosch, J; Stevens, M; Jutte, PC				Nijland, H.; Gerbers, J. G.; Bulstra, S. K.; Overbosch, J.; Stevens, M.; Jutte, P. C.			Evaluation of accuracy and precision of CT-guidance in Radiofrequency Ablation for osteoid osteoma in 86 patients	PLOS ONE			English	Article								Background and purpose Osteoid osteoma is a benign skeletal tumour that accounts for 2-3% of all bone tumours. The male-to-female ratio is around 4: 1 and it predominates in children and young adults. The most common symptom is pain, frequently at night-time. Historically the main form of treatment has been surgical excision. With the development of Radiofrequency Ablation (RFA) there is a percutaneus alternative. Success rates of RFA are lower but the main advantage is the minimal invasive character of the therapy and the low complication rate. As a result of the minimal invasiveness the hospitalization-and rehabilitation periods are relatively short. However, in current literature no values for accuracy and precision are known for the CT-guided positioning. Methods Accuracy and precision of the needle position are determined for 86 procedures. Furthermore the population is divided into groups based on tumour diameter, location and procedure outcome. Results The clinical success rate was 81.4%. In 79% of procedures complete ablation was achieved. Accuracy was 2.84 mm on average, precision was 2.94 mm. Accuracy was significantly lower in more profound lesions. Accuracy in tibia and fibula was significantly higher compared to the femur. No significant difference was found between different tumour diameters. Interpretation The accuracy and precision found are considered good. Needle position is of major importance for procedure outcomes. The question however rises how the results of this therapy will turn out in treatment of larger tumours.	[Nijland, H.; Gerbers, J. G.; Bulstra, S. K.; Stevens, M.; Jutte, P. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Overbosch, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Nijland, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	h.nijland@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; jutte, paul/0000-0002-6022-2807; Nijland, Hendricus/0000-0002-0130-2452				Busser WMH, 2011, CARDIOVASC INTER RAD, V34, P180, DOI 10.1007/s00270-010-9950-7; Cantwell CP, 2004, EUR RADIOL, V14, P607, DOI 10.1007/s00330-003-2171-6; Ghanem I, 2006, CURR OPIN PEDIATR, V18, P36, DOI 10.1097/01.mop.0000193277.47119.15; KRANSDORF MJ, 1991, RADIOGRAPHICS, V11, P671, DOI 10.1148/radiographics.11.4.1887121; Okada Kiyoshi, 2014, Eur J Orthop Surg Traumatol, V24, P231, DOI 10.1007/s00590-013-1180-7; Rachbauer F, 2003, ARCH ORTHOP TRAUM SU, V123, P86, DOI 10.1007/s00402-003-0478-z; Rosenthal DI, 2003, RADIOLOGY, V229, P171, DOI 10.1148/radiol.2291021053; ROSENTHAL DI, 1992, RADIOLOGY, V183, P29, DOI 10.1148/radiology.183.1.1549690; Toothaker LE., 1991, MULTIPLE COMP RES, P37; Widmann G, 2013, INT J MED ROBOT COMP, V9, P274, DOI 10.1002/rcs.1435	10	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0169171	10.1371/journal.pone.0169171	http://dx.doi.org/10.1371/journal.pone.0169171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384223	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900001
J	Then, CK; Chi, NF; Chung, KH; Kuo, L; Liu, KH; Hu, CJ; Shen, SC; Lin, YK				Then, Chee-Kin; Chi, Nai-Fang; Chung, Kuo-Hsuan; Kuo, Lynn; Liu, Kao-Hui; Hu, Chaur-Jong; Shen, Shing-Chuan; Lin, Yen-Kuang			Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan	PLOS ONE			English	Article							POPULATION-BASED COHORT; DEPRESSIVE SYMPTOMS; ALZHEIMER-DISEASE; TEMPORAL RELATIONSHIP; CELL-PROLIFERATION; BIPOLAR DISORDER; MAJOR DEPRESSION; SERTRALINE; STRESS; MEDICATIONS	Depression and dementia are common mental health problems and are associated in several ways. Early-life depression is associated with increased risk of later life dementia, and depression can present as a preclinical symptom or consequence of dementia. Despite the plausible relationship between these two clinical entities, the potential association between antidepressant medication and dementia has rarely been investigated. We conducted a 9-year retrospective analysis of Taiwan's National Health Insurance Research Database (NHIRD), enrolling 5819 cases who had received prescriptions of antidepressants between 2003 and 2006, and 23,276 (with ratio of 1: 4) age, sex, and index date-matched controls. The hazard ratio (HR) of dementia among antidepressant users with depression was 2.42 (95% confidence interval (CI): 1.15-5.10), for those without depression was 4.05 (95% CI: 3.19-5.15), compared to antidepressant non-users respectively. Among the 6 classes of common antidepressants used in Taiwan, the adjusted HRs were 3.66 (95% CI: 2.62-5.09) for SSRIs, 4.73 (95% CI: 2.54-8.80) for SNRI, 3.26 (95% CI: 2.30-4.63) for TCAs, 6.62 (95% CI: 3.34-13.13) for TeCA, 4.94 (95% CI: 2.17-11.24) for MAOI, and 4.48 (95% CI: 3.13-6.40) for SARI. Furthermore, the multivariate analysis result showed that the adjusted HRs of cumulative defined daily doses (cDDDs) were 3.74 (95% CI: 2.91-4.82), 3.73 (95% CI: 2.39-5.80) and 5.22 (95% CI: 3.35-8.14) for those who had cDDDs of <90, 90-180 and >180 compared to those who had taken no antidepressant medication. This is a retrospective study based on secondary data, hence, we could not claim causality between antidepressant medication and dementia. However, a potential association between antidepressant and occurrence of dementia after controlling for the status of depression was observed. Lack of patients' data about smoking status and body mass index in NHIRD, which are considered related to dementia, was also a limitation in this study. In this study, we concluded that antidepressant medication is a potential risk factor for dementia, independent from any effect of depression itself.	[Then, Chee-Kin] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Then, Chee-Kin; Shen, Shing-Chuan] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Coll Med, Taipei, Taiwan; [Chi, Nai-Fang; Hu, Chaur-Jong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Chung, Kuo-Hsuan] Taipei Med Univ, Sch Med, Dept Psychiat, Coll Med, Taipei, Taiwan; [Kuo, Lynn] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Liu, Kao-Hui] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, Taipei, Taiwan; [Liu, Kao-Hui] Natl Taiwan Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; University of Connecticut; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University	Shen, SC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.; Lin, YK (corresponding author), Taipei Med Univ, Biostat Ctr, Taipei, Taiwan.	scshen@tmu.edu.tw; robbinlin@tmu.edu.tw	Chi, Nai-Fang/E-2851-2017; Chi, Nai-Fang/G-3561-2016; Kuo, Lynn/AAQ-6409-2021	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; Kuo, Lynn/0000-0002-1903-4425; Chung, Kuo-Hsuan/0000-0002-5570-3972; Then, Chee Kin/0000-0003-3551-0767	Ministry of Science and Technology (MOST), Taiwan [MOST 103-2320-B-038-024, MOST 105-2 314-B-038-013-MY3]; National Science Council (NSC), Taiwan [NSC 102-2 314-B-038-042, NSC101-2314-B-038-013]; Taipei Medical University (TMU) [TMU104-F-004, TMU104-AE1-B09]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan); National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University (TMU)	This work was supported by the Ministry of Science and Technology (MOST), Taiwan [grant numbers MOST 103-2320-B-038-024, MOST 105-2 314-B-038-013-MY3]; the National Science Council (NSC), Taiwan [grant number NSC 102-2 314-B-038-042,NSC101-2314-B-038-013];and Taipei Medical University (TMU) [grant number TMU104-F-004, TMU104-AE1-B09]. The funders had no role instudy design, data collection and analysis, decision to publish,or preparation of the manuscript.	Andrews PW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00117; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Bartholoma P, 2002, BIOCHEM PHARMACOL, V63, P1507, DOI 10.1016/S0006-2952(02)00882-1; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chen S, 2014, TOXICOL SCI, V137, P404, DOI 10.1093/toxsci/kft254; Cheng BH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004655; Chong MY, 2001, BRIT J PSYCHIAT, V178, P29, DOI 10.1192/bjp.178.1.29; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chung CM, 2016, ONCOTARGET, V7, P11687, DOI 10.18632/oncotarget.7049; Coupland C, 2011, BRITISH MEDICAL JOUR, V343; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Howland RH, 2011, DRUG SAFETY, V34, P709, DOI 10.2165/11593960-000000000-00000; Hsiao FY, 2014, J AM MED DIR ASSOC, V15, P509, DOI 10.1016/j.jamda.2014.02.009; Hsieh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143668; Kessing LV, 2009, J AFFECT DISORDERS, V117, P24, DOI 10.1016/j.jad.2008.11.020; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Lee CWS, 2016, J CLIN PSYCHIAT, V77, P117, DOI 10.4088/JCP.14m09580; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Li Y, 2012, TOXICOL SCI, V127, P582, DOI 10.1093/toxsci/kfs100; MacQueen GM, 2017, PSYCHIAT CLIN NEUROS, V71, P18, DOI 10.1111/pcn.12463; Madhusoodanan S, 2010, ANN CLIN PSYCHIATRY, V22, P148; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Moore RA, 2012, COCHRANE DB SYST REV; Moret Chantal, 2006, Neuropsychiatr Dis Treat, V2, P537, DOI 10.2147/nedt.2006.2.4.537; Mossello E, 2008, DEMENT GERIATR COGN, V25, P372, DOI 10.1159/000121334; Muliyala KP, 2010, ANN INDIAN ACAD NEUR, V13, P69, DOI 10.4103/0972-2327.74248; Nierenberg AA, 2008, J OCCUP ENVIRON MED, V50, P428, DOI 10.1097/JOM.0b013e31816b5034; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Schipke CG, 2011, J PSYCHIATR RES, V45, P242, DOI 10.1016/j.jpsychires.2010.06.005; Schmitt JAJ, 2002, J PSYCHOPHARMACOL, V16, P207, DOI 10.1177/026988110201600303; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Sun Y, 2014, PLOS ONE, V9; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Wu C. S., 2009, PHARMACOEPIDEM DR S, V21, P980, DOI DOI 10.1002/PDS.3255; Xia ZL, 1997, INT J IMMUNOPHARMACO, V19, P645; Yang D, 2012, EUR J NEUROSCI, V36, P2573, DOI 10.1111/j.1460-9568.2012.08187.x	53	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175187	10.1371/journal.pone.0175187	http://dx.doi.org/10.1371/journal.pone.0175187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384235	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900114
J	Bytautiene, J; Baranauskas, G				Bytautiene, Juntaute; Baranauskas, Gytis			Rat superior colliculus neurons respond to large visual stimuli flashed outside the classical receptive field	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CONTRAST SENSITIVITY; EVOKED-POTENTIALS; ALBINO-RAT; CORTEX; MOUSE; FEEDBACK; URETHANE; AWAKE; CELLS	Spatial integration of visual stimuli is a crucial step in visual information processing yet it is often unclear where this integration takes place in the visual system. In the superficial layers of the superior colliculus that form an early stage in visual information processing, neurons are known to have relatively small visual receptive fields, suggesting limited spatial integration. Here it is shown that at least for rats this conclusion may be wrong. Extracellular recordings in urethane-anaesthetized young adult rats (1.5-2 months old) showed that large stimuli of over 10 could evoke detectable responses well outside the borders of 'classical' receptive fields determined by employing 2-3.5 stimuli. The presence of responses to large stimuli well outside these 'classical' receptive fields could not be explained neither by partial overlap between the visual stimulus and the receptive field, nor by reflections or light dispersion from the stimulation site. However, very low frequency (<0.1 Hz) residual responses to small stimuli presented outside the receptive field may explain the obtained results if we assume that the frequency of action potentials during a response to a stimulus outside RF is proportional to the stimulus area. Thus, responses to large stimuli outside RF may be predicted by scaling according to the stimulus area of the responses to small stimuli. These data demonstrate that neurons in the superficial layers of the superior colliculus are capable of integrating visual stimuli over much larger area than it can be deduced from the classical receptive field.	[Bytautiene, Juntaute; Baranauskas, Gytis] Lithuanian Univ Hlth Sci, Neurophysiol Lab, Neurosci Inst, Kaunas, Lithuania	Lithuanian University of Health Sciences	Baranauskas, G (corresponding author), Lithuanian Univ Hlth Sci, Neurophysiol Lab, Neurosci Inst, Kaunas, Lithuania.	gytis.baranauskas@lsmuni.lt			Lithuanian Research Council via the European Social Fund under the Global Grant measure [VP1-3.1:SMM-07-K-02-059]; Fund for Studies of Faculty of Medicine of Lithuanian University of Health Science	Lithuanian Research Council via the European Social Fund under the Global Grant measure(Research Council of Lithuania (LMTLT)); Fund for Studies of Faculty of Medicine of Lithuanian University of Health Science(Research Council of Lithuania (LMTLT))	This project was funded in part by the Lithuanian Research Council via the European Social Fund under the Global Grant measure, grant number VP1-3.1:SMM-07-K-02-059 to GB and by the Fund for Studies of the Faculty of Medicine of Lithuanian University of Health Science to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Baranauskas G, 2013, THE PROPERTIES OF CO; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Binns KE, 1997, DEV BRAIN RES, V99, P263, DOI 10.1016/S0165-3806(97)00004-7; Binns KE, 1997, J PHYSIOL-LONDON, V504, P629, DOI 10.1111/j.1469-7793.1997.629bd.x; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690, DOI 10.1152/jn.1975.38.3.690; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Durand S, 2016, J NEUROSCI, V36, P12144, DOI 10.1523/JNEUROSCI.1741-16.2016; DYER RS, 1987, PHYSIOL BEHAV, V41, P327, DOI 10.1016/0031-9384(87)90396-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Felisberti F, 1999, VISUAL NEUROSCI, V16, P943, DOI 10.1017/S0952523899165143; FUKUDA Y, 1978, JPN J PHYSIOL, V28, P385; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Girman SV, 2007, J NEUROPHYSIOL, V98, P161, DOI 10.1152/jn.00059.2007; Glickfeld LL, 2014, CURR OPIN NEUROBIOL, V24, P28, DOI 10.1016/j.conb.2013.08.009; Graham NV, 2011, VISION RES, V51, P1397, DOI 10.1016/j.visres.2011.02.007; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; HETZLER BE, 1981, NEUROPHARMACOLOGY, V20, P969, DOI 10.1016/0028-3908(81)90028-9; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY NK, 1968, EXP NEUROL, V20, P312, DOI 10.1016/0014-4886(68)90076-9; Kato R, 2011, EUR J NEUROSCI, V33, P1952, DOI 10.1111/j.1460-9568.2011.07729.x; Lahiri SN, 1999, ANN STAT, V27, P386, DOI 10.1214/aos/1018031117; Liu YJ, 2011, BRAIN BEHAV EVOLUT, V77, P193, DOI 10.1159/000327045; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; OYSTER CW, 1975, J NEUROPHYSIOL, V38, P301, DOI 10.1152/jn.1975.38.2.301; Paxinos G., 2007, THE RAT BRAIN IN STE; Politis D.N., 1992, EXPLORING LIMITS BOO, P263; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; POWERS MK, 1978, VISION RES, V18, P1533, DOI 10.1016/0042-6989(78)90008-1; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Razak KA, 2003, J NEUROPHYSIOL, V90, P110, DOI 10.1152/jn.01029.2002; RIGDON GC, 1988, PHARMACOL BIOCHEM BE, V30, P421, DOI 10.1016/S0091-3057(88)80003-0; Rind EC, 1999, TRENDS NEUROSCI, V22, P215, DOI 10.1016/S0166-2236(98)01332-0; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; Sharma SC, 2008, PROG BRAIN RES, V173, P479, DOI 10.1016/S0079-6123(08)01133-3; Snyder AC, 2014, J NEUROSCI, V34, P11222, DOI 10.1523/JNEUROSCI.0762-14.2014; Svirskis G, 2009, J NEUROSCI METH, V180, P22, DOI 10.1016/j.jneumeth.2009.02.012; TIAO YC, 1976, J COMP NEUROL, V168, P483; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Webb BS, 2002, VISUAL NEUROSCI, V19, P583, DOI 10.1017/S0952523802195046; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174409	10.1371/journal.pone.0174409	http://dx.doi.org/10.1371/journal.pone.0174409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379979	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500045
J	Kaczmarek, DJ; Kokordelis, P; Kramer, B; Glassner, A; Wolter, F; Goeser, F; Lutz, P; Schwarze-Zander, C; Boesecke, C; Strassburg, CP; Rockstroh, JK; Spengler, U; Nattermann, J				Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob			Alterations of the NK cell pool in HIV/HCV co-infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-KILLER-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; T-CELLS; ANTIVIRAL TREATMENT; SURFACE EXPRESSION; CYTOLYTIC FUNCTION; IMMUNE ACTIVATION	Background A relevant proportion of human immunodeficiency virus (HIV) infected patients is co-infected with the hepatitis C virus (HCV). HCV co-infection in HIV-positive patients is associated with faster progression of liver disease in comparison to HCV mono-infection. Natural killer (NK) cells critically modulate the natural course of HCV infection. Both HIV and HCV mono-infection are associated with alterations of the NK cell pool. However, little data is available concerning phenotype and function of NK cells in HIV/HCV co-infection. Methods A total of 34 HIV/HCV co-infected, 35 HIV and 39 HCV mono-infected patients and 43 healthy control persons were enrolled into this study. All HIV-positive patients were under effective antiretroviral therapy. NK cell phenotype, IFN-y production and degranulation were studied by flow cytometry. Results NK cell frequency in HIV/HCV co-infection was significantly lower than in healthy individuals but did not differ from HIV and HCV mono-infection. HIV/HCV co-infection was associated with significantly decreased expression of the maturation/differentiation markers CD27/62U 127 on NK cells but increased expression of CD57 compared to healthy controls. Of note, expression also differed significantly from HCV mono-infection but was similar to HIV mono infection, suggesting a pronounced impact of HIV on these alterations. Similar findings were made with regard to the NK cell receptors NKG2A/C and NKp30. More importantly, NK cells in co-infection displayed a highly impaired functional activity with significantly lower IFN-y production and degranulation than in healthy donors as well as HIV and HCV mono-infection, suggesting a synergistic effect of both viruses. Conclusions Our data indicate that HIV/HCV co-infection is associated with significant alterations of the NK cell pool, which might be involved in the rapid progression of liver disease in co-infected patients and which mainly reflect alterations observed in HIV mono-infection.	[Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Kaczmarek, Dominik J.; Kokordelis, Pavlos; Kraemer, Benjamin; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Lutz, Philipp; Schwarze-Zander, Carolynne; Boesecke, Christoph; Strassburg, Christian P.; Rockstroh, Juergen K.; Spengler, Ulrich; Nattermann, Jacob] German Ctr Infect Res DZIF, Bonn, Germany	University of Bonn; German Center for Infection Research	Kaczmarek, DJ (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Kaczmarek, DJ (corresponding author), German Ctr Infect Res DZIF, Bonn, Germany.	dominik.kaczmarek@ukbonn.de	Krämer, Benjamin/AAC-9618-2019; Goeser, Felix/AAT-4315-2021	Krämer, Benjamin/0000-0002-1385-9709; Goeser, Felix/0000-0003-3190-9981; Kaczmarek, Dominik/0000-0003-0093-7832; Lutz, Philipp/0000-0002-4921-200X	BONFOR [0-107.0116]; German Research Foundation (DFG) [SFB/TR 57]; DFG [KR4521/1-1]; H.W. and J. Hector Foundation [M69]; German Center for Infection Research (DZIF) [TTU 04.810]	BONFOR; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); H.W. and J. Hector Foundation; German Center for Infection Research (DZIF)	This work was supported by a BONFOR grant (0-107.0116 [DK]), the German Research Foundation (DFG SFB/TR 57 [US, JN], DFG KR4521/1-1 [BK], the H.W. and J. Hector Foundation (grant number M69 [J N]) and the German Center for Infection Research (DZIF TTU 04.810 [JN]).	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P1473; Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764; Bengner M, 2014, AGE, V36, P571, DOI 10.1007/s11357-013-9587-y; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Benjamini Y, 2001, ANN STAT, V29, P1165; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bisio F, 2013, IMMUNOL LETT, V152, P16, DOI 10.1016/j.imlet.2013.03.003; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Boesecke C, 2012, SEMIN LIVER DIS, V32, P130, DOI 10.1055/s-0032-1316468; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Dessouki O, 2010, BIOCHEM BIOPH RES CO, V393, P331, DOI 10.1016/j.bbrc.2010.02.008; Dillon SM, 2014, JAIDS-J ACQ IMM DEF, V65, P259, DOI 10.1097/01.qai.0000435603.50598.2b; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Goeser F, 2015, AIDS; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Gonzalez VD, 2008, CLIN IMMUNOL, V128, P46, DOI 10.1016/j.clim.2008.03.521; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J IMMUNOL, V183, P6612, DOI 10.4049/jimmunol.0901437; Goodier MR, 2003, CLIN EXP IMMUNOL, V134, P470, DOI 10.1111/j.1365-2249.2003.02329.x; Harrison RJ, 2010, CLIN EXP IMMUNOL, V161, P306, DOI 10.1111/j.1365-2249.2010.04169.x; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; HO HN, 1993, J IMMUNOL, V150, P3070; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P27, DOI 10.1189/jlb.0907649; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kanof ME, 2001, CURR PROTOC IMMUNOL; Kokordelis P, 2013, HEPATOLOGY; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Marras F, 2013, P NATL ACAD SCI USA, V110, P11970, DOI 10.1073/pnas.1302090110; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mela CM, 2005, AIDS, V19, P1761, DOI 10.1097/01.aids.0000183632.12418.33; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nattermann J, 2005, ANTIVIR THER, V10, P95; Nattermann J, 2011, J HEPATOL, V55, P265, DOI 10.1016/j.jhep.2011.01.005; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; Oliviero B, 2013, J HEPATOL, V59, P38, DOI 10.1016/j.jhep.2013.03.003; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005	66	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174465	10.1371/journal.pone.0174465	http://dx.doi.org/10.1371/journal.pone.0174465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380039	gold, Green Published, Green Submitted			2022-12-26	WOS:000399353500049
J	Nyongesa, MK; Sigilai, A; Hassan, AS; Thoya, J; Odhiambo, R; Van de Vijver, FJR; Newton, CRJC; Abubakar, A				Nyongesa, Moses K.; Sigilai, Antipa; Hassan, Amin S.; Thoya, Janet; Odhiambo, Rachael; Van de Vijver, Fons J. R.; Newton, Charles R. J. C.; Abubakar, Amina			A mixed methods approach to adapting and evaluating the functional assessment of HIV infection (FAHI), Swahili version, for use with low literacy populations	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV/AIDS; IMPACT; VALIDATION; OUTCOMES; QUESTIONNAIRE; INSTRUMENTS; RELIABILITY; THERAPY	Background Despite bearing the largest HIV-related burden, little is known of the Health-Related Quality of Life (HRQoL) among people living with HIV in sub-Saharan Africa. One of the factors contributing to this gap in knowledge is the lack of culturally adapted and validated measures of HRQoL that are relevant for this setting. Aims We set out to adapt the Functional Assessment of HIV Infection (FAHI) Questionnaire, an HIV-specific measure of HRQoL, and evaluate its internal consistency and validity. Methods The three phase mixed-methods study took place in a rural setting at the Kenyan Coast. Phase one involved a scoping review to describe the evidence base of the reliability and validity of FAHI as well as the geographical contexts in which it has been administered. Phase two involved in-depth interviews (n = 38) to explore the content validity, and initial piloting for face validation of the adapted FAHI. Phase three was quantitative (n = 103) and evaluated the internal consistency, convergent and construct validities of the adapted interviewer-administered questionnaire. Results In the first phase of the study, we identified 16 studies that have used the FAHI. Most (82%) were conducted in North America. Only seven (44%) of the reviewed studies reported on the psychometric properties of the FAHI. In the second phase, most of the participants (37 out of 38) reported satisfaction with word clarity and content coverage whereas 34 (89%) reported satisfaction with relevance of the items, confirming the face validity of the adapted questionnaire during initial piloting. Our participants indicated that HIV impacted on their physical, functional, emotional, and social wellbeing. Their responses overlapped with items in four of the five subscales of the FAHI Questionnaire establishing its content validity. In the third phase, the internal consistency of the scale was found to be satisfactory with subscale Cronbach's a ranging from 0.55 to 0.78. The construct and convergent validity of the tool were supported by acceptable factor loadings for most of the items on the respective sub scales and confirmation of expected significant correlations of the FAHI subscale scores with scores of a measure of common mental disorders. Conclusion The adapted interviewer-administered Swahili version of FAHI questionnaire showed initial strong evidence of good psychometric properties with satisfactory internal consistency and acceptable validity (content, face, and convergent validity). It gives impetus for further validation work, especially construct validity, in similar settings before it can be used for research and clinical purposes in the entire East African region.	[Nyongesa, Moses K.; Sigilai, Antipa; Hassan, Amin S.; Thoya, Janet; Odhiambo, Rachael; Newton, Charles R. J. C.; Abubakar, Amina] Kenya Govt Med Res Ctr, Ctr Geog Med Coast, Kilifi, Kenya; [Nyongesa, Moses K.; Sigilai, Antipa; Abubakar, Amina] Pwani Univ, Kilifi, Kenya; [Van de Vijver, Fons J. R.] Tilburg Univ, Tilburg, Netherlands; [Van de Vijver, Fons J. R.] North West Univ, Potchefstroom, South Africa; [Van de Vijver, Fons J. R.] Univ Queensland, Brisbane, Qld, Australia; [Newton, Charles R. J. C.; Abubakar, Amina] Univ Oxford, Oxford, England	Kenya Medical Research Institute; Pwani University; Tilburg University; North West University - South Africa; University of Queensland; University of Oxford	Nyongesa, MK (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Coast, Kilifi, Kenya.; Nyongesa, MK (corresponding author), Pwani Univ, Kilifi, Kenya.	MKachama@kemri-wellcome.org	Nyongesa, Moses/AAZ-8780-2021; Nyongesa, Moses/AAG-7796-2020; van de Vijver, Fons/A-4317-2012; Newton, Charles RJC/B-7578-2014; Abubakar, Amina/F-1479-2017	Nyongesa, Moses/0000-0002-7761-0718; Nyongesa, Moses/0000-0002-7761-0718; van de Vijver, Fons/0000-0003-0220-2485; Newton, Charles RJC/0000-0002-6999-5507; Hassan, Amin S./0000-0001-5296-4264; Odhiambo, Rachel/0000-0002-7525-0659; Abubakar, Amina/0000-0002-3686-7904	IUPsyS; ICP Change Fellowship Award; Jacobs Foundation/NRC/international Congress of Psychology; Wellcome Trust [084538]	IUPsyS; ICP Change Fellowship Award; Jacobs Foundation/NRC/international Congress of Psychology; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by IUPsyS and ICP2012 Change Fellowship Award to Amina Abubakar, fellowship awards were funds by Jacobs Foundation/NRC/international Congress of Psychology. Moses Kachama Nyongesa was funded through a strategic award by Wellcome Trust grant number 084538.	Abrams DI, 2000, INT J STD AIDS, V11, P659, DOI 10.1258/0956462001915020; Abubakar A, 2009, HERODOTUS ETHNOGRAPH, P169; Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Badia X, 1999, AIDS, V13, P1727, DOI 10.1097/00002030-199909100-00017; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Bernal H, 1997, NURS RES, V46, P179, DOI 10.1097/00006199-199705000-00009; BOZZETTE SA, 1994, MED CARE, V32, P716, DOI 10.1097/00005650-199407000-00005; Byrne S, 2013, AIDS CARE, V25, P118, DOI 10.1080/09540121.2012.687811; Cella D, 2010, HIV CLIN TRIALS; Cella DF, 1996, QUAL LIFE RES, V5, P450, DOI 10.1007/BF00449920; Cianfrocca M, 2010, CANCER-AM CANCER SOC, V116, P3969, DOI 10.1002/cncr.25362; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clayson DJ, 2006, PHARMACOECONOMICS, V24, P751, DOI 10.2165/00019053-200624080-00003; Davis EA, 2001, ANN PHARMACOTHER, V35, P546, DOI 10.1345/aph.10222; Diamond C, 2010, QUAL LIFE RES, V19, P149, DOI 10.1007/s11136-009-9565-0; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Earthman CP, 2002, JPEN-PARENTER ENTER, V26, P357, DOI 10.1177/0148607102026006357; Feinberg J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/349165; GANZ PA, 1993, QUAL LIFE RES, V2, P109, DOI 10.1007/BF00435730; Hasanah CI, 2011, QUAL LIFE RES, V20, P91, DOI 10.1007/s11136-010-9729-y; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Holding P, SYSTEMATIC APPROACH; Holmes WC, 1997, QUAL LIFE RES, V6, P561, DOI 10.1023/A:1018464200708; Louwagie GM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-244; Lubeck DP, 1997, QUAL LIFE RES, V6, P494, DOI 10.1023/A:1018404014821; NACC, 2014, KEN HIV COUNT PROF 2; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; O'Brien KK, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-88; Olagunju AT, 2012, HIV AIDS REV, V11, P31, DOI 10.1016/j.hivar.2012.02.002; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Peterman AH, 1997, QUAL LIFE RES, V6, P572, DOI 10.1023/A:1018416317546; Pietersma S, 2013, INT J WELLBEING, V3; Pitt J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-5; Rao D, 2007, AIDS PATIENT CARE ST, V21, P339, DOI 10.1089/apc.2006.0124; Robberstad Bjarne, 2010, Cost Eff Resour Alloc, V8, P5, DOI 10.1186/1478-7547-8-5; Sikkema KJ, 2005, QUAL LIFE RES, V14, P991, DOI 10.1007/s11136-004-2959-0; Swindells S, 1999, INT J STD AIDS, V10, P383, DOI 10.1258/0956462991914302; Tomita A, 2014, AIDS BEHAV, V18, P1801, DOI 10.1007/s10461-014-0800-5; Tomita A, 2014, AIDS BEHAV, V18, P1114, DOI 10.1007/s10461-013-0682-y; Vaus D., 2002, ANAL SOCIAL SCI DATA; Viala-Danten M, 2010, QUAL LIFE RES, V19, P1215, DOI 10.1007/s11136-010-9674-9; Vidrine DJ, 2005, QUAL LIFE RES, V14, P923, DOI 10.1007/s11136-004-2148-1; Winston A, 2010, HIV CLIN TRIALS; World Health Organization, 2013, GLOB HLTH OBS GHO DA; Wouters E, 2007, QUAL LIFE RES, V16, P1461, DOI 10.1007/s11136-007-9260-y; WU AW, 1991, MED CARE, V29, P786, DOI 10.1097/00005650-199108000-00011	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175021	10.1371/journal.pone.0175021	http://dx.doi.org/10.1371/journal.pone.0175021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380073	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500086
J	Wolosin, JM; Zamudio, A; Wang, Z				Wolosin, J. Mario; Zamudio, Aldo; Wang, Zheng			Application of JC1 for non-toxic isolation of cells with MDR transporter activity by flow cytometry	PLOS ONE			English	Article							SIDE-POPULATION CELLS; CANCER RESISTANCE PROTEIN; HEMATOPOIETIC STEM-CELLS; RAT-LIVER MITOCHONDRIA; FUMITREMORGIN-C; P-GLYCOPROTEIN; BONE-MARROW; HOECHST-33342; MEMBRANE; ABCG2	The DNA intercalating dye Hoechst 33342 or its close analog DCV are actively removed from cells by the multidrug resistance transporter ABCG2, a protein overexpressed in metastatic cells and somatic stem cells. In bivariate blue-red flow cytometry fluorescent plots active Hoechst or DCV efflux combined with a concentration dependent bathochromic shifts of these nuclear dyes leads to the segregation of the transporter-rich cells into a distinct cell cohort tilted towards the shorter wavelength axis of the plot, the cohort is generically known as the side population (SP). This feature has facilitated the surface marker-independent isolation of live stem cells. A drawback, though, is the known toxicity of Hoechst dyes. In this study we show that JC1, a bathochromic mitochondrial membrane potential-sensitive dye applied at proper concentration, can yield flow cytometry fluorescent emission bivariate plots containing a low JC1 accumulation (JC1(low)) cohort. Using a combination of multiple cell lines, ABC-transporter inhibitors and viral vector-driven insertion of the ABCG2 gene or ABCG2 and ABCB1 shRNAs we demonstrate that JC1(low) can be generated by either of the two aforementioned multidrug resistance transporters. Complete wash out of mitochondrial bound JC1 required more than 24 h. In spite of this tight binding, the dye did not affect either the mitochondrial membrane potentials or the proliferation rate. In contrast, contemporaneous with its nuclear accumulation, Hoechst 33342 or DVC, caused changes in the fluorescent emission of mitochondrial membrane potential sensitive dyes resembling the effects caused by the mitochondrial uncoupler FCCP. In a number of cell lines exposure to Hoechst resulted in marked slow-down of proliferation and abolition of ABCG2 transport activity during the subsequent 2 days but in K562 cells the exposure induced cell extended death. Overall, its lack of toxicity vis. a vis. the toxicity and genotoxicity of the DNA intercalating dyes makes JC1 an ideal tool for isolating live cells expressing high multidrug resistance transport activity.	[Wolosin, J. Mario; Zamudio, Aldo; Wang, Zheng] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Wolosin, J. Mario] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wolosin, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA.; Wolosin, JM (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	Jmario.wolosin@mssm.edu		wolosin, j. mario/0000-0002-6751-2794	National Institutes of Health [EY 014878]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY014878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health [grant number EY 014878] and by Unrestricted Grant to The Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci MA, INVEST OPHTHALMOL VI, V50, P4162; Allen JD, 2002, MOL CANCER THER, V1, P417; Antczak C, 2014, ASSAY DRUG DEV TECHN, V12, P28, DOI 10.1089/adt.2013.521; Boesch M, 2014, ONCOTARGET, V5, P7027, DOI 10.18632/oncotarget.2053; Boesch M, 2012, CYTOM PART A, V81A, P517, DOI 10.1002/cyto.a.22038; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Chaoui D, 2006, CYTOM PART B-CLIN CY, V70B, P189, DOI 10.1002/cyto.b.20100; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Gardner RV, 1998, STEM CELLS, V16, P112, DOI 10.1002/stem.160112; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Jackson C, 2015, CURR EYE RES, V23, P1; Kim M, 2003, J NEUROSCI, V23, P10703; Kuhnel JM, 1997, LEUKEMIA, V11, P1147, DOI 10.1038/sj.leu.2400698; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; LIBBUS BL, 1987, MUTAT RES, V182, P265, DOI 10.1016/0165-1161(87)90011-2; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Mease K, 2012, J PHARM SCI-US, V101, P1888, DOI 10.1002/jps.23069; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mordente A, 2012, ADV EXP MED BIOL, V942, P385, DOI 10.1007/978-94-007-2869-1_18; Rabindran SK, 2000, CANCER RES, V60, P47; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Selver OB, 2016, MOL VIS, V22, P138; Selver OB, 2011, INVEST OPHTH VIS SCI, V52, P4330, DOI 10.1167/iovs.10-5897; SIEMANN DW, 1986, CANCER RES, V46, P3556; Singh S, 2004, J PHOTOCH PHOTOBIO B, V77, P45, DOI 10.1016/j.jphotobiol.2004.08.009; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064; VANZANT G, 1983, CYTOMETRY, V4, P40, DOI 10.1002/cyto.990040106; Weidner LD, 2015, J PHARMACOL EXP THER, V354, P384, DOI 10.1124/jpet.115.225482; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Zamudio A, 2016, EXP EYE RES, V145, P48, DOI 10.1016/j.exer.2015.10.021; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174905	10.1371/journal.pone.0174905	http://dx.doi.org/10.1371/journal.pone.0174905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380010	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500076
J	Zoni, E; Chen, L; Karkampouna, S; Granchi, Z; Verhoef, EI; La Manna, F; Kelber, J; Pelger, RCM; Henry, MD; Snaar-Jagalska, E; van Leenders, GJLH; Beimers, L; Kloen, P; Gray, PC; van der Pluijm, G; Julio, MKD				Zoni, E.; Chen, L.; Karkampouna, S.; Granchi, Z.; Verhoef, E. I.; La Manna, F.; Kelber, J.; Pelger, R. C. M.; Henry, M. D.; Snaar-Jagalska, E.; van Leenders, G. J. L. H.; Beimers, L.; Kloen, P.; Gray, P. C.; van der Pluijm, G.; Julio, M. Kruithof-de			CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; TGF-BETA; BONE METASTASIS; EMBRYONIC GENE; GROWTH; EXPRESSION; ZEBRAFISH; PROMOTES; DIFFERENTIATION	CRIPTO (CR-1, TDGF1) is a cell surface/secreted oncoprotein actively involved in development and cancer. Here, we report that high expression of CRIPTO correlates with poor survival in stratified risk groups of prostate cancer (PCa) patients. CRIPTO and its signaling partner glucose-regulated protein 78 (GRP78) are highly expressed in PCa metastases and display higher levels in the metastatic ALDH(high) sub-population of PC-3M-Pro4Luc2 PCa cells compared with non-metastatic ALDH(low). Coculture of the osteotropic PC-3M-Pro4Luc2 PCa cells with differentiated primary human osteoblasts induced CRIPTO and GRP78 expression in cancer cells and increases the size of the ALDH(high) sub-population. Additionally, CRIPTO or GRP78 knockdown decreases proliferation, migration, clonogenicity and the size of the metastasis-initiating ALDH(high) sub-population. CRIPTO knockdown reduces the invasion of PC-3M-Pro4Luc2 cells in zebrafish and inhibits bone metastasis in a preclinical mouse model. These results highlight a functional role for CRIPTO and GRP78 in PCa metastasis and suggest that targeting CRIPTO/GRP78 signaling may have significant therapeutic potential.	[Zoni, E.; Karkampouna, S.; La Manna, F.; Pelger, R. C. M.; van der Pluijm, G.; Julio, M. Kruithof-de] Leiden Univ, Dept Urol, Med Ctr, Leiden, Netherlands; [Zoni, E.; Karkampouna, S.; La Manna, F.; Snaar-Jagalska, E.; Julio, M. Kruithof-de] Univ Bern, Urol Res Lab, Dept Urol, Murtenstr 35, CH-3008 Bern, Switzerland; [Zoni, E.; Karkampouna, S.; La Manna, F.; Snaar-Jagalska, E.; Julio, M. Kruithof-de] Univ Bern, Dept Clin Res, Murtenstr 35, CH-3008 Bern, Switzerland; [Chen, L.] Leiden Univ, Inst Biol, Dept Mol Cell Biol, Leiden, Netherlands; [Granchi, Z.] Genome Scan, Leiden, Netherlands; [Verhoef, E. I.; van Leenders, G. J. L. H.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Kelber, J.] Calif State Univ Northbridge, Dept Biol, Northbridge, CA USA; [Henry, M. D.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Beimers, L.] Slotervaart Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands; [Kloen, P.] Acad Med Ctr, Dept Orthoped Trauma Surg, Amsterdam, Netherlands; [Gray, P. C.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; University of Bern; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Iowa; Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Salk Institute	Julio, MKD (corresponding author), Univ Bern, Urol Res Lab, Dept Urol, Murtenstr 35, CH-3008 Bern, Switzerland.; Julio, MKD (corresponding author), Univ Bern, Dept Clin Res, Murtenstr 35, CH-3008 Bern, Switzerland.	marianna.kruithofdejulio@dkf.unibe.ch	Pelger, Rob/ABF-9029-2021; Zoni, Eugenio/AAH-7016-2019	Pelger, Rob/0000-0001-6328-6462; Zoni, Eugenio/0000-0002-3070-7694; van der Pluijm, Gabri/0000-0002-1351-1884; La Manna, Federico/0000-0003-3644-8395; Kelber, Jonathan/0000-0002-4606-1445; Verhoef, Esther/0000-0002-2734-0254; Granchi, Zoraide/0000-0002-0227-9266; Henry, Michael/0000-0002-7871-245X; Kruithof-de Julio, Marianna/0000-0002-6085-7706	FP7 Marie Curie ITN [264817-BONE-NET]; Dutch Cancer Society [UL2015-7599 KWF]; Leiden University Fond; Clayton Foundation for Biomedical Research; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM121182] Funding Source: NIH RePORTER	FP7 Marie Curie ITN; Dutch Cancer Society(KWF Kankerbestrijding); Leiden University Fond; Clayton Foundation for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tim Rodenburg and Janine Melsen (Department of Urology, LUMC) for technical support and Dr Boudewijn PT Kruithof (Department of Molecular Cell Biology, LUMC) for technical support and critical reading of the manuscript, Guido de Roo from the Flow cytometry facility (Department of Hematology, LUMC) and Jan Kroon (Department of Urology, LUMC) for providing experimental metastases. This research received funding from: FP7 Marie Curie ITN, Grant No. 264817-BONE-NET (to GvdP, EZ, ZG); Dutch Cancer Society, Grant No. UL2015-7599 KWF (to MK-dJ, GvdP, PK); Leiden University Fond (to MK-dJ) and Clayton Foundation for Biomedical Research (to PCG).	Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Castro NP, 2015, ONCOTARGET, V6, P11910, DOI 10.18632/oncotarget.4182; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; de Castro NP, 2010, FUTURE ONCOL, V6, P1127, DOI [10.2217/fon.10.68, 10.2217/FON.10.68]; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ghotra VPS, 2015, CANCER RES, V75, P230, DOI 10.1158/0008-5472.CAN-14-0629; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Karkampouna S, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.69; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Klauzinska M, 2014, SEMIN CANCER BIOL, V29, P51, DOI 10.1016/j.semcancer.2014.08.003; Kroon J, 2014, ONCOTARGET, V5, P8986, DOI 10.18632/oncotarget.1510; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Morhayim J, 2015, FASEB J, V29, P274, DOI 10.1096/fj.14-261404; Nagaoka T, 2012, GROWTH FACTORS, V30, P13, DOI 10.3109/08977194.2011.641962; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Ozdemir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107407; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pilli VS, 2015, FEBS LETT, V589, P1249, DOI 10.1016/j.febslet.2015.04.005; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Spike BT, 2014, STEM CELL REP, V2, P427, DOI 10.1016/j.stemcr.2014.02.010; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Terry S, 2015, ONCOTARGET, V6, P11994, DOI 10.18632/oncotarget.2740; THALMANN GN, 1994, CANCER RES, V54, P2577; van den Hoogen C, 2011, AM J PATHOL, V179, P2559, DOI 10.1016/j.ajpath.2011.07.011; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; van der Pluijm G, 2011, BONE, V48, P37, DOI 10.1016/j.bone.2010.07.023; Zoni E, 2015, CANCER RES, V75, P2326, DOI 10.1158/0008-5472.CAN-14-2155	44	25	27	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4739	4749		10.1038/onc.2017.87	http://dx.doi.org/10.1038/onc.2017.87			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394345	Green Published, hybrid			2022-12-26	WOS:000407702400007
J	Ding, LA; Zhang, LF; Kim, M; Byzova, T; Podrez, E				Ding, Liang; Zhang, Lifang; Kim, Michael; Byzova, Tatiana; Podrez, Eugene			Akt3 kinase suppresses pinocytosis of low-density lipoprotein by macrophages via a novel WNK/SGK1/Cdc42 protein pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID-PHASE PINOCYTOSIS; FOAM CELL-FORMATION; CHOLESTEROL ACCUMULATION; ATHEROSCLEROTIC LESIONS; DEPENDENT REGULATION; FAMILY-MEMBERS; CANCER CELLS; IN-VITRO; ACTIN; MACROPINOCYTOSIS	Fluid-phase pinocytosis of LDL by macrophages is regarded as a novel promising target to reduce macrophage cholesterol accumulation in atherosclerotic lesions. The mechanisms of regulation of fluid-phase pinocytosis in macrophages and, specifically, the role of Akt kinases are poorly understood. We have found previously that increased lipoprotein uptake via the receptor-independent process in Akt3 kinase-deficient macrophages contributes to increased atherosclerosis in Akt3(-/-) mice. The mechanism by which Akt3 deficiency promotes lipoprotein uptake in macrophages is unknown. Wenow report that Akt3 constitutively suppresses macropinocytosis in macrophages through a novel WNK1/SGK1/Cdc42 pathway. Mechanistic studies have demonstrated that the lack of Akt3 expression in murine and human macrophages results in increased expression of with-no-lysine kinase 1 (WNK1), which, in turn, leads to increased activity of serum and glucocorticoid-inducible kinase 1 (SGK1). SGK1 promotes expression of the Rho family GTPase Cdc42, a positive regulator of actin assembly, cell polarization, and pinocytosis. Individual suppression of WNK1 expression, SGK1, or Cdc42 activity in Akt3-deficient macrophages rescued the phenotype. These results demonstrate that Akt3 is a specific negative regulator of macropinocytosis in macrophages.	[Ding, Liang; Zhang, Lifang; Byzova, Tatiana; Podrez, Eugene] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kim, Michael] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Podrez, E (corresponding author), Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA.; Podrez, E (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB5-87, Cleveland, OH 44195 USA.	podreze@ccf.org		Kim, Michael/0000-0003-0087-0199; Byzova, Tatiana/0000-0002-2615-875X	National Institutes of Health [HL077213, HL126738, 5P01HL073311, HL071625]; American Heart Association [13POST17240041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, R01HL071625, R01HL126738, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL077213, HL126738, and 5P01HL073311 (to E. P.) and HL071625 (to T. B.) and American Heart Association Grant 13POST17240041 (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Anzinger JJ, 2010, ARTERIOSCL THROM VAS, V30, P2022, DOI 10.1161/ATVBAHA.110.210849; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CANO ML, 1991, J CELL BIOL, V115, P677, DOI 10.1083/jcb.115.3.677; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Fujii M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02385; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; Ghoshal P., 2017, ANTIOXID REDOX SIGN, DOI [10.1089/ars.2017.7059, DOI 10.1089/ARS.2017.7059]; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heise CJ, 2010, J BIOL CHEM, V285, P25161, DOI 10.1074/jbc.M110.103432; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Huang YQ, 2016, CELL PHYSIOL BIOCHEM, V40, P1521, DOI 10.1159/000453202; KAGAYA K, 1992, J MED VET MYCOL, V30, P179; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kruth HS, 2013, CURR PHARM DESIGN, V19, P5865; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lang F, 2013, HORM-INT J ENDOCRINO, V12, P160, DOI 10.14310/horm.2002.1401; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Levin MC, 2011, CIRC RES, V109, P1210, DOI 10.1161/CIRCRESAHA.111.246702; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mc F. A., 1958, NATURE, V182, P53; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Oh YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9698; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Redelman-Sidi G, 2013, CANCER RES, V73, P1156, DOI 10.1158/0008-5472.CAN-12-1882; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rotllan N, 2015, FASEB J, V29, P597, DOI 10.1096/fj.14-262097; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Shelly C, 2002, J CELL SCI, V115, P1985; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Ulrich V, 2016, EMBO MOL MED, V8, P643, DOI 10.15252/emmm.201506031; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wilson SM, 2010, BRIT J PHARMACOL, V159, P678, DOI 10.1111/j.1476-5381.2009.00564.x; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yoshida S, 2015, J CELL BIOL, V211, P159, DOI 10.1083/jcb.201504097; Yoshida S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00008	67	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9283	9293		10.1074/jbc.M116.773739	http://dx.doi.org/10.1074/jbc.M116.773739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28389565	Green Published, hybrid			2022-12-26	WOS:000402538900023
J	Gao, YS; Zhou, YL; Goldstein, JL; Brown, MS; Radhakrishnan, A				Gao, Yansong; Zhou, Yulian; Goldstein, Joseph L.; Brown, Michael S.; Radhakrishnan, Arun			Cholesterol-induced conformational changes in the sterol-sensing domain of the Scap protein suggest feedback mechanism to control cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol regulation; cholesterol-binding protein; conformational change; membrane lipid; membrane protein	CLEAVAGE-ACTIVATING PROTEIN; HAMSTER OVARY CELLS; MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; REGULATED TRANSPORT; LOOP 1; BINDING; SREBPS; GOLGI; IDENTIFICATION	Scap is a polytopic protein of endoplasmic reticulum (ER) membranes that transports sterol regulatory element-binding proteins to the Golgi complex for proteolytic activation. Cholesterol accumulation in ER membranes prevents Scap transport and decreases cholesterol synthesis. Previously, we provided evidence that cholesterol inhibition is initiated when cholesterol binds to loop 1 of Scap, which projects into the ER lumen. Within cells, this binding causes loop 1 to dissociate from loop 7, another luminal Scap loop. However, we have been unable to demonstrate this dissociation when we added cholesterol to isolated complexes of loops 1 and 7. We therefore speculated that the dissociation requires a conformational change in the intervening polytopic sequence separating loops 1 and 7. Here we demonstrate such a change using a protease protection assay in sealed membrane vesicles. In the absence of cholesterol, trypsin or proteinase K cleaved cytosolic loop 4, generating a protected fragment that we visualized with a monoclonal antibody against loop 1. When cholesterol was added to these membranes, cleavage in loop 4 was abolished. Because loop 4 is part of the so-called sterol-sensing domain separating loops 1 and 7, these results support the hypothesis that cholesterol binding to loop 1 alters the conformation of the sterol-sensing domain. They also suggest that this conformational change helps transmit the cholesterol signal from loop 1 to loop 7, thereby allowing separation of the loops and facilitating the feedback inhibition of cholesterol synthesis. These insights suggest a new structural model for cholesterol-mediated regulation of Scap activity.	[Gao, Yansong; Zhou, Yulian; Goldstein, Joseph L.; Brown, Michael S.; Radhakrishnan, Arun] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Gao, Yansong] Cross Strait Tsinghua Res Inst, Biol & Med Res Ctr, Xiamen 361006, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL; Brown, MS; Radhakrishnan, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu; arun.radhakrishnan@utsouthwestern.edu	Radhakrishnan, Arun/R-8440-2019; Radhakrishnan, Arun/Q-7437-2019	Radhakrishnan, Arun/0000-0001-8972-7086; Radhakrishnan, Arun/0000-0002-7266-7336	National Institutes of Health [HL20948]; Robert A. Welch Foundation [I-1793]; American Heart Association [12SDG12040267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL20948 (to J. L. G. and M. S. B.), Robert A. Welch Foundation Grant I-1793 (to A. R.), and American Heart Association Grant 12SDG12040267 (to A. R.).	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	23	23	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8729	8737		10.1074/jbc.M117.783894	http://dx.doi.org/10.1074/jbc.M117.783894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377508	hybrid, Green Published			2022-12-26	WOS:000402153900019
J	de Castro, RO; Previato, L; Goitea, V; Felberg, A; Guiraldelli, MF; Filiberti, A; Pezza, RJ				de Castro, Rodrigo O.; Previato, Luciana; Goitea, Victor; Felberg, Anna; Guiraldelli, Michel F.; Filiberti, Adrian; Pezza, Roberto J.			The chromatin-remodeling subunit Baf200 promotes homology-directed DNA repair and regulates distinct chromatin-remodeling complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SWI/SNF COMPLEX; HEPATOCELLULAR-CARCINOMA; PBAF; GENOME; ROLES; GENE; SPERMATOGENESIS; SPECIFICITY; GAMMA-H2AX	The efficiency and type of pathway chosen to repair DNA double-strand breaks (DSBs) are critically influenced by the nucleosome packaging and the chromatin architecture surrounding the DSBs. The Swi/Snf (PBAF and BAF) chromatin-remodeling complexes contribute to DNA damage-induced nucleosome remodeling, but the mechanism by which it contributes to this function is poorly understood. Herein, we report how the Baf200 (Arid2) PBAF-defining subunit regulates DSB repair. We used cytological and biochemical approaches to show that Baf200 plays an important function by facilitating homologous recombination-dependent processes, such as recruitment of Rad51 (a key component of homologous recombination) to DSBs, homology-directed repair, and cell survival after DNA damage. Furthermore, we observed that Baf200 and Rad51 are present in the same complex and that this interaction is mediated by C-terminal sequences in both proteins. It has been recognized previously that the interplay between distinct forms of Swi/Snf has profound functional consequences, but we understand little about the composition of complexes formed by PBAF protein subunits. Our biochemical analyses reveal that Baf200 forms at least two distinct complexes. One is a canonical form of PBAF including the Swi/Snf-associated Brg1 catalytic subunit, and the other contains Baf180 but not Brg1. This distinction of PBAF complexes based on their unique composition provides the foundation for future studies on the specific contributions of the PBAF forms to the regulation of DNA repair.	[de Castro, Rodrigo O.; Previato, Luciana; Goitea, Victor; Felberg, Anna; Guiraldelli, Michel F.; Filiberti, Adrian; Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Cell Cycle & Canc Biol Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cell Cycle & Canc Biol Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.; Pezza, RJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		Felberg, Anna/0000-0001-6271-6483; Goitea, Victor/0000-0002-1564-4111	National Institutes of Health [GM103636]; March of Dimes [FY14-256]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by the National Institutes of Health Grant GM103636 and March of Dimes Grant FY14-256 (to R. J. P.). The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Brechalov AV, 2014, CELL CYCLE, V13, P1970, DOI 10.4161/cc.28922; Brownlee PM, 2015, DNA REPAIR, V32, P127, DOI 10.1016/j.dnarep.2015.04.023; Choi KY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.129; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Gerhold CB, 2015, J MOL BIOL, V427, P637, DOI 10.1016/j.jmb.2014.10.015; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; He LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109493; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jeggo PA, 2014, EXP CELL RES, V329, P69, DOI 10.1016/j.yexcr.2014.09.023; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Kim Y, 2012, DEVELOPMENT, V139, P1133, DOI 10.1242/dev.073478; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Narayanan R, 2014, CELL TISSUE RES, V356, P575, DOI 10.1007/s00441-013-1791-7; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qi WJ, 2015, J CELL SCI, V128, P317, DOI 10.1242/jcs.159103; Raab JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005748; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep21776; Wang JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097097; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Xu FH, 2012, J BIOL CHEM, V287, P5033, DOI 10.1074/jbc.M111.279968; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhang XM, 2006, BIOCHEM BIOPH RES CO, V346, P794, DOI 10.1016/j.bbrc.2006.05.211; Zhao H, 2011, ONCOTARGET, V2, P886; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	40	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8459	8471		10.1074/jbc.M117.778183	http://dx.doi.org/10.1074/jbc.M117.778183			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28381560	hybrid, Green Published			2022-12-26	WOS:000401788600029
J	Filipowicz, W				Filipowicz, Witold			Traversing the RNA world	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; SMALL NUCLEOLAR RNA; DOUBLE-STRANDED-RNA; POLYPEPTIDE-CHAIN INITIATION; RIBOSE 1,2-CYCLIC PHOSPHATE; MIRNA-MEDIATED REPRESSION; EUKARYOTIC MESSENGER-RNAS; HELA-CELL EXTRACT; MOSAIC-VIRUS RNA; U-SNRNA GENES	An invitation to write a "Reflections" type of article creates a certain ambivalence: it is a great honor, but it also infers the end of your professional career. Before you vanish for good, your colleagues look forward to an interesting but entertaining account of the ups-and-downs of your past research and your views on science in general, peppered with indiscrete anecdotes about your former competitors and collaborators. What follows will disappoint those who await complaint and criticism, for example, about the difficulties of doing research in the 1960s and 1970s in Eastern Europe, or those seeking very personal revelations. My scientific life has in fact seen many happy coincidences, much good fortune, and several lucky escapes from situations that at the time were quite scary. I have also been fortunate with regard to competitors and collaborators, particularly because, whenever possible, I tried to "neutralize" my rivals by collaborating with them - to the benefit of all. I recommend this strategy to young researchers to dispel the nightmares that can occur when competing against powerful contenders. I have been blessed with the selection of my research topic: RNA biology. Over the last five decades, new and unexpected RNA-related phenomena emerged almost yearly. I experienced them very personally while studying transcription, translation, RNA splicing, ribosome biogenesis, and more recently, different classes of regulatory non-coding RNAs, including microRNAs. Some selected research and para-research stories, also covering many wonderful people I had a privilege to work with, are summarized below.	[Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, Maulberstr 66, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Filipowicz, W (corresponding author), Friedrich Miescher Inst Biomed Res, Maulberstr 66, CH-4058 Basel, Switzerland.	witold.filipowicz@fmi.ch						Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BESTER AJ, 1975, P NATL ACAD SCI USA, V72, P1523, DOI 10.1073/pnas.72.4.1523; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Billy E, 2000, EMBO J, V19, P2115, DOI 10.1093/emboj/19.9.2115; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; CECH TR, 1983, CELL, V34, P713, DOI 10.1016/0092-8674(83)90527-5; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chekulaeva M, 2010, NUCLEIC ACIDS RES, V38, P6673, DOI 10.1093/nar/gkq501; CULVER GM, 1994, J BIOL CHEM, V269, P24928; Doyle M, 2012, ENZYMES, V32, P1, DOI 10.1016/B978-0-12-404741-9.00001-5; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; Engl C, 2016, NUCLEIC ACIDS RES, V44, P9933, DOI 10.1093/nar/gkw628; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FILIPOWICZ W, 1976, P NATL ACAD SCI USA, V73, P1559, DOI 10.1073/pnas.73.5.1559; FILIPOWICZ W, 1979, P NATL ACAD SCI USA, V76, P3111, DOI 10.1073/pnas.76.7.3111; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1990, METHOD ENZYMOL, V181, P499; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; FILIPOWICZ W, 1972, FEBS LETT, V23, P249, DOI 10.1016/0014-5793(72)80353-3; FILIPOWICZ W, 1972, BIOCHEM BIOPH RES CO, V49, P1272, DOI 10.1016/0006-291X(72)90605-5; FILIPOWICZ W, 1975, P NATL ACAD SCI USA, V72, P3947, DOI 10.1073/pnas.72.10.3947; Filipowicz W, 1995, PREMRNA PROCESSING, V4, P65; Filipowicz Witold, 2016, Postepy Biochem, V62, P327; Filipowicz W, 2015, RNA, V21, P519, DOI 10.1261/rna.051219.115; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Genschik P, 1997, J BIOL CHEM, V272, P13211, DOI 10.1074/jbc.272.20.13211; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; GOODALL GJ, 1991, EMBO J, V10, P2635, DOI 10.1002/j.1460-2075.1991.tb07806.x; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0; GRUNBERGMANAGO M, 1956, BIOCHIM BIOPHYS ACTA, V20, P269, DOI 10.1016/0006-3002(56)90286-4; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hershko A, 2009, J BIOL CHEM, V284, P10291, DOI 10.1074/jbc.X800016200; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; KIKUCHI Y, 1982, NUCLEIC ACIDS RES, V10, P7521, DOI 10.1093/nar/10.23.7521; KISS T, 1991, CELL, V65, P517, DOI 10.1016/0092-8674(91)90469-F; Kiss T, 1996, MOL CELL BIOL, V16, P1391; KISS T, 1992, EMBO J, V11, P3737, DOI 10.1002/j.1460-2075.1992.tb05459.x; KISS T, 1993, EMBO J, V12, P2913, DOI 10.1002/j.1460-2075.1993.tb05953.x; KISS T, 1995, GENE DEV, V9, P1411, DOI 10.1101/gad.9.11.1411; KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; KOZAK M, 1978, CELL, V13, P201, DOI 10.1016/0092-8674(78)90150-2; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1979, NATURE, V280, P82, DOI 10.1038/280082a0; Krol J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8305; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lambermon MHL, 2002, MOL CELL BIOL, V22, P4346, DOI 10.1128/MCB.22.12.4346-4357.2002; LASKI FA, 1983, J BIOL CHEM, V258, P1974; LEEHUANG S, 1977, ARCH BIOCHEM BIOPHYS, V180, P276, DOI 10.1016/0003-9861(77)90039-X; LEVERETTE RD, 1992, CELL, V71, P1215, DOI 10.1016/S0092-8674(05)80069-8; LODISH HF, 1970, J MOL BIOL, V50, P689, DOI 10.1016/0022-2836(70)90093-8; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MURPHY S, 1989, TRENDS GENET, V5, P122, DOI 10.1016/0168-9525(89)90043-7; MUTHUKRISHNAN S, 1975, J BIOL CHEM, V250, P9336; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Ozgur S, 2015, CELL REP, V13, P703, DOI 10.1016/j.celrep.2015.09.033; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; ROTTMAN F, 1974, CELL, V3, P197, DOI 10.1016/0092-8674(74)90131-7; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; SHIMBA S, 1992, J BIOL CHEM, V267, P13772; Sonenberg N, 2012, SCIENCE, V337, P309, DOI 10.1126/science.1226820; Song YQ, 2015, NAT NEUROSCI, V18, P817, DOI 10.1038/nn.4019; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Temmel H, 2017, NUCLEIC ACIDS RES, V45, P4708, DOI 10.1093/nar/gkw1018; TYC K, 1983, EMBO J, V2, P605, DOI 10.1002/j.1460-2075.1983.tb01470.x; TYC K, 1987, J BIOL CHEM, V262, P12994; TYC K, 1984, EUR J BIOCHEM, V140, P503, DOI 10.1111/j.1432-1033.1984.tb08131.x; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; WAIBEL F, 1990, NATURE, V346, P199, DOI 10.1038/346199a0; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; WIEBAUER K, 1988, MOL CELL BIOL, V8, P2042, DOI 10.1128/MCB.8.5.2042; WODNARFILIPOWICZ A, 1975, ACTA BIOCHIM POL, V22, P11; WODNARFILIPOWICZ A, 1978, EUR J BIOCHEM, V92, P69, DOI 10.1111/j.1432-1033.1978.tb12724.x; ZANKOWALCZEWSKA M, 1977, NUCLEIC ACIDS RES, V4, P3065, DOI 10.1093/nar/4.9.3065; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	107	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8122	8135		10.1074/jbc.X117.789065	http://dx.doi.org/10.1074/jbc.X117.789065			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28381442	Green Published, hybrid			2022-12-26	WOS:000401788600001
J	McDermott, ME; DeGroote, LW				McDermott, Molly E.; DeGroote, Lucas W.			Linking phenological events in migratory passerines with a changing climate: 50 years in the Laurel Highlands of Pennsylvania	PLOS ONE			English	Article							EGG-LAYING TRENDS; TITS PARUS-MAJOR; GREAT TITS; SPRING TEMPERATURES; BREEDING PHENOLOGY; FICEDULA-HYPOLEUCA; PIED FLYCATCHERS; POPULATION-SIZE; BIRD MIGRATION; ARRIVAL DATE	Advanced timing of both seasonal migration and reproduction in birds has been strongly associated with a warming climate for many bird species. Phenological responses to climate linking these stages may ultimately impact fitness. We analyzed five decades of banding data from 17 migratory bird species to investigate 1) how spring arrival related to timing of breeding, 2) if the interval between arrival and breeding has changed with increasing spring temperatures, and 3) whether arrival timing or breeding timing best predicted local productivity. Four of 17 species, all mid-to long-distance migrants, hatched young earlier in years when migrants arrived earlier to the breeding grounds (similar to 1: 1 day advancement). The interval between arrival on breeding grounds and appearance of juveniles shortened with warmer spring temperatures for 12 species ( 1 - 6 days for every 1 degrees C increase) and over time for seven species ( 1 - 8 days per decade), suggesting that some migratory passerines adapt to climate change by laying more quickly after arrival or reducing the time from laying to fledging. We found more support for the former, that the rate of reproductive advancement was higher than that for arrival in warm years. Timing of spring arrival and breeding were both poor predictors of avian productivity for most migrants analyzed. Nevertheless, we found evidence that fitness benefits may occur from shifts to earlier spring arrival for the multibrooded Song Sparrow. Our results uniquely demonstrate that co-occurring avian species are phenologically plastic in their response to climate change on their breeding grounds. If migrants continue to show a weaker response to temperatures during migration than breeding, and the window between arrival and optimal breeding shortens further, biological constraints to plasticity may limit the ability of species to adapt successfully to future warming.	[McDermott, Molly E.; DeGroote, Lucas W.] Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA		DeGroote, LW (corresponding author), Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA.	DegrooteL@carnegieMNH.org			Colcom Foundation; Laurel Foundation; Powdermill Avian Research Center (PARC); Carnegie Museum of Natural History	Colcom Foundation; Laurel Foundation; Powdermill Avian Research Center (PARC); Carnegie Museum of Natural History	This research was supported by grants from Colcom Foundation, Laurel Foundation, and private donors who have supported the Powdermill Avian Research Center since its inception. This manuscript is a contribution of the Powdermill Avian Research Center, a long-term bird monitoring program located at Powdermill Nature Reserve, operated and supported by the Carnegie Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to R. Leberman, R. Mulvihill, A. Leppold, A. Vitz, M. Shidel, and countless seasonal technicians and volunteers for collecting field data, and to M. Niedermeier for maintaining the database for many years. Thanks to J. Wenzel, A. Kautz, and J. Slyder for providing constructive comments on earlier drafts of the manuscript. Funding for this research was generously provided by the Colcom Foundation, Laurel Foundation, and numerous private donors who have supported the Powdermill Avian Research Center (PARC) since its inception. This manuscript is a contribution of the PARC, a long-term bird monitoring program located at Powdermill Nature Reserve, operated and supported by the Carnegie Museum of Natural History.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; [Anonymous], 2013, AICCMODAVG MODEL SEL; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Borgman CC, 2016, OECOLOGIA, V180, P279, DOI 10.1007/s00442-015-3456-6; Both C, 2005, ARDEA, V93, P79; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bourgault P, 2010, OECOLOGIA, V162, P885, DOI 10.1007/s00442-009-1545-0; Brown CR, 2014, ECOLOGY, V95, P2736, DOI 10.1890/14-0425.1; Bulluck L, 2013, ECOLOGY EVOLUTION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cohen EB, 2015, STUDIES AVIAN BIOL, P63; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Cresswell W, 2003, J ANIM ECOL, V72, P356, DOI 10.1046/j.1365-2656.2003.00701.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DESANTE DF, 1987, CONDOR, V89, P636, DOI 10.2307/1368653; Desante DF, 1995, J APPL STAT, V22, P935, DOI 10.1080/02664769524720; Doxa A, 2012, AUK, V129, P753, DOI 10.1525/auk.2012.11213; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; Dunn PO, 2014, J ANIM ECOL, V83, P729, DOI 10.1111/1365-2656.12162; Dunn PO, 2011, ECOLOGY, V92, P450, DOI 10.1890/10-0478.1; Dunn Peter O., 2010, P113; Dybala KE, 2013, GLOBAL CHANGE BIOL, V19, P2688, DOI 10.1111/gcb.12228; Forstmeier W, 2002, J ANIM ECOL, V71, P1, DOI 10.1046/j.0021-8790.2001.00569.x; Gienapp P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046165; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; HAFTORN S, 1988, ORNIS SCAND, V19, P97, DOI 10.2307/3676458; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; Hotker H, 2002, ARDEA, V90, P379; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; Irons R., 2015, CHANGES TREE SWALLOW; JARVINEN A, 1989, IBIS, V131, P572, DOI 10.1111/j.1474-919X.1989.tb04792.x; Johansson J, 2012, AM NAT, V179, P463, DOI 10.1086/664624; Laaksonen T, 2006, OIKOS, V114, P277, DOI 10.1111/j.2006.0030-1299.14652.x; Lany NK, 2015, OIKOS; Lehikoinen Esa, 2010, P89; Low M, 2015, J AVIAN BIOL, V46, P325, DOI 10.1111/jav.00623; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Matthysen E, 2011, GLOBAL CHANGE BIOL, V17, P1, DOI 10.1111/j.1365-2486.2010.02213.x; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; McDermott ME, 2016, GLOBAL CHANGE BIOL, V22, P3304, DOI 10.1111/gcb.13363; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moller AP, 2006, J ANIM ECOL, V75, P657, DOI 10.1111/j.1365-2656.2006.01086.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Moller AP, 2002, J ANIM ECOL, V71, P201, DOI 10.1046/j.1365-2656.2002.00589.x; Morrison CA, 2015, BIRD STUDY, V62, P161, DOI 10.1080/00063657.2015.1006575; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Nur N, 2000, 3 PARTN FLIGHT WORKS, P185; Oberg M, 2015, ECOL EVOL, V5, P345, DOI 10.1002/ece3.1345; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pearce-Higgins JW, 2015, J ANIM ECOL, V84, P943, DOI 10.1111/1365-2656.12364; PearceHiggins JW, 2014, ECOL BIODIVERS CONS, P1; R Core Team, 2013, R LANG ENV STAT COMP; Redfern Chris P. F., 2010, Ringing & Migration, V25, P27; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Sanz JJ, 2003, ECOGRAPHY, V26, P45, DOI 10.1034/j.1600-0587.2003.03251.x; Schaefer T, 2006, J ORNITHOL, V147, P47, DOI 10.1007/s10336-005-0011-y; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Seward AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111180; Shiao MT, 2015, AUK, V132, P671, DOI 10.1642/AUK-15-10.1; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Studds CE, 2011, P ROY SOC LOND B BIO; Tarka M, 2015, J EVOLUTION BIOL, V28, P1024, DOI 10.1111/jeb.12638; Tomas G, 2015, J AVIAN BIOL, V46, P107, DOI 10.1111/jav.00499; Townsend AK, 2015, GLOBAL CHANGE BIOL; Townsend AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059467; Vedder O, 2012, OECOLOGIA, V170, P619, DOI 10.1007/s00442-012-2335-7; Velmala W, 2015, ECOL EVOL, V5, P1205, DOI 10.1002/ece3.1423; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Wiebe KL, 2010, AUK, V127, P917, DOI 10.1525/auk.2010.10025; Williams TD, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140301; Wilson A.M., 2012, 2 ATLAS BREEDING BIR; Wilson S, 2003, P NATL ACAD SCI USA, V100, P11139, DOI 10.1073/pnas.1931407100; Winkel W, 1997, J AVIAN BIOL, V28, P187, DOI 10.2307/3677313	82	8	9	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174247	10.1371/journal.pone.0174247	http://dx.doi.org/10.1371/journal.pone.0174247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403152	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200010
J	Hasibuzzaman, MM; Hossain, S; Islam, MS; Rahman, A; Anjum, A; Hossain, F; Mohanto, NC; Karim, MR; Hoque, M; Saud, ZA; Miyataka, H; Himeno, S; Hossain, K				Hasibuzzaman, M. M.; Hossain, Shakhawoat; Islam, Md Shofikul; Rahman, Atiqur; Anjum, Adiba; Hossain, Faruk; Mohanto, Nayan Chandra; Karim, Md Rezaul; Hoque, Mominul; Saud, Zahangir Alam; Miyataka, Hideki; Himeno, Seiichiro; Hossain, Khaled			Association between arsenic exposure and soluble thrombomodulin: A cross sectional study in Bangladesh	PLOS ONE			English	Article							ENDOTHELIAL-CELL MARKERS; DRINKING-WATER; CIRCULATING MARKERS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; PLASMA THROMBOMODULIN; ADHESION MOLECULE-1; ELEVATED LEVELS; INCREASED RISK; HEART-DISEASE	Chronic exposure to arsenic is associated with increased morbidity and mortality from cardiovascular disease (CVD); however, plausible biomarker for early prediction and the underlying mechanism of arsenic-related CVD have not yet been clearly understood. Endothelial dysfunction plays a central role in the development of CVD. We hypothesized that endothelial damage or dysfunction is an important aspect and may be an early event of arsenic-related CVD. Soluble thrombomodulin (sTM) in serum is thought to be a specific and stable marker for endothelial damage or dysfunction. This study was designed to evaluate the association between chronic exposure to arsenic and sTM among human subjects in arsenic- endemic and non-endemic rural areas in Bangladesh. A total of 321 study subjects (217 from arsenic-endemic areas and 104 from a non-endemic area) were recruited. Subjects' arsenic exposure levels (i.e., drinking water, hair and nail arsenic concentrations) were measured by Inductively Coupled Plasma Mass Spectroscopy. The subjects' serum sTM levels were quantified by immunoassay kit. The average sTM levels of the subjects in arsenic-endemic and non-endemic areas were 4.58 +/- 2.20 and 2.84 +/- 1.29 (ng mL(-1)) respectively, and the difference was significant (p<0.001). Arsenic exposure levels showed a significant (water arsenic: rs = 0.339, p<0.001, hair arsenic: rs = 0.352, p<0.001 and nail arsenic: rs = 0.308, p<0.001) positive associations with sTM levels. Soluble TM levels were higher in the higher exposure gradients if we stratified the subjects into tertile groups (low, medium and high) based on the arsenic concentrations of the subjects' drinking water, hair and nails. Finally, increased levels of sTM were negatively correlated with high density lipoprotein cholesterol (HDL-C), and positively correlated with intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Results of this study show that chronic exposure to arsenic has mild to moderate association with sTM levels.	[Hasibuzzaman, M. M.; Hossain, Shakhawoat; Islam, Md Shofikul; Rahman, Atiqur; Anjum, Adiba; Hossain, Faruk; Mohanto, Nayan Chandra; Hoque, Mominul; Saud, Zahangir Alam; Hossain, Khaled] Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Islam, Md Shofikul; Karim, Md Rezaul] Islamic Univ, Dept Appl Nutr & Food Technol, Kushtia, Bangladesh; [Miyataka, Hideki; Himeno, Seiichiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Mol Nutr & Toxicol, Tokushima, Japan	University of Rajshahi; Islamic University; Tokushima Bunri University	Hossain, K (corresponding author), Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh.	khossainbio@gmail.com	Mohanto, Nayan Chandra/GLR-0463-2022; Himeno, Seiichiro/AAW-3421-2020; Rahman, Md Atiqur/GSE-2794-2022; Saud, Zahangir Alam/ADC-1753-2022	Mohanto, Nayan Chandra/0000-0002-5803-1534; Himeno, Seiichiro/0000-0002-0773-2373; Hasibuzzaman, MM/0000-0002-0081-6742; Saud, Zahangir Alam/0000-0003-0019-053X; Anjum, Adiba/0000-0003-2713-8109; Hossain, Khaled/0000-0003-0878-915X	R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh [39.012.002.02.01.016.2013-463]; Ministry of Science and Technology, Government of the People's Republic of Bangladesh [39.009.006.01.00.042.2012-2013/ES-21/558]; TWAS [12-103 RG/BIO/AS_I-UNESCO FR: 3240271353]; Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan [24406009]; Grants-in-Aid for Scientific Research [16H05834] Funding Source: KAKEN	R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh; Ministry of Science and Technology, Government of the People's Republic of Bangladesh; TWAS(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the R & D project, Ministry of Science and Technology, Government of the People's Republic of Bangladesh (Grant No. 39.012.002.02.01.016.2013-463), TWAS (Grant No. 12-103 RG/BIO/AS_I-UNESCO FR: 3240271353), Ministry of Science and Technology, Governent of the People's Republic of Bangladesh [Grant No. 39.009.006.01.00.042.2012-2013/ES-21/558], and Japan Society for the Promotion of Science (JSPS) Kakenhi, Japan (Grant No. 24406009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Ali N, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-36; Blann AD, 1996, BRIT J HAEMATOL, V92, P498, DOI 10.1046/j.1365-2141.1996.d01-1486.x; Blann AD, 1997, EUR J HAEMATOL, V59, P115; Blann AD, 1997, EUR J CLIN INVEST, V27, P916, DOI 10.1046/j.1365-2362.1997.2180766.x; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Boffa MC, 1998, LUPUS, V7, pS120, DOI 10.1177/096120339800700227; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen Y., 2013, ENVIRON HEALTH PERSP, V121, P1; Chen Y, 2006, J HEALTH POPUL NUTR, V24, P253; Chen Y, 2013, AM J EPIDEMIOL, V178, P372, DOI 10.1093/aje/kwt001; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P832, DOI 10.1289/ehp.1205797; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Chowdhury AMR, 2004, SCI AM, V291, P86; Constans J, 2000, THROMB RES, V99, P557, DOI 10.1016/S0049-3848(00)00284-X; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Dohi Y, 2003, HYPERTENS RES, V26, P479, DOI 10.1291/hypres.26.479; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Frisbie SH, 2002, ENVIRON HEALTH PERSP, V110, P1147, DOI 10.1289/ehp.021101147; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Hossain E, 2012, TOXICOL APPL PHARM, V259, P187, DOI 10.1016/j.taap.2011.12.023; Hsieh YC, 2011, ENVIRON RES, V111, P804, DOI 10.1016/j.envres.2011.05.003; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Huda N, 2014, TOXICOL APPL PHARM, V281, P11, DOI 10.1016/j.taap.2014.09.011; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618; Islam MS, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0079-7; IWASHIMA Y, 1990, DIABETES, V39, P983, DOI 10.2337/diabetes.39.8.983; Karim MR, 2013, TOXICOL SCI, V135, P17, DOI 10.1093/toxsci/kft130; Karim MR, 2010, SCI TOTAL ENVIRON, V409, P278, DOI 10.1016/j.scitotenv.2010.10.001; Kawauchi K, 2014, J CARDIOL, V64, P312, DOI 10.1016/j.jjcc.2014.02.004; Larsson PT, 2005, INT ANGIOL, V24, P43; MARKULJAK I, 1995, NOUV REV FR HEMATOL, V37, P137; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; MCLENACHAN JM, 1990, CIRCULATION, V82, P1169, DOI 10.1161/01.CIR.82.4.1169; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Olivot JM, 2004, STROKE, V35, P1946, DOI 10.1161/01.STR.0000133340.37712.9b; Peter K, 1997, ARTERIOSCL THROM VAS, V17, P505, DOI 10.1161/01.ATV.17.3.505; Porreca E, 2004, ATHEROSCLEROSIS, V172, P175, DOI 10.1016/j.atherosclerosis.2003.09.022; Rahman M, 2013, PLOS ONE, V8, P61; Rahman M, 2015, CHEMOSPHERE, V120, P336, DOI 10.1016/j.chemosphere.2014.08.003; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Salomaa V, 1999, LANCET, V353, P1729, DOI 10.1016/S0140-6736(98)09057-6; Salomaa V, 2001, ATHEROSCLEROSIS, V157, P309, DOI 10.1016/S0021-9150(00)00729-2; SEIGNEUR M, 1993, THROMB RES, V71, P423, DOI 10.1016/0049-3848(93)90116-6; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Wade TJ, 2009, INT J ENV RES PUB HE, V6, P1107, DOI 10.3390/ijerph6031107; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang YH, 2007, ATHEROSCLEROSIS, V192, P305, DOI 10.1016/j.atherosclerosis.2006.07.029; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; Wu MM, 2010, TOXICOL APPL PHARM, V248, P226, DOI 10.1016/j.taap.2010.08.005; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175154	10.1371/journal.pone.0175154	http://dx.doi.org/10.1371/journal.pone.0175154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399171	gold, Green Published, Green Submitted			2022-12-26	WOS:000399949000021
J	Wang, Y; Xuan, LY; Cui, XX; Wang, YL; Chen, SQ; Wei, CX; Zhao, M				Wang, Yu; Xuan, Liying; Cui, Xiaoxue; Wang, Yilin; Chen, Shaoqing; Wei, Chengxi; Zhao, Ming			Ibutilide treatment protects against ER stress induced apoptosis by regulating calumenin expression in tunicamycin treated cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEONATAL-RAT CARDIOMYOCYTES; ISCHEMIA/REPERFUSION INJURY; ATRIAL-FIBRILLATION; ENDOTHELIAL-CELLS; DEATH; HEART; ACTIVATION; INDUCTION; MODEL	Background Ibutilide, a class III antiarrhythmic agent has been shown to be cardioprotective in treating atrial fibrillation, promoting cardioconversion and recently this agent has been shown to protect against ER stress induced apoptosis in cardiomyocytes. In this study we begin to identify the mechanism by which ibutilide exerts its cardioprotection in tunicamycin treated cardiomyocytes. We examined ER stress markers including calumenin; a calcium binding ER chaperone protein that has recently been linked to ER stress in cardiomyocytes, in our treated cells. Methods To assess the effect of ibutilide we used the well characterized in vitro model of ER stress induced apoptosis in rat neonatal cardiomyocytes (RNC). RNC were treated with tunicamycin and the degree of ER stress was assessed by quantifying mRNA and protein levels of GRP78, GRP94 and calumenin, and examined the extent of apoptosis by assessing the protein levels of caspase-3/9/12, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of deoxynucleotidyl-transferase- mediated dUTP nick end labeling (TUNEL) positive cells. Results We demonstrate ibutilide attenuated the up-regulation of ER stress markers GRP78 and GRP94 and rescued the decline in calumenin mRNA and protein levels in tunicamycin treated cardiomyocytes. The up-regulation of apoptotic markers caspase-3, CHOP, ATF6, p-PERK, spliced XBP-1, the ratio of Bax/Bcl-2 and the percentage of TUNEL positive cells were also attenuated after ibutilide treatment while the protein levels of Caspase-9 and Caspase-12 were unaffected. Conclusions This study suggests another cardioprotective effect of the antiarrhythmic agent ibutilide whereby pretreatment leads to the attenuation of ER stress induced apoptosis by regulating calumenin expression. This study provides further evidence for the role of calumenin in the cardiomyocyte ER stress response.	[Wang, Yu; Xuan, Liying; Wei, Chengxi] Inner Mongolia Univ Nationalities, Med Chem & Pharmacol Inst, Tongliao, Inner Mongolia, Peoples R China; [Wang, Yu; Xuan, Liying; Wei, Chengxi; Zhao, Ming] Inner Mongolia Prov Key Lab Mongolian Med Pharmac, Tongliao, Inner Mongolia, Peoples R China; [Cui, Xiaoxue; Wang, Yilin; Chen, Shaoqing; Zhao, Ming] Inner Mongolia Univ Nationalities, Clin Med Coll 1, Tongliao, Inner Mongolia, Peoples R China	Inner Mongolia University for Nationalities; Inner Mongolia University for Nationalities	Wei, CX (corresponding author), Inner Mongolia Univ Nationalities, Med Chem & Pharmacol Inst, Tongliao, Inner Mongolia, Peoples R China.; Wei, CX; Zhao, M (corresponding author), Inner Mongolia Prov Key Lab Mongolian Med Pharmac, Tongliao, Inner Mongolia, Peoples R China.; Zhao, M (corresponding author), Inner Mongolia Univ Nationalities, Clin Med Coll 1, Tongliao, Inner Mongolia, Peoples R China.	weichengxi1224@163.com; langzhe73@163.com			National Natural Science Foundation of China [81360587]; Natural Science Foundation of Inner Mongolia [2016BS0806]; Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia	The study was supported by a grant from the National Natural Science Foundation of China (No.81360587), the Natural Science Foundation of Inner Mongolia (No.2016BS0806) and the Mongolian Medicine Systems Biology Science and Technology Innovation Team Plan of Inner Mongolia.	Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Glatter KA, 2001, CIRCULATION, V104, P1933, DOI 10.1161/hc4101.097538; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Han W, 2008, INT J CARDIOL, V130, P165, DOI 10.1016/j.ijcard.2008.02.026; Kito H, 2011, BIOCHEM BIOPH RES CO, V411, P293, DOI 10.1016/j.bbrc.2011.06.128; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Murray KT, 1998, CIRCULATION, V97, P493; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Ren DY, 2012, J BIOMED RES, V26, P432, DOI 10.7555/JBR.26.20120006; Scarabelli TM, 2004, CELL DEATH DIFFER, V11, pS144, DOI 10.1038/sj.cdd.4401544; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.479; Shen MZ, 2015, MOL MED REP, V12, P5149, DOI 10.3892/mmr.2015.4040; Shi JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117567; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Wang Y, 2016, HEART VESSELS	22	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173469	10.1371/journal.pone.0173469	http://dx.doi.org/10.1371/journal.pone.0173469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399139	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000003
J	Harris, VK; Bell, L; Langan, RA; Tuddenham, J; Landy, M; Sadiq, SA				Harris, Violaine K.; Bell, Lena; Langan, Ruth -Anne; Tuddenham, John; Landy, Mark; Sadiq, Saud A.			Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response	PLOS ONE			English	Article							GROWTH-FACTOR; TGF-BETA; INTERLEUKIN-12; MIGRATION; CELLS	Fetuin-A is a biomarker of disease activity in multiple sclerosis. Our aim was to investigate whether Fetuin-A plays a direct role in the neuroinflammatory response in the mouse EAE model. Peak Fetuin-A expression in the CNS and in peripheral lymphoid tissue correlated with peak EAE disease activity. Fetuin-A-deficient mice showed reduced EAE severity associated with an accumulation of splenic monocyte and dendritic cell populations, increased IL-12p40, ASC1, and IL-1 beta expression, and an increase in T regulatory cells. The upregulation of Fetuin-A in LPS-stimulated dendritic cells and microglia further supports an intrinsic role of Fetuin-A in regulating innate immune activation during EAE.	[Harris, Violaine K.; Bell, Lena; Langan, Ruth -Anne; Tuddenham, John; Landy, Mark; Sadiq, Saud A.] Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA		Harris, VK (corresponding author), Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA.	vharris@tischms.org	Sadiq, Saud/AAA-9871-2020	Landy, Mark/0000-0002-2789-0774; Pai, Ruth-Anne/0000-0001-9413-7611; Harris, Violaine/0000-0002-3057-3059; Tuddenham, John/0000-0002-0186-2652	Shubert Foundation	Shubert Foundation	This research was supported by grants to SS from the Shubert Foundation. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Chatterjee P, 2013, J BIOL CHEM, V288, P28324, DOI 10.1074/jbc.C113.495473; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Du CG, 1998, J LEUKOCYTE BIOL, V64, P92, DOI 10.1002/jlb.64.1.92; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Harris VK, 2013, MULT SCLER J, V19, P1462, DOI 10.1177/1352458513477923; Harris VK, 2012, J NEUROL SCI, V313, P167, DOI 10.1016/j.jns.2011.08.036; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Heim CE, 2015, J IMMUNOL, V194, P3861, DOI 10.4049/jimmunol.1402689; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Li HM, 2008, J IMMUNOL, V181, P2483, DOI 10.4049/jimmunol.181.4.2483; Mirshafiey A, 2009, NEUROPHARMACOLOGY, V56, P929, DOI 10.1016/j.neuropharm.2009.02.007; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Ohnishi T, 1997, EUR J BIOCHEM, V243, P753, DOI 10.1111/j.1432-1033.1997.00753.x; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Pollak Y, 2000, J NEUROIMMUNOL, V104, P31, DOI 10.1016/S0165-5728(99)00257-X; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175575	10.1371/journal.pone.0175575	http://dx.doi.org/10.1371/journal.pone.0175575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388685	gold, Green Submitted, Green Published			2022-12-26	WOS:000399375800064
J	Schmidt, C; Fischer, T; Ruckert, RI; Oberwahrenbrock, T; Harms, L; Kronenberg, G; Kunte, H				Schmidt, Charlotte; Fischer, Thomas; Rueckert, Ralph-Ingo; Oberwahrenbrock, Timm; Harms, Lutz; Kronenberg, Golo; Kunte, Hagen			Identification of neovascularization by contrast-enhanced ultrasound to detect unstable carotid stenosis	PLOS ONE			English	Article							PLAQUE NEOVASCULARIZATION; INTRAPLAQUE NEOVASCULARIZATION; ATHEROSCLEROSIS; HEMORRHAGE; ARTERY; US; ANGIOGENESIS; INFLAMMATION; EXPRESSION; DISEASE	Background Plaque neovascularization accompanies local inflammation and critically contributes to plaque instability. Correct identification of intraplaque neovascularization by contrast-enhanced ultrasound (CEUS) may provide an additional risk marker in carotid stenosis. This pilot study investigates the correlation between histological evaluation of carotid plaque specimens and pre-surgery CEUS to identify neovascularization. Methods 17 patients with high-grade internal carotid artery (ICA) stenosis were studied. CEUS was performed in all patients shortly before carotid endarterectomy. Neovascularization, infiltration of T cells and macrophages along with intraplaque hemorrhage were studied in excised plaques by immunohistochemistry. Ultrasound-based four-level and two-level classification systems for neovascularization were used. CEUS findings were compared with histological findings. Results Scores on the CEUS-based four-level and two-level classifications were robustly correlated with the density of intraplaque vessels (r = 0.635, p = 0.006 and r = 0.578, p = 0.015, respectively). Histological evaluation of regions with strong and prolonged intraplaque enhancement typically showed strong intraplaque neovascularization in conjunction with acute intraplaque hemorrhage. Moreover, higher grades of intraplaque neovascularization as determined by ultrasound were associated with a higher percentage of macrophage-rich areas. Conclusion CEUS is a technique well suited to gauge the degree of neovascularization of carotid plaques. Future research will have to define the reliability and validity of CEUS in everyday clinical practice. Further, our study suggests that CEUS may also be useful to pick up features of vulnerable plaques such as acute intraplaque hemorrhages.	[Schmidt, Charlotte; Harms, Lutz; Kronenberg, Golo; Kunte, Hagen] Charite, Charite Ctr Neurol Neurosurg & Psychiat 15, Berlin, Germany; [Fischer, Thomas] Charite Univ Med Berlin, Inst Radiol, Berlin, Germany; [Rueckert, Ralph-Ingo] Franziskus Krankenhaus Berlin, Berlin, Germany; [Oberwahrenbrock, Timm] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Kronenberg, Golo] Univ Med Rostock, Klin & Poliklin Psychiat & Psychotherapie, Zentrum Nervenheilkunde, Rostock, Germany; [Kunte, Hagen] MSB Med Sch Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock	Kunte, H (corresponding author), Charite, Charite Ctr Neurol Neurosurg & Psychiat 15, Berlin, Germany.; Kunte, H (corresponding author), MSB Med Sch Berlin, Berlin, Germany.	hagen.kunte@charite.de		Kronenberg, Golo/0000-0002-5310-9849				Ammirati E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/718329; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Cattaneo M, 2016, INT J CARDIOL, V223, P917, DOI 10.1016/j.ijcard.2016.08.261; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; HENNERICI M, 1987, BRAIN, V110, P777, DOI 10.1093/brain/110.3.777; Hjelmgren O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166918; Huang PT, 2010, WORLD J CARDIOL, V2, P89, DOI 10.4330/wjc.v2.i4.89; Ibrahimi P, 2013, ATHEROSCLEROSIS, V231, P323, DOI 10.1016/j.atherosclerosis.2013.09.035; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kopriva D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143138; Kunte H, 2013, CASE REP VASC MED, V2013, P1; Kunte H, 2008, J VASC SURG, V47, P513, DOI 10.1016/j.jvs.2007.11.045; Kunte H, 2013, NEUROLOGY, V80, P122, DOI 10.1212/WNL.0b013e31827b1b06; Kunte H, 2012, NEUROLOGY, V79, P2081, DOI 10.1212/WNL.0b013e3182749f4c; Leong-Poi H, 2005, CIRCULATION, V111, P3248, DOI 10.1161/CIRCULATIONAHA.104.481515; Li CL, 2014, ULTRASOUND MED BIOL, V40, P1827, DOI 10.1016/j.ultrasmedbio.2014.02.010; Magnoni M, 2015, J CARDIOL, V65, P261, DOI 10.1016/j.jjcc.2015.01.004; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; Moreno PR, 2006, CURR MOL MED, V6, P457, DOI 10.2174/156652406778018635; Owen DR, 2010, RADIOLOGY, V255, P638, DOI 10.1148/radiol.10091365; Partovi S, 2012, AM J ROENTGENOL, V198, pW13, DOI 10.2214/AJR.11.7312; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; Saito K, 2014, STROKE, V45, P3073, DOI 10.1161/STROKEAHA.114.006483; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Staub D, 2010, STROKE, V41, P41, DOI 10.1161/STROKEAHA.109.560342; ten Kate GL, 2013, J VASC SURG, V57, P539, DOI 10.1016/j.jvs.2012.07.028; Teng ZZ, 2014, J BIOMECH, V47, P847, DOI 10.1016/j.jbiomech.2014.01.013; Thapar A, 2012, RADIOLOGY, V262, P672, DOI 10.1148/radiol.11110968; van Dijk AC, 2015, AM J NEURORADIOL, V36, P2127, DOI 10.3174/ajnr.A4414; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829; Yuan C, 1998, CIRCULATION, V98, P2666, DOI 10.1161/01.CIR.98.24.2666	33	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175331	10.1371/journal.pone.0175331	http://dx.doi.org/10.1371/journal.pone.0175331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388659	Green Published, gold, Green Submitted			2022-12-26	WOS:000399375800041
J	Onodera, Y; Takahashi, K; Goto, M; Anzai, M; Ono, N; Shirasawa, H; Sato, W; Miura, H; Sato, N; Sato, A; Kumazawa, Y; Terada, Y				Onodera, Yohei; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Ono, Natsuki; Shirasawa, Hiromitsu; Sato, Wataru; Miura, Hiroshi; Sato, Naoki; Sato, Akira; Kumazawa, Yukiyo; Terada, Yukihiro			The location of "8"-shaped hatching influences inner cell mass formation in mouse blastocysts	PLOS ONE			English	Article							IN-VITRO; ZONA-PELLUCIDA; TIME-LAPSE; EMBRYOS; TROPHECTODERM; IMPLANTATION	The hatching of a blastocyst where the blastocyst portions on the inside and the outside of the zona pellucida feature a figure-of-eight shape is termed "8"-shaped hatching; this type of hatching has been reported to affect the proper presentation of the inner cell mass (ICM) in both human and mouse embryos. Here, our aim was to investigate the factors that affect ICM presentation during "8"-shaped hatching. We performed IVF by using B6D2F1 female mice and ICR male mice, and used the 104 captured blastocysts. Embryos were maintained in KSOM at 37 degrees C in a 5% CO2, 5% O-2, and 90% N-2 environment, and their growth behavior was monitored individually and continuously using time-lapse cinematography. At 120 h after insemination, embryos were immunostained and examined under a confocal microscope. We used the hatching form to identify "8-shaped hatching, and we classified the "8" shaped- hatching blastocysts into two groups, one in which the hatching site was near the ICM center, and the other in which the hatching site was far from the ICM center. We measured each group for ICM size and the number of Oct3/4-positive cells. Of the 95 hatching or hatched embryos, 74 were "8"-shaped-hatching blastocysts, and in these embryos, the ICM was significantly wider when the hatching site was near the ICM than when the hatching site was far from the ICM (P = 0.0091). Moreover, in the "8"-shaped-hatching blastocysts in which the ICM was included in the blastocyst portion outside the zona pellucida. the portion defined as the "outside blastocyst". after the collapse of this outside blastocyst, the ICM adhered to the trophectoderm of the outside blastocyst, opposite the hatching site. Our results indicate that in "8"-shaped-hatching blastocysts, the hatching site and the collapse of outside blastocyst affect ICM formation. Thus, the assessment of "8"-shaped hatching behaviors could yield indices for accurately evaluating embryo quality.	[Onodera, Yohei; Takahashi, Kazumasa; Goto, Mayumi; Anzai, Mibuki; Ono, Natsuki; Shirasawa, Hiromitsu; Sato, Wataru; Miura, Hiroshi; Sato, Naoki; Sato, Akira; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan	Akita University	Onodera, Y (corresponding author), Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan.	onoderay@med.akita-u.ac.jp			Japan Society for the Promotion of Science [26462473]; Grants-in-Aid for Scientific Research [15K15593] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https/7wwispsgoipterglisiitindexMoll, Grant Number 26462473).	Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Barcroft LC, 2003, DEV BIOL, V256, P342, DOI 10.1016/S0012-1606(02)00127-6; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bodri D, 2016, FERTIL STERIL, V105, P1476, DOI 10.1016/j.fertnstert.2016.02.014; Cheon YP, 1999, ZYGOTE, V7, P123, DOI 10.1017/S0967199499000477; DeMeestere I, 1997, INT J FERTIL WOMEN M, V42, P219; EDWARDS R G, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P114, DOI 10.1007/BF01139357; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Kim J, 2004, MOL CELLS, V17, P248; Kirkegaard K, 2013, FERTIL STERIL, V100, P1277, DOI 10.1016/j.fertnstert.2013.07.005; Laeno AMA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109470; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Marcos J, 2015, HUM REPROD, V30, P2501, DOI 10.1093/humrep/dev216; Mio Y Iwata K Yumoto K Maeda K ., 2014, J HLTH MED INFO, V5, P143, DOI DOI 10.4172/2157-7420.1000143; Mio Y, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.023; Miyata H, 2010, FERTIL STERIL, V94, P2444, DOI 10.1016/j.fertnstert.2010.01.056; Niimura S, 2003, J REPROD DEVELOP, V49, P413, DOI 10.1262/jrd.49.413; Otsuki J, 2016, FERTIL STERIL, V106, P640, DOI 10.1016/j.fertnstert.2016.05.007; PERONA RM, 1986, DEV BIOL, V114, P42, DOI 10.1016/0012-1606(86)90382-9; Richter KS, 2001, FERTIL STERIL, V76, P1157, DOI 10.1016/S0015-0282(01)02870-9; TALANSKY BE, 1988, GAMETE RES, V21, P277, DOI 10.1002/mrd.1120210309; Thomas M, 1997, J CELL SCI, V110, P1597; Togashi K, 2015, J ASSIST REPROD GEN, V32, P969, DOI 10.1007/s10815-015-0479-1; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; WATSON AJ, 1992, MOL REPROD DEV, V33, P492, DOI 10.1002/mrd.1080330417; Yan Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145172	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175150	10.1371/journal.pone.0175150	http://dx.doi.org/10.1371/journal.pone.0175150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384351	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900101
J	Vincent-Chong, VK; Salahshourifar, I; Woo, KM; Anwar, A; Razali, R; Gudimella, R; Rahman, ZAA; Ismail, SM; Kallarakkal, TG; Ramanathan, A; Mustafa, WMW; Abraham, MT; Tay, KK; Zain, RB				Vincent-Chong, Vui King; Salahshourifar, Iman; Woo, Kar Mun; Anwar, Arif; Razali, Rozaimi; Gudimella, Ranganath; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong; Zain, Rosnah Binti			Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance	PLOS ONE			English	Article							DNA COPY NUMBER; CANCER; HEAD; BIOMARKERS; OVEREXPRESSION; PROGRESSION; ACTIVATION; EXPRESSION; DELETION; RISK	Background Cancers of the oral cavity are primarily oral squamous cell carcinomas (OSCCs). Many of the OSCCs present at late stages with an exceptionally poor prognosis. A probable limitation in management of patients with OSCC lies in the insufficient knowledge pertaining to the linkage between copy number alterations in OSCC and oral tumourigenesis thereby resulting in an inability to deliver targeted therapy. Objectives The current study aimed to identify copy number alterations (CNAs) in OSCC using array comparative genomic hybridization (array CGH) and to correlate the CNAs with clinico-pathologic parameters and clinical outcomes. Materials and methods Using array CGH, genome-wide profiling was performed on 75 OSCCs. Selected genes that were harboured in the frequently amplified and deleted regions were validated using quantitative polymerase chain reaction (qPCR). Thereafter, pathway and network functional analysis were carried out using Ingenuity Pathway Analysis (IPA) software. Results Multiple chromosomal regions including 3q, 5p, 7p, 8q, 9p, 10p, 11 q were frequently amplified, while 3p and 8p chromosomal regions were frequently deleted. These findings were in confirmation with our previous study using ultra-dense array CGH. In addition, amplification of 8q, 11q, 7p and 9p and deletion of 8p chromosomal regions showed a significant correlation with clinico-pathologic parameters such as the size of the tumour, metastatic lymph nodes and pathological staging. Co-amplification of 7p, 8q, 9p and 11q regions that harbored amplified genes namely CCND1, EGFR, TPM2 and LRP12 respectively, when combined, continues to be an independent prognostic factor in OSCC. Conclusion Amplification of 3q, 5p, 7p, 8q, 9p, 10p, 11q and deletion of 3p and 8p chromosomal regions were recurrent among OSCC patients. Co-alteration of 7p, 8q, 9p and 11q was found to be associated with clinico-pathologic parameters and poor survival. These regions contain genes that play critical roles in tumourigenesis pathways.	[Vincent-Chong, Vui King; Salahshourifar, Iman; Woo, Kar Mun; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Oral Canc Res & Coordinating Ctr, Fac Dent, Kuala Lumpur, Malaysia; [Vincent-Chong, Vui King; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Dept Oral & Maxillofacial Clin Sci, Fac Dent, Kuala Lumpur, Malaysia; [Salahshourifar, Iman] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran; [Anwar, Arif; Razali, Rozaimi; Gudimella, Ranganath] Sengen Sdn Bhd, High Impact Res HIR Bldg, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan] Hosp Kuala Lumpur, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Abraham, Mannil Thomas] Hosp Tengku Ampuan Rahimah, Dept Oral & Maxillofacial Surg, Klang, Selangor Darul, Malaysia; [Tay, Keng Kiong] Hosp Umum Kuching, Dept Oral Surg, Kuching, Sarawak, Malaysia	Universiti Malaya; Universiti Malaya; Islamic Azad University	Zain, RB (corresponding author), Univ Malaya, Oral Canc Res & Coordinating Ctr, Fac Dent, Kuala Lumpur, Malaysia.; Zain, RB (corresponding author), Univ Malaya, Dept Oral & Maxillofacial Clin Sci, Fac Dent, Kuala Lumpur, Malaysia.	rosnahbz12@yahoo.corn	Ramanathan, Anand/J-2943-2014; RAZALI, ROZAIMI/O-8694-2017; Razali, Rozaimi/AAF-9115-2021; George, Thomas/B-7774-2010	Ramanathan, Anand/0000-0001-6496-7139; RAZALI, ROZAIMI/0000-0002-8996-3975; Razali, Rozaimi/0000-0002-8996-3975; George, Thomas/0000-0002-5986-6170	High Impact Research MoE from the Ministry of Education Malaysia [UM.C/625/1/HIR/DENT/08]	High Impact Research MoE from the Ministry of Education Malaysia	This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/DENT/08 from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-32; Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; Ariffin OZ, 2011, NCR REPORT 2007; Bronstad I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-111; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135074; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Deschler DG, 2014, OTOLARYNG HEAD NECK, V151, P375, DOI 10.1177/0194599814538605; Dienstmann R, 2015, CANCER DISCOV, V5, P118, DOI 10.1158/2159-8290.CD-14-1118; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Ghani WMN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-82; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li Y, 2014, CANCER INFORM, V13, P129, DOI 10.4137/CIN.S14073; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Mendez E, 2009, CLIN CANCER RES, V15, P1353, DOI 10.1158/1078-0432.CCR-08-1816; Mutation C, 2015, NAT METHODS, V12, P615, DOI DOI 10.1038/NMETH.3440; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Que L, 2016, ONCOL REP, V35, P89, DOI 10.3892/or.2015.4374; Shah J P, 1990, Oncology (Williston Park), V4, P61; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Sobin LH, 2011, TNM CLASSIFICATION M; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; Towle R, 2014, CANCER MED-US, V3, P1170, DOI 10.1002/cam4.307; Uchida K, 2011, ONCOL REP, V26, P463, DOI 10.3892/or.2011.1327; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Viet CT, 2010, HEAD NECK-J SCI SPEC, V32, P1246, DOI 10.1002/hed.21358; Vincent-Chong VK, 2015, HEAD NECK; Vincent-Chong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054705; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Woolgar JA, 2006, ORAL ONCOL, V42, P229, DOI 10.1016/j.oraloncology.2005.05.008; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Zain RB, 2013, CELL TISSUE BANK, V14, P45, DOI 10.1007/s10561-012-9298-0; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174865	10.1371/journal.pone.0174865	http://dx.doi.org/10.1371/journal.pone.0174865			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384287	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900045
J	Wong, E; Sastri, AR; Lin, FS; Hsieh, CH				Wong, Esther; Sastri, Akash R.; Lin, Fan-Sian; Hsieh, Chih-hao			Modified FlowCAM procedure for quantifying size distribution of zooplankton with sample recycling capacity	PLOS ONE			English	Article							EAST CHINA SEA; BODY-SIZE; METABOLIC THEORY; GROWTH-RATES; ECOLOGY	We have developed a modified FlowCAM procedure for efficiently quantifying the size distribution of zooplankton. The modified method offers the following new features: 1) prevents animals from settling and clogging with constant bubbling in the sample container; 2) prevents damage to sample animals and facilitates recycling by replacing the built-in peristaltic pump with an external syringe pump, in order to generate negative pressure, creates a steady flow by drawing air from the receiving conical flask (i.e. vacuum pump), and transfers plankton from the sample container toward the main flowcell of the imaging system and finally into the receiving flask; 3) aligns samples in advance of imaging and prevents clogging with an additional flowcell placed ahead of the main flowcell. These modifications were designed to overcome the difficulties applying the standard FlowCAM procedure to studies where the number of individuals per sample is small, and since the FlowCAM can only image a subset of a sample. Our effective recycling procedure allows users to pass the same sample through the FlowCAM many times (i.e. bootstrapping the sample) in order to generate a good size distribution. Although more advanced FlowCAM models are equipped with syringe pump and Field of View (FOV) flowcells which can image all particles passing through the flow field; we note that these advanced setups are very expensive, offer limited syringe and flowcell sizes, and do not guarantee recycling. In contrast, our modifications are inexpensive and flexible. Finally, we compared the biovolumes estimated by automated FlowCAM image analysis versus conventional manual measurements, and found that the size of an individual zooplankter can be estimated by the FlowCAM image system after ground truthing.	[Wong, Esther; Lin, Fan-Sian; Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Wong, Esther] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Sastri, Akash R.] Univ Victoria, Ocean Networks Canada, Victoria, BC, Canada; [Sastri, Akash R.] Univ Victoria, Biol Dept, Victoria, BC, Canada; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Dept Life Sci, Taipei, Taiwan; [Hsieh, Chih-hao] Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan; [Hsieh, Chih-hao] Natl Ctr Theoret Sci, Taipei, Taiwan	National Taiwan University; Hong Kong University of Science & Technology; University of Victoria; University of Victoria; National Taiwan University; Academia Sinica - Taiwan	Hsieh, CH (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.; Hsieh, CH (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Dept Life Sci, Taipei, Taiwan.; Hsieh, CH (corresponding author), Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan.; Hsieh, CH (corresponding author), Natl Ctr Theoret Sci, Taipei, Taiwan.	chsieh@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272	National Center for Theoretical Sciences; Foundation for the Advancement of Outstanding Scholarship; Ministry of Science and Technology of Taiwan	National Center for Theoretical Sciences; Foundation for the Advancement of Outstanding Scholarship; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by the National Center for Theoretical Sciences, Foundation for the Advancement of Outstanding Scholarship, and Ministry of Science and Technology of Taiwan to CHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2014, J PLANKTON RES, V36, P170, DOI 10.1093/plankt/fbt069; Alvarez E, 2012, J PLANKTON RES, V34, P454, DOI 10.1093/plankt/fbs017; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brucet S, 2010, LIMNOL OCEANOGR, V55, P1697, DOI 10.4319/lo.2010.55.4.1697; Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003; Chang CW, 2014, ECOLOGY, V95, P897, DOI 10.1890/13-0742.1; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Garcia-Comas C, 2016, J PLANKTON RES, V38, P1006, DOI 10.1093/plankt/fbw039; Garcia-Comas C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2129; Garcia-Comas C, 2014, PROG OCEANOGR, V121, P141, DOI 10.1016/j.pocean.2013.10.010; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Ide K, 2008, J PLANKTON RES, V30, P275, DOI 10.1093/plankt/fbm108; Kimmerer WJ, 2007, MAR ECOL PROG SER, V336, P187, DOI 10.3354/meps336187; Krupica KL, 2012, CONT SHELF RES, V36, P29, DOI 10.1016/j.csr.2012.01.008; Le Bourg B, 2015, J PLANKTON RES, V37, P666, DOI 10.1093/plankt/fbv025; Lin KY, 2013, BIOGEOSCIENCES, V10, P1877, DOI 10.5194/bg-10-1877-2013; Litchman E, 2013, J PLANKTON RES, V35, P473, DOI 10.1093/plankt/fbt019; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; SHELDON RW, 1967, J FISH RES BOARD CAN, V24, P909, DOI 10.1139/f67-081; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327	20	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175235	10.1371/journal.pone.0175235	http://dx.doi.org/10.1371/journal.pone.0175235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384288	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900130
J	Yuan, J; Hou, L; Wei, X; Shang, ZC; Cheng, F; Zhang, SX				Yuan, Jie; Hou, Lin; Wei, Xin; Shang, Zhengchun; Cheng, Fei; Zhang, Shuoxin			Decay and nutrient dynamics of coarse woody debris in the Qinling Mountains, China	PLOS ONE			English	Article							MIXED-CONIFER FORESTS; BROAD-LEAVED FOREST; DECOMPOSITION RATES; DEAD TREES; NATIONAL-PARK; CARBON; TEMPERATE; CHRONOSEQUENCE; ATTRIBUTES; NITROGEN	As an ecological unit, coarse woody debris (CWD) plays an essential role in productivity, nutrient cycling, carbon sequestration, community regeneration and biodiversity. However, thus far, the information on quantification the decomposition and nutrient content of CWD in forest ecosystems remains considerably limited. In this study, we conducted a long-term (1996-2013) study on decay and nutrient dynamics of CWD for evaluating accurately the ecological value of CWD on the Huoditang Experimental Forest Farm in the Qinling Mountains, China. The results demonstrated that there was a strong correlation between forest biomass and CWD mass. The single exponential decay model well fit the CWD density loss at this site, and as the CWD decomposed, the CWD density decreased significantly. Annual temperature and precipitation were all significantly correlated with the annual mass decay rate. The K contents and the C/ N ratio of the CWD decreased as the CWD decayed, but the C, N, P, Ca and Mg contents increased. We observed a significant CWD decay effect on the soil C, N and Mg contents, especially the soil C content. The soil N, P, K, Ca and Mg contents exhibited large fluctuations, but the variation had no obvious regularity and changed with different decay times. The results showed that CWD was a critical component of nutrient cycling in forest ecosystems. Further research is needed to determine the effect of diameter, plant tissue components, secondary wood compounds, and decomposer organisms on the CWD decay rates in the Qinling Mountains, which will be beneficial to clarifying the role of CWD in carbon cycles of forest ecosystems.	[Yuan, Jie; Hou, Lin; Wei, Xin; Shang, Zhengchun; Cheng, Fei; Zhang, Shuoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Hou, Lin; Zhang, Shuoxin] Qinling Natl Forest Ecosyst Res Stn, Ningshan, Shaanxi, Peoples R China; [Shang, Zhengchun] Yangtze Univ, Coll Agr, Jingzhou, Hubei, Peoples R China	Northwest A&F University - China; Yangtze University	Zhang, SX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.; Zhang, SX (corresponding author), Qinling Natl Forest Ecosyst Res Stn, Ningshan, Shaanxi, Peoples R China.	sxzhang@nwsuaf.edu.cn		Yuan, Jie/0000-0002-5094-7441	State Forestry Administration of China [201004036]	State Forestry Administration of China	This research was funded by the project of Technical management system for increasing the capacity of carbon sink and water regulation of mountain forests in the Qinling Mountains (201004036) from the State Forestry Administration of China. Shuoxin Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2008, FOREST ECOL MANAG, V255, P410, DOI 10.1016/j.foreco.2007.09.008; Aakala T, 2007, CAN J FOREST RES, V37, P50, DOI 10.1139/X06-201; ARTHUR MA, 1990, CAN J FOREST RES, V20, P730, DOI 10.1139/x90-096; Baker TR, 2007, OECOLOGIA, V152, P495, DOI 10.1007/s00442-007-0667-5; Beets PN, 2008, FOREST ECOL MANAG, V256, P548, DOI 10.1016/j.foreco.2008.05.036; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Brais S, 2005, FOREST ECOL MANAG, V220, P216, DOI 10.1016/j.foreco.2005.08.013; Brischke C, 2008, WOOD SCI TECHNOL, V42, P663, DOI 10.1007/s00226-008-0190-9; Brown PM, 1998, CAN J FOREST RES, V28, P932, DOI 10.1139/cjfr-28-6-932; BUSSE MD, 1994, SOIL SCI SOC AM J, V58, P221, DOI 10.2136/sssaj1994.03615995005800010033x; Carmona MR, 2002, FOREST ECOL MANAG, V164, P265, DOI 10.1016/S0378-1127(01)00602-8; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Chen C., 1996, J NW FOR COLL, V11, P92; Chen H., 1992, CHINESE J APPL ECOLO, V3, P99; Chen H, 1991, CHINESE J ECOL, V10, P45; Chen H, 1992, CHINESE J ECOL, V11, P17; Clark DB, 2002, FOREST ECOL MANAG, V164, P237, DOI 10.1016/S0378-1127(01)00597-7; Creed IF, 2004, CAN J FOREST RES, V34, P744, DOI 10.1139/X03-212; Dai LM, 2000, CHINESE J APPL ECOLO, V13, P107; Dunn CJ, 2012, FOREST ECOL MANAG, V276, P71, DOI 10.1016/j.foreco.2012.03.013; FAHEY TJ, 1983, ECOL MONOGR, V53, P51, DOI 10.2307/1942587; Fraver S, 2013, ECOSYSTEMS, V16, P1262, DOI 10.1007/s10021-013-9682-z; Fravolini G, 2016, SCI TOTAL ENVIRON, V569, P1064, DOI 10.1016/j.scitotenv.2016.06.167; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Ganjegunte GK, 2004, FOREST ECOL MANAG, V187, P197, DOI 10.1016/S0378-1127(03)00332-3; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Garrett Loretta, 2007, New Zealand Journal of Forestry Science, V37, P227; Ge XG, 2013, SOIL SCI, V178, P442, DOI 10.1097/SS.0000000000000004; Goldin SR, 2015, APPL VEG SCI, V18, P134, DOI 10.1111/avsc.12120; Gough CM, 2007, FOREST ECOL MANAG, V244, P60, DOI 10.1016/j.foreco.2007.03.039; Graham SA, 1925, ECOLOGY, V6, P397, DOI 10.2307/1929106; Harmon M.E., 1996, GUIDELINES MEASUREME; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1987, CAN J FOREST RES, V17, P1265, DOI 10.1139/x87-196; Holub SM, 2001, CAN J FOREST RES, V31, P1894, DOI 10.1139/cjfr-31-11-1894; Hou Ping, 2001, Yingyong Shengtai Xuebao, V12, P309; Janisch JE, 2002, TREE PHYSIOL, V22, P77, DOI 10.1093/treephys/22.2-3.77; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Kang Y.X., 1996, J NW FORESTRY COLL, V11, P1; Kim RH, 2006, ECOL RES, V21, P819, DOI 10.1007/s11284-006-0034-8; Krankina ON, 1999, CAN J FOREST RES, V29, P20, DOI 10.1139/cjfr-29-1-20; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; Laiho R, 1999, CAN J FOREST RES, V29, P1592, DOI 10.1139/cjfr-29-10-1592; Lei R.D., 1996, J NW FORESTRY COLL, V11, P43; LI LH, 1996, ACTA PHYTOECOLOGICA, V20, P132; Li LH, 1998, ACTA PHYTOECOL SIN, V22, P434; Li Zhou, 2007, Journal of Forestry Research (Harbin), V18, P48, DOI 10.1007/s11676-007-0009-9; Liu WenYao, 1995, Acta Botanica Sinica, V37, P807; Liu YanYan, 2010, Scientia Silvae Sinicae, V46, P8; Lu Ming-he, 2006, Journal of Tropical and Subtropical Botany, V14, P107; Mac Nally R, 2001, BIOL CONSERV, V99, P191, DOI 10.1016/S0006-3207(00)00180-4; Mackensen J, 2003, AUST J BOT, V51, P27, DOI 10.1071/BT02014; MARRA JL, 1994, CAN J FOREST RES, V24, P1811, DOI 10.1139/x94-234; Muller-Using S, 2009, EUR J FOREST RES, V128, P287, DOI 10.1007/s10342-009-0264-8; Nilsson SG, 2002, FOREST ECOL MANAG, V161, P189, DOI 10.1016/S0378-1127(01)00480-7; Olajuyigbe SO, 2011, FOREST ECOL MANAG, V262, P1109, DOI 10.1016/j.foreco.2011.06.010; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Palviainen M, 2010, FOREST ECOL MANAG, V259, P390, DOI 10.1016/j.foreco.2009.10.034; Pedlar JH, 2002, FOREST ECOL MANAG, V158, P189, DOI 10.1016/S0378-1127(00)00711-8; Preston CM, 1998, FOREST ECOL MANAG, V111, P51, DOI 10.1016/S0378-1127(98)00307-7; Ringvall A, 1999, FOREST ECOL MANAG, V119, P163, DOI 10.1016/S0378-1127(98)00521-0; Santiago LS, 2000, BIOTROPICA, V32, P633, DOI 10.1646/0006-3606(2000)032[0633:UOCWDB]2.0.CO;2; Silva LFSG, 2016, FOREST ECOL MANAG, V364, P1, DOI 10.1016/j.foreco.2015.12.045; Sefidi K, 2016, IFOREST, V9, P658, DOI 10.3832/ifor1080-008; Shorohova E, 2014, FOREST ECOL MANAG, V315, P173, DOI 10.1016/j.foreco.2013.12.025; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; SOLLINS P, 1987, CAN J FOREST RES, V17, P1585, DOI 10.1139/x87-243; Spears JDH, 2003, CAN J FOREST RES, V33, P2193, DOI 10.1139/X03-148; Stevenson SK, 2006, FOREST ECOL MANAG, V233, P176, DOI 10.1016/j.foreco.2006.06.023; Stewart GH, 2011, CANADIAN J FOREST RE, V24, P1989; Stone JN, 1998, CAN J FOREST RES, V28, P788, DOI 10.1139/cjfr-28-5-788; [唐旭利 Tang Xuli], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P484; Tobin B, 2007, FORESTRY, V80, P455, DOI 10.1093/forestry/cpm024; Wang CK, 2002, OECOLOGIA, V132, P374, DOI 10.1007/s00442-002-0987-4; Wang Wen-juan, 2009, Yingyong Shengtai Xuebao, V20, P773; Weedon JT, 2009, ECOL LETT, V12, P45, DOI 10.1111/j.1461-0248.2008.01259.x; Wei X, 2011, CANADIAN J FOREST RE, V27, P148, DOI DOI 10.1139/X96-169; Wenger KF, 1984, FORESTRY HDB, VSecond; Wilcke W, 2005, FOREST ECOL MANAG, V205, P139, DOI 10.1016/j.foreco.2004.10.044; Woodall Christopher W, 2008, Carbon Balance Manag, V3, P5, DOI 10.1186/1750-0680-3-5; World Reference Base for Soil Resources, 2014, WORLD SOIL RESOURCES, V106; Wu Jia-bing, 2005, Journal of Forestry Research (Harbin), V16, P247, DOI 10.1007/BF02856826; Yamashita S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131510; Yan E., 2006, FRONTIERS BIOL CHINA, V1, P76, DOI [10.1007/s11515-005-0019-y, DOI 10.1007/S11515-005-0019-Y]; Yang FF, 2010, FOREST ECOL MANAG, V259, P1666, DOI 10.1016/j.foreco.2010.01.046; Yang Li-pan, 2007, Yingyong Shengtai Xuebao, V18, P2153; Yang LY, 2002, CHIN J APPL ECOL, V13, P1069; Yatskov M, 2003, CAN J FOREST RES, V33, P1211, DOI [10.1139/x03-033, 10.1139/X03-033]; Yuan Jie, 2014, Acta Ecologica Sinica - International Journal, V34, P232, DOI 10.1016/j.chnaes.2014.05.001; [袁杰 YUAN Jie], 2011, [西北林学院学报, Journal of Northwest Forestry College], V26, P90; Zell J, 2009, ECOL MODEL, V220, P904, DOI 10.1016/j.ecolmodel.2009.01.020; Zhang, 2010, J SUBTROP RESOUR ENV, V5, P46; [张修玉 ZHANG Xiu-Yu], 2009, [生态学报, Acta Ecologica Sinica], V29, P5227; Zhao XH, 1995, J JILIN FORESTRY U, V11, P200; [赵玉涛 Zhao Yutao], 2002, [山地学报, Journal of mountain science], V20, P12; ZIMMERMAN JK, 1995, OIKOS, V72, P314, DOI 10.2307/3546116	98	19	21	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175203	10.1371/journal.pone.0175203	http://dx.doi.org/10.1371/journal.pone.0175203			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384317	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900118
J	Chereau, F; Madec, Y; Sabina, C; Obel, N; Ruiz-Mateos, E; Chrysos, G; Fidler, S; Lehmann, C; Zangerle, R; Wittkop, L; Reiss, P; Hamouda, O; Perez, VE; Leal, M; Mocroft, A; De Olalla, PG; Ammassari, A; Monforte, AD; Mussini, C; Segura, F; Castagna, A; Cavassini, M; Grabar, S; Morlat, P; De Wit, S; Lambotte, O; Meyer, L				Chereau, Fanny; Madec, Yoann; Sabina, Caroline; Obel, Niels; Ruiz-Mateos, Ezequiel; Chrysos, Georgios; Fidler, Sarah; Lehmann, Clara; Zangerle, Robert; Wittkop, Linda; Reiss, Peter; Hamouda, Osamah; Estrada Perez, Vicente; Leal, Manuel; Mocroft, Amanda; Garcia De Olalla, Patricia; Ammassari, Adriana; Monforte, Antonella D'Arminio; Mussini, Cristina; Segura, Ferran; Castagna, Antonella; Cavassini, Matthias; Grabar, Sophie; Morlat, Philippe; De Wit, Stephane; Lambotte, Olivier; Meyer, Laurence		HIV Controllers Project; Collaboration Observational HIV	Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; T-CELLS; INVERSE PROBABILITY; NATURAL-HISTORY; RNA LEVELS; INFECTION; PROGRESSION; REPLICATION; ACTIVATION; ABSENCE	Objective HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretroviral therapy (ART), a small number of whom will eventually lose this ability to control HIV viremia. The objective was to identify factors associated with loss of virological control. Methods HICs were identified in COHERE on the basis of >= 5 consecutive viral loads (VL) <= 500 copies/mL over >= 1 year whilst ART-naive, with the last VL <= 500 copies/mL measured >= 5 years after HIV diagnosis. Loss of virological control was defined as 2 consecutive VL > 2000 copies/mL. Duration of HIV control was described using cumulative incidence method, considering loss of virological control, ART initiation and death during virological control as competing outcomes. Factors associated with loss of virological control were identified using Cox models. CD4 and CD8 dynamics were described using mixed-effect linear models. Results We identified 1067 HICs; 86 lost virological control, 293 initiated ART, and 13 died during virological control. Six years after confirmation of HIC status, the probability of losing virological control, initiating ART and dying were 13%, 37%, and 2%. Current lower CD4/CD8 ratio and a history of transient viral rebounds were associated with an increased risk of losing virological control. CD4 declined and CD8 increased before loss of virological control, and before viral rebounds. Discussion Expansion of CD8 and decline of CD4 during HIV control may result from repeated low-level viremia. Our findings suggest that in addition to superinfection, other mechanisms, such as low grade viral replication, can lead to loss of virological control in HICs.	[Chereau, Fanny; Meyer, Laurence] Univ Paris Saclay, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] Univ Paris Sud, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] Univ Versailles Saint Quentin en Yvelines, Le Kremlin Bicetre, France; [Chereau, Fanny; Meyer, Laurence] INSERM, CESP, U1018, Le Kremlin Bicetre, France; [Madec, Yoann] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Sabina, Caroline; Mocroft, Amanda] UCL, Res Dept Infect & Populat Hlth, Royal Free Campus,Rowland Hill St, London, England; [Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Ruiz-Mateos, Ezequiel; Leal, Manuel] Univ Seville, Virgen Rocio Univ Hosp CSIC, Inst Biomed Seville, Lab Immunovirol,Clin Unit Infect Dis Microbiol &, Seville, Spain; [Chrysos, Georgios] Tzaneio Gen Hosp Piraeus, Infect Dis Unit, Dept Med, Piraeus, Greece; [Fidler, Sarah] Imperial Coll, London, England; [Lehmann, Clara] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Lehmann, Clara] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venereol, Innsbruck, Austria; [Wittkop, Linda] Univ Bordeaux, ISPED,Serv Informat Med, INSERM,Pole Sante Publ,Ctr INSERM, Bordeaux Populat Hlth,U1219, Bordeaux, France; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Reiss, Peter] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Hamouda, Osamah] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Estrada Perez, Vicente] IdISSC Univ Complutense, Hosp Clin San Carlos, Madrid, Spain; [Garcia De Olalla, Patricia] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Garcia De Olalla, Patricia] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ammassari, Adriana] IRCCS, Ist Nazl Malattie Infett L Spallanzani, Rome, Italy; [Monforte, Antonella D'Arminio] Univ Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci, Infect Dis Unit, Milan, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy; [Segura, Ferran] Parc Tauli Hosp Univ, Infect Dis Serv, Barcelona, Spain; [Segura, Ferran] Univ Autonoma Barcelona, Barcelona, Spain; [Castagna, Antonella] San Raffaele Vita Salute Univ, Milan, Italy; [Cavassini, Matthias] Univ Lausanne, Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Grabar, Sophie] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Grabar, Sophie] UPMC Univ Paris 06, Paris, France; [Grabar, Sophie] Univ Paris 05, Hop Cochin Hotel Dieu Paris, Paris, France; [Morlat, Philippe] Univ Bordeaux, CHU Bordeaux, INSERM, Serv Med Interne & Malad Infectieuses,U1219, Bordeaux, France; [De Wit, Stephane] Univ Libre Bruxelles, St Pierre Univ Hosp, Dept Infect Dis, Brussels, Belgium; [Lambotte, Olivier] Univ Paris Sud, UMR 1184, Le Kremlin Bicetre, France; [Lambotte, Olivier] IDMIT, DSV iMETI, CEA, Fontenay Aux Roses, France; [Lambotte, Olivier] INSERM, Immunol Viral Infect & Autoimmune Dis, U1184, Le Kremlin Bicetre, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Rigshospitalet; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Imperial College London; University of Cologne; German Center for Infection Research; University of Cologne; Medical University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Amsterdam; Academic Medical Center Amsterdam; Robert Koch Institute; Hospital Clinico San Carlos; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; IRCCS Lazzaro Spallanzani; Universita di Modena e Reggio Emilia; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Vita-Salute San Raffaele University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Meyer, L (corresponding author), Univ Paris Saclay, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), Univ Paris Sud, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), Univ Versailles Saint Quentin en Yvelines, Le Kremlin Bicetre, France.; Meyer, L (corresponding author), INSERM, CESP, U1018, Le Kremlin Bicetre, France.	laurence.meyer@inserm.fr	Perez Hoyos, Santiago/O-1075-2019; Sabin, Caroline/C-2464-2008; Grabar, Sophie/AAM-9857-2020; Castagna, Antonella/K-3280-2018; Lambotte, Olivier/GRT-0160-2022; Antinori, Andrea/K-7125-2016; DORRUCCI, MARIA/C-6485-2016; Ruiz-Mateos, Ezequiel/P-9741-2019; Mussini, Cristina/K-8672-2016; Wittkop, Linda/E-3319-2014; cavassini, matthias/F-8987-2017; Kouyos, Roger/G-6226-2014	Perez Hoyos, Santiago/0000-0001-9797-4917; Sabin, Caroline/0000-0001-5173-2760; Castagna, Antonella/0000-0002-8338-9714; Antinori, Andrea/0000-0003-2121-4684; DORRUCCI, MARIA/0000-0002-8543-6430; Ruiz-Mateos, Ezequiel/0000-0001-6747-7813; Mussini, Cristina/0000-0002-6615-4198; Wittkop, Linda/0000-0003-2403-0960; Obel, Niels/0000-0002-5031-0045; van der Valk, Marc/0000-0002-8290-6425; Ammassari, Adriana/0000-0002-0284-0340; Chereau, Fanny/0000-0002-5651-9800; cavassini, matthias/0000-0003-0933-7833; Egger, Matthias/0000-0001-7462-5132; Puoti, Massimo/0000-0003-3278-7138; Fidler, Sarah/0000-0003-1676-7583; Kouyos, Roger/0000-0002-9220-8348; Madec, Yoann/0000-0002-6201-1261	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, The Netherlands; Augustinus Foundation, Denmark; European Union [260694]; Medical Research Council [MR/M004236/1, MR/L00528X/1] Funding Source: researchfish; MRC [MR/M004236/1, MR/L00528X/1] Funding Source: UKRI	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); HIV Monitoring Foundation, The Netherlands(Netherlands Government); Augustinus Foundation, Denmark; European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The COHERE study group has received unrestricted funding from: Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, The Netherlands; and the Augustinus Foundation, Denmark. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. A list of the funders of the participating cohorts can be found at www.COHERE.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Cabrera-Munoz E, 2012, MINI-REV MED CHEM, V12, P1049, DOI 10.2174/138955712802762185; Cao W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20697; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; European AIDS Clinical Society, GUID 2015 VERS 8; Fine JP, 2012, J AM STAT ASS; Geskus RB, 2015, DATA ANAL COMPETING, V82; Goujard C, 2009, CLIN INFECT DIS, V49, P982, DOI 10.1086/605504; Huang XJ, 2013, JAIDS-J ACQ IMM DEF, V62, P441, DOI 10.1097/QAI.0b013e31827f5c9a; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Krantz EM, 2011, JAIDS-J ACQ IMM DEF, V57, P396, DOI 10.1097/QAI.0b013e318221c62a; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Leon A, 2016, AIDS, V30, P1209, DOI 10.1097/QAD.0000000000001050; Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Noel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131922; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Peris-Pertusa A, 2010, JAIDS-J ACQ IMM DEF, V55, P29, DOI 10.1097/QAI.0b013e3181e69609; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Rachinger A, 2008, CLIN INFECT DIS, V47, pE86, DOI 10.1086/592978; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; van der Wal WM, 2011, J STAT SOFTW, V43, P1; van Geloven N, 2014, STAT MED, V33, P4671, DOI 10.1002/sim.6280; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; World Health Organization, CONS GUID US ANT DRU	36	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173893	10.1371/journal.pone.0173893	http://dx.doi.org/10.1371/journal.pone.0173893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380038	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500028
J	Lundqvist, S; Borjesson, M; Larsson, MEH; Hagberg, L; Cider, A				Lundqvist, Stefan; Borjesson, Mats; Larsson, Maria E. H.; Hagberg, Lars; Cider, Asa			Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health care	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; EXERCISE REFERRAL PROGRAM; ACTIVITY QUESTIONNAIRE; SPORTS-MEDICINE; ACTIVITY LEVEL; VALIDITY; RELIABILITY; FITNESS; DISEASE	There is strong evidence that inadequate physical activity (PA) leads to an increased risk of lifestyle-related diseases and premature mortality. Physical activity on prescription (PAP) is a method to increase the level of PA of patients in primary care, but needs further evaluation. The aim of this observational study was to explore the association between PAP-treatment and the PA level of patients with metabolic risk factors and the relationship between changes in the PA level and health outcomes at the 6 month follow-up. This study included 444 patients in primary care, aged 27-85 years (56% females), who were physically inactive with at least one component of metabolic syndrome. The PAP-treatment model included: individualized dialogue concerning PA, prescribed PA, and a structured follow-up. A total of 368 patients (83%) completed the 6 months of follow-up. Of these patients, 73% increased their PA level and 42% moved from an inadequate PA level to sufficient, according to public health recommendations. There were significant improvements (p <= 0.05) in the following metabolic risk factors: body mass index, waist circumference, systolic blood pressure, fasting plasma glucose, cholesterol, and low density lipoprotein. There were also significant improvements regarding health-related quality of life, assessed by the Short Form 36, in: general health, vitality, social function, mental health, role limitation-physical/emotional, mental component summary, and physical component summary. Regression analysis showed a significant association between changes in the PA level and health outcomes. During the first 6-month period, the caregiver provided PAP support 1-2 times. This study indicates that an individual-based model of PAP-treatment has the potential to change people's PA behavior with improved metabolic risk factors and self-reported quality of life at the 6 month follow-up. Thus, PAP seems to be feasible in a clinical primary care practice, with minimum effort from healthcare professionals.	[Lundqvist, Stefan; Cider, Asa] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil,Unit Physotherapy, Gothenburg, Sweden; [Lundqvist, Stefan] Narhalsan Rehabil FaR teamet Cent & western Gothe, Gothenburg, Sweden; [Borjesson, Mats] Univ Gothenburg, Fac Educ, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Borjesson, Mats] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Larsson, Maria E. H.] Narhalsan Res & Dev Primary Hlth Care, Gothenburg, Sweden; [Hagberg, Lars] Univ Orebro, Univ Hlth Care Res Ctr, Fac Med & Hlth, Orebro, Sweden	University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Orebro University	Lundqvist, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Hlth & Rehabil,Unit Physotherapy, Gothenburg, Sweden.; Lundqvist, S (corresponding author), Narhalsan Rehabil FaR teamet Cent & western Gothe, Gothenburg, Sweden.				Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland	Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland	Funding was provided as economic support for doctoral thesis by Narhalsan Research & Development Primary Health Care, Region Vastra Gotaland, http://www.nartialsan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2008, J PEDIATR GASTR NUTR, V47, P277, DOI 10.1097/MPG.0b013e31816c749f; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; [Anonymous], 2008, FYSS 2008 FYSISK AKT; Blomstrand A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001154; Borg G, 1998, BORGS PERCEIVED EXER; Borjesson Mats, 2012, Lakartidningen, V109, P2340; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook CE, 2008, J MAN MANIP THER, V16, p82E, DOI 10.1179/jmt.2008.16.4.82E; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duda JL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-10; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekblom O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2316-y; Ekblom-Bak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126336; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Feldman Inna, 2013, Cost Eff Resour Alloc, V11, P19, DOI 10.1186/1478-7547-11-19; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Frandin K., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P41; Grimby G, 2015, SCAND J MED SCI SPOR, V25, P119, DOI 10.1111/sms.12611; GRIMBY G, 1986, ACTA MED SCAND, P233; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Gusi N, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-231; Harrison RA, 2005, J PUBLIC HEALTH-UK, V27, P25, DOI 10.1093/pubmed/fdh197; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Isaacs AJ, 2007, HEALTH TECHNOL ASSES, V11, P1; Joy E, 2013, BRIT J SPORT MED, V47, P49, DOI 10.1136/bjsports-2012-091620; Kallings LV, 2008, SCAND J MED SCI SPOR, V18, P154, DOI 10.1111/j.1600-0838.2007.00678.x; Kallings Lena V, 2012, Lakartidningen, V109, P2348; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; Lawton BA, 2009, BRIT J SPORT MED, V43, P120, DOI 10.1136/bmj.a2509; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Leijon ME, 2009, SCAND J MED SCI SPOR, V19, P627, DOI 10.1111/j.1600-0838.2008.00820.x; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; Morgan O, 2005, PUBLIC HEALTH, V119, P361, DOI 10.1016/j.puhe.2004.06.008; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Oja P., 2001, MED SCI SPORTS EXERC, V33, pS52; Olsson SJG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2036-3; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Parschau L, 2014, HEALTH EDUC BEHAV, V41, P414, DOI 10.1177/1090198114529132; Pavey TG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6462; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Persson Gerthi, 2010, BMC Res Notes, V3, P304, DOI 10.1186/1756-0500-3-304; Persson G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-128; Prochaska JO, 2008, MED DECIS MAKING, V28, P845, DOI 10.1177/0272989X08327068; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rejeski WJ, 2003, HEALTH PSYCHOL, V22, P414, DOI 10.1037/0278-6133.22.4.414; Rodjer Lars, 2012, BMC Public Health, V12, P693, DOI 10.1186/1471-2458-12-693; Rodjer L, 2016, SCAND J PRIM HEALTH, V34, P443, DOI 10.1080/02813432.2016.1253820; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Rome A, 2009, SCAND J PRIM HEALTH, V27, P216, DOI 10.3109/02813430903438734; Sallis R, 2015, PROG CARDIOVASC DIS, V57, P375, DOI 10.1016/j.pcad.2014.10.003; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Socialstyrelsen, 2011, NAT RIKTL VUX 2011 S; Sorensen JB, 2008, SCAND J MED SCI SPOR, V18, P288, DOI 10.1111/j.1600-0838.2008.00811.x; Stewart KJ, 2005, AM J PREV MED, V28, P9, DOI 10.1016/j.amepre.2004.09.006; Stott NCH, 1995, FAM PRACT, V12, P413, DOI 10.1093/fampra/12.4.413; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Taylor AH, 1998, J EPIDEMIOL COMMUN H, V52, P595, DOI 10.1136/jech.52.9.595; Thune I, 1998, ARCH INTERN MED, V158, P1633, DOI 10.1001/archinte.158.15.1633; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wing RR, 2004, OBES RES, V12, P1426; World Health Organization, 2010, Global recommendations on physical activity for health	73	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175190	10.1371/journal.pone.0175190	http://dx.doi.org/10.1371/journal.pone.0175190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LZ	28403151	gold, Green Published, Green Submitted			2022-12-26	WOS:000399955200040
J	Simcock, NK; Wakeling, LA; Ford, D; Wright, GA				Simcock, Nicola K.; Wakeling, Luisa A.; Ford, Dianne; Wright, Geraldine A.			Effects of age and nutritional state on the expression of gustatory receptors in the honeybee (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; IONOTROPIC GLUTAMATE RECEPTORS; DROSOPHILA-MELANOGASTER; ADULT DROSOPHILA; GENE-EXPRESSION; SUGAR RECEPTION; METABOLIC-RATE; BEE; TASTE; SENSILLA	Gustatory receptors (Grs) expressed in insect taste neurons signal the presence of carbohydrates, sugar alcohols, CO2, bitter compounds and oviposition stimulants. The honeybee (Apis mellifera) has one of the smallest Gr gene sets (12 Gr genes) of any insect whose genome has been sequenced. Honeybees live in eusocial colonies with a division of labour and perform age-dependent behavioural tasks, primarily food collection. Here, we used RT-qPCR to quantify Gr mRNA in honeybees at two ages (newly-emerged and foraging-age adults) to examine the relationship between age-related physiology and expression of Gr genes. We measured the Gr mRNAs in the taste organs and also the brain and gut. The mRNA of all Gr genes was detected in all tissues analysed but showed plasticity in relative expression across tissues and in relation to age. Overall, Gr gene expression was higher in the taste organs than in the internal tissues but did not show an overall age-dependent difference. In contrast Gr gene expression in brain was generally higher in foragers, which may indicate greater reliance on internal nutrient sensing. Expression of the candidate sugar receptors AmGr1, AmGr2 and AmGr3 in forager brain was affected by the types of sugars bees fed on. The levels of expression in the brain were greater for AmGr1 but lower for AmGr2 and AmGr3 when bees were fed with glucose and fructose compared with sucrose. Additionally, AmGr3 mRNA was increased in starved bees compared to bees provided ad libitum sucrose. Thus, expression of these Grs in forager brain reflects both the satiety state of the bee (AmGr3) and the type of sugar on which the bee has fed.	[Simcock, Nicola K.; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Wakeling, Luisa A.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Ford, Dianne] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Simcock, NK (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	Nicola.simcock2@ncl.ac.uk	Simcock, Nicola/AAM-9073-2021	Simcock, Nicola/0000-0001-9382-2828	Newcastle University Faculty of Medical Sciences [C0169N3009]; Biotechnology and Biological Sciences Research Council [BB/M00709X/1]; Leverhulme Trust research project grant [RPG-2012-708]; Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Wellcome Trust; Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative [BB/I000968/1]; BBSRC [BB/M00709X/1] Funding Source: UKRI	Newcastle University Faculty of Medical Sciences; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust research project grant(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported jointly by the Newcastle University Faculty of Medical Sciences MRes/PhD, http://www.ncl.ac.uk/medicalsciences/ [C0169N3009 scholarship to NKS], the Biotechnology and Biological Sciences Research Council, http://www.bbsrc.ac.uk/ [BB/M00709X/1 to GAW and DF], a Leverhulme Trust research project grant, https://www.leverhulme.ac.uk/ [Grant number RPG-2012-708 to GAW] and a grant from the Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; the Wellcome Trust; Department for Environment, Food and Rural Affairs, and the Scottish Government under the Insect Pollinators Initiative [Grant number BB/I000968/1 to GAW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; BALDERRAMA NM, 1992, J COMP PHYSIOL B, V162, P440, DOI 10.1007/BF00258967; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernays EA, 1998, J COMP PHYSIOL A, V183, P69, DOI 10.1007/s003590050235; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; FELL RD, 1990, COMP BIOCHEM PHYS A, V95, P539, DOI 10.1016/0300-9629(90)90735-B; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Gronke S, 2010, RES PERSPECT END INT, P105, DOI 10.1007/978-3-642-04302-4_9; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jiang XJ, 2015, INSECT BIOCHEM MOLEC, V60, P39, DOI 10.1016/j.ibmb.2015.03.002; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Johnson BR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-586; Jung JW, 2015, J ASIA-PAC ENTOMOL, V18, P19, DOI 10.1016/j.aspen.2014.10.011; Kain P, 2010, CHEM SENSES, V35, P663, DOI 10.1093/chemse/bjq055; Kessler S, NATURE, V21, P74; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Moffatt L, 2001, J EXP BIOL, V204, P759; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nishimura A, 2012, J NEUROGENET, V26, P206, DOI 10.3109/01677063.2012.694931; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Park JM, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/105637; Percival M. S, 2007, NEW PHYTOL, V60, P235; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Rogers SM, 1997, J EXP BIOL, V200, P2313; ROLLS BJ, 1986, NUTR REV, V44, P93, DOI 10.1111/j.1753-4887.1986.tb07593.x; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Vannette RL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16224; Wagener-Hulme C, 1999, J COMP PHYSIOL A, V184, P471, DOI 10.1007/s003590050347; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; WHITEHEAD A T, 1976, International Journal of Insect Morphology and Embryology, V5, P301, DOI 10.1016/0020-7322(76)90030-1; WHITEHEAD AT, 1978, PHYSIOL ENTOMOL, V3, P241, DOI 10.1111/j.1365-3032.1978.tb00153.x; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston ML, 1987, THE BIOLOGY OF THE H; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Xu W, 2012, J CHEM ECOL, V38, P1513, DOI 10.1007/s10886-012-0221-8; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]	70	14	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175158	10.1371/journal.pone.0175158	http://dx.doi.org/10.1371/journal.pone.0175158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403157	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000399955200037
J	Wan, XH; Koster, K; Qian, LS; Desmond, E; Brostrom, R; Hou, SB; Douglas, JT				Wan, Xuehua; Koster, Kent; Qian, Lishi; Desmond, Edward; Brostrom, Richard; Hou, Shaobin; Douglas, James T.			Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis	PLOS ONE			English	Article							SER/THR PROTEIN-KINASE; ABC TRANSPORTER; PHOSPHORYLATION; IDENTIFICATION; ALIGNMENTS; RESISTANCE; SELECTION; VIRUSES; DISEASE; RV1747	With its airborne transmission and prolonged latency period, Mycobacterium tuberculosis spreads worldwide as one of the most successful bacterial pathogens and continues to kill millions of people every year. M. tuberculosis lineage 1 is inferred to originate ancestrally based on the presence of the 52-bp TbD1 sequence and analysis of single nucleotide polymorphisms. Previously, we briefly reported the complete genome sequencing of M. tuberculosis strains 96121 and 96075, which belong to the ancient Manila family and modern Beijing family respectively. Here we present the comprehensive genomic analyses of the Manila family in lineage 1 compared to complete genomes in lineages 2-4. Principal component analysis of the presence and absence of CRISPR spacers suggests that Manila isolate 96121 is distinctly distant from lineages 2-4. We further identify a truncated whiB5 gene and a putative operon consisting of genes encoding a putative serine/threonine kinase PknH and a putative ABC transporter, which are only found in the genomes of Manila family isolates. Six single nucleotide polymorphisms are uniquely conserved in 38 Manila strains. Moreover, when compared to M. tuberculosis H37Rv, 59 proteins are under positive selection in Manila family isolate 96121 but not in Beijing family isolate 96075. The unique features further serve as biomarkers for Manila strains and may shed light on the limited transmission of this ancestral lineage outside of its Filipino host population.	[Wan, Xuehua; Hou, Shaobin] Univ Hawaii, Adv Studies Genom Prote & Bioinformat, Honolulu, HI USA; [Koster, Kent; Qian, Lishi; Douglas, James T.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA; [Brostrom, Richard] Hawaii State Dept Hlth, TB Control Program, Honolulu, HI USA	University of Hawaii System; University of Hawaii System; California Department of Public Health	Douglas, JT (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	jtd379@gmail.com	Wan, Xuehua/AAE-4237-2022	Wan, Xuehua/0000-0002-6367-848X	University of Hawai'i Office of Research Services; Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii; College of Natural Sciences; University of Hawaii; Leahi Trust of the Hawaii Community Foundation	University of Hawai'i Office of Research Services; Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii; College of Natural Sciences; University of Hawaii; Leahi Trust of the Hawaii Community Foundation	This research was supported by the University of Hawai'i Office of Research Services and the Leahi Trust of the Hawai'i Community Foundation, Honolulu, Hawaii. Partial funding for the work described here was provided by the Dean of the College of Natural Sciences, Dr. William Ditto, to JTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shuli Kang for advice regarding Roary pipeline, and acknowledge the support of The Leahi Trust of the Hawaii Community Foundation and The University of Hawaii.	[Anonymous], 2015, GLOB TUB REP; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Burge SW, 2012, RFAM 11 0 10 YEARS R; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Douglas JT, 2003, J CLIN MICROBIOL, V41, P2723, DOI 10.1128/JCM.41.6.2723-2726.2003; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gardner SN, 2013, PLOS ONE, V8; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schwalb B., 2015, LSD LOTS SUPERIOR DE; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; Wan X, 2014, GENOME ANNOUNC, V2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2014, GLOB TUB REP; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Y, 2011, COMPUT BIOL CHEM, V35, P319, DOI 10.1016/j.compbiolchem.2011.08.001; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175330	10.1371/journal.pone.0175330	http://dx.doi.org/10.1371/journal.pone.0175330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394899	gold, Green Submitted, Green Published			2022-12-26	WOS:000399954800029
J	Fan, CY; Huang, WY; Lin, CS; Su, YF; Lo, CH; Tsao, CC; Liu, MY; Lin, CL; Kao, CH				Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Chun-Shu; Su, Yu-Fu; Lo, Cheng-Hsiang; Tsao, Chih-Cheng; Liu, Ming-Yueh; Lin, Cheng-Li; Kao, Chia-Hung			Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study	PLOS ONE			English	Article							PRIMARY TUMORS; ASSOCIATION; AUSTRALIA; NEOPLASMS; MEN	Purpose The rising incidence and life expectancy associated with prostate cancer (PCa) has led to increasing interest in predicting the risk of second primary malignancies (SPMs) among PCa survivors, although data regarding SPMs after PCa are controversial. Methods We identified 30,964 patients from the National Health Insurance Research Database in Taiwan who had newly diagnosed PCa between 2000 and 2010. Each patient was randomly frequency-matched with an individual without PCa, based on age, comorbidity, and index year. Competing-risks regression models were used to estimate subhazard ratios (SHRs) of SPMs development associated with PCa. The Bonferroni adjustment was used in multiple comparisons. Results Men with PCa had a trend of lower risk of developing overall SPMs compared to those without PCa (adjusted SHR = 0.94, 99.72% confidence interval [CI] = 0.89-1.00, p = 0.06). The risks of lung and liver cancer were significantly lower. In contrast, these patients had a significantly higher risk of thyroid cancer. There is a trend for a higher risk of developing SPMs in the urinary bladder and rectum/anus. Further analyses indicated that PCa patients who received radiation therapy (RT) had an increased risk of overall SPMs, hematologic malignancies, esophageal cancer, liver cancer, lung cancer, and urinary bladder cancer compared with those who did not receive RT. Conclusion Men with PCa tended to have a lower risk of SPMs, but a significantly higher risk of subsequent thyroid cancer. Continued cancer surveillance is required among PCa survivors, especially in specific sites and in individuals who received RT.	[Fan, Chao-Yueh; Huang, Wen-Yen; Lin, Chun-Shu; Su, Yu-Fu; Lo, Cheng-Hsiang; Tsao, Chih-Cheng; Liu, Ming-Yueh] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	huang, wen/GXW-0661-2022		project of Tri-service General Hospital [TSGH-C106-038]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, (Taiwan) [MOHW104-TDU-B-212-124-002]	project of Tri-service General Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence, (Taiwan)	This study is supported in part by study project of Tri-service General Hospital (TSGH-C106-038); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and Health, and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002,Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	American Cancer Society, 2011, CANC FACTS FIG 2012; Braisch U, 2012, EUR J CANCER PREV, V21, P552, DOI 10.1097/CEJ.0b013e328351c748; Cassetti T, 2008, TUMORI, V94, P7; Cluze C, 2009, EUR J CANCER PREV, V18, P343, DOI 10.1097/CEJ.0b013e32832abd76; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; Davis EJ, 2014, CANCER-AM CANCER SOC, V120, P2735, DOI 10.1002/cncr.28769; Dawson DM, 1998, J NATL CANCER I, V90, P519, DOI 10.1093/jnci/90.7.519; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Heard A, 2005, CANCER CAUSE CONTROL, V16, P475, DOI 10.1007/s10552-004-8023-0; Hellawell GO, 2007, BJU INT, V99, P698, DOI 10.1111/j.1464-410X.2007.06779_1.x; Huang KW, 2016, EUR J INTERN MED, V32, P91, DOI 10.1016/j.ejim.2016.04.016; Joung JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140693; Kawakami S, 1997, UROL INT, V59, P243, DOI 10.1159/000283072; Kleinerman RA, 1985, J NATL CANC I MONOGR, V68, P139; Levi F, 1999, CANCER, V86, P1567, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1567::AID-CNCR25>3.0.CO;2-Z; LISKOW AS, 1987, CANCER, V59, P380, DOI 10.1002/1097-0142(19870115)59:2<380::AID-CNCR2820590236>3.0.CO;2-E; McCredie M, 1996, CANCER CAUSE CONTROL, V7, P337, DOI 10.1007/BF00052939; Nelson WG, 2012, PROSTATE INFLAMMATIO, P103; Osterlind A, 1985, J NATL CANC I MONOGR, V68, P341; Peng YC, 2015, BRIT J CLIN PHARMACO, V80, P755, DOI 10.1111/bcp.12641; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Singh A, 2005, J UROLOGY, V173, P1526, DOI 10.1097/01.ju.0000154700.80042.c6; TEPPO L, 1985, J NATL CANCER I, V75, P207; Tomaszewski JJ, 2015, ANN SURG ONCOL, V22, P1043, DOI 10.1245/s10434-014-4066-y; Van Hemelrijck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102596; Wallis CJD, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i851	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175217	10.1371/journal.pone.0175217	http://dx.doi.org/10.1371/journal.pone.0175217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384363	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900123
J	Hu, CC; Zhang, CL; Sun, L; Zhang, Y; Xie, WL; Zhang, BW; Chang, Q				Hu, Chaochao; Zhang, Chenling; Sun, Lei; Zhang, Yi; Xie, Wenli; Zhang, Baowei; Chang, Qing			The mitochondrial genome of pin-tailed snipe Gallinago stenura, and its implications for the phylogeny of Charadriiformes	PLOS ONE			English	Article							CHROICOCEPHALUS-SAUNDERSI CHARADRIIFORMES; TRANSFER-RNA GENES; SUBSTITUTION MODELS; SEQUENCES; BIRDS; NUCLEOTIDE; EVOLUTION; PROGRAM; REANALYSIS; SELECTION	The Charadriiformes, among the most diverse orders of bird, is a good source to research on evolution. The mitochondrial genome sequencing database has rapidly increased in recent years, while Charadriiformes mitogenome has not been well studied. In this research, we determined the complete mitogenome sequence of Gallinago stenura, and comparatively analysed 20 mitogenomes of Charadriiformes. The mitogenomes display moderate size variation, and most of variation due to mutations in the control region. In 13 protein-coding genes, we found: 1. The GC skews are always negative, while the negative AT skews are found in 5 genes, 2. The average uncorrected pairwise distances reveal heterogeneity of evolutionary rate for each gene, 3. The ATG and TAA, respectively, are observed the most commonly start and stop codon. The highest dN/dS is detected for ATP8 (0.16) among Charadriiformes, while the lowest for COI (0.01), indicating that 13 protein-coding genes are evolving under the purifying selection. Predicted secondary structures of tRNAs indicate that the sequences and structures of anticodon, amino acceptor, and T psi C arms are highly conserved, and most nucleotide variation is restricted to dihydrouridine arms with obvious indel polymorphisms. A total of 15 conserved sequence boxes were recognized in the control regions, and the 4 bp (5' -AAAC-3') and 7 bp (5' -AAACAAC-3') repeat sequences occurred frequently. Phylogenomic analysis based on the nearly complete mitochondrial genomes strongly supported the monophyly of the order, and the suborder Charadrii is at the basal of Charadriiformes. Moreover, our results well resolved the complexity family-level relationships and clearly depicted the evolutionary processes of Charadriiformes, based on 12 mitochondrial protein-coding genes from 18 families. This study improves our understanding of mitogenomic structure and evolution, which can provide further insights into our understanding of phylogeny and taxonomy in Charadriiformes.	[Hu, Chaochao] Nanjing Normal Univ, Analyt & Testing Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Chenling] Jiangsu Second Normal Univ, Fac Life Sci & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Sun, Lei] Utah State Univ, Dept Biol Engn, 4105 Old Main Hill, Logan, UT 84322 USA; [Zhang, Yi; Xie, Wenli; Chang, Qing] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China	Nanjing Normal University; Jiangsu Second Normal University; Utah System of Higher Education; Utah State University; Nanjing Normal University; Anhui University	Chang, Q (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	qingchangnj@163.com			National Natural Science Foundation of China [31071901, 41271057]; Natural Science Research of Jiangsu Higher Education Institutions of China [16KJB180012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research of Jiangsu Higher Education Institutions of China	This research was supported by grants from the Program of National Natural Science Foundation of China (#31071901 and #41271057) and Natural Science Research of Jiangsu Higher Education Institutions of China (#16KJB180012).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177; Barbosa A, 1999, BIOL J LINN SOC, V67, P313, DOI 10.1111/j.1095-8312.1999.tb01936.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BJORKLUND M, 1994, AUK, V111, P825; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CHU PC, 1995, CONDOR, V97, P174, DOI 10.2307/1368995; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ericson PGP, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-16; Fain MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-35; Friesen VL, 2015, J ORNITHOL, V156, pS27, DOI 10.1007/s10336-015-1235-0; Gibson R, 2012, MOL PHYLOGENET EVOL, V64, P66, DOI 10.1016/j.ympev.2012.03.008; Gower DJ, 2006, MOL BIOL EVOL, V23, P227, DOI DOI 10.1093/M0LBEV/MSJ025; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Jiang L, 2014, PLOS ONE, V10; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Li X., 2014, BIORESOUR BIOPROCESS, V1, P1, DOI DOI 10.3109/19401736.2014.953080; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livezey BC, 2010, ZOOL J LINN SOC-LOND, V160, P567, DOI 10.1111/j.1096-3642.2010.00635.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Paton TA, 2003, MOL PHYLOGENET EVOL, V29, P268, DOI 10.1016/S1055-7903(03)00098-8; Paton TA, 2006, MOL PHYLOGENET EVOL, V39, P657, DOI 10.1016/j.ympev.2006.01.011; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Ryu SH, 2012, MITOCHONDR DNA, V23, P134, DOI 10.3109/19401736.2012.660927; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Smith NA, 2015, J AVIAN BIOL, V46, P125, DOI 10.1111/jav.00487; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Van Tuinen M, 2004, J AVIAN BIOL, V35, P191, DOI 10.1111/j.0908-8857.2004.03362.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang ZH, 2000, GENETICS, V155, P431; Yoon KB, 2015, GENE, V572, P227, DOI 10.1016/j.gene.2015.07.022; Zhang L, 2015, SCI REP, V6, P28; Zhou X., 2016, INT J AUDIOL, V1, P1, DOI DOI 10.18632/0NC0TARGET.6418; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	52	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175244	10.1371/journal.pone.0175244	http://dx.doi.org/10.1371/journal.pone.0175244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384231	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900135
J	Fernandez, CE; Rejas, D				Fernandez, Carla Eloisa; Rejas, Danny			Effects of UVB radiation on grazing of two cladocerans from high-altitude Andean lakes	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; ULTRAVIOLET-RADIATION; VERTICAL-DISTRIBUTION; DAPHNIA-MAGNA; DNA-REPAIR; CRUSTACEAN ZOOPLANKTON; FOOD CONCENTRATION; B RADIATION; DAMAGE; EXPOSURE	Climate change and water extraction may result in increased exposition of the biota to ultraviolet -B radiation (UVB) in high-altitude Andean lakes. Although exposition to lethal doses in these lakes is unlikely, sub-lethal UVB doses may have strong impacts in key compartments such as zooplankton. Here, we aimed at determining the effect of sub-lethal UVB doses on filtration rates of two cladoceran species (Daphnia pulicaria and Ceriodaphnia dubia). We firstly estimated the Incipient Limiting Concentration (ILC) and the Gut Passage Time (GPT) for both species. Thereafter we exposed clones of each species to four increasing UVB doses (treatments): i) DUV-0 (Control), ii) DUV-1 (0.02 MJ m(2)), iii) DUV-2 (0.03 MJ m(2)) and iv) DUV-3 (0.15 MJ m(2)); and estimated their filtration rates using fluorescent micro-spheres. Our results suggest that increasing sub-lethal doses of UVB radiation may strongly disturb the structure and functioning of high-altitude Andean lakes. Filtration rates of D. pulicaria were not affected by the lowest dose applied (DUV-1), but decreased by 50% in treatments DUV-2 and DUV-3. Filtration rates for C. dubia were reduced by more than 80% in treatments DUV-1 and DUV-2 and 100% of mortality occurred at the highest UVB dose applied (DUV-3).	[Fernandez, Carla Eloisa; Rejas, Danny] Univ Mayor San Simon, Unidad Limnol & Recursos Acuat, Cochabamba, Bolivia; [Fernandez, Carla Eloisa] Lund Univ, Div Water Resources Engn, Lund, Sweden	Lund University	Fernandez, CE (corresponding author), Univ Mayor San Simon, Unidad Limnol & Recursos Acuat, Cochabamba, Bolivia.; Fernandez, CE (corresponding author), Lund Univ, Div Water Resources Engn, Lund, Sweden.	carlaelo.fernandez@gmail.com	Espinoza, Carla Eloisa Fernández/M-7497-2014	Espinoza, Carla Eloisa Fernández/0000-0002-2200-5991; Rejas, Danny/0000-0003-2561-1214	Sweedish International Development Cooperation Agency (SIDA); Universidad Mayor de San Simon (UMSS); GIRH cooperation; Project FC-18	Sweedish International Development Cooperation Agency (SIDA); Universidad Mayor de San Simon (UMSS); GIRH cooperation; Project FC-18	This study was funded by the agreement between the Sweedish International Development Cooperation Agency (SIDA; vvww.sida.se/English/) and the Universidad Mayor de San Simon (UMSS). Project FC-18 and project GIRH cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, LIMNOL OCEANOGR, V49, P225, DOI 10.4319/lo.2004.49.1.0225; Boersma M, 2006, ARCH HYDROBIOL, V167, P489, DOI 10.1127/0003-9136/2006/0167-0489; Bornman JF, 2015, PHOTOCH PHOTOBIO SCI, V14, P88, DOI 10.1039/c4pp90034k; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Brown James H., 2007, P1; Campero M, 2011, REV BOLIVIANA ECOLOG, P83; Cauchie H-M, 2001, NOTE USE FLUORESCENT; Ceresoli N, 2003, INTERCIENCIA, V28, P469; Connelly SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131847; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Coronell JS, 2007, WETLANDS, V27, P1166, DOI 10.1672/0277-5212(2007)27[1166:HPTPIB]2.0.CO;2; Daugherty HE, 1971, C LAT AM GEOGR 1971; de Bernardi R., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P1; De Los Rios P, 2007, BIOLOGIA, V62, P210, DOI 10.2478/s11756-007-0031-6; De los Rios-Escalante P, 2015, CRUSTACEANA, V88, P208, DOI 10.1163/15685403-00003401; DeMott WR, 2010, ECOLOGY, V91, P540, DOI 10.1890/08-2103.1; ECHEVARRIA F, 1990, J PLANKTON RES, V12, P415, DOI 10.1093/plankt/12.2.415; Fields DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026333; Fischer C, 2013, J EXP BIOL, V216, P3090, DOI 10.1242/jeb.087064; Fischer JM, 2006, HYDROBIOLOGIA, V563, P217, DOI 10.1007/s10750-005-0007-x; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Flint SD, 2009, J PHOTOCH PHOTOBIO B, V97, P48, DOI 10.1016/j.jphotobiol.2009.07.010; Gianuca AT, 2016, P ROYAL SOC B; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Hansson L-A, 2009, P ROYAL SOC B; Hansson LA, 2016, ECOLOGY, V97, P279, DOI 10.1890/15-1014.1; Moresino RDH, 2014, J PLANKTON RES, V36, P877, DOI 10.1093/plankt/fbu010; Hock AN, 2008, BOLIVIA LIFE ATACAMA; Hofstede R, 2003, RAMOS MUNDO; Huebner JD, 2006, PHOTOCHEM PHOTOBIOL, V82, P1656, DOI 10.1562/2006-05-03-RA-890; Huebner JD, 2013, PHOTOCHEM PHOTOBIOL, V89, P103, DOI 10.1111/j.1751-1097.2012.01197.x; Huebner JD, 2009, PHOTOCHEM PHOTOBIOL, V85, P374, DOI 10.1111/j.1751-1097.2008.00454.x; Hurtubise RD, 1998, LIMNOL OCEANOGR, V43, P1082, DOI 10.4319/lo.1998.43.6.1082; Hutchinson G., 1957, COLD SPRIG HARB S QU, P66; Hylander S, 2013, AQUAT ECOL, V47, P467, DOI 10.1007/s10452-013-9459-7; Hylander S, 2010, J PLANKTON RES, V32, P971, DOI 10.1093/plankt/fbq037; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Kumar S, 2015, INT J PHARM BIOL SCI, V9, P1; Lampert W., 2007, LIMNOECOLOGY ECOLOGY, V2; Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P501, DOI 10.4319/lo.1976.21.4.0501; Ma ZL, 2012, ACTA OCEANOL SIN, V31, P126, DOI 10.1007/s13131-012-0230-2; Magrin G., 2007, CLIMATE CHANGE 2007; Martinez G, 2000, REV CHIL HIST NAT, V73, P47; Martynova DM, 2010, J PLANKTON RES, V32, P441, DOI 10.1093/plankt/fbp144; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Mitchell David L., 1993, P345; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; MURTAUGH PA, 1985, J PLANKTON RES, V7, P415, DOI 10.1093/plankt/7.3.415; Muylaert K, 2003, AQUAT ECOL, V37, P137, DOI 10.1023/A:1023988702926; Navarro L, 2009, RED VISUAL, P1; Nevalainen L, 2016, QUATERNARY SCI REV, V144, P44, DOI 10.1016/j.quascirev.2016.05.022; Nevalainen L, 2015, FRESHWATER BIOL, V60, P2435, DOI 10.1111/fwb.12670; Pescheck F, 2014, J PHOTOCH PHOTOBIO B, V132, P85, DOI 10.1016/j.jphotobiol.2014.02.006; R Core Team, 2021, R LANGUAGE ENV STAT; Rautio M, 2002, LIMNOL OCEANOGR, V47, P295, DOI 10.4319/lo.2002.47.1.0295; Rautio M, 2003, POLAR BIOL, V26, P659, DOI 10.1007/s00300-003-0533-9; Rautio Milla, 2010, Freshwater Reviews, V3, P105, DOI 10.1608/FRJ-3.2.157; Rautio M, 2009, AQUAT BIOL, V7, P93, DOI 10.3354/ab00184; Rejas D, 2012, REV BOLIVIANA ECOLOG, V30, P1; Rhee JS, 2012, COMP BIOCHEM PHYS C, V155, P359, DOI 10.1016/j.cbpc.2011.10.005; Rios PD, 2007, POL J ENVIRON STUD, V16, P481; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; ROMANOVSKY YE, 1985, OIKOS, V44, P243, DOI 10.2307/3544696; Saito H, 2003, J EXP MAR BIOL ECOL, V282, P135, DOI 10.1016/S0022-0981(02)00468-9; Siebeck O., 1994, Advances in Limnology, V43, P197; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smirnov NN, 1974, CHYDORIDAE FAUNA USS, V1; Smirnov NN, 1971, CRUSTACEA, V1, P1; Smirnov NN, 2013, PHYSL CLADOCERA PHYS, P99; Souza MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032046; Sommaruga R, 2003, COMP SER PHOTOCHEM, V1, P485; Straskrabova AV, 1999, J LIMNOLOGY, V58, P77; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; Uttieri M., 2014, DAPHNIA BIOL MATH PE, P309; Vincent Warwick F., 1993, Environmental Reviews, V1, P1; Wang JH, 2011, ACTA OCEANOL SIN, V30, P113, DOI 10.1007/s13131-011-0111-x; Wetzel R.G, 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; WIEDNER C, 1995, HYDROBIOLOGIA, V302, P89, DOI 10.1007/BF00027033; Williamson CE, 2003, COMP SER PHOTOCHEM, V1, P547; Won EJ, 2015, AQUAT TOXICOL, V165, P1, DOI 10.1016/j.aquatox.2015.05.002; WUBBEN D, 2002, PROC INT ASSOC THE 6, V27, P3354; Wubben DL, 2001, NEW ZEAL J MAR FRESH, V35, P635, DOI 10.1080/00288330.2001.9517029; Zaratti F, 2014, PHOTOCH PHOTOBIO SCI, V13, P980, DOI 10.1039/c4pp00006d; Zellmer ID, 2006, ARCH HYDROBIOL, V167, P515, DOI 10.1127/0003-9136/2006/0167-0515; Zellmer ID, 2004, ARCT ANTARCT ALP RES, V36, P370, DOI 10.1657/1523-0430(2004)036[0370:EOSDID]2.0.CO;2; Zellmer ID, 1996, HYDROBIOLOGIA, V319, P87, DOI 10.1007/BF00016876	89	7	7	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174334	10.1371/journal.pone.0174334	http://dx.doi.org/10.1371/journal.pone.0174334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379975	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500041
J	Ilyechova, EY; Tsymbalenko, NV; Puchkova, LV				Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.			The role of subcutaneous adipose tissue in supporting the copper balance in rats with a chronic deficiency in holo-ceruloplasmin	PLOS ONE			English	Article							TRANSPORTING ATPASES; SILVER IONS; METABOLISM; EXPRESSION; HEPHAESTIN; MECHANISM; PROTEINS; OXIDASES; REVEALS; GENES	We have previously shown that (1) an acute deficiency in blood serum holo-ceruloplasmin (Cp) developed in rats that were fed fodder containing silver ions (Ag-fodder) for one month and (2) the deficiency in holo-Cp was compensated by non-hepatic holo-Cp synthesis in rats that were chronically fed Ag-fodder for 6 months (Ag-rats). The purpose of the present study is to identify the organ(s) that compensate for the hepatic holo-Cp deficiency in the circulation. This study was performed on rats that were fed Ag-fodder (40 mg Ag.kg(-1) body mass daily) for 6 months. The relative expression levels of the genes responsible for copper status were measured by RT-PCR. The in vitro synthesis and secretion of [C-14] Cp were analyzed using a metabolic labeling approach. Oxidase activity was determined using a gel assay with o-dianisidine. Copper status and some hematological indexes were measured. Differential centrifugation, immunoblotting, immunoelectrophoresis, and atomic absorption spectrometry were included in the investigation. In the Ag-rats, silver accumulation was tissue-specific. Skeletal muscles and internal (IAT) and subcutaneous (SAT) adipose tissues did not accumulate silver significantly. In SAT, the mRNAs for the soluble and glycosylphosphatidylinositol-anchored ceruloplasmin isoforms were expressed, and their relative levels were increased two-fold in the Ag-rats. In parallel, the levels of the genes responsible for Cp metallation (Ctr1 and Atp7a/b) increased correspondingly. In the SAT of the Ag-rats, Cp oxidase activity was observed in the Golgi complex and plasma membrane. Moreover, full-length [14 C] Cp polypeptides were released into the medium by slices of SAT. The possibilities that SAT is part of a system that controls the copper balance in mammals, and it plays a significant role in supporting copper homeostasis throughout the body are discussed.	[Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.] Inst Expt Med, Dept Mol Genet, St Petersburg, Russia; [Ilyechova, Ekaterina Y.; Tsymbalenko, Nadezhda V.; Puchkova, Ludmila V.] ITMO Univ, Int Res & Educ Ctr Funct Mat & Devices Optoelect, St Petersburg, Russia; [Puchkova, Ludmila V.] Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Dept Biophys, St Petersburg, Russia	Institute of Experimental Medicine; ITMO University; Peter the Great St. Petersburg Polytechnic University	Ilyechova, EY (corresponding author), Inst Expt Med, Dept Mol Genet, St Petersburg, Russia.; Ilyechova, EY (corresponding author), ITMO Univ, Int Res & Educ Ctr Funct Mat & Devices Optoelect, St Petersburg, Russia.	ilichevaey@gmail.com		Ilyechova, Ekaterina/0000-0002-5623-2156	Russian Foundation for Basic Research grants [16-34-60219, 14-04-01640, 15-04-06770-a]	Russian Foundation for Basic Research grants(Russian Foundation for Basic Research (RFBR))	The work was supported by Russian Foundation for Basic Research grants 16-34-60219 (EYI), 14-04-01640 (NVT), 15-04-06770-a (LVP), http://www.rfbr.ru/rffi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Arciello M, 2015, BIOMETALS, V28, P1017, DOI 10.1007/s10534-015-9886-0; Arner E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080274; Arredondo M, 2014, BIOMETALS, V27, P115, DOI 10.1007/s10534-013-9691-6; Babich PS, 2013, CANCER BIOL THER, V14, P614, DOI 10.4161/cbt.24594; Banha J, 2008, FREE RADICAL BIO MED, V44, P483, DOI 10.1016/j.freeradbiomed.2007.10.032; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Brewer GJ, 2014, J TRACE ELEM MED BIO, V28, P372, DOI 10.1016/j.jtemb.2014.07.015; Easter RN, 2010, VASC MED, V15, P61, DOI 10.1177/1358863X09346656; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; FLEMING RE, 1991, AM J PHYSIOL, V260, pL68, DOI 10.1152/ajplung.1991.260.2.L68; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y; Gambling L, 2003, J NUTR, V133, p1554S, DOI 10.1093/jn/133.5.1554S; Giurgea N, 2005, MED SCI MONITOR, V11, pRA48; Gletsu-Miller N, 2012, INT J OBESITY, V36, P328, DOI 10.1038/ijo.2011.159; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Harvey LJ, 2009, AM J CLIN NUTR, V89, p2009S, DOI 10.3945/ajcn.2009.27230E; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Ilyechova EY, 2014, METALLOMICS, V6, P1970, DOI 10.1039/c4mt00107a; Ilyechova E, 2011, J TRACE ELEM MED BIO, V25, P27, DOI 10.1016/j.jtemb.2010.08.002; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; JAEGER JL, 1991, BIOCHEM J, V280, P671, DOI 10.1042/bj2800671; Kaplan JH, 2016, BIOPHYS J, V110, P7, DOI 10.1016/j.bpj.2015.11.025; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Li S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12410; Lin C, 2015, METALLOMICS, V7, P1285, DOI 10.1039/c5mt00097a; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]; MASON KE, 1979, J NUTR, V109, P1979, DOI 10.1093/jn/109.11.1979; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MOSHKOV KA, 1979, EUR J BIOCHEM, V94, P127, DOI 10.1111/j.1432-1033.1979.tb12879.x; Mostad EJ, 2011, EXP BIOL MED, V236, P298, DOI 10.1258/ebm.2010.010256; Opazo CM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00143; OWEN JA, 1961, CLIN CHIM ACTA, V6, P441, DOI 10.1016/0009-8981(61)90074-2; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Platonova N A, 2005, Izv Akad Nauk Ser Biol, P141; Prohaska JR, 2011, ADV NUTR, V2, P89, DOI 10.3945/an.110.000208; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; SKINNER MK, 1983, BIOL REPROD, V28, P1225, DOI 10.1095/biolreprod28.5.1225; Sokolov AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P631, DOI 10.1134/S0006297912060107; Sugawara N, 2000, ARCH TOXICOL, V74, P190, DOI 10.1007/s002040000115; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Vashchenko G, 2011, ARCH BIOCHEM BIOPHYS, V514, P50, DOI 10.1016/j.abb.2011.07.010; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Zatulovskaia YA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140797; Zatulovskiy EA, 2012, J INORG BIOCHEM, V116, P88, DOI 10.1016/j.jinorgbio.2012.07.003	53	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175214	10.1371/journal.pone.0175214	http://dx.doi.org/10.1371/journal.pone.0175214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380026	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500107
J	Shim, E				Shim, Eunha			Cost-effectiveness of dengue vaccination in Yucatan, Mexico using a dynamic dengue transmission model	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; VECTOR CONTROL; VIRUS SEROTYPES; ECONOMIC-IMPACT; INFECTION; VACCINES; DISEASE; ILLNESS; BURDEN; THAILAND	Background The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health systems with consequent morbidities and mortalities. On December 9 th, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In anticipation of a vaccine rollout, analysis of the cost-effectiveness of the dengue vaccination program that quantifies the dynamics of disease transmission is essential. Methods We developed a dynamic transmission model of dengue in Yucatan, Mexico and its proposed vaccination program to incorporate herd immunity into our analysis of cost-effectiveness analysis. Our model also incorporates important characteristics of dengue epidemiology, such as clinical cross-immunity and susceptibility enhancement upon secondary infection. Using our model, we evaluated the cost-effectiveness and economic impact of an imperfect dengue vaccine in Yucatan, Mexico. Conclusions Our study indicates that a dengue vaccination program would prevent 90% of cases of symptomatic DF incidence as well as 90% of dengue hemorrhagic fever (DHF) incidence and dengue-related deaths annually. We conclude that a dengue vaccine program in Yucata A n, Mexico would be very cost-effective as long as the vaccination cost per individual is less than $ 140 and $ 214 from health care and societal perspectives, respectively. Furthermore, at an exemplary vaccination cost of $ 250 USD per individual on average, dengue vaccination is likely to be cost-effective 43% and 88% of the time from health care and societal perspectives, respectively.	[Shim, Eunha] Soongsil Univ, Dept Math, Seoul, South Korea	Soongsil University	Shim, E (corresponding author), Soongsil Univ, Dept Math, Seoul, South Korea.	alicia@ssu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058208]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education (2015R1D1A1A01058208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Adams B, 2006, J THEOR BIOL, V242, P337, DOI 10.1016/j.jtbi.2006.03.002; Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2; Lorono-Pino MA, 2014, TROP MED INT HEALTH, V19, P1267, DOI 10.1111/tmi.12364; Amarasinghe A, 2010, HUMAN VACCINES, V6; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; [Anonymous], 2016, NAT BIOTECHNOL, V34, P8, DOI 10.1038/nbt0116-8b; [Anonymous], 2016, UNDATA D A DATA ACCE; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bianco S, 2009, CHAOS, V19, DOI 10.1063/1.3270261; Billings L, 2007, J THEOR BIOL, V246, P18, DOI 10.1016/j.jtbi.2006.12.023; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7; Coudeville L, 2015, VACCINE; Coudeville L, 2016, VACCINE; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036; Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Flasche S, 2016, COMPARATIVE MODELLIN; Goamez-Carro S, 2017, JOURNAL OF EPIDEMIOL, V3, P23; Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661; Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545; Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kawaguchi I, 2003, P ROY SOC B-BIOL SCI, V270, P2241, DOI 10.1098/rspb.2003.2440; Knipl D, 2015, B MATH BIOL, V77, P2212, DOI 10.1007/s11538-015-0120-6; Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Mbah MLN, 2014, J THEOR BIOL, V342, P15, DOI 10.1016/j.jtbi.2013.10.006; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Orellano PW, 2015, VACCINE; Pandey A, 2015, EPIDEMIOL INFECT, V143, P1276, DOI 10.1017/S0950268814001939; Polwiang S, 2016, PEERJ JOURNAL IN PRE; Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Shim E, 2016, AMERICAN JOURNAL OF; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Tang LIC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-3; Thavara U, 2014, EPIDEMIOL INFECT, V142, P1245, DOI 10.1017/S0950268813001866; Undurraga EA, 2015, ECONOMIC AND DISEASE, V9; Villar L, 2014, THE NEW ENGLAND JOUR; VONALLMEN SD, 1979, AM J TROP MED HYG, V28, P1040, DOI 10.4269/ajtmh.1979.28.1040; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; World Health Organization, 2012, GLOBAL STRATEGY FOR	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175020	10.1371/journal.pone.0175020	http://dx.doi.org/10.1371/journal.pone.0175020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380060	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500085
J	Chernov, KG; Neuvonen, M; Brock, I; Ikonen, E; Verkhusha, VV				Chernov, Konstantin G.; Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina; Verkhusha, Vladislav V.			Introducing inducible fluorescent split cholesterol oxidase to mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol metabolism; cholesterol regulation; cholesterol-binding protein; enzyme	PROTEIN-PROTEIN INTERACTIONS; CHROMOBACTERIUM SP DS-1; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; STRUCTURAL-CHARACTERIZATION; LIVING ANIMALS; ACTIVE-SITE; ANNEXIN-V; COMPLEMENTATION; EXPRESSION	Cholesterol oxidase (COase) is a bacterial enzyme catalyzing the first step in the biodegradation of cholesterol. COase is an important biotechnological tool for clinical diagnostics and production of steroid drugs and insecticides. It is also used for tracking intracellular cholesterol; however, its utility is limited by the lack of an efficient temporal control of its activity. To overcome this we have developed a regulatable fragment complementation system for COase cloned from Chromobacterium sp. The enzyme was split into two moieties that were fused to FKBP (FK506-binding protein) and FRB (rapamycin-binding domain) pair and split GFP fragments. The addition of rapamycin reconstituted a fluorescent enzyme, termed split GFP-COase, the fluorescence level of which correlated with its oxidation activity. A rapid decrease of cellular cholesterol induced by intracellular expression of the split GFP-COase promoted the dissociation of a cholesterol biosensor D4H from the plasma membrane. The process was reversible as upon rapamycin removal, the split GFP-COase fluorescence was lost, and cellular cholesterol levels returned to normal. These data demonstrate that the split GFP-COase provides a novel tool to manipulate cholesterol in mammalian cells.	[Chernov, Konstantin G.; Verkhusha, Vladislav V.] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, FIN-00290 Helsinki, Finland; [Neuvonen, Maarit; Brock, Ivonne; Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki 00290, Finland; [Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of Helsinki; University of Helsinki; Yeshiva University; Albert Einstein College of Medicine	Ikonen, E (corresponding author), Univ Helsinki, Fac Med, Dept Anat, FIN-00290 Helsinki, Finland.; Verkhusha, VV (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	elina.ikonen@helsinki.fi; vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121; Ikonen, Elina/0000-0001-8382-1135; Neuvonen, Maarit/0000-0002-7209-3029	Academy of Finland [263371, 266992, 272130, 284667]; EU FP7 program [ERC-2013-ADG-340233]	Academy of Finland(Academy of Finland); EU FP7 program(European Commission)	This work was supported by Academy of Finland Grants 263371 and 266992 (to V. V. V.) and 272130 and 284667 (to E. I.) and by an EU FP7 program ERC-2013-ADG-340233 grant (to V. V. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BERNHEIMER AW, 1987, BIOCHEM BIOPH RES CO, V148, P260, DOI 10.1016/0006-291X(87)91104-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Doukyu N, 2009, APPL MICROBIOL BIOT, V82, P479, DOI 10.1007/s00253-008-1775-9; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Gadda G, 1997, EUR J BIOCHEM, V250, P369, DOI 10.1111/j.1432-1033.1997.0369a.x; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gniadecki R, 2004, BIOCHEM BIOPH RES CO, V320, P165, DOI 10.1016/j.bbrc.2004.05.145; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuypers FA, 1996, BLOOD, V87, P1179, DOI 10.1182/blood.V87.3.1179.bloodjournal8731179; Lajoie Patrick, 2013, Methods Mol Biol, V1017, P229, DOI 10.1007/978-1-62703-438-8_17; LANGE Y, 1992, J LIPID RES, V33, P315; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.324; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Martell JD, 2016, NAT BIOTECHNOL, V34, P774, DOI 10.1038/nbt.3563; Mathieu JM, 2012, BIOTECHNOL BIOENG, V109, P2409, DOI 10.1002/bit.24506; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Neuvonen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103743; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paulmurugan R, 2005, CANCER RES, V65, P7413, DOI 10.1158/0008-5472.CAN-05-0588; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pollegioni L, 2009, FEBS J, V276, P6857, DOI 10.1111/j.1742-4658.2009.07379.x; PORN MI, 1995, BIOCHEM J, V308, P269; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Vrielink A, 2009, FEBS J, V276, P6826, DOI 10.1111/j.1742-4658.2009.07377.x; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wehr MC, 2016, DRUG DISCOV TODAY, V21, P415, DOI 10.1016/j.drudis.2015.11.004; Wustner D, 2015, BBA-BIOMEMBRANES, V1848, P1908, DOI 10.1016/j.bbamem.2015.05.010; Yue QK, 1999, BIOCHEMISTRY-US, V38, P4277, DOI 10.1021/bi982497j; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhuang LY, 2002, CANCER RES, V62, P2227; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	54	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8811	8822		10.1074/jbc.M116.761718	http://dx.doi.org/10.1074/jbc.M116.761718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28391244	hybrid, Green Published			2022-12-26	WOS:000402153900026
J	Earls, MR; Kinnevey, PM; Brennan, GI; Lazaris, A; Skally, M; O'Connell, B; Humphreys, H; Shore, AC; Coleman, DC				Earls, Megan R.; Kinnevey, Peter M.; Brennan, Grainne I.; Lazaris, Alexandros; Skally, Mairead; O'Connell, Brian; Humphreys, Hilary; Shore, Anna C.; Coleman, David C.			The recent emergence in hospitals of multidrug-resistant community-associated sequence type 1 and spa type t127 methicillin-resistant Staphylococcus aureus investigated by whole-genome sequencing: Implications for screening	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; ANTIMICROBIAL SUSCEPTIBILITY; NOSOCOMIAL TRANSMISSION; GENTAMICIN-RESISTANT; MRSA; STRAINS; DUBLIN; MEC; IMPORTATION; INFECTION	Community-associated spa type t127/t922 methicillin-resistant Staphylococcus aureus (MRSA) prevalence increased from 1%-7% in Ireland between 2010-2015. This study tracked the spread of 89 such isolates from June 2013-June 2016. These included 78 healthcare-associated and 11 community associated-MRSA isolates from a prolonged hospital outbreak (H1) (n = 46), 16 other hospitals (n = 28), four other healthcare facilities (n = 4) and community-associated sources (n = 11). Isolates underwent antimicrobial susceptibility testing, DNA microarray profiling and whole-genome sequencing. Minimum spanning trees were generated following core-genome multilocus sequence typing and pairwise single nucleotide variation (SNV) analysis was performed. All isolates were sequence type 1 MRSA staphylococcal cassette chromosome mec type IV (ST1-MRSA-IV) and 76/89 were multidrug-resistant. Fifty isolates, including 40/46 from H1, were high-level mupirocin-resistant, carrying a conjugative 39 kb iles2-encoding plasmid. Two closely related ST1-MRSA-IV strains (I and II) and multiple sporadic strains were identified. Strain I isolates (57/89), including 43/46 H1 and all high-level mupirocin-resistant isolates, exhibited <= 80 SNVs. Two strain I isolates from separate H1 healthcare workers differed from other H1/strain I isolates by 7-47 and 12-53 SNVs, respectively, indicating healthcare worker involvement in this outbreak. Strain II isolates (19/89), including the remaining H1 isolates, exhibited <= 127 SNVs. For each strain, the pairwise SNVs exhibited by healthcare-associated and community-associated isolates indicated recent transmission of ST1-MRSA-IV within and between multiple hospitals, healthcare facilities and communities in Ireland. Given the interchange between healthcare-associated and community-associated isolates in hospitals, the risk factors that inform screening for MRSA require revision.	[Earls, Megan R.; Kinnevey, Peter M.; Brennan, Grainne I.; Lazaris, Alexandros; Shore, Anna C.; Coleman, David C.] Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll, Microbiol Res Unit, Dublin, Ireland; [Brennan, Grainne I.; O'Connell, Brian] St James Hosp, Natl MRSA Reference Lab, Dublin 8, Ireland; [Skally, Mairead; Humphreys, Hilary] Beaumont Hosp, Dept Microbiol, Dublin, Ireland; [O'Connell, Brian] St James Hosp, Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin 8, Ireland; [Humphreys, Hilary] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Clin Microbiol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Coleman, DC (corresponding author), Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll, Microbiol Res Unit, Dublin, Ireland.	david.coleman@dental.tcd.ie	Coleman, David C./C-2008-2009; Kinnevey, Peter M/O-1908-2015	Coleman, David C./0000-0003-1797-2888; Kinnevey, Peter M/0000-0001-7334-5745; Humphreys, Hilary/0000-0002-9646-2183	University of Dublin Faculty of Health Science Dean's Research Initiative Fund [DRI 02-2015-16]	University of Dublin Faculty of Health Science Dean's Research Initiative Fund	This study was supported by the University of Dublin Faculty of Health Science Dean's Research Initiative Fund 2015-16 (grant no. DRI 02-2015-16, Dr. Anna C Shore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATIONAL MRSA REFERE; [Anonymous], 2015, NATIONAL MRSA REFERE; Ballhausen B, 2014, ANTIMICROB AGENTS CH, V58, P3791, DOI 10.1128/AAC.02731-13; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bosch T, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.21.30236; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Carfora V, 2016, J DAIRY SCI, V99, P4251, DOI 10.3168/jds.2016-10912; CARROLL D, 1995, MOL MICROBIOL, V16, P877, DOI 10.1111/j.1365-2958.1995.tb02315.x; CARROLL JD, 1989, J MED MICROBIOL, V28, P15, DOI 10.1099/00222615-28-1-15; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2015, CLSI DOCUMENT M100 S; COLEMAN DC, 1985, J MED MICROBIOL, V20, P157, DOI 10.1099/00222615-20-2-157; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; David MZ, 2014, PLOS ONE, V9; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Department of Mines and Petroleum, 2013, PUBL UN, P1; Caboclo RMF, 2013, AM J INFECT CONTROL, V41, pE21, DOI 10.1016/j.ajic.2012.08.008; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Giuffre Mario, 2012, BMC Pediatr, V12, P64, DOI 10.1186/1471-2431-12-64; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Health Protection Surveillance Centre, 2015, PRIMARY CARE ANTIBIO; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Joo EJ, 2012, J HOSP INFECT, V81, P149, DOI 10.1016/j.jhin.2012.04.018; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; Kinnevey PM, 2016, J CLIN MICROBIOL, V54, P445, DOI 10.1128/JCM.02662-15; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kong ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149844; Lee SS, 2010, J CLIN MICROBIOL, V48, P311, DOI 10.1128/JCM.00297-09; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Li M, 2016, EMERG INFECT DIS, V22, P1988, DOI 10.3201/eid2211.160587; Loncaric I, 2014, VET MICROBIOL, V168, P381, DOI 10.1016/j.vetmic.2013.11.022; Luini M, 2015, VET MICROBIOL, V178, P270, DOI 10.1016/j.vetmic.2015.05.010; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Muller-Premru M, 2005, EUR J CLIN MICROBIOL, V24, P848, DOI 10.1007/s10096-005-0048-0; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Parisi A, 2016, FOOD MICROBIOL, V58, P36, DOI 10.1016/j.fm.2016.03.004; Perez-Roth E, 2010, ANTIMICROB AGENTS CH, V54, P2252, DOI 10.1128/AAC.01074-09; Price JR, 2013, J HOSP INFECT, V83, P14, DOI 10.1016/j.jhin.2012.10.003; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Ramsing BGU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066904; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Rossney AS, 2002, EUR J CLIN MICROBIOL, V21, P123, DOI 10.1007/s10096-001-0677-x; Seidl K, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0075-3; SenGupta DJ, 2014, J CLIN MICROBIOL, V52, P2787, DOI 10.1128/JCM.00759-14; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2016, ANTIMICROB AGENTS CH, V60, P3007, DOI 10.1128/AAC.02949-15; Shore AC, 2014, J CLIN MICROBIOL, V52, P859, DOI 10.1128/JCM.02799-13; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKPOINT TABLES FO; Udo EE, 1997, ANTIMICROB AGENTS CH, V41, P693, DOI 10.1128/AAC.41.3.693; Wang LJ, 2012, J MED MICROBIOL, V61, P1240, DOI 10.1099/jmm.0.042663-0; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137593	61	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175542	10.1371/journal.pone.0175542	http://dx.doi.org/10.1371/journal.pone.0175542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399151	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000046
J	Reiley, BM; Benson, TJ; Everitts, J; Bednarz, JC				Reiley, Bryan M.; Benson, Thomas J.; Everitts, Jeremy; Bednarz, James C.			Does flooding effect the apparent survival and body condition of a ground foraging migrant passerine?	PLOS ONE			English	Article							POPULATION-GROWTH RATE; SWAINSONS-WARBLER; HABITAT QUALITY; MARKED ANIMALS; BIRDS; CONSERVATION; RIVER; ECOLOGY; FOOD; DISTURBANCE	Natural disturbances play a fundamental role in maintaining habitat and landscape heterogeneity; however, these events can also have negative effects on some species. While we know that disturbances can reduce habitat quality for many species, leading to diminished populations and altered community structure, the effect of these events on individuals that continue to occupy affected areas remains unknown. We focused on understanding the impact of flood-mediated reduction of habitat quality on Swainson's Warblers (Limnothlypis swainsonii). In 2008, a catastrophic flood event occurred on the Mississippi River and its tributaries, severely affecting one of two locations where we had studied territorial males since 2004. To determine the impact of flooding on this species, we evaluated how body condition and apparent survival of males differed between locations and in pre-flood (2004-2007) and post-flood (2008-2010) periods. Body condition did not differ between locations after the flood, suggesting that flooding did not cause food limitation for this obligate ground forager. Apparent survival in the post-flood period was lower at both locations and led to near population extirpation at the heavily flood-impacted site. Overall, this study demonstrates the vulnerability of species to extreme hydrological events, an increasing threat due to climate change. Future research should focus on identifying species that are vulnerable to these events and determining appropriate conservation strategies. Conservation for the Swainson's Warbler should focus on identifying and conserving the highest elevation, least flood prone areas within bottomland hardwood forests and managing those areas for thick understory vegetation.	[Reiley, Bryan M.; Everitts, Jeremy] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Reiley, Bryan M.; Benson, Thomas J.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Bednarz, James C.] Univ North Texas, Dept Biol Sci, Denton, TX USA	Arkansas State University; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of North Texas System; University of North Texas Denton	Reiley, BM (corresponding author), Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA.; Reiley, BM (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA.	bryan.reiley@gmail.com			United Stated Fish and Wildlife Service; Arkansas Game and Fish Commission	United Stated Fish and Wildlife Service(US Fish & Wildlife Service); Arkansas Game and Fish Commission	Financial support was provided by the United Stated Fish and Wildlife Service and the Arkansas Game and Fish Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by the U.S. Fish and Wildlife Service and the Arkansas Game and Fish Commission. R. Hines, S. Reagan, and D. Sharp of the White River National Wildlife Refuge provided accommodation and access. We thank N. Anich, C. Roa, A. Zachary, S. Rune, A. Overfield, J. Brown, W. Kohler, N. Bieber, and A. Beeler for their assistance in the field.	Andersen DC, 2000, J MAMMAL, V81, P1087, DOI 10.1644/1545-1542(2000)081<1087:MPORSM>2.0.CO;2; ANICH N. M., 2010, BIRDS N AM ONLINE; Anich NM, 2010, WILSON J ORNITHOL, V122, P165, DOI 10.1676/09-031.1; Anich NM, 2009, AUK, V126, P626, DOI 10.1525/auk.2009.08219; [Anonymous], 2006, SAS MIXED MODELS; BARROW W. C., 1990, THESIS; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; Bednarz JC, 2005, DISTRIBUTION HABITAT, V191, P576; Benson TJ, 2011, J FIELD ORNITHOL, V82, P25, DOI 10.1111/j.1557-9263.2010.00304.x; Benson TJ, 2010, CONDOR, V112, P138, DOI 10.1525/cond.2010.080089; Benson TJ, 2010, WETLANDS, V30, P29, DOI 10.1007/s13157-009-0004-3; Benson TJ, 2009, CONDOR, V111, P694, DOI 10.1525/cond.2009.080074; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown JD, 2009, WETLANDS, V29, P586, DOI 10.1672/08-54.1; Brown Margaret E., 1996, Current Ornithology, V13, P67; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chiavacci SJ, 2014, CONDOR, V116, P215, DOI 10.1650/CONDOR-12-157-R1.1; Chiu MC, 2013, IBIS, V155, P377, DOI 10.1111/ibi.12035; DeRagon WR, 1988, THESIS; DiQuinzio DA, 2002, WETLANDS, V22, P179, DOI 10.1672/0277-5212(2002)022[0179:NEOSST]2.0.CO;2; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; Everitts JL, 2015, WILDLIFE SOC B, V39, P292, DOI 10.1002/wsb.536; Golet GH, 2013, RIVER RES APPL, V29, P183, DOI 10.1002/rra.1588; Graves GR, 1998, J FIELD ORNITHOL, V69, P121; Graves GR, 2001, AUK, V118, P650, DOI 10.1642/0004-8038(2001)118[0650:FGTDOS]2.0.CO;2; Hering D, 2004, RIVER RES APPL, V20, P445, DOI 10.1002/rra.759; Hoover JP, 2006, BIOL CONSERV, V127, P37, DOI 10.1016/j.biocon.2005.07.017; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Jacob J, 2003, MAMM BIOL, V68, P102, DOI 10.1078/1616-5047-00068; Johnson DM, 2004, ECOLOGY, V85, P2037, DOI 10.1890/03-0508; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Klaus NA, 2004, ORIOLE, V69, P19; KNOPF FL, 1987, CONDOR, V89, P869, DOI 10.2307/1368536; Knutson MG, 1997, AUK, V114, P367, DOI 10.2307/4089239; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; MEANLEY B, 1970, WILSON BULL, V82, P228; Meanley B., 1966, Living Bird, V5, P151; MEANLEY B, 1971, N AM FAUNA, V69; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434; RAPPOLE JH, 1994, AUK, V111, P652; Reiley BM, 2013, CONDOR, V115, P650, DOI 10.1525/cond.2013.120163; Reinert Steven E., 2006, Studies in Avian Biology, P77; Rogers JC, 1988, J CLIMATE, V1, P172, DOI 10.1175/1520-0442(1988)001<0172:PVOTCA>2.0.CO;2; Royan A, 2014, BIOL CONSERV, V177, P64, DOI 10.1016/j.biocon.2014.06.017; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Schramm HL, 2009, WETLANDS, V29, P476, DOI 10.1672/08-62.1; Sharp DW, 2012, WHITE RIVER NATL WIL; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Thompson J.I., 2005, THESIS; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 1998, ECOSYSTEMS, V1, P493, DOI 10.1007/s100219900045; Twedt DJ, 2009, J WILDLIFE MANAGE, V73, P1140, DOI 10.2193/2008-441; Twedt DJ, 1999, J BIOGEOGR, V26, P1215, DOI 10.1046/j.1365-2699.1999.00348.x; US Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	64	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175179	10.1371/journal.pone.0175179	http://dx.doi.org/10.1371/journal.pone.0175179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394910	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800020
J	Ueki, M; Takeshita, H; Utsunomiya, N; Chino, T; Oyama, N; Hasegawa, M; Kimura-Kataoka, K; Fujihara, J; Iida, R; Yasuda, T				Ueki, Misuzu; Takeshita, Haruo; Utsunomiya, Natsuko; Chino, Takanao; Oyama, Noritaka; Hasegawa, Minoru; Kimura-Kataoka, Kaori; Fujihara, Junko; Iida, Reiko; Yasuda, Toshihiro			Survey of single-nucleotide polymorphisms in the gene encoding human deoxyribonuclease I-like 2 producing loss of function potentially implicated in the pathogenesis of parakeratosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NUCLEAR-DNA; DNASE1L2; SNPS; DIFFERENTIATION; AUTOIMMUNITY; EXPRESSION; APOPTOSIS; RELEVANT	Dysfunction of DNase I-like 2 (DNase 1L2) has been assumed to play a role in the etiology of parakeratosis through incomplete degradation of DNA in the epidermis. However, the pathogenetic background factor for such pathophysiologic conditions remains unknown. In this context, non-synonymous single-nucleotide polymorphisms (SNPs) in DNASE1L2 that would potentially result in loss of in vivo DNase 1L2 activity might serve as a genetic risk factor for such pathophysiologic conditions. Our aim was to effectively survey the non-synonymous SNPs of DNASE1L2 that would produce a loss-of-function variant of the enzyme together with a genetic distribution in the various populations. Here, the effects of all of the SNPs predicted by PolyPhen-2 analysis to be "probably damaging" (score = 1.000), and derived from frameshift/nonsense mutations, on the activity of DNase 1L2 were examined using the corresponding DNase 1L2 variants expressed in COS-7 cells. Genotyping of these SNPs was also performed in three ethnic groups including 14 different populations. Among the 28 SNPs examined, the minor allele of 23 SNPs was defined as a loss-of-function variant resulting in loss of DNase 1L2 function, indicating that Polyphen-2 analysis could be effective for surveys of at least non-synonymous SNPs resulting in loss of function. On the other hand, these minor alleles were not distributed worldwide, thereby avoiding any marked reduction of the enzyme activity in human populations. Furthermore, all of the 19 SNPs originating from frameshift/nonsense mutations found in DNASE1L2 resulted in loss of function of the enzyme. Thus, the present findings suggest that each of the minor alleles for these SNPs may serve as one of genetic risk factors for parakeratotic skin diseases such as psoriasis, even though they lack a worldwide genetic distribution.	[Ueki, Misuzu; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Dept Med Genet & Biochem, Fukui, Japan; [Takeshita, Haruo; Kimura-Kataoka, Kaori; Fujihara, Junko] Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan; [Utsunomiya, Natsuko; Chino, Takanao; Oyama, Noritaka; Hasegawa, Minoru] Univ Fukui, Fac Med Sci, Dept Dermatol, Fukui, Japan; [Iida, Reiko] Univ Fukui, Fac Med Sci, Dept Life Sci, Fukui, Japan	University of Fukui; Shimane University; University of Fukui; University of Fukui	Takeshita, H (corresponding author), Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan.	htakeshi@meci.shimane-u.ac.jp	Fujihara, Junko/V-7818-2019	Fujihara, Junko/0000-0001-5359-5181; Hasegawa, Minoru/0000-0003-3738-2682; Takenao, Chino/0000-0002-2224-3383; Utsunomiya, Natsuko/0000-0001-6764-3252; Oyama, Noritaka/0000-0003-4934-5205	Japan Society for the Promotion of Science [16H05272, 25460864]; Grants-in-Aid for Scientific Research [16K19295] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/e-grants/ (16H05272 to T.Y. and 25460864 to M.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by Grants-in-Aid from Japan Society for the Promotion of Science (16H05272 to T.Y. and 25460864 to M.U.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Adzubei IA, 2013, CURRENT PROTOCOLS HU; Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Dittmar M, 2009, J AUTOIMMUN, V32, P7, DOI 10.1016/j.jaut.2008.09.005; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V277, P655, DOI 10.1006/bbrc.2000.3698; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Eckhart L, 2012, FRONT BIOSCI-LANDMRK, V17, P2461, DOI 10.2741/4065; Fischer H, 2016, J INVEST DERMATOL; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fischer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017581; Fujihara J, 2016, IMMUNOL INVEST, V45, P406, DOI 10.3109/08820139.2016.1157813; Fujihara J, 2010, ELECTROPHORESIS, V31, P3552, DOI 10.1002/elps.201000319; Jager K, 2007, DIFFERENTIATION, V75, P939; Kimura-Kataoka K, 2013, ELECTROPHORESIS, V34, P3361, DOI 10.1002/elps.201300399; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rodriguez AM, 1997, GENOMICS, V42, P507, DOI 10.1006/geno.1997.4748; Shiokawa D, 2004, GENOMICS, V84, P95, DOI 10.1016/j.ygeno.2004.02.003; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Szabo S, 2012, INT J LEGAL MED, V126, P63, DOI 10.1007/s00414-011-0566-5; Ueki M, 2015, GENE, V561, P15, DOI 10.1016/j.gene.2015.01.006; Ueki M, 2014, DNA CELL BIOL, V33, P79, DOI 10.1089/dna.2013.2248; Ueki M, 2014, FEBS J, V281, P376, DOI 10.1111/febs.12608; Ueki M, 2013, ELECTROPHORESIS, V34, P456, DOI 10.1002/elps.201200415; Ueki M, 2010, ELECTROPHORESIS, V31, P2063, DOI 10.1002/elps.201000002; Yasuda T, 1999, BIOCHEM BIOPH RES CO, V260, P280, DOI 10.1006/bbrc.1999.0900; YASUDA T, 1995, ELECTROPHORESIS, V16, P1889, DOI 10.1002/elps.11501601310; Yasuda T, 2010, INT J BIOCHEM CELL B, V42, P1216, DOI 10.1016/j.biocel.2010.04.012; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175083	10.1371/journal.pone.0175083	http://dx.doi.org/10.1371/journal.pone.0175083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394916	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800015
J	Torok, HP; Bellon, V; Konrad, A; Lacher, M; Tonenchi, L; Siebeck, M; Brand, S; De Toni, EN				Toeroek, Helga Paula; Bellon, Victor; Konrad, Astrid; Lacher, Martin; Tonenchi, Laurian; Siebeck, Matthias; Brand, Stephan; De Toni, Enrico Narciso			Functional Toll-Like Receptor (TLR) 2 polymorphisms in the susceptibility to inflammatory bowel disease	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; MICROSATELLITE POLYMORPHISM; INTRON-II; GENETIC RISK; ASSOCIATION; TUBERCULOSIS; PROMOTER; LOCI	Background The recent genome-wide association studies (GWAS) in inflammatory bowel disease (IBD) suggest significant genetic overlap with complex mycobacterial diseases like tuberculosis or leprosy. TLR variants have previously been linked to susceptibility for mycobacterial diseases. Here we investigated the contribution to IBD risk of two TLR2 polymorphisms, the low-prevalence variant Arg753Gln and the GTn microsatellite repeat polymorphism in intron 2. We studied association with disease, possible correlations with phenotype and genegene interactions. Methodology/Principal findings We conducted a large study in 843 patients with Crohn's disease, 426 patients with ulcerative colitis and 805 healthy, unrelated controls, all of European origin. Overall, the frequency for carriers of shorter GT(n) repeats in intron 2 of the TLR2 gene, which have previously been associated with low TLR2 expression and high IL-10 production, was slightly elevated in Crohn's disease and ulcerative colitis compared to healthy controls (16.0% resp. 16.7% vs. 12.8%). The highest frequency of short GT(n) carriers was noted among IBD patients on anti TNF-alpha therapy. However, none of these differences was significant in the multivariate analysis. The Arg753Gln polymorphism showed no association with any clinical subtype of IBD, including extensive colitis, for which such an association was previously described. We found no association with specific phenotypic disease subgroups. Also, epistasis analysis revealed no significant interactions between the two TLR2 variants and confirmed IBD susceptibility genes. Conclusions The two functional relevant polymorphisms in TLR2, the GT(n) microsatellite repeat polymorphism in intron 2 and the Arg753Gln variant do not seem to play a role in the susceptibility to Crohn's disease or ulcerative colitis.	[Toeroek, Helga Paula; Konrad, Astrid; Brand, Stephan; De Toni, Enrico Narciso] Ludwig Maximilians Univ Munchen, Dept Med 2, Munich, Germany; [Bellon, Victor] PSL Res Univ, CBIO Ctr Computat Biol, MINES ParisTech, Fontainebleau, France; [Bellon, Victor] Inst Curie, Paris, France; [Bellon, Victor] INSERM U900, Paris, France; [Lacher, Martin] Univ Leipzig, Dept Pediat Surg, Leipzig, Germany; [Tonenchi, Laurian; Siebeck, Matthias] Ludwig Maximilians Univ Munchen, Dept Gen Visceral Vasc & Transplantat Surg, Munich, Germany; [Brand, Stephan] Kantonsspital St Gallen, Dept Gastroenterol & Hepatol, St Gallen, Switzerland	University of Munich; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Leipzig University; University of Munich; Kantonsspital St. Gallen	Torok, HP (corresponding author), Ludwig Maximilians Univ Munchen, Dept Med 2, Munich, Germany.	helga.toeroek@med.uni-muenchen.de	De Toni, Enrico N/C-6496-2008					Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Cheng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126803; Folwaczny M, 2011, CLIN ORAL INVEST, V15, P435, DOI 10.1007/s00784-010-0396-8; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kormann MSD, 2009, ALLERGY, V64, P636, DOI 10.1111/j.1398-9995.2008.01891.x; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Moore CE, 2004, CLIN DIAGN LAB IMMUN, V11, P1194, DOI 10.1128/CDLI.11.6.1194-1197.2004; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Suryadevara NC, 2013, HUM IMMUNOL, V74, P1034, DOI 10.1016/j.humimm.2013.04.009; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Veltkamp M, 2007, CLIN EXP IMMUNOL, V149, P453, DOI 10.1111/j.1365-2249.2007.03428.x; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yang ZQ, 2007, GASTROENTEROLOGY, V133, P1510, DOI 10.1053/j.gastro.2007.07.025; Yim JJ, 2008, HUM IMMUNOL, V69, P572, DOI 10.1016/j.humimm.2008.06.003; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274; Yim JJ, 2004, FEMS IMMUNOL MED MIC, V40, P163, DOI 10.1016/S0928-8244(03)00342-0; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	32	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175180	10.1371/journal.pone.0175180	http://dx.doi.org/10.1371/journal.pone.0175180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388655	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800027
J	Briant, K; Johnson, N; Swanton, E				Briant, Kit; Johnson, Nicholas; Swanton, Eileithyia			Transmembrane domain quality control systems operate at the endoplasmic reticulum and Golgi apparatus	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; HUMAN CD8 GLYCOPROTEIN; UBIQUITIN LIGASE; PLASMA-MEMBRANE; SECRETORY PATHWAY; HYDROPHOBIC MISMATCH; SURFACE EXPRESSION; RECYCLING PATHWAY; ER RETENTION; DEGRADATION	Multiple protein quality control systems operate to ensure that misfolded proteins are efficiently cleared from the cell. While quality control systems that assess the folding status of soluble domains have been extensively studied, transmembrane domain (TMD) quality control mechanisms are poorly understood. Here, we have used chimeras based on the type I plasma membrane protein CD8 in which the endogenous TMD was substituted with transmembrane sequences derived from different polytopic membrane proteins as a mode to investigate the quality control of unassembled TMDs along the secretory pathway. We find that the three TMDs examined prevent trafficking of CD8 to the cell surface via potentially distinct mechanisms. CD8 containing two distinct non-native transmembrane sequences escape the ER and are subsequently retrieved from the Golgi, possibly via Rer1, leading to ER localisation at steady state. A third chimera, containing an altered transmembrane domain, was predominantly localised to the Golgi at steady state, indicating the existence of an additional quality control checkpoint that identifies non-native transmembrane domains that have escaped ER retention and retrieval. Preliminary experiments indicate that protein retained by quality control mechanisms at the Golgi are targeted to lysosomes for degradation.	[Briant, Kit; Johnson, Nicholas; Swanton, Eileithyia] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Mol & Cellular Funct,Sch Biol Sci, Manchester, Lancs, England; [Briant, Kit] UCL, Fac Life Sci, Dept Struct & Mol Biol, Div Biosci, London, England; [Johnson, Nicholas] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	University of Manchester; University of London; University College London; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Swanton, E (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Mol & Cellular Funct,Sch Biol Sci, Manchester, Lancs, England.	lisa.swanton@manchester.ac.uk	Johnson, Nicholas/G-5930-2014	Swanton, Eileithyia/0000-0002-3299-4228; Johnson, Nicholas/0000-0002-8247-2874; Briant, Kit/0000-0002-1368-6262	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F017227/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), Grant reference BB/F017227/1, http://www.bbsrc.ac.uk/.	Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Babst M, 2014, J CELL BIOL, V205, P11, DOI 10.1083/jcb.201310113; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Briant K, 2015, J CELL SCI, V128, P4112, DOI 10.1242/jcs.171215; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Chu CY, 2014, AM J PHYSIOL-CELL PH, V307, pC296, DOI 10.1152/ajpcell.00310.2013; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cosson P, 2013, TRENDS CELL BIOL, V23, P511, DOI 10.1016/j.tcb.2013.05.005; Cymer F, 2012, BIOL CHEM, V393, P1215, DOI 10.1515/hsz-2012-0231; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Dhaunchak AS, 2011, J NEUROSCI, V31, P14961, DOI 10.1523/JNEUROSCI.2097-11.2011; Duque D, 2002, J CHEM PHYS, V116, P10478, DOI 10.1063/1.1477927; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hara T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06992; Hauri HP, 2000, J CELL SCI, V113, P587; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Klumperman J, 1998, J CELL SCI, V111, P3411; Koenig Paul-Albert, 2014, F1000Prime Rep, V6, P49, DOI 10.12703/P6-49; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Li QA, 2010, J BIOL CHEM, V285, P32977, DOI 10.1074/jbc.M110.143024; Li Y, 1999, MOL CELL BIOL, V19, P3588; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Merulla J, 2015, MOL BIOL CELL, V26, P1532, DOI 10.1091/mbc.E14-12-1615; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; PASCALE MC, 1992, J BIOL CHEM, V267, P9940; PASCALE MC, 1992, J BIOL CHEM, V267, P25196; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Roxrud I, 2009, EXP CELL RES, V315, P3014, DOI 10.1016/j.yexcr.2009.07.012; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1991, J CELL SCI, V100, P415; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; Watson HR, 2011, MOL MEMBR BIOL, V28, P216, DOI 10.3109/09687688.2011.572566; Yamasaki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05973	62	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173924	10.1371/journal.pone.0173924	http://dx.doi.org/10.1371/journal.pone.0173924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384259	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900010
J	Chen, XD; Mao, CC; Wu, RS; Zhang, WT; Lin, J; Sun, XW; Chi, CH; Lou, N; Wang, PF; Shen, X; Zhu, GB; Shen, SR				Chen, Xiao-dong; Mao, Chen-chen; Wu, Rui-sen; Zhang, Wei-teng; Lin, Ji; Sun, Xiang-wei; Chi, Chu-huai; Lou, Neng; Wang, Peng-fei; Shen, Xian; Zhu, Guan-bao; Shen, Shu-rong			Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE; PROGNOSTIC-SIGNIFICANCE; MONOCYTE COUNT; SURVIVAL; DISSEMINATION; CHEMOTHERAPY; SENSITIVITY; RECURRENCE; BIOMARKERS; IMPROVES	The aims of the present study were to evaluate the predictive value of the platelet-to-lymphocyte ratio for peritoneal metastasis in patients with gastric cancer and to construct an available preoperative prediction system for peritoneal metastasis. A total of 1080 patients with gastric cancer were enrolled in our study. The preoperative platelet-to-lymphocyte ratio and other serum markers and objective clinical tumor characteristics were evaluated by receiver operating characteristic curves. A logistic analysis was performed to determine the independent predictive indicators of peritoneal metastasis. A prediction system that included the independent predictive indicators was constructed and evaluated by receiver operating characteristic curves. Based on the receiver operating characteristic curves, the ideal platelet- to-lymphocyte ratio cutoff value to predict peritoneal metastasis was 131.00. The logistic analysis showed that the platelet-to-lymphocyte ratio was an independent indicator to predict peritoneal metastasis. The area under the receiver operating characteristic curve was 0.599. When integrating all independent indicators (i.e., platelet-to-lymphocyte ratio, invasion depth, lymphatic invasion, pathological type), the prediction system more reliably predicted peritoneal metastasis with a higher area under the receiver operating characteristic curve (0.769). The preoperative platelet-to-lymphocyte ratio was an indicator that could be used to predict peritoneal metastasis. Our prediction system could be a reliable instrument to discriminate between patients with gastric cancer with and those without peritoneal metastasis.	[Chen, Xiao-dong; Mao, Chen-chen; Wu, Rui-sen; Zhang, Wei-teng; Lin, Ji; Sun, Xiang-wei; Chi, Chu-huai; Lou, Neng; Wang, Peng-fei; Shen, Xian; Zhu, Guan-bao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China; [Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China; [Shen, Shu-rong] Wenzhou Integrated Tradit Chinese & Western Med H, Dept Breast Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Shen, X; Zhu, GB (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China.; Shen, X (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Wenzhou, Zhejiang, Peoples R China.; Shen, SR (corresponding author), Wenzhou Integrated Tradit Chinese & Western Med H, Dept Breast Surg, Wenzhou, Zhejiang, Peoples R China.	shenxian5166@gmail.com; 352161451@qq.com; 995477163@qq.com	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022					Ahmed A, 2011, AFR HEALTH SCI, V11, P353; Barar J, 2012, BIOIMPACTS, V2, P1, DOI 10.5681/bi.2012.001; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Cannon NA, 2015, J THORAC ONCOL, V10, P280, DOI 10.1097/JTO.0000000000000399; Dhobi MA, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/981654; ELHAG A, 1987, J IMMUNOL, V139, P2406; Hwang Gun Ick, 2004, Cancer Res Treat, V36, P178, DOI 10.4143/crt.2004.36.3.178; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KAY HD, 1983, J IMMUNOL, V130, P475; Kim EY, 2015, ANN SURG ONCOL, V22, P4363, DOI 10.1245/s10434-015-4518-z; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Kishi K, 2016, SURG TODAY; Kurita N, 2010, HEPATO-GASTROENTEROL, V57, P980; Lai H, 2014, TUMOR BIOL, V35, P10547, DOI 10.1007/s13277-014-2355-5; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Liu J, 2016, ONCOTARGET; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Maehara Y, 2000, BRIT J SURG, V87, P353, DOI 10.1046/j.1365-2168.2000.01358.x; Mo A, 2016, MOL CANC RES; Namikawa T, 2016, ONCOLOGY-BASEL, V90, P321, DOI 10.1159/000446373; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; Ohi M, 2015, ANTICANCER RES, V35, P3511; Osugi J, 2016, J CANCER RES THER, V12, P945, DOI 10.4103/0973-1482.176168; Ozkan E, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-75; Quigley DA, 2015, MOL ONCOL, V9, P2054, DOI 10.1016/j.molonc.2015.10.003; Sakakura C, 2004, BRIT J CANCER, V90, P665, DOI 10.1038/sj.bjc.6601544; Sato Y, 2016, GASTRIC CANC; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Stotz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159448; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Tan KW, 2013, BLOOD, V122, P3666, DOI 10.1182/blood-2012-11-466532; Turner N, 2016, INT J CANCER, V138, P671, DOI 10.1002/ijc.29805; VanCutsem E., 2016, LANCET; Wang JP, 2015, ANN SURG ONCOL, V22, P2965, DOI 10.1245/s10434-015-4388-4; Wang Z, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-19; Wen JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002266; Yonemura Y, 2005, BRIT J SURG, V92, P370, DOI 10.1002/bjs.4695; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang LN, 2015, TUMOR BIOL, V36, P8213, DOI 10.1007/s13277-015-3560-6	40	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175074	10.1371/journal.pone.0175074	http://dx.doi.org/10.1371/journal.pone.0175074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384215	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900080
J	Hsu, SY; Ou, CY; Ho, YN; Huang, YH				Hsu, Shih-Yuan; Ou, Chien-Yu; Ho, Yu-Ni; Huang, Yu-Hua			Application of Surgical Apgar Score in intracranial meningioma surgery	PLOS ONE			English	Article							SYSTEM; VALIDATION; CARE	Surgical resection is the main therapeutic option for intracranial meningiomas, but it is not without significant morbidities. The Surgical Apgar Score (SAS), assessed by intraoperative blood pressure, heart rate, and blood loss, was developed for prognostic prediction in general and vascular surgery. We aimed to examine whether the application of SAS in patients undergoing craniotomy for meningioma resection can predict postoperative major complications. We retrospectively enrolled 99 patients that had undergone intracranial meningioma surgery. The patients were subdivided into 2 groups based on whether major complications were present (N = 34) or not (N = 65). We recognized the intergroup differences in SAS and clinical variables. The incidence of 30-day major complications in patients after operation was 34.3%. The lengths of ICU and hospital stay for the morbid cases were prolonged significantly (p = 0.009, p < 0.001, respectively). In the multivariate logistic regression model, SAS was an independent predicting factor of major complications following surgery for intracranial meningiomas (odds ratio, 95% confidence interval = 0.57, 0.38-0.87; p = 0.009), and thus a decrease of one mean SAS increased the rate of major complications by 43%. In conclusions, SAS is an independent predictor of major complications in patients undergoing intracranial meningioma surgery, and provides acceptable risk discrimination. Since this scoring system is relatively simple, objective, and practical, we suggest that SAS be included as an indicator in the guidance for the level of care after craniotomy for meningioma resection.	[Hsu, Shih-Yuan; Ou, Chien-Yu; Huang, Yu-Hua] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Hsu, Shih-Yuan; Ou, Chien-Yu; Ho, Yu-Ni; Huang, Yu-Hua] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ou, Chien-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Ho, Yu-Ni] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	newlupin2001@yahoo.com.tw						Barie PS, 1996, J TRAUMA, V40, P513, DOI 10.1097/00005373-199604000-00002; Bateman BT, 2005, NEUROSURGERY, V57, P866, DOI 10.1227/01.NEU.0000179923.66729.87; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; Caroli M, 2005, J NEUROSURG, V102, P290, DOI 10.3171/jns.2005.102.2.0290; Cohen-Inbar O, 2010, ACTA NEUROCHIR, V152, P87, DOI 10.1007/s00701-009-0552-6; COPELAND GP, 1991, BRIT J SURG, V78, P356; Gawande AA, 2007, J AM COLL SURGEONS, V204, P201, DOI 10.1016/j.jamcollsurg.2006.11.011; Haynes AB, 2011, SURGERY, V149, P519, DOI 10.1016/j.surg.2010.10.019; Lefering R, 2000, INTENS CARE MED, V26, P1794, DOI 10.1007/s001340000723; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Patil CG, 2010, J NEUROL NEUROSUR PS, V81, P502, DOI 10.1136/jnnp.2009.185074; Poon MTC, 2014, BRIT J NEUROSURG, V28, P303, DOI 10.3109/02688697.2013.841857; Regenbogen SE, 2010, SURGERY, V148, P559, DOI 10.1016/j.surg.2010.01.015; Reynolds PQ, 2011, ANESTHESIOLOGY, V114, P1305, DOI 10.1097/ALN.0b013e318219d734; Sacko O, 2007, NEUROSURGERY, V61, P950, DOI 10.1227/01.neu.0000303190.80049.7d; Schul DB, 2012, NEUROSURGERY, V70, P555, DOI 10.1227/NEU.0b013e318233a99a; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Thorn CC, 2012, WORLD J SURG, V36, P1066, DOI 10.1007/s00268-012-1495-2; Urrutia J, 2015, SPINE J, V15, P105, DOI 10.1016/j.spinee.2013.06.042; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Ziewacz JE, 2013, J NEUROSURG, V118, P270, DOI 10.3171/2012.10.JNS12436	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174328	10.1371/journal.pone.0174328	http://dx.doi.org/10.1371/journal.pone.0174328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384177	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900015
J	Juri, H; Tsuboyama, T; Koyama, M; Yamamoto, K; Nakai, G; Nakamoto, A; Yamamoto, K; Azuma, H; Narumi, Y				Juri, Hiroshi; Tsuboyama, Takahiro; Koyama, Mitsuhiro; Yamamoto, Kiyohito; Nakai, Go; Nakamoto, Atsushi; Yamamoto, Kazuhiro; Azuma, Haruhito; Narumi, Yoshifumi			Assessment of the ability of CT urography with low-dose multi-phasic excretory phases for opacification of the urinary system	PLOS ONE			English	Article							STATISTICAL ITERATIVE RECONSTRUCTION; FILTERED BACK-PROJECTION; MDCT UROGRAPHY; TRACT; EXPERIENCE; RADIATION; SALINE; DELAY	Objective To prospectively evaluate the ability of CT urography with a low-dose multi-phasic excretory phase for opacification of the urinary system. Materials and methods Thirty-two patients underwent CT urography with low-dose multi-phasic s using adaptive iterative dose reduction 3D acquired at 5-, 10-, and 15-minute delays. Opacification scores of the upper urinary tracts and the urinary bladder were assigned for each excretory phase by two radiologists, who recorded whether adequate (>75%) or complete (100%) opacification of the upper urinary tract and urinary bladder was achieved in each patient. Adequate and complete opacification rates of the upper urinary tracts and the urinary bladder were compared among three excretory phases and among combined multi-phasic excretory phases using Cochran's Q test. Results There was no significant difference among three excretory phases with 5-, 10-, and 15-minute delays in adequate (56.3, 43.8, and 63.5%, respectively; P = 0.174) and complete opacification rates (9.3, 15.6, and 18.7%, respectively; P = 0.417) of the upper urinary tracts. Combined tri-phasic excretory phases significantly improved adequate and complete opacification rates to 84.4% and 43.8%, respectively (P = 0.002). In contrast, there were significant differences among three excretory phases for the rate of adequate (31.3, 84.4, and 93.8%, respectively; P<0.001) and complete opacification (21.9, 53.1, and 81.3%, respectively; P<0.001) of the urinary bladder. Multi-phasic excretory phases did not improve these rates because opacification was always better with a longer delay. Conclusion Although multi-phasic acquisition of excretory phases is effective at improving opacification of the upper urinary tracts, complete opacification is difficult even with tri-phasic acquisition.	[Juri, Hiroshi; Koyama, Mitsuhiro; Yamamoto, Kiyohito; Nakai, Go; Yamamoto, Kazuhiro; Narumi, Yoshifumi] Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan; [Tsuboyama, Takahiro; Nakamoto, Atsushi] Osaka Univ, Sch Med, Dept Radiol, 2-15 Yamadaoka, Suita, Osaka, Japan; [Azuma, Haruhito] Osaka Med Coll, Dept Urol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka University; Osaka Medical College	Juri, H (corresponding author), Osaka Med Coll, Dept Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka, Japan.	rad103@osaka-med.ac.jp			Toshiba Medical Systems; Daiichi Sankyo	Toshiba Medical Systems; Daiichi Sankyo(Daiichi Sankyo Company Limited)	Both Toshiba Medical Systems and Daiichi Sankyo provided financial support to Yoshifumi Narumi in the form of research materials (Toshiba Medical Systems: adaptive iterative reconstruction algorithm; Daiichi Sankyo: contrast media) rather than research grants. None of the authors are employed by Toshiba Medical Systems or Daiichi Sankyo.These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caloili EM, 2001, ACAD RADIOL, V8, P1100; Caoili EM, 2005, RADIOLOGY, V235, P116, DOI 10.1148/radiol.2351031085; Caoili EM, 2002, RADIOLOGY, V222, P353, DOI 10.1148/radiol.2222010667; Dillman JR, 2007, J COMPUT ASSIST TOMO, V31, P750, DOI 10.1097/RCT.0b013e318033df36; Dillman JR, 2007, ABDOM IMAGING, V32, P519, DOI 10.1007/s00261-007-9185-5; Hack K, 2012, RADIOLOGY, V265, P143, DOI 10.1148/radiol.12110548; Honda O, 2011, BRIT J RADIOL, V84, P335, DOI 10.1259/bjr/57998586; Jinzaki M, 2011, AM J ROENTGENOL, V196, P1102, DOI [10.1590/S1677-55382011000300019, 10.2214/AJR.10.5249]; Juri H, 2013, J COMPUT ASSIST TOMO, V37, P426, DOI 10.1097/RCT.0b013e3182830aa9; Kim S, 2008, RADIOLOGY, V247, P747, DOI 10.1148/radiol.2473070965; Meindl T, 2007, EUR RADIOL, V17, P2512, DOI 10.1007/s00330-007-0600-7; Meindl T, 2006, EUR RADIOL, V16, P1667, DOI 10.1007/s00330-006-0149-x; Metser U, 2012, RADIOLOGY, V264, P110, DOI 10.1148/radiol.12111623; Nawfel RD, 2004, RADIOLOGY, V232, P126, DOI 10.1148/radiol.2321030222; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Silverman SG, 2006, RADIOLOGY, V240, P749, DOI 10.1148/radiol.2403050233; Van der Molen AJ, 2008, EUR RADIOL, V18, P4, DOI 10.1007/s00330-007-0792-x	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174800	10.1371/journal.pone.0174800	http://dx.doi.org/10.1371/journal.pone.0174800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384174	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900037
J	Milonas, PG; Partsinevelos, GK; Andow, DA				Milonas, Panagiotis G.; Partsinevelos, George K.; Andow, David A.			Effect of male mating history and age on remating by female European corn borer	PLOS ONE			English	Article							OSTRINIA-NUBILALIS LEPIDOPTERA; SELFISH GENETIC ELEMENTS; HELICOVERPA-ARMIGERA; SEXUAL SELECTION; APYRENE SPERM; VIRGIN MALE; FECUNDITY; CONFLICT; BENEFITS; MOTH	If mating with an inferior male has high fitness costs, females may try to avoid mating with these males. Alternatively, females may accept an inferior male to ensure they have obtained at least one mate, and/or to avoid the costs of resisting these males. We hypothesized that females compensate for mating with an inferior male by remating. We tested this hypothesis by measuring remating propensity in females that had mated with an old, multiply-mated male, a 9-day-old virgin male, or a young, virgin male. Females were more likely to remate when they had mated with multiply-mated males than when they had mated with a 9-day-old or young virgin male. We discuss the observed mating behavior by females in terms of sexual selection for multiple mating.	[Milonas, Panagiotis G.; Partsinevelos, George K.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece; [Milonas, Panagiotis G.; Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Milonas, PG (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece.; Milonas, PG (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN USA.	p.milonas@bpi.gr	Milonas, Panagiotis/AAV-3805-2020	Milonas, Panagiotis/0000-0001-5391-7750; Partsinevelos, Georgios/0000-0002-2515-0158	Fulbright research fellowship	Fulbright research fellowship	The present study was partially funded by a Fulbright research fellowship awarded to Panagiotis Milonas.	Andersson J, 2000, P ROY SOC B-BIOL SCI, V267, P1271, DOI 10.1098/rspb.2000.1138; Andersson Malte, 1994; Andow DA, EUROPEAN CORN BORER; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; COOK PA, 1995, BEHAV ECOL SOCIOBIOL, V36, P261; Cook PA, 1999, NATURE, V397, P486, DOI 10.1038/17257; Cox D. R., 1984, ANAL SURVIVAL DATA; Eliyahu D, 2003, J INSECT PHYSIOL, V49, P569, DOI 10.1016/S0022-1910(03)00028-3; Fadamiro HY, 1999, J INSECT PHYSIOL, V45, P385, DOI 10.1016/S0022-1910(98)00137-1; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; Friedlander M, 2005, ADV INSECT PHYSIOL, V32, P206, DOI 10.1016/S0065-2806(05)32003-0; GELMAN DB, 1982, ANN ENTOMOL SOC AM, V75, P485, DOI 10.1093/aesa/75.5.485; HAMILTON WD, 1990, AM ZOOL, V30, P341; Hinton JL, 2003, GREAT LAKES ENTOMOL, V36, P156; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2009, BIOL LETTERS, V5, P697, DOI 10.1098/rsbl.2009.0066; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; KARLSSON B, 1994, OIKOS, V69, P224, DOI 10.2307/3546142; Kokko H, 2013, ENTOMOL EXP APPL, V146, P26, DOI 10.1111/j.1570-7458.2012.01296.x; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; Milonas PG, 2011, BEHAV ECOL SOCIOBIOL, V65, P1249, DOI 10.1007/s00265-011-1138-x; Milonas PG, 2010, ANIM BEHAV, V79, P509, DOI 10.1016/j.anbehav.2009.12.005; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Muller K, 2016, ANIM BEHAV, V114, P165, DOI 10.1016/j.anbehav.2016.02.005; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; Price TAR, 2008, GENETICA, V134, P99, DOI 10.1007/s10709-008-9253-y; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; ROYER L, 1993, FUNCT ECOL, V7, P209, DOI 10.2307/2389889; Schlaepfer MA, 2000, CAN J ZOOL, V78, P2045, DOI 10.1139/cjz-78-11-2045; SUGAWARA T, 1979, J COMP PHYSIOL, V130, P191, DOI 10.1007/BF00614605; Teng ZQ, 2009, PHYSIOL ENTOMOL, V34, P338, DOI 10.1111/j.1365-3032.2009.00696.x; Thornhill R., 1983, pi; Torres-Vila LM, 2005, BEHAV ECOL SOCIOBIOL, V57, P318, DOI 10.1007/s00265-004-0857-7; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Valimaki P, 2010, ANIM BEHAV, V79, P1173, DOI 10.1016/j.anbehav.2010.02.030; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	43	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175512	10.1371/journal.pone.0175512	http://dx.doi.org/10.1371/journal.pone.0175512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384242	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900173
J	Patin, EC; Geffken, AC; Willcocks, S; Leschczyk, C; Haas, A; Nimmerjahn, F; Lang, R; Ward, TH; Schaible, UE				Patin, Emmanuel C.; Geffken, Anna C.; Willcocks, Sam; Leschczyk, Christoph; Haas, Albert; Nimmerjahn, Falk; Lang, Roland; Ward, Theresa H.; Schaible, Ulrich E.			Trehalose dimycolate interferes with FcyR-mediated phagosome maturation through Mincle, SHP-1 and FcyRIIB signalling	PLOS ONE			English	Article							C-TYPE LECTIN; GAMMA RECEPTORS; ACTIVATING RECEPTOR; CORD FACTOR; PHAGOCYTOSIS; INFECTION; RIIB; PHOSPHATASES; TRAFFICKING; MACROPHAGES	The causative agent of tuberculosis, Mycobacterium tuberculosis (M. tuberculosis), contains an abundant cell wall glycolipid and a crucial virulence factor, trehalose-6,6'-dimycolate (TDM). TDM causes delay of phagosome maturation and thus promotes survival of mycobacteria inside host macrophages by a not fully understood mechanism. TDM signals through the Monocyte-INducible C-type LEctin (Mincle), a recently identified pattern recognition receptor. Here we show that recruitment of Mincle by TDM coupled to immunoglobulin (Ig) G-opsonised beads during Fcy receptor (FcyR)-mediated phagocytosis interferes with phagosome maturation. In addition, modulation of phagosome maturation by TDM requires SH2-domain-containing inositol polyphosphate 5' phosphatase (SHP-1) and the FcyRIIB, which strongly suggests inhibitory downstream signalling of Mincle during phagosome formation. Overall, our study reveals important mechanisms contributing to the virulence of TDM.	[Patin, Emmanuel C.; Willcocks, Sam; Ward, Theresa H.; Schaible, Ulrich E.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England; [Patin, Emmanuel C.; Geffken, Anna C.; Leschczyk, Christoph; Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany; [Leschczyk, Christoph; Schaible, Ulrich E.] German Ctr Infect Res, Borstel, Germany; [Haas, Albert] Univ Bonn, Inst Cell Biol, Bonn, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Div Genet, Dept Biol, Erwin, Germany; [Lang, Roland] Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, Univ Hosp Erlangen, Erlangen, Germany; [Patin, Emmanuel C.] INSERM U1019, Ctr Infect & Immunite Lille, Inst Pasteur Lille, Lille, France	University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel; German Center for Infection Research; University of Bonn; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Schaible, UE (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England.; Schaible, UE (corresponding author), Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany.; Schaible, UE (corresponding author), German Ctr Infect Res, Borstel, Germany.	uschaible@fz-borstel.de	Ward, Theresa H./E-9650-2013	Ward, Theresa H./0000-0002-9881-8649; Lang, Roland/0000-0003-0502-3677	Wellcome Trust UK [WT082825]; German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' [0315834C-D]; DFG [SFB 796, TB B6]	Wellcome Trust UK(Wellcome Trust); German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics'(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was funded by the Wellcome Trust UK (WT082825), to US, https://wellcome.ac.uk; German 'Bundesministerium for Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' (0315834C-D), to US, https://www.bmbf.de/en/index.html; DFG SFB 796, TB B6, to RL. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We thank Otto Holst, Research Center Borstel, Germany, for kindly providing TDM from M. tuberculosis. This work was supported by grants to U. S. from the Wellcome Trust UK (WT082825) and the German 'Bundesministerium fur Bildung und Forschung' (BMBF) program 'Medical Infection Genomics' (0315834C-D), and to R.L. DFG SFB 796, TB B6.	Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Gomez CP, 2012, J IMMUNOL, V189, P2203, DOI 10.4049/jimmunol.1103021; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Iborra S, 2016, IMMUNITY, V45, P788, DOI 10.1016/j.immuni.2016.09.012; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kant AM, 2002, BLOOD, V100, P1852; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Masumoto M, 1999, J IMMUNOL, V163, P5039; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Patin EC, 2016, INNATE IMMUN; Perley CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098938; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Sydor T, 2013, CELL MICROBIOL, V15, P458, DOI 10.1111/cmi.12050; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhou DL, 2010, J LEUKOCYTE BIOL, V87, P845, DOI 10.1189/jlb.0409289	33	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174973	10.1371/journal.pone.0174973	http://dx.doi.org/10.1371/journal.pone.0174973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384255	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000399371900066
J	Paul, CPL; de Graaf, M; Bisschop, A; Holewijn, RM; de Ven, PMV; van Royer, BJ; Mullender, MG; Smit, TH; Helder, MN				Paul, Cornelis P. L.; de Graaf, Magda; Bisschop, Arno; Holewijn, Roderick M.; de Ven, Peter M. van; van Royer, Barend J.; Mullender, Margriet G.; Smit, Theodoor H.; Helder, Marco N.			Static axial overloading primes lumbar caprine intervertebral discs for posterior herniation	PLOS ONE			English	Article							ANNULUS FIBROSUS; CELL-DEATH; BACK-PAIN; IN-VITRO; DEGENERATION; MECHANICS; DISTRIBUTIONS; MORPHOLOGY; THERAPIES; COLLAGEN	Introduction Lumbar hernias occur mostly in the posterolateral region of IVDs and mechanical loading is an important risk factor. Studies show that dynamic and static overloading affect the nucleus and annulus of the IVD differently. We hypothesize there is also variance in the effect of overloading on the IVD's anterior, lateral and posterior annulus, which could explain the predilection of herniations in the posterolateral region. We assessed the regional mechanical and cellular responses of lumbar caprine discs to dynamic and static overloading. Material and methods IVDs (n = 125) were cultured in a bioreactor and subjected to simulated-physiological loading (SPL), high dynamic (HD), or high static (HS) overloading. The effect of loading was determined in five disc regions: nucleus, inner-annulus and anterior, lateral and posterior outer-annulus. IVD height loss and external pressure transfer during loading were measured, cell viability was mapped and quantified, and matrix integrity was assessed. Results During culture, overloaded IVDs lost a significant amount of height, yet the distribution of axial pressure remained unchanged. HD loading caused cell death and disruption of matrix in all IVD regions, whereas HS loading particularly affected cell viability and matrix integrity in the posterior region of the outer annulus. Conclusion Axial overloading is detrimental to the lumbar IVD. Static overloading affects the posterior annulus more strongly, while the nucleus is relatively spared. Hence, static overloading predisposes the disc for posterior herniation. These findings could have implications for working conditions, in particular of sedentary occupations, and the design of interventions aimed at prevention and treatment of early intervertebral disc degeneration.	[Paul, Cornelis P. L.; de Graaf, Magda; Bisschop, Arno; Holewijn, Roderick M.; van Royer, Barend J.; Mullender, Margriet G.; Smit, Theodoor H.; Helder, Marco N.] Vrije Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands; [de Ven, Peter M. van] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Mullender, Margriet G.] Vrije Univ Amsterdam, Dept Plast Reconstruct & Hand Surg, Med Ctr, Amsterdam, Netherlands; [Smit, Theodoor H.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Amsterdam, Netherlands; [Helder, Marco N.] Vrije Univ Amsterdam, Dept Oral & Maxillofacial Surg, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Paul, CPL (corresponding author), Vrije Univ Amsterdam, Dept Orthopaed Surg, Med Ctr, Amsterdam Movement Sci, Amsterdam, Netherlands.	cpl.paul@gmail.com	Paul/O-8870-2017; Smit, Theo/N-7534-2019; Smit, Theodoor/AAX-6657-2020	Smit, Theo/0000-0002-8906-7433; 	Dutch Government ZonMw Program "Alternatives for life animal testing" [11400090]; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials	Dutch Government ZonMw Program "Alternatives for life animal testing"; Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials	This work is supported by the Dutch Government ZonMw Program "Alternatives for life animal testing" (grant number 11400090). The development of the LDCS is co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation led Government research program IDiDAS for the development of BioMedical Materials (BMM project P2.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287; ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; ADAMS MA, 1985, SPINE, V10, P524, DOI 10.1097/00007632-198507000-00006; ADAMS MA, 1982, INT ORTHOP, V6, P249; Alkhatib B, 2014, EUR CELLS MATER, V28, P98, DOI 10.22203/eCM.v028a08; Belavy DL, 2015, EUR SPINE J; Benoist M, 2002, JOINT BONE SPINE, V69, P155, DOI 10.1016/S1297-319X(02)00385-8; Brimacombe JM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005165; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Ding F, 2013, APOPTOSIS, V18, P777, DOI 10.1007/s10495-013-0839-1; Dormans K. W., 2004, P 14 EUR SOC BIOM ES, P224; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Gawri R, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4449; Gregory DE, 2014, SPINE J, V14, P1265, DOI 10.1016/j.spinee.2013.07.489; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Holzapfel GA, 2005, BIOMECH MODEL MECHAN, V3, P125, DOI 10.1007/s10237-004-0053-8; Hoogendoorn R, 2008, SPINE, V33, P1714, DOI 10.1097/BRS.0b013e31817d2468; Hoogendoorn RJ, 2007, SPINE, V32, P1816, DOI 10.1097/BRS.0b013e31811ebac5; Hutton W C, 1987, Acta Orthop Belg, V53, P143; Iatridis JC, 2007, SPINE, V32, P1493, DOI 10.1097/BRS.0b013e318067dd3f; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; INOUE H, 1981, SPINE, V6, P139, DOI 10.1097/00007632-198103000-00006; INOUE H, 1975, ACTA ORTHOP SCAND, V46, P949, DOI 10.3109/17453677508989283; Kanayama M, 2009, J NEUROSURG-SPINE, V11, P501, DOI 10.3171/2009.5.SPINE08675; Kerr D, 2015, CLIN ORTHOP RELAT R, V473, P1920, DOI 10.1007/s11999-014-3803-7; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Lama P, 2013, BONE JOINT J, V95B, P1127, DOI [10.1302/0301-620X.95B8.31660, 10.1302/0301-620X.95138.31660]; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Masuoka K, 2007, SPINE, V32, P1974, DOI 10.1097/BRS.0b013e318133d591; MCNALLY DS, 1993, SPINE, V18, P1525; MCNALLY DS, 1992, SPINE, V17, P66, DOI 10.1097/00007632-199201000-00011; Moore K. L., 2011, ESSENTIAL CLIN ANATO, P293; Mroz T, 2009, AAOS COMPREHENSIVE O, P761; Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Rannou F, 2001, JOINT BONE SPINE, V68, P543, DOI 10.1016/S1297-319X(01)00325-6; Riches PE, 2002, J BIOMECH, V35, P1263, DOI 10.1016/S0021-9290(02)00070-2; Roberts S, 2002, BIOCHEM SOC T, V30, P864, DOI 10.1042/BST0300864; Rutges JPHJ, 2013, OSTEOARTHR CARTILAGE, V21, P2039, DOI 10.1016/j.joca.2013.10.001; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; van der Veen AJ, 2005, SPINE, V30, pE534, DOI 10.1097/01.brs.0000179306.40309.3a; van der Veen AJ, 2013, J BIOMECH, V46, P2101, DOI 10.1016/j.jbiomech.2013.05.026; Vergroesen PPA, 2014, EUR SPINE J, V23, P2359, DOI 10.1007/s00586-014-3450-4; Vergroesen PP, 2015, OSTEOARTHR CARTILAGE, pS1063; Videman T, 2003, SPINE, V28, P582, DOI 10.1097/00007632-200303150-00013; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Wade KR, 2014, SPINE, V39, P1018, DOI 10.1097/BRS.0000000000000262; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Wilder D G, 1988, J Spinal Disord, V1, P16; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Yates JP, 2010, SPINE, V35, P734, DOI 10.1097/BRS.0b013e3181ba3a60	58	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174278	10.1371/journal.pone.0174278	http://dx.doi.org/10.1371/journal.pone.0174278			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384266	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900013
J	Adams, AM; Ahmed, R; Latif, AHMM; Rasheed, S; Das, SK; Hasib, E; Farzana, FD; Ferdous, F; Ahmed, S; Faruque, ASG				Adams, Alayne M.; Ahmed, Rushdia; Latif, A. H. M. Mahbub; Rasheed, Sabrina; Das, Sumon K.; Hasib, Enamul; Farzana, Fahmida Dil; Ferdous, Farzana; Ahmed, Shahnawaz; Faruque, A. S. G.			Impact of fortified biscuits on micronutrient deficiencies among primary school children in Bangladesh	PLOS ONE			English	Article							IRON SUPPLEMENTATION; AGED CHILDREN	Background Micronutrient deficiencies can compromise the development potential of school-aged children, and their later health and productivity as adults. School feeding and school-based fortification approaches have been utilized globally to redress nutritional deficiencies in this age group. Objective We explored the acceptability and micronutrient impact of a Bangladesh Government supported school-based micronutrient fortification program for children attending rural primary schools in 10 disadvantaged sub-districts. Methods We applied a mixed methods approach. The quantitative component assessed the impact of micronutrient fortification on 351 children aged 6-11 years using a cohort pre-post research design with a control group. The qualitative component explored the acceptability of the intervention using focus group discussions, body mapping and semi-structured interviews with teachers, school-going children and school authorities. Results Daily consumption of fortified biscuits by primary school children had a significant positive impact on mean levels of iron, folic acid, vitamin B12, retinol and vitamin D controlling for sex, baseline deficiency status, CRP, and H. pylori. Levels of anemia and vitamin D deficiency were also significantly reduced. Qualitative findings indicated the widespread acceptability of the daily biscuit. Teachers perceived students to be more attentive in class, less tired, and some attributed better school performance to biscuit consumption. Children reported similar improvements in concentration and energy levels. Conclusions This study is among the first in Bangladesh to comprehensively assess a school-based fortification program in terms of its acceptability and impact on micronutrient status of children aged 6-11 years of age. While results strongly support this modality of school feeding, research on the cognitive impacts of micronutrient fortified biscuits will help clarify the case for scaled-up investments in school-based feeding program in Bangladesh and other low and middle income countries.	[Adams, Alayne M.; Ahmed, Rushdia; Rasheed, Sabrina] Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Adams, Alayne M.; Hasib, Enamul] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Adams, Alayne M.] Georgetown Univ, Dept Int Hlth, Washington, DC USA; [Latif, A. H. M. Mahbub] Univ Dhaka, Inst Stat Res & Training, Dhaka, Bangladesh; [Latif, A. H. M. Mahbub] St Lukes Int Univ, Ctr Clin Epidemiol, Tokyo, Japan; [Das, Sumon K.; Farzana, Fahmida Dil; Ahmed, Shahnawaz; Faruque, A. S. G.] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Das, Sumon K.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Ferdous, Farzana] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; Georgetown University; University of Dhaka; St. Luke's International Hospital; International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; University of Tsukuba	Ahmed, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.	rushdia@icddrb.org	Das, Sumon Kumar/T-6384-2019; Latif, Mahbub AHM/ABD-1002-2021; Das, Sumon Kumar/AAD-1551-2019; rasheed, sabrina/A-4145-2010	Latif, Mahbub AHM/0000-0001-7838-2158; Adams, Alayne/0000-0002-0961-9825; rasheed, sabrina/0000-0002-7444-200X; AHMED, RUSHDIA/0000-0001-6917-3266; FERDOUS, FARZANA/0000-0002-6373-3581; Ahmed, Shahnawaz/0000-0001-8339-4137	European Union (EU), through a sub-contract from the James P. Grant School of Public Health; BRAG University, Dhaka Bangladesh [EU/GR-00909]; Department for International Development (DFID) [201888] Funding Source: researchfish	European Union (EU), through a sub-contract from the James P. Grant School of Public Health; BRAG University, Dhaka Bangladesh; Department for International Development (DFID)	This study was supported by the European Union (EU), through a sub-contract from the James P. Grant School of Public Health, BRAG University, Dhaka Bangladesh. Grant number/information: EU/GR-00909. icddr,b acknowledges with gratitude the commitment of EU to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.	Ahmed A., 2004, IMPACT FEEDING CHILD; Al-Saleh Y, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0369-9; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; [Anonymous], 2002, HEL H PYL COMM BACT, p[1, 4]; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2007, ASS IOD DEF DIS MON; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bundy D, RETHINKING SCH FEEDI; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; Franceschi F, 2014, WORLD J GASTROENTERO, V20, P12809, DOI 10.3748/wjg.v20.i36.12809; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Helen Keller International & James P. Grant School of Public Health, 2014, STAT FOOD SEC NUTR B; Hotz C, FOOD NUTR B, V25, pS91; icddrb UNICEF Bangladesh GAIN Institute of Public Health and Nutrition, 2013, NAT MICR STAT SURV 2; Iron deficiency anaemia. Assessment prevention and control, 2001, WHONHD013; Irwin L.G., 2007, EARLY CHILDHOOD DEV; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Lawson TM, 2012, THESIS; Marschner IC, 2012, BIOSTATISTICS, V13, P179, DOI 10.1093/biostatistics/kxr030; Masalha R, 2008, J PEDIAT NEUROL, V6, P6; Murray-Kolb LE, 2013, CURR OPIN CLIN NUTR, V16, P703, DOI 10.1097/MCO.0b013e3283653ef8; Neyestani TR, 2012, PUBLIC HEALTH NUTR, V15, P324, DOI 10.1017/S1368980011000188; Hieu NT, 2012, BRIT J NUTR, V108, P1419, DOI 10.1017/S0007114511006945; SCRIMSHAW N S, 1992, Proceedings of the National Science Council Republic of China Part B Life Sciences, V16, P46; SESHADRI S, 1989, AM J CLIN NUTR, V50, P675, DOI 10.1093/ajcn/50.3.675; Social protection for food security, 2012, 4 HLPE COMM WORLD FO; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; van Stuijvenberg ME, 1999, AM J CLIN NUTR, V69, P497; Vitale G, 2011, Minerva Gastroenterol Dietol, V57, P369; Walter Tomas, 2003, Food and Nutrition Bulletin, V24, pS104; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 2015, GUID SUG INT AD CHIL; Yoko D., 2010, FINANCIAL INCLUSION	35	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174673	10.1371/Journal.pone.0174673	http://dx.doi.org/10.1371/Journal.pone.0174673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380009	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500057
J	Gates, KC; Goetzmann, LN; Cantlon, JD; Jeckel, KM; Anthony, RV				Gates, Katherine C.; Goetzmann, Lindsey N.; Cantlon, Jeremy D.; Jeckel, Kimberly M.; Anthony, Russell V.			Effect of proline rich 15-deficiency on trophoblast viability and survival	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; INTRAUTERINE GROWTH RESTRICTION; ALPHA-B-CRYSTALLIN; GENE-EXPRESSION; INCREASED APOPTOSIS; BETA SUPERFAMILY; EPITHELIAL-CELLS; MATERNAL SERUM; IN-VITRO; PREGNANCY	Deviations from the normal program of gene expression during early pregnancy can lead to early embryonic loss as well as dysfunctional placentation, which can cause significant morbidity and mortality. Proline rich 15 (PRR15) is a low molecular weight nuclear protein expressed by the trophoblast during early gestation. Lentivirus-mediated knockdown of PRR15 mRNA in ovine trophectoderm led to demise of the embryo by gestational day 15, providing compelling evidence that PRR15 expression is critical during this precarious window of development. Our objective was to determine the effect of PRR15 knockdown on trophoblast gene expression, proliferation, and survival. The first-trimester human trophoblast cell line, ACH-3P, was infected with control lentivirus or a lentivirus expressing a short hairpin (sh) RNA to target PRR15 mRNA for degradation, resulting in a 68% reduction in PRR15 mRNA. Microarray analysis of these cell lines revealed differential expression of genes related to cancer, focal adhesion, and p53 signaling. These changes included significant up-regulation of GDF15, a cytokine increased in pregnancies with preeclampsia. Viability and proliferation decreased in PRR15-deficient cells, which was consistent with down-regulation of cell cycle-related genes CCND1 and CDK6 and an up-regulation of CCNG2 and CDKN1A in the PRR15-deficient cells. TNFSF10, a tumor necrosis factor superfamily member known to induce apoptosis increased significantly in the PRR15-deficient cells. Migration through a basement membrane matrix decreased and an increased population of apoptotic cells was present when treated with shRNA to target PRR15. These results suggest that PRR15 enhances trophoblast viability and survival during early implantation and placentation.	[Gates, Katherine C.; Goetzmann, Lindsey N.; Cantlon, Jeremy D.; Jeckel, Kimberly M.; Anthony, Russell V.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Anthony, RV (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA.	russ.anthany@colostate.edu		Anthony, Russell/0000-0003-3929-626X	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture [2009-65203-05670]	Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture National Institute of Food and Agriculture	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-65203-05670 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RV, 2010, SOC REPROD FERTIL, V67, P119; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bousette N, 2010, P NATL ACAD SCI USA, V107, P18478; Bruchim I, 2009, EXPERT OPIN THER TAR, V13, P1179, DOI 10.1517/14728220903201702; Chaouat G, 1995, HUM REPROD, V10, P55, DOI 10.1093/humrep/10.suppl_2.55; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Glover MD, 2003, BIOL REPROD, V69, P1002, DOI 10.1095/biolreprod.102.015065; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GUILLOMOT M, 1995, J REPROD FERTIL, P39; HAMILTON WJ, 1960, J ANAT, V94, P297; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Hiden U, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-137; Hopfer U, 1996, AM J PHYSIOL-CELL PH, V270, pC1, DOI 10.1152/ajpcell.1996.270.1.C1; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kiba T, 2010, PANCREAS, V39, P627, DOI 10.1097/MPA.0b013e3181c52bc5; Krause R, 1999, GENE, V232, P35, DOI 10.1016/S0378-1119(99)00120-1; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; Li HS, 2005, J CLIN ENDOCR METAB, V90, P3045, DOI 10.1210/jc.2004-0808; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Marjono AB, 2003, PLACENTA, V24, P100, DOI 10.1053/plac.2002.0881; Meunier D, 2003, ANAT EMBRYOL, V207, P109, DOI 10.1007/s00429-003-0330-9; Meunier D, 2011, MOL CARCINOGEN, V50, P8, DOI 10.1002/mc.20692; Michaylira CZ, 2006, AM J PHYSIOL-GASTR L, V291, pG472, DOI 10.1152/ajpgi.00218.2005; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Morrish DW, 2001, CURR PROTEIN PEPT SC, V2, P245, DOI 10.2174/1389203013381116; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Prakash GJ, 2011, REPROD FERT DEVELOP, V23, P714, DOI 10.1071/RD10315; Purcell SH, 2009, BIOL REPROD, V81, P1112, DOI 10.1095/biolreprod.109.076190; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Sugulle M, 2009, HYPERTENSION, V54, P106, DOI 10.1161/HYPERTENSIONAHA.109.130583; Tarrade A, 2002, BIOL REPROD, V67, P1628, DOI 10.1095/biolreprod.101.001925; Tawfeek MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-10; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Tong S, 2012, OBSTET GYNECOL, V119, P1000, DOI 10.1097/AOG.0b013e3182518fd3; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Voelkel-Johnson C, 2011, NAT REV UROL, V8, P417, DOI 10.1038/nrurol.2011.81; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Yelich JV, 1997, BIOL REPROD, V57, P1256, DOI 10.1095/biolreprod57.5.1256; Yu DH, 2013, MOL CELL BIOL, V33, P1845, DOI 10.1128/MCB.01124-12; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	57	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174976	10.1371/journal.pone.0174976	http://dx.doi.org/10.1371/journal.pone.0174976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380025	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500083
J	Taylorl, LA; Powell, EC; McGraw, KJ				Taylorl, Lisa A.; Powell, Erin C.; McGraw, Kevin J.			Frequent misdirected courtship in a natural community of colorful Habronattus jumping spidersle	PLOS ONE			English	Article							MATE-CHOICE DECISIONS; REPRODUCTIVE INTERFERENCE; COSMOPHASIS-UMBRATICA; ENERGETIC COSTS; ARANEAE; SIGNALS; BEHAVIOR; SUCCESS; DISPLAY; UV	Male courtship display is common in many animals; in some cases, males engage in courtship indiscriminately, spending significant time and energy courting heterospecifics with whom they have no chance of mating or producing viable offspring. Due to high costs and few if any benefits, we might expect mechanisms to evolve to reduce such misdirected courtship (or 'reproductive interference'). In Habronattus jumping spiders, males frequently court heterospecifics with whom they do not mate or hybridize; females are larger and are voracious predators, posing a severe risk to males who court indiscriminately. In this study, we examined patterns of misdirected courtship in a natural community of four sympatric Habronattus species (H. clypeatus, H. hallani, H. hirsutus, and H. pyrrithrix). We used direct field observations to weigh support for two hypotheses (differential microhabitat use and species recognition signaling) to explain how these species reduce the costs associated with misdirected courtship. We show that, while the four species of Habronattus do show some differences in microhabitat use, all four species still overlap substantially, and in three of the four species individuals equally encountered heterospecifics and conspecifics. Males courted females at every opportunity, regardless of species, and in some cases, this led to aggression and predation by the female. These results suggest that, while differences in microhabitat use might reduce misdirected courtship to some extent, co-existence of these four species may be possible due to complex communication (i.e. species-specific elements of a male's courtship display). This study is the first to examine misdirected courtship in jumping spiders. Studies of misdirected courtship and its consequences in the field are limited and may broaden our understanding of how biodiversity is maintained within a community.	[Taylorl, Lisa A.; Powell, Erin C.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Taylorl, Lisa A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Taylorl, Lisa A.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Powell, Erin C.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; University of Auckland	Taylorl, LA (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.; Taylorl, LA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Taylorl, LA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	lisa.taylor@ufl.edu			Animal Behavior Society; Sigma Xi; Arizona State University Graduate and Professional Students' Association; National Science Foundation Graduate Research Fellowship; National Science Foundation [IOS-1557867]; University of Florida Open Access Publishing Fund; Direct For Biological Sciences [1557867] Funding Source: National Science Foundation	Animal Behavior Society; Sigma Xi; Arizona State University Graduate and Professional Students' Association; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); University of Florida Open Access Publishing Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by research grants from the Animal Behavior Society, Sigma Xi, and the Arizona State University Graduate and Professional Students' Association, as well as a National Science Foundation Graduate Research Fellowship to LAT. ECP was supported by a National Science Foundation grant (IOS-1557867 to LAT) during writing and publication. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ANDREWS RH, 1982, OECOLOGIA, V52, P281, DOI 10.1007/BF00363851; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Arnqvist Goran, 2005, pUnpaginated; Blackburn GS, 2015, BEHAVIOUR, V152, P1168, DOI 10.1163/1568539X-00003273; Bulbert MW, 2015, ECOL EVOL, V5, P914, DOI 10.1002/ece3.1419; Cady AB, 2011, J ARACHNOL, V39, P161, DOI 10.1636/Hi09-70.1; Clark DL, 2016, ETHOLOGY, V122, P364, DOI 10.1111/eth.12476; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Costa-Schmidt LE, 2012, ANIM BEHAV, V84, P1201, DOI 10.1016/j.anbehav.2012.08.026; Cross FR, 2009, P NATL ACAD SCI USA, V106, P19416, DOI 10.1073/pnas.0904125106; CUTLER B, 1988, GREAT LAKES ENTOMOL, V21, P129; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Elias DO, 2012, BIOL J LINN SOC, V105, P522, DOI 10.1111/j.1095-8312.2011.01817.x; Elias DO, 2005, ANIM BEHAV, V69, P931, DOI 10.1016/j.anbehav.2004.06.024; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Fea MP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0746; Foelix R., 2011, BIOL SPIDERS, V3; Griswald C.E., 1987, University of California Publications in Entomology, V107, P1; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Groning J, 2007, OIKOS, V116, P1449, DOI 10.1111/j.2007.0030-1299.15850.x; GWYNNE DT, 1983, J AUST ENTOMOL SOC, V22, P79; Hettyey A, 2014, OECOLOGIA, V176, P457, DOI 10.1007/s00442-014-3046-z; Hoback WW, 1997, PHYSIOL ENTOMOL, V22, P286, DOI 10.1111/j.1365-3032.1997.tb01170.x; Hochkirch A, 2007, J ANIM ECOL, V76, P633, DOI 10.1111/j.1365-2656.2007.01241.x; Hoefler CD, 2008, BEHAV ECOL, V19, P974, DOI 10.1093/beheco/arn055; Hoefler CD, 2008, J ARACHNOL, V36, P210, DOI 10.1636/St07-08SC.1; Jackson Robert R., 1997, P340, DOI 10.1017/CBO9780511721946.021; Jackson RR, 1982, SPIDER COMMUNICATION; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kyogoku D, 2015, J EVOLUTION BIOL, V28, P1283, DOI 10.1111/jeb.12646; Li JJ, 2008, CURR BIOL, V18, P699, DOI 10.1016/j.cub.2008.04.020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Lim MLM, 2007, SCIENCE, V315, P481, DOI 10.1126/science.1134254; LOSOS JB, 1985, COPEIA, P905, DOI 10.2307/1445240; Maddison W, 2003, SYST ENTOMOL, V28, P1, DOI 10.1046/j.1365-3113.2003.00195.x; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; MADDISON WP, 1988, J ARACHNOL, V16, P199; Mappes J, 1996, P ROY SOC B-BIOL SCI, V263, P785, DOI 10.1098/rspb.1996.0117; Masta SE, 2002, P NATL ACAD SCI USA, V99, P4442, DOI 10.1073/pnas.072493099; Nelson XJ, 2012, BIOL J LINN SOC, V107, P664, DOI 10.1111/j.1095-8312.2012.01965.x; Ptacek MB, 2000, BEHAV PROCESS, V51, P111, DOI 10.1016/S0376-6357(00)00123-6; Quinones- Lebron SG, 2016, SCI REPORTS, P6; RICHMAN DB, 1982, J ARACHNOL, V10, P47; Richman DB, 1973, THESIS; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; Su KFY, 2006, ANIM BEHAV, V71, P531, DOI 10.1016/j.anbehav.2005.04.024; Taylor LA, 2012, COLOR COMMUNICATION; Taylor LA, 2014, J ARACHNOL, V42, P268, DOI 10.1636/0161-8202-42.3.268; Taylor LA, 2013, BEHAV ECOL, V24, P955, DOI 10.1093/beheco/art011; Taylor LA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1133, DOI 10.1007/s00265-010-1127-5; Warburton K, 1996, ANIM BEHAV, V52, P371, DOI 10.1006/anbe.1996.0181; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101; WELLS KD, 1989, BEHAV ECOL SOCIOBIOL, V25, P13, DOI 10.1007/BF00299706; Woods WA, 2007, AM NAT, V170, P702, DOI 10.1086/521964; World Spider Catalog, 2016, WORLD SPIDER CATALOG; Zurek DB, 2015, CURR BIOL, V25, pR403, DOI 10.1016/j.cub.2015.03.033	61	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173156	10.1371/journal.pone.0173156	http://dx.doi.org/10.1371/journal.pone.0173156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379968	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500013
J	Ssempiira, J; Nambuusi, B; Kissa, J; Agaba, B; Makumbi, F; Kasasa, S; Vounatsou, P				Ssempiira, Julius; Nambuusi, Betty; Kissa, John; Agaba, Bosco; Makumbi, Fredrick; Kasasa, Simon; Vounatsou, Penelope			Geostatistical modelling of malaria indicator survey data to assess the effects of interventions on the geographical distribution of malaria prevalence in children less than 5 years in Uganda	PLOS ONE			English	Article							VECTOR-CONTROL INTERVENTIONS; RISK-FACTORS; BED NETS; TRANSMISSION; INFECTION; HIGHLANDS; ASSOCIATION; PARASITEMIA; PERMETHRIN; ANTIBODIES	Background Malaria burden in Uganda has declined disproportionately among regions despite overall high intervention coverage across all regions. The Uganda Malaria Indicator Survey (MIS) 2014-15 was the second nationally representative survey conducted to provide estimates of malaria prevalence among children less than 5 years, and to track the progress of control interventions in the country. In this present study, 2014-15 MIS data were analysed to assess intervention effects on malaria prevalence in Uganda among children less than 5 years, assess intervention effects at regional level, and estimate geographical distribution of malaria prevalence in the country. Methods Bayesian geostatistical models with spatially varying coefficients were used to determine the effect of interventions on malaria prevalence at national and regional levels. Spike-and-slab variable selection was used to identify the most important predictors and forms. Bayesian kriging was used to predict malaria prevalence at unsampled locations. Results Indoor Residual Spraying (IRS) and Insecticide Treated Nets (ITN) ownership had a significant but varying protective effect on malaria prevalence. However, no effect was observed for Artemisinin Combination-based Therapies (ACTs). Environmental factors, namely, land cover, rainfall, day and night land surface temperature, and area type were significantly associated with malaria prevalence. Malaria prevalence was higher in rural areas, increased with the child's age, and decreased with higher household socioeconomic status and higher level of mother's education. The highest prevalence of malaria in children less than 5 years was predicted for regions of East Central, North East and West Nile, whereas the lowest was predicted in Kampala and South Western regions, and in the mountainous areas in Mid-Western and Mid-Eastern regions. Conclusions IRS and ITN ownership are important interventions against malaria prevalence in children less than 5 years in Uganda. The varying effects of the interventions calls for selective implementation of control tools suitable to regional ecological settings. To further reduce malaria burden and sustain malaria control in Uganda, current tools should be supplemented by health system strengthening, and socio-economic development.	[Ssempiira, Julius; Nambuusi, Betty; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ssempiira, Julius; Nambuusi, Betty; Vounatsou, Penelope] Univ Basel, Basel, Switzerland; [Ssempiira, Julius; Nambuusi, Betty; Makumbi, Fredrick; Kasasa, Simon] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kissa, John; Agaba, Bosco] Minist Hlth, Kampala, Uganda	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Makerere University	Vounatsou, P (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Vounatsou, P (corresponding author), Univ Basel, Basel, Switzerland.	penelope.vounalsou@unibas.ch		Vounatsou, Penelope/0000-0002-4904-5352				Adigun AB, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0683-6; [Anonymous], 2016, NAT POP HOUS CENS 20; [Anonymous], 2010, UG MAL IND SURV 2009; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2013, HOUS SURV IND MAL CO; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2006, IND RES SPRAYING US; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bivand RS, 2013, HELLO WORLD INTRO SP, P1; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; Cressie, 2015, STAT SPATIAL DATA; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Dhimal M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-457; Diboulo E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1282-x; Diggle PJ, 2016, J AM STAT ASSOC, V111, P1096, DOI 10.1080/01621459.2015.1123158; Dobbs KR, 2016, PARASITOLOGY, V143, P129, DOI 10.1017/S0031182015001626; Fana SA, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0054-0; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Giardina F, 2014, LANCET GLOB HEALTH, V2, pE601, DOI 10.1016/S2214-109X(14)70300-6; Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Gullan Cranston, 2014, INSECTS OUTLINE ENTO; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Jacquez Geoffrey M, 2004, Int J Health Geogr, V3, P22, DOI 10.1186/1476-072X-3-22; Katureebe A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002167; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; Koita OA, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/367160; Mehta A, 2016, MINTAGE J PHARM MED, P22; Ministry of Finance, 2014, UG POV STAT REP; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Mukwaya PI, 2010, URBAN FORUM, V21, P267, DOI DOI 10.1007/S12132-010-9090-9; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Munguambe K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-344; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Owens S, 2015, ARCH DIS CHILD, V100, pS53, DOI 10.1136/archdischild-2013-305441; Protopopoff N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008022; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2; Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37; Roberts D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1290-x; Rutstein S. O., 2004, DHS WEALTH INDEX; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Stevenson J, 2012, EMERG INFECT DIS, V18, P1547, DOI 10.3201/eid1809.120283; Teo A, 2016, TRENDS PARASITOL, V32, P887, DOI 10.1016/j.pt.2016.07.003; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; Uganda Bureau of Statistics (UBOS) and ICF International, 2015, UG MAL IND SURV 2014; Uganda Malaria Control Program, 2016, UG MAL OP PLAN; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; Weiss DJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0574-x; WHO, 2015, WORLD MAL REP 2015; WHO, 2016, EVALUATION RAPID DIA; Yeka, 2012, MAL UG CHALL CONTR L	61	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174948	10.1371/journal.pone.0174948	http://dx.doi.org/10.1371/journal.pone.0174948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376112	Green Submitted, Green Published, gold			2022-12-26	WOS:000399352000027
J	Yao, TC; Tsai, HJ; Chang, SW; Chung, RH; Hsu, JY; Tsai, MH; Liao, SL; Hua, MC; Lai, SH; Chen, LC; Yeh, KW; Tseng, YL; Lin, WC; Chang, SC; Huang, JL				Yao, Tsung-Chieh; Tsai, Hui-Ju; Chang, Su-Wei; Chung, Ren-Hua; Hsu, Jing-Ya; Tsai, Ming-Han; Liao, Sui-Ling; Hua, Man-Chin; Lai, Shen-Hao; Chen, Li-Chen; Yeh, Kuo-Wei; Tseng, Yu-Lun; Lin, Wan-Chen; Chang, Su-Ching; Huang, Jing-Long		Prediction Allergies Taiwanese Chi	Obesity disproportionately impacts lung volumes, airflow and exhaled nitric oxide in children	PLOS ONE			English	Article							BODY-MASS INDEX; IMMUNOGLOBULIN-E SENSITIZATION; INTERNATIONAL SURVEY; GENERAL-POPULATION; PULMONARY-FUNCTION; ASTHMA; AGE; ADOLESCENTS; OVERWEIGHT; PREVALENCE	Background The current literature focusing on the effect of obesity and overweight on lung function and fraction of exhaled nitric oxide (FeNO) in children, particularly among healthy children of non-European descent, remains controversial. Furthermore, whether the relationship of obesity and overweight with lung function and FeNO in children is modified by atopy is unclear. The objective of this study was to examine the effect of excess weight on lung function parameters and FeNO among Asian children, with a particular focus on exploring the potential effect modification by atopy. Methods We investigated the effect of excess weight on lung function and FeNO in a population sample of 1,717 children aged 5 to 18 years and explored the potential modifying effect of atopy. Results There were positive associations of body mass index (BMI) z-score with forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), and forced expiratory flow at 25 - 75% (FEF25-75) (all P<0.001), after controlling for confounders. The beta coefficient for FEV1 (0.084) was smaller than that for FVC (0.111). In contrast, a negative association was found between BMI z-score and FEV1/FVC ratio (P<0.001) and FeNO (P = 0.03). A consistent pattern of association for lung function variables was observed when stratifying by atopy. There was a negative association of BMI z-score with FeNO in atopic subjects (P = 0.006), but not in non-atopic subjects (P = 0.46). Conclusions Excess weight disproportionately impacts lung volumes and airflow in children from the general population, independent of atopic status. Excess weight inversely affects FeNO in atopic but not in non-atopic children.	[Yao, Tsung-Chieh; Chang, Su-Wei; Hsu, Jing-Ya; Chen, Li-Chen; Yeh, Kuo-Wei; Tseng, Yu-Lun; Lin, Wan-Chen; Chang, Su-Ching; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Chang, Su-Wei; Hsu, Jing-Ya; Chen, Li-Chen; Yeh, Kuo-Wei; Tseng, Yu-Lun; Lin, Wan-Chen; Chang, Su-Ching; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yao, Tsung-Chieh] Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Hsu, Jing-Ya; Tsai, Ming-Han; Liao, Sui-Ling; Hua, Man-Chin; Lai, Shen-Hao; Chen, Li-Chen; Yeh, Kuo-Wei; Tseng, Yu-Lun; Lin, Wan-Chen; Chang, Su-Ching; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Tsai, Hui-Ju; Chung, Ren-Hua] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli, Taiwan; [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tsai, Hui-Ju] Natl Cheng Kung Univ, Allergy & Clin Immunol Res Ctr, Tainan, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Tsai, Ming-Han; Liao, Sui-Ling; Hua, Man-Chin] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Lai, Shen-Hao] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Pulmonol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Northwestern University; Feinberg School of Medicine; National Cheng Kung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yao, TC; Huang, JL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Yao, TC (corresponding author), Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	yao@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Chung, Ren-Hua/AAB-8364-2019	Huang, Jing-Long/0000-0002-3530-7753; Huang, Jing-Long/0000-0001-9280-920X	Ministry of Science and Technology of Taiwan [NSC 101-2314-B-182A-044, NSC 102-2314-B-182A048, NSC 101-2314-B-400-009-MY2, MOST 103-2314-B-182-030, MOST 103-2314-B-400-004MY3, MOST 104-2314-B-182-046-MY2]; Chang Gung Memorial Hospital [CMRPG260291-260293, CMRPG4B0031-4130033, CMRPG3E1201-3E1202, CORPG3F0081, CMRPG3F1711]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the Ministry of Science and Technology of Taiwan (grants NSC 101-2314-B-182A-044,NSC 102-2314-B-182A048, NSC 101-2314-B-400-009-MY2, MOST 103-2314-B-182-030, MOST 103-2314-B-400-004MY3, and MOST 104-2314-B-182-046-MY2) and by Chang Gung Memorial Hospital (grants CMRPG260291-260293, CMRPG4B0031-4130033, CMRPG3E1201-3E1202, CORPG3F0081, and CMRPG3F1711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bekkers MBM, 2013, PEDIATR PULM, V48, P674, DOI 10.1002/ppul.22722; Buchvald F, 2005, J ALLERGY CLIN IMMUN, V115, P1130, DOI 10.1016/j.jaci.2005.03.020; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Cibella F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127154; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Davidson WJ, 2014, PEDIATR PULM, V49, P1003, DOI 10.1002/ppul.22915; Derraik JGB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16692; Forno E, 2017, AM J RESP CRIT CARE, V195, P314, DOI 10.1164/rccm.201605-1039OC; Han YY, 2014, AM J RESP CRIT CARE, V190, P32, DOI 10.1164/rccm.201403-0565OC; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Kovesi T, 2008, CHEST, V133, P169, DOI 10.1378/chest.07-1177; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032477; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Liou TH, 2009, ANN HUM BIOL, V36, P176, DOI 10.1080/03014460802691174; Maniscalco M, 2007, RESP PHYSIOL NEUROBI, V156, P370, DOI 10.1016/j.resp.2006.10.003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Myint PK, 2005, EUR RESPIR J, V26, P494, DOI 10.1183/09031936.05.00023605; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Salome CM, 1985, J APPL PHYSIOL, V2010, P206; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Spathopoulos D, 2009, PEDIATR PULM, V44, P273, DOI 10.1002/ppul.20995; Tantisira KG, 2003, THORAX, V58, P1036, DOI 10.1136/thorax.58.12.1036; Tu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080996; WEISS ST, 1995, AM J EPIDEMIOL, V142, P493, DOI 10.1093/oxfordjournals.aje.a117665; Yao TC, 2014, ALLERGY, V69, P678, DOI 10.1111/all.12378; Yao TC, 2016, ALLERGY, V71, P90, DOI 10.1111/all.12775; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911; Yao TC, 2011, CLIN EXP ALLERGY, V41, P556, DOI 10.1111/j.1365-2222.2010.03687.x; Yao TC, 2014, J PEDIATR-US, V165, P1098, DOI 10.1016/j.jpeds.2014.08.048; Yao TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099105; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Zammit C, 2010, INT J GEN MED, V3, P335, DOI 10.2147/IJGM.S11926	39	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174691	10.1371/journal.pone.0174691	http://dx.doi.org/10.1371/journal.pone.0174691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376119	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000016
J	Sociali, G; Magnone, M; Ravera, S; Damonte, P; Vigliarolo, T; Von Holtey, M; Vellone, VG; Millo, E; Caffa, I; Cea, M; Parenti, MD; Del Rio, A; Murone, M; Mostoslavsky, R; Grozio, A; Nencioni, A; Bruzzone, S				Sociali, Giovanna; Magnone, Mirko; Ravera, Silvia; Damonte, Patrizia; Vigliarolo, Tiziana; Von Holtey, Maria; Vellone, Valerio G.; Millo, Enrico; Caffa, Irene; Cea, Michele; Parenti, Marco Daniele; Del Rio, Alberto; Murone, Maximilien; Mostoslavsky, Raul; Grozio, Alessia; Nencioni, Alessio; Bruzzone, Santina			Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model	FASEB JOURNAL			English	Article						sirtuin inhibitors; glucose metabolism; glucose transporters	DEACETYLASE SIRT6; MICE; SECRETION; SIRTUINS; OBESITY; CELLS	Sirtuin 6 (SIRT6) is a sirtuin family member involved in a wide range of physiologic and disease processes, including cancer and glucose homeostasis. Based on the roles played by SIRT6 in different organs, including its ability to repress the expression of glucose transporters and glycolytic enzymes, inhibiting SIRT6 has been proposed as an approach for treating type 2 diabetes mellitus (T2DM). However, so far, the lack of small-molecule Sirt6 inhibitors has hampered the conduct of in vivo studies to assess the viability of this strategy. We took advantage of a recently identified SIRT6 inhibitor, compound 1, to study the effect of pharmacological Sirt6 inhibition in a mouse model of T2DM (i.e., in high-fat-diet fed animals). The administration of the Sirt6 inhibitor for 10 d was well tolerated and improved oral glucose tolerance, it increased the expression of the glucose transporters GLUT1 and 4 in the muscle and enhanced the activity of the glycolytic pathway. Sirt6 inhibition also resulted in reduced insulin, triglycerides, and cholesterol levels in plasma. This study represents the first in vivo study of a SIRT6 inhibitor and provides the proof-of concept that targeting SIRT6 maybe a viable strategy for improving glycemic control in T2DM. Sociali, G., Magnone, M., Ravera, S., Damonte, P., Vigliarolo, T., Von Holtey, M., Vellone, V. G., Millo, E., Caffa, I., Cea, M., Parenti, M. D., Del Rio, A., Murone, M., Mostoslaysky, R., Grozio, A., Nencioni, A., Bruzzone S. Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model.	[Sociali, Giovanna; Magnone, Mirko; Vigliarolo, Tiziana; Millo, Enrico; Grozio, Alessia; Bruzzone, Santina] Univ Genoa, CEBR, Dept Expt Med, Biochem Sect, Genoa, Italy; [Ravera, Silvia] Univ Genoa, Dept Pharm, Biochem Lab, Genoa, Italy; [Damonte, Patrizia; Caffa, Irene; Cea, Michele; Nencioni, Alessio] Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy; [Vellone, Valerio G.] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Von Holtey, Maria; Murone, Maximilien] Debiopharm Int SA, Lausanne, Switzerland; [Parenti, Marco Daniele; Del Rio, Alberto] Natl Res Council CNR, Inst Organ Synth & Photoreact ISOF, Bologna, Italy; [Del Rio, Alberto] Innovamol Srls, Modena, Italy; [Murone, Maximilien] Cellestia Biotech AG, Basel, Switzerland; [Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Nencioni, Alessio] Azienda Osped Univ San Martino, Ist Nazl Ric Canc IST, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; [Bruzzone, Santina] CNR, Inst Prot Biochem, Naples, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; Debiopharm; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy.; Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	alessio.nencioni@unige.it; santina.bruzzone@unige.it	Caffa, Irene/J-9835-2016; Vellone, Valerio Gaetano/M-6139-2019; Ravera, Silvia/AAA-7982-2019; Millo, Enrico/K-3218-2018; Bruzzone, Santina/A-4264-2015; Vellone, Valerio Gaetano/A-4342-2018; cea, Michele/K-3863-2018; Nencioni, Alessio/K-3692-2018	Caffa, Irene/0000-0003-1111-9915; Vellone, Valerio Gaetano/0000-0002-5107-1584; Ravera, Silvia/0000-0002-0803-1042; Millo, Enrico/0000-0002-4019-0051; Bruzzone, Santina/0000-0003-2034-3716; Vellone, Valerio Gaetano/0000-0002-5107-1584; cea, Michele/0000-0002-1530-6729; Del Rio, Alberto/0000-0002-1890-6797; NENCIONI, ALESSIO/0000-0001-5068-8884; Parenti, Marco Daniele/0000-0001-6837-8294; Grozio, Alessia/0000-0003-4699-3303	Collegio Ghislieri (Pavia, Italy); Italian Ministry of Health Grant [GR-2011-02347192]; University of Genova; Programme FP7 PANACREAS Grant [256986]; Athero-B-Cell Grant [602114]; Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant [17736]; Fondazione Umberto Veronesi; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER	Collegio Ghislieri (Pavia, Italy); Italian Ministry of Health Grant(Ministry of Health, Italy); University of Genova; Programme FP7 PANACREAS Grant; Athero-B-Cell Grant; Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Thierry Dupraz and Yogeshwar Bacchav (Debiopharm International SA) for technical support. G.S. is a recipient of a fellowship for young investigators granted by Collegio Ghislieri (Pavia, Italy). This work was supported by the Italian Ministry of Health Grant GR-2011-02347192 (to A.N., A.G., and A.D.R.); the University of Genova (to S.B. and AN.); Programme FP7 PANACREAS Grant 256986 (to A.N. and S.B.) and Athero-B-Cell, Grant 602114 (to AN.); Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant 17736 (to AN.); and the Fondazione Umberto Veronesi (to A.N.). G.S. and M.M. contributed equally to this work as first authors. A.N. and S.B. contributed equally to this work as senior authors. The authors declare no conflicts of interest.	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bianchi G, 2015, ONCOTARGET, V6, P11806, DOI 10.18632/oncotarget.3688; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Marin-Penalver JJ, 2016, WORLD J DIABETES, V7, P354, DOI 10.4239/wjd.v7.i17.354; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Manco M, 2010, OBES SURG, V20, P1682, DOI 10.1007/s11695-010-0129-8; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Nonalcoholic Steatohepatitis Clinical Research Network, 2005, HEPATOLOGY, V41, P1313; Parenti MD, 2014, J MED CHEM, V57, P4796, DOI 10.1021/jm500487d; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; Sociali G, 2016, ONCOTARGET, V7, P2968, DOI 10.18632/oncotarget.6502; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30321; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zhang XY, 2016, NAT CHEM BIOL, V12, P614, DOI [10.1038/NCHEMBIO.2106, 10.1038/nchembio.2106]; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	26	44	45	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3138	3149		10.1096/fj.201601294R	http://dx.doi.org/10.1096/fj.201601294R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386046	Green Published, Green Submitted			2022-12-26	WOS:000405931000037
J	Espinoza-Lewis, RA; Yang, QM; Liu, JM; Huang, ZP; Hu, XY; Chen, DW; Wang, DZ				Espinoza-Lewis, Ramon A.; Yang, Qiumei; Liu, Jianming; Huang, Zhan-Peng; Hu, Xiaoyun; Chen, Daiwen; Wang, Da-Zhi			Poly(C)-binding protein 1 (Pcbp1) regulates skeletal muscle differentiation by modulating microRNA processing in myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; HEPATOMA-CELL LINE; MESSENGER-RNA; FIBER-TYPE; RIBONUCLEOPROTEIN-PARTICLES; 3'-UNTRANSLATED REGION; ANDROGEN RECEPTOR; ENERGY-METABOLISM; GENE-EXPRESSION; P-BODIES	Regulation of gene expression during muscle development and disease remains incompletely understood. microRNAs are a class of small non-coding RNAs that regulate gene expression and function post-transcriptionally. The poly(C)-binding protein1 (Pcbp1, hnRNP-E1, or alpha CP-1) is an RNA-binding protein that has been reported to bind the 3'-UTRs of target genes to regulate mRNA stability and protein translation. However, Pcbp1's biological function and the general mechanism of action remain largely undetermined. Here, we report that Pcbp1 is a component of the miRNA-processing pathway that regulates miRNA biogenesis. siRNA-based inhibition of Pcbp1 in mouse skeletal muscle myoblasts led to dysregulated cellular proliferation and differentiation. We also found that Pcbp1 null mutant mice exhibit early embryonic lethality, indicating that Pcbp1 is indispensable for embryonic development. Interestingly, hypomorphic Pcbp1 mutant mice displayed defects in muscle growth due to defects in the proliferation and differentiation of myoblasts and muscle satellite cells, in addition to a slow to fast myofibril switch. Moreover, Pcbp1 modulated the processing of muscle-enriched miR-1, miR-133, and miR-206 by physically interacting with argonaute 2 (AGO2) and other miRNA pathway components. Our study, therefore, uncovers the important function of Pcbp1 in skeletal muscle and the microRNA pathway, signifying its potential as a therapeutic target for muscle disease.	[Espinoza-Lewis, Ramon A.; Yang, Qiumei; Liu, Jianming; Huang, Zhan-Peng; Hu, Xiaoyun; Wang, Da-Zhi] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Yang, Qiumei; Chen, Daiwen] Sichuan Agr Univ, Anim Nutr Inst, Chengdu 6111130, Sichuan, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Agricultural University	Wang, DZ (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	Zhan-Peng, Huang/I-2318-2017	Zhan-Peng, Huang/0000-0001-7054-655X; Espinoza-Lewis, Ramon/0000-0003-3068-5517	National Institutes of Health [HL085635, HL116919]; American Heart Association; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125925, R01HL085635, T32HL007572, R01HL116919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085635 and HL116919. This work was also supported by the American Heart Association and Muscular Dystrophy Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Cloke B, 2010, ENDOCRINOLOGY, V151, P3954, DOI [10.1210/en.2009-1264, 10.1210//en.2009-1264]; Comai G, 2014, CURR TOP DEV BIOL, V110, P1, DOI 10.1016/B978-0-12-405943-6.00001-4; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Ding J, 2015, NAT GENET, V47, P776, DOI 10.1038/ng.3324; Diniz GP, 2016, COMPR PHYSIOL, V6, P1279, DOI 10.1002/cphy.c150041; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Ghanem LR, 2014, GENE EXPR PATTERNS, V14, P78, DOI 10.1016/j.gep.2014.01.004; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hongbing Wang, 2010, 2010 Proceedings of 22nd International Conference on Tools with Artificial Intelligence (ICTAI 2010), P3, DOI 10.1109/ICTAI.2010.9; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kasim V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059445; Kirby TJ, 2015, FRONT BIOSCI-LANDMRK, V20, P37, DOI 10.2741/4298; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lian WX, 2012, FEBS LETT, V586, P1431, DOI 10.1016/j.febslet.2012.04.016; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WILK HE, 1985, EUR J BIOCHEM, V146, P71, DOI 10.1111/j.1432-1033.1985.tb08621.x; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-72; Zheng DH, 2011, RNA, V17, P1619, DOI 10.1261/rna.2789611	52	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9540	9550		10.1074/jbc.M116.773671	http://dx.doi.org/10.1074/jbc.M116.773671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28381556	Green Published, hybrid			2022-12-26	WOS:000403113000008
J	Chen, LW; Chen, FP; Hsieh, CW; Kuo, SF; Chien, RN				Chen, Li-Wei; Chen, Fang-Ping; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan			Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TUMOR-NECROSIS-FACTOR; POSTMENOPAUSAL WOMEN; SERUM LEPTIN; FACTOR-ALPHA; OSTEOPOROSIS; DISEASE; MEN; GASTRITIS; ESTROGEN	Helicobacter pylori (H. pylori) infection may induce inflammatory cytokines or adipokines that influence bone turnover and bone fracture risk. This study aimed to evaluate the association among H. pylori infection, adipokines, and 10-year fracture risk using the Fracture Risk Assessment Tool scale. From August 2013 to February 2016, a community-based cohort was surveyed by Keelung Chang-Gung Memorial Hospital. Subjects were included if they were older than 40 years and not pregnant. All participants underwent a standardized questionnaire survey, physical examination, urea breath test, and blood tests. A total of 2,689 participants (1,792 women) were included in this cross-sectional study. In both sexes, participants with a high fracture risk were older and had higher adiponectin values than participants without a high fracture risk (mean age, female: 72.9 +/- 5.6 vs. 55.8 +/- 7.3 years, P < 0.0001; male: 78.9 +/- 4.7 vs. 58.1 +/- 8.9 years, P < 0.001) (adiponectin, female: 10.8 +/- 6.3 vs. 8.7 +/- 5.2 ng/ml, P < 0.001; male: 9.7 +/- 6.1 vs. 5.5 +/- 3.8 ng/ml, P < 0.001). Adiponectin was correlated with high fracture risk in both sexes, but H. pylori infection and leptin was not. In logistic regression analysis, adiponectin could not predict high fracture risk when adjusting the factor of body mass index (BMI) in men group. In conclusion, H. pylori infection and leptin could not predict 10-year fracture risk in either sex. Adiponectin was correlated with bone fracture risk in both sexes and the correlation might be from the influence of BMI.	[Chen, Li-Wei; Chien, Rong-Nan] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Keelung, Taiwan; [Chen, Li-Wei; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan] Univ Keelung, Keelung, Taiwan; [Chen, Li-Wei; Hsieh, Chia-Wen; Kuo, Sheng-Fong; Chien, Rong-Nan] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chen, Fang-Ping] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Keelung, Taiwan; [Kuo, Sheng-Fong] Chang Gung Mem Hosp, Metab & Endocrinol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chien, RN (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Keelung, Taiwan.; Chien, RN (corresponding author), Univ Keelung, Keelung, Taiwan.; Chien, RN (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	ronald@cgmh.org.hiv	Chen, Li-Wei/ABA-5139-2021	Chen, Li-Wei/0000-0001-8805-2275	Chang-Gung Memorial Hospital [CMRPG2B0123, CMRPG2B0173]	Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from Chang-Gung Memorial Hospital (No CMRPG2B0123 and CMRPG2B0173). The funder has no role in this study.	Adachi Y, 2000, CALCIFIED TISSUE INT, V66, P119, DOI 10.1007/s002230010025; Akkaya N, 2011, J PHYS THER SCI, V23, P61, DOI 10.1589/jpts.23.61; Asaoka D, 2015, THER CLIN RISK MANAG, V11, P381, DOI 10.2147/TCRM.S80647; Asaoka D, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/340765; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Biver E, 2011, J CLIN ENDOCR METAB, V96, P2703, DOI 10.1210/jc.2011-0047; Breidert M, 1999, SCAND J GASTROENTERO, V34, P954, DOI 10.1080/003655299750025039; Chao AS, 2015, TAIWAN J OBSTET GYNE, V54, P722, DOI 10.1016/j.tjog.2015.10.005; Chen LW, 2007, HEPATO-GASTROENTEROL, V54, P2209; Crabtree JE, 1996, ALIMENT PHARM THER, V10, P29, DOI 10.1046/j.1365-2036.1996.22164003.x; Dubuc GR, 1998, METABOLISM, V47, P429, DOI 10.1016/S0026-0495(98)90055-5; Figura N, 2005, DIGEST DIS SCI, V50, P847, DOI 10.1007/s10620-005-2651-4; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kakehasi AM, 2009, DIGEST DIS SCI, V54, P819, DOI 10.1007/s10620-008-0417-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Kim JW, 2015, BONE, V75, P27, DOI 10.1016/j.bone.2015.02.013; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P75, DOI 10.1007/s00198-011-1747-2; Lim S, 2004, BONE, V35, P792, DOI 10.1016/j.bone.2004.05.016; Lin SC, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/814756; Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009; Liu K, 2015, CLIN CHIM ACTA, V444, P260, DOI 10.1016/j.cca.2015.02.040; Lubkowska A, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/975178; Mechanick JI, 2010, ENDOCR PRACT, V16, P270, DOI 10.4158/EP.16.2.270; Mohiti-Ardekani J, 2014, J BONE MINER METAB, V32, P400, DOI 10.1007/s00774-013-0511-4; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Odabasi E, 2000, EUR J ENDOCRINOL, V142, P170, DOI 10.1530/eje.0.1420170; Ozdem S, 2007, DIGEST DIS SCI, V52, P967, DOI 10.1007/s10620-006-9292-0; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Polyzos SA, 2013, METABOLISM, V62, P121, DOI 10.1016/j.metabol.2012.06.007; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Schulte CMS, 2004, ALIMENT PHARM THERAP, V20, P43, DOI 10.1111/j.1365-2036.2004.02057.x; Siris E, 2014, OSTEOPOROSIS INT, V25, P1439, DOI 10.1007/s00198-014-2655-z; Suzuki T, 2010, OSTEOPOROSIS INT, V21, P71, DOI 10.1007/s00198-009-0970-6; TEPPO AM, 1987, CLIN CHEM, V33, P2024; Thalmaier U, 2002, INFECT IMMUN, V70, P3149, DOI 10.1128/IAI.70.6.3149-3155.2002	41	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175365	10.1371/journal.pone.0175365	http://dx.doi.org/10.1371/journal.pone.0175365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388631	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800045
J	Belic, JJ; Kumar, A; Kotaleski, JH				Belic, Jovana J.; Kumar, Arvind; Kotaleski, Jeanette Hellgren			Interplay between periodic stimulation and GABAergic inhibition in striatal network oscillations	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; SPINY PROJECTION NEURONS; BASAL GANGLIA; FIRE NEURONS; OUTPUT; ROLES; ORGANIZATION; FEEDFORWARD; NEOSTRIATUM; MECHANISMS	Network oscillations are ubiquitous across many brain regions. In the basal ganglia, oscillations are also present at many levels and a wide range of characteristic frequencies have been reported to occur during both health and disease. The striatum, the main input nucleus of the basal ganglia, receives massive glutamatergic inputs from the cortex and is highly susceptible to external oscillations. However, there is limited knowledge about the exact nature of this routing process and therefore, it is of key importance to understand how time-dependent, external stimuli propagate through the striatal circuitry. Using a network model of the striatum and corticostriatal projections, we try to elucidate the importance of specific GABAergic neurons and their interactions in shaping striatal oscillatory activity. Here, we propose that fast-spiking interneurons can perform an important role in transferring cortical oscillations to the striatum especially to those medium spiny neurons that are not directly driven by the cortical oscillations. We show how the activity levels of different populations, the strengths of different inhibitory synapses, degree of outgoing projections of striatal cells, ongoing activity and synchronicity of inputs can influence network activity. These results suggest that the propagation of oscillatory inputs into the medium spiny neuron population is most efficient, if conveyed via the fast-spiking interneurons. Therefore, pharmaceuticals that target fast-spiking interneurons may provide a novel treatment for regaining the spectral characteristics of striatal activity that correspond to the healthy state.	[Belic, Jovana J.; Kotaleski, Jeanette Hellgren] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden; [Belic, Jovana J.; Kumar, Arvind; Kotaleski, Jeanette Hellgren] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Sci & Technol, Stockholm, Sweden; [Belic, Jovana J.] Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany; [Kotaleski, Jeanette Hellgren] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; University of Freiburg; Karolinska Institutet	Belic, JJ (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, Stockholm, Sweden.; Belic, JJ (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Sci & Technol, Stockholm, Sweden.; Belic, JJ (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany.	belic@kth.se		Kotaleski, Jeanette/0000-0002-0550-0739	European Union Seventh Framework Programme (FP7) [604102]; European Horizon Framework Programme [720270]; Swedish Research Council; NIAAA [2R01AA016022]; Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program	European Union Seventh Framework Programme (FP7); European Horizon Framework Programme; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604102 (Human Brain Project); The European Horizon2020 Framework Programme under grant agreement no 720270 (Human Brain Project SGA1); The Swedish Research Council; NIAAA (grant 2R01AA016022); Swedish e-Science Research Center; EuroSPIN - an Erasmus Mundus Joint Doctoral program. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bahuguna J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004233; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beatty JA, 2015, J NEUROPHYSIOL, V113, P688, DOI 10.1152/jn.00827.2014; Belic JJ, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00026, 10.3389/fnsys.7016.00026]; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Berke JD, 2009, EUR J NEUROSCI, V30, P848, DOI 10.1111/j.1460-9568.2009.06843.x; Berke JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00045; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Boraud T., 2005, OSCILLATIONS BASAL G, P1; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brunel N, 1998, J THEOR BIOL, V195, P87, DOI 10.1006/jtbi.1998.0782; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dupre KB, 2016, NEUROBIOL DIS, V86, P1, DOI 10.1016/j.nbd.2015.11.009; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Gonzalez OJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100899; GRAYBIEL AM, 1995, TRENDS NEUROSCI, V18, P60; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Halje P, 2012, J NEUROSCI, V32, P16541, DOI 10.1523/JNEUROSCI.3047-12.2012; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hjorth J, 2009, J NEUROSCI, V29, P5276, DOI 10.1523/JNEUROSCI.6031-08.2009; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kemp J. M., 1978, PHILOS T R SOC B, V262, P441; Klaus A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00057; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Kremkow J, 2010, J NEUROSCI, V30, P15760, DOI 10.1523/JNEUROSCI.3874-10.2010; Kumar A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00086; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Planert H, 2010, J NEUROSCI, V30, P3499, DOI 10.1523/JNEUROSCI.5139-09.2010; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Plenz D, 2003, TRENDS NEUROSCI, V26, P436, DOI 10.1016/S0166-2236(03)00196-6; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reig R, 2014, NEURON, V83, P1200, DOI 10.1016/j.neuron.2014.07.033; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Stamey W, 2008, NEUROLOGIST, V14, P89, DOI 10.1097/NRL.0b013e31816606a7; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tepper JM, 2006, MICROCIRCUITS INTERF, P127; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Tunstall MJ, 2002, J NEUROPHYSIOL, V88, P1263, DOI 10.1152/jn.2002.88.3.1263; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Yim MY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002254; Zheng T, 2002, J NEUROPHYSIOL, V87, P1007, DOI 10.1152/jn.00519.2001	69	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175135	10.1371/journal.pone.0175135	http://dx.doi.org/10.1371/journal.pone.0175135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384268	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900097
J	Calderaro, A; Buttrini, M; Piergianni, M; Montecchini, S; Martinelli, M; Covan, S; Piccolo, G; Medici, MC; Arcangeletti, MC; Chezzi, C; De Conto, F				Calderaro, Adriana; Buttrini, Mirko; Piergianni, Maddalena; Montecchini, Sara; Martinelli, Monica; Covan, Silvia; Piccolo, Giovanna; Medici, Maria Cristina; Arcangeletti, Maria Cristina; Chezzi, Carlo; De Conto, Flora			Evaluation of a modified meropenem hydrolysis assay on a large cohort of KPC and VIM carbapenemase-producing Enterobacteriaceae	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; IDENTIFICATION; GENES	Carbapenem-resistant Enterobacteriaceae (CRE) have spread globally and represent a serious and growing threat to public health. The introduction of rapid and sensitive methods for the detection of carbapenemase-producing bacteria is of increasing importance. The carbapenemase production can be detected using non-molecular methods (such as the modified Hodge test, the synergy test, the Carba NP test and the antibiotic hydrolysis assays) and DNA-based methods. In this study, we propose a modified version of a previously described meropenem hydrolysis assay (MHA) by MALDI-TOF MS for the phenotypic detection in 2h of carbapenemase-producing Enterobacteriaceae. The MHA was successfully applied to detect carbapenemase activity in 981 well-characterized Enterobacteriaceae strains producing KPC or VIM carbapenemases, and in 146 carbapenem fully susceptible strains. This assay, applied also to NDM and OXA-48-producing strains and to CRE with resistance mechanisms other than carbapenemase production, has proved to be able to distinguish between carbapenemase-producing and-nonproducing Enterobacteriaceae. As already stated and as observed in our hands, MHA by MALDI-TOF MS analysis is independent from the type of carbapenemases involved, it is faster and easier to perform/ interpret than culture-based methods. On the other hand, it cannot detect other carbapenem resistance mechanisms, such as porin alterations and efflux mechanisms.	[Calderaro, Adriana; Buttrini, Mirko; Piergianni, Maddalena; Montecchini, Sara; Martinelli, Monica; Covan, Silvia; Piccolo, Giovanna; Medici, Maria Cristina; Arcangeletti, Maria Cristina; Chezzi, Carlo; De Conto, Flora] Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, Parma, Italy	University of Parma; University Hospital of Parma	Calderaro, A (corresponding author), Univ Parma, Dept Clin & Expt Med, Unit Microbiol & Virol, Parma, Italy.	adriana.calderaro@unipr.it	De Conto, Flora/H-9760-2019; piccolo, giovanna/HHZ-8454-2022	De Conto, Flora/0000-0002-0493-2353; 				AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; Bisiklis A, 2007, CLIN MICROBIOL INFEC, V13, P1201, DOI 10.1111/j.1469-0691.2007.01832.x; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Lau AF, 2014, J CLIN MICROBIOL, V52, P2804, DOI 10.1128/JCM.00694-14; Ledeboer N. A., 2011, Journal of Clinical Microbiology, V49, pS20, DOI 10.1128/JCM.00771-11; Monaco M, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.42.20939; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2013, J ANTIMICROB CHEMOTH, V68, P487, DOI 10.1093/jac/dks426; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Oviano M, 2016, INT J ANTIMICROB AG, V48, P655, DOI 10.1016/j.ijantimicag.2016.08.024; Papagiannitsis CC, 2015, J CLIN MICROBIOL, V53, P1731, DOI 10.1128/JCM.03094-14; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Wang LJ, 2013, ANAL BIOANAL CHEM, V405, P5259, DOI 10.1007/s00216-013-6913-2	24	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174908	10.1371/journal.pone.0174908	http://dx.doi.org/10.1371/journal.pone.0174908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384185	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900050
J	Frutos, MC; Gastaldello, R; Balangero, M; Remondegul, C; Blanco, S; Otsuki, K; Vicente, ACP; Elias, D; Mangeaud, A; Natesl, S; Gallego, S				Frutos, Maria C.; Gastaldello, Rene; Balangero, Marcos; Remondegul, Carlos; Blanco, Sebastian; Otsuki, Koko; Paulo Vicente, Ana Carolina; Elias, David; Mangeaud, Arnaldo; Natesl, Silvia; Gallego, Sandra			Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission	PLOS ONE			English	Article							T-LYMPHOTROPIC VIRUS; CELL LEUKEMIA-VIRUS; BLOOD-DONORS; SPASTIC PARAPARESIS; TYPE-1 INFECTION; PREGNANT-WOMEN; I INFECTION; SUBTYPE B; BRAZIL; SEROPREVALENCE	Background Molecular and epidemiological studies of transmission routes and risk factors for infection by HTLV-1 are extremely important in order to implement control measures, especially because of the high prevalence of HTLV-1 in several regions of the world. San Salvador de Jujuy, Northwest Argentina, is a highly endemic area for HTLV-1 and foci of tropical spastic paraparesis/HTLV-1-associated myelopathy. Objective To gain further insight into the role of intrafamilial transmission of HTLV-1 in a highly endemic region in Argentina. Method Cross-sectional study in Northwest Argentina. Epidemiological data and blood samples were collected from 28 HTLV-1 infected subjects (index cases) and 92 close relatives/cohabitants. HTLV-1 infection was diagnosed by detection of antibodies and proviral DNA. The LTR region was sequenced and analyzed for genetic distances (VESPA software), in addition to determination and identification of polymorphisms to define HTLV-1 family signatures. Results Fifty seven of the 120 subjects enrolled had antibodies against HTLV-1 and were typified as HTLV-1 by PCR. The prevalence rate of HTLV-1 infection in family members of infected index cases was 31.52% (29/92). The infection was significantly associated with gender, age and prolonged lactation. Identity of LTR sequences and presence of polymorphisms revealed high prevalence of mother-to-child and interspousal transmission of HTLV-1 among these families. Conclusion There is an ongoing and silent transmission of HTLV-1 through vertical and sexual routes within family clusters in Northwest Argentina. This evidence highlights that HTLV-1 infection should be considered as a matter of public health in Argentina, in order to introduce preventive measures as prenatal screening and breastfeeding control.	[Frutos, Maria C.; Gastaldello, Rene; Balangero, Marcos; Blanco, Sebastian; Natesl, Silvia; Gallego, Sandra] Univ Nacl Cordoba, Inst Virol Dr JM Vanella, Fac Ciencias Med, Cordoba, Argentina; [Remondegul, Carlos] Hosp San Roque, Dept Enfermedades Infecc, San Salvador De Jujuy, Argentina; [Otsuki, Koko; Paulo Vicente, Ana Carolina] Fundacao Oswaldo Cruz, Lab Genet Mol Microorganismos, Rio De Janeiro, Brazil; [Elias, David; Mangeaud, Arnaldo] Univ Nacl Cordoba, Dept Matemat, Fac Ciencias Exactas Fis & Nat, Cordoba, Argentina	National University of Cordoba; Fundacao Oswaldo Cruz; National University of Cordoba	Frutos, MC (corresponding author), Univ Nacl Cordoba, Inst Virol Dr JM Vanella, Fac Ciencias Med, Cordoba, Argentina.	mariaceliafrutos@gmail.com	Frutos, Celia/AAU-9948-2020	Frutos, Maria Celia/0000-0002-6349-6264; Blanco, Sebastian/0000-0001-7832-2833; Mangeaud, Arnaldo Pedro/0000-0002-7370-7256	SeCyT UNC [202/2016]	SeCyT UNC(Secretaria de Ciencia y Tecnologia (SECYT))	Authors state that the research was totally supported by SeCyT UNC 202/2016 URL:http://www.unc.edu.ar/investigacion and that there was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berini CA, 2013, SEX TRANSM INFECT, V89, P333, DOI 10.1136/sextrans-2012-050594; Berini CA, 2012, AIDS RES HUM RETROV, V28, P902, DOI [10.1089/aid.2011.0311, 10.1089/AID.2011.0311]; Berini CA, 2010, J MED VIROL, V82, P873, DOI 10.1002/jmv.21728; Martins RMB, 2010, J CLIN VIROL, V48, P155, DOI 10.1016/j.jcv.2010.03.004; Brun RO, 2004, MEDICINA-BUENOS AIRE, V64, P125; CARTIER L, 1995, REV MED CHILE, V123, P7; Catalan-Soares B, 2004, REV PANAM SALUD PUBL, V16, P387, DOI 10.1590/S1020-49892004001200004; Cooper CMJ, 2010, W INDIAN MED J, V59, P35; da Costa CA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002272; Dominguez MC, 2015, BIOMEDICA, V35, P337, DOI 10.7705/biomedica.v35i3.2601; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Eirin ME, 2010, J MED VIROL, V82, P2116, DOI 10.1002/jmv.21834; Eshima N, 2009, J CLIN VIROL, V45, P135, DOI 10.1016/j.jcv.2009.03.012; Romanelli LCF, 2013, AIDS RES HUM RETROV, V29, P1199, DOI [10.1089/aid.2013.0086, 10.1089/AID.2013.0086]; Gallego S, 1997, VIRAL IMMUNOL, V10, P149, DOI 10.1089/vim.1997.10.149; Gastaldello R, 2005, J MED VIROL, V76, P386, DOI 10.1002/jmv.20370; Gastaldello R, 2004, JAIDS-J ACQ IMM DEF, V35, P301, DOI 10.1097/00126334-200403010-00012; Gastaldello R, 2008, AIDS RES HUM RETROV, V24, P1139, DOI 10.1089/aid.2007.0299; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Mello MAG, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-28; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; Houinato D, 1998, INT J EPIDEMIOL, V27, P146, DOI 10.1093/ije/27.1.146; Ita F, 2014, INT J INFECT DIS, V19, P46, DOI 10.1016/j.ijid.2013.10.005; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; Kakuda K, 2002, AM J TROP MED HYG, V66, P404, DOI 10.4269/ajtmh.2002.66.404; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; LIU HF, 1994, AIDS RES HUM RETROV, V10, P1135, DOI 10.1089/aid.1994.10.1135; Lu S C, 2001, Kaohsiung J Med Sci, V17, P126; Macia C, 2016, BIOMEDICA, V36, P108, DOI [10.7705/biomedica.v36i0.2942, 10.7705/biomedica.v3610.2942]; Monteiro DLM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003146; Malan R, 2010, MEDICINA-BUENOS AIRE, V70, P71; MONTGOMERY RD, 1993, T ROY SOC TROP MED H, V87, P154, DOI 10.1016/0035-9203(93)90467-5; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ribeiro MA, 2010, REV PANAM SALUD PUBL, V27, P330, DOI 10.1590/S1020-49892010000500002; Rouet F, 1999, INT J CANCER, V81, P330, DOI 10.1002/(SICI)1097-0215(19990505)81:3&lt;330::AID-IJC3&gt;3.0.CO;2-2; Vandamme AM, 1997, J MED VIROL, V52, P1, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;1::AID-JMV1&gt;3.0.CO;2-8; Zihlmann KF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001705	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174920	10.1371/journal.pone.0174920	http://dx.doi.org/10.1371/journal.pone.0174920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384180	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900051
J	Guo, Y; Du, ZY; Chen, J; Zhang, ZJ				Guo, Yan; Du, Ziyi; Chen, Jiang; Zhang, Zhongjun			QTL mapping of wheat plant architectural characteristics and their genetic relationship with seven QTLs conferring resistance to sheath blight	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BREAD WHEAT; RICE CULTIVARS; DISEASE; DNA; RUST; L.	Sheath blight is one of the most devastating wheat diseases worldwide. Breeding resistant cultivars is the most powerful strategy to defeat the disease. Plant resistance on "disease escape" works through modulation of morphological traits and shows sustainable resistance to disease. Plant architectural traits have been reported to play a significant role in disease response. Therefore, exploring the genetic relationship between plant architecture and disease resistance is of importance to the understanding of plant resistance via "disease escape". Using an F-9 population of 266 RILs ( Recombinant Inbred Lines) derived from the cross of Luke x AQ24788-83, we have generated a linkage map of 631 markers on 21 chromosomes. In this study, we present the QTL identification of fourteen plant architectural characteristics and heading time from two years and analyze their genetic relationships with seven previously published QTLs to sheath blight (QSBs, QSe. cau), including plant height (PH), the space between the flag leaf and penultimate leaf (fdR), heading date (Hd), and other traits. Twelve stable QTLs of the morphological traits were identified with good consistency across five replicates. For the seven previously published QSBs, we found no significant association with plant height. However, some of the QSBs displayed strong associations with plant architectural traits and heading date. Especially, Q(fdR). cau-1AS, Q(Hd). cau-2BS, Q(fdR). cau-5DL, and Q(fdR). cau-6BL were respectively mapped to the same regions as QSe. cau-1AS, QSe. cau-2BS, QSe. cau-5DL, and QSe. cau-6BL. Taken together, we have demonstrated that plant height did not exert a direct influence on the resistance to sheath blight conferred by the seven QSBs and that the plant architecture and heading date did exhibit a tight relationship with the resistance. Therefore, this study provides a novel evidence to help understand sheath blight resistance in wheat. In addition, the linked morphological characteristics and the generated flanking markers will facilitate breeding for resistance to sheath blight in wheat.	[Guo, Yan; Du, Ziyi; Chen, Jiang; Zhang, Zhongjun] China Agr Univ, Plant Pathol Dept, Coll Plant Protect, Beijing, Peoples R China	China Agricultural University	Guo, Y (corresponding author), China Agr Univ, Plant Pathol Dept, Coll Plant Protect, Beijing, Peoples R China.	guoyan001@cau.edu.cn			National Natural Science Foundation of China [30871612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30871612).	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Channamallikarjuna V, 2010, MOL BREEDING, V25, P155, DOI 10.1007/s11032-009-9316-5; Che KP, 2003, THEOR APPL GENET, V106, P293, DOI 10.1007/s00122-002-1001-6; Chen J, 2013, THEOR APPL GENET, V126, P2865, DOI 10.1007/s00122-013-2178-6; Dey S, 2016, AUSTRALAS PLANT PATH, V45, P145, DOI 10.1007/s13313-016-0404-9; Dong ZP, 2003, ACTA AGR BOREALI SIN, P103; Du ZY, 2015, THEOR APPL GENET, V128, P1579, DOI 10.1007/s00122-015-2533-x; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Han YP, 2003, ACTA BOT SIN, V45, P825; Han Yue-Peng, 2002, Acta Genetica Sinica, V29, P622; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEE FN, 1983, PLANT DIS, V67, P829, DOI 10.1094/PD-67-829; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; Pan XB, 1999, CHINESE SCI BULL, V44, P1783, DOI 10.1007/BF02886159; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pinson SRM, 2005, CROP SCI, V45, P503, DOI 10.2135/cropsci2005.0503; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sato H, 2004, BREEDING SCI, V54, P265, DOI 10.1270/jsbbs.54.265; SAVARY S, 1995, PHYTOPATHOLOGY, V85, P959, DOI 10.1094/Phyto-85-959; Sharma A, 2009, CROP SCI, V49, P256, DOI 10.2135/cropsci2008.03.0124; Singh A, 2014, THEOR APPL GENET, V127, P1005, DOI 10.1007/s00122-014-2280-4; Singh A, 2016, THEOR APPL GENET, V129, P243, DOI 10.1007/s00122-015-2624-8; Song YY, 2011, MYCORRHIZA, V21, P721, DOI 10.1007/s00572-011-0380-4; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Srinivasachary, 2013, PLANT PATHOL, V62, P888, DOI 10.1111/j.1365-3059.2012.02695.x; Srinivasachary, 2011, EUPHYTICA, V178, P1, DOI 10.1007/s10681-010-0296-7; Taguchi-Shiobara F, 2013, BREEDING SCI, V63, P301, DOI 10.1270/jsbbs.63.301; Wang ChenJiaoZi, 2015, Journal of South China Agricultural University, V36, P82; Willocquet L, 2012, EUPHYTICA, V183, P227, DOI 10.1007/s10681-011-0451-9; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Wu W, 2014, PLANT PATHOL, V63, P98, DOI 10.1111/ppa.12078; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zhong Xu-Hua, 2006, Zhongguo Shuidao Kexue, V20, P535; Zou JH, 2000, THEOR APPL GENET, V101, P569, DOI 10.1007/s001220051517	37	12	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174939	10.1371/journal.pone.0174939	http://dx.doi.org/10.1371/journal.pone.0174939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384183	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900058
J	Hauke, CA; Taylor, RK				Hauke, Caitlyn A.; Taylor, Ronald K.			Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus	PLOS ONE			English	Article							EL-TOR BIOTYPE; SOLUBLE COLONIZATION FACTOR; CLASSICAL CTX PROPHAGE; VIBRIO-CHOLERAE; PROTECTIVE ANTIGEN; WHOLE-CELL; O1; GENES; MUCOSAL; BANGLADESH	The use of whole cell killed (WCK) oral cholera vaccines is an important strategy for cholera prevention in endemic areas. To overcome current vaccine limitations, we engineered strains of V. cholerae to be non-toxigenic and to express the protective protein colonization factor, toxin-coregulated pilus (TCP), under scale-up conditions potentially amenable to vaccine production. Two V. cholerae clinical strains were selected and their cholera toxin genes deleted. The tcp operon was placed under control of a rhamnose-inducible promoter. Production and stability of TCP were assessed under various conditions. The strains lack detectable cholera toxin production. The addition of 0.1% rhamnose to the growth medium induced robust production of TCP and TcpA antigen. The strains produced intact TCP in larger growth volumes (1 L), and pili appeared stable during heat-killing or acid treatment of the bacterial cultures. To date, no WCK cholera vaccines have included TCP. We have constructed putative strains of V. cholerae for use in a vaccine that produce high levels of stable TCP antigen, which has not previously been achieved.	[Hauke, Caitlyn A.; Taylor, Ronald K.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Hauke, CA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	caitlyn.a.hauke@dartmouth.edu			National Institute of Allergy and Infectious Diseases [AI025096]; National Institute of Allergyand Infectious Diseases training [AI007363, AI007519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025096] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergyand Infectious Diseases training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases [AI025096 to R.K.T.] and National Institute of Allergyand Infectious Diseases training grants [AI007363 and AI007519 to C.A.H.], (https://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Asaduzzaman M, 2004, INFECT IMMUN, V72, P4448, DOI 10.1128/IAI.72.8.4448-4454.2004; Attridge SR, 1999, J BIOTECHNOL, V73, P109, DOI 10.1016/S0168-1656(99)00114-5; Baik YO, 2015, VACCINE, V33, P6360, DOI 10.1016/j.vaccine.2015.08.075; BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P347; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Bishop AL, 2011, EXPERT REV VACCINES, V10, P79, DOI [10.1586/erv.10.150, 10.1586/ERV.10.150]; Bougoudogo F, 1995, B I PASTEUR, V93, P273, DOI 10.1016/0020-2452(96)85762-9; DELORENZO RA, 1994, AM J EMERG MED, V12, P262, DOI 10.1016/0735-6757(94)90264-X; Dharmasena MN, 2009, MICROBIOL-SGM, V155, P2353, DOI 10.1099/mic.0.025726-0; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Kirn TJ, 2003, MOL MICROBIOL, V49, P81, DOI 10.1046/j.1365-2958.2003.03546.x; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Martinez RM, 2010, CURR PROTOC MICROBIO; Meeks MD, 2001, INFECT IMMUN, V69, P7687, DOI 10.1128/IAI.69.12.7687-7694.2001; Mukhopadhyay AK, 2014, CURR TOP MICROBIOL, V379, P17, DOI 10.1007/82_2014_363; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Rollenhagen JE, 2006, INFECT IMMUN, V74, P5834, DOI 10.1128/IAI.00438-06; SAKAZAKI R, 1971, JPN J MED SCI BIOL, V24, P93, DOI 10.7883/yoken1952.24.93; Sambrook J., 2001, MOL CLONING LAB MANU; SHARMA DP, 1989, MICROB PATHOGENESIS, V7, P437, DOI 10.1016/0882-4010(89)90024-7; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUN D, 1991, INFECT IMMUN, V59, P114, DOI 10.1128/IAI.59.1.114-118.1991; SUN D, 1990, J INFECT DIS, V161, P1231, DOI 10.1093/infdis/161.6.1231; Taylor R K, 1986, Ann Sclavo Collana Monogr, V3, P51; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Udden SMN, 2008, P NATL ACAD SCI USA, V105, P11951, DOI 10.1073/pnas.0805560105; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WHO, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization [Internet], 2015, CHOLERA	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175170	10.1371/journal.pone.0175170	http://dx.doi.org/10.1371/journal.pone.0175170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384206	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900108
J	Lahti, S; Ludwig, JM; Xing, MZ; Sun, LY; Zeng, DX; Kim, HS				Lahti, Steven; Ludwig, Johannes M.; Xing, Minzhi; Sun, Lingyi; Zeng, Dexing; Kim, Hyun S.			In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RENAL-CELL CARCINOMA; EXPRESSION; LEVEL	Purpose Sunitinib drug eluting beads (DEB) are a novel anti-angiogenic bead preparation for use in transarterial chemoembolization. However, systematic studies of sunitinib DEB's effect on cancer cells have not been reported. Herein, we assess their direct biologic efficacy against carcinoma cell lines and correlate cell viability with drug release in vitro. Materials and methods Sunitinib-HCl (10mg/mL) in Milli-Q water was mixed with LC Bead (R) 300-500 mu m (Biocom-patibles UK Ltd.). Loading and release were assessed by measurement of drug UV absorbance using UV-visible spectrophotometer. Viability of human colorectal cancer (CRC, HCT116 and HT29) and hepatocellular carcinoma (HCC, HepG2) cells upon exposure to sunitinib DEB was measured using a bioluminescent assay. Drug concentration during exposure was quantified using HPLC. Results When added to cultured HepG2 cells, sunitinib DEB rapidly inhibited viability with a significant decrease observed within 1 hour of incubation. Viability of HCT116 and HT29 cells decreased relatively slower, with significant reductions observed after 8 and 24 hours, respectively. After 24 hours there was nearly complete inhibition of all three cell lines. There was no difference in viability observed between cells treated with 5 mu l, 10 mu L, or 20 mu L of sunitinib DEB. HPLC analysis of the cell culture supernatant demonstrated saturation of the cell medium within approximately 4 hours for each amount added, with sunitinib achieving a final concentration of 17.61 mu M (SE +/- 1.01). Conclusions Sunitinib can be efficiently loaded to and released from LC beads, and the resulting sunitinib DEB demonstrate strong in vitro inhibition of human CRC and HCC cells.	[Lahti, Steven; Ludwig, Johannes M.; Xing, Minzhi; Kim, Hyun S.] Pittsburgh Sch Med, Intervent Oncol Translat Lab, Presbyterian South Tower, Pittsburgh, PA 15213 USA; [Ludwig, Johannes M.; Xing, Minzhi; Kim, Hyun S.] Yale Sch Med, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06510 USA; [Sun, Lingyi; Zeng, Dexing] Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA 15213 USA; [Kim, Hyun S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Kim, HS (corresponding author), Pittsburgh Sch Med, Intervent Oncol Translat Lab, Presbyterian South Tower, Pittsburgh, PA 15213 USA.; Kim, HS (corresponding author), Yale Sch Med, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06510 USA.; Zeng, DX (corresponding author), Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA 15213 USA.; Kim, HS (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.	zengd@upmc.edu; kevin.kim@yale.edu	sun, lingyi/A-1211-2018	Kim, Hyun/0000-0002-3077-9989				[Anonymous], 2014, STUDENT PRODUCT MONO; Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Bize P, 2016, RADIOLOGY, V280, P425, DOI 10.1148/radiol.2016150361; Brown KT, 2016, J CLIN ONCOL; Facciorusso A, 2016, DIG LIVER DIS; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Fuchs K, 2014, J VASC INTERV RADIOL, V25, P379, DOI 10.1016/j.jvir.2013.11.039; Gadaleta CD, 2011, CRIT REV ONCOL HEMAT, V80, P40, DOI 10.1016/j.critrevonc.2010.10.005; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Habib A, 2015, NAT REV CLIN ONCOL, V12, P481, DOI 10.1038/nrclinonc.2015.78; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Li T, 2012, J CLIN PATHOL, V65, P808, DOI 10.1136/jclinpath-2012-200721; Li X, 2004, WORLD J GASTROENTERO, V10, P2878; Liu DM, 2015, FUTURE ONCOL, V11, P1421, DOI 10.2217/fon.15.3; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Peng S, 2014, HEPATOLOGY, V60, P1264, DOI 10.1002/hep.27236; Schmid TA, 2016, THER ADV UROL, V8, P348, DOI 10.1177/1756287216663979; Sergio A, 2008, AM J GASTROENTEROL, V103, P914, DOI 10.1111/j.1572-0241.2007.01712.x; Shim JH, 2008, CANCER SCI, V99, P2037, DOI 10.1111/j.1349-7006.2008.00909.x; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043158	21	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174539	10.1371/journal.pone.0174539	http://dx.doi.org/10.1371/journal.pone.0174539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384190	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900019
J	Nassal, DM; Wan, XP; Liu, HY; Laurita, KR; Deschenes, I				Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Laurita, Kenneth R.; Deschenes, Isabelle			KChIP2 regulates the cardiac Ca2+ transient and myocyte contractility by targeting ryanodine receptor activity	PLOS ONE			English	Article							SINGLE-CHANNEL ACTIVITY; I-TO; ALZHEIMERS-DISEASE; VENTRICULAR MYOCYTES; POTASSIUM CHANNELS; N-TERMINUS; PROTEIN; PRESENILINS; CALSENILIN; HYPERTROPHY	Pathologic electrical remodeling and attenuated cardiac contractility are featured characteristics of heart failure. Coinciding with these remodeling events is a loss of the K+ channel interacting protein, KChIP2. While, KChIP2 enhances the expression and stability of the Kv4 family of potassium channels, leading to a more pronounced transient outward K+ current, I-to,I-f, the guinea pig myocardium is unique in that Kv4 expression is absent, while KChIP2 expression is preserved, suggesting alternative consequences to KChIP2 loss. Therefore, KChIP2 was acutely silenced in isolated guinea pig myocytes, which led to significant reductions in the Ca2+ transient amplitude and prolongation of the transient duration. This change was reinforced by a decline in sarcomeric shortening. Notably, these results were unexpected when considering previous observations showing enhanced I-Ca,I-L and prolonged action potential duration following KChIP2 loss, suggesting a disruption of fundamental Ca2+ handling proteins. Evaluation of SERCA2a, phospholamban, RyR, and sodium calcium exchanger identified no change in protein expression. However, assessment of Ca2+ spark activity showed reduced spark frequency and prolonged Ca2+ decay following KChIP2 loss, suggesting an altered state of RyR activity. These changes were associated with a delocalization of the ryanodine receptor activator, presenilin, away from sarcomeric banding to more diffuse distribution, suggesting that RyR open probability are a target of KChIP2 loss mediated by a dissociation of presenilin. Typically, prolonged action potential duration and enhanced Ca2+ entry would augment cardiac contractility, but here we see KChIP2 fundamentally disrupts Ca2+ release events and compromises myocyte contraction. This novel role targeting presenilin localization and RyR activity reveals a significance for KChIP2 loss that reflects adverse remodeling observed in cardiac disease settings.	[Nassal, Drew M.; Wan, Xiaoping; Liu, Haiyan; Laurita, Kenneth R.; Deschenes, Isabelle] Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA; [Nassal, Drew M.; Deschenes, Isabelle] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University	Deschenes, I (corresponding author), Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.; Deschenes, I (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	isabelle.deschenes@case.edu			National Institute of Health R01s [R01HL096962, 1R01HL132520]; American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate [13PRE17060106]; T32 Training Grant [HL105338-01]; NIH R01s [R01HL096962, 1R01HL132520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105338, R01HL096962, R01HL132520] Funding Source: NIH RePORTER	National Institute of Health R01s; American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate; T32 Training Grant; NIH R01s(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health R01s (R01HL096962 and 1R01HL132520) (ID), an American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate 13PRE17060106 (DMN) and a T32 Training Grant HL105338-01 (DMN).; This work was supported by NIH R01s (R01HL096962 and 1R01HL132520) (ID), an American Heart Association Pre-Doctoral Fellowship from the Great Rivers Affiliate 13PRE17060106 (DMN) and a T32 Training Grant HL105338-01 (DMN).	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cowburn RF, 2007, PHYSIOL BEHAV, V92, P93, DOI 10.1016/j.physbeh.2007.05.053; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; El-Armouche A, 2010, BIOCHEM BIOPH RES CO, V402, P340, DOI 10.1016/j.bbrc.2010.10.030; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Findlay I, 2003, AM J PHYSIOL-HEART C, V284, pH598, DOI 10.1152/ajpheart.00687.2002; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004; Jin HW, 2010, J MOL CELL CARDIOL, V48, P1169, DOI 10.1016/j.yjmcc.2009.12.019; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058334; Link WA, 2004, J NEUROSCI, V24, P5346, DOI 10.1523/JNEUROSCI.1460-04.2004; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nassal DM, 2017, ELIFE, V6, DOI 10.7554/eLife.17304; Nassal DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146561; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Payne AJ, 2013, EXP NEUROL, V250, P143, DOI 10.1016/j.expneurol.2013.09.001; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Rybalchenko V, 2008, INT J BIOCHEM CELL B, V40, P84, DOI 10.1016/j.biocel.2007.06.023; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175221	10.1371/journal.pone.0175221	http://dx.doi.org/10.1371/journal.pone.0175221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384221	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900124
J	Nordenvall, AS; Norrby, C; Butwicka, A; Frisen, L; Nordenstrom, A; Almqvist, C; Nordenskjold, A				Nordenvall, Anna Skarin; Norrby, Christina; Butwicka, Agnieszka; Frisen, Louise; Nordenstrom, Anna; Almqvist, Catarina; Nordenskjold, Agneta			Psychosocial outcomes in adult men born with hypospadias: A register-based study	PLOS ONE			English	Article							CHILDHOOD; ADJUSTMENT; SURGERY; ADOLESCENTS; CHILDREN; HEALTH; BOYS; LIFE	In this nationwide matched cohort study, we have investigated whether being born with hypospadias affect subsequent psychosocial outcomes in adulthood. We analyzed prospectively collected data from national Swedish registers. Data on the diagnoses were collected from the National Patient Register and the Medical Birth Register. Data on psychosocial outcomes such as educational and income level, marital status and disability pension were collected from Statistics Sweden. The effects of covariates, such as age, county of birth, presence of other malformations and psychiatric illness, were taken into account. The associations between hypospadias and psychosocial outcomes were calculated using conditional logistic regression and expressed as odds ratios (OR) and 95% confidence intervals (CI). We included 4378 men diagnosed with hypospadias, born between 1969 and 1993 in Sweden. Patients with hypospadias were matched with unaffected men by year of birth and birth county. We did not detect any differences in educational or income level. The probability of entering marriage (OR 1.02, 95% CI 0.90-1.14) did not differ, regardless of phenotype. We did, however, detect a 40% increased probability of receiving a disability pension, (OR 1.39, 95% CI 1.20-1.61). In conclusion, men born with hypospadias in Sweden do not differ from unaffected men with respect to the majority of psychosocial outcomes studied. They are, however, at increased risk of receiving a disability pension, which motivates further investigations.	[Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Nordenvall, Anna Skarin; Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden; [Norrby, Christina; Butwicka, Agnieszka; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Butwicka, Agnieszka] Med Univ Warsaw, Dept Child Psychiat, Warsaw, Poland; [Frisen, Louise] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Frisen, Louise] Child & Adolescent Psychiat Res Ctr, Stockholm, Sweden; [Nordenstrom, Anna] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Nordenstrom, Anna] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Endocrinol, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Medical University of Warsaw; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.; Nordenvall, AS; Nordenskjold, A (corresponding author), Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden.	anna.skarin-nordenvall@ki.se; agneta.nordenskjold@ki.se	Butwicka, Agnieszka/X-4297-2018; Nordenström, Anna/ABC-6970-2021	Butwicka, Agnieszka/0000-0002-7247-2141; Skarin Nordenvall, Anna/0000-0003-3034-9222; Nordenstrom, Anna/0000-0003-0405-3401; Nordenskjold, Agneta/0000-0001-6638-4631	Swedish Research Council [K2012-64X-14506-10-5]; Stockholm City Council; Foundation Frimurare Barnhuset in Stockholm; Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; Foundation Frimurare Barnhuset in Stockholm; Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM)	We acknowledge financial support from the Swedish Research Council grant no. K2012-64X-14506-10-5, the Stockholm City Council, the Foundation Frimurare Barnhuset in Stockholm and the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho MO, 2000, EUR UROL, V37, P95, DOI 10.1159/000020107; [Anonymous], 2016, WHO CAN RECEIVE SICK; BERG R, 1981, J UROLOGY, V125, P313, DOI 10.1016/S0022-5347(17)55019-3; BERG R, 1982, ACTA PSYCHIAT SCAND, V66, P398, DOI 10.1111/j.1600-0447.1982.tb06721.x; Butwicka A, 2015, J CHILD PSYCHOL PSYC, V56, P155, DOI 10.1111/jcpp.12290; Hardwicke JT, 2015, J PLAST RECONSTR AES; Jack SE, 2016, NELSON TXB PEDIAT, P2586; MITTENDORFER RUIZ EML, 2011, SJUKSKRIVNING PSYKIS; Mondaini N, 2002, UROL INT, V68, P81, DOI 10.1159/000048423; Mureau MAM, 1997, J PEDIATR PSYCHOL, V22, P371, DOI 10.1093/jpepsy/22.3.371; Ortqvist L, 2015, J UROLOGY, V193, P975, DOI 10.1016/j.juro.2014.09.103; Rynja SP, 2011, J PEDIATR UROL, V7, P504, DOI 10.1016/j.jpurol.2011.02.008; Rynja SP, 2009, J UROLOGY, V182, P1736, DOI 10.1016/j.juro.2009.03.073; SANDBERG DE, 1989, J PEDIATR PSYCHOL, V14, P491, DOI 10.1093/jpepsy/14.4.491; Sandberg DE, 2001, J PEDIATR PSYCHOL, V26, P465, DOI 10.1093/jpepsy/26.8.465; Schonbucher VB, 2008, J PEDIATR-US, V152, P865, DOI 10.1016/j.jpeds.2007.11.036; Thorup J, 2014, CURR OPIN ENDOCRINOL, V21, P227, DOI 10.1097/MED.0000000000000063; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Wang WW, 2010, ANDROLOGIA, V42, P384, DOI 10.1111/j.1439-0272.2010.01061.x	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174923	10.1371/journal.pone.0174923	http://dx.doi.org/10.1371/journal.pone.0174923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384289	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900053
J	Reid, VL; McDonald, R; Nwosu, AC; Mason, SR; Probert, C; Ellershaw, JE; Coyle, S				Reid, Victoria Louise; McDonald, Rachael; Nwosu, Amara Callistus; Mason, Stephen R.; Probert, Chris; Ellershaw, John E.; Coyle, Seamus			A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying	PLOS ONE			English	Review							PALLIATIVE PROGNOSTIC SCORE; SYSTEMIC INFLAMMATORY RESPONSE; TERMINALLY-ILL PATIENTS; PREDICTOR MODELS; IMPENDING DEATH; SURVIVAL-TIME; LACTATE-DEHYDROGENASE; CLINICAL SIGNS; HEART-RATE; CARE	Background The Neuberger review made a number of recommendations to improve end of life care, including research into the biology of dying. An important aspect of the biology of dying is the identification of biomarkers as indices of disease processes. Biomarkers have the potential to inform the current, limited understanding of the dying process and assist clinicians in recognising dying, in particular how to distinguish dying from reversible acute deterioration. Objectives To critically appraise the literature on biological factors that may be used as prognostic indicators in advanced cancer patients and to identify candidate biomarkers of the dying process that can be measured serially in cancer patients' bodily fluids. Methods A systematically structured review was conducted using three electronic databases. A hand search of six peer-reviewed journals and conference abstracts was also conducted. Studies reporting prognostic biomarkers in cancer patients with a median survival of <= 90 days and post-mortem studies were included. Final levels of evidence and recommendations were made using the Evidence Based Medicine modified GRADE system. Results 30 articles were included. Seven prognostic biological factors demonstrated Grade A evidence (lymphocyte count, white blood cell count, serum C-reactive protein, albumin, sodium, urea and alkaline phosphatase). An additional eleven prognostic factors were identified with Grade B evidence (platelet count, international normalised ratio, serum vitamin B12, prealbumin, bilirubin, cholesterol, aspartate aminotransferase, alanine transaminase, lactate dehydrogenase, pseudocholinesterase and urate). A number of biomarkers were specifically identified in the last two weeks of life but limitations exist. No post-mortem studies met the inclusion criteria. Conclusion The biology of dying is an important area for future research, with the evidence focused on signs, symptoms and prognostic factors. This review identifies a number of common themes shared amongst advanced cancer patients and highlights candidate biomarkers which may be indicative of a common biological process to dying.	[Reid, Victoria Louise; Nwosu, Amara Callistus; Mason, Stephen R.; Ellershaw, John E.; Coyle, Seamus] Univ Liverpool, Marie Curie Palliat Care Inst Liverpool, Liverpool, Merseyside, England; [McDonald, Rachael] Aintree Univ Hosp NHS Fdn Trust, Renal Med, Liverpool, Merseyside, England; [Probert, Chris] Univ Liverpool, Dept Gastroenterol, Liverpool, Merseyside, England	University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Liverpool	Reid, VL; Coyle, S (corresponding author), Univ Liverpool, Marie Curie Palliat Care Inst Liverpool, Liverpool, Merseyside, England.	victoria.reid@nhs.net; s.coyle@liverpool.ac.uk		Nwosu, Amara Callistus/0000-0003-0014-3741; Reid, Victoria/0000-0003-2804-8308; Mason, Stephen/0000-0002-4020-6869; Coyle, Seamus/0000-0002-4761-9703; Ellershaw, John/0000-0001-9789-3180; Probert, Christopher/0000-0003-4550-0239	Marie Curie [MCCC-FCO-11-L, MCCC-APCU-15] Funding Source: researchfish	Marie Curie(European Commission)		Abdel-Karim IA, 2007, J PALLIAT MED, V10, P894, DOI 10.1089/jpm.2006.0240; Alsirafy Samy A, 2009, J Support Oncol, V7, P154; Alsirafy SA, 2009, J PALLIAT MED, V12, P177, DOI 10.1089/jpm.2008.0200; Amano K, 2016, J PAIN SYMPTOM MANAG, V51, P860, DOI 10.1016/j.jpainsymman.2015.11.025; [Anonymous], 2006, METHODS DEV NICE PUB, P1; Baba M, 2015, EUR J CANCER, V51, P1618, DOI 10.1016/j.ejca.2015.04.025; Baba M, 2015, J PAIN SYMPTOM MANAG, V49, P853, DOI 10.1016/j.jpainsymman.2014.10.010; Barry H, 2016, ESSENTIAL EVIDENCE P; Baur M, 2001, ACTA MED AUST, V28, P135, DOI 10.1046/j.1563-2571.2001.01033.x; Bruera S, 2014, J PAIN SYMPTOM MANAG, V48, P510, DOI 10.1016/j.jpainsymman.2013.10.019; Chang C, 2012, CANCER ASSOCIATED IM; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Coyle S, 2015, EUROPEAN ASSOCIATION, V2015, P206; Coyle S, 2016, PALLIATIVE MED, V30, pNP1; Cui J, 2014, J PALLIAT MED, V17, P545, DOI 10.1089/jpm.2013.0368; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Elmehdawi RR, 2008, LIBYAN J MED, V3, P84, DOI 10.4176/071221; FAHN HJ, 1991, J UROLOGY, V145, P248, DOI 10.1016/S0022-5347(17)38305-2; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Feliu J, 2011, JNCI-J NATL CANCER I, V103, P1613, DOI 10.1093/jnci/djr388; Geissbuhler P, 2000, J PAIN SYMPTOM MANAG, V20, P93, DOI 10.1016/S0885-3924(00)00169-X; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Hawker S, 2002, QUAL HEALTH RES, V12, P1284, DOI 10.1177/1049732302238251; Ho SY, 2003, J FORMOS MED ASSOC, V102, P544; Hui D, 2015, CANCER-AM CANCER SOC, V121, P960, DOI 10.1002/cncr.29048; Hui D, 2014, ONCOLOGIST, V19, P681, DOI 10.1634/theoncologist.2013-0457; Hyodo I, 2010, JPN J CLIN ONCOL, V40, P442, DOI 10.1093/jjco/hyp182; Iwase S, 2004, EUR CYTOKINE NETW, V15, P312; Kadhim H, 2012, MED HYPOTHESES, V78, P793, DOI 10.1016/j.mehy.2012.03.010; Kadhim H, 2010, NEUROSCI LETT, V480, P122, DOI 10.1016/j.neulet.2010.06.021; Kehl KA, 2013, AM J HOSP PALLIAT ME, V30, P601, DOI 10.1177/1049909112468222; Kelly L, 2007, ANN ONCOL, V18, P1395, DOI 10.1093/annonc/mdm138; Kennedy C, 2014, BMJ SUPPORT PALLIAT, V4, P263, DOI 10.1136/bmjspcare-2013-000621; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Kim ES, 2014, KOREAN J FAM MED, V35, P283, DOI 10.4082/kjfm.2014.35.6.283; Kontoyiannis DP, 2002, CLIN INFECT DIS, V34, P400, DOI 10.1086/338404; Lam P. T., 2007, Hong Kong Medical Journal, V13, P453; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lichter I, 1990, J Palliat Care, V6, P7; Liu J, 2005, INCIDENCE PROGNOSTIC, V2, P511; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; Mallik S, 2016, SUPPORT CARE CANCER, V24, P1771, DOI 10.1007/s00520-015-2962-8; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Miura T, 2015, SUPPORT CARE CANCER, V23, P3149, DOI 10.1007/s00520-015-2693-x; Nakano T, 1998, BRIT J CANCER, V77, P907, DOI 10.1038/bjc.1998.150; Neuberger J, 2013, MORE CARE LESS PATHW, P1; Niki K, 2016, PALLIATIVE MED, V30, pNP1; O'Gorman P, 2000, NUTR CANCER, V37, P36, DOI 10.1207/S15327914NC3701_4; Pasanisi F, 2001, NUTRITION, V17, P581, DOI 10.1016/S0899-9007(01)00579-2; Paulsen O, 2016, PALLIATIVE MED, V30, pNP1; Pautex S, 2013, J PALLIAT MED, V16, P669, DOI 10.1089/jpm.2012.0369; Pedersen LM, 1996, ACTA ONCOL, V35, P691, DOI 10.3109/02841869609084000; Penel N, 2005, ORAL ONCOL, V41, P884, DOI 10.1016/j.oraloncology.2005.04.013; PERRY EK, 1982, NEUROSCI LETT, V29, P303, DOI 10.1016/0304-3940(82)90334-2; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Simmons CPL, 2017, J PAIN SYMPTOM MANAG; Strasser F, 2002, HEMATOL ONCOL CLIN N, V16, P589, DOI 10.1016/S0889-8588(02)00011-4; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Suh SY, 2007, EUR J CANCER, V43, P1051, DOI 10.1016/j.ejca.2007.01.031; Tankersley CG, 2003, J APPL PHYSIOL, V95, P1681, DOI 10.1152/japplphysiol.00190.2003; Tankersley CG, 2003, AM J PHYSIOL-REG I, V284, pR742, DOI 10.1152/ajpregu.00416.2002; Tarumi Y, 2011, J PAIN SYMPTOM MANAG, V42, P419, DOI 10.1016/j.jpainsymman.2010.12.013; Taylor P, 2015, PALLIATIVE MED, V29, P120, DOI 10.1177/0269216314554967; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Tucci M, 2009, PROSTATE CANCER P D, V12, P94, DOI 10.1038/pcan.2008.10; Vigano A, 1999, J PALLIATIVE CARE, V15, P32, DOI 10.1177/082585979901500406; Walsh D, 2002, SUPPORT CARE CANCER, V10, P523, DOI 10.1007/s00520-002-0376-x; WON C, 1983, CANCER, V52, P2261, DOI 10.1002/1097-0142(19831215)52:12<2261::AID-CNCR2820521217>3.0.CO;2-K; Wrafter S, 2016, PALLIATIVE MED, V30, pNP1; Wu CW, 1996, AM J GASTROENTEROL, V91, P1417; Yoon J, 2015, SUPPORT CARE CANCER, V23, P1735, DOI 10.1007/s00520-014-2522-7	81	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175123	10.1371/journal.pone.0175123	http://dx.doi.org/10.1371/journal.pone.0175123			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384249	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900092
J	Riba, A; Deres, L; Eros, K; Szabo, A; Magyar, K; Sumegi, B; Toth, K; Halmosi, R; Szabados, E				Riba, Adam; Deres, Laszlo; Eros, Krisztian; Szabo, Aliz; Magyar, Klara; Sumegi, Balazs; Toth, Kalman; Halmosi, Robert; Szabados, Eszter			Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; DYSFUNCTION; MINOCYCLINE; REPERFUSION; INHIBITION; THERAPY; DISEASE; ASSAY	In addition to their anti-bacterial action, tetracyclines also have complex biological effects, including the modification of mitochondrial protein synthesis, metabolism and gene-expression. Long-term clinical studies have been performed using tetracyclines, without significant side effects. Previous studies demonstrated that doxycycline (DOX), a major tetracyclin antibiotic, exerted a protective effect in animal models of heart failure; however, its exact molecular mechanism is still unknown. Here, we provide the first evidence that DOX reduces oxidative stress D induced mitochondrial fragmentation and depolarization in H9c2 cardiomyocytes and beneficially alters the expression of Mfn-2, OPA-1 and Drp-1 -the main regulators of mitochondrial fusion and fission D in our isoproterenol (ISO)-induced heart failure model, ultimately decreasing the severity of heart failure. In mitochondria, oxidative stress causes a shift toward fission which leads to mitochondrial fragmentation and cell death. Protecting mitochondria from oxidative stress, and the regulation of mitochondrial dynamics by drugs that shift the balance toward fusion, could be a novel therapeutic approach for heart failure. On the basis of our findings, we raise the possibility that DOX could be a novel therapeutic agent in the future treatment of heart failure.	[Riba, Adam; Deres, Laszlo; Eros, Krisztian; Magyar, Klara; Toth, Kalman; Halmosi, Robert; Szabados, Eszter] Univ Pecs, Dept Med 1, Pecs, Hungary; [Riba, Adam; Deres, Laszlo; Eros, Krisztian; Magyar, Klara; Sumegi, Balazs; Halmosi, Robert; Szabados, Eszter] Univ Pecs, Szentagothai ResearchCtr, Pecs, Hungary; [Szabo, Aliz; Sumegi, Balazs; Toth, Kalman] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs; Toth, Kalman] MTA PTE Nucl Mitochondrial Interact Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs	Halmosi, R (corresponding author), Univ Pecs, Dept Med 1, Pecs, Hungary.; Halmosi, R (corresponding author), Univ Pecs, Szentagothai ResearchCtr, Pecs, Hungary.	halmosi.robert@pte.hu	Halmosi, Róbert/AAK-1880-2020	Halmosi, Robert/0000-0002-6965-7743	Hungarian National Research Foundations [OTKA K104220, PTE AOK-KA-2015-05, GINOP-2.3.3-15-2016-00025, GINOP 2.3.2-15-2016-00022]; MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs	Hungarian National Research Foundations(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs	This study was supported by Hungarian National Research Foundations (OTKA K104220, PTE AOK-KA-2015-05, GINOP-2.3.3-15-2016-00025 grant, GINOP 2.3.2-15-2016-00022 grant) and MTA-PTE Nuclear-Mitochondrial Interactions Research Group, University of Pecs.	Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091848; Antonio RC, 2014, MOL CELL BIOCHEM, V386, P99, DOI 10.1007/s11010-013-1848-7; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Camp TM, 2004, J HEART LUNG TRANSPL, V23, P729, DOI 10.1016/j.healun.2003.06.005; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Chung AWY, 2008, LONG TERM DOXYCYCLIN; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deres L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102148; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Elewa MAF, 2015, CLIN EXP METASTAS, V32, P479, DOI 10.1007/s10585-015-9721-6; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Giacomotto J, 2013, HUM MOL GENET, V22, P4562, DOI 10.1093/hmg/ddt302; Godefroy E, 2014, CELL REP, V9, P1856, DOI 10.1016/j.celrep.2014.10.067; Gompels LL, 2006, J RHEUMATOL, V33, P224; Grieve D.J., 2003, OXIDATIVE STRESS HEA; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; Gupte TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126829; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352; Hori Y, 2009, BIOL PHARM BULL, V32, P1678, DOI 10.1248/bpb.32.1678; Hughes BG, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0424-y; Knowlton AA, 2014, J CARDIOVASC PHARM, V63, P196, DOI 10.1097/01.fjc.0000432861.55968.a6; LANGEVITZ P, 1992, J RHEUMATOL, V19, P1502; Liaudet L, 2000, PROTECTION HEMORRHAG; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Massie BM, J AM COLL CARDIOLOGY; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Okonko DO, 2015, NAT REV CARDIOL, V12, P6, DOI 10.1038/nrcardio.2014.189; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Ozcinar E, 2014, CARDIOVASC TOXICOL, V14, P64, DOI 10.1007/s12012-013-9231-1; Palfi A, 2006, J MOL CELL CARDIOL, V41, P149, DOI 10.1016/j.yjmcc.2006.03.427; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3; Ramani GV, 2010, MAYO CLIN PROC, V85, P180, DOI 10.4065/mcp.2009.0494; Roberts AW, 2009, DIABETES VASC DIS RE, V6, P153, DOI 10.1177/1479164109338774; Sawyer D.B., 2000, MITOCHONDRIAL OXIDAT; Schulze CJ, 2013, CRIT CARE MED, V41, P2512, DOI 10.1097/CCM.0b013e318292373c; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Smith CJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3491; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Voigt W, 2005, METH MOLEC MED, V110, P39; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252	50	33	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175195	10.1371/journal.pone.0175195	http://dx.doi.org/10.1371/journal.pone.0175195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384228	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900116
J	Heim, B; Pertl, MT; Stefani, A; Delazer, M; Heidbreder, A; Zamarian, L; Brandauer, E; Seppi, K; Hogl, B; Poewe, W; Djamshidian, A				Heim, Beatrice; Pertl, Marie-Theres; Stefani, Ambra; Delazer, Margarete; Heidbreder, Anna; Zamarian, Laura; Brandauer, Elisabeth; Seppi, Klaus; Hoegl, Birgit; Poewe, Werner; Djamshidian, Atbin			Haste makes waste: Decision making in patients with restless legs syndrome with and without augmentation	PLOS ONE			English	Article							PARKINSONS-DISEASE; REFLECTION IMPULSIVITY; SYNDROME RLS; DOPAMINERGIC AUGMENTATION; CONCLUSIONS; DISORDERS; ASSOCIATION; VALIDATION; BEHAVIORS; COMMUNITY	Objectives To investigate decision making in patients with primary restless legs syndrome (RLS) with and without augmentation treated with dopaminergic medication. Methods A total of 64 non-demented RLS patients treated with dopaminergic medication with and without augmentation were included in this study. We used an information sampling task to assess how much evidence participants gather before making a decision. Performance was compared to the results of 21 healthy controls. Results All patients with and without augmentation gathered less information than healthy controls before making a decision (p< 0.001), but there was no difference between the two patient groups (p = 1.0). Furthermore, both patient groups made more irrational decisions (e. g. decisions against the evidence they had at the time) than healthy controls (p <= 0.002). In addition, RLS patients with augmentation made significantly more irrational decisions than RLS patients without augmentation (p = 0.037) and controls (p< 0.001). Conclusions Our results show that RLS patients treated with dopaminergic drugs, regardless of having augmentation or not, jumped to conclusions and decided significantly more often against the evidence they had at the time of their decision. However, those with augmentation performed worse than all other groups and made more often irrational decisions, a phenomenon which is also common in patients with substance abuse or behavioural addictions. Thus, jumping to conclusions and deciding with a higher degree of uncertainty as well as irrational decision making is more common in RLS patients treated with dopaminergic medication particularly in those with augmentation.	[Heim, Beatrice; Pertl, Marie-Theres; Stefani, Ambra; Delazer, Margarete; Heidbreder, Anna; Zamarian, Laura; Brandauer, Elisabeth; Seppi, Klaus; Hoegl, Birgit; Poewe, Werner; Djamshidian, Atbin] Med Univ Innsbruck, Dept Neurol, Innsbruck, Tyrol, Austria; [Djamshidian, Atbin] Univ London, Dept Mol Neurosci, London, England; [Djamshidian, Atbin] Univ London, Reta Lila Weston Inst Neurol Studies, London, England	Medical University of Innsbruck; University of London; University College London; University of London; University College London	Djamshidian, A (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Tyrol, Austria.; Djamshidian, A (corresponding author), Univ London, Dept Mol Neurosci, London, England.; Djamshidian, A (corresponding author), Univ London, Reta Lila Weston Inst Neurol Studies, London, England.	atbin.djamshidian-tehrani@i-med.ac.at	Zamarian, Laura/J-9575-2018; Heidbreder, Anna/GLR-3355-2022; Stefani, Ambra/AAK-2172-2020	Zamarian, Laura/0000-0002-1640-4179; Heidbreder, Anna/0000-0002-9552-7619; Stefani, Ambra/0000-0003-4259-8824; Heim, Beatrice/0000-0002-6749-3044; Seppi, Klaus/0000-0001-6503-1455; Hogl, Birgit/0000-0003-1894-7641; Delazer, Margarete/0000-0001-6482-4445; Djamshidian, Atbin/0000-0001-7174-6000				Al-Khaled M, 2015, PARKINSONISM RELAT D, V21, P1330, DOI 10.1016/j.parkreldis.2015.09.026; Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Banca P, 2015, ADDICT BIOL; Bayard S, 2013, SLEEP, V36, P1501, DOI 10.5665/sleep.3044; Bayard S, 2010, MOVEMENT DISORD, V25, P2634, DOI 10.1002/mds.23326; Chang Y, 2015, CLIN IMAG, V39, P20, DOI 10.1016/j.clinimag.2014.07.010; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Cornelius JR, 2010, SLEEP, V33, P81; Costa FHD, 2016, NEUROPSYCHOLOGIA, V85, P19, DOI 10.1016/j.neuropsychologia.2016.03.002; Djamshidian A, 2013, J PARKINSON DIS, V3, P139, DOI 10.3233/JPD-130178; Djamshidian A, 2013, ADDICTION, V108, P771, DOI 10.1111/add.12080; Djamshidian A, 2012, MOVEMENT DISORD, V27, P1137, DOI 10.1002/mds.25105; Evans SL, 2015, NEUROPSYCH DIS TREAT, V11, P1615, DOI 10.2147/NDT.S56870; Fulda S, 2010, MOVEMENT DISORD, V25, P2641, DOI 10.1002/mds.23353; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Gamaldo CE, 2008, SLEEP MED, V9, P500, DOI 10.1016/j.sleep.2007.07.014; Garcia-Borreguero D, 2016, SLEEP MED IN PRESS; Garcia-Borreguero D, 2007, MOVEMENT DISORD, V22, pS476, DOI 10.1002/mds.21610; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garcia-Borreguero D, 2016, SLEEP MED, V21, P1, DOI 10.1016/j.sleep.2016.01.017; Garety P, 2013, SCHIZOPHR RES, V150, P570, DOI 10.1016/j.schres.2013.08.035; Heim B, 2016, NEUROLOGY, V87, P36, DOI 10.1212/WNL.0000000000002803; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Kalaydjian A, 2009, SLEEP MED, V10, P672, DOI 10.1016/j.sleep.2008.07.004; Lee HB, 2008, J NEUROPSYCH CLIN N, V20, P101, DOI 10.1176/jnp.2008.20.1.101; Lee HB, 2014, J NEUROPSYCH CLIN N, V26, P87, DOI 10.1176/appi.neuropsych.12120394; Lunt L, 2012, J NEUROPSYCHOL, V6, P65, DOI 10.1111/j.1748-6653.2011.02005.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pearson VE, 2006, SLEEP MED, V7, P25, DOI 10.1016/j.sleep.2005.05.006; Poletti M, 2012, MOVEMENT DISORD, V27, P1679, DOI 10.1002/mds.25129; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Scholz H, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-73; Voon V, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv074; Voon V, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-117; Voon V, 2010, PSYCHOPHARMACOLOGY, V207, P645, DOI 10.1007/s00213-009-1697-y; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Winkelmann J, 2005, J NEUROL, V252, P67, DOI 10.1007/s00415-005-0604-7; Ye Z, 2011, HUM BRAIN MAPP, V32, P800, DOI 10.1002/hbm.21067	39	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174793	10.1371/journal.pone.0174793	http://dx.doi.org/10.1371/journal.pone.0174793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380045	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500064
J	Mifsud, B; Martincorena, I; Darbo, E; Sugar, R; Schoenfelder, S; Fraser, P; Luscombe, NM				Mifsud, Borbala; Martincorena, Inigo; Darbo, Elodie; Sugar, Robert; Schoenfelder, Stefan; Fraser, Peter; Luscombe, Nicholas M.			GOTHiC, a probabilistic model to resolve complex biases and to identify real interactions in Hi-C data	PLOS ONE			English	Article							HUMAN GENOME; CHROMATIN; ORGANIZATION; PRINCIPLES	Hi-C is one of the main methods for investigating spatial co-localisation of DNA in the nucleus. However, the raw sequencing data obtained from Hi-C experiments suffer from large biases and spurious contacts, making it difficult to identify true interactions. Existing methods use complex models to account for biases and do not provide a significance threshold for detecting interactions. Here we introduce a simple binomial probabilistic model that resolves complex biases and distinguishes between true and false interactions. The model corrects biases of known and unknown origin and yields a p-value for each interaction, providing a reliable threshold based on significance. We demonstrate this experimentally by testing the method against a random ligation dataset. Our method outperforms previous methods and provides a statistical framework for further data analysis, such as comparisons of Hi-C interactions between different conditions. GOTHiC is available as a BioConductor package (http://www.bioconductor.org/packages/release/bioc/html/GOTHiC.html).	[Mifsud, Borbala; Martincorena, Inigo; Darbo, Elodie; Sugar, Robert; Luscombe, Nicholas M.] Francis Crick Inst, London, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London, England; [Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Okinawa, Japan; [Mifsud, Borbala] Queen Mary Univ London, Sch Med & Dent, William Harvey Res Inst, London, England; [Martincorena, Inigo] Wellcome Trust Sanger Inst, Hinxton, England; [Darbo, Elodie] Bordeaux Bioinformat Ctr, Bordeaux, France	Francis Crick Institute; University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Okinawa Institute of Science & Technology Graduate University; University of London; Queen Mary University London; Wellcome Trust Sanger Institute	Mifsud, B (corresponding author), Francis Crick Inst, London, England.; Mifsud, B (corresponding author), UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London, England.; Mifsud, B (corresponding author), Queen Mary Univ London, Sch Med & Dent, William Harvey Res Inst, London, England.	b.mifsud@qmul.ac.uk	Mifsud, Borbala/AAB-5379-2020	Martincorena, Inigo/0000-0003-1122-4416; Mifsud, Borbala/0000-0003-3429-3094	MRC [MR/L016311/1] Funding Source: UKRI; Medical Research Council [MR/L016311/1] Funding Source: Medline; Cancer Research UK [16358, 21777] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); The Francis Crick Institute		Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bau A D, 2010, NATURE, V18, P107; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Hu M, 2012, BIOINFORMATICS; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin F, ALL RIGHTS RESERVED, V503, P290; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Li W, 2014, BIOINFORMATICS, P1; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Shavit Y, 2014, MOL BIOSYST, V10, P1576, DOI 10.1039/c4mb00142g; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	17	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174744	10.1371/journal.pone.0174744	http://dx.doi.org/10.1371/journal.pone.0174744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379994	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500062
J	Huhn, SC; Liu, J; Ye, C; Lu, H; Jiang, X; Feng, X; Ganesan, S; White, E; Shen, Z				Huhn, S. C.; Liu, J.; Ye, C.; Lu, H.; Jiang, X.; Feng, X.; Ganesan, S.; White, E.; Shen, Z.			Regulation of spindle integrity and mitotic fidelity by BCCIP	ONCOGENE			English	Article							XENOPUS EGG EXTRACTS; MICROTUBULE ATTACHMENT; CHROMOSOME INSTABILITY; SELF-ORGANIZATION; MOTHER CENTRIOLE; TUMOR-SUPPRESSOR; DNA-DAMAGE; CENTROSOMES; PROTEIN; CANCER	Centrosomes together with the mitotic spindle ensure the faithful distribution of chromosomes between daughter cells, and spindle orientation is a major determinant of cell fate during tissue regeneration. Spindle defects are not only an impetus of chromosome instability but are also a cause of developmental disorders involving defective asymmetric cell division. In this work, we demonstrate BCCIP, especially BCCIP alpha, as a previously unidentified component of the mitotic spindle pole and the centrosome. We demonstrate that BCCIP localizes proximal to the mother centriole and participates in microtubule organization and then redistributes to the spindle pole to ensure faithful spindle architecture. We find that BCCIP depletion leads to morphological defects, disoriented mitotic spindles, chromosome congression defects and delayed mitotic progression. Our study identifies BCCIP as a novel factor critical for microtubule regulation and explicates a mechanism utilized by BCCIP in tumor suppression.	[Huhn, S. C.; Liu, J.; Ye, C.; Lu, H.; Jiang, X.; Feng, X.; Ganesan, S.; White, E.; Shen, Z.] Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA; [Huhn, S. C.; Liu, J.; Ye, C.; Lu, H.; Jiang, X.; Feng, X.; Shen, Z.] Rutgers Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA; [Ganesan, S.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ USA; [White, E.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ USA; [Jiang, X.] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Jilin University	Shen, Z (corresponding author), Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Radiat Oncol, 195 Little Albany St, New Brunswick, NJ USA.	shenzh@cinj.rutgers.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065; Shen, Zhiyuan/0000-0003-2834-0309; Feng, Xing/0000-0002-2253-4180; feng, xing/0000-0001-8226-3389	NIH [R01CA156706, R01CA195612-01]; New Jersey Commission on Cancer Research Pre-Doctoral fellowship [DFHS15PPC042]; Histopathology and Imaging shared resources of The Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [R01CA156706, R01CA115488, R01CA195612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research Pre-Doctoral fellowship; Histopathology and Imaging shared resources of The Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH R01CA156706 and R01CA195612-01 to ZS, by New Jersey Commission on Cancer Research Pre-Doctoral fellowship (DFHS15PPC042) to SH and by the Histopathology and Imaging shared resources of The Cancer Institute of New Jersey (P30CA072720).	Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Fan JJ, 2009, CELL CYCLE, V8, P3019; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hernandez P, 2010, DIS MODEL MECH, V3, P304, DOI 10.1242/dmm.004507; Hori A, 2014, EMBO REP, V15, P175, DOI 10.1002/embr.201337929; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Huang YY, 2013, CANCER RES, V73, P7122, DOI 10.1158/0008-5472.CAN-13-1766; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; King JM, 2000, J CELL SCI, V113, P3815; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lu HM, 2005, MOL CELL BIOL, V25, P1949, DOI 10.1128/MCB.25.5.1949-1957.2005; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Lu HM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002291; Mao NH, 2007, DNA REPAIR, V6, P1651, DOI 10.1016/j.dnarep.2007.05.012; Meng XB, 2003, GENE, V302, P139, DOI 10.1016/S0378-1119(02)01098-3; Meng XB, 2007, J BIOL CHEM, V282, P1570, DOI 10.1074/jbc.M607520200; Merdes A, 1997, J CELL BIOL, V138, P953, DOI 10.1083/jcb.138.5.953; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Mogensen MM, 2000, J CELL SCI, V113, P3013; Namba M, 1996, CRIT REV ONCOGENESIS, V7, P19, DOI 10.1615/CritRevOncog.v7.i1-2.20; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Salisbury JL, 2003, CURR BIOL, V13, pR88, DOI 10.1016/S0960-9822(03)00033-2; Sehrawat S, 2011, BLOOD, V117, P708, DOI 10.1182/blood-2010-02-268870; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang HF, 2011, CANCER RES, V71, P68, DOI 10.1158/0008-5472.CAN-10-0030; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Waters JC, 1996, J CELL SCI, V109, P2823; Wyler E, 2014, FEBS LETT, V588, P3685, DOI 10.1016/j.febslet.2014.08.013; Yang YF, 2014, P NATL ACAD SCI USA, V111, P2158, DOI 10.1073/pnas.1319341111; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017	64	16	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4750	4766		10.1038/onc.2017.92	http://dx.doi.org/10.1038/onc.2017.92			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28394342	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000407702400008
J	Rueckert, C; Rand, U; Roy, U; Kasmapour, B; Strowig, T; Guzman, CA				Rueckert, Christine; Rand, Ulfert; Roy, Urmi; Kasmapour, Bahram; Strowig, Till; Guzman, Carlos A.			Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING	FASEB JOURNAL			English	Article						adjuvant; immune response; vaccine development; regulation inflammatory response; pathogen recognition receptor	C-DI-GMP; BETA INTERFERON; DNA SENSOR; KAPPA-B; AMP; 2ND-MESSENGER; ACTIVATION; CGAS; TBK1; PHOSPHORYLATION	The cyclic dinucleotides, GMP AMP (cGAMP) and c-di-AMP [bis-(3',5')-cyclic dimeric AMP], are potent type I IFN inducers via STING-TBK1-IRF3 cascade. They are promising adjuvants that promote antigen-specific humoral and cellular immune responses in different preclinical models; however, an optimal outcome of vaccination depends on a balanced immune activation. Here, we characterize the process of IFN-beta induction by c-di-AMP and cGAMP in an in vitro model on the basis of primary mouse dendritic cells. Results obtained show decreased IFN-beta production upon prolonged cell stimulation. We demonstrate that this effect depends on c-di-AMP/cGAMP-mediated down-regulation of stimulator of IFN gene (STING) protein levels. These results were confirmed by using human peripheral blood mononuclear cell derived dendritic cells. Studies performed to explore the potential mechanism of STING modulation suggested proteolytic degradation to be a contributing factor to the observed decrease in cellular STING levels. Our work contributes to the elucidation of the molecular mode of action of vaccine constituents, which, in turn, is a prerequisite for the rational design of vaccines with predictable efficacy and safety profiles Rueckert, C., Rand, U., Roy, U., Kasmapour, B., Strowig, T., Guzman, C. A. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.	[Rueckert, Christine; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Vaccinol Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Rand, Ulfert; Kasmapour, Bahram] Helmholtz Ctr Infect Res, Immune Aging & Chron Infect Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Roy, Urmi; Strowig, Till] Helmholtz Ctr Infect Res, Microbial Immune Regulat Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Rueckert, Christine] CureVac AG, Tubingen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; CureVac N.V.	Guzman, CA (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	carlos.guzman@helmholtz-hzi.de		Strowig, Till/0000-0003-0185-1459	German Research Foundation (DFG) [RA 2377/2-1]; European Union (UniVax) [601738]; Helmholtz Association (HAI-IDR) [SO-073]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union (UniVax); Helmholtz Association (HAI-IDR)	The authors thank Ulrich Kalinke (Twincore, Hannover, Germany) for providing IFNR<SUP>-/-</SUP> mice, Elena Reinhard for excellent technical assistance, Ivana Skrnjug for handling IFNR<SUP>-/-</SUP> mice, and Blair Prochnow (all from Hemholtz Centre for Infection Research) for critically reading the manuscript. This work was supported, in part, by the German Research Foundation (DFG; Grant RA 2377/2-1), European Union (UniVax; Grant 601738), and the Helmholtz Association (HAI-IDR; Grant SO-073). C.A.G. is named as inventor in a patent application covering the use of c-di-AMP as adjuvant (PCT/EP 2006010693)	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen LH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004301; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schwartz KT, 2012, INFECT IMMUN, V80, P1537, DOI 10.1128/IAI.06286-11; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110150; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095728; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang YM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005012; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	43	12	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3107	3115		10.1096/fj.201601093R	http://dx.doi.org/10.1096/fj.201601093R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28396343				2022-12-26	WOS:000405931000034
J	Ibusuki, R; Uto, H; Oda, K; Ohshige, A; Tabu, K; Mawatari, S; Kumagai, K; Kanmura, S; Tamai, T; Moriuchi, A; Tsubouchi, H; Ido, A				Ibusuki, Rie; Uto, Hirofumi; Oda, Kohei; Ohshige, Akihiko; Tabu, Kazuaki; Mawatari, Seiichi; Kumagai, Kotaro; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Tsubouchi, Hirohito; Ido, Akio			Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED LIVER-INJURY; RAT-LIVER; DISEASE; MICE; DEFENSINS; CELLS; EXPRESSION; ALPHA-DEFENSIN-1; STEATOHEPATITIS	Background and aims Neutrophil infiltration of the liver is a typical feature of alcoholic liver injury. Human neutrophil peptide (HNP)-1 is an antimicrobial peptide secreted by neutrophils. The aim of this study was to determine if HNP-1 affects ethanol-induced liver injury and to examine the mechanism of liver injury induced by HNP-1. Methods Transgenic (TG) mice expressing HNP-1 under the control of a beta-actin-based promoter were established. Ethanol was orally administered to HNP-1 TG or wild-type C57BL/6N (WT) mice. SK-Hep1 hepatocellular carcinoma cells were used to investigate the effect of HNP-1 on hepatocytes in vitro. Results After 24 weeks of ethanol intake, hepatic fibrosis and hepatocyte apoptosis were significantly more severe in TG mice than in WT mice. Levels of CD14, TLR4, and IL-6 in liver tissues were higher in TG mice than in WT mice. Apoptosis was accompanied by higher protein levels of caspase-3, caspase-8, and cleaved PARP in liver tissue. In addition, phosphorylated ASK1, ASK1, phosphorylated JNK, JNK1, JNK2, Bax, Bak and Bim were all more abundant in TG mice than in WT mice. In contrast, the level of anti-apoptotic Bcl2 in the liver was significantly lower in TG mice than in WT mice. Analysis of microRNAs in liver tissue showed that miR-34a-5p expression was significantly higher in TG mice than in WT mice. Furthermore, in the presence of ethanol, HNP-1 increased the apoptosis with the decreased level of Bcl2 in a concentration-dependent manner in vitro. Conclusions HNP-1 secreted by neutrophils may exacerbate alcohol-induced hepatic fibrosis and hepatocyte apoptosis with a decrease in Bcl2 expression and an increase in miR-34a-5p expression.	[Ibusuki, Rie; Uto, Hirofumi; Ohshige, Akihiko; Tabu, Kazuaki; Mawatari, Seiichi; Kumagai, Kotaro; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Japan; [Ibusuki, Rie] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima, Japan; [Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan; [Oda, Kohei; Tsubouchi, Hirohito; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima City Hospital	Uto, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Japan.; Uto, H (corresponding author), Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23249043]; Ministry of Health, Labour and Welfare of Japan [H20-Hepatitis-general-008]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23249043), and the Ministry of Health, Labour and Welfare of Japan (H20-Hepatitis-general-008).	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; BENEDETTI A, 1988, J HEPATOL, V6, P137, DOI 10.1016/S0168-8278(88)80024-2; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; BUSAM KJ, 1990, J HEPATOL, V11, P367, DOI 10.1016/0168-8278(90)90223-E; CH P., 1952, ALCOHOL CULTURE AND; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Dabirian S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002491; Dippold RP, 2013, ALCOHOL CLIN EXP RES, V37, pE59, DOI 10.1111/j.1530-0277.2012.01852.x; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Gaspar D, 2015, BBA-MOL CELL RES, V1853, P308, DOI 10.1016/j.bbamcr.2014.11.006; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Grigat J, 2007, J IMMUNOL, V179, P3958, DOI 10.4049/jimmunol.179.6.3958; Hashimoto S, 2012, INFLAMM BOWEL DIS, V18, P667, DOI 10.1002/ibd.21855; Horie Y, 2011, CLIN RES HEPATOL GAS, V35, P738, DOI 10.1016/j.clinre.2011.07.005; Hui CK, 2003, J HEPATOL, V38, P511, DOI 10.1016/S0168-8278(03)00004-7; Ibusuki R, 2013, LIVER INT, V33, P1549, DOI 10.1111/liv.12203; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 2002, ALCOHOL, V27, P23, DOI 10.1016/S0741-8329(02)00200-8; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Kanmura S, 2009, INFLAMM BOWEL DIS, V15, P909, DOI 10.1002/ibd.20854; Khandoga A, 2005, BLOOD, V106, P725, DOI 10.1182/blood-2004-11-4416; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Li D, 2014, ONCOL REP, V31, P1287, DOI 10.3892/or.2013.2947; Liu CY, 2007, LIFE SCI, V80, P749, DOI 10.1016/j.lfs.2006.11.016; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Morio Y, 2013, TOXICOL IN VITRO, V27, P1820, DOI 10.1016/j.tiv.2013.05.009; Natori S, 2001, J HEPATOL, V34, P248, DOI 10.1016/S0168-8278(00)00089-1; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Rehm J, 2013, ALCOHOL RES-CURR REV, V35, P174; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; van den Broek I, 2010, J CHROMATOGR B, V878, P1085, DOI 10.1016/j.jchromb.2010.03.014; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Wang YS, 2009, CLIN CANCER RES, V15, P6901, DOI 10.1158/1078-0432.CCR-09-0484; Welling MM, 1998, J CLIN INVEST, V102, P1583, DOI 10.1172/JCI3664; Xu N, 2008, MOL CANCER THER, V7, P1588, DOI 10.1158/1535-7163.MCT-08-0010; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737	52	13	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174913	10.1371/journal.pone.0174913	http://dx.doi.org/10.1371/journal.pone.0174913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403148	gold, Green Published, Green Submitted			2022-12-26	WOS:000399955200025
J	Lempp, C; Jungwirth, N; Grilo, ML; Reckendorf, A; Ulrich, A; van Neer, A; Bodewes, R; Pfankuche, VM; Bauer, C; Osterhaus, ADME; Baumgartner, W; Siebertf, U				Lempp, Charlotte; Jungwirth, Nicole; Grilo, Miguel L.; Reckendorf, Anja; Ulrich, Arlene; van Neer, Abbo; Bodewes, Rogier; Pfankuche, Vanessa M.; Bauer, Christian; Osterhaus, Albert D. M. E.; Baumgaertner, Wolfgang; Siebertf, Ursula			Pathological findings in the red fox (Vulpes vulpes), stone marten (Martes foina) and raccoon dog (Nyctereutes procyonoides), with special emphasis on infectious and zoonotic agents in Northern Germany	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; FELINE LEUKEMIA-VIRUS; TOXOPLASMA-GONDII; NEOSPORA-CANINUM; HUMAN ANELLOVIRUSES; WILD CARNIVORES; VIRAL-PROTEINS; DOMESTIC DOGS; SAXONY-ANHALT; EXPRESSION	Anthropogenic landscape changes contributed to the reduction of availability of habitats to wild animals. Hence, the presence of wild terrestrial carnivores in urban and peri-urban sites has increased considerably over the years implying an increased risk of interspecies spill-over of infectious diseases and the transmission of zoonoses. The present study provides a detailed characterisation of the health status of the red fox (Vulpes vulpes), stone marten (Martes foina) and raccoon dog (Nyctereutes procyonoides) in their natural rural and peri-urban habitats in Schleswig-Holstein, Germany between November 2013 and January 2016 with focus on zoonoses and infectious diseases that are potentially threatening to other wildlife or domestic animal species. 79 red foxes, 17 stone martens and 10 raccoon dogs were collected from traps or hunts. In order to detect morphological changes and potential infectious diseases, necropsy and pathohistological work-up was performed. Additionally, in selected animals immunohistochemistry (influenza A virus, parvovirus, feline leukemia virus, Borna disease virus, tick-borne encephalitis, canine adenovirus, Neospora caninum, Toxoplasma gondii and Listeria monocytogenes), next-generation sequencing, polymerase chain reaction (fox circovirus) and serum-neutralisation analysis (canine distemper virus) were performed. Furthermore, all animals were screened for fox rabies virus (immunofluorescence), canine distemper virus (immunohistochemistry) and Aujeszky's disease (virus cultivation). The most important findings included encephalitis (n = 16) and pneumonia (n = 20). None of the investigations revealed a specific cause for the observed morphological alterations except for one animal with an elevated serum titer of 1:160 for canine distemper. Animals displayed macroscopically and/or histopathologically detectable infections with parasites, including Taenia sp., Toxocara sp. and Alaria alata. In summary, wildlife predators carry zoonotic parasitic disease and suffer from inflammatory diseases of yet unknown etiology, possibly bearing infectious potential for other animal species and humans. This study highlights the value of monitoring terrestrial wildlife following the "One Health" notion, to estimate the incidence and the possible spread of zoonotic pathogens and to avoid animal to animal spillover as well as transmission to humans.	[Lempp, Charlotte; Jungwirth, Nicole; Pfankuche, Vanessa M.; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany; [Jungwirth, Nicole; Pfankuche, Vanessa M.; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Grilo, Miguel L.; Reckendorf, Anja; Ulrich, Arlene; van Neer, Abbo; Siebertf, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Schleswig Holst, Germany; [Bodewes, Rogier] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands; [Bauer, Christian] Justus Liebig Univ, Inst Parasitol, Giessen, Germany; [Osterhaus, Albert D. M. E.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Lower Saxony, Germany; [Bodewes, Rogier] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Erasmus University Rotterdam; Erasmus MC; Justus Liebig University Giessen; University of Veterinary Medicine Hannover, Foundation; Utrecht University	Baumgartner, W (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Lower Saxony, Germany.; Baumgartner, W (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Christian, Bauer/P-7293-2017	Christian, Bauer/0000-0002-6671-2102; Bodewes, Rogier/0000-0002-0689-7889; Reckendorf, PhD, Anja/0000-0002-2428-6280; van Neer, Abbo/0000-0002-3519-0356; Grilo, Miguel/0000-0001-7364-821X	Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein; German Hunting Union; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; COMPARE project; European Union's Horizon research and innovation program COMPARE [643476]	Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein; German Hunting Union; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; COMPARE project; European Union's Horizon research and innovation program COMPARE	The investigation was funded by the Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein and the German Hunting Union and partly supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany, and by the COMPARE project and received funding from the European Union's Horizon 2020 research and innovation program COMPARE (grant agreement no. 643476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The investigation was funded by the Ministry of Energy, Agriculture, the Environment and Rural Affairs of Schleswig-Holstein and the German Hunting Union and partly supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany and by the COMPARE project. Funding was also received from the European Union's Horizon 2020 research and innovation program COMPARE (grant agreement no. 643476). The authors wish to thank Bettina Buck, Petra Grunig, Caroline Schutz and Danuta Waschke for their excellent technical assistance. Furthermore, the authors would like to thank the local hunters for their cooperation in handing over animals, as well as Jorg Driver, Neele Gundlach, Eva Ludes-Wehrmeister, Steffen Mumme, Emilie Ulrikka Andersen-Ranberg, Peter Wohlsein, Frauke Seehusen, Christina Puff, Ingo Gerhauser, Kathrin Becker, Iris Volker, Stefanie Lapp, Aimara Bello, Barbara Raddatz and Malgorzata Ciurkiewicz for sampling and examining animals and for their scientific advice and assistance.	Akerstedt J, 2010, J WILDLIFE DIS, V46, P474, DOI 10.7589/0090-3558-46.2.474; ALLDINGER S, 1993, ARCH VIROL, V132, P421, DOI 10.1007/BF01309550; ALLDINGER S, 1993, ACTA NEUROPATHOL, V85, P635, DOI 10.1007/BF00334674; [Anonymous], 2007, WILDSCHWEINFLEISCH K; [Anonymous], 2016, WORLD POPULATION TRE; [Anonymous], 2015, JAGD ARTENSCHUTZ JAH; [Anonymous], 2016, ECHINOCOCCOSIS WHO; APPEL M, 1973, AM J VET RES, V34, P1459; Ballard WB, 2001, J WILDLIFE DIS, V37, P133, DOI 10.7589/0090-3558-37.1.133; Bartova E, 2016, ANN AGR ENV MED, V23, P84, DOI 10.5604/12321966.1196858; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Baumgartner W, 2003, DEUT TIERARZTL WOCH, V110, P137; BAUMGARTNER W, 1989, ACTA NEUROPATHOL, V78, P504, DOI 10.1007/BF00687712; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Bexton S, 2015, EMERG INFECT DIS, V21, P1205, DOI 10.3201/eid2107.150228; Bodewes R, 2013, VIROLOGY, V440, P84, DOI 10.1016/j.virol.2013.02.011; Bodewes R, 2015, EMERG INFECT DIS, V21, P720, DOI 10.3201/eid2104.141675; Bodewes R, 2015, J VIROL METHODS, V214, P54, DOI 10.1016/j.jviromet.2015.02.002; Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Bodewes R, 2014, J GEN VIROL, V95, P2480, DOI 10.1099/vir.0.068700-0; Bourg M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0608-1; Brack M., 1998, Primate Report, V50, P71; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Butina TV, 2010, VET MICROBIOL, V144, P192, DOI 10.1016/j.vetmic.2009.12.027; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Denzin N, 2014, TRANSBOUND EMERG DIS, V61, P239, DOI 10.1111/tbed.12026; Denzin N, 2013, VET MICROBIOL, V162, P214, DOI 10.1016/j.vetmic.2012.08.031; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Deplazes P, 2004, TRENDS PARASITOL, P20; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Eckert J., 2001, WHO OIE MANUAL ECHIN; ELDER JH, 1987, J VIROL, V61, P8, DOI 10.1128/JVI.61.1.8-15.1987; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143; Gottstein B, 2015, TRENDS PARASITOL, V31, P407, DOI 10.1016/j.pt.2015.06.001; Gozdzik K, 2011, PARASITOL RES, V108, P991, DOI 10.1007/s00436-010-2143-0; Haist V, 2008, EMERG INFECT DIS, V14, P988, DOI 10.3201/eid1406.071463; Heinrich F, 2015, VET IMMUNOL IMMUNOP, V168, P140, DOI 10.1016/j.vetimm.2015.10.015; Herr J, 2008, DISSERTATION; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Institut RK., 2006, EP FUCHSB DEUTSCHL D; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Jungwirth N, 2014, VET MICROBIOL, V170, P403, DOI 10.1016/j.vetmic.2014.02.029; Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kipar A, 2000, VET PATHOL, V37, P129, DOI 10.1354/vp.37-2-129; Klein S, 2010, J COMP PATHOL, V142, P228, DOI 10.1016/j.jcpa.2009.08.155; Klopfleisch R, 2007, J COMP PATHOL, V137, P155, DOI 10.1016/j.jcpa.2007.06.001; Kreutzer M, 2008, ARCH VIROL, V153, P187, DOI 10.1007/s00705-007-1070-6; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Laurimaa L, 2016, VET PARASITOL, V219, P24, DOI 10.1016/j.vetpar.2016.01.020; Leal FE, 2007, CLIN INFECT DIS, V44, pE62, DOI 10.1086/511871; Lobato J, 2006, CLIN VACCINE IMMUNOL, V13, P84, DOI 10.1128/CVI.13.1.84-89.2006; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Manzin A, 2015, J INFECT DEV COUNTR, V9, P562, DOI 10.3855/jidc.6912; Meredith AL, 2015, TRANSBOUND EMERG DIS, V62, P148, DOI 10.1111/tbed.12091; Mohl K, 2009, PARASITOL RES, V105, P1, DOI 10.1007/s00436-009-1444-7; Muller T, 2015, VET J, V203, P10, DOI 10.1016/j.tvjl.2014.10.026; Murphy TM, 2007, VET PARASITOL, V146, P227, DOI 10.1016/j.vetpar.2007.02.017; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Pawlowski ZS., 2001, WHO OIE MANUAL ECHIN; Plumer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115124; Prachayangprecha S, 2014, J CLIN MICROBIOL, V52, P3722, DOI 10.1128/JCM.01641-14; Pruss H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12805; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Reynolds BS, 2013, J FELINE MED SURG, V15, P3, DOI 10.1177/1098612X13495234; Schaudien D, 2007, J COMP PATHOL, V137, P151, DOI 10.1016/j.jcpa.2007.05.007; Schaudien D, 2010, J CLIN MICROBIOL, V48, P3169, DOI 10.1128/JCM.01582-09; Schurch AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105227; Schwab S, 2007, J COMP PATHOL, V136, P96, DOI 10.1016/j.jcpa.2006.11.006; Scott DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099059; Seehusen F, 2007, ACTA NEUROPATHOL, V114, P597, DOI 10.1007/s00401-007-0307-5; Seeley KE, 2016, J ZOO WILDLIFE MED, V47, P83, DOI 10.1638/2014-0198.1; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Stuart P, 2013, PARASITOL RES, V112, P3587, DOI 10.1007/s00436-013-3544-7; Tabaran F, 2013, EMERG INFECT DIS, V19, P1547, DOI 10.3201/eid1909.130081; van Baalen CA, 2014, J CLIN MICROBIOL, V52, P1672, DOI 10.1128/JCM.03575-13; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; VANMOLL P, 1995, VET MICROBIOL, V44, P193, DOI 10.1016/0378-1135(95)00012-Y; Viana M, 2015, P NATL ACAD SCI USA, V112, P1464, DOI 10.1073/pnas.1411623112; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Weber A., 2003, HEIMTIERHALTUNG CHAN; Weissenbock H, 1998, ACTA NEUROPATHOL, V95, P361, DOI 10.1007/s004010050811	88	31	31	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175469	10.1371/journal.pone.0175469	http://dx.doi.org/10.1371/journal.pone.0175469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399176	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000042
J	Omachi, T; Ichikawa, T; Kimura, Y; Ueda, K; Kioka, N				Omachi, Tomohiro; Ichikawa, Takafumi; Kimura, Yasuhisa; Ueda, Kazumitsu; Kioka, Noriyuki			Vinculin association with actin cytoskeleton is necessary for stiffness-dependent regulation of vinculin behaviore	PLOS ONE			English	Article							FOCAL ADHESIONS; CELL; ACTIVATION; TALIN; RECRUITMENT; VINEXIN; ORGANIZATION; COMPLEX; PROTEIN	The extracellular matrix (ECM) is a major regulator of cell behavior. Recent studies have indicated the importance of the physical properties of the ECM, including its stiffness, for cell migration and differentiation. Using actomyosin-generated forces, cells pull the ECM and sense stiffness via cell-ECM adhesion structures called focal adhesions (FAs). Vinculin, an actin-binding FA protein, has emerged as a major player in FA-mediated mechanotransduction. Although vinculin is important for sensing ECM stiffness, the role of vinculin binding to actin in the ECM stiffness-mediated regulation of vinculin behavior remains unknown. Here, we show that an actin binding-deficient mutation disrupts the ECM stiffness-dependent regulation of CSB (cytoskeleton stabilization buffer) resistance and the stable localization of vinculin. These results suggest that the vinculin-actin interaction participates in FA-mediated mechanotransduction.	[Omachi, Tomohiro; Ichikawa, Takafumi; Kimura, Yasuhisa; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Ichikawa, Takafumi; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.; Kioka, N (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto, Japan.	nkioka@kais.kyoto-u.ac.jp		Kimura, Yasuhisa/0000-0001-6466-1324; Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Naito Foundation; Japan Society for the Promotion of Science [24380185, 26660291, 16K15090]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25221203, 26112707]; Japan Agency for Medical Research and development	Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by The Naito Foundation(NK), a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24380185)(NK), a Grant-in-aid for Exploratory Research (JSPS KAKENHI Grant Number 26660291, 16K15090)(NK) from The Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), Grants-in-Aid for Scientific Research (S) (25221203)(KU) and a Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 26112707) (NK) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http//www.mext.go.jp/en/), and the Advanced Research and Development Programs for Medical Innovation (NK) from Japan Agency for Medical Research and development (http://www.amed.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton P, 2016, EXP CELL RES, V343, P21, DOI 10.1016/j.yexcr.2015.11.017; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Golji J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002995; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Holle AW, 2013, STEM CELLS, V31, P2467, DOI 10.1002/stem.1490; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Jannie KM, 2015, BIOCHEM J, V465, P383, DOI 10.1042/BJ20140872; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Kim LY, 2016, J MOL BIOL, V428, P10, DOI 10.1016/j.jmb.2015.09.031; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Kioka N, 2010, EXP CELL RES, V316, P1728, DOI 10.1016/j.yexcr.2010.03.019; Kuroda M, 2017, J CELL SCI; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Nagasato AI, 2017, BIOSCI BIOTECH BIOCH, V81, P1136, DOI 10.1080/09168451.2017.1289074; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson PM, 2014, STRUCTURE, V22, P697, DOI 10.1016/j.str.2014.03.002; Xu WM, 1998, DEVELOPMENT, V125, P327; Yamashita H, 2014, J CELL SCI, V127, P1875, DOI 10.1242/jcs.133645; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	39	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							0175324	10.1371/journal.pone.0175324	http://dx.doi.org/10.1371/journal.pone.0175324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388663	Green Submitted, gold, Green Published			2022-12-26	WOS:000399375800040
J	Damantil, S; Bourron, O; Doulazmi, M; Sossol, ALM; Nguyen-Michell, VH; Mariani, J; Kinugawa, K				Damantil, Sarah; Bourron, Olivier; Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Vi-Huong Nguyen-Michell; Mariani, Jean; Kinugawa, Kiyoka			Relationship between sleep parameters, insulin resistance and age-adjusted insulin like growth factor-1 score in non diabetic older patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; APNEA SYNDROME; GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; HEART HEALTH; METAANALYSIS; ASSOCIATION; ADULTS	Background Sleep complaints are prevalent in older patients. Sleepiness, short or long sleep duration and obstructive sleep apnea (OSA) are associated with insulin resistance (IR). These parameters have not yet been considered together in the same study exploring the possible association between IR and sleep in older patients. IR is involved in cardiovascular and metabolic diseases, pathologies which are highly prevalent in older patients. Here we assess, in older non-diabetic patients with sleep complaints, the associations between IR and sleep parameters objectively recorded by polysomnography (PSG) rather than self-report. The Growth Hormone/Insulin like growth factor-1 axis could play a role in the development of IR during sleep disorders. The second objective of this study was to analyze the association between sleep parameters and age-adjusted IGF-1 score, which could explain the association between OSA and IR. Methods 72 non-diabetic older patients, mean age 74.5 7.8 years, were included in this observational study. We evaluated anthropometric measures, subjective and objective sleepiness, polysomnography, Homeostatic Model Assessment for IR (HOMA-IR) and age-adjusted IGF-1 score. A multivariate regression was used to determine factors associated with HOMA-IR. Results The 47 OSA patients were over-weight but not obese and had higher IR than the non-OSA patients. In multilinear regression analysis, apnea-hypopnea index was independently associated with IR after adjustment for several confounding factors. Neither IGF-1 level nor IGF-1 score were different in the two groups. Conclusions We demonstrate that in non-diabetic older patients with sleep complaints, OSA is independently associated with IR, regardless of anthropometric measurements and sleep parameters (sleep duration/sleepiness/arousals). Targeting OSA to reduce IR could be useful in the elderly, although further exploration is required.	[Damantil, Sarah; Sossol, Anne-Laure Mandengue; Vi-Huong Nguyen-Michell; Mariani, Jean; Kinugawa, Kiyoka] Grp Hosp Pitie Salpetriere Charles Foix, APHP, DHU FAST, Funct Explorat Unit Older Patients, Paris, France; [Damantil, Sarah; Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Mariani, Jean; Kinugawa, Kiyoka] UPMC Univ Paris 06, Sorbonne Univ, UMR 8256, Biol Adaptat & Aging, Paris, France; [Damantil, Sarah] Univ Milan, Milan, Italy; [Bourron, Olivier] Hop La Pitie Salpetriere, APHP, Diabetol Dept, Paris, France; [Bourron, Olivier] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Bourron, Olivier] INSERM, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Doulazmi, Mohamed; Sossol, Anne-Laure Mandengue; Mariani, Jean; Kinugawa, Kiyoka] CNRS, UMR 8256, Biol Adaptat & Aging, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kinugawa, K (corresponding author), Grp Hosp Pitie Salpetriere Charles Foix, APHP, DHU FAST, Funct Explorat Unit Older Patients, Paris, France.	kiyoka.kinugawa@aphp.fr	Damanti, Sarah/ABI-2999-2020; Kinugawa, Kiyoka/AAM-7853-2020	Mariani, Jean/0000-0002-2701-1581; Damanti, Sarah/0000-0002-2399-3688; Kinugawa, Kiyoka/0000-0001-6914-6102; Bourron, Olivier/0000-0001-7348-7161; Doulazmi, Mohamed/0000-0002-0313-1490				Aleman-Mateo H, 2014, J GERONTOL A-BIOL, V69, P871, DOI 10.1093/gerona/glt193; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Baoying H, 2014, BMJ OPEN, V4; Barcelo A, 2008, THORAX, V63, P946, DOI 10.1136/thx.2007.093740; Borel AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071000; Bourron O, 2015, J CLIN ENDOCR METAB, V100, P1879, DOI 10.1210/jc.2014-3968; Chen LD, 2015, GROWTH HORM IGF RES, V25, P75, DOI 10.1016/j.ghir.2014.12.006; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Gianotti L, 2002, J CLIN ENDOCR METAB, V87, P5052, DOI 10.1210/jc.2001-011441; Grant RW, 2004, DRUG AGING, V21, P141, DOI 10.2165/00002512-200421030-00001; Iber C., 2007, AASM MANUAL SCORING; Iftikhar Imran H, 2013, Ann Am Thorac Soc, V10, P115, DOI 10.1513/AnnalsATS.201209-081OC; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Makino S, 2012, CLIN ENDOCRINOL, V76, P593, DOI 10.1111/j.1365-2265.2011.04237.x; Malhotra A, 2006, AM J MED, V119, pe9, DOI DOI 10.1016/J.AMJMED.2005.01.077; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Onen F, 2013, SLEEP BREATH, V17, P343, DOI 10.1007/s11325-012-0700-8; Pamidi Sushmita, 2012, Front Neurol, V3, P126; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Pyykkonen AJ, 2014, ANN MED, V46, P324, DOI 10.3109/07853890.2014.902226; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Shah N, 2013, J CLIN SLEEP MED, V9, P1245, DOI 10.5664/jcsm.3260; Shechter A, 2012, AM J PHYSIOL-REG I, V303, pR883, DOI 10.1152/ajpregu.00222.2012; Strand LB, 2015, DIABETES CARE; Tanno S, 2014, SLEEP MED; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Ursavas A, 2007, LUNG, V185, P309, DOI 10.1007/s00408-007-9026-x; Xu SY, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0102-3; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174876	10.1371/journal.pone.0174876	http://dx.doi.org/10.1371/journal.pone.0174876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384333	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900047
J	Li, JM; Liu, HY; Yang, M; Du, LS				Li, Junmin; Liu, Haiyan; Yang, Ming; Du, Leshan			No evidence for local adaptation to salt stress in the existing populations of invasive Solidago canadensis in China	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TOLERANCE; SALINITY; PLANTS; MECHANISMS	Local adaptation is an important mechanism underlying the adaptation of plants to environmental heterogeneity, and the toxicity of salt results in strong selection pressure on salt tolerance in plants and different ecotypes. Solidago canadensis, which is invasive in China, has spread widely and has recently colonized alkali sandy loams with a significant salt content. A common greenhouse experiment was conducted to test the role of local adaptation in the successful invasion of S. canadensis into salty habitats. Salt treatment significantly decreased the growth of S. canadensis, including rates of increase in the number of leaves and plant height; the root, shoot, and total biomass. Furthermore, salt stress significantly reduced the net photosynthetic rate, stomatal conductance, transpiration rate and relative chlorophyll content but significantly increased peroxidase activity and the proline content of S. canadensis and the root/shoot ratio. Two-way analysis of variance showed that salt treatment had a significant effect on the physiological traits of S. canadensis, except for the intercellular CO2 concentration, whereas the population and the salt x population interaction had no significant effect on any physiological traits. Most of the variation in plasticity existed within and not among populations, excep for the root/shoot ratio. S. canadensis populations from soil with moderate/high salt levels grew similarly to S. canadensis populations from soils with low salt levels. No significant correlation between salt tolerance indices and soil salinity levels was observed. The plasticity of the proline content, intercellular CO2 concentration and chlorophyll content had significant correlations with the salt tolerance index. These findings indicate a lack of evidence for local adaption in the existing populations of invasive S. canadensis in China; instead, plasticity might be more important than local adaptation in influencing the physiological traits and salt tolerance ability across the S. canadensis distribution.	[Li, Junmin; Liu, Haiyan; Du, Leshan] Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China; [Liu, Haiyan; Yang, Ming] Shanxi Normal Univ, Sch Life Sci, Linfen, Shanxi, Peoples R China; [Liu, Haiyan; Du, Leshan] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Taizhou University; Shanxi Normal University; Chinese Research Academy of Environmental Sciences	Li, JM (corresponding author), Taizhou Univ, Zhejiang Prov Key Lab Evolutionary Ecol & Conserv, Taizhou, Zhejiang, Peoples R China.; Yang, M (corresponding author), Shanxi Normal Univ, Sch Life Sci, Linfen, Shanxi, Peoples R China.	lijm@tzc.edu.cn; mycorrhiza@sina.com	李, 钧敏/L-7390-2019		National Key Research and Development Program [2016YFC1201102, 2016YFC1201100]; National Natural Science Foundation of China [31270461]; Qianjiang Talents Project of Zhejiang Province [QJD1302021]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of Zhejiang Province	This study was financially support by the National Key Research and Development Program (2016YFC1201102; 2016YFC1201100), the National Natural Science Foundation of China (No. 31270461), and the Qianjiang Talents Project of Zhejiang Province (type D) (No. QJD1302021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates E., 2007, World Journal of Agricultural Sciences, V3, P71; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Cheplick GP, 2006, AM J BOT, V93, P539, DOI 10.3732/ajb.93.4.539; Dong M, 2006, ACTA PHYTOTAXON SIN, V44, P72, DOI 10.1360/aps050068; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Droste T, 2010, PLANT ECOL, V207, P297, DOI 10.1007/s11258-009-9673-5; Du LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170049; Du LS, 2016, ACTA OECOL, V71, P22, DOI 10.1016/j.actao.2016.01.003; Fischer G., 2008, GLOBAL AGROECOLOGICA; Godoy O, 2011, BIOL INVASIONS, V13, P1615, DOI 10.1007/s10530-010-9919-0; Gondim FA, 2013, THEOR EXP PLANT PHYS, V25, P251, DOI 10.1590/S2197-00252013000400003; Grassein F, 2014, GLOBAL CHANGE BIOL, V20, P1452, DOI 10.1111/gcb.12445; Huang QQ, 2015, ECOL EVOL, V5, P1169, DOI 10.1002/ece3.1424; Kawecki TJ, ECOLOGY LETT, V7, P1225; Keser LH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00273; Kuhn NL, 1997, ESTUARIES, V20, P391, DOI 10.2307/1352352; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Li JM, 2016, OECOLOGIA, V182, P755, DOI 10.1007/s00442-016-3699-x; Li JM, 2012, ACTA PHYSIOL PLANT, V34, P1747, DOI 10.1007/s11738-012-0971-5; Liu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149262; Liu YJ, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plv141; Lortie CJ, 1996, INT J PLANT SCI, V157, P484, DOI 10.1086/297365; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Minchinton TE, 2006, J ECOL, V94, P342, DOI 10.1111/j.1365-2745.2006.01099.x; Moran EV., 2014, 99 ESA ANN CONV 2014; MULLIGAN GA, 1970, CAN J BOTANY, V48, P859, DOI 10.1139/b70-119; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Nasim M, 2009, J PLANT NUTR, V32, P1427, DOI 10.1080/01904160903092648; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Riis T, 2010, ANN BOT-LONDON, V106, P813, DOI 10.1093/aob/mcq176; Rouifed S, 2012, ENVIRON MANAGE, V50, P1027, DOI 10.1007/s00267-012-9934-2; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schittko C, 2014, BIOL INVASIONS, V16, P1465, DOI 10.1007/s10530-013-0584-y; Si CC, 2014, BIOL INVASIONS, V16, P2323, DOI 10.1007/s10530-014-0667-4; Siebenkas A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv029; Song H., 2010, CHINESE J INFORM TRA, V53, P1849; SULTAN SE, 1987, EVOL BIOL, V21, P127; [孙万春 Sun Wanchun], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P1560; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WANG Y, 2013, PLOS ONE, V2013; [徐高峰 Xu Gaofeng], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1258; Xu Xiangqin, 2011, Shengwu Duoyangxing, V19, P519, DOI 10.3724/SP.J.1003.2011.09048; Zhu JK, 2010, PLANT PHYSIOL, V124, P941; Zhu Lin., 2012, THESIS	50	8	10	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175252	10.1371/journal.pone.0175252	http://dx.doi.org/10.1371/journal.pone.0175252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384230	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900138
J	Koami, H; Sakamoto, Y; Sakurai, R; Ohta, M; Imahase, H; Yahata, M; Umeka, M; Miike, T; Nagashima, F; Iwamura, T; Yamada, KC; Inoue, S				Koami, Hiroyuki; Sakamoto, Yuichiro; Sakurai, Ryota; Ohta, Miho; Imahase, Hisashi; Yahata, Mayuko; Umeka, Mitsuru; Miike, Toru; Nagashima, Futoshi; Iwamura, Takashi; Yamada, Kosuke Chris; Inoue, Satoshi			Thromboelastometric analysis of the risk factors for return of spontaneous circulation in adult patients with out-of-hospital cardiac arrest	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CARDIOPULMONARY-RESUSCITATION; PULMONARY-EMBOLISM; COAGULATION; HYPERFIBRINOLYSIS; MANAGEMENT; SURGERY; THERAPY	It is well known that coagulopathy is observed in patients with out-of-hospital cardiac arrest (OHCA). Thrombolytic therapy for those patients has been controversial until now. The purpose of this study was to identify a significant predictor for return of spontaneous circulation (ROSC) of OHCA patients in the emergency department (ED) using whole blood viscoelastic testing. Adult non-trauma OHCA patients transported to our hospital that underwent thromboelastometry (ROTEM) during cardiopulmonary resuscitation between January 2013 and December 2015 were enrolled in this study. We divided patients into two groups based on the presence or absence of ROSC, and performed statistical analysis utilizing patient characteristics, prehospital data, laboratory data, and ROTEM data. Seventy-five patients were enrolled. The ROSC group and non-ROSC group included 23 and 52 patients, respectively. The logistic regression analysis, utilizing significant parameters by univariate analysis, demonstrated that lactate level [odds ratio (OR) 0.880, 95% confidence interval (CI) 0.785-0.986, p = 0.028] and A30 of EXTEM test [OR 1.039, 95% CI 1.010-1.070, p = 0.009] were independent risk factors for ROSC. The cut-off values of lactate and A30 in EXTEM were 12.0 mmol/L and A 48.0 mm, respectively. We defined a positive prediction for ROSC if the patient presented lower lactate level (<12.0 mmol/L) and higher A30 of EXTEM (>= 48.0 mm) with high specificity (94.7%) and accuracy (75.0%). The present study showed that lactate level and ROTEM parameter of clot firmness were reliable predictors of ROSC in the ED for adult patients with OHCA.	[Koami, Hiroyuki; Sakamoto, Yuichiro; Iwamura, Takashi] Saga Univ, Dept Emergency & Crit Care Med, Fac Med, Saga, Japan; [Sakurai, Ryota; Ohta, Miho; Imahase, Hisashi; Yahata, Mayuko; Umeka, Mitsuru; Miike, Toru; Nagashima, Futoshi; Yamada, Kosuke Chris] Saga Univ Hosp, Adv Emergency Care Ctr, Saga, Japan; [Inoue, Satoshi] Saga Univ, Div Trauma Surg & Surg Crit Care, Fac Med, Saga, Japan	Saga University; Saga University; Saga University	Koami, H (corresponding author), Saga Univ, Dept Emergency & Crit Care Med, Fac Med, Saga, Japan.	hkoami@cc.saga-u.ac.jp	Koami, Hiroyuki/L-7981-2018	Koami, Hiroyuki/0000-0001-6268-4602				Abu-Laban RB, 2002, NEW ENGL J MED, V346, P1522, DOI 10.1056/NEJMoa012885; Ahn Y, 2016, CRITICAL CARE HDB MA, P322; Alamo JM, 2013, TRANSPL P, V45, P3637, DOI 10.1016/j.transproceed.2013.11.008; Bottiger BW, 2008, NEW ENGL J MED, V359, P2651, DOI 10.1056/NEJMoa070570; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bozeman WP, 2006, RESUSCITATION, V69, P399, DOI 10.1016/j.resuscitation.2005.09.027; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Engberink RHGO, 2014, J CARDIOTHOR VASC AN, V28, P210, DOI 10.1053/j.jvca.2013.12.004; Gando S, 1999, THROMB RES, V96, P107, DOI 10.1016/S0049-3848(99)00073-0; Janata K, 2003, RESUSCITATION, V57, P49, DOI 10.1016/S0300-9572(02)00430-6; Keuper W, 2007, RESUSCITATION, V73, P189, DOI 10.1016/j.resuscitation.2006.08.030; Koami H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004514; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; Lederer W, 2001, RESUSCITATION, V50, P71, DOI 10.1016/S0300-9572(01)00317-3; Li X, 2006, RESUSCITATION, V70, P31, DOI 10.1016/j.resuscitation.2005.11.016; Nakayama Y, 2015, BRIT J ANAESTH, V114, P91, DOI 10.1093/bja/aeu339; Schochl H, 2013, RESUSCITATION, V84, P454, DOI 10.1016/j.resuscitation.2012.08.318; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; Viersen VA, 2012, RESUSCITATION, V83, P1451, DOI 10.1016/j.resuscitation.2012.05.008	20	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175257	10.1371/journal.pone.0175257	http://dx.doi.org/10.1371/journal.pone.0175257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380019	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500112
J	Takashio, S; Nagai, T; Sugano, Y; Honda, S; Okada, A; Asaumi, Y; Aiba, T; Noguchi, T; Kusano, KF; Ogawa, H; Yasuda, S; Anzai, T				Takashio, Seiji; Nagai, Toshiyuki; Sugano, Yasuo; Honda, Satoshi; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo F.; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa		NaDEF Investigators	Persistent increase in cardiac troponin Tat hospital discharge predicts repeat hospitalization in patients with acute decompensated heart failure	PLOS ONE			English	Article							NATIONAL REGISTRY; OUTCOMES; INSIGHTS; RELEASE	Background High-sensitive cardiac troponin T (hsTnT) is a sensitive biomarker of myocardial damage and predictor of acute decompensated heart failure (ADHF). However, there is little information on changes over time in hsTnT level during ADHF management. The aim of this prospective study was to evaluate changes in hsTnT levels between admission and at discharge in patients with ADHF, and identify factors that determine such levels and their prognostic significance. Methods and results We evaluated 404 ADHF patients with abnormal hsTnT levels (>0.0135 ng/ml) on admission. The median (interquartile ranges) hsTnT levels on admission, at discharge, and percent changes in hsTnT levels were 0.038 (0.026 to 0.065), 0.032 (0.021 to 0.049) ng/ml, and -12.0 (-39.8 to 7.4) % respectively. The numbers of patients with falling (hsTnT decrease > -15%), stable (hsTnT change between-15 and +15%) and rising (hsTnT increase > +15%) hsTnT level at discharge were 190, 146, and 68, respectively. The percent change in B-type natriuretic peptide (BNP) levels was greater in the falling group, compared to the stable (p<0.001) and rising groups (p<0.001). Changes in hsTnT levels correlated significantly with changes in BNP levels (p = 0.22, p<0.001). Multivariate Cox regression analysis identified rising or stable hsTnT at discharge as a significant predictor of heart failure-related rehospitalization (hazard ratio: 1.69; 95% confidence interval: 1.06 to 2.70; p = 0.03). Conclusions Persistent increase in hsTnT levels at discharge correlated with inadequate decrease of BNP levels, and was a predictor of poor clinical outcome, with repeat heart failure hospitalizations.	[Takashio, Seiji; Nagai, Toshiyuki; Sugano, Yasuo; Honda, Satoshi; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo F.; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa; NaDEF Investigators] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan	Anzai, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan.	anzai@ncvc.go.jp	Honda, Satoshi/GXG-5198-2022	Asaumi, Yasuhide/0000-0002-9009-7234; Honda, Satoshi/0000-0002-1393-4270	Japan Cardiovascular Research Foundation (Toshihisa Anzai) [24-4-2]; Japan Society for the Promotion of Science (Seiji Takashio) [26860574]; Japan Agency for Medical Research and Development (Toshiyuki Nagai) [201439103A]; Japan Society for the Promotion of Science (Toshiyuki Nagai) [15K19402]	Japan Cardiovascular Research Foundation (Toshihisa Anzai); Japan Society for the Promotion of Science (Seiji Takashio)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (Toshiyuki Nagai)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (Toshiyuki Nagai)	This work was supported by Grants-in-Aid for Young Scientists B from Japan Society for the Promotion of Science (Seiji Takashio, 26860574), Grant from the Japan Cardiovascular Research Foundation (Toshihisa Anzai, 24-4-2), Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (Toshiyuki Nagai, 15K19402), and a Grant from the Japan Agency for Medical Research and Development (Toshiyuki Nagai, 201439103A).	Braga JR, 2013, CIRC-HEART FAIL, V6, P193, DOI 10.1161/CIRCHEARTFAILURE.112.000075; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Felker GM, 2015, EUR J HEART FAIL, V17, P1262, DOI 10.1002/ejhf.341; Felker GM, 2012, EUR J HEART FAIL, V14, P1257, DOI 10.1093/eurjhf/hfs110; Feng J, 2001, CIRCULATION, V103, P2035; Gheorghiade M, 2005, AM J CARDIOL, V96, p11G, DOI 10.1016/j.amjcard.2005.07.016; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Espartero MEG, 2014, EUR J INTERN MED, V25, P739, DOI 10.1016/j.ejim.2014.08.005; Hessel MHM, 2008, PFLUG ARCH EUR J PHY, V455, P979, DOI 10.1007/s00424-007-0354-8; Kociol RD, 2010, J AM COLL CARDIOL, V56, P1071, DOI 10.1016/j.jacc.2010.06.016; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005; Nieminen MS, 2008, EUR J HEART FAIL, V10, P140, DOI 10.1016/j.ejheart.2007.12.012; O'Connor CM, 2011, CIRC-HEART FAIL, V4, P724, DOI 10.1161/CIRCHEARTFAILURE.111.961581; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Sherwood MW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000403; Takashio S, 2013, J AM COLL CARDIOL, V62, P632, DOI 10.1016/j.jacc.2013.03.065; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022	23	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173336	10.1371/journal.pone.0173336	http://dx.doi.org/10.1371/journal.pone.0173336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379962	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500016
J	Waugh, K; Snell-Bergeon, J; Michels, A; Dong, F; Steck, AK; Frohnert, BI; Norris, JM; Rewers, M				Waugh, Kathleen; Snell-Bergeon, Janet; Michels, Aaron; Dong, Fran; Steck, Andrea K.; Frohnert, Brigitte I.; Norris, Jill M.; Rewers, Marian			Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)	PLOS ONE			English	Article							T-CELL RESPONSES; HIGH-RISK; AUTOANTIBODIES; CYTOKINES; CHILDREN; INSULIN; ASSAY; PROGRESSION; APPEARANCE; CHEMOKINES	Background Type 1 diabetes (TID) is characterized by a loss of pancreatic islet beta cell function resulting in loss of insulin production. Genetic and environmental factors may trigger immune responses targeting beta cells thus generating islet antibodies (IA). Immune response pathways involve a cascade of events, initiated by cytokines and chemokines, producing inflammation which can result in tissue damage. Methods A nested case-control study was performed to identify temporal changes in cytokine levels in 75 DAISY subjects: 25 diagnosed T1D, 25 persistent IA, and 25 controls. Serum samples were selected at four time points: (T1) earliest, (T2) just prior to IA, (T3) just after IA, and (T4) prior to T1D diagnosis or most recent. Cytokines (IFN-alpha 2a, IL-6, IL-17, IL-1 beta, IP-10, MCP-1, IFN-gamma, IL-1 alpha, and IL-1ra) were measured using the Meso Scale Discovery system Human Custom Cytokine 9-Plex assay. Results Multivariate mixed models adjusting for HLA risk, first-degree relative status, age, and gender, showed MCP-1 and IFN-gamma to be significantly higher at T3 in T1D compared to IA subjects. At T4, IP-10 was significantly higher in IA subjects than controls. Conclusions This repeated measures nested case-control study identified increased inflammatory markers in IA children who developed T1D compared to IA children who had not progressed to clinical disease. It also showed increased inflammation in both T1D and IA children when compared to controls. Results suggest inflammation may be related to both the development of IA and progression to T1D.	[Waugh, Kathleen; Snell-Bergeon, Janet; Michels, Aaron; Dong, Fran; Steck, Andrea K.; Frohnert, Brigitte I.; Rewers, Marian] Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA; [Norris, Jill M.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Waugh, K (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA.	kathleen.waugh@ucdenver.edu		Snell-Bergeon, Janet/0000-0002-9337-3740	National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK032493-32]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032083, K12DK094712, K08DK095995, R01DK032493] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx), grant 5R01DK032493-32 to MR. The funder supports the overall cohort study design, The Natural History of Pre-diabetic Autoimm unity (DAISY), including participant biological sample and data collection as well as analysis. The Principal Investigator makes decisions for nested case-control experiments, analysis, and publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx), grant 5R01DK032493-32 to MR.	Alkanani AK, 2012, DIABETES, V61, P2525, DOI 10.2337/db12-0099; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bonifacio E, 2005, CLIN IMMUNOL, V115, P173, DOI 10.1016/j.clim.2005.01.004; Cabrera SM, 2016, TRANSL RES, V167, P214, DOI 10.1016/j.trsl.2015.04.011; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Cieslak M, 2015, ACTA BIOCHIM POL, V62, P15; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; GIANANI R, 1995, DIABETES, V44, P1340, DOI 10.2337/diabetes.44.11.1340; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hawa MI, 2009, DIABETES CARE, V32, P160, DOI 10.2337/dc08-1419; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Kawasaki E, 2004, DIABETES RES CLIN PR, V66, pS27, DOI 10.1016/j.diabres.2003.09.015; Lee JM, 2015, J PEDIATR-US, V167, P449, DOI 10.1016/j.jpeds.2015.04.067; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Nakayama M, 2015, P NATL ACAD SCI USA, V112, P4429, DOI 10.1073/pnas.1502967112; Nicoletti F, 2002, DIABETOLOGIA, V45, P1107, DOI 10.1007/s00125-002-0879-5; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Ryden A, 2009, DIABETES-METAB RES, V25, P335, DOI 10.1002/dmrr.958; Shrestha SS, 2011, DIABETES CARE, V34, P1097, DOI 10.2337/dc10-2177; Stechova K, 2007, DIABETES-METAB RES, V23, P462, DOI 10.1002/dmrr.718; Steck AK, 2016, J AUTOIMMUN, V72, P113, DOI 10.1016/j.jaut.2016.05.010; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081	31	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174840	10.1371/journal.pone.0174840	http://dx.doi.org/10.1371/journal.pone.0174840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380011	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500067
J	Au, NT; Reyes, M; Boyer, BB; Hopkins, SE; Black, J; O'Brien, D; Fohner, AE; Yracheta, J; Thornton, T; Austin, MA; Burke, W; Thummel, KE; Rettiel, AE				Au, Nicholas T.; Reyes, Morayma; Boyer, Bert B.; Hopkins, Scarlett E.; Black, Jynene; O'Brien, Diane; Fohner, Alison E.; Yracheta, Joe; Thornton, Timothy; Austin, Melissa A.; Burke, Wylie; Thummel, Kenneth E.; Rettiel, Allan E.			Dietary and genetic influences on hemostasis in a Yup'ik Alaska Native population	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; VITAMIN-K; FISH-OIL; MYOCARDIAL-INFARCTION; CHRONIC DISEASE; HEART-DISEASE; RISK; PLASMA; HEALTH; CYP4F2	Fish and marine animals are important components of the subsistence diet of Alaska Native people, resulting in a high omega 3 PUFA intake. The historical record for circumpolar populations highlights a tendency for facile bleeding, possibly related to omega 3 PUFA effects on platelet activation and/or vitamin K-dependent clotting factors. To evaluate these two scenarios in Yup'ik people of southwestern Alaska, we examined the association between dietary omega 3 PUFA intake and activities of clotting factor II, V, fibrinogen, PT, INR, PTT, and sP-selectin in 733 study participants, using the nitrogen isotope ratio of red blood cells as a biomarker of omega 3 PUFA consumption. sP-selectin alone correlated strongly and inversely with omega 3 PUFA consumption. Approximately 36% of study participants exhibited PIVKA-II values above the threshold of 2 ng/ml, indicative of low vitamin K status. To assess genetic influences on vitamin K status, study participants were genotyped for common vitamin K cycle polymorphisms in VKORC1, GGCX and CYP4F2. Only CYP4F2*3 associated significantly with vitamin K status, for both acute (plasma vitamin K) and long-term (PIVKA-II) measures. These findings suggest: (i) a primary association of omega 3 PUFAs on platelet activation, as opposed to vitamin K-dependent clotting factor activity, (ii) that reduced CYP4F2 enzyme activity associates with vitamin K status. We conclude that high omega 3 PUFA intake promotes an anti-platelet effect and speculate that the high frequency of the CYP4F2*3 allele in Yup'ik people (similar to 45%) evolved in response to a need to conserve body stores of vitamin K due to environmental limitations on its availability.	[Au, Nicholas T.; Rettiel, Allan E.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Reyes, Morayma] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Boyer, Bert B.; Hopkins, Scarlett E.; Black, Jynene; O'Brien, Diane] Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA; [Fohner, Alison E.] Univ Washington, Publ Hlth Genet, Seattle, WA 98195 USA; [Yracheta, Joe; Rettiel, Allan E.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Thornton, Timothy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Austin, Melissa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Burke, Wylie] Univ Washington, Dept Med Eth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alaska System; University of Alaska Fairbanks; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rettiel, AE (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.	bboyer@alaska.edu; rettie@um.edu	O'Brien, Diane/B-2919-2010	O'Brien, Diane/0000-0001-5807-9661	National Institutes of Health [U01GM092676, R01GM109743, TL1 RR025016, P30 ES007033, P30 GM103325, R01DK074842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was conducted with funding from the following National Institutes of Health (https://grants.nih.gov/funding/index.htm) grants: U01GM092676, R01GM109743, TL1 RR025016, P30 ES007033, P30 GM103325, R01DK074842.	Andriamampandry M, 1998, CR ACAD SCI III-VIE, V321, P415, DOI 10.1016/S0764-4469(98)80306-5; Athinarayanan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095366; Au N-T., 2014, GEN ENV FACT AFF HEM; Baye TM, 2011, PERS MED, V8, P59, DOI 10.2217/PME.10.75; Bevans CG, 2013, BBA-GEN SUBJECTS, V1830, P4202, DOI 10.1016/j.bbagen.2013.04.018; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Colussi Gianluca, 2007, Recent Pat Cardiovasc Drug Discov, V2, P13, DOI 10.2174/157489007779606158; Dashti HS, 2014, AM J CLIN NUTR, V100, P1462, DOI 10.3945/ajcn.114.093146; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; DYERBERG J, 1979, LANCET, V2, P433, DOI 10.1016/S0140-6736(79)91490-9; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Eschen O, 2004, NUTR METAB CARDIOVAS, V14, P180, DOI 10.1016/S0939-4753(04)80002-4; Fohner AE, 2015, PHARMACOGENET GENOM, V25, P343, DOI 10.1097/FPC.0000000000000143; Fu XY, 2009, ANAL CHEM, V81, P5421, DOI 10.1021/ac900732w; Greer FR, 1998, ARCH DIS CHILD, V79, P300, DOI 10.1136/adc.79.4.300; Hirai K, 2015, THROMB RES, V135, P861, DOI 10.1016/j.thromres.2015.02.019; JONES DY, 1991, AM J CLIN NUTR, V53, P943, DOI 10.1093/ajcn/53.4.943; Kishi K, 1992, Radiat Med, V10, P189; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Makhoul Z, 2011, EUR J CLIN NUTR, V65, P808, DOI 10.1038/ejcn.2011.39; Marckmann P, 1997, ARTERIOSCL THROM VAS, V17, P3384, DOI 10.1161/01.ATV.17.12.3384; Moertl D, 2011, THROMB HAEMOSTASIS, V106, P457, DOI [10.1160/TH-11-03-0169, 10.1160/TH11-03-0169]; Mohammadi E, 2012, EFFECTS OMEGA 3 FATT; Mohatt GV, 2007, INT J CIRCUMPOL HEAL, V66, P8, DOI 10.3402/ijch.v66i1.18219; Nash SH, 2012, J NUTR, V142, P84, DOI 10.3945/jn.111.147595; Nieuwenhuys CMA, 2001, THROMB RES, V104, P137, DOI 10.1016/S0049-3848(01)00347-4; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; OOSTHUIZEN W, 1994, THROMB HAEMOSTASIS, V72, P557; Paroni R, 2009, J CHROMATOGR B, V877, P351, DOI 10.1016/j.jchromb.2008.12.044; SHAHAR E, 1993, ARTERIOSCLER THROMB, V13, P1205, DOI 10.1161/01.ATV.13.8.1205; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Sommer P, 1966, Vitam Horm, V24, P349; SUTTIE JW, 1988, AM J CLIN NUTR, V47, P475, DOI 10.1093/ajcn/47.3.475; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vecka M, 2012, NEUROENDOCRINOL LETT, V33, P87; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0173616	10.1371/journal.pone.0173616	http://dx.doi.org/10.1371/journal.pone.0173616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376131	Green Submitted, Green Published, gold			2022-12-26	WOS:000399352000001
J	Lee, BH; Stallcup, MR				Lee, Brian H.; Stallcup, Michael R.			Glucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN RECEPTOR; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL EXPRESSION; OSTEOBLAST PHENOTYPE; CONFERS RESISTANCE; GENE-EXPRESSION; LIM PROTEIN; IN-SITU; COACTIVATOR; DNA	The steroid hormone-activated glucocorticoid receptor (GR) regulates cellular stress pathways by binding to genomic regulatory elements of target genes and recruiting coregulator proteins to remodel chromatin and regulate transcription complex assembly. The coregulator hydrogen peroxide-inducible clone 5 (Hic-5) is required for glucocorticoid (GC) regulation of some genes but not others and blocks the regulation of a third gene set by inhibiting GR binding. How Hic-5 exerts these gene-specific effects and specifically how it blocks GR binding to some genes but not others is unclear. Here we show that site-specific blocking of GR binding is due to gene-specific requirements for ATP-dependent chromatin remodeling enzymes. By depletion of 11 different chromatin remodelers, we found that ATPases chromodomain helicase DNA-binding protein 9 (CHD9) and Brahma homologue (BRM, a product of the SMARCA2 gene) are required for GC-regulated expression of the blocked genes but not for other GC-regulated genes. Furthermore, CHD9 and BRM were required for GR occupancy and chromatin remodeling at GR-binding regions associated with blocked genes but not at GR-binding regions associated with other GC-regulated genes. Hic-5 selectively inhibits GR interaction with CHD9 and BRM, thereby blocking chromatin remodeling and robust GR binding at GR-binding sites associated with blocked genes. Thus, Hic-5 regulates GR binding site selection by a novel mechanism, exploiting gene-specific requirements for chromatin remodeling enzymes to selectively influence DNA occupancy and gene regulation by a transcription factor.	[Lee, Brian H.; Stallcup, Michael R.] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu			National Institutes of Health [R37DK055274, R01DK043093]; Cancer Center Support Grant [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093, R37DK055274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R37DK055274 and R01DK043093 (to M. R. S.) and Cancer Center Support Grant P30CA014089 (to the USC Norris Comprehensive Cancer Center, which supported the Molecular Genomics, Bioreagent, Biostatistics, and Molecular and Cell Biology Core Facilites used in this project). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chodankar R, 2015, MOL ENDOCRINOL, V29, P716, DOI 10.1210/me.2014-1403; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Engel KB, 2011, MOL CELL BIOL, V31, P3267, DOI 10.1128/MCB.05351-11; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Glass CK, 2000, GENE DEV, V14, P121; Ishino M, 2000, FEBS LETT, V474, P179, DOI 10.1016/S0014-5793(00)01597-0; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Nguyen KH, 2015, STEM CELLS, V33, P3028, DOI 10.1002/stem.2064; Kim-Kaneyama J, 2012, J ATHEROSCLER THROMB, V19, P601, DOI 10.5551/jat.10736; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leach DA, 2014, MOL CELL ENDOCRINOL, V384, P185, DOI 10.1016/j.mce.2014.01.004; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Lutz T, 2006, FEBS LETT, V580, P5851, DOI 10.1016/j.febslet.2006.09.049; Marom R, 2006, J CELL PHYSIOL, V207, P628, DOI 10.1002/jcp.20611; Maudsley S, 2006, NEUROENDOCRINOLOGY, V84, P285, DOI 10.1159/000098402; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; POCKWINSE SM, 1995, EXP CELL RES, V216, P244, DOI 10.1006/excr.1995.1031; Pradhan SK, 2016, MOL CELL, V61, P27, DOI 10.1016/j.molcel.2015.10.039; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wang X, 2002, J BIOL CHEM, V277, P15426, DOI 10.1074/jbc.M111218200; Wiechens N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005940; Won J.K., 2012, MOL ENDOCRINOL, V26, P955; Wu Dai-Ying, 2014, Nucl Recept Signal, V12, pe002, DOI 10.1621/nrs.12002; Yang CK, 2006, MOL ENDOCRINOL, V20, P3251, DOI 10.1210/me.2006-0200; Yang L, 2000, MOL BIOL CELL, V11, P2007, DOI 10.1091/mbc.11.6.2007; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	62	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9320	9334		10.1074/jbc.M117.782607	http://dx.doi.org/10.1074/jbc.M117.782607			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381557	hybrid, Green Published			2022-12-26	WOS:000402538900026
J	Geng, YY; Ferreira, JJ; Dzikunu, V; Butler, A; Lybaert, P; Yuan, P; Magleby, KL; Salkoff, L; Santi, CM				Geng, Yanyan; Ferreira, Juan J.; Dzikunu, Victor; Butler, Alice; Lybaert, Pascale; Yuan, Peng; Magleby, Karl L.; Salkoff, Lawrence; Santi, Celia M.			A genetic variant of the sperm-specific SLO3 K+ channel has altered pH and Ca2+ sensitivities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fertilization; patch clamp; potassium channel; reproduction; sperm; spermatozoa; calcium sensitivity; genetic variant; human SLO3; pH sensitivity	ACTIVATED POTASSIUM CHANNELS; INTRACELLULAR PH; CALCIUM SENSITIVITY; POSITIVE SELECTION; RAPID EVOLUTION; BK CHANNEL; DOMAIN; SPERMATOZOA; PROTEINS; CURRENTS	To fertilize an oocyte, sperm must first undergo capacitation in which the sperm plasma membrane becomes hyperpolarized via activation of potassium (K+) channels and resultant K+ efflux. Sperm-specific SLO3 K+ channels are responsible for these membrane potential changes critical for fertilization in mouse sperm, and they are only sensitive to pH(i). However, in human sperm, the major K+ conductance is both Ca2+- and pH(i)-sensitive. It has been debated whether Ca2+-sensitive SLO1 channels substitute for human SLO3 (hSLO3) in human sperm or whether human SLO3 channels have acquired Ca2+ sensitivity. Here we show that hSLO3 is rapidly evolving and reveal a natural structural variant with enhanced apparent Ca2+ and pH sensitivities. This variant allele (C382R) alters an amino acid side chain at a principal interface between the intramembrane-gated pore and the cytoplasmic gating ring of the channel. Because the gating ring contains sensors to intracellular factors such as pH and Ca2+, the effectiveness of transduction between the gating ring and the pore domain appears to be enhanced. Our results suggest that sperm-specific genes can evolve rapidly and that natural genetic variation may have led to a SLO3 variant that differs from wild type in both pH and intracellular Ca2+ sensitivities. Whether this physiological variation confers differences in fertility among males remains to be established.	[Ferreira, Juan J.; Lybaert, Pascale; Santi, Celia M.] Washington Univ, Sch Med, Dept Obstet & Gynecol, BJC Inst Hlth Bldg,425 South Euclid, St Louis, MO 63110 USA; [Dzikunu, Victor; Butler, Alice; Salkoff, Lawrence] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Salkoff, Lawrence] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Yuan, Peng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Geng, Yanyan; Magleby, Karl L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Miami	Santi, CM (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, BJC Inst Hlth Bldg,425 South Euclid, St Louis, MO 63110 USA.	santic@wustl.edu	Ferreira, Juan/GNW-6445-2022	Bouca-Machado, Raquel/0000-0003-3756-2763; Ferreira, Juan/0000-0001-8175-9067	National Institute of Health [R01 HD069631, R21 NS 088611, R21 MH107955, R01 GM114694]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088611] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants R01 HD069631 (to C. M. S.), R21 NS 088611 and R21 MH107955 (to L. S.), and R01 GM114694 (to K. L. M. and L. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Brewis IA, 2000, J ANDROL, V21, P238; Budelli G, 2013, P NATL ACAD SCI USA, V110, P16657, DOI 10.1073/pnas.1313433110; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Cross NL, 1997, BIOL REPROD, V56, P1169, DOI 10.1095/biolreprod56.5.1169; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Gonzalez-Perez V, 2014, P NATL ACAD SCI USA, V111, P4868, DOI 10.1073/pnas.1322123111; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Hou SW, 2009, CHANNELS, V3, P249; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Leonetti MD, 2012, P NATL ACAD SCI USA, V109, P19274, DOI 10.1073/pnas.1215078109; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Podlaha O, 2005, MOL BIOL EVOL, V22, P1845, DOI 10.1093/molbev/msi178; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Santi CM, 2009, J BIOL CHEM, V284, P21589, DOI 10.1074/jbc.M109.015040; SASAKI S, 1992, BIOCHIM BIOPHYS ACTA, V1137, P45, DOI 10.1016/0167-4889(92)90098-V; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang CT, 2011, P NATL ACAD SCI USA, V108, P19419, DOI 10.1073/pnas.1111104108; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2010, J GEN PHYSIOL, V136, P189, DOI 10.1085/jgp.200910374; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zhang X, 2006, J GEN PHYSIOL, V128, P301, DOI 10.1085/jgp.200609551	40	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8978	8987		10.1074/jbc.M117.776013	http://dx.doi.org/10.1074/jbc.M117.776013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377504	Green Published, hybrid			2022-12-26	WOS:000402153900048
J	Snelling, SJB; Bas, S; Puskas, GJ; Dakin, SG; Suva, D; Finckh, A; Gabay, C; Hoffmeyer, P; Carr, AJ; Lubbeke, A				Snelling, Sarah J. B.; Bas, Sylvette; Puskas, Gabor J.; Dakin, Stephanie G.; Suva, Domizio; Finckh, Axel; Gabay, Cem; Hoffmeyer, Pierre; Carr, Andrew J.; Luebbeke, Anne			Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; UNITED-STATES; II COLLAGEN; TH17 CELLS; INTERLEUKIN-17; EXPRESSION; PREVALENCE; CYTOKINE	Purpose Osteoarthritis (OA) is a common and heterogeneous arthritic disorder. Patients suffer pain and their joints are characterized by articular cartilage loss and osteophyte formation. Risk factors for OA include age and obesity with inflammation identified as a key mediator of disease pathogenesis. Interleukin-17A (IL-17) is a pro-inflammatory cytokine that has been implicated in inflammatory diseases such as rheumatoid arthritis. IL-17 can upregulate expression of inflammatory cytokines and adipocytokines. The aim of this study was to evaluate IL-17 levels in the synovial fluid of patients with end-stage knee and hip OA in relation to inflammation-and pain-related cytokines and adipocytokines in synovial fluid and serum, and clinical and radiographic disease parameters. Methods This is a cross-sectional study of 152 patients undergoing total hip and knee arthroplasty for OA. IL-17, IL-6, leptin, adiponectin, visfatin, resistin, C-C Motif Chemokine Ligand 2 (CCL2), C-C Motif Chemokine Ligand 7 (CCL7) and nerve growth factor (NGF) protein levels were measured in synovial fluid and serum using enzyme-linked immunosorbent assay (ELISA). Baseline characteristics included age, sex, body mass index, co-morbidities, pain and function, and radiographic analyses (OA features, K&L grade, minimal joint space width). Results 14 patients (9.2%) had detectable IL-17 in synovial fluid. These patients had significantly higher median concentrations of IL-6, leptin, resistin, CCL7 and NGF. Osteophytes, sclerosis and minimum joint space width were significantly reduced in patients with detectable IL-17 in synovial fluid. No differences were found in pain, function and comorbidities. IL-17 concentrations in synovial fluid and serum were moderately correlated (r = 0.482). Conclusion The presence of IL-17 in the synovial fluid therefore identifies a substantial subset of primary end-stage OA patients with distinct biological and clinical features. Stratification of patients on the basis of IL-17 may identify those responsive to therapeutic targeting.	[Snelling, Sarah J. B.; Dakin, Stephanie G.; Carr, Andrew J.; Luebbeke, Anne] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Bas, Sylvette; Finckh, Axel; Gabay, Cem] Univ Hosp Geneva, Div Rheumatol, Geneva, Switzerland; [Puskas, Gabor J.; Suva, Domizio; Hoffmeyer, Pierre; Luebbeke, Anne] Univ Hosp Geneva, Div Orthopaed Surg & Traumatol, Geneva, Switzerland	University of Oxford; University of Geneva; University of Geneva	Snelling, SJB (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.	sarah.snelling@ndorms.ox.ac.uk	hoffmeyer, pierre/AAY-1392-2021; Hoffmeyer, Pierre/X-4491-2019	Lubbeke, Anne/0000-0002-6905-6120; Snelling, Sarah/0000-0002-7052-3793; Dakin, Stephanie Georgina/0000-0003-2470-1031; Hoffmeyer, Pierre/0000-0001-9736-828X	Medacta; Johnson Johnson; Zimmer; Arthritis Research UK [20087, 20506]; NIHR Musculoskeletal Biomedical Research Unit; Medical Research Council [MC_PC_15069, MC_PC_14103] Funding Source: researchfish; Versus Arthritis [20087, 20506] Funding Source: researchfish; MRC [MC_PC_15069, MC_PC_14103] Funding Source: UKRI	Medacta; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Zimmer; Arthritis Research UK(Versus Arthritis); NIHR Musculoskeletal Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Internal institutional funding was received for this study. Prof. Pierre Hoffmeyer received institutional financial support from Medacta, Johnson & Johnson, and Zimmer. SJBS was funded by Arthritis Research UK www.artritisresearchuk.org grant 20087. SGD was funded by Arthritis Research UK grant 20506. The NIHR Musculoskeletal Biomedical Research Unit also funded this work. The funding sources had no role in the collection, analysis, or interpretation of the data, in the preparation of the manuscript, or its submission for publication.	Atukorala I, 2014, ANN RHEUMATIC DIS; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Camporeale A, FRONT BIOSCI; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen B, 2014, J INT MED RES, V42, P138, DOI 10.1177/0300060513501751; Chen L, 2011, OSTEOARTHR CARTILAGE, V19, P711, DOI 10.1016/j.joca.2011.01.018; Conrozier T, 2007, OSTEOARTHR CARTILAGE, V15, P462, DOI 10.1016/j.joca.2006.09.002; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Deligne C, 2015, OSTEOARTHR CARTILAGE, V23, P1843, DOI 10.1016/j.joca.2014.12.007; Deng J, 2012, ARTHRITIS RHEUM-US, V64, P3564, DOI 10.1002/art.34637; Furst DE, 2014, RHEUMATOLOGY, V53, P1560, DOI 10.1093/rheumatology/ket414; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Garnero P, 2006, ANN RHEUM DIS, V65, P1639, DOI 10.1136/ard.2006.052621; Griffin TM, 2009, ARTHRITIS RHEUM-US, V60, P2935, DOI 10.1002/art.24854; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Kang XZ, 2009, ARTHRIT RHEUM-ARTHR, V61, P641, DOI 10.1002/art.24464; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Karvonen-Gutierrez CA, 2015, J GERONTOLOGY A; Kim YG, 2014, ARCH ORAL BIOL, V59, P897, DOI 10.1016/j.archoralbio.2014.05.009; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; LAU EMC, 1995, ANN RHEUM DIS, V54, P965, DOI 10.1136/ard.54.12.965; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liu YS, 2015, MED SCI MONITOR, V21, P1732; Mabey T, 2015, WORLD J ORTHOP, V6, P95, DOI 10.5312/wjo.v6.i1.95; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Murphy L, 2012, ORTHOP NURS, V31, P85, DOI 10.1097/NOR.0b013e31824fcd42; Nevitt MC, 2002, ARTHRITIS RHEUM-US, V46, P1773, DOI 10.1002/art.10332; Noh M, 2012, BIOCHEM PHARMACOL, V83, P661, DOI 10.1016/j.bcp.2011.12.010; Poonpet T, 2014, WORLD J ORTHOP, V5, P319, DOI 10.5312/wjo.v5.i3.319; Richter F, 2012, ARTHRITIS RHEUM-US, V64, P4125, DOI 10.1002/art.37695; Richter M, 2015, INT ORTHOP, V39, P1211, DOI 10.1007/s00264-015-2707-9; Sandy JD, 2015, OSTEOARTHR CARTILAGE, V23, P1939, DOI 10.1016/j.joca.2015.03.027; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin JH, 2009, BIOCHEM PHARMACOL, V77, P1835, DOI 10.1016/j.bcp.2009.03.008; Song YZ, 2015, J CLIN LAB ANAL; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; van Baarsen LGM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0426-z; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003	44	49	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175109	10.1371/journal.pone.0175109	http://dx.doi.org/10.1371/journal.pone.0175109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399156	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000020
J	Bogard, JR; Farook, S; Marks, GC; Waid, J; Belton, B; Ali, M; Toufique, K; Mamun, A; Thilsted, SH				Bogard, Jessica R.; Farook, Sami; Marks, Geoffrey C.; Waid, Jillian; Belton, Ben; Ali, Masum; Toufique, Kazi; Mamun, Abdulla; Thilsted, Shakuntala H.			Higher fish but lower micronutrient intakes: Temporal changes in fish consumption from capture fisheries and aquaculture in Bangladesh	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; INCOME COUNTRIES; YOUNG-CHILDREN; HEALTH; INFANTS; FOOD	Malnutrition is one of the biggest challenges of the 21 st century, with one in three people in the world malnourished, combined with poor diets being the leading cause of the global burden of disease. Fish is an under-recognised and undervalued source of micronutrients, which could play a more significant role in addressing this global challenge. With rising pressures on capture fisheries, demand is increasingly being met from aquaculture. However, aquaculture systems are designed to maximise productivity, with little consideration for nutritional quality of fish produced. A global shift away from diverse capture species towards consumption of few farmed species, has implications for diet quality that are yet to be fully explored. Bangladesh provides a useful case study of this transition, as fish is the most important animal-source food in diets, and is increasingly supplied from aquaculture. We conducted a temporal analysis of fish consumption and nutrient intakes from fish in Bangladesh, using nationally representative household expenditure surveys from 1991, 2000 and 2010 (n = 25,425 households), combined with detailed species-level nutrient composition data. Fish consumption increased by 30% from 1991-2010. Consumption of non-farmed species declined by 33% over this period, compensated (in terms of quantity) by large increases in consumption of farmed species. Despite increased total fish consumption, there were significant decreases in iron and calcium intakes from fish (P<0.01); and no significant change in intakes of zinc, vitamin A and vitamin B12 from fish, reflecting lower overall nutritional quality of fish available for consumption over time. Our results challenge the conventional narrative that increases in food supply lead to improvements in diet and nutrition. As aquaculture becomes an increasingly important food source, it must embrace a nutrition-sensitive approach, moving beyond maximising productivity to also consider nutritional quality. Doing so will optimise the complementary role that aquaculture and capture fisheries play in improving nutrition and health.	[Bogard, Jessica R.; Marks, Geoffrey C.; Mamun, Abdulla] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Bogard, Jessica R.] CSIRO, Agr Flagship, St Lucia, Qld, Australia; [Farook, Sami; Toufique, Kazi] Bangladesh Inst Dev Studies, Dhaka, Bangladesh; [Waid, Jillian; Ali, Masum] Helen Keller Int, House 10E, Dhaka, Bangladesh; [Waid, Jillian] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Belton, Ben] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA; [Thilsted, Shakuntala H.] WorldFish, Bayan Lepas, Penang, Malaysia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Bangladesh Institute of Development Studies (BIDS); Ruprecht Karls University Heidelberg; Michigan State University; CGIAR; Worldfish	Bogard, JR (corresponding author), Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia.; Bogard, JR (corresponding author), CSIRO, Agr Flagship, St Lucia, Qld, Australia.	jessica.bogard@live.com	Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022; Abed, Farook Nehad/AAV-4188-2020; Bogard, Jessica R/A-7161-2018; Marks, Geoffrey C/E-7368-2010	Mamun, Abdullah A/0000-0002-1535-8086; Abed, Farook Nehad/0000-0003-0338-0283; Bogard, Jessica R/0000-0001-5503-5284; Marks, Geoffrey C/0000-0002-9497-680X; Thilsted, Shakuntala/0000-0002-4041-1651	Australian Government Research Training Programme Scholarship; Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages"; U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented -World Fish, in Bangladesh	Australian Government Research Training Programme Scholarship(Australian Government); Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages"; U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented -World Fish, in Bangladesh(United States Agency for International Development (USAID))	JRB was financially supported by an Australian Government Research Training Programme Scholarship. Part of the work was under taken with the financial support of the Federal Ministry for Economic Cooperation and Development,Germany,through the project "Aquaculture and the poor:improving fish production,consumption and nutrition linkages" as well as of the U.S. Agency for International Development (USAID) Feed the Future initiative, through the project "Aquaculture for Income and Nutrition" (AIN), implemented by World Fish,in Bangladesh. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript. The contents and opinions expressed here in are those of the authors and do not necessarily reflect the views of USAID or the United States Government. This work is acontribution to the CGIAR Research Program (CRP)on Fish Agri-Food Systems (FISH).	Allison E., 2011, WORKING PAPER; Bangladesh Bureau of Statistics (BBS), 2010, BANGL HOUS INC EXP S; BBS, 2000, BANGL HOUS INC EXP S; BBS, 1995, REP HOUS EXP 1991 92; BBS, 2003, REP HOUS INC EXP SUR; BBS, 2011, REP BANGL HOUS INC E; BBS, 1992, BANGL HOUS EXP SURV; Belton B, 2014, FOOD POLICY, V44, P77, DOI 10.1016/j.foodpol.2013.11.003; Belton B, 2012, ASIA PAC VIEWP, V53, P133, DOI 10.1111/j.1467-8373.2012.01487.x; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bogard JR, 2015, J FOOD COMPOS ANAL, V42, P120, DOI 10.1016/j.jfca.2015.03.002; Bogard JR, 2016, PUBLIC HEALTH NUTR, P1; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; FAO (Food and Agriculture Organization), 2016, STAT WORLD FISH AQ 2, DOI 10.18356/8e4e0ebf-en; FAO World Health Organization, 2004, VIT MIN REQ HUM NUTR, V2nd ed; Food and Agriculture Organization, 2016, FOOD BALANCE SHEETS; FRSS, 1994, FISH STAT YB BANGL 1; FRSS, 2015, FISH STAT YB BANGL 2; FRSS, 2012, FISH STAT YB BANGL 2; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Hansen M, 1998, J TRACE ELEM MED BIO, V12, P148, DOI 10.1016/S0946-672X(98)80003-5; HLPE, 2020, FOOD SEC NUTR BUILD; Howlader SR, 2012, INVESTING NUTR NOW S; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; INFS, 2013, FOOD COMPOSITION TAB; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP PROM I; Jhingran V., 1985, HATCHERY MANUAL COMM; [JPGSPH HKI], 2011, STAT FOOD SEC NUTR B; Kawarazuka N, 2011, PUBLIC HEALTH NUTR, V14, P1927, DOI 10.1017/S1368980011000814; Kobayashi M, 2015, AQUACULT ECON MANAG, V19, P282, DOI 10.1080/13657305.2015.994240; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Larsen T, 2000, BRIT J NUTR, V83, P191, DOI 10.1017/S0007114500000246; Michaelsen KF, 2011, MATERN CHILD NUTR, V7, P124, DOI 10.1111/j.1740-8709.2011.00302.x; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Nestel P, 2015, HEART LUNG CIRC, V24, P769, DOI 10.1016/j.hlc.2015.03.020; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Sales J, 2011, AQUACULT NUTR, V17, pE271, DOI 10.1111/j.1365-2095.2010.00761.x; Scheers N, 2014, EUR J NUTR, V53, P1327, DOI 10.1007/s00394-013-0632-5; Thilsted SH, 2014, POND POLYCULTURE TEC; UNICEF GAIN Institute of Public Health and Nutrition, 2013, NATL MICRONUTRIENTS; Usher Sarah, 2015, Metab Eng Commun, V2, P93, DOI 10.1016/j.meteno.2015.04.002; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; Wheal MS, 2016, FOOD CHEM, V201, P222, DOI 10.1016/j.foodchem.2016.01.080	45	55	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175098	10.1371/journal.pone.0175098	http://dx.doi.org/10.1371/journal.pone.0175098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384232	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900085
J	Cacciani, L; Agabiti, N; Bargagli, AM; Davoli, M				Cacciani, Laura; Agabiti, Nera; Bargagli, Anna Maria; Davoli, Marina			Access to percutaneous transluminal coronary angioplasty and 30-day mortality in patients with incident STEMI: Differentials by educational level and gender over 11 years	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; HEART-DISEASE MORTALITY; SOCIOECONOMIC POSITION; REVASCULARIZATION PROCEDURES; POPULATION TRENDS; TEMPORAL TRENDS; SEX-DIFFERENCES; ASSOCIATION; OUTCOMES	Background Socioeconomic status and gender are associated with access to cardiac procedures and mortality after AMI, also in countries with universal health care systems. Our objective was to evaluate the association and trends of educational level or gender and the following outcomes: 1) access to PTCA; 2) 30-day mortality. Methods We conducted an observational study based on 14,013 subjects aged 35-74 years, residing in Rome in 2001, and hospitalised for incident STEMI within 2012 in the Lazio region. We estimated adjusted ORs of educational level or gender and: 1) PTCA within 2 days after hospitalisation, 2) 30-day mortality. We evaluated time trends of outcomes, and time trends of educational or gender differentials estimating ORs stratified by time period (two time periods between 2001 and 2012). We performed a hierarchical analysis to account for clustering of hospitals. Results Access to PTCA among patients with incident STEMI increased during the study period, while 30-day mortality was stable. We observed educational differentials in PTCA procedure only in the first time period, and gender differentials in both periods. Patterns for 30-day mortality were less marked, with educational differentials emerging only in the second period, and gender differentials only in the first one, with patients with low educational level and females being disadvantaged. Conclusions Educational differentials in the access to PTCA disappeared in Lazio region over time, coherently with scientific literature, while gender differentials seem to persist. It may be important to assess the role of female gender in patients with STEMI, both from a social and a clinical point of view.	[Cacciani, Laura; Agabiti, Nera; Bargagli, Anna Maria; Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy		Bargagli, AM (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	a.bargagli@deplazio.it	Cacciani, Laura/Y-1409-2019	Cacciani, Laura/0000-0002-5800-3285				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Agabiti Nera, 2011, Epidemiol Prev, V35, P1; Barchielli A, 2015, EPIDEMIOL PREV, V39, P167; Barnhart JA, 2006, J HEALTH CARE POOR U, V17, P559, DOI 10.1353/hpu.2006.0097; Blais C, 2012, CAN J CARDIOL, V28, P169, DOI 10.1016/j.cjca.2011.10.009; Cesaroni G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-41; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Cowburn G, 2009, CARDIOVASCULAR DIS P; Di Domenicantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158336; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Eitel I, 2012, CIRC-CARDIOVASC IMAG, V5, P119, DOI 10.1161/CIRCIMAGING.111.965467; Falcone M, 2013, EPIDEMIOL PREV, V37, P386; Fang J, 2006, AM J CARDIOL, V97, P1722, DOI 10.1016/j.amjcard.2006.01.032; Gnavi R, 2014, INT J CARDIOL, V176, P724, DOI 10.1016/j.ijcard.2014.07.107; Greco C, 2015, INT J CARDIOL, V184, P115, DOI 10.1016/j.ijcard.2015.01.073; Jakobsen L, 2012, CIRC-CARDIOVASC INTE, V5, P641, DOI 10.1161/CIRCINTERVENTIONS.112.968271; Journath G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140201; Khera S, 2015, J AM COLL CARDIOL, V66, P1961, DOI 10.1016/j.jacc.2015.08.865; Koopman C, 2013, INT J CARDIOL, V168, P993, DOI 10.1016/j.ijcard.2012.10.036; Lawesson SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000726; Leurent G, 2014, ARCH CARDIOVASC DIS, V107, P291, DOI 10.1016/j.acvd.2014.04.005; Luepker RV, 2010, CIRCULATION, V121, P1280, DOI 10.1161/CIR.0b013e3181d98478; Marmot M, 2015, HLTH GAP CHALLENGE U; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; Nante N, 2009, J EPIDEMIOL COMMUN H, V63, P203, DOI 10.1136/jech.2008.077537; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Philbin EF, 2000, CIRCULATION, V102, P107; Picciotto S, 2006, J EPIDEMIOL COMMUN H, V60, P37, DOI 10.1136/jech.2005.037846; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Sarti S, 2016, SOC SCI RES, V57, P116, DOI 10.1016/j.ssresearch.2015.12.010; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sulo E, 2016, INT J CARDIOL, V212, P122, DOI 10.1016/j.ijcard.2016.03.050; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; World Health Organization, GLOB BURD DIS PROJ; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175038	10.1371/journal.pone.0175038	http://dx.doi.org/10.1371/journal.pone.0175038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384181	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900075
J	Chou, CC; Wei, SY; Lou, YC; Chen, CP				Chou, Chun-Chi; Wei, Shu-Yi; Lou, Yuan-Chao; Chen, Chinpan			In-depth study of DNA binding of Cys(2)His(2) finger domains in testis zinc-finger protein	PLOS ONE			English	Article							NONSPECIFIC DNA; TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; LINKER SEQUENCES; RECOGNITION; COMPLEXES; INSIGHTS; AFFINITY; SYSTEM; TRANSITION	Previously, we identified that both fingers 1 and 2 in the three Cys(2)His(2) zinc-finger domains (TZD) of testis zinc-finger protein specifically bind to its cognate DNA; however, finger 3 is non-sequence-specific. To gain insights into the interaction mechanism, here we further investigated the DNA-binding characteristics of TZD bound to non-specific DNAs and its finger segments bound to cognate DNA. TZD in non-specific DNA binding showed smaller chemical shift perturbations, as expected. However, the direction of shift perturbation, change of DNA imino-proton NMR signal, and dynamics on the N-15 backbone atom significantly differed between specific and non-specific binding. Using these unique characteristics, we confirmed that the three single-finger segments (TZD(1), TZD(2) and TZD(3)) and the two-finger segment (TZD(23)) non-specifically bind to the cognate DNA. In comparison, the other two-finger segment (TZD(12)) binding to the cognate DNA features simultaneous nonspecific and semi-specific binding, both slowly exchanged in terms of NMR timescale. The process of TZD binding to the cognate DNA is likely stepwise: initially TZD non-specifically binds to DNA, then fingers 1 and 2 insert cooperatively into the major groove of DNA by semi-specific binding, and finally finger 3 non-specifically binds to DNA, which promotes the specific binding on fingers 1 and 2 and stabilizes the formation of a specific TZD-DNA complex.	[Chou, Chun-Chi; Wei, Shu-Yi; Lou, Yuan-Chao; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Chen, CP (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmchinp@ibms.sinica.edu.tw	Chen, Chinpan/O-4202-2018		Academia Sinica; Ministry of Science and Technology [104-0210-01-09-02]; Ministry of Science and Technology, Taiwan, ROC [MOST 103-2311-B-001-026-MY3, MOST 105-2320-B-001-019-MY3]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by funds from Academia Sinica and Ministry of Science and Technology [104-0210-01-09-02] and the Ministry of Science and Technology, Taiwan, ROC [MOST 103-2311-B-001-026-MY3 and MOST 105-2320-B-001-019-MY3].	Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Chou CC, 2010, PROTEINS, V78, P2202, DOI 10.1002/prot.22732; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desjardins G, 2016, BIOCHEMISTRY-US, V55, P4105, DOI 10.1021/acs.biochem.6b00460; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Furu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062314; Garton M, 2015, NUCLEIC ACIDS RES, V43, P9147, DOI 10.1093/nar/gkv919; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Lee J, 2010, J PHYS CHEM B, V114, P7662, DOI 10.1021/jp1017289; Liu L, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064107; Loth K, 2013, J BIOMOL NMR, V56, P41, DOI 10.1007/s10858-013-9723-0; NEDVED ML, 1994, NUCLEIC ACIDS RES, V22, P4705, DOI 10.1093/nar/22.22.4705; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Sauve S, 2007, J MOL BIOL, V365, P1163, DOI 10.1016/j.jmb.2006.10.044; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Squires A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11643; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Vandevenne M, 2013, J BIOL CHEM, V288, P10616, DOI 10.1074/jbc.M112.441451; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Vivas P, 2008, J PHYS CHEM B, V112, P5997, DOI 10.1021/jp076042s; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yonetani Y, 2013, J PHYS CHEM B, V117, P7535, DOI 10.1021/jp402664w; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175051	10.1371/journal.pone.0175051	http://dx.doi.org/10.1371/journal.pone.0175051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384299	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900077
J	Lee, JY; Chang, J				Lee, Jeong-Yoon; Chang, Jun			Universal vaccine against respiratory syncytial virus A and B subtypes	PLOS ONE			English	Article							ATTACHMENT G PROTEIN; CENTRAL UNGLYCOSYLATED REGION; BALB/C MICE; G-GLYCOPROTEIN; RSV INFECTION; PULMONARY EOSINOPHILIA; INTRANASAL DELIVERY; CX3C-CX3CR1 BINDING; INACTIVATED VACCINE; ENHANCED DISEASE	Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory tract infection in infants, young children, and the elderly. Two subtypes of RSV, A and B, circulate alternately at 1-2-year intervals during epidemics. The attachment glycoprotein (G protein) of RSV is one of the major targets for immune responses. In this study, we generated a recombinant fusion protein, GcfAB, which consists of the central regions (a. a. residues 131-230) of the G proteins of both RSV A (A2 strain) and B (B1 strain) subtypes, and investigated immunogenicity, protective efficacy, and immunopathology. We immunized mice with GcfAB plus cholera toxin as a mucosal adjuvant via intranasal ( -IN) or sublingual (SL) routes. The IN group showed higher levels of RSV G-specific antibody responses, including serum IgG and mucosal IgA, compared with the SL group. On the contrary, more vigorous RSV G-specific CD4(+) T-cell responses were elicited in the SL group than in the IN group after RSV-A but not RSV-B viral challenge. Furthermore, the SL group showed more pulmonary eosinophil recruitment and body weight loss than did the IN group after RSV-A challenge. Both IN and SL immunization with GcfAB provided potential protection against both subtypes of infections. Together, these results suggest that vaccination with GcfAB via an IN route could be a universal vaccine regimen preventing both RSV A and B infections.	[Lee, Jeong-Yoon; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Ewha Womans University	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060008]; Korean Health Technology R& D Project, the Ministry of Health & Welfare, Republic of Korea [HI13C0826]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology; Korean Health Technology R& D Project, the Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060008) and by a grant of Korean Health Technology R& D Project, the Ministry of Health & Welfare (HI13C0826), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; Cane PA, 1996, J MED VIROL, V48, P253, DOI 10.1002/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; Cheon IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094269; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hancock GE, 1996, J VIROL, V70, P7783, DOI 10.1128/JVI.70.11.7783-7791.1996; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Haynes LM, 2003, J VIROL, V77, P9831, DOI 10.1128/JVI.77.18.9831-9844.2003; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jafri HS, 2013, PEDIATR INFECT DIS J, V32, P335, DOI 10.1097/INF.0b013e318282603a; Jang JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023797; Johnson TR, 2004, PEDIATR INFECT DIS J, V23, pS46, DOI 10.1097/01.inf.0000108192.94692.d2; KIM HW, 1976, PEDIATR RES, V10, P75, DOI 10.1203/00006450-197601000-00015; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim S, 2012, PLOS ONE; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Murata Y, 2012, VACCINE, V30, P5382, DOI 10.1016/j.vaccine.2012.06.016; Murata Y, 2010, VACCINE, V28, P6242, DOI 10.1016/j.vaccine.2010.07.011; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Papadopoulos NG, 2004, RESP MED, V98, P879, DOI 10.1016/j.rmed.2004.01.009; PIEDRA PA, 1989, VACCINE, V7, P34, DOI 10.1016/0264-410X(89)90008-X; PIEDRA PA, 1993, VACCINE, V11, P1415, DOI 10.1016/0264-410X(93)90170-3; Plotnicky-Gilquin H, 2000, J VIROL, V74, P3455, DOI 10.1128/JVI.74.8.3455-3463.2000; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Power UF, 2001, VACCINE, V19, P2345, DOI 10.1016/S0264-410X(00)00525-9; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Srikiatkhachorn A, 1999, J VIROL, V73, P6590, DOI 10.1128/JVI.73.8.6590-6597.1999; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; TRUDEL M, 1991, VIROLOGY, V185, P749, DOI 10.1016/0042-6822(91)90546-N; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6; WALSH EE, 1989, J GEN VIROL, V70, P2953, DOI 10.1099/0022-1317-70-11-2953; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09	51	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175384	10.1371/journal.pone.0175384	http://dx.doi.org/10.1371/journal.pone.0175384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384263	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900166
J	Sun, XF; Ding, ZS; Wang, XB; Hou, HP; Zhou, BY; Yue, Y; Ma, W; Ge, JZ; Wang, ZM; Zhao, M				Sun, Xuefang; Ding, Zaisong; Wang, Xinbing; Hou, Haipeng; Zhou, Baoyuan; Yue, Yang; Ma, Wei; Ge, Junzhu; Wang, Zhimin; Zhao, Ming			Subsoiling practices change root distribution and increase post-anthesis dry matter accumulation and yield in summer maize	PLOS ONE			English	Article							SOIL PHYSICAL-PROPERTIES; LEAF-SENESCENCE; BULK-DENSITY; GRAIN-YIELD; STAY GREEN; TILLAGE; COMPACTION; NITROGEN; WHEAT; HYBRIDS	Subsoiling is an important management practice for improving maize yield, especially for maize planted at high plant density. However, the affected physiological processes have yet to be specifically identified. In this study, field experiments with two soil tillage (CK: notillage, SS: subsoiling) and three planting densities ( low: 45000 plants ha(-1), medium: 67500plants ha(-1), and high: 90000 plants ha(-1)) were conducted from 2010 to 2012 at Xinxiang, Henan province. Yield, canopy function, and root system were investigated to determine the associated physiological processes for improving maize production affected by soil tillage and plant density. Subsoiling significantly increased the grain yield of the low-, medium-, and high-planting densities by 6.21%, 8.92%, and 10.09%, respectively. Yield increase in the SS plots was mainly attributed to greater post-anthesis DMA and improved grain filling compared to CK plots. Greater green leaf area, leaf net photosynthetic rate, F-V/F-m and phi PSII in the SS plots were mainly contributed to enhanced dry matter production post-anthesis. This is mainly because subsoiling increased density of root dry weight in deep soil and root bleeding sap amount due to decreased the bulk density of the 0-30 cm soil profile layer. Density of root dry weight at 10-50 cm depth with SS increased by 40.68%, 32.17%, and 20.14% at low, medium, and high planting densities compared to CK, respectively, while the root bleeding sap amount increased by 17.41%, 15.82%, and 20.91%. These results indicate that subsoiling could change the root distribution and improve soil layer environment for root growth, thus maintaining a higher canopy photosynthetic capacity post-anthesis and in turn promoting DMA and yield, particularly at higher planting densities.	[Sun, Xuefang; Ding, Zaisong; Wang, Xinbing; Hou, Haipeng; Zhou, Baoyuan; Ma, Wei; Ge, Junzhu; Zhao, Ming] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Ecophysiol & Cultivat, Minist Agr, Beijing, Peoples R China; [Yue, Yang; Wang, Zhimin] China Agr Univ, Coll Agron & Biotechnol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University	Zhao, M (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Ecophysiol & Cultivat, Minist Agr, Beijing, Peoples R China.	zhaoming@caas.cn	Wang, Xin/GYU-1129-2022; Zhou, Baoyuan/HDM-1095-2022; Wang, Xin/AAN-8435-2021	Zhou, Baoyuan/0000-0003-0979-4460; Wang, Xin/0000-0002-4457-7376	National Science and Technology Support Project [2013BAD07B00]; State Key Program of China [2016YFD0300103]; National Agricultural Industry and Technology of China [CRRS-02]	National Science and Technology Support Project; State Key Program of China(State Key Development Program for Basic Research of China); National Agricultural Industry and Technology of China	This work was supported by the National Science and Technology Support Project (2013BAD07B00), http://program.most.gov.cn/, and the State Key Program of China (2016YFD0300103), http://service.most.gov.cn/, and the National Agricultural Industry and Technology of China (CRRS-02), http://cars.wmelon.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonietta M, 2014, FIELD CROP RES, V155, P111, DOI 10.1016/j.fcr.2013.09.016; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, FIELD CROP RES, V82, P13, DOI 10.1016/S0378-4290(03)00002-9; Cai HG, 2014, CROP J, V2, P297, DOI 10.1016/j.cj.2014.04.006; Cavigelli MA, 2005, APPL SOIL ECOL, V29, P99, DOI 10.1016/j.apsoil.2004.12.007; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Dai MingHong, 2011, Scientia Agricultura Sinica, V44, P1585; Ding L, 2007, BIOL PLANTARUM, V51, P165, DOI 10.1007/s10535-007-0032-x; Ding ZS, 2014, CROP J, V2, P22, DOI 10.1016/j.cj.2013.12.003; [董学会 Dong Xuehui], 2005, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V25, P587; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Ekelof J, 2015, POTATO RES, V58, P15, DOI 10.1007/s11540-014-9261-5; Escobar-Gutierrez AJ, 2012, FIELD CROP RES, V134, P47, DOI 10.1016/j.fcr.2012.04.013; Gambin BL, 2006, FIELD CROP RES, V95, P316, DOI 10.1016/j.fcr.2005.04.002; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILL KS, 1990, SOIL TILL RES, V18, P37, DOI 10.1016/0167-1987(90)90091-Q; Guan DH, 2015, SOIL TILL RES, V146, P286, DOI 10.1016/j.still.2014.09.016; Hall DJM, 2010, AUST J SOIL RES, V48, P178, DOI 10.1071/SR09078; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; Hou HaiPeng, 2013, Acta Agronomica Sinica, V39, P1069, DOI 10.3724/SP.J.1006.2013.01069; [黄智鸿 HUANG Zhihong], 2007, [玉米科学, Maize Science], V15, P95; Ishaq M, 2001, SOIL TILL RES, V59, P57, DOI 10.1016/S0167-1987(00)00189-6; Jones RJ, 1996, CROP SCI, V36, P301, DOI 10.2135/cropsci1996.0011183X003600020015x; Klepper B., 1990, Agronomy, P281; Kumar S, 2012, SUGAR TECH, V14, P398, DOI 10.1007/s12355-012-0170-0; [李飒 Li Sa], 2011, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V17, P325; [梁金凤 LIANG Jinfeng], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P945; Lipiec J, 2012, SOIL TILL RES, V121, P74, DOI 10.1016/j.still.2012.01.013; Liu JL, 2014, AGRON J, V106, P390, DOI 10.2134/agronj2013.0404; Liu TD, 2012, PHOTOSYNTHETICA, V50, P215, DOI 10.1007/s11099-012-0011-0; Lu Hai-dong, 2010, Yingyong Shengtai Xuebao, V21, P895; Marchiori PER, 2014, FIELD CROP RES, V155, P30, DOI 10.1016/j.fcr.2013.09.025; Mosaddeghi MR, 2009, SOIL TILL RES, V104, P173, DOI 10.1016/j.still.2008.10.011; Mu XY, 2016, EUR J AGRON, V78, P32, DOI 10.1016/j.eja.2016.04.010; NITANT HC, 1995, SOIL TILL RES, V34, P17, DOI 10.1016/0167-1987(94)00454-M; Qi WenZeng, 2012, Plant Nutrition and Fertilizer Science, V18, P69; [秦红灵 QIN Hongling], 2008, [中国农业科学, Scientia Agricultura Sinica], V41, P78; Sala RG, 2007, FIELD CROP RES, V101, P19, DOI 10.1016/j.fcr.2006.09.004; Sangoi L., 2001, Ciencia Rural, V31, P159, DOI 10.1590/S0103-84782001000100027; Sasal MC, 2006, SOIL TILL RES, V87, P9, DOI 10.1016/j.still.2005.02.025; [宋日 Song Ri], 2002, [作物学报, Acta Agronomica Sinica], V28, P393; Stirzaker RJ, 1996, PLANT SOIL, V185, P151, DOI 10.1007/BF02257571; Sun XueFang, 2013, Acta Agronomica Sinica, V39, P1284, DOI 10.3724/SP.J.1006.2013.01284; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Tollenaar M, 2011, PL BRED RE, V34, P37; Tollenaar M, 2006, AGRON J, V98, P930, DOI 10.2134/agronj2005.0336; Tolon-Becerra A, 2011, SOIL TILL RES, V117, P184, DOI 10.1016/j.still.2011.10.003; Wang XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129231; Wingler A, 2004, NEW PHYTOL, V161, P781, DOI 10.1111/j.1469-8137.2004.00996.x; [翟振 Zhai Zhen], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P2322; Zhang Y, 2017, CHINESE J ECOAGRICUL, V3; [张子山 Zhang Zishan], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4794; [赵明 Zhao Ming], 2015, [作物杂志, Crops], P70; Zhou BY, 2016, AGRON J, V108, P1, DOI DOI 10.2134/AGR0NJ2015.0196; Zhu M, 2011, AFR J AGR RES, V6, P2820; ZHU Q, 1988, Acta Agronomica Sinica, V14, P182	58	34	38	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174952	10.1371/journal.pone.0174952	http://dx.doi.org/10.1371/journal.pone.0174952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384233	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900062
J	Cho, GJ; Kang, J				Cho, Geum-Jin; Kang, Jiyeon			Type D personality and post-traumatic stress disorder symptoms among intensive care unit nurses: The mediating effect of resilience	PLOS ONE			English	Article							CONSTRUCT; VALIDITY; GROWTH	The purpose of this study was to investigate the relationship between Type D personality and post-traumatic stress disorder (PTSD) symptoms of intensive care unit (ICU) nurses and to determine the mediating effect of resilience on this relationship. A cross-sectional survey was performed with 179 ICU nurses from 7 hospitals in Gyeong-Nam province, South Korea. The Type D personality, resilience, and PTSD symptoms of subjects were measured using a self-report questionnaire. The mediating effect was analyzed by a series of hierarchical multiple regressions. A total of 38.6% of the study participants turned out to have Type D personality. The Type D personality was positively correlated with PTSD symptoms, and negatively correlated with resilience. There was a negative correlation between resilience and PTSD symptoms. The indirect effect of Type D personality on PTSD symptoms via resilience (beta =.51, p < .001) was smaller than the direct effect (beta =.58, p<.001). Based on the above results, it can be concluded that resilience had a partial mediating effect on the relationship between Type D personality and PTSD symptoms of ICU nurses. Further studies need to be done to develop interventions for enhancing resilience in ICU nurses.	[Cho, Geum-Jin] Dong A Univ, Med Ctr, Neurol Intens Care Unit, Busan, South Korea; [Kang, Jiyeon] Dong A Univ, Dept Nursing, Busan, South Korea	Dong A University; Dong A University	Kang, J (corresponding author), Dong A Univ, Dept Nursing, Busan, South Korea.	jykang@dau.ac.kr	Kang, Jiyeon/AAD-1016-2021	Kang, Jiyeon/0000-0002-8938-7656				American Psychiatric Association, POSTTR STRESS DIS; [Anonymous], 2011, AM J HLTH SCI, DOI DOI 10.19030/AJHS.V2I1.4365; Baek HS, 2010, PSYCHIAT INVEST, V7, P109, DOI 10.4306/pi.2010.7.2.109; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Booth L, 2015, J HEALTH PSYCHOL, V20, P921, DOI 10.1177/1359105315573433; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Czaja AS, 2012, J PEDIATR NURS, V27, P357, DOI 10.1016/j.pedn.2011.04.024; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Dyer JG, 1996, ARCH PSYCHIAT NURS, V10, P276, DOI 10.1016/S0883-9417(96)80036-7; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Geuens N, 2015, BURNOUT RES, V2, P80, DOI [DOI 10.1016/J.BURN.2015.05.003, DOI 10.1016/j.burn.2015.05.003]; Greene T, 2016, J CLIN PSYCHOL MED S, V23, P160, DOI 10.1007/s10880-016-9449-8; Gu Q, 2007, TEACH TEACH EDUC, V23, P1302, DOI 10.1016/j.tate.2006.06.006; Horn SR, 2016, EXP NEUROL; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Karlsson MR, 2007, J BEHAV MED, V30, P253, DOI 10.1007/s10865-007-9096-5; Kim YH, 2016, J ADV NURS; Kunst MJJ, 2011, CLIN PSYCHOL PSYCHOT, V18, P13, DOI 10.1002/cpp.698; Laschinger HKS, 2015, J NURS MANAGE, V23, P252, DOI 10.1111/jonm.12122; Lim HT, 2011, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2011-91; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mealer M, 2014, AM J CRIT CARE, V23, pE97, DOI 10.4037/ajcc2014747; Mealer M, 2012, INTENS CARE MED, V38, P1445, DOI 10.1007/s00134-012-2600-6; Mealer M, 2012, INT J NURS STUD, V49, P292, DOI 10.1016/j.ijnurstu.2011.09.015; Mealer M, 2009, DEPRESS ANXIETY, V26, P1118, DOI 10.1002/da.20631; Mealer ML, 2007, AM J RESP CRIT CARE, V175, P693, DOI 10.1164/rccm.200606-735OC; Miller MW, 2003, CLIN PSYCHOL-SCI PR, V10, P373, DOI 10.1093/clipsy/bpg040; Mols F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-9; Mommersteeg PMC, 2012, SCAND J PUBLIC HEALT, V40, P35, DOI 10.1177/1403494811421533; Pai A, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7010007; Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7; Polman R, 2010, BRIT J HEALTH PSYCH, V15, P681, DOI 10.1348/135910709X479069; Shin HY, 2015, CRISISONOMY, V11, P97; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Tekin A, 2016, ARCH ENVIRON OCCUP H, P1; Williams L, 2012, PSYCHOL HEALTH, V27, P1075, DOI 10.1080/08870446.2012.667098; Wooten NR, 2012, SOC WORK HEALTH CARE, V51, P828, DOI 10.1080/00981389.2012.692353; Yu NX, 2017, AIDS CARE, V29, P79, DOI 10.1080/09540121.2016.1210073; 안현의, 2005, [Korean Journal Of Counseling And Psychotherapy, 한국심리학회지: 상담 및 심리치료], V17, P217	39	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175067	10.1371/journal.pone.0175067	http://dx.doi.org/10.1371/journal.pone.0175067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380063	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500092
J	da Silva, LG; Kawanishi, K; Henschel, P; Kittle, A; Sanei, A; Reebin, A; Miquelle, D; Stein, AB; Watson, A; Kekule, LB; Machado, RB; Eizirik, E				da Silva, Lucas G.; Kawanishi, Kae; Henschel, Philipp; Kittle, Andrew; Sanei, Arezoo; Reebin, Alexander; Miquelle, Dale; Stein, Andrew B.; Watson, Anjali; Kekule, Laurence Bruce; Machado, Ricardo B.; Eizirik, Eduardo			Mapping black panthers: Macroecological modeling of melanism in leopards (Panthera pardus)	PLOS ONE			English	Article							NATURAL-SELECTION; COLOR VARIATION; EVOLUTION; HABITAT; NICHE; GENETICS; CAT	The geographic distribution and habitat association of most mammalian polymorphic phenotypes are still poorly known, hampering assessments of their adaptive significance. Even in the case of the black panther, an iconic melanistic variant of the leopard (Panthera pardus), no map exists describing its distribution. We constructed a large database of verified records sampled across the species' range, and used it to map the geographic occurrence of melanism. We then estimated the potential distribution of melanistic and non-melanistic leopards using niche-modeling algorithms. The overall frequency of melanism was ca. 11%, with a significantly non-random spatial distribution. Distinct habitat types presented significantly different frequencies of melanism, which increased in Asian moist forests and approached zero across most open/dry biomes. Niche modeling indicated that the potential distributions of the two phenotypes were distinct, with significant differences in habitat suitability and rejection of niche equivalency between them. We conclude that melanism in leopards is strongly affected by natural selection, likely driven by efficacy of camouflage and/or thermoregulation in different habitats, along with an effect of moisture that goes beyond its influence on vegetation type. Our results support classical hypotheses of adaptive coloration in animals (e.g. Gloger's rule), and open up new avenues for in-depth evolutionary analyses of melanism in mammals.	[da Silva, Lucas G.; Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Kawanishi, Kae] Malaysian Conservat Alliance Tigers, Petaling Jaya, Malaysia; [Henschel, Philipp] Panthera Lion Program, New York, NY USA; [Kittle, Andrew; Watson, Anjali] Wilderness & Wildlife Conservat Trust, Colombo, Sri Lanka; [Sanei, Arezoo] Asian Leopard Specialist Soc, Tehran, Iran; [Reebin, Alexander; Miquelle, Dale] Wildlife Conservat Soc, New York, NY USA; [Stein, Andrew B.] Landmark Coll, Putney, VT USA; [Stein, Andrew B.] Botswana Predator Conservat Trust, Maun, Botswana; [Kekule, Laurence Bruce] BK Wildlife Photog Co, Bangkok, Thailand; [Machado, Ricardo B.] Univ Brasilia, Brasilia, DF, Brazil; [Eizirik, Eduardo] Inst Procarnivoros, Atibaia, SP, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Wildlife Conservation Society; Universidade de Brasilia	da Silva, LG; Eizirik, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.; Eizirik, E (corresponding author), Inst Procarnivoros, Atibaia, SP, Brazil.	lucas.silva@pucrs.br; eduardo.eizirik@pucrs.br	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022; Eizirik, Eduardo/K-8034-2012; Gonçalves da Silva, Lucas/B-8702-2014; Silva, Diego/GRF-5446-2022; Silva, Lucas/GQH-8201-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Eizirik, Eduardo/0000-0002-9658-0999; Gonçalves da Silva, Lucas/0000-0002-7993-9015; Kittle, Andrew/0000-0002-7334-4766; Sanei, Arezoo/0000-0002-8873-2489	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [150529/2014-7]; CNPq/Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), www.cnpq.br., Grant 150529/2014-7, awarded to EE and LGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company 'BK Wildlife Photography' provided support in the form of salaries for author LBK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; Authors would like to thank Rafael D. Loyola, Marcio B. Martins, Kristofer Helgen, Katia B. Ferraz, Francesca Palmeira, Everton Quadros, Regis Lahm, Eileen Westwig, Esther Langan, Milind Pariwakam, Biswajit Mohanty, Kashmira Kakati, Anhar Harahap, Vidya Athreya, Jane Budd, Arash Ghoddousi, Ezequiel Fabiano, Peter Crawshaw Jr., Guy Balme, David Stanton, Yury Shibnev, Dipankar Ghose and Joao F. Moraes for location records and/or helpful discussions. We also thank Drs. Tim Caro and Andrew Kitchener for insightful comments on a previous version of this manuscript, which helped improve our analyses and interpretations of the observed patterns. We thank the American Museum of Natural History, Smithsonian Institution, Panthera, Wildlife Conservation Society, World Wild Fund, Asian Leopard Specialist Group, Cape Leopard Trust, and the IUCN Cat Specialist Group for assistance with data collection, and CNPq/Brazil for financial support to L.G. Silva, R.B. Machado and E. Eizirik. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2010, P ROYAL SOC BIOL SCI, P277; [Anonymous], [No title captured]; Baylis HA, 1927, J NAT HIST, V9, P214; Beddard FE, 1985, ANIMAL COLORATION CO; Burtt EH, 2004, CONDOR, V106, P681, DOI 10.1650/7383; Calabrese JM, 2013, GLOBAL ECOL BIOGEOGR; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Cott H.B., 1940, ADAPTIVE COLORATION; da Silva LG, 2016, J ZOOL, V299, P295, DOI 10.1111/jzo.12358; Daniel J. C., 1996, THE LEOPARD IN INDIA; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik Eduardo, 2003, Cat News, V38, P37; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esri, 2010, ARCGIS SOFTW; Fischer MM, 2011, SPRINGERBR REG SCI, P1, DOI 10.1007/978-3-642-21720-3; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gloger, 1833, ABANDERN VOGEL DURCH; Hammond S., 2001, BLACK LEOPARD SPOTTE; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Hedges L, 2015, J WILDLIFE MANAGE, V79, P846, DOI 10.1002/jwmg.901; Henschel P, IUCN 2008 IUCN RED L; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Jacobson AP, 2016, PEER J; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Koyabu DB, 2008, INT J PRIMATOL, V29, P531, DOI 10.1007/s10764-007-9152-6; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Luo SJ, 2014, MOL ECOL, V23, P2072, DOI 10.1111/mec.12716; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; MEN Majerus, 1998, EVOLUTION ACTION; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Ferraz KMPMD, 2012, NAT CONSERVACAO, V10, P214, DOI 10.4322/natcon.2012.032; Mukherjee S, 2010, PLOS ONE, V5; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ortolani A, 1996, CARNIVORES BEHAV ECO, V2; PEARSON RG, 2007, SPECIES DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; POCOCK R. I., 1930, JOUR BOMBAY NAT HIST SOC, V34, P64; Pocock RI, 1930, J BOMBAY NATURAL HIS, V34, P307; Poulton EB, 1890, COLORS ANIMALS THEIR; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Schneider A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004892; Schneider AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032824; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sterndale RA, 1984, NATURAL HIST MAMMALI; Sunquist ME, 2002, WILD CATS WORLD; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Thapa Kamal, 2013, Cat News, V58, P26; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Wallace A. R., 1877, MACMILLANS MAGAZINE, V36, P384; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei CTK, 2015, TROP CONSERV SCI, V8, P732, DOI 10.1177/194008291500800310; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wilting A, 2016, J ZOOLOGY	63	23	24	9	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0170378	10.1371/journal.pone.0170378	http://dx.doi.org/10.1371/journal.pone.0170378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379961	gold, Green Published, Green Submitted			2022-12-26	WOS:000399353500003
J	Wang, AH; Wang, FG; Zhang, WW; Ma, XD; Li, XW; Yi, QF; Li, DL; Duan, L; Yan, YH; Xing, FW				Wang, Ai-Hua; Wang, Fa-Guo; Zhang, Wan-Wan; Ma, Xiao-Dong; Li, Xu-Wen; Yi, Qi-Fei; Li, Dong-Lin; Duan, Lei; Yan, Yue-Hong; Xing, Fu-Wu			Revision of series Gravesiana (Adiantum L.) based on morphological characteristics, spores and phylogenetic analyses	PLOS ONE			English	Article							CHLOROPLAST DNA; DRYOPTERIDACEAE; ORIGIN	Since the adoption of some ambiguous and quantitative characters in Flora Republicae Popularis Sinicae 3(1), species identifications of the series Gravesiana have been in disarray, requiring clarification. Two hundred and fifty-nine individuals from 47 different populations were collected for the estimation of morphological characters and phylogenetic analyses. Spores of 26 populations were observed through scanning electron microscope. Our results were different from those of previous research: (1) six identifiable species, rather than five species observed previously, were confirmed in the series Gravesiana, they are A. gravesii, A. juxtapositum, A. mariesii, A. dentatum, A. longzhouensis and A. obovatum, of which the latter three are newly recognized species. (2) Thirteen characters were measured and estimated through the program Mesquite v. 2.71. The character whether the pinna stalks were 1/3-1/2 times longer than the pinna was used to distinguish A. gravesii and A. lianxianense previously and was found to be unreliable here, whereas such characters as the height of the plant (H), pinna aligned forms (FP), number of pinna (NP), pinna margin (M), number of veins flabellate at base (NV), sori number and shape per pinna (NSS), pinna texture (T), and powder-covered or not on the abaxial surface of the pinna (P) are estimated to be stable and reliable characters useful for identification. Descriptions of new species and their retrieve keys are also listed. (3) Surface ornamentations and spore sizes are helpful for us to distinguish species in series Gravesiana.	[Wang, Ai-Hua; Wang, Fa-Guo; Zhang, Wan-Wan; Ma, Xiao-Dong; Li, Xu-Wen; Yi, Qi-Fei; Li, Dong-Lin; Duan, Lei; Xing, Fu-Wu] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Wang, Ai-Hua] Guangxi Teachers Educ Univ, Minist Educ, Key Lab Environm Change & Resources Use Beibu Gul, Nanning, Peoples R China; [Wang, Ai-Hua; Ma, Xiao-Dong; Li, Dong-Lin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xu-Wen] Guangzhou Inst Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Yan, Yue-Hong] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Nanning Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xing, FW (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	xinfw@scib.ac.cn	Duan, Lei/HGT-9132-2022; Ma, Xiao-dong/AAX-1333-2021; Duan, Lei/HGT-9055-2022	Ma, Xiao-dong/0000-0002-6537-7920; Duan, Lei/0000-0001-6152-5458	Youth Innovation Promotion Association of Chinese Academy of Sciences [2013229]; Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [201214ZS]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA13020500]	Youth Innovation Promotion Association of Chinese Academy of Sciences; Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013229), and the Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (201214ZS), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020500).; We thank Ri-Hong JIANG in Guangxi Forestry Group for his help with many collection sites provided; we also thank Yun-Xiao LIU (South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, China) for their help with the morphology figures. This work was funded by the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013229), and the Key Laboratory of Plant Resource Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (201214ZS), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020500).	[Anonymous], 2014, IUCN GUID US IUCN RE; Baker JG, 1880, GARDENERS CHRONICLE, V16, P494; Ching R.-C., 1957, ACTA PHYTOTAXONOMICA, V6, P312; Ching RC, 1930, SINENSIA, V1, P50; Doyle J. J., 1987, PHYTOCHEM B, P11; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hance HF, 1875, J BOT BRIT FOREIGN, V13, P197; Harris JG, 2001, PLANT IDENTIFICATION, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin YX, 1980, ACTA PHYTOTAXONOMICA, V18, P102; Little DP, 2003, AM J BOT, V90, P508, DOI 10.3732/ajb.90.3.508; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; Lu JM, 2005, J PLANT RES, V118, P129, DOI 10.1007/s10265-005-0201-y; Maddison W, 2009, MESQUITE VERSION 2 7; Nylander JAA., 2004, MRMODELTEST 2 2; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shing K.H., 1990, FLORA REPUBLICAE POP, V3, P173; SouzaChies TT, 1997, PLANT SYST EVOL, V204, P109, DOI 10.1007/BF00982535; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Wang AH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0361-9; Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01157; Wang QX, 2010, SPORES POLYPODIALES, P10; Yan YueHong, 2012, Biodiversity Science, V20, P517, DOI 10.3724/SP.J.1003.2012.05215; [严岳鸿 Yan Yuehong], 2011, [广西植物, Guihaia], V31, P5; Zhang WY, 2014, SYST BOT, V39, P1034, DOI 10.1600/036364414X682616	27	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172729	10.1371/journal.pone.0172729	http://dx.doi.org/10.1371/journal.pone.0172729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379966	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500007
J	Zhang, JJ; Kong, QY				Zhang, Jian-Jun; Kong, Qingyao			Locomotor activity: A distinctive index in morphine self-administration in rats	PLOS ONE			English	Article							BEHAVIORAL SENSITIZATION; SEEKING BEHAVIOR; HEROIN-SEEKING; KAPPA-AGONIST; REINSTATEMENT; COCAINE; ADDICTION; RECEPTORS; RELAPSE	Self-administration of addictive drugs is a widely used tool for studying behavioral, neurobiological, and genetic factors in addiction. However, how locomotor activity is affected during self-administration of addictive drugs has not been extensively studied. In our present study, we tested the locomotor activity levels during acquisition, extinction and reinstatement of morphine self-administration in rats. We found that compared with saline self-administration (SA), rats that trained with morphine SA had higher locomotor activity. Rats that successfully acquired SA also showed higher locomotor activity than rats that failed in acquiring SA. Moreover, locomotor activity was correlated with the number of drug infusions but not with the number of inactive pokes. We also tested the locomotor activity in the extinction and the morphine-primed reinstatement session. Interestingly, we found that in the first extinction session, although the number of active pokes did not change, the locomotor activity was significantly lower than in the last acquisition session, and this decrease can be maintained for at least six days. Finally, morphine priming enhanced the locomotor activity during the reinstatement test, regardless of if the active pokes were significantly increased or not. Our results clearly suggest that locomotor activity, which may reflect the pharmacological effects of morphine, is different from drug seeking behavior and is a distinctive index in drug self administration.	[Zhang, Jian-Jun] Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Jian-Jun] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Zhang, Jian-Jun; Kong, Qingyao] Peking Univ, Coll Life Sci, Lab Neurobiol, Beijing, Peoples R China; [Zhang, Jian-Jun; Kong, Qingyao] Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Zhang, JJ (corresponding author), Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Peking Univ, Coll Life Sci, Lab Neurobiol, Beijing, Peoples R China.; Zhang, JJ (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.	zhangjj@psych.ac.cn			National Natural Science Research Foundation of China (NSFC) [31400880]	National Natural Science Research Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Research Foundation of China (NSFC: 31400880).	Bailey A, 2010, EUR J NEUROSCI, V31, P742, DOI 10.1111/j.1460-9568.2010.07104.x; Deiana S, 2007, NEUROPHARMACOLOGY, V52, P646, DOI 10.1016/j.neuropharm.2006.09.007; Dempsey S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00087; DEWIT H, 1983, PSYCHOPHARMACOLOGY, V79, P29, DOI 10.1007/BF00433012; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Frankel PS, 2007, PHARMACOL BIOCHEM BE, V86, P511, DOI 10.1016/j.pbb.2007.01.012; Gardner EL, 2000, AM J ADDICTION, V9, P285, DOI 10.1080/105504900750047355; GRIFFITHS RR, 1975, PSYCHOPHARMACOLOGIA, V43, P81, DOI 10.1007/BF00437619; Hough LB, 2014, EUR J PHARMACOL, V740, P255, DOI 10.1016/j.ejphar.2014.07.028; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; KUCZENSKI R, 1991, J NEUROSCI, V11, P2703; Landa L, 2014, EUR J PHARMACOL, V730, P77, DOI 10.1016/j.ejphar.2014.02.028; Liu Z, 2012, AGU FALL M, V1, DOI DOI 10.1016/J.NEULET.2012.05.003; Liu Z, 2012, NEUROSCI LETT, V526, P39, DOI 10.1016/j.neulet.2012.07.042; Pautassi RM, 2012, PHARMACOL BIOCHEM BE, V100, P630, DOI 10.1016/j.pbb.2011.11.005; Marinelli M, 1998, PSYCHOPHARMACOLOGY, V139, P281, DOI 10.1007/s002130050717; Mizoguchi H, 2010, PSYCHOPHARMACOLOGY, V212, P215, DOI 10.1007/s00213-010-1946-0; NARITA M, 1993, JPN J PHARMACOL, V62, P15, DOI 10.1254/jjp.62.15; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P215, DOI 10.1007/BF02245526; Shalev U, 2001, J NEUROSCI, V21; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174272	10.1371/journal.pone.0174272	http://dx.doi.org/10.1371/journal.pone.0174272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380023	gold, Green Published, Green Submitted			2022-12-26	WOS:000399353500038
J	Wang, FX; Xiong, XY; Zhong, Q; Meng, ZY; Yang, H; Yang, QW				Wang, Fa-Xiang; Xiong, Xiao-Yi; Zhong, Qi; Meng, Zhao-You; Yang, Hui; Yang, Qing-Wu			Foxp3 exhibits antiepileptic effects in ictogenesis involved in TLR4 signaling	FASEB JOURNAL			English	Article						NMDA receptor; epilepsy; inflammation; Toll-like receptors; glial cells	REGULATORY T-CELLS; TEMPORAL-LOBE EPILEPSY; CORTICAL-LESIONS; IMMUNE DYSREGULATION; STATUS EPILEPTICUS; NEURONAL-ACTIVITY; NMDA RECEPTOR; KAPPA-B; EXPRESSION; SEIZURES	Inflammatory processes play critical roles in epileptogenesis, but the exact mechanisms that underlie these processes are still not completely understood. In this study, we investigated the role of forkhead transcription factor 3 (Foxp3), a transcription factor that is involved in T-cell differentiation, in epileptogenesis. In both human epileptic tissues Foxp3(-/-) mice were susceptible to kainic acid-induced seizures, whereas overexpression of Foxp3 reduced acute seizure occurrence and decreased chronic seizure recurrence. In addition, in vitro experiments revealed that Foxp3 inhibited neuronal excitability via glial cells and not neurons. The protective effects of Foxp3 were manifested as a reduction in glial cell activation and proinflammatory cytokine production and increased neuronal survival. Moreover, we showed that beneficial effects of Foxp3 involved the attenuation of TLR4 signaling and inflammation, which led to the inactivation of NR2B-containing NMDA receptors. These results suggest that Foxp3 in glial cells may play an antiepileptic role in epileptogenesis and may act as a modulator of TLR4. Taken together, our results indicate that Foxp3 may represent a novel therapeutic target for achieving anticonvulsant effects in patients with epilepsy that is currently resistant to drugs. Wang, F.-X., Xiong, X.-Y., Zhong, Q., Meng, Z.-Y., Yang, H., Yang, Q.-W. Foxp3 exhibits antiepileptic effects in ictogenesis involved in TLR4 signaling.	[Wang, Fa-Xiang; Xiong, Xiao-Yi; Zhong, Qi; Meng, Zhao-You; Yang, Qing-Wu] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, 183 Xinqiao Zhengjie, Chongqing 400037, Peoples R China; [Yang, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, QW (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, 183 Xinqiao Zhengjie, Chongqing 400037, Peoples R China.	yangqwmlys@hotmail.com	Xiong, Xiao-Yi/AAJ-5423-2020	Xiong, Xiao-Yi/0000-0003-0720-907X	National Basic Research Program of China (973 Program) [2014CB541605]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program, 2014CB541605; to Q.-W.Y.). The authors declare no conflicts of interest.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Bell MP, 2007, J IMMUNOL, V179, P1893, DOI 10.4049/jimmunol.179.3.1893; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; Chiavegato A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00155; Choi J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-38; Chung HS, 2010, GLIA, V58, P1247, DOI 10.1002/glia.21006; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fang H, 2014, J IMMUNOL, V192, P5984, DOI 10.4049/jimmunol.1400054; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Furtado MA, 2002, EPILEPSIA, V43, P37; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gan N, 2014, MOL NEUROBIOL, V49, P337, DOI 10.1007/s12035-013-8522-7; Guo W, 2014, J NEUROPATH EXP NEUR, V73, P206, DOI 10.1097/NEN.0000000000000042; Hadjilambreva G, 2005, J NEUROPHYSIOL, V93, P843, DOI 10.1152/jn.01224.2003; Hashioka S, 2015, CNS NEUROL DISORD-DR, V14, P251, DOI 10.2174/1871527314666150217122305; He JJ, 2013, J NEUROPATH EXP NEUR, V72, P152, DOI 10.1097/NEN.0b013e318281262e; Holzer FJ, 2014, EXPERT REV NEUROTHER, V14, P1181, DOI 10.1586/14737175.2014.956457; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Hosford BE, 2016, J NEUROSCI, V36, P11013, DOI 10.1523/JNEUROSCI.1371-16.2016; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kubova H, 2002, EPILEPSIA, V43, P54, DOI 10.1046/j.1528-1157.43.s.5.36.x; Kumar VSS, 2014, CURR MED CHEM, V21, P2065, DOI 10.2174/0929867321666131228204246; Lee YH, 2000, J NEUROCHEM, V74, P2401, DOI 10.1046/j.1471-4159.2000.0742401.x; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liu SY, 2014, ANN NEUROL, V75, P614, DOI 10.1002/ana.24037; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Naziroglu M, 2015, NEUROSCIENCE, V293, P55, DOI 10.1016/j.neuroscience.2015.02.041; Pietranera L, 2010, J NEUROENDOCRINOL, V22, P1082, DOI 10.1111/j.1365-2826.2010.02058.x; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rivas MN, 2012, J CLIN INVEST, V122, P1933, DOI 10.1172/JCI40591; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Shu HF, 2010, J NEUROPATH EXP NEUR, V69, P838, DOI 10.1097/NEN.0b013e3181eaeae5; Smialowska M, 2012, NEUROTOX RES, V21, P379, DOI 10.1007/s12640-011-9293-4; Suri-Payer E, 2006, SPRINGER SEMIN IMMUN, V28, P3, DOI 10.1007/s00281-006-0021-8; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x; Vezzani A, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2011.03028.x; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang F., 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1007/S00425-015-2443-9; Wang PF, 2014, J IMMUNOL, V192, P4783, DOI 10.4049/jimmunol.1303108; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437	62	8	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2948	2962		10.1096/fj.201600989R	http://dx.doi.org/10.1096/fj.201600989R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386044				2022-12-26	WOS:000405931000020
J	Choi, IS; Choi, BH				Choi, In-Su; Choi, Byoung-Hee			The distinct plastid genome structure of Maackia fauriei (Fabaceae: Papilionoideae) and its systematic implications for genistoids and tribe Sophoreae	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; PHYLOGENETIC-RELATIONSHIPS; THERMOPSIDEAE LEGUMINOSAE; DNA; LEGUMES; STYPHNOLOBIUM; SEQUENCES; PHYLOGEOGRAPHY; EVOLUTION; INSIGHTS	Traditionally, the tribe Sophoreae sensu lato has been considered a basal but also heterogeneous taxonomic group of the papilionoid legumes. Phylogenetic studies have placed Sophoreae sensu stricto (s.s.) as a member of the core genistoids. The recently suggested new circumscription of this tribe involved the removal of traditional members and the inclusion of Euchresteae and Thermopsideae. Nonetheless, definitions and inter-and intra-taxonomic issues of Sophoreae remain unclear. Within the field of legume systematics, the molecular characteristics of a plastid genome (plastome) have an important role in helping to define taxonomic groups. Here, we examined the plastome of Maackia fauriei, belonging to Sophoreae s.s., to elucidate the molecular characteristics of Sophoreae. Its gene contents are similar to the plastomes of other typical legumes. Putative pseudogene rps16 of Maackia and Lupinus species imply independent functional gene loss from the genistoids. Our overall examination of that loss among legumes suggests that it is common among all major clades of Papilionoideae. The M. fauriei plastome has a novel 24-kb inversion in its large single copy region, as well as previously recognized 50-kb and 36-kb inversions. The 36-kb inversion is shared by the core genistoids. The 24-kb inversion is present in the eight genera belonging to three tribes: Euchresteae, Sophoreae s. s., and Thermopsideae. The phylogenetic distribution of this 24-kb inversion strongly supports the monophyly of members of Sophoreae s. s. with Euchresteae and Thermopsideae. Hence, it can be used as a putative synapomorphic characteristic for the newly circumscribed Sophoreae, including Euchresteae and Thermopsideae. However, plastome conformation suggests a slightly narrower taxonomic group because of heterogeneous results from Bolusanthus and Dicraeopetalum. The phylogenetic analysis, based on plastome sequences from 43 legumes, represents well our understanding of legume systematics while resolving the genistoid clade as a sister group to an Old World clade. It also demonstrates the value that plastomes are powerful marker for systematic studies of basal papilionoid legumes.	[Choi, In-Su; Choi, Byoung-Hee] Inha Univ, Dept Biol Sci, Incheon, South Korea	Inha University	Choi, BH (corresponding author), Inha Univ, Dept Biol Sci, Incheon, South Korea.	bhchoi@inha.ac.kr			Inha University grant	Inha University grant	This research was supported by Inha University grant.	Aoki K, 2006, AM J BOT, V93, P1852, DOI 10.3732/ajb.93.12.1852; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Cardoso D, 2013, S AFR J BOT, V89, P58, DOI 10.1016/j.sajb.2013.05.001; Cardoso D, 2012, AM J BOT, V99, P1991, DOI 10.3732/ajb.1200380; Chappil J.A., 1995, ADV LEGUM SYSTEMAT 7, P1; Choi IS, 2016, MITOCHONDRIAL DNA A, V27, P2838, DOI 10.3109/19401736.2015.1053118; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Crisp MD, 2000, ADV LEGUME SYSTEMATI, V9, P249; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Doyle J. J., 2000, ADV LEGUME SYSTEMATI, V9, P1; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2007, MOL PHYLOGENET EVOL, V45, P952, DOI 10.1016/j.ympev.2007.09.014; Fougere-Danezan M, 2010, ANN BOT-LONDON, V105, P311, DOI 10.1093/aob/mcp280; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Han JE, 2010, BOT J LINN SOC, V164, P221, DOI 10.1111/j.1095-8339.2010.01084.x; HERENDEEN PS, 1995, ADV LEGUM SYSTEMAT, P123; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kajita T, 2001, SYST BOT, V26, P515; Kellar PR, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400108; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kite GC, 2003, BIOCHEM SYST ECOL, V31, P1409, DOI 10.1016/S0305-1978(03)00118-2; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee JH, 2013, J PLANT RES, V126, P193, DOI 10.1007/s10265-012-0519-1; Lee ST, 2013, BIOCHEM SYST ECOL, V49, P87, DOI 10.1016/j.bse.2013.03.018; Lee WK, 2004, J PLANT RES, V117, P209, DOI 10.1007/s10265-004-0150-x; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALOMINO G, 1993, ANN MO BOT GARD, V80, P284, DOI 10.2307/2399828; Pennington RT, 2001, SYST BOT, V26, P537; PENNINGTON RT, 2005, LEGUMES WORLD, P227; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; POLHILL RM, 1981, ADV LEGUME SYSTEMATI, V1, P213; POLHILL RM, 1994, PHYTOCHEMICAL DICT L, V1, pR69; Sabir J, 2014, PLANT BIOTECHNOL J, V12, P743, DOI 10.1111/pbi.12179; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schwarz EN, 2015, J SYST EVOL, V53, P458, DOI 10.1111/jse.12179; SOUSA M, 1993, ANN MO BOT GARD, V80, P270, DOI 10.2307/2399827; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stull GW, 2015, AM J BOT, V102, P1794, DOI 10.3732/ajb.1500298; Sugahara K, 2011, J PLANT RES, V124, P75, DOI 10.1007/s10265-010-0356-z; TUCKER SC, 1994, AM J BOT, V81, P368, DOI 10.2307/2445465; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HC, 2006, BOT J LINN SOC, V151, P365, DOI 10.1111/j.1095-8339.2006.00512.x; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Williams AV, 2016, MOL PHYLOGENET EVOL, V96, P1, DOI 10.1016/j.ympev.2015.11.021; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang ML, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/864804	60	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173766	10.1371/journal.pone.0173766	http://dx.doi.org/10.1371/journal.pone.0173766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399123	gold, Green Submitted, Green Published			2022-12-26	WOS:000399949000005
J	Ito, T; Ichinosawa, T; Shimizu, T				Ito, Tatsuro; Ichinosawa, Takahiro; Shimizu, Takehiko			Streptococcal adhesin SspA/B analogue peptide inhibits adherence and impacts biofilm formation of Streptococcus mutans	PLOS ONE			English	Article							SURFACE PROTEIN-PEPTIDES; COMPETITIVE-BINDING; ORAL STREPTOCOCCI; GORDONII; ANTIGEN; SALIVARIUS; CYSTEINE; BIOLOGY; FAMILY; DOMAIN	Streptococcus mutans, the major causative agent of dental caries, adheres to tooth surfaces via the host salivary glycoprotein-340 (gp340). This adherence can be competitively inhibited by peptides derived from the SspA/B adhesins of Streptococcus gordonii, a human commensal microbe that competes for the same binding sites. Ssp(A4K-A11K), a doublelysine substituted SspA/B peptide analogue, has been shown to exhibit superior in vitro binding affinity for a gp340-derived peptide (SRCRP2), suggesting that Ssp(A4K-A11K) may be of clinical interest. In the present work, we tested the inhibitory effects of Ssp(A4K-A11K) on adherence and biofilm formation of S. mutans by reconstructing an artificial oral environment using saliva-coated polystyrene plates and hydroxyapatite disks. Bacterial adherence (adherence period: 1 h) was assessed by an enzyme-linked immunosorbent assay using biotinylated bacterial cells. Biofilm formation (periods: 8, 11, or 14 h) was assessed by staining and imaging of the sessile cells, or by recovering biofilm cells and plating for cell counts. The pH values of the culture media were measured as a biofilm acido-genicity indicator. Bactericidality was measured by loss of optical density during culturing in the presence of the peptide. We observed that 650 mu M Ssp(A4K-A11K) significantly inhibited adherence of S. mutans to saliva-coated polystyrene; a similar effect was seen on bacterial affinity for SRCRP2. Ssp(A4K-A11K) had lesser effects on the adherence of commensal streptococci. Pretreatment of polystyrene and hydroxyapatite with 650 mu M Ssp(A4K-A11K) significantly attenuated biofilm formation, whether tested with glucose- or sucrose-containing media. The SspA/B peptide's activity did not reflect bactericidality. Strikingly, pH in Ssp-treated 8-h (6.8 +/- 0.06) and 11-h (5.5 +/- 0.06) biofilms showed higher values than the critical pH. Thus, Ssp(A4K-A11K) acts by inhibiting bacterial adherence and cariogrnic biofilm formation. We further consider these results in the context of the safety, specificity, and stability properties of the Ssp(A4K-A11K) peptide.	[Ito, Tatsuro; Ichinosawa, Takahiro; Shimizu, Takehiko] Nihon Univ, Sch Dent Matsudo, Dept Pediat Dent, Chiba, Japan; [Ito, Tatsuro; Shimizu, Takehiko] Nihon Univ, Res Inst Oral Sci, Chiba, Japan	Nihon University; Nihon University	Ito, T (corresponding author), Nihon Univ, Sch Dent Matsudo, Dept Pediat Dent, Chiba, Japan.; Ito, T (corresponding author), Nihon Univ, Res Inst Oral Sci, Chiba, Japan.	ito.tatsuro@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20610]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) 15K20610 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, ACTA ODONTOL SCAND, V70, P504, DOI 10.3109/00016357.2011.640277; APPELBAUM B, 1979, INFECT IMMUN, V25, P717, DOI 10.1128/IAI.25.2.717-728.1979; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Cheng RP, 2007, BIOCHEMISTRY-US, V46, P10528, DOI 10.1021/bi700701z; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; DEMUTH DR, 1990, J BIOL CHEM, V265, P7120; Demuth DR, 1996, MOL MICROBIOL, V20, P403, DOI 10.1111/j.1365-2958.1996.tb02627.x; DEMUTH DR, 1990, MICROB PATHOGENESIS, V9, P199, DOI 10.1016/0882-4010(90)90022-I; FORESTER H, 1983, J GEN MICROBIOL, V129, P2779; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hamada T, 2004, INFECT IMMUN, V72, P4819, DOI 10.1128/IAI.72.8.4819-4826.2004; Ito T, 2016, OJST, V6, P81; Ito T, 2015, OJST, V5, P259; Ito T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032063; Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213; Kim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145844; Koba H, 2009, ORAL MICROBIOL IMMUN, V24, P162, DOI 10.1111/j.1399-302X.2008.00490.x; LILJEMARK WF, 1977, J DENT RES, V56, P157, DOI 10.1177/00220345770560021001; Liljemark WF, 1996, CRIT REV ORAL BIOL M, V7, P180, DOI 10.1177/10454411960070020601; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Oho T, 2004, INFECT IMMUN, V72, P6181, DOI 10.1128/IAI.72.10.6181-6184.2004; OKAHASHI N, 1989, MOL MICROBIOL, V3, P221, DOI 10.1111/j.1365-2958.1989.tb01811.x; Okuda K, 2010, ARCH ORAL BIOL, V55, P754, DOI 10.1016/j.archoralbio.2010.06.014; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; Sendamangalam V, 2011, BIOFOULING, V27, P13, DOI 10.1080/08927014.2010.535897; Shimotoyodome A, 2007, ANTIMICROB AGENTS CH, V51, P3634, DOI 10.1128/AAC.00380-07; Sissons CH, 2000, ORAL MICROBIOL IMMUN, V15, P317, DOI 10.1034/j.1399-302x.2000.150509.x; Yoneda M, 2012, INT J DENT, V2012, DOI 10.1155/2012/814913	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175483	10.1371/journal.pone.0175483	http://dx.doi.org/10.1371/journal.pone.0175483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394940	gold, Green Published, Green Submitted			2022-12-26	WOS:000399954800037
J	Xu, WJ; Zheng, LJ; Zheng, Y				Xu, Wenjian; Zheng, Lijun; Zheng, Yong			Prevalence of non-contact and contact childhood sexual abuse: An Internet-based sample of men who have sex with men in China	PLOS ONE			English	Article							HIV-RISK BEHAVIORS; CULTURAL-FACTORS; PHYSICAL ABUSE; BISEXUAL MEN; GAY MEN; METAANALYSIS; WOMEN; INFECTION; HISTORY; VICTIMIZATION	Background The prevalence of childhood sexual abuse (CSA) is high among Western men who have sex with men (MSM), and CSA is associated with certain socio-demographic variables and with human immunodeficiency virus (HIV) status. Little is known about CSA among Chinese MSM; therefore, we explored the prevalence and frequency of non-contact (e.g., sexual invitations, exhibitionism) and contact (e.g., intercourse, genital contact) forms of CSA in an Internet-based sample of MSM in China. We also examined the associations between the participants' socio-demographic characteristics and HIV status, and their histories of CSA. Methods We surveyed MSM from 30 Chinese provinces in 2014-2015; 1,030 (mean age = 25.15 years, SD = 6.32) and 1,020 (mean age = 25.05 years, SD = 5.95) respondents were eligible for inclusion in the non-contact and contact CSA groups, respectively. Results Prevalence of non-contact and contact CSA was 36.2% and 29.8%, respectively; 20.4% and 15.0% had experienced non-contact and contact CSA >= 3 times, respectively. Most respondents were young adults, well educated, single, had never "come out," and self-identified as gay or bisexual men. Univariate analyses showed that respondents who had experienced contact CSA were more likely to be HIV-positive than those who had never experienced contact CSA. Multivariate analyses showed that non-contact CSA was associated with less education, being in a relationship with a woman or a man, and having "come out." Contact CSA was associated with less education, higher income, and being in a relationship with a man. Respondents who had experienced non-contact CSA >= 3 times were more likely to be less educated, "out," and to be in a relationship with a woman or a man. Respondents who had experienced contact CSA >= 3 times were more likely to be less educated and to be in a relationship with a man. Conclusions It is necessary to pay closer attention to CSA among MSM and other sexual minorities in China.	[Xu, Wenjian; Zheng, Lijun; Zheng, Yong] Southwest Univ, MOE, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Xu, Wenjian; Zheng, Lijun; Zheng, Yong] Southwest Univ, Fac Psychol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Zheng, Y (corresponding author), Southwest Univ, MOE, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Zheng, Y (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	zhengy@swu.edu.cn						[Anonymous], 2014, NATL CTR AIDS STD CO; Austin SB, 2008, AM J PUBLIC HEALTH, V98, P1015, DOI 10.2105/AJPH.2006.099473; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Blain LM, 2012, CHILD ABUSE NEGLECT, V36, P413, DOI 10.1016/j.chiabu.2012.03.003; Brennan DJ, 2007, AM J PUBLIC HEALTH, V97, P1107, DOI 10.2105/AJPH.2005.071423; Brewer MB, 2007, PSYCHOL REV, V114, P133, DOI 10.1037/0033-295X.114.1.133; CARBALLODIEGUEZ A, 1995, CHILD ABUSE NEGLECT, V19, P595, DOI 10.1016/0145-2134(95)00018-4; Catania JA, 2008, CHILD ABUSE NEGLECT, V32, P925, DOI 10.1016/j.chiabu.2007.12.010; Chen J, 2014, PLOS ONE, V9; Chen JQ, 2006, J ADOLESCENT HEALTH, V38, P544, DOI 10.1016/j.jadohealth.2005.04.001; Chen JQ, 2014, CHIN J WOMEN CHILD H, V5, p71 ; Chow EPF, 2013, SEX TRANSM DIS, V40, P964, DOI 10.1097/OLQ.0000000000000050; COLLINGS SJ, 1995, CHILD ABUSE NEGLECT, V19, P1, DOI 10.1016/0145-2134(94)00098-F; Dunne MP, 2003, CHILD ABUSE NEGLECT, V27, P141, DOI 10.1016/S0145-2134(02)00539-2; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fleming JM, 1997, MED J AUSTRALIA, V166, P65, DOI 10.5694/j.1326-5377.1997.tb138722.x; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; Futa KT, 2001, CLIN PSYCHOL-SCI PR, V8, P189, DOI 10.1093/clipsy/8.2.189; Homma Y, 2012, J ADOLESCENT HEALTH, V51, P18, DOI 10.1016/j.jadohealth.2011.12.032; Jiang J, 2014, CHIN J AIDS STD, V22, p818 ; Jinich S, 1998, AIDS BEHAV, V2, P41, DOI DOI 10.1023/A:1022307323744; Kenny MC, 2000, CLIN PSYCHOL REV, V20, P905, DOI 10.1016/S0272-7358(99)00022-7; Lehavot K, 2011, J CONSULT CLIN PSYCH, V79, P159, DOI 10.1037/a0022839; Lenderking WR, 1997, J GEN INTERN MED, V12, P250, DOI 10.1046/j.1525-1497.1997.012004250.x; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Lu HY, 2013, DRUG ALCOHOL DEPEN, V133, P317, DOI 10.1016/j.drugalcdep.2013.06.013; Meyer IH, 2002, J SEX RES, V39, P139, DOI 10.1080/00224490209552133; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2015, ARCH SEX BEHAV, V44, P1869, DOI 10.1007/s10508-015-0488-2; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Song Y, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24418; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sweet T, 2012, JAIDS-J ACQ IMM DEF, V59, P400, DOI 10.1097/QAI.0b013e3182400e75; Tang CSK, 2002, CHILD ABUSE NEGLECT, V26, P23, DOI 10.1016/S0145-2134(01)00306-4; Wei CY, 2016, JAIDS-J ACQ IMM DEF, V71, P87, DOI 10.1097/QAI.0000000000000815; Wei CY, 2009, AM J PUBLIC HEALTH, V99, P1978, DOI 10.2105/AJPH.2008.150037; Welles SL, 2009, AM J PUBLIC HEALTH, V99, P1079, DOI 10.2105/AJPH.2007.133280; WYATT GE, 1985, CHILD ABUSE NEGLECT, V9, P507, DOI 10.1016/0145-2134(85)90060-2; Xu Y, 2015, J CHILD SEX ABUS, V24, P315, DOI 10.1080/10538712.2015.1006746; Zhang JY, 2014, CHIN J AIDS STD, V20, P91; Zheng LJ, 2012, ARCH SEX BEHAV, V41, P683, DOI 10.1007/s10508-011-9819-0; Zhu ZY, 2014, CHIN J QUANT TECHN E, V31, P52	44	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175444	10.1371/journal.pone.0175444	http://dx.doi.org/10.1371/journal.pone.0175444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394934	Green Published, gold, Green Submitted			2022-12-26	WOS:000399954800035
J	Manzano-Garcia, G; Ayala, JC				Manzano-Garcia, Guadalupe; Ayala, Juan-Carlos			Insufficiently studied factors related to burnout in nursing: Results from an e-Delphi study	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; PSYCHOLOGICAL EMPOWERMENT; RISK-FACTORS; JOB BURNOUT; NURSES; CARE; PERSONALITY; ENVIRONMENT; PREVALENCE; SATISFACTION	Objective This study aimed to identify potentially important factors in explaining burnout in nursing that have been insufficiently studied or ignored. Methods A three-round Delphi study via e-mail correspondence was conducted, with a group of 40 European experts. The e-Delphi questionnaire consisted of 52 factors identified from a literature review. Experts rated and scored the importance of factors in the occurrence of burnout and the degree of attention given by researchers to each of the variables listed, on a sixpoint Likert scale. We used the agreement percentage (> 80%) to measure the level of consensus between experts. Furthermore, to confirm the level of consensus, we also calculated mean scores and modes. Regardless of the degree of consensus reached by the experts, we have calculated the mean of the stability of the answers for each expert (individual's qualitative stability) and the mean of the stability percentages of the experts (qualitative group stability). Results The response rate in the three rounds was 93.02% (n = 40). Eight new factors were suggested in the first round. After modified, the e-Delphi questionnaire in the second and third rounds had 60 factors. All the factors reached the third round with a consensus level above 80% in terms of the attention that researchers gave them in their studies. Moreover, the data show a total mean qualitative group stability of 96.21%. In the third round 9 factors were classified by experts as 'studied very little', 17 as 'studied little' and 34 as 'well studied' Conclusion Findings show that not all the factors that may influence nursing burnout have received the same attention from researchers. The panel of experts has identified factors that, although important in explaining burnout, have been poorly studied or even forgotten. Our results suggest that further study into factors such as a lack of recognition of part of the tasks that nurses perform, feminine stereotype or excessive bureaucracy is needed for a better understanding of this syndrome and improve the quality of life in nurses.	[Manzano-Garcia, Guadalupe] Univ La Rioja, Dept Sci Educ, La Rioja, Spain; [Ayala, Juan-Carlos] Univ La Rioja, Dept Econ & Business, La Rioja, Spain	Universidad de La Rioja; Universidad de La Rioja	Ayala, JC (corresponding author), Univ La Rioja, Dept Econ & Business, La Rioja, Spain.	juan-carlos.ayala@unirioja.es	manzano, guadalupe/AAA-5932-2019; Ayala, Juan/AAA-5954-2019	Ayala Calvo, Juan-Carlos/0000-0002-0883-2149				Abdo SAM, 2015, E MEDITERR HEALTH J, V21, P906, DOI 10.26719/2015.21.12.906; Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Albendin L, 2016, REV LAT AM PSICOL, V48, P137, DOI 10.1016/j.rlp.2015.05.004; Allen J, 2002, WESTERN J NURS RES, V24, P905, DOI 10.1177/019394502237701; [Anonymous], 2004, Nurs Stand, V18, P14; Ariapooran Saeed, 2014, Iran J Nurs Midwifery Res, V19, P279; Bakker AB, 2000, ANXIETY STRESS COPIN, V13, P247, DOI 10.1080/10615800008549265; Bakker AB, 2002, ANXIETY STRESS COPIN, V15, P245, DOI 10.1080/1061580021000020716; Berry J. W., 2002, CROSS CULTURAL PSYCH, DOI DOI 10.1017/CBO9780511974274; Bianchi R, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00158; Brady Mike, 2015, Emerg Nurse, V23, P32, DOI 10.7748/en.23.4.32.e1448; Canadas-De La Fuente GA, 2015, INT J NURS STUD, V52, P240, DOI 10.1016/j.ijnurstu.2014.07.001; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Clausen T, 2012, J ADV NURS, V68, P127, DOI 10.1111/j.1365-2648.2011.05724.x; Consiglio C, 2014, MED LAV, V105, P255; Currie EJ, 2013, INT NURS REV, V60, P67, DOI 10.1111/j.1466-7657.2012.00997.x; DAJANI JS, 1979, TECHNOL FORECAST SOC, V13, P83, DOI 10.1016/0040-1625(79)90007-6; das Merces MC, 2016, PSICOL-REFLEX CRIT, V29, DOI 10.1186/s41155-016-0051-7; Elst TV, 2016, NURS OUTLOOK, V64, P542, DOI 10.1016/j.outlook.2016.06.004; Engelbrecht M, 2008, P EUR APPL BUS C EAB, P8; Errasti-Ibarrondo B, 2012, AN SIST SANIT NAVAR, V35, P269, DOI 10.4321/s1137-66272012000200009; Fairclough Norman., 2001, LANGUAGE POWER, V2ndedition; Finfgeld-Connett D, 2005, J NURS SCHOLARSHIP, V37, P4, DOI 10.1111/j.1547-5069.2005.00004.x; Furingsten L, 2015, NURS ETHICS, V22, P176, DOI 10.1177/0969733014533234; Garrosa E, 2010, INT J NURS STUD, V47, P205, DOI 10.1016/j.ijnurstu.2009.05.014; Gil-Monte Pedro R., 2002, Psicol. Estud., V7, P3, DOI 10.1590/S1413-73722002000100003; Gordon, 2006, COMPLEXITIES CARE NU, P122; Gordon S., 2005, NURSING ODDS, P290; Grzywacz JG, 2006, RES NURS HEALTH, V29, P414, DOI 10.1002/nur.20133; Hamaideh Shaher H, 2011, Issues Ment Health Nurs, V32, P234, DOI 10.3109/01612840.2010.546494; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Iliopoulou KK, 2010, J ADV NURS, V66, P2520, DOI 10.1111/j.1365-2648.2010.05424.x; Kanter R.M., 2008, MEN WOMEN CORPORATIO; Kearns S., 2009, WHY PUBLIC IMAGE NUR; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Kiekkas P, 2006, J CLIN NURS, V15, P178, DOI 10.1111/j.1365-2702.2006.01243.x; Kubo Tomohide, 2013, Sangyo Eiseigaku Zasshi, V55, P90; Lanquetin JP, 2013, SOINS PSYCHIAT, V284, P12; Laschinger H.K.S., 2003, LONGWOODS REV, V1, P2, DOI DOI 10.12927/HCQ.2003.17242; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Leineweber C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096991; Leiter MP, 2004, R OCC ST W, V3, P91; Leiter MP, 2008, J NURS MANAGE, V16, P1; Li BY, 2013, INT J NURS STUD, V50, P281, DOI 10.1016/j.ijnurstu.2012.07.001; Li H, 2004, WORLDV EVID-BASED NU, V1, P185; Listone HA, 2008, DELPHI METHOD TECHNI; Loera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114987; Lohmer M, 2013, PSYCHOTHERAPEUT, V58, P117, DOI 10.1007/s00278-013-0966-8; Manojlovich M, 2002, J NURS ADMIN, V32, P586, DOI 10.1097/00005110-200211000-00006; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C., 2008, TRUTH BURNOUT ORG CA; Maslach C, 2016, MASLACH BURNOUT INVE; Maslach C., 2005, HDB STRESS MED HLTH, P153, DOI DOI 10.1201/9781420039702.CH8; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Meadus RJ, 2011, NURS FORUM, V46, P269, DOI 10.1111/j.1744-6198.2011.00239.x; Montalban FM, 2000, REV PSICOLOGIA TRABA, V16, P103; Moreno-Jimenez B., 2003, REV COLOMB PSICOL, V12, P9; Mullan B, 2008, J RES NURS, V13, P527, DOI 10.1177/1744987107085500; Nie ZH, 2015, INT J CLIN EXP MED, V8, P19144; O'Brien JL, 2011, NEPHROL NURS J, V38, P475; Olanrewaju A.S., 2013, INT, V1, P112; Palaiou K, 2016, PERS INDIV DIFFER, V88, P12, DOI 10.1016/j.paid.2015.08.029; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Prandir R, 2007, AGORA ENFERMERIA, V11, P1156; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Ramelet AS, 2012, AUST CRIT CARE, V25, P41, DOI 10.1016/j.aucc.2011.08.003; Rousseau D., 1995, PSYCHOL CONTRACTS OR; Sanclemente-Vinue I, 2014, METAS ENFERM, V17, P1138; Schaufeli W., 1998, BURNOUT COMPANION ST; Schaufeli W.B., 2007, HDB HUMAN FACTORS ER, P217; Schwarzkopf K, 2002, BURNOUT RES, V3, P25; Seligman MEP, 2003, PSYCHOL INQ, V14, P159; Shirom A, 2005, WORK STRESS, V19, P263, DOI 10.1080/02678370500376649; Singh C, 2016, INT J MENT HEALTH NU, V25, P50; Singh C, 2015, ISSUES MENT HEALTH N, V36, P528, DOI 10.3109/01612840.2014.996838; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; Sun C, 2012, J NURS RES, V64, P466; Tartakovsky E, 2013, RES DEV DISABIL, V34, P3807, DOI 10.1016/j.ridd.2013.08.026; Tausch N, 2010, SOC PSYCHOL-GERMANY, V41, P169, DOI 10.1027/1864-9335/a000024; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Tunlind A, 2015, INTENS CRIT CARE NUR, V31, P116, DOI 10.1016/j.iccn.2014.07.005; Van Bogaert P, 2013, INT J NURS STUD, V50, P1667, DOI 10.1016/j.ijnurstu.2013.05.010; VANYPEREN NW, 1992, J APPL SOC PSYCHOL, V22, P173, DOI 10.1111/j.1559-1816.1992.tb01534.x; Vargas C, 2014, INT J CLIN HLTH PSYC, V14, P28, DOI 10.1016/S1697-2600(14)70034-1; Workgroup of European Nurse Researchers (WENR), 2012, WORKGROUP EUROPEAN N; Wu S, 2016, ONCOL NURS FORUM, V43, pE161, DOI 10.1188/16.ONF.E161-E169	88	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175352	10.1371/journal.pone.0175352	http://dx.doi.org/10.1371/journal.pone.0175352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2RO	28388660	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800042
J	Tsai, WC; Kung, PT; Wang, YH; Huang, KH; Liu, SA				Tsai, Wen-Chen; Kung, Pei-Tseng; Wang, Yueh-Hsin; Huang, Kuang-Hua; Liu, Shih-An			Influence of time interval from diagnosis to treatment on survival for oral cavity cancer: A nationwide cohort study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TREATMENT DELAY; NECK-CANCER; HEAD; IMPACT; EXPERIENCE; PROGNOSIS	Objectives We aimed to explore the relationship between the time interval from diagnosis to treatment and survival of oral cavity squamous cell carcinoma patients. Materials and methods A population-based study was conducted between 2004 and 2010. Claims data of oral squamous cell carcinoma patients were retrieved from the Taiwan Cancer Registry Database. Secondary data were obtained from Taiwan's National Health Insurance Research Database. Results A total of 21,263 patients were included in the final analysis. The majority of the patients received treatment within 30 days of diagnosis (n = 18,193, 85.5%), while 572 patients (2.7%) underwent treatment after 120 days. The patients who were treated after 120 days had a higher risk of death when compared to those treated within 30 days (Hazard ratio: 1.32, 95% Confidence intervals: 1.19 to 1.47). Conclusion A longer time interval from diagnosis to treatment was found to be associated with a poorer prognosis among patients suffering from oral squamous cell carcinoma.	[Tsai, Wen-Chen; Wang, Yueh-Hsin; Huang, Kuang-Hua] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Liu, Shih-An] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Liu, Shih-An] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Liu, Shih-An] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SA (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan.; Liu, SA (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Liu, SA (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	saliu@vghtc.gov.tw	; Tsai, Wen-Chen/O-3095-2015	Wang, Yueh-Hsin/0000-0002-1282-5945; Tsai, Wen-Chen/0000-0002-9684-0789	Ministry of Science and Technology, Taiwan, Republic of China [MOST 104-2410-H-039-002]	Ministry of Science and Technology, Taiwan, Republic of China	This study was funded by grants from the Ministry of Science and Technology, Taiwan, Republic of China (MOST 104-2410-H-039-002) (WCT). Website: https://www.most.gov.tw/en/public. The Ministry of Science and Technology had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Chen SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131305; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Esmaelbeigi F, 2014, ARCH IRAN MED, V17, P253, DOI 014174/AIM.007; Gomez DR, 2015, RADIOTHER ONCOL, V115, P257, DOI 10.1016/j.radonc.2015.04.010; Hansen RP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-284; Hansen RP, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-100; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Huo Q, 2015, ANN SURG ONCOL, V22, P883, DOI 10.1245/s10434-014-4076-9; Joshi P, 2014, INDIAN J CANCER, V51, P95, DOI 10.4103/0019-509X.137934; Kowalski LP, 2001, ORAL ONCOL, V37, P94, DOI 10.1016/S1368-8375(00)00066-X; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767; Liao CT, 2010, ANN SURG ONCOL, V17, P2984, DOI 10.1245/s10434-010-1174-1; Lin JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124322; Liu SA, 2012, EUR ARCH OTO-RHINO-L, V269, P1665, DOI 10.1007/s00405-011-1806-5; Murphy CT, 2016, J CLIN ONCOL, V34, P169, DOI 10.1200/JCO.2015.61.5906; Ohlstein JF, 2015, JAMA OTOLARYNGOL, V141, P804, DOI 10.1001/jamaoto.2015.1467; Perri T, 2014, INT J GYNECOL CANCER, V24, P1326, DOI 10.1097/IGC.0000000000000211; Ragin C, 2016, CARCINOGENESIS; Stefanuto P, 2014, OR SURG OR MED OR PA, V117, P424, DOI 10.1016/j.oooo.2013.12.407; Teppo H, 2009, ORAL ONCOL, V45, P692, DOI 10.1016/j.oraloncology.2008.10.012; Tsai WC, 2015, ORAL ONCOL, V51, P105, DOI 10.1016/j.oraloncology.2014.11.006; van Harten MC, 2015, ORAL ONCOL, V51, P272, DOI 10.1016/j.oraloncology.2014.12.003; van Harten MC, 2014, ORAL ONCOL, V50, P282, DOI 10.1016/j.oraloncology.2013.12.018; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Xavier FD, 2014, CLINICS, V69, P367, DOI 10.6061/clinics/2014(05)12; Yun YH, 2012, ANN ONCOL, V23, P2731, DOI 10.1093/annonc/mds101	28	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175148	10.1371/journal.pone.0175148	http://dx.doi.org/10.1371/journal.pone.0175148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388649	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800025
J	Wang, B; Studdert, DM; Sarpatwari, A; Franklin, JM; Landon, J; Kesselheim, AS				Wang, Bo; Studdert, David M.; Sarpatwari, Ameet; Franklin, Jessica M.; Landon, Joan; Kesselheim, Aaron S.			The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine	PLOS ONE			English	Article							UNITED-STATES; TEMPORARY RECOMMENDATIONS	In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Administration (FDA) ("off-label" uses). State governments can choose to coordinate with the federal investigation, or pursue their own independent state investigations. One of the largest-ever off-label prosecutions relates to the atypical antipsychotic drug olanzapine (Zyprexa). In a series of settlements between 2008 and 2010, Eli Lilly paid $1.4 billion to the federal government and over $290 million to state governments. We examined the effect of these settlements on off-label prescribing of this medication, taking advantage of geographical differences in states' involvement in the investigations and the timing of the settlements. However, we did not find a reduction in off-label prescribing; rather, there were no prescribing changes among states that joined the federal investigation, those that pursued independent state investigations, and states that pursued no investigations at all. Since the settlements of state investigations of off-label prescribing do not appear to significantly impact prescribing rates, policymakers should consider alternate ways of reducing the prevalence of non-evidence-based off-label use to complement their ongoing investigations.	[Wang, Bo] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Wang, Bo; Sarpatwari, Ameet; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 75 Francis St, Boston, MA 02115 USA; [Wang, Bo; Sarpatwari, Ameet; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA; [Studdert, David M.] Stanford Univ, Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, Stanford Med Sch, Stanford, CA USA; [Studdert, David M.] Stanford Univ, Stanford Law Sch, Stanford, CA USA; [Franklin, Jessica M.; Landon, Joan] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Franklin, Jessica M.; Landon, Joan] Harvard Med Sch, Boston, MA USA	Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 75 Francis St, Boston, MA 02115 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	akesselheim@partners.org	Studdert, David/AAF-3116-2021; Kesselheim, Aaron/R-6793-2017	Studdert, David/0000-0003-0585-5537; Kesselheim, Aaron/0000-0002-8867-2666	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Greenwall Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Greenwall Foundation	Dr. Kesselheim's work is funded by the Laura and John Arnold Foundation, with additional support from the Harvard Program in Therapeutic Science and Greenwall Foundation. No other coauthors have funding statements or financial disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administrative Office of the U.S. Courts, 2016, PACER PUBL ACC COURT; [Anonymous], 2010, INDIANAPOLIS BUSINES; [Anonymous], 2008, INF HEALTHC PROF CON; Berenson A., 2006, NY TIMES; Braillon A, 2016, HEALTH POLICY, V120, P890, DOI 10.1016/j.healthpol.2016.06.012; Buse JB, 2003, J CLIN EPIDEMIOL, V56, P164, DOI 10.1016/S0895-4356(02)00588-7; Conti RM, 2013, J CLIN ONCOL, V31, P1134, DOI 10.1200/JCO.2012.42.7252; Degrassat-Theas A, 2015, HEALTH POLICY, V119, P1399, DOI 10.1016/j.healthpol.2015.09.003; Eli Lilly and Company, 2010, LILL REP 4 QUART FUL; Eli Lilly and Company, 2008, EL LILL CO RES INV I; Justice Department Press Release, 2022, JUST DEP INV LEADS S; Kesselheim AS, 2008, ANN INTERN MED, V149, P342, DOI 10.7326/0003-4819-149-5-200809020-00009; Kesselheim AS, 2011, HLTH AFF MILLWOOD, V30, P2381; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Sheller P.C., 1 4 BILLION SETTLEME; Sohn M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003784; US Department of Justice, 2012, GLAXOSMITHKLINE PLEA; US Department of Justice, 2009, EL LILL CO AGR PAY 1; US Department of Justice, 2013, JOHNS JOHNS PAY MOR; US Department of Justice, 2012, ABB LAB PAY 1 5 BILL; US Food and Drug Administration, APPR PACK; US Food and Drug Administration, 2009, FED REGISTER, V74, P1694; US Food and Drug Administration, GUID IND DISTR SCI M; Wang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152195; Wang B, 2015, AM HEART J, V169, P379, DOI 10.1016/j.ahj.2014.12.014; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539	27	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175313	10.1371/journal.pone.0175313	http://dx.doi.org/10.1371/journal.pone.0175313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388667	Green Published, gold			2022-12-26	WOS:000399375800039
J	Bruckner, A; Heethoff, M; Bluthgen, N				Brueckner, Adrian; Heethoff, Michael; Bluethgen, Nico			The relationship between epicuticular long-chained hydrocarbons and surface area-volume ratios in insects (Diptera, Hymenoptera, Lepidoptera)	PLOS ONE			English	Article							CUTICULAR HYDROCARBON; RESPONSE DIVERSITY; WATER-BALANCE; DROSOPHILA; PERMEABILITY; PHEROMONES; PROFILES; LIPIDS; COMMUNICATION; RESILIENCE	Long-chain cuticular hydrocarbons (CHCs) are common components of the epicuticle of terrestrial arthropods. CHC serve as a protective barrier against environmental influences but also act as semiochemicals in animal communication. Regarding the latter aspect, speciesor intra-functional group specific CHCs composition and variation are relatively well studied. However, comparative knowledge about the relationship of CHC quantity and their relation to surface area-volume ratios in the context of water loss and protection is fragmentary. Hence, we aim to study the taxon-specific relationship of the CHC amount and surface-area to volume ratio related to their functional role (e.g. in water loss). We focused on flower visiting insects and analyzed the CHC amounts of three insect orders (Hymenoptera, Lepidoptera and Diptera) using gas chromatography-mass spectrometry (GC-MS). We included 113 species from two grassland plots, quantified their CHCs, and measured their body mass and surface area. We found differences in the surface area, CHCs per body mass and the CHC density (= amount of CHCs per surface area) across the three insect taxa. Especially the Hymenoptera had a higher CHC density compared to Diptera and Lepidoptera. CHC density could be explained by surface area-volume ratios in Hymenoptera but not in Diptera and Lepidoptera. Unexpectedly, CHC density decreased with increasing surface area-volume ratios.	[Brueckner, Adrian; Heethoff, Michael; Bluethgen, Nico] Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany	Technical University of Darmstadt	Bruckner, A (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, Darmstadt, Germany.	adrian.brueckner@gmail.com	Blüthgen, Nico/F-5983-2010		German National Academic Foundation (Studienstiftung des deutschen Volkes); DFG Priority Program 1374 "Biodiversity-Exploratories" [BL9602-1]	German National Academic Foundation (Studienstiftung des deutschen Volkes); DFG Priority Program 1374 "Biodiversity-Exploratories"	AB was supported by a scholarship for under graduate students as well as a PhD scholarship provided by the German National Academic Foundation (Studienstiftung des deutschen Volkes). This work has partly been funded by the DFG Priority Program 1374 "Biodiversity-Exploratories" (BL9602-1) to NB funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, R LANG ENV STAT COMP; Arcaz AC, 2016, J EXP BIOL, V219, P1675, DOI 10.1242/jeb.135665; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Cariveau DP, 2013, ECOL LETT, V16, P903, DOI 10.1111/ele.12126; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Colazza S, 2007, J CHEM ECOL, V33, P1405, DOI 10.1007/s10886-007-9300-7; Ferveur JF, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P325, DOI 10.1017/CBO9780511711909.016; Freund L, 2014, APPL VEG SCI, V17, P74, DOI 10.1111/avsc.12052; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Galilei G, 1638, DISCORSI DIMOSTRAZIO; Gefen E, 2015, COMP BIOCHEM PHYS A, V182, P58, DOI 10.1016/j.cbpa.2014.12.004; Gibbs AG, 1998, AM ZOOL, V38, P471; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Gibbs AG, 2002, J INSECT PHYSIOL, V48, P391, DOI 10.1016/S0022-1910(02)00059-8; Gibbs AG, 2001, PHYSIOL BIOCHEM ZOOL, V74, P520, DOI 10.1086/322162; Gibbs AG, 1995, COMP BIOCH PHYSL B, V112, P391; Gibbs AG, 2011, J INSECT PHYSIOL, V57, P1066, DOI 10.1016/j.jinsphys.2011.05.003; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Hadley N. F, 1994, WATER RELATIONS TERR; HADLEY NF, 1981, INSECT BIOCHEM, V11, P173, DOI 10.1016/0020-1790(81)90093-7; HADLEY NF, 1977, INSECT BIOCHEM, V7, P277, DOI 10.1016/0020-1790(77)90025-7; HADLEY NF, 1989, PROG LIPID RES, V28, P1, DOI 10.1016/0163-7827(89)90005-2; HICKMAN JC, 1975, OECOLOGIA, V21, P117, DOI 10.1007/BF00345554; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ingleby FC, 2015, INSECTS, V6, P732, DOI 10.3390/insects6030732; Jennings JH, 2014, J INSECT PHYSIOL, V61, P16, DOI 10.1016/j.jinsphys.2013.12.004; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Kuhsel S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8989; Kuhsel S, 2016, INSECT SCI; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Liebig J, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P254, DOI 10.1017/CBO9780511711909.014; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Menzel F, P R SOC LON IN PRESS; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Millar JG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P390, DOI 10.1017/CBO9780511711909.019; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Nehring V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0089-5; Nelson DR, 1995, INSECT WAXES; Peters MK, 2016, J BIOGEOGR; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Raspotnig G, 2008, ANN ZOOL, V58, P445, DOI 10.3161/000345408X326771; Rosillo-Calle F., 2007, BIOMASS ASSESSMENT H; Saint-Germain M, 2007, J APPL ECOL, V44, P330, DOI 10.1111/j.1365-2664.2006.01269.x; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Stinziano JR, 2015, COMP BIOCHEM PHYS A, V180, P38, DOI 10.1016/j.cbpa.2014.11.004; TOOLSON EC, 1982, J EXP ZOOL, V222, P249, DOI 10.1002/jez.1402220307; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; von Beeren Christoph, 2011, BMC Ecology, V11, P30, DOI 10.1186/1472-6785-11-30; Wachter GA, 2015, MOL ECOL, V24, P863, DOI 10.1111/mec.13077; Witjes S, 2009, J CHEM ECOL, V35, P1320, DOI 10.1007/s10886-009-9720-7; Wurdack M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1777	54	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175001	10.1371/journal.pone.0175001	http://dx.doi.org/10.1371/journal.pone.0175001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384308	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900070
J	Suttisunhakul, V; Pumpuang, A; Ekchariyawat, P; Wuthiekanun, V; Elrod, MG; Turner, P; Currie, BJ; Phetsouvanh, R; Dance, DAB; Limmathurotsakul, D; Peacock, SJ; Chantratita, N				Suttisunhakul, Vichaya; Pumpuang, Apinya; Ekchariyawat, Peeraya; Wuthiekanun, Vanaporn; Elrod, Mindy G.; Turner, Paul; Currie, Bail J.; Phetsouvanh, Rattanaphone; Dance, David A. B.; Limmathurotsakul, Direk; Peacock, Sharon J.; Chantratita, Narisara			Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MALDI-TOF MS; III SECRETION SYSTEM; RAPID IDENTIFICATION; PCR ASSAY; CLINICAL-EVALUATION; DIAGNOSIS; MELIOIDOSIS; ACCURACY; CLUSTER	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is increasingly used for rapid bacterial identification. Studies of Burkholderia pseudomallei identification have involved small isolate numbers drawn from a restricted geographic region. There is a need to expand the reference database and evaluate B. pseudomallei from a wider geographic distribution that more fully captures the extensive genetic diversity of this species. Here, we describe the evaluation of over 650 isolates. Main spectral profiles (MSP) for 26 isolates of B. pseudomallei (N = 5) and other Burkholderia species (N = 21) were added to the Biotyper database. MALDI-TOF MS was then performed on 581 B. pseudomallei, 19 B. mallei, 6 B. thailandensis and 23 isolates representing a range of other bacterial species. B. pseudomallei originated from northeast and east Thailand (N = 524), Laos (N = 12), Cambodia (N = 14), Hong Kong (N = 4) and Australia (N = 27). All 581 B. pseudomallei were correctly identified, with 100% sensitivity and specificity. Accurate identification required a minimum inoculum of 5 x 10(7) CFU/ml, and identification could be performed on spiked blood cultures after 24 hours of incubation. Comparison between a dendrogram constructed from MALDI-TOF MS main spectrum profiles and a phylogenetic tree based on recA gene sequencing demonstrated that MALDI-TOF MS distinguished between B. pseudomallei and B. mallei, while the recA tree did not. MALDI-TOF MS is an accurate method for the identification of B. pseudomallei, and discriminates between this and other related Burkholderia species.	[Suttisunhakul, Vichaya; Ekchariyawat, Peeraya; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Pumpuang, Apinya] Navamindradhiraj Univ, Dept Clin Pathol, Fac Med, Bangkok, Thailand; [Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Elrod, Mindy G.] Ctr Dis Control & Prevent CDC, Div High Consequence Pathogens & Pathol, Bacterial Special Pathogens Branch, Natl Ctr Zoonot & Emerging Infect Dis, Atlanta, GA USA; [Turner, Paul] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Turner, Paul] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Currie, Bail J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Currie, Bail J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Phetsouvanh, Rattanaphone; Dance, David A. B.] Mahosot Hosp, Microbiol Lab, Wellcome Trust Res Unit, Lao Oxford Mahosot Hosp, Viangchan, Laos; [Phetsouvanh, Rattanaphone; Dance, David A. B.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Dance, David A. B.; Peacock, Sharon J.] London Sch Hyg & Trop Med, London, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Centers for Disease Control & Prevention - USA; University of Oxford; Charles Darwin University; Menzies School of Health Research; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Mahidol University	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.; Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	narisara@tropmedres.ac	Chantratita, Narisara/P-2169-2019; Peacock, Sharon J/ABE-6331-2020	Dance, David/0000-0001-9189-7244; Peacock, Sharon/0000-0002-1718-2782; Turner, Paul/0000-0002-1013-7815	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U01AI115520]; Faculty of Tropical Medicine Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115520] Funding Source: NIH RePORTER	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK(Wellcome Trust); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Faculty of Tropical Medicine Mahidol University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z to NC) (http://www.wellcome.ac.uk) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U01AI115520 to NC (https://www.nih.gov). VS was supported by a Ph.D. scholarship from Faculty of Tropical Medicine Mahidol University (www.tm.mahidol.ac.th). The funder had no role in study design and interpretation, or the decision to publish, or preparation of the manuscript.	Amornchai P, 2007, J CLIN MICROBIOL, V45, P3774, DOI 10.1128/JCM.00935-07; Anuntagool N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075; Boyd MA, 2015, J APPL MICROBIOL, V118, P1199, DOI 10.1111/jam.12769; Calderaro A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36082; Calderaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088895; Chantratita N, 2006, AM J TROP MED HYG, V74, P345, DOI 10.4269/ajtmh.2006.74.345; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Chantratita N, 2008, J CLIN MICROBIOL, V46, P568, DOI 10.1128/JCM.01817-07; Chantratita N, 2007, AM J TROP MED HYG, V77, P814, DOI 10.4269/ajtmh.2007.77.814; Chantratita N, 2013, AM J TROP MED HYG, V89, P971, DOI 10.4269/ajtmh.13-0212; Cox Christopher R, 2014, Bacteriophage, V4, pe29011; Dingle TC, 2014, J CLIN MICROBIOL, V52, P3490, DOI 10.1128/JCM.01238-14; Drevinek M, 2012, LETT APPL MICROBIOL, V55, P40, DOI 10.1111/j.1472-765X.2012.03255.x; Duval BD, 2014, AM J TROP MED HYG, V90, P1043, DOI 10.4269/ajtmh.14-0025; Elschner MC, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0283-7; Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P1007, DOI 10.1111/j.1469-0691.2010.03339.x; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Gekenidis MT, 2014, APPL ENVIRON MICROB, V80, P4234, DOI 10.1128/AEM.00740-14; Ginther JL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003892; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Houghton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002727; Inglis TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/ajtmh.2012.11-0454; Jang HR, 2015, INT J INFECT DIS, V38, P62, DOI 10.1016/j.ijid.2015.07.012; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Koh TH, 2003, J CLIN MICROBIOL, V41, P1809, DOI 10.1128/JCM.41.4.1809.2003; Lasch P, 2015, J CLIN MICROBIOL, V53, P2632, DOI 10.1128/JCM.00813-15; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lowe P, 2006, J CLIN MICROBIOL, V44, P854, DOI 10.1128/JCM.44.3.854-856.2006; Lowe P, 2002, J CLIN MICROBIOL, V40, P4625, DOI 10.1128/JCM.40.12.4625-4627.2002; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Niyompanich S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144128; Niyompanich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099160; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Saidani N, 2015, TRAVEL MED INFECT DI, V13, P367, DOI 10.1016/j.tmaid.2015.08.007; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaipadungpanit J, 2014, EMERG INFECT DIS, V20, P1947, DOI 10.3201/eid2011.140832; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Walewski V., 2016, New Microbes and New Infections, V12, P31, DOI 10.1016/j.nmni.2016.04.004; Wang H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00415; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812; Wuthiekanun V, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000496; Zong ZY, 2012, J MED MICROBIOL, V61, P1483, DOI 10.1099/jmm.0.041525-0	50	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175294	10.1371/journal.pone.0175294	http://dx.doi.org/10.1371/journal.pone.0175294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384252	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000399371900149
J	Clarke, G; Fistein, E; Holland, A; Barclay, M; Theimann, P; Barclay, S				Clarke, Gemma; Fistein, Elizabeth; Holland, Anthony; Barclay, Matthew; Theimann, Pia; Barclay, Stephen			Preferences for care towards the end of life when decision-making capacity may be impaired: A large scale cross-sectional survey of public attitudes in Great Britain and the United States	PLOS ONE			English	Article							PHYSICIAN-ASSISTED DEATH	Background There is continuing public debate about treatment preferences at the end of life, and the acceptability and legal status of treatments that sustain or end life. However, most surveys use binary yes/no measures, and little is known about preferences in neurological disease when decision-making capacity is lost, as most studies focus on cancer. This study investigates changes in public preferences for care towards the end of life, with a focus on measures to sustain or end life. Methods Large-scale international public opinion surveys using a six-stage patient vignette, respondents chose a level of intervention for each stage as health and decision-making capacity deteriorated. Cross-sectional representative samples of the general public in Great Britain and the USA (N = 2016). Primary outcome measure: changes in respondents' preferences for care, measured on a four-point scale designed before data collection. The scale ranged from: maintaining life at all costs; to intervention with agreement; to no intervention; to measures for ending life. Results There were no significant differences between GB and USA. Preference for measures to sustain life at all costs peaked at short-term memory loss (30.2%, n = 610). Respondents selecting 'measures to help me die peacefully' increased from 3.9% to 37.0% as the condition deteriorated, with the largest increase occurring when decision-making capacity was lost (10.3% to 23.0%). Predictors of choosing 'measures to help me die peacefully' at any stage were: previous personal experience (OR = 1.34, p<0.010), and older age (OR = 1.09 per decade, p<0.010). Negative predictors: living with children (OR = 0.72, p<0.010) and being of "black" race/ethnicity (OR = 0.45, p<0.001). Conclusions Public opinion was uniform between GB and USA, but markedly heterogeneous. Despite contemporaneous capacitous consent providing an essential legal safeguard in most jurisdictions, there was a high prevalence of preference for "measures to end my life peacefully" when decision-making capacity was compromised, which increased as dementia progressed. In contrast, a significant number chose preservation of life at all costs, even in end stage dementia. It is challenging to respect the longstanding values of people with dementia concerning either the inviolability of life or personal autonomy, whilst protecting those without decision-making capacity.	[Clarke, Gemma; Fistein, Elizabeth; Barclay, Matthew; Theimann, Pia; Barclay, Stephen] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge Biomed Campus,Forvie Site,Robinson Way, Cambridge, England; [Holland, Anthony] Univ Cambridge, Dept Psychiat, Cambridge Intellectual & Dev Disabil Res Grp, Douglas House, Cambridge, England	University of Cambridge; University of Cambridge	Clarke, G (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge Biomed Campus,Forvie Site,Robinson Way, Cambridge, England.	gcc29@medschl.cam.ac.uk	Barclay, Matthew Edward/Q-2626-2019	Barclay, Matthew Edward/0000-0003-1148-1922; Clarke, Gemma/0000-0001-8438-7131	Dunhill Medical Trust [R317/1113]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust; Health Foundation; National Institute for Health Research (NIHR); National Institute for Health Research [NF-SI-0509-10211] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust(National Institute for Health Research (NIHR)); Health Foundation; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Dunhill Medical Trust [grant number R317/1113]. AH and SB are supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England at Cambridgeshire and Peterborough NHS Foundation Trust. AH is also supported by the Health Foundation. The funders had no role in the design, undertaking or writing of this paper, and no part in the decision to submit for publication. This paper presents independent research partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.; All authors meet the criteria for authorship. GC, AH, SB designed the research, undertook analysis, and contributed to writing the paper. EF, MB, PT undertook analysis, and contributed to writing the paper. This paper presents independent research partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	AMA, 2009, H140952 AMA; Barter C, 1999, USES VIGNETTES QUALI; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; BMA, 2016, END LIF CAR PHYS ASS; Burstein P, 2003, POLIT RES QUART, V56, P29, DOI 10.1177/106591290305600103; Clarke G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061475; Clarke G, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0034-8; Cohen-Almagor R, 2004, EUTHANASIA NETHERLAN; Cox K, 2013, BMJ SUPPORT PALLIAT, V3, P37, DOI 10.1136/bmjspcare-2012-000203; Davis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4437; Dresser Rebecca, 1986, Ariz Law Rev, V28, P373; Dugan A, 2015, SUPPORT DOCTOR ASSIS; Fischer KE, 2012, HEALTH POLICY, V107, P218, DOI 10.1016/j.healthpol.2012.07.005; Godlee F, 2015, ASSISTED DYING D TIM, V09, P46; Hawkins O, 2015, CBP7186; IpsosMORI, 2015, PUBL ATT ASS DYING P; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lewis-Black M, 2004, ENCY SOCIAL SCI RES; Magelssen M, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0107-3; McGuinness F, 2012, HOUSE LORDS STAT SN; McLean J, 2008, RISK PROTECTIVE FACT; Periyakoil VS, 2016, J PALLIAT MED, V19, P1060, DOI 10.1089/jpm.2016.0160; Prokopetz JJZ, 2012, NEW ENGL J MED, V367, P97, DOI 10.1056/NEJMp1205283; Quill TE, 2016, JAMA-J AM MED ASSOC, V315, P245, DOI 10.1001/jama.2015.16210; Shapiro RY, 2011, PUBLIC OPIN QUART, V75, P982, DOI 10.1093/poq/nfr053; Thulesius HO, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-13; WALTER T, 1991, SOCIOLOGY, V25, P293, DOI 10.1177/0038038591025002009; Yang YT, 2016, JAMA-J AM MED ASSOC, V315, P247, DOI 10.1001/jama.2015.16194; YouGov, 2014, MAJ PUBL WOULD PROB; YouGov, 2013, WESTM FAITH DEB YOUG; Zulman DM, 2014, J GEN INTERN MED, V29, P529, DOI 10.1007/s11606-013-2616-9	31	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0172104	10.1371/journal.pone.0172104	http://dx.doi.org/10.1371/journal.pone.0172104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28379955	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500004
J	Huang, DTN; Lu, CY; Shao, PL; Chang, LY; Wang, JY; Chang, YH; Lai, MJ; Chi, YH; Huang, LM				Huang, Daniel Tsung-Ning; Lu, Chun-Yi; Shao, Pei-Lan; Chang, Luan-Yin; Wang, Jin-Yuan; Chang, Yi-Hsuan; Lai, Mei-Ju; Chi, Ya-Hui; Huang, Li-Min			In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery	PLOS ONE			English	Article							GENE; CELLS; MICE; H5N1; INFECTION; PROTEIN; MATRIX	Background Influenza virus infection is a major threat to human health. Small interfering RNA (siRNA) is a promising approach for the prevention and treatment of viral infections. In this study, we constructed a series of DNA vector-based short hairpin RNAs (shRNAs) that target various genes of the influenza A virus using the polymerase III U6-RNA promoter to prevent influenza virus infection in vitro and in a mouse model. Results Three sets of DNA vector-based shRNA, two targeting genes encoding the polymerase acidic protein (PA) and one targeting polymerase basic protein 2 (PB2), efficiently inhibited the replication of influenza virus A/WSN/33(H1 N1) in vitro. We also successfully prevented influenza virus A/WSN/33(H1N1) infection in a C57BU6 mouse model by intratracheal delivery of anti-PB2 shRNA. Conclusions Our findings suggest that the PB2-targeting shRNA plasmid showed potential for use as an RNAi-based therapeutic for influenza virus infection.	[Huang, Daniel Tsung-Ning; Wang, Jin-Yuan] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Huang, Daniel Tsung-Ning; Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lu, Chun-Yi; Shao, Pei-Lan; Chang, Luan-Yin; Chang, Yi-Hsuan; Lai, Mei-Ju; Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; [Chi, Ya-Hui] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan	Mackay Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Huang, DTN (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.; Huang, DTN; Huang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, LM (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan.	zoning12huang@gmail.com; lmhuang@ntu.edu.tw	Chi, Ya-Hui/ABE-8550-2020	Chi, Ya-Hui/0000-0002-9216-0938; LU, CHUN-YI/0000-0002-5240-2808; CHANG, LUAN-YIN/0000-0003-2632-1956; HUANG, LI-MIN/0000-0002-9291-260X; Huang, Daniel Tsung-Ning/0000-0001-6940-6701				Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Barik S, 2015, METHODS MOL BIOL, V1218, P251, DOI 10.1007/978-1-4939-1538-5_14; Betakova T, 2013, ACTA VIROL, V57, P97, DOI 10.4149/av_2013_02_97; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Li WY, 2011, ARCH VIROL, V156, P1979, DOI 10.1007/s00705-011-1087-8; Li YC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-603; Matskevich AA, 2009, J INNATE IMMUN, V1, P389, DOI 10.1159/000191408; Mauskopf Josephine, 2013, J Med Econ, V16, P264, DOI 10.3111/13696998.2012.752376; McMillen CM, 2016, VIROLOGY, V497, P171, DOI 10.1016/j.virol.2016.07.019; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Rajput R, 2012, NUCLEIC ACID THER, V22, P414, DOI 10.1089/nat.2012.0359; Stiver G, 2003, CAN MED ASSOC J, V168, P49; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Wu YH, 2008, BIOCHEM BIOPH RES CO, V365, P369, DOI 10.1016/j.bbrc.2007.10.196; Zhang W, 2009, BIOCHEM BIOPH RES CO, V390, P421, DOI 10.1016/j.bbrc.2009.09.039; Zhou HB, 2007, ANTIVIR RES, V76, P186, DOI 10.1016/j.antiviral.2007.07.002; Zhou K, 2008, J BIOTECHNOL, V135, P140, DOI 10.1016/j.jbiotec.2008.03.007	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174523	10.1371/journal.pone.0174523	http://dx.doi.org/10.1371/journal.pone.0174523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380007	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500051
J	Poulsen, SS; Knudsen, KB; Jackson, P; Weydahl, IEK; Saber, AT; Wallin, H; Vogel, U				Poulsen, Sarah S.; Knudsen, Kristina B.; Jackson, Petra; Weydahl, Ingrid E. K.; Saber, Anne T.; Wallin, Hakan; Vogel, Ulla			Multi-walled carbon nanotube-physicochemical properties predict the systemic acute phase response following pulmonary exposure in mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM-AMYLOID-A; TITANIUM-DIOXIDE NANOPARTICLES; PARTICULATE AIR-POLLUTION; GENE-EXPRESSION CHANGES; CARDIOVASCULAR-DISEASE; INFLAMMATORY RESPONSES; SUSTAINED INFLAMMATION; LUNG INFLAMMATION; MESSENGER-RNA	Pulmonary exposure to multi-walled carbon nanotubes (MWCNTs) has been linked to an increased risk of developing cardiovascular disease in addition to the well-documented physicochemical-dependent adverse lung effects. A proposed mechanism is through a strong and sustained pulmonary secretion of acute phase proteins to the blood. We identified physicochemical determinants of MWCNT-induced systemic acute phase response by analyzing effects of pulmonary exposure to 14 commercial, well-characterized MWCNTs in female C57BLI6J mice pulmonary exposed to 0, 6, 18 or 54 lag MWCNT/mouse. Plasma levels of acute phase response proteins serum amyloid A1/2 (SAA1/2) and SAA3 were determined on day 1, 28 or 92. Expression levels of hepatic Saal and pulmonary Saa3 mRNA levels were assessed to determine the origin of the acute phase response proteins. Pulmonary Saa3 mRNA expression levels were greater and lasted longer than hepatic Saal mRNA expression. Plasma SAA1/2 and SAA3 protein levels were related to time and physicochemical properties using adjusted, multiple regression analyses. SAA3 and SAA1/2 plasma protein levels were increased after exposure to almost all of the MWCNTs on day 1, whereas limited changes were observed on day 28 and 92. SAA1/2 and SAA3 protein levels did not correlate and only SAA3 protein levels correlated with neutrophil influx. The multiple regression analyses revealed a protective effect of MWCNT length on SAA1/2 protein level on day 1, such that a longer length resulted in lowered SAA1/2 plasma levels. Increased SAA3 protein levels were positively related to dose and content of Mn, Mg and Co on day 1, whereas oxidation and diameter of the MWCNTs were protective on day 28 and 92, respectively. The results of this study reveal very differently controlled pulmonary and hepatic acute phase responses after MWCNT exposure. As the responses were influenced by the physicochemical properties of the MWCNTs, this study provides the first step towards designing MWCNT that induce less SAA.	[Poulsen, Sarah S.; Knudsen, Kristina B.; Jackson, Petra; Weydahl, Ingrid E. K.; Saber, Anne T.; Wallin, Hakan; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Wallin, Hakan] Univ Copenhagen, Inst Publ Hlth, Copenhagen K, Denmark; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	National Research Centre for the Working Environment; University of Copenhagen; Technical University of Denmark	Poulsen, SS (corresponding author), Natl Res Ctr Working Environm, Copenhagen O, Denmark.	spo@nrcwo.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Wallin, Håkan/I-6459-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Wallin, Håkan/0000-0001-7716-0166; Poulsen, Sarah S/0000-0001-7456-0017; bram knudsen, kristina/0000-0001-9362-2893	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation [20110092173-3]; Danish Centre for Nanosafety	Danish Centre for Nanosafety from the Danish Working Environment Research Foundation; Danish Centre for Nanosafety	This work was supported by Danish Centre for Nanosafety [grant# 20110092173-3] [https llarbejdstilsynet dkidaiom% 20arbeicistilsynet/arbeidsmiljoforskningsfonden] from the Danish Working Environment Research Foundation and Danish Centre for Nanosafety 2.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BANKA CL, 1995, J LIPID RES, V36, P1058; Beg S, 2011, J PHARM PHARMACOL, V63, P141, DOI 10.1111/j.2042-7158.2010.01167.x; Birch ME, 2011, ANN OCCUP HYG, V55, P1016, DOI 10.1093/annhyg/mer073; Bourdon JA, 2012, ENVIRON MOL MUTAGEN, V53, P462, DOI 10.1002/em.21706; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Cao Y, 2014, TOXICOL SCI, V138, P104, DOI 10.1093/toxsci/kft328; Chen LC, 2005, INHAL TOXICOL, V17, P217, DOI 10.1080/08958370590912815; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gordon T, 2000, TOXICOL SCI, V56, P2, DOI 10.1093/toxsci/56.1.2; Grosse Y, 2014, LANCET ONCOL, V15, P1427, DOI 10.1016/S1470-2045(14)71109-X; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Halappanavar S, 2015, ENVIRON MOL MUTAGEN, V56, P245, DOI 10.1002/em.21936; Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI [10.1080/08958370801942238, 10.1080/08958370801942238 ]; Harding AH, 2012, OCCUP ENVIRON MED, V69, P417, DOI 10.1136/oemed-2011-100313; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Husain M, 2015, TOXICOL APPL PHARM, V289, P573, DOI 10.1016/j.taap.2015.11.003; Husain M, 2015, NANOTOXICOLOGY, V9, P1013, DOI 10.3109/17435390.2014.996192; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, COB HARD MET COB SUL, V86; Jackson P., 2011, MUTAT RES, V745, P73, DOI DOI 10.1016/J.MRGENT0X.2011.09.018; Jackson P, 2015, ENVIRON MOL MUTAGEN, V56, P183, DOI 10.1002/em.21922; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kim JE, 2015, NANOTOXICOLOGY, V9, P613, DOI 10.3109/17435390.2014.963186; King PT, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0068-z; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008; Kuschner WG, 1997, ENVIRON HEALTH PERSP, V105, P1234, DOI 10.1289/ehp.971051234; Kyjovska ZO, 2015, ENVIRON MOL MUTAGEN, V56, P41, DOI 10.1002/em.21888; Labib S, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0125-9; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Lee HY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741403; Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Liu XY, 2010, CARBON, V48, P1961, DOI 10.1016/j.carbon.2010.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Manley PN, 2006, MED HYPOTHESES, V66, P784, DOI 10.1016/j.mehy.2005.10.018; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Mezaki T, 2003, JPN HEART J, V44, P601, DOI 10.1536/jhj.44.601; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451; MUHLE H, 1987, ANN OCCUP HYG, V31, P755, DOI 10.1093/annhyg/31.4B.755; Murphy FA, 2011, AM J PATHOL, V178, P2587, DOI 10.1016/j.ajpath.2011.02.040; Nanogenotox, 2013, DEL 4 1 SUMM REP PRI; National Institute for Occupational Safety and Health NIOSH, 2013, NIOSH CURR INT B, V65; NIOSH, 1978, OCC SAF HLTH GUID CO; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Nurkiewicz TR, 2004, ENVIRON HEALTH PERSP, V112, P1299, DOI 10.1289/ehp.7001; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Poulsen SS, 2016, NANOTOXICOLOGY, V10, P1263, DOI 10.1080/17435390.2016.1202351; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Poulsen SS, 2015, TOXICOL APPL PHARM, V283, P210, DOI 10.1016/j.taap.2015.01.011; Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452; Reddy A. R., 2010, ENVIRON TOXICOL, V27, P211, DOI DOI 10.1002/T0X.20632; Reverri EJ, 2014, FREE RADICAL BIO MED, V76, P261, DOI 10.1016/j.freeradbiomed.2014.08.005; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rittinghausen S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0059-z; Rong Yi, 2015, Prev Med Rep, V2, P920, DOI 10.1016/j.pmedr.2015.10.005; Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279; Saber AT, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-12; Saber AT, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0148-2; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011; Shvedova AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150628; Skafar DF, 1997, J CLIN ENDOCR METAB, V82, P3913, DOI 10.1210/jc.82.12.3913; Snyder-Talkington BN, 2013, TOXICOL APPL PHARM, V272, P476, DOI 10.1016/j.taap.2013.06.026; Stapleton PA, 2012, INT J MOL SCI, V13, P13781, DOI 10.3390/ijms131113781; Takagi A, 2012, CANCER SCI, V103, P1440, DOI 10.1111/j.1349-7006.2012.02318.x; Thompson LC, 2014, NANOTOXICOLOGY, V8, P38, DOI 10.3109/17435390.2012.744858; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Vietti G, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0123-y; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wang XJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-24; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	100	53	53	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174167	10.1371/journal.pone.0174167	http://dx.doi.org/10.1371/journal.pone.0174167			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380028	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500034
J	Ruff, JS; Saffarini, RB; Ramoz, LL; Morrison, LC; Baker, S; Laverty, SM; Tvrdik, P; Capecchi, MR; Potts, WK				Ruff, James S.; Saffarini, Raed B.; Ramoz, Leda L.; Morrison, Linda C.; Baker, Shambralyn; Laverty, Sean M.; Tvrdik, Petr; Capecchi, Mario R.; Potts, Wayne K.			Mouse fitness measures reveal incomplete functional redundancy of Hox paralogous group 1 proteins	PLOS ONE			English	Article							MAGNIFIES INBREEDING DEPRESSION; NEURAL CREST; BRAIN-STEM; INNER-EAR; GENE; HINDBRAIN; EVOLUTION; EQUIVALENCE; CONSUMPTION; KNOCKOUT	Here we assess the fitness consequences of the replacement of the Hoxa1 coding region with its paralog Hoxb1 in mice (Mus musculus) residing in semi-natural enclosures. Previously, this Hoxa1(B1) swap was reported as resulting in no discernible embryonic or physiological phenotype (i.e., functionally redundant), despite the 51% amino acid sequence differences between these two Hox proteins. Within heterozygous breeding cages no differences in litter size nor deviations from Mendelian genotypic expectations were observed in the outbred progeny; however, within semi-natural population enclosures mice homozygous for the Hoxa1(B1) swap were out-reproduced by controls resulting in the mutant allele being only 87.5% as frequent as the control in offspring born within enclosures. Specifically, Hoxa1 B1 founders produced only 77.9% as many offspring relative to controls, as measured by homozygous pups, and a 22.1% deficiency of heterozygous offspring was also observed. These data suggest that Hoxa1 and Hoxb1 have diverged in function through either sub-or neo-functionalization and that the HoxA1 and HoxB1 proteins are not mutually interchangeable when expressed from the Hoxa1 locus. The fitness assays conducted under naturalistic conditions in this study have provided an ultimate-level assessment of the postulated equivalence of competing alleles. Characterization of these differences has provided greater understanding of the forces shaping the maintenance and diversifications of Hox genes as well as other paralogous genes. This fitness assay approach can be applied to any genetic manipulation and often provides the most sensitive way to detect functional differences.	[Ruff, James S.; Saffarini, Raed B.; Ramoz, Leda L.; Morrison, Linda C.; Baker, Shambralyn; Potts, Wayne K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Laverty, Sean M.] Univ Cent Oklahoma, Dept Math & Stat, Edmond, OK USA; [Tvrdik, Petr] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Capecchi, Mario R.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; University of Central Oklahoma; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Potts, WK (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	Potts@biology.utah.edu	Tvrdik, Petr/AAK-4398-2021	Ruff, James/0000-0002-8292-8640	National Institutes of Health [R01-GM039578, R01-GM109500]; National Science Foundation [IBN-0344907]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109500, R01GM039578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01-GM039578 and National Science Foundation Grant IBN-0344907, both to WKP. The work was partially conducted while WKP was supported by National Institutes of Health grant R01-GM109500. LLR was supported by the National Science Foundation funded Western Alliance to Expand Student Opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2015, DEV GENES EVOL, V225, P353, DOI 10.1007/s00427-015-0518-z; Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Balenger SL, 2014, INTEGR COMP BIOL, V54, P601, DOI 10.1093/icb/icu059; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell G, 2010, P ROY SOC B-BIOL SCI, V277, P1459, DOI 10.1098/rspb.2009.2099; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; Carroll LS, 2006, ADV STUD BEHAV, V36, P173, DOI 10.1016/S0065-3454(06)36004-4; Carroll LS, 2004, EVOLUTION, V58, P1318, DOI 10.1111/j.0014-3820.2004.tb01710.x; Chalfin L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5569; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; Erickson RP, 1999, GENET MED, V1, P151; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; Gaukler SM, 2016, EVOL APPL, V9, P685, DOI 10.1111/eva.12365; Gaukler SM, 2015, NEUROTOXICOL TERATOL, V47, P46, DOI 10.1016/j.ntt.2014.11.002; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Holve S, 2003, AM J MED GENET A, V120A, P169, DOI 10.1002/ajmg.a.20087; Ilmonen P, 2008, J EVOLUTION BIOL, V21, P834, DOI 10.1111/j.1420-9101.2008.01510.x; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Makki N, 2011, DEV BIOL, V357, P295, DOI 10.1016/j.ydbio.2011.06.042; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Nelson AC, 2013, P NATL ACAD SCI USA, V110, P19848, DOI 10.1073/pnas.1310427110; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; R Core Team, 2021, R LANGUAGE ENV STAT; Remacle S, 2004, MOL CELL BIOL, V24, P8567, DOI 10.1128/MCB.24.19.8567-8575.2004; Ruff JS, 2015, GENETICS, V201, P727, DOI 10.1534/genetics.115.178079; Ruff JS, 2015, J NUTR, V145, P434, DOI 10.3945/jn.114.202531; Ruff JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3245; Shabalina SA, 1997, P NATL ACAD SCI USA, V94, P13034, DOI 10.1073/pnas.94.24.13034; Studer M, 1998, DEVELOPMENT, V125, P1025; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Vitobello A, 2011, DEV CELL, V20, P469, DOI 10.1016/j.devcel.2011.03.011; West SA, 2009, SEX ALLOCATION PRINC; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; Zhao YX, 2001, DEVELOPMENT, V128, P3197	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174975	10.1371/journal.pone.0174975	http://dx.doi.org/10.1371/journal.pone.0174975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380068	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500082
J	Bardwell, AJ; Lagunes, L; Zebarjedi, R; Bardwell, L				Bardwell, A. Jane; Lagunes, Leonila; Zebarjedi, Ronak; Bardwell, Lee			The WW domain of the scaffolding protein IQGAP1 is neither necessary nor sufficient for binding to the MAPKs ERK1 and ERK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell signaling; extracellular-signal-regulated kinase (ERK); mitogen-activated protein kinase (MAPK); protein complex; protein kinase; protein-protein interaction; scaffold protein; IQGAP1	PROLINE-RICH LIGANDS; HIGH-AFFINITY INTERACTION; YES-ASSOCIATED PROTEIN; DOCKING SITES; SUBSTRATE PHOSPHORYLATION; TRANSCRIPTION FACTOR; C-JUN; KINASE; ACTIVATION; CANCER	Mitogen-activated protein kinase (MAPK) scaffold proteins, such as IQ motif containing GTPase activating protein 1 (IQGAP1), are promising targets for novel therapies against cancer and other diseases. Such approaches require accurate information about which domains on the scaffold protein bind to the kinases in the MAPK cascade. Results from previous studies have suggested that the WW domain of IQGAP1 binds to the cancer-associated MAPKs ERK1 and ERK2, and that this domain might thus offer a new tool to selectively inhibit MAPK activation in cancer cells. The goal of this work was therefore to critically evaluate which IQGAP1 domains bind to ERK1/2. Here, using quantitative in vitro binding assays, we show that the IQ domain of IQGAP1 is both necessary and sufficient for binding to ERK1 and ERK2, as well as to the MAPK kinases MEK1 and MEK2. Furthermore, we show that the WW domain is not required for ERK-IQGAP1 binding, and contributes little or no binding energy to this interaction, challenging previous models of how WW-based peptides might inhibit tumorigenesis. Finally, we show that the ERK2-IQGAP1 interaction does not require ERK2 phosphorylation or catalytic activity and does not involve known docking recruitment sites on ERK2, and we obtain an estimate of the dissociation constant (K-d) for this interaction of 8 m. These results prompt a re-evaluation of published findings and a refined model of IQGAP scaffolding.	[Bardwell, A. Jane; Lagunes, Leonila; Zebarjedi, Ronak; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	National Institutes of Health NIGMS [P50 GM76516]; United States Department of Education GAANN fellowship [P200A150181]; United States National Science Foundation Graduate Research Fellowship Program; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Education GAANN fellowship; United States National Science Foundation Graduate Research Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NIGMS Grant P50 GM76516. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States Department of Education GAANN fellowship P200A150181 and the United States National Science Foundation Graduate Research Fellowship Program.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Ang Boon K, 2007, J Mol Signal, V2, P1, DOI 10.1186/1750-2187-2-1; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Banon-Rodriguez I, 2014, EMBO J, V33, P129, DOI 10.1002/embj.201385946; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cheung KL, 2013, J BIOL CHEM, V288, P22378, DOI 10.1074/jbc.M112.444182; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Fang LK, 2015, CANCER CELL, V28, P183, DOI 10.1016/j.ccell.2015.07.004; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gordon EA, 2013, CELL SIGNAL, V25, P2518, DOI 10.1016/j.cellsig.2013.08.004; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Goto T, 2013, J BIOL CHEM, V288, P36351, DOI 10.1074/jbc.M113.520528; Goto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060865; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu J, 2014, J PROTEOME RES, V13, P1156, DOI 10.1021/pr400787p; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005200; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Molina DM, 2005, J BIOL CHEM, V280, P42051, DOI 10.1074/jbc.M510590200; Osman MA, 1998, J CELL BIOL, V142, P443, DOI 10.1083/jcb.142.2.443; Osman MA, 2013, BBA-REV CANCER, V1836, P166, DOI 10.1016/j.bbcan.2013.04.005; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Piserchio A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11127; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sanchez-Laorden B, 2013, CANCER CELL, V23, P715, DOI 10.1016/j.ccr.2013.05.017; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Shannon KB, 2012, INT J CELL BIOL, DOI [10.1155/2012/894817(2012, DOI 10.1155/2012/894817(2012]; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; STRUHL K, 1991, METHOD ENZYMOL, V194, P520; Stuart DD, 2013, NAT MED, V19, P538, DOI 10.1038/nm.3195; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tekletsadik YK, 2012, J CELL SCI, V125, P2041, DOI 10.1242/jcs.098947; Wallrabe H, 2013, CYTOSKELETON, V70, P819, DOI 10.1002/cm.21146; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu Y, 2014, BIOMED REP, V2, P3, DOI 10.3892/br.2013.204; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710	87	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8750	8761		10.1074/jbc.M116.767087	http://dx.doi.org/10.1074/jbc.M116.767087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28396345	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000402153900021
J	Mitchell, RK; Nguyen-Tu, MS; Chabosseau, P; Callingham, RM; Pullen, TJ; Cheung, R; Leclerc, I; Hodson, DJ; Rutter, GA				Mitchell, Ryan K.; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Callingham, Rebecca M.; Pullen, Timothy J.; Cheung, Rebecca; Leclerc, Isabelle; Hodson, David J.; Rutter, Guy A.			The transcription factor Pax6 is required for pancreatic beta cell identity, glucose-regulated ATP synthesis, and Ca2+ dynamics in adult mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; gene expression; imaging; islet; insulin	INSULIN-SECRETION; ALPHA-CELLS; EARLY-ONSET; ISLET; EXPRESSION; GENES; REVEALS; DIFFERENTIATION; INACTIVATION; SLC30A8/ZNT8	Heterozygous mutations in the human paired box gene PAX6 lead to impaired glucose tolerance. Although embryonic deletion of the Pax6 gene in mice leads to loss of most pancreatic islet cell types, the functional consequences of Pax6 loss in adults are poorly defined. Here we developed a mouse line in which Pax6 was selectively inactivated in beta cells by crossing animals with floxed Pax6 alleles to mice expressing the inducible Pdx1CreERT transgene. Pax6 deficiency, achieved by tamoxifen injection, caused progressive hyperglycemia. Although beta cell mass was preserved 8 days post-injection, total insulin content and insulin:chromogranin A immunoreactivity were reduced by similar to 60%, and glucose-stimulated insulin secretion was eliminated. RNA sequencing and quantitative real-time PCR analyses revealed that, although the expression of key beta cell genes, including Ins2, Slc30a8, MafA, Slc2a2, G6pc2, and Glp1r, was reduced after Pax6 deletion, that of several genes that are usually selectively repressed (disallowed) in beta cells, including Slc16a1, was increased. Assessed in intact islets, glucose-induced ATP:ADP increases were significantly reduced (p < 0.05) in Pax6KO versus control beta cells, and the former displayed attenuated increases in cytosolic Ca2+. Unexpectedly, glucose-induced increases in intercellular connectivity were enhanced after Pax6 deletion, consistent with increases in the expression of the glucose sensor glucokinase, but decreases in that of two transcription factors usually expressed in fully differentiated -cells, Pdx1 and Nkx6.1, were observed in islet hub cells. These results indicate that Pax6 is required for the functional identity of adult beta cells. Furthermore, deficiencies in beta cell glucose sensing are likely to contribute to defective insulin secretion in human carriers of PAX6 mutations.	[Mitchell, Ryan K.; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Callingham, Rebecca M.; Pullen, Timothy J.; Cheung, Rebecca; Leclerc, Isabelle; Hodson, David J.; Rutter, Guy A.] Imperial Coll London, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, Du Can Rd, London W12 0NN, England; [Hodson, David J.] Univ Birmingham, Inst Metab & Syst Res, Edgbaston B15 2TT, England; [Hodson, David J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Edgbaston B15 2TT, England; [Hodson, David J.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TH, W Midlands, England	Imperial College London; University of Birmingham; University of Birmingham	Hodson, DJ; Rutter, GA (corresponding author), Imperial Coll London, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, Du Can Rd, London W12 0NN, England.; Hodson, DJ (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Edgbaston B15 2TT, England.; Hodson, DJ (corresponding author), Univ Birmingham, Ctr Membrane Prot & Receptors, Edgbaston B15 2TT, England.; Hodson, DJ (corresponding author), Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TH, W Midlands, England.	d.hodson@imperial.ac.uk; g.rutter@imperial.ac.uk	Pullen, Timothy/H-2143-2011	Pullen, Timothy/0000-0002-6853-5701; Leclerc, Isabelle/0000-0003-0044-7921; Hodson, David/0000-0002-8641-8568; Rutter, Guy/0000-0001-6360-0343	Wellcome Trust [WT098424AIA]; Diabetes UK [BDA 11/0004210]; MRC (UK) [GO401641, MR/J0003042/1]; Royal Society Research Merit Award; Diabetes UK R.D. Lawrence [12/0004431]; EFSD/Novo Nordisk Rising Star; ERC starting grant (OptoBETA) [715884]; MRC [MR/N00275X/1]; Imperial Confidence in Concept grants; Birmingham fellowships; MRC [MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1, MR/N00275X/1] Funding Source: researchfish; European Foundation for the Study of Diabetes [RS FS 2015_3] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Research Merit Award; Diabetes UK R.D. Lawrence(Diabetes UK); EFSD/Novo Nordisk Rising Star; ERC starting grant (OptoBETA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial Confidence in Concept grants; Birmingham fellowships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); European Foundation for the Study of Diabetes	This work was supported by grants to G. A. R. from the Wellcome Trust (Senior Investigator Award WT098424AIA), Diabetes UK (Project BDA 11/0004210), the MRC (UK, Project GO401641; Programme MR/J0003042/1), and by a Royal Society Research Merit Award. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Diabetes UK R.D. Lawrence (12/0004431), EFSD/Novo Nordisk Rising Star and Birmingham fellowships, a Wellcome Trust institutional support award, an ERC starting grant (OptoBETA, 715884), MRC Project Grant MR/N00275X/1), and Imperial Confidence in Concept grants.	Adriaenssens AE, 2016, DIABETOLOGIA, V59, P2156, DOI 10.1007/s00125-016-4033-1; Ahlqvist E, 2012, DIABETOLOGIA, V55, P94, DOI 10.1007/s00125-011-2300-8; Ahmad Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144597; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Brun PJ, 2015, FASEB J, V29, P671, DOI 10.1096/fj.14-256743; Carrat GR, 2017, AM J HUM GENET, V100, P238, DOI 10.1016/j.ajhg.2017.01.011; Chen YY, 2014, DIABETES-METAB RES, V30, P467, DOI 10.1002/dmrr.2572; DEFTOS LJ, 1991, ENDOCR REV, V12, P181, DOI 10.1210/edrv-12-2-181; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; ELAYAT AA, 1995, J ANAT, V186, P629; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gutierrez GD, 2017, J CLIN INVEST, V127, P244, DOI 10.1172/JCI88017; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Hodson DJ, 2014, MOL ENDOCRINOL, V28, P860, DOI 10.1210/me.2014-1038; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Katsuta H, 2012, ENDOCRINOLOGY, V153, P5180, DOI 10.1210/en.2012-1257; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Lee HJ, 2013, SEMIN OPHTHALMOL, V28, P306, DOI 10.3109/08820538.2013.825293; Li J, 2015, FASEB J, V29, P3379, DOI 10.1096/fj.14-265918; Loder Merewyn K, 2013, Methods Mol Biol, V950, P13, DOI 10.1007/978-1-62703-137-0_2; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; MEDA P, 1984, Q J EXP PHYSIOL CMS, V69, P719; Mitchell RK, 2016, MOL ENDOCRINOL, V30, P77, DOI 10.1210/me.2015-1227; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Oropeza D, 2015, DIABETES, V64, P3798, DOI 10.2337/db15-0272; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; Pullen TJ, 2013, DIABETES OBES METAB, V15, P503, DOI 10.1111/dom.12029; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Simpson TI, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-19; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Soedling H, 2015, MOL METAB, V4, P619, DOI 10.1016/j.molmet.2015.06.007; Solomou A, 2015, J BIOL CHEM, V290, P21432, DOI 10.1074/jbc.M115.645291; Sun G, 2011, DIS MODEL MECH, V4, P193, DOI 10.1242/dmm.006833; Swisa A, 2017, J CLIN INVEST, V127, P230, DOI 10.1172/JCI88015; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137	67	34	35	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8892	8906		10.1074/jbc.M117.784629	http://dx.doi.org/10.1074/jbc.M117.784629			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377501	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000402153900042
J	Nilsen, KT; N'Diaye, A; MacLachlan, PR; Clarke, JM; Ruan, YF; Cuthbert, RD; Knox, RE; Wiebe, K; Cory, AT; Walkowiak, S; Beres, BL; Graf, RJ; Clarke, FR; Sharpe, AG; Distelfeld, A; Pozniak, CJ				Nilsen, Kirby T.; N'Diaye, Amidou; MacLachlan, P. R.; Clarke, John M.; Ruan, Yuefeng; Cuthbert, Richard D.; Knox, Ron E.; Wiebe, Krystalee; Cory, Aron T.; Walkowiak, Sean; Beres, Brian L.; Graf, Robert J.; Clarke, Fran R.; Sharpe, Andrew G.; Distelfeld, Assaf; Pozniak, Curtis J.			High density mapping and haplotype analysis of the major stem-solidness locus SSt1 in durum and common wheat	PLOS ONE			English	Article							SAWFLY HYMENOPTERA; SPRING WHEAT; RESISTANCE; GENE; INVOLVEMENT; EXPRESSION; MANAGEMENT; PROTEINS; QUALITY; DAMAGE	Breeding for solid-stemmed durum (Triticum turgidum L. var durum) and common wheat (Triticum aestivum L.) cultivars is one strategy to minimize yield losses caused by the wheat stem sawfly (Cephus cinctus Norton). Major stem-solidness QTL have been localized to the long arm of chromosome 3B in both wheat species, but it is unclear if these QTL span a common genetic interval. In this study, we have improved the resolution of the QTL on chromosome 3B in a durum (Kofa/W9262-260D3) and common wheat (Lillian/Vesper) mapping population. Coincident QTL (LOD = 94-127, R-2 = 78-92%) were localized near the telomere of chromosome 3BL in both mapping populations, which we designate SSt1. We further examined the SSt1 interval by using available consensus maps for durum and common wheat and compared genetic to physical intervals by anchoring markers to the current version of the wild emmer wheat (WEW) reference sequence. These results suggest that the SSt1 interval spans a physical distance of 1.6 Mb in WEW (positions 833.4-835.0 Mb). In addition, minor QTL were identified on chromosomes 2A, 2D, 4A, and 5A that were found to synergistically enhance expression of SSt1 to increase stem-solidness. These results suggest that developing new wheat cultivars with improved stem-solidness is possible by combining SSt1 with favorable alleles at minor loci within both wheat species.	[Nilsen, Kirby T.; N'Diaye, Amidou; MacLachlan, P. R.; Clarke, John M.; Wiebe, Krystalee; Cory, Aron T.; Pozniak, Curtis J.] Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK, Canada; [Ruan, Yuefeng; Cuthbert, Richard D.; Knox, Ron E.; Clarke, Fran R.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Beres, Brian L.; Graf, Robert J.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Sharpe, Andrew G.] Univ Saskatchewan, Global Inst Food Secur, 110 Gymnasium Pl, Saskatoon, SK, Canada; [Distelfeld, Assaf] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, Tel Aviv, Israel	University of Saskatchewan; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; University of Saskatchewan; Tel Aviv University	Pozniak, CJ (corresponding author), Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK, Canada.	curtis.pozniak@usask.ca	Distelfeld, Assaf/D-4951-2014	Distelfeld, Assaf/0000-0003-1777-3053; Graf, Robert/0000-0003-0922-5049; Cory, Aron/0000-0002-7215-459X; N'Diaye, Amidou/0000-0001-7769-7801; Cuthbert, Richard/0000-0002-1640-4929; Knox, Ron/0000-0002-2030-3899; Nilsen, Kirby/0000-0002-9477-5549	Genome Canada; Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Saskatchewan and Alberta Wheat Development Commissions; AgriFlex Program of Agriculture; Agri-Food Canada; Robert P. Knowles scholarship	Genome Canada(Genome Canada); Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Saskatchewan and Alberta Wheat Development Commissions; AgriFlex Program of Agriculture; Agri-Food Canada(Agriculture & Agri Food Canada); Robert P. Knowles scholarship	This research was carried out under the Canadian Triticum Applied Genomics (CTAG2) project. We are grateful for the funding provided by Genome Canada, and project support provided by Genome Prairie. We also acknowledge financial support provided by the Saskatchewan Ministry of Agriculture, Western Grains Research Foundation, and the Saskatchewan and Alberta Wheat Development Commissions. The financial support provided through the AgriFlex Program of Agriculture and Agri-Food Canada is also acknowledged. K. Nilsen acknowledges funding provided by the Robert P. Knowles scholarship administered by the University of Saskatchewan.	Ainslie CN, 1920, W GRASS STEM SAWFLY, P32; Beres BL, 2007, J ECON ENTOMOL, V100, P79, DOI 10.1603/0022-0493(2007)100[79:EOWSSD]2.0.CO;2; Beres BL, 2013, CAN J PLANT SCI, V93, P1169, DOI [10.4141/CJPS2013-035, 10.4141/cjps2013-035]; Beres BL, 2013, CAN J PLANT SCI, V93, P607, DOI [10.4141/CJPS2012-088, 10.4141/cjps2012-088]; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Beres BL, 2009, J ECON ENTOMOL, V102, P2137, DOI 10.1603/029.102.0617; Beres B.L., 2011, PRAIRIE SOILS CROPS, V4, P54; Beres BL, 2011, AGRON J, V103, P1755, DOI 10.2134/agronj2011.0187; Carcamo HA, 2005, ENVIRON ENTOMOL, V34, P1579, DOI 10.1603/0046-225X-34.6.1579; Clarke FR, 2002, CAN J PLANT SCI, V82, P661, DOI 10.4141/P01-053; Clarke J.M., 2012, DURUM WHEAT CHEM TEC; Cook JP, 2004, CROP SCI, V44, P1397, DOI 10.2135/cropsci2004.1397; Criddle N., 1923, Canadian Entomologist, V55, P1; CYMMY I., 2005, LAB PROTOCOLS CIMMYT; DePauw RM, 2005, CAN J PLANT SCI, V85, P397, DOI 10.4141/P04-137; DEPAUW RM, 1982, CAN J PLANT SCI, V62, P593, DOI 10.4141/cjps82-089; HOLMES N. D., 1961, CANADIAN ENT, V93, P250; HOLMES N. D., 1962, CANADIAN ENTOMOL, V94, P348; HOLMES ND, 1984, CAN ENTOMOL, V116, P677, DOI 10.4039/Ent116677-5; Houshmand S, 2007, MOL BREEDING, V20, P261, DOI 10.1007/s11032-007-9088-8; Knodel JJ, 2009, J AGR URBAN ENTOMOL, V26, P183, DOI 10.3954/1523-5475-26.4.183; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lanning SP, 2006, CROP SCI, V46, P1701, DOI 10.2135/cropsci2005.10-0379; LARSON RI, 1962, CAN J GENET CYTOL, V4, P97, DOI 10.1139/g62-014; LARSON RUBY I, 1959, CANADIAN JOUR BOT, V37, P135, DOI 10.1139/b59-012; LARSON RUBY I., 1959, CANADIAN JOUR BOT, V37, P365, DOI 10.1139/b59-028; LARSON RUBY I., 1959, CANADIAN JOUR BOT, V37, P1207, DOI 10.1139/b59-101; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Maccaferri M, 2014, PLANT BIOTECHNOL J; Macedo TB, 2007, J ENTOMOL SCI, V42, P228, DOI 10.18474/0749-8004-42.2.228; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Nilsen KT, 2016, AGRON J, V108, P219, DOI 10.2134/agronj2015.0298; PLATT A. W., 1941, SCI AGRIC [OTTAWA], V22, P139; Pozniak C, 2015, CAN J PLANT IN PRESS; Pozniak CJ, 2015, CAN J PLANT SCI, P1243; Rozen S, 2000, Methods Mol Biol, V132, P365; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Singh AK, 2017, CAN J PLANT SCI, V97, P135, DOI 10.1139/cjps-2016-0044; Singh AK, 2014, CAN J PLANT SCI, V94, P1289, DOI [10.4141/CJPS-2014-048, 10.4141/cjps-2014-048]; Skirycz A, 2008, PLANT J, V56, P779, DOI 10.1111/j.1365-313X.2008.03641.x; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Varella AC, 2015, CROP SCI, V55, P2046, DOI 10.2135/cropsci2014.12.0852; Varella AC, 2016, PLANT BREEDING, V135, P546, DOI 10.1111/pbr.12398; Wallace L.E., 1966, STEM SAWFLIES EC IMP; WALLACE LE, 1973, J ECON ENTOMOL, V66, P1121, DOI 10.1093/jee/66.5.1121; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xu PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27705; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75	51	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175285	10.1371/journal.pone.0175285	http://dx.doi.org/10.1371/journal.pone.0175285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399136	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000025
J	Singh, AV; Baylan, S; Park, BW; Richter, G; Sitti, M				Singh, Ajay Vikram; Baylan, Semanur; Park, Byung-Wook; Richter, Gunther; Sitti, Metin			Hydrophobic pinning with copper nanowhiskers leads to bactericidal properties	PLOS ONE			English	Article							SURFACES; CELLS	The considerable morbidity associated with hospitalized patients and clinics in developed countries due to biofilm formation on biomedical implants and surgical instruments is a heavy economic burden. An alternative to chemically treated surfaces for bactericidal activity started emerging from micro/nanoscale topographical cues in the last decade. Here, we demonstrate a putative antibacterial surface using copper nanowhiskers deposited by molecular beam epitaxy. Furthermore, the control of biological response is based on hydrophobic pinning of water droplets in the Wenzel regime, causing mechanical injury and cell death. Scanning electron microscopy images revealed the details of the surface morphology and non-contact mode laser scanning of the surface revealed the microtopography-associated quantitative parameters. Introducing the bacterial culture over nanowhiskers produces mechanical injury to cells, leading to a reduction in cell density over time due to local pinning of culture medium to whisker surfaces. Extended culture to 72 hours to observe biofilm formation revealed biofilm inhibition with scattered microcolonies and significantly reduced bio-volume on nanowhiskers. Therefore, surfaces patterned with copper nanowhiskers can serve as potential antibiofilm surfaces. The topography-based antibacterial surfaces introduce a novel prospect in developing mechanoresponsive nanobiomaterials to reduce the risk of medical device biofilm-associated infections, contrary to chemical leaching of copper as a traditional bactericidal agent.	[Singh, Ajay Vikram; Park, Byung-Wook; Sitti, Metin] Max Planck Inst Intelligent Syst, Phys Intelligence Dept, Stuttgart, Germany; [Baylan, Semanur; Richter, Gunther] Max Planck Inst Intelligent Syst, CSF Thin Films Grp, Stuttgart, Germany	Max Planck Society; Max Planck Society	Sitti, M (corresponding author), Max Planck Inst Intelligent Syst, Phys Intelligence Dept, Stuttgart, Germany.	sitti@is.mpg.de	Richter, Gunther/F-6222-2011; Singh, Ajay Vikram/AAM-3665-2020; Sitti, Metin/AGP-6288-2022; Singh, Ajay/AAF-4414-2020; Singh, Ajay Vikram/R-9055-2017	Singh, Ajay Vikram/0000-0002-9875-7727; Sitti, Metin/0000-0001-8249-3854	Maxplanck Society	Maxplanck Society(Max Planck Society)	Authors acknowledge Maxplanck Society for financial support.	Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Diu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07122; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Friedlander RS, 2013, P NATL ACAD SCI USA, V110, P5624, DOI 10.1073/pnas.1219662110; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5; Hosseinidoust Z, 2016, ADV DRUG DELIVERY RE; Ivanova EP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3838; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Marechal Y, 2011, J MOL STRUCT, V1004, P146, DOI 10.1016/j.molstruc.2011.07.054; May RM, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-8; Meng KK, 2014, J MATER SCI, V49, P3379, DOI 10.1007/s10853-014-8046-1; Park BW, 2016, ADV ENG MATER, V18, P518, DOI 10.1002/adem.201500282; Poulston S, 1996, SURF INTERFACE ANAL, V24, P811, DOI 10.1002/(SICI)1096-9918(199611)24:12<811::AID-SIA191>3.0.CO;2-Z; Richter G, 2009, NANO LETT, V9, P3048, DOI 10.1021/nl9015107; Singh AV, 2016, CURR PHARM DESIGN, V22, P1534, DOI 10.2174/1381612822666151210124001; Singh AV, 2015, SCI REP-UK, V5, DOI 10.1038/srep07847; Singh AV, 2012, MATER DESIGN, V36, P829, DOI 10.1016/j.matdes.2011.01.061; Singh AV, 2010, CURR NANOSCI, V6, P365; Singh AV, 2016, CURR PHARM DESIGN, V22, P1415, DOI 10.2174/1381612822999160122121713; Singh AV, 2016, CURR PHARM DESIGN, V22, P1418, DOI 10.2174/1381612822666151210124326; Singh AV, 2013, J BIOMED MATER RES A, V101, P3019, DOI 10.1002/jbm.a.34586; Singh AV, 2013, J BIOMED MATER RES A, V101, P2994, DOI 10.1002/jbm.a.34601; Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727; Singh AV, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025001; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Son S, 2002, INT J MACH TOOL MANU, V42, P889, DOI 10.1016/S0890-6955(02)00030-5; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; VANDERLAAN G, 1981, PHYS REV B, V23, P4369, DOI 10.1103/PhysRevB.23.4369; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521	31	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175428	10.1371/journal.pone.0175428	http://dx.doi.org/10.1371/journal.pone.0175428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399162	gold, Green Submitted, Green Published			2022-12-26	WOS:000399949000036
J	Roitberg, E; Shoshany, M				Roitberg, Elena; Shoshany, Maxim			Can spatial patterns along climatic gradients predict ecosystem responses to climate change? Experimenting with reaction-diffusion simulations	PLOS ONE			English	Article							VEGETATION PATTERNS; PRECIPITATION GRADIENT; SEMIARID WOODLANDS; SOIL; PRODUCTIVITY; PATCHINESS; ORGANIZATION; FACILITATION; COMPETITION; LANDSCAPES	Following a predicted decline in water resources in the Mediterranean Basin, we used reaction-diffusion equations to gain a better understanding of expected changes in properties of vegetation patterns that evolve along the rainfall transition between semi-arid and arid rainfall regions. Two types of scenarios were investigated: the first, a discrete scenario, where the potential consequences of climate change are represented by patterns evolving at discrete rainfall levels along a rainfall gradient. This scenario concerns space-for-time substitutions characteristic of the rainfall gradient hypothesis. The second, a continuous scenario, represents explicitly the effect of rainfall decline on patterns which evolved at different rainfall levels along the rainfall gradient prior to the climate change. The eccentricity of patterns that emerge through these two scenarios was found to decrease with decreasing rainfall, while their solidity increased. Due to their inverse modes of change, their ratio was found to be a highly sensitive indicator for pattern response to rainfall decline. An eccentricity ratio versus rainfall (ER:R) line was generalized from the results of the discrete experiment, where ERs above this line represent developed (recovered) patterns and ERs below this line represent degraded patterns. For the rainfall range of 1.2 to 0.8 mm/day, the continuous rainfall decline experiment with ERs that lie above the ER: R line, yielded patterns less affected by rainfall decline than would be expected according to the discrete representation of ecosystems' response. Thus, for this range, space-for-time substitution represents an overestimation of the consequences of the expected rainfall decline. For rainfall levels below 0.8 mm/day, eccentricity ratios from the discrete and continuous experiments practically converge to the same trend of pattern change along the ER: R line. Thus, the rainfall gradient hypothesis may be valid for regions characterized by this important rainfall range, which typically include desert fringe ecosystems.	[Roitberg, Elena; Shoshany, Maxim] Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel	Technion Israel Institute of Technology	Roitberg, E (corresponding author), Technion Israel Inst Technol, Fac Civil & Environm Engn, Haifa, Israel.	elenaroitberg@gmail.com		Shoshany, Maxim/0000-0002-6894-8995	Israel Science Foundation [1286/12]; Ministry of Science, Space Infrastructure Research (ISR) [3-13140]	Israel Science Foundation(Israel Science Foundation); Ministry of Science, Space Infrastructure Research (ISR)	The research was funded by Israel Science Foundation Grant number 1286/12 (https://www.isf.org.il/) and Ministry of Science, Space Infrastructure Research (ISR), 3-13140.	Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; BELSKY AJ, 1986, J ECOL, V74, P841, DOI 10.2307/2260402; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Borgogno F, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000256; Bromley J, 1997, J HYDROL, V198, P1, DOI 10.1016/S0022-1694(96)03322-7; Cantrell RS, 2003, SPATIAL ECOLOGY VIA; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; D'Odorico P, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000176; Dagbovie AS, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0465; Dunkerley DL, 1997, J ARID ENVIRON, V35, P419, DOI 10.1006/jare.1995.0158; Dunkerley DL, 2002, J ARID ENVIRON, V51, P163, DOI 10.1006/jare.2001.0940; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Elmendorf SC, 2015, P NATL ACAD SCI USA, V112, P448, DOI 10.1073/pnas.1410088112; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Gilad E, 2004, CONTINUUM MODELS DIS, V158, P405; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; HilleRisLambers R, 2001, ECOLOGY, V82, P50, DOI 10.1890/0012-9658(2001)082[0050:VPFISA]2.0.CO;2; Imeson AC, 2004, AGR ECOSYST ENVIRON, V104, P333, DOI 10.1016/j.agee.2004.01.033; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; Leprun JC, 1999, CATENA, V37, P25, DOI 10.1016/S0341-8162(98)00054-X; Ludwig JA, 1999, CATENA, V37, P257, DOI 10.1016/S0341-8162(98)00067-8; LUDWIG JA, 1995, LANDSCAPE ECOL, V10, P51, DOI 10.1007/BF00158553; Manor A, 2008, J THEOR BIOL, V253, P838, DOI 10.1016/j.jtbi.2008.04.012; Mariotti A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044001; MAUCHAMP A, 1994, ECOL MODEL, V71, P107, DOI 10.1016/0304-3800(94)90078-7; Meron E, 2004, CHAOS SOLITON FRACT, V19, P367, DOI 10.1016/S0960-0779(03)00049-3; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; MONTANA C, 1992, J ECOL, V80, P315, DOI 10.2307/2261014; Ni J, 2003, J ARID ENVIRON, V53, P501, DOI 10.1006/jare.2002.1063; Philandras CM, 2011, NAT HAZARD EARTH SYS, V11, P3235, DOI 10.5194/nhess-11-3235-2011; PICKETT S T A, 1989, P110; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2000, PLANT ECOL, V148, P207, DOI 10.1023/A:1009828432690; Saco PM, 2007, HYDROL EARTH SYST SC, V11, P1717, DOI 10.5194/hess-11-1717-2007; Sherratt JA, 2005, J MATH BIOL, V51, P183, DOI 10.1007/s00285-005-0319-5; Sherratt JA, 2014, SIAM J APPL DYN SYST, V13, P1517, DOI 10.1137/140969725; Shoshany M, 2002, GEOMORPHOLOGY, V45, P3, DOI 10.1016/S0169-555X(01)00186-6; Shoshany M, 2006, GEOMORPHOLOGY, V77, P35, DOI 10.1016/j.geomorph.2005.12.009; Stewart J, 2014, ECOL MONOGR, V84, P373, DOI 10.1890/12-1253.1; THIERY JM, 1995, J ECOL, V83, P497, DOI 10.2307/2261602; Tietjen B, 2007, J APPL ECOL, V44, P425, DOI 10.1111/j.1365-2664.2007.01280.x; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Valentin C, 1999, CATENA, V37, P1, DOI 10.1016/S0341-8162(99)00053-3; von Hardenberg J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198101; Yizhaq H, 2014, WATER RESOUR RES, V50, P5743, DOI 10.1002/2014WR015362	52	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0174942	10.1371/journal.pone.0174942	http://dx.doi.org/10.1371/journal.pone.0174942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394914	Green Submitted, Green Published, gold			2022-12-26	WOS:000399954800009
J	Gao, QQ; Lin, SH; Bai, PG; Du, M; Ni, XL; Ke, DZ; Tong, T				Gao, Qinquan; Lin, Shaohui; Bai, Penggang; Du, Min; Ni, Xiaolei; Ke, Dongzhong; Tong, Tong			FZUlmageReg: A toolbox for medical image registration and dose fusion in cervical cancer radiotherapy	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; NONRIGID REGISTRATION; INTRACAVITARY BRACHYTHERAPY; ACCUMULATION; DEFORMATIONS	The combination external-beam radiotherapy and high-dose-rate brachytherapy is a standard form of treatment for patients with locally advanced uterine cervical cancer. Personalized radiotherapy in cervical cancer requires efficient and accurate dose planning and assessment across these types of treatment. To achieve radiation dose assessment, accurate mapping of the dose distribution from HDR-BT onto EBRT is extremely important. However, few systems can achieve robust dose fusion and determine the accumulated dose distribution during the entire course of treatment. We have therefore developed a toolbox (FZUlmageReg), which is a user-friendly dose fusion system based on hybrid image registration for radiation dose assessment in cervical cancer radiotherapy. The main part of the software consists of a collection of medical image registration algorithms and a modular design with a user-friendly interface, which allows users to quickly configure, test, monitor, and compare different registration methods for a specific application. Owing to the large deformation, the direct application of conventional state-of-the-art image registration methods is not sufficient for the accurate alignment of EBRT and HDRBT images. To solve this problem, a multi-phase non-rigid registration method using local landmark-based free-form deformation is proposed for locally large deformation between EBRT and HDR-BT images, followed by intensity-based free-form deformation. With the transformation, the software also provides a dose mapping function according to the deformation field. The total dose distribution during the entire course of treatment can then be presented. Experimental results clearly show that the proposed system can achieve accurate registration between EBRT and HDR-BT images and provide radiation dose warping and fusion results for dose assessment in cervical cancer radiotherapy in terms of high accuracy and efficiency.	[Gao, Qinquan; Lin, Shaohui; Du, Min; Ke, Dongzhong] Fuzhou Univ, Fujian Prov Key Lab Med Instrument & Pharmaceut T, Fuzhou, Fujian Province, Peoples R China; [Bai, Penggang] Fujian Prov Canc Hosp, Fuzhou, Fujian Province, Peoples R China; [Ni, Xiaolei] First Hosp Longyan City, Longyan, Fujian Province, Peoples R China; [Tong, Tong] MGH Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Cambridge, MA 02115 USA	Fuzhou University	Ke, DZ (corresponding author), Fuzhou Univ, Fujian Prov Key Lab Med Instrument & Pharmaceut T, Fuzhou, Fujian Province, Peoples R China.; Tong, T (corresponding author), MGH Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Cambridge, MA 02115 USA.	kedongz@fzu.edu.cn; ttraveltong@gmail.com			Fujian Provincial Natural Science Foundation of China [2015J01366, 2016J05157]; Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN) [JAT160074]; National Natural Science Foundation of China [U1505251]	Fujian Provincial Natural Science Foundation of China; Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by the Fujian Provincial Natural Science Foundation of China, under Grant 2015J01366 (XLN) and 2016J05157 (QQG), the Foundation of Fujian Provincial Educational and Scientific Research Projects for Young and Middle-aged Teachers of Fujian Province (CN) under grant JAT160074 (QQG), and the National Natural Science Foundation of China, under Grant U1505251 (QQG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadur YA, 2011, SAUDI MED J, V32, P495; Barney BM, 2011, INT J RADIAT ONCOL, V80, P301, DOI 10.1016/j.ijrobp.2010.06.007; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Berendsen FF, 2014, PHYS MED BIOL, V59, P4033, DOI 10.1088/0031-9155/59/4/4033; Bondar L, 2010, MED PHYS, V37, P3760, DOI 10.1118/1.3443436; Christensen GE, 2001, INT J RADIAT ONCOL, V51, P227, DOI 10.1016/S0360-3016(01)01667-4; Crum WR, 2004, BRIT J RADIOL, V77, pS140, DOI 10.1259/bjr/25329214; d'Aische AD, 2005, MED IMAGE ANAL, V9, P538, DOI 10.1016/j.media.2005.04.003; Foskey M, 2005, PHYS MED BIOL, V50, P5869, DOI 10.1088/0031-9155/50/24/008; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; Han K, 2013, INT J RADIAT ONCOL, V87, P111, DOI 10.1016/j.ijrobp.2013.05.033; Ibanez L., 2005, ITK SOFTWARE GUIDE; Jadon R, 2014, CLIN ONCOL-UK, V26, P185, DOI 10.1016/j.clon.2013.11.031; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kessler ML, 2006, BRIT J RADIOL, V79, pS99, DOI 10.1259/bjr/70617164; Kessler ML, 2014, BRIT J RADIOLOGY; Kim H, 2014, J CONTEMP BRACHYTHER, V6, P178, DOI 10.5114/jcb.2014.43240; Kirby N, 2013, MED PHYS, V40, DOI 10.1118/1.4769114; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; Lim K, 2009, INT J RADIAT ONCOL, V74, P304, DOI 10.1016/j.ijrobp.2008.12.043; Lindegaard JC, 2013, ACTA ONCOL, V52, P1510, DOI 10.3109/0284186X.2013.818253; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Mackie TR, 2003, INT J RADIAT ONCOL, V56, P89, DOI 10.1016/S0360-3016(03)00090-7; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Osorio EMV, 2015, MED PHYS, V42, P206, DOI 10.1118/1.4903300; Potter R, 2011, RADIOTHER ONCOL, V100, P116, DOI 10.1016/j.radonc.2011.07.012; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schnabel JA, 2001, INT C MED IM COMP CO; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tian J, 2008, IEEE T INF TECHNOL B, V12, P800, DOI 10.1109/TITB.2008.926395; Toita T, 2003, INT J RADIAT ONCOL, V56, P1344, DOI 10.1016/S0360-3016(03)00288-8; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Wang H, 2005, PHYS MED BIOL, V50, P2887, DOI 10.1088/0031-9155/50/12/011; Wolf I, P SPIE, V2004; Yan D, 1997, PHYS MED BIOL, V42, P123, DOI 10.1088/0031-9155/42/1/008; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047; Zhen X, 2015, PHYS MED BIOL, V60, P2981, DOI 10.1088/0031-9155/60/7/2981	39	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174926	10.1371/journal.pone.0174926	http://dx.doi.org/10.1371/journal.pone.0174926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388623	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800014
J	Vicente, CR; Herbinger, KH; Cerutti, C; Romano, CM; Cabidelle, ADA; Froschl, G				Vicente, Creuza Rachel; Herbinger, Karl-Heinz; Cerutti Junior, Crispim; Romano, Camila Malta; Areias Cabidelle, Aline de Souza; Froeschl, Guenter			Determination of clusters and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitoria, Brazil	PLOS ONE			English	Article							AEDES-AEGYPTI; ENVIRONMENTAL VARIABLES; RISK-FACTORS; CITY; TRANSMISSION; DYNAMICS; CLIMATE; FEVER	Dengue occurrence is partially influenced by the immune status of the population. Consequently, the introduction of a new Dengue virus serotype can trigger explosive epidemics in susceptible populations. The determination of clusters in this scenario can help to identify hotspots and understand the disease dispersion regardless of the influence of the population herd immunity. The present study evaluated the pattern and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitoria, Espirito Santo state, Brazil. Data on 18,861 dengue cases reported in Vitoria from September 2012 to June 2013 were included in the study. The analysis of spatial variation in temporal trend was performed to detect clusters that were compared by their respective relative risk, house index, population density, and income in an ecological study. Overall, 11 clusters were detected. The time trend increase of dengue incidence in the overall study population was 636%. The five clusters that showed a lower time trend increase than the overall population presented a higher incidence in the beginning of the epidemic and, compared to the six clusters with higher time trend increase, they presented higher relative risk for their inhabitants to acquire dengue infection (P-value = 0.02) and a lower income (P-value < 0.01). House index and population density did not differ between the clusters. Early increase of dengue incidence and higher relative risk for acquiring dengue infection were favored in low-income areas. Preventive actions and improvement of infrastructure in low-income areas should be prioritized in order to diminish the magnitude of dengue dispersion after the introduction of a new serotype.	[Vicente, Creuza Rachel; Froeschl, Guenter] Univ Munich LMU, Med Ctr, Ctr Int Hlth, Munich, Germany; [Herbinger, Karl-Heinz; Froeschl, Guenter] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Cerutti Junior, Crispim] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Brazil; [Romano, Camila Malta] Univ Sao Paulo, Inst Trop Med, LIM52 LIMHC, Sao Paulo, Brazil; [Areias Cabidelle, Aline de Souza] Coordinat Epidemiol Surveillance, Dept Hlth, Vitoria, Brazil	University of Munich; University of Munich; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Vicente, CR (corresponding author), Univ Munich LMU, Med Ctr, Ctr Int Hlth, Munich, Germany.	vicentecrachel@gmail.com	Cerutti, Crispim/C-4529-2011; Romano, Camila M/C-8185-2013; Romano, Camila/ABC-2883-2020	Romano, Camila/0000-0003-4550-1987	Coordination for the Improvement of Higher Education Personnel (CAPES) [9589-13-9]; Brazilian National Council for Scientific and Technological Development (CNPq) [482261/2010-2]; Federal Ministry for Economic Cooperation and Development (BMZ); German Academic Exchange Services (DAAD); the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal Ministry for Economic Cooperation and Development (BMZ); German Academic Exchange Services (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED)	This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES, www.capes.gov.br) (grant number 9589-13-9 to CRV) and the Brazilian National Council for Scientific and Technological Development (CNPq, www.cnpq.br) (grant number 482261/2010-2 to CCJ). The Federal Ministry for Economic Cooperation and Development (BMZ) and the German Academic Exchange Services (DAAD) fund the Center for International Health at Medical Center of the University of Munich, Germany, through the Excellence Centers for Exchange and Development (EXCEED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51; Bertolacci-Rocha LG, 2014, CAD SAUDE PUBLICA, V30, P1789, DOI 10.1590/0102-311X00003914; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Brazilian Institute of Geography and Statistics, 2010, CENS 2010; Brazilian Ministry of Health, 2013, DENG DIAGN MAN CLIN; Brazilian Ministry of Health, 2012, LEV RAP IND AED AEG; Brazilian National Institute of Meteorology, 2010, WEATH 2010; Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009; Cardoso IM, 2011, REV SOC BRAS MED TRO, V44, P430, DOI 10.1590/S0037-86822011005000044; Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059; Cordeiro R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-355; Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003; Health Department of Vitoria, 2012, RES LEV IND INF PRED; Health Department of Vitoria, 2013, RES LEV IND INF PRED; Jeefoo P, 2011, INT J ENV RES PUB HE, V8, P51, DOI 10.3390/ijerph8010051; Khormi HM, 2012, GEOSPATIAL HEALTH, V6, P171, DOI 10.4081/gh.2012.135; Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937; Kulldorff M., 2015, SATSCAN USER GUIDE V; Maciel-de-Freitas R, 2010, MED VET ENTOMOL, V24, P74, DOI 10.1111/j.1365-2915.2009.00851.x; Medronho Roberto de Andrade, 2006, Rev. bras. epidemiol., V9, P159; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; de Melo PRS, 2007, MEM I OSWALDO CRUZ, V102, P905, DOI 10.1590/S0074-02762007000800003; Stewart-Ibarra A. M., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0078263; Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4; Teixeira M.G., 1999, INF EPIDEMIOLOGICO S, V8, P5, DOI [10.5123/S0104-16731999000400002, DOI 10.5123/S0104-16731999000400002]; Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002; Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175432	10.1371/journal.pone.0175432	http://dx.doi.org/10.1371/journal.pone.0175432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388694	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800054
J	Bjorniand, T; Langaas, M; Grill, V; Mostad, IL				Bjorniand, Thea; Langaas, Mette; Grill, Valdemar; Mostad, Ingrid Lovold			Assessing gene-environment interaction effects of FTO, MC4R and lifestyle factors on obesity using an extreme phenotype sampling design: Results from the HUNT study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; ARTIFICIAL SWEETENERS; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; COMMON VARIANT; FAT MASS; WEIGHT; ASSOCIATION; INSIGHTS	Background Our aim was to assess the influence of age, gender and lifestyle factors on the effect of the obesity-promoting alleles of FTO and MCR4. Methods The HUNT study comprises health information on the population of Nord-Trondelag county, Norway. Extreme phenotype participants (gender-wise lower and upper quartiles of waisthip-ratio and BMI >= 35 kg/m(2)) in the third survey, HUNT3 (2006-08), were genotyped for the single- nucleotide polymorphisms rs9939609 (FTO) and rs17782313 (MC4R); 25686 participants were successfully genotyped. Extreme sampling was chosen to increase power to detect genetic and gene-environment effects on waist-hip-ratio and BMI. Statistical inference was based on linear regression models and a missing-covariate likelihood approach for the extreme phenotype sampling design. Environmental factors were physical activity, diet (artificially sweetened beverages) and smoking. Longitudinal analysis was performed using material from HUNT2 (1995-97). Results Cross-sectional and longitudinal genetic effects indicated stronger genetic associations with obesity in young than in old, as well as differences between women and men. We observed larger genetic effects among physically inactive compared to active individuals. This interaction was age-dependent and seen mainly in 20-40 year olds. We observed a greater FTO effect among men with a regular intake of artificially sweetened beverages, compared to non-drinkers. Interaction analysis of smoking was mainly inconclusive. Conclusions In a large all-adult and area-based population survey the effects of obesity-promoting minoralleles of FTO and MCR4, and interactions with life style factors are age-and genderrelated. These findings appear relevant when designing individualized treatment for and prophylaxis against obesity.	[Bjorniand, Thea; Langaas, Mette] Norwegian Univ Sci & Technol, Fac Informat Technol & Elect Engn, Dept Math Sci, Trondheim, Norway; [Grill, Valdemar; Mostad, Ingrid Lovold] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Grill, Valdemar] Univ Trondheim Hosp, St Olays Hosp, Dept Endocrinol, Trondheim, Norway; [Mostad, Ingrid Lovold] Univ Trondheim Hosp, St Olays Hosp, Dept Clin Nutr & Speech Language Therapy, Clin Clin Serv, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bjorniand, T (corresponding author), Norwegian Univ Sci & Technol, Fac Informat Technol & Elect Engn, Dept Math Sci, Trondheim, Norway.	thea.bjornland@ntnu.no	Langaas, Mette/AAD-5948-2020; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Langaas, Mette/G-7423-2012	Langaas, Mette/0000-0002-5714-0288; 	Liaison Committee	Liaison Committee	ILM received funding from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (https://helse-midt.no/samarbeidsorganet). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; [Anonymous], 2010, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Boks MPM, 2007, INT J EPIDEMIOL, V36, P1363, DOI 10.1093/ije/dym215; Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027; Cuypers KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046912; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Fesinmeyer MD, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-6; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Huang BE, 2007, AM J HUM GENET, V80, P567, DOI 10.1086/512727; Hubacek JA, 2009, CLIN CHEM LAB MED, V47, P389, DOI 10.1515/CCLM.2009.109; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Krokstad S, 2012, INTERNATIONAL JOURNA; Kvaloy K, 2013, INT J OBESITY, V37, P1221, DOI 10.1038/ijo.2012.220; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Mostad IL, 2014, APPL PHYSIOL NUTR ME, P1; Pinnick KE, 2014, DIABETES, V63, P3785, DOI 10.2337/db14-0385; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi QB, 2014, HUM MOL GENET, V23, P6961, DOI 10.1093/hmg/ddu411; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Rukh G, 2016, INT J OBESITY, V40, P252, DOI 10.1038/ijo.2015.180; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Thorgeirsson TE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.81; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Yang Qing, 2010, Yale Journal of Biology and Medicine, V83, P101; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	46	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175071	10.1371/journal.pone.0175071	http://dx.doi.org/10.1371/journal.pone.0175071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384342	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900079
J	Jabo, B; Morgan, JW; Martinez, ME; Ghamsary, M; Wieduwilt, MJ				Jabo, Brice; Morgan, John W.; Martinez, Maria Elena; Ghamsary, Mark; Wieduwilt, Matthew J.			Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients	PLOS ONE			English	Article							TREATMENT PATTERNS; CORD BLOOD; CANCER; REMISSION; SURVIVAL; ACCESS; RISK; CALIFORNIA; INTENSITY; OUTCOMES	Introduction Identifying sociodemographic disparities in chemotherapy and hematopoietic cell transplantation (HCT) utilization for acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) may improve survival for underserved populations. In this study, we incorporate neighborhood socioeconomic status (nSES), marital status, and distance from transplant center with previously studied factors to provide a comprehensive analysis of sociodemographic factors influencing treatments for ALL and AML. Methods Using the California Cancer Registry, we performed a retrospective, population-based study of patients 15 years old with ALL (n = 3,221) or AML (n = 10,029) from 2003 through 2012. The effect of age, sex, race/ethnicity, marital status, nSES, and distance from nearest transplant center on receiving no treatment, chemotherapy alone, or chemotherapy then HCT was analyzed. Results No treatment, chemotherapy alone, or chemotherapy then HCT were received by 11%, 75%, and 14% of ALL patients and 36%, 53%, and 11% of AML patients, respectively. For ALL patients >= 60 years old, HCT utilization increased from 5% in 2005 to 9% in 2012 (p = 0.03). For AML patients >= 60 years old, chemotherapy utilization increased from 39% to 58% (p<0.001) and HCT utilization from 5% to 9% from 2005 to 2012 (p<0.001). Covariateadjusted analysis revealed decreasing relative risk (RR) of chemotherapy with increasing age for both ALL and AML (trend p <0.001). Relative to non-Hispanic whites, lower HCT utilization occurred in Hispanic [ALL, RR = 0.80 (95% CI = 0.65-0.98); AML, RR = 0.86 (95% CI = 0.75-0.99)] and non-Hispanic black patients [ALL, RR = 0.40 (95% CI = 0.180-0.89); AML, RR = 0.60 (95% CI = 0.44-0.83)]. Compared to married patients, never married patients had a lower RR of receiving chemotherapy [ALL, RR = 0.96 (95% CI = 0.92-0.99); AML, RR = 0.94 (95% CI = 0.90-0.98)] or HCT [ALL, RR = 0.58 (95% CI = 0.47-0.71); AML, RR = 0.80 (95% CI = 0.70-0.90)]. Lower nSES quintiles predicted lower chemotherapy and HCT utilization for both ALL and AML (trend p <0.001). Conclusions Older age, lower nSES, and being unmarried predicted lower utilization of chemotherapy and HCT among ALL and AML patients whereas having Hispanic or black race/ethnicity predicted lower rates of HCT. Addressing these disparities may increase utilization of curative therapies in underserved acute leukemia populations	[Jabo, Brice; Morgan, John W.; Ghamsary, Mark] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Martinez, Maria Elena; Wieduwilt, Matthew J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Loma Linda University; University of California System; University of California San Diego	Morgan, JW (corresponding author), Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA.	jmorgan@llu.edu		Wieduwilt, Matthew/0000-0002-5414-9228	National Cancer Institute [N01-PC-35136, N01-PC-35139, N02-PC-15105]; Surveillance Epidemiology and End Results (SEER) program; Centers for Disease Control and Prevention [U58DP000807-01]; National Program for Cancer Registries; California Department of Public Health Cancer Surveillance Branch	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Surveillance Epidemiology and End Results (SEER) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Program for Cancer Registries; California Department of Public Health Cancer Surveillance Branch	This study was supported, in part, by contracts N01-PC-35136, N01-PC-35139 and N02-PC-15105 from the National Cancer Institute and the Surveillance Epidemiology and End Results (SEER) program; contract U58DP000807-01 from the Centers for Disease Control and Prevention and the National Program for Cancer Registries; and the California Department of Public Health Cancer Surveillance Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Barker JN, 2010, BIOL BLOOD MARROW TR, V16, P1541, DOI 10.1016/j.bbmt.2010.08.011; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bierenbaum J, 2012, LEUKEMIA RES, V36, P140, DOI 10.1016/j.leukres.2011.10.018; Burnett AK, 2002, BRIT J HAEMATOL, V118, P385, DOI 10.1046/j.1365-2141.2002.03724.x; Chan JK, 2006, MED CARE, V44, P952, DOI 10.1097/01.mlr.0000220830.46929.43; Cho MM, 2013, DIS COLON RECTUM, V56, P1357, DOI 10.1097/01.dcr.0000436362.81611.de; Cohen RA, 2015, HLTH INSURANCE COVER; Craddock CF, 2008, BONE MARROW TRANSPL, V41, P415, DOI 10.1038/sj.bmt.1705975; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Eleni LD, 2010, J ONCOL, V2010, DOI 10.1155/2010/943823; Fritz A, 2000, INT CLASSIFICATION D; Gyurkocza B, 2011, J NATL COMPR CANC NE, V9, P319, DOI 10.6004/jnccn.2011.0028; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hwang JP, 2004, CANCER-AM CANCER SOC, V101, P2230, DOI 10.1002/cncr.20628; Joshua TV, 2010, CANCER-AM CANCER SOC, V116, P3469, DOI 10.1002/cncr.25297; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Kutner M. H., 2004, APPL LINEAR REGRESSI; Laport GG, 2008, BLOOD, V112, P903, DOI 10.1182/blood-2008-03-143115; Majhail NS, 2012, BONE MARROW TRANSPL, V47, P1385, DOI 10.1038/bmt.2011.214; Majhail NS, 2010, BIOL BLOOD MARROW TR, V16, P1070, DOI 10.1016/j.bbmt.2009.12.529; Marks DI, 2006, BONE MARROW TRANSPL, V38, P467, DOI 10.1038/sj.bmt.1705464; Medeiros BC, 2015, ANN HEMATOL, V94, P1127, DOI 10.1007/s00277-015-2351-x; Medeiros BC, 2012, LEUKEMIA RES, V36, P127, DOI 10.1016/j.leukres.2011.10.028; Mitchell JM, 1997, J CLIN ONCOL, V15, P2644, DOI 10.1200/JCO.1997.15.7.2644; Patel MI, 2015, CANCER EPIDEM BIOMAR, V24, P344, DOI 10.1158/1055-9965.EPI-14-0963; Pidala J, 2013, BONE MARROW TRANSPL, V48, P63, DOI 10.1038/bmt.2012.95; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Ragon BK, 2014, BIOL BLOOD MARROW TR, V20, P53, DOI 10.1016/j.bbmt.2013.10.004; Ram R, 2010, CANCER-AM CANCER SOC, V116, P3447, DOI 10.1002/cncr.25136; Ribera JM, 2011, HAEMATOL-HEMATOL J, V96, P1083, DOI 10.3324/haematol.2011.048348; Ruggeri A, 2010, BEST PRACT RES CL HA, V23, P207, DOI 10.1016/j.beha.2010.06.002; Saghari S, 2015, ANN EPIDEMIOL, V25, P250, DOI 10.1016/j.annepidem.2015.01.008; Sekeres MA, 2009, BLOOD, V113, P28, DOI 10.1182/blood-2008-05-157065; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; U. S. Census Bureau, 2016, SMALL AR INC POV EST; Yanada M, 2006, CANCER-AM CANCER SOC, V106, P2657, DOI 10.1002/cncr.21932; Yang J., 2014, DEV AREA BASED SOCIO; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	38	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174760	10.1371/journal.pone.0174760	http://dx.doi.org/10.1371/journal.pone.0174760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384176	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900034
J	Wu', YP; Li, ZY; Zhu, SF; Lu, L; Cai, ZB				Wu', Yan-Ping; Li, Zheng-Yang; Zhu, Sheng-Fa; Lu, Lei; Cai, Zhen-Bing			Effect of frequency on fretting wear behavior of Ti/TiN multilayer film on depleted uranium	PLOS ONE			English	Article							CORROSION-RESISTANCE; TI ALLOY; COATINGS; EVOLUTION; ADHESION; SURFACE; DAMAGE; 316L	The Ti/TiN multi-layer film was prepared on the depleted uranium (DU) substrate by cathodic arc ion plating equipment. The character of multi-layer film was studied by SEM, XRD and AES, revealed that the surface was composed of small compact particle and the cross-section had a multi-layer structure. The fretting wear performance under different frequencies was performed by a MFT-6000 machine with a ball-on-plate configuration. The wear morphology was analyzed by white light interferometer, OM and SEM with an EDX. The result shows the Ti/TiN multi-layer film could greatly improve the fretting wear performance compared to the DU substrate. The fretting wear running and damaged behavior are strongly dependent on the film and test frequency. The fretting region of DU substrate and Ti/TiN multi-layer under low test frequency is gross slip. With the increase of test frequency, the fretting region of Ti/TiN multi-layer change from gross slip to mixed fretting, then to partial slip.	[Wu', Yan-Ping; Zhu, Sheng-Fa; Lu, Lei] China Acad Engn Phys, Inst Mat, Jiangyou, Sichuan, Peoples R China; [Li, Zheng-Yang; Cai, Zhen-Bing] Southwest Jiaotong Univ, Tribol Res Inst, Key Lab Adv Technol Mat, Chengdu, Peoples R China	Chinese Academy of Engineering Physics; Southwest Jiaotong University	Cai, ZB (corresponding author), Southwest Jiaotong Univ, Tribol Res Inst, Key Lab Adv Technol Mat, Chengdu, Peoples R China.	czb-jiaoda@126.com			National Nature Foundation of China [U1530136, 51375407]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Foundation of China (No. U1530136 and 51375407). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2015, MATER DESIGN, V75, P47, DOI 10.1016/j.matdes.2015.03.007; Amrute AP, 2013, CHEM SCI, V4, P2209, DOI 10.1039/c3sc22067b; Benea L, 2015, MATER DESIGN, V65, P550, DOI 10.1016/j.matdes.2014.09.050; Bundit Jarimopas, 2005, Packaging Technology and Science, V18, P179, DOI 10.1002/pts.687; Cai ZB, 2013, TRIBOL INT, V59, P312, DOI 10.1016/j.triboint.2012.06.009; Cai ZB, 2010, TRIBOL INT, V43, P361, DOI 10.1016/j.triboint.2009.06.016; CHANG F, 1991, SURF COAT TECH, V48, P31, DOI 10.1016/0257-8972(91)90126-H; CHANG FC, 1991, SURF COAT TECH, V49, P87, DOI 10.1016/0257-8972(91)90037-W; Fouvry S, 1997, WEAR, V203, P393, DOI 10.1016/S0043-1648(96)07436-4; Holmes AL, 2014, MUTAT RES-FUND MOL M, V762, P1, DOI 10.1016/j.mrfmmm.2014.02.001; Kim K, 2008, SURF COAT TECH, V202, P5838, DOI 10.1016/j.surfcoat.2008.06.051; Kot M, 2013, MATER DESIGN, V51, P280, DOI 10.1016/j.matdes.2013.04.008; Li LQ, 2011, WEAR, V270, P857, DOI 10.1016/j.wear.2011.02.014; Liu TW, 2007, SURF COAT TECH, V201, P6737, DOI 10.1016/j.surfcoat.2006.09.126; Marc E, 2016, SURF COAT TECH, V308, P226, DOI 10.1016/j.surfcoat.2016.06.091; Mi X, 2016, TRIBOL INT, V100, P400, DOI 10.1016/j.triboint.2016.05.012; Saravanan I, 2015, MATER DESIGN, V67, P469, DOI 10.1016/j.matdes.2014.10.051; Singh AK, 2014, MATER CHEM PHYS, V143, P1446, DOI 10.1016/j.matchemphys.2013.11.063; Wang QZ, 2015, MATER CHEM PHYS, V158, P74, DOI 10.1016/j.matchemphys.2015.03.039; Warmuth AR, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0291; Wu YP, 2016, J NUCL MATER, V478, P7, DOI 10.1016/j.jnucmat.2016.05.035; Xin L, 2016, MATER DESIGN, V104, P152, DOI 10.1016/j.matdes.2016.05.030; Zhou R, 2007, POSTHARVEST BIOL TEC, V46, P20, DOI 10.1016/j.postharvbio.2007.04.006; Zhu MH, 2007, WEAR, V263, P472, DOI 10.1016/j.wear.2007.01.050; Zhu SF, 2014, CORROS SCI, V82, P420, DOI 10.1016/j.corsci.2014.02.011; Zhu SF, 2013, ACS APPL MATER INTER, V5, P6598, DOI 10.1021/am401284e	26	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175084	10.1371/journal.pone.0175084	http://dx.doi.org/10.1371/journal.pone.0175084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384200	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900083
J	Gyurkovics, M; Baumann, T; Carvalho, TS; Assuncao, CM; Lussi, A				Gyurkovics, Milan; Baumann, Tommy; Carvalho, Thiago Saads; Assuncao, Cristiane Meira; Lussi, Adrian			In vitro evaluation of modified surface microhardness measurement, focus variation 3D microscopy and contact stylus profilometry to assess enamel surface loss after erosive-abrasive challenges	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; DENTAL EROSION; TOOTH WEAR; FLUORIDE; SITU	The aim of the study was to compare surface loss values after erosion abrasion cycles obtained with modified surface microhardness measurement (mSMH), focus variation 3D microscopy (FVM) and contact stylus profilometry (CSP). We cut human molars into buccal and lingual halves, embedded them in resin and ground 200 pm of enamel away. The resulting surfaces were polished. To maintain a reference area, we applied Block-Out resin to partly cover the enamel surface. The samples were incubated in artificial saliva (37 degrees C; 1 h), then rinsed in deionized water (10 s) and dried with oil-free air (5 s). We immersed the specimens individually in 30 mL citric acid (1%, pH 3.6) for 2 min (25 degrees C, 70 rpm dynamic conditions) before brushing them (50 strokes, 200 g) in an automatic brushing machine with toothpaste-slurry. We calculated the surface loss as per mSMH, by re-measuring the length of the same six indentations made before the abrasive challenge. The experiment consisted of five experimental groups that received between 2 and 10 erosion abrasion cycles. Each group contained 15 specimens and samples in groups 1, 2, 3, 4 and 5 underwent a total of 2, 4, 6, 8 and 10 cycles, respectively. The resin was removed from the reference area in one piece under 10x magnification and the FVM and CSP were performed. Agreement between the methods was calculated with the intraclass correlation coefficient (ICC) and depicted in Bland-Altman plots. All methods presented a linear pattern of surface loss measurements throughout the experiment, leading overall to a strong, statistically significant correlation between the methods (ICC = 0.85; p<0.001). So, despite the different surface loss values, all methods presented consistent results for surface loss measurement.	[Gyurkovics, Milan; Baumann, Tommy; Carvalho, Thiago Saads; Assuncao, Cristiane Meira; Lussi, Adrian] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland; [Gyurkovics, Milan] Semmelweis Univ, Dept Conservat Dent, Fac Dent, Budapest, Hungary; [Assuncao, Cristiane Meira] Univ Fed Rio Grande do Sul, Sch Dent, Pediat Dent Div, Porto Alegre, RS, Brazil	University of Bern; Semmelweis University; Universidade Federal do Rio Grande do Sul	Gyurkovics, M (corresponding author), Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.; Gyurkovics, M (corresponding author), Semmelweis Univ, Dept Conservat Dent, Fac Dent, Budapest, Hungary.	miIan.gyurkovics@zmk.unibe.ch	ASSUNCAO, CRISTIANE MEIRA/V-7914-2019; Carvalho, Thiago/GWC-7662-2022; Carvalho, Thiago Saads/B-8945-2012	Carvalho, Thiago Saads/0000-0002-2435-1169; Gyurkovics, Milan/0000-0002-7561-6032; Assuncao, Cristiane Meira/0000-0002-1464-7812; Baumann, Tommy/0000-0002-5950-4137				Attin T, 2014, MONOGR ORAL SCI, V25, P123, DOI 10.1159/000360355; Barbour ME, 2004, J DENT, V32, P591, DOI 10.1016/j.jdent.2004.05.001; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Carvalho TS, 2015, CLIN ORAL INVEST, V19, P1557, DOI 10.1007/s00784-015-1511-7; Carvalho TS, 2014, J DENT, V42, P450, DOI 10.1016/j.jdent.2014.01.004; Carvalho TS, 2015, CARIES RES, V49, P109, DOI 10.1159/000369104; Cheng ZJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015020; Danzl R, 2011, STROJ VESTN-J MECH E, V57, P245, DOI 10.5545/sv-jme.2010.175; Eisenburger M, 2003, CARIES RES, V37, P450, DOI 10.1159/000073399; Field J, 2010, J DENT, V38, P182, DOI 10.1016/j.jdent.2010.01.002; Fujii M, 2011, DENT MATER J, V30, P404, DOI 10.4012/dmj.2010-204; Heurich E, 2010, DENT MATER, V26, P326, DOI 10.1016/j.dental.2009.12.001; Huysmans MCDNJM, 2011, CARIES RES, V45, P60, DOI 10.1159/000325947; Imfeld T, 1996, EUR J ORAL SCI, V104, P151, DOI 10.1111/j.1600-0722.1996.tb00063.x; Jaeggi T, 1999, CARIES RES, V33, P455, DOI 10.1159/000016551; Jaeggi T, 2014, MONOGR ORAL SCI, V25, P55, DOI 10.1159/000360973; Lima JPM, 2013, MICROSC RES TECHNIQ, V76, P904, DOI 10.1002/jemt.22246; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; LUSSI A, 1993, CARIES RES, V27, P387, DOI 10.1159/000261569; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Lussi A, 2014, EUR J ORAL SCI, V122, P353, DOI 10.1111/eos.12144; Mann C, 2014, J DENT, V42, P1411, DOI 10.1016/j.jdent.2014.06.011; Paepegaey AM, 2013, DENT MATER, V29, P1265, DOI 10.1016/j.dental.2013.09.015; Passos VF, 2013, MICROSC RES TECHNIQ, V76, P178, DOI 10.1002/jemt.22150; Ren YF, 2011, J DENT, V39, P672, DOI 10.1016/j.jdent.2011.07.009; Ren YF, 2009, J DENT, V37, P424, DOI 10.1016/j.jdent.2009.01.011; Ren YF, 2009, J DENT, V37, P167, DOI 10.1016/j.jdent.2008.09.008; Rodriguez JM, 2010, DENT MATER, V26, pE221, DOI 10.1016/j.dental.2010.07.001; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; Schwendicke F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108064; Stenhagen KR, 2010, CARIES RES, V44, P555, DOI 10.1159/000321536; Voronets J, 2010, CLIN ORAL INVEST, V14, P251, DOI 10.1007/s00784-009-0288-y; Zero DT, 1996, EUR J ORAL SCI, V104, P162, DOI 10.1111/j.1600-0722.1996.tb00065.x; ZERO DT, 1990, CARIES RES, V24, P181, DOI 10.1159/000261263	35	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175027	10.1371/journal.pone.0175027	http://dx.doi.org/10.1371/journal.pone.0175027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380015	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500087
J	Sarojini, H; Billeter, AT; Eichenberger, S; Druen, D; Barnett, R; Gardner, SA; Galbraith, NJ; Polk, HC; Chien, S				Sarojini, Harshini; Billeter, Adrian T.; Eichenberger, Sarah; Druen, Devin; Barnett, Rebecca; Gardner, Sarah A.; Galbraith, Norman J.; Polk, Hiram C., Jr.; Chien, Sufan			Rapid tissue regeneration induced by intracellular ATP delivery-A preliminary mechanistic study	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; T-HELPER-CELL; MACROPHAGE POLARIZATION; ADENOSINE-TRIPHOSPHATE; IN-VITRO; ALTERNATIVE ACTIVATION; MONONUCLEAR PHAGOCYTES; EXTRACELLULAR-MATRIX; LOCAL PROLIFERATION; CYTOKINE PRODUCTION	We have reported a new phenomenon in acute wound healing following the use of intracellular ATP delivery-extremely rapid tissue regeneration, which starts less than 24 h after surgery, and is accompanied by massive macrophage trafficking, in situ proliferation, and direct collagen production. This unusual process bypasses the formation of the traditional provisional extracellular matrix and significantly shortens the wound healing process. Although macrophages/monocytes are known to play a critical role in the initiation and progression of wound healing, their in situ proliferation and direct collagen production in wound healing have never been reported previously. We have explored these two very specific pathways during wound healing, while excluding confounding factors in the in vivo environment by analyzing wound samples and performing in vitro studies. The use of immunohistochemical studies enabled the detection of in situ macrophage proliferation in ATP-vesicle treated wounds. Primary human macrophages and Raw 264.7 cells were used for an in vitro study involving treatment with ATP vesicles, free Mg-ATP alone, lipid vesicles alone, Regranex, or culture medium. Collagen type 1 alpha 1, MCP-1, IL-6, and IL-10 levels were determined by ELISA of the culture supernatant. The intracellular collagen type 1 alpha 1 localization was determined with immunocytochemistry. ATP-vesicle treated wounds showed high immunoreactivity towards BrdU and PCNA antigens, indicating in situ proliferation. Most of the cultured macrophages treated with ATP-vesicles maintained their classic phenotype and expressed high levels of collagen type 1 alpha 1 for a longer duration than was observed with cells treated with Regranex. These studies provide the first clear evidence of in situ macrophage proliferation and direct collagen production during wound healing. These findings provide part of the explanation for the extremely rapid tissue regeneration, and this treatment may hold promise for acute and chronic wound care.	[Sarojini, Harshini; Billeter, Adrian T.; Eichenberger, Sarah; Druen, Devin; Barnett, Rebecca; Gardner, Sarah A.; Galbraith, Norman J.; Polk, Hiram C., Jr.; Chien, Sufan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA	University of Louisville	Chien, S (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	sufanc@aim.com	Billeter, Adrian/O-2185-2019; Sarojini, Harshini/AAD-4870-2019	Sarojini, Harshini/0000-0002-3103-9712; Galbraith, Norman/0000-0002-6354-6946	NIH [DK74566, AR52984, HL114235, GM106639, DK104625, DK105692, OD021317]; Kentucky Cabinet for Economic Development, Office of Entrepreneurship [KSTC-184-512-12-138, KSTC-184-512-14-174]; Kentucky Science and Technology Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL114235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR052984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK105692, R01DK074566, R43DK104625, R43DK105692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM106639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Cabinet for Economic Development, Office of Entrepreneurship; Kentucky Science and Technology Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants DK74566, AR52984, HL114235, GM106639, DK104625, DK105692, and OD021317 from the NIH and in part from the Kentucky Cabinet for Economic Development, Office of Entrepreneurship, under the Grant Agreement KSTC-184-512-12-138, KSTC-184-512-14-174 with the Kentucky Science and Technology Corporation.	Ahuja V, 2007, NUTR WOUND HEALING, P87; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Barbul A, 2008, J NUTR, V138, p2021S, DOI 10.1093/jn/138.10.2021S; Becker LC, 2005, CIRC RES, V96, P812, DOI 10.1161/01.RES.0000165652.82726.d9; Beekman B, 1998, OSTEOARTHR CARTILAGE, V6, P330, DOI 10.1053/joca.1998.0132; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Chien, 2006, RECENT RES DEV BIOPH, V5, P1; Chien S, 2012, JOVE-J VIS EXP, V2012, P1; Chien S, 2007, WOUND REPAIR REGEN, V15, P928, DOI 10.1111/j.1524-475X.2007.00285.x; Chien SF, 2010, METHODS MOL BIOL, V605, P377, DOI 10.1007/978-1-60327-360-2_26; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Chvapil M, 1988, J Burn Care Rehabil, V9, P279, DOI 10.1097/00004630-198805000-00009; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Distler JHW, 2006, ARTHRITIS RHEUM-US, V54, P214, DOI 10.1002/art.21497; Eming SA, 2007, AM J PATHOL, V170, P188, DOI 10.2353/ajpath.2007.060370; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Howard JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091787; Howes EL, 1943, SURG GYNECOL OBSTET, V76, P738; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Iwasaki Y, 2011, CELL TISSUE RES, V346, P99, DOI 10.1007/s00441-011-1231-5; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kasiewicz LN, 2016, ACTA BIOMATER, V32, P120, DOI 10.1016/j.actbio.2015.12.023; Khan B, 2013, J SURG RES, V183, P963, DOI 10.1016/j.jss.2013.02.019; Kimura T, 2013, J LEUKOCYTE BIOL, V94, P137, DOI 10.1189/jlb.0812408; La Flamme AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046989; Lansdown ABG, 2001, INT J EXP PATHOL, V82, P35, DOI 10.1046/j.1365-2613.2001.00180.x; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lehmann I, 2008, EXP TOXICOL PATHOL, V60, P185, DOI 10.1016/j.etp.2008.01.009; Lindblad, 1992, WOUND HEALING BIOCH, P248; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Murphy AJ, 2014, CIRC RES, V114, P236, DOI 10.1161/CIRCRESAHA.113.302813; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Patel S, 2016, J WOUND CARE, V25, P46, DOI 10.12968/jowc.2016.25.1.46; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rorsman C, 2016, J BIOL CHEM, V291, P11608, DOI 10.1074/jbc.M115.705814; Schaffer Michael, 2002, Int J Low Extrem Wounds, V1, P104, DOI 10.1177/1534734602001002005; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Schultz GS, 2005, WORLD WIDE WOUNDS, V1, P1; Toledo-Pereyra L.H., 2010, ORGAN PROCUREMENT PR, P82; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Ueno T, 2000, CLIN CANCER RES, V6, P3282; VAAGE J, 1991, BRIT J CANCER, V63, P758, DOI 10.1038/bjc.1991.169; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Van den BJ, 2012, J LEUKOCYTE BIOL, V91, P1; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wang JP, 2010, AM J SURG, V199, P823, DOI 10.1016/j.amjsurg.2009.05.040; Wang JP, 2009, ANN PLAS SURG, V62, P180, DOI 10.1097/SAP.0b013e31817fe47e; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Weitkamp B, 1999, FASEB J, V13, P1445, DOI 10.1096/fasebj.13.11.1445; WILLIAMSBOYCE PK, 1986, J ANAT, V149, P55; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang C, 2015, WOUND REPAIR REGEN, V23, pA46; Yang C, 2016, WOUND REPAIR REG SPR, V2016, pW54; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	78	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174899	10.1371/journal.pone.0174899	http://dx.doi.org/10.1371/journal.pone.0174899			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380006	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000399353500075
J	Olivier, PI; Rolo, V; van Aarde, RJ				Olivier, Pieter I.; Rolo, Victor; van Aarde, Rudi J.			Pattern or process? Evaluating the peninsula effect as a determinant of species richness in coastal dune forests	PLOS ONE			English	Article							BAJA-CALIFORNIA; SCALE; LANDSCAPE; BIOGEOGRAPHY; TOPOGRAPHY; DIVERSITY; BEHAVIOR; DENSITY; AFRICA; TRENDS	The peninsula effect predicts that the number of species should decline from the base of a peninsula to the tip. However, evidence for the peninsula effect is ambiguous, as different analytical methods, study taxa, and variations in local habitat or regional climatic conditions influence conclusions on its presence. We address this uncertainty by using two analytical methods to investigate the peninsula effect in three taxa that occupy different trophic levels: trees, millipedes, and birds. We surveyed 81 tree quadrants, 102 millipede transects, and 152 bird points within 150 km of coastal dune forest that resemble a habitat peninsula along the northeast coast of South Africa. We then used spatial (trend surface analyses) and nonspatial regressions (generalized linear mixed models) to test for the presence of the peninsula effect in each of the three taxa. We also used linear mixed models to test if climate (temperature and precipitation) and/or local habitat conditions (water availability associated with topography and landscape structural variables) could explain gradients in species richness. Non-spatial models suggest that the peninsula effect was present in all three taxa. However, spatial models indicated that only bird species richness declined from the peninsula base to the peninsula tip. Millipede species richness increased near the centre of the peninsula, while tree species richness increased near the tip. Local habitat conditions explained species richness patterns of birds and trees, but not of millipedes, regardless of model type. Our study highlights the idiosyncrasies associated with the peninsula effect-conclusions on the presence of the peninsula effect depend on the analytical methods used and the taxon studied. The peninsula effect might therefore be better suited to describe a species richness pattern where the number of species decline from a broader habitat base to a narrow tip, rather than a process that drives species richness.	[Olivier, Pieter I.; Rolo, Victor; van Aarde, Rudi J.] Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, Pretoria, Hatfield, South Africa	University of Pretoria	Olivier, PI (corresponding author), Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, Pretoria, Hatfield, South Africa.	polivier@zoology.up.ac.za	Rolo, Victor/H-1713-2016	Rolo, Victor/0000-0001-5854-9512	Richards Bay Minerals (RBM); Department of Trade and Industry's Technology and Human Resources for Industry Program (THRIP); National Research Foundation; National Research Foundation [88173, 88365]	Richards Bay Minerals (RBM); Department of Trade and Industry's Technology and Human Resources for Industry Program (THRIP); National Research Foundation; National Research Foundation	Richards Bay Minerals (RBM), the Department of Trade and Industry's Technology and Human Resources for Industry Program (THRIP) and the National Research Foundation provided financial and logistical support for this study. Pieter Olivier and Victor Rolo were supported by post-doctoral fellowships from the National Research Foundation (Grant no's: 88173 and 88365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ASTER GDEM ASTER GLO; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; BAILEY PT, 1993, J ZOOL, V231, P523, DOI 10.1111/j.1469-7998.1993.tb01935.x; Banks-Leite C, 2013, ECOL INDIC, V31, P82, DOI 10.1016/j.ecolind.2012.04.015; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battisti C, 2014, J NAT HIST, V48, P2701, DOI 10.1080/00222933.2014.925599; Besnard AG, 2013, DIVERS DISTRIB, V19, P955, DOI 10.1111/ddi.12047; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Botzat A, 2015, PLANT ECOL, V216, P535, DOI 10.1007/s11258-015-0457-9; BROWN JW, 1987, J BIOGEOGR, V14, P359, DOI 10.2307/2844943; BROWN JW, 1990, J BIOGEOGR, V17, P615, DOI 10.2307/2845143; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Burgess N. D., 2000, Coastal forests of eastern Africa; BUSACK SD, 1984, AM NAT, V123, P266, DOI 10.1086/284201; Cagnin M, 1998, J BIOGEOGR, V25, P1105, DOI 10.1046/j.1365-2699.1998.00248.x; Choi SW, 2004, J BIOGEOGR, V31, P587, DOI 10.1046/j.1365-2699.2003.01007.x; da Silva JMC., 1996, ORNITOL NEOTROP, V7, P1; David Jean-Francois, 2009, Soil Organisms, V81, P719; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; DUE AD, 1986, AM NAT, V128, P460, DOI 10.1086/284580; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; Ezemvelo KZN Wildlife, 2012, CONS PLANN KWAZULU N; Greyling MD, 2001, AFR J ECOL, V39, P51, DOI 10.1046/j.1365-2028.2001.00277.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOCKEY PAR, 2005, ROBERTS BIRDS SO AFR; Hopkins SP, 1992, BIOL MILLIPEDES; Jenkins DG, 2008, J BIOGEOGR, V35, P2128, DOI 10.1111/j.1365-2699.2008.01943.x; Johnson RA, 2002, J BIOGEOGR, V29, P1009, DOI 10.1046/j.1365-2699.2002.00746.x; Kaukinen D., 2012, PATCH ANAL PATCH GRI; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Lomolino M. V., 2005, BIOGEOGRAPHY; MARTIN J, 1990, J BIOGEOGR, V17, P85, DOI 10.2307/2845190; Mucina L., 2006, VEGETATION S AFRICA; Olivier PI, 2014, THESIS; Olivier PI, BIOTROPICA; Olivier PI, 2013, DIVERS DISTRIB, V19, P1353, DOI 10.1111/ddi.12099; Ott T, 2014, LANDSC ECOL ENG, V10, P17, DOI 10.1007/s11355-013-0211-1; Peck SB, 2005, ANN ENTOMOL SOC AM, V98, P951, DOI 10.1603/0013-8746(2005)098[0951:BOGBOF]2.0.CO;2; Petroselli A, 2013, TREES-STRUCT FUNCT, V27, P1201, DOI 10.1007/s00468-013-0869-x; Pryke JS, 2009, J INSECT CONSERV, V13, P627, DOI 10.1007/s10841-009-9213-6; R Core Team, 2021, R LANGUAGE ENV STAT; Rolo V, 2016, APPL VEG SCI, V19, P235, DOI 10.1111/avsc.12210; Schindler S, 2013, ECOL INDIC, V31, P41, DOI 10.1016/j.ecolind.2012.04.012; SEIB RL, 1980, AM NAT, V115, P613, DOI 10.1086/283586; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Tackaberry R, 1996, GLOBAL ECOL BIOGEOGR, V5, P85, DOI 10.2307/2997445; Tubelis DP, 2007, J ZOOL, V271, P11, DOI 10.1111/j.1469-7998.2006.00174.x; Van Aarde R. J., 2014, COASTAL CONSERVATION, P161; van Rensburg BJ, 2002, AM NAT, V159, P566, DOI 10.1086/339464; van Wyk AE., 2001, REGIONS FLORISTIC EN; vanAarde RJ, 1996, RESTOR ECOL, V4, P334, DOI 10.1111/j.1526-100X.1996.tb00186.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiggins DA, 1999, ECOGRAPHY, V22, P542, DOI 10.1111/j.1600-0587.1999.tb00543.x	61	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0173694	10.1371/journal.pone.0173694	http://dx.doi.org/10.1371/journal.pone.0173694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376096	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000002
J	Ghatak, S; Hascall, VC; Markwald, RR; Feghali-Bostwick, C; Artlett, CM; Gooz, M; Bogatkevich, GS; Atanelishvili, I; Silver, RM; Wood, J; Thannickal, VJ; Misra, S				Ghatak, Shibnath; Hascall, Vincent C.; Markwald, Roger R.; Feghali-Bostwick, Carol; Artlett, Carol M.; Gooz, Monika; Bogatkevich, Galina S.; Atanelishvili, Ilia; Silver, Richard M.; Wood, Jeanette; Thannickal, Victor J.; Misra, Suniti			Transforming growth factor 1 (TGF1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; differentiation; hyaluronan; NOx; reactive oxygen species (ROS)	SMOOTH-MUSCLE-CELLS; CONSTITUTIVELY REGULATES ACTIVATION; ANCHORAGE-INDEPENDENT GROWTH; FACTOR RECEPTOR ACTIVATION; COLLAGEN GENE-EXPRESSION; TGF-BETA; HYALURONIC-ACID; LUNG FIBROSIS; REACTIVE OXYGEN; SYSTEMIC-SCLEROSIS	Idiopathic pulmonary fibrosis (IPF) is a progressive clinical syndrome of fatal outcome. The lack of information about the signaling pathways that sustain fibrosis and the myofibroblast phenotype has prevented the development of targeted therapies for IPF. Our previous study showed that isolated fibrogenic lung fibroblasts have high endogenous levels of the hyaluronan receptor, CD44V6 (CD44 variant containing exon 6), which enhances the TGF1 autocrine signaling and induces fibroblasts to transdifferentiate into myofibroblasts. NADPH oxidase 4 (NOX4) enzyme, which catalyzes the reduction of O-2 to hydrogen peroxide (H2O2), has been implicated in the cardiac and lung myofibroblast phenotype. However, whether CD44V6 regulates NOX4 to mediate tissue repair and fibrogenesis is not well-defined. The present study assessed the mechanism of how TGF--1-induced CD44V6 regulates the NOX4/reactive oxygen species (ROS) signaling that mediates the myofibroblast differentiation. Specifically, we found that NOX4/ROS regulates hyaluronan synthesis and the transcription of CD44V6 via an effect upon AP-1 activity. Further, CD44V6 is part of a positive-feedback loop with TGF1/TGFRI signaling that acts to increase NOX4/ROS production, which is required for myofibroblast differentiation, myofibroblast differentiation, myofibroblast extracellular matrix production, myofibroblast invasion, and myofibroblast contractility. Both NOX4 and CD44v6 are up-regulated in the lungs of mice subjected to experimental lung injury and in cases of human IPF. Genetic (CD44v6 shRNA) or a small molecule inhibitor (CD44v6 peptide) targeting of CD44v6 abrogates fibrogenesis in murine models of lung injury. These studies support a function for CD44V6 in lung fibrosis and offer proof of concept for therapeutic targeting of CD44V6 in lung fibrosis disorders.	[Ghatak, Shibnath; Markwald, Roger R.; Misra, Suniti] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Feghali-Bostwick, Carol; Bogatkevich, Galina S.; Atanelishvili, Ilia; Silver, Richard M.] Med Univ South Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Gooz, Monika] Med Univ South Carolina, Coll Pharm Pharmaceut Biomed Sci, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA; [Artlett, Carol M.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Wood, Jeanette] Genkyotex, 16 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland; [Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation; Drexel University; Genkyotex; University of Alabama System; University of Alabama Birmingham	Ghatak, S; Misra, S (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu; misra@musc.edu			National Institutes of Health (NIH) [1R03CA167722-01A1]; NIH Grants [1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, 1P20 GM103444]; NIH [1 R01HL113325, 1 P01HL107147]; pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina [5P30GM103339-03]; Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant) [P30 CA138313]; Shared Instrumentation Grant [S10 OD018113]; NATIONAL CANCER INSTITUTE [P30CA138313, R03CA167722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325, R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499, P30GM103342, P30GM103339, P20GM103444] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant) at the Medical University of South Carolina(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant); Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) Grant 1R03CA167722-01A1 (to S. M. and S. G.); NIH Grants 1RO1 (HL33756), P30 GM103342-03, 5P20GM103499-16, AHA16GRNT31330032, and 1P20 GM103444 (to S. M., S. G., and R. R. M.); NIH Grants 1 R01HL113325 and 1 P01HL107147 (to V. C. H.); a pilot project award from the COBRE in Lipidomics and Pathobiology (NIH Grant 5P30GM103339-03) at the Medical University of South Carolina (to S. M.); and the Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (NIH Grant P30 CA138313) and Shared Instrumentation Grant S10 OD018113. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Basoni C, 2006, BIOCHEM BIOPH RES CO, V343, P609, DOI 10.1016/j.bbrc.2006.03.003; Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dinarello C A, 1992, Semin Immunol, V4, P133; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evans HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4199; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Flannery CR, 1998, BIOCHEM BIOPH RES CO, V251, P824, DOI 10.1006/bbrc.1998.9561; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galuppo M, 2011, N-S ARCH PHARMACOL, V384, P21, DOI 10.1007/s00210-011-0637-7; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; Ghatak Shibnath, 2015, Int J Cell Biol, V2015, P834893, DOI 10.1155/2015/834893; Ghatak S, 2014, J BIOL CHEM, V289, P8545, DOI 10.1074/jbc.M113.539882; Ghatak S, 2014, J BIOL CHEM, V289, P7856, DOI 10.1074/jbc.M113.505065; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Ghatak S, 2008, CONNECT TISSUE RES, V49, P265, DOI 10.1080/03008200802147845; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Goransson V, 2001, MATRIX BIOL, V20, P129, DOI 10.1016/S0945-053X(01)00129-9; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2012, CELL MOL LIFE SCI, V69, P2365, DOI 10.1007/s00018-012-1012-7; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Henke C, 1996, AM J PATHOL, V149, P1639; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; HUNT TK, 1984, SURGERY, V96, P48; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P727, DOI 10.1089/ars.2007.1942; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P249, DOI 10.1089/ars.2007.1912; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; Kosaki R, 1999, CANCER RES, V59, P1141; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Laurent UBG, 1996, ACTA NEUROL SCAND, V94, P194, DOI 10.1111/j.1600-0404.1996.tb07052.x; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 2000, J BIOL CHEM, V275, P26967; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; Ley B, 2012, AM J RESP CRIT CARE, V185, P6, DOI 10.1164/rccm.201111-1960ED; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Li YJ, 2016, MATRIX BIOL, V55, P35, DOI 10.1016/j.matbio.2016.03.004; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MCANULTY RJ, 1995, EXP NEPHROL, V3, P96; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S., 2012, DELIVERY SYSTEMS TAR, P855; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P723; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murakami M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00323; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pascal M, 2000, T ROY SOC TROP MED H, V94, P66, DOI 10.1016/S0035-9203(00)90443-7; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rangarajan S, 2016, DRUGS, V76, P291, DOI 10.1007/s40265-015-0523-6; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; SOUTHCOTT AM, 1995, AM J RESP CRIT CARE, V151, P1604, DOI 10.1164/ajrccm.151.5.7735620; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; TAMMI R, 1991, EXP CELL RES, V195, P524, DOI 10.1016/0014-4827(91)90405-J; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thannickal VJ, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S23; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vaz ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136116; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; Vendrov AE, 2010, J BIOL CHEM, V285, P26545, DOI 10.1074/jbc.M110.143917; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; White B, 1996, RHEUM DIS CLIN N AM, V22, P695, DOI 10.1016/S0889-857X(05)70296-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yew NS, 2005, ADV GENET, V53, P189, DOI 10.1016/S0065-2660(05)53007-4; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zha LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107655; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119; Zhang K, 1997, J IMMUNOL, V158, P954; ZHANG K, 1994, AM J PATHOL, V145, P114; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	155	51	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10490	10519		10.1074/jbc.M116.752469	http://dx.doi.org/10.1074/jbc.M116.752469			30	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28389561	Green Published, hybrid			2022-12-26	WOS:000404115400013
J	Fernandez, B; Moneim, AEA; Ortiz, F; Shen, YQ; Soto-Mercado, V; Mendivil-Perez, M; Guerra-Librero, A; Acuna-Castroviejo, D; Molina-Navarro, MM; Garcia-Verdugo, JM; Sayed, RKA; Florido, J; Luna, JD; Lopez, LC; Escames, G				Fernandez, Beatriz; Moneim, Ahmed E. Abdel; Ortiz, Francisco; Shen, Ying-Qiang; Soto-Mercado, Viviana; Mendivil-Perez, Miguel; Guerra-Librero, Ana; Acuna-Castroviejo, Dario; Molina-Navarro, Maria M.; Garcia-Verdugo, Jose M.; Sayed, Ramy K. A.; Florido, Javier; Luna, Juan D.; Carlos Lopez, Luis; Escames, Germaine			Melatonin protects rats from radiotherapy-induced small intestine toxicity	PLOS ONE			English	Article							INFLAMMASOME ACTIVATION; LIPID-PEROXIDATION; RADIATION-INJURY; MUCOSITIS; EXPRESSION; CANCER; PATHOBIOLOGY; GLUTATHIONE; APOPTOSIS; SEPSIS	Radiotherapy-induced gut toxicity is among the most prevalent dose-limiting toxicities following radiotherapy. Prevention of radiation enteropathy requires protection of the small intestine. However, despite the prevalence and burden of this pathology, there are currently no effective treatments for radiotherapy-induced gut toxicity, and this pathology remains unclear. The present study aimed to investigate the changes induced in the rat small intestine after external irradiation of the tongue, and to explore the potential radio-protective effects of melatonin gel. Male Wistar rats were subjected to irradiation of their tongues with an X-Ray YXLON Y. Tu 320-D03 irradiator, receiving a dose of 7.5 Gy/day for 5 days. For 21 days post-irradiation, rats were treated with 45 mg/day melatonin gel or vehicle, by local application into their mouths. Our results showed that mitochondrial oxidative stress, bioenergetic impairment, and subsequent NLRP3 inflammasome activation were involved in the development of radiotherapy-induced gut toxicity. Oral treatment with melatonin gel had a protective effect in the small intestine, which was associated with mitochondrial protection and, consequently, with a reduced inflammatory response, blunting the NF-kappa B/NLRP3 inflammasome signaling activation. Thus, rats treated with melatonin gel showed reduced intestinal apoptosis, relieving mucosal dysfunction and facilitating intestinal mucosa recovery. Our findings suggest that oral treatment with melatonin gel may be a potential preventive therapy for radiotherapy-induced gut toxicity in cancer patients.	[Fernandez, Beatriz; Ortiz, Francisco; Shen, Ying-Qiang; Guerra-Librero, Ana; Acuna-Castroviejo, Dario; Florido, Javier; Carlos Lopez, Luis; Escames, Germaine] Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Granada, Spain; [Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt; [Soto-Mercado, Viviana; Mendivil-Perez, Miguel] Univ Antioquia, Med Res Inst, Neurosci Res Grp, Fac Med, Medellin, Colombia; [Acuna-Castroviejo, Dario; Carlos Lopez, Luis; Escames, Germaine] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [Molina-Navarro, Maria M.; Garcia-Verdugo, Jose M.] Univ Valencia, Inst Cavanilles, Valencia, Spain; [Sayed, Ramy K. A.] Sohag Univ, Fac Vet Med, Dept Anat & Embryol, Sohag, Egypt; [Luna, Juan D.] Univ Granada, Fac Med, Dept Bioestadast, Granada, Spain; [Escames, Germaine] Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada, Spain	University of Granada; Egyptian Knowledge Bank (EKB); Helwan University; Universidad de Antioquia; University of Granada; University of Valencia; Egyptian Knowledge Bank (EKB); Sohag University; University of Granada	Escames, G (corresponding author), Univ Granada, Inst Biotecnol, Ctr Invest Biomed, Granada, Spain.; Escames, G (corresponding author), Univ Granada, Fac Med, Dept Fisiol, Granada, Spain.; Escames, G (corresponding author), Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Granada, Spain.	gescames@ugr.es	Sayed, Ramy K. A./AAD-2215-2019; Acuña-Castroviejo, Dario/N-7456-2016; Florido, Javier/B-8988-2019; de dios luna del castillo, juan/N-9183-2016; shen, ying/HHS-5635-2022; Lopez, Luis Carlos/AAP-9411-2020; Lopez, Luis Carlos/L-5129-2014; Moneim, Ahmed E. Abdel/C-7461-2012; García-Verdugo, José Manuel/L-8421-2017; Fernandez-Gil, Beatriz Irene/C-1723-2019; Guerra-Librero, Ana/B-8987-2019; Escames, Germaine/N-7501-2016	Sayed, Ramy K. A./0000-0003-4467-6742; Acuña-Castroviejo, Dario/0000-0002-9680-1560; Florido, Javier/0000-0001-7541-4898; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Moneim, Ahmed E. Abdel/0000-0002-2654-2591; García-Verdugo, José Manuel/0000-0001-9872-6499; Fernandez-Gil, Beatriz Irene/0000-0003-2347-2687; Guerra-Librero, Ana/0000-0002-6243-6593; mendivil-perez, miguel/0000-0002-8824-379X; , Micaela/0000-0002-2103-0351; Escames, Germaine/0000-0003-1256-7656	Spanish Ministry of Economy and Competitivity (MINECO) [SAF2009-14037]; CEIBiotic Program of the University of Granada, Spain [GREIB.PT_2010_04]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [CTS-101]	Spanish Ministry of Economy and Competitivity (MINECO); CEIBiotic Program of the University of Granada, Spain; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia)	This study was partially supported by grant no. SAF2009-14037 from the Spanish Ministry of Economy and Competitivity (MINECO), GREIB.PT_2010_04 from the CEIBiotic Program of the University of Granada, Spain, and CTS-101 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Al-Dasooqi N, 2013, SUPPORT CARE CANCER, V21, P2075, DOI 10.1007/s00520-013-1810-y; Arifa RDN, 2014, AM J PATHOL, V184, P2023, DOI 10.1016/j.ajpath.2014.03.012; Boerma M, 2006, INT J RADIAT ONCOL, V66, P552, DOI 10.1016/j.ijrobp.2006.05.067; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Cameron S, 2012, EXP MOL PATHOL, V92, P243, DOI 10.1016/j.yexmp.2011.11.007; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Diaz-Casado ME, 2016, J PINEAL RES, V61, P96, DOI 10.1111/jpi.12332; Doerrier C, 2016, MITOCHONDRION, V27, P56, DOI 10.1016/j.mito.2015.12.010; Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Garcia JA, 2015, FASEB J, V29, P3863, DOI 10.1096/fj.15-273656; Glenister R., 2013, TRANSL GASTROINTEST, V2, P2; GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong Y, 2014, J PINEAL RES, V56, P264, DOI 10.1111/jpi.12119; JASKOT RH, 1983, J ANAL TOXICOL, V7, P86, DOI 10.1093/jat/7.2.86; Khan S, 2016, ENV TOXICOL; Lalla RV, 2015, EXPERT REV GASTROENT, V9, P127, DOI 10.1586/17474124.2015.965146; Lissoni P, 2000, ANTICANCER RES, V20, P2103; Logan RM, 2008, CANCER BIOL THER, V7, P1139; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Z, 2016, ONCOTARGET, DOI 10.18632/oncotarget; Maj JG, 2003, CANCER RES, V63, P4338; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x; Matsuu-Matsuyama M, 2006, J RADIAT RES, V47, P1, DOI 10.1269/jrr.47.1; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Murphy CK, 2008, CLIN CANCER RES, V14, P4292, DOI 10.1158/1078-0432.CCR-07-4669; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Ong ZY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-22; Ortiz F, 2015, J PINEAL RES, V58, P34, DOI 10.1111/jpi.12191; Pacini N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030341; Puig A, 2016, EXP GERONTOL, V75, P1, DOI 10.1016/j.exger.2015.11.021; Shirazi A, 2007, J RADIAT RES, V48, P263, DOI 10.1269/jrr.06070; Son TG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-103; SONIS ST, 1990, ORAL SURG ORAL MED O, V69, P437, DOI 10.1016/0030-4220(90)90376-4; Sonis ST, 2002, CELL PROLIFERAT, V35, P93, DOI 10.1046/j.1365-2184.35.s1.10.x; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Tahamtan R, 2015, CELL J, V17, P111; Tan DX, 2015, MOLECULES, V20, P18886, DOI 10.3390/molecules201018886; Venegas C, 2013, J PINEAL RES, V54, P313, DOI 10.1111/jpi.12019; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Villa A, 2015, CURR OPIN ONCOL, V27, P159, DOI 10.1097/CCO.0000000000000180; Volt H, 2016, J PINEAL RES, V60, P193, DOI 10.1111/jpi.12303; WANG Y, 2013, PLOS ONE, V2013; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227; Zetner D, 2016, DRUG RES, V66, P281, DOI 10.1055/s-0035-1569358	49	83	85	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174474	10.1371/journal.pone.0174474	http://dx.doi.org/10.1371/journal.pone.0174474			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403142	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200014
J	Wang, JH; Zhang, L; Huang, ST; Xu, J; Zhou, Y; Yu, XJ; Luo, RZ; Wen, ZS; Jia, WH; Zheng, M				Wang, Jian-Hua; Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Luo, Rong-Zhen; Wen, Zhe-Sheng; Jia, Wei-Hua; Zheng, Min			Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY LIGHT-CHAIN; MUSCLE-CONTRACTION; METASTASIS; TRANSCRIPTION; MIGRATION; INVASION; KINASE; PHOSPHORYLATION; INVASIVENESS	Objective Myosin light chain 9 (MYL9) is necessary for cytoskeletal dynamics and experimental metastasis, but its expression in esophageal squamous cell carcinoma (ESCC) has not been addressed. We investigated the expression pattern and clinical significance of MYL9 in patients with ESCC. Methods We examined MYL9 expression using quantitative real-time PCR and western blotting in NE1 immortalized esophageal epithelial cells, ESCC cell lines, and paired ESCC tissues. MYL9 protein in 136 primary ESCC tissues and other types of solid tumor was detected using immunohistochemistry. The association between MYL9 expression and clinical parameters and survival was evaluated by statistical analysis. Results MYL9 was significantly upregulated in the ESCC cell lines as compared with NE1 cells. In the paired ESCC samples, MYL9 mRNA and protein expression was not significantly different between lesion tissues and the matched adjacent noncancerous tissues. In ESCC tissue, both intratumoral and peritumoral stroma were positive for MYL9. In the 136 ESCC samples, high MYL9 expression in the tumor cells significantly correlated with histological differentiation (p = 0.028), recurrence (p = 0.01), and vital status (p < 0.01). Patients with high MYL9 expression in the tumor cells had poorer overall survival (OS) and recurrence-free survival. Multivariate analysis revealed that high MYL9 expression in tumor cells was an independent and significant risk factor affecting OS after curative treatment (hazard ratio = 2.254, 95% confidence interval = 1.347-3.771, p = 0.002). Conclusions MYL9 expression might be a promising prognostic marker and therapeutic target in ESCC.	[Wang, Jian-Hua] Guangdong Second Prov Gen Hosp, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Zhou, Yun; Zheng, Min] Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Jia, Wei-Hua; Zheng, Min] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan; Huang, Shu-Ting; Xu, Jing; Zhou, Yun; Yu, Xing-Juan; Jia, Wei-Hua; Zheng, Min] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Lan] Kunming Med Univ, Yunnan Tumor Hosp, Dept Radiat Oncol, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China; [Luo, Rong-Zhen] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wen, Zhe-Sheng] Sun Yat Sen Univ, Ctr Canc, Dept Chest, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Kunming Medical University; Sun Yat Sen University; Sun Yat Sen University	Wang, JH (corresponding author), Guangdong Second Prov Gen Hosp, Dept Chest, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Zheng, M (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	wangjh296@163.com; zhengmin@sysucc.org.cn			National Natural Science Foundation of China [81171948, 81372275]; Project of State Key Laboratory of Oncology in South China [030041060004]; Project of Guangzhou Science and Technology Plan [2014J4100238]; Science and Technology Plan Program of Guangdong Province [2016A020215080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of State Key Laboratory of Oncology in South China; Project of Guangzhou Science and Technology Plan; Science and Technology Plan Program of Guangdong Province	This work was supported by the National Natural Science Foundation of China [grant numbers 81171948, 81372275], the Project of State Key Laboratory of Oncology in South China [grant number 030041060004], and the Project of Guangzhou Science and Technology Plan [2014J4100238 to Min Zheng]. In addition, this work has also been sponsored by Science and Technology Plan Program of Guangdong Province (M.Z., No. 2016A020215080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Cao R, 2014, BRIT J CANCER, V111, P539, DOI 10.1038/bjc.2014.298; Cermak V, 2010, CELL MOL LIFE SCI, V67, P3557, DOI 10.1007/s00018-010-0395-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franco CA, 2013, DEVELOPMENT, V140, P2321, DOI 10.1242/dev.091074; Gilkes DM, 2014, P NATL ACAD SCI USA, V111, pE384, DOI 10.1073/pnas.1321510111; Gilles L, 2009, BLOOD, V114, P4221, DOI 10.1182/blood-2009-03-209932; Huang YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0820-4; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Ishihara S, 2013, FEBS LETT, V587, P732, DOI 10.1016/j.febslet.2013.01.055; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Ji H, 2014, BIOMED REP, V2, P787, DOI 10.3892/br.2014.323; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Li QJ, 2009, GASTROENTEROLOGY, V137, P1051, DOI 10.1053/j.gastro.2009.03.040; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Lu Y, 2011, AM J TRANSL RES, V3, P8; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Ogata S, 2009, INT J GYNECOL CANCER, V19, P1473, DOI 10.1111/IGC.0b013e3181c03909; Ouderkirk JL, 2014, CYTOSKELETON, V71, P447, DOI 10.1002/cm.21187; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Szent-Gyorgyi AG, 2004, J GEN PHYSIOL, V123, P631, DOI 10.1085/jgp.200409091; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Yan Z, 2012, ONCOL REP, V28, P1036, DOI 10.3892/or.2012.1891; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024	30	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175280	10.1371/journal.pone.0175280	http://dx.doi.org/10.1371/journal.pone.0175280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388691	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800035
J	Darrah, R; Bederman, I; Vitko, M; Valerio, DM; Drumm, ML; Hodges, CA				Darrah, Rebecca; Bederman, Ilya; Vitko, Megan; Valerio, Dana M.; Drumm, Mitchell L.; Hodges, Craig A.			Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PULMONARY-FUNCTION; NUTRITIONAL-STATUS; MECONIUM ILEUS; CFTR-KNOCKOUT; MODEL; DISEASE; MOUSE; RETARDATION; CHILDREN	Growth deficits are common in cystic fibrosis (CF), but their cause is complex, with contributions from exocrine pancreatic insufficiency, pulmonary complications, gastrointestinal obstructions, and endocrine abnormalities. The CF mouse model displays similar growth impairment despite exocrine pancreatic function and in the absence of chronic pulmonary infection. The high incidence of intestinal obstruction in the CF mouse has been suggested to significantly contribute to the observed growth deficits. Previous studies by our group have shown that restoration of the cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium prevents intestinal obstruction but does not improve growth. In this study, we further investigate growth deficits in CF and gut-corrected CF mice by assessing insulin-like growth factor 1 (IGF-1). IGF-1 levels were significantly decreased in CF and gut-corrected CF adult mice compared to wildtype littermates and were highly correlated with weight. Interestingly, perinatal IGF-1 levels were not significantly different between CF and wildtype littermates, even though growth deficits in CF mice could be detected late in gestation. Since CFTR has been suggested to play a role in water and nutrient exchange in the placenta through its interaction with aquaporins, we analyzed placental aquaporin expression in late-gestation CF and control littermates. While significant differences were observed in Aquaporin 9 expression in CF placentas in late gestation, there was no evidence of placental fluid exchange differences between CF and control littermates. The results from this study indicate that decreased IGF-1 levels are highly correlated with growth in CF mice, independent of CF intestinal obstruction. However, the perinatal growth deficits that are observed in CF mice are not due to decreased IGF-1 levels or differences in placenta-mediated fluid exchange. Further investigation is necessary to understand the etiology of early growth deficits in CF, as growth has been shown to be a significant factor in disease outcomes.	[Darrah, Rebecca] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA; [Darrah, Rebecca; Vitko, Megan; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Bederman, Ilya; Valerio, Dana M.; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	craig.hodges@case.edu		Piazza, Megan/0000-0002-1062-7144	Cystic Fibrosis Foundation [Hodges11G0]; National Institutes of Health [P30DK27651, R24RR032425]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Cystic Fibrosis Foundation (Hodges11G0, https://www.cff.org/CFF) and the National Institutes of Health (P30DK27651 and R24RR032425, https://www.nig.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; BOYER PH, 1955, PEDIATRICS, V16, P778; Castro-Parodi M, 2009, PLACENTA, V30, P642, DOI 10.1016/j.placenta.2009.04.012; Cheung KH, 2003, BIOL REPROD, V68, P1505, DOI 10.1095/biolreprod.102.010017; Cohen JC, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-21; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Cystic Fibrosis Foundation Patient Registry, 2006, 2005 ANNUAL DATA REP; Darrah R, 2016, BIOL RES NURS, V18, P498, DOI 10.1177/1099800416643585; Darrah RJ, 2016, J CYST FIBROS; DAVIS B, 1985, LANCET, V1, P392; DURIE PR, 1989, ACTA PAEDIATR SCAND, P41; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; FALLER DP, 1995, AM J PHYSIOL-CELL PH, V269, pC148, DOI 10.1152/ajpcell.1995.269.1.C148; Festini F, 2005, J PEDIATR-US, V147, P316, DOI 10.1016/j.jpeds.2005.04.031; Gaskin KJ, 2013, EUR J CLIN NUTR, V67, P558, DOI 10.1038/ejcn.2013.20; GHOSAL S, 1995, ARCH DIS CHILD, V72, P150, DOI 10.1136/adc.72.2.150; HAEUSLER G, 1994, EUR J PEDIATR, V153, P158, DOI 10.1007/BF01958975; HAN VKM, 1988, J CLIN ENDOCR METAB, V66, P422, DOI 10.1210/jcem-66-2-422; Hardin DS, 2005, CLIN ENDOCRINOL, V62, P560, DOI 10.1111/j.1365-2265.2005.02259.x; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; Kent G, 1997, J CLIN INVEST, V100, P3060, DOI 10.1172/JCI119861; Konstan MW, 2003, J PEDIATR-US, V142, P624, DOI 10.1067/mpd.2003.152; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; Lai HC, 1999, AM J CLIN NUTR, V69, P531; Lai HC, 2000, PEDIATRICS, V105, P53, DOI 10.1542/peds.105.1.53; LEVY E, 1993, PEDIATR RES, V34, P162, DOI 10.1203/00006450-199308000-00011; Mylona P, 1996, MOL HUM REPROD, V2, P693, DOI 10.1093/molehr/2.9.693; Netchine I, 2011, BEST PRACT RES CL EN, V25, P181, DOI 10.1016/j.beem.2010.08.005; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; Pascua P, 2009, PFLUG ARCH EUR J PHY, V459, P203, DOI 10.1007/s00424-009-0704-9; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; ROBERTS CT, 1987, MOL ENDOCRINOL, V1, P243, DOI 10.1210/mend-1-3-243; Rogan MP, 2010, PROC NATL ACAD SCI U; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; Schreiber R, 1999, J BIOL CHEM, V274, P11811, DOI 10.1074/jbc.274.17.11811; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Vitko M, 2016, J CYST FIBROS; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	52	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175467	10.1371/journal.pone.0175467	http://dx.doi.org/10.1371/journal.pone.0175467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384265	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900172
J	Kim, MS; Kim, JY; Noh, SC; Choi, HH				Kim, Mi-sun; Kim, Ju-Young; Noh, Si-Cheol; Choi, Heung-Ho			Thermal characteristics of non-biological vessel phantoms for treatment of varicose veins using high-intensity focused ultrasound	PLOS ONE			English	Article								The ultrasonic treatment of varicose veins uses high-intensity focused ultrasound, in which a blood vessel is contracted by converting acoustic energy into thermal energy. In this study, we propose a phantom of varicose veins that can be applied for the efficient evaluation of ultrasonic treatment in varicose veins. The proposed phantom consisted of glycerol base tissue equivalent material, vessel mimic tube, and blood mimic substances. The vessel mimic tube was placed inner glycerol phantom and it was filled with blood mimic substances. Blood-mimicked substances are prepared by adjusting the concentration of the glycerol solution to be similar to the acoustic properties of the blood, and vessel-mimicking materials are selected by measuring acoustic properties and thermal shrinkage of various materials in a heat-shrinkable tube. The blood vessels surrounding the tissue are replaced with the phantom similar to glycerol-based organization, and venous blood flow is implemented using a DC motor. The heating characteristics according to the ultrasonic wave using the manufactured varicose veins phantom were evaluated. As the sound wave irradiation time and power increased, the contractility of the vessel mimicking materials and the temperature of the surrounding tissues were increased. When the blood-mimicking material was circulated, the highest temperature in the focused region and the contractility of vessel mimicking materials were reduced under the same conditions as used for sonication. The manufactured phantom may contribute to the treatment of varicose veins and can be used to predict the ultrasonic therapeutic efficiency of varicose veins.	[Kim, Mi-sun] Natl Inst Food & Drug Safety Evaluat, Med Device Evaluat Dept, Cheongju, Chungcheongbuk, South Korea; [Kim, Ju-Young; Choi, Heung-Ho] Inje Univ, Dept Biomed Engn, Gimhae, Kyoungsangnam D, South Korea; [Noh, Si-Cheol] Int Univ Korea, Dept Radiol Sci, Jinju, Kyoungsangnam D, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Inje University; International University Korea	Choi, HH (corresponding author), Inje Univ, Dept Biomed Engn, Gimhae, Kyoungsangnam D, South Korea.	hhichoi@inje.ac.kr			Research year of Inje University	Research year of Inje University	This work was supported by a grant from Research year of Inje University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dasgupta S, 2011, ULTRASONICS, V51, P171, DOI 10.1016/j.ultras.2010.07.007; FRAYNE R, 1993, MED PHYS, V20, P415, DOI 10.1118/1.597141; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Greaby R, 2007, ULTRASOUND MED BIOL, V33, P1269, DOI 10.1016/j.ultrasmedbio.2007.02.011; Henderson PW, 2010, J VASC SURG, V51, P707, DOI 10.1016/j.jvs.2009.10.049; Hoskins PR, 2007, ULTRASOUND MED BIOL, V33, P1527, DOI 10.1016/j.ultrasmedbio.2007.04.020; Huang J.-C., 2002, THESIS; Naoum JJ, 2007, VASCULAR, V15, P242, DOI 10.2310/6670.2007.00069; Petrusca L, 2009, PHYS MED BIOL, V54, P5123, DOI 10.1088/0031-9155/54/17/004; Pichardo S, 2006, ULTRASOUND MED BIOL, V32, P883, DOI 10.1016/j.ultrasmedbio.2006.02.1419; RICKEY DW, 1995, ULTRASOUND MED BIOL, V21, P1163, DOI 10.1016/0301-5629(95)00044-5; Salomir R, 2000, J MAGN RESON IMAGING, V12, P571, DOI 10.1002/1522-2586(200010)12:4<571::AID-JMRI9>3.3.CO;2-U; Senooa Naohiko, 2010, AIP C P, V1359; Ushijimaa Hiroyuki, 2010, AIP C P, V1359	14	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174922	10.1371/journal.pone.0174922	http://dx.doi.org/10.1371/journal.pone.0174922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384210	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900052
J	Klinkhamer, AJ; Wilhite, DR; White, MA; Wroe, S				Klinkhamer, Ada J.; Wilhite, D. Ray; White, Matt A.; Wroe, Stephen			Digital dissection and three-dimensional interactive models of limb musculature in the Australian estuarine crocodile (Crocodylus porosus)	PLOS ONE			English	Article							SOFT-TISSUE ANATOMY; HINDLIMB MUSCULATURE; COMPUTED-TOMOGRAPHY; ASYMMETRICAL GAITS; JAW MUSCULATURE; ALLIGATOR; EVOLUTION; RELEVANCE; LOCOMOTION; MUSCLES	Digital dissection is a relatively new technique that has enabled scientists to gain a better understanding of vertebrate anatomy. It can be used to rapidly disseminate detailed, three-dimensional information in an easily accessible manner that reduces the need for destructive, traditional dissections. Here we present the results of a digital dissection on the appendicular musculature of the Australian estuarine crocodile (Crocodylus porosus). A better understanding of this until now poorly known system in C. porosus is important, not only because it will expand research into crocodilian locomotion, but because of its potential to inform muscle reconstructions in dinosaur taxa. Muscles of the forelimb and hindlimb are described and three-dimensional interactive models are included based on CT and MRI scans as well as fresh-tissue dissections. Differences in the arrangement of musculature between C. porosus and other groups within the Crocodylia were found. In the forelimb, differences are restricted to a single tendon of origin for triceps longus medialis. For the hindlimb, a reduction in the number of heads of ambiens was noted as well as changes to the location of origin and insertion for iliofibularis and gastrocnemius externus.	[Klinkhamer, Ada J.; Wroe, Stephen] Univ New England, Funct Evolut & Anat Res Lab, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Klinkhamer, Ada J.; White, Matt A.] Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia; [Wilhite, D. Ray] Auburn Univ, Dept Anat Physiol & Pharmacol, Coll Vet Med, Auburn, AL 36849 USA; [White, Matt A.] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia	University of New England; Auburn University System; Auburn University; University of Newcastle	Klinkhamer, AJ (corresponding author), Univ New England, Funct Evolut & Anat Res Lab, Sch Environm & Rural Sci, Armidale, NSW, Australia.; Klinkhamer, AJ (corresponding author), Australian Age Dinosaurs Museum Nat Hist, Winton, Qld, Australia.	aklinkha@myune.edu.au		White, Matt/0000-0002-4765-0356; Wroe, Stephen/0000-0002-6365-5915	ARC Discovery [DP140102656, DP140102659]	ARC Discovery(Australian Research Council)	Work was supported by ARC Discovery grants to SW (DP140102656 and DP140102659).	Allen V, 2014, J ANAT, V225, P569, DOI 10.1111/joa.12245; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Baier DB, 2013, J ANATOMY WILEY ONLI, V223, P1; Bates KT, 2012, J ANAT, V220, P212, DOI 10.1111/j.1469-7580.2011.01469.x; Bonnan MF., 2001, THESIS; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Chiasson R.B., 1962, LAB ANATOMY ALLIGATO; Cox PG, 2014, PEERJ, V2, DOI 10.7717/peerj.448; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Curtis N, 2009, PALAEONTOLOGIA ELECT, V12; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Fechner R, 2009, THESIS; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; Gignac PM, 2014, J EXP ZOOL PART B, V322, P166, DOI 10.1002/jez.b.22561; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer Max Cardoso, 2003, Paleobios, V23, P1; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; Lautenschlager S, 2014, PALAEONTOL Z, V88, P111, DOI 10.1007/s12542-013-0184-2; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Materialise, 2016, MIM MED IM SEG ENG A; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Miller CE, 2008, J R SOC INTERFACE, V5, P465, DOI 10.1098/rsif.2007.1220; Otero A, 2008, AMEGHINIANA, V45, P333; Otero A, 2010, HERPETOL J, V20, P173; Parrish JM, 1987, JSTOR, P396; Pixologic, 2015, ZBRUSH 4R7; Quayle MR, 2014, PEERJ, V2, DOI 10.7717/peerj.355; Reese A. M., 1915, ALLIGATOR ITS ALLIES; Reilly SA, 2005, J EXP BIOL, V208, P993, DOI 10.1242/jeb.01473; Reilly SM, 1998, J EXP BIOL, V201, P2559; Reilly SM, 2003, J EXP BIOL, V206, P4327, DOI 10.1242/jeb.00688; Remes K, 2008, THESIS; Renous S, 2002, J ZOOL, V256, P311, DOI 10.1017/S0952836902000353; Romer AS, 1922, LOCOMOTOR APPARATUS; Romer AS., 1923, B AMNH, P48; ROWE T, 1986, J MORPHOL, V189, P327, DOI 10.1002/jmor.1051890310; Sellers W, 2013, PLOS ONE, V8, P1; Sharp AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117730; Wilhite R., 2003, THESIS; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; ZUG GR, 1974, COPEIA, P550	50	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175079	10.1371/journal.pone.0175079	http://dx.doi.org/10.1371/journal.pone.0175079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384201	Green Submitted, gold, Green Published			2022-12-26	WOS:000399371900082
J	Maritz, JM; Sullivan, SA; Prill, RJ; Aksoy, E; Scheid, P; Carlton, JM				Maritz, Julia M.; Sullivan, Steven A.; Prill, Robert J.; Aksoy, Emre; Scheid, Paul; Carlton, Jane M.			Filthy lucre: A metagenomic pilot study of microbes found on circulating currency in New York City	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SKIN; COMMUNITY; PAPER; MONEY; CONTAMINATION; SURFACES; SURVIVAL; PHONES	Background Paper currency by its very nature is frequently transferred from one person to another and represents an important medium for human contact with-and potential exchange of-microbes. In this pilot study, we swabbed circulating $1 bills obtained from a New York City bank in February (Winter) and June (Summer) 2013 and used shotgun metagenomic sequencing to profile the communities found on their surface. Using basic culture conditions, we also tested whether viable microbes could be recovered from bills. Results Shotgun metagenomics identified eukaryotes as the most abundant sequences on money, followed by bacteria, viruses and archaea. Eukaryotic assemblages were dominated by human, other metazoan and fungal taxa. The currency investigated harbored a diverse microbial population that was dominated by human skin and oral commensals, including Propionibacterium acnes, Staphylococcus epidermidis and Micrococcus luteus. Other taxa detected not associated with humans included Lactococcus lactis and Streptococcus thermophilus, microbes typically associated with dairy production and fermentation. Culturing results indicated that viable microbes can be isolated from paper currency. Conclusions We conducted the first metagenomic characterization of the surface of paper money in the United States, establishing a baseline for microbes found on $1 bills circulating in New York City. Our results suggest that money amalgamates DNA from sources inhabiting the human microbiome, food, and other environmental inputs, some of which can be recovered as viable organisms. These monetary communities may be maintained through contact with human skin, and DNA obtained from money may provide a record of human behavior and health. Understanding these microbial profiles is especially relevant to public health as money could potentially mediate interpersonal transfer of microbes.	[Maritz, Julia M.; Sullivan, Steven A.; Aksoy, Emre; Scheid, Paul; Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Prill, Robert J.] IBM Almaden Res Ctr, Accelerated Discovery Lab, San Jose, CA USA; [Aksoy, Emre] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	New York University; International Business Machines (IBM); University of California System; University of California Riverside	Carlton, JM (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	jane.carlton@nyu.edu		Maritz, Julia M./0000-0003-0116-6910	MacCracken Program in the Graduate School of Arts and Science; New York University Grand Challenge project	MacCracken Program in the Graduate School of Arts and Science; New York University Grand Challenge project	JMM is supported by the MacCracken Program in the Graduate School of Arts and Science at New York University. This study was funded by a New York University Grand Challenge project "Microbes, Sewage, Health and Disease: Mapping the New York City Metagenome" to JMC. IBM Almaden Research provided support in the form of salaries and computational resources for author RJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ABRAMS BL, 1972, J AMER MED ASSOC, V219, P1202, DOI 10.1001/jama.219.9.1202; Afshinnekoo E, 2015, CELL SYST, V1, P97, DOI 10.1016/j.cels.2015.07.006; Angelakis E, 2014, FUTURE MICROBIOL, V9, P249, DOI 10.2217/fmb.13.161; [Anonymous], 1884, NATURE; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Bik HM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00226-16; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Dawson P, 2007, J APPL MICROBIOL, V102, P945, DOI 10.1111/j.1365-2672.2006.03171.x; DeLong EF, 2004, NATURE, V428, P25, DOI 10.1038/428025a; Desroches TC, 2014, INDOOR AIR, V24, P533, DOI 10.1111/ina.12100; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; El-Dars FMSE, 2005, INT J ENVIRON HEAL R, V15, P235, DOI 10.1080/09603120500105976; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fischer G, 2003, ARCH MICROBIOL, V179, P75, DOI 10.1007/s00203-002-0495-2; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gedik H, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-22; Gibbons SM, 2015, APPL ENVIRON MICROB, V81, P765, DOI 10.1128/AEM.03117-14; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HAYDEN NJ, 1994, PLANT PATHOL, V43, P562, DOI 10.1111/j.1365-3059.1994.tb01591.x; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Hsu T, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00018-16; Hubner NO, 2011, AM J NURS, V111, P30, DOI 10.1097/01.NAJ.0000408181.37017.82; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang XP, 1999, J FOOD PROTECT, V62, P805, DOI 10.4315/0362-028X-62.7.805; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Lamichhane J., 2009, NEPAL J SCI TECHNOL, V10, P161; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lax S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0082-9; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Lund AH, 1996, NUCLEIC ACIDS RES, V24, P800, DOI 10.1093/nar/24.4.800; Mathieu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065288; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Meadow JF, 2014, PEERJ, V2, DOI 10.7717/peerj.447; Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Michaels B., 2002, Food Service Technology, V2, P1, DOI 10.1046/j.1471-5740.2002.00030.x; Ojima M, 2002, INT J ENVIRON HEAL R, V12, P41, DOI 10.1080/09603120120110040; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Palaniraj A, 2011, J FOOD ENG, V106, P1, DOI 10.1016/j.jfoodeng.2011.03.035; Pope CTW, 2002, SOUTH MED J, V95, P1408, DOI 10.1097/00007611-200295120-00011; Reserve UF, 2015, COIN CURRENCY SERVIC; Reserve UF, 2015, LONG IS LIFESPAN US; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vriesekoop F, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040042; Vriesekoop F, 2010, FOODBORNE PATHOG DIS, V7, P1497, DOI 10.1089/fpd.2010.0606; Zhang Q, 2014, RES J BIOTECHNOL, V9, P7	65	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175527	10.1371/journal.pone.0175527	http://dx.doi.org/10.1371/journal.pone.0175527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384336	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900175
J	Saudi, WSW; Sjoblom, M				Saudi, Wan Salman Wan; Sjoblom, Markus			Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats	PLOS ONE			English	Article							JEJUNUM IN-VIVO; NITRIC-OXIDE; MUCOSAL PERMEABILITY; ALCOHOL-CONSUMPTION; INTESTINAL WATER; HEART-FAILURE; L-ARGININE; RECEPTOR; ABSORPTION; EXPRESSION	Alcohol disrupts the intestinal mucosal barrier by inducing metabolic and functional changes in epithelial cells. Recently, we showed that neuropeptide S (NPS) decreases duodenal motility and increases mucosal paracellular permeability, suggesting a role of NPS in the pathogenesis of disorders and dysfunctions in the small intestine. The aim of the present study was to investigate the effects of NPS on ethanol-and HCl-induced changes of duodenal mucosal barrier function and motility. Rats were anaesthetized with thiobarbiturate, and a 30-mm segment of the proximal duodenum with an intact blood supply was perfused in situ. The effects on duodenal bicarbonate secretion, the blood-to-lumen clearance of Cr-51-EDTA, motility and transepithelial net fluid flux were investigated. Intravenous (i.v.) administration of NPS significantly reduced duodenal mucosal bicarbonate secretion and stimulated mucosal transepithelial fluid absorption, mechanisms dependent on nitrergic signaling. NPS dose-dependently reduced ethanol-induced increases in duodenal motility. NPS (83 pmol center dot kg(-1)center dot min(-1),i.v.) reduced the bicarbonate and fluid secretory response to luminal ethanol, whereas a 10-fold higher dose stimulated fluid secretion but did not influence bicarbonate secretion. In NPS-treated animals, duodenal perfusion of acid (pH 3) induced greater bicarbonate secretory rates than in controls. Pre-treating animals with N.-nitro-L-arginine methyl ester (L-NAME) inhibited the effect of NPS on bicarbonate secretion. In response to luminal acid, NPS-treated animals had significantly higher paracellular permeability compared to controls, an effect that was abolished by L-NAME. Our findings demonstrate that NPS reduces basal and ethanol-induced increases in duodenal motility. In addition, NPS increases luminal alkalinization and mucosal permeability in response to luminal acid via mechanisms that are dependent on nitric oxide signaling. The data support a role for NPS in neurohumoral regulation of duodenal mucosal barrier function and motility.	[Saudi, Wan Salman Wan; Sjoblom, Markus] Uppsala Univ, Div Physiol, Dept Neurosci, Uppsala, Sweden	Uppsala University	Sjoblom, M (corresponding author), Uppsala Univ, Div Physiol, Dept Neurosci, Uppsala, Sweden.	Markus.Sjoblom@neuro.uu.se	Saudi, Wan Salman Wan/I-5866-2016	Saudi, Wan Salman Wan/0000-0001-6424-2066; Sjoblom, Markus/0000-0002-1406-9389	Uppsala University; Ministry of Education of Malaysia; Universiti Malaysia Sabah	Uppsala University; Ministry of Education of Malaysia; Universiti Malaysia Sabah	The current study was supported by Uppsala University (MS), the Ministry of Education of Malaysia (WSWS) and the Universiti Malaysia Sabah (WSWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; [Anonymous], 2012, PHYSL GASTROINTESTIN; BARAONA E, 1974, GASTROENTEROLOGY, V66, P226; Camilleri M, 2010, GASTROENTEROLOGY, V138, P98, DOI 10.1053/j.gastro.2009.08.051; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Han RW, 2009, PEPTIDES, V30, P1313, DOI 10.1016/j.peptides.2009.03.012; ISENBERG JI, 1987, NEW ENGL J MED, V316, P374, DOI 10.1056/NEJM198702123160704; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Levitt MD, 1997, ALCOHOL CLIN EXP RES, V21, P293, DOI 10.1111/j.1530-0277.1997.tb03763.x; Levitt MD, 1997, AM J PHYSIOL-GASTR L, V273, pG951, DOI 10.1152/ajpgi.1997.273.4.G951; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; MAHER MM, 1995, J SURG RES, V58, P687, DOI 10.1006/jsre.1995.1108; MAZZANTI R, 1987, GUT, V28, P52, DOI 10.1136/gut.28.1.52; Mourad FH, 1999, GUT, V44, P143, DOI 10.1136/gut.44.2.143; Mourad FH, 1996, GUT, V39, P539, DOI 10.1136/gut.39.4.539; NYLANDER O, 1989, AM J PHYSIOL, V257, pG653; Nylander O, 2003, AM J PHYSIOL GASTROI, V285; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Petrella C, 2011, PHARMACOL RES, V64, P471, DOI 10.1016/j.phrs.2011.06.007; Pihl L, 2006, ACTA PHYSIOL, V186, P279, DOI 10.1111/j.1748-1716.2006.01559.x; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; SABABI M, 1994, AM J PHYSIOL, V266, pG22, DOI 10.1152/ajpgi.1994.266.1.G22; Saudi WSW, 2015, AM J PHYSIOL-GASTR L, V309, pG625, DOI 10.1152/ajpgi.00104.2015; SCHIRGIDEGEN A, 1995, BRIT J PHARMACOL, V114, P13, DOI 10.1111/j.1476-5381.1995.tb14899.x; SchirgiDegen A, 1996, EUR J PHARMACOL, V316, P257, DOI 10.1016/S0014-2999(96)00683-8; Sommansson A, 2014, ACTA PHYSIOL, V212, P152, DOI 10.1111/apha.12339; Sommansson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102654; Sommansson A, 2013, AM J PHYSIOL-GASTR L, V305, pG95, DOI 10.1152/ajpgi.00074.2013; Sommansson A, 2013, J PINEAL RES, V54, P282, DOI 10.1111/jpi.12013; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, P79, DOI 10.1111/j.1365-2982.2009.01366.x; Takeuchi K, 1999, J PHYSIOL PHARMACOL, V50, P155; Turvill JL, 1999, GUT, V44, P33, DOI 10.1136/gut.44.1.33; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005; Wapnir RA, 1997, GUT, V40, P602, DOI 10.1136/gut.40.5.602; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175312	10.1371/journal.pone.0175312	http://dx.doi.org/10.1371/journal.pone.0175312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384243	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900153
J	Sproule, MKJ; Chacron, MJ				Sproule, Michael K. J.; Chacron, Maurice J.			Electrosensory neural responses to natural electro-communication stimuli are distributed along a continuum	PLOS ONE			English	Article							LATERAL-LINE LOBE; RECEPTIVE-FIELD ORGANIZATION; INTERNEURON-DIVERSITY-SERIES; CA1 PYRAMIDAL NEURONS; APTERONOTUS-LEPTORHYNCHUS; DENDRITIC MORPHOLOGY; RAT HIPPOCAMPUS; GAIN-CONTROL; CELL-TYPES; FISH	Neural heterogeneities are seen ubiquitously within the brain and greatly complicate classification efforts. Here we tested whether the responses of an anatomically well-characterized sensory neuron population to natural stimuli could be used for functional classification. To do so, we recorded from pyramidal cells within the electrosensory lateral line lobe (ELL) of the weakly electric fish Apteronotus leptorhynchus in response to natural electro-communication stimuli as these cells can be anatomically classified into six different types. We then used two independent methodologies to functionally classify responses: one relies of reducing the dimensionality of a feature space while the other directly compares the responses themselves. Both methodologies gave rise to qualitatively similar results: while ON and OFF-type cells could easily be distinguished from one another, ELL pyramidal neuron responses are actually distributed along a continuum rather than forming distinct clusters due to heterogeneities. We discuss the implications of our results for neural coding and highlight some potential advantages.	[Sproule, Michael K. J.; Chacron, Maurice J.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Chacron, MJ (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	maurice.chacron@mcgill.ca		Chacron, Maurice/0000-0002-3032-452X	Natural Sciences and Engineering Research Council; Canada Research Chairs	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	This research was supported by the Natural Sciences and Engineering Research Council and the Canada Research Chairs (MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Sciences and Engineering Research Council and the Canada Research Chairs (M.J.C).	Aumentado-Armstrong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004430; Avila-Akerberg O, 2010, NEUROSCIENCE, V168, P300, DOI 10.1016/j.neuroscience.2010.03.012; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Baraban SC, 2004, TRENDS NEUROSCI, V27, P135, DOI 10.1016/j.tins.2004.01.008; Bastian J, 1999, J EXP BIOL, V202, P1327; BASTIAN J, 1986, J NEUROSCI, V6, P553; Bastian J, 2004, NEURON, V41, P767, DOI 10.1016/S0896-6273(04)00071-6; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1991, J COMP PHYSIOL A, V168, P393, DOI 10.1007/BF00199600; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; BASTIAN J, 1986, J COMP PHYSIOL A, V158, P505, DOI 10.1007/BF00603796; Berman NJ, 1999, J EXP BIOL, V202, P1243; BOCK HH, 1989, J CLASSIF, V6, P126; Bol K, 2011, J NEUROSCI, V31, P11028, DOI 10.1523/JNEUROSCI.0193-11.2011; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Chacron MJ, 2008, J NEUROPHYSIOL, V99, P1825, DOI 10.1152/jn.01266.2007; Chacron MJ, 2011, CURR OPIN NEUROBIOL, V21, P752, DOI 10.1016/j.conb.2011.05.016; Chacron MJ, 2006, J NEUROPHYSIOL, V95, P2933, DOI 10.1152/jn.01296.2005; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Clarke SE, 2015, NAT REV NEUROSCI, V16, P733, DOI 10.1038/nrn4037; Clarke SE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9764; Clarke SE, 2014, J NEUROSCI, V34, P5583, DOI 10.1523/JNEUROSCI.4988-13.2014; DAVIS TL, 1979, J COMP NEUROL, V188, P599, DOI 10.1002/cne.901880407; Deemyad T, 2013, P NATL ACAD SCI USA, V110, P19609, DOI 10.1073/pnas.1314008110; Dunteman G.H., 1989, PRINCIPAL COMPONENTS; Frank K, 1964, ELECTROPHYSIOLOGICAL, P22, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; Fusi S, 2016, CURR OPIN NEUROBIOL, V37, P66, DOI 10.1016/j.conb.2016.01.010; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; Huang CJG, 2016, J NEUROSCI, V36, P9859, DOI 10.1523/JNEUROSCI.1433-16.2016; Huang CJG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11353; Hupe GJ, 2008, J EXP BIOL, V211, P1657, DOI 10.1242/jeb.013516; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kim J.-O., 1978, INTRO FACTOR ANAL WH; Kim J-O, FACTOR ANAL STAT MET; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Krahe R, 2008, J NEUROPHYSIOL, V100, P852, DOI 10.1152/jn.90300.2008; Krahe R, 2014, CURR OPIN NEUROBIOL, V24, P13, DOI 10.1016/j.conb.2013.08.013; Long J.S., 1983, CONFIRMATORY FACTOR; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; Maler L, 2009, J COMP NEUROL, V516, P394, DOI 10.1002/cne.22120; Maler L, 2009, J COMP NEUROL, V516, P376, DOI 10.1002/cne.22124; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Mardia K.V., 1999, DIRECTIONAL STAT, DOI [10.1002/9780470316979, DOI 10.1002/9780470316979]; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marquez BT, 2013, J EXP BIOL, V216, P2442, DOI 10.1242/jeb.082370; Marsat G, 2012, CURR OPIN NEUROBIOL, V22, P686, DOI 10.1016/j.conb.2012.01.009; Marsat G, 2010, J NEUROPHYSIOL, V104, P2543, DOI 10.1152/jn.00256.2010; Marsat G, 2009, J NEUROPHYSIOL, V102, P714, DOI 10.1152/jn.91366.2008; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Mejias JF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003180; Metzen MG, 2016, ELIFE, V5, DOI 10.7554/eLife.12993; Mott DD, 2003, TRENDS NEUROSCI, V26, P484, DOI 10.1016/S0166-2236(03)00200-5; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Rabiner L., 1993, FUNDAMENTALS SPEECH; Ratanamahatana CA, 2005, P 5 SIAM INT C DAT M; Rath TM, 2003, PROC CVPR IEEE, P521; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Savard M, 2011, NEUROSCIENCE, V172, P270, DOI 10.1016/j.neuroscience.2010.10.061; SCHEICH H, 1973, J NEUROPHYSIOL, V36, P39, DOI 10.1152/jn.1973.36.1.39; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Sharpee TO, 2014, NEURON, V83, P1329, DOI 10.1016/j.neuron.2014.08.040; Simmonds B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004034; Sproule MKJ, 2015, NEUROSCI LETT, V607, P1, DOI 10.1016/j.neulet.2015.09.014; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Toporikova N, 2009, J NEUROPHYSIOL, V102, P2273, DOI 10.1152/jn.00282.2009; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tripathy SJ, 2013, P NATL ACAD SCI USA, V110, P8248, DOI 10.1073/pnas.1221214110; Vonderschen K, 2011, J NEUROPHYSIOL, V106, P3102, DOI 10.1152/jn.00588.2011; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; Zhang ZBD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28716	82	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175322	10.1371/journal.pone.0175322	http://dx.doi.org/10.1371/journal.pone.0175322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384244	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900157
J	Valdivieso, P; Toigo, M; Hoppeler, H; Fluck, M				Valdivieso, Paola; Toigo, Marco; Hoppeler, Hans; Fluck, Martin			T/T homozygosity of the tenascin-C gene polymorphism rs2104772 negatively influences exercise-induced angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN SKELETAL-MUSCLE; RAT SOLEUS MUSCLE; ANGIOTENSIN-II; BLOOD-VESSELS; TRANSCRIPT EXPRESSION; HYPERTENSIVE RATS; STRESS; TENDON; CELLS	Background Mechanical stress, including blood pressure related factors, up-regulate expression of the pro-angiogenic extracellular matrix protein tenascin-C in skeletal muscle. We hypothesized that increased capillarization of skeletal muscle with the repeated augmentation in perfusion during endurance training is associated with blood vessel-related expression of tenascin-C and would be affected by the single-nucleotide polymorphism (SNP) rs2104772, which characterizes the non-synonymous exchange of thymidine (T)-to-adenosine (A) in the amino acid codon 1677 of tenascin-C. Methods Sixty-one healthy, untrained, male white participants of Swiss descent performed thirty 30-min bouts of endurance exercise on consecutive weekdays using a cycling ergometer. Genotype and training interactions were called significant at Bonferroni-corrected p-value of 5% (repeated measures ANOVA). Results Endurance training increased capillary-to-fiber-ratio (+11%), capillary density (+7%), and mitochondrial volume density (+30%) in m. vastus lateralis. Tenascin-C protein expression in this muscle was confined to arterioles and venules (80% of cases) and increased after training in A-allele carriers. Prior to training, volume densities of subsarcolemmal and myofibrillar mitochondria in m. vastus lateralis muscle were 49% and 18%, respectively, higher in A/A homozygotes relative to T-nucleotide carriers (A/T and T/T). Training specifically increased capillary-to-fiber ratio in A-nucleotide carriers but not in T/T homozygotes. Genotype specific regulation of angiogenesis was reflected by the expression response of 8 angiogenesis-associated transcripts after exercise, and confirmed by training-induced alterations of the shear stress related factors, vimentin and VEGF A. Conclusion Our findings provide evidence for a negative influence of T/T homozygosity in rs2104772 on capillary remodeling with endurance exercise.	[Valdivieso, Paola; Toigo, Marco; Fluck, Martin] Univ Zurich, Dept Orthoped, Lab Muscle Plast, Balgrist Campus, Zurich, Switzerland; [Hoppeler, Hans; Fluck, Martin] Univ Bern, Inst Anat, Bern, Switzerland	University of Zurich; University of Bern	Fluck, M (corresponding author), Univ Zurich, Dept Orthoped, Lab Muscle Plast, Balgrist Campus, Zurich, Switzerland.; Fluck, M (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	mflueck@research.balgrist.ch		Valdivieso, Paola/0000-0001-9322-4510	Swiss National Science Foundation; RESORTHO Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); RESORTHO Foundation	Financial support was received from the Swiss National Science Foundation (HH, MF), and the RESORTHO Foundation (MF).	Alagappan VKT, 2007, CELL BIOCHEM BIOPHYS, V47, P109, DOI 10.1385/CBB:47:1:109; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; ASMUSSEN MA, 1994, GENETICS, V138, P1351; Ballard VLT, 2006, FASEB J, V20, P717, DOI 10.1096/fj.05-5131fje; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; BELLISSANT E, 1994, J CARDIOVASC PHARM, V24, P500, DOI 10.1097/00005344-199409000-00020; Bilalic S, 2012, TRANSPL IMMUNOL, V27, P101, DOI 10.1016/j.trim.2012.06.006; Busso T, 2013, EUR J APPL PHYSIOL, V113, P1279, DOI 10.1007/s00421-012-2547-x; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Chu TJ, 2008, PHYSIOL GENOMICS, V34, P185, DOI 10.1152/physiolgenomics.90201.2008; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; David S, 2013, J PHARMACOL EXP THER, V345, P2, DOI 10.1124/jpet.112.201061; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Egginton S, 1998, J APPL PHYSIOL, V85, P2025, DOI 10.1152/jappl.1998.85.6.2025; Fluck M, 2000, J CELL SCI, V113, P3583; Fluck M, 2005, AM J PHYSIOL-REG I, V289, pR4, DOI 10.1152/ajpregu.00833.2004; Fluck M, 2003, AM J PHYSIOL-REG I, V284, pR792, DOI 10.1152/ajpregu.00060.2002; Flueck M, 2011, SCAND J MED SCI SPOR, V21, P29, DOI 10.1111/j.1600-0838.2011.01339.x; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Flueck M, 2009, HIGH ALT MED BIOL, V10, P183, DOI 10.1089/ham.2008.1104; HAHN AWA, 1993, BIOCHEM BIOPH RES CO, V192, P189, DOI 10.1006/bbrc.1993.1399; HAHN AWA, 1995, J VASC RES, V32, P162, DOI 10.1159/000159090; Hoier B, 2013, EXP PHYSIOL, V98, P585, DOI 10.1113/expphysiol.2012.067967; Hoier B, 2012, J PHYSIOL-LONDON, V590, P595, DOI 10.1113/jphysiol.2011.216135; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huber-Abel FAM, 2012, EUR J APPL PHYSIOL, V112, P155, DOI 10.1007/s00421-011-1960-x; Imanaka-Yoshida K, 2014, ANAT REC, V297, P1747, DOI 10.1002/ar.22985; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Kale S, 2005, FASEB J, V19, pA306; KAYAR SR, 1988, J EXP BIOL, V137, P253; LIGHTMAN S, 1987, HYPERTENSION, V10, P390, DOI 10.1161/01.HYP.10.4.390; LIGHTNER VA, 1989, J CELL BIOL, V108, P2483, DOI 10.1083/jcb.108.6.2483; MACKIE EJ, 1992, AM J PATHOL, V141, P377; Mathes S, 2015, ANAT PHYSL S, VS5; Matsuda A, 2005, HUM MOL GENET, V14, P2779, DOI 10.1093/hmg/ddi311; McDonald DM, 2002, CANCER RES, V62, P5381; Nadar SK, 2005, J INTERN MED, V258, P336, DOI 10.1111/j.1365-2796.2005.01550.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prior BM, 1985, J APPL PHYSIOL, V2004, P1119; Saunders CJ, 2013, J ORTHOP RES, V31, P632, DOI 10.1002/jor.22278; Schnittler HJ, 1998, HISTOCHEM CELL BIOL, V110, P161, DOI 10.1007/s004180050277; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; SUTER E, 1995, INT J SPORTS MED, V16, P160, DOI 10.1055/s-2007-972985; Szczepkowska A, 2012, CELL TISSUE RES, V350, P157, DOI 10.1007/s00441-012-1431-7; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ginkel S, 2016, SCAND J MED SCI SPOR, V26, P1180, DOI 10.1111/sms.12572; van Ginkel S, SCAND J MED SCI SPOR; van Ginkel S, 2015, APPL TRANSL GENOM, V4, P33, DOI 10.1016/j.atg.2015.03.002; Vaughan D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149046; Vaughan D, 2013, EUR J APPL PHYSIOL, V113, P1719, DOI 10.1007/s00421-012-2583-6; Wagner PD, 1996, ANNU REV PHYSIOL, V58, P21, DOI 10.1146/annurev.physiol.58.1.21; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008; Zanini A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-132; Zantop T, 2003, ARCH ORTHOP TRAUM SU, V123, P501, DOI 10.1007/s00402-003-0491-2	60	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174864	10.1371/journal.pone.0174864	http://dx.doi.org/10.1371/journal.pone.0174864			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384286	Green Accepted, Green Published, gold			2022-12-26	WOS:000399371900044
J	Zhang, XZ; Wang, HZ; Lv, TY				Zhang, Xizhe; Wang, Huaizhen; Lv, Tianyang			Efficient target control of complex networks based on preferential matching	PLOS ONE			English	Article							CONTROLLABILITY; EMERGENCE	Controlling a complex network towards a desired state is of great importance in many applications. Existing works present an approximate algorithm to find the input nodes used to control partial nodes of the network. However, the input nodes obtained by this algorithm depend on the node matching order and cannot achieve optimum results. Here we present a novel algorithm to find the input nodes for target control based on preferential matching. The algorithm elaborately arranges the matching order of the nodes to reduce the size of the input node set. The results on both synthetic and real networks indicate that the proposed algorithm outperforms the previous algorithm.	[Zhang, Xizhe] Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China; [Zhang, Xizhe; Wang, Huaizhen] Northeastern Univ, Sch Comp Sci & Engn, Shenyang, Liaoning, Peoples R China; [Lv, Tianyang] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin IT CTR, Heilongjiang, Peoples R China; [Lv, Tianyang] IT Ctr, Natl Audit Off, Beijing, Peoples R China	Northeastern University - China; Northeastern University - China; Harbin Engineering University	Zhang, XZ (corresponding author), Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China.; Zhang, XZ (corresponding author), Northeastern Univ, Sch Comp Sci & Engn, Shenyang, Liaoning, Peoples R China.	zhangxizhe@mail.neu.edu.cn	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Fundamental Research Funds for the Central Universities of China [N140404011]; Natural Science Foundation of China [60903009, 71272216, 91546110]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase)	This work was supported by the Fundamental Research Funds for the Central Universities of China under grand number N140404011, the Natural Science Foundation of China under grant numbers 60903009, 71272216, 91546110, and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Handcock M.S., 2003, STATNET R PACKAGE ST; Jia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05379; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Leskovec J., 2012, ADV NEURAL INFORM PR, P539, DOI DOI 10.1109/ICDM.2012.159; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger D. G., 1979, P IEEE, V69, P1173; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V42, P285; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Murota K., 2000, MATRICES MATROIDS SY; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Piao XF, 2015, PHYSICA A, V421, P98, DOI 10.1016/j.physa.2014.10.081; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Slotine J. J. E., 2004, APPL NONLINEAR CONTR; Ulanowicz RE, 2005, NETWORK ANAL TROPHIC, P114; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang XZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38209	31	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175375	10.1371/journal.pone.0175375	http://dx.doi.org/10.1371/journal.pone.0175375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384303	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900165
J	Beaton, KH; Wong, AL; Lowen, SB; Shelhamer, M				Beaton, Kara H.; Wong, Aaron L.; Lowen, Steven B.; Shelhamer, Mark			Strength of baseline inter-trial correlations forecasts adaptive capacity in the vestibulo-ocular reflex	PLOS ONE			English	Article							MOTOR VARIABILITY; TIME-SERIES; ADAPTATION; REHABILITATION	Individual differences in sensorimotor adaptability may permit customized training protocols for optimum learning. Here, we sought to forecast individual adaptive capabilities in the vestibulo- ocular reflex (VOR). Subjects performed 400 head-rotation steps (400 trials) during a baseline test, followed by 20 min of VOR gain adaptation. All subjects exhibited mean baseline VOR gain of approximately 1.0, variable from trial to trial, and showed desired reductions in gain following adaptation with variation in extent across individuals. The extent to which a given subject adapted was inversely proportional to a measure of the strength and duration of baseline inter-trial correlations (beta). beta is derived from the decay of the autocorrelation of the sequence of VOR gains, and describes how strongly correlated are past gain values; it thus indicates how much the VOR gain on any given trial is informed by performance on previous trials. To maximize the time that images are stabilized on the retina, the VOR should maintain a gain close to 1.0 that is adjusted predominantly according to the most recent error; hence, it is not surprising that individuals who exhibit smaller a (weaker intertrial correlations) also exhibited the best adaptation. Our finding suggests that the temporal structure of baseline behavioral data contains important information that may aid in forecasting adaptive capacities. This has significant implications for the development of personalized physical therapy protocols for patients, and for other cases when it is necessary to adjust motor programs to maintain movement accuracy in response to pathological and environmental changes.	[Beaton, Kara H.; Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Wong, Aaron L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lowen, Steven B.] Harvard Med Sch, Dept Psychiat, McLean Hosp, Belmont, MA USA; [Shelhamer, Mark] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; McLean Hospital; Johns Hopkins University	Shelhamer, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.; Shelhamer, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	mjs@dizzy.med.jhu.edu		Shelhamer, Mark/0000-0002-5040-6573; Wong, Aaron/0000-0001-7211-0653	National Aeronautics and Space Administration [NNX10A019G]; National Institutes of Health [T32 EB003383]; National Science Foundation [BCS-1126957]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Aeronautics and Space Administration grant NNX10A019G (MS, KB), National Institutes of Health grant T32 EB003383 (KB), and National Science Foundation grant BCS-1126957 (MS, SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RA, 2005, ARCH NEUROL-CHICAGO, V62, P290, DOI 10.1001/archneur.62.2.290; Cass SP, 1996, AM J OTOL, V17, P581; Chaisanguanthum KS, 2014, J NEUROSCI, V34, P12071, DOI 10.1523/JNEUROSCI.3001-13.2014; Clement G, 2008, NEUROSCIENCE IN SPAC; Cohen HS., 2000, VESTIBULAR REHABILIT, V2nd ed., P373; Conrad M, 1986, CHAOS, P3; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; DEMER JL, 1989, INVEST OPHTH VIS SCI, V30, P159; Glass L., 1988, CLOCKS CHAOS RHYTHMS; HARRIS CM, 1995, VISION RES, V35, P691, DOI 10.1016/0042-6989(94)00163-G; Huang RJ, 2016, SLEEP BREATH, V20, P975, DOI 10.1007/s11325-016-1320-5; Jorns-Haderli M, 2007, J NEUROL NEUROSUR PS, V78, P1113, DOI 10.1136/jnnp.2006.109512; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; NORRE ME, 1989, OTOLARYNG HEAD NECK, V101, P14, DOI 10.1177/019459988910100104; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Schweigart G, 1997, VISION RES, V37, P1643, DOI 10.1016/S0042-6989(96)00315-X; Shelhamer M., 2006, NONLINEAR DYNAMICS I; SHUMWAYCOOK A, 1990, NEUROL CLIN, V8, P441, DOI 10.1016/S0733-8619(18)30366-9; Smith T, 2002, EVOL COMPUT, V10, P1, DOI 10.1162/106365602317301754; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; West BJ, 2013, FRACTAL PHYSIOLOGY A; Wong AL, 2014, J NEUROPHYSIOL, V111, P2084, DOI 10.1152/jn.00779.2013; Wong AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025225; Wood SJ, 2011, NEUROREHABILITATION, V29, P185, DOI 10.3233/NRE-2011-0694; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174977	10.1371/journal.pone.0174977	http://dx.doi.org/10.1371/journal.pone.0174977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380076	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500084
J	Guo, H; Wei, M; Liu, Y; Zhu, Y; Xu, WT; Meng, L; Wang, N; Shao, CW; Lu, S; Gao, FT; Cui, ZK; Wei, ZF; Zhao, FZ; Chen, SL				Guo, Hua; Wei, Min; Liu, Yang; Zhu, Ying; Xu, Wenteng; Meng, Liang; Wang, Na; Shao, Changwei; Lu, Sheng; Gao, Fengtao; Cui, Zhongkai; Wei, Zhanfei; Zhao, Fazhen; Chen, Songlin			Molecular cloning and expression analysis of the aqp1aa gene in half-smooth tongue sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							SPERM MOTILITY; WATER CHANNELS; MARINE FISH; STRUCTURAL BASIS; CELL-LINE; AQUAPORINS; EVOLUTION; TELEOSTS; SPERMATOGENESIS; ESTABLISHMENT	Aquaporin 1 (AQP1) is a member of the transmembrane water channel family of proteins with special structural features, and two AQP1 paralogous genes (aqplaa and aqplab) are reported in teleosts. In the present study, the aqplaa gene of half-smooth tongue sole (Cynoglossus semilaevis) was cloned and characterized. The full-length cDNA of aqplaa is 1411 bp with a 786 bp open reading frame encoding a 261-amino acid putative protein with a characteristic structure consisting of 6 membrane-spanning alpha-helical domains and two highly conserved asparagine proline alanine motifs. Real-time quantitative PCR revealed that aqplaa mRNA is expressed predominantly in the testis of males and pseudo males, while its expression is low in the ovary and lowest in doublesex and mab-3-related transcription factor 1 (DMRT1) knock out fish and triploid males. In situ hybridization indicated that aqplaa mRNA is expressed mainly in the germ cells of males and pseudo-males, especially in spermatozoa and spermatids. These results suggest that the aqplaa may play a role in spermatogenesis of C. semilaevis.	[Guo, Hua; Wei, Min; Liu, Yang; Zhu, Ying; Xu, Wenteng; Meng, Liang; Wang, Na; Shao, Changwei; Lu, Sheng; Gao, Fengtao; Cui, Zhongkai; Wei, Zhanfei; Zhao, Fazhen; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Guo, Hua; Cui, Zhongkai; Wei, Zhanfei; Chen, Songlin] Shanghai Ocean Univ, Coll Fisheries & Life, Shanghai, Peoples R China; [Wei, Min; Liu, Yang; Zhao, Fazhen; Chen, Songlin] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China; [Zhao, Fazhen; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Nanjing Agricultural University; Qingdao National Laboratory for Marine Science & Technology	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.; Chen, SL (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life, Shanghai, Peoples R China.; Chen, SL (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China.; Chen, SL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	chensi@ysfri.ac.cn	Xu, Wenteng/Q-1552-2018; Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; guo, hua/0000-0002-0329-0088; Meng, Liang/0000-0003-2642-8446	National Nature Science Foundation of China [31130057, 31530078, 31472269]; Taishan Scholar Climbing Project Fund of Shandong of China; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2015C03YQ01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Climbing Project Fund of Shandong of China; Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences	This work was supported by grants from National Nature Science Foundation of China (31130057, 31530078, and 31472269), Taishan Scholar Climbing Project Fund of Shandong of China, and Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2015C03YQ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Ahmadpour D, 2014, BBA-GEN SUBJECTS, V1840, P1482, DOI 10.1016/j.bbagen.2013.09.027; An KW, 2008, FISH PHYSIOL BIOCHEM, V34, P185, DOI 10.1007/s10695-007-9175-0; Boj M, 2015, BIOL BULL-US, V229, P93, DOI 10.1086/BBLv229n1p93; Boj M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131524; BROWN D, 1993, EUR J CELL BIOL, V61, P264; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chauvigne F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110783; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen SongLin, 2011, Journal of Fisheries of China, V35, P925; Cooper TG, 2003, MICROSC RES TECHNIQ, V61, P28, DOI 10.1002/jemt.10314; Cosson J, 2008, J APPL ICHTHYOL, V24, P460, DOI 10.1111/j.1439-0426.2008.01151.x; Cosson J, 2008, REPRODUCTION, V136, P277, DOI 10.1530/REP-07-0522; Cui ZK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42213; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; Dong ZD, 2016, ACTA OCEANOL SIN, V35, P19, DOI 10.1007/s13131-016-0865-2; Eddy EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; Finn RN, 2015, BIOL BULL-US, V229, P6, DOI 10.1086/BBLv229n1p6; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Fisher JS, 1998, ENDOCRINOLOGY, V139, P3935, DOI 10.1210/en.139.9.3935; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; Ishibashi K, 2013, BIOCHIM BIOPHYS ACTA, V1840, P1507; Jiang JS, 2006, J BIOL CHEM, V281, P454, DOI 10.1074/jbc.M508926200; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Li HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28219; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng L., 2014, COMPUTATIONAL SOCIAL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0107922; Mukhopadhyay R, 2014, BBA-GEN SUBJECTS, V1840, P1583, DOI 10.1016/j.bbagen.2013.11.021; Pandian TJ, 1998, HYDROBIOLOGIA, V384, P167, DOI 10.1023/A:1003332526659; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao CW, 2010, MICRON, V41, P47, DOI 10.1016/j.micron.2009.08.002; Skowronski MT, 2009, J HISTOCHEM CYTOCHEM, V57, P915, DOI 10.1369/jhc.2009.954057; Song J, 2014, BBA-GEN SUBJECTS, V1840, P1566, DOI 10.1016/j.bbagen.2013.10.014; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun A, 2015, J FISH BIOL, V86, P46, DOI 10.1111/jfb.12535; Sun Y, 2009, CLONING EXPRESSION A, V55, P335; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wintour EM, 1997, CLIN EXP PHARMACOL P, V24, P1, DOI 10.1111/j.1440-1681.1997.tb01775.x; Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062; Yool AJ, 2012, MOL ASPECTS MED, V33, P553, DOI 10.1016/j.mam.2012.02.001; Zapater C, 2013, DEV BIOL, V377, P345, DOI 10.1016/j.ydbio.2013.03.001; Zapater C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102533; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang B, 2011, INT J BIOL SCI, V7, P452, DOI 10.7150/ijbs.7.452; Zhang H, 2015, EXP NEUROL, V265, P152, DOI 10.1016/j.expneurol.2015.01.002; Zhang LY, 2014, MAR GENOM, V18, P45, DOI 10.1016/j.margen.2014.04.004; Zilli L, 2011, THERIOGENOLOGY, V76, P737, DOI 10.1016/j.theriogenology.2011.04.006; Zilli L, 2009, BIOL REPROD, V81, P880, DOI 10.1095/biolreprod.109.077933	61	11	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175033	10.1371/journal.pone.0175033	http://dx.doi.org/10.1371/journal.pone.0175033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380032	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500088
J	Hviid, MM; Skovlund, CW; Morch, LS; Lidegaard, O				Hviid, Malene Meisner; Skovlund, Charlotte Wessel; Morch, Lina Steinrud; Lidegaard, Ozvind			Maternal age and child morbidity: A Danish national cohort study	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; POPULATION-BASED COHORT; PARENTAL AGE; DELAYED CHILDBEARING; BIRTH-ORDER; PREGNANCY; RISK; MALFORMATIONS; DETERMINANTS; FERTILITY	Introduction The mean age at delivery has increased over the latest half of a century. Women of advanced maternal age have increased obstetrical risks and increased risk of chromosomal abnormalities and some other specified diagnoses in the offspring. The aim of this study was to assess the association between maternal age and overall child morbidity according to main diagnosis groups. Material and methods We conducted a national cohort study including 352 027 live firstborn singleton children. The children were born between Jan 1994 and Dec 2009 and followed to Dec 2012. Children were divided into groups according to maternal age: 15-24, 25-29, 30-34, and 35+ years. Poisson regression analyses calculated adjusted incidence rate ratios (IRR) of child morbidities according to main diagnoses groups A-Q of the International Classification of Disease 10 with adjustment for year of birth, body mass index, smoking, and mother's level of education. Results Average follow-up time was 11 years. Compared to children born to women 25 - 29 years, firstborn children to mothers aged 35+ had higher child morbidity in 8 of 19 main diagnosis groups and firstborn children to mothers 15-24 years had higher child morbidity in 12 of 19 main diagnosis groups. Thus, for a majority of diseases a U-shaped correlation was found, with lowest rates in women 25-29 years. Conclusion Firstborn children to both older and younger mothers have higher overall morbidity as compared to children born by mothers 25-29 years.	[Hviid, Malene Meisner] Zealand Univ Hosp, Dept Gynecol, Roskilde, Denmark; [Skovlund, Charlotte Wessel; Morch, Lina Steinrud; Lidegaard, Ozvind] Univ Copenhagen, Rigshosp, Dept Gynecol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hviid, MM (corresponding author), Zealand Univ Hosp, Dept Gynecol, Roskilde, Denmark.	mmhviid@gmail.com		Morch, Lina/0000-0001-6506-2569				Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; BAIRD PA, 1991, LANCET, V337, P527, DOI 10.1016/0140-6736(91)91306-F; Balasch J, 2012, CURR OPIN OBSTET GYN, V24, P187, DOI 10.1097/GCO.0b013e3283517908; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bingley PJ, 2000, BMJ-BRIT MED J, V321, P420, DOI 10.1136/bmj.321.7258.420; Blackburn CM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-101; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; CROEN LA, 1995, AM J PUBLIC HEALTH, V85, P710, DOI 10.2105/AJPH.85.5.710; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; Gilbert WM, 1999, OBSTET GYNECOL, V93, P9, DOI 10.1016/S0029-7844(98)00382-2; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goswmai S, 2015, J PEDIAT-BRAZIL, V91, P471, DOI 10.1016/j.jped.2014.09.009; Hassold T, 1984, AM J HUM GENET, P1349; Hemminki K, 1999, EPIDEMIOLOGY, V10, P271, DOI 10.1097/00001648-199905000-00014; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; Idring S, 2014, INT J EPIDEMIOL, V43, P107, DOI 10.1093/ije/dyt262; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Johnson KJ, 2009, EPIDEMIOLOGY, V20, P475, DOI 10.1097/EDE.0b013e3181a5a332; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Myrskyla M, 2012, DEMOGRAPHY, V49, P1231, DOI 10.1007/s13524-012-0132-x; Neill MO, 2013, ADV MATERNAL AGE ADV, V8, P1; Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; PRYSAK M, 1995, OBSTET GYNECOL, V85, P65, DOI 10.1016/0029-7844(94)00330-G; Salem S, 2011, SIGNIFICANT LINEAR A, P755; Salem YS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI DOI 10.1007/S00404-010-1459-4; Savage T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058869; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Sorensen NO, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0258-1; Statistikbanken. dk, 2012, AV AG 1 TIM MOTH; Stene LC, 2001, BRIT MED J, V323, P369, DOI 10.1136/bmj.323.7309.369; Yib B, 2006, INT J EPIDEMIOL, V35, P1495; Yogev Y, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.039; Ziadeh S., 2001, Archives of Gynecology and Obstetrics, V265, P30, DOI 10.1007/s004040000122	38	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174770	10.1371/journal.pone.0174770	http://dx.doi.org/10.1371/journal.pone.0174770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380000	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500063
J	Leung, C; Duclos, KK; Grunbaum, T; Cloutier, R; Angers, B				Leung, Christelle; Duclos, Kevin Karl; Grunbaum, Thomas; Cloutier, Richard; Angers, Bernard			Asymmetry in dentition and shape of pharyngeal arches in the clonal fish Chrosomus eos-neogaeus: Phenotypic plasticity and developmental instability	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DNA METHYLATION; EMBRYONIC-DEVELOPMENT; KUPFFERS VESICLE; EVOLUTION; CYPRINIDAE; PATTERNS; STRESS; PISCES; CANALIZATION	The effect of the environment may result in different developmental outcomes. Extrinsic signals can modify developmental pathways and result in alternative phenotypes (phenotypic plasticity). The environment can also be interpreted as a stressor and increase developmental instability (developmental noise). Directional and fluctuating asymmetry provide a conceptual background to discriminate between these results. This study aims at assessing whether variation in dentition and shape of pharyngeal arches of the clonal fish Chrosomus eos-neogaeus results from developmental instability or environmentally induced changes. A total of 262 specimens of the Chrosomus eos-neogaeus complex from 12 natural sites were analysed. X-ray microcomputed tomography (X-ray micro-CT) was used to visualize the pharyngeal arches in situ with high resolution. Variation in the number of pharyngeal teeth is high in hybrids in contrast to the relative stability observed in both parental species. The basal dental formula is symmetric while the most frequent alternative dental formula is asymmetric. Within one lineage, large variation in the proportion of individuals bearing basal or alternative dental formulae was observed among sites in the absence of genetic difference. Both dentition and arch shape of this hybrid lineage were explained significantly by environmental differences. Only individuals bearing asymmetric dental formula displayed fluctuating asymmetry as well as directional left-right asymmetry for the arches. The hybrids appeared sensitive to environmental signals and intraspecific variation on pharyngeal teeth was not random but reflects phenotypic plasticity. Altogether, these results support the influence of the environment as a trigger for an alternative developmental pathway resulting in left-right asymmetry in dentition and shape of pharyngeal arches.	[Leung, Christelle; Duclos, Kevin Karl; Grunbaum, Thomas; Angers, Bernard] Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Cloutier, Richard] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada	Universite de Montreal; University of Quebec	Angers, B (corresponding author), Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada.	bernard.angers@umontreal.ca	Angers, Bernard/U-9340-2019	Angers, Bernard/0000-0002-0992-140X; Cloutier, Richard/0000-0001-5780-3304	Natural Sciences and Engineering Research Council of Canada [238612, 238600]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, Discovery grant #238612 (RC) and #238600 (BA), http rAvvvvr use rc crsng gc car Protessors-Protesseurs/Grants-Subs/DGIGP- PSIGP_eng asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Angers B, 2007, MOL ECOL, V16, P4562, DOI 10.1111/j.1365-294X.2007.03511.x; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Bookstein F L, 1997, Med Image Anal, V1, P225; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Demontis D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14107; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dong GY, 2014, J APPL CLIN MED PHYS, V15, P335, DOI 10.1120/jacmp.v15i4.4956; Dryden I.L., 1998, SANKYA A, V55, P460; EASTMAN JT, 1973, COPEIA, P45; Eastman JT, 1970, THESIS; ELDER JF, 1995, P NATL ACAD SCI USA, V92, P5001, DOI 10.1073/pnas.92.11.5001; Engeman JM, 2009, J MORPHOL, V270, P291, DOI 10.1002/jmor.10688; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; EVANS HOWARD E., 1955, COPEIA, V1955, P31, DOI 10.2307/1439449; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Goddard KA, 1998, J HERED, V89, P151, DOI 10.1093/jhered/89.2.151; Goddard KA, 1989, EVOLUTION ECOLOGY UN, V466, P268; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hubbs C, 1945, PAPERS MICHIGAN ACAD, V30, P229, DOI [10.2307/1438166, DOI 10.2307/1438166]; Huysseune A, 1998, EUR J ORAL SCI, V106, P437, DOI 10.1111/j.1600-0722.1998.tb02211.x; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; Klingenberg Christian Peter, 2003, P14; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Leung C, 2016, ECOL EVOL, V6, P5234, DOI 10.1002/ece3.2283; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moller AP, 1997, ASYMMETRY DEV STABIL; Murren CJ, 2015, HEREDITY, V115, P293, DOI 10.1038/hdy.2015.8; New J. G., 1962, Copeia, V1962, P147, DOI 10.2307/1439489; Hung NM, 2015, BIOL CONTROL, V80, P156, DOI 10.1016/j.biocontrol.2014.10.001; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pasco-Viel E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2688; Pasco-Viel E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011293; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PEYER B, 1968, COMPARATIVE ODONTOLO; Qian ML, 2013, DEV BIOL, V374, P85, DOI 10.1016/j.ydbio.2012.11.022; Roff DA, 1996, Q REV BIOL, V71, P3, DOI 10.1086/419266; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SMITH RE, 1981, COPEIA, P222; STASIAK RH, 1977, COPEIA, P771; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Vergilino R, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0754-5; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	69	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174235	10.1371/journal.pone.0174235	http://dx.doi.org/10.1371/journal.pone.0174235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380079	gold, Green Submitted, Green Published			2022-12-26	WOS:000399353500037
J	Trautmann, J; Meier-Dinkel, L; Gertheiss, J; Morlein, D				Trautmann, Johanna; Meier-Dinkel, Lisa; Gertheiss, Jan; Moerlein, Daniel			Noise and accustomation: A pilot study of trained assessors' olfactory performance	PLOS ONE			English	Article							BOAR TAINT; ACUITY AFFECTS; MUSICAL NOTES; PERCEPTION; PITCH	While recent studies suggest an influence of noise on olfactory performance, it is unclear as to what extent the influence varies between subjects who are accustomed to noise and those who are not. Two groups of panelists were selected: a University panel usually working under silent conditions and an abattoir panel usually working on the slaughter line with abattoir noise. Odor discrimination, odor identification, and odor detection thresholds were studied. Furthermore, a sensory quality control task using 40 boar samples was performed. All tests were accomplished both with and without extraneous noise recorded at an abattoir (70 dB) using headphones. Contrary to the researchers' expectations, abattoir noise hardly affected the olfactory tests nor was the quality control task impaired. Abattoir noise did not influence the perceived intensity of boar taint and the classification results of the testers, regardless of whether they were accustomed to such noise or not. The results indicate that sensory quality control can be conducted in a manufacturing environment with constant noise without diminishing the assessors' performance.	[Trautmann, Johanna; Meier-Dinkel, Lisa; Moerlein, Daniel] Univ Gottingen, Dept Anim Sci, Meat Sci Grp, Gottingen, Germany; [Gertheiss, Jan] Tech Univ Clausthal, Inst Appl Stochast & Operat Res, Clausthal Zellerfeld, Germany	University of Gottingen; TU Clausthal	Morlein, D (corresponding author), Univ Gottingen, Dept Anim Sci, Meat Sci Grp, Gottingen, Germany.	daniel.moerlein@agr.uni-goettingen.de		Morlein, Daniel/0000-0001-8235-4635	Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE)	Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE)	This project (acronym STRAT-E-GER) is supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2003, LME4 PACKAGE R LINEA; Belojevic G, 2003, Noise Health, V6, P77; Core Team R R Development Core Team, 2016, LANG ENV STAT COMP; Crisinel AS, 2012, CHEM SENSES, V37, P151, DOI 10.1093/chemse/bjr085; Crisinel AS, 2010, ATTEN PERCEPT PSYCHO, V72, P1994, DOI 10.3758/APP.72.7.1994; Crisinel AS, 2009, NEUROSCI LETT, V464, P39, DOI 10.1016/j.neulet.2009.08.016; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; HOLTHANSEN K, 1968, PERCEPT MOTOR SKILL, V27, P59, DOI 10.2466/pms.1968.27.1.59; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; Lawless H. T., 2010, SENSORY EVALUATION F; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Meier-Dinkel L, 2015, MEAT SCI, V100, P73, DOI 10.1016/j.meatsci.2014.09.013; Meier-Dinkel L, 2013, MEAT SCI, V94, P19, DOI 10.1016/j.meatsci.2012.12.009; Morlein D, 2016, J AGR FOOD CHEM, V64, P4556, DOI 10.1021/acs.jafc.6b00355; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Revelle W., 2015, PSYCH PROCEDURES PER; Seo HS, 2011, EXP BRAIN RES, V212, P305, DOI 10.1007/s00221-011-2729-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SMITH A, 1986, ENVIRON BEHAV, V18, P214, DOI 10.1177/0013916586182004; Spence C, 2001, EXP BRAIN RES, V138, P432, DOI 10.1007/s002210100713; Torchiano M., 2016, EFFICIENT EFFECT SIZ; Trautmann J, 2016, MEAT SCI, V111, P92, DOI 10.1016/j.meatsci.2015.08.011; Trautmann J, 2014, MEAT SCI, V98, P255, DOI 10.1016/j.meatsci.2014.05.037; Walliczek-Dworschak U, 2016, CHEM SENSES, V41, P50, DOI 10.1093/chemse/bjw079; Weinstein N.D., 1982, J ENVIRON PSYCHOL, V2, P87, DOI [10.1016/S0272-4944(82)80041-8, DOI 10.1016/S0272-4944(82)80041-8]	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174697	10.1371/Journal.pone.0174697	http://dx.doi.org/10.1371/Journal.pone.0174697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380041	gold, Green Submitted, Green Published			2022-12-26	WOS:000399353500059
J	Bui, CM; Gardner, L; Macintyre, R; Sarkar, S				Bui, Chau Minh; Gardner, Lauren; Macintyre, Raina; Sarkar, Sahotra			Influenza A H5N1 and H7N9 in China: A spatial risk analysis	PLOS ONE			English	Article							LIVE-POULTRY MARKETS; AVIAN INFLUENZA; HUMAN INFECTION; A(H7N9) VIRUS; SAMPLE-SIZE; WILD BIRDS; SPREAD; TRANSMISSION; CLOSURE; EPIDEMIC	Background Zoonotic avian influenza poses a major risk to China, and other parts of the world. H5N1 has remained endemic in China and globally for nearly two decades, and in 2013, a novel zoonotic influenza A subtype H7N9 emerged in China. This study aimed to improve upon our current understanding of the spreading mechanisms of H7N9 and H5N1 by generating spatial risk profiles for each of the two virus subtypes across mainland China. Methods and findings In this study, we (i) developed a refined data set of H5N1 and H7N9 locations with consideration of animal/animal environment case data, as well as spatial accuracy and precision; (ii) used this data set along with environmental variables to build species distribution models (SDMs) for each virus subtype in high resolution spatial units of 1km(2) cells using Maxent; (iii) developed a risk modelling framework which integrated the results from the SDMs with human and chicken population variables, which was done to quantify the risk of zoonotic transmission; and (iv) identified areas at high risk of H5N1 and H7N9 transmission. We produced high performing SDMs (6 of 8 models with AUC > 0.9) for both H5N1 and H7N9. In all our SDMs, H7N9 consistently showed higher AUC results compared to H5N1, suggesting H7N9 suitability could be better explained by environmental variables. For both subtypes, high risk areas were primarily located in south-eastern China, with H5N1 distributions found to be more diffuse and extending more inland compared to H7N9. Conclusions We provide projections of our risk models to public health policy makers so that specific high risk areas can be targeted for control measures. We recommend comparing H5N1 and H7N9 prevalence rates and survivability in the natural environment to better understand the role of animal and environmental transmission in human infections.	[Bui, Chau Minh; Macintyre, Raina] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Gardner, Lauren] Univ New South Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia; [Macintyre, Raina] Arizona State Univ, Coll Publ Serv & Community Solut, Phoenix, AZ USA; [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA; [Sarkar, Sahotra] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of New South Wales Sydney; University of New South Wales Sydney; Arizona State University; Arizona State University-Downtown Phoenix; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bui, CM (corresponding author), Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	chau.bui@unsw.edu.au		Bui, Chau/0000-0001-9046-5810; MacIntyre, C Raina/0000-0002-3060-0555	National Health and Medical Research Council [APP1082524]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors received no specific funding for this work. This study is part of CB's PhD thesis. CB's PhD scholarship was partially (from March 2015 to June 2016) funded by the National Health and Medical Research Council, project grant number APP1082524 (https.//www.nhmrc.gov.au/) which was received by PhD supervisors: LG and RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the National Health and Medical Research Council (NHMRC), project grant number APP1082524. The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of the NHMRC.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; ANDERSON R M, 1991; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bethmont A, 2016, EPIDEMIOL INFECT, V144, P2633, DOI 10.1017/S0950268816001035; Bingsheng K, 2007, POULTRY SECTOR CHINA; Bodbyl-Roels S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-21; Bui C, 2016, TRANSBOUND EMERG DIS, V63, P602, DOI [10.1111/tbed.12327, 10.1]; Bui C, 2016, TRANSBOUND EMERG DIS; Cappelle J, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-60; Chong KC, 2016, EPIDEMIOL INFECT, V144, P1584, DOI 10.1017/S0950268815002812; Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174; Fang LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02722; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009; Ferenczi M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0308-2; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Food and Agriculture Organisation of the United Nations, 2016, EMPRES I GLOB AN DIS; Foote KE, 2014, ERROR ACCURACY PRECI; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fournie G, 2014, LANCET, V383, P496, DOI 10.1016/S0140-6736(13)62109-1; Fuller T, 2014, J INFECTION, V69, P174, DOI 10.1016/j.jinf.2014.03.006; Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Golding N, 2016, METHODS ECOL EVOL, V7, P598, DOI 10.1111/2041-210X.12523; Hayes DP, 2010, MED HYPOTHESES, V74, P831, DOI 10.1016/j.mehy.2009.12.002; He Y, 2014, EMERG INFECT DIS, V20, P1565, DOI 10.3201/eid2009.131243; Herrick KA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-42; Hill AA, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150173; Hsieh YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111834; Hu WB, 2015, ENVIRON RES, V136, P405, DOI 10.1016/j.envres.2014.07.033; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Li J, 2015, SCI REPORTS, V5; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li R, 2017, EUROSURVEILLANCE, V22, P28, DOI 10.2807/1560-7917.ES.2017.22.7.30462; Li XH, 2011, AVIAN DIS, V55, P21, DOI 10.1637/9306-031710-Reg.1; Li XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep18610; Liu ZF, 2015, INT J INFECT DIS, V41, P73, DOI 10.1016/j.ijid.2015.11.003; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Lu J, 2016, J BIOMED RES, V30, P112, DOI 10.7555/JBR.30.20150054; Magalhaes RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049712; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Minnesota Department of Agriculture, 2010, WORKSH EX DIG TERR A; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Moriguchi S, 2013, DIVERS DISTRIB, V19, P78, DOI 10.1111/ddi.12006; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Paul MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31096; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peiris JSM, 2016, LANCET INFECT DIS, V16, P252, DOI 10.1016/S1473-3099(15)00502-2; Peiris JSM, 2015, LANCET INFECT DIS; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Qiu J, 2014, PREV VET MED, V115, P229, DOI 10.1016/j.prevetmed.2014.03.030; Resource Management and Sustainable Ecosystem, RES MAN SUST EC, P707; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Saksena S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138138; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; SHORTRIDGE KF, 1982, B WORLD HEALTH ORGAN, V60, P129; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Simms L, 2014, ECOHEALTH, V11, P4, DOI 10.1007/s10393-014-0927-x; Stevens KB, 2013, SPAT SPATIO-TEMPORAL, V4, P1, DOI 10.1016/j.sste.2012.11.002; Stevens KB, 2011, SPAT SPATIO-TEMPORAL, V2, P125, DOI 10.1016/j.sste.2011.07.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Tian HY, 2015, ECOL MODEL, V306, P6, DOI 10.1016/j.ecolmodel.2014.08.005; Tuncer N, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400044; Wang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135718; Wardrop NA, 2014, GEOSPATIAL HEALTH, V9, P237, DOI 10.4081/gh.2014.397; WHO, 2021, CUMULATIVE NUMBER CO; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; Williams RAJ, 2011, GEOSPATIAL HEALTH, V5, P247, DOI 10.4081/gh.2011.177; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; World Organization of Animal Health (OIE), 2016, OIE REP; Wu P, 2014, EMERG INFECT DIS, V20, P1891, DOI 10.3201/eid2011.140556; Xu M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060600; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu Y, 2015, J VIROL, V89, P8806, DOI 10.1128/JVI.00653-15; Yuan J, 2015, EMERG INFECT DIS, V21, P1784, DOI 10.3201/eid2110.150623; Zhang Y, 2015, INT J INFECT DIS, V30, P122, DOI 10.1016/j.ijid.2014.11.010; Zhou ZY, 2014, FOOD CONSUMPTION CHI, P1; Zhu GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093390; Zou SM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-289	89	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174980	10.1371/journal.pone.0174980	http://dx.doi.org/10.1371/journal.pone.0174980			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376125	Green Published, gold, Green Submitted			2022-12-26	WOS:000399352000032
J	Elayyan, J; Lee, EJ; Gabay, O; Smith, CA; Qiq, O; Reich, E; Mobasheri, A; Henrotin, Y; Kimber, SJ; Dvir-Ginzberg, M				Elayyan, Jinan; Lee, Eun-Jin; Gabay, Odile; Smith, Christopher A.; Qiq, Omar; Reich, Eli; Mobasheri, Ali; Henrotin, Yves; Kimber, Susan J.; Dvir-Ginzberg, Mona			LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes	FASEB JOURNAL			English	Article						cartilage; osteoarthritis; inflammation; IL-10; catabolism	MESENCHYMAL STEM-CELLS; NF-KAPPA-B; ARTICULAR CHONDROCYTES; INHIBITS APOPTOSIS; MMP-13 EXPRESSION; ACTIVATING SIRT1; OSTEOARTHRITIS; CARTILAGE; PROTEIN; PATHOGENESIS	Reduced SIRT1 activity and levels during osteoarthritis (OA) promote gradual loss of cartilage. Loss of cartilage matrix is accompanied by an increase in matrix metalloproteinase (MMP) 13, partially because of enhanced LEF1 transcriptional activity. In this study, we assessed the role of SIRT1 in LEF1-mediated MMP13 gene expression in human OA chondrocytes. Results showed that MMP13 protein levels and enzymatic activity decreased significantly during SIRT1 overexpression or activation by resveratrol. Conversely, MMP13 gene expression was reduced in chondrocytes transfected with SIRT1 siRNA or treated with nicotinamide (NAM), a sirtuin inhibitor. Chondrocytes challenged with IL-113, a cytokine involved in OA pathogenesis, enhanced LEF1 protein levels and gene expression, resulting in increased MMP13 gene expression; however, overexpression of SIRT1 during IL-113 challenge impeded LEF1 levels and MMP13 gene expression. Previous reports showed that LEF1 binds to the MMP13 promoter and transactivates its expression, but we observed that SIRT1 repressed LEF1 protein and mRNA expression, ultimately reducing LEF1 transcriptional activity, as judged by luciferase assay. Finally, mouse articular cartilage from Sirt1-/presented increased LEF1 and MMP13 protein levels, similar to human OA cartilage. Thus, demonstrating for the first time that SIRT1 represses MMP13 in human OA chondrocytes, which appears to be mediated, at least in part, through repression of the transcription factor LEF1, a known modulator of MMP13 gene expression. Elayyan, J., Lee, E.-J., Gabay, O., Smith, C. A., Qiq, O., Reich, E., Mobasheri, A., Henrotin, Y., Kimber, S. J., Dvir-Ginzberg, M. LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes.	[Elayyan, Jinan; Qiq, Omar; Reich, Eli; Dvir-Ginzberg, Mona] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Lab Cartilage Biol, Hadassah Ein Kerem Campus, Jerusalem, Israel; [Lee, Eun-Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea; [Gabay, Odile] US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 1, Silver Spring, MD USA; [Smith, Christopher A.; Kimber, Susan J.] Univ Manchester, Fac Biol Med & Hlth, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Mobasheri, Ali] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Dept Vet Preclin Sci, Guildford, Surrey, England; [Mobasheri, Ali] Queens Med Ctr, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nottingham, England; [Henrotin, Yves] Univ Liege, Inst Pathol, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium	Hebrew University of Jerusalem; University of Ulsan; Asan Medical Center; US Food & Drug Administration (FDA); University of Manchester; University of Surrey; University of Nottingham; University of Liege	Dvir-Ginzberg, M (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Lab Cartilage Biol, Hadassah Ein Kerem Campus, Jerusalem, Israel.	monad@ekmd.huji.ac.il	Mobasheri, Ali/D-5770-2011; Smith, Christopher Andrew/A-7229-2015	Mobasheri, Ali/0000-0001-6261-1286; Henrotin, Yves/0000-0003-1073-449X; Smith, Christopher Andrew/0000-0001-6478-2310; Lee, Eun-Jin/0000-0001-5718-542X	Israel Science Foundation [121/12]; Rosetrees Trust [A770]; Arthritis Research UK [AR 20786]; European Commission (EU) [HEALTH.2012.2.4.5-2, 305815]; Rosetrees Trust [M447] Funding Source: researchfish; Versus Arthritis [20786] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Arthritis Research UK(Versus Arthritis); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	The authors thank the National Disease Research Interchange for providing the human cartilage tissue samples. This work was funded by Israel Science Foundation Grant 121/12 (to M.D.-G.), Rosetrees Trust Grant A770 (to M.D.-G.), Arthritis Research UK Grant AR 20786 (to S.J.K. and M.D.-G.), and the European Commission Framework 7 Programme (EU FP7; HEALTH.2012.2.4.5-2, Project 305815, Novel Diagnostics and Biomarkers for Early Identification of Chronic Inflammatory Joint Diseases; to A.M., Y.H., and M.D.-G.). The authors declare no conflicts of interest.	Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; Cheng AX, 2014, STEM CELL TRANSL MED, V3, P1287, DOI 10.5966/sctm.2014-0101; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Dvir-Ginzberg M, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0591-y; Dvir-Ginzberg M, 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI 10.1002/art.30279; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Hedbom E, 2002, CELL MOL LIFE SCI, V59, P45, DOI 10.1007/s00018-002-8404-z; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Jiang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep07456; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Lei M, 2012, EUR J PHARMACOL, V674, P73, DOI 10.1016/j.ejphar.2011.10.015; Li WY, 2015, J ORTHOP RES, V33, P1061, DOI 10.1002/jor.22859; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; VANDELOO FAJ, 1995, ARTHRITIS RHEUM, V38, P164; Wang DW, 2013, AGE, V35, P1741, DOI 10.1007/s11357-012-9474-y; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Yun K, 2007, BIOCHEM BIOPH RES CO, V357, P589, DOI 10.1016/j.bbrc.2007.03.170; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744	49	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3116	3125		10.1096/fj.201601253R	http://dx.doi.org/10.1096/fj.201601253R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28389425	Green Published, hybrid			2022-12-26	WOS:000405931000035
J	Tanaka, BS; Nguyen, PT; Zhou, EYH; Yang, Y; Yarov-Yarovoy, V; Dib-Hajj, SD; Waxman, SG				Tanaka, Brian S.; Nguyen, Phuong T.; Zhou, Eray Yihui; Yang, Yong; Yarov-Yarovoy, Vladimir; Dib-Hajj, Sulayman D.; Waxman, Stephen G.			Gain-of-function mutation of a voltage-gated sodium channel Na(V)1.7 associated with peripheral pain and impaired limb development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSED-STATE INACTIVATION; SMALL FIBER NEUROPATHY; ROOT GANGLION NEURONS; IMMUNOREACTIVE NERVES; ELECTROPHYSIOLOGICAL PROPERTIES; PRIMARY ERYTHERMALGIA; SLOW-INACTIVATION; SENSORY NEURONS; ALPHA-SUBUNIT; DRG NEURONS	Dominant mutations in voltage-gated sodium channelNa(V)1.7 cause inherited erythromelalgia, a debilitating pain disorder characterized by severe burning pain and redness of the distal extremities. Na(V)1.7 is preferentially expressed within peripheral sensory and sympathetic neurons. Here, we describe a novel Na(V)1.7 mutation in an 11-year-old male with underdevelopment of the limbs, recurrent attacks of burning pain with erythema, and swelling in his feet and hands. Frequency and duration of the episodes gradually increased with age, and relief by cooling became less effective. The patient's sister had short stature and reported similar complaints of erythema and burning pain, but with less intensity. Genetic analysis revealed a novel missense mutation in Na(V)1.7 (2567G>C; p.Gly856Arg) in both siblings. The G856R mutation, located within the DII/S4-S5 linker of the channel, substitutes a highly conserved non-polar glycine by a positively charged arginine. Voltage-clamp analysis of G856R currents revealed that the mutation hyperpolarized (-11.2 mV) voltage dependence of activation and slowed deactivation but did not affect fast inactivation, compared with wildtype channels. A mutation of Gly-856 to aspartic acid was previously found in a family with limb pain and limb underdevelopment, and its functional assessment showed hyperpolarized activation, depolarized fast inactivation, and increased ramp current. Structural modeling using the Rosetta computational modeling suite provided structural clues to the divergent effects of the substitution of Gly-856 by arginine and aspartic acid. Although the proexcitatory changes in gating properties of G856R contribute to the pathophysiology of inherited erythromelalgia, the link to limb underdevelopment is not well understood.	[Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, 333 Cedar St, New Haven, CT 06510 USA; [Tanaka, Brian S.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA; [Nguyen, Phuong T.; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Nguyen, Phuong T.; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Zhou, Eray Yihui; Yang, Yong] Peking Univ, Dept Dermatol, Hosp 1, Beijing 100034, Peoples R China; [Zhou, Eray Yihui] Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing 102218, Peoples R China	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of California System; University of California Davis; University of California System; University of California Davis; Peking University; Tsinghua University	Waxman, SG (corresponding author), VA Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res Ctr, 950 Campbell Ave,Bldg 34, West Haven, CT 06516 USA.	stephen.waxman@yale.edu	Nguyen, Phuong T./AAT-6194-2020; Zhou, Eray/HHC-3301-2022; Yarov-Yarovoy, Vladimir/ABE-5454-2020; Waxman, Stephen/Z-2507-2019	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Waxman, Stephen/0000-0001-5718-7177; Tanaka, Brian/0000-0002-6678-6478	Medical Research Service and Rehabilitation Research Service; Department of Veterans Affairs; University of California, Davis startup funds	Medical Research Service and Rehabilitation Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); University of California, Davis startup funds(University of California System)	This work was supported by the Medical Research Service and Rehabilitation Research Service, the Department of Veterans Affairs (to S.D. D.-H. and S. G. W.), and University of California, Davis startup funds (to V. Y.-Y.). The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America with Yale University. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; BEVAN S, 1985, PROC R SOC SER B-BIO, V225, P299, DOI 10.1098/rspb.1985.0063; BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X; BLACK JA, 1995, MOL BRAIN RES, V34, P89, DOI 10.1016/0169-328X(95)00141-E; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Burns TM, 2005, BRIT J DERMATOL, V153, P174, DOI 10.1111/j.1365-2133.2005.06441.x; Cheng X, 2011, BRAIN, V134, P1972, DOI 10.1093/brain/awr143; CHIU SY, 1984, NATURE, V311, P156, DOI 10.1038/311156a0; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Ding YX, 2010, BONE, V46, P1591, DOI 10.1016/j.bone.2010.02.022; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Han CY, 2015, NEUROMOL MED, V17, P158, DOI 10.1007/s12017-015-8347-9; Han CY, 2012, BRAIN, V135, P2613, DOI 10.1093/brain/aws187; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hite RK, 2014, ELIFE, V3, DOI 10.7554/eLife.04366; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7; Hurrell DJ, 1937, J ANAT, V72, P54; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stoffels M, 2016, ANNU REV GENOM HUM G, V17, P245, DOI 10.1146/annurev-genom-090413-025334; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X., 2011, 261582010 GBT STAND; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	57	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9262	9272		10.1074/jbc.M117.778779	http://dx.doi.org/10.1074/jbc.M117.778779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28381558	Green Published, hybrid			2022-12-26	WOS:000402538900021
J	Polevoda, B; Joseph, R; Friedman, AE; Bennett, RP; Greiner, R; Zoysa, T; Stewart, RA; Smith, HC				Polevoda, Bogdan; Joseph, Rebecca; Friedman, Alan E.; Bennett, Ryan P.; Greiner, Rebecca; De Zoysa, Thareendra; Stewart, Ryan A.; Smith, Harold C.			DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytidine deaminase; DNA binding protein; human immunodeficiency virus (HIV); mass spectrometry (MS); protein cross-linking; RNA; RNA binding protein; APOBEC; HIV	ANTIVIRAL PROTEIN APOBEC3G; PHOTO-CROSS-LINKING; REVERSE TRANSCRIPTION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; 7SL RNA; FUNCTIONAL-ANALYSIS; IN-VITRO; P-BODIES; ENZYME	APOBEC3G (A3G) belongs to the AID/APOBEC protein family of cytidine deaminases (CDA) that bind to nucleic acids. A3G mutates the HIV genome by deamination of dC to dU, leading to accumulation of virus-inactivating mutations. Binding to cellular RNAs inhibits A3G binding to substrate single-stranded (ss) DNA and CDA activity. Bulk RNA and substrate ssDNA bind to the same three A3G tryptic peptides (amino acids 181-194, 314-320, and 345-374) that form parts of a continuously exposed protein surface extending from the catalytic domain in the C terminus of A3G to its N terminus. We show here that the A3G tyrosines 181 and 315 directly cross-linked ssDNA. Binding experiments showed that a Y315A mutation alone significantly reduced A3G binding to both ssDNA and RNA, whereas Y181A and Y182A mutations only moderately affected A3G nucleic acid binding. Consistent with these findings, the Y315A mutant exhibited little to no deaminase activity in an Escherichia coli DNA mutator reporter, whereas Y181A and Y182A mutants retained similar to 50% of wild-type A3G activity. The Y315A mutant also showed a markedly reduced ability to assemble into viral particles and had reduced antiviral activity. In uninfected cells, the impaired RNA-binding capacity of Y315A was evident by a shift of A3G from high-molecular-mass ribonucleoprotein complexes to low-molecular-mass complexes. We conclude that Tyr-315 is essential for coordinating ssDNA interaction with or entry to the deaminase domain and hypothesize that RNA bound to Tyr-315 may be sufficient to competitively inhibit ssDNA deaminase-dependent antiviral activity.	[Polevoda, Bogdan; Joseph, Rebecca; Greiner, Rebecca; De Zoysa, Thareendra; Smith, Harold C.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Friedman, Alan E.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr AIDS Res, Rochester, NY 14642 USA; [Bennett, Ryan P.; Stewart, Ryan A.; Smith, Harold C.] OyaGen Inc, Rochester, NY 14623 USA; [Friedman, Alan E.] Univ Buffalo State Univ New York, Dept Mat Design & Innovat, Buffalo, NY 14260 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smith, HC (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Ctr RNA Biol, Rochester, NY 14642 USA.; Smith, HC (corresponding author), Univ Rochester, Med Ctr, Ctr AIDS Res, Rochester, NY 14642 USA.	harold.smith@rochester.edu	Polevoda, Bogdan/A-4880-2008; Friedman, Alan/Q-4858-2018	Friedman, Alan/0000-0002-4764-8168; Smith, Harold/0000-0001-6257-6791	National Institutes of Health [NIGMS110568]; University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health [P30 AI078498]; DeKiewiet Summer Research Fellowship in Biology and Medicine; University of Rochester, Rochester [NY 14642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health; DeKiewiet Summer Research Fellowship in Biology and Medicine; University of Rochester, Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant NIGMS110568 (to H. C. S.) and by a grant from the University of Rochester Center for AIDS Research (CFAR), a National Institutes of Health-funded program by Grant P30 AI078498.; Supported by a DeKiewiet Summer Research Fellowship in Biology and Medicine.; Supported through the Summer Undergraduate Research Fellowship Program from the University of Rochester, Rochester, NY 14642.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Belanger K, 2015, VIROLOGY, V483, P141, DOI 10.1016/j.virol.2015.04.019; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Dang Y, 2011, J VIROL, V85, P5691, DOI 10.1128/JVI.00243-11; DIETZ TM, 1987, PHOTOCHEM PHOTOBIOL, V46, P971, DOI 10.1111/j.1751-1097.1987.tb04879.x; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; GOTT JM, 1991, BIOCHEMISTRY-US, V30, P6290, DOI 10.1021/bi00239a030; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kramer K, 2014, NAT METHODS, V11, P1064, DOI [10.1038/NMETH.3092, 10.1038/nmeth.3092]; Kramer K, 2011, INT J MASS SPECTROM, V304, P184, DOI 10.1016/j.ijms.2010.10.009; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lapek JD, 2012, J CHROMATOGR B, V893, P34, DOI 10.1016/j.jchromb.2012.02.029; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Li XY, 2011, VIROLOGY, V414, P130, DOI 10.1016/j.virol.2011.03.014; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Ma JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064047; Marx A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18191; McDougall WM, 2011, BIOCHEM BIOPH RES CO, V412, P612, DOI 10.1016/j.bbrc.2011.08.009; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Pan YG, 2017, BIOCHEMISTRY-US, V56, P1473, DOI 10.1021/acs.biochem.6b01189; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polevoda B, 2016, METHODS, V107, P10, DOI 10.1016/j.ymeth.2016.03.006; Polevoda B, 2015, NUCLEIC ACIDS RES, V43, P9434, DOI 10.1093/nar/gkv970; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 2017, RNA BIOL, V14, P1153, DOI 10.1080/15476286.2016.1259783; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tian CJ, 2007, NUCLEIC ACIDS RES, V35, P7288, DOI 10.1093/nar/gkm816; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; WILLIS MC, 1994, NUCLEIC ACIDS RES, V22, P4947, DOI 10.1093/nar/22.23.4947; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; York A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005833; Zhang WY, 2010, J VIROL, V84, P12903, DOI 10.1128/JVI.01632-10	88	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8642	8656		10.1074/jbc.M116.767889	http://dx.doi.org/10.1074/jbc.M116.767889			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381554	Green Published, hybrid			2022-12-26	WOS:000402153900012
J	Zhu, J; Miao, QH; Tan, YG; Guo, HM; Liu, T; Wang, BB; Chen, ZY; Li, CF; Liu, GQ				Zhu, Jie; Miao, Qiuhong; Tan, Yonggui; Guo, Huimin; Liu, Teng; Wang, Binbin; Chen, Zongyan; Li, Chuanfeng; Liu, Guangqing			Inclusion of an Arg-Gly-Asp receptor-recognition motif into the capsid protein of rabbit hemorrhagic disease virus enables culture of the virus in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YOUNG-RABBITS; INTEGRINS; CALICIVIRUS; CELLS; ENTRY; VP60; GENE; EXPRESSION; PARTICLES; INFECTION	The fact that rabbit hemorrhagic disease virus (RHDV), an important member of the Caliciviridae family, cannot be propagated in vitro has greatly impeded the progress of investigations into the mechanisms of pathogenesis, translation, and replication of this and related viruses. In this study, we have successfully bypassed this obstacle by constructing a mutant RHDV (mRHDV) by using a reverse genetics technique. By changing two amino acids (S305R,N307D), we produced a specific receptor-recognition motif (Arg-Gly-Asp; called RGD) on the surface of the RHDV capsid protein. mRHDV was recognized by the intrinsic membrane receptor (integrin) of the RK-13 cells, which then gained entry and proliferated as well as imparted apparent cytopathic effects. After 20 passages, the titers of RHDV reached 1 x 10(4.3) 50% tissue culture infectious dose (TCID50)/ml at 72 h. Furthermore, mRHDV-infected rabbits showed typical rabbit plague symptoms and died within 48-72 h. After immunization with inactivated mRHDV, the rabbits survived wild-type RHDV infection, indicating that mRHDV could be a candidate virus strain for producing a vaccine against RHDV infection. In summary, this study offers a novel strategy for overcoming the challenges of proliferating RHDV in vitro. Because virus uptake via specific membrane receptors, several of which specifically bind to the RGD peptide motif, is a common feature of host cells, we believe that this the strategy could also be applied to other RNA viruses that currently lack suitable cell lines for propagation such as hepatitis E virus and norovirus.	[Zhu, Jie; Miao, Qiuhong; Tan, Yonggui; Guo, Huimin; Liu, Teng; Wang, Binbin; Chen, Zongyan; Li, Chuanfeng; Liu, Guangqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Liu, GQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021; Miao, Qiuhong/AAJ-1747-2020; Zhu, Jie/X-6219-2019	Miao, Qiuhong/0000-0003-3670-6227; Zhu, Jie/0000-0001-7941-4166	key research project of National Science and Technology [2016YFD0500108]; National Natural Science Foundation of China [31672572]; key project of Agricultural Science and Technology of Shanghai [2016043]; Fundamental Research Funds for the Central Institutes program [2016JB01]; Special Fund for Agro-scientific Research in the Public Interest [201303046]	key research project of National Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Agricultural Science and Technology of Shanghai; Fundamental Research Funds for the Central Institutes program; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the key research project of National Science and Technology (Grant 2016YFD0500108) (to G.L.), the National Natural Science Foundation of China (Grant 31672572) (to G.L.), the key project of Agricultural Science and Technology of Shanghai (Grant 2016043) (to G.L.), the Fundamental Research Funds for the Central Institutes program (Grant 2016JB01) (to G.L.), and the Special Fund for Agro-scientific Research in the Public Interest (Grant 201303046) (to G.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Arguello Villares JL, 1991, REV SCI TECH OIE, V10, P459; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cancellotti F.M., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P409; Carter RT, 2009, VET OPHTHALMOL, V12, P2, DOI 10.1111/j.1463-5224.2009.00726.x; Cheng YJ, 2013, ANTIVIR RES, V97, P227, DOI 10.1016/j.antiviral.2012.12.028; Cheshenko N, 2014, J VIROL, V88, P10026, DOI 10.1128/JVI.00725-14; Cordoba L, 2012, J GEN VIROL, V93, P2183, DOI 10.1099/vir.0.043711-0; CS L, 1987, KOREAN J VET RES, V27, P277; Farnos O, 2005, J BIOTECHNOL, V117, P215, DOI 10.1016/j.jbiotec.2005.01.013; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Ferreira PG, 2006, RES VET SCI, V81, P362, DOI 10.1016/j.rvsc.2006.02.001; Ferreira PG, 2004, RES VET SCI, V76, P83, DOI 10.1016/j.rvsc.2003.08.003; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gregg D A, 1991, Rev Sci Tech, V10, P435; Guo HM, 2016, ANTIVIR RES, V131, P85, DOI 10.1016/j.antiviral.2016.04.011; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Konig M, 1998, J VIROL, V72, P4492; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu GQ, 2006, J VIROL, V80, P6597, DOI 10.1128/JVI.02078-05; Liu S. J., 1984, Animal Husbandry and Veterinary Medicine (Xumu yu Shouyi), V16, P253; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Mikami D, 1999, RES VET SCI, V66, P237, DOI 10.1053/rvsc.1998.0266; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; Nystrom K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002188; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; Yoon CS, 2001, BIOCHEM BIOPH RES CO, V283, P668, DOI 10.1006/bbrc.2001.4838; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143467	44	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8605	8615		10.1074/jbc.M117.780924	http://dx.doi.org/10.1074/jbc.M117.780924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28381555	Green Published, hybrid			2022-12-26	WOS:000402153900009
J	Kass, L; Rosanoff, A; Tanner, A; Sullivan, K; McAuley, W; Plesset, M				Kass, Lindsy; Rosanoff, Andrea; Tanner, Amy; Sullivan, Keith; McAuley, William; Plesset, Michael			Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study	PLOS ONE			English	Article							BLOOD-PRESSURE; DIETARY MAGNESIUM; SUPPLEMENTATION; RISK; METAANALYSIS; EXERCISE; DISEASE	Background Oral magnesium supplementation is commonly used to support a low magnesium diet. This investigation set out to determine whether magnesium in a cream could be absorbed transdermally in humans to improve magnesium status. Methods and findings In this single blind, parallel designed pilot study, n = 25 participants (aged 34.3+/-14.8y, height 171.5+/-11cm, weight 75.9 +/- 14 Kg) were randomly assigned to either a 56mg/day magnesium cream or placebo cream group for two weeks. Magnesium serum and 24hour urinary excretion were measured at baseline and at 14 days intervention. Food diaries were recorded for 8 days during this period. Mg test and placebo groups' serum and urinary Mg did not differ at baseline. After the Mg2+ cream intervention there was a clinically relevant increase in serum magnesium (0.82 to 0.89 mmol/l,p = 0.29) that was not seen in the placebo group (0.77 to 0.79 mmol/L), but was only statistically significant (p = 0.02)) in a subgroup of non-athletes. Magnesium urinary excretion increased from baseline slightly in the Mg2+ group but with no statistical significance (p = 0.48). The Mg2+ group showed an 8.54% increase in serum Mg2+ and a 9.1% increase in urinary Mg2+ while these figures for the placebo group were smaller, i.e. +2.6% for serum Mg2+ and -32% for urinary Mg2+. In the placebo group, both serum and urine concentrations showed no statistically significant change after the application of the placebo cream. Conclusion No previous studies have looked at transdermal absorbency of Mg2+ in human subjects. In this pilot study, transdermal delivery of 56 mg Mg/day (a low dose compared with commercial transdermal Mg2+ products available) showed a larger percentage rise in both serum and urinary markers from pre to post intervention compared with subjects using the placebo cream, but statistical significance was achieved only for serum Mg2+ in a subgroup of nonathletes. Future studies should look at higher dosage of magnesium cream for longer durations.	[Kass, Lindsy; Tanner, Amy; Sullivan, Keith; McAuley, William] Univ Hertfordshire, Hatfield, Herts, England; [Rosanoff, Andrea; Plesset, Michael] Ctr Magnesium Educ & Res, Pahoa, HI USA	University of Hertfordshire	Kass, L (corresponding author), Univ Hertfordshire, Hatfield, Herts, England.	l.s.kass@herts.ac.uk	Rosanoff, Andrea/L-6869-2019	McAuley, William/0000-0003-3065-4649				Bain LKM, 2015, INT J CARDIOL, V196, P108, DOI 10.1016/j.ijcard.2015.05.166; Chen K, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600115; Cunha AR, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/754250; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; DJURHUUS MS, 1995, SCAND J CLIN LAB INV, V55, P549, DOI 10.3109/00365519509075394; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.0213; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Hostynek JJ, 2003, FOOD CHEM TOXICOL, V41, P327, DOI 10.1016/S0278-6915(02)00257-0; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Kass L, 2012, EUR J CLIN NUTR, V66, P411, DOI 10.1038/ejcn.2012.4; Laires MJ, 2008, MAGNESIUM RES, V21, P92; Larsson SC, 2013, AM J CLIN NUTR, V97, P1159, DOI 10.3945/ajcn.113.063354; Laurant P, 2000, J HYPERTENS, V18, P1177, DOI 10.1097/00004872-200018090-00003; LUKASKI HC, 1995, INT J SPORT NUTR, V5, pS74, DOI 10.1123/ijsn.5.s1.s74; Lutsey PL, 2014, AM J CLIN NUTR, V100, P756, DOI 10.3945/ajcn.114.085167; Newhouse IJ, 2000, CLIN J SPORT MED, V10, P195, DOI 10.1097/00042752-200007000-00008; Nielsen FH, 2006, MAGNESIUM RES, V19, P180; Royal College of Physicians and surgeons C, 2015, CLIN LAB TESTS REF V; Staff K, 2011, TOXICOL LETT, V202, P155, DOI 10.1016/j.toxlet.2011.01.017; Trauninger A, 2002, HEADACHE, V42, P114, DOI 10.1046/j.1526-4610.2002.02026.x; Zhang X, 2016, HYPERTENSION, V68, P324, DOI 10.1161/HYPERTENSIONAHA.116.07664	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174817	10.1371/journal.pone.0174817	http://dx.doi.org/10.1371/journal.pone.0174817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403154	Green Published, Green Submitted, gold			2022-12-26	WOS:000399955200023
J	Jia, XG; Zhu, GQ; Han, QH; Lu, ZH				Jia, Xingang; Zhu, Guanqun; Han, Qiuhong; Lu, Zuhong			The biological knowledge discovery by PCCF measure and PCA-F projection	PLOS ONE			English	Article							VISUALIZATION	In the process of biological knowledge discovery, PCA is commonly used to complement the clustering analysis, but PCA typically gives the poor visualizations for most gene expression data sets. Here, we propose a PCCF measure, and use PCA-F to display clusters of PCCF, where PCCF and PCA-F are modeled from the modified cumulative probabilities of genes. From the analysis of simulated and experimental data sets, we demonstrate that PCCF is more appropriate and reliable for analyzing gene expression data compared to other commonly used distances or similarity measures, and PCA-F is a good visualization technique for identifying clusters of PCCF, where we aim at such data sets that the expression values of genes are collected at different time points.	[Jia, Xingang] Southeast Univ, Dept Math, Nanjing 210096, Jiangsu, Peoples R China; [Jia, Xingang; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Zhu, Guanqun] Nanjing Agr Univ, Dept Chem, Nanjing 210000, Jiangsu, Peoples R China; [Han, Qiuhong] Nanjing Forestry Univ, Dept Math, Nanjing 210037, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Nanjing Agricultural University; Nanjing Forestry University	Jia, XG (corresponding author), Southeast Univ, Dept Math, Nanjing 210096, Jiangsu, Peoples R China.; Jia, XG (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	hanqh15@163.com		Lu, Zuhong/0000-0003-3332-2615				Bushati N, 2011, NUCLEIC ACIDS RES, V39, P7380, DOI 10.1093/nar/gkr462; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hinton G., 2003, ADV NEURAL INFORM PR, P857; Jaskowiak PA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S2; Kim K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-29; Limb JK, 2009, CELL MOL LIFE SCI, V66, P1962, DOI 10.1007/s00018-009-8775-5; Lotfi E, 2014, COMPUT BIOL MED, V54, P180, DOI 10.1016/j.compbiomed.2014.09.008; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanguinetti G, 2008, IEEE T PATTERN ANAL, V30, P535, DOI 10.1109/TPAMI.2007.70819; Taskesen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149853; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175104	10.1371/journal.pone.0175104	http://dx.doi.org/10.1371/journal.pone.0175104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399180	Green Published, gold, Green Submitted			2022-12-26	WOS:000399949000019
J	Kim, MS; Kim, SY; Kim, JH; Park, B; Choi, HG				Kim, Min-Su; Kim, So Young; Kim, Jin-Hwan; Park, Bumjung; Choi, Hyo Geun			Depression in breast cancer patients who have undergone mastectomy: A national cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POPULATION-BASED COHORT; MOOD DISORDERS; ANXIETY; PREVALENCE; MANAGEMENT; PRINCIPLES; SURVIVORS; SYMPTOMS; DISEASE	Objective The objective of this study was to compare the incidence of post-operative depression in breast cancer patients who have undergone mastectomy with the incidence of post-operative depression in non-breast cancer participants (controls). Methods Using data from the Korean Health Insurance Review and Assessment Service (HIRA), we selected 2,130 patients with breast cancer who have undergone mastectomy for this national cohort study and matched these patients 1:4 with 8,520 control participants according to age, sex, income, region, and pre-operative depression. The incidence of post-operative depression was measured from mastectomy year to post-op year 10. The MannWhitney U test was used for data analysis, and the false-discovery rate was applied to determine statistical significance (P < 0.05). Results The incidence of depression was higher in the breast cancer with mastectomy group than in the control group up to 3 years after mastectomy). However, there was no difference in the incidence of depression between the breast cancer with mastectomy group and the control group after post-op 4 years. The incidence of depression was higher in the breast cancer with mastectomy group than in the control group up to 2 years after mastectomy, and there was no difference in the incidence of depression between the two groups after post-op 3 years in middle-aged and older adults (>= 40 years old). In young adults (<= 39 years old), the incidence of depression was significantly higher in the breast cancer with mastectomy group than in the control group in mastectomy year. Conclusion Patients undergoing mastectomy for breast cancer experience depression more frequently than healthy people. However, patients overcome their depressive mood symptoms during the postoperative period. Young adults overcome their symptoms more quickly than middle-aged and older adults.	[Kim, Min-Su; Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Jin-Hwan; Park, Bumjung] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019; Kim, Min-Su/AAG-4346-2020	Choi, Hyo Geun/0000-0003-1655-9549; Kim, Min-Su/0000-0001-8311-4174	 [NRF-2015-R1D1A1A01060860]		This work was supported by NRF-2015-R1D1A1A01060860, http://www.nrf.re.kr/.	Agarwal M, 2011, J Assoc Physicians India, V59, P636; Anna G, 2013, SUPPORT CARE CANCER, V21, P2453, DOI 10.1007/s00520-013-1794-7; Ashing K, 2014, PSYCHO-ONCOLOGY, V23, P507, DOI 10.1002/pon.3441; Calkin CV, 2013, ANN MED, V45, P171, DOI 10.3109/07853890.2012.687835; Carota A, 2012, FRONT NEUROL NEUROSC, V30, P70, DOI 10.1159/000333413; Eskelinen M, 2015, ANTICANCER RES, V35, P2215; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Ho SSM, 2013, EUR J ONCOL NURS, V17, P877, DOI 10.1016/j.ejon.2013.04.005; Hopwood P, 2010, BREAST, V19, P84, DOI 10.1016/j.breast.2009.11.007; Huang CJ, 2012, GEN HOSP PSYCHIAT, V34, P242, DOI 10.1016/j.genhosppsych.2011.12.011; Hung YP, 2013, PSYCHO-ONCOLOGY, V22, P2227, DOI 10.1002/pon.3277; Jang JE, 2013, PSYCHO-ONCOLOGY, V22, P922, DOI 10.1002/pon.3083; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Klein D, 2011, BREAST CANCER RES TR, V129, P125, DOI 10.1007/s10549-011-1408-3; Maass SWMC, 2015, MATURITAS, V82, P100, DOI 10.1016/j.maturitas.2015.04.010; McGuire A, 2015, CANCERS, V7, P908, DOI 10.3390/cancers7020815; Ng CG, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0401-7; Qiu JY, 2013, J PSYCHOSOM OBST GYN, V34, P60, DOI 10.3109/0167482X.2013.766791; Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Service NHIS, NAT SAMPL CHORT; Spiegel D, 2015, BREAST J, V21, P97, DOI 10.1111/tbj.12355; Stewart BaW C. P, 2014, WORLD CANC REPORT 20; Suppli NP, 2014, J CLIN ONCOL, V32, P3831, DOI 10.1200/JCO.2013.54.0419; Vahdaninia M, 2010, SOC PSYCH PSYCH EPID, V45, P355, DOI 10.1007/s00127-009-0068-7; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Zainal NZ, 2013, ASIAN PAC J CANCER P, V14, P2649, DOI 10.7314/APJCP.2013.14.4.2649; Zdenkowski N, 2016, BREAST, V26, P31, DOI 10.1016/j.breast.2015.12.007	28	40	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175395	10.1371/journal.pone.0175395	http://dx.doi.org/10.1371/journal.pone.0175395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394909	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800032
J	Ha, J; Jo, K; Lim, DJ; Lee, JM; Chang, SA; Kang, MIL; Cha, BY; Kim, MH				Ha, Jeonghoon; Jo, Kwanhoon; Lim, Dong-Jun; Lee, Jung-Min; Chang, Sang-Ah; Kang, Moo I. L.; Cha, Bong Yun; Kim, Min-Hee			Parathyroid hormone and vitamin D are associated with the risk of metabolic obesity in a middle-aged and older Korean population with preserved renal function: A cross-sectional study	PLOS ONE			English	Article							INSULIN-RESISTANCE; SERUM; 25-HYDROXYVITAMIN-D; KDIGO	Background In general, obesity is a major contributor to metabolic syndrome (MetS) and is associated with insulin resistance (IR). Metabolically obese but normal weight (MONW) individuals present metabolic abnormalities and features of MetS despite having a normal range of body mass index (BMI). In recent years, different subtypes of obesity have been introduced, including metabolically healthy obese (MHO) and metabolically obese obese (MOO). Also, it has been reported that vitamin D and parathyroid hormone (PTH) are possibly linked with MetS. Methods and findings In this study, we aimed to evaluate the association between serum 25(OH) D, serum PTH, and the risk of metabolic obesity in four subtypes using nationally representative survey data for a Korean population conducted between 2008 and 2010. Of the 29,235 Korean participants, 18,997 subjects aged under 50 years were excluded. Participants with diabetes (n = 1,520), renal insufficiency (glomerular filtration rate [GFR] < 45 ml/min/1.73 m(2), chronic kidney disease [CKD] stage 3b, 4, and 5 according to KDOQI classification [1]) (n = 49), history of treatment for osteoporosis (n = 455), insufficient data (n = 1,613), and fasting time less than 8 hours prior to blood collection (n = 771) were excluded for analysis. Ultimately, 5,830 adults (2,582 men and 3,248 women) were eligible for the present study. And, subtypes of obesity were divided into four types: Metabolically healthy normal weight (MHNW), Metabolically healthy obese (MHO), Metabolically obese but normal weight (MONW), and Metabolically obese obese (MOO). Female subjects with metabolic obesity were more likely to have higher levels of PTH and Male subjects with metabolic health were more likely to have higher serum 25(OH) D levels Conclusion We concluded that a positive association between serum PTH concentration and metabolic obesity among female subjects and an inverse relationship between serum 25(OH) D levels and the risk of metabolic obesity were found among male subjects. Further prospective studies are necessary to explore the biological mechanisms underlying these sex-specific findings.	[Ha, Jeonghoon; Jo, Kwanhoon; Lim, Dong-Jun; Lee, Jung-Min; Chang, Sang-Ah; Kang, Moo I. L.; Cha, Bong Yun; Kim, Min-Hee] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea	Kim, MH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	benedict@catholic.ac.kr	Lim, Dong Jun/AAB-4011-2019; jo, kwanhoon/ABC-6723-2020; Kim, Minhee/M-1628-2019	Lim, Dong Jun/0000-0003-0995-6482; Ha, Jeonghoon/0000-0001-9219-7135				Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Body JJ, 2012, OSTEOPOROSIS INT, V23, pS1, DOI 10.1007/s00198-011-1891-8; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; de Barboza GD, 2015, WORLD J GASTROENTERO, V21, P7142, DOI 10.3748/wjg.v21.i23.7142; Ford ES, 2009, J DIABETES, V1, P296, DOI 10.1111/j.1753-0407.2009.00046.x; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002; Geetha Loganathan, 2011, J Diabetes Sci Technol, V5, P439; George JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061282; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; HEANEY RP, 1989, J BONE MINER RES, V4, P469; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Ito H, 2012, J DIABETES COMPLICAT, V26, P286, DOI 10.1016/j.jdiacomp.2012.04.011; Kim J, 2015, EUR J CLIN NUTR, V69, P425, DOI 10.1038/ejcn.2014.192; Kim J, 2013, J HUM NUTR DIET, V26, P171, DOI 10.1111/jhn.12098; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lee SH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.46; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muntner P, 2009, CLIN J AM SOC NEPHRO, V4, P186, DOI 10.2215/CJN.03050608; Need AG, 2000, AM J CLIN NUTR, V71, P1577; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Zammit AR, 2016, CARDIORENAL MED, V6, P108, DOI 10.1159/000441624	32	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175132	10.1371/journal.pone.0175132	http://dx.doi.org/10.1371/journal.pone.0175132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384340	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900096
J	Patsch, JM; Rasul, S; Huber, FA; Leitner, K; Thomas, A; Kocijan, R; Boutroy, S; Weber, M; Resch, H; Kainberger, F; Schuller-Weidekamm, C; Kautzky-Willer, A				Patsch, Janina M.; Rasul, Sazan; Huber, Florian A.; Leitner, Karoline; Thomas, Anita; Kocijan, Roland; Boutroy, Stephanie; Weber, Michael; Resch, Heinrich; Kainberger, Franz; Schueller-Weidekamm, Claudia; Kautzky-Willer, Alexandra			Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus	PLOS ONE			English	Article							BONE MICROARCHITECTURE; POSTMENOPAUSAL WOMEN; DISTAL RADIUS; AGE; DENSITY; RISK; BMD; ASSOCIATION; TURNOVER; FRACTURE	The goal of our study was to investigate interactions between sex and type 2 diabetes mellitus (T2DM) with regard to morphology of the peripheral skeleton. We recruited 85 subjects (mean age, 57 +/- 11.4 years): women with and without T2DM (n = 17; n = 16); and men with and without T2DM (n = 26; n = 26). All patients underwent high-resolution, peripheral, quantitative, computed tomography (HR-pQCT) imaging of the ultradistal radius (UR) and tibia (UT). Local bone geometry, bone mineral density (BMD), and bone microarchitecture were obtained by quantitative analysis of HR-pQCT images. To reduce the amount of data and avoid multi-collinearity, we performed a factor-analysis of HR-pQCT parameters. Based on factor weight, trabecular BMD, trabecular number, cortical thickness, cortical BMD, and total area were chosen for post-hoc analyses. At the radius and tibia, diabetic men and women exhibited trabecular hypertrophy, with a significant positive main effect of T2DM on trabecular number. At the radius, cortical thickness was higher in diabetic subjects (+20.1%, p = 0.003). Interestingly, there was a statistical trend that suggested attenuation of tibial cortical hypertrophy in diabetic men (cortical thickness, p(interaction) = 0.052). Moreover, we found an expected sexual dichotomy, with higher trabecular BMD, Tb. N, cortical BMD, Ct. Th, and total area in men than in women (p <= 0.003) at both measurement sites. Our results suggest that skeletal hypertrophy associated with T2DM is present in men and women, but appears attenuated at the tibial cortex in men.	[Patsch, Janina M.; Huber, Florian A.] Med Univ Vienna, Div Gen Radiol & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Rasul, Sazan] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Leitner, Karoline; Thomas, Anita; Kautzky-Willer, Alexandra] Med Univ Vienna, Gender Med Unit, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Kocijan, Roland] St Vincent Hosp Vienna, Karl Landsteiner Inst Rheumatol & Gastroenterol, Dept Internal Med 2, Vienna, Austria; [Boutroy, Stephanie] Univ Lyon, INSERM, Res Unit 831, Lyon, France; [Weber, Michael] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Kainberger, Franz; Schueller-Weidekamm, Claudia] Med Univ Vienna, Div Neuroradiol & Musculoskeletal Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Vienna; Medical University of Vienna	Patsch, JM (corresponding author), Med Univ Vienna, Div Gen Radiol & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	janina.patsch@meduniwien.ac.at	Rasul, Sazan/AAX-4248-2021; Patsch, Janina M/AAF-6040-2019; Weber, Michael/L-9836-2016	Patsch, Janina M/0000-0002-5936-5608; Thomas, Anita/0000-0002-1679-3098; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Weber, Michael/0000-0002-8507-2219; Rasul, Sazan/0000-0003-2898-3232				Baker JF, 2013, BONE, V53, P34, DOI 10.1016/j.bone.2012.11.035; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Bouxsein ML, 2009, BEST PRACT RES CL RH, V23, P741, DOI 10.1016/j.berh.2009.09.008; Burghardt AJ, 2010, OSTEOPOROSIS INT, V21, P45; Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226; Chaitou A, 2010, J BONE MINER RES, V25, P2313, DOI 10.1002/jbmr.124; Cohen A, 2010, OSTEOPOROSIS INT, V21, P263, DOI 10.1007/s00198-009-0945-7; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Davis KA, 2007, CALCIFIED TISSUE INT, V81, P364, DOI 10.1007/s00223-007-9076-3; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Farr JN, 2016, BONE, V82, P28, DOI 10.1016/j.bone.2015.07.027; Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901; Heilmeier U, 2015, OSTEOPOROSIS INT, V26, P1283, DOI 10.1007/s00198-014-2988-7; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Karim L, 2016, BONE, V82, P21, DOI 10.1016/j.bone.2015.07.028; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Liu XS, 2010, J BONE MINER RES, V25, P2229, DOI 10.1002/jbmr.111; Macdonald HM, 2011, J BONE MINER RES, V26, P50, DOI 10.1002/jbmr.171; Marshall LM, 2006, J BONE MINER RES, V21, P1197, DOI 10.1359/JBMR.060506; Paccou J, 2016, CALCIFIED TISSUE INT, V98, P465, DOI 10.1007/s00223-015-0100-8; Patsch JM, 2014, BONE, V58, P42, DOI 10.1016/j.bone.2013.08.006; Patsch JM, 2011, J BONE MINER RES, V26, P1584, DOI 10.1002/jbmr.344; Patsch JM, 2012, J BONE MINER RES; Pialat JB, 2011, BONE; PIETSCHMANN P, 1988, DIABETOLOGIA, V31, P892; Pritchard JM, 2012, ARTHRIT CARE RES, V64, P83, DOI 10.1002/acr.20602; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Rubin MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.1; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Shanbhogue VV, 2016, EUR J ENDOCRINOL, V174, P115, DOI 10.1530/EJE-15-0860; Shanbhogue VV, 2016, J CLIN ENDOCR METAB; Shu A, 2011, OSTEOPOROS INT; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vico L, 2008, J BONE MINER RES, V23, P1741, DOI 10.1359/JBMR.080704; Yu EW, 2014, OSTEOPOROS INT	42	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174664	10.1371/journal.pone.0174664	http://dx.doi.org/10.1371/journal.pone.0174664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384358	gold, Green Published, Green Submitted			2022-12-26	WOS:000399371900024
J	Sherry-Lynes, MM; Sengupta, S; Kulkarni, S; Cochran, BH				Sherry-Lynes, Maureen M.; Sengupta, Sejuti; Kulkarni, Shreya; Cochran, Brent H.			Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3	PLOS ONE			English	Article							GENE-EXPRESSION; H3K27 DEMETHYLASE; INK4A/ARF LOCUS; SELF-RENEWAL; CANCER; DIFFERENTIATION; METHYLATION; ACTIVATION; TARGET; EZH2	The growth factor and cytokine regulated transcription factor STAT3 is required for the self-renewal of several stem cell types including tumor stem cells from glioblastoma. Here we show that STAT3 inhibition leads to the upregulation of the histone H3K27me2/3 demethylase Jmjd3 (KDM6B), which can reverse polycomb complex-mediated repression of tissue specific genes. STAT3 binds to the Jmjd3 promoter, suggesting that Jmjd3 is a direct target of STAT3. Overexpression of Jmjd3 slows glioblastoma stem cell growth and neurosphere formation, whereas knockdown of Jmjd3 rescues the STAT3 inhibitor-induced neurosphere formation defect. Consistent with this observation, STAT3 inhibition leads to histone H3K27 demethylation of neural differentiation genes, such as Myt1, FGF21, and GDF15. These results demonstrate that the regulation of Jmjd3 by STAT3 maintains repression of differentiation specific genes and is therefore important for the maintenance of self-renewal of normal neural and glioblastoma stem cells.	[Cochran, Brent H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell & Mol Physiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University; Tufts University	Cochran, BH (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Grad Program Cell & Mol Physiol, Boston, MA 02111 USA.	Brent.cochran@tufts.edu	sengupta, sejuti/C-7137-2019	sengupta, sejuti/0000-0002-1019-2785; Cochran, Brent/0000-0002-7598-5604	NIH [R01NS072414]; Tufts University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243, R01NS072414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH R01NS072414 to BHC. Details can be found by searching https://projectreporter.nih.gov/reporter. cfm. Additional funding was provided by Tufts University.There was no additional external funding received for this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank G. Testa for shRNA to Jmjd3, Y. Shi for anti-Jmjd3 antibodies, P. Khavari for the Jmjd3 retroviral vectors obtained from Addgene, and H. Wakimoto for the MGG8 cell line. S3I-201 (NSC 74859) and STA-21 (NSC 628869) inhibitors were obtained from the NCI/DTP Open Chemical Repository (http://dtp.cancer.gov). The Tufts Neuroscience Core (P30 NS047243) provided the Stratagene qPCR machine. We thank J. Wu and A. Yee for critical reading of the manuscript. This work was supported in part by NIH R01NS072414 to BHC.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Carrillo-Garcia C, 2014, DEVELOPMENT, V141, P773, DOI 10.1242/dev.096131; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; de Vries NA, 2015, CELL REPORTS; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Gallo M, 2015, CANCER CELL, V28, P715, DOI 10.1016/j.ccell.2015.10.005; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Huang XH, 2013, BRAIN RES, V1530, P13, DOI 10.1016/j.brainres.2013.07.043; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Karolchik D., 2009, UCSC GENOME BROWSER; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li GH, 2010, INT J ONCOL, V37, P103, DOI 10.3892/ijo_00000658; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marei HES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028420; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rajan P, 1998, J NEUROSCI, V18, P3620; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Urayama S, 2013, CELL STRUCT FUNCT, V38, P55, DOI 10.1247/csf.12034; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Venneti S, 2013, BRIAN PATHOLOGY ZURI; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang L, 2004, MOL ENDOCRINOL, V18, P1520, DOI 10.1210/me.2003-0458; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang JX, 2015, CANCER LETT, V356, P929, DOI 10.1016/j.canlet.2014.11.003; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	81	34	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174775	10.1371/journal.pone.0174775	http://dx.doi.org/10.1371/journal.pone.0174775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384648	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900035
J	Bromag, DI; Taferner, S; Pillar, M; Yellen, DM; Davidsonr, SM				Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.			A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies	PLOS ONE			English	Article							STEM-CELL RECRUITMENT; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; G-CSF; CXCR4 EXPRESSION; SDF-1-CXCR4 AXIS; HEART-FAILURE; FACTOR-1-ALPHA; MOBILIZATION; SDF-1-ALPHA	Background Stromal derived factor-1 alpha (SDF-1 alpha/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemia applied remote from the heart that protects the heat from lethal ischaemia-reperfusion injury. Accordingly, there is considerable interest in SDF-1 alpha as a potential biomarker of such conditions. However, SDF-1 alpha is rapidly degraded and inactivated by dipeptidyl peptidase 4 and other peptidases, and the kinetics of intact SDF-1 alpha remain unknown. Methods & results To facilitate investigation of full-length SDF-1 alpha we established an ELISA using a novel recombinant human antibody we developed called HCI.SDF1. HCI.SDF1 is specific to the N-terminal sequence of all isoforms of SDF-1 and has a comparable KD to commercially available antibodies. Together with a detection antibody specific to the a-isoform, HCI.SDF1 was used to specifically quantify full-length SDF-1 alpha in blood for the first time. Using RIC applied to the hind limb of Sprague-Dawley rats or the arms of healthy human volunteers, we demonstrate an increase in SDF-1 alpha using a commercially available antibody, as previously reported, but an unexpected decrease in full-length SDF-1 alpha after RIC in both species. Conclusions We report for the first time the development of a novel recombinant antibody specific to fulllength SDF-1. Applied to RIC, we demonstrate a significant decrease in SDF-1 alpha that is at odds with the literature and suggests a need to investigate the kinetics of full-length SDF-1 alpha in conditions characterised by tissue hypoxia.	[Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.] UCL, Hatter Cardiovasc Inst, London, England; [Bromage, Daniel I.; Taferner, Stasa; Pillar, Mahesh; Yellen, Derek M.; Davidsonr, Sean M.] Lambeth Wing St Thomas Hosp, Rayne Inst, London, England	University of London; University College London; University of London; King's College London	Davidsonr, SM (corresponding author), UCL, Hatter Cardiovasc Inst, London, England.; Davidsonr, SM (corresponding author), Lambeth Wing St Thomas Hosp, Rayne Inst, London, England.	s.davidson@ucl.ac.uk	Davidson, Sean M/F-5275-2010; Yellon, Derek M/ABD-5110-2021	Davidson, Sean M/0000-0001-5182-4980; Bromage, Daniel/0000-0002-4243-5964; Yellon, Derek/0000-0001-7791-9320	British Heart Foundation (BHF) [PG/15/52/31598]; National Institute of Health Research University College London Hospital Biomedical Research Council [BRC233/CM/SD/101320]; MRC Clinical Research Training Fellow [MR/L002043/1]; Department of Health's NIHR Biomedical Research Centres; MRC [MR/L002043/1] Funding Source: UKRI; Medical Research Council [MR/L002043/1] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); National Institute of Health Research University College London Hospital Biomedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Research Training Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the British Heart Foundation (BHF PG/15/52/31598) and National Institute of Health Research University College London Hospital Biomedical Research Council (BRC233/CM/SD/101320). Dr. Daniel Bromage is an MRC Clinical Research Training Fellow (grant MR/L002043/1). This work was undertaken at UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baerts L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141408; Chang LT, 2009, CIRC J, V73, P1097, DOI 10.1253/circj.CJ-08-0497; Chatterjee M, 2013, J THROMBOSIS HAEMOST; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Damas JK, 2002, CIRCULATION, V106, P36, DOI 10.1161/01.CIR.0000020001.09990.90; Davidson SM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0377-6; Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Fortunato O, 2013, CARDIOVASC RES, V100, P192, DOI 10.1093/cvr/cvt153; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Gray AC, 2016, SCIENCE, V353, P452, DOI 10.1126/science.aag3305; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jiang Q, 2013, J MOL CELL CARDIOL, V56, P1, DOI 10.1016/j.yjmcc.2012.12.016; Jung C, 2009, PEDIATR DIABETES, V10, P329, DOI 10.1111/j.1399-5448.2008.00486.x; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kanki S, 2011, CIRC-HEART FAIL, V4, P509, DOI 10.1161/CIRCHEARTFAILURE.110.960302; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim BS, 2016, J CARDIOVASC TRANSL, V9, P230, DOI 10.1007/s12265-016-9689-x; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Leone AM, 2006, INT J CARDIOL, V111, P202, DOI 10.1016/j.ijcard.2005.06.043; Liu KP, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/510618; Malik A., 2015, CARDIOVASC DRUGS THE; Matsuoka S, 2017, J CARDIOL, V69, P320, DOI 10.1016/j.jjcc.2016.06.011; Mehta NN, 2014, EUR HEART J, V35, P2115, DOI 10.1093/eurheartj/eht481; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Subramanian S, 2014, ARTERIOSCL THROM VAS, V34, P2100, DOI 10.1161/ATVBAHA.114.303579; Theiss HD, 2013, INT J CARDIOL, V168, P3359, DOI 10.1016/j.ijcard.2013.04.121; Tong GX, 2014, INT HEART J, V55, P219, DOI 10.1536/ihj.13-289; Wang WX, 2014, J AM SOC MASS SPECTR, V25, P614, DOI 10.1007/s13361-013-0822-7; Yamani MH, 2005, J AM COLL CARDIOL, V46, P1029, DOI 10.1016/j.jacc.2005.04.059; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174447	10.1371/journal.pone.0174447	http://dx.doi.org/10.1371/journal.pone.0174447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379992	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500047
J	Hakimian, J; Minasyan, A; Zhe-Ying, L; Loureiro, M; Beltrand, A; Johnston, C; Vorperian, A; Romaneschi, N; Atallah, W; Gomez-Pinilla, F; Walwyn, W				Hakimian, Joshua; Minasyan, Ani; Zhe-Ying, Lily; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Gomez-Pinilla, Fernando; Walwyn, Wendy			Specific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; DOCOSAHEXAENOIC ACID; NUCLEUS-ACCUMBENS; COGNITIVE IMPAIRMENT; DOPAMINE NEURONS; DRUG-ADDICTION; N-3 PUFAS; BRAIN; COCAINE; OMEGA-3-FATTY-ACIDS	Opiates, one of the oldest known drugs, are the benchmark for treating pain. Regular opioid exposure also induces euphoria making these compounds addictive and often misused, as shown by the current epidemic of opioid abuse and overdose mortalities. In addition to the effect of opioids on their cognate receptors and signaling cascades, these compounds also induce multiple adaptations at cellular and behavioral levels. As omega-3 polyunsaturated fatty acids (n-3 PUFAs) play a ubiquitous role in behavioral and cellular processes, we proposed that supplemental n-3 PUFAs, enriched in docosahexanoic acid (DHA), could offset these adaptations following chronic opioid exposure. We used an 8 week regimen of n-3 PUFA supplementation followed by 8 days of morphine in the presence of this diet. We first assessed the effect of morphine in different behavioral measures and found that morphine increased anxiety and reduced wheel-running behavior. These effects were reduced by dietary n-3 PUFAs without affecting morphine-induced analgesia or hyperlocomotion, known effects of this opiate acting at mu opioid receptors. At the cellular level we found that morphine reduced striatal DHA content and that this was reversed by supplemental n-3 PUFAs. Chronic morphine also increased glutamatergic plasticity and the proportion of Grin2B-NMDARs in striatal projection neurons. This effect was similarly reversed by supplemental n-3 PUFAs. Gene analysis showed that supplemental PUFAs offset the effect of morphine on genes found in neurons of the dopamine receptor 2 (D2)-enriched indirect pathway but not of genes found in dopamine receptor 1(D1)-enriched direct-pathway neurons. Analysis of the D2 striatal connectome by a retrogradely transported pseudorabies virus showed that n-3 PUFA supplementation reversed the effect of chronic morphine on the innervation of D2 neurons by the dorsomedial prefontal and piriform cortices. Together these changes outline specific behavioral and cellular effects of morphine that can be reduced or reversed by dietary n-3 PUFAs.	[Hakimian, Joshua; Minasyan, Ani; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Walwyn, Wendy] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Hakimian, Joshua; Minasyan, Ani; Zhe-Ying, Lily; Loureiro, Mariana; Beltrand, Austin; Johnston, Camille; Vorperian, Alexander; Romaneschi, Nicole; Atallah, Waleed; Gomez-Pinilla, Fernando; Walwyn, Wendy] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Zhe-Ying, Lily; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Integrat Biol & Physiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Walwyn, W (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Walwyn, W (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	wwalwyn@g.ucla.edu		Johnston, Camille/0000-0001-9217-8647; Walwyn, Wendy/0000-0001-8101-2844; Hakimian, Joshua/0000-0003-2712-6204; Beltrand, Austin/0000-0002-3644-5488	Shirley and Stefan Hatos Foundation [NIDA: DA005010, NINDS:NS0504650, NIH:P40RR01860]; NIH Virus Center grant [P40RR01860]	Shirley and Stefan Hatos Foundation; NIH Virus Center grant	Support was provided by Shirley and Stefan Hatos Foundation (NIDA: DA005010, NINDS:NS0504650, NIH:P40RR01860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Dr. David Pena and Maxwell Roth for assistance with the cell counting technique and program. The pseudorabies virus was provided by Dr Lynn Enquist and supported by the NIH Virus Center grant P40RR01860.	Almeida DM, 2015, NUTR NEUROSCI; [Anonymous], 2016, F1000RES; Banerjee G, 2016, ADDICTION, V111, P2021, DOI 10.1111/add.13491; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; Bozzatello P, 2016, J CLIN MED, V5, DOI 10.3390/jcm5080067; Buydens-Branchey L, 2003, DRUG ALCOHOL DEPEN, V71, P319, DOI 10.1016/S0376-8716(03)00168-6; Buydens-Branchey L, 2008, PSYCHIAT RES, V157, P95, DOI 10.1016/j.psychres.2007.01.004; Buydens-Branchey L, 2009, AM J ADDICTION, V18, P73, DOI 10.1080/10550490802544003; Cahill CM, 2016, TRENDS PHARMACOL SCI, V37, P963, DOI 10.1016/j.tips.2016.08.002; Cansev M, 2016, NEUROMOL MED, V18, P426, DOI 10.1007/s12017-016-8414-x; Card J.P., 2014, CURR PROTOC NEUROSCI, V68, P1; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen LH, 2012, CELL SIGNAL, V24, P1565, DOI 10.1016/j.cellsig.2012.03.016; Chen XL, 2007, CELL RES, V17, P689, DOI 10.1038/cr.2007.63; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Compton WM, 2016, NEW ENGL J MED, V374, P1296, DOI 10.1056/NEJMc1601875; Cunha-Oliveira T, 2007, J NEUROCHEM, V101, P543, DOI 10.1111/j.1471-4159.2006.04406.x; Cunha-Oliveira T, 2013, LIFE SCI, V92, P1157, DOI 10.1016/j.lfs.2013.04.016; Cunha-Oliveira T, 2013, TOXICOL LETT, V219, P298, DOI 10.1016/j.toxlet.2013.03.025; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Dasgupta N, 2014, DRUG ALCOHOL DEPEN, V145, P238, DOI 10.1016/j.drugalcdep.2014.10.005; de Vera IMS, 2016, ACS CHEM BIOL, V11, P1795, DOI 10.1021/acschembio.6b00037; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Enoksson T, 2012, NEUROPHARMACOLOGY, V62, P2463, DOI 10.1016/j.neuropharm.2012.02.020; Erdtmann-Vourliotis M, 1998, MOL BRAIN RES, V61, P51, DOI 10.1016/S0169-328X(98)00197-1; Guo QC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123381; HERON DS, 1982, BIOCHEM PHARMACOL, V31, P2435, DOI 10.1016/0006-2952(82)90543-3; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hoback Jane, 2016, State Legis, V42, P9; Huang CT, 2016, J NUTR BIOCHEM, V29, P97, DOI 10.1016/j.jnutbio.2015.11.009; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Jacobs EH, 2005, EUR J PHARMACOL, V511, P27, DOI 10.1016/j.ejphar.2005.02.009; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Jiang C, 2015, EUR J PAIN, V19, P908, DOI 10.1002/ejp.617; Jones CR, 1996, J NEUROCHEM, V67, P822; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2015, EUR J PHARMACOL, V753, P73, DOI 10.1016/j.ejphar.2014.11.044; Kuhn FT, 2015, NEUROTOX RES, V28, P319, DOI 10.1007/s12640-015-9549-5; Larance B, 2015, J SUBST ABUSE TREAT, V58, P51, DOI 10.1016/j.jsat.2015.06.001; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lesperance F, 2011, J CLIN PSYCHIAT, V72, P1054, DOI 10.4088/JCP.10m05966blu; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Lowe AS, 2002, NEUROIMAGE, V17, P902, DOI 10.1006/nimg.2002.1251; Mazzocchi-Jones D, 2015, BRAIN RES BULL, V111, P69, DOI 10.1016/j.brainresbull.2014.12.010; McNamara RK, 2008, SYNAPSE, V62, P725, DOI 10.1002/syn.20542; Miladi-Gorji H, 2012, PHYSIOL BEHAV, V105, P195, DOI 10.1016/j.physbeh.2011.08.010; Miller EC, 2012, MOL PHARMACOL, V82, P333, DOI 10.1124/mol.112.078162; Moniri NH, 2016, BIOCHEM PHARMACOL, V110, P1, DOI 10.1016/j.bcp.2016.01.021; MORABIA A, 1989, BRIT J ADDICT, V84, P173; Pal A, 2013, NEUROCHEM INT, V62, P956, DOI 10.1016/j.neuint.2013.03.011; Pifferi F, 2015, J LIPID RES, V56, P1511, DOI 10.1194/jlr.M058933; Pusceddu MM, 2015, PSYCHONEUROENDOCRINO, V58, P79, DOI 10.1016/j.psyneuen.2015.04.015; Robinson TE, 1999, SYNAPSE, V33, P160; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Rudd R. A., 2016, INCREASES DRUG OPIOI; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; SAMHSA, 2012, RES 2011 NAT SURV DR; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Sidhu VK, 2011, J PROTEOME RES, V10, P5472, DOI 10.1021/pr2007285; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Suzuki H, 1997, INT J VITAM NUTR RES, V67, P272; Taylor AMW, 2015, J NEUROSCI, V35, P8442, DOI 10.1523/JNEUROSCI.4036-14.2015; Trivedi MS, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00444; Trofimiuk E, 2013, PHYSIOL BEHAV, V118, P171, DOI 10.1016/j.physbeh.2013.05.002; U S Department Of Health And Human Services, 2015, J Pain Palliat Care Pharmacother, V29, P133, DOI 10.3109/15360288.2015.1037530; van Elst K, 2014, NEUROSCI BIOBEHAV R, V45, P369, DOI 10.1016/j.neubiorev.2014.07.004; Volkow N., 2016, PRESCRIPTION OPIOID; Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480; Wu A., 2013, NEUROREHABIL NEURAL; Wu XB, 2012, J NEUROSCI RES, V90, P1270, DOI 10.1002/jnr.23025; Zaparoli JX, 2016, EUR ADDICT RES, V22, P153, DOI 10.1159/000439525; Zhang XW, 2016, AGING CLIN EXP RES, V28, P165, DOI 10.1007/s40520-015-0381-9; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	86	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175090	10.1371/journal.pone.0175090	http://dx.doi.org/10.1371/journal.pone.0175090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380057	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500096
J	Jarillo, J; Morin, JA; Beltran-Heredia, E; Villaluenga, JPG; Ibarra, B; Cao, FJ				Jarillo, Javier; Morin, Jose A.; Beltran-Heredia, Elena; Villaluenga, Juan P. G.; Ibarra, Borja; Cao, Francisco J.			Mechanics, thermodynamics, and kinetics of ligand binding to biopolymers	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI SSB; REPLICATION PROTEIN-A; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; OPTICAL TWEEZERS; STRETCHING DNA; NUCLEIC-ACIDS; MOLECULE; POLYELECTROLYTES	Ligands binding to polymers regulate polymer functions by changing their physical and chemical properties. This ligand regulation plays a key role in many biological processes. We propose here a model to explain the mechanical, thermodynamic, and kinetic properties of the process of binding of small ligands to long biopolymers. These properties can now be measured at the single molecule level using force spectroscopy techniques. Our model performs an effective decomposition of the ligand-polymer system on its covered and uncovered regions, showing that the elastic properties of the ligand-polymer depend explicitly on the ligand coverage of the polymer (i.e., the fraction of the polymer covered by the ligand). The equilibrium coverage that minimizes the free energy of the ligand-polymer system is computed as a function of the applied force. We show how ligands tune the mechanical properties of a polymer, in particular its length and stiffness, in a force dependent manner. In addition, it is shown how ligand binding can be regulated applying mechanical tension on the polymer. Moreover, the binding kinetics study shows that, in the case where the ligand binds and organizes the polymer in different modes, the binding process can present transient shortening or lengthening of the polymer, caused by changes in the relative coverage by the different ligand modes. Our model will be useful to understand ligand-binding regulation of biological processes, such as the metabolism of nucleic acid. In particular, this model allows estimating the coverage fraction and the ligand mode characteristics from the force extension curves of a ligand-polymer system.	[Jarillo, Javier; Beltran-Heredia, Elena; Cao, Francisco J.] Univ Complutense Madrid, Fac Ciencias Fis, Dept Fis Atom Mol & Nucl, Pza Ciencias 1, Madrid, Spain; [Morin, Jose A.; Ibarra, Borja] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain; [Morin, Jose A.; Ibarra, Borja] CNB CSIC IMDEA Nanociencia Associated Unit, Unidad Nanobiotecnol, Madrid, Spain; [Villaluenga, Juan P. G.] Univ Complutense Madrid, Dept Fis Aplicada 1, Fac Ciencias Fis, Pza Ciencias 1, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid	Cao, FJ (corresponding author), Univ Complutense Madrid, Fac Ciencias Fis, Dept Fis Atom Mol & Nucl, Pza Ciencias 1, Madrid, Spain.	francao@ucm.es	Cao, Francisco J./B-7794-2008; García Villaluenga, Juan Pedro/H-5155-2015; Jarillo, Javier/AAD-2044-2021; Jarillo, Javier/Q-4591-2018; ibarra, borja/H-5840-2015	Cao, Francisco J./0000-0003-1611-913X; García Villaluenga, Juan Pedro/0000-0001-9540-7134; Jarillo, Javier/0000-0003-2337-0170; Jarillo, Javier/0000-0003-2337-0170; Morin, Jose A./0000-0002-0956-6508; ibarra, borja/0000-0001-6597-797X; Beltran-Heredia, Elena/0000-0003-4251-7289	Banco Santander [GR35/14-920911]; Universidad Complutense de Madrid, Spain [GR35/14-920911]; MINECO, Spain [FIS2010-17440, FIS2015-67765-R, BFU2012-31825, BFU2015-63714-R]; Ministerio de Educacion, Cultura y Deporte, Spain [FPU13/02934, FPU13/02826]	Banco Santander; Universidad Complutense de Madrid, Spain; MINECO, Spain; Ministerio de Educacion, Cultura y Deporte, Spain	This work was supported by grants GR35/14-920911 (Banco Santander and Universidad Complutense de Madrid, Spain), and FIS2010-17440 and FIS2015-67765-R (MINECO, Spain) to JJ, EB, JPGV, and FJC, and by grant BFU2012-31825 and BFU2015-63714-R (MINECO, Spain) to JM and BI. Additionally, JJ and EB acknowledge financial support from FPU13/02934 and FPU13/02826 grants (Ministerio de Educacion, Cultura y Deporte, Spain), respectively.; This work was supported by grants GR35/14-920911 (Banco Santander and Universidad Complutense de Madrid, Spain), and FI52010-17440 and FIS2015-67765-R (MINECO, Spain) to J.J., E.B., J.P.G.V., and F.J.C., and by grant BFU2012-31825 and BFU2015-63714-R (MINECO, Spain) to J.M. and B.I. Additionally, J.J. and E.B. acknowledge financial support from FPU13/02934 and FPU13/02826 grants (Ministerio de Educacion, Cultura y Deporte, Spain), respectively.	Ahmad S, 2006, TRANSIT METAL CHEM, V31, P1003, DOI 10.1007/s11243-006-0100-7; Bell JC, 2015, ELIFE, V4, DOI 10.7554/eLife.08646; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Cesconetto EC, 2013, PHYS CHEM CHEM PHYS, V15, P11070, DOI 10.1039/c3cp50898f; Chaurasiya KR, 2010, PHYS LIFE REV, V7, P299, DOI 10.1016/j.plrev.2010.06.001; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09296; Corless R.M., 1993, MAPLE TECH NEWSL, V9, P12; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; Cruceanu M, 2006, ANAL BIOCHEM, V358, P159, DOI 10.1016/j.ab.2006.08.037; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hatch K, 2008, NUCLEIC ACIDS RES, V36, P294, DOI 10.1093/nar/gkm1014; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lambert J. H., 1758, ACTA HELVETICA, V3, P128; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Leger JF, 1998, P NATL ACAD SCI USA, V95, P12295, DOI 10.1073/pnas.95.21.12295; Lim CJ, 2013, NUCLEIC ACIDS RES, V41, P746, DOI 10.1093/nar/gks1126; Lohman TM, 1996, BIOCHEMISTRY-US, V35, P5272, DOI 10.1021/bi9527606; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marceau Aimee H, 2012, Methods Mol Biol, V922, P1, DOI 10.1007/978-1-62703-032-8_1; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MASCOTTI DP, 1990, P NATL ACAD SCI USA, V87, P3142, DOI 10.1073/pnas.87.8.3142; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McIntosh DB, 2011, MACROMOLECULES, V44, P2328, DOI 10.1021/ma1028196; McIntosh DB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041803; McIntosh DB, 2014, BIOPHYS J, V106, P659, DOI 10.1016/j.bpj.2013.12.018; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; Montanari A, 2001, PHYS REV LETT, V86, P2178, DOI 10.1103/PhysRevLett.86.2178; Morin JA, 2017, DNA SYNTHESIS DETERM; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044; Pant K, 2004, J MOL BIOL, V336, P851, DOI 10.1016/j.jmb.2003.12.025; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Rouzina I, 2005, BIOPHYS J, V89, P1941, DOI 10.1529/biophysj.105.063776; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Saleh OA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068301; Siman L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248103; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Stigter D, 1996, BIOPHYS J, V71, P2064, DOI 10.1016/S0006-3495(96)79405-5; Storm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051906; Suksombat S, 2015, ELIFE, V4, DOI 10.7554/eLife.08193; Toan NM, 2006, J PHYS-CONDENS MAT, V18, pS269, DOI 10.1088/0953-8984/18/14/S11; Toan NM, 2005, BIOPHYS J, V89, P80, DOI 10.1529/biophysj.104.058081; Tonks L, 1936, PHYS REV, V50, P955, DOI 10.1103/PhysRev.50.955; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Vladescu ID, 2007, NAT METHODS, V4, P517, DOI 10.1038/nmeth1044; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	66	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174830	10.1371/journal.pone.0174830	http://dx.doi.org/10.1371/journal.pone.0174830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380044	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500066
J	Liu, RJ; Gao, CF; Chen, HJ; Li, YX; Jin, Y; Qi, H				Liu, Rongjun; Gao, Caifeng; Chen, Huijin; Li, Yaxin; Jin, Ying; Qi, Hong			Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease	PLOS ONE			English	Article							PATHOGENIC T(H)17 CELLS; DIAGNOSTIC-TESTS; SJOGREN-SYNDROME; SYMPTOMS; SIGNS; DIFFERENTIATION; INTERLEUKIN-17; TEARS	We aimed to investigate the expressions of three Th17-associated cytokines, interleukin (IL)-17A, IL-6 and IL-23, in protein and mRNA levels and their correlations with ocular surface parameters in patients with dry eye disease (DED) through a small sample size case control study. A total of 45 female subjects were divided into Sjogren's syndrome (SS) DED group, non-Sjogren's syndrome (non-SS) DED group and control group. Ocular surface disease index (OSDI) was self-answered and clinical tests including tear-film breakup time (BUT), Schirmer I test, cornea fluorescein staining (CFS) were performed. The conjunctival mRNA expressions of these cytokines were investigated by real-time polymerase chain reaction (PCR) and the levels of protein in tears were measured by mutiplex bead analysis. The correlations between cytokines and ocular surface parameters were analyzed. Results show that the expressions of IL-17A and IL-6 in protein and mRNA levels were both significantly increased in the DED group (P<0.05), and also higher in SS group comparing to the non-SS group (P<0.05). Moreover, IL-17A and IL-6 correlated well with ocular surface parameters (all P<0.05, R values range from 0.5-0.8). Despite the expression of IL-23 was significantly increased in the DED group (P<0.05), there was no significant difference found between the expressions of IL-23 in SS group and non-SS group (P>0.05) and no correlation found between the IL-23 and any ocular surface parameter (P>0.05). These findings indicates that the three Th17-associated cytokines, IL-17A, IL-6 and IL-23, play roles in the pathogenesis of DED and the expressions of IL-17A and IL-6 in tears have potential to be diagnostic biomarkers for DED.	[Liu, Rongjun; Gao, Caifeng; Chen, Huijin; Li, Yaxin; Jin, Ying; Qi, Hong] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China; [Gao, Caifeng] Guangdong Women & Children Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Yaxin] First Hosp Fangshan Dist, Beijing, Peoples R China	Peking University	Qi, H (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China.	doctorqihong@hotmail.com			National Natural Science Foundation of China [30872813, 81570813]; LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by National Natural Science Foundation of China (No. 30872813); National Natural Science Foundation of China (81570813); the LinHu Scientific Research Foundation of Department of Ophthalmology, Peking University Third Hospital; the Scientific Research Foundation for the Excellent Returned Overseas Chinese Scholars, Peking University Third Hospital; the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2015, CLIN OPHTHALMOL, V9, P1719, DOI 10.2147/OPTH.S89700; Begley CG, 2003, INVEST OPHTH VIS SCI, V44, P4753, DOI 10.1167/iovs.03-0270; Chauhan SK, 2009, MUCOSAL IMMUNOL, V2, P375, DOI 10.1038/mi.2009.21; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; [高彩凤 Gao Caifeng], 2014, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V32, P641; Geerling G, 2011, INVEST OPHTH VIS SCI, V52, P2050, DOI 10.1167/iovs.10-6997g; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gipson IK, 2007, OCUL SURF, V5, P179; Kallarackal GU, 2002, EYE, V16, P594, DOI 10.1038/sj.eye.6700177; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp MA, 2007, OCUL SURF, V5, P75; Liu Z, 2013, CHINESE J OPHTHALMOL, V49, P73; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Macri A, 2000, OPHTHALMOLOGY, V107, P1338, DOI 10.1016/S0161-6420(00)00101-9; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moore JE, 2009, BRIT J OPHTHALMOL, V93, P66, DOI 10.1136/bjo.2007.131722; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Oh Joo Youn, 2011, Korean J Ophthalmol, V25, P73, DOI 10.3341/kjo.2011.25.2.73; Pflugfelder Stephen C, 2003, Ocul Surf, V1, P31; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Tan X, 2014, EYE, V28, P608, DOI 10.1038/eye.2014.38; Tishler M, 1998, OPHTHALMOLOGY, V105, P2327, DOI 10.1016/S0161-6420(98)91236-2; Versura P, 2010, CURR EYE RES, V35, P553, DOI 10.3109/02713683.2010.484557; Vitali C, 2002, CLASSIFICATION CRITE; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	34	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173301	10.1371/journal.pone.0173301	http://dx.doi.org/10.1371/journal.pone.0173301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379971	gold, Green Submitted, Green Published			2022-12-26	WOS:000399353500015
J	Oskui, SM; Bhakta, HC; Diamante, G; Liu, HN; Schlenk, D; Grover, WH				Oskui, Shirin Mesbah; Bhakta, Heran C.; Diamante, Gracie; Liu, Huinan; Schlenk, Daniel; Grover, William H.			Measuring the mass, volume, and density of microgram-sized objects in fluid	PLOS ONE			English	Article							SEED IMBIBITION; DRUG DISCOVERY; HUMAN-DISEASE; SINGLE CELLS; MODEL SYSTEM; ZEBRAFISH; BIOMATERIALS; GERMINATION; RESONATORS; MAGNESIUM	Measurements of an object's fundamental physical properties like mass, volume, and density can offer valuable insights into the composition and state of the object. However, many important biological samples reside in a liquid environment where it is difficult to accurately measure their physical properties. We show that by using a simple piece of glass tubing and some inexpensive off-the-shelf electronics, we can create a sensor that can measure the mass, volume, and density of microgram-sized biological samples in their native liquid environment. As a proof-of-concept, we use this sensor to measure mass changes in zebrafish embryos reacting to toxicant exposure, density changes in seeds undergoing rehydration and germination, and degradation rates of biomaterials used in medical implants. Since all objects have these physical properties, this sensor has immediate applications in a wide variety of different fields including developmental biology, toxicology, materials science, plant science, and many others.	[Oskui, Shirin Mesbah; Bhakta, Heran C.; Liu, Huinan; Grover, William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Diamante, Gracie; Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Grover, WH (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	wgrover@engr.ucr.edu		Grover, William/0000-0001-6854-8951	National Science Foundation's Instrument Development for Biological Research program [DBI-1353974]	National Science Foundation's Instrument Development for Biological Research program	This work was supported by the National Science Foundation's Instrument Development for Biological Research program under award DBI-1353974, http://www.nsf.gov. There was no additional external funding received for this study.; This work was supported by the National Science Foundation's Instrument Development for Biological Research program under award DBI-1353974.	[Anonymous], 1998, ISO 15212 1 OSCILLAT; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bryan AK, 2014, LAB CHIP, V14, P569, DOI 10.1039/c3lc51022k; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dohn S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804074; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Grover W., NACL PYTHON CODE PRE; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Lee D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33799; Lele Z, 1996, BIOTECHNOL ADV, V14, P57, DOI 10.1016/0734-9750(96)00004-3; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Mai ED, 2014, PROG NAT SCI-MATER, V24, P554, DOI 10.1016/j.pnsc.2014.08.012; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Moutopoulos DK, 2002, J APPL ICHTHYOL, V18, P200, DOI 10.1046/j.1439-0426.2002.00281.x; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Rasband W, IMAGEJ; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; WOODSTOCK LW, 1988, J SEED TECHNOL, V12, P1; Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	28	7	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174068	10.1371/journal.pone.0174068	http://dx.doi.org/10.1371/journal.pone.0174068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379982	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500030
J	Edwards, RD; Crisp, MD; Cook, DH; Cook, LG				Edwards, Robert D.; Crisp, Michael D.; Cook, Dianne H.; Cook, Lyn G.			Congruent biogeographical disjunctions at a continent-wide scale: Quantifying and clarifying the role of biogeographic barriers in the Australian tropics	PLOS ONE			English	Article							RAIN-FOREST; COMPARATIVE PHYLOGEOGRAPHY; NORTHERN-TERRITORY; PATTERNS; SPECIATION; VICARIANCE; EVOLUTION; REFUGIA; HISTORY; DIFFERENTIATION	Aim To test whether novel and previously hypothesized biogeogaphic barriers in the Australian Tropics represent significant disjunction points or hard barriers, or both, to the distribution of plants. Location Australian tropics: Australian Monsoon Tropics and Australian Wet Tropics. Methods The presence or absence of 6,861 plant species was scored across 13 putative biogeographic barriers in the Australian Tropics, including two that have not previously been recognised. Randomizations of these data were used to test whether more species showed disjunctions (gaps in distribution) or likely barriers (range limits) at these points than expected by chance. Results Two novel disjunctions in the Australian Tropics flora are identified in addition to eleven putative barriers previously recognized for animals. Of these, eleven disjunction points (all within the Australian Monsoon Tropics) were found to correspond to range-ending barriers to a significant number of species, while neither of the two disjunctions found within the Australian Wet Tropics limited a significant number of species' ranges. Main conclusions Biogeographic barriers present significant distributional limits to native plant species in the Australian Monsoon Tropics but not in the Australian Wet Tropics.	[Edwards, Robert D.; Cook, Lyn G.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Crisp, Michael D.] Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia; [Cook, Dianne H.] Monash Univ, Dept Econometr & Business Stat, Clayton, Vic, Australia; [Edwards, Robert D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC166, Washington, DC USA	University of Queensland; Australian National University; Monash University; Smithsonian Institution; Smithsonian National Museum of Natural History	Edwards, RD (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.; Edwards, RD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC166, Washington, DC USA.	bortedwards@gmail.com	Cook, Lyn/G-7336-2012; Crisp, Michael D/A-4888-2008	Cook, Lyn/0000-0002-3172-4920; Crisp, Michael D/0000-0002-8255-6349; Edwards, Robert/0000-0002-4993-2453; Cook, Dianne/0000-0002-3813-7155	University of Queensland; Australian Research Council	University of Queensland(University of Queensland); Australian Research Council(Australian Research Council)	The authors would like to thank the 'Coopers and Cladistics' systematics discussion group at the ANU for comments on early versions of the manuscript. They would also like to acknowledge the University of Queensland for supporting RDE via a Postgraduate Research Scholarship, and the Australian Research Council for supporting LGC and MDC via Discovery Grants during data collection, analysis and manuscript preparation.; The authors would like to thank the 'Coopers and Cladistics' systematics discussion group at the ANU for comments on early versions of the manuscript. They would also like to acknowledge the University of Queensland for supporting RDE via a Postgraduate Research Scholarship and the Australian Research Council for supporting LGC and MDC via Discovery Grants.	[Anonymous], AUSTR VIRT HERB; [Anonymous], AUSTR PLANT NAM IND; [Anonymous], AUSTR BIOL RES STUD; [Anonymous], 1991, AUSTR BIOL RES STUD; Baker CH, 2008, MOL PHYLOGENET EVOL, V48, P506, DOI 10.1016/j.ympev.2008.04.037; Barlow B. A., 1988, Proceedings of the Ecological Society of Australia, V15, P1; Bell KL, 2007, MOL ECOL, V16, P4984, DOI 10.1111/j.1365-294X.2007.03533.x; Bostock PD, 2008, CENSUS QUEENSLAND FL; Bostock PD, 2007, CENSUS QUEENSLAND FL; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Braby MF, 2008, AUST J ZOOL, V56, P41, DOI 10.1071/ZO08021; Brown M, 2006, AUST J ZOOL, V54, P305, DOI 10.1071/ZO06034; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Catullo RA, 2014, J BIOGEOGR, V41, P659, DOI 10.1111/jbi.12230; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Colgan DJ, 2009, AUST J ZOOL, V57, P317, DOI 10.1071/ZO08088; Costion CM, 2016, DIVERSITY-BASEL, V8, DOI 10.3390/d8010005; CRACRAFT J, 1982, AM ZOOL, V22, P411; CRACRAFT J, 1986, EVOLUTION, V40, P977, DOI 10.1111/j.1558-5646.1986.tb00566.x; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Crowley L.E.L.M., 1991, Ichthyological Exploration of Freshwaters, V2, P129; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; Di Virgilio G, 2012, J BIOGEOGR, V39, P1862, DOI 10.1111/j.1365-2699.2012.02739.x; Dolman G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003499; Ebach MC, 2012, ZOOTAXA, P1; Edwards DL, 2010, J BIOGEOGR, V37, P1543, DOI 10.1111/j.1365-2699.2010.02293.x; EDWARDS SV, 1993, P ROY SOC B-BIOL SCI, V252, P177, DOI 10.1098/rspb.1993.0063; Eldridge MDB, 2011, AUST J ZOOL, V59, P270, DOI 10.1071/ZO12012; Eliot I, 2010, ENCY WORLDS COASTAL; Eriksson O, 2000, AM NAT, V156, P47, DOI 10.1086/303367; FORD J, 1987, EMU, V87, P158, DOI 10.1071/MU9870158; FORD J, 1978, EMU, V78, P25, DOI 10.1071/MU9780025; FORD J, 1986, EMU, V86, P87, DOI 10.1071/MU9860087; FORD J, 1982, EMU, V82, P12, DOI 10.1071/MU9820012; Glor RE, 2011, EVOLUTION, V65, P673, DOI 10.1111/j.1558-5646.2010.01177.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hopley D, 2010, ENCY WORLDS COASTAL; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; James CH, 2000, MOL ECOL, V9, P349, DOI 10.1046/j.1365-294x.2000.00885.x; Jennings WB, 2005, EVOLUTION, V59, P2033; Joseph L, 2009, EMU, V109, P1, DOI 10.1071/MU08024; Kearns AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4994; Kearns AM, 2011, MOL ECOL, V20, P5042, DOI 10.1111/j.1365-294X.2011.05330.x; KEAST A., 1957, AUSTRALIAN JOUR ZOOL, V5, P474, DOI 10.1071/ZO9570474; Keast A., 1961, B MUS COMP ZOOL HARV, V123, P307; Keast A.M., 1981, ECOLOGICAL BIOGEOGRA, P605; Kench PS, 1999, AUST J ECOL, V24, P367, DOI 10.1046/j.1442-9993.1999.00985.x; Kerrigan KA, 2007, CHECKLIST NT VASCULA; Laffan SW, 2016, METHODS ECOL EVOL, V7, P580, DOI 10.1111/2041-210X.12513; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Lucky A, 2011, MOL PHYLOGENET EVOL, V59, P281, DOI 10.1016/j.ympev.2011.03.004; MACDONALD J D, 1969, Emu, V69, P169; McDonald MW, 2000, AUST SYST BOT, V13, P21, DOI 10.1071/SB98031; McKinnon GE, 2004, PHILOS T R SOC B, V359, P275, DOI 10.1098/rstb.2003.1391; Melville J, 2011, MOL PHYLOGENET EVOL, V58, P257, DOI 10.1016/j.ympev.2010.11.025; Moise A, 2007, TRACKING MONSOON USI; Moritz C, 2005, CONSERV BIOL SER, V8, P243; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Moussalli A, 2005, MOL PHYLOGENET EVOL, V34, P190, DOI 10.1016/j.ympev.2004.08.022; Nicholls JA, 2005, MOL ECOL, V14, P1485, DOI 10.1111/j.1365-294X.2005.02544.x; Nix H, 1982, EVOLUTION FLORA FAUN, P47; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; PERRY RA, 1960, CSIRO LAND RES SERIE, V5; Potter S, 2012, MOL ECOL, V21, P2254, DOI 10.1111/j.1365-294X.2012.05523.x; Proches S, 2006, BIOL LETTERS, V2, P69, DOI 10.1098/rsbl.2005.0396; Rollins LA, 2012, ECOL EVOL, V2, P1208, DOI 10.1002/ece3.259; Rossetto M, 2007, AUST J BOT, V55, P416, DOI 10.1071/BT06195; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; ROWLEY I, 1993, EMU, V93, P220, DOI 10.1071/MU9930220; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schodde R., 1982, P191; Schodde R., 1980, NOCTURNAL BIRDS AUST; Schodde R, 1999, DIRECTORY AUSTR BIRD, V2; Speck NH, 1964, GEN REPORT LANDS W K, P1; Thornhill AH, 2016, J BIOGEOGR, V43, P2085, DOI 10.1111/jbi.12797; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Toon A, 2007, MOL ECOL, V16, P2525, DOI 10.1111/j.1365-294X.2007.03289.x; UITENBROEK D, SIMPLE INTERACTIVE S; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Wannan B, 2014, AUST J BOT, V62, P85, DOI 10.1071/BT13295; WHITEHEAD PJ, 1992, J BIOGEOGR, V19, P151, DOI 10.2307/2845501; Williams S. E., 1996, Pacific Conservation Biology, V2, P327; Williams SE, 1997, WILDLIFE RES, V24, P513, DOI 10.1071/WR96040; WINTER JW, 1984, SPECIFIC HABITATS SE; Woinarski JCZ, 2006, AUST J BOT, V54, P627, DOI 10.1071/BT05041; Wong BBM, 2004, MOL ECOL, V13, P391, DOI 10.1046/j.1365-294X.2003.02085.x	90	24	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174812	10.1371/journal.pone.0174812	http://dx.doi.org/10.1371/journal.pone.0174812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376094	Green Published, gold, Green Submitted			2022-12-26	WOS:000399352000020
J	Loeffler, J; Raab, M; Canal-Bruland, R				Loeffler, Jonna; Raab, Markus; Canal-Bruland, Rouwen			Does movement influence representations of time and space?	PLOS ONE			English	Article							LANGUAGE; METAPHORS; MANDARIN; ENGLISH; FUTURE; PERSPECTIVE; COGNITION; FRAMES; THINK; BODY	Embodied cognition posits that abstract conceptual knowledge such as mental representations of time and space are at least partially grounded in sensorimotor experiences. If true, then the execution of whole-body movements should result in modulations of temporal and spatial reference frames. To scrutinize this hypothesis, in two experiments participants either walked forward, backward or stood on a treadmill and responded either to an ambiguous temporal question (Experiment 1) or an ambiguous spatial question (Experiment 2) at the end of the walking manipulation. Results confirmed the ambiguousness of the questions in the control condition. Nevertheless, despite large power, walking forward or backward did not influence the answers or response times to the temporal (Experiment 1) or spatial (Experiment 2) question. A follow-up Experiment 3 indicated that this is also true for walking actively (or passively) in free space (as opposed to a treadmill). We explore possible reasons for the null-finding as concerns the modulation of temporal and spatial reference frames by movements and we critically discuss the methodological and theoretical implications.	[Loeffler, Jonna; Raab, Markus] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Raab, Markus] London South Bank Univ, Sch Appl Sci, London, England; [Canal-Bruland, Rouwen] Friedrich Schiller Univ Jena, Inst Sport Sci, Jena, Germany	German Sport University Cologne; London South Bank University; Friedrich Schiller University of Jena	Loeffler, J (corresponding author), German Sport Univ Cologne, Inst Psychol, Cologne, Germany.	J.Loeffler@dshs-koeln.de	Raab, Markus/B-4919-2009	Canal-Bruland, Rouwen/0000-0002-7731-0934	German Research Foundation (DFG) [RA 940/15-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) - RA 940/15-1.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bender A, 2010, J COGN CULT, V10, P283, DOI 10.1163/156853710X531195; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Borghi AM, 2014, SPRINGERBR PSYCHOL, P1, DOI 10.1007/978-1-4614-9539-0_1; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boroditsky L, 2001, P 23 ANN M COGN SCI; Buccino G, 2016, NEUROSCI BIOBEHAV R, V69, P69, DOI 10.1016/j.neubiorev.2016.07.033; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2009, HUM COGN PROCESS, V24, P127; Clark H.H., 1973, COGNITIVE DEV ACQUIS, P27; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crandall CS, 2016, J EXP SOC PSYCHOL, V66, P93, DOI 10.1016/j.jesp.2015.10.002; Field A.P., 2020, DISCOVERING STAT USI, V4th; Gallagher S., 2005, BODY SHAPES MIND; Gervais WM, 2010, ATTEN PERCEPT PSYCHO, V72, P1437, DOI 10.3758/APP.72.6.1437; Hartmann M, 2014, CONSCIOUS COGN, V30, P201, DOI 10.1016/j.concog.2014.09.007; Hartmann M, 2012, CONSCIOUS COGN, V21, P1558, DOI 10.1016/j.concog.2012.06.015; Hartmann M, 2012, J EXP PSYCHOL HUMAN, V38, P1416, DOI 10.1037/a0026706; Hubbard E, 2010, NEURAL CONSTRAINTS T; Huther L, 2013, P 35 ANN C COGN SCI, P2602; Kiefer M, 2012, TRENDS NEUROSCI EDUC, V1, P15, DOI 10.1016/j.tine.2012.07.002; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Kruglanski AW, 2015, PERSONAL SOC PSYCHOL; Lai VT, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00142; LAKOFF G, 1980, J PHILOS, V77, P453, DOI 10.2307/2025464; Lebois LAM, 2015, COGNITIVE SCI, V39, P1764, DOI 10.1111/cogs.12174; Leiner DJ, 2015, SOSCI SURVEY; Lleras M, 2014, METAPHORS WE SPEAK A; Loeffler J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00845; Matlock T, 2005, COGNITIVE SCI, V29, P655, DOI 10.1207/s15516709cog0000_17; Matlock T, 2011, METAPHOR SYMBOL, V26, P260, DOI 10.1080/10926488.2011.609065; McGlone MS, 1998, J EXP PSYCHOL LEARN, V24, P1211, DOI 10.1037/0278-7393.24.5.1211; Merleau-Ponty M, 2009, PHENOMENOLOGIE PERCE; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Miles LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010825; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; Nunez RE, 2006, METAPHOR SYMBOL, V21, P133, DOI 10.1207/s15327868ms2103_1; Rashidi-Ranjbar N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00072; Richmond J, 2012, EUR J SOC PSYCHOL, V42, P813, DOI 10.1002/ejsp.1906; Rothe-Wulf A, 2015, Q J EXP PSYCHOL, V68, P917, DOI 10.1080/17470218.2014.970205; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2016, PSYCHOL METHODS; Rueschemeyer SA, 2010, EXP PSYCHOL, V57, P260, DOI 10.1027/1618-3169/a000031; Sinha C, 2014, ANN NY ACAD SCI, V1326, P72, DOI 10.1111/nyas.12491; Sullivan JL, 2012, Q J EXP PSYCHOL, V65, P1101, DOI 10.1080/17470218.2011.641025; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Wilson AD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00058	51	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175192	10.1371/journal.pone.0175192	http://dx.doi.org/10.1371/journal.pone.0175192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IO	28376130	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000399352000040
J	Guan, CC; Li, J; Sun, DP; Liu, YF; Liang, HH				Guan, Chengcheng; Li, Jun; Sun, Dapeng; Liu, Yingfang; Liang, Huanhuan			The structure and polymerase-recognition mechanism of the crucial adaptor protein AND-1 in the human replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; LINKS DNA-REPLICATION; S-PHASE CHECKPOINT; BINDING PROTEIN; CTF4; COMPLEX; ESTABLISHMENT; PROGRESSION; HELICASE; ALPHA	DNA replication in eukaryotic cells is performed by a multiprotein complex called the replisome, which consists of helicases, polymerases, and adaptor molecules. Human (a) under bar cidic (n) under bar ucleoplasmic (D) under bar NA-binding protein 1 (AND-1), also known as WD repeat and high mobility group (HMG)-box DNA-binding protein 1 (WDHD1), is an adaptor molecule crucial for DNA replication. Although structural information for the AND-1 yeast ortholog is available, the mechanistic details for how human AND-1 protein anchors the lagging-strand DNA polymerase alpha (pol alpha) to the DNA helicase complex ((C) under bar dc45-(M) over bar CM2-7-(G) under bar INS, CMG) await elucidation. Here, we report the structures of the N-terminal WD40 and SepB domains of human AND-1, as well as a biochemical analysis of the C-terminal HMG domain. We show that AND-1 exists as a homotrimer mediated by the SepB domain. Mutant study results suggested that a positively charged groove within the SepB domain provides binding sites for pol alpha. Different from its ortholog protein in budding yeast, human AND-1 is recruited to the CMG complex, mediated by unknown participants other than Go Ichi Ni San. In addition, we show that AND-1 binds to DNA in vitro, using its C-terminal HMG domain. In conclusion, our findings provide important insights into the mechanistic details of human AND-1 function, advancing our understanding of replisome formation during eukaryotic replication.	[Guan, Chengcheng; Li, Jun; Sun, Dapeng; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Guan, Chengcheng; Li, Jun] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, YF; Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	liuyingfang@ibp.ac.cn; hhliang@moon.ibp.ac.cn		sun, dapeng/0000-0003-0220-8844	NSFC Foundation [31530015]; CAS [XDB08000000]; Frontier Sciences Project [CAS QYZDY-SSW-SMC018]	NSFC Foundation(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Frontier Sciences Project	This work was supported by NSFC Foundation Grant 31530015, Strategic Priority Research Program CAS Grant XDB08000000, and Frontier Sciences Project Grant CAS QYZDY-SSW-SMC018. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chen Z, 2016, MOL CELL PROTEOMICS, V15, P1299, DOI [10.1074/mcp.M115.056093, 10.1074/mcp.M115.056093 ]; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gosnell JA, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-13; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hao J, 2015, EMBO J, V34, P2096, DOI 10.15252/embj.201488016; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jaramillo-Lambert A, 2013, J BIOL CHEM, V288, P1480, DOI 10.1074/jbc.M112.429266; Kang YH, 2013, P NATL ACAD SCI USA, V110, P19760, DOI 10.1073/pnas.1320202110; Kohler A, 1997, J CELL SCI, V110, P1051; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Li YC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-1; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; O'Donnell M., 2013, COLD SPRING HARB PER; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Villa F, 2016, MOL CELL, V63, P385, DOI 10.1016/j.molcel.2016.06.009; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	54	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9627	9636		10.1074/jbc.M116.758524	http://dx.doi.org/10.1074/jbc.M116.758524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28381552	Green Published, hybrid			2022-12-26	WOS:000403113000014
J	Hirano, M; Takada, Y; Wong, CF; Yamaguchi, K; Kotani, H; Kurokawa, T; Mori, MX; Snutch, TP; Ronjat, M; De Waard, M; Mori, Y				Hirano, Mitsuru; Takada, Yoshinori; Wong, Chee Fah; Yamaguchi, Kazuma; Kotani, Hiroshi; Kurokawa, Tatsuki; Mori, Masayuki X.; Snutch, Terrance P.; Ronjat, Michel; De Waard, Michel; Mori, Yasuo			C-terminal splice variants of P/Q-type Ca2+ channel Ca(V)2.1 alpha(1) subunits are differentially regulated by Rab3-interacting molecule proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; NEURONAL CALCIUM-CHANNELS; PRESYNAPTIC ACTIVE ZONES; N-TYPE; DEPENDENT INACTIVATION; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; TRANSMITTER RELEASE; STATE INACTIVATION; PURKINJE-CELLS	Voltage-dependent Ca2+ channels (VDCCs) mediate neurotransmitter release controlled by presynaptic proteins such as the scaffolding proteins Rab3-interacting molecules (RIMs). RIMs confer sustained activity and anchoring of synaptic vesicles to the VDCCs. Multiple sites on the VDCC alpha(1) and beta subunits have been reported to mediate the RIMs-VDCC interaction, but their significance is unclear. Because alternative splicing of exons 44 and 47 in the P/Q-type VDCC alpha(1) subunit Ca(V)2.1 gene generates major variants of the Ca(V)2.1 C-terminal region, known for associating with presynaptic proteins, we focused here on the protein regions encoded by these two exons. Co-immunoprecipitation experiments indicated that the C-terminal domain (CTD) encoded by Ca(V)2.1 exons 40-47 interacts with the alpha-RIMs, RIM1 alpha and RIM2 alpha, and this interaction was abolished by alternative splicing that deletes the protein regions encoded by exons 44 and 47. Electrophysiological characterization of VDCC currents revealed that the suppressive effect of RIM2 alpha on voltage-dependent inactivation (VDI) was stronger than that of RIM1 alpha for the Ca(V)2.1 variant containing the region encoded by exons 44 and 47. Importantly, in the CaV2.1 variant in which exons 44 and 47 were deleted, strong RIM2 alpha-mediated VDI suppression was attenuated to a level comparable with that of RIM1 alpha-mediated VDI suppression, which was unaffected by the exclusion of exons 44 and 47. Studies of deletion mutants of the exon 47 region identified 17 amino acid residues on the C-terminal side of a polyglutamine stretch as being essential for the potentiated VDI suppression characteristic of RIM2 alpha. These results suggest that the interactions of the Ca(V)2.1 CTD with RIMs enable Ca(V)2.1 proteins to distinguish alpha-RIM isoforms in VDI suppression of P/Q-type VDCC currents.	[Hirano, Mitsuru; Takada, Yoshinori; Wong, Chee Fah; Yamaguchi, Kazuma; Kotani, Hiroshi; Kurokawa, Tatsuki; Mori, Masayuki X.; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto 6158510, Japan; [Wong, Chee Fah] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Biol, Tanjung Malim 35900, Perak, Malaysia; [Snutch, Terrance P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Snutch, Terrance P.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z4, Canada; [Ronjat, Michel; De Waard, Michel] Univ Nantes, LabEx Ion Channels Sci & Therapeut, CNRS UMR6291, INSERM UMR1087,Inst Thorax, F-44000 Nantes, France	Kyoto University; Kyoto University; Universiti Pendidikan Sultan Idris; University of British Columbia; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Lab Mol Biol, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	De Waard, Michel/G-7406-2014; Snutch, Terrance P/L-3464-2019; Mori, Masayuki/AAI-6992-2020	De Waard, Michel/0000-0002-2782-9615; Snutch, Terrance P/0000-0001-5182-1296; Ronjat, Michel/0000-0002-9728-6425; Wong, Chee Fah/0000-0003-1114-7000	Japan Society for the Promotion of Science [16H05140]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research (B) 16H05140 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann F, 2015, EMBO REP, V16, P923, DOI 10.15252/embr.201540434; Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Bachnoff N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01620; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Chen HY, 2007, AM J PHYSIOL-CELL PH, V292, pC1078, DOI 10.1152/ajpcell.00353.2006; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giunti P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00036; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hu QP, 2005, GENES CELLS, V10, P87, DOI 10.1111/j.1365-2443.2005.00820.x; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kanumilli S, 2006, PHYSIOL GENOMICS, V24, P86, DOI 10.1152/physiolgenomics.00149.2005; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kulik A, 2004, EUR J NEUROSCI, V19, P2169, DOI 10.1111/j.0953-816X.2004.03319.x; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Ludwig A, 1997, J NEUROSCI, V17, P1339; Matsuyama Z, 1997, HUM MOL GENET, V6, P1283, DOI 10.1093/hmg/6.8.1283; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Miki Takafumi, 2007, Channels (Austin), V1, P144; Miki T, 2013, J NEUROSCI, V33, P18755, DOI 10.1523/JNEUROSCI.3161-13.2013; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nakao A, 2015, PFLUG ARCH EUR J PHY, V467, P737, DOI 10.1007/s00424-014-1555-6; Nishimune H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038029; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; RANDALL A, 1995, J NEUROSCI, V15, P2995; Ricoy UM, 2014, J NEUROPHYSIOL, V111, P2404, DOI 10.1152/jn.00335.2013; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Soong TW, 2002, J NEUROSCI, V22, P10142; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Takada Y, 2015, CELL CALCIUM, V58, P296, DOI 10.1016/j.ceca.2015.06.007; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Tsunemi T, 2002, J BIOL CHEM, V277, P7214, DOI 10.1074/jbc.M108222200; Tsunemi T, 2008, NEUROSCI LETT, V447, P78, DOI 10.1016/j.neulet.2008.09.065; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Wong FK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00071; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	91	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9365	9381		10.1074/jbc.M117.778829	http://dx.doi.org/10.1074/jbc.M117.778829			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377503	Green Published, hybrid			2022-12-26	WOS:000402538900030
J	Gangoiti, J; Lamothe, L; van Leeuwen, SS; Vafiadi, C; Dijkhuizen, L				Gangoiti, Joana; Lamothe, Lisa; van Leeuwen, Sander Sebastiaan; Vafiadi, Christina; Dijkhuizen, Lubbert			Characterization of the Paenibacillus beijingensis DSM 24997 GtfD and its glucan polymer products representing a new glycoside hydrolase 70 subfamily of 4,6-alpha-glucanotransferase enzymes	PLOS ONE			English	Article							ALPHA-AMYLASE; STRUCTURAL-ANALYSIS; GLUCANSUCRASE GTFA; CRYSTAL-STRUCTURE; FAMILY; SEQUENCE; SPECIFICITY; MECHANISMS; SYNTHESIZE; PROVIDES	Previously we have reported that the Gram-negative bacterium Azotobacter chroococcum NCIMB 8003 uses the 4,6-alpha-glucanotransferase GtfD to convert maltodextrins and starch into a reuteran-like polymer consisting of (alpha 1 -> 4) glucan chains connected by alternating (alpha 1 -> 4)/(alpha 1 -> 6) linkages and (alpha 1 -> 4,6) branching points. This enzyme constituted the single evidence for this reaction and product specificity in the GH70 family, mostly containing glucansucrases encoded by lactic acid bacteria (http://www.CAZy.org). In this work, 4 additional GtfD-like proteins were identified in taxonomically diverse plant-associated bacteria forming a new GH70 subfamily with intermediate characteristics between the evolutionary related GH13 and GH70 families. The GtfD enzyme encoded by Paenibacillus beijingensis DSM 24997 was characterized providing the first example of a reuteran-like polymer synthesizing 4,6-alpha-glucanotransferase in a Gram-positive bacterium. Whereas the A. chroococcum GtfD activity on amylose resulted in the synthesis of a high molecular polymer, in addition to maltose and other small oligosaccharides, two reuteran-like polymer distributions are produced by P. beijingensis GtfD: a high-molecular mass polymer and a low-molecular mass polymer with an average M-w of 27 MDa and 19 kDa, respectively. Compared to the A. chroooccum GtfD product, both P. beijingensis GtfD polymers contain longer linear (alpha 1 -> 4) sequences in their structure reflecting a preference for transfer of even longer glucan chains by this enzyme. Overall, this study provides new insights into the evolutionary history of GH70 enzymes, and enlarges the diversity of natural enzymes that can be applied for modification of the starch present in food into less and/or more slowly digestible carbohydrate structures.	[Gangoiti, Joana; van Leeuwen, Sander Sebastiaan; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol, Groningen, Netherlands; [Lamothe, Lisa; Vafiadi, Christina] Nestle Res Ctr, Lausanne, Switzerland	University of Groningen; Nestle SA	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol, Groningen, Netherlands.	L.Dijkhuizen@rug.nl	Gangoiti, Joana/N-6863-2018; Dijkhuizen, Lubbert/K-3539-2019; van Leeuwen, Sander/C-7140-2012; Dijkhuizen, Lubbert/E-9454-2014	Gangoiti, Joana/0000-0001-6821-8143; Dijkhuizen, Lubbert/0000-0003-2312-7162; van Leeuwen, Sander/0000-0003-0017-2841; Lamothe, Lisa/0000-0002-5270-1875	Nestec Ltd; University of Groningen	Nestec Ltd; University of Groningen	This work was financially supported by Nestec Ltd and by the University of Groningen. Nestec Ltd provided support in the form of salaries for authors CV and LL. The University of Groningen provided support in the form of salaries for authors JG, SSvL, and LD. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Bai YX, 2015, APPL ENVIRON MICROB, V81, P7223, DOI 10.1128/AEM.01860-15; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Dona AC, 2010, CARBOHYD POLYM, V80, P599, DOI 10.1016/j.carbpol.2010.01.002; Ekhart P, 2006, Branched alpha-glucans for weight management, Patent No. [US 20060100171 A1, 20060100171]; Gangoiti J, 2016, SCI REP IN PRESS; Gangoiti J, 2016, BBA-GEN SUBJECTS, V1860, P1224, DOI 10.1016/j.bbagen.2016.02.005; Gangoiti J, 2016, APPL ENVIRON MICROB, V82, P756, DOI 10.1128/AEM.03420-15; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Janecek S, 2016, CELL MOL LIFE SCI, V73, P2707, DOI 10.1007/s00018-016-2246-6; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2011, APPL ENVIRON MICROB, V77, P8154, DOI 10.1128/AEM.05735-11; Kwak Y, 2015, J BIOTECHNOL, V206, P75, DOI 10.1016/j.jbiotec.2015.04.015; Lee BH, 2016, PLOS ONE, V8; Leemhuis H, 2014, J AGR FOOD CHEM, V62, P12034, DOI 10.1021/jf503970a; Leemhuis H, 2013, APPL MICROBIOL BIOT, V97, P181, DOI 10.1007/s00253-012-3943-1; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Lin AHM, 2016, FOOD HYDROCOLLOID, V53, P163, DOI 10.1016/j.foodhyd.2015.03.002; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; Meng XF, 2016, CELL MOL LIFE SCI, V73, P2681, DOI 10.1007/s00018-016-2245-7; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Plijter J, 2009, Bread improver, Patent No. [US 20090297663 A1, 20090297663]; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; Raga-Carbajal E, 2016, GLYCOBIOLOGY, V26, P377, DOI 10.1093/glycob/cwv112; Robson RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127997; Shin JE, 2008, J AGR FOOD CHEM, V56, P10879, DOI 10.1021/jf801073u; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1251, DOI 10.1016/j.carres.2008.01.044; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	38	21	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0172622	10.1371/journal.pone.0172622	http://dx.doi.org/10.1371/journal.pone.0172622			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399167	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000001
J	Odhiambo, C; Omolo, P; Oyaro, B; Williamson, J; Kinuthia, J; Matemo, D; Drake, A; John-Stewart, G; Zeh, C				Odhiambo, Collins; Omolo, Paul; Oyaro, Boaz; Williamson, John; Kinuthia, John; Matemo, Daniel; Drake, Alison; John-Stewart, Grace; Zeh, Clement			Establishment of reference intervals during normal pregnancy through six months postpartum in western Kenya	PLOS ONE			English	Article							REFERENCE VALUES; LIVER-FUNCTION; BLOOD; TESTS; WOMEN	Background Pregnancy is associated with changes in hematological and biochemistry values, yet there are no African reference intervals for clinical management of pregnant women. We sought to 1) develop laboratory reference intervals during pregnancy and up to 24 weeks postpartum and 2) determine the proportion of women in a previous clinical trial who would be mis-classified as having out-of-range values using reference intervals from a United States (U.S.) population. Methods and findings This was a longitudinal sub-study of 120 clinically healthy, HIV-uninfected, self-selected pregnant women seeking antenatal care services at either of two public hospitals in western Kenya. Blood specimens were obtained from consented women at gestational ages 28 and 36 weeks and at 2, 6, 14 and 24 weeks postpartum. Median and 95% reference intervals were calculated for immune-hematological and biochemistry parameters and compared to reference intervals from a Kenyan and United States (U.S.) population, using Wilcoxon tests. Differences with p <= 0.05 were considered significant. Some hematological parameters, including hemoglobin and neutrophils showed significant variations compared to reference intervals for non-pregnant women. Hemoglobin values were significantly lower during pregnancy but were comparable to the values in non-pregnant women by 6 weeks postpartum. CD4, CD8 and platelets were significantly elevated in early postpartum but declined gradually, reaching normal levels by 24 weeks postpartum. Using the new hemoglobin reference levels from this study to estimate prevalence of 'out of range' values in a prior Kisumu research cohort of pregnant/postpartum women, resulted in 0% out of range values, in contrast to 96.3% using US non-pregnant reference values Conclusion There were substantial differences in U.S. and Kenyan values for immune-hematological parameters among pregnant/postpartum women, specifically in red blood cell parameters in late pregnancy and 2 weeks postpartum. Use of U.S. reference intervals markedly increases likelihood of out of range values, highlighting the need for suitable locally developed reference intervals.	[Odhiambo, Collins; Omolo, Paul; Oyaro, Boaz] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Williamson, John; Zeh, Clement] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Kisumu, Kenya; [Kinuthia, John; Matemo, Daniel] Kenyatta Natl Hosp, Dept Res Program, Nairobi, Kenya; [Drake, Alison; John-Stewart, Grace] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Kenya Medical Research Institute; Kenyatta National Hospital; University of Washington; University of Washington Seattle	Odhiambo, C (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	odhiamboc@hotmail.com	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	odhiambo, collins/0000-0002-5534-8720; John-Stewart, Grace/0000-0002-4301-1573	CDC, Division of HIV and AIDS Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI116298] Funding Source: NIH RePORTER	CDC, Division of HIV and AIDS Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported througha grant from CDC, Division of HIV and AIDS Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Akinbami AA, 2013, INT J WOMENS HEALTH, V5, P227, DOI 10.2147/IJWH.S42110; [Anonymous], 2004, DIV AIDS TABL GRAD S; Bacq Y, 1996, HEPATOLOGY, V23, P1030; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; CARTER J, 1990, AUST NZ J OBSTET GYN, V30, P296, DOI 10.1111/j.1479-828X.1990.tb02014.x; DAHLSTROM BL, 1994, ACTA OBSTET GYN SCAN, V73, P695, DOI 10.3109/00016349409029405; Edelstam G, 2001, SCAND J CLIN LAB INV, V61, P583, DOI 10.1080/003655101753267937; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Ezeilo G C, 1974, East Afr Med J, V51, P936; Harm Sarah K, 2012, Korean J Hematol, V47, P136, DOI 10.5045/kjh.2012.47.2.136; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kelton J, 1988, HEMATOLOGIC DISORDER; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Larsson A, 2008, BJOG-INT J OBSTET GY, V115, P874, DOI 10.1111/j.1471-0528.2008.01709.x; Lurie S, 2008, EUR J OBSTET GYN R B, V136, P16, DOI 10.1016/j.ejogrb.2006.12.013; Milhorat AT, 1942, ARCH NEURO PSYCHIATR, V47, P779, DOI 10.1001/archneurpsyc.1942.02290050081006; Milman N, 2007, EUR J HAEMATOL, V79, P39, DOI 10.1111/j.1600-0609.2007.00873.x; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; Ruiz-Extremera A, 2005, AM J OBSTET GYNECOL, V193, P2010, DOI 10.1016/j.ajog.2005.04.045; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; SHAPER AG, 1971, LANCET, V2, P1021; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0175546	10.1371/journal.pone.0175546	http://dx.doi.org/10.1371/journal.pone.0175546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399133	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000047
J	Mejia-Salazar, MF; Goldizen, AW; Menz, CS; Dwyer, RG; Blomberg, SP; Weidner, CL; Cullingham, CI; Bollinger, TK				Mejia-Salazar, Maria Fernanda; Goldizen, Anne W.; Menz, Clementine S.; Dwyer, Ross G.; Blomberg, Simon P.; Weidner, Cheryl L.; Cullingham, Catherine I.; Bollinger, Trent K.			Mule deer spatial association patterns and potential implications for transmission of an epizootic disease	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ODOCOILEUS-HEMIONUS; SOCIAL-ORGANIZATION; GENETIC-STRUCTURE; PRECLINICAL DIAGNOSIS; BEHAVIOR; SCALE; NETWORKS; DYNAMICS	Animal social behaviour can have important effects on the long-term dynamics of diseases. In particular, preferential spatial relationships between individuals can lead to differences in the rates of disease spread within a population. We examined the concurrent influence of genetic relatedness, sex, age, home range overlap, time of year, and prion disease status on proximal associations of adult Rocky Mountain mule deer (Odocoileus hemionus hemionus) in a chronic wasting disease endemic area. We also quantified the temporal stability of these associations across different sex, age, and disease status classes. We used three years of high frequency telemetry data from 74 individuals to record encounters within 25 m of each other, and to calculate seasonal home range overlap measured by volume of intersection (VI). The strength of pairwise spatial association between adult mule deer was independent of genetic relatedness, age and disease status. Seasonal variation in association strength was not consistent across years, perhaps due to annual changes in weather conditions. The influence of home range overlap on association strength varied seasonally, whereby associations were stronger in pre-rut and fawning than in the rest of the seasons. The sexes of individuals also interacted with both VI and season. At increasing levels of VI, associations were stronger between females than between males and between females and males. The strongest associations in pre-rut were between males, while the strongest in rut were between females and males. The temporal stability of associations was markedly dependant on the sex and the diagnosis of the associating pair. Our findings highlight the importance of considering concurrent effects of biological and environmental factors when seeking to understand the role of social preference in behavioural ecology and disease spread. Applying this knowledge in epidemiological modelling will shed light on the dynamics of disease transmission among mule deer.	[Mejia-Salazar, Maria Fernanda; Weidner, Cheryl L.; Bollinger, Trent K.] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada; [Goldizen, Anne W.; Menz, Clementine S.; Dwyer, Ross G.; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Cullingham, Catherine I.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bollinger, Trent K.] CWHC, Saskatoon, SK, Canada	University of Saskatchewan; University of Queensland; University of Alberta; University of Saskatchewan	Mejia-Salazar, MF (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada.	mihicoltia@gmail.com	Cullingham, Catherine/AAE-9591-2020; Blomberg, Simone P/B-7613-2008	Cullingham, Catherine/0000-0002-6715-0674; Blomberg, Simone P/0000-0003-1062-0839; Waldner, Cheryl/0000-0002-7152-4261; Dwyer, Ross/0000-0003-1136-5489	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded primarily by PrioNet Canada a Network of Centres of Excellence of Canada (www.nce-rce.gc.ca). Additional funding and support was provided by Saskatchewan Ministry of Environment (http://environment gov sk ca/) and the Canadian Wildlife Health Cooperative (http://www.ccwhc ca/). MFMS received a scholarship funding from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; ALBON SD, 1992, J ANIM ECOL, V61, P131, DOI 10.2307/5516; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson A. E., 1984, MAMMALIAN SPECIES, V219, P1, DOI DOI 10.2307/3504024; Barton K., 2015, PACKAGE MUMIN MULTIM, P63; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Best EC, 2014, ANIM BEHAV, V89, P1, DOI 10.1016/j.anbehav.2013.12.011; Biosa D, 2015, J ZOOL, V296, P30, DOI 10.1111/jzo.12214; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Bonnot N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014436; Bouwman KM, 2010, BIOL LETTERS, V6, P462, DOI 10.1098/rsbl.2010.0020; Bowyer RT, 2001, ALCES-N AM MOOSE CON, V37, P371; Bullard F, 1991, ESTIMATING HOME RANG; Burnham KP, 2003, MODEL SELECTION MULT, P149; Calenge C., 2015, HOME RANGE ESTIMATIO, P61; Calenge C, 2015, ANAL HABITAT SELECTI, P224; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canadian Wildlife Health Cooperative, 2017, CHRON WAST DIS TEST; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; Castles M, 2014, ANIM BEHAV, V96, P59, DOI 10.1016/j.anbehav.2014.07.023; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Colson KE, 2016, J MAMMAL, V97, P788, DOI 10.1093/jmammal/gyw006; Colson KE, 2013, CONSERV GENET, V14, P439, DOI 10.1007/s10592-012-0388-0; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; COWAN I. M., 1961, JOUR MAMMAL, V42, P522, DOI 10.2307/1377372; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Cullingham CI, 2011, CAN J ZOOL, V89, P134, DOI 10.1139/Z10-104; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; DASMANN RAYMOND F., 1956, JOUR WILDLIFE MANAGEMENT, V20, P78, DOI 10.2307/3797252; DEVOS A, 1967, AM MIDL NAT, V77, P390, DOI 10.2307/2423349; Dixon JS., 1934, STUDY LIFE HIST FOOD; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Environmental Systems Research Institute (ESRI), 2016, ARCGIS DESKT REL 10; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; Geremia C, 2015, J WILDLIFE DIS, V51, P801, DOI 10.7589/2014-12-284; Government of Canada, 2014, CAN CLIM NORM 1981 2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Iacolina L, 2009, J MAMMAL, V90, P666, DOI 10.1644/08-MAMM-A-074R1.1; Jensen W., 1996, N DAKOTA OUTDOORS, P2; Lingle S, 2003, CAN J ZOOL, V81, P1119, DOI 10.1139/Z03-097; Linsdale JM, 1953, HERD MULE DEER RECOR; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Magle SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056568; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0111; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Podgorski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099875; PORTER WF, 1991, ENVIRON MANAGE, V15, P809, DOI 10.1007/BF02394818; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Powell JH, 2013, WILDLIFE BIOL, V19, P102, DOI 10.2981/11-081; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; Salazar MFM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150830; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Schauber EM, 2015, J MAMMAL, V96, P16, DOI 10.1093/jmammal/gyu027; Schreuder BEC, 1998, VET REC, V142, P564, DOI 10.1136/vr.142.21.564; Seidel KD., 1992, THESIS; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Skelton NK, 2010, MIGRATION DISPERSAL; Smith JE, 2014, ANIM BEHAV, V92, P291, DOI 10.1016/j.anbehav.2014.02.029; Statistics Canada, 2017, ROAD NETW FIL 2016; Strickland K, 2014, ANIM BEHAV, V97, P53, DOI 10.1016/j.anbehav.2014.08.009; Thomsen BV, 2012, J VET DIAGN INVEST, V24, P878, DOI 10.1177/1040638712453582; Vander Wal E, 2016, BEHAV ECOL, V27, P560, DOI 10.1093/beheco/arv193; Vander Wal E, 2012, MOL ECOL, V21, P1271, DOI 10.1111/j.1365-294X.2011.05431.x; WACHTEL MA, 1978, BIOL BEHAV, V3, P319; Weather Spark, 2016, DAIL WEATH DAT SWIFT; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 2008, ANAL ANIMAL SOC QUAN; Whitehead H., 2014, SOCPROG PROGRAMS ANA, P83; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123	90	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175385	10.1371/journal.pone.0175385	http://dx.doi.org/10.1371/journal.pone.0175385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388681	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800047
J	Ahn, BS; Park, SY; Park, JM; Choi, CH; Chun, M; Kim, JI				Ahn, Beom Seok; Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in			Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets	PLOS ONE			English	Article							PROSTATE-CANCER; TREATMENT PLANS; RADIOTHERAPY; IMRT; RAPIDARC; VMAT	Purpose To calculate an optimal collimator angle at each of sectional arcs in a full-arc volumetric modulated arc therapy (VMAT) plan and evaluate dosimetric quality of these VMAT plans comparing full-arc VMAT plans with a fixed collimator angle. Methods Seventeen patients who had irregularly-shaped target in abdominal, head and neck, and chest cases were selected retrospectively. To calculate an optimal collimator angle at each of sectional arcs in VMAT, integrated MLC apertures which could cover all shapes of target determined by beam's-eye view (BEV) within angular sections were obtained for each VMAT plan. The angular sections were 40 degrees, 60 degrees, 90 degrees and 120 degrees. When the collimator settings were rotated at intervals of 2 degrees, we obtained the optimal collimator angle to minimize area size difference between the integrated MLC aperture and collimator settings with 5 mm-margins to the integrated MLC aperture. The VMAT plans with the optimal collimator angles (Colli-VMAT) were generated in the Eclipse (TM). For comparison purposes, one full-arc VMAT plans with a fixed collimator angles (Std-VMAT) were generated. The dose-volumetric parameters and total MUs were evaluated. Results The mean dose-volumetric parameters for target volume of Colli-VMAT were comparable to Std-VMAT. Colli-VMAT improved sparing of most normal organs but for brain stem, compared to Std-VMAT for all cases. There were decreasing tendencies in mean total MUs with decreasing angular section. The mean total MUs for Colli-VMAT with the angular section of 40 degrees (434 +/- 95 MU, 317 +/- 81 MU, and 371 +/- 43 MU for abdominal, head and neck, and chest cases, respectively) were lower than those for Std-VMAT (654 +/- 182 MU, 517 +/- 116 MU, and 533 +/- 25 MU, respectively). Conclusions For an irregularly-shaped target, Colli-VMAT with the angular section of 40 degrees reduced total MUs and improved sparing of normal organs, compared to Std-VMAT.	[Ahn, Beom Seok; Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ, Biomed Res Inst, Coll Med, Seoul, South Korea; [Park, So-Yeon; Park, Jong Min; Choi, Chang Heon; Chun, Minsoo; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min] Adv Inst Convergence Technol, Ctr Convergence Res Robot, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.	madangin@gmail.com	Chun, Minsoo/C-4493-2014	Chun, Minsoo/0000-0001-8578-9976	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1C1A1A02036331]; National Research Foundation of Korea (NRF); Korean government (MEST) [2016M2A2A7952290]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. 2015R1C1A1A02036331) and by a grant from the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST, grant no. 2016M2A2A7952290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allisy A., 1993, J INT COMMISSION RAD, V26, DOI 10.1093/jicru/ndq001; Bortfeld T, 2009, PHYS MED BIOL, V54, pN9, DOI 10.1088/0031-9155/54/1/N02; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; de Boer J, 2015, INT J RADIAT ONCOL, V91, P1009, DOI 10.1016/j.ijrobp.2014.11.020; Fogliata A, 2008, RADIOTHER ONCOL, V89, P254, DOI 10.1016/j.radonc.2008.07.021; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Holtzer N, 2012, INT J RADIAT ONCOL, V84, pS28, DOI 10.1016/j.ijrobp.2012.07.079; Kim H, 2014, RADIAT ONCOL J, V32, P187, DOI 10.3857/roj.2014.32.3.187; Kim YS, 2016, RADIAT ONCOL J, V34, P18, DOI 10.3857/roj.2016.34.1.18; Kjaer-Kristoffersen F, 2009, ACTA ONCOL, V48, P227, DOI 10.1080/02841860802266748; Mattes MD, 2016, RADIAT ONCOL J, V34, P145, DOI 10.3857/roj.2015.01592; Ostheimer C, 2016, RADIAT ONCOL J, V34, P313, DOI 10.3857/roj.2016.01935; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Paik EK, 2015, RADIAT ONCOL J, V33, P233, DOI 10.3857/roj.2015.33.3.233; Park JM, 2012, BRIT J RADIOL, V85, pE323, DOI 10.1259/bjr/19088580; Park JM, 2014, BRIT J RADIOL, P87; Park JM, 2012, MED PHYS, V39, P1265, DOI 10.1118/1.3682172; Park JM, 2011, J APPL CLIN MED PHYS, V12, P147, DOI 10.1120/jacmp.v12i4.3563; Schneider U, 2005, INT J RADIAT ONCOL, V61, P1510, DOI 10.1016/j.ijrobp.2004.12.040; 김동욱, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P295, DOI 10.14316/pmp.2013.24.4.295; Treutwein M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-108; Varian Medical Systems, 2015, ECL PHOT EL INST USE; Yoon M, 2010, INT J RADIAT ONCOL, V77, P1477, DOI 10.1016/j.ijrobp.2009.07.011; Zhang PP, 2010, INT J RADIAT ONCOL, V77, P591, DOI 10.1016/j.ijrobp.2009.08.056	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174924	10.1371/journal.pone.0174924	http://dx.doi.org/10.1371/journal.pone.0174924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384262	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900054
J	Ding, PH; Darveau, RP; Wang, CY; Jin, LJ				Ding, Pei-Hui; Darveau, Richard P.; Wang, Cun-Yu; Jin, Lijian			3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; EPITHELIAL-CELLS; INNATE IMMUNITY; EXPRESSION; RECOGNITION; ACTIVATION; MEMBRANES; MOLECULE; MD-1; LBP	Lipopolysaccharide (LPS)-binding protein (LBP) as an acute-phase protein plays a crucial role in innate host response to bacterial challenge. Our previous study shows that LBP expression in human gingiva is associated with periodontal status. Porphyromonas gingivalis is a keystone periodontopathogen, and its LPS with lipid A structural heterogeneity critically accounts for periodontal pathogenesis. This study investigated the effects of LBP and its interactions with two featured isoforms of P. gingivalis LPS (tetra-acylated LPS1435/1449 and penta-acylated LPS1690) on the expression of pro-inflammatory cytokines in human oral keratinocytes (HOKs), and the involvement of Toll-like receptor (TLR) signaling. HOKs were pre-incubated with recombinant human LBP (rhLBP) at 10ng/ml, 100ng/ml and 1 mu g/ml for 1 h, followed by the treatment of P. gingivalis LPS1690 or LPS1435/1449 for 3h or 24h respectively. The expression of IL-6 and IL-8, and involvements of TLR2 and TLR4 were analyzed. The genes associated with TLR signaling were assessed by PCR array. Interestingly, rhLBP per se significantly up-egulated the expression of IL-6 and IL-8 in HOKs (p<0.05), which was blocked by TLR2 antibody (p<0.001). LPS1435/1449 down-regulated more significantly rhLBP-induced IL-6 and IL-8 mRNAs with reference to P. gingivalis LPS1690 (approximately 80% vs. 40%, p<0.05; and 90% vs. 36%, p<0.001, respectively). Moreover, rhLBP markedly down-regulated the gene expression of TLRs and their adaptors such as CD180 (-2.44 folds) and MD-1 (-9.62 folds), while the interaction of P. gingivalis LPS1435/1449 with rhLBP greatly up-regulated both transcripts (7.11 and 4.05 folds, respectively). Notably, P. gingivalis LPS1690-rhLBP interaction dramatically upregulated CD180 transcript (20.86 folds) and significantly down-regulated MD-1 transcript (-6.93 folds). This pioneering study shows that rhLBP enables to enhance the expression of pro-inflammatory cytokines in HOKs through TLR2 signaling pathway. P. gingivalis LPS with different lipid A structures down-regulates to different extents rhLBP-induced cytokine expression, possibly through fine-tuning of the CD180-MD1 complex and relevant TLRs.	[Ding, Pei-Hui] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Periodontol, Hangzhou, Zhejiang, Peoples R China; [Ding, Pei-Hui; Jin, Lijian] Univ Hong Kong, Discipline Periodontol, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Darveau, Richard P.] Univ Washington, Sch Dent, Dept Periodont, D-570,Hlth Sci Bldg, Seattle, WA 98195 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, CHS, Dept Oral Biol & Med, Room 33-030, Los Angeles, CA 90024 USA	Zhejiang University; University of Hong Kong; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Jin, LJ (corresponding author), Univ Hong Kong, Discipline Periodontol, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	ljjin@hku.hk	Ding, Pei-Hui/CAG-8041-2022		Hong Kong Research Grants Council [768411M, 768713M, 17155216]; Modern Dental Laboratory/HKU Endowment Fund	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund	This study has been supported by the Hong Kong Research Grants Council (General Research Funds 768411M, 768713M and 17155216) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ.; This study has been supported by the Hong Kong Research Grants Council (General Research Funds 768411M, 768713M and 17155216) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The authors have declared that no competing interests exist.	Ahren IL, 2001, J INFECT DIS, V184, P926, DOI 10.1086/323398; Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Curtis MA, 2011, INFECT IMMUN, V79, P1187, DOI 10.1128/IAI.00900-10; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Ding PH, 2013, MOL ORAL MICROBIOL, V28, P129, DOI 10.1111/omi.12010; Ding PH, 2013, INNATE IMMUN-LONDON, V19, P66, DOI 10.1177/1753425912450348; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gutsmann T, 2001, BIOL CHEM, V382, P425, DOI 10.1515/BC.2001.052; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Miyake K, 1998, J IMMUNOL, V161, P1348; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Nagai Y, 2005, J IMMUNOL, V174, P7043, DOI 10.4049/jimmunol.174.11.7043; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Ren L, 2005, J PERIODONTOL, V76, P1950, DOI 10.1902/jop.2005.76.11.1950; Ren L, 2005, J PERIODONTAL RES, V40, P407, DOI 10.1111/j.1600-0765.2005.00822.x; Ren L, 2004, J PERIODONTAL RES, V39, P242, DOI 10.1111/j.1600-0765.2004.00732.x; Roes S, 2006, J BIOL CHEM, V281, P2757, DOI 10.1074/jbc.M507634200; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Vreugdenhil ACE, 2000, J IMMUNOL, V165, P4561, DOI 10.4049/jimmunol.165.8.4561; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173223	10.1371/journal.pone.0173223	http://dx.doi.org/10.1371/journal.pone.0173223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4YU	28384159	Green Published, gold, Green Submitted			2022-12-26	WOS:000416013800001
J	Nyflot, LT; Stray-Pedersen, B; Forsen, L; Vangen, S				Nyflot, Lill Trine; Stray-Pedersen, Babill; Forsen, Lisa; Vangen, Siri			Duration of labor and the risk of severe postpartum hemorrhage: A case-control study	PLOS ONE			English	Article							PROLONGED 2ND-STAGE; ELECTIVE INDUCTION; OXYTOCIN RECEPTORS; PROGRESSION; MORBIDITY; DELIVERY	Objective Our main objective was to investigate the association between duration of active labor and severe postpartum hemorrhage. We examined the effect of the total duration of active labor, the effect of each stage of active labor, and the gradient effect of duration of labor on severe postpartum hemorrhage. Methods A case-control study was generated from a source population of all women admitted for delivery at Oslo University Hospital and Drammen Hospital in Buskerud municipality during the time period January 1, 2008 to December 31, 2011. The study population included all cases of severe postpartum hemorrhage (n = 859) and a random sample of controls (n = 1755). Severe postpartum hemorrhage was defined as postpartum blood loss >= 1500 mL or need for blood transfusion. Prolonged labor was defined as duration of active labor >12 hours according to the definition of the World Health Organization. We used logistic multi-variable regression in the analysis. Results We observed a significantly longer mean duration of labor in women who experienced severe postpartum hemorrhage compared to controls (5.4 versus 3.8 hours, p<0.001). Women with severe postpartum hemorrhage also had a longer duration of all stages of active labor compared to controls. The association between the duration of active labor and severe postpartum changed from a linear dose-response association to a threshold association after adjusting for augmentation with oxytocin, induction of labor, primiparity, and fever during labor. Compared to controls, women with severe postpartum hemorrhage were more likely to have a prolonged labor >12 hours (adjusted odds ratio = 2.44, 95% confidence interval: 1.69-3.53, p< 0.001). Conclusion Prolonged active labor (duration > 12 hours) was associated with severe postpartum hemorrhage. Increased vigilance seems required when the labor is prolonged to reduce the risk of severe postpartum hemorrhage.	[Nyflot, Lill Trine] Oslo Univ Hosp, Div Obstet & Gynecol, Oslo, Norway; [Nyflot, Lill Trine; Stray-Pedersen, Babill; Vangen, Siri] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Forsen, Lisa] Norwegian Inst Publ Hlth, Oslo, Norway; [Forsen, Lisa; Vangen, Siri] Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Nyflot, LT (corresponding author), Oslo Univ Hosp, Div Obstet & Gynecol, Oslo, Norway.; Nyflot, LT (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	l.t.nyflot@medisin.uio.no			South Eastern Norway Regional Health Authority	South Eastern Norway Regional Health Authority	This work was supported by the South Eastern Norway Regional Health Authority (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority). The funding source had no role in the design, collection, analysis and interpretation of data, or writing of or decision to submit the article for publication.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Altman MR, 2006, BIRTH-ISS PERINAT C, V33, P315, DOI 10.1111/j.1523-536X.2006.00129.x; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Bergstrom S, 2003, J NUTR, V133, p1656S, DOI 10.1093/jn/133.5.1656S; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Cheng Y, 2009, AM J OBSTET GYNECOL, V201, pS46, DOI 10.1016/j.ajog.2009.10.097; Cheng YW, 2007, AM J OBSTET GYNECOL, V196, P585, DOI 10.1016/j.ajog.2007.03.021; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Harper LM, 2012, OBSTET GYNECOL, V119, P1113, DOI 10.1097/AOG.0b013e318253d7aa; Hoffman MK, 2006, OBSTET GYNECOL, V107, P1029, DOI 10.1097/01.AOG.0000210528.32940.c6; Janni W, 2002, ACTA OBSTET GYN SCAN, V81, P214, DOI 10.1034/j.1600-0412.2002.810305.x; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Kleinbaum DG, 1982, PRINCIPLES QUANTITAT; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Laughon SK, 2012, AM J OBSTET GYNECOL, V206, pe1, DOI DOI 10.1016/J.AJ0G.2012.03.003; Le Ray C, 2011, EUR J OBSTET GYN R B, V158, P167, DOI 10.1016/j.ejogrb.2011.04.035; Magalhaes JKRS, 2009, REPROD SCI, V16, P501, DOI 10.1177/1933719108329954; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Moore J, 2012, J PERINAT NEONAT NUR, V26, P242, DOI 10.1097/JPN.0b013e31826288a9; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x; ODriscoll K, 1980, ACTIVE MANAGEMENT LA; Phaneuf S, 2000, J REPROD FERTIL, V120, P91, DOI 10.1530/reprod/120.1.91; Phaneuf S, 1997, J ENDOCRINOL, V154, P7, DOI 10.1677/joe.0.1540007; STONES RW, 1993, EUR J OBSTET GYN R B, V48, P15, DOI 10.1016/0028-2243(93)90047-G; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; World Health Organization, 2006, MAN PROL OBSTR LAB; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	34	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175306	10.1371/journal.pone.0175306	http://dx.doi.org/10.1371/journal.pone.0175306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384337	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000399371900151
J	Piedra-Carrasco, N; Fabrega, A; Calero-Caceres, W; Cornejo-Sanchez, T; Brown-Jaque, M; Mir-Cros, A; Muniesa, M; Gonzalez-Lopez, JJ				Piedra-Carrasco, Nuria; Fabrega, Anna; Calero-Caceres, William; Cornejo-Sanchez, Thais; Brown-Jaque, Maryury; Mir-Cros, Alba; Muniesa, Maite; Jose Gonzalez-Lopez, Juan			Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; PREVALENCE; DIVERSITY; VIRULENCE; PLASMIDS; SUSCEPTIBILITY; IDENTIFICATION	The increasing resistance to carbapenems is an alarming threat in the fight against multiresistant bacteria. The dissemination properties of antimicrobial resistance genes are supported by their detection in a diverse population of bacteria, including strains isolated from the environment. The objective of this study was to investigate the presence of carbapenemase- producing Enterobacteriaceae (CPE) collected from a river ecosystem in the Barcelona metropolitan area (Spain). Identification of beta-lactamases and other resistance determinants was determined as was the antimicrobial susceptibility profile. Moreover, screening of virulence factors, plasmid addiction systems, plasmid partition systems and replicon typing was performed. The results identified 8 isolates belonging to different species (Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella oxytoca, Raoultella ornithinolytica). The most prevalent enzyme was KPC-2 (n = 6), followed by VIM-1 (n = 2) and IMI-2 (n = 1), whereas no OXA-48-type was detected. In addition, one strain was positive for both KPC-2 and VIM-1 enzymes. All the carbapenemase- encoding plasmids carried at least one plasmid addiction or partition system, being vagCD and parAB the most frequently detected, respectively. E. coli and K. pneumoniae isolates carried a low number of virulence-associated factors and none of the detected clones has previously been identified in the clinical setting. These findings support the high dissemination potential of the carbapanemase-encoding genes and reinforce the idea that the environment is another reservoir that may play an important role in the capture, selection and dissemination of carbapenem resistance genes.	[Piedra-Carrasco, Nuria; Fabrega, Anna; Cornejo-Sanchez, Thais; Mir-Cros, Alba; Jose Gonzalez-Lopez, Juan] Univ Autonoma Barcelona, VHIR, Hosp Vall dHebron, Dept Clin Microbiol, Barcelona, Spain; [Calero-Caceres, William; Brown-Jaque, Maryury; Muniesa, Maite] Univ Barcelona, Dept Genet Microbiol & Stat, Fac Biol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona	Fabrega, A; Gonzalez-Lopez, JJ (corresponding author), Univ Autonoma Barcelona, VHIR, Hosp Vall dHebron, Dept Clin Microbiol, Barcelona, Spain.	anna.fabrega@vhir.org; jjgonzal@vhebron.net	González-López, Juanjo/C-5366-2014; Fàbrega-Santamaria, Anna/W-7009-2018; Muniesa, Maite/K-4577-2014; Brown, Maryury/AAA-2827-2020; Cáceres, William Calero/K-8827-2015	González-López, Juanjo/0000-0003-2419-5909; Fàbrega-Santamaria, Anna/0000-0002-3866-2291; Muniesa, Maite/0000-0001-5549-1394; Cáceres, William Calero/0000-0003-3819-9206; Brown Jaque, Maryury Andrea/0000-0002-9236-5247	Ministerio de Economia y Competitividad; Institute de Salud Carlos III; European Regional Development Fund (ERDF) 'A Way to Achieve Europe'; Spanish Network for Research in Infectious Diseases; Spanish Ministry of Health [FIS PI15/00604]; REIPI [RD12/0015/0003]; hD fellowship SENESCYT from the Republic of Ecuador Government; grant from COLCIENCIAS (Republic of Colombia)	Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (ERDF) 'A Way to Achieve Europe'; Spanish Network for Research in Infectious Diseases; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); REIPI; hD fellowship SENESCYT from the Republic of Ecuador Government; grant from COLCIENCIAS (Republic of Colombia)	This study was supported by the Ministerio de Economia y Competitividad (littp:// www.mineco.gob.es/), Institute de Salud Carlos III (http://www.isciii.es/), co-financed by the European Regional Development Fund (ERDF) 'A Way to Achieve Europe' (http://ec.europa.eu/regional_policy/en/funding/erdf/), the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0003) (http://reipi.org/), and the Spanish Ministry of Health (FIS PI15/00604 to JGL). NPC is financially supported by the REIPI RD12/0015/0003. WC-C is recipient of PhD fellowship SENESCYT 2012 from the Republic of Ecuador Government. MB-J has a grant from COLCIENCIAS (Republic of Colombia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2015, CLIN MICROBIOL INFEC, V21, P230, DOI 10.1016/j.cmi.2014.10.008; Adler A, 2014, CLIN MICROBIOL INFEC, V20, pO516, DOI 10.1111/1469-0691.12560; Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; Aubron C, 2005, EMERG INFECT DIS, V11, P260, DOI 10.3201/eid1102.030684; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Calero-Caceres W, 2017, ENVIRON POLLUT, V223, P384, DOI 10.1016/j.envpol.2017.01.035; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123063; Chouchani C, 2013, SCAND J INFECT DIS, V45, P95, DOI 10.3109/00365548.2012.717712; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2016, PERFORMANCE STANDARD; Dolejska M, 2016, J ANTIMICROB CHEMOTH, V71, P63, DOI 10.1093/jac/dkv306; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, BREAKPOINT TABLES FO; Gonzalez-Gonzalez A, 2013, INFECT GENET EVOL, V13, P187, DOI 10.1016/j.meegid.2012.09.003; Gudeta DD, 2016, J ANTIMICROB CHEMOTH; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hansen DS, 2012, SCAND J INFECT DIS, V44, P174, DOI 10.3109/00365548.2011.632642; Hazen TH, 2014, ANTIMICROB AGENTS CH, V58, P4814, DOI 10.1128/AAC.02573-14; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kieffer N, 2016, ANTIMICROB AGENTS CH, V60, P2585, DOI 10.1128/AAC.02632-15; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Mnif B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-147; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Muniesa M, 2012, WATER RES, V46, P6410, DOI 10.1016/j.watres.2012.09.015; Oteo J, 2015, ANTIMICROB AGENTS CH, V59, P3406, DOI 10.1128/AAC.00086-15; Oteo J, 2014, ANTIMICROB AGENTS CH, V58, P3874, DOI 10.1128/AAC.02738-13; Papagiannitsis CC, 2012, INT J ANTIMICROB AG, V39, P178, DOI 10.1016/j.ijantimicag.2011.09.024; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Rojo-Bezares B, 2012, ANTIMICROB AGENTS CH, V56, P1146, DOI 10.1128/AAC.05478-11; Ruiz-Garbajosa P, 2016, J ANTIMICROB CHEMOTH, V71, P348, DOI 10.1093/jac/dkv355; Sabater S, 2015, CONTRIBUTIONS TO SCI, P161; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Walckenaer E, 2008, J MICROBIOL METH, V75, P405, DOI 10.1016/j.mimet.2008.07.011; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Yu YS, 2006, ANTIMICROB AGENTS CH, V50, P1610, DOI 10.1128/AAC.50.4.1610-1611.2006; Zhang XZ, 2012, DIAGN MICR INFEC DIS, V73, P204, DOI 10.1016/j.diagmicrobio.2012.02.007	41	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175246	10.1371/journal.pone.0175246	http://dx.doi.org/10.1371/journal.pone.0175246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380016	gold, Green Published, Green Submitted			2022-12-26	WOS:000399353500109
J	Pinero, JC; Souder, SK; Vargas, RI				Pinero, Jaime C.; Souder, Steven K.; Vargas, Roger I.			Vision-mediated exploitation of a novel host plant by a tephritid fruit fly	PLOS ONE			English	Article							BACTROCERA-CUCURBITAE DIPTERA; MELON FLY; FLIES DIPTERA; LOCATION; BEHAVIOR; BAIT; ECOLOGY; INSECT; APHIDS; PAPAYA	Shortly after its introduction into the Hawaiian Islands around 1895, the polyphagous, invasive fruit fly Bactrocera (Zeugodacus) cucurbitae (Coquillett) (Diptera: Tephritidae) was provided the opportunity to expand its host range to include a novel host, papaya (Carica papaya). It has been documented that female B. cucurbitae rely strongly on vision to locate host fruit. Given that the papaya fruit is visually conspicuous in the papaya agro-ecosystem, we hypothesized that female B. cucurbitae used vision as the main sensory modality to find and exploit the novel host fruit. Using a comparative approach that involved a series of studies under natural and semi-natural conditions in Hawaii, we assessed the ability of female B. cucurbitae to locate and oviposit in papaya fruit using the sensory modalities of olfaction and vision alone and also in combination. The results of these studies demonstrate that, under a variety of conditions, volatiles emitted by the novel host do not positively stimulate the behavior of the herbivore. Rather, vision seems to be the main mechanism driving the exploitation of the novel host. Volatiles emitted by the novel host papaya fruit did not contribute in any way to the visual response of females. Our findings highlight the remarkable role of vision in the host-location process of B. cucurbitae and provide empirical evidence for this sensory modality as a potential mechanism involved in host range expansion.	[Pinero, Jaime C.] Lincoln Univ, Cooperat Res & Extens, Jefferson City, MO 65101 USA; [Souder, Steven K.; Vargas, Roger I.] USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA	Lincoln University - Missouri; United States Department of Agriculture (USDA)	Pinero, JC (corresponding author), Lincoln Univ, Cooperat Res & Extens, Jefferson City, MO 65101 USA.	pineroj@lincolnu.edu		Pinero, Jaime/0000-0003-1069-5603	United States Department of Agriculture (USDA); Lincoln University Cooperative Extension and Research	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Lincoln University Cooperative Extension and Research	This study has been financed by the United States Department of Agriculture (USDA) and Lincoln University Cooperative Extension and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of a proprietary product does not constitute an endorsement or a recommendation by the USDA for its use. USDA is an equal opportunity provider and employer.	ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; Back E. A., 1917, USDA B, V491; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; BUSH GUY L., 1966, BULL MUS COMP ZOOL HARVARD UNIV, V134, P431; Carvalho FA, 2015, CLADISTICS, V31, P321, DOI 10.1111/cla.12095; Dhillon MK, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.40; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Dorn S., 2009, Biorational tree-fruit pest management, P85, DOI 10.1079/9781845934842.0085; Drew R., 2016, KEYS TROPICAL FRUIT; Fischer S, 2004, ENVIRON ENTOMOL, V33, P81, DOI 10.1603/0046-225X-33.1.81; Gassmann AJ, 2006, FUNCT ECOL, V20, P478, DOI 10.1111/j.1365-2435.2006.01118.x; Gish M, 2006, J INSECT BEHAV, V19, P143, DOI 10.1007/s10905-005-9009-9; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Jacquard C, 2013, BIOL INVASIONS, V15, P759, DOI 10.1007/s10530-012-0324-8; LIQUIDO NJ, 1989, J ECON ENTOMOL, V82, P213, DOI 10.1093/jee/82.1.213; Miller NW, 2004, ANN ENTOMOL SOC AM, V97, P1063, DOI 10.1603/0013-8746(2004)097[1063:SAOPBA]2.0.CO;2; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Otalora-Luna F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053120; Pinero JC, 2011, B ENTOMOL RES, V101, P373, DOI 10.1017/S0007485310000386; Pinero JC, 2006, ENTOMOL EXP APPL, V121, P261, DOI [10.1111/j.1570-8703.2006.00485.x, 10.1111/j.1570-7458.2006.00485.x]; Pinero JC, 2009, ENTOMOL EXP APPL, V133, P208, DOI 10.1111/j.1570-7458.2009.00912.x; Pinero JC, 2004, J INSECT BEHAV, V17, P493, DOI 10.1023/B:JOIR.0000042537.09796.5f; PROKOPY RJ, 1978, ENTOMOL EXP APPL, V24, P609, DOI 10.1007/BF02385116; Prokopy RJ, 2003, J ECON ENTOMOL, V96, P1485, DOI 10.1603/0022-0493-96.5.1485; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Reeves JL, 2011, ENVIRON ENTOMOL, V40, P855, DOI 10.1603/EN10212; Ryckewaert P, 2010, FRUITS, V65, P113, DOI 10.1051/fruits/20010006; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; SEVERIN H. H. P., 1914, Annals of the Entomological Society of America, V7, P178, DOI 10.1093/aesa/7.3.177; StatSoft Inc, 2013, STAT DAT AN SOFTW SY; TALLAMY DW, 2000, P SESS HOST SPEC TES, P11; VARGAS RI, 1990, J ECON ENTOMOL, V83, P1344, DOI 10.1093/jee/83.4.1344; VARGAS RI, 1991, J ECON ENTOMOL, V84, P1695, DOI 10.1093/jee/84.6.1695; Vayssieres J.F., 1999, THESIS; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	40	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174636	10.1371/journal.pone.0174636	http://dx.doi.org/10.1371/journal.pone.0174636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380069	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500054
J	Zhao, YJ; Healy, BC; Rotstein, D; Guttmann, CRG; Bakshi, R; Weiner, HL; Brodley, CE; Chitnis, T				Zhao, Yijun; Healy, Brian C.; Rotstein, Delia; Guttmann, Charles R. G.; Bakshi, Rohit; Weiner, Howard L.; Brodley, Carla E.; Chitnis, Tanuja			Exploration of machine learning techniques in predicting multiple sclerosis disease course	PLOS ONE			English	Article							SHORT-TERM DISABILITY; NATURAL-HISTORY; BRAIN ATROPHY; MRI; ABNORMALITIES; PROGRESSION; EVOLUTION	Objective To explore the value of machine learning methods for predicting multiple sclerosis disease course. Methods 1693 CLIMB study patients were classified as increased EDSS >= 1.5 (worsening) or not (non-worsening) at up to five years after baseline visit. Support vector machines (SVM) were used to build the classifier, and compared to logistic regression (LR) using demographic, clinical and MRI data obtained at years one and two to predict EDSS at five years follow-up. Results Baseline data alone provided little predictive value. Clinical observation for one year improved overall SVM sensitivity to 62% and specificity to 65% in predicting worsening cases. The addition of one year MRI data improved sensitivity to 71% and specificity to 68%. Use of non-uniform misclassification costs in the SVM model, weighting towards increased sensitivity, improved predictions (up to 86%). Sensitivity, specificity, and overall accuracy improved minimally with additional follow-up data. Predictions improved within specific groups defined by baseline EDSS. LR performed more poorly than SVM in most cases. Race, family history of MS, and brain parenchymal fraction, ranked highly as predictors of the non-worsening group. Brain T2 lesion volume ranked highly as predictive of the worsening group. Interpretation SVM incorporating short-term clinical and brain MRI data, class imbalance corrective measures, and classification costs may be a promising means to predict MS disease course, and for selection of patients suitable for more aggressive treatment regimens.	[Zhao, Yijun] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Healy, Brian C.; Rotstein, Delia; Guttmann, Charles R. G.; Bakshi, Rohit; Weiner, Howard L.; Chitnis, Tanuja] Brigham & Womens Hosp, Partners MS Ctr, Brookline, MA 02115 USA; [Healy, Brian C.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA	Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Chitnis, T (corresponding author), Brigham & Womens Hosp, Partners MS Ctr, Brookline, MA 02115 USA.	tchitnis@partners.org	Guttmann, Charles RG/J-3093-2018	Guttmann, Charles/0000-0002-7006-9762	National MS Society [RG-4256A4/2]; Pilot grant [PV2873]	National MS Society(National Multiple Sclerosis Society); Pilot grant	Drs. Healy and Chitnis would like to acknowledge Merck Serono Inc. for research support during the completion of this manuscript. This work is supported in part by grants from the National MS Society (RG-4256A4/2 (to TC) and Pilot grant PV2873 (to CB). The study funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs. Healy and Chitnis would like to acknowledge Merck Serono Inc. for research support during the completion of this manuscript. This work is supported in part by grants from the National MS Society (RG-4256A4/2 (to TC) and Pilot grant PV2873 (to CB). We would like to thank Mariann Polgar-Turcsanyi, MS, for her role in managing the Partners MS Center research database.	Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Bejarano B, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-67; Bergamaschi R, 2013, EUR J NEUROL, V20, P995, DOI 10.1111/ene.12020; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bosma LVAE, 2012, MULT SCLER J, V18, P345, DOI 10.1177/1352458511419880; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cristianini Na J S-T, 2000, INTRO SUPPORT VECTOR; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Gauthier SA, 2007, NEUROLOGY, V68, P2059, DOI 10.1212/01.wnl.0000264890.97479.b1; Gauthier SA, 2006, AUTOIMMUN REV, V5, P532, DOI 10.1016/j.autrev.2006.02.012; Gauthier SA, 2009, ARCH NEUROL-CHICAGO, V66, P234, DOI 10.1001/archneurol.2008.567; Gourraud PA, 2014, ANN NEUROLOGY; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hastie T., 2009, ELEMENTS STAT LEARNI, Vxxii; Healy BC, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/189624; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; Minneboo A, 2008, J NEUROL NEUROSUR PS, V79, P917, DOI 10.1136/jnnp.2007.124123; Mowry EM, 2011, NEUROL CLIN, V29, P279, DOI 10.1016/j.ncl.2011.01.001; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sormani MP, 2011, MULT SCLER J, V17, P541, DOI 10.1177/1352458510391837; Wei XC, 2002, J MAGN RESON IMAGING, V15, P203, DOI 10.1002/jmri.10053; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WOLFSON C, 1985, Neuroepidemiology, V4, P227, DOI 10.1159/000110234; WOLFSON C, 1987, Neuroepidemiology, V6, P101, DOI 10.1159/000110105; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341	32	79	83	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174866	10.1371/journal.pone.0174866	http://dx.doi.org/10.1371/journal.pone.0174866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379999	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500071
J	Acion, L; Kelmansky, D; van der Laan, M; Sahker, E; Jones, D; Arndt, S				Acion, Laura; Kelmansky, Diana; van der Laan, Mark; Sahker, Ethan; Jones, DeShauna; Arndt, Stephan			Use of a machine learning framework to predict substance use disorder treatment success	PLOS ONE			English	Article							DRUG-ABUSE; UNMET NEED; DISPARITIES; COMPLETION; RISK; ALCOHOL	There are several methods for building prediction models. The wealth of currently available modeling techniques usually forces the researcher to judge, a priori, what will likely be the best method. Super learning (SL) is a methodology that facilitates this decision by combining all identified prediction algorithms pertinent for a particular prediction problem. SL generates a final model that is at least as good as any of the other models considered for predicting the outcome. The overarching aim of this work is to introduce SL to analysts and practitioners. This work compares the performance of logistic regression, penalized regression, random forests, deep learning neural networks, and SL to predict successful substance use disorders (SUD) treatment. A nationwide database including 99,013 SUD treatment patients was used. All algorithms were evaluated using the area under the receiver operating characteristic curve (AUC) in a test sample that was not included in the training sample used to fit the prediction models. AUC for the models ranged between 0.793 and 0.820. SL was superior to all but one of the algorithms compared. An explanation of SL steps is provided. SL is the first step in targeted learning, an analytic framework that yields double robust effect estimation and inference with fewer assumptions than the usual parametric methods. Different aspects of SL depending on the context, its function within the targeted learning framework, and the benefits of this methodology in the addiction field are discussed.	[Acion, Laura; Kelmansky, Diana] Univ Buenos Aires, CONICET, Fac Ciencias Exactas Nat, Inst Calculo, Buenos Aires, DF, Argentina; [Acion, Laura; Sahker, Ethan; Jones, DeShauna; Arndt, Stephan] Univ Iowa, Iowa Consortium Substance Abuse Res & Evaluat, Iowa City, IA USA; [van der Laan, Mark] Univ Calif Berkeley, Div Biostat, Berkeley, CA USA; [Sahker, Ethan] Univ Iowa, Dept Psychol, Counseling Psychol Program, Iowa City, IA USA; [Sahker, Ethan] Univ Iowa, Quantitat Fdn, Coll Educ, Iowa City, IA USA; [Arndt, Stephan] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Psychiat, Iowa City, IA USA; [Arndt, Stephan] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Iowa; University of California System; University of California Berkeley; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Acion, L (corresponding author), Univ Buenos Aires, CONICET, Fac Ciencias Exactas Nat, Inst Calculo, Buenos Aires, DF, Argentina.; Acion, L (corresponding author), Univ Iowa, Iowa Consortium Substance Abuse Res & Evaluat, Iowa City, IA USA.	laura.acion@ic.fcen.uba.ar	Sahker, Ethan/AAC-5365-2020; Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204; Acion, Laura/0000-0001-5213-6012	Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship [2651/2014]; CONICET [2651/2014]	Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by Consejode Investigaciones Cientificas y Tecnicas Postdoctoral Fellowship 2651/2014 awarded to LA.; This work was partially funded by postdoctoral fellowship 2651/2014 awarded to Dr. Acion by CONICET. The authors thank all open source software developers that made the analysis possible.	Acion L, 2006, STAT MED, V25, P591, DOI 10.1002/sim.2256; Acion L, 2013, ADDICTION, V108, P1418, DOI 10.1111/add.12161; Aiello SK, 2015, CONTRIBUTIONS H2O TE; Alang SM, 2015, PSYCHIATR REHABIL J, V38, P293, DOI 10.1037/prj0000113; Arndt S, 2013, DRUG ALCOHOL DEPEN, V132, P547, DOI 10.1016/j.drugalcdep.2013.03.015; Bembom O, 2007, STAT APPL GENET MOL, V6; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brierley P, 2011, HERITAGE PROVIDER NE; Compton WM, 2003, AM J PSYCHIAT, V160, P890, DOI 10.1176/appi.ajp.160.5.890; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Evans E, 2009, EVAL PROGRAM PLANN, V32, P204, DOI 10.1016/j.evalprogplan.2008.12.003; Garnick DW, 2009, J SUBST ABUSE TREAT, V36, P265, DOI 10.1016/j.jsat.2008.06.008; Glasheen C, 2015, ADDICT BEHAV, V43, P42, DOI 10.1016/j.addbeh.2014.12.005; Goldklang S, 2003, J SUBST ABUSE TREAT, V25, P9, DOI 10.1016/S0740-5472(03)00050-3; Gowin JL, 2015, DRUG ALCOHOL DEPEN, V152, P93, DOI 10.1016/j.drugalcdep.2015.04.018; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Launay CP, 2015, EUR J INTERN MED, V26, P478, DOI 10.1016/j.ejim.2015.06.002; LeDell EE, 2016, H2OENSEMBLE H2O ENSE; LeDell EE, 2015, SCALABLE ENSEMBLE LE; Marzell MSE., 2016, J ETHN SUBST ABUSE, P1; National Institutes of Health, 2016, RES INSTR NIH OTHER; Pflueger MO, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0447-4; Polley EC., 2011, TARGETED LEARNING CA, P43; RCore Team, 2020, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rose S, 2011, WINE TRADE MEDIEVAL, P101; Rose S., 2016, HDB OF BIG DATA, P411; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Sahker E, 2017, DRUG ALCOHOL DEPEN, V171, P1, DOI 10.1016/j.drugalcdep.2016.11.022; Sahker E, 2016, ARCH WOMEN MENT HLTH, V19, P79, DOI 10.1007/s00737-015-0520-5; Sahker E, 2015, ADDICT BEHAV, V48, P25, DOI 10.1016/j.addbeh.2015.04.006; Sahker E, 2015, J AM COLL HEALTH, V63, P118, DOI 10.1080/07448481.2014.990970; SIMPSON DD, 1993, PSYCHOTHER, V30, P357, DOI 10.1037/0033-3204.30.2.357; Substance Abuse and Mental Health Services Administration, 2013, NEED REC SUBST TREAT; Substance Abuse and Mental Health Services Administration, 2012, NSDUH REP NEED REC S; United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Statistics, 2014, OFF APPL STAT TREATM; Wells K, 2001, AM J PSYCHIAT, V158, P2027, DOI 10.1176/appi.ajp.158.12.2027; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Zarkin GA, 2002, J SUBST ABUSE TREAT, V23, P261, DOI 10.1016/S0740-5472(02)00273-8	42	49	49	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175383	10.1371/journal.pone.0175383	http://dx.doi.org/10.1371/journal.pone.0175383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET0LV	28394905	Green Published, gold			2022-12-26	WOS:000399954800031
J	Diggle, CP; Martinez-Garay, I; Molnar, Z; Brinkworth, MH; White, E; Fowler, E; Hughes, R; Hayward, BE; Carr, IM; Watson, CM; Crinnion, L; Asipu, A; Woodman, B; Coletta, PL; Markham, AF; Dear, TN; Bonthron, DT; Peckham, M; Morrison, EE; Sheridan, E				Diggle, Christine P.; Martinez-Garay, Isabel; Molnar, Zoltan; Brinkworth, Martin H.; White, Ed; Fowler, Ewan; Hughes, Ruth; Hayward, Bruce E.; Carr, Ian M.; Watson, Christopher M.; Crinnion, Laura; Asipu, Aruna; Woodman, Ben; Coletta, P. Louise; Markham, Alexander F.; Dear, T. Neil; Bonthron, David T.; Peckham, Michelle; Morrison, Ewan E.; Sheridan, Eamonn			A tubulin alpha 8 mouse knockout model indicates a likely role in spermatogenesis but not in brain development	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATION; SERTOLI-CELLS; MICROTUBULES; MUTATIONS; ACETYLATION; SNAP29; TUBA8; MICE; ACETYLTRANSFERASE; DETYROSINATION	Tubulin alpha 8 (Tuba8) is the most divergent member of the highly conserved alpha tubulin family, and uniquely lacks two key post-translational modification sites. It is abundantly expressed in testis and muscle, with lower levels in the brain. We previously identified homozygous hypomorphic TUBA8 mutations in human subjects with a polymicrogyria (PMG) syndrome, suggesting its involvement in development of the cerebral cortex. We have now generated and characterized a Tuba8 knockout mouse model. Homozygous mice were confirmed to lack Tuba8 protein in the testis, but did not display PMG and appeared to be neurologically normal. In response to this finding, we re-analyzed the human PMG subjects using whole exome sequencing. This resulted in identification of an additional homozygous loss-of-function mutation in SNAP29, suggesting that SNAP29 deficiency, rather than TUBA8 deficiency, may underlie most or all of the neurodevelopmental anomalies in these subjects. Nonetheless, in the mouse brain, Tuba8 specifically localised to the cerebellar Purkinje cells, suggesting that the human mutations may affect or modify motor control. In the testis, Tuba8 localisation was cell-type specific. It was restricted to spermiogenesis with a strong acrosomal localization that was gradually replaced by cytoplasmic distribution and was absent from spermatozoa. Although the knockout mice were fertile, the localisation pattern indicated that Tuba8 may have a role in spermatid development during spermatogenesis, rather than as a component of the mature microtubule-rich flagellum itself.	[Diggle, Christine P.; Hayward, Bruce E.; Carr, Ian M.; Asipu, Aruna; Woodman, Ben; Coletta, P. Louise; Markham, Alexander F.; Dear, T. Neil; Bonthron, David T.; Morrison, Ewan E.; Sheridan, Eamonn] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England; [Martinez-Garay, Isabel; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Brinkworth, Martin H.] Univ Bradford, Sch Med Sci, Bradford, W Yorkshire, England; [White, Ed; Fowler, Ewan] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hughes, Ruth; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Watson, Christopher M.; Crinnion, Laura] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Martinez-Garay, Isabel] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Fowler, Ewan] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Hayward, Bruce E.] NIDDK, NIH, Bethesda, MD 20892 USA; [Dear, T. Neil] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Saint James's University Hospital; University of Leeds; University of Oxford; University of Bradford; University of Leeds; University of Leeds; Saint James's University Hospital; Cardiff University; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); South Australian Health & Medical Research Institute (SAHMRI)	Diggle, CP (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds, W Yorkshire, England.	c.p.diggle@leeds.ac.uk	Garay, Isabel Martinez/AAI-8951-2021; Molnar, Zoltan/J-7281-2012; Peckham, Michelle/J-4991-2015	Garay, Isabel Martinez/0000-0001-6849-7496; Molnar, Zoltan/0000-0002-6852-6004; Peckham, Michelle/0000-0002-3754-2028; Fowler, Ewan/0000-0001-5580-2156; Hughes, Ruth/0000-0001-6167-8286	WellcomeTrust [094279/Z/10/Z]; Medical Research Council [MR/L01629X/1, MR/N026039/1, 1371002] Funding Source: researchfish; MRC [MR/L01629X/1, MR/N026039/1] Funding Source: UKRI	WellcomeTrust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a research grant(094279/Z/10/Z) awarded to ES by the WellcomeTrust, https://wellcome.ac.uk/. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; BARRA HS, 1974, BIOCHEM BIOPH RES CO, V60, P1384, DOI 10.1016/0006-291X(74)90351-9; Bhagwat S, 2014, FERTIL STERIL, V101, P95, DOI 10.1016/j.fertnstert.2013.09.016; Braun A, 2010, AM J HUM GENET, V86, P819, DOI 10.1016/j.ajhg.2010.03.019; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Correa LM, 2002, TOXICOL SCI, V69, P175, DOI 10.1093/toxsci/69.1.175; De Gendt K, 2011, BIOL REPROD, V85, P934, DOI 10.1095/biolreprod.110.090704; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fuchs-Telem D, 2011, BRIT J DERMATOL, V164, P610, DOI 10.1111/j.1365-2133.2010.10133.x; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Khodiyar VK, 2007, GENOMICS, V90, P285, DOI 10.1016/j.ygeno.2007.04.008; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1985, J CELL BIOL, V100, P457, DOI 10.1083/jcb.100.2.457; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Luo JP, 2010, MOL REPROD DEV, V77, P348, DOI 10.1002/mrd.21153; McDonald-McGinn DM, 2013, J MED GENET, V50, P80, DOI 10.1136/jmedgenet-2012-101320; OKE BO, 1993, BIOL REPROD, V48, P621, DOI 10.1095/biolreprod48.3.621; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Session DR, 2001, FERTIL STERIL, V75, P669, DOI 10.1016/S0015-0282(00)01794-5; Sheridan E, 2010, AM J HUM GENET, V86, P822, DOI 10.1016/j.ajhg.2010.03.020; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Stanchi F, 2000, BIOCHEM BIOPH RES CO, V270, P1111, DOI 10.1006/bbrc.2000.2571; Tang El, 2014, ENDOCRINOLOGY; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Wakamiya M, 1998, HUM MOL GENET, V7, P1835, DOI 10.1093/hmg/7.12.1835; Watson CM, 2014, HUM MUTAT, V35, P434, DOI 10.1002/humu.22490; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Yamada D, 2006, MOL CELL BIOL, V26, P3610, DOI 10.1128/MCB.26.9.3610-3624.2006	36	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0174264	10.1371/journal.pone.0174264	http://dx.doi.org/10.1371/journal.pone.0174264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388629	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000399375800004
J	Suzuki, S; Nakajima, T; Irie, S; Ariyasu, R; Komiyama, T; Ohki, Y				Suzuki, Shinya; Nakajima, Tsuyoshi; Irie, Shun; Ariyasu, Ryohei; Komiyama, Tomoyoshi; Ohki, Yukari			Vestibular stimulation-induced facilitation of cervical premotoneuronal systems in humans	PLOS ONE			English	Article							SOLEUS H-REFLEX; PROPRIOSPINAL NEURONS; CORTICOSPINAL EXCITATION; VOLUNTARY CONTRACTION; EMG RESPONSES; SPINAL-CORD; CAT; FORELIMB; MODULATION; NERVE	It is unclear how descending inputs from the vestibular system affect the excitability of cervical interneurons in humans. To elucidate this, we investigated the effects of galvanic vestibular stimulation (GVS) on the spatial facilitation of motor-evoked potentials (MEPs) induced by combined pyramidal tract and peripheral nerve stimulation. To assess the spatial facilitation, electromyograms were recorded from the biceps brachii muscles (BB) of healthy subjects. Transcranial magnetic stimulation (TMS) over the contralateral primary motor cortex and electrical stimulation of the ipsilateral ulnar nerve at the wrist were delivered either separately or together, with interstimulus intervals of 10 ms (TMS behind). Anodal/cathodal GVS was randomly delivered with TMS and/or ulnar nerve stimulation. The combination of TMS and ulnar nerve stimulation facilitated BB MEPs significantly more than the algebraic summation of responses induced separately by TMS and ulnar nerve stimulation (i.e., spatial facilitation). MEP facilitation significantly increased when combined stimulation was delivered with GVS (p < 0.01). No significant differences were found between anodal and cathodal GVS. Furthermore, single motor unit recordings showed that the short-latency excitatory peak in peri-stimulus time histograms during combined stimulation increased significantly with GVS. The spatial facilitatory effects of combined stimulation with short interstimulus intervals (i.e., 10 ms) indicate that facilitation occurred at the premotoneuronal level in the cervical cord. The present findings therefore suggest that GVS facilitates the cervical interneuron system that integrates inputs from the pyramidal tract and peripheral nerves and excites motoneurons innervating the arm muscles.	[Suzuki, Shinya; Nakajima, Tsuyoshi; Irie, Shun; Ariyasu, Ryohei; Ohki, Yukari] Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan; [Suzuki, Shinya; Komiyama, Tomoyoshi] Tokyo Gakugei Univ, United Grad Sch Educ, Div Hlth & Sports Educ, Koganei, Tokyo, Japan; [Komiyama, Tomoyoshi] Chiba Univ, Fac Educ, Div Hlth & Sports Sci, Chiba, Chiba, Japan	Kyorin University; Tokyo Gakugei University; Chiba University	Nakajima, T (corresponding author), Kyorin Univ, Dept Integrat Physiol, Sch Med, Mitaka, Tokyo, Japan.	tsunakaj@ks.kyorin-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [25702033, 26560282, 23500617, 26120002]; Grants-in-Aid for Scientific Research [26120002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI: 25702033 and 26560282 (TN), 23500617 and 26120002 (YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1981, EXP NEUROL, V72, P592, DOI 10.1016/0014-4886(81)90008-X; Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P308, DOI 10.1007/BF00236286; AOYAMA M, 1971, BRAIN RES, V35, P250, DOI 10.1016/0006-8993(71)90612-3; ASHBY P, 1977, J NEUROL NEUROSUR PS, V40, P910, DOI 10.1136/jnnp.40.9.910; Baldissera F, 1990, Neuroreport, V1, P191, DOI 10.1097/00001756-199011000-00003; Blouin J, 2015, MULTISENS RES, V28, P487, DOI 10.1163/22134808-00002501; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Chiba R, 2013, ADV INTELL SYST, V194, P479; Coats A C, 1973, Adv Otorhinolaryngol, V19, P318; Cohen Bernard, 2011, Front Neurol, V2, P90, DOI 10.3389/fneur.2011.00090; Cohen J.E., 1988, STAT POWER ANAL BEHA; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; DAWSON GD, 1956, J PHYSIOL-LONDON, V131, P436, DOI 10.1113/jphysiol.1956.sp005473; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Delwaide PJ, 1973, HUMAN REFLEXES PATHO, V3, P336; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; DIETZ V, 1978, BRAIN RES, V142, P576, DOI 10.1016/0006-8993(78)90921-6; ERULKAR SD, 1966, J NEUROPHYSIOL, V29, P626, DOI 10.1152/jn.1966.29.4.626; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Ghanim Z, 2009, J APPL PHYSIOL, V106, P893, DOI 10.1152/japplphysiol.90594.2008; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GRACIES JM, 1991, J PHYSIOL-LONDON, V434, P151, DOI 10.1113/jphysiol.1991.sp018463; Hirschfeld H, 1997, J VESTIBUL RES-EQUIL, V7, P265, DOI 10.1016/S0957-4271(96)00180-2; Iglesias C, 2007, J PHYSIOL-LONDON, V582, P1361, DOI 10.1113/jphysiol.2007.133199; ILLERT M, 1981, EXP BRAIN RES, V42, P269; ILLERT M, 1977, EXP BRAIN RES, V29, P323; Kennedy PM, 2001, CLIN NEUROPHYSIOL, V112, P2159, DOI 10.1016/S1388-2457(01)00665-4; KERNELL D, 1990, BRAIN RES, V507, P176, DOI 10.1016/0006-8993(90)90542-J; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Lowrey CR, 2009, MUSCLE NERVE, V40, P213, DOI 10.1002/mus.21275; LUND S, 1983, ACTA PHYSIOL SCAND, V117, P307, DOI 10.1111/j.1748-1716.1983.tb07212.x; MACEFIELD G, 1989, BRAIN, V112, P1519, DOI 10.1093/brain/112.6.1519; MAEDA M, 1975, EXP BRAIN RES, V22, P69; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; MCILROY WE, 1995, NEUROSCI LETT, V184, P177, DOI 10.1016/0304-3940(94)11200-3; Nakajima T, 2005, BRAIN RES, V1053, P146, DOI 10.1016/j.brainres.2005.06.033; NAKAJIMA T, 2017, FRONT HUM NEUROSCI, V11; Nakajima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104910; Nicolas G, 2001, J PHYSIOL-LONDON, V533, P903, DOI 10.1111/j.1469-7793.2001.t01-1-00903.x; NIELSEN J, 1993, ACTA PHYSIOL SCAND, V147, P385, DOI 10.1111/j.1748-1716.1993.tb09515.x; Pauvert V, 1998, J PHYSIOL-LONDON, V508, P301, DOI 10.1111/j.1469-7793.1998.301br.x; PETERSON BW, 1971, BRAIN RES, V27, P373, DOI 10.1016/0006-8993(71)90264-2; Pierrot-Deseilligny E, 2002, MUSCLE NERVE, V26, P155, DOI 10.1002/mus.1240; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; PierrotDeseilligny E, 1996, PROG NEUROBIOL, V48, P489, DOI 10.1016/0301-0082(96)00002-0; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Sasada S, 2016, J NEUROPHYSIOL, V115, P2065, DOI 10.1152/jn.00638.2015; SCHOR RH, 1986, J NEUROPHYSIOL, V56, P1147, DOI 10.1152/jn.1986.56.4.1147; SCHOR RH, 1981, J NEUROPHYSIOL, V46, P167, DOI 10.1152/jn.1981.46.1.167; SHINODA Y, 1986, J COMP NEUROL, V249, P226, DOI 10.1002/cne.902490208; STEPHENS JA, 1976, NATURE, V263, P343, DOI 10.1038/263343a0; Stinear JW, 2004, MUSCLE NERVE, V29, P506, DOI 10.1002/mus.20003; SUZUKI JI, 1964, EXP NEUROL, V10, P393, DOI 10.1016/0014-4886(64)90031-7; Suzuki S, 2015, GALVANIC VESTIBULAR; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Tsushima E, 2013, METHODS MED DATA ANA; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Watson SRD, 2003, CLIN NEUROPHYSIOL, V114, P1456, DOI 10.1016/S1388-2457(03)00121-4; Watson SRD, 1997, ELECTROMYOGR MOTOR C, V105, P476, DOI 10.1016/S0924-980X(97)00044-1; WILSON VJ, 1988, PROG BRAIN RES, V76, P137; ZANETTE G, 1995, EVOKED POTENTIAL, V96, P114, DOI 10.1016/0168-5597(94)00212-W; Zink R, 1997, NEUROSCI LETT, V232, P171, DOI 10.1016/S0304-3940(97)00610-1	69	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175131	10.1371/journal.pone.0175131	http://dx.doi.org/10.1371/journal.pone.0175131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388686	Green Submitted, Green Published, gold			2022-12-26	WOS:000399375800022
J	Gao, P; Pinkston, KL; Bourgogne, A; Murray, BE; van Hoof, A; Harvey, BR				Gao, Peng; Pinkston, Kenneth L.; Bourgogne, Agathe; Murray, Barbara E.; van Hoof, Ambro; Harvey, Barrett R.			Functional studies of E-faecalis RNase J2 and its role in virulence and fitness	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; MESSENGER-RNA; BACILLUS-SUBTILIS; GENE-EXPRESSION; RESPONSE REGULATOR; BIOFILM FORMATION; RIBONUCLEASES J1; SERINE-PROTEASE; DEGRADATION; ANTIBODY	Post-transcriptional control provides bacterial pathogens a method by which they can rapidly adapt to environmental change. Dual exo- and endonucleolytic activities of RNase J enzymes contribute to Gram-positive RNA processing and decay. First discovered in Bacillus subtilis, RNase J1 plays a key role in mRNA maturation and degradation, while the function of the paralogue RNase J2 is largely unknown. Previously, we discovered that deletion of the Enterococcus faecalis rnjB gene significantly attenuates expression of a major virulence factor involved in enterococcal pathogenesis, the Ebp pili. In this work, we demonstrate that E. faecalis rnjB encodes an active RNase J2, and that the ribonuclease activity of RNase J2 is required for regulation of Ebp pili. To further investigate how rnjB affects E. faecalis gene expression on a global scale, we compared transcriptomes of the E. faecalis strain OG1RF with its isogenic rnjB deletion mutant (Delta rnjB). In addition to Ebp pili regulation, previously demonstrated to have a profound effect on the ability of E. faecalis to form biofilm or establish infection, we identified that rnjB regulates the expression of several other genes involved in bacterial virulence and fitness, including gls24 (a virulence factor important in stress response). We further demonstrated that the E. faecalis RNase J2 deletion mutant is more sensitive to bile salt and greatly attenuated in in vivo organ infection as determined by an IV-sublethal challenge infection mouse model, indicating that E. faecalis RNase J2 plays an important role in E. faecalis virulence.	[Gao, Peng; Pinkston, Kenneth L.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA; [Bourgogne, Agathe; Murray, Barbara E.; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA; [Murray, Barbara E.; van Hoof, Ambro; Harvey, Barrett R.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Mol Imaging, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA.; Harvey, BR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	barrett.harvey@uth.tmc		van Hoof, Ambro/0000-0002-7800-9764	John S. Dunn Foundation; National Institutes of Health (NIH) from NIAID [R01 AI047923-14, R01 GM099790]; National Science Foundation (NSF) [MCB-1020739]; Dunn Foundation; NIH from NIAID [R01 AI047923-14]; NSF [MCB-1020739]; NIH [R01 GM099790]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	John S. Dunn Foundation; National Institutes of Health (NIH) from NIAID; National Science Foundation (NSF)(National Science Foundation (NSF)); Dunn Foundation; NIH from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was provided in part by the John S. Dunn Foundation to BRH, the National Institutes of Health (NIH) grant R01 AI047923-14 from NIAID to BEM and grant R01 GM099790 to AvH, and by the National Science Foundation (NSF) grant MCB-1020739 to AvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for this work was provided in part by the Dunn Foundation to BRH, NIH grant R01 AI047923-14 from NIAID to BEM and NSF MCB-1020739, NIH R01 GM099790 to AvH.	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2007, J BACTERIOL, V189, P6490, DOI 10.1128/JB.00594-07; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Bugrysheva JV, 2010, MOL MICROBIOL, V75, P731, DOI 10.1111/j.1365-2958.2009.07012.x; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Condon C, 1996, P NATL ACAD SCI USA, V93, P6992, DOI 10.1073/pnas.93.14.6992; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Condon C, 2011, CURR OPIN MICROBIOL, V14, P148, DOI 10.1016/j.mib.2011.01.010; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Deikus G, 2008, J BIOL CHEM, V283, P17158, DOI 10.1074/jbc.M801461200; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Gao P, 2010, J BACTERIOL; Gao P, 2013, J BACTERIOL, V195, P4761, DOI 10.1128/JB.00706-13; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; Kinder M, 2015, MABS-AUSTIN, V7, P494, DOI 10.1080/19420862.2015.1022692; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; Newman JA, 2011, STRUCTURE, V19, P1241, DOI 10.1016/j.str.2011.06.017; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pinkston KL, 2014, INFECT IMMUN, V82, P1540, DOI 10.1128/IAI.01403-13; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Shioya K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023948; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; Sinturel F, 2009, RNA, V15, P2057, DOI 10.1261/rna.1670909; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Xu Y, 1997, INFECT IMMUN, V65, P4207, DOI 10.1128/IAI.65.10.4207-4215.1997; Yao SY, 2007, NUCLEIC ACIDS RES, V35, P4464, DOI 10.1093/nar/gkm460	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175212	10.1371/journal.pone.0175212	http://dx.doi.org/10.1371/journal.pone.0175212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384222	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900121
J	Kasaras, A; Kunze, R				Kasaras, Alexis; Kunze, Reinhard			Dual-targeting of Arabidopsis DMP1 isoforms to the tonoplast and the plasma membrane	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASES; ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; PLANT-CELLS; GOLGI NETWORK; K+ CHANNEL; PROTEIN; LOCALIZATION; TRANSPORTERS; THALIANA	The reports of dual-targeted proteins in plants have steadily increased over the past years. The vast majority of these proteins are soluble proteins distributed between compartments of the non-secretory pathway, predominantly chloroplasts and mitochondria. In contrast, dual-targeted transmembrane proteins, especially of the secretory pathway, are rare and the mechanisms leading to their differential targeting remain largely unknown. Here, we report dual-targeting of the Arabidopsis DUF679 Membrane Protein 1 (DMP1) to the tonoplast (TP) and the plasma membrane (PM). In Arabidopsis and tobacco two equally abundant DMP1 isoforms are synthesized by alternative translation initiation: a full length protein, DMP1.1, and a truncated one, DMP1.2, which lacks the N-terminal 19 amino acids including a TP-targeting dileucine motif. Accumulation of DMP1.1 and DMP1.2 in the TP and the PM, respectively, is Brefeldin A-sensitive, indicating transit via the Golgi. However, DMP1.2 interacts with DMP1.1, leading to extensive rerouting of DMP1.2 to the TP and "eclipsed" localization of DMP1.2 in the PM where it is barely visible by confocal laser scanning micros-copy but clearly detectable by membrane fractionation. It is demonstrated that eGFP fusion to either DMP1 terminus can cause mistargeting artifacts: C-terminal fusion to DMP1.1 or DMP1.2 results in altered ER export and N-terminal fusion to DMP1.1 causes mistargeting to the PM, presumably by masking of the TP targeting signal. These results illustrate how the interplay of alternative translation initiation, presence or absence of targeting information and rerouting due to protein-protein interaction determines the ultimate distribution of a transmembrane protein between two membranes.	[Kasaras, Alexis; Kunze, Reinhard] Free Univ Berlin, Inst Biol Appl Genet, DCPS, Berlin, Germany	Free University of Berlin	Kunze, R (corresponding author), Free Univ Berlin, Inst Biol Appl Genet, DCPS, Berlin, Germany.	reinhard.kunze@fu-berlin.de		Kunze, Reinhard/0000-0002-3304-5550	Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948) [KU715/10-2]	Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948)	This work was supported by the Deutsche Forschungsgemeinschaft (Forschergruppe FOR 948 grant no. KU715/10-2 to RK).	Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Carrie C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25034; Carrie C, 2009, FEBS J, V276, P1187, DOI 10.1111/j.1742-4658.2009.06876.x; Carrie C, 2013, BBA-MOL CELL RES, V1833, P253, DOI 10.1016/j.bbamcr.2012.05.029; Cho EJ, 2011, MOL CELLS, V32, P459, DOI 10.1007/s10059-011-0150-3; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; CREISSEN G, 1995, PLANT J, V8, P167, DOI 10.1046/j.1365-313X.1995.08020167.x; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Duchene AM, 2001, J BIOL CHEM, V276, P15275, DOI 10.1074/jbc.M011525200; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grefen C, 2012, BIOTECHNIQUES, V53, P311, DOI 10.2144/000113941; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; Hooks KB, 2012, J PLANT PHYSIOL, V169, P1631, DOI 10.1016/j.jplph.2012.05.026; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jung C, 2011, TRAFFIC, V12, P1774, DOI 10.1111/j.1600-0854.2011.01276.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kasaras A, 2010, PLANT BIOLOGY, V12, P140, DOI 10.1111/j.1438-8677.2010.00381.x; Kasaras A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-54; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Komarova NY, 2012, TRAFFIC, V13, P1090, DOI 10.1111/j.1600-0854.2012.01370.x; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Larisch N, 2012, TRAFFIC, V13, P1012, DOI 10.1111/j.1600-0854.2012.01366.x; Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Mackenzie SA, 2005, TRENDS CELL BIOL, V15, P548, DOI 10.1016/j.tcb.2005.08.007; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mikosch M, 2009, CURR OPIN PLANT BIOL, V12, P685, DOI 10.1016/j.pbi.2009.09.020; Mikosch M, 2009, TRAFFIC, V10, P1481, DOI 10.1111/j.1600-0854.2009.00962.x; Mitschke J, 2009, NEW PHYTOL, V183, P224, DOI 10.1111/j.1469-8137.2009.02832.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pedrazzini E, 2013, TRAFFIC, V14, P622, DOI 10.1111/tra.12051; Porter BW, 2015, PLANT SCI, V234, P174, DOI 10.1016/j.plantsci.2015.02.013; Puyaubert J, 2008, PLANT PHYSIOL, V146, P478, DOI 10.1104/pp.107.111534; Ratajczak R, 1999, PLANTA, V208, P205, DOI 10.1007/s004250050551; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Robert N, 2012, PLANT MOL BIOL, V78, P431, DOI 10.1007/s11103-012-9874-5; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Schwacke R, 2007, MOL GENET GENOMICS, V277, P631, DOI 10.1007/s00438-007-0214-4; Silva-Filho MC, 2003, CURR OPIN PLANT BIOL, V6, P589, DOI 10.1016/j.pbi.2003.09.008; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Suwastika IN, 2008, CELL STRUCT FUNCT, V33, P185, DOI 10.1247/csf.08024; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Teardo E, 2011, BBA-BIOENERGETICS, V1807, P359, DOI 10.1016/j.bbabio.2010.11.008; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Wamboldt Y, 2009, PLANT CELL, V21, P157, DOI 10.1105/tpc.108.063644; Wang H, 2011, MOL PLANT, V4, P845, DOI 10.1093/mp/ssr011; Wang XF, 2014, PLANT CELL, V26, P4102, DOI 10.1105/tpc.114.129759; Weichert A, 2012, PLANTA, V235, P311, DOI 10.1007/s00425-011-1508-7; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xicluna J, 2007, J BIOL CHEM, V282, P486, DOI 10.1074/jbc.M607607200; Yamada K, 2010, J BIOL CHEM, V285, P1138, DOI 10.1074/jbc.M109.054288; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yuen CYL, 2013, BIOMOLECULES, V3, P848, DOI 10.3390/biom3040848; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104	85	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174062	10.1371/journal.pone.0174062	http://dx.doi.org/10.1371/journal.pone.0174062			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384172	Green Submitted, Green Published, gold			2022-12-26	WOS:000399371900012
J	Li, L; Dai, XY; Wang, Y; Yang, YF; Zhao, X; Wang, L; Zeng, MH				Li, Lin; Dai, Xingyang; Wang, Ying; Yang, Yanfei; Zhao, Xia; Wang, Lei; Zeng, Minghua			RNA-seq-based analysis of drug-resistant Salmonella enterica serovar Typhimurium selected in vivo and in vitro	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; INFECTION MODEL; SYSTEMS; EFFLUX; ANTIMICROBIALS; MECHANISMS; MUTATIONS	The aim of this study was to characterize the mechanism of fluoroquinolone (FQ) resistance in Salmonella Typhimurium. We established the Caenorhabditis elegans-Salmonella Typhimurium model to select for ciprofloxacin resistance in Salmonella Typhimurium colonizing C. elegans, generating the resistant strains TN4. Gradient doses of ciprofloxacin were used to generate the resistant strain TW4 in vitro. RNA sequencing was used to establish the whole-transcriptome profile of three strains of Salmonella Typhimurium. The gene expression patterns of resistant strains TN4 and TW4 differed from those of the parental strain. In TN4, 2,277 genes were differentially expressed (1,833 upregulated and 444 downregulated) relative to the parental strain, and in TW4, 3,464 genes were differentially expressed (3,433 upregulated and 31 downregulated). Among these differentially expressed genes, 28 were associated with drug resistance and 26 were associated with the two-component systems in the two resistant strains. Seven different pathways were significantly sffected in two strains. Efflux pump overexpression was identified as one of the main mechanisms underlying FQ resistance in the two resistant strains. TW4 differentially expressed more efflux pump genes than TN4 and most of these genes were more strongly expressed than in TN4. However, expression of the efflux pump repressor gene and the mar operon was downregulated in TN4 but not in TW4. Two-component systems are also important in drug resistance. Our findings provide an important basis for further studies of the complex network that regulate FQ resistance in Salmonella.	[Li, Lin; Dai, Xingyang; Wang, Ying; Yang, Yanfei; Zhao, Xia; Wang, Lei; Zeng, Minghua] Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China	Anhui Agricultural University	Zeng, MH (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China.	zmhahau@126.com	yang, yanfei/GZK-2283-2022; Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240	National Natural Science Foundation of China [31201957]; Key Program in the Youth Elite Support Plan in Universities of Anhui Province [gxyqZD2016041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program in the Youth Elite Support Plan in Universities of Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (grant number 31201957) and the Key Program in the Youth Elite Support Plan in Universities of Anhui Province (grant number gxyqZD2016041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Chen S, 2007, ANTIMICROB AGENTS CH, V51, P535, DOI 10.1128/AAC.00600-06; CLSI, 2013, PERFORMANCE STANDARD; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; Epstein H F, 1995, CAENORHABDITIS ELEGA; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hu WS, 2011, ANTIMICROB AGENTS CH, V55, P3829, DOI 10.1128/AAC.00216-11; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nishino K, 2002, J BACTERIOL, V184, P2319, DOI 10.1128/JB.184.8.2319-2323.2002; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Olliver A, 2004, FEMS MICROBIOL LETT, V238, P267, DOI 10.1016/j.femsle.2004.07.046; Paulander W, 2007, ANTIMICROB AGENTS CH, V51, P766, DOI 10.1128/AAC.00615-06; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Randall LP, 2001, APPL ENVIRON MICROB, V67, P1190, DOI 10.1128/AEM.67.3.1190-1197.2001; ROSNER JL, 1994, J BACTERIOL, V176, P6262, DOI 10.1128/jb.176.20.6262-6269.1994; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Smith KP, 2009, ARCH MICROBIOL, V191, P903, DOI 10.1007/s00203-009-0521-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webber MA, 2001, ANTIMICROB AGENTS CH, V45, P1550, DOI 10.1128/AAC.45.5.1550-1552.2001	26	7	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175234	10.1371/journal.pone.0175234	http://dx.doi.org/10.1371/journal.pone.0175234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380031	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500108
J	Privett, AJ; Teixeira, ES; Stopera, C; Morales, JA				Privett, Austin J.; Teixeira, Erico S.; Stopera, Christopher; Morales, Jorge A.			Exploring water radiolysis in proton cancer therapy: Time-dependent, non-adiabatic simulations of H+ + (H2O) 1-6	PLOS ONE			English	Article							ELECTRON-NUCLEAR DYNAMICS; RELATIVE ENERGIES; CROSS-SECTIONS; DNA-DAMAGE; RADIATION; CLUSTERS; IONIZATION; COLLISIONS; HEXAMER; CAPTURE	To elucidate microscopic details of proton cancer therapy (PCT), we apply the simplest-level electron nuclear dynamics (SLEND) method to H+ + (H2O) 1-6 at E-Lab = 100 keV. These systems are computationally tractable prototypes to simulate water radiolysis reactions D i.e. the PCT processes that generate the DNA-damaging species against cancerous cells. To capture incipient bulk-water effects, ten (H2O)(1-6) isomers are considered, ranging from quasi-planar/ multiplanar (H2O) 1-6 to "smallest-drop" prism and cage (H2O)(6) structures. SLEND is a time-dependent, variational, non-adiabatic and direct method that adopts a nuclear classicalmechanics description and an electronic single-determinantal wavefunction in the Thouless representation. Short-time SLEND/6-31G* (n = 1-6) and /6-31G** (n = 1-5) simulations render cluster-to-projectile 1-electron-transfer (1-ET) total integral cross sections (ICSs) and 1ET probabilities. In absolute quantitative terms, SLEND/6-31G* 1-ET ICS compares satisfactorily with alternative experimental and theoretical results only available for n = 1 and exhibits almost the same accuracy of the best alternative theoretical result. SLEND/6-31G** overestimates 1-ET ICS for n = 1, but a comparable overestimation is also observed with another theoretical method. An investigation on H+ + H indicates that electron direct ionization (DI) becomes significant with the large virtual-space quasi-continuum in large basis sets; thus, SLEND/6-31G** 1-ET ICS is overestimated by DI contributions. The solution to this problem is discussed. In relative quantitative terms, both SLEND/6-31* and /6-31G** 1-ET ICSs precisely fit into physically justified scaling formulae as a function of the cluster size; this indicates SLEND's suitability for predicting properties of water clusters with varying size. Longtime SLEND/6-31G* (n = 1-4) simulations predict the formation of the DNA-damaging radicals H, OH, O and H3O. While "smallest-drop" isomers are included, no early manifestations of bulk water PCT properties are observed and simulations with larger water clusters will be needed to capture those effects. This study is the largest SLEND investigation on water radiolysis to date.	[Privett, Austin J.; Teixeira, Erico S.; Stopera, Christopher; Morales, Jorge A.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Privett, Austin J.] Lipscomb Univ, Dept Chem & Biochem, Nashville, TN USA; [Stopera, Christopher] Univ North Alabama, Dept Chem & Ind Hyg, Florence, AL, Italy	Texas Tech University System; Texas Tech University	Morales, JA (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	jorge.morales@ttu.edu	Teixeira, Erico Souza/AAS-9520-2020	Teixeira, Erico Souza/0000-0003-0520-5075	Science without Borders Fellowship Program of the National Council for Scientific and Technological Development of Brazil; Cancer Prevention and Research Institute of Texas [RP140478]	Science without Borders Fellowship Program of the National Council for Scientific and Technological Development of Brazil; Cancer Prevention and Research Institute of Texas	This work was supported by 1) Science without Borders Fellowship Program of the National Council for Scientific and Technological Development of Brazil, to EST, http://www.cienciasemfronteiras.gov.br/web/csf-eng/faq: 2) Cancer Prevention and Research Institute of Texas to JAM, grant: RP140478 http://www.cprit.state.tx.us/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Baccarelli I, 2007, ADV QUANTUM CHEM, V52, P189, DOI 10.1016/S0065-3276(06)52009-X; Bates DM, 2009, J PHYS CHEM A, V113, P3555, DOI 10.1021/jp8105919; Cabrera-Trujillo R, 2005, ADV QUANTUM CHEM, V48, P47, DOI 10.1016/S0065-3276(05)48005-3; Cabrera-Trujillo R, 2000, NUCL INSTRUM METH B, V168, P484, DOI 10.1016/S0168-583X(00)00064-1; Cabrera-Trujillo R, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.032719; Cabrera-Trujillo R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052714; Champion C, 2015, PHYS MED BIOL, V60, P7805, DOI 10.1088/0031-9155/60/20/7805; Champion C, 2012, PHYS MED BIOL, V57, P3039, DOI 10.1088/0031-9155/57/10/3039; Chang H, 2003, FREE RADICAL RES, V37, P655, DOI 10.1080/1071576031000094907; Child M. S., 1974, MOL COLLISION THEORY; Coutinho-Neto M, 2002, J CHEM PHYS, V116, P2794, DOI 10.1063/1.1434991; Dahlke EE, 2008, J PHYS CHEM A, V112, P3976, DOI 10.1021/jp077376k; DELOS JB, 1981, REV MOD PHYS, V53, P287, DOI 10.1103/RevModPhys.53.287; DEUMENS E, 1994, REV MOD PHYS, V66, P917, DOI 10.1103/RevModPhys.66.917; Dinesh Mayani Devanshi, 2011, J Oncol Pharm Pract, V17, P186, DOI 10.1177/1078155210375858; Fasso A, 2009, RADIAT PROT DOSIM, V137, P118, DOI 10.1093/rpd/ncp190; Flocke N, 2008, J COMPUT CHEM, V29, P2722, DOI 10.1002/jcc.21018; Friedland W, 2003, RADIAT RES, V159, P401, DOI 10.1667/0033-7587(2003)159[0401:SODDAP]2.0.CO;2; Garcia-Molina R, 2009, NUCL INSTRUM METH B, V267, P2647, DOI 10.1016/j.nimb.2009.05.038; Gillan MJ, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4944633; Girdhani S, 2013, RADIAT RES, V179, P257, DOI 10.1667/RR2839.1; Gobet F, 2006, CHEM PHYS LETT, V421, P68, DOI 10.1016/j.cplett.2006.01.016; Gobet F, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062716; Gobet F, 2001, PHYS REV LETT, V86, P3751, DOI 10.1103/PhysRevLett.86.3751; Hagelberg F, 2014, ELECT DYNAMICS MOL I; Hedstrom M, 1997, CHEM PHYS LETT, V279, P241, DOI 10.1016/S0009-2614(97)01010-5; Hincapie G, 2010, J PHYS CHEM A, V114, P7809, DOI 10.1021/jp103683m; Illescas C, 2012, J PHYS CONF SER, V388, DOI 10.1088/1742-6596/388/10/102007; Incerti S, 2010, MED PHYS, V37, P4692, DOI 10.1118/1.3476457; Jacquemin D, 1997, J CHEM PHYS, V107, P6146, DOI 10.1063/1.474343; Jakel O, 2009, RADIAT PROT DOSIM, V137, P156, DOI 10.1093/rpd/ncp192; Jungwirth P, 2000, J PHYS CHEM A, V104, P145, DOI 10.1021/jp993010z; Keutsch FN, 2003, CHEM REV, V103, P2533, DOI 10.1021/cr980125a; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Lee HM, 2000, J CHEM PHYS, V112, P9759, DOI 10.1063/1.481613; Levin WP, 2005, BRIT J CANCER, V93, P849, DOI 10.1038/sj.bjc.6602754; Liu XJ, 2011, CHEM PHYS LETT, V508, P270, DOI 10.1016/j.cplett.2011.04.055; LONGO R, 1994, CHEM PHYS LETT, V220, P305, DOI 10.1016/0009-2614(94)00171-5; LONGO R, 1993, J CHEM PHYS, V99, P4554, DOI 10.1063/1.466055; Losada M, 2002, J CHEM PHYS, V117, P2003, DOI 10.1063/1.1487371; Lotrich V, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2920482; Luna H, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042711; Maiti B, 2007, CHEM PHYS, V340, P105, DOI 10.1016/j.chemphys.2007.07.033; Mamone S, 2010, SYMMETRY-BASEL, V2, P1423, DOI 10.3390/sym2031423; Mclaurin PM, 2015, MOL PHYS, V113, P297, DOI 10.1080/00268976.2014.938709; McLaurin PM, 2011, THESIS; MORALES J, 1995, J CHEM PHYS, V103, P9968, DOI 10.1063/1.469886; Murakami M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.052704; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; Oi T, 2002, J NUCL SCI TECHNOL, V39, P419, DOI 10.3327/jnst.39.419; Perera SA, 2010, CHEM PHYS LETT, V496, P188, DOI 10.1016/j.cplett.2010.07.034; Perez C, 2012, SCIENCE, V336, P897, DOI 10.1126/science.1220574; Pichl L, 2004, IEEE T NUCL SCI, V51, P1407, DOI 10.1109/TNS.2004.832311; Privett AJ, 2014, CHEM PHYS LETT, V603, P82, DOI 10.1016/j.cplett.2014.04.018; Quinet O, 2009, INT J QUANTUM CHEM, V109, P259, DOI 10.1002/qua.21771; RUDD ME, 1985, PHYS REV A, V31, P492, DOI 10.1103/PhysRevA.31.492; Saykally RJ, 2012, SCIENCE, V336, P814, DOI 10.1126/science.1222007; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; SHAH MB, 1987, J PHYS B-AT MOL OPT, V20, P2481, DOI 10.1088/0022-3700/20/11/016; Shields RM, 2010, J PHYS CHEM A, V114, P11725, DOI 10.1021/jp104865w; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Solov'yov AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011909; Stopera C, 2013, ADV QUANTUM CHEM, V66, P113, DOI 10.1016/B978-0-12-408099-7.00003-9; Surdutovich E, 2010, EUR PHYS J D, V60, P101, DOI 10.1140/epjd/e2010-00232-3; Surdutovich E, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50004-0; Surdutovich E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051915; Szabo A., 2012, MODERN QUANTUM CHEM; Tabet J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022703; Tainter CJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4746157; THOULESS DJ, 1960, NUCL PHYS, V21, P225, DOI 10.1016/0029-5582(60)90048-1; TURNER JE, 1988, RADIAT PHYS CHEM, V32, P503; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Wang YM, 2012, J AM CHEM SOC, V134, P11116, DOI 10.1021/ja304528m; Watanabe R, 2002, RADIAT ENVIRON BIOPH, V41, P207, DOI 10.1007/s00411-002-0161-8; WERNER U, 1995, PHYS REV LETT, V74, P1962, DOI 10.1103/PhysRevLett.74.1962; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599; Yoshikawa A, 2004, J MOL STRUC-THEOCHEM, V681, P27, DOI 10.1016/j.theochem.2004.04.047; Zare R. N., 1988, ANGULAR MOMENTUM UND	80	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174456	10.1371/journal.pone.0174456	http://dx.doi.org/10.1371/journal.pone.0174456			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376128	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000008
J	Wang, MY; He, J; Lu, HB; Liu, YJ; Deng, YR; Zhu, LS; Gun, CM; Tu, CC; Wang, XP				Wang, Mingyue; He, Jia; Lu, Haibing; Liu, Yajing; Deng, Yingrui; Zhu, Lisai; Gun, Changming; Tu, Changchun; Wang, Xinping			A novel enterovirus species identified from severe diarrheal goats	PLOS ONE			English	Article							GENOME SEQUENCE; BOVINE	Backgrounds The Enterovirus genus of the family of Picornaviridae consists of 9 species of Enteroviruses and 3 species of Rhinoviruses based on the latest virus taxonomy. Those viruses contribute significantly to respiratory and digestive disorders in human and animals. Out of 9 Enterovirus species, Enterovirus E-G are closely related to diseases affecting on livestock industry. While enterovirus infection has been increasingly reported in cattle and swine, the enterovirus infections in small ruminants remain largely unknown. Methods Virology, molecular and bioinformatics methods were employed to characterize a novel enterovirus CEV-JL14 from goats manifesting severe diarrhea with morbidity and mortality respectively up to 84% and 54% in China. Results CEV-JL14 was defined and proposed as a new Enterovirus species L within the genus of Enterovirus of the family Picornaviridae. CEV-JL14 had a complete genome sequence of 7461 nucleotides with an ORF encoding 2172 amino acids, and shared 77.1% of genomic sequence identity with TB4-OEV, an ovine enterovirus. Comparison of 5'-UTR and structural genes of CEV-JL14 with known Enterovirus species revealed highly genetic variations among CEV-JL14 with known Enterovirus species. VP1 nucleotide sequence identities of CEV-14 were 51.8%-53.5% with those of Enterovirus E and F, 30.9%-65.3% with Enterovirus G, and 43.8-51. 5% with Enterovirus A-D, respectively. CEV-JL14 was proposed as a novel species within the genus of Enterovirus according to the current ICTV demarcation criteria of enteroviruses. Conclusions CEV-JL14 clustered phylogenetically to neither Enterovirus E and F, nor to Enterovirus G. It was defined and proposed as novel species L within the genus of Enterovirus. This is the first report of caprine enterovirus in China, the first complete genomic sequence of a caprine enterovirus revealed, and the unveiling of significant genetic variations between ovine enterovirus and caprine enterovirus, thus broadening the current understanding of enteroviruses.	[Wang, Mingyue; He, Jia; Lu, Haibing; Liu, Yajing; Deng, Yingrui; Zhu, Lisai; Gun, Changming; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China; [Tu, Changchun; Wang, Xinping] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China; [Tu, Changchun; Wang, Xinping] Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China	Jilin University; Academy of Military Medical Sciences - China	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun, Jilin, Peoples R China.; Tu, CC; Wang, XP (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China.; Tu, CC; Wang, XP (corresponding author), Minist Educ, Key Lab Zoonosis, Changchun, Jilin, Peoples R China.	changchun_tu@hotmail.com; wangxp88@hotmail.com	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Natural Science Foundation of China [31572531]; Ministry of Science and Technology Major Project [2016YFD0500904]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology Major Project	This study is supported by grants from the Natural Science Foundation of China (31572531), and the Ministry of Science and Technology Major Project (2016YFD0500904) to XPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097517; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; Donin DG, 2014, TROP ANIM HEALTH PRO, V46, P523, DOI 10.1007/s11250-013-0523-z; Dubois E, 2004, INT J FOOD MICROBIOL, V92, P35, DOI 10.1016/j.ijfoodmicro.2003.06.001; Fong TT, 2005, APPL ENVIRON MICROB, V71, P2070, DOI 10.1128/AEM.71.4.2070-2078.2005; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; King A.M., 2012, VIRUS TAXONOMY, V9; Kosoltanapiwat N, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0468-8; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; MOLL T, 1963, AM J VET RES, V24, P545; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Omatsu T, 2014, VIRUS GENES, V48, P550, DOI 10.1007/s11262-014-1057-9; REED L. J., 1938, AMER JOUR HYG, V27, P493; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaukat S, 2012, APPL ENVIRON MICROB, V78, P4497, DOI 10.1128/AEM.00109-12; Straub O C, 1965, Dtsch Tierarztl Wochenschr, V72, P54; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-291; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zell R, 1997, VIRUS RES, V51, P213, DOI 10.1016/S0168-1702(97)00096-8; Zhang HL, 2014, VIRUS RES, V191, P101, DOI 10.1016/j.virusres.2014.07.032	27	16	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174600	10.1371/journal.pone.0174600	http://dx.doi.org/10.1371/journal.pone.0174600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376123	Green Published, gold, Green Submitted			2022-12-26	WOS:000399352000012
J	Wang, Y; Huang, XZ; He, LJ; Pu, WJ; Li, Y; Liu, QZ; Li, Y; Zhang, LB; Yu, W; Zhao, H; Zhou, YQ; Zhou, B				Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Yingqun; Zhou, Bin			Genetic tracing of hepatocytes in liver homeostasis, injury, and regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; MOUSE-LIVER; PERIPORTAL HEPATOCYTES; MATURE HEPATOCYTES; STEM-CELLS; RISE; DIFFERENTIATION; CHOLANGIOCYTES; CONTRIBUTES; RATHER	The liver possesses a remarkable capacity to regenerate after damage. There is a heated debate on the origin of new hepatocytes after injuries in adult liver. Hepatic stem/progenitor cells have been proposed to produce functional hepatocytes after injury. Recent studies have argued against this model and suggested that pre-existing hepatocytes, rather than stem cells, contribute new hepatocytes. This hepatocyte-to-hepatocyte model is mainly based on labeling of hepatocytes with Cre-recombinase delivered by the adeno-associated virus. However, the impact of virus infection on cell fate determination, consistency of infection efficiency, and duration of Cre-virus in hepatocytes remain confounding factors that interfere with the data interpretation. Here, we generated a new genetic tool Alb-DreER to label almost all hepatocytes (>99.5%) and track their contribution to different cell lineages in the liver. By pulse-and-chase strategy, we found that pre-existing hepatocytes labeled by Alb-DreER contribute to almost all hepatocytes during normal homeostasis and after liver injury. Virtually all hepatocytes in the injured liver are descendants of pre-existing hepatocytes through self-expansion. We concluded that stem cell differentiation is unlikely to be responsible for the generation of a substantial number of new hepatocytes in adult liver. Our study also provides a new mouse tool for more precise in vivo genetic study of hepatocytes in the field.	[Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Bin] Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Wang, Yue; Huang, XiuZhen; He, Lingjuan; Pu, Wenjuan; Li, Yan; Liu, Qiaozhen; Li, Yi; Zhang, Libo; Yu, Wei; Zhao, Huan; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Zhou, Yingqun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, 301 Yanchang Rd, Shanghai 200072, Peoples R China; [Zhou, Bin] Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Guangdong, Peoples R China; [Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tongji University; Jinan University; ShanghaiTech University	Zhou, YQ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, 301 Yanchang Rd, Shanghai 200072, Peoples R China.; Zhou, B (corresponding author), 320 Yueyang Rd,Life Sci Res Bld A-2112, Shanghai 200031, Peoples R China.	yqzh02@163.com; zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	National Science Foundation of China [91639302, 31625019, 91339104, 31271552, 31222038, 31571503, 31501172, 31601168, 81300340]; Ministry of Science and Technology [2013CB945302, 2016YFC1300600]; Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB19000000]; Youth Innovation Promotion Association of CAS [2015218]; Key Project of Frontier Sciences of CAS [QYZDB-SSW-SMC003]; International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project [ZJ2014-ZD002]; Shanghai Science and Technology Commission [14JC1407400, 16DZ2280800]; Shanghai Yangfan Project [15YF1414000]; Rising Star Program [15QA1404300]; China Postdoctoral Science Foundation [2015M581669, 2016T90387, 2016LH0042]; President Fund of Shanghai Institutes for Biological Sciences (SIBS); AstraZeneca and SanofiSIBS Fellowship	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); Youth Innovation Promotion Association of CAS; Key Project of Frontier Sciences of CAS; International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Yangfan Project; Rising Star Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); President Fund of Shanghai Institutes for Biological Sciences (SIBS); AstraZeneca and SanofiSIBS Fellowship	This work was supported by the National Science Foundation of China (91639302, 31625019, 91339104, 31271552, 31222038, 31571503, 31501172, 31601168, and 81300340), Ministry of Science and Technology (2013CB945302 and 2016YFC1300600), Strategic Priority Research Program of the Chinese Academy of Sciences (CAS, XDB19000000), Youth Innovation Promotion Association of CAS (2015218), Key Project of Frontier Sciences of CAS (QYZDB-SSW-SMC003), International Cooperation Fund of CAS, Shanghai Zhangjiang Stem Cell Research Project (ZJ2014-ZD002), Shanghai Science and Technology Commission (14JC1407400 and 16DZ2280800), Shanghai Yangfan Project (15YF1414000) and Rising Star Program (15QA1404300), China Postdoctoral Science Foundation (2015M581669, 2016T90387, and 2016LH0042), President Fund of Shanghai Institutes for Biological Sciences (SIBS), and an AstraZeneca and SanofiSIBS Fellowship. The authors declare that they have no conflicts of interest with the contents of this article.	Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225; Arroyo V, 2014, J HEPATOL, V61, P396, DOI 10.1016/j.jhep.2014.04.012; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; He LJ, 2016, CARDIOVASC RES, V109, P419, DOI 10.1093/cvr/cvw005; Heinrich C, 2015, NAT CELL BIOL, V17, P204, DOI 10.1038/ncb3108; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Overturf K, 1997, AM J PATHOL, V151, P1273; Pu WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13369; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202	34	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8594	8604		10.1074/jbc.M117.782029	http://dx.doi.org/10.1074/jbc.M117.782029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377509	hybrid, Green Published			2022-12-26	WOS:000402153900008
J	Flajsman, K; Jerina, K; Pokorny, B				Flajsman, Katarina; Jerina, Klemen; Pokorny, Bostjan			Age-related effects of body mass on fertility and litter size in roe deer	PLOS ONE			English	Article							FEMALE RED DEER; CONTRASTED POPULATIONS; FITNESS COMPONENTS; DENSITY-DEPENDENCE; 1ST REPRODUCTION; CERVUS-ELAPHUS; TOOTH WEAR; SENESCENCE; PATTERNS; FECUNDITY	We analysed effects of females' body mass and age on reproductive capacity of European roe deer (Capreolus capreolus) in a large sample set of 1312 females (305 yearlings and 1007 adults), hunted throughout Slovenia, central Europe, in the period 2013- 2015. Body mass positively affected probability of ovulation and potential litter size (number of corpora lutea), although its effect was more pronounced in yearlings than in adults. Between age groups, we found clear differences in responses of both reproductive parameters to body mass which influences primarily reproductive performance of younger, and in particular, lighter individuals: at the same body mass yearlings would at average have smaller litters than adults, and at lower body mass also young to middle-aged adults would have smaller litters than old ones. In addition, while yearlings have to reach a critical threshold body mass to attain reproductive maturity, adult females are fertile (produce ova) even at low body mass. However, at higher body mass also younger individuals shift their efforts into the reproduction, and after reaching an age-specific threshold the body mass does not have any further effects on the reproductive output of roe deer females. Increased reproductive capacity at more advanced age, combined with declining body mass suggests that old does allocate more of their resources in reproduction than in body condition.	[Flajsman, Katarina; Pokorny, Bostjan] Slovenian Forestry Inst, Ljubljana, Slovenia; [Jerina, Klemen] Univ Ljubljana, Biotech Fac, Dept Forestry & Renewable Forest Resources, Ljubljana, Slovenia; [Pokorny, Bostjan] Environm Protect Coll, Velenje, Slovenia; [Pokorny, Bostjan] Ecol Res & Ind Cooperat, Velenje, Slovenia	Slovenian Forestry Institute; University of Ljubljana	Flajsman, K (corresponding author), Slovenian Forestry Inst, Ljubljana, Slovenia.	katarina.flajsman@gozdis.si			Slovenian Research Agency [1000-12-0404]; Hunters Association of Slovenia	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Hunters Association of Slovenia	The study was performed by the financial support of the Slovenian Research Agency, financing the education of Katarina Flajsman as a young researcher (Contract no. 1000-12-0404), and was financially supported also by the Hunters Association of Slovenia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1974, J REPROD FERTIL, V39, P225, DOI 10.1530/jrf.0.0390225; ALBON SD, 1986, J ZOOL, V209, P447, DOI 10.1111/j.1469-7998.1986.tb03603.x; ALBON SD, 1983, J ANIM ECOL, V52, P969, DOI 10.2307/4467; Andersen R, 2000, J WILDLIFE MANAGE, V64, P698, DOI 10.2307/3802739; Andersen R, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P285; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; [Anonymous], 1982, ACTA THERIOL, V27, P385; Apollonio M., 2010, EUROPEAN UNGULATES T; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertouille SB, 2002, Z JAGDWISS, V48, P87, DOI 10.1007/BF02192396; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Borg K, 1970, VILTREVY, V7, P121; Borowik T., 2014, FACTORS AFFECTING FE; BRONSON FH, 1991, BIOL REPROD, V44, P945, DOI 10.1095/biolreprod44.6.945; Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cook JG, 2004, WILDLIFE MONOGR, P1; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; DelGiudice GD, 2007, J MAMMAL, V88, P427, DOI 10.1644/06-MAMM-A-164R.1; Flajsman K., 2017, EFFECTS OF INDIVIDUA; Flajsman K, 2013, ACTA SILVAE LIGNI, P1; Focardi S, 2002, OECOLOGIA, V130, P411, DOI 10.1007/s00442-001-0825-0; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GAILLARD JM, 1992, CAN J ZOOL, V70, P1541, DOI 10.1139/z92-212; Gaillard JM, 2003, J WILDLIFE MANAGE, V67, P767, DOI 10.2307/3802684; Gaillard JM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P309; Garel M, 2009, AM NAT, V173, P89, DOI 10.1086/593359; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; HAMILTON WJ, 1980, J AGR SCI, V95, P261, DOI 10.1017/S0021859600039289; Hewison AJM, 2011, OIKOS, V120, P1217, DOI 10.1111/j.1600-0706.2011.19316.x; Hewison AJM, 1999, CAN J ZOOL, V77, P58, DOI 10.1139/cjz-77-1-58; Hewison AJM, 1996, ACTA THERIOL, V41, P187, DOI 10.4098/AT.arch.96-18; Hewison AJM, 2001, J ANIM ECOL, V70, P600, DOI 10.1046/j.1365-2656.2001.00528.x; HUDSON RJ, 1991, SMALL RUMINANT RES, V4, P19, DOI 10.1016/0921-4488(91)90049-V; Jelenko I, 2013, OPLOJENOST PROSTOZIV; Jerina K, 2013, PROSTORSKA RAZSIRJEN; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kjellander P, 2000, DENSITY DEPENDENCE R; Langbein J., 1991, EFFECTS DENSITY AGE; Langbein Jochen, 1992, P293; Langvatn R, 1996, J ANIM ECOL, V65, P653, DOI 10.2307/5744; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; Linnell JDC, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P11; MacDonald DW, 2008, OECOLOGIA, V158, P361, DOI 10.1007/s00442-008-1142-7; Mauget C, 2003, ACTA THERIOL, V48, P197, DOI 10.1007/BF03194159; Mauget C, 1997, CAN J ZOOL, V75, P731, DOI 10.1139/z97-094; Mitchell B., 1974, XIth International Congress of Game Biologists, Stockholm, 3-7 Sep. 1973., P89; Mitchell B., 1977, Ecology of red deer. A research review relevant to their management in Scotland.; Morin A, 2016, CAN J ZOOL, V94, P311, DOI 10.1139/cjz-2015-0153; Nilsen EB, 2004, J ANIM ECOL, V73, P44, DOI 10.1111/j.1365-2656.2004.00790.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Oslis, 2016, OSR SLOV LOVSK INF S; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Pokorny B., 2012, Zbornik Gozdarstva in Lesarstva, P3; Ratcliffe P. R., 1992, ROE DEER BIOL MANAGE; Red B. deer, 2016, J MAMMAL, V97, P1671; Sand H, 1996, OECOLOGIA, V106, P212, DOI 10.1007/BF00328601; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; SHORT R. V., 1966, SYMP ZOOL SOC LONDON, V15, P173; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; StatSoft Inc, 2014, STAT DAT AN SOFTW SY; STRANDGAARD H, 1972, Danish Review of Game Biology, V6, P1; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; Vetter SG, 2016, ANIM BEHAV, V115, P193, DOI 10.1016/j.anbehav.2016.03.026; Weladji R, 2003, ACTA AGR SCAND A-AN, V53, P35, DOI 10.1080/09064700310002026	69	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0175579	10.1371/journal.pone.0175579	http://dx.doi.org/10.1371/journal.pone.0175579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403161	Green Submitted, gold, Green Published			2022-12-26	WOS:000399955200082
J	Deinlein, T; Arzberger, E; Zalaudek, I; Massone, C; Garcias-Ladaria, J; Oliveira, A; Schulter, G; Hofmann-Wellenhof, R				Deinlein, Teresa; Arzberger, Edith; Zalaudek, Iris; Massone, Cesare; Garcias-Ladaria, Juan; Oliveira, Andre; Schulter, Guenter; Hofmann-Wellenhof, Rainer			Dermoscopic characteristics of melanoma according to the criteria "ulceration" and "mitotic rate" of the AJCC 2009 staging system for melanoma	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; NAKED-EYE EXAMINATION; CUTANEOUS MELANOMA; PREOPERATIVE EVALUATION; THICKNESS; DIAGNOSIS	Objective The present study was conducted to identify possible dermoscopic patterns, associated with mitotic rate > 1/mm(2), histological ulceration in melanoma and metastatic disease. Methods For this retrospective data analysis all clinical and dermoscopic digital images of primary malignant melanomas between 2008 and 2013 documented at the Department of Dermatology Graz were included, using the internal image data-base. 550 patients with 559 melanomas were included. Results While clinical or dermoscopic analysis considered ulceration to be present in 120 (21.5%) and 117 (20.9%) of all lesions, respectively, histopathology reported ulceration in only 96 cases (17.2%). The presence of milky-red areas, shiny-white streaks, a blue-white veil and blue-grey areas in dermoscopy is highly correlated with histological ulceration and a mitotic rate > 1/mm(2). The dermoscopic patterns shiny-white streaks, milky-red areas and blue-white veil were also significantly associated with development of distant metastases. Conclusion Our study proves a significant correlation between the dermoscopic patterns "blue white veil", "milky-red areas" and "shiny-white streaks" and the histological findings "ulceration" and "mitotic rate > 1/mm(2)". Furthermore these dermoscopic patterns are highly related to distant metastases. Thus, dermoscopy renders earlier prognostic statements possible.	[Deinlein, Teresa; Arzberger, Edith; Zalaudek, Iris; Massone, Cesare; Hofmann-Wellenhof, Rainer] Med Univ Graz, Dept Dermatol, Graz, Austria; [Massone, Cesare] Galliera Hosp, Dept Dermatol, Genoa, Italy; [Garcias-Ladaria, Juan] Hosp Gen Univ Valencia, Valencia, Spain; [Oliveira, Andre] Hosp Curry Cabral, Ctr Hosp Lisboa Cent, Dept Dermatol, Lisbon, Portugal; [Schulter, Guenter] Karl Franzens Univ Graz, Dept Psychol, Biol Psychol Unit, Graz, Austria	Medical University of Graz; Ente Ospedaliero Ospedali Galliera; University of Genoa; Hospital Clinic Universitari de Valencia; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of Graz	Hofmann-Wellenhof, R (corresponding author), Med Univ Graz, Dept Dermatol, Graz, Austria.	rainer.hofmann@medunigraz.at	Zalaudek, Iris/AAL-5436-2020; Ladaria, Juan Garcias/AAR-5480-2021; Zalaudek, Iris/E-5910-2010	Zalaudek, Iris/0000-0002-7878-4955; Ladaria, Juan Garcias/0000-0002-0831-9468; Zalaudek, Iris/0000-0002-7878-4955; massone, cesare/0000-0002-0996-643X				Argenziano G, 1999, J AM ACAD DERMATOL, V40, P61, DOI 10.1016/S0190-9622(99)70528-1; Argenziano G, 1997, J AM ACAD DERMATOL, V37, P68, DOI 10.1016/S0190-9622(97)70213-5; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Argenziano G, 2009, SEMIN CUTAN MED SURG, V28, P142, DOI 10.1016/j.sder.2009.06.001; Azzola MF, 2003, CANCER-AM CANCER SOC, V97, P1488, DOI 10.1002/cncr.11196; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barnhill RL, 2005, J CUTAN PATHOL, V32, P268, DOI 10.1111/j.0303-6987.2005.00310.x; Carli P, 2004, J AM ACAD DERMATOL, V50, P683, DOI 10.1016/j.jaad.2003.09.009; Ciudad-Blanco C, 2014, ACTAS DERMO-SIFILOGR, V105, P683, DOI 10.1016/j.ad.2014.01.008; De Giorgi V, 2002, CLIN DERMATOL, V20, P305, DOI 10.1016/S0738-081X(02)00224-9; Ivarez T, 2014, BRIT J DERMATOLOGY; da Silva VPM, 2013, AN BRAS DERMATOL, V88, P712, DOI 10.1590/abd1806-4841.20132017; Pagnanelli G, 2007, ANTICANCER RES, V27, P2939; Shen S, 2014, JAMA DERMATOL, V150, P1048, DOI 10.1001/jamadermatol.2014.635; Shitara D, 2014, ACTA DERM-VENEREOL, V94, P132, DOI 10.2340/00015555-1683; SMOLLE J, 1989, J INVEST DERMATOL, V93, P178, DOI 10.1111/1523-1747.ep12277396; Stante M, 2001, MELANOMA RES, V11, P147, DOI 10.1097/00008390-200104000-00009; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x; Wang Yan, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P178, DOI 10.3760/cma.j.issn.0529-5807.2013.03.008	19	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174871	10.1371/journal.pone.0174871	http://dx.doi.org/10.1371/journal.pone.0174871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399177	Green Published, Green Submitted, gold			2022-12-26	WOS:000399949000013
J	Hall, JA; Yerramilli, M; Obare, E; Li, J; Yerramilli, M; Jewell, DE				Hall, Jean A.; Yerramilli, Maha; Obare, Edward; Li, Jun; Yerramilli, Murthy; Jewell, Dennis E.			Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones	PLOS ONE			English	Article							CALCIUM-OXALATE; FUNCTION BIOMARKERS; IDENTICAL-TWINS; URINARY-TRACT; RENAL-DISEASE; NEPHROLITHIASIS; RISK; DOGS; MINNESOTA; UROLITHS	Serum concentrations of symmetric dimethylarginine (SDMA) correlate with renal function in cats and SDMA has been shown to be a more reliable and earlier marker for chronic kidney disease (CKD) compared with serum creatinine (Cr). Calcium oxalate uroliths tend to develop in mid-to-older aged cats and kidney stones may cause a reduction in renal function with increased SDMA, but normal serum Cr. The purpose of this retrospective study was to determine if cats with kidney stones had increased serum SDMA concentrations, and whether SDMA increased earlier than serum creatinine concentrations. Cats in the colony with kidney stones diagnosed between August 2010 and December 2015 (n = 43) were compared with healthy geriatric cats (n = 21) without kidney stones. Serum SDMA concentrations were determined by liquid chromatography-mass spectrometry and serum Cr concentrations were determined by enzymatic colorimetry. Cats with kidney stones were diagnosed antemortem by radiographic imaging (n = 12) or by postmortem necropsy (n = 31). Retrospectively, serum SDMA was found to be increased above the upper reference limit in 39 of 43 cats with kidney stones. Serum Cr was increased above the upper reference limit in 18 of 43 cats; 6 of these 18 cats had terminal azotemia only. The mean time that serum SDMA was increased before serum Cr was increased was 26.9 months (range 0 to 60 months). Kidney stones were composed of calcium oxalate in 30 of 34 cats. The lifespan for cats with kidney stones (mean, 12.5 years; range, 6.1 to 18.1 years) was shorter (P < 0.001) than for control cats (mean, 15.2 years; range, 13.0 to 17.2 years), suggesting that non-obstructive kidney stones have an effect on mortality rate or rate of CKD progression. In conclusion, if SDMA concentrations are elevated in mid-to-older aged cats, further imaging studies are warranted to check for the presence of kidney stones.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Yerramilli, Maha; Obare, Edward; Li, Jun; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA; [Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS; IDEXX Laboratories, Inc	performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS; IDEXX Laboratories, Inc	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hilispetcom/our-company.html). Hill's Pet Nutrition, Inc. and IDEXX Laboratories, Inc. provided support in the form of salaries for authors [DJ] and [MY,EO,JL, MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LG, 2013, NEW ZEAL VET J, V61, P212, DOI 10.1080/00480169.2013.775691; Bartges JW, 2013, AM J VET RES, V74, P1347, DOI 10.2460/ajvr.74.10.1347; Bartges JW, 1999, VET CLIN N AM-SMALL, V29, P45, DOI 10.1016/S0195-5616(99)50004-1; Berent AC, 2011, J VET EMERG CRIT CAR, V21, P86, DOI 10.1111/j.1476-4431.2011.00628.x; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Haleblian GE, 2007, BJU INT, V100, P621, DOI 10.1111/j.1464-410X.2007.06936.x; Hall JA, 2016, J VET INTERN MED, V30, P794, DOI 10.1111/jvim.13942; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; HERRING LC, 1962, J UROLOGY, V88, P545, DOI 10.1016/S0022-5347(17)64842-0; Hesse A, 1984, URINARY STONE, P57; HIATT RA, 1982, KIDNEY INT, V22, P63, DOI 10.1038/ki.1982.133; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Keddis MT, 2013, CURR OPIN NEPHROL HY, V22, P390, DOI 10.1097/MNH.0b013e32836214b9; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; KIRK CA, 1995, J AM VET MED ASSOC, V207, P1429; Monga M, 2006, J UROLOGY, V175, P2125, DOI 10.1016/S0022-5347(06)00272-2; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; ROBERTSON WG, 1978, BRIT J UROL, V50, P449, DOI 10.1111/j.1464-410X.1978.tb06189.x; Ross SJ, 2007, JAVMA-J AM VET MED A, V230, P1854, DOI 10.2460/javma.230.12.1854; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; SOUCIE JM, 1994, KIDNEY INT, V46, P893, DOI 10.1038/ki.1994.347; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820	29	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174854	10.1371/journal.pone.0174854	http://dx.doi.org/10.1371/journal.pone.0174854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384169	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900042
J	Lichtenhan, JT; Hirose, K; Buchman, CA; Duncan, RK; Salt, AN				Lichtenhan, J. T.; Hirose, K.; Buchman, C. A.; Duncan, R. K.; Salt, A. N.			Direct administration of 2-Hydroxypropyl-Beta-Cyclodextrin into guinea pig cochleae: Effects on physiological and histological measurements	PLOS ONE			English	Article							OUTER HAIR CELL; LOW-FREQUENCY; OPERATING POINT; OTOACOUSTIC EMISSIONS; DRUG-DELIVERY; HEARING-LOSS; SALICYLATE; ELECTROMOTILITY; PERILYMPH; PRESTIN	2-Hydroxypropyl-Beta-Cyclodextrin (HP beta CD) can be used to treat Niemann-Pick type C disease, Alzheimer's disease, and atherosclerosis. But, a consequence is that HP beta CD can cause hearing loss. HP beta CD was recently found to be toxic to outer hair cells (OHCs) in the organ of Corti. Previous studies on the chronic effects of in vivo HP beta CD toxicity did not know the intra-cochlear concentration of HP beta CD and attributed variable effects on OHCs to indirect drug delivery to the cochlea. We studied the acute effects of known HP beta CD concentrations administered directly into intact guinea pig cochleae. Our novel approach injected solutions through pipette sealed into scala tympani in the cochlear apex. Solutions were driven along the length of the cochlear spiral toward the cochlear aqueduct in the base. This method ensured that therapeutic levels were achieved throughout the cochlea, including those regions tuned to mid to low frequencies and code speech vowels and background noise. A wide variety of measurements were made. Results were compared to measurements from ears treated with the HP beta CD analog methyl-beta-cyclodextrin (M beta CD), salicylate that is well known to attenuate the gain of the cochlear amplifier, and injection of artificial perilymph alone (controls). Histological data showed that OHCs appeared normal after treatment with a low dose of HP beta CD, and physiological data was consistent with attenuation of cochlear amplifier gain and disruption of non-linearity associated with transferring acoustic sound into neural excitation, an origin of distortion products that are commonly used to objectively assess hearing and hearing loss. A high dose of HP beta CD caused sporadic OHC losses and markedly affected all physiologic measurements. M beta CD caused virulent destruction of OHCs and physiologic responses. Toxicity of HP beta CD to OHC along the cochlear length is variable even when a known intra-cochlear concentration is administered, at least for the duration of our acute studies.	[Lichtenhan, J. T.; Hirose, K.; Buchman, C. A.; Salt, A. N.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Duncan, R. K.] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	Washington University (WUSTL); University of Michigan System; University of Michigan	Lichtenhan, JT (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	jlichtenhan@wustl.edu		Salt, Alec/0000-0003-3462-9256; Lichtenhan, Jeffery/0000-0002-6050-7845	National Institutes of Health [RO1 DC014997, RO1 DC011315, RO1 DC001368]; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014997, R01DC001368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by RO1 DC014997 (J.T.L.), RO1 DC011315 (K.H.), and RO1 DC001368 (A.N.S.) from the National Institutes of Health, National Institute on Deafness and Other Communication Disorders.	Bian L, 1998, J ACOUST SOC AM, V104, P2261, DOI 10.1121/1.423739; Bian L, 2002, J ACOUST SOC AM, V112, P198, DOI 10.1121/1.1488943; Brown DJ, 2009, J ACOUST SOC AM, V125, P2129, DOI 10.1121/1.3083228; Brownell WE, 2011, PFLUG ARCH EUR J PHY, V461, P677, DOI 10.1007/s00424-011-0942-5; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Chen ZQ, 2005, J CONTROL RELEASE, V110, P1, DOI 10.1016/j.jconrel.2005.09.003; Chen ZQ, 2006, J NEUROSCI METH, V150, P67, DOI 10.1016/j.jneumeth.2005.05.017; Chertoff ME, 2008, J ACOUST SOC AM, V124, P2174, DOI 10.1121/1.2967890; Chertoff Mark E., 2001, Seminars in Hearing, V22, P325, DOI 10.1055/s-2001-19108; Chertoff ME, 2003, J ACOUST SOC AM, V114, P3251, DOI 10.1121/1.1625932; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Cronin S, 2015, JARO-J ASSOC RES OTO, V16, P599, DOI 10.1007/s10162-015-0528-6; Crow AL, 2015, G3-GENES GENOM GENET, V5, P2329, DOI 10.1534/g3.115.021592; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; DIELER R, 1991, J NEUROCYTOL, V20, P637, DOI 10.1007/BF01187066; DOLAN DF, 1989, J ACOUST SOC AM, V86, P2167, DOI 10.1121/1.398477; EGGERMONT JJ, 1979, J ACOUST SOC AM, V65, P463, DOI 10.1121/1.382345; Frank G, 1997, HEARING RES, V113, P57, DOI 10.1016/S0378-5955(97)00131-7; Frank G, 1996, HEARING RES, V98, P104, DOI 10.1016/0378-5955(96)00083-4; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kang WS, 2016, OTOL NEUROTOL; KUJAWA SG, 1992, HEARING RES, V64, P73, DOI 10.1016/0378-5955(92)90169-N; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Prell CG, 2014, NEUROSCI LETT, V571, P17, DOI 10.1016/j.neulet.2014.04.024; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lichtenhan JT, 2014, JARO-J ASSOC RES OTO, V15, P395, DOI 10.1007/s10162-014-0447-y; Lichtenhan JT, 2008, J ACOUST SOC AM, V123, P2200, DOI 10.1121/1.2885748; Lichtenhan JT, 2013, EAR HEARING, V34, P42, DOI 10.1097/AUD.0b013e31825f9bd3; Lichtenhan JT, 2012, JARO-J ASSOC RES OTO, V13, P17, DOI 10.1007/s10162-011-0296-x; Lichtenhan JT, 2016, J NEUROSCI METHODS; Lichtenhan JT, 2015, AUDITORY NERVE OVERL; MILLS DM, 1993, J ACOUST SOC AM, V94, P2108, DOI 10.1121/1.407483; Rodrigues HA, 2013, EUR J NEUROSCI, V38, P2978, DOI 10.1111/ejn.12300; Salt AN, 2015, JARO-J ASSOC RES OTO, V16, P357, DOI 10.1007/s10162-015-0512-1; Salt AN, 2013, J ACOUST SOC AM, V133, P1561, DOI 10.1121/1.4789005; Salt AN, 2009, HEARING RES, V250, P63, DOI 10.1016/j.heares.2009.02.001; Salt AN, 2001, HEARING RES, V154, P88, DOI 10.1016/S0378-5955(01)00223-4; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Shera CA, 2010, JARO-J ASSOC RES OTO, V11, P343, DOI 10.1007/s10162-010-0217-4; Sirjani DB, 2004, J ACOUST SOC AM, V115, P1219, DOI 10.1121/1.1647479; Yamashita T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005500; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8; Zimmer S, 2016, MOLECULES, V21	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175236	10.1371/journal.pone.0175236	http://dx.doi.org/10.1371/journal.pone.0175236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384320	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900131
J	Hayat, T; Haider, F; Muhammad, T; Alsaedi, A				Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer; Alsaedi, Ahmed			Darcy-Forchheimer flow with Cattaneo-Christov heat flux and homogeneous-heterogeneous reactions	PLOS ONE			English	Article							VARIABLE THERMAL-CONDUCTIVITY; NANOFLUID NATURAL-CONVECTION; NONLINEAR STRETCHING SURFACE; HOMOTOPY ANALYSIS METHOD; BOUNDARY-LAYER FLOW; POROUS-MEDIA; VISCOELASTIC FLUID; PERMEABLE CHANNEL; MIXED CONVECTION; CARBON NANOTUBES	Here Darcy-Forchheimer flow of viscoelastic fluids has been analyzed in the presence of Cattaneo-Christov heat flux and homogeneous-heterogeneous reactions. Results for two viscoelastic fluids are obtained and compared. A linear stretching surface has been used to generate the flow. Flow in porous media is characterized by considering the Darcy-Forchheimer model. Modified version of Fourier's law through Cattaneo-Christov heat flux is employed. Equal diffusion coefficients are employed for both reactants and auto catalyst. Optimal homotopy scheme is employed for solutions development of nonlinear problems. Solutions expressions of velocity, temperature and concentration fields are provided. Skin friction coefficient and heat transfer rate are computed and analyzed. Here the temperature and thermal boundary layer thickness are lower for Cattaneo-Christov heat flux model in comparison to classical Fourier's law of heat conduction. Moreover, the homogeneous and heterogeneous reactions parameters have opposite behaviors for concentration field.	[Hayat, Tasawar; Haider, Farwa; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	taseer@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Muhammad, Taseer/0000-0002-0838-2731; 				Akbar NS, 2015, J MAGN MAGN MATER, V381, P405, DOI 10.1016/j.jmmm.2014.12.087; Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14185-0; Ariel PD, 2003, J COMPUT APPL MATH, V154, P1, DOI 10.1016/S0377-0427(02)00744-6; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; Cattaneo C., 1948, ATTI SEMIN MAT FIS ATTI SEM MAT FIS U M, V3, P83; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P335, DOI 10.1016/0169-5983(95)90813-H; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dehghan M, 2010, NUMER METH PART D E, V26, P448, DOI 10.1002/num.20460; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Forchheimer P, 1901, Z VER DTSCH ING, V45, P1781; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Haddad SAM, 2014, INT J HEAT MASS TRAN, V68, P659, DOI 10.1016/j.ijheatmasstransfer.2013.09.039; Hayat T, 2017, J TAIWAN INST CHEM E, V70, P119, DOI 10.1016/j.jtice.2016.11.002; Hayat T, 2016, INT J NUMER METHOD H, V26, P2355, DOI 10.1108/HFF-08-2015-0333; Hayat T, 2016, J MOL LIQ, V220, P200, DOI 10.1016/j.molliq.2016.04.012; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4929523; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4905780; Hayat T, 2017, J MOL LIQ, V230, P608, DOI 10.1016/j.molliq.2017.01.074; Hayat T, 2016, RESULTS PHYS, V6, P897, DOI 10.1016/j.rinp.2016.10.017; Hayat T, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6110346; Hayat T, 2016, ADV POWDER TECHNOL, V27, P1992, DOI 10.1016/j.apt.2016.07.002; Hayat T, 2017, INT J THERM SCI, V111, P274, DOI 10.1016/j.ijthermalsci.2016.08.009; Hayat T, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4964684; Hayat T, 2016, J MOL LIQ, V221, P1121, DOI 10.1016/j.molliq.2016.06.083; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155185; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Imtiaz M, 2016, J MOL LIQ, V221, P245, DOI 10.1016/j.molliq.2016.05.060; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Karniadakis GE., 2002, MICROFLOWS; Li J, 2016, J MOL LIQ, V221, P19, DOI 10.1016/j.molliq.2016.05.051; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Majeed A, 2016, J MOL LIQ, V223, P528, DOI 10.1016/j.molliq.2016.07.145; Malvandi A., 2013, J THERMODYN, V2013, DOI DOI 10.1155/2013/764827; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Muskat M., 1946, FLOW HOMOGENEOUS FLU, V763, P100; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Nield DA, 1999, CONVECTION POROUS ME, V2nd; Pal D, 2012, INT COMMUN HEAT MASS, V39, P913, DOI 10.1016/j.icheatmasstransfer.2012.05.012; Sadiq MA, 2016, RESULTS PHYS, V6, P884, DOI 10.1016/j.rinp.2016.10.019; Sajid M, 2017, J MOL LIQ, V233, P115, DOI 10.1016/j.molliq.2017.02.081; Seddeek MA, 2006, J COLLOID INTERF SCI, V293, P137, DOI 10.1016/j.jcis.2005.06.039; Shehzad SA, 2016, J MOL LIQ, V224, P274, DOI 10.1016/j.molliq.2016.09.109; Sheikholeslami M, 2017, J MOL LIQ, V229, P566, DOI 10.1016/j.molliq.2016.12.107; Sheikholeslami M, 2017, INT J HEAT MASS TRAN, V109, P82, DOI 10.1016/j.ijheatmasstransfer.2017.01.096; Sheikholeslami M, 2017, COMPUT METHOD APPL M, V317, P419, DOI 10.1016/j.cma.2016.12.028; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2017, J MOL LIQ, V229, P137, DOI 10.1016/j.molliq.2016.12.024; Sheikholeslami M, 2017, PHYS LETT A, V381, P494, DOI 10.1016/j.physleta.2016.11.042; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Tan WC, 2005, INT J NONLIN MECH, V40, P515, DOI 10.1016/j.ijnonlinmec.2004.07.016; Tanveer A, 2017, J MOL LIQ, V233, P131, DOI 10.1016/j.molliq.2017.03.001; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Turkyilmazoglu M, 2016, MEDITERR J MATH, V13, P4019, DOI 10.1007/s00009-016-0730-8; Turkyilmazoglu M, 2016, FILOMAT, V30, P1633, DOI 10.2298/FIL1606633T; Turkyilmazoglu M, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4945650; Waqas M, 2016, J MOL LIQ, V220, P642, DOI 10.1016/j.molliq.2016.04.086; Zeeshan A, 2016, J MOL LIQ, V215, P549, DOI 10.1016/j.molliq.2015.12.110	60	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174938	10.1371/journal.pone.0174938	http://dx.doi.org/10.1371/journal.pone.0174938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380014	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500079
J	Loos, J; Nostlinger, C; Vuylsteke, B; Deblonde, J; Ndungu, M; Kint, I; Manirankunda, L; Reyniers, T; Adobea, D; Laga, M; Colebunders, R				Loos, Jasna; Nostlinger, Christiana; Vuylsteke, Bea; Deblonde, Jessika; Ndungu, Morgan; Kint, Ilse; Manirankunda, Lazare; Reyniers, Thijs; Adobea, Dorothy; Laga, Marie; Colebunders, Robert			First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium	PLOS ONE			English	Article							POPULATIONS; PREVENTION; IMMIGRANTS; INFECTION; COUNTRIES	Introduction While sub-Saharan African migrants are the second largest group affected by HIV in Europe, sound HIV prevalence estimates based on representative samples of these heterogeneous communities are lacking. Such data are needed to inform prevention and public health policy. Methods This community-based, cross-sectional study combined oral fluid HIV testing with an electronic behavioral survey. Adopting a two-stage time location sampling HIV prevalence estimates for a representative sample of adult sub-Saharan African migrants in Antwerp, Belgium were obtained. Sample proportions and estimated adjusted population proportions were calculated for all variables. Univariable and multivariable logistic regression analysis explored factors independently associated with HIV infection. Results Between December 2013 and October 2014, 744 sub-Saharan African migrants were included (37% women). A substantial proportion was socially, legally and economically vulnerable: 21% were probably of undocumented status, 63% had financial problems in the last year and 9% lacked stable housing. Sexual networks were mostly African and crossed national borders, i.e. sexual encounters during travels within Europa and Africa. Concurrency is common, 34% of those in a stable relationship had a partner on the side in the last year. HIV prevalence was 5.9%(95%CI:3.4%-10.1%) among women and 4.2% (95% CI:1.6%-10.6%) among men. Although high lifetime HIV testing was reported at community level (73%), 65.2% (CI95%:32.4%-88.0%) of sub-Saharan African migrants were possibly undiagnosed. Being 45 years or older, unprotected sex when travelling within Europe in the last year, high intentions to use condoms, being unaware of their last sexual partners' HIV status, recent HIV testing and not having encountered partner violence in the last year were independently associated with HIV infection in multivariable logical regression. In univariable analysis, HIV infection was additionally associated to unemployment. Conclusions This is the first HIV prevalence study among adult sub-Saharan African migrants resettling in a European city based on a representative sample. HIV prevalence was high and could potentially increase further due to the high number of people with an undiagnosed HIV infection, social vulnerability, high levels of concurrency and mainly African sexual networks. Given this population's mobility, an aligned European combination prevention approach addressing these determinants is urgently needed.	[Loos, Jasna; Nostlinger, Christiana; Vuylsteke, Bea; Manirankunda, Lazare; Reyniers, Thijs; Laga, Marie] Inst Trop Med, HIV & Sexual Hlth Unit, Dept Publ Hlth, Antwerp, Belgium; [Deblonde, Jessika] Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Epidemiol Infect Dis Unit, Brussels, Belgium; [Ndungu, Morgan; Adobea, Dorothy] Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Unit, TOGETHER Project, Antwerp, Belgium; [Kint, Ilse; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, AIDS Reference Ctr, Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Fac Med & Hlth Sci, Epidemiol Global Hlth Inst, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp	Loos, J (corresponding author), Inst Trop Med, HIV & Sexual Hlth Unit, Dept Publ Hlth, Antwerp, Belgium.	jloos@itg.be	Reyniers, Thijs/C-7466-2018; Loos, Jasna/GVS-6862-2022	Reyniers, Thijs/0000-0003-3756-921X; Colebunders, Robert/0000-0002-1919-1340	Scientific Fund for Research on AIDS	Scientific Fund for Research on AIDS	This work was supported by the Scientific Fund for Research on AIDS, managed by the King Baudouin Foundation (https Away kbs trb betent Activities/Calls0tberne-795t12531cOd45a9B td55t1cc0769f8a&themeNameaMedicallit 20scierbfic3t2Otesearch).	Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; Alvarez-el Arco D, 2015, 15 EUR AIDS C BARC O; Arrey AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159488; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Deblonde J, 2011, HEALTH POLICY, V103, P101, DOI 10.1016/j.healthpol.2011.06.012; Desgrees-du-Lou A, 2016, AIDS, V30, P645, DOI 10.1097/QAD.0000000000000957; European Centre for Disease Prevention and Control World Health Organisation Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Fransen K, 2013, J VIROL METHODS, V194, P46, DOI 10.1016/j.jviromet.2013.08.004; Gokengin D, 2014, INT J STD AIDS, V25, P695, DOI 10.1177/0956462414531244; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Karon JM, 2012, J URBAN HEALTH, V89, P565, DOI 10.1007/s11524-012-9676-8; Loos Jasna, 2016, JMIR Public Health Surveill, V2, pe33, DOI 10.2196/publichealth.5519; Loos Jasna, 2016, JMIR Res Protoc, V5, pe48, DOI 10.2196/resprot.5162; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Marks G, 2015, J ACQ IMMUN DEF SYND, V39, P446; Marsicano E, 2013, CULT HEALTH SEX, V15, P819, DOI 10.1080/13691058.2013.785024; MAYISHA II Collaborative Group, 2005, ASS FEAS ACC ITY COM; NAT, 2014, HIV BLACK AFR COMM U; Ndiaye B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-11; Nostlinger C, 2016, AIDS CARE, V28, P119, DOI 10.1080/09540121.2016.1146398; Perez-Molina JA, 2009, J TRAVEL MED, V16, P248, DOI 10.1111/j.1708-8305.2009.00308.x; Platt L, 2013, SEX TRANSM INFECT, V89, P311, DOI 10.1136/sextrans-2012-050491; Public Health England, 2015, HIV UK SIT REP 2015; Roberfroid DDM., 2015, WHAT HLTH CARE UNDOC; Sadler KE, 2007, SEX TRANSM INFECT, V83, P523, DOI 10.1136/sti.2007.027128; Saracino A, 2008, AIDS PATIENT CARE ST, V22, P691, DOI 10.1089/apc.2008.0016; Sasse A, 2015, EPIDEMIOLOGIE AIDS H; UNAIDS GNP+, 2013, POS HLTH DIGN PREV O; van Veen MG, 2011, INT J STD AIDS, V22, P245, DOI 10.1258/ijsa.2009.008511; Xia Q, 2013, AIDS BEHAV, V17, P3120, DOI 10.1007/s10461-013-0528-7	33	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174677	10.1371/journal.pone.0174677	http://dx.doi.org/10.1371/journal.pone.0174677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2JD	28380051	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500058
J	Metzler-Zebell, BU; Lawlor, PG; Magowan, E; McCormack, UM; Curiao, T; Hollmann, M; Ertl, R; Aschenbach, JR; Zebell, Q				Metzler-Zebell, Barbara U.; Lawlor, Peadar G.; Magowan, Elizabeth; McCormack, Ursula M.; Curiao, Tania; Hollmann, Manfred; Ertl, Reinhard; Aschenbach, Joerg R.; Zebell, Qendrim			Finishing pigs that are divergent in feed efficiency show small differences in intestinal functionality and structure	PLOS ONE			English	Article							NUTRIENT DIGESTIBILITY; ENZYME-ACTIVITIES; BARRIER FUNCTION; GENE-EXPRESSION; PERFORMANCE; MORPHOLOGY; HEALTH; VARIABILITY; SELECTION; GROWTH	Controversial information is available regarding the feed efficiency-related variation in intestinal size, structure and functionality in pigs. The present objective was therefore to investigate the differences in visceral organ size, intestinal morphology, mucosal enzyme activity, intestinal integrity and related gene expression in low and high RFI pigs which were reared at three different geographical locations (Austria, AT; Northern Ireland, NI; Republic of Ireland, ROI) using similar protocols. Pigs (n = 369) were ranked for their RFI between days 42 and 91 postweaning and low and high RFI pigs (n = 16 from AT, n = 24 from NI, and n = 60 from ROI) were selected. Pigs were sacrificed and sampled on similar to day 110 of life. In general, RFI-related variation in intestinal size, structure and function was small. Some energy saving mechanisms and enhanced digestive and absorptive capacity were indicated in low versus high RFI pigs by shorter crypts, higher duodenal lactase and maltase activity and greater mucosal permeability (P < 0.05), but differences were mainly seen in pigs from AT and to a lesser degree in pigs from ROI. Additionally, low RFI pigs from AT had more goblet cells in duodenum but fewer in jejunum compared to high RFI pigs (P < 0.05). Together with the lower expression of TLR4 and TNFA in low versus high RFI pigs from AT and ROI (P < 0.05), these results might indicate differences in the innate immune response between low and high RFI pigs. Results demonstrated that the variation in the size of visceral organs and intestinal structure and functionality was greater between geographic location (local environmental factors) than between RFI ranks of pigs. In conclusion, present results support previous findings that the intestinal size, structure and functionality do not significantly contribute to variation in RFI of pigs.	[Metzler-Zebell, Barbara U.] Univ Clin Swine, Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria; [Lawlor, Peadar G.; McCormack, Ursula M.; Curiao, Tania] Fermoy Co, Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Moorepk, Cork, Ireland; [Magowan, Elizabeth] Agri Food & Biosci Inst, Agr Branch, Large Pk, Hillsborough, North Ireland; [McCormack, Ursula M.] Waterford Co, Waterford Inst Technol, Dept Sci & Comp, Waterford, Ireland; [Hollmann, Manfred] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria; [Ertl, Reinhard] Univ Vet Med, VetCore Facil Res, Vienna, Austria; [Ertl, Reinhard] Free Univ Berlin, Berlin, Germany; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany	University of Veterinary Medicine Vienna; Teagasc; Agri-Food & Biosciences Institute; South East Technological University (SETU); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Free University of Berlin; Free University of Berlin	Metzler-Zebell, BU (corresponding author), Univ Clin Swine, Univ Vet Med, Dept Farm Animals & Vet Publ Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Aschenbach, Joerg R/R-7572-2016; McCormack, Ursula/M-3010-2019	Aschenbach, Joerg R/0000-0001-5080-1007; McCormack, Ursula/0000-0002-9485-0502; Curiao, Tania/0000-0002-5269-0387; Ertl, Reinhard/0000-0001-7485-3661	European Union's Seventh Framework Programme for research, technological development and demonstration [311794]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project (ECO-FCE) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 311794.	Barea R, 2010, J ANIM SCI, V88, P2062, DOI 10.2527/jas.2009-2395; Boddicker N, 2011, ANIMAL, V5, P1344, DOI 10.1017/S175173111100036X; CASPARY WF, 1992, AM J CLIN NUTR, V55, P299, DOI 10.1093/ajcn/55.1.299s; Chen H, 2015, J NUTR, V145, P51, DOI 10.3945/jn.114.201772; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Douglas SL, 2015, ANIMAL, V9, P1210, DOI 10.1017/S1751731115000269; Fitzsimons C, 2014, ANIMAL, V8, P949, DOI 10.1017/S1751731114000652; Gondret F, 2014, J ANIM SCI, V92, P4865, DOI 10.2527/jas.2014-7995; Harris AJ, 2012, J ANIM SCI, V90, P164, DOI 10.2527/jas.53855; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lalles JP, 2012, J ANIM SCI, V90, P421, DOI 10.2527/jas.53904; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Liu YL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0040-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; McCormack UM, 2016, 67 ANN M EUR FED AN, P199; Metzler-Zebeli B, 2017, BR POULT SC IN PRESS; Metzler-Zebeli BU, 2016, J ANIM SCI, V94, P2890, DOI 10.2527/jas.2016-0375; Metzler-Zebeli BU, 2012, J NUTR, V142, P668, DOI 10.3945/jn.111.153007; Metzler-Zebeli BU, 2016, ANIMAL IN PRESS; Meunier-Salaun MC, 2014, ANIMAL, V8, P1898, DOI 10.1017/S1751731114001839; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Nain S, 2012, POULTRY SCI, V91, P888, DOI 10.3382/ps.2011-01661; Naumann C., 2012, CHEM UNTERSUCHUNG FU; Noblet J, 2013, ANIMAL, V7, P1259, DOI 10.1017/S1751731113000463; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Saintilan R, 2015, ANIMAL, V9, P18, DOI 10.1017/S1751731114002171; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vigors S, 2016, ANIMAL, V10, P1848, DOI 10.1017/S1751731116000847; Vigors S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148145; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Yen J.T., 2001, SWINE NUTR, P21; Young JM, 2011, J ANIM SCI, V89, P639, DOI 10.2527/jas.2010-2892	39	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174917	10.1371/journal.pone.0174917	http://dx.doi.org/10.1371/journal.pone.0174917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380012	Green Published, gold			2022-12-26	WOS:000399353500078
J	Ribera, J; Fink, S; Bas, MD; Schwarze, FWMR				Ribera, Javier; Fink, Siegfried; del Carmen Bas, Maria; Schwarze, Francis W. M. R.			Integrated control of wood destroying basidiomycetes combining Cu-based wood preservatives and Trichoderma spp	PLOS ONE			English	Article							TREATED DISTRIBUTION POLES; BIOLOGICAL-CONTROL; DECAY; ROT; BIOCONTROL; MECHANISMS; STRAINS; FUNGI; RESISTANCE; ISOLATE	The production of new generation of wood preservatives (without addition of a co-biocide) in combination with an exchange of wood poles on identical sites with high fungal inoculum, has resulted in an increase of premature failures of wood utility poles in the last decades. Wood destroying basidiomycetes inhabiting sites where poles have been installed, have developed resistance against wood preservatives. The objective of the in vitro studies was to identify a Trichoderma spp. with a highly antagonistic potential against wood destroying basidiomycetes that is capable of colonizing Cu-rich environments. For this purpose, the activity of five Trichoderma spp. on Cu-rich medium was evaluated according to its growth and sporulation rates. The influence of the selected Trichoderma spp. on wood colonization and degradation by five wood destroying basidiomycetes was quantitatively analyzed by means of dry weight loss of wood specimens. Furthermore, the preventative effect of the selected Trichoderma spp. in combination with four Cu-based preservatives was also examined by mass loss and histological changes in the wood specimens. Trichoderma harzianum (T-720) was considered the biocontrol agent with higher antagonistic potential to colonize Cu-rich environments (up to 0.1% CuSO4 amended medium). T. harzianum demonstrated significant preventative effect on wood specimens against four wood destroying basidiomycetes. The combined effect of T. harzianum and Cu-based wood preservatives demonstrated that after 9 months incubation with two wood destroying basidiomycetes, wood specimens treated with 3.8 kg m-(3) copper-chromium had weight losses between 55-65%, whereas containers previously treated with T. harzianum had significantly lower weight losses (0-25%). Histological studies on one of the wood destroying basidiomycetes revealed typical decomposition of wood cells by brown-rot fungi in Cu-impregnated samples, that were notably absent in wood specimens previously exposed to T. harzianum. It is concluded that carefully selected Trichoderma isolates can be used for integrated wood protection against a range of wood destroying basidiomycetes and may have potential for integrated wood protection in the field.	[Ribera, Javier; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, St Gallen, Switzerland; [Ribera, Javier; Fink, Siegfried; Schwarze, Francis W. M. R.] Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany; [del Carmen Bas, Maria] Univ Politecn Valencia, Appl Stat & Operat Res & Qual, Valencia, Spain	Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of Freiburg; Universitat Politecnica de Valencia	Ribera, J (corresponding author), Empa, Appl Wood Mat, St Gallen, Switzerland.; Ribera, J (corresponding author), Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany.	javier.ribera@empa.ch	Ribera, Javier/V-7140-2019; del Carmen Bas Cerdá, María/J-4354-2016; Schwarze, Francis/Y-2157-2018	del Carmen Bas Cerdá, María/0000-0002-1221-0641; Ribera, Dr. Javier/0000-0001-6677-3020; Schwarze, Francis/0000-0003-3306-8303	Swiss CTI [17001.1]	Swiss CTI	The authors are pleased to acknowledge the financial support by the Swiss CTI (Project No. 17001.1 PFLS-LS).	Arland P, 2006, BIORESOURCE TECHNOL, V97, P1018, DOI 10.1016/j.biortech.2005.04.046; Benitez T, 2004, INT MICROBIOL, V7, P249; Bollmus S., 2012, IRGWP1240584; Brown HL, 1999, INT BIODETER BIODEGR, V44, P225, DOI 10.1016/S0964-8305(99)00083-9; BRUCE A, 1991, HOLZFORSCHUNG, V45, P307, DOI 10.1515/hfsg.1991.45.4.307; BRUCE A, 1991, FOREST PROD J, V41, P63; BRUCE A, 1986, MATER ORGANISMEN, V21, P165; BRUCE A, 1990, MATER ORGANISMEN, V25, P15; Bruce A, 1986, MAT ORG, V27, P1; CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121, DOI 10.1016/0168-6445(94)90002-7; Civardi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142578; Civardi C, 2015, ENVIRON POLLUT, V200, P126, DOI 10.1016/j.envpol.2015.02.018; Errasquin EL, 2003, CHEMOSPHERE, V50, P137; European Committee for Standardization (CEN), 2001, 807 CEN ENV EUR COMM; European Committee for Standardization (CEN), 1996, 113 CEN EUR COMM STA; European Committee for Standardization (CEN), 1989, 252 CEN EUR COMM STA; Freeman MH, 2008, FOREST PROD J, V58, P6; Gandia M, 2014, FUNGAL GENET BIOL, V67, P58, DOI 10.1016/j.fgb.2014.04.002; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Herrera-Estrella A., 2004, Fungal biotechnology in agricultural, food, and environmental applications, P147; HIGHLEY TL, 1988, MATER ORGANISMEN, V23, P157; Hingston JA, 2001, ENVIRON POLLUT, V111, P53, DOI 10.1016/S0269-7491(00)00030-0; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Humar M, 2007, HOLZ ROH WERKST, V65, P329, DOI 10.1007/s00107-006-0157-1; Kartal SN, 2015, INT BIODETER BIODEGR, V99, P95, DOI 10.1016/j.ibiod.2015.01.004; Kredics L, 2003, FOOD TECHNOL BIOTECH, V41, P37; Kredics L, 2001, LETT APPL MICROBIOL, V33, P112, DOI 10.1046/j.1472-765x.2001.00963.x; Kredics L, 2001, B ENVIRON CONTAM TOX, V66, P249, DOI 10.1007/s001280000231; Kundu A., 2008, Asian Journal of Experimental Sciences, V22, P373; Lebow S, 2003, ENVIRON SCI TECHNOL, V37, P4077, DOI 10.1021/es0343048; Lohwag GK, 1937, MIKROCHEMIE, V23, P198; MORRELL JJ, 1990, WOOD FIBER SCI, V22, P10; MURPHY RJ, 1983, T BRIT MYCOL SOC, V81, P165, DOI 10.1016/S0007-1536(83)80223-X; Obanda DN, 2008, BIORESOURCE TECHNOL, V99, P7312, DOI 10.1016/j.biortech.2007.12.077; Racic G, 2016, ENV SCI POLLUT RES; Ribera J, 2016, J TROP FOR SCI, V28, P457; Ribera J, 2016, HOLZFORSCHUNG; RICARD J, 1976, J I WOOD SCI, V7, P6; Schubert M, 2008, BIOL CONTROL, V45, P111, DOI 10.1016/j.biocontrol.2008.01.001; SCHULZE B, 1937, HOLZ ROH WERKST, V1, P548; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Schwarze F. W. M. R., 2003, Mycological Progress, V2, P267, DOI 10.1007/s11557-006-0064-1; Schwarze Francis W. M. R., 2007, Fungal Biology Reviews, V21, P133, DOI 10.1016/j.fbr.2007.09.001; Schwarze FWMR, 2012, BIOL CONTROL, V61, P160, DOI 10.1016/j.biocontrol.2012.01.016; Schwarze FWMR, 1998, NEW PHYTOL, V139, P721, DOI 10.1046/j.1469-8137.1998.00238.x; SCORE AJ, 1994, INT BIODETER BIODEGR, V33, P115, DOI 10.1016/0964-8305(94)90031-0; SIEBER TN, 1995, MYCOL RES, V99, P274, DOI 10.1016/S0953-7562(09)80897-6; Susi P, 2011, J ENVIRON MANAGE, V92, P1681, DOI 10.1016/j.jenvman.2011.03.004; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Ting ASY, 2009, WORLD J MICROB BIOT, V25, P1431, DOI 10.1007/s11274-009-0030-6; Tripathi P, 2013, CLEAN TECHNOL ENVIR, V15, P541, DOI 10.1007/s10098-012-0553-7; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; WILCOX WW, 1993, IAWA J, V14, P127; Young GY, 1961, 2223 USDA FOR SERV F	56	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174335	10.1371/journal.pone.0174335	http://dx.doi.org/10.1371/journal.pone.0174335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379978	Green Published, gold			2022-12-26	WOS:000399353500042
J	Mitsuishi, T; Hamatani, S; Hirooka, S; Fukasawa, N; Aizawa, D; Hara, Y; Dobashi, A; Goda, K; Fukuda, T; Saruta, M; Urashima, M; Ikegami, M				Mitsuishi, Takehiro; Hamatani, Shigeharu; Hirooka, Shinichi; Fukasawa, Nei; Aizawa, Daisuke; Hara, Yuko; Dobashi, Akira; Goda, Kenichi; Fukuda, Takahiro; Saruta, Masayuki; Urashima, Mitsuyoshi; Ikegami, Masahiro			Clinicopathological characteristics of duodenal epithelial neoplasms: Focus on tumors with a gastric mucin phenotype (pyloric gland-type tumors)	PLOS ONE			English	Article							BRUNNERS GLAND; FOVEOLAR METAPLASIA; ADENOCARCINOMA; ADENOMA; BULB; HYPERPLASIA; CARCINOMA; PORTION; LESIONS	Objective Epithelial tumors less commonly occur in the duodenum than in the stomach or large intestine. The clinicopathological characteristics of duodenal epithelial tumors remain a matter of debate. We therefore studied resected specimens to investigate the clinicopathological characteristics of duodenal epithelial tumors. Materials and methods Among duodenal epithelial tumors resected endoscopically or surgically in our hospital, we studied the clinicopathological characteristics of 110 adenomas or intramucosal carcinomas. The grade of atypia of all tumors was classified into 3 groups according to the World Health Organization (WHO) 2010 classification. The tumors were immunohistochemically evaluated to determine the frequency of differentiation toward fundic glands. Results As for patient characteristics, there were 76 men (75.2%) and 25 women (24.8%), with a median age of 65 years (range, 34 to 84). The tumors most commonly arose in the first to second part of the duodenum. Many lesions were flat, and the median tumor diameter was 8.0 mm. The lesions were classified into 2 types according to mucin phenotype: intestinal-type tumors (98 lesions, 89.1%) and gastric-type tumors (12 lesions, 10.9%). Intestinal-type tumors were subdivided into 2 groups: tubular-type tumors (91 lesions, 82.7%) and tubulo-villous- type tumors (7 lesions, 6.4%). Gastric-type tumors were classified into 2 types: foveolar type (3 lesions, 2.7%) and pyloric gland-type (PG) tumors (9 lesions, 8.2%). The grade of atypia was significantly higher in gastric-type tumors (p<0.01). PG tumors were gastric-type tumors characterized by pyloric glands and findings suggesting differentiation toward fundic glands. Conclusions About 10% of the duodenal tumors had a gastric-type mucin phenotype. Gastric-type tumors showed high-grade atypia. In particular, PG tumors showed similarities to PG tumors of the stomach, such as differentiation toward fundic glands.	[Mitsuishi, Takehiro; Hamatani, Shigeharu; Hirooka, Shinichi; Fukasawa, Nei; Aizawa, Daisuke; Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan; [Hara, Yuko; Dobashi, Akira; Goda, Kenichi] Jikei Univ, Dept Endoscopy, Sch Med, Minato Ku, Tokyo, Japan; [Fukuda, Takahiro] Jikei Univ, Dept Pathol, Sch Med, Div Neuropathol,Minato Ku, Tokyo, Japan; [Saruta, Masayuki] Jikei Univ, Dept Internal Med, Sch Med, Div Gastroenterol & Hepatol,Minato Ku, Tokyo, Japan; [Urashima, Mitsuyoshi] Jikei Univ, Div Mol Epidemiol, Sch Med, Res Ctr Med Sci,Minato Ku, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Jikei University; Jikei University	Mitsuishi, T (corresponding author), Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan.	takeccho86@gmail.com	Saruta, Masayuki/ABL-4991-2022	Saruta, Masayuki/0000-0001-8172-3240				Ajioka Yoichi, 1993, Stomach and Intestine, V28, P627; Bandi M, 2015, G CHIR, V36, P183, DOI 10.11138/gchir/2015.36.4.183; DORANDEU A, 1995, ANN PATHOL, V15, P211; Endo M, 2010, DIGEST ENDOSC, V22, P360, DOI 10.1111/j.1443-1661.2010.01014.x; Friedrich-Rust M, 2006, Z GASTROENTEROL, V44, P323, DOI 10.1055/s-2006-926492; Guan CS, 2015, J COLL PHYS SURG PAK; Hida R, 2016, AM J SURG PATHOL; HOEDEMAEKER PJ, 1970, DIGESTION, V3, P165, DOI 10.1159/000197027; ITSUNO M, 1993, GASTROENTEROL JPN, V28, P118; JOHANSEN A, 1973, ACTA PATH MICRO IM A, VA 81, P676; Kakushima N, 2015, WORLD J GASTROENTERO; KAWAMOTO K, 1994, GASTROINTEST ENDOSC, V40, P233, DOI 10.1016/S0016-5107(94)70176-8; Khor TS, 2010, BMJ CASE REP; Kim K, 2013, DIGEST DIS SCI, V58, P194, DOI 10.1007/s10620-012-2320-3; Kojima E, 2006, J JAPAN BILIARY ASS, V20, P635; Kushima R, 2002, VIRCHOWS ARCH, V440, P655, DOI 10.1007/s00428-002-0615-z; Kushima R, 1999, HISTOPATHOLOGY, V35, P38; Kushima R, 2013, PATHOL INT, V63, P318, DOI 10.1111/pin.12070; Lauwers GY, 2010, WHO CLASSIFICATION T, P55; Mann NS, 2000, J CLIN GASTROENTEROL, V30, P303, DOI 10.1097/00004836-200004000-00020; Maruoka D, 2015, ENDOSCOPY S1, V47; Matsubara A, 2015, BR J CANC; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; MIYAMOTO T, 1991, Stomach and Intestine (Tokyo), V26, P1395; Nakai Hisao, 2001, Stomach and Intestine (Tokyo), V36, P1499; Sakurai T, 2005, AM J SURG PATHOL, V29, P1442, DOI 10.1097/01.pas.0000180449.15827.88; Takahashi M, 2011, STOMACH INTESTINE, V46, P1619; Terada T, 2012, INT J CLIN EXP PATHO, V5, P203; Tomizawa M, 2016, CASE REP GASTROENTER; Tsuji S, 2015, WORLD J GASTROENTERO; Ushiku T, 2014, AM J SURG PATHOL, V38, P1484, DOI 10.1097/PAS.0000000000000278; WOLFF M, 1971, AM J CLIN PATHOL, V55, P604; Xue Y, 2016, MOD PATHOL; You Hyun Seon, 2015, Korean J Gastroenterol, V66, P194, DOI 10.4166/kjg.2015.66.4.194; ZANETTI G, 1981, TUMORI J, V67, P75, DOI 10.1177/030089168106700114	35	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174985	10.1371/journal.pone.0174985	http://dx.doi.org/10.1371/journal.pone.0174985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376132	gold, Green Published, Green Submitted			2022-12-26	WOS:000399352000033
J	Ishikawa, Y; Mizuno, K; Bachinger, HP				Ishikawa, Yoshihiro; Mizuno, Kazunori; Bachinger, Hans Peter			Ziploc-ing the structure 2.0: Endoplasmic reticulum-resident peptidyl prolyl isomerases show different activities toward hydroxyproline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERASE; BASEMENT-MEMBRANE COLLAGEN; EHLERS-DANLOS-SYNDROME; RECESSIVE OSTEOGENESIS IMPERFECTA; CHICK TENDON COLLAGEN; TRIPLE-HELIX; CYCLOPHILIN-B; FK506-BINDING PROTEIN; III COLLAGEN; I COLLAGEN	Extracellular matrix proteins are biosynthesized in the rough endoplasmic reticulum (rER), and the triple-helical protein collagen is the most abundant extracellular matrix component in the human body. Many enzymes, molecular chaperones, and post-translational modifiers facilitate collagen biosynthesis. Collagen contains a large number of proline residues, so the cis/trans isomerization of proline peptide bonds is the rate-limiting step during triple-helix formation. Accordingly, the rER-resident peptidyl prolyl cis/trans isomerases (PPIases) play an important role in the zipper-like triple-helix formation in collagen. We previously described this process as "Ziploc-ing the structure" and now provide additional information on the activity of individual rER PPIases. We investigated the substrate preferences of these PPIases in vitro using type III collagen, the unhydroxylated quarter fragment of type III collagen, and synthetic peptides as substrates. We observed changes in activity of six rER-resident PPIases, cyclophilin B (encoded by the PPIB gene), FKBP13 (FKBP2), FKBP19 (FKBP11), FKBP22 (FKBP14), FKBP23 (FKBP7), and FKBP65 (FKBP10), due to posttranslational modifications of proline residues in the substrate. Cyclophilin B and FKBP13 exhibited much lower activity toward post- translationally modified substrates. In contrast, FKBP19, FKBP22, and FKBP65 showed increased activity toward hydroxyproline-containing peptide substrates. Moreover, FKBP22 showed a hydroxyproline- dependent effect by increasing the amount of refolded type III collagen in vitro and FKBP19 seems to interact with triple helical type I collagen. Therefore, we propose that hydroxyproline modulates the rate of Ziploc-ing of the triple helix of collagen in the rER.	[Ishikawa, Yoshihiro; Bachinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Mizuno, Kazunori; Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Mizuno, Kazunori] Nippi Res Inst Biomatrix, Ibaraki 3020017, Japan	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children [85100, 85500]	Shriners Hospitals for Children	This work was supported by Shriners Hospitals for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no competing interests related to this work.	BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Bella J, 2016, BIOCHEM J, V473, P1001, DOI 10.1042/BJ20151169; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boudko SP, 2014, PROTEIN SCI, V23, P67, DOI 10.1002/pro.2391; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Islam M, 2013, J BIOL CHEM, V288, P35526, DOI 10.1074/jbc.M113.504530; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mizuno K, 2013, J BIOL CHEM, V288, P19166, DOI 10.1074/jbc.M113.462002; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murray ML, 2014, AM J MED GENET A, V164, P1750, DOI 10.1002/ajmg.a.36492; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Schmelzer CEH, 2016, BBA-GEN SUBJECTS, V1860, P2169, DOI 10.1016/j.bbagen.2016.05.013; Szabadkai G, 2007, ADV EXP MED BIOL, V594, P64; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	54	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9273	9282		10.1074/jbc.M116.772657	http://dx.doi.org/10.1074/jbc.M116.772657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28385890	Green Published, hybrid			2022-12-26	WOS:000402538900022
J	Guntupalli, S; Jang, SE; Zhu, TY; Huganir, RL; Widagdo, J; Anggono, V				Guntupalli, Sumasri; Jang, Se Eun; Zhu, Tianyi; Huganir, Richard L.; Widagdo, Jocelyn; Anggono, Victor			GluA1 subunit ubiquitination mediates amyloid-beta-induced loss of surface alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT UBIQUITINATION; ALZHEIMERS-DISEASE; REGULATORY PHOSPHORYLATION; TRAFFICKING; SITES; GLUR1; ENDOCYTOSIS; OLIGOMERS; REQUIRE	The accumulation of soluble amyloid-beta (A beta) peptides produces profound neuronal changes in the brain during the pathogenesis of Alzheimer's disease. Excessive levels of A beta disrupt excitatory synaptic transmission by promoting the removal of synaptic AMPA receptors (AMPARs), dendritic spine loss, and synaptic depression. Recently, activity-dependent ubiquitination of the GluA1 subunit has been shown to regulate the intracellular sorting of AMPARs toward late endosomes for degradation. However, whether this ubiquitin signaling pathway mediates A beta-induced loss of surface AMPARs is unknown. In this study, we demonstrate that acute exposure of cultured neurons to soluble A beta oligomers induces AMPAR ubiquitination concomitant with the removal of AMPARs from the plasma membrane. Importantly, expression of the GluA1 ubiquitin-deficient mutants inhibited the adverse effects of A beta on the surface expression of AMPARs in neurons. Furthermore, we revealed the cross-talk between GluA1 ubiquitination and phosphorylation, in particular phosphorylation at Ser-845, which is crucial for AMPAR recycling and is known to be dephosphorylated in the presence of A beta. Our data showed that the GluA1 ubiquitin-deficient mutant enhances GluA1 phosphorylation on Ser-845. Conversely, the GluA1 S845D phosphomimetic mutant reduced binding with Nedd4-1 and hence the ubiquitination of AMPARs. Importantly, the GluA1 S845D mutant also prevented A beta-induced removal of surface AMPARs. Taken together, these findings provide the first demonstration of the dynamic cross-modulation of GluA1 ubiquitination and phosphorylation, a process that is perturbed by A beta, in regulating the membrane sorting decision that ultimately determines the number of AMPARs on the cell surface.	[Guntupalli, Sumasri; Jang, Se Eun; Zhu, Tianyi; Widagdo, Jocelyn; Anggono, Victor] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA	University of Queensland; Johns Hopkins University; Johns Hopkins University	Anggono, V (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia.	v.anggono@uq.edu.au	Anggono, Victor/J-2750-2013; Widagdo, Jocelyn/J-6316-2013	Anggono, Victor/0000-0002-4062-4884; Widagdo, Jocelyn/0000-0001-9667-9203	John T. Reid Charitable Trusts; Alzheimer's Australia Dementia Research Foundation [DGP14-57]; Australian National Health and Medical Research Council [GNT1083209, GNT1099114, 477108]; Clem Jones Centre for Ageing Dementia Research; National Institutes of Health [P50AG005146]; Millipore Corporation; University of Queensland International Scholarships; Australian Research Council Discovery Early Career Researcher Award [DE170100112]; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	John T. Reid Charitable Trusts; Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Clem Jones Centre for Ageing Dementia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore Corporation; University of Queensland International Scholarships; Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from the John T. Reid Charitable Trusts, Alzheimer's Australia Dementia Research Foundation Grant DGP14-57, Australian National Health and Medical Research Council Grants GNT1083209 and GNT1099114, and the Clem Jones Centre for Ageing Dementia Research (to V. A.) and by National Institutes of Health Grant P50AG005146 (to R. L. H.). Under a licensing agreement between Millipore Corporation and The Johns Hopkins University, R. L. H. is entitled to a share of royalties received by the University on sales of products described in this article. R. L. H. is a paid consultant to Millipore Corporation. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict-of-interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of University of Queensland International Scholarships.; Supported by Australian Research Council Discovery Early Career Researcher Award Fellowship DE170100112.; Supported by Australian National Health and Medical Research Council Fellowship 477108.	Alfonso S, 2014, EUR J NEUROSCI, V39, P1225, DOI 10.1111/ejn.12499; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anggono V, 2013, P NATL ACAD SCI USA, V110, P13976, DOI 10.1073/pnas.1312467110; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; DEWAR D, 1991, BRAIN RES, V553, P58, DOI 10.1016/0006-8993(91)90230-S; Diering GH, 2016, P NATL ACAD SCI USA, V113, pE4920, DOI 10.1073/pnas.1610631113; Dong ZF, 2015, J CLIN INVEST, V125, P234, DOI 10.1172/JCI77888; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Goo MS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00060; Guntupalli S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3204519; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Liu SJ, 2010, J ALZHEIMERS DIS, V21, P655, DOI 10.3233/JAD-2010-091654; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rodrigues EM, 2016, J NEUROSCI, V36, P1590, DOI 10.1523/JNEUROSCI.2964-15.2016; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Widagdo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31070; Widagdo J, 2015, ONCOTARGET, V6, P15718, DOI 10.18632/oncotarget.4645; Widagdo J, 2015, CELL REP, V10, P783, DOI 10.1016/j.celrep.2015.01.015; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	39	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8186	8194		10.1074/jbc.M116.774554	http://dx.doi.org/10.1074/jbc.M116.774554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28377502	Green Published, hybrid			2022-12-26	WOS:000401788600006
J	Sur, M; Suffredini, T; Wessells, SM; Bloom, PH; Lanzone, M; Blackshire, S; Sridhar, S; Katzner, T				Sur, Maitreyi; Suffredini, Tony; Wessells, Stephen M.; Bloom, Peter H.; Lanzone, Michael; Blackshire, Sheldon; Sridhar, Srisarguru; Katzner, Todd			Improved supervised classification of accelerometry data to distinguish behaviors of soaring birds	PLOS ONE			English	Article							BODY ACCELERATION; ENERGY; MIGRATION; ETHOGRAMS; MOVEMENT; ANIMALS; MODES; TIME; LIFE	Soaring birds can balance the energetic costs of movement by switching between flapping, soaring and gliding flight. Accelerometers can allow quantification of flight behavior and thus a context to interpret these energetic costs. However, models to interpret accelerometry data are still being developed, rarely trained with supervised datasets, and difficult to apply. We collected accelerometry data at 140Hz from a trained golden eagle (Aquila chrysaetos) whose flight we recorded with video that we used to characterize behavior. We applied two forms of supervised classifications, random forest (RF) models and K-nearest neighbor (KNN) models. The KNN model was substantially easier to implement than the RF approach but both were highly accurate in classifying basic behaviors such as flapping (85.5% and 83.6% accurate, respectively), soaring (92.8% and 87.6%) and sitting (84.1% and 88.9%) with overall accuracies of 86.6% and 92.3% respectively. More detailed classification schemes, with specific behaviors such as banking and straight flights were well classified only by the KNN model (91.24% accurate; RF = 61.64% accurate). The RF model maintained its accuracy of classifying basic behavior classification accuracy of basic behaviors at sampling frequencies as low as 10Hz, the KNN at sampling frequencies as low as 20Hz. Classification of accelerometer data collected from free ranging birds demonstrated a strong dependence of predicted behavior on the type of classification model used. Our analyses demonstrate the consequence of different approaches to classification of accelerometry data, the potential to optimize classification algorithms with validated flight behaviors to improve classification accuracy, ideal sampling frequencies for different classification algorithms, and a number of ways to improve commonly used analytical techniques and best practices for classification of accelerometry data.	[Sur, Maitreyi] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Suffredini, Tony] Sky Patrol Abatement, Simi Valley, CA USA; [Wessells, Stephen M.] US Geol Survey, Henderson, NV USA; [Bloom, Peter H.] Bloom Biol, Santa Ana, CA USA; [Lanzone, Michael; Blackshire, Sheldon] Cellular Tracking Technol, Rio Grande, NJ USA; [Sridhar, Srisarguru] Boise State Univ, Dept Comp Sci, Boise, ID 83725 USA; [Katzner, Todd] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA	Idaho; Boise State University; United States Department of the Interior; United States Geological Survey; Idaho; Boise State University; United States Department of the Interior; United States Geological Survey	Sur, M (corresponding author), Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA.	maitreyisur@boisestate.edu		Sur, Maitreyi/0000-0002-7174-1813	U.S. Bureau of Land Management IAA [L14PG00265]	U.S. Bureau of Land Management IAA	This research was funded by the U.S. Bureau of Land Management IAA #L14PG00265 to TK. The commercial affiliations Bloom Biological, Cellular Tracking Technologies & Sky Patrol Abatement provided support in the form of salaries for authors [PB, ML, SB and TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Algar AC, 2007, GLOBAL ECOL BIOGEOGR, V16, P170, DOI 10.1111/j.1466-8238.2006.00275.x; Altun K, 2010, PATTERN RECOGN, V43, P3605, DOI 10.1016/j.patcog.2010.04.019; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; Berlincourt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139351; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2002, MANUAL SETTING USING; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hawkins DM, 2003, J QUAL TECHNOL, V35, P355, DOI 10.1080/00224065.2003.11980233; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; Katzner TE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0530; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Miller TA, 2014, CONSERV BIOL, V28, P745, DOI 10.1111/cobi.12227; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Peters A., 2015, IPRED IMPROVED PREDI; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2021, R LANGUAGE ENV STAT; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Resheff YS, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0027-0; Reynolds KV, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0645; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Ross G.J, 2013, J STAT SOFTW, V78; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Venables WN., 2002, MODERN APPL STAT S, V4; Walker JS, 2015, VISUAL COMPUT, V31, P1067, DOI 10.1007/s00371-015-1112-0; Warrick D, 2012, CURR BIOL, V22, pR472, DOI 10.1016/j.cub.2012.04.057; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Williams H.J., 2015, ANIM BIOTELEM, V1; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2001, J EXP BIOL, V204, P685; YOST M, 1983, BEHAV RES METH INSTR, V15, P258, DOI 10.3758/BF03203558	45	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2017	12	4							e0174785	10.1371/journal.pone.0174785	http://dx.doi.org/10.1371/journal.pone.0174785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LZ	28403159	Green Published, gold, Green Submitted			2022-12-26	WOS:000399955200021
J	Frank, J; Eklund, A				Frank, Jens; Eklund, Ann			Poor construction, not time, takes its toll on subsidised fences designed to deter large carnivores	PLOS ONE			English	Article							WOLF DEPREDATION; TOLERANCE	Large carnivore conservation may be considered as successful in Sweden, as wolf (Canis lupus), lynx (Lynx lynx), brown bear (Ursus arctos), golden eagles (Aquila chrysaetos), and wolverine (Gulo gulo) populations have recovered from extinction or near extinction to viable populations during the last three decades. Particularly the wolf and lynx populations have returned at the cost of an increasing number of carnivore attacks on domestic livestock. To support coexistence between carnivores and livestock production, the Swedish authorities subsidise interventions to prevent or reduce the number of carnivore attacks. The most commonly used intervention is carnivore deterring fencing, and all livestock owners can apply for subsidies to build a fence. To receive reimbursement the fence must be approved by the authorities according to predefined criteria. An important part of any management aiming to be adaptive is evaluating interventions. In this paper we evaluate to what extent previously subsidised fences still meet the criteria 1-15 years after their approval. Of 296 fences that had received subsidies in the county of Varmland, 100 randomly selected fences were revisited in 2016. From this subsample 14% of the fences still met the initial criteria for subsidies. None of the fences that still fulfilled the criteria were more than 8 years old, whereas fences with identified failures occurred in all age groups. Of the 86 fences that failed to meet the criteria, construction failures were the most commonly occurring problem. Maintenance failures, wear and tear, only explain a minor part of the failures. To improve the quality of fencing, as well as the quality and longevity of the subsidies programme, there is a need for improved communication between authorities, and improved communication and support from the authorities to livestock producers before and during construction of fences, as well as more rigorous inspection when the fences are built.	[Frank, Jens; Eklund, Ann] Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Frank, J (corresponding author), Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden.	jens.frank@slu.se		Frank, Jens/0000-0002-4489-5171	Swedish EPA [NV-01740-14]; Swedish Research Council Formas [2013-11335-26221-38]	Swedish EPA; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	There was no additional external funding received for this study. Both authors have full-time positions at the Swedish University of Agriculture Sciences and received no specific funding for this work. Our unit received funding from the Swedish EPA (http://www.swedishepa.se) (Grant NV-01740-14) and The Swedish Research Council Formas (http://www.formas.se/en/) (Grant 2013-11335-26221-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2013, AUST VET J, V91, P261, DOI 10.1111/avj.12075; [Anonymous], 2015, KOMPLETTERANDE BESKR; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Frank J, 2016, VILTSKADESTATISTIK 2; Gubbi S, 2006, THESIS; Kaczensky Petra, 1999, Ursus, V11, P59; Karlsson J, 2011, ECOL SOC, V16; MONTAG J, 2003, CARNIVORE DAMAGE PRE, V6, P2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Nyhus P. J., 2003, CONSERVATION PRACTIC, V4, P39; Olsson O, 1997, WILDLIFE BIOL, V3, P13, DOI 10.2981/wlb.1997.003; Ripple WJ, 2017, BIOSCIENCE, V67, P197; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Statistics Sweden, 2015, AGR STAT 2014; Treves A, 2002, WILDLIFE SOC B, V30, P231; Van Tassell LW, 1999, WILDLIFE SOC B, V27, P479; Woodroffe R., 2005, CONSERV BIOL	19	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e017521	10.1371/journal.pone.0175211	http://dx.doi.org/10.1371/journal.pone.0175211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394912	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800021
J	Miyauchi, S; Navarro, D; Grisel, S; Chevret, D; Berrin, JG; Rosso, MN				Miyauchi, Shingo; Navarro, David; Grisel, Sacha; Chevret, Didier; Berrin, Jean-Guy; Rosso, Marie-Noelle			The integrative omics of white-rot fungus Pycnoporus coccineus reveals co-regulated CAZymes for orchestrated lignocellulose breakdown	PLOS ONE			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASES; GENE-EXPRESSION; CELLOBIOSE DEHYDROGENASE; DEGRADATION; CELLULOSE; OXIDATION; DATABASE; ENZYMES	Innovative green technologies are of importance for converting plant wastes into renewable sources for materials, chemicals and energy. However, recycling agricultural and forestry wastes is a challenge. A solution may be found in the forest. Saprotrophic white-rot fungi are able to convert dead plants into consumable carbon sources. Specialized fungal enzymes can be utilized for breaking down hard plant biopolymers. Thus, understanding the enzymatic machineries of such fungi gives us hints for the efficient decomposition of plant materials. Using the saprotrophic white-rot fungus Pycnoporus coccineus as a fungal model, we examined the dynamics of transcriptomic and secretomic responses to different types of lignocellulosic substrates at two time points. Our integrative omics pipeline (SHIN+GO) enabled us to compress layers of biological information into simple heatmaps, allowing for visual inspection of the data. We identified co-regulated genes with corresponding cosecreted enzymes, and the biological roles were extrapolated with the enriched Carbohydrate-Active Enzyme (CAZymes) and functional annotations. We observed the fungal early responses for the degradation of lignocellulosic substrates including; 1) simultaneous expression of CAZy genes and secretion of the enzymes acting on diverse glycosidic bonds in cellulose, hemicelluloses and their side chains or lignin (i.e. hydrolases, esterases and oxido-reductases); 2) the key role of lytic polysaccharide monooxygenases (LPMO); 3) the early transcriptional regulation of lignin active peroxidases; 4) the induction of detoxification processes dealing with biomass-derived compounds; and 5) the frequent attachments of the carbohydrate binding module 1 (CBM1) to enzymes from the lignocellulose-responsive genes. Our omics combining methods and related biological findings may contribute to the knowledge of fungal systems biology and facilitate the optimization of fungal enzyme cocktails for various industrial applications.	[Miyauchi, Shingo; Navarro, David; Grisel, Sacha; Berrin, Jean-Guy; Rosso, Marie-Noelle] Aix Marseille Univ, INRA, UMR 1163, BBF, Marseille, France; [Chevret, Didier] Univ Paris Saclay, AgroParisTech, INRA, PAPPSO,Micalis Inst, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rosso, MN (corresponding author), Aix Marseille Univ, INRA, UMR 1163, BBF, Marseille, France.	marie-noelle.rosso@inra.fr	BERRIN, Jean-Guy/AAF-3107-2021; BERRIN, Jean-Guy/E-1460-2014; Navarro, David/AAB-2178-2022; miyauchi, shingo/AAP-9669-2021	BERRIN, Jean-Guy/0000-0001-7570-3745; Navarro, David/0000-0002-3266-8270; miyauchi, shingo/0000-0002-0620-5547; Grisel, Sacha/0000-0001-6983-0107	Agence Nationalede la Recherche [ANR-14-CE06-0020]	Agence Nationalede la Recherche(French National Research Agency (ANR))	The research was funded by the Agence Nationalede la Recherche (ANR-14-CE06-0020). The fund was obtained by MNR. http://www.agence-nationale-recherche.fr/en/anr-funded-project/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Beckham GT, 2016, CURR OPIN BIOTECH, V42, P40, DOI 10.1016/j.copbio.2016.02.030; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; Couturier M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0407-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feinerer I, 2008, J STAT SOFTW, V25, P1; Fernandez-Fueyo E, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0462-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fong M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0428-y; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Gaskell J, 2014, APPL ENVIRON MICROB, V80, P5828, DOI 10.1128/AEM.01604-14; Gupta R, 2011, BIODEGRADATION, V22, P797, DOI 10.1007/s10532-010-9404-6; Hori C, 2014, APPL ENV MICROBIOL; Hori C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004759; Johnson Norman L., 1994, COMPUTATIONAL STAT D; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersten P, 2014, FUNGAL GENET BIOL, V72, P124, DOI 10.1016/j.fgb.2014.05.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; Kuuskeri J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0608-9; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lomascolo A, 2011, APPL MICROBIOL BIOT, V92, P1129, DOI 10.1007/s00253-011-3596-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacDonald J, 2012, APPL ENVIRON MICROB, V78, P1596, DOI 10.1128/AEM.06511-11; Miyauchi S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01335; Nagy LG, 2017, MOL BIOL EVOL, V34, P35, DOI 10.1093/molbev/msw238; Perlack RD, 2011, BIOMASS SUPPLY BIOEN, P1; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; R Core Team, 2013, R LANG ENV STAT COMP; Scarlat N, 2015, ENVIRON DEV, V15, P3, DOI 10.1016/j.envdev.2015.03.006; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wehrens R, 2007, JSS J STAT SOFTW, P21; Wittek P, 2013, EFFICIENT PARALLEL L; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Zhu N, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0461-x	42	41	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175528	10.1371/journal.pone.0175528	http://dx.doi.org/10.1371/journal.pone.0175528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394946	Green Published, Green Submitted, gold			2022-12-26	WOS:000399954800043
J	Nagata, N; Iwanari, H; Kumagai, H; Kusano-Arai, O; Ikeda, Y; Aritake, K; Hamakubo, T; Urade, Y				Nagata, Nanae; Iwanari, Hiroko; Kumagai, Hidetoshi; Kusano-Arai, Osamu; Ikeda, Yuichi; Aritake, Kosuke; Hamakubo, Takao; Urade, Yoshihiro			Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ALLERGIC INFLAMMATION; CRTH2; D-2; EOSINOPHILS; BASOPHILS; MODULATION; PATHWAY; BINDING; SYSTEM	Prostaglandin D-2 (PGD(2)) is a lipid mediator involved in sleep regulation and inflammation. PGD(2) interacts with 2 types of G protein-coupled receptors, DP1 and DP2/CRTH2 (chemoattractant receptor homologous molecule expressed on T helper type 2 cells)/GPR44 to show a variety of biological effects. DP1 activation leads to Gs-mediated elevation of the intracellular cAMP level, whereas activation of DP2 decreases this level via the Gi pathway; and it also induces G protein-independent, arrestin-mediated cellular responses. Activation of DP2 by PGD(2) causes the progression of inflammation via the recruitment of lymphocytes by enhancing the production of Th2-cytokines. Here we developed monoclonal antibodies (MAbs) against the extracellular domain of mouse DP2 by immunization of DP2-null mutant mice with DP2-overexpressing BAF3, murine interleukin-3 dependent pro-B cells, to reduce the generation of antibodies against the host cells by immunization of mice. Moreover, we immunized DP2-KO mice to prevent immunological tolerance to mDP2 protein. After cell ELISA, immunocytochemical, and Western blot analyses, we successfully obtained a novel monoclonal antibody, MAb-1D8, that specifically recognized native mouse DP2, but neither human DP2 nor denatured mouse DP2, by binding to a particular 3D receptor conformation formed by the N-terminus and extracellular loop 1, 2, and 3 of DP2. This antibody inhibited the binding of 0.5 nM [H-3]PGD(2) to mouse DP2 (IC50 = 46.3 +/- 18.6 nM), showed antagonistic activity toward 15(R)-15-methyl PGD(2)- induced inhibition of 300 nM forskolin-activated cAMP production (IC50 = 16.9 +/- 2.6 nM), and gave positive results for immunohistochemical staining of DP2-expressing CD4+ Th2 lymphocytes that had accumulated in the kidney of unilateral ureteral obstruction model mice. This monoclonal antibody will be very useful for in vitro and in vivo studies on DP2-mediated diseases.	[Nagata, Nanae; Aritake, Kosuke; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Nagata, Nanae; Ikeda, Yuichi; Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka, Japan; [Iwanari, Hiroko; Kusano-Arai, Osamu; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Kumagai, Hidetoshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Kumagai, Hidetoshi; Ikeda, Yuichi] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	University of Tsukuba; University of Tokyo; University of Tokyo; University of Tokyo	Nagata, N; Urade, Y (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.; Nagata, N; Urade, Y (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka, Japan.	nagata.nanae.gm@u.tsukuba.ac.jp; urade.yoshihiro.ft@u.tsukuba.ac.jp			Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [16H01881, 26293051, 14463492]; Grants-in-Aid for Scientific Research [16K15199, 17K08585] Funding Source: KAKEN	Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO, http://www.nedo.go.jp/) of Japan (to TH); by Takeda Science Foundation (http://www.takeda-sci.or.jp/assist/) (to YU); by Osaka City (http://www.city.osaka.lg.jp/) (to YU); and by the program Grants-in-Aid for Scientific Research (A) to Y.U. (16H01881), (B) to KA (26293051), and (C) to HK (14463492) from Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andresen Bradley T., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P92; Apter AJ, 2014, J ALLERGY CLIN IMMUN, V133, P49, DOI 10.1016/j.jaci.2013.11.005; Arima M, 2008, CURR MOL MED, V8, P365, DOI 10.2174/156652408785160970; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Brandt E. B., 2011, J CLIN CELL IMMUNOL, V2; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; CHARLESWORTH EN, 1991, J IMMUNOL, V146, P671; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Ito H, 2012, J AM SOC NEPHROL, V23, P1797, DOI 10.1681/ASN.2012020126; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kremer Leonor, 2004, Methods Mol Biol, V239, P243; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miyazaki K, 2013, J NEUROIMMUNOL, V260, P107, DOI 10.1016/j.jneuroim.2013.03.003; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P942, DOI 10.1016/j.jaci.2009.07.006; Ramadhanti Julia, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P270, DOI 10.1089/mab.2013.0007; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Shiraishi Y, 2014, CLIN EXP ALLERGY, V44, P1076, DOI 10.1111/cea.12280; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wright DH, 1999, EUR J PHARMACOL, V377, P101, DOI 10.1016/S0014-2999(99)00358-1; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2017	12	4							e0175452	10.1371/journal.pone.0175452	http://dx.doi.org/10.1371/journal.pone.0175452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0LV	28394950	gold, Green Published, Green Submitted			2022-12-26	WOS:000399954800036
J	Chiu, SK; Chan, MC; Huang, LY; Lin, YT; Lin, JC; Lu, PL; Siu, LK; Chang, FY; Yeh, KM				Chiu, Sheng-Kang; Chan, Ming-Chin; Huang, Li-Yueh; Lin, Yi-Tsung; Lin, Jung-Chung; Lu, Po-Liang; Siu, L. Kristopher; Chang, Feng-Yee; Yeh, Kuo-Ming			Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; FIELD GEL-ELECTROPHORESIS; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; EMERGENCE; ENTEROBACTERIACEAE; MECHANISMS; CLONE; NONSUSCEPTIBILITY; SUSCEPTIBILITY	Objectives Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Emerging tigecycline resistance in CRKP represents a growing threat. Knowledge of the clinical, microbiological, and molecular characteristics of tigecycline- and carbapenem-resistant Klebsiella pneumoniae (TCRKP) is limited. Methods Patients infected with TCRKP were identified from a Taiwanese national surveillance study. Clinical data were collected from medical records. We performed susceptibility tests, carbapenemase gene detection, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Furthermore, we performed quantitative real-time polymerase chain reaction (qRT-PCR) analyses to assess the expression levels of the efflux pump genes acrB and oqxB. Results We identified 16 patients infected with TCRKP, with urinary tract infection (UTI) being the most common type of infection (63%). The all-cause 30-day mortality rate was 44% in patients with TCRKP infection. Patients with a site of infection other than the urinary tract had a significantly higher mortality rate than patients with UTIs (83% vs. 20%, p = 0.035). PFGE and MLST revealed no dominant clone or sequence type. Using qRT-PCR, overexpression of both the acrB and oqxB genes was identified in seven isolates, and overexpression of the oqxB gene was observed in another seven. There was poor correlation between acrB or oqxB expression and tigecycline MICs (r = -0.038 and -0.166, respectively). Conclusions The mortality rate in patients infected with TCRKP in this study was 44% and this is an important subset of patients. The absence of a linear relationship between efflux pump genes expression and MICs indicates that tigecycline resistance may be mediated by other factors. Continuous monitoring of tigecycline resistance among CRKP isolates and resistance mechanisms are necessary.	[Chiu, Sheng-Kang; Lin, Jung-Chung; Siu, L. Kristopher; Chang, Feng-Yee; Yeh, Kuo-Ming] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chiu, Sheng-Kang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chan, Ming-Chin] Triserv Gen Hosp, Natl Def Med Ctr, Infect Control Off, Taipei, Taiwan; [Huang, Li-Yueh; Siu, L. Kristopher] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Lin, Yi-Tsung] Natl Yan Ming Univ, Taipei Vet Gen Hosp, Infect Dis Sect, Dept Med, Taipei, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan	Yeh, KM (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	kmyeh@ndmctsgh.edu.tw	Lu, Po-Liang/D-4499-2009; Chiu, Sheng-Kang/GQO-8638-2022	Lu, Po-Liang/0000-0002-7423-6783; 	Centers for Disease Control, Taiwan [MOHW104-CDC-C-114-144406]; Tri-Service General Hospital [TSGH-C103-124]	Centers for Disease Control, Taiwan; Tri-Service General Hospital	The work was supported by research grants from the Centers for Disease Control, Taiwan (MOHW104-CDC-C-114-144406; http://www.cdc.gov.tw/english/index.aspx; JCL) and Tri-Service General Hospital (TSGH-C103-124; http://www.tsgh.ndmctsgh.edu.tw/; SKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balm MND, 2012, J CLIN MICROBIOL, V50, P475, DOI 10.1128/JCM.05914-11; Bialek-Davenet S, 2015, J ANTIMICROB CHEMOTH, V70, P81, DOI 10.1093/jac/dku340; Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Clinical and Laboratory Standards Institute, 100S252015 CLIN LAB; D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P550, DOI 10.1086/501950; De Majumdar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004627; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Jeong SH, 2016, ANN LAB MED, V36, P529, DOI 10.3343/alm.2016.36.6.529; Juan CH, 2016, ANTIMICROB AGENTS CH, V60, P7357, DOI 10.1128/AAC.01503-16; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582, DOI 10.1128/AAC.01574-08; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Nielsen LE, 2014, ANTIMICROB AGENTS CH, V58, P6151, DOI 10.1128/AAC.03053-14; Nigo M, 2013, ANTIMICROB AGENTS CH, V57, P5743, DOI 10.1128/AAC.00827-13; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Palacios-Baena ZR, 2016, J INFECTION, V72, P152, DOI 10.1016/j.jinf.2015.10.008; Pournaras S, 2016, INT J ANTIMICROB AG, V48, P11, DOI 10.1016/j.ijantimicag.2016.04.017; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Sheng ZK, 2016, J MICROBIOL IMMUNOL, V49, P962, DOI 10.1016/j.jmii.2015.10.014; Sheng ZK, 2014, ANTIMICROB AGENTS CH, V58, P6982, DOI 10.1128/AAC.03808-14; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Sun Y, 2013, INT J ANTIMICROB AG, V41, P110, DOI 10.1016/j.ijantimicag.2012.09.005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; van Duin D, 2014, CLIN MICROBIOL INFEC, V20, pO1117, DOI 10.1111/1469-0691.12714; van Duin D, 2015, INFECT CONT HOSP EP, V36, P942, DOI 10.1017/ice.2015.118; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Wu PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep32665; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	38	29	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175140	10.1371/journal.pone.0175140	http://dx.doi.org/10.1371/journal.pone.0175140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388651	gold, Green Published, Green Submitted			2022-12-26	WOS:000399375800023
J	Yagai, T; Matsui, S; Harada, K; Inagaki, FF; Saijou, E; Miura, Y; Nakanuma, Y; Miyajima, A; Tanaka, M				Yagai, Tomoki; Matsui, Satoshi; Harada, Kenichi; Inagaki, Fuyuki F.; Saijou, Eiko; Miura, Yasushi; Nakanuma, Yasuni; Miyajima, Atsushi; Tanaka, Minoru			Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree	PLOS ONE			English	Article							INTRAHEPATIC PERIBILIARY GLANDS; STEM/PROGENITOR CELLS; LIVER-REGENERATION; MOUSE-LIVER; SAM DOMAINS; HEPATOCYTES; PROTEIN; CHOLANGIOCARCINOMA; CHOLANGIOCYTES; HETEROGENEITY	Cholangiocarcinoma (CC) is a type of relatively rare neoplasm in adenocarcinoma. The characteristics of CCs as well as biliary epithelial cells are heterogeneous at the different portion of the biliary tree. There are two candidate stem/progenitor cells of the biliary tree, i.e., biliary tree stem/progenitor cell (BTSC) at the peribiliary gland (PBG) of large bile ducts and liver stem/progenitor cell (LPC) at the canals of Hering of peripheral small bile duct. Although previous reports suggest that intrahepatic CC (ICC) can arise from such stem/progenitor cells, the characteristic difference between BTSC and LPC in pathological process needs further investigation, and the etiology of CC remains poorly understood. Here we show that Sterile alpha motif domain containing 5 (SAMD5) is exclusively expressed in PBGs of large bile ducts in normal mice. Using a mouse model of cholestatic liver disease, we demonstrated that SAMD5 expression was upregulated in the large bile duct at the hepatic hilum, the extrahepatic bile duct and PBGs, but not in proliferating intrahepatic ductules, suggesting that SAMD5 is expressed in BTSC but not LPC. Intriguingly, human ICCs and extrahepatic CCs exhibited striking nuclear localization of SAMD5 while the normal hilar large bile duct displayed slight-to-moderate expression in cytoplasm. In vitro experiments using siRNA for SAMD5 revealed that SAMD5 expression was associated with the cell cycle regulation of CC cell lines. Conclusion: SAMD5 is a novel marker for PBG but not LPC in mice. In humans, the expression and location of SAMD5 could become a promising diagnostic marker for the cell type as well as malignancy of bile ducts and CCs.	[Yagai, Tomoki; Matsui, Satoshi; Inagaki, Fuyuki F.; Saijou, Eiko; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo, Japan; [Matsui, Satoshi; Nakanuma, Yasuni; Tanaka, Minoru] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan; [Harada, Kenichi; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa, Japan; [Miura, Yasushi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Tanaka, Minoru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan; [Yagai, Tomoki] Natl Canc Inst, Natl Inst Hlth, Ctr Canc Res, Lab Metab, Bethesda, MD USA; [Inagaki, Fuyuki F.] Univ Tokyo, Grad Sch Med, Hepato Biliary Pancreat Surg Div, Artificial Organ & Transplantat Div, Tokyo, Japan; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; Kanazawa University; Waseda University; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo; Shizuoka Cancer Center	Tanaka, M (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan.; Tanaka, M (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Stem Cell Regulat, Tokyo, Japan.	m-tanaka@ri.ncgm.go.jp			Japan Society for the Promotion of Science, Japan [2611007, 26253023]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Support was provided by Grants-in-Aid for Scientific Research on Innovative Areas (2611007 to MT) and Scientific Research A (26253023 to AM) from the Japan Society for the Promotion of Science, Japan (https://www.jsps.go.jp.english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2015, J HEPATO-BIL-PAN SCI, V22, P94, DOI 10.1002/jhbp.154; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Fickert P, 2002, AM J PATHOL, V161, P2019, DOI 10.1016/S0002-9440(10)64480-X; Glaser S, 2006, WORLD J GASTROENTERO, V12, P3523, DOI 10.3748/wjg.v12.i22.3523; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Inagaki FF, 2013, BIOCHEM BIOPH RES CO, V430, P751, DOI 10.1016/j.bbrc.2012.11.076; ISHIDA F, 1989, LAB INVEST, V60, P260; Katayanagi K, 1998, LIVER, V18, P90; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Luo N, 2010, BMB REP, V43, P355, DOI 10.5483/BMBRep.2010.43.5.355; Marzioni M, 2002, SEMIN LIVER DIS, V22, P227, DOI 10.1055/s-2002-34501; Matsuo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113606; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nakanishi Y, 2011, PATHOL INT, V61, P773, DOI 10.1111/j.1440-1827.2011.02738.x; Nakanishi Y, 2009, J HEPATO-BILIARY-PAN, V16, P869, DOI 10.1007/s00534-009-0070-1; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Paylakhi SH, 2011, MOL VIS, V17, P1209; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; Sa JK, 2017, ONCOTARGET, V8, P1321, DOI 10.18632/oncotarget.13616; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; TERADA T, 1990, HEPATOLOGY, V12, P92, DOI 10.1002/hep.1840120115; TERADA T, 1995, GASTROENTEROLOGY, V108, P1236, DOI 10.1016/0016-5085(95)90225-2; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Watanabe T, 2014, DIS COLON RECTUM, V57, P23, DOI 10.1097/01.dcr.0000437688.33795.9d; Yagai T, 2014, AM J PATHOL, V184, P2250, DOI 10.1016/j.ajpath.2014.04.018	42	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175355	10.1371/journal.pone.0175355	http://dx.doi.org/10.1371/journal.pone.0175355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388653	gold, Green Submitted, Green Published			2022-12-26	WOS:000399375800043
J	Uren, C; Henn, BM; Franke, A; Wittig, M; van Heiden, PD; Hoal, EG; Moller, M				Uren, Caitlin; Henn, Brenna M.; Franke, Andre; Wittig, Michael; van Heiden, Paul D.; Hoal, Eileen G.; Moller, Mario			A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN COLORED POPULATION; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; ANCESTRY; LOCUS; RISK; DISEASE; INDIVIDUALS; ANNOTATION	Utilizing data from published tuberculosis (TB) genome-wide association studies (GWAS), we use a bioinformatics pipeline to detect all polymorphisms in linkage disequilibrium (LD) with variants previously implicated in TB disease susceptibility. The probability that these variants had a predicted regulatory function was estimated using RegulomeDB and Ensembl's Variant Effect Predictor. Subsequent genotyping of these 133 predicted regulatory polymorphisms was performed in 400 admixed South African TB cases and 366 healthy controls in a population-based case-control association study to fine-map the causal variant. We detected associations between tuberculosis susceptibility and six intronic polymorphisms located in MARCO, IFNGR2, ASHAS2, ACACA, NISCH and TLR10. Our post-GWAS approach demonstrates the feasibility of combining multiple TB GWAS datasets with linkage information to identify regulatory variants associated with this infectious disease.	[Uren, Caitlin; van Heiden, Paul D.; Hoal, Eileen G.; Moller, Mario] Stellenbosch Univ, SA MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Franke, Andre; Wittig, Michael] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str, Kiel, Germany	National Research Foundation - South Africa; Stellenbosch University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Kiel	Moller, M (corresponding author), Stellenbosch Univ, SA MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa.	marlom@sun.ac.za	Moller, Marlo/AAC-6973-2020; Franke, Andre/B-2151-2010	Moller, Marlo/0000-0002-0805-6741; Franke, Andre/0000-0003-1530-5811; Uren, Caitlin/0000-0003-2358-0135	Faculty of Medicine and Health Sciences Early-Career Research; NRF National Bioinformatics Functional Genomics [93666]; DFG Cluster of Excellence 306 "Inflammation at Interfaces"	Faculty of Medicine and Health Sciences Early-Career Research; NRF National Bioinformatics Functional Genomics; DFG Cluster of Excellence 306 "Inflammation at Interfaces"	This work was supported by the Faculty of Medicine and Health Sciences Early-Career Research Funding for 2015 and the NRF National Bioinformatics Functional Genomics Grant No 93666 to M. M .A.F. and M.W. are supported through the DFG Cluster of Excellence 306 "Inflammation at Interfaces". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Bastami M, 2016, GENE, V594, P74, DOI 10.1016/j.gene.2016.08.054; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bowdish DME, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-47; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Bukhari M, 2015, INT J IMMUNOGENET, V42, P46, DOI 10.1111/iji.12170; Bulat-Kardum LJ, 2015, SCAND J IMMUNOL, V82, P63, DOI 10.1111/sji.12300; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Campbell H., 2002, Pharmacogenomics Journal, V2, P349; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chimusa ER, 2016, BIOINFORMATICS, V32, P549, DOI 10.1093/bioinformatics/btv619; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Chimusa ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073971; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; Dalgic N, 2011, DIS MARKERS, V31, P33, DOI [10.1155/2011/545972, 10.3233/DMA-2011-0800]; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; DeLorenze GN, 2016, J INFECT DIS, V213, P816, DOI 10.1093/infdis/jiv483; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Gallant CJ, 2010, INT J TUBERC LUNG D, V14, P952; Grant AV, 2016, HUM GENET, V135, P299, DOI 10.1007/s00439-016-1633-2; Haider SA, 2015, BIOGERONTOLOGY, V16, P529, DOI 10.1007/s10522-015-9575-y; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong XF, 2013, HUM MOL GENET, V22, P769, DOI 10.1093/hmg/dds484; Kuijl C, 2013, EMBO J, V32, P713, DOI 10.1038/emboj.2013.10; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024069; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oki Noffisat O, 2011, BMC Res Notes, V4, P28, DOI 10.1186/1756-0500-4-28; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Pollard K., 2004, UC BERKELEY DIVISION; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Salie M, 2014, J INFECT DIS, V209, P216, DOI 10.1093/infdis/jit443; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobota RS, 2016, AM J HUM GENET, V98, P514, DOI 10.1016/j.ajhg.2016.01.015; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Sveinbjornsson G, 2016, NAT GENET, V48, P318, DOI 10.1038/ng.3498; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Warnes G., 1967, J AM STAT ASSOC, V62, P626; Wei ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10879; World Health Organization, GLOB TUB REP 2016	57	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0174738	10.1371/journal.pone.0174738	http://dx.doi.org/10.1371/journal.pone.0174738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384278	Green Published, gold			2022-12-26	WOS:000399371900032
J	Yang, YW; Liu, HH; Lin, TH; Chuang, HY; Hsieh, T				Yang, Yu-Wan; Liu, Hsin-Ho; Lin, Tien-Huang; Chuang, Hsun-Yang; Hsieh, Tengfu			Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus	PLOS ONE			English	Article							LOWER URINARY-TRACT; OVERACTIVE BLADDER; COGNITIVE IMPAIRMENT; TAIWAN; PREVALENCE; QUALITY; PLACEBO; IMPACT	Background The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes mellitus (DM) remain unknown. We investigated the effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with DM. Methods We conducted a cohort study by using the diabetes dataset of the Taiwan National Health Insurance Research Database from 1 January, 2002 to 31 December, 2013. We included 10,938 patients received one type of oxybutynin, solifenacin, or tolterodine, while 564,733 had not. We included a comparable number of patients not receiving oxybutynin, solifenacin, or tolterodine as controls through systematic random sampling matching by age, gender, and the year of the index date with 1 to 1 ratio. The dementia risk was estimated through multivariate Cox proportional hazard regression after adjustment for several confounding factors. Results The dementia event rates were 3.9% in the oxybutynin group, 4.3% in the solifenacin group, 2.2% in the tolterodine group and 1.2% in the control group (P<0.001). The adjusted HRs compared to nonusers of anticholinergic drugs were 2.35 (95% CI, 1.96 to 2.81), 2.16 (95% CI, 1.81 to 2.58), and 2.24 (95% CI, 1.85 to 2.73), respectively, for patients receiving oxybutynin, solifenacin, or tolterodine. Conclusion Our study indicates an association between taking oxybutynin, solifenacin and tolterodine and the subsequent diagnosis of dementia in DM patients. Moreover, the patients using oxybutynin had highest risk. The impact of these three drugs on risk of dementia in non-diabetic populations is warrant.	[Yang, Yu-Wan] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Yu-Wan] China Med Univ, Sch Med, Taichung, Taiwan; [Liu, Hsin-Ho; Lin, Tien-Huang; Chuang, Hsun-Yang; Hsieh, Tengfu] Taichung Tzu Chi Hosp, Dept Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Liu, Hsin-Ho; Lin, Tien-Huang; Hsieh, Tengfu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chuang, Hsun-Yang; Hsieh, Tengfu] Taichung Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Hsieh, T (corresponding author), Taichung Tzu Chi Hosp, Dept Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.; Hsieh, T (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hsieh, T (corresponding author), Taichung Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan.	hdf95@yahoo.com.tw						Andersson KE, 2011, EUR UROL, V59, P377, DOI 10.1016/j.eururo.2010.11.040; Bertram S, 2016, ENDOCRINE; Chen CC, 2016, HEALTH POLICY PLANN, V31, P83, DOI 10.1093/heapol/czv024; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Giglio D, 2009, PHARMACOLOGY, V83, P259, DOI 10.1159/000209255; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Gormley EA, 2015, J UROLOGY, V193, P1572, DOI 10.1016/j.juro.2015.01.087; Herbison P, 2003, BMJ-BRIT MED J, V326, P841, DOI 10.1136/bmj.326.7394.841; Hsieh HM, 2015, MED CARE, V53, P106, DOI 10.1097/MLR.0000000000000264; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Ikeda M, 2015, ENDOCR J, V62, P847, DOI 10.1507/endocrj.EJ15-0237; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; Maman K, 2014, EUR UROL, V65, P755, DOI 10.1016/j.eururo.2013.11.010; Tuccori M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1541; Wagg A, 2010, INT J CLIN PRACT, V64, P1279, DOI 10.1111/j.1742-1241.2010.02449.x; Wagg A, 2013, EUR UROL, V64, P74, DOI 10.1016/j.eururo.2013.01.002; Womack KB, 2003, ARCH NEUROL-CHICAGO, V60, P771, DOI 10.1001/archneur.60.5.771	25	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e175335	10.1371/journal.pone.0175335	http://dx.doi.org/10.1371/journal.pone.0175335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384267	Green Published, gold, Green Submitted			2022-12-26	WOS:000399371900159
J	de Albuquerque, FS; Gregory, A				de Albuquerque, Fabio Suzart; Gregory, Andrew			The geography of hotspots of rarity-weighted richness of birds and their coverage by Natura 2000	PLOS ONE			English	Article							TERRESTRIAL VERTEBRATES; SPECIES RICHNESS; CONSERVATION; SELECTION; ENDEMISM; POLICY; AREAS	A major challenge for biogeographers and conservation planners is to identify where to best locate or distribute high-priority areas for conservation and to explore whether these areas are well represented by conservation actions such as protected areas (PAs). We aimed to identify high-priority areas for conservation, expressed as hotpots of rarity-weighted richness (HRR) sites that efficiently represent species for birds across EU countries, and to explore whether HRR are well represented by the Natura 2000 network. Natura 2000 is an evolving network of PAs that seeks to conserve biodiversity through the persistence of the most patrimonial species and habitats across Europe. This network includes Sites of Community Importance (SCI) and Special Areas of Conservation (SAC), where the latter regulated the designation of Special Protected Areas (SPA). Distribution maps for 416 bird species and complementarity-based approaches were used to map geographical patterns of rarity-weighted richness (RWR) and HRR for birds. We used species accumulation index to evaluate whether RWR was efficient surrogates to identify HRRs for birds. The results of our analysis support the proposition that prioritizing sites in order of RWR is a reliable way to identify sites that efficiently represent birds. HRRs were concentrated in the Mediterranean Basin and alpine and boreal biogeographical regions of northern Europe. The cells with high RWR values did not correspond to cells where Natura 2000 was present. We suggest that patterns of RWR could become a focus for conservation biogeography. Our analysis demonstrates that identifying HRR is a robust approach for prioritizing management actions, and reveals the need for more conservation actions, especially on HRR.	[de Albuquerque, Fabio Suzart] Arizona State Univ, Coll Integrat Sci & Arts, Sci & Math Fac, Mesa, AZ 85212 USA; [Gregory, Andrew] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA	Arizona State University; University System of Ohio; Bowling Green State University	de Albuquerque, FS (corresponding author), Arizona State Univ, Coll Integrat Sci & Arts, Sci & Math Fac, Mesa, AZ 85212 USA.	Fabio.Albuquerque@asu.edu		Gregory, Andrew/0000-0003-1905-3236	Arizona State University; University of Granada	Arizona State University; University of Granada	This work was partly funded by the Arizona State University and University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119905; Albuquerque FS, 2013, BIOL CONSERV, V159, P45, DOI 10.1016/j.biocon.2012.10.012; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Assuncao-Albuquerque M.J.T., 2012, Web Ecology, V12, P65; Barov B, 2012, CONSERVATION RECOVER; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; BirdLife International, 2008, CRIT END GLOB AUD; Carter F.W., 2002, ENV PROBLEMS E CENTR; Conde A S, 2006, 152 EUR ENV AG; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Dudley N., 2010, NATURAL SOLUTIONS PR; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; EC (European Commission), 2000, NAT 2000 EUR NAT YOU; EEA, 2015, NAT 2000 DAT EUR NET; Ellis EC, 2000, ANTHROPOGENIC BIOMES; European Commission, 1996, INT MAN EUR UN HAB V; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferrier S., 2009, SPATIAL CONSERVATION, P13; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Haight R., 2009, SPATIAL CONSERVATION, P43; Hanski I., 2004, MUCH PRACTICAL TOOLS; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION, P58; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; Pressey R. L., 2009, SPATIAL CONSERVATION, P211; R Core Team, 2020, R LANG ENV STAT COMP; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rosin ZM, 2016, J APPL ECOL, V53, P1363, DOI 10.1111/1365-2664.12715; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Stein BA, 2000, PRECIOUS HERITAGE ST; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Wilson K.A., 2009, SPATIAL CONSERVATION	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174179	10.1371/journal.pone.0174179	http://dx.doi.org/10.1371/journal.pone.0174179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379991	Green Published, gold, Green Submitted			2022-12-26	WOS:000399353500035
J	Hinds, LR; Chun, LE; Woodruff, ER; Christensen, JA; Hartsock, MJ; Spencer, RL				Hinds, Laura R.; Chun, Lauren E.; Woodruff, Elizabeth R.; Christensen, Jennifer A.; Hartsock, Matthew J.; Spencer, Robert L.			Dynamic glucocorticoid-dependent regulation of Sgk1 expression in oligodendrocytes of adult male rat brain by acute stress and time of day	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; MESSENGER-RNA; PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM; PROTEIN-KINASE; CORTICOSTERONE; PLASTICITY; INDUCTION; AMYGDALA; PHASE	Recent studies support plasticity in adult brain white matter structure and myelination in response to various experiential factors. One possible contributor to this plasticity may be activity-dependent modulation of serum-and glucocorticoid-inducible kinase 1 (Sgk1) expression in oligodendrocytes. We examined whether Sgk1 expression in adult rat brain white matter is increased by acute stress-induced elevations in endogenous corticosterone and whether it fluctuates with diurnal variations in corticosterone. We observed rapid increases (within 30 min) in Sgk1 mRNA in the corpus callosum in response to acute stress, as well as large increases at the beginning of the rat's active period (the time of peak corticosterone secretion). These increases were absent in adrenalectomized rats. Corticosterone treatment of adrenalectomized rats also rapidly increased corpus callosum Sgk1 mRNA. The majority of Sgk1 mRNA in corpus callosum was co-localized with myelin basic protein mRNA, suggesting that mature oligodendrocytes respond dynamically to acute stress and circadian rhythms. The regulation of Sgk1 expression by acute stress and time of day was selective for white matter, with limited alteration of Sgk1 expression by these factors in hippocampus and somatosensory cortex. These results indicate a unique sensitivity of oligodendrocyte Sgk1 expression to activity-dependent fluctuations in corticosterone hormone secretion, and raises the prospect that hypothalamic-pituitary-adrenal axis dysregulation or glucocorticoid pharmacotherapy may compromise the normal activity-dependent interactions between oligodendrocytes and neurons.	[Hinds, Laura R.; Chun, Lauren E.; Woodruff, Elizabeth R.; Christensen, Jennifer A.; Hartsock, Matthew J.; Spencer, Robert L.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Spencer, RL (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	Robert.spencer@colorado.edu		Woodruff, Elizabeth/0000-0003-0237-7453; SPENCER, ROBERT/0000-0003-3120-6303; Hartsock, Matthew/0000-0002-1077-2448	National Science Foundation [IOS1456706]; University of Colorado Boulder Undergraduate Research Opportunity Program	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder Undergraduate Research Opportunity Program	This work was supported by National Science Foundation Grant IOS1456706 (RLS) and University of Colorado Boulder Undergraduate Research Opportunity Program (JAC).	Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Bali B, 2008, J NEUROENDOCRINOL, V20, P1045, DOI 10.1111/j.1365-2826.2008.01759.x; Bohacek J, 2015, PSYCHONEUROENDOCRINO, V52, P1, DOI 10.1016/j.psyneuen.2014.10.026; Chun LE, 2015, J BIOL RHYTHM, V30, P417, DOI 10.1177/0748730415598608; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Deschenes M, 2005, PROG BRAIN RES, V149, P31, DOI 10.1016/S0079-6123(05)49003-2; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Herman JP, 2006, NEUROL CLIN, V24, P461, DOI 10.1016/j.ncl.2006.03.006; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Lang F, 2013, EXPERT OPIN INV DRUG, V22, P701, DOI 10.1517/13543784.2013.778971; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Miyata S, 2015, BIOCHEM BIOPH RES CO, V464, P76, DOI 10.1016/j.bbrc.2015.05.109; Miyata S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/492367; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Murata S, 2005, FEBS LETT, V579, P2137, DOI 10.1016/j.febslet.2005.02.069; Oray M, 2016, EXPERT OPIN DRUG SAF, V15, P457, DOI 10.1517/14740338.2016.1140743; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sarabdjitsingh RA, 2010, ENDOCRINOLOGY, V151, P1177, DOI 10.1210/en.2009-1119; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; Spencer R.L., 2016, PHYSL BEHAV; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weiser MJ, 2011, J NEUROENDOCRINOL, V23, P1231, DOI 10.1111/j.1365-2826.2011.02217.x; Woodruff ER, 2016, ENDOCRINOLOGY, V157, P1522, DOI 10.1210/en.2015-1884; Xydous M, 2014, BBA-GENE REGUL MECH, V1839, P866, DOI 10.1016/j.bbagrm.2014.07.011; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	35	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0175075	10.1371/journal.pone.0175075	http://dx.doi.org/10.1371/journal.pone.0175075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376115	Green Published, Green Submitted, gold			2022-12-26	WOS:000399352000038
J	Budelier, MM; Cheng, WWL; Bergdoll, L; Chen, ZW; Janetka, JW; Abramson, J; Krishnan, K; Mydock-McGrane, L; Covey, DF; Whitelegge, JP; Evers, AS				Budelier, Melissa M.; Cheng, Wayland W. L.; Bergdoll, Lucie; Chen, Zi-Wei; Janetka, James W.; Abramson, Jeff; Krishnan, Kathiresan; Mydock-McGrane, Laurel; Covey, Douglas F.; Whitelegge, Julian P.; Evers, Alex S.			Photoaffinity labeling with cholesterol analogues precisely maps a cholesterol-binding site in voltage-dependent anion channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; INNER MEMBRANES; PROTEIN; VDAC; LIPIDS; OUTER; CRYSTALLOGRAPHY; PURIFICATION; DETERGENTS	Voltage-dependent anion channel-1 (VDAC1) is a highly regulated beta-barrel membrane protein that mediates transport of ions and metabolites between the mitochondria and cytosol of the cell. VDAC1 co-purifies with cholesterol and is functionally regulated by cholesterol, among other endogenous lipids. Molecular modeling studies based on NMR observations have suggested five cholesterol-binding sites in VDAC1, but direct experimental evidence for these sites is lacking. Here, to determine the sites of cholesterol binding, we photolabeled purified mouse VDAC1 (mVDAC1) with photoactivatable cholesterol analogues and analyzed the photolabeled sites with both top-down mass spectrometry (MS), and bottom-upMSpaired with a clickable, stable isotope-labeled tag, FLI-tag. Using cholesterol analogues with a diazirine in either the 7 position of the steroid ring (LKM38) or the aliphatic tail (KK174), we mapped a binding pocket in mVDAC1 localized to Thr(83) and Glu(73), respectively. When Glu(73) was mutated to a glutamine, KK174 no longer photolabeled this residue, but instead labeled the nearby Tyr(62) within this same binding pocket. The combination of analytical strategies employed in this work permits detailed molecular mapping of a cholesterol-binding site in a protein, including an orientation of the sterol within the site. Our work raises the interesting possibility that cholesterol-mediated regulation of VDAC1 may be facilitated through a specific binding site at the functionally important Glu(73) residue.	[Budelier, Melissa M.; Cheng, Wayland W. L.; Chen, Zi-Wei; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; [Budelier, Melissa M.; Janetka, James W.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Krishnan, Kathiresan; Mydock-McGrane, Laurel; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zi-Wei; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA; [Bergdoll, Lucie; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Abramson, Jeff] Tata Inst Fundamental Res, Inst Stem Cell Biol & Regenerat Med, Nation Ctr Biol Sci, Bangalore 560065, Karnataka, India	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR)	Evers, AS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054, St Louis, MO 63110 USA.	eversa@wustl.edu	bergdoll, lucie/M-9346-2018; Janetka, James/A-8216-2011	bergdoll, lucie/0000-0001-6068-238X; Evers, Alex/0000-0002-0342-0575; Janetka, James/0000-0002-9888-5411; Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [R01GM108799, R01GM078844, R21AI120490-01, P01GM47969, T32-GM108539, R01HL067773, T32 HL007275]; National Science Foundation [DGE-1143954]; Taylor Family Institute for Innovative Psychiatric Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108799, P01GM047969, R01GM078844, T32GM108539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Taylor Family Institute for Innovative Psychiatric Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM108799, R01GM078844, R21AI120490-01, P01GM47969, T32-GM108539, and R01HL067773, and T32 HL007275, National Science Foundation Grant DGE-1143954, and the Taylor Family Institute for Innovative Psychiatric Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aufschnaiter A, 2017, CELL TISSUE RES, V367, P125, DOI 10.1007/s00441-016-2463-1; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Budelier MM, 2017, ANAL CHEM, V89, P2636, DOI 10.1021/acs.analchem.6b05003; Castellano BM, 2017, SCIENCE, V355, P1306, DOI 10.1126/science.aag1417; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chen ZW, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011445; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; DEPINTO V, 1989, EUR J BIOCHEM, V183, P179; FREITAG H, 1982, EUR J BIOCHEM, V123, P629; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; Guner H, 2014, J AM SOC MASS SPECTR, V25, P464, DOI 10.1007/s13361-013-0789-4; HALLERMAYER G, 1974, H-S Z PHYSIOL CHEM, V355, P279, DOI 10.1515/bchm2.1974.355.1.279; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; PARSONS DF, 1967, BIOCHIM BIOPHYS ACTA, V135, P362, DOI 10.1016/0005-2736(67)90132-0; POPP B, 1995, BIOCHEMISTRY-US, V34, P3352, DOI 10.1021/bi00010a026; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Ujwal R, 2012, JOVE-J VIS EXP, DOI 10.3791/3383; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge J, 2006, EXPERT REV PROTEOMIC, V3, P585, DOI 10.1586/14789450.3.6.585; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Xia Y, 2013, CHEM REV, V113, P7880, DOI 10.1021/cr300419p; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	42	40	42	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9294	9304		10.1074/jbc.M116.773069	http://dx.doi.org/10.1074/jbc.M116.773069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28396346	hybrid, Green Published			2022-12-26	WOS:000402538900024
J	Singh, A; Xu, YJ				Singh, Amanpreet; Xu, Yong-jie			Heme deficiency sensitizes yeast cells to oxidative stress induced by hydroxyurea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION CHECKPOINT; RIBONUCLEOTIDE REDUCTASE; FISSION YEAST; IN-VIVO; COPROPORPHYRINOGEN OXIDASE; HEREDITARY COPROPORPHYRIA; OXYGEN; ACTIVATION; BIOSYNTHESIS; EXPRESSION	Hydroxyurea (HU) has a long history of clinical and scientific use as an antiviral, antibacterial, and antitumor agent. It inhibits ribonucleotide reductase and reversibly arrests cells in S phase. However, high concentrations or prolonged treatment with low doses of HU can cause cell lethality. Although the cytotoxicity of HU may significantly contribute to its therapeutic effects, the underlying mechanisms remain poorly understood. We have previously shown that HU can induce cytokinesis arrest in the erg11-1 mutant of fission yeast, which has a partial defect in the biosynthesis of fungal membrane sterol ergosterol. Here, we report the identification of a new mutant in heme biosynthesis, hem13-1, that is hypersensitive to HU. We found that the HU hypersensitivity of the hem13-1 mutant is caused by oxidative stress and not by replication stress or a defect in cellular response to replication stress. The mutation is hypomorphic and causes heme deficiency, which likely sensitizes the cells to the HU-induced oxidative stress. Because the heme biosynthesis pathway is highly conserved in eukaryotes, this finding, as we show in our separate report, may help to expand the therapeutic spectrum of HU to additional pathological conditions.	[Singh, Amanpreet; Xu, Yong-jie] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Singh, Amanpreet] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	University System of Ohio; Wright State University Dayton; State University of New York (SUNY) System; Wadsworth Center	Xu, YJ (corresponding author), Wright State Univ, Boonshoft Sch Med, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu			National Institutes of Health [RO1 GM110132]; Wright State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wright State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM110132 and the start-up fund provided by Wright State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKERBLOM L, 1981, P NATL ACAD SCI-BIOL, V78, P2159, DOI 10.1073/pnas.78.4.2159; Bandhu A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004136; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; BRODIE MJ, 1977, Q J MED, V46, P229; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; CHOY BK, 1988, CANCER RES, V48, P2029; Culotta VC, 2000, CURR TOP CELL REGUL, V36, P117; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Di YJ, 2012, EMBO J, V31, P563, DOI 10.1038/emboj.2011.438; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Harris P, 1996, MOL GEN GENET, V252, P284; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Huang ZW, 2011, EUKARYOT CELL, V10, P1536, DOI 10.1128/EC.05170-11; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Juul T, 2010, J BIOL CHEM, V285, P21411, DOI 10.1074/jbc.M110.103564; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kluza K, 2005, EUR J PHARMACOL, V525, P32, DOI 10.1016/j.ejphar.2005.09.050; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Lamoril J, 1998, BLOOD, V91, P1453, DOI 10.1182/blood.V91.4.1453; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Marchetti MA, 2006, J CELL SCI, V119, P124, DOI 10.1242/jcs.02703; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakayashiki T, 2013, J BACTERIOL, V195, P1226, DOI 10.1128/JB.02145-12; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; Philpott CC, 2012, NUTR HEALTH SER, P653, DOI 10.1007/978-1-60327-485-2_30; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342; Scozzafava A, 2003, BIOORGAN MED CHEM, V11, P2241, DOI 10.1016/S0968-0896(03)00112-3; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Singh A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7110099; Sneeden JL, 2004, J BIOL CHEM, V279, P40723, DOI 10.1074/jbc.M402699200; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Spivak JL, 2011, EXPERT REV ANTICANC, V11, P403, DOI [10.1586/ERA.11.10, 10.1586/era.11.10]; Stevens MR, 1999, J BIOL REG HOMEOS AG, V13, P172; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tang HL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09015; TSUCHIYA M, 1994, METHOD ENZYMOL, V233, P128; TURI TG, 1992, J BIOL CHEM, V267, P2046; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Xu YJ, 2016, GENETICS, V204, P959, DOI 10.1534/genetics.116.191536; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092936; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; ZAGOREC M, 1986, J BIOL CHEM, V261, P2506; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	59	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9088	9103		10.1074/jbc.M117.781211	http://dx.doi.org/10.1074/jbc.M117.781211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28377506	Green Published, hybrid			2022-12-26	WOS:000402538900008
J	Casillas-Ituarte, NN; Cruz, CHB; Lins, RD; DiBartola, AC; Howard, J; Liang, XW; Hook, M; Viana, IFT; Sierra-Hernandez, MR; Lower, SK				Casillas-Ituarte, Nadia N.; Cruz, Carlos H. B.; Lins, Roberto D.; DiBartola, Alex C.; Howard, Jessica; Liang, Xiaowen; Hoeoek, Magnus; Viana, Isabelle F. T.; Sierra-Hernandez, M. Roxana; Lower, Steven K.			Amino acid polymorphisms in the fibronectin-binding repeats of fibronectin-binding protein A affect bond strength and fibronectin conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); fibronectin; molecular dynamics; single-nucleotide polymorphism (SNP); Staphylococcus aureus (S; aureus); surface plasmon resonance (SPR); binding; bond; energy; ligand	RESISTANT STAPHYLOCOCCUS-AUREUS; DYNAMIC FORCE SPECTROSCOPY; RECEPTOR-LIGAND BONDS; PRESSURE TRANSIENTS; HOT-SPOT; SELECTIN; MOLECULE; DISSOCIATION; COMPLEXES; FIBRINOGEN	The Staphylococcus aureus cell surface contains cell wall anchored proteins such as fibronectin-binding protein A (FnBPA) that bind to host ligands (e.g. fibronectin; Fn) present in the extracellular matrix of tissue or coatings on cardiac implants. Recent clinical studies have found a correlation between cardiovascular infections caused by S. aureus and nonsynonymous SNPs in FnBPA. Atomic force microscopy (AFM), surface plasmon resonance (SPR), and molecular simulations were used to investigate interactions between Fn and each of eight 20-mer peptide variants containing amino acids Ala, Asn, Gln, His, Ile, and Lys at positions equivalent to 782 and/or 786 in Fn-binding repeat-9 of FnBPA. Experimentally measured bond lifetimes and dissociation constants determined by mechanically dissociating the Fn<bold>peptide complex at loading rates relevant to the cardiovascular system</bold>, varied from the lowest-affinity H782A/K786A peptide (0.011 s, 747 m) to the highest-affinity H782Q/K786N peptide (0.192 s, 15.7 m). These atomic force microscopy results tracked remarkably well to metadynamics simulations in which peptide detachment was defined solely by the free-energy landscape. Simulations and SPR experiments suggested that an Fn conformational change may enhance the stability of the binding complex for peptides with K786I or H782Q/K786I app = 0.2-0.5 m, compared with the lowest-affinity double-alanine peptide Together, these findings demonstrate that amino acid substitutions in Fn-binding repeat-9 can significantly affect bond strength and influence the conformation of Fn upon binding. They provide a mechanistic explanation for the observation of nonsynonymous SNPs in fnbA among clinical isolates of S. aureus that cause endovascular infections.	[Casillas-Ituarte, Nadia N.; DiBartola, Alex C.; Howard, Jessica; Sierra-Hernandez, M. Roxana; Lower, Steven K.] Ohio State Univ, 125 S Oval Mall,275 Mendenhall Lab, Columbus, OH 43210 USA; [Cruz, Carlos H. B.; Lins, Roberto D.; Viana, Isabelle F. T.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil; [Liang, Xiaowen; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lower, SK (corresponding author), Ohio State Univ, 125 S Oval Mall,275 Mendenhall Lab, Columbus, OH 43210 USA.; Lins, RD (corresponding author), Av Prof Moraes Rego S-N,Campus UFPE, BR-50740465 Recife, PE, Brazil.	roberto.lins@cpqam.fiocruz.br; Lower.9@osu.edu	Viana, Isabelle/M-4435-2017; Lower, Steven/A-2440-2008; Lins, Roberto/J-7511-2012	Viana, Isabelle/0000-0003-4648-6635; Lower, Steven/0000-0001-9796-0830; Lins, Roberto/0000-0002-3983-8025; bezerra da cruz, carlos henrique/0000-0003-3490-1213; Liang, Xiaowen/0000-0002-6174-2951; Sierra Hernandez, Roxana/0000-0001-8566-8170	Brazilian National Scientific Computing Center (LNCC); National Institutes of Health [R01 HL119648]; National Science Foundation [EAR-1424138]; American Heart Association Fellowship [14POST20460073]; Fundacao do Amparo a Ciencia e Tecnologia (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Joanna S. Diehl Trust [03171990]; Division Of Earth Sciences [1424138] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	Brazilian National Scientific Computing Center (LNCC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association Fellowship(American Heart Association); Fundacao do Amparo a Ciencia e Tecnologia (FACEPE); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Joanna S. Diehl Trust; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 HL119648, National Science Foundation Grant EAR-1424138, and American Heart Association Fellowship 14POST20460073 (to N. N. C.-I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Fundacao do Amparo a Ciencia e Tecnologia (FACEPE), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; Supported by Joanna S. Diehl Trust 03171990.	Albrecht VS, 2015, J CLIN MICROBIOL, V53, P3478, DOI 10.1128/JCM.01371-15; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERENDSEN HJC, 1987, COMPUT PHYS COMMUN, V44, P233, DOI 10.1016/0010-4655(87)90078-6; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Bozna BL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.192674; Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Casillas-Ituarte NN, 2012, J BIOL CHEM, V287, P6693, DOI 10.1074/jbc.M111.285692; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Chandran KB, 1997, ANN BIOMED ENG, V25, P926; Chandran KB, 1998, ANN BIOMED ENG, V26, P546, DOI 10.1114/1.79; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; Cheung LSL, 2012, BIOPHYS J, V102, P407, DOI 10.1016/j.bpj.2012.01.004; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Eichenberger EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141436; El-Kirat-Chatel S, 2013, MOL MICROBIOL, V89, P649, DOI 10.1111/mmi.12301; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Farrance OE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001489; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hos NJ, 2015, J INFECTION, V70, P153, DOI 10.1016/j.jinf.2014.09.005; HUFF S, 1994, J BIOL CHEM, V269, P15563; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Li YJ, 2013, J MOL RECOGNIT, V26, P46, DOI 10.1002/jmr.2242; Liang XW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159118; Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lower SK, 2010, BIOPHYS J, V99, P2803, DOI 10.1016/j.bpj.2010.08.063; Ma WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124941; Meadows PY, 2003, LANGMUIR, V19, P9566, DOI 10.1021/la035217w; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Miskei M, 2017, NUCLEIC ACIDS RES, V45, pD228, DOI 10.1093/nar/gkw1019; Neundlinger I, 2014, J BIOL CHEM, V289, P21673, DOI 10.1074/jbc.M113.529875; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oh YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33909; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piroth L, 2008, INFECT IMMUN, V76, P3824, DOI 10.1128/IAI.00405-08; Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Ros R, 1998, P NATL ACAD SCI USA, V95, P7402, DOI 10.1073/pnas.95.13.7402; Rotzschke O, 1999, P NATL ACAD SCI USA, V96, P7445, DOI 10.1073/pnas.96.13.7445; Sarangapani KK, 2011, J BIOL CHEM, V286, P32749, DOI 10.1074/jbc.M111.240044; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Taylor ES, 2017, PROTEINS, V85, P561, DOI 10.1002/prot.25220; te Riet J, 2007, J CELL SCI, V120, P3965, DOI 10.1242/jcs.004010; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633; Wildling L, 2012, J BIOL CHEM, V287, P105, DOI 10.1074/jbc.M111.304873; Xiong YQ, 2015, INFECT IMMUN, V83, P4772, DOI 10.1128/IAI.01074-15; Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012; Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v; Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	86	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8797	8810		10.1074/jbc.M117.786012	http://dx.doi.org/10.1074/jbc.M117.786012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28400484	Green Published, hybrid			2022-12-26	WOS:000402153900025
J	Song, R; Fullerton, DA; Ao, LH; Zhao, KS; Meng, XZ				Song, Rui; Fullerton, David A.; Ao, Lihua; Zhao, Ke-seng; Meng, Xianzhong			An epigenetic regulatory loop controls pro-osteogenic activation by TGF-beta 1 or bone morphogenetic protein 2 in human aortic valve interstitial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcification; gene regulation; growth factor; microRNA (miRNA); signaling; aortic valve	OSTEOBLAST DIFFERENTIATION; CALCIFICATION; EXPRESSION; MICRORNAS; RUNX2; OSTERIX; PROGRESSION; MECHANISMS; DISEASE; FAMILY	Calcific aortic valve disease (CAVD) is common in the elderly population, but pharmacological interventions for managing valvular calcification are unavailable. Transforming growth factor beta 1 (TGF-beta 1) and bone morphogenetic protein 2 (BMP-2) induce pro-osteogenic activation of human aortic valve interstitial cells (AVICs) that play an important role in valvular calcification. However, the molecular mechanism underlying pro-osteogenic activation in AVICs is incompletely understood. Here, we investigated an epigenetic regulatory mechanism in human AVIC pro-osteogenic activation induced by TGF-beta 1 and BMP-2. Microarray and real-time PCR analyses revealed that microRNA (miR)-486 up-regulation and miR-204 down-regulation were characteristic changes in TGF-beta 1- and BMP-2-stimulated normal AVICs and in AVICs from calcified valves. Both TGF-beta 1 and BMP-2 down-regulated miR-204 through Smad pathways. Interestingly, an miR-486 antagomir diminished the effect of TGF-beta 1 and BMP-2 on miR-204 levels and calcium deposit formation. Furthermore, the miR-486 antagomir increased the expression of Smurf2, a Smad inhibitor, in the presence or absence of TGF-beta 1 or BMP-2 stimulation, whereas a miR-486 mimic reduced Smurf2 expression. Smurf2 knockdown augmented TGF-beta 1- or BMP-2-induced miR-204 down-regulation and resulted in increased expression of the osteoblastic biomarkers Osx and Runx2. In summary, we found that TGF-beta 1 and BMP-2 up-regulate miR-486 and down-regulate miR-204 in human AVICs to promote pro-osteogenic activity and that miR-486 inhibits Smurf2 expression to augment the miR-204 down-regulation. We conclude that the miR-486-Smurf2-Smad loop plays an important role in regulating AVIC pro-osteogenic activation in response to TGF-beta 1 or BMP-2. Targeting this regulatory loop may have therapeutic potential for suppressing aortic valve calcification.	[Song, Rui; Fullerton, David A.; Ao, Lihua; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA; [Zhao, Ke-seng] Southern Med Univ, Dept Pathophysiol, Guangdong Key Lab Shock & Microcirculat Res, Guangzhou 510515, Guangdong, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Medical University - China	Meng, XZ (corresponding author), Box C-320,12700 E 19th Ave, Aurora, CO 80045 USA.	Xianzhong.meng@ucdenver.edu		SONG, RUI/0000-0002-5485-3741	National Institutes of Health NHLBI [HL106582, HL121776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106582, R01HL121776] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health NHLBI Grants HL106582 and HL121776.	Alexopoulos A, 2010, INT J CARDIOL, V139, P142, DOI 10.1016/j.ijcard.2008.10.014; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benton JA, 2008, J HEART VALVE DIS, V17, P689; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cowan CM, 2012, BIOCHEM BIOPH RES CO, V422, P351, DOI 10.1016/j.bbrc.2012.04.077; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Du YY, 2011, CIRC RES, V108, P917, DOI 10.1161/CIRCRESAHA.110.234328; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Mohler ER, 2004, AM J CARDIOL, V94, P1396, DOI 10.1016/j.amjcard.2004.08.013; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Nigam V, 2010, J HEART VALVE DIS, V19, P459; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song R, 2015, J MOL MED, V93, P403, DOI 10.1007/s00109-014-1229-z; Song R, 2012, ARTERIOSCL THROM VAS, V32, P2711, DOI 10.1161/ATVBAHA.112.300116; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang YJ, 2015, J CARDIOVASC PHARM, V66, P63, DOI 10.1097/FJC.0000000000000244; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Yanagawa B, 2012, J THORAC CARDIOV SUR, V144, P256, DOI 10.1016/j.jtcvs.2011.10.097; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Zeng QC, 2012, CIRCULATION, V126, pS222, DOI 10.1161/CIRCULATIONAHA.111.083675; Zhang M, 2014, J THORAC CARDIOV SUR, V147, P1073, DOI 10.1016/j.jtcvs.2013.05.011; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	41	31	35	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8657	8666		10.1074/jbc.M117.783308	http://dx.doi.org/10.1074/jbc.M117.783308			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28377507	Green Published, hybrid			2022-12-26	WOS:000402153900013
J	Pastor-Idoate, S; Bonshek, R; Irion, L; Zambrano, I; Carlin, P; Mironov, A; Bishop, P; McLeod, D; Stanga, PE				Pastor-Idoate, Salvador; Bonshek, Richard; Irion, Luciane; Zambrano, Isaac; Carlin, Paul; Mironov, Aleksandr; Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo			Ultrastructural and histopathologic findings after pars plana vitrectomy with a new hypersonic vitrector system. Qualitative preliminary assessment	PLOS ONE			English	Article							ULTRASONIC VITRECTOMY; TISSUE; PHYSICS; ORGANIZATION; LESIONS; RETINA	Purpose Preliminary assessment of a new prototype ultrasound-based hypersonic vitrector (HV) by qualitatively examining the histopathological changes in the retina and vitreous body after pars plana vitrectomy (PPV) and its ability to fragment vitreous collagen. Methods Fourteen porcine cadaveric eyes, 20 eyes in live swine and six human cadaveric eyes underwent PPV using the HV or a pneumatic guillotine vitrector (GV). An additional 4 porcine crystalline lenses were touched with either the HV or GV for 1 minute. Following PPV, human vitreous was removed and processed for electron microscopy (EM). Eyes and lenses were fixed and sectioned for light microscopy (LM). Results There were no macroscopic retinal or optic nerve defects associated with either HV or GV PPVs. Cadaveric retinal specimens showed separation of the inner limiting membrane (ILM) and vacuolization and fragmentation at the nerve fiber layer (NFL) and the ganglion cell layer (GCL). ILM fragmentation and separation were found after PPV in live swine with both vitrectors. Small disruptions of the posterior capsule or structural lens defects were found after HV touch. The EM analysis revealed more fragmentation of human vitreous collagen fibrils after HV compared to GV PPV. Conclusions LM and EM analysis of retina, vitreous, and crystalline lens after PPV showed similar morphological changes using the HV or the GV. Vitreous fragmentation appeared more effective with the HV. Overall this study suggests that the HV may be a promising new technology. More work is needed to quantitatively assess its safety and efficacy.	[Pastor-Idoate, Salvador; Bonshek, Richard; Irion, Luciane; Zambrano, Isaac; Carlin, Paul; Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England; [Pastor-Idoate, Salvador; Stanga, Paulo Eduardo] NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England; [Bonshek, Richard; Irion, Luciane] Manchester Royal Eye Hosp, Natl Specialist Ophthalm Pathol Serv, Manchester, Lancs, England; [Zambrano, Isaac] Manchester Royal Eye Hosp, Eye Bank, Manchester, Lancs, England; [Carlin, Paul] Manchester Royal Eye Hosp, Operating Theatre Serv, Manchester, Lancs, England; [Mironov, Aleksandr] Univ Manchester, Fac Life Sci, Electron Microscopy Core Facil, Manchester, Lancs, England; [Bishop, Paul; McLeod, David; Stanga, Paulo Eduardo] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	Manchester Royal Eye Hospital; University of Manchester; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital; University of Manchester; University of Manchester	Stanga, PE (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Stanga, PE (corresponding author), Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England.; Stanga, PE (corresponding author), NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England.; Stanga, PE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	retinaspecialist@btinternet.com	PASTOR-IDOATE, SALVADOR/G-2548-2016	PASTOR-IDOATE, SALVADOR/0000-0002-6463-4227; Mironov, Aleksandr/0000-0002-1497-328X	Bausch Lomb	Bausch Lomb	This work was supported by Salvador Pastor-Idoate: Bausch & Lomb: Research Funding; Paulo Stanga: Bausch & Lomb: Consultancy, Equipment, Research Funding, Lecture Fees, Travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSO NN, 1994, ULTRASON SONOCHEM, V1, pS69, DOI 10.1016/1350-4177(94)90031-0; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; Barnett SB, 1997, ULTRASOUND MED BIOL, V23, P805, DOI 10.1016/S0301-5629(97)00027-6; BAUM G, 1958, AM J OPHTHALMOL, V46, P319, DOI 10.1016/0002-9394(58)90813-4; Bond LJ, 1996, ULTRASOUND MED BIOL, V22, P101, DOI 10.1016/0301-5629(95)02022-5; BOPP S, 1993, GRAEF ARCH CLIN EXP, V231, P295, DOI 10.1007/BF00919108; Bos KJ, 2001, MICRON, V32, P301, DOI 10.1016/S0968-4328(00)00035-4; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; CHAN KK, 1986, ULTRASOUND MED BIOL, V12, P279, DOI 10.1016/0301-5629(86)90337-6; Chang IA, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-27; Cimino WW, 1999, CLIN PLAST SURG, V26, P447; Cimino WW, 1996, ULTRASOUND MED BIOL, V22, P89, DOI 10.1016/0301-5629(95)02021-7; de Nie KF, 2013, GRAEF ARCH CLIN EXP, V251, P1373, DOI 10.1007/s00417-012-2205-3; Fabian ID, 2011, BRIT J OPHTHALMOL, V95, P318, DOI 10.1136/bjo.2009.176495; Ghasemi Falavarjani Khalil, 2012, J Ophthalmic Vis Res, V7, P125; GIRARD LJ, 1976, T AM ACAD OPHTHALMOL, V81, pP432; GOSS S A, 1979, Ultrasound in Medicine and Biology, V5, P181, DOI 10.1016/0301-5629(79)90086-3; Jackson T, 2000, AM J OPHTHALMOL, V129, P116, DOI 10.1016/S0002-9394(99)00377-3; JOHNSON NF, 1976, ACTA OPHTHALMOL, V54, P529; KAPLAN LJ, 1983, ANN OPHTHALMOL, V15, P1132; KARLIN DB, 1969, AM J OPHTHALMOL, V68, P84, DOI 10.1016/0002-9394(69)94937-X; LEITGEB N, 1979, A GRAEF ARCH KLIN EX, V209, P263, DOI 10.1007/BF00419061; Lima LH, 2010, RETINA-J RET VIT DIS, V30, P1515, DOI 10.1097/IAE.0b013e3181ea48f9; Malinowski SM, 2010, RETINA-J RET VIT DIS, V30, P828, DOI 10.1097/IAE.0b013e3181d37554; MARMOR MF, 1977, INVEST OPHTH VIS SCI, V16, P660; O'Daly BJ, 2008, J MATER PROCESS TECH, V200, P38, DOI 10.1016/j.jmatprotec.2007.11.041; RADEK U, 1972, ACUSTICA, V26, P270; Rizzo S, 2011, RETINA-J RET VIT DIS, V31, P2007, DOI 10.1097/IAE.0b013e318213623a; Rofagha S, 2011, CURR OPIN OPHTHALMOL, V22, P137, DOI 10.1097/ICU.0b013e3283436fc5; Ruiz-Moreno JM, 2006, EUR J OPHTHALMOL, V16, P40, DOI 10.1177/112067210601600108; SCHMUT O, 1978, A GRAEF ARCH KLIN EX, V207, P189, DOI 10.1007/BF00411053; Sharif-Kashani P, 2013, RETINA-J RET VIT DIS, V33, P166, DOI 10.1097/IAE.0b013e31825db758; Steel DHW, 2011, OPHTHALMOLOGICA, V226, P27, DOI 10.1159/000328207; Thompson JT, 2011, SURV OPHTHALMOL, V56, P162, DOI 10.1016/j.survophthal.2010.08.003; Wuchinich D, 2015, PHYSCS PROC, V63, P217, DOI 10.1016/j.phpro.2015.03.035; Yao K, 2002, EUR J OPHTHALMOL, V12, P200, DOI 10.1177/112067210201200305	36	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0173883	10.1371/journal.pone.0173883	http://dx.doi.org/10.1371/journal.pone.0173883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399127	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000006
J	Shah, J; Weltman, H; Narciso, P; Murphy, C; Poruri, A; Baliga, S; Sharon, L; York, M; Cunningham, G; Miller, S; Caviedes, L; Gilman, R; Desmond, E; Ramasamy, R				Shah, Jyotsna; Weltman, Helena; Narciso, Patricia; Murphy, Christina; Poruri, Akhila; Baliga, Shrikala; Sharon, Leesha; York, Mary; Cunningham, Gail; Miller, Steve; Caviedes, Luz; Gilman, Robert; Desmond, Edward; Ramasamy, Ranjan			Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures	PLOS ONE			English	Article							NUCLEIC-ACID PROBES; NONTUBERCULOUS MYCOBACTERIA; SMEAR PREPARATIONS	Two rapid dual color fluorescence in situ hybridization (FISH) assays were evaluated for detecting M. tuberculosis and related pathogens in cultures. The MN Genus-MTBC FISH assay uses an orange fluorescent probe specific for the Mycobacterium tuberculosis complex (MTBC) and a green fluorescent probe specific for the Mycobacterium and Nocardia genera (MN Genus) to detect and distinguish MTBC from other Mycobacteria and Nocardia. A complementary MTBC-MAC FISH assay uses green and orange fluorescent probes specific for the MTBC and M. avium complex (MAC) respectively to identify and differentiate the two species complexes. The assays are performed on acid-fast staining bacteria from liquid or solid cultures in less than two hours. Forty-three of 44 reference mycobacterial isolates were correctly identified by the MN Genus-specific probe as Mycobacterium species, with six of these correctly identified as MTBC with the MTBC-specific probe and 14 correctly as MAC by the MAC-specific probe. Of the 25 reference isolates of clinically relevant pathogens of other genera tested, only four isolates representing two species of Corynebacterium gave a positive signal with the MN Genus probe. None of these 25 isolates were detected by the MTBC and MAC specific probes. A total of 248 cultures of clinical mycobacterial isolates originating in India, Peru and the USA were also tested by FISH assays. DNA sequence of a part of the 23S ribosomal RNA gene amplified by PCR was obtained from 243 of the 248 clinical isolates. All 243 were confirmed by DNA sequencing as Mycobacterium species, with 157 and 50 of these identified as belonging to the MTBC and the MAC, respectively. The accuracy of the MN Genus-, MTBC-and MAC -specific probes in identifying these 243 cultures in relation to their DNA sequence-based identification was 100%. All ten isolates of Nocardia, (three reference strains and seven clinical isolates) tested were detected by the MN Genus-specific probe but not the MTBC- or MAC-specific probes. The limit of detection for M. tuberculosis was determined to be 5.1x10(4) cfu per ml and for M. avium 1.5x10(4) cfu per ml in liquid cultures with the respective MTBC- and MAC-specific probes in both the MN Genus-MTBC and MTBC-MAC FISH assays. The only specialized equipment needed for the FISH assays is a standard light microscope fitted with a LED light source and appropriate filters. The two FISH assays meet an important diagnostic need in peripheral laboratories of resource-limited tuberculosis- endemic countries.	[Shah, Jyotsna; Weltman, Helena; Narciso, Patricia; Murphy, Christina; Poruri, Akhila; York, Mary; Ramasamy, Ranjan] ID FISH Technol Inc, Palo Alto, CA 94303 USA; [Baliga, Shrikala; Sharon, Leesha] Manipal Univ, Kasturba Med Coll, Mangalore, India; [Cunningham, Gail; Miller, Steve] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caviedes, Luz; Gilman, Robert] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Iquitos, Peru; [Gilman, Robert] Johns Hopkins Univ, Baltimore, MD USA; [Desmond, Edward] Calif Dept Publ Hlth, Microbial Dis Lab, Richmond, CA USA	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; University of California System; University of California San Francisco; Universidad Peruana Cayetano Heredia; Johns Hopkins University; California Department of Public Health	Shah, J (corresponding author), ID FISH Technol Inc, Palo Alto, CA 94303 USA.	jyotsna@aol.com	Ramasamy, Ranjan/AAF-3921-2020	Ramasamy, Ranjan/0000-0003-0246-7053; Shah, Jyotsna/0000-0001-9890-366X; Poruri, Akhila/0000-0003-3033-061X	NIH SBIR Phase I Grant [AI075745]; ID-FISH Technology Inc.; NIH SBIR Phase II Grant [AI075745]	NIH SBIR Phase I Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ID-FISH Technology Inc.; NIH SBIR Phase II Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH SBIR Phase I and Phase II Grants # #AI075745. ID-FISH Technology Inc.' provided support in the form of salaries for authors HW, PN, CM, LS and RR; ID-FISH Technology Inc. and IGeneX Inc. provided support inform of salaries to authors JS and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand ALS, 2005, J CLIN MICROBIOL, V43, P5369, DOI 10.1128/JCM.43.10.5369-5371.2005; [Anonymous], 2016, GLOBAL REPORT DIABET; Asmar S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01184; Brown BA, 1999, INT J SYST BACTERIOL, V49, P1493, DOI 10.1099/00207713-49-4-1493; Centre for Disease Control, 2016, NOC; Chedore P, 2002, J CLIN MICROBIOL, V40, P4077, DOI 10.1128/JCM.40.11.4077-4080.2002; Daou NadineAbiZeid., 2015, ROLE WOMEN NGOS EMPO, V22, P1; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Epson E., 2012, OPEN LONGEV SCI, V6, P92; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Huang JH, 1991, CHEST J, V115, P1033; Kim N, 2015, ANN LAB MED, V35, P500, DOI 10.3343/alm.2015.35.5.500; KOCH ML, 1965, AM REV RESPIR DIS, V91, P283; Lan R, 2011, INT J TUBERC LUNG D, V15, P1669, DOI 10.5588/ijtld.11.0036; Lehtola MJ, 2006, APPL ENVIRON MICROB, V72, P848, DOI 10.1128/AEM.72.1.848-853.2006; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Shah J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136726; St Amand AL, 2005, J CLIN MICROBIOL, V43, P1505, DOI 10.1128/JCM.43.4.1505-1514.2005; Stender H, 1999, J CLIN MICROBIOL, V37, P2760, DOI 10.1128/JCM.37.9.2760-2765.1999; WHO, 2014, TECHN OP CONS IMPL H, P1; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	23	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2017	12	4							e0174989	10.1371/journal.pone.0174989	http://dx.doi.org/10.1371/journal.pone.0174989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0JS	28399124	Green Submitted, Green Published, gold			2022-12-26	WOS:000399949000015
J	Xie, JY; Chen, PC; Zhang, JL; Gao, ZS; Neves, H; Zhang, SD; Wen, Q; Chen, WD; Kwok, HF; Lin, Y				Xie, Jian-Yun; Chen, Peng-Chen; Zhang, Jia-Li; Gao, Ze-Shou; Neves, Henrique; Zhang, Shu-Dong; Wen, Qing; Chen, Wei-Dong; Kwok, Hang Fai; Lin, Yao			The prognostic significance of DAPK1 in bladder cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; CONNECTIVITY MAP; GENE; EXPRESSION; MUTATION; PROTEIN; TRAK1; IDENTIFICATION; VEMURAFENIB; METHYLATION	Bladder cancer is one of the leading causes of cancer-related death in men, however, there was only limited effective treatment for invasive bladder cancer. DAPK1 has been shown to play important role in apoptosis and autophagy to suppress cancer progression. Previous results have shown that DAPK1 promoter was hypermethylated in the majority of bladder cancer specimens, however, the prognostic significance of DAPK1 in bladder cancer has yet to be demonstrated. In the present study, we found that DAPK1 expression was negatively associated with tumor stage and a low level expression of DAPK1 in bladder cancer specimens were associated with shorter survival in bladder cancer patients in 3 independent bladder cancer datasets (n = 462). Further investigation showed that FGFR3 knockdown resulted in downregulation of DAPK1 in bladder cancer cell line, suggesting that FGFR3 may be an upstream factor of DAPK1. Further analysis of the 3 independent bladder cancer datasets have identified ACOX1, UPK2, TRAK1, PLEKHG6 and MT1X genes had their expression significantly correlated with that of DAPK1. Knockdown of DAPK1 in bladder cancer T24 cells resulted in downregulation of ACOX1, UPK2 and TRAK1. Interestingly, TRAK1, by itself, was a favorable prognostic marker in the 3 independent bladder cancer datasets. Importantly, by using connectivity mapping with DAPK1-associated gene signature, we found that vemurafenib and trametinib could possibly reverse DAPK1-associated gene signature, suggesting that inhibition of Raf/MEK pathway may be a potential therapeutic approach for bladder cancer. Indeed, treatment of vemurafenib in T24 bladder cancer cells resulted in upregulation of DAPK1 confirming our connectivity mapping, while knockdown of DAPK1 resulted in reduced sensitivity towards inhibition of Braf signaling by vemurafenib. Together, our results suggest that DAPK1 is an important prognostic marker and therapeutic target for bladder cancer and have identified possible therapeutic agents for future testing in bladder cancer models with low DAPK1 expression.	[Xie, Jian-Yun; Zhang, Jia-Li; Gao, Ze-Shou; Chen, Wei-Dong] Fujian Univ Tradit Chinese Med, Dept Urol, Affiliated Peoples Hosp, Fuzhou, Fujian Province, Peoples R China; [Chen, Peng-Chen; Lin, Yao] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian Province, Peoples R China; [Neves, Henrique; Kwok, Hang Fai] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China; [Chen, Wei-Dong] Univ Ulster, Northern Ireland Ctr Stratified Med, C TRIC Bldg,Altnagelvin Hosp Campus,Glenshane Rd, Londonderry, England; [Wen, Qing] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Fujian University of Traditional Chinese Medicine; Fujian Normal University; University of Macau; Ulster University; Queens University Belfast	Chen, WD (corresponding author), Fujian Univ Tradit Chinese Med, Dept Urol, Affiliated Peoples Hosp, Fuzhou, Fujian Province, Peoples R China.; Lin, Y (corresponding author), Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian Province, Peoples R China.; Kwok, HF (corresponding author), Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China.	13305018298@189.cn; hfkwok@umac.mo; yaolin@fjnu.edu.cn	Chen, Wei/GZK-7348-2022; Kwok, Hang Fai/AAY-2044-2021; Zhang, Shu-Dong/G-1269-2010; Zhang, Shudong/GMW-9520-2022	Kwok, Hang Fai/0000-0002-6349-4517; Zhang, Shu-Dong/0000-0002-7721-0167; Wen, Qing/0000-0003-4325-7829	International S&T Cooperation Program of China [2016YFE0121900]; Science and Technology Development Fund of Macau SAR [FDCT 023/2015/AMJ]; National Natural Science Foundation of China [31640053]; University of Macau [MYRG2015-00065-FHS]; Natural Science Foundation of Fujian Province [2016Y0029, 2016J01573]; Engineering and Physical Sciences Research Council [1232316] Funding Source: researchfish	International S&T Cooperation Program of China; Science and Technology Development Fund of Macau SAR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Macau; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the International S&T Cooperation Program of China (2016YFE0121900) to YL, the Science and Technology Development Fund of Macau SAR (FDCT 023/2015/AMJ) to HFK, the National Natural Science Foundation of China (31640053) to YL, the University of Macau (MYRG2015-00065-FHS) to HFK, and the Natural Science Foundation of Fujian Province (2016Y0029 & 2016J01573) to YL & JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; An YX, 2011, INT J COLORECTAL DIS, V26, P1397, DOI 10.1007/s00384-011-1237-1; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; Christoph F, 2007, J CANCER RES CLIN, V133, P343, DOI 10.1007/s00432-006-0174-9; Christoph F, 2006, INT J CANCER, V119, P1396, DOI 10.1002/ijc.21971; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Couffignal C, 2015, UROLOGY, V86, P1185, DOI 10.1016/j.urology.2015.07.036; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Fahmy O, 2016, CLIN EXP METASTASIS; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Lin Y, 2011, FEBS J, V278, P354, DOI 10.1111/j.1742-4658.2010.07959.x; Lin Y, 2009, MOL CELL BIOCHEM, V328, P101, DOI 10.1007/s11010-009-0079-4; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mitra AP, 2016, THER ADV UROL, V8, P215, DOI 10.1177/1756287216638981; Neuhausen A, 2006, CANCER BIOL THER, V5, P993, DOI 10.4161/cbt.5.8.2885; Pouessel D, 2016, ANN ONCOL, V27, P1311, DOI 10.1093/annonc/mdw170; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Singh PK, 2016, IET POWER ELECTRON, V9, P900, DOI 10.1049/iet-pel.2015.0139; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Webber E, 2008, J MOL BIOL, V382, P638, DOI 10.1016/j.jmb.2008.07.045; Zhang FM, 2009, CANCER LETT, V274, P250, DOI 10.1016/j.canlet.2008.09.031; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zheng XK, 2014, MOL MED REP, V9, P1773, DOI 10.3892/mmr.2014.2054	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2017	12	4							e0175290	10.1371/journal.pone.0175290	http://dx.doi.org/10.1371/journal.pone.0175290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2RO	28388658	Green Published, Green Submitted, gold			2022-12-26	WOS:000399375800036
J	Camara, J; Marimon, JM; Cercenado, E; Larrosa, N; Quesada, MD; Fontanals, D; Cubero, M; Perez-Trallero, E; Fenoll, A; Linares, J; Ardanuy, C				Camara, Jordi; Maria Marimon, Jose; Cercenado, Emilia; Larrosa, Nieves; Quesada, Maria Dolores; Fontanals, Dionisia; Cubero, Meritxell; Perez-Trallero, Emilio; Fenoll, Asuncion; Linares, Josefina; Ardanuy, Carmen			Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain	PLOS ONE			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; GENETIC-STRUCTURE; CHILDREN; EPIDEMIOLOGY; IMPACT; ERA; MASSACHUSETTS; SURVEILLANCE	A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008-2009) and after (2012-2013). The 13-valent pneumococcal conjugate vaccine (PCV13) licensure was conducted in order to analyze the impact of PCV13 introduction for children on adult IPD. A total of 1558 IPD episodes were detected. The incidence of IPD decreased significantly in the second period by-33.9% (95% CI,-40.3% to-26.8%). IPD due to PCV7 serotypes (-52.7%; 95% CI,-64.2% to-37.5%) and to PCV13 additional serotypes (-55.0% 95% CI, -62.0% to-46.7%) significantly decreased whereas IPD due to non-PCV13 serotypes remained stable (1.0% 95% CI,-12.9% to 17.2%). IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95% CI-35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95% CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST386(6C), and serotype 8 that decreased (-34.9%, 95% CI,-57.1 to-1.2, p = 0.049), related to a decline of the ST63(8). The recombinant clone ST6521(11A) (variant of ST156(9V)) increased in frequency. The decrease of serotype 19A IPD was linked to a fall in those antibiotic susceptible clones. In the last period, rates of penicillin-and cefotaxime-resistance remained under 10% and 4%, respectively. Adult IPD decreased after the PCV13 introduction in Spain due to herd protection. The spread of multidrug resistant clones (ST386(6C), ST6521(11A)) related to non-PCV13 serotypes needs further surveillance.	[Camara, Jordi; Cubero, Meritxell; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain; [Maria Marimon, Jose; Perez-Trallero, Emilio] Hosp Univ Donostia, Donostia San Sebastian, Spain; [Maria Marimon, Jose; Cercenado, Emilia; Quesada, Maria Dolores; Cubero, Meritxell; Perez-Trallero, Emilio; Linares, Josefina; Ardanuy, Carmen] GIBER Enfermedades Resp, Madrid, Spain; [Cercenado, Emilia] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Larrosa, Nieves] Hosp Univ Vall dHebron, Barcelona, Spain; [Quesada, Maria Dolores] HU Germans Trias & Pujol, Badalona, Spain; [Fontanals, Dionisia] IU UAB, Corp Sanitaria Parc Tauli, Sabadell, Spain; [Fenoll, Asuncion] ISCIII, Lab Referencia Neumococo, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; General University Gregorio Maranon Hospital; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Instituto de Salud Carlos III	Ardanuy, C (corresponding author), Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Lhospitalet De Llobregat, Spain.; Ardanuy, C (corresponding author), GIBER Enfermedades Resp, Madrid, Spain.	c.ardanuy@bellvitgehospital.cat	MARIMON, JOSE MARIA/AAM-5581-2021; Ardanuy, Carmen/C-4463-2015; Cubero, Meritxell/AAV-4585-2020; Larrosa, María Nieves/C-5004-2014	MARIMON, JOSE MARIA/0000-0002-2787-7094; Larrosa, María Nieves/0000-0001-8808-0233; Camara, Jordi/0000-0002-0817-0931; Ardanuy, Carmen/0000-0003-0225-607X	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI11/00763, PI14/00627, INT 15/00186]; Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias [CIBERES CB06/06/0037]; initiative of the Instituto de Salud Carlos III, Madrid, Spain; European Regional Development Fund (ERDF)	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias; initiative of the Instituto de Salud Carlos III, Madrid, Spain; European Regional Development Fund (ERDF)(European Commission)	This study was supported by grants from Fondo de Investigaciones Sanitarias de la Seguridad Social (PI11/00763, PI14/00627 and INT 15/00186) and from Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias (CIBERES CB06/06/0037), an initiative of the Instituto de Salud Carlos III, Madrid, Spain. Financial support was also provided by the European Regional Development Fund (ERDF).	Aguinagalde L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137565; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2014, EMERG INFECT DIS, V20, P1848, DOI 10.3201/eid2011.131215; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Burgos J, 2014, EUR RESPIR J, V43, P545, DOI 10.1183/09031936.00050413; Chang QZ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0797-z; CLSI, 2015, M100S25 CLSI; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Garcia-Vidal C, 2010, THORAX, V65, P77, DOI 10.1136/thx.2009.123612; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054; Hanage WP, 2011, VACCINE, V29, P8877, DOI 10.1016/j.vaccine.2011.09.075; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Hulten KG, 2013, J CLIN MICROBIOL, V51, P1294, DOI 10.1128/JCM.00058-13; Janoir C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090935; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mendes RE, 2014, DIAGN MICR INFEC DIS, V80, P19, DOI 10.1016/j.diagmicrobio.2014.05.020; Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Moraga-Llop F, 2016, PEDIATR INFECT DIS J, V35, P460, DOI 10.1097/INF.0000000000001041; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Picazo J, 2013, PEDIATR INFECT DIS J, V32, P656, DOI 10.1097/INF.0b013e31827e8594; Regev-Yochay G, 2015, VACCINE, V33, P1135, DOI 10.1016/j.vaccine.2015.01.030; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sanz JC, 2011, CLIN MICROBIOL INFEC, V17, P1094, DOI 10.1111/j.1469-0691.2011.03495.x; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; Vila-Corcoles A, 2016, HUM VACC IMMUNOTHER, V12, P2953, DOI 10.1080/21645515.2016.1210744; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watkins ER, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005034; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	44	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175224	10.1371/journal.pone.0175224	http://dx.doi.org/10.1371/journal.pone.0175224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2QB	28384325	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900125
J	Kullberg, A; Sharp, L; Johansson, H; Brandberg, Y; Bergenmar, M				Kullberg, Anna; Sharp, Lena; Johansson, Hemming; Brandberg, Yvonne; Bergenmar, Mia			Patient satisfaction after implementation of person-centred handover in oncological inpatient care - A cross-sectional study	PLOS ONE			English	Article							INFORMATION EXCHANGE; NURSING HANDOVER; BEDSIDE; PARTICIPATION	Effective nurse shift-to-shift handover is a prerequisite for high-quality inpatient care. Combining person-centeredness with the need for improved handover rituals, we introduced and evaluated person-centered handover (PCH) in an oncological inpatient setting. PCH is the shift-to-shift nursing report performed together with the patient according to a set structure focused on patient participation, relevant clinical information, and patient safety. Non-verbal handover, standard at the department, is conducted via the electronic health record, in absence of the patient, and without a set structure. The aim of the study was to compare person-centered handover with non-verbal handover in an oncological inpatient setting with regard to patient satisfaction. A cross-sectional design featuring two points of measurement at one intervention ward and two control wards was applied. The EORTC IN-PATSAT32 questionnaire was used for measuring patient satisfaction. Baseline measurements were taken during the spring of 2014, when all three wards used a non-verbal handover model, and included responses from 116 patients. Follow-up measurements (comparing PCH and non-verbal handover) involved 209 patients and were on-going from September 2014 to May 2015. After the introduction of PCH, one change in patient satisfaction was detected regarding the subscale measuring exchange of information between caregivers. Patients from the intervention ward scored statistically higher after the implementation of PCH when compared to the control wards (p = .0058). The difference remained after a multivariate regression analysis controlling for clinical variables. In conclusion, PCH is feasible in oncological inpatient care but does not seem to affect patient satisfaction.	[Kullberg, Anna; Johansson, Hemming; Brandberg, Yvonne; Bergenmar, Mia] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Sharp, Lena] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Sharp, Lena] Reg Canc Ctr, Stockholm, Sweden; [Johansson, Hemming] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Bergenmar, Mia] Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Kullberg, A (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	anna.kullberg@ki.se	Kullberg, Anna/M-1447-2019	Bergenmar, Mia/0000-0002-7256-6105				Alharbi TSJ, 2012, HEALTH POLICY, V108, P294, DOI 10.1016/j.healthpol.2012.09.003; Blegen Mary A, 2009, J Patient Saf, V5, P139, DOI 10.1097/PTS.0b013e3181b53f6e; Bredart A, 2007, EUR J CANCER, V43, P323, DOI 10.1016/j.ejca.2006.10.016; Bredart A, 2005, EUR J CANCER, V41, P2120, DOI 10.1016/j.ejca.2005.04.041; Chaboyer W, 2010, INT J NURS PRACT, V16, P27, DOI 10.1111/j.1440-172X.2009.01809.x; Chaboyer W, 2009, J NURS CARE QUAL, V24, P136, DOI 10.1097/01.NCQ.0000347450.90676.d9; Cohen MD, 2010, QUAL SAF HEALTH CARE, V19, P493, DOI 10.1136/qshc.2009.033480; Davis K, 2014, MIRROR MIRROR WALL 2; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Farley H, 2014, ANN EMERG MED, V64, P351, DOI 10.1016/j.annemergmed.2014.02.021; Kerr D, 2014, J CLIN NURS, V23, P1685, DOI 10.1111/jocn.12308; Kullberg A, 2015, EUR J ONCOL NURS, V19, P142, DOI 10.1016/j.ejon.2014.10.005; Lee RG, 2003, SOC SCI MED, V56, P449, DOI 10.1016/S0277-9536(02)00045-X; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Malfait S, 2016, J ADV NURS; McMurray A, 2011, COLLEGIAN, V18, P19, DOI 10.1016/j.colegn.2010.04.004; Meum T, 2011, INT J TELEMED APPL, V2011, DOI 10.1155/2011/505426; Novak K, 2012, J PEDIATR NURS, V27, P760, DOI 10.1016/j.pedn.2012.09.001; Papastavrou E, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-26; Sand-Jecklin K, 2014, J CLIN NURS, V23, P2854, DOI 10.1111/jocn.12575; Sharp S, 2015, CONTEMP NURSE, V52, P1, DOI DOI 10.1080/10376178.2015.102098; Smeulers M, 2014, COCHRANE DB SYST REV, V6; Sondergaard Eva Gad, 2013, BMC Res Notes, V6, P378, DOI 10.1186/1756-0500-6-378; Spooner AJ, 2013, INT J NURS PRACT, V19, P214, DOI 10.1111/ijn.12058; Tidwell T, 2011, J NEUROSCI NURS, V43, pE1, DOI 10.1097/JNN.0b013e3182212a1d; Vaismoradi M, 2015, J CLIN NURS, V24, P627, DOI 10.1111/jocn.12664; Vardanalys, 2014, VARDANALYS VARDEN PA; Vines MM, 2014, J NURSES PROF DEV, V30, P166, DOI 10.1097/NND.0000000000000057; Wentworth L, 2012, J NURS CARE QUAL, V27, P125, DOI 10.1097/NCQ.0b013e31823cc9a0; Wolf DM, 2008, J NURS CARE QUAL, V23, P316, DOI 10.1097/01.NCQ.0000336672.02725.a5	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0175397	10.1371/journal.pone.0175397	http://dx.doi.org/10.1371/journal.pone.0175397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384314	Green Published, Green Submitted, gold			2022-12-26	WOS:000399371900168
J	Peyroux, E; Santaella, N; Broussolle, E; Rigard, C; Favre, E; Brunet, AS; Bost, M; Lachaux, A; Demily, C				Peyroux, Elodie; Santaella, Nelly; Broussolle, Emmanuel; Rigard, Caroline; Favre, Emilie; Brunet, Anne-Sophie; Bost, Muriel; Lachaux, Alain; Demily, Caroline			Social cognition in Wilson's disease: A new phenotype?	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; IMPAIRMENT; BRAIN; ABNORMALITIES; MANIFESTATIONS; RECOGNITION; CIRCUITS; DEFICITS	Studies focusing on neuropsychological impairments in Wilson's disease (WD) have highlighted that patients showing neurological signs present significant deficits in a wide range of cognitive domains. Attentional and executive impairments have also been described in people with hepatic WD. However, social cognition abilities, i.e. cognitive processes required to perceive the emotions, intentions and dispositions of other people, have not been clearly investigated in WD. In this study we examined the social cognitive functioning in 19 patients with WD depending on their clinical status-Neurological versus Non-Neurological ("hepatic") forms-compared to 20 healthy controls. For the very first time, results highlighted that patients with WD had significant impairments in the three major components of social cognition: emotion recognition, Theory of Mind and attributional style. However, these deficits differ depending on the form of the disease: patients with neurological signs showed a wide range of deficits in the three components that were assessed-results notably revealed impairments in recognizing "fear", "anger", and "disgust", a significant Theory of Mind deficit and an "aggression bias"-whereas Non-Neurological patients only showed deficits on test assessing attributional bias, with a trend to react more "aggressively" to ambiguous social situations than healthy controls, as observed in Neurological WD patients, and a specific impairment in "anger" recognition. Our findings are discussed in the light of both neurocognitive impairments and brain damages, and especially those affecting the basal ganglia, as observed in people with WD.	[Peyroux, Elodie; Rigard, Caroline; Demily, Caroline] Le Vinatier Hosp, Genopsy Ctr Diag & Management Genet Psychiat Diso, Lyon, France; [Peyroux, Elodie] Le Vinatier Hosp, Univ Dept Rehabil SUR CL3R, Lyon, France; [Santaella, Nelly] Lumiere Lyon 2 Univ, Lyon, France; [Broussolle, Emmanuel; Favre, Emilie] Hosp Civils Lyon, Pierre Wertheimer Neurol Hosp, Dept Neurol C, Lyon, France; [Broussolle, Emmanuel; Demily, Caroline] CNRS, Ctr Cognit Neurosci, UMR 5229, Lyon, France; [Broussolle, Emmanuel; Lachaux, Alain] Claude Bernard Lyon 1 Univ, Lyon, France; [Favre, Emilie; Brunet, Anne-Sophie; Bost, Muriel; Lachaux, Alain] Hosp Civils Lyon, French Natl Ctr Wilsons Dis, Lyon, France; [Favre, Emilie; Brunet, Anne-Sophie; Lachaux, Alain] Hosp Civils Lyon, Childrens Hosp Lyon, Dept Pediat Gastroenterol Hepatol & Nutr, Lyon, France; [Bost, Muriel] CBPE, Lab Inherited Metab Dis, Lyon, France; [Bost, Muriel] Hop Edouard Herriot, Lab Trace Element & Tox Met Anal, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon	Peyroux, E (corresponding author), Le Vinatier Hosp, Genopsy Ctr Diag & Management Genet Psychiat Diso, Lyon, France.; Peyroux, E (corresponding author), Le Vinatier Hosp, Univ Dept Rehabil SUR CL3R, Lyon, France.	elodie.peyroux@gmail.com	Broussolle, Emmanuel/H-1592-2017	Broussolle, Emmanuel/0000-0002-0410-9519; alain, lachaux/0000-0003-3852-788X	Le Vinatier Hospital	Le Vinatier Hospital	This project was supported by Le Vinatier Hospital (no specific funding).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Akil M, 1995, Adv Neurol, V65, P171; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Bandmann O, 2015, LANCET NEUROL, V14, P103, DOI 10.1016/S1474-4422(14)70190-5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brickenkamp R, 1988, D2 TEST ATTENTION; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frota NAF, 2013, ACTA NEUROL SCAND, V127, P391, DOI 10.1111/ane.12037; Gaudelus B, 2015, ENCEPHALE, V41, P251, DOI 10.1016/j.encep.2014.08.013; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Humphreys L, 2006, BRIT J CLIN PSYCHOL, V45, P231, DOI 10.1348/014466505X50509; Iwanski S, 2015, NEUROPSYCHOLOGY, V29, P25, DOI 10.1037/neu0000103; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lorincz MT, 2010, ANN NY ACAD SCI, V1184, P173, DOI 10.1111/j.1749-6632.2009.05109.x; Mackinnon A, 2005, ENCEPHALE, V31, P31; Martinez G, 2017, PHENOTYPIC CONTINUUM; MEDALIA A, 1988, ARCH NEUROL-CHICAGO, V45, P502, DOI 10.1001/archneur.1988.00520290030009; Mikol J, 2005, ACTA NEUROPATHOL, V110, P451, DOI 10.1007/s00401-005-1061-1; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Portala K, 2001, EUR ARCH PSY CLIN N, V251, P262, DOI 10.1007/PL00007543; Pulai S, 2014, NEUROL INDIA, V62, P153, DOI 10.4103/0028-3886.132349; Seniow J, 2003, CLIN NEUROPSYCHOL, V17, P367, DOI 10.1076/clin.17.3.367.18085; Seniow J, 2002, MOVEMENT DISORD, V17, P1077, DOI 10.1002/mds.10195; Stracciari A, 2000, ARCH NEUROL-CHICAGO, V57, P384, DOI 10.1001/archneur.57.3.384; Trocello JM, 2011, J NEUROL NEUROSUR PS, V82, P1119, DOI 10.1136/jnnp.2009.204651; Trocello JM, 2013, NEUROLOGY, V81, P1557, DOI 10.1212/WNL.0b013e3182a95883; Wang K, 2003, NEUROPSYCHOLOGIA, V41, P527, DOI 10.1016/S0028-3932(02)00171-9; Warrington EK., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiss KH, 2013, CLIN TRANSPLANT, V27, P914, DOI 10.1111/ctr.12259; Wenisch E, 2013, REV NEUROL-FRANCE, V169, P944, DOI 10.1016/j.neurol.2013.06.002; Yagci MA, 2015, TRANSPL P, V47, P1469, DOI 10.1016/j.transproceed.2015.04.017; Zimbrean PC, 2014, GEN HOSP PSYCHIAT, V36, P53, DOI 10.1016/j.genhosppsych.2013.08.007	43	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2017	12	4							e0173467	10.1371/journal.pone.0173467	http://dx.doi.org/10.1371/journal.pone.0173467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2QB	28384152	gold, Green Submitted, Green Published			2022-12-26	WOS:000399371900008
J	Ahrens, LAJ; Vonwil, D; Christensen, J; Shastri, VP				Ahrens, Lucas A. J.; Vonwil, Daniel; Christensen, Jon; Shastri, V. Prasad			Gelatin device for the delivery of growth factors involved in endochondral ossification	PLOS ONE			English	Article							BONE-FORMATION; CROSS-LINKING; ELECTROSPUN GELATIN; CONTROLLED-RELEASE; POLYMER IMPLANTS; STEM-CELLS; TGF-BETA; IN-VITRO; DIFFERENTIATION; VEGF	Controlled release drug delivery systems are well established as oral and implantable dosage forms. However, the controlled release paradigm can also be used to present complex soluble signals responsible for cellular organization during development. Endochondral ossification (EO), the developmental process of bone formation from a cartilage matrix is controlled by several soluble signals with distinct functions that vary in structure, molecular weight and stability. This makes delivering them from a single vehicle rather challenging. Herein, a gelatin-based delivery system suitable for the delivery of small molecules as well as recombinant human (rh) proteins (rhWNT3A, rhFGF2, rhVEGF, rhBMP4) is reported. The release behavior and biological activity of the released molecules was validated using analytical and biological assays, including cell reporter systems. The simplicity of fabrication of the gelatin device should foster its adaptation by the diverse scientific community interested in interrogating developmental processes, in vivo.	[Ahrens, Lucas A. J.; Vonwil, Daniel; Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus, Freiburg, Germany; [Ahrens, Lucas A. J.; Christensen, Jon; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus, Freiburg, Germany.; Shastri, VP (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	prasad.shastri@gmail.com			Swiss National Science Foundation (SNF) [CRSII3_136179]; Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments [EXC 294]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments(German Research Foundation (DFG))	This study was supported by the Swiss National Science Foundation (SNF) (grant no. CRSII3_136179) to VPS and Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments Grant EXC 294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441; Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Capan Y., 2003, AAPS PHARMSCITECH, V4, P147; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; COSTANTINO HR, 1995, BIO-TECHNOL, V13, P493, DOI 10.1038/nbt0595-493; Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040; Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650; DISILVIO L, 1994, BIOMATERIALS, V15, P931, DOI 10.1016/0142-9612(94)90120-1; DISILVIO L, 1994, J MATER SCI-MATER M, V5, P819, DOI 10.1007/BF00213141; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; FOLKMAN J, 1964, J Surg Res, V4, P139, DOI 10.1016/S0022-4804(64)80040-8; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gospodarowicz D., 1986, J CELL PHYSL, V128, P475, DOI DOI 10.1002/JCP.1041280317; Groppa E, 2015, EMBO MOL MED, V7, P1366, DOI 10.15252/emmm.201405003; Guglieri S, 2008, BIOCHEMISTRY-US, V47, P13862, DOI 10.1021/bi801007p; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Iwanaga K, 2003, J MICROENCAPSUL, V20, P767, DOI 10.1080/02652040310001600523; Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Kress H, 2009, NAT METHODS, V6, P905, DOI 10.1038/nmeth.1400; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9; Lee KY, 2000, NATURE, V408, P998, DOI 10.1038/35050141; Lee TJ, 2013, BIOCHEM BIOPH RES CO, V430, P793, DOI 10.1016/j.bbrc.2012.11.067; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; LIU WR, 1991, BIOTECHNOL BIOENG, V37, P177, DOI 10.1002/bit.260370210; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Merino R, 1999, DEVELOPMENT, V126, P5515; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Ofner CM, 1996, PHARM RES-DORDR, V13, P1821; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Paguirigan AL, 2007, NAT PROTOC, V2, P1782, DOI 10.1038/nprot.2007.256; Park K, 2014, J CONTROL RELEASE, V190, P3, DOI 10.1016/j.jconrel.2014.03.054; PARKER KL, 1989, J CLIN ENDOCR METAB, V69, P689, DOI 10.1210/jcem-69-3-689; Parsons-Wingerter P, 2000, ARTERIOSCLER THROMB, V20; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0; Purpura KA, 2012, BIOMATERIALS, V33, P1271, DOI 10.1016/j.biomaterials.2011.10.051; Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052; RHINE WD, 1980, J PHARM SCI, V69, P265, DOI 10.1002/jps.2600690305; Ribatti D, 1997, J VASC RES, V34, P455, DOI 10.1159/000159256; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sarem M, 2013, CARBOHYD POLYM, V93, P635, DOI 10.1016/j.carbpol.2012.11.099; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Srisuwan T, 2012, TISSUE CELL, V44, P111, DOI 10.1016/j.tice.2011.12.003; SUN H W, 1990, Pediatric Dentistry, V12, P303; Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916	82	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0175095	10.1371/journal.pone.0175095	http://dx.doi.org/10.1371/journal.pone.0175095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380024	Green Submitted, gold, Green Published			2022-12-26	WOS:000399353500097
J	Coudrat, T; Christopoulos, A; Sexton, PM; Wootten, D				Coudrat, Thomas; Christopoulos, Arthur; Sexton, Patrick Michael; Wootten, Denise			Structural features embedded in G protein coupled receptor co-crystal structures are key to their success in virtual screening	PLOS ONE			English	Article							LIGAND; DOCKING; AGONIST; BETA(2)-ADRENOCEPTOR; PREDICTION; BINDING; GPCRS; STATE	Structure based drug discovery on GPCRs harness atomic detail X-ray binding pockets and large libraries of potential drug lead candidates in virtual screening (VS) to identify novel lead candidates. Relatively small conformational differences between such binding pockets can be critical to the success of VS. Retrospective VS on GPCR/ligand co-crystal structures revealed stark differences in the ability of different structures to identify known ligands, despite being co-crystallized with the same ligand. When using the OpenEye toolkit and the ICM modeling package, we identify criteria associated with the predictive power of binding pockets in VS that consists of a combination of ligand/receptor interaction pattern and predicted ligand/receptor interaction strength. These findings can guide the selection and refinement of GPCR binding pockets for use in SBDD programs and may also provide a potential framework for evaluating the ability of computational GPCR binding pocket refinement tools in improving the predictive power of binding pockets.	[Sexton, Patrick Michael; Wootten, Denise] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; Monash Univ, Dept Pharmacol, Parkville, Vic, Australia	Monash University; Monash University	Sexton, PM; Wootten, D (corresponding author), Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	patrick.sexton@monash.edu; denise.wootten@monash.edu	Wootten, Denise/ABD-5703-2021; Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Wootten, Denise/0000-0003-4563-1642; Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Coudrat, Thomas/0000-0001-9197-1889	National Health and Medical Research Council of Australia (NHMRC) [APP1055134, APP106101044, APP1089966]; NHMRC Career Development Fellow; Melbourne Bioinformatics at the University of Melbourne [VR0024]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellow(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Bioinformatics at the University of Melbourne	This research was supported by the National Health and Medical Research Council of Australia (NHMRC), award numbers APP1055134 and APP106101044 to PMS and APP1089966 to DW, a NHMRC Career Development Fellow. This research was also supported by Melbourne Bioinformatics at the University of Melbourne, grant number VR0024 to PMS. PMS is a NHMRC Principal Research Fellow, and AC a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; BRANDEN CI, 1990, NATURE, V343, P687, DOI 10.1038/343687a0; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciancetta A, 2014, J CHEM INF MODEL, V54, P2243, DOI 10.1021/ci5002857; Costanzi S, 2012, J COMPUT CHEM, V33, P561, DOI 10.1002/jcc.22893; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Gatica EA, 2012, J CHEM INF MODEL, V52, P1, DOI 10.1021/ci200412p; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gentry PR, 2013, J MED CHEM, V56, P9351, DOI 10.1021/jm4013246; Goldfeld DA, 2015, J PHYS CHEM B, V119, P824, DOI 10.1021/jp5053612; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jones E., 2001, SCIPY OPEN SOURCE SC; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kooistra AJ, 2015, J CHEM INF MODEL, V55, P1045, DOI 10.1021/acs.jcim.5b00066; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawton G, 2014, PROGR MED CHEM; Lebon G, 2015, MOL PHARM; Lenselink EB, 2014, J CHEM INF MODEL, V54, P1737, DOI 10.1021/ci5000455; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; OpenEye Scientific Software Inc., 2010, OECHEM VERS 1 7 4; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Pearlman DA, 2001, J MED CHEM, V44, P502, DOI 10.1021/jm000375v; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174719	10.1371/journal.pone.0174719	http://dx.doi.org/10.1371/journal.pone.0174719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380046	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500060
J	Gess, RW; Trinajstic, KM				Gess, Robert W.; Trinajstic, Kate M.			New morphological information on, and species of placoderm fish Africanaspis (Arthrodira, Placodermi) from the Late Devonian of South Africa	PLOS ONE			English	Article							INTERNAL FERTILIZATION; GOGO FORMATION; VERTEBRATE; PRESERVATION; DECAY; MINERALIZATION; LAGERSTATTE; ESTUARINE; AUSTRALIA; NURSERIES	Here we present a new species of placoderm fish, Africanaspis edmountaini sp. nov., and redescribe Africanaspis doryssa on the basis of new material collected from the type locality of Africanaspis. The new material includes the first head shields of Africanaspis doryssa in addition to soft anatomy for both taxa. Hitherto Africanaspis was entirely described from trunk armour and no record of body and fin outlines had been recorded. In addition the first record of embryonic and juvenile specimens of Africanaspis doryssa is presented and provides a growth series from presumed hatchlings to presumed adults. The presence of a greater number of juveniles compared to adults indicates that the Waterloo Farm fossil site in South Africa represents the first nursery site of arthrodire placoderms known from a cold water environment. The preservation of an ontogenetic series demonstrates that variation within the earlier known sample, initially considered to have resulted from ontogenetic change, instead indicates the presence of a second, less common species Africanaspis edmountaini sp. nov. There is some faunal overlap between the Waterloo Farm fossil site and faunas described from Strud in Belgium and Red Hill, Pennsylvania, in north America, supporting the concept of a more cosmopolitan vertebrate fauna in the Famennian than earlier in the Devonian.	[Gess, Robert W.] Rhodes Univ, Geol Dept, Grahamstown, South Africa; [Gess, Robert W.] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci CoE Pal, 1 Jan Smuts Ave Braamfontein, Johannesburg, South Africa; [Gess, Robert W.] Albany Museum, Somerset St, Grahamstown, South Africa; [Trinajstic, Kate M.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia	Rhodes University; University of Witwatersrand; Rhodes University; Curtin University	Trinajstic, KM (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA, Australia.	K.Trinajstic@curtin.edu.au		Trinajstic, Kate/0000-0002-6519-6396	South African DST/NRF Centre of Excellence in Palaeosciences; South African Millennian Trust; Australian Research Council [ARC DP110101127]; Rhodes University	South African DST/NRF Centre of Excellence in Palaeosciences; South African Millennian Trust; Australian Research Council(Australian Research Council); Rhodes University	Research support by the South African DST/NRF Centre of Excellence in Palaeosciences (CoE in Palaeosciences) and support by the South African Millennian Trust is acknowledged by RG and support by an Australian Research Council (ARC DP110101127) grant is acknowledged by KT. Rhodes University is thanked for supporting a visiting fellowship for KT.	Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; Anderson M. Eric, 1999, Records of the Western Australian Museum Supplement, V57, P151; ANDERSON ME, 1994, S AFR J SCI, V90, P397; Bechard I., 2014, PALAEONTOL ELECTRON, V17, P1, DOI DOI 10.26879/417; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P627, DOI 10.1098/rspb.2004.3006; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Brunton M, 1992, 1ST CAPTURE COELACAN, P225; Cloutier R, 2010, FOSSIL RECORD FISH O; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; Daeschler E. B., 1997, J VERTEBRATE PALEO S, V17, p41A; Daeschler Edward B., 2003, Records of the Australian Museum, V55, P45; Davidson RG, 2005, SCOT J GEOL, V41, P129, DOI 10.1144/sjg41020129; DENISON ROBERT H., 1941, JOUR PALEONTOL, V15, P553; Downs JP, 2011, P ACAD NAT SCI PHILA, V161, P191, DOI 10.1635/053.161.0111; Gess R, 2008, J VERTEBR PALEONTOL; Gess R.W., 2011, HIGH LATITUDE GONDWA; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gess RW, 2015, ZOOL J LINN SOC-LOND, V175, P360, DOI 10.1111/zoj.12276; Gess RW, 2015, PALAEONTOL Z, V89, P147, DOI 10.1007/s12542-014-0221-9; Gess RW, 1995, PRELIMINARY CATALOGU; Gess RW, 2001, ANN PALEONTOLOGIE; Gross W., 1962, Palaeontologische Zeitschrift H Schmidt-Festband, P45; Gross W, 1965, B I ROYAL SCI NATURE, V41; Hammerschlag N, 2010, MAR ECOL PROG SER, V414, P223, DOI 10.3354/meps08731; Hiller N., 1992, S AFR J GEOL, V95, P203; Igulu MM, 2013, ECOSYSTEMS, V16, P1336, DOI 10.1007/s10021-013-9687-7; Janvier P, 2006, NEW GROENLANDASPIDID; Johanson Z, 2014, PALAEONTOLOGY, V57, P505, DOI 10.1111/pala.12093; Long J, 1995, RECORDS W AUSTR MU S, V17, P34; Long JA, 1997, J VERTEBR PALEONTOL, V17, P253, DOI 10.1080/02724634.1997.10010973; Long J, 2008, J VERTEBR PALEONTOL, V28, p107A; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Miles R.S., 1973, Palaeontographica Abt A, V143, P109; Miles R.S., 1968, EARTH ENV SCI T R SO, V67, P373, DOI [10.1017/S0080456800024078, DOI 10.1017/S0080456800024078]; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Newman MJ, 2001, PALAEONTOLOGY, V44, P43, DOI 10.1111/1475-4983.00168; Obruchev D, 1964, OSNOVY PALEONTOLOGII; Olds AD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1040, DOI 10.1111/geb.12072; Olive S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161540; Olive S, 2015, PALAEONTOLOGY, V58, P981, DOI 10.1111/pala.12190; RITCHIE A, 1975, NATURE, V254, P569, DOI 10.1038/254569a0; Ritchie A, 2005, P LINN SOC N S W; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Sansom RS, 2011, P ROY SOC B-BIOL SCI, V278, P1150, DOI 10.1098/rspb.2010.1641; Schultze H, 1984, P LINN SOC N S W; Sheaves M, 2015, ESTUAR COAST, V38, P401, DOI 10.1007/s12237-014-9846-x; SMITH CL, 1975, SCIENCE, V190, P1105, DOI 10.1126/science.190.4219.1105; Streel M, 2000, EARTH-SCI REV, V52, P121, DOI 10.1016/S0012-8252(00)00026-X; Taylor F, 1993, NEW DEVONIAN FOSSIL, P565; THAMM A.G., 2006, GEOLOGY S AFRICA GEO, P443; Trinajstic K, 2009, ACTA ZOOL-STOCKHOLM, V90, P83, DOI 10.1111/j.1463-6395.2008.00363.x; Trinajstic K, 2007, J VERTEBR PALEONTOL, V27, P571, DOI 10.1671/0272-4634(2007)27[571:OPVAPI]2.0.CO;2; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2015, BIOL REV, V90, P467, DOI 10.1111/brv.12118; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic Katherine M., 1999, Records of the Western Australian Museum Supplement, V57, P93; Upeniece I, FOSSIL FISHES LIVING, P167; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Watson DMS, 1927, REPROD COELACANTH FI; WERDELIN L, 1986, LETHAIA, V19, P161, DOI 10.1111/j.1502-3931.1986.tb00727.x; Woodward A, 1891, BRIT MUS NAT HIST, P52; Woodward A. S., 1895, CATALOGUE FOSSIL FIS, DOI 10.5962/bhl.title.162378; Young G.C., 1993, P293; Young GC, 2003, DEVONIAN FISH REMAIN; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	70	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173169	10.1371/journal.pone.0173169	http://dx.doi.org/10.1371/journal.pone.0173169			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379973	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500014
J	Hasegawa, Y; Tachibana, Y; Ono, T; Kishimoto, H				Hasegawa, Yoko; Tachibana, Yoshihisa; Ono, Takahiro; Kishimoto, Hiromitsu			Flavour-enhanced cortisol release during gum chewing	PLOS ONE			English	Article							SALIVARY CORTISOL; STRESS; RESPONSES; FEEDBACK; DISEASE; REWARD; MOOD; MEN	There is some evidence to suggest that chewing gum reduces chronic stress. However, it remains controversial how the taste and odour properties of chewing gum influence stress. The present study was designed to investigate this issue in human subjects. Using an enzyme-linked immunosorbent assay, we tested salivary cortisol concentration, which is thought to be a stress marker, in 96 adults who chewed gum with different combinations of taste and odour. Subjects could discriminate between the types of gum without prior information. Salivary cortisol concentrations were highest and lowest for the subjects who chewed the most flavourful gum and the least flavourful gum, respectively. These findings suggest that the salivary cortisol level during gum chewing is not a marker of negative emotions (i.e., stressful conditions) as traditionally considered but, rather, an index of positive emotions that can facilitate biological responses to overcome stressful conditions.	[Hasegawa, Yoko; Kishimoto, Hiromitsu] Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo, Japan; [Tachibana, Yoshihisa] Kobe Univ, Grad Sch Med, Div Syst Neurosci, Kobe, Hyogo, Japan; [Ono, Takahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Comprehens Prosthodont, Niigata, Japan	Hyogo College of Medicine; Kobe University; Niigata University	Hasegawa, Y (corresponding author), Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo, Japan.	cem17150@hyo-med.ac.jp		Hasegawa, Yoko/0000-0001-9112-5981	KAKENHI from the Ministry of Education, Science and Culture of Japan [25463043, 16K11640]; Society for Research on Umami Taste and Foundation for Total Health Promotion; Lotte Research Promotion Grant;  [24120522]	KAKENHI from the Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Society for Research on Umami Taste and Foundation for Total Health Promotion; Lotte Research Promotion Grant; 	This study was supported by KAKENHI from the Ministry of Education, Science and Culture of Japan (Grant No. 25463043, No. 16K11640), Grant-in-Aid for Scientific Research on Innovative Areas (No. 24120522), the Society for Research on Umami Taste and Foundation for Total Health Promotion, and a Lotte Research Promotion Grant.	Allen A.P., 2011, J BEHAV NEUROSCIENCE, V9, P7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carnell S, 2012, INT REV PSYCHIATR, V24, P189, DOI 10.3109/09540261.2012.676988; Deiss V, 2009, FOOD QUAL PREFER, V20, P57, DOI 10.1016/j.foodqual.2008.07.004; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Gray G, 2012, APPETITE, V58, P554, DOI 10.1016/j.appet.2011.11.013; Groschl M, 2006, STEROIDS, V71, P1097, DOI 10.1016/j.steroids.2006.09.007; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hasegawa Y, 2009, CLIN ORAL INVEST; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Iso H, 2002, CIRCULATION, V106, P1229, DOI 10.1161/01.CIR.0000028145.58654.41; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Ladd CO, 2004, BIOL PSYCHIAT, V55, P367, DOI 10.1016/j.biopsych.2003.10.007; Lovallo W. R., 2004, STRESS HLTH BIOL PSY; MANUCK SB, 1986, ARTERIOSCLEROSIS, V6, P2, DOI 10.1161/01.ATV.6.1.2; Matsui F, 2009, ENDOCR J, V56, P1083, DOI 10.1507/endocrj.K09E-186; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Ministry of Environment and Rural and Marine, 2008, EUFOR CHAD MISS GREA, P1; Nishijo H, 2000, J NUTR, V130, p954S, DOI 10.1093/jn/130.4.954S; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Petrowski K, 2014, PSYCHONEUROENDOCRINO, V48, P64, DOI 10.1016/j.psyneuen.2014.06.008; Scholey A, 2009, PHYSIOL BEHAV, V97, P304, DOI 10.1016/j.physbeh.2009.02.028; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith A, 2010, NUTR NEUROSCI, V13, P7, DOI 10.1179/147683010X12611460763526; Spielman AI, 1998, CRIT REV ORAL BIOL M, V9, P267, DOI 10.1177/10454411980090030201; Tahara Yasuaki, 2007, J Prosthodont, V16, P129, DOI 10.1111/j.1532-849X.2007.00178.x; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Yu HC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066447, 10.1371/journal.pone.0055705, 10.1371/journal.pone.0057111]	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0173475	10.1371/journal.pone.0173475	http://dx.doi.org/10.1371/journal.pone.0173475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379983	Green Submitted, Green Published, gold			2022-12-26	WOS:000399353500019
J	Ioannidis, J; Donadeu, FX				Ioannidis, Jason; Donadeu, F. Xavier			Changes in circulating microRNA levels can be identified as early as day 8 of pregnancy in cattle	PLOS ONE			English	Article							EXPRESSION PROFILES; DAIRY-COWS; ANGIOGENESIS; MIR-26A; CLUSTER; MIRNAS; GENOME; CELLS; SERUM; TOOLS	Poor reproductive performance remains a major issue in the dairy industry, with low conception rates having a significant impact on milk production through extended calving intervals. A major limiting factor is the lack of reliable methods for early pregnancy diagnosis. Identification of animals within a herd that fail to conceive within 3 weeks after insemination would allow early re-insemination and shorten calving intervals. In a previous study, we found an increase in plasma miR-26a levels in Day 16-pregnant relative to non-pregnant heifers, however changes in miRNA levels that early during pregnancy were very small which likely prevented the identification of robust biomarkers. In this study, we extended our analyses to a wider interval during pregnancy (Days 8 to 60, n = 11 heifers) with the rationale that this may facilitate the identification of additional early pregnancy miRNA biomarkers. Using small RNA sequencing we identified a total of 77 miRNAs that were differentially expressed on Day 60 relative to Day 0 of pregnancy. We selected 14 miRNAs for validation by RT-qPCR and confirmed significant differences in the expression of let-7f, let-7c, miR-30c, miR-101, miR-26a, miR-205 and miR-143 between Days 0 and 60. RT-qPCR profiling throughout Days 0, 8, 16 and 60 of pregnancy showed a distinct increase in circulating levels of miR-26a (3.1-fold, P = 0.046) as early as Day 8 of pregnancy. In summary, in contrast to earlier stages of pregnancy (<= Day 24), marked differences in the levels of multiple miRNAs can be detected in circulation by Day 60 in cattle. Retrospective analyses showed miR-26a levels to be increased in circulation as early as Day 8, sooner than previously reported in any species, suggesting a biological role for this miRNA in the very early events of pregnancy.	[Ioannidis, Jason; Donadeu, F. Xavier] Univ Edinburgh, Roslin Inst & RDSVS, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Donadeu, FX (corresponding author), Univ Edinburgh, Roslin Inst & RDSVS, Roslin, Midlothian, Scotland.	xavier.donadeu@roslin.ed.ac.uk		Donadeu, Xavier/0000-0002-0331-2996; Ioannidis, Jason/0000-0003-1628-4928	BBSRC [BB/K501578/1]; Zoetis Inc; BBSRC [BBS/E/D/20221656, BBS/E/D/10002071] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/10002071, BBS/E/D/20221656, 1248216] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis Inc; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported BBSRC, grant BB/K501578/1 to FXD (http://www.bbsrc.ac.uk/) and Zoetis Inc (https://www.zoetis.com) to FXD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Naby WS, 2011, ZYGOTE, P1; Ahanda MLE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114598; Aungier SPM, 2014, J DAIRY SCI, V97, P3472, DOI 10.3168/jds.2013-7404; Balhara AK, 2013, SCI WORLD J, DOI 10.1155/2013/958540; Barbat A, 2010, J REPROD DEVELOP, V56, pS15, DOI 10.1262/jrd.1056S15; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barturen G, 2014, METHODS NEXT GENERAT, P1; Casey MC, 2015, PEERJ, V3, DOI 10.7717/peerj.829; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Department for Environment Food and Rural Affairs (DEFRA), 2016, AGR UK; Dillon P, 2006, LIVEST SCI, V99, P141, DOI 10.1016/j.livprodsci.2005.06.011; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Diskin MG, 2016, REPROD FERT DEVELOP, V28, P83, DOI 10.1071/RD15366; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD834, DOI 10.1093/nar/gkv1077; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Fkih M'hamed I, 2017, MIR 10B MIR 26A MIR; Floris I, 2015, ARTERIOSCL THROM VAS, V35, P664, DOI 10.1161/ATVBAHA.114.304730; Fu XH, 2015, J CLIN INVEST, V125, P2497, DOI 10.1172/JCI75438; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hansen EP, 2016, VET PARASITOL, V223, P30, DOI 10.1016/j.vetpar.2016.03.025; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Ioannidis J, 2016, CIRCULATING MICRORNA; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Kilic ID, 2015, GENE, V560, P140, DOI 10.1016/j.gene.2015.01.048; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li ZX, 2011, J IMMUNOL, V186, P6182, DOI 10.4049/jimmunol.1000917; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lucy MC, 2004, ANIM REPROD SCI, V82-3, P495, DOI 10.1016/j.anireprosci.2004.05.004; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura K, 2015, J OBSTET GYNAECOL RE; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; National Animal Disease Information Service, 2016, FERT DAIR HERDS PREG; Ni B, 2014, J IMMUNOL, V193, P4537, DOI 10.4049/jimmunol.1400124; R Core Team, 2013, LANG ENV STAT COMP; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Smits M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016282; Tabruyn SP, 2013, ANGIOGENESIS, V16, P877, DOI 10.1007/s10456-013-9362-9; Thapa DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020781; Ul Hussain M, 2012, CELL TISSUE RES, V349, P405, DOI 10.1007/s00441-012-1438-0; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wang T, 2016, BBA-MOL BASIS DIS, V1862, P1443, DOI 10.1016/j.bbadis.2016.05.004; Williams Z, 2013, P NATL ACAD SCI US; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Xu P, 2014, HYPERTENSION; Yeganeh B, 2015, AM J PHYSIOL-LUNG C, V308, pL270, DOI 10.1152/ajplung.00011.2014; Yin X, 2017, MOL MED REP, V15, P551, DOI 10.3892/mmr.2016.6035; Yu J, 2010, EUR J RADIOL, V2, P2, DOI DOI 10.1096/FJ.10-157404; Zgheib C, 2016, J MOL CELL CARDIOL, V92, P203, DOI 10.1016/j.yjmcc.2016.02.009; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553	64	22	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174892	10.1371/journal.pone.0174892	http://dx.doi.org/10.1371/journal.pone.0174892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28380001	Green Published, Green Submitted, gold			2022-12-26	WOS:000399353500074
J	Kolipaka, SS; Tamis, WLM; van't Zelfde, M; Persoon, GA; de Longh, HH				Kolipaka, S. S.; Tamis, W. L. M.; van't Zelfde, M.; Persoon, G. A.; de Longh, H. H.			Wild versus domestic prey in the diet of reintroduced tigers (Panthera tigris) in the livestock-dominated multiple-use forests of Panna Tiger Reserve, India	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; TROPICAL DRY FOREST; WESTERN INDIA; FOOD-HABITS; SPACE USE; ABUNDANCE; CONSERVATION; PREDATION; LANDSCAPE; PATTERNS	Grazing livestock in openly accessible areas is a common practice in the multiple-use forests of India; however, its compatibility with the reintroduction of tigers to these areas requires examination. Here, we investigated the diet of tigers in a livestock-dominated multiple-use buffer zone of the Panna Tiger Reserve, India. We hypothesised that the presence of feral cattle, along with open-access grazing practices in multiple-use forests, would increase the incidence of predation on livestock by tigers, even when wild prey are available. We used generalised linear models to test whether predation of livestock versus wild animals was influenced by (1) the sex and age class of tigers, (2) season, and (3) the distance of prey from the core-zone boundary of the reserve. Overall, sub-adult tigers and male tigers killed more livestock than wild prey, even when wild prey was available. In the winter and rainy seasons livestock were killed in higher numbers in the buffer zone than in summers, this may be because of the seasonally changing livestock herding patterns in the area. Further, with increasing distance from the core-zone boundary, all tigers killed more livestock, possibly because livestock were more easily accessible than wild prey. Our results show that open-access and unregulated livestock grazing is not currently compatible with large carnivore conservation in the same landscape. Such practices will lead to an increase in negative tiger-human-livestock interactions. In conclusion, we suggest the need to encourage locals to corral valuable cattle, leaving feral/unwanted livestock for tigers. This simple strategy would benefit both local inhabitants and tiger conservation in the multiple-use forests of India.	[Kolipaka, S. S.; Tamis, W. L. M.; van't Zelfde, M.; de Longh, H. H.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [Kolipaka, S. S.; Persoon, G. A.] Leiden Univ, Inst Cultural Anthropol & Dev Sociol FSW, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Kolipaka, SS (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.; Kolipaka, SS (corresponding author), Leiden Univ, Inst Cultural Anthropol & Dev Sociol FSW, Leiden, Netherlands.	kolipaka.s.s@gmail.com	van 't Zelfde, Maarten/K-6708-2013		Madhya Pradesh State Biodiversity Board, India; Louwes Fund for Water and Food; Leiden University; DeFries- Bajpai foundation; M.P. State Biodiversity Board; DeFries-Bajpai Foundation	Madhya Pradesh State Biodiversity Board, India; Louwes Fund for Water and Food; Leiden University; DeFries- Bajpai foundation; M.P. State Biodiversity Board; DeFries-Bajpai Foundation	We thank the Madhya Pradesh State Biodiversity Board, India, Louwes Fund for Water and Food, Leiden University and DeFries- Bajpai foundation for partially funding Kolipaka's studies in the Panna region of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Madhya Pradesh Forest Department and the management and field staff of Panna Tiger Reserve for enthusiastically supporting the study. We thank para-ecologist Mr Sushil Kumar and the volunteers who have contributed to the project. We thank the M.P. State Biodiversity Board, Louwes Fund for Water and Food, Leiden University and DeFries-Bajpai Foundation for partially funding Kolipaka's studies in Panna. We also thank an anonymous reviewer for critically commenting on the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2003, J ZOOL, V260, P285, DOI 10.1017/S0952836903003765; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Biswas S, 2002, J ZOOL, V256, P411, DOI 10.1017/S0952836902000456; Chundawat Raghunandan S., 1999, P123; Chundawat RS, 2016, BIOL CONSERV, V197, P146, DOI 10.1016/j.biocon.2016.03.004; Chundawat Raghunandan Singh, 2008, Journal of the Bombay Natural History Society, V105, P64; Erb KH, 2016, HUMAN ENVIRON INTERA, P295, DOI 10.1007/978-3-319-33326-7_13; GTI, 2012, GLOB TIG REC PROGR 2; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jedrzejewska B, J ZOOL; Jethva BD, 2004, BIOL CONSERV, V116, P351, DOI 10.1016/S0006-3207(03)00218-0; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Kenney J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3337; Kerley LL, 2015, INTEGR ZOOL, V10, P354, DOI 10.1111/1749-4877.12135; Kolipaka S. S., 2015, Journal of Human Ecology, V52, P192; Kuiper TR, 2015, BIOL CONSERV, V191, P546, DOI 10.1016/j.biocon.2015.08.012; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; NIC, 2017, DISTR WIS PER CAP IN; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; R Core Team, 2013, LANG ENV STAT COMP; Rajaratnam R, 2016, PROBLEMATIC WILDLIFE, P143, DOI DOI 10.1007/978-3-319-22246-2; Ramakrishnan U, BIOL CONS, V89, P113; Reddy HS, 2004, MAMMALIAN BIOL Z SAU, V69; Sankar K, 2002, MAMMALIA, V66, P285, DOI 10.1515/mamm.2002.66.2.285; Santoshi N., 2016, HINDUSTAN TIMES 0608; Sarkar MS, 2016, EUR J WILDLIFE RES, V62, P537, DOI 10.1007/s10344-016-1026-9; Sharma RK, 2015, BIOL CONSERV, V190, P8, DOI 10.1016/j.biocon.2015.04.026; Srivastava DP, 2014, THESIS; Talwar DM, 2003, C POL COMM ART DEV S; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Thorn M, 2012, BIOL CONSERV, V150, P23, DOI 10.1016/j.biocon.2012.02.017; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x	37	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2017	12	4							e0174844	10.1371/journal.pone.0174844	http://dx.doi.org/10.1371/journal.pone.0174844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2JD	28379997	Green Published, gold			2022-12-26	WOS:000399353500068
